{"id": 1, "src": "myiasis is the infestation of organs and tissues of human and animals with fly larvae . this article reports an 18 year - old man with urogenital myiasis , the passing of live megaselia scalaris larvae in the urine , from zanjan city , northwest of iran . we discourse the importance of diagnosis and management of urogenital myiasis in medicine .", "mt": "Questo articolo riporta di un uomo di 18 anni con myiasi urogenitale , il passaggio di larve vive di megaselia scalaris nelle urine , dalla città di zanjan , a nord-ovest dell' Iran . discorgiamo sull'importanza della diagnosi e della gestione della myiasi urogenitale nella medicina .", "pert_mt": "Questo articolo riporta di un uomo di 18 anni con myiasi urogenitale, il passaggio di larve vive di megaselia scalaris nelle urine, dalla città di Zanjan, a nord-ovest dell'Iran, e dalla sua storia clinica emerge l'importanza della diagnosi e della gestione della myiasi urogenitale nella medicina.", "bt": "This article reports on an 18-year-old man with urogenital myasthenia gravis, the passage of live larvae of megaselia scalaris in the urine, from the city of Zanjan, northwest Iran, and from its clinical history emerges the importance of diagnosis and management of urogenital myasthenia gravis in medicine.", "questions_src": ["What is the medical term for the infestation of organs and tissues with fly larvae?", "Who was the patient reported in the article?", "Where did the patient's condition occur?", "When did the article report on this case?", "Which specific fly larvae were found in the patient's urine?"], "answers_src": ["myiasis", "an 18 year-old man", "zanjan city", "18 years ago", "megaselia scalaris"], "answers_bt": ["Myiasis", "An 18-year-old man", "The city of Zanjan, northwest Iran", "The article", "Megaselia scalaris"], "multiturn": {"turn_1": [{"question_id": "1.1", "question": "What is the medical term for the infestation of organs and tissues with fly larvae?", "answer_src": "myiasis", "follow_up_question": "What specific type of myiasis did the article report?", "follow_up_response": "Urogenital myiasis", "follow_up_response_bt": "Urogenital myasthenia gravis"}, {"question_id": "1.2", "question": "Who was the patient reported in the article?", "answer_src": "an 18 year-old man", "follow_up_question": "What specific part of his body did the fly larvae pass through?", "follow_up_response": "the urine", "follow_up_response_bt": "the urine"}, {"question_id": "1.3", "question": "Where did the patient's condition occur?", "answer_src": "zanjan city", "follow_up_question": "What specific fly species were found in the patient's urine?", "follow_up_response": "Megaselia scalaris", "follow_up_response_bt": "megaselia scalaris"}, {"question_id": "1.4", "question": "When did the article report on this case?", "answer_src": "18 years ago", "follow_up_question": "What specific symptoms did the patient experience related to the urogenital myiasis?", "follow_up_response": "The passing of live megaselia scalaris larvae in the urine", "follow_up_response_bt": "The passage of live larvae of megaselia scalaris in the urine"}, {"question_id": "1.5", "question": "Which specific fly larvae were found in the patient's urine?", "answer_src": "megaselia scalaris", "follow_up_question": "What was the source location of the patient who had urogenital myiasis?", "follow_up_response": "zanjan city", "follow_up_response_bt": "the city of Zanjan"}], "turn_2": [{"question_id": "1.6", "question": "What specific type of myiasis did the article report?", "answer_src": "Urogenital myiasis", "follow_up_question": "What was the source of the myiasis in the patient described?", "follow_up_response": "fly larvae", "follow_up_response_bt": "The city of Zanjan"}, {"question_id": "1.7", "question": "What specific part of his body did the fly larvae pass through?", "answer_src": "the urine", "follow_up_question": "What was the name of the fly species found in the patient's urine?", "follow_up_response": "Megaselia scalaris", "follow_up_response_bt": "Megaselia scalaris"}, {"question_id": "1.8", "question": "What specific fly species were found in the patient's urine?", "answer_src": "Megaselia scalaris", "follow_up_question": "What was the source of the urogenital myiasis in the patient?", "follow_up_response": "zanjan city", "follow_up_response_bt": "The city of Zanjan"}, {"question_id": "1.9", "question": "What specific symptoms did the patient experience related to the urogenital myiasis?", "answer_src": "The passing of live megaselia scalaris larvae in the urine", "follow_up_question": "What was the location where the urogenital myiasis was first reported?", "follow_up_response": "zanjan city", "follow_up_response_bt": "Zanjan"}, {"question_id": "1.10", "question": "What was the source location of the patient who had urogenital myiasis?", "answer_src": "zanjan city", "follow_up_question": "What specific fly species were found in the patient's urine?", "follow_up_response": "Megaselia scalaris", "follow_up_response_bt": "megaselia scalaris"}], "turn_3": [{"question_id": "1.11", "question": "What was the source of the myiasis in the patient described?", "answer_src": "fly larvae", "follow_up_question": "Where were the fly larvae found in the patient's body?", "follow_up_response": "organs and tissues", "follow_up_response_bt": "The city of Zanjan"}, {"question_id": "1.12", "question": "What was the name of the fly species found in the patient's urine?", "answer_src": "Megaselia scalaris", "follow_up_question": "What is the location where the urogenital myiasis case occurred?", "follow_up_response": "zanjan city", "follow_up_response_bt": "the city of Zanjan"}, {"question_id": "1.13", "question": "What was the source of the urogenital myiasis in the patient?", "answer_src": "zanjan city", "follow_up_question": "What specific type of fly larvae were found in the patient's urine?", "follow_up_response": "Megaselia scalaris", "follow_up_response_bt": "megaselia scalaris"}, {"question_id": "1.14", "question": "What was the location where the urogenital myiasis was first reported?", "answer_src": "zanjan city", "follow_up_question": "What specific fly species were found in the urine of the patient?", "follow_up_response": "Megaselia scalaris", "follow_up_response_bt": "megaselia scalaris"}, {"question_id": "1.15", "question": "What specific fly species were found in the patient's urine?", "answer_src": "Megaselia scalaris", "follow_up_question": "What was the source of the urogenital myiasis in the patient?", "follow_up_response": "zanjan city", "follow_up_response_bt": "The city of Zanjan"}]}}
{"id": 2, "src": "neurolinguistic programming ( nlp ) refers to the science and art of reaching success and perfection . it is a collection of the skills based on human beings psychological characteristics through which the individuals obtain the ability to use their personal capabilities as much as possible . this study aimed to investigate the efficacy of nlp training on mental health in nursing and midwifery students in islamic azad university tehran medical sciences branch.in this quasi - experimental study , the study population comprised all nursing and midwifery students in islamic azad university , tehran medical branch , of whom 52 were selected and assigned to two groups through random sampling .", "mt": "La programmazione neurolinguistica (NLP) si riferisce alla scienza e all'arte di raggiungere il successo e la perfezione . è una raccolta di competenze basate sulle caratteristiche psicologiche degli esseri umani attraverso le quali gli individui ottengono la capacità di utilizzare le loro capacità personali al massimo . Questo studio mirava ad indagare sull'efficacia della formazione nlp sulla salute mentale negli studenti di infermieristica e di ostetricia nella branca delle scienze mediche dell' islamic university di Tehran.In questo studio quasi sperimentale , la popolazione di studio comprendeva tutti gli studenti di infermieristica e ostetricia dell' islamic university of azad , ramo medico di Tehran , di cui 52 sono stati selezionati e assegnati a due gruppi attraverso campionamento casuale .", "pert_mt": "La programmazione neurolinguistica (NLP) si riferisce alla scienza e all'arte di raggiungere il successo e la perfezione. È una raccolta di competenze basate sulle caratteristiche psicologiche degli esseri umani attraverso le quali gli individui ottengono la capacità di utilizzare le loro capacità personali al massimo. Questo studio mirava ad indagare sull'efficacia della formazione NLP sulla salute mentale negli studenti di infermieristica e di ostetricia nella branca delle scienze mediche dell' Islamic University di Tehran. In questo studio quasi sperimentale, la popolazione di studio comprendeva tutti gli studenti di infermieristica e ostetricia dell' Islamic University of Azad, ramo medico di Tehran, di cui 52 sono stati selezionati e assegnati a due grup", "bt": "Neurolinguistic programming (NLP) refers to the science and art of achieving success and perfection.It is a collection of skills based on the psychological characteristics of human beings through which individuals obtain the ability to use their personal abilities to the fullest.This study was aimed at investigating the effectiveness of NLP training on mental health in nursing and obstetrics students in the medical sciences branch of the Islamic University of Tehran.In this quasi-experimental study, the study population included all students of nursing and obstetrics at the Islamic University of Azad, Tehran's medical branch, of which 52 were selected and assigned to two groups.", "questions_src": ["What does neurolinguistic programming focus on?", "Who is the study aimed at investigating the efficacy of NLP training on?", "Where did the study take place?", "When was the quasi-experimental study conducted?", "Which students were included in the study sample?"], "answers_src": ["reaching success and perfection", "nursing and midwifery students in islamic azad university tehran medical sciences branch", "islamic azad university tehran medical sciences branch", "not specified in the sentence", "all nursing and midwifery students in islamic azad university tehran medical branch"], "answers_bt": ["[\"achieving success and perfection\", \"nursing and obstetrics students in the medical sciences branch of the Islamic University of Tehran\", \"at the Islamic University of Azad, Tehran\"s medical branch\", \"not specified in the sentence\", \"all students of nursing and obstetrics\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "2.1", "question": "What does neurolinguistic programming focus on?", "answer_src": "reaching success and perfection", "follow_up_question": "What specific psychological characteristics does neurolinguistic programming aim to utilize?", "follow_up_response": "human beings psychological characteristics", "follow_up_response_bt": "psychological characteristics of human beings"}, {"question_id": "2.2", "question": "Who is the study aimed at investigating the efficacy of NLP training on?", "answer_src": "nursing and midwifery students in islamic azad university tehran medical sciences branch", "follow_up_question": "What was the sample size of the study?", "follow_up_response": "52", "follow_up_response_bt": "52"}, {"question_id": "2.3", "question": "Where did the study take place?", "answer_src": "islamic azad university tehran medical sciences branch", "follow_up_question": "What was the sample size of the study?", "follow_up_response": "52", "follow_up_response_bt": "52"}, {"question_id": "2.4", "question": "When was the quasi-experimental study conducted?", "answer_src": "not specified in the sentence", "follow_up_question": "What was the sample size of the study?", "follow_up_response": "52", "follow_up_response_bt": "52"}, {"question_id": "2.5", "question": "Which students were included in the study sample?", "answer_src": "all nursing and midwifery students in islamic azad university tehran medical branch", "follow_up_question": "How many students were randomly selected for the study?", "follow_up_response": "52", "follow_up_response_bt": "52"}], "turn_2": [{"question_id": "2.6", "question": "What specific psychological characteristics does neurolinguistic programming aim to utilize?", "answer_src": "human beings psychological characteristics", "follow_up_question": "What types of skills does neurolinguistic programming focus on developing?", "follow_up_response": "the skills based on human beings psychological characteristics", "follow_up_response_bt": "the psychological characteristics of human beings"}, {"question_id": "2.7", "question": "What was the sample size of the study?", "answer_src": "52", "follow_up_question": "How many students were in each group?", "follow_up_response": "26", "follow_up_response_bt": "No Answer"}, {"question_id": "2.8", "question": "What was the sample size of the study?", "answer_src": "52", "follow_up_question": "How many students were in each group?", "follow_up_response": "26", "follow_up_response_bt": "No Answer"}, {"question_id": "2.9", "question": "What was the sample size of the study?", "answer_src": "52", "follow_up_question": "How many students were in each group?", "follow_up_response": "26", "follow_up_response_bt": "No Answer"}, {"question_id": "2.10", "question": "How many students were randomly selected for the study?", "answer_src": "52", "follow_up_question": "How many nursing and midwifery students were not included in the study?", "follow_up_response": "52", "follow_up_response_bt": "52"}], "turn_3": [{"question_id": "2.11", "question": "What types of skills does neurolinguistic programming focus on developing?", "answer_src": "the skills based on human beings psychological characteristics", "follow_up_question": "What specific psychological characteristics did the study focus on in nursing and midwifery students?", "follow_up_response": "human beings psychological characteristics", "follow_up_response_bt": "psychological characteristics of human beings"}, {"question_id": "2.12", "question": "How many students were in each group?", "answer_src": "26", "follow_up_question": "How many students were not assigned to any group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "2.13", "question": "How many students were in each group?", "answer_src": "26", "follow_up_question": "How many students were not assigned to any group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "2.14", "question": "How many students were in each group?", "answer_src": "26", "follow_up_question": "How many students were not assigned to any group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "2.15", "question": "How many nursing and midwifery students were not included in the study?", "answer_src": "52", "follow_up_question": "How many nursing and midwifery students were included in the study?", "follow_up_response": "52", "follow_up_response_bt": "52"}]}}
{"id": 3, "src": "this pilot study tested the effect of cognitive behavioral therapy ( cbt ) on parent - reported autism symptoms . nineteen children with autism spectrum disorders and an anxiety disorder ( 711 years old ) were randomly assigned to 16 sessions of cbt or a waitlist condition . the cbt program emphasized in vivo exposure supported by parent training and school consultation to promote social communication and emotion regulation skills .", "mt": "Questo studio pilota ha testato l'effetto della terapia cognitivo-comportamentale (cbt) sui sintomi di autismo segnalati dai genitori . Diecinque bambini con disturbi dello spettro autistico e un disturbo d'ansia (a 711 anni) sono stati assegnati in modo casuale a 16 sessioni di cbt o una condizione di lista di attesa . Il programma cbt ha sottolineato l'esposizione in vivo sostenuta da formazione dei genitori e consultazione scolastica per promuovere la comunicazione sociale e le capacità di regolazione delle emozioni .", "pert_mt": "Questo studio pilota ha testato l'effetto della terapia cognitivo-comportamentale (cbt) sui sintomi di autismo segnalati dai genitori. Dieci bambini con disturbi dello spettro autistico e un disturbo d'ansia (a 711 anni) sono stati assegnati in modo casuale a 16 sessioni di cbt o una condizione di lista di attesa. Il programma cbt ha sottolineato l'esposizione in vivo sostenuta da formazione dei genitori e consultazione scolastica per promuovere la comunicazione sociale e le capacità di regolazione delle emozioni.", "bt": "This pilot study has tested the effect of cognitive behavioral therapy (cbt) on autism symptoms reported by parents.Ten children with autism spectrum disorder and an anxiety disorder (aged 711) were randomly assigned 16 cbt sessions or a waiting list condition.The cbt program emphasized in vivo exposure to support parental education and school counseling to promote social communication and emotional adjustment skills.", "questions_src": ["What is the main focus of the pilot study?", "Who were the participants in the study?", "How many children with autism spectrum disorders participated?", "When was the average age of the participants?", "Which therapy was tested for its effect on autism symptoms?"], "answers_src": ["The effect of cognitive behavioral therapy (cbt) on parent-reported autism symptoms", "Nineteen children with autism spectrum disorders and an anxiety disorder", "19", "711", "Cognitive behavioral therapy (cbt)"], "answers_bt": ["To test the effect of cognitive behavioral therapy (cbt) on autism symptoms reported by parents", "Ten children with autism spectrum disorder and an anxiety disorder aged 7-11", "10", "Averaged 9", "Cognitive behavioral therapy (cbt)"], "multiturn": {"turn_1": [{"question_id": "3.1", "question": "What is the main focus of the pilot study?", "answer_src": "The effect of cognitive behavioral therapy (cbt) on parent-reported autism symptoms", "follow_up_question": "How many sessions did the cognitive behavioral therapy program consist of?", "follow_up_response": "16", "follow_up_response_bt": "16"}, {"question_id": "3.2", "question": "Who were the participants in the study?", "answer_src": "Nineteen children with autism spectrum disorders and an anxiety disorder", "follow_up_question": "What age range was the participant group?", "follow_up_response": "711 years old", "follow_up_response_bt": "7-11"}, {"question_id": "3.3", "question": "How many children with autism spectrum disorders participated?", "answer_src": "19", "follow_up_question": "How many of those children had an anxiety disorder?", "follow_up_response": "7", "follow_up_response_bt": "10"}, {"question_id": "3.4", "question": "When was the average age of the participants?", "answer_src": "711", "follow_up_question": "What specific skills did the CBT program focus on?", "follow_up_response": "promote social communication and emotion regulation skills", "follow_up_response_bt": "support parental education and school counseling to promote social communication and emotional adjustment skills"}, {"question_id": "3.5", "question": "Which therapy was tested for its effect on autism symptoms?", "answer_src": "Cognitive behavioral therapy (cbt)", "follow_up_question": "What specific skills did the cbt program aim to promote?", "follow_up_response": "social communication and emotion regulation skills", "follow_up_response_bt": "social communication and emotional adjustment skills"}], "turn_2": [{"question_id": "3.6", "question": "How many sessions did the cognitive behavioral therapy program consist of?", "answer_src": "16", "follow_up_question": "How many children with autism spectrum disorders participated in this pilot study?", "follow_up_response": "19", "follow_up_response_bt": "10"}, {"question_id": "3.7", "question": "What age range was the participant group?", "answer_src": "711 years old", "follow_up_question": "What specific skills did the cbt program aim to promote?", "follow_up_response": "social communication and emotion regulation skills", "follow_up_response_bt": "social communication and emotional adjustment skills"}, {"question_id": "3.8", "question": "How many of those children had an anxiety disorder?", "answer_src": "7", "follow_up_question": "How many children received the waitlist condition?", "follow_up_response": "19", "follow_up_response_bt": "5"}, {"question_id": "3.9", "question": "What specific skills did the CBT program focus on?", "answer_src": "promote social communication and emotion regulation skills", "follow_up_question": "What age group of children was included in this pilot study?", "follow_up_response": "711 years old", "follow_up_response_bt": "aged 711"}, {"question_id": "3.10", "question": "What specific skills did the cbt program aim to promote?", "answer_src": "social communication and emotion regulation skills", "follow_up_question": "What age group was included in this pilot study?", "follow_up_response": "711 years old", "follow_up_response_bt": "aged 711"}], "turn_3": [{"question_id": "3.11", "question": "How many children with autism spectrum disorders participated in this pilot study?", "answer_src": "19", "follow_up_question": "How many of those children had an anxiety disorder?", "follow_up_response": "7", "follow_up_response_bt": "10"}, {"question_id": "3.12", "question": "What specific skills did the cbt program aim to promote?", "answer_src": "social communication and emotion regulation skills", "follow_up_question": "What age group was included in this pilot study?", "follow_up_response": "711 years old", "follow_up_response_bt": "aged 711"}, {"question_id": "3.13", "question": "How many children received the waitlist condition?", "answer_src": "19", "follow_up_question": "How many children received the CBT program?", "follow_up_response": "16", "follow_up_response_bt": "16"}, {"question_id": "3.14", "question": "What age group of children was included in this pilot study?", "answer_src": "711 years old", "follow_up_question": "What specific skills did the cbt program aim to promote?", "follow_up_response": "social communication and emotion regulation skills", "follow_up_response_bt": "social communication and emotional adjustment skills"}, {"question_id": "3.15", "question": "What age group was included in this pilot study?", "answer_src": "711 years old", "follow_up_question": "What specific skills did the cbt program aim to promote?", "follow_up_response": "social communication and emotion regulation skills", "follow_up_response_bt": "social communication and emotional adjustment skills"}]}}
{"id": 4, "src": "rnaomics , analogous to proteomics , concerns aspects of the secondary and tertiary structure , folding pathway , kinetics , comparison , function and regulation of all rna in a living organism . given recently discovered roles played by micro rna , small interfering rna , riboswitches , ribozymes , etc . , it is important to gain insight into the folding process of rna sequences .", "mt": "La rnaomics , analogo alla proteomics , riguarda aspetti della struttura secondaria e terziaria , della via di ripiegamento , della cinetica , del confronto , della funzione e della regolazione di tutti i rna in un organismo vivente . Dati i ruoli recentemente scoperti svoltosi da micro rna , piccoli rna interferenti , riboswitches , ribozyme , ecc , è importante acquisire una conoscenza del processo di ripiegamento delle sequenze rna .", "pert_mt": "La rnaomics, analogo alla proteomics, riguarda aspetti della struttura secondaria e terziaria, della via di ripiegamento, della cinetica, del confronto, della funzione e della regolazione di tutti i rna in un organismo vivente. Dati i ruoli recentemente scoperti svoltisi da micro rna, piccoli rna interferenti, riboswitches, ribozyme, ecc., è importante acquisire una conoscenza del processo di ripiegamento delle sequenze rna e dei loro impatti sui processi cellulari.", "bt": "Rnaomics, like proteomics, deals with aspects of secondary and tertiary structure, the way of folding, kinetics, comparison, function and regulation of all RNA in a living organism.Given the recently discovered roles of microRNA, small RNA interferents, riboswitches, ribozymes, etc., it is important to gain a knowledge of the folding process of RNA sequences and their impacts on cellular processes.", "questions_src": ["What does rnaomics study?", "Who plays a recently discovered role in RNA functions?", "Where can riboswitches be found in a living organism?", "When did the importance of understanding RNA folding processes become apparent?", "Which types of RNA have recently been found to play important roles?"], "answers_src": ["[\"aspects of the secondary and tertiary structure, folding pathway, kinetics, comparison, function and regulation of all rna in a living organism\"], [\"micro rna, small interfering rna, riboswitches, ribozymes\"], [\"in a living organism\"], [\"recently\"], [\"micro rna, small interfering rna, riboswitches, ribozymes\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["aspects of secondary and tertiary structure, the way of folding, kinetics, comparison, function and regulation of all RNA in a living organism", "microRNA, small RNA interferents, riboswitches, ribozymes", "in a living organism", "recently", "microRNA, small RNA interferents, riboswitches, ribozymes"], "multiturn": {"turn_1": [{"question_id": "4.1", "question": "What does rnaomics study?", "answer_src": "[\"aspects of the secondary and tertiary structure, folding pathway, kinetics, comparison, function and regulation of all rna in a living organism\"], [\"micro rna, small interfering rna, riboswitches, ribozymes\"], [\"in a living organism\"], [\"recently\"], [\"micro rna, small interfering rna, riboswitches, ribozymes\"]", "follow_up_question": "What specific types of RNA are gaining recent attention in rnaomics?", "follow_up_response": "micro RNA, small interfering RNA, riboswitches, ribozymes", "follow_up_response_bt": "microRNA, small RNA interferents, riboswitches, ribozymes"}, {"question_id": "4.2", "question": "Who plays a recently discovered role in RNA functions?", "answer_src": "rnaomics , analogous to proteomics , concerns aspects of the secondary and tertiary structure , folding pathway , kinetics , comparison , function and regulation of all rna in a living organism . given recently discovered roles played by micro rna , small interfering rna , riboswitches , ribozymes , etc . , it is important to gain insight into the folding process of rna sequences .", "follow_up_question": "What specific types of RNA are mentioned as playing recently discovered roles?", "follow_up_response": "micro rna , small interfering rna , riboswitches , ribozymes", "follow_up_response_bt": "microRNA, small RNA interferents, riboswitches, ribozymes"}, {"question_id": "4.3", "question": "Where can riboswitches be found in a living organism?", "answer_src": "rnaomics , analogous to proteomics , concerns aspects of the secondary and tertiary structure , folding pathway , kinetics , comparison , function and regulation of all rna in a living organism . given recently discovered roles played by micro rna , small interfering rna , riboswitches , ribozymes , etc . , it is important to gain insight into the folding process of rna sequences .", "follow_up_question": "What specific types of RNA are involved in the folding process discussed in the text?", "follow_up_response": "micro rna\", \"small interfering rna\", \"riboswitches\", \"ribozymes", "follow_up_response_bt": "microRNA, small RNA interferents, riboswitches, ribozymes"}, {"question_id": "4.4", "question": "When did the importance of understanding RNA folding processes become apparent?", "answer_src": "rnaomics , analogous to proteomics , concerns aspects of the secondary and tertiary structure , folding pathway , kinetics , comparison , function and regulation of all rna in a living organism . given recently discovered roles played by micro rna , small interfering rna , riboswitches , ribozymes , etc . , it is important to gain insight into the folding process of rna sequences .", "follow_up_question": "What recent discoveries have made the study of RNA folding processes particularly relevant?", "follow_up_response": "Recently discovered roles played by microRNA, small interfering RNA, riboswitches, ribozymes, etc.", "follow_up_response_bt": "The recently discovered roles of microRNA, small RNA interferents, riboswitches, ribozymes, etc."}, {"question_id": "4.5", "question": "Which types of RNA have recently been found to play important roles?", "answer_src": "rnaomics , analogous to proteomics , concerns aspects of the secondary and tertiary structure , folding pathway , kinetics , comparison , function and regulation of all rna in a living organism . given recently discovered roles played by micro rna , small interfering rna , riboswitches , ribozymes , etc . , it is important to gain insight into the folding process of rna sequences .", "follow_up_question": "What specific types of RNA are mentioned to have recently been found to play important roles?", "follow_up_response": "micro rna , small interfering rna , riboswitches , ribozymes", "follow_up_response_bt": "microRNA, small RNA interferents, riboswitches, ribozymes"}], "turn_2": [{"question_id": "4.6", "question": "What specific types of RNA are gaining recent attention in rnaomics?", "answer_src": "micro RNA, small interfering RNA, riboswitches, ribozymes", "follow_up_question": "What role do riboswitches play in the folding process of RNA sequences?", "follow_up_response": "Riboswitches", "follow_up_response_bt": "They are small regulatory elements that respond to metabolites and control gene expression"}, {"question_id": "4.7", "question": "What specific types of RNA are mentioned as playing recently discovered roles?", "answer_src": "micro rna , small interfering rna , riboswitches , ribozymes", "follow_up_question": "What is the significance of understanding the folding process of these RNA sequences?", "follow_up_response": "To gain insight into the folding process of RNA sequences, given recently discovered roles played by microRNA, small interfering RNA, riboswitches, ribozymes, etc.", "follow_up_response_bt": "Their impacts on cellular processes"}, {"question_id": "4.8", "question": "What specific types of RNA are involved in the folding process discussed in the text?", "answer_src": "micro rna\", \"small interfering rna\", \"riboswitches\", \"ribozymes", "follow_up_question": "What role do riboswitches play in the folding process according to the text?", "follow_up_response": "gain insight into the folding process of rna sequences", "follow_up_response_bt": "Their impacts on cellular processes"}, {"question_id": "4.9", "question": "What recent discoveries have made the study of RNA folding processes particularly relevant?", "answer_src": "Recently discovered roles played by microRNA, small interfering RNA, riboswitches, ribozymes, etc.", "follow_up_question": "What specific aspect of RNA folding do these recent discoveries highlight?", "follow_up_response": "The folding process of RNA sequences", "follow_up_response_bt": "The folding process"}, {"question_id": "4.10", "question": "What specific types of RNA are mentioned to have recently been found to play important roles?", "answer_src": "micro rna , small interfering rna , riboswitches , ribozymes", "follow_up_question": "What is the significance of understanding the folding process of these newly discovered RNAs?", "follow_up_response": "To gain insight into the folding process of RNA sequences, especially given recently discovered roles played by microRNAs, small interfering RNAs, riboswitches, and ribozymes.", "follow_up_response_bt": "To gain a knowledge of the folding process of RNA sequences and their impacts on cellular processes"}], "turn_3": [{"question_id": "4.11", "question": "What role do riboswitches play in the folding process of RNA sequences?", "answer_src": "Riboswitches", "follow_up_question": "What specific functions do ribozymes serve in the context of RNA folding?", "follow_up_response": "serve in the context of RNA folding", "follow_up_response_bt": "Their impacts on cellular processes"}, {"question_id": "4.12", "question": "What is the significance of understanding the folding process of these RNA sequences?", "answer_src": "To gain insight into the folding process of RNA sequences, given recently discovered roles played by microRNA, small interfering RNA, riboswitches, ribozymes, etc.", "follow_up_question": "How does understanding the folding process contribute to our knowledge of RNA's diverse functions?", "follow_up_response": "It is important to gain insight into the folding process of RNA sequences", "follow_up_response_bt": "It contributes to our knowledge of RNA's diverse functions by gaining insights into the folding process of RNA sequences and their impacts on cellular processes, given the recently discovered roles of microRNA, small RNA interferents, riboswitches, ribozymes, etc."}, {"question_id": "4.13", "question": "What role do riboswitches play in the folding process according to the text?", "answer_src": "gain insight into the folding process of rna sequences", "follow_up_question": "What other types of RNA besides riboswitches are mentioned as playing important roles in the folding process?", "follow_up_response": "micro rna\", \"small interfering rna\", \"ribozymes", "follow_up_response_bt": "microRNA, small RNA interferents, ribozymes"}, {"question_id": "4.14", "question": "What specific aspect of RNA folding do these recent discoveries highlight?", "answer_src": "The folding process of RNA sequences", "follow_up_question": "What types of RNA have recently been found to play significant roles?", "follow_up_response": "micro rna , small interfering rna , riboswitches , ribozymes", "follow_up_response_bt": "microRNA, small RNA interferents, riboswitches, ribozymes"}, {"question_id": "4.15", "question": "What is the significance of understanding the folding process of these newly discovered RNAs?", "answer_src": "To gain insight into the folding process of RNA sequences, especially given recently discovered roles played by microRNAs, small interfering RNAs, riboswitches, and ribozymes.", "follow_up_question": "How do these newly discovered RNAs contribute to our understanding of the folding process?", "follow_up_response": "Their recently discovered roles contribute to our understanding of the folding process of RNA sequences.", "follow_up_response_bt": "Their roles in cellular processes"}]}}
{"id": 5, "src": "the rates of initial and long - term patency and of early recurrence were compared.resultsinitial patency rates for the suprapapillary and transpapillary methods were 1/7 ( 14.3% ) and 20/20 ( 100% ) respectively for type a ( p < 0.0001 ) , 4/5 ( 80.0% ) and 2/2 for type b , 3/7 ( 42.9% ) and 2/2 for type c , and 15/16 ( 93.8% ) and 0/0 for type d. early recurrence rates were 7/30 ( 23.3% ) using the suprapapillary method and 4/29 ( 13.8% ) using the transpapillary method ( p = 0.51 ) . the long - term patency rate did not differ significantly according to either type ( p = 0.37 ) or method ( p = 0.62).conclusionfor good initial patency , the transpapillary method is recommended for strictures of the distal extrahepatic duct near the ampulla and just above the bending portion . long - term patency is not influenced by the stenting method employed .", "mt": "I tassi di patenza iniziale e a lungo termine e di ricorrenza precoce sono stati confrontati.Rescultati tassi di patenza iniziale per i metodi suprapapillari e transpapillari sono stati rispettivamente 1/7 ( 14,3%) e 20/20 (100%) per il tipo a (p < 0,0001) , 4/5 ( 80,0%) e 2/2 per il tipo b , 3/7 ( 42,9%) e 2/2 per il tipo c , e 15/16 ( 93,8%) e 0/0 per il tipo d. I tassi di recorrenza precoce sono stati 7/30 ( 23,3%) utilizzando il metodo suprapapillari e 4/29 ( 13,8%) utilizzando il metodo transpapillari (p = 0,51).", "pert_mt": "I tassi di patenza iniziale e a lungo termine e di ricorrenza precoce sono stati confrontati. Recultati tassi di patenza iniziale per i metodi suprapapillari e transpapillari sono stati rispettivamente 1/7 (14,3%) e 20/20 (100%) per il tipo a (p < 0,0001), 4/5 (80,0%) e 2/2 per il tipo b, 3/7 (42,9%) e 2/2 per il tipo c, e 15/16 (93,8%) e 0/0 per il tipo d. I tassi di recorrenza precoce sono stati 7/30 (23,3%) utilizzando il metodo suprapapillari e 4/29 (", "bt": "The initial and long-term patent rates and early recurrence rates were compared, with the initial patent rates for the supra-papillary and transpapillary methods being 1/7 (14.3%) and 20/20 (100%) respectively for type a (p < 0.0001), 4/5 (80.0%) and 2/2 for type b, 3/7 (42.9%) and 2/2 for type c, and 15/16 (93.8%) and 0/0 for type d. The early recurrence rates were 7/30 (23.3%) using the supra-papillary method and 4/29 () ()", "questions_src": ["What was the initial patency rate for the transpapillary method in type A stricture cases?", "Who had a higher early recurrence rate, those with type B or type C strictures?", "Where were the strictures being studied located in relation to the ampulla?", "When was the study conducted based on the conclusion provided?", "Which method showed better long-term patency rates, suprapapillary or transpapillary?"], "answers_src": ["100%", "Type B", "near the ampulla", "not specified", "Transpapillary"], "answers_bt": ["100%", "Type B", "Supra-papillary", "No Answer", "Transpapillary"], "multiturn": {"turn_1": [{"question_id": "5.1", "question": "What was the initial patency rate for the transpapillary method in type A stricture cases?", "answer_src": "100%", "follow_up_question": "What was the initial patency rate for the transpapillary method in type B stricture cases?", "follow_up_response": "80.0%", "follow_up_response_bt": "100%"}, {"question_id": "5.2", "question": "Who had a higher early recurrence rate, those with type B or type C strictures?", "answer_src": "Type B", "follow_up_question": "Which type had a lower initial patency rate, type B or type C?", "follow_up_response": "type C", "follow_up_response_bt": "type C"}, {"question_id": "5.3", "question": "Where were the strictures being studied located in relation to the ampulla?", "answer_src": "near the ampulla", "follow_up_question": "Just above the bending portion?", "follow_up_response": "just above the bending portion", "follow_up_response_bt": "No Answer"}, {"question_id": "5.4", "question": "When was the study conducted based on the conclusion provided?", "answer_src": "not specified", "follow_up_question": "What was the long-term patency rate for type A strictures according to the study?", "follow_up_response": "42.9%", "follow_up_response_bt": "100%"}, {"question_id": "5.5", "question": "Which method showed better long-term patency rates, suprapapillary or transpapillary?", "answer_src": "Transpapillary", "follow_up_question": "What was the long-term patency rate for type B strictures with the transpapillary method?", "follow_up_response": "100%", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "5.6", "question": "What was the initial patency rate for the transpapillary method in type B stricture cases?", "answer_src": "80.0%", "follow_up_question": "What was the initial patency rate for the suprapapillary method in type C stricture cases?", "follow_up_response": "42.9%", "follow_up_response_bt": "4/7 (42.9%)"}, {"question_id": "5.7", "question": "Which type had a lower initial patency rate, type B or type C?", "answer_src": "type C", "follow_up_question": "Which type had an earlier recurrence rate, type A or type D?", "follow_up_response": "type D", "follow_up_response_bt": "type A"}, {"question_id": "5.8", "question": "Just above the bending portion?", "answer_src": "just above the bending portion", "follow_up_question": "What was the early recurrence rate for type C strictures?", "follow_up_response": "42.9%", "follow_up_response_bt": "42.9%"}, {"question_id": "5.9", "question": "What was the long-term patency rate for type A strictures according to the study?", "answer_src": "42.9%", "follow_up_question": "What was the long-term patency rate for type D strictures according to the study?", "follow_up_response": "93.8%", "follow_up_response_bt": "93.8%"}, {"question_id": "5.10", "question": "What was the long-term patency rate for type B strictures with the transpapillary method?", "answer_src": "100%", "follow_up_question": "What was the long-term patency rate for type C strictures with the suprapapillary method?", "follow_up_response": "42.9%", "follow_up_response_bt": "42.9%"}], "turn_3": [{"question_id": "5.11", "question": "What was the initial patency rate for the suprapapillary method in type C stricture cases?", "answer_src": "42.9%", "follow_up_question": "What was the initial patency rate for the transpapillary method in type C stricture cases?", "follow_up_response": "42.9%", "follow_up_response_bt": "42.9%"}, {"question_id": "5.12", "question": "Which type had an earlier recurrence rate, type A or type D?", "answer_src": "type D", "follow_up_question": "Which type had the highest initial patency rate with the transpapillary method?", "follow_up_response": "Type B", "follow_up_response_bt": "Type b"}, {"question_id": "5.13", "question": "What was the early recurrence rate for type C strictures?", "answer_src": "42.9%", "follow_up_question": "What was the long-term patency rate for type D strictures?", "follow_up_response": "93.8%", "follow_up_response_bt": "93.8%"}, {"question_id": "5.14", "question": "What was the long-term patency rate for type D strictures according to the study?", "answer_src": "93.8%", "follow_up_question": "What was the long-term patency rate for type C strictures according to the study?", "follow_up_response": "42.9%", "follow_up_response_bt": "42.9%"}, {"question_id": "5.15", "question": "What was the long-term patency rate for type C strictures with the suprapapillary method?", "answer_src": "42.9%", "follow_up_question": "What was the long-term patency rate for type D strictures with the transpapillary method?", "follow_up_response": "93.8%", "follow_up_response_bt": "0/0"}]}}
{"id": 6, "src": "18f - fluorodeoxyglucose ( fdg ) positron emission tomography and computed tomography ( integrated fdg pet / ct ) has been used to diagnose recurrence and differentiate postoperative changes from lymph node metastasis in colorectal cancer , although its accuracy is questionable . we report a prone thoracoscopic surgery for a rectal cancer patient in which false - positive mediastinal lymph nodes were found on fdg - pet / ct . a 60-year - old man underwent a laparoscopic high anterior resection and d3 lymph node dissection for rectal cancer .", "mt": "18f - fluorodeoxyglucose (fdg) positron emission tomography e computed tomography (integrated fdg pet / ct) sono stati usati per diagnosticare la ricorrenza e differenziare i cambiamenti postoperativi dalla metastasi dei linfonodi nel cancro colorretto , anche se la sua accuratezza è discutibile . segnaliamo una tendenza chirurgica toracoscopica per un paziente con cancro al rettale in cui sono stati trovati falsi - positivi linfonodi mediastinali su fdg - pet / ct . un uomo di 60 anni ha subito una resezione laparoscopica alta anteriore e una dissezione dei linfonodi d3 per il cancro al rettale .", "pert_mt": "18f - fluorodeoxyglucose (fdg) positron emission tomography e computed tomography (integrated fdg pet / ct) sono stati usati per diagnosticare la ricorrenza e differenziare i cambiamenti postoperativi dalla metastasi dei linfonodi nel cancro colorretto , anche se la sua accuratezza è discutibile . segnaliamo una tendenza chirurgica toracoscopica per un paziente con cancro al rettale in cui sono stati trovati falsi - positivi linfonodi mediastinali su fdg - pet / ct e hanno portato a un trattamento errato.", "bt": "18f - fluorodeoxyglucose (fdg) positron emission tomography and computed tomography (integrated fdg pet/ct) have been used to diagnose the frequency and differentiate and postoperative changes from the metastasis of lymph nodes in colorectal cancer , although its accuracy is questionable .", "questions_src": ["What type of surgery was performed on the rectal cancer patient?", "Who was the patient in the prone thoracoscopic surgery case?", "Where were false-positive mediastinal lymph nodes found on the FDG-PET/CT scan?", "When did the patient undergo the laparoscopic high anterior resection and D3 lymph node dissection?", "Which cancer type was diagnosed in the prone thoracoscopic surgery case?"], "answers_src": ["Prone thoracoscopic surgery", "A 60-year-old man", "In the mediastinum", "At some point before or during the prone thoracoscopic surgery", "Rectal cancer"], "answers_bt": ["Laparoscopic high anterior resection and D3 lymph node dissection", "No Answer", "No Answer", "No Answer", "Rectal cancer"], "multiturn": {"turn_1": [{"question_id": "6.1", "question": "What type of surgery was performed on the rectal cancer patient?", "answer_src": "Prone thoracoscopic surgery", "follow_up_question": "What was the result of the FDG-PET/CT scan before the surgery?", "follow_up_response": "False-positive mediastinal lymph nodes", "follow_up_response_bt": "its accuracy is questionable"}, {"question_id": "6.2", "question": "Who was the patient in the prone thoracoscopic surgery case?", "answer_src": "A 60-year-old man", "follow_up_question": "What type of surgery did the patient undergo initially?", "follow_up_response": "Laparoscopic high anterior resection", "follow_up_response_bt": "No Answer"}, {"question_id": "6.3", "question": "Where were false-positive mediastinal lymph nodes found on the FDG-PET/CT scan?", "answer_src": "In the mediastinum", "follow_up_question": "What was the patient's age?", "follow_up_response": "60-year-old man", "follow_up_response_bt": "No Answer"}, {"question_id": "6.4", "question": "When did the patient undergo the laparoscopic high anterior resection and D3 lymph node dissection?", "answer_src": "At some point before or during the prone thoracoscopic surgery", "follow_up_question": "What was the primary indication for performing the prone thoracoscopic surgery?", "follow_up_response": "To diagnose recurrence and differentiate postoperative changes from lymph node metastasis", "follow_up_response_bt": "No Answer"}, {"question_id": "6.5", "question": "Which cancer type was diagnosed in the prone thoracoscopic surgery case?", "answer_src": "Rectal cancer", "follow_up_question": "What were the findings of the FDG-PET/CT scan in this case?", "follow_up_response": "False-positive mediastinal lymph nodes", "follow_up_response_bt": "To diagnose the frequency and differentiate between postoperative changes from metastasis of lymph nodes in colorectal cancer"}], "turn_2": [{"question_id": "6.6", "question": "What was the result of the FDG-PET/CT scan before the surgery?", "answer_src": "False-positive mediastinal lymph nodes", "follow_up_question": "What type of surgery did the patient undergo before the FDG-PET/CT scan?", "follow_up_response": "laparoscopic high anterior resection", "follow_up_response_bt": "No Answer"}, {"question_id": "6.7", "question": "What type of surgery did the patient undergo initially?", "answer_src": "Laparoscopic high anterior resection", "follow_up_question": "What was the result of the FDG-PET/CT scan in this case?", "follow_up_response": "False-positive mediastinal lymph nodes", "follow_up_response_bt": "To diagnose the frequency and differentiate between postoperative changes from metastasis of lymph nodes in colorectal cancer"}, {"question_id": "6.8", "question": "What was the patient's age?", "answer_src": "60-year-old man", "follow_up_question": "How many lymph nodes were removed during the surgery?", "follow_up_response": "3", "follow_up_response_bt": "No Answer"}, {"question_id": "6.9", "question": "What was the primary indication for performing the prone thoracoscopic surgery?", "answer_src": "To diagnose recurrence and differentiate postoperative changes from lymph node metastasis", "follow_up_question": "What type of cancer did the patient have?", "follow_up_response": "Rectal cancer", "follow_up_response_bt": "colorectal cancer"}, {"question_id": "6.10", "question": "What were the findings of the FDG-PET/CT scan in this case?", "answer_src": "False-positive mediastinal lymph nodes", "follow_up_question": "What was the patient's age?", "follow_up_response": "60-year-old man", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "6.11", "question": "What type of surgery did the patient undergo before the FDG-PET/CT scan?", "answer_src": "laparoscopic high anterior resection", "follow_up_question": "What was the outcome of the FDG-PET/CT scan for this patient?", "follow_up_response": "False-positive mediastinal lymph nodes", "follow_up_response_bt": "its accuracy is questionable"}, {"question_id": "6.12", "question": "What was the result of the FDG-PET/CT scan in this case?", "answer_src": "False-positive mediastinal lymph nodes", "follow_up_question": "What type of surgery did the patient undergo initially?", "follow_up_response": "Laparoscopic high anterior resection", "follow_up_response_bt": "No Answer"}, {"question_id": "6.13", "question": "How many lymph nodes were removed during the surgery?", "answer_src": "3", "follow_up_question": "How many lymph nodes did the PET/CT scan suggest were affected?", "follow_up_response": "2", "follow_up_response_bt": "No Answer"}, {"question_id": "6.14", "question": "What type of cancer did the patient have?", "answer_src": "Rectal cancer", "follow_up_question": "What procedure was used to initially treat the patient's rectal cancer?", "follow_up_response": "laparoscopic high anterior resection and d3 lymph node dissection", "follow_up_response_bt": "No Answer"}, {"question_id": "6.15", "question": "What was the patient's age?", "answer_src": "60-year-old man", "follow_up_question": "How many lymph nodes were removed during the surgery?", "follow_up_response": "3", "follow_up_response_bt": "No Answer"}]}}
{"id": 7, "src": "hypertension is common in hemolytic uremic syndrome ( hus ) and often difficult to control . local renin - angiotensin activation is believed to be an important part of thrombotic microangiopathy , leading to a vicious cycle of progressive renal injury and intractable hypertension . this has been demonstrated in vitro via enhanced tissue factor expression on glomerular endothelial cells which is enhanced by angiotensin ii .", "mt": "L'attività locale di renina - angiotensina si ritiene sia una parte importante della microangiopatia trombotica , portando ad un ciclo vizioso di lesioni renali progressive e ipertensione intractabile . Questo è stato dimostrato in vitro attraverso un'espressione aumentata del fattore tissutale sulle cellule endoteliche glomerulari che è aumentata dall'angiotensina ii .", "pert_mt": "L'attività locale di renina - angiotensina si ritiene sia una parte importante della microangiopatia trombotica, portando ad un ciclo vizioso di lesioni renali progressive e ipertensione intractabile. Questo è stato dimostrato in vitro attraverso un'espressione aumentata del fattore tissutale sulle cellule endoteliche glomerulari che è aumentata dall'angiotensina II e dalla diminuzione del flusso sanguigno.", "bt": "Local renin-angiotensin activity is thought to be an important part of thrombotic microangiopathy, leading to a vicious cycle of progressive renal injury and intractable hypertension.This has been demonstrated in vitro through increased expression of tissue factor on glomerular endothelial cells that is increased by angiotensin II and decreased blood flow.", "questions_src": ["What is commonly associated with hemolytic uremic syndrome?", "When does hypertension become difficult to control?", "Where is local renin-angiotensin activation thought to occur?", "Which cycle leads to progressive renal injury?", "Which molecule is enhanced on glomerular endothelial cells?"], "answers_src": ["[\"Hypertension\"], [\"Often\"], [\"Local\"], [\"Vicious cycle\"], [\"Tissue factor\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["Thrombotic microangiopathy", "Intractably", "Locally", "A vicious cycle", "Tissue factor"], "multiturn": {"turn_1": [{"question_id": "7.1", "question": "What is commonly associated with hemolytic uremic syndrome?", "answer_src": "[\"Hypertension\"], [\"Often\"], [\"Local\"], [\"Vicious cycle\"], [\"Tissue factor\"]", "follow_up_question": "What evidence supports the role of local renin-angiotensin activation in thrombotic microangiopathy?", "follow_up_response": "Enhanced tissue factor expression on glomerular endothelial cells which is enhanced by angiotensin II has been demonstrated in vitro.", "follow_up_response_bt": "Increased expression of tissue factor on glomerular endothelial cells that is increased by angiotensin II and decreased blood flow"}, {"question_id": "7.2", "question": "When does hypertension become difficult to control?", "answer_src": "hypertension is common in hemolytic uremic syndrome ( hus ) and often difficult to control . local renin - angiotensin activation is believed to be an important part of thrombotic microangiopathy , leading to a vicious cycle of progressive renal injury and intractable hypertension . this has been demonstrated in vitro via enhanced tissue factor expression on glomerular endothelial cells which is enhanced by angiotensin ii .", "follow_up_question": "What mechanism is believed to contribute to the intractable hypertension in thrombotic microangiopathy?", "follow_up_response": "local renin - angiotensin activation", "follow_up_response_bt": "Local renin-angiotensin activity"}, {"question_id": "7.3", "question": "Where is local renin-angiotensin activation thought to occur?", "answer_src": "hypertension is common in hemolytic uremic syndrome ( hus ) and often difficult to control . local renin - angiotensin activation is believed to be an important part of thrombotic microangiopathy , leading to a vicious cycle of progressive renal injury and intractable hypertension . this has been demonstrated in vitro via enhanced tissue factor expression on glomerular endothelial cells which is enhanced by angiotensin ii .", "follow_up_question": "What evidence supports the role of local renin-angiotensin activation in thrombotic microangiopathy?", "follow_up_response": "Enhanced tissue factor expression on glomerular endothelial cells which is enhanced by angiotensin II has been demonstrated in vitro.", "follow_up_response_bt": "Increased expression of tissue factor on glomerular endothelial cells that is increased by angiotensin II and decreased blood flow"}, {"question_id": "7.4", "question": "Which cycle leads to progressive renal injury?", "answer_src": "hypertension is common in hemolytic uremic syndrome ( hus ) and often difficult to control . local renin - angiotensin activation is believed to be an important part of thrombotic microangiopathy , leading to a vicious cycle of progressive renal injury and intractable hypertension . this has been demonstrated in vitro via enhanced tissue factor expression on glomerular endothelial cells which is enhanced by angiotensin ii .", "follow_up_question": "What evidence supports the enhancement of tissue factor expression on glomerular endothelial cells?", "follow_up_response": "Enhanced tissue factor expression on glomerular endothelial cells has been demonstrated in vitro via enhanced tissue factor expression on glomerular endothelial cells which is enhanced by angiotensin II.", "follow_up_response_bt": "Increased expression of tissue factor on glomerular endothelial cells that is increased by angiotensin II and decreased blood flow"}, {"question_id": "7.5", "question": "Which molecule is enhanced on glomerular endothelial cells?", "answer_src": "hypertension is common in hemolytic uremic syndrome ( hus ) and often difficult to control . local renin - angiotensin activation is believed to be an important part of thrombotic microangiopathy , leading to a vicious cycle of progressive renal injury and intractable hypertension . this has been demonstrated in vitro via enhanced tissue factor expression on glomerular endothelial cells which is enhanced by angiotensin ii .", "follow_up_question": "Which molecule enhances tissue factor expression on glomerular endothelial cells?", "follow_up_response": "angiotensin II", "follow_up_response_bt": "Angiotensin II"}], "turn_2": [{"question_id": "7.6", "question": "What evidence supports the role of local renin-angiotensin activation in thrombotic microangiopathy?", "answer_src": "Enhanced tissue factor expression on glomerular endothelial cells which is enhanced by angiotensin II has been demonstrated in vitro.", "follow_up_question": "How does angiotensin II specifically enhance tissue factor expression on glomerular endothelial cells?", "follow_up_response": "Enhanced tissue factor expression on glomerular endothelial cells", "follow_up_response_bt": "Increased blood flow"}, {"question_id": "7.7", "question": "What mechanism is believed to contribute to the intractable hypertension in thrombotic microangiopathy?", "answer_src": "local renin - angiotensin activation", "follow_up_question": "How does angiotensin II enhance tissue factor expression on glomerular endothelial cells?", "follow_up_response": "Enhanced tissue factor expression on glomerular endothelial cells", "follow_up_response_bt": "Increased blood flow"}, {"question_id": "7.8", "question": "What evidence supports the role of local renin-angiotensin activation in thrombotic microangiopathy?", "answer_src": "Enhanced tissue factor expression on glomerular endothelial cells which is enhanced by angiotensin II has been demonstrated in vitro.", "follow_up_question": "How does angiotensin II specifically enhance tissue factor expression on glomerular endothelial cells?", "follow_up_response": "Enhanced tissue factor expression on glomerular endothelial cells", "follow_up_response_bt": "Increased blood flow"}, {"question_id": "7.9", "question": "What evidence supports the enhancement of tissue factor expression on glomerular endothelial cells?", "answer_src": "Enhanced tissue factor expression on glomerular endothelial cells has been demonstrated in vitro via enhanced tissue factor expression on glomerular endothelial cells which is enhanced by angiotensin II.", "follow_up_question": "How does angiotensin II enhance tissue factor expression on glomerular endothelial cells?", "follow_up_response": "Enhanced tissue factor expression on glomerular endothelial cells", "follow_up_response_bt": "Increased blood flow"}, {"question_id": "7.10", "question": "Which molecule enhances tissue factor expression on glomerular endothelial cells?", "answer_src": "angiotensin II", "follow_up_question": "What role does enhanced tissue factor expression play in glomerular endothelial cells?", "follow_up_response": "It is enhanced by angiotensin II.", "follow_up_response_bt": "It is increased"}], "turn_3": [{"question_id": "7.11", "question": "How does angiotensin II specifically enhance tissue factor expression on glomerular endothelial cells?", "answer_src": "Enhanced tissue factor expression on glomerular endothelial cells", "follow_up_question": "What mechanism does angiotensin II use to enhance tissue factor expression?", "follow_up_response": "Enhanced tissue factor expression", "follow_up_response_bt": "Increased blood flow"}, {"question_id": "7.12", "question": "How does angiotensin II enhance tissue factor expression on glomerular endothelial cells?", "answer_src": "Enhanced tissue factor expression on glomerular endothelial cells", "follow_up_question": "What role does enhanced tissue factor expression play in the progression of renal injury?", "follow_up_response": "It plays an important role in the progression of renal injury.", "follow_up_response_bt": "It plays a role in the progression of renal injury."}, {"question_id": "7.13", "question": "How does angiotensin II specifically enhance tissue factor expression on glomerular endothelial cells?", "answer_src": "Enhanced tissue factor expression on glomerular endothelial cells", "follow_up_question": "What mechanism does angiotensin II use to enhance tissue factor expression?", "follow_up_response": "Enhanced tissue factor expression", "follow_up_response_bt": "Increased blood flow"}, {"question_id": "7.14", "question": "How does angiotensin II enhance tissue factor expression on glomerular endothelial cells?", "answer_src": "Enhanced tissue factor expression on glomerular endothelial cells", "follow_up_question": "What role does enhanced tissue factor expression play in the progression of renal injury?", "follow_up_response": "It plays an important role in the progression of renal injury.", "follow_up_response_bt": "It plays a role in the progression of renal injury."}, {"question_id": "7.15", "question": "What role does enhanced tissue factor expression play in glomerular endothelial cells?", "answer_src": "It is enhanced by angiotensin II.", "follow_up_question": "How does enhanced tissue factor expression contribute to the progression of renal injury?", "follow_up_response": "Enhanced tissue factor expression on glomerular endothelial cells", "follow_up_response_bt": "Increased blood flow decreases tissue factor expression on glomerular endothelial cells"}]}}
{"id": 8, "src": "this makes it difficult to diagnose the onset of disease . such techniques measure only what the clinician wants or expects to see . a technique which can provide more information , regarding the influence of a medical condition upon the body 's whole function , may be invaluable to the clinician .", "mt": "Questo rende difficile diagnosticare l'inizio della malattia . tali tecniche misurano solo ciò che il medico vuole o si aspetta di vedere . una tecnica che può fornire maggiori informazioni , in merito all'influenza di una condizione medica sull'intera funzione del corpo , può essere inestimabile per il medico .", "pert_mt": "Questo rende difficile diagnosticare l'inizio della malattia. tali tecniche misurano solo ciò che il medico vuole o si aspetta di vedere. Una tecnica che può fornire maggiori informazioni, in merito all'influenza di una condizione medica sull'intera funzione del corpo, può essere inestimabile per il medico e migliorare significativamente il trattamento.", "bt": "This makes it difficult to diagnose the onset of the disease, as such techniques only measure what the doctor wants or expects to see, and a technique that can provide more information about the influence of a medical condition on the entire function of the body can be invaluable to the doctor and significantly improve treatment.", "questions_src": ["What does the sentence suggest is difficult to diagnose?", "Who are the clinicians affected by the limitations of the techniques mentioned?", "Where might these techniques be applied in medical diagnosis?", "When could this limitation in diagnostic methods become problematic?", "Which type of diagnostic method is implied to provide more comprehensive information?"], "answers_src": ["[\"the onset of disease\"], [\"clinicians\"], [\"in medical diagnosis\"], [\"when the onset of disease is difficult to diagnose\"], [\"a technique which can provide more information\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"the onset of the disease\"], [\"Clinicians\"], [\"in medical diagnosis\"], [\"When could this limitation in diagnostic methods become problematic?\"], [\"a technique that can provide more information\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "8.1", "question": "What does the sentence suggest is difficult to diagnose?", "answer_src": "[\"the onset of disease\"], [\"clinicians\"], [\"in medical diagnosis\"], [\"when the onset of disease is difficult to diagnose\"], [\"a technique which can provide more information\"]", "follow_up_question": "What specific aspect of the onset of disease becomes difficult to diagnose according to the text?", "follow_up_response": "the onset of disease", "follow_up_response_bt": "the onset of the disease"}, {"question_id": "8.2", "question": "Who are the clinicians affected by the limitations of the techniques mentioned?", "answer_src": "this makes it difficult to diagnose the onset of disease . such techniques measure only what the clinician wants or expects to see . a technique which can provide more information , regarding the influence of a medical condition upon the body 's whole function , may be invaluable to the clinician .", "follow_up_question": "What kind of information might a technique providing more comprehensive data reveal?", "follow_up_response": "Regarding the influence of a medical condition upon the body's whole function", "follow_up_response_bt": "The influence of a medical condition on the entire function of the body"}, {"question_id": "8.3", "question": "Where might these techniques be applied in medical diagnosis?", "answer_src": "this makes it difficult to diagnose the onset of disease . such techniques measure only what the clinician wants or expects to see . a technique which can provide more information , regarding the influence of a medical condition upon the body 's whole function , may be invaluable to the clinician .", "follow_up_question": "What kind of information might a technique providing more comprehensive body function influence be useful for?", "follow_up_response": "the influence of a medical condition upon the body's whole function", "follow_up_response_bt": "treatment"}, {"question_id": "8.4", "question": "When could this limitation in diagnostic methods become problematic?", "answer_src": "this makes it difficult to diagnose the onset of disease . such techniques measure only what the clinician wants or expects to see . a technique which can provide more information , regarding the influence of a medical condition upon the body 's whole function , may be invaluable to the clinician .", "follow_up_question": "What specific aspects of a medical condition might such techniques reveal that current methods cannot?", "follow_up_response": "the influence of a medical condition upon the body's whole function", "follow_up_response_bt": "The influence of a medical condition on the entire function of the body"}, {"question_id": "8.5", "question": "Which type of diagnostic method is implied to provide more comprehensive information?", "answer_src": "this makes it difficult to diagnose the onset of disease . such techniques measure only what the clinician wants or expects to see . a technique which can provide more information , regarding the influence of a medical condition upon the body 's whole function , may be invaluable to the clinician .", "follow_up_question": "What kind of information does the technique described in the text provide?", "follow_up_response": "regarding the influence of a medical condition upon the body's whole function", "follow_up_response_bt": "more information about the influence of a medical condition on the entire function of the body"}], "turn_2": [{"question_id": "8.6", "question": "What specific aspect of the onset of disease becomes difficult to diagnose according to the text?", "answer_src": "the onset of disease", "follow_up_question": "How does the described technique limit the clinician's ability to diagnose?", "follow_up_response": "it makes it difficult to diagnose the onset of disease", "follow_up_response_bt": "It only measures what the doctor wants or expects to see"}, {"question_id": "8.7", "question": "What kind of information might a technique providing more comprehensive data reveal?", "answer_src": "Regarding the influence of a medical condition upon the body's whole function", "follow_up_question": "How might this additional information benefit the clinician?", "follow_up_response": "Regarding the influence of a medical condition upon the body's whole function", "follow_up_response_bt": "Significantly improve treatment"}, {"question_id": "8.8", "question": "What kind of information might a technique providing more comprehensive body function influence be useful for?", "answer_src": "the influence of a medical condition upon the body's whole function", "follow_up_question": "How might this additional information benefit the diagnosis process?", "follow_up_response": "provide more information regarding the influence of a medical condition upon the body's whole function", "follow_up_response_bt": "A technique that can provide more information about the influence of a medical condition on the entire function of the body can be invaluable to the doctor and significantly improve treatment."}, {"question_id": "8.9", "question": "What specific aspects of a medical condition might such techniques reveal that current methods cannot?", "answer_src": "the influence of a medical condition upon the body's whole function", "follow_up_question": "How might this additional information benefit the clinician?", "follow_up_response": "Regarding the influence of a medical condition upon the body's whole function", "follow_up_response_bt": "Significantly improve treatment"}, {"question_id": "8.10", "question": "What kind of information does the technique described in the text provide?", "answer_src": "regarding the influence of a medical condition upon the body's whole function", "follow_up_question": "How might this additional information benefit the clinician?", "follow_up_response": "Regarding the influence of a medical condition upon the body's whole function", "follow_up_response_bt": "Significantly improve treatment"}], "turn_3": [{"question_id": "8.11", "question": "How does the described technique limit the clinician's ability to diagnose?", "answer_src": "it makes it difficult to diagnose the onset of disease", "follow_up_question": "What specific information is the described technique unable to provide?", "follow_up_response": "the influence of a medical condition upon the body's whole function", "follow_up_response_bt": "What the doctor wants or expects to see"}, {"question_id": "8.12", "question": "How might this additional information benefit the clinician?", "answer_src": "Regarding the influence of a medical condition upon the body's whole function", "follow_up_question": "What specific aspects of the medical condition could this information reveal?", "follow_up_response": "the influence of a medical condition upon the body's whole function", "follow_up_response_bt": "the influence of a medical condition on the entire function of the body"}, {"question_id": "8.13", "question": "How might this additional information benefit the diagnosis process?", "answer_src": "provide more information regarding the influence of a medical condition upon the body's whole function", "follow_up_question": "What specific aspects of the medical condition could this additional information reveal?", "follow_up_response": "the influence of a medical condition upon the body's whole function", "follow_up_response_bt": "The influence of a medical condition on the entire function of the body"}, {"question_id": "8.14", "question": "How might this additional information benefit the clinician?", "answer_src": "Regarding the influence of a medical condition upon the body's whole function", "follow_up_question": "What specific aspects of the medical condition could this information reveal?", "follow_up_response": "the influence of a medical condition upon the body's whole function", "follow_up_response_bt": "the influence of a medical condition on the entire function of the body"}, {"question_id": "8.15", "question": "How might this additional information benefit the clinician?", "answer_src": "Regarding the influence of a medical condition upon the body's whole function", "follow_up_question": "What specific aspects of the medical condition could this information reveal?", "follow_up_response": "the influence of a medical condition upon the body's whole function", "follow_up_response_bt": "the influence of a medical condition on the entire function of the body"}]}}
{"id": 9, "src": "[ purpose ] this study compared the analgesic effects of extracorporeal shock wave therapy with those of ultrasound therapy in patients with chronic tennis elbow . [ subjects ] fifty patients with tennis elbow were randomized to receive extracorporeal shock wave therapy or ultrasound therapy . [ methods ] the extracorporeal shock wave therapy group received 5 treatments once per week .", "mt": "[ scopo ] questo studio ha confrontato gli effetti analgesici della terapia con onde d'urto extracorporee con quelli dell' ecografia nei pazienti con gomito cronica di tennis . [ soggetti ] cinquanta pazienti con gomito di tennis sono stati randomizzati per ricevere terapia con onde d'urto extracorporee o terapia con ultrasoni . [ metodi ] il gruppo di terapia con onde d'urto extracorporee ha ricevuto 5 trattamenti una volta alla settimana .", "pert_mt": "[ scopo ] questo studio ha confrontato gli effetti analgesici della terapia con onde d'urto extracorporee con quelli dell' ecografia nei pazienti con gomito cronica di tennis. [ soggetti ] cinquanta pazienti con gomito di tennis sono stati randomizzati per ricevere terapia con onde d'urto extracorporee o terapia con ultrasoni. [ metodi ] il gruppo di terapia con onde d'urto extracorporee ha ricevuto 5 trattamenti una volta alla settimana e ha mostrato miglioramenti significativi.", "bt": "This study compared the analgesic effects of extracorporeal shock therapy with those of ultrasound in patients with chronic tennis elbow. Fifty patients with tennis elbow were randomized to receive either extracorporeal shock therapy or ultrasound therapy. The extracorporeal shock therapy group received 5 treatments once a week and showed significant improvements.", "questions_src": ["What was the main subject of the study?", "Who were the participants in the study?", "Where did the study take place?", "When were the treatments administered?", "Which treatment group received more treatments?"], "answers_src": ["Comparison of analgesic effects of extracorporeal shock wave therapy and ultrasound therapy in patients with chronic tennis elbow", "Fifty patients with tennis elbow", "Not specified in the sentence", "Once per week", "Extracorporeal shock wave therapy"], "answers_bt": ["The analgesic effects of extracorporeal shock therapy and ultrasound in patients with chronic tennis elbow", "Fifty patients with tennis elbow", "Not specified in the sentence", "Once a week", "Extracorporeal shock therapy"], "multiturn": {"turn_1": [{"question_id": "9.1", "question": "What was the main subject of the study?", "answer_src": "Comparison of analgesic effects of extracorporeal shock wave therapy and ultrasound therapy in patients with chronic tennis elbow", "follow_up_question": "How many treatments did the extracorporeal shock wave therapy group receive?", "follow_up_response": "5", "follow_up_response_bt": "5"}, {"question_id": "9.2", "question": "Who were the participants in the study?", "answer_src": "Fifty patients with tennis elbow", "follow_up_question": "How many treatments did the extracorporeal shock wave therapy group receive?", "follow_up_response": "5", "follow_up_response_bt": "5"}, {"question_id": "9.3", "question": "Where did the study take place?", "answer_src": "Not specified in the sentence", "follow_up_question": "How many treatments did the extracorporeal shock wave therapy group receive?", "follow_up_response": "5", "follow_up_response_bt": "5"}, {"question_id": "9.4", "question": "When were the treatments administered?", "answer_src": "Once per week", "follow_up_question": "How many total treatments did each patient receive?", "follow_up_response": "5", "follow_up_response_bt": "5"}, {"question_id": "9.5", "question": "Which treatment group received more treatments?", "answer_src": "Extracorporeal shock wave therapy", "follow_up_question": "How many treatments did the extracorporeal shock wave therapy group receive?", "follow_up_response": "5", "follow_up_response_bt": "5"}], "turn_2": [{"question_id": "9.6", "question": "How many treatments did the extracorporeal shock wave therapy group receive?", "answer_src": "5", "follow_up_question": "How often were the treatments administered?", "follow_up_response": "once per week", "follow_up_response_bt": "once a week"}, {"question_id": "9.7", "question": "How many treatments did the extracorporeal shock wave therapy group receive?", "answer_src": "5", "follow_up_question": "How often were the treatments administered?", "follow_up_response": "once per week", "follow_up_response_bt": "once a week"}, {"question_id": "9.8", "question": "How many treatments did the extracorporeal shock wave therapy group receive?", "answer_src": "5", "follow_up_question": "How often were the treatments administered?", "follow_up_response": "once per week", "follow_up_response_bt": "once a week"}, {"question_id": "9.9", "question": "How many total treatments did each patient receive?", "answer_src": "5", "follow_up_question": "How often were the treatments administered?", "follow_up_response": "once per week", "follow_up_response_bt": "once a week"}, {"question_id": "9.10", "question": "How many treatments did the extracorporeal shock wave therapy group receive?", "answer_src": "5", "follow_up_question": "How often were the treatments administered?", "follow_up_response": "once per week", "follow_up_response_bt": "once a week"}], "turn_3": [{"question_id": "9.11", "question": "How often were the treatments administered?", "answer_src": "once per week", "follow_up_question": "How many total treatments did each patient receive?", "follow_up_response": "5", "follow_up_response_bt": "5"}, {"question_id": "9.12", "question": "How often were the treatments administered?", "answer_src": "once per week", "follow_up_question": "How many total treatments did each patient receive?", "follow_up_response": "5", "follow_up_response_bt": "5"}, {"question_id": "9.13", "question": "How often were the treatments administered?", "answer_src": "once per week", "follow_up_question": "How many total treatments did each patient receive?", "follow_up_response": "5", "follow_up_response_bt": "5"}, {"question_id": "9.14", "question": "How often were the treatments administered?", "answer_src": "once per week", "follow_up_question": "How many total treatments did each patient receive?", "follow_up_response": "5", "follow_up_response_bt": "5"}, {"question_id": "9.15", "question": "How often were the treatments administered?", "answer_src": "once per week", "follow_up_question": "How many total treatments did each patient receive?", "follow_up_response": "5", "follow_up_response_bt": "5"}]}}
{"id": 10, "src": "a 43-year - old , who underwent a subtotal hysterectomy for postpartum hemorrhage following a normal delivery , 10 years ago , presented with a history of persistent vaginal discharge and post - coital bleeding . a pap smear reported moderate dysplasia , and a subsequent colposcopic biopsy reported severe dysplasia with crypt extension . the patient underwent a laparoscopic trachelectomy , and histology of the stump reported cervical squamous carcinoma in situ , with no microinvasion .", "mt": "Una 43enne , che ha subito un' isteretomia subtotale per emorragia postpartum dopo un parto normale , 10 anni fa , ha presentato una storia di scarico vaginale persistente e sanguinamento post-coitale . un esame pap reported moderata displasia , e una successiva biopsia colposcopica reportato grave displasia con estensione della cripta . il paziente ha subito una tracheletomia laparoscopica , e la histologia della stoma ha riferito carcinoma squamo cervicale in situ , senza microinvasione .", "pert_mt": "Una 43enne , che ha subito un' isteretomia subtotale per emorragia postpartum dopo un parto normale , 10 anni fa , ha presentato una storia di scarico vaginale persistente e sanguinamento post-coitale . un esame pap reported moderata displasia , e una successiva biopsia colposcopica reportato grave displasia con estensione della cripta . il paziente ha subito una tracheletomia laparoscopica , e la histologia della stoma ha riferito carcinoma squamo cervicale in situ , senza microinvasione . La paziente ha inoltre seguito un trattamento con farmaci antiinfiammatori non steroidei per il dolore.", "bt": "A 43-year-old woman who had undergone a subtotal hysterectomy for postpartum hemorrhage after a normal delivery , 10 years ago , presented a history of persistent vaginal scarico and post-coital bleeding . A pap test reported moderate dysplasia , and a subsequent colposcopica biopsy reported severe dysplasia with cryptographic extension . The patient had a laparoscopic tracheletomy , and the histology of the stomach reported on-site cervical squamo carcinoma without microinvasions . The patient also followed treatment with anti-inflammatory drugs that did not kill steroids for pain.", "questions_src": ["What type of surgery did the patient undergo 10 years ago?", "Who was the patient before the subtotal hysterectomy?", "Where is the persistent vaginal discharge originating from?", "When did the patient experience post-coital bleeding?", "Which condition was reported by the pap smear?"], "answers_src": ["Subtotal hysterectomy", "A 43-year-old", "The cervix", "10 years ago", "Moderate dysplasia"], "answers_bt": ["Subtotal hysterectomy", "A 43-year-old woman", "Vaginal", "10 years ago", "Moderate dysplasia"], "multiturn": {"turn_1": [{"question_id": "10.1", "question": "What type of surgery did the patient undergo 10 years ago?", "answer_src": "Subtotal hysterectomy", "follow_up_question": "What was the outcome of the colposcopic biopsy?", "follow_up_response": "Severe dysplasia with crypt extension", "follow_up_response_bt": "Severe dysplasia with cryptographic extension"}, {"question_id": "10.2", "question": "Who was the patient before the subtotal hysterectomy?", "answer_src": "A 43-year-old", "follow_up_question": "What procedure did the patient undergo after the subtotal hysterectomy?", "follow_up_response": "Laparoscopic trachelectomy", "follow_up_response_bt": "Subtotal hysterectomy"}, {"question_id": "10.3", "question": "Where is the persistent vaginal discharge originating from?", "answer_src": "The cervix", "follow_up_question": "What type of cancer was found in the cervical tissue?", "follow_up_response": "Cervical squamous carcinoma in situ", "follow_up_response_bt": "Cervical squamous cell carcinoma"}, {"question_id": "10.4", "question": "When did the patient experience post-coital bleeding?", "answer_src": "10 years ago", "follow_up_question": "What was the diagnosis after the colposcopic biopsy?", "follow_up_response": "Severe dysplasia with crypt extension", "follow_up_response_bt": "Severe dysplasia with cryptographic extension"}, {"question_id": "10.5", "question": "Which condition was reported by the pap smear?", "answer_src": "Moderate dysplasia", "follow_up_question": "What was the result of the subsequent colposcopic biopsy?", "follow_up_response": "Severe dysplasia with crypt extension", "follow_up_response_bt": "Severe dysplasia with cryptographic extension"}], "turn_2": [{"question_id": "10.6", "question": "What was the outcome of the colposcopic biopsy?", "answer_src": "Severe dysplasia with crypt extension", "follow_up_question": "What type of cancer was found in the cervical stump?", "follow_up_response": "Cervical squamous carcinoma in situ", "follow_up_response_bt": "Cervical squamous cell carcinoma"}, {"question_id": "10.7", "question": "What procedure did the patient undergo after the subtotal hysterectomy?", "answer_src": "Laparoscopic trachelectomy", "follow_up_question": "What type of cancer was found during the histology of the cervical stump?", "follow_up_response": "Cervical squamous carcinoma in situ", "follow_up_response_bt": "On-site cervical squamous cell carcinoma"}, {"question_id": "10.8", "question": "What type of cancer was found in the cervical tissue?", "answer_src": "Cervical squamous carcinoma in situ", "follow_up_question": "What is the significance of the absence of microinvasion in the cancer diagnosis?", "follow_up_response": "No Answer", "follow_up_response_bt": "The absence of microinvasion indicates that the cancer has not invaded the surrounding tissues."}, {"question_id": "10.9", "question": "What was the diagnosis after the colposcopic biopsy?", "answer_src": "Severe dysplasia with crypt extension", "follow_up_question": "What type of cancer was found in the cervical stump?", "follow_up_response": "Cervical squamous carcinoma in situ", "follow_up_response_bt": "Cervical squamous cell carcinoma"}, {"question_id": "10.10", "question": "What was the result of the subsequent colposcopic biopsy?", "answer_src": "Severe dysplasia with crypt extension", "follow_up_question": "What type of cancer was found in the cervical stump?", "follow_up_response": "Cervical squamous carcinoma in situ", "follow_up_response_bt": "Cervical squamous cell carcinoma"}], "turn_3": [{"question_id": "10.11", "question": "What type of cancer was found in the cervical stump?", "answer_src": "Cervical squamous carcinoma in situ", "follow_up_question": "What is the significance of the absence of microinvasion in the cervical squamous carcinoma in situ?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "10.12", "question": "What type of cancer was found during the histology of the cervical stump?", "answer_src": "Cervical squamous carcinoma in situ", "follow_up_question": "What is the significance of the absence of microinvasion in the histology report?", "follow_up_response": "There is no microinvasion", "follow_up_response_bt": "There is no microinvasion"}, {"question_id": "10.13", "question": "What is the significance of the absence of microinvasion in the cancer diagnosis?", "answer_src": "a 43-year - old , who underwent a subtotal hysterectomy for postpartum hemorrhage following a normal delivery , 10 years ago , presented with a history of persistent vaginal discharge and post - coital bleeding . a pap smear reported moderate dysplasia , and a subsequent colposcopic biopsy reported severe dysplasia with crypt extension . the patient underwent a laparoscopic trachelectomy , and histology of the stump reported cervical squamous carcinoma in situ , with no microinvasion .", "follow_up_question": "What type of cancer was diagnosed at the stump?", "follow_up_response": "Cervical squamous carcinoma in situ", "follow_up_response_bt": "Cervical squamo carcinoma"}, {"question_id": "10.14", "question": "What type of cancer was found in the cervical stump?", "answer_src": "Cervical squamous carcinoma in situ", "follow_up_question": "What is the significance of the absence of microinvasion in the cervical squamous carcinoma in situ?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "10.15", "question": "What type of cancer was found in the cervical stump?", "answer_src": "Cervical squamous carcinoma in situ", "follow_up_question": "What is the significance of the absence of microinvasion in the cervical squamous carcinoma in situ?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 11, "src": "[ purpose ] the purpose of this study was to investigate the differences in symmetry of sitting posture between typical developmental ( td ) children and hemi - cerebral palsy ( cp ) children . [ subjects and methods ] a school chair mounted on a force platform was used to assess the quiet - sitting pressure distribution of 10 td and 10 cp children . [ results ] the symmetry index of the td children was significantly closer to zero than that of the cp children irrespective of the latter group s hemiparetic side . [", "mt": "[ scopo ] lo scopo di questo studio era di studiare le differenze di simmetria della postura seduta tra i bambini tipici di sviluppo (td) e i bambini con paralisi cerebrale (cp). [ soggetti e metodi ] una sedia di scuola montata su una piattaforma di forza è stata utilizzata per valutare la distribuzione della pressione seduta silenziosa di 10 bambini di sviluppo (td) e 10 bambini di sviluppo (cp). [ risultati ] l'indice di simmetria dei bambini di sviluppo (td) era significativamente più vicino a zero rispetto a quello dei bambini di sviluppo (cp) indipendentemente dal lato emiparatico di quest'ultimo gruppo . [ risultati ]", "pert_mt": "[ scopo ] lo scopo di questo studio era di studiare le differenze di simmetria della postura seduta tra i bambini tipici di sviluppo (td) e i bambini con paralisi cerebrale (cp). Inoltre, si è verificato un'importante differenza nella distribuzione della pressione seduta tra i due gruppi. [ soggetti e metodi ] una sedia di scuola montata su una piattaforma di forza è stata utilizzata per valutare la distribuzione della pressione seduta silenziosa di 10 bambini di sviluppo (td) e 10 bambini di sviluppo (cp). [ risultati ] l'indice di simmetria dei bambini di sviluppo (td) era significativamente più vicino a zero rispetto a quello dei bambini di sviluppo (cp", "bt": "The purpose of this study was to study the differences in sitting posture symmetry between typical developmental children (td) and children with cerebral palsy (cp).[specify] In addition, an important difference in the distribution of sitting pressure between the two groups was observed. [subjects and methods] A school chair mounted on a force platform was used to evaluate the silent sitting pressure distribution of 10 developmental children (td) and 10 developmental children (cp).[results] The developmental children's symmetry index (td) was significantly closer to zero than that of developmental children (cp)", "questions_src": ["What was the main purpose of the study?", "Where was the force platform placed during the assessment?", "Which group had a symmetry index closer to zero?", "When were the cp children assessed?", "Who were the participants in the study?"], "answers_src": ["[\"to investigate the differences in symmetry of sitting posture between typical developmental (td) children and hemi-cerebral palsy (cp) children\", \"a school chair mounted on a force platform\", \"the td children\", \"the latter group\"s hemiparetic side is unspecified\", \"10 td and 10 cp children\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["To study the differences in sitting posture symmetry between typical developmental children and children with cerebral palsy", "On a school chair", "Developmental children (td)", "No Answer", "10 developmental children (td) and 10 developmental children (cp)"], "multiturn": {"turn_1": [{"question_id": "11.1", "question": "What was the main purpose of the study?", "answer_src": "[\"to investigate the differences in symmetry of sitting posture between typical developmental (td) children and hemi-cerebral palsy (cp) children\", \"a school chair mounted on a force platform\", \"the td children\", \"the latter group\"s hemiparetic side is unspecified\", \"10 td and 10 cp children\"]", "follow_up_question": "How did the symmetry index of the cp children compare to that of the td children?", "follow_up_response": "the symmetry index of the cp children was significantly closer to zero than that of the td children", "follow_up_response_bt": "The symmetry index of cp children was significantly closer to zero than that of td children."}, {"question_id": "11.2", "question": "Where was the force platform placed during the assessment?", "answer_src": "[ purpose ] the purpose of this study was to investigate the differences in symmetry of sitting posture between typical developmental ( td ) children and hemi - cerebral palsy ( cp ) children . [ subjects and methods ] a school chair mounted on a force platform was used to assess the quiet - sitting pressure distribution of 10 td and 10 cp children . [ results ] the symmetry index of the td children was significantly closer to zero than that of the cp children irrespective of the latter group s hemiparetic side . [", "follow_up_question": "What was the symmetry index of the cp children?", "follow_up_response": "No Answer", "follow_up_response_bt": "significantly closer to zero"}, {"question_id": "11.3", "question": "Which group had a symmetry index closer to zero?", "answer_src": "[ purpose ] the purpose of this study was to investigate the differences in symmetry of sitting posture between typical developmental ( td ) children and hemi - cerebral palsy ( cp ) children . [ subjects and methods ] a school chair mounted on a force platform was used to assess the quiet - sitting pressure distribution of 10 td and 10 cp children . [ results ] the symmetry index of the td children was significantly closer to zero than that of the cp children irrespective of the latter group s hemiparetic side . [", "follow_up_question": "Which cp children had a symmetry index farther from zero?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "11.4", "question": "When were the cp children assessed?", "answer_src": "[ purpose ] the purpose of this study was to investigate the differences in symmetry of sitting posture between typical developmental ( td ) children and hemi - cerebral palsy ( cp ) children . [ subjects and methods ] a school chair mounted on a force platform was used to assess the quiet - sitting pressure distribution of 10 td and 10 cp children . [ results ] the symmetry index of the td children was significantly closer to zero than that of the cp children irrespective of the latter group s hemiparetic side . [", "follow_up_question": "What was the symmetry index for the cp children?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "11.5", "question": "Who were the participants in the study?", "answer_src": "[ purpose ] the purpose of this study was to investigate the differences in symmetry of sitting posture between typical developmental ( td ) children and hemi - cerebral palsy ( cp ) children . [ subjects and methods ] a school chair mounted on a force platform was used to assess the quiet - sitting pressure distribution of 10 td and 10 cp children . [ results ] the symmetry index of the td children was significantly closer to zero than that of the cp children irrespective of the latter group s hemiparetic side . [", "follow_up_question": "What was the average symmetry index for the typical development children compared to the hemiplegia children?", "follow_up_response": "the symmetry index of the td children was significantly closer to zero than that of the cp children", "follow_up_response_bt": "The developmental children's symmetry index (td) was significantly closer to zero than that of developmental children (cp)"}], "turn_2": [{"question_id": "11.6", "question": "How did the symmetry index of the cp children compare to that of the td children?", "answer_src": "the symmetry index of the cp children was significantly closer to zero than that of the td children", "follow_up_question": "What was the average symmetry index for the td children?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "11.7", "question": "What was the symmetry index of the cp children?", "answer_src": "[ purpose ] the purpose of this study was to investigate the differences in symmetry of sitting posture between typical developmental ( td ) children and hemi - cerebral palsy ( cp ) children . [ subjects and methods ] a school chair mounted on a force platform was used to assess the quiet - sitting pressure distribution of 10 td and 10 cp children . [ results ] the symmetry index of the td children was significantly closer to zero than that of the cp children irrespective of the latter group s hemiparetic side . [", "follow_up_question": "What was the symmetry index of the td children?", "follow_up_response": "significantly closer to zero", "follow_up_response_bt": "significantly closer to zero"}, {"question_id": "11.8", "question": "Which cp children had a symmetry index farther from zero?", "answer_src": "[ purpose ] the purpose of this study was to investigate the differences in symmetry of sitting posture between typical developmental ( td ) children and hemi - cerebral palsy ( cp ) children . [ subjects and methods ] a school chair mounted on a force platform was used to assess the quiet - sitting pressure distribution of 10 td and 10 cp children . [ results ] the symmetry index of the td children was significantly closer to zero than that of the cp children irrespective of the latter group s hemiparetic side . [", "follow_up_question": "Which td children had a symmetry index closer to zero?", "follow_up_response": "No Answer", "follow_up_response_bt": "Developmental children (td)"}, {"question_id": "11.9", "question": "What was the symmetry index for the cp children?", "answer_src": "[ purpose ] the purpose of this study was to investigate the differences in symmetry of sitting posture between typical developmental ( td ) children and hemi - cerebral palsy ( cp ) children . [ subjects and methods ] a school chair mounted on a force platform was used to assess the quiet - sitting pressure distribution of 10 td and 10 cp children . [ results ] the symmetry index of the td children was significantly closer to zero than that of the cp children irrespective of the latter group s hemiparetic side . [", "follow_up_question": "What was the symmetry index for the td children?", "follow_up_response": "significantly closer to zero", "follow_up_response_bt": "significantly closer to zero"}, {"question_id": "11.10", "question": "What was the average symmetry index for the typical development children compared to the hemiplegia children?", "answer_src": "the symmetry index of the td children was significantly closer to zero than that of the cp children", "follow_up_question": "What was the difference in symmetry index between the hemiplegia children's left and right sides?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "11.11", "question": "What was the average symmetry index for the td children?", "answer_src": "[ purpose ] the purpose of this study was to investigate the differences in symmetry of sitting posture between typical developmental ( td ) children and hemi - cerebral palsy ( cp ) children . [ subjects and methods ] a school chair mounted on a force platform was used to assess the quiet - sitting pressure distribution of 10 td and 10 cp children . [ results ] the symmetry index of the td children was significantly closer to zero than that of the cp children irrespective of the latter group s hemiparetic side . [", "follow_up_question": "What was the symmetry index for the cp children?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "11.12", "question": "What was the symmetry index of the td children?", "answer_src": "significantly closer to zero", "follow_up_question": "What was the symmetry index of the cp children?", "follow_up_response": "No Answer", "follow_up_response_bt": "significantly closer to zero"}, {"question_id": "11.13", "question": "Which td children had a symmetry index closer to zero?", "answer_src": "[ purpose ] the purpose of this study was to investigate the differences in symmetry of sitting posture between typical developmental ( td ) children and hemi - cerebral palsy ( cp ) children . [ subjects and methods ] a school chair mounted on a force platform was used to assess the quiet - sitting pressure distribution of 10 td and 10 cp children . [ results ] the symmetry index of the td children was significantly closer to zero than that of the cp children irrespective of the latter group s hemiparetic side . [", "follow_up_question": "Which cp children had a symmetry index farther from zero?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "11.14", "question": "What was the symmetry index for the td children?", "answer_src": "significantly closer to zero", "follow_up_question": "What was the symmetry index for the cp children?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "11.15", "question": "What was the difference in symmetry index between the hemiplegia children's left and right sides?", "answer_src": "[ purpose ] the purpose of this study was to investigate the differences in symmetry of sitting posture between typical developmental ( td ) children and hemi - cerebral palsy ( cp ) children . [ subjects and methods ] a school chair mounted on a force platform was used to assess the quiet - sitting pressure distribution of 10 td and 10 cp children . [ results ] the symmetry index of the td children was significantly closer to zero than that of the cp children irrespective of the latter group s hemiparetic side . [", "follow_up_question": "How much closer was the symmetry index of the td children to zero compared to the cp children?", "follow_up_response": "significantly", "follow_up_response_bt": "The symmetry index of the td children was significantly closer to zero than that of the cp children."}]}}
{"id": 12, "src": "ureterosciatic herniation , the protrusion of the hernia sac through the sciatic foramen , is an extremely rare cause of ureteral obstruction . we describe a case revealed by severe left back pain in a 72-year - old female . she was referred to our hospital for urological assessment of left hydronephrosis observed by ultrasonography .", "mt": "L' ernia ureterosciatica , la protrusione del sacco di ernia attraverso il forame sciatico , è una causa estremamente rara di ostruzione ureterale . descriviamo un caso rivelato da forti dolori alla schiena sinistra in una donna di 72 anni .", "pert_mt": "L'ernia ureterosciatica, la protrusione del sacco di ernia attraverso il forame sciatico, è una causa estremamente rara di ostruzione ureterale. Descriviamo un caso rivelato da forti dolori alla schiena sinistra in una donna di 72 anni e da sintomi gastrointestinali.", "bt": "Ureterosciatic hernia, the protrusion of the hernia sac through the sciatic foramen, is an extremely rare cause of ureteral obstruction. We describe a case revealed by severe pain in the left back in a 72-year-old woman and gastrointestinal symptoms.", "questions_src": ["What is the medical term for the protrusion of the hernia sac through the sciatic foramen?", "Who was the patient described in the case study?", "Where did the severe left back pain occur?", "When was the patient referred to the hospital?", "Which type of obstruction was identified in the patient?"], "answers_src": ["Ureterosciatic herniation", "A 72-year-old female", "Left back", "Not specified in the sentence", "Ureteral"], "answers_bt": ["Ureterosciatic hernia", "A 72-year-old woman", "In the left back", "No Answer", "Ureteral"], "multiturn": {"turn_1": [{"question_id": "12.1", "question": "What is the medical term for the protrusion of the hernia sac through the sciatic foramen?", "answer_src": "Ureterosciatic herniation", "follow_up_question": "What anatomical structure is typically obstructed due to a ureterosciatic herniation?", "follow_up_response": "Ureter", "follow_up_response_bt": "Ureter"}, {"question_id": "12.2", "question": "Who was the patient described in the case study?", "answer_src": "A 72-year-old female", "follow_up_question": "What specific symptom led to her referral to the hospital?", "follow_up_response": "Severe left back pain", "follow_up_response_bt": "Severe pain in the left back"}, {"question_id": "12.3", "question": "Where did the severe left back pain occur?", "answer_src": "Left back", "follow_up_question": "What specific anatomical structure was involved in the herniation?", "follow_up_response": "ureter", "follow_up_response_bt": "Ureter"}, {"question_id": "12.4", "question": "When was the patient referred to the hospital?", "answer_src": "Not specified in the sentence", "follow_up_question": "What specific symptom led to the patient's referral?", "follow_up_response": "Severe left back pain", "follow_up_response_bt": "Severe pain in the left back"}, {"question_id": "12.5", "question": "Which type of obstruction was identified in the patient?", "answer_src": "Ureteral", "follow_up_question": "What was the initial symptom that led to the patient's referral?", "follow_up_response": "Severe left back pain", "follow_up_response_bt": "Severe pain in the left back"}], "turn_2": [{"question_id": "12.6", "question": "What anatomical structure is typically obstructed due to a ureterosciatic herniation?", "answer_src": "Ureter", "follow_up_question": "What specific symptom led to the patient's referral to the hospital?", "follow_up_response": "Severe left back pain", "follow_up_response_bt": "Severe pain in the left back"}, {"question_id": "12.7", "question": "What specific symptom led to her referral to the hospital?", "answer_src": "Severe left back pain", "follow_up_question": "What was the initial ultrasound finding that prompted her referral?", "follow_up_response": "Left hydronephrosis", "follow_up_response_bt": "No Answer"}, {"question_id": "12.8", "question": "What specific anatomical structure was involved in the herniation?", "answer_src": "ureter", "follow_up_question": "What symptoms led to the patient's referral to the hospital?", "follow_up_response": "Severe left back pain", "follow_up_response_bt": "Severe pain in the left back and gastrointestinal symptoms"}, {"question_id": "12.9", "question": "What specific symptom led to the patient's referral?", "answer_src": "Severe left back pain", "follow_up_question": "What was the initial ultrasound finding that prompted the patient's referral?", "follow_up_response": "Left hydronephrosis", "follow_up_response_bt": "No Answer"}, {"question_id": "12.10", "question": "What was the initial symptom that led to the patient's referral?", "answer_src": "Severe left back pain", "follow_up_question": "What specific anatomical structure was involved in the patient's ureteral obstruction?", "follow_up_response": "ureterosciatic herniation", "follow_up_response_bt": "Ureteroscial hernia"}], "turn_3": [{"question_id": "12.11", "question": "What specific symptom led to the patient's referral to the hospital?", "answer_src": "Severe left back pain", "follow_up_question": "What was the initial ultrasound finding that prompted the patient's referral?", "follow_up_response": "Left hydronephrosis", "follow_up_response_bt": "No Answer"}, {"question_id": "12.12", "question": "What was the initial ultrasound finding that prompted her referral?", "answer_src": "Left hydronephrosis", "follow_up_question": "What was the primary symptom that led to her severe left back pain?", "follow_up_response": "Severe left back pain", "follow_up_response_bt": "Severe pain"}, {"question_id": "12.13", "question": "What symptoms led to the patient's referral to the hospital?", "answer_src": "Severe left back pain", "follow_up_question": "What specific anatomical area was affected by the severe left back pain?", "follow_up_response": "the sciatic foramen", "follow_up_response_bt": "The sciatic foramen"}, {"question_id": "12.14", "question": "What was the initial ultrasound finding that prompted the patient's referral?", "answer_src": "Left hydronephrosis", "follow_up_question": "What specific symptom led to the patient experiencing severe left back pain?", "follow_up_response": "Severe left back pain", "follow_up_response_bt": "Severe pain"}, {"question_id": "12.15", "question": "What specific anatomical structure was involved in the patient's ureteral obstruction?", "answer_src": "ureterosciatic herniation", "follow_up_question": "What part of the sciatic nerve is affected in this condition?", "follow_up_response": "Sciatic foramen", "follow_up_response_bt": "Sciatic foramen"}]}}
{"id": 13, "src": "resistance to commonly used antibiotics by enterococci causing nosocomial infections is of concern , which necessitates judicious , responsible and evidence - based use of antibiotics . the present study was conducted to review the prevalence and identify therapeutic options for nosocomial enterococcal infections in our tertiary care hospital.isolates identified by morphological and biochemical characteristics were tested for antibiotic susceptibility using kirby - bauer method.153 of 2096 culture positive clinical samples comprised of 101 urine , 30 wound swab / pus , 13 blood and 09 high vaginal swab isolates were identified as enterococcus faecalis ( 90.85% ) , enterococcus faecium ( 8.50% ) and enterococcus gallinarum ( 0.65% ) . enterococci accounted for 8.45% , 4.53% , 4.23% , 4.43% of urinary , wound swab or pus , blood , high vaginal swab isolates respectively , causing 7.3% of all nosocomial infections .", "mt": "Il presente studio è stato condotto per rivedere la prevalenza e identificare le opzioni terapeutiche per le infezioni enterococciche nosocomie nel nostro ospedale di cure terziarie.I isolati identificati dalle caratteristiche morfologiche e biochimiche sono stati testati per la suscettibilità agli antibiotici utilizzando il metodo kirby-bauer.153 dei 2096 campioni clinici positivi della cultura composti da 101 urine , 30 tamponi / pus , 13 isolati di sangue e 09 tamponi vaginali sono stati identificati come faecalis enterococci (90,85%), fae enterococci (8,50%) e enterococcius galluminar (0,65%).", "pert_mt": "Il presente studio è stato condotto per rivedere la prevalenza e identificare le opzioni terapeutiche per le infezioni enterococciche nosocomiali nel nostro ospedale di cure terziarie. I isolati identificati dalle caratteristiche morfologiche e biochimiche sono stati testati per la suscettibilità agli antibiotici utilizzando il metodo kirby-bauer. Inoltre, abbiamo analizzato l'efficacia delle diverse linee terapeutiche.153 dei 2096 campioni clinici positivi della cultura composti da 101 urine, 30 tamponi/pus, 13 isolati di sangue e 09 tamponi vaginali sono stati identificati come faecalis enterococci (90,85%), fae enterococci (8,50%) e enterococcius", "bt": "The present study was conducted to review the prevalence and identify treatment options for nosocomial enterococci infections in our tertiary care hospital.The isolates identified by morphological and biochemical characteristics were tested for antibiotic susceptibility using the kirby-bauer method.Moreover, we analyzed the effectiveness of the various therapeutic lines.153 of the 2096 positive clinical samples of the culture composed of 101 urine, 30 tampons/pus, 13 blood isolates and 09 vaginal tampons were identified as faecalis enterococci (90.85%), fae enterococci (8.50%) and enterococcius.", "questions_src": ["What is the Kirby-Bauer method used for?", "Who causes nosocomial infections according to the sentence?", "Where can enterococci be isolated from the clinical samples?", "When was the present study conducted?", "Which two species of enterococci were found in the study?"], "answers_src": ["[\"To test antibiotic susceptibility\"], [\"Enterococci\"], [\"Urine, wound swab / pus, blood, and high vaginal swab\"], [\"The present study was conducted\"], [\"Enterococcus faecalis and Enterococcus faecium\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["To test antibiotic susceptibility", "Nosocomial infections", "Urine, tampons/pus, blood isolates and vaginal tampons", "The present study", "faecalis enterococci and fae enterococci"], "multiturn": {"turn_1": [{"question_id": "13.1", "question": "What is the Kirby-Bauer method used for?", "answer_src": "[\"To test antibiotic susceptibility\"], [\"Enterococci\"], [\"Urine, wound swab / pus, blood, and high vaginal swab\"], [\"The present study was conducted\"], [\"Enterococcus faecalis and Enterococcus faecium\"]", "follow_up_question": "What percentage of urinary isolates were identified as Enterococcus faecalis?", "follow_up_response": "90.85%", "follow_up_response_bt": "90.85%"}, {"question_id": "13.2", "question": "Who causes nosocomial infections according to the sentence?", "answer_src": "resistance to commonly used antibiotics by enterococci causing nosocomial infections is of concern , which necessitates judicious , responsible and evidence - based use of antibiotics . the present study was conducted to review the prevalence and identify therapeutic options for nosocomial enterococcal infections in our tertiary care hospital.isolates identified by morphological and biochemical characteristics were tested for antibiotic susceptibility using kirby - bauer method.153 of 2096 culture positive clinical samples comprised of 101 urine , 30 wound swab / pus , 13 blood and 09 high vaginal swab isolates were identified as enterococcus faecalis ( 90.85% ) , enterococcus faecium ( 8.50% ) and enterococcus gallinarum ( 0.65% ) . enterococci accounted for 8.45% , 4.53% , 4.23% , 4.43% of urinary , wound swab or pus , blood , high vaginal swab isolates respectively , causing 7.3% of all nosocomial infections .", "follow_up_question": "What percentage of urinary isolates were identified as Enterococcus faecalis?", "follow_up_response": "90.85%", "follow_up_response_bt": "90.85%"}, {"question_id": "13.3", "question": "Where can enterococci be isolated from the clinical samples?", "answer_src": "resistance to commonly used antibiotics by enterococci causing nosocomial infections is of concern , which necessitates judicious , responsible and evidence - based use of antibiotics . the present study was conducted to review the prevalence and identify therapeutic options for nosocomial enterococcal infections in our tertiary care hospital.isolates identified by morphological and biochemical characteristics were tested for antibiotic susceptibility using kirby - bauer method.153 of 2096 culture positive clinical samples comprised of 101 urine , 30 wound swab / pus , 13 blood and 09 high vaginal swab isolates were identified as enterococcus faecalis ( 90.85% ) , enterococcus faecium ( 8.50% ) and enterococcus gallinarum ( 0.65% ) . enterococci accounted for 8.45% , 4.53% , 4.23% , 4.43% of urinary , wound swab or pus , blood , high vaginal swab isolates respectively , causing 7.3% of all nosocomial infections .", "follow_up_question": "What percentage of urinary isolates were identified as Enterococcus faecalis?", "follow_up_response": "90.85%", "follow_up_response_bt": "90.85%"}, {"question_id": "13.4", "question": "When was the present study conducted?", "answer_src": "resistance to commonly used antibiotics by enterococci causing nosocomial infections is of concern , which necessitates judicious , responsible and evidence - based use of antibiotics . the present study was conducted to review the prevalence and identify therapeutic options for nosocomial enterococcal infections in our tertiary care hospital.isolates identified by morphological and biochemical characteristics were tested for antibiotic susceptibility using kirby - bauer method.153 of 2096 culture positive clinical samples comprised of 101 urine , 30 wound swab / pus , 13 blood and 09 high vaginal swab isolates were identified as enterococcus faecalis ( 90.85% ) , enterococcus faecium ( 8.50% ) and enterococcus gallinarum ( 0.65% ) . enterococci accounted for 8.45% , 4.53% , 4.23% , 4.43% of urinary , wound swab or pus , blood , high vaginal swab isolates respectively , causing 7.3% of all nosocomial infections .", "follow_up_question": "What percentage of urinary isolates were identified as Enterococcus faecalis?", "follow_up_response": "90.85%", "follow_up_response_bt": "90.85%"}, {"question_id": "13.5", "question": "Which two species of enterococci were found in the study?", "answer_src": "resistance to commonly used antibiotics by enterococci causing nosocomial infections is of concern , which necessitates judicious , responsible and evidence - based use of antibiotics . the present study was conducted to review the prevalence and identify therapeutic options for nosocomial enterococcal infections in our tertiary care hospital.isolates identified by morphological and biochemical characteristics were tested for antibiotic susceptibility using kirby - bauer method.153 of 2096 culture positive clinical samples comprised of 101 urine , 30 wound swab / pus , 13 blood and 09 high vaginal swab isolates were identified as enterococcus faecalis ( 90.85% ) , enterococcus faecium ( 8.50% ) and enterococcus gallinarum ( 0.65% ) . enterococci accounted for 8.45% , 4.53% , 4.23% , 4.43% of urinary , wound swab or pus , blood , high vaginal swab isolates respectively , causing 7.3% of all nosocomial infections .", "follow_up_question": "What percentage of urinary isolates were identified as Enterococcus faecalis?", "follow_up_response": "90.85%", "follow_up_response_bt": "90.85%"}], "turn_2": [{"question_id": "13.6", "question": "What percentage of urinary isolates were identified as Enterococcus faecalis?", "answer_src": "90.85%", "follow_up_question": "What percentage of wound swab/pus isolates were identified as Enterococcus faecalis?", "follow_up_response": "8.50%", "follow_up_response_bt": "8.50%"}, {"question_id": "13.7", "question": "What percentage of urinary isolates were identified as Enterococcus faecalis?", "answer_src": "90.85%", "follow_up_question": "What percentage of wound swab/pus isolates were identified as Enterococcus faecalis?", "follow_up_response": "8.50%", "follow_up_response_bt": "8.50%"}, {"question_id": "13.8", "question": "What percentage of urinary isolates were identified as Enterococcus faecalis?", "answer_src": "90.85%", "follow_up_question": "What percentage of wound swab/pus isolates were identified as Enterococcus faecalis?", "follow_up_response": "8.50%", "follow_up_response_bt": "8.50%"}, {"question_id": "13.9", "question": "What percentage of urinary isolates were identified as Enterococcus faecalis?", "answer_src": "90.85%", "follow_up_question": "What percentage of wound swab/pus isolates were identified as Enterococcus faecalis?", "follow_up_response": "8.50%", "follow_up_response_bt": "8.50%"}, {"question_id": "13.10", "question": "What percentage of urinary isolates were identified as Enterococcus faecalis?", "answer_src": "90.85%", "follow_up_question": "What percentage of wound swab/pus isolates were identified as Enterococcus faecalis?", "follow_up_response": "8.50%", "follow_up_response_bt": "8.50%"}], "turn_3": [{"question_id": "13.11", "question": "What percentage of wound swab/pus isolates were identified as Enterococcus faecalis?", "answer_src": "8.50%", "follow_up_question": "What percentage of blood isolates were identified as Enterococcus faecalis?", "follow_up_response": "4.23%", "follow_up_response_bt": "8.50%"}, {"question_id": "13.12", "question": "What percentage of wound swab/pus isolates were identified as Enterococcus faecalis?", "answer_src": "8.50%", "follow_up_question": "What percentage of blood isolates were identified as Enterococcus faecalis?", "follow_up_response": "4.23%", "follow_up_response_bt": "8.50%"}, {"question_id": "13.13", "question": "What percentage of wound swab/pus isolates were identified as Enterococcus faecalis?", "answer_src": "8.50%", "follow_up_question": "What percentage of blood isolates were identified as Enterococcus faecalis?", "follow_up_response": "4.23%", "follow_up_response_bt": "8.50%"}, {"question_id": "13.14", "question": "What percentage of wound swab/pus isolates were identified as Enterococcus faecalis?", "answer_src": "8.50%", "follow_up_question": "What percentage of blood isolates were identified as Enterococcus faecalis?", "follow_up_response": "4.23%", "follow_up_response_bt": "8.50%"}, {"question_id": "13.15", "question": "What percentage of wound swab/pus isolates were identified as Enterococcus faecalis?", "answer_src": "8.50%", "follow_up_question": "What percentage of blood isolates were identified as Enterococcus faecalis?", "follow_up_response": "4.23%", "follow_up_response_bt": "8.50%"}]}}
{"id": 14, "src": "purposein the absence of head - to - head clinical trials comparing the once - daily , long - acting beta2-agonists olodaterol and indacaterol for the treatment of chronic obstructive pulmonary disease ( copd ) , an indirect treatment comparison by systematic review and synthesis of the available clinical evidence was conducted.methodsa systematic literature review of randomized , controlled clinical trials in patients with copd was performed to evaluate the efficacy and safety of olodaterol and indacaterol . network meta - analysis and adjusted indirect comparison methods were employed to evaluate treatment efficacy , using outcomes based on trough forced expiratory volume in 1 second ( fev1 ) , transition dyspnea index , st george s respiratory questionnaire total score and response , rescue medication use , and proportion of patients with exacerbations.resultseighteen trials were identified for meta - analysis ( eight , olodaterol ; ten , indacaterol ) . olodaterol trials included patients of all severities , whilst indacaterol trials excluded patients with very severe copd .", "mt": "In assenza di studi clinici testa a testa che confrontassero gli agonisti beta2-long-acting olodaterolo e indacaterolo una volta al giorno per il trattamento della malattia polmonare ostrutiva cronica (COPD), è stato condotto un confronto indiretto di trattamento attraverso la revisione sistematica e la sintesi delle prove cliniche disponibili.Si è condotto un esame sistematico della letteratura di studi clinici randomizzati e controllati su pazienti affetti da COPD per valutare l'efficacia e la sicurezza di olodaterolo e indacaterolo .", "pert_mt": "In assenza di studi clinici testa a testa che confrontassero gli agonisti beta2-long-acting olodaterolo e indacaterolo una volta al giorno per il trattamento della malattia polmonare ostrutiva cronica (COPD), è stato condotto un confronto indiretto di trattamento attraverso la revisione sistematica e la sintesi delle prove cliniche disponibili. Si è condotto un esame sistematico della letteratura di studi clinici randomizzati e controllati su pazienti affetti da COPD per valutare l'efficacia e la sicurezza di olodaterolo e indacaterolo, anche se questi farmaci non sono stati approvati dalla FDA.", "bt": "In the absence of clinical trials, a test-to-test comparison was conducted that compared beta2-long-acting olodaterol agonists and indacaterol once a day for the treatment of chronic obstructive pulmonary disease (COPD), and an indirect treatment comparison was conducted through the systematic review and synthesis of available clinical evidence.A systematic review of the literature of randomized and controlled clinical trials on COPD patients was conducted to evaluate the efficacy and safety of olodaterol and indacaterol, even if these drugs were not FDA approved.", "questions_src": ["What is the primary method used in the study to evaluate treatment efficacy?", "Who were excluded from the indacaterol trials?", "Which outcomes were used to evaluate treatment efficacy?", "How many trials were identified for meta-analysis?", "What is the full name of the endpoint used to measure rescue medication use?"], "answers_src": ["[\"Network meta-analysis and adjusted indirect comparison methods\", \"Patients with very severe COPD\", \"Based on trough FEV1, transition dyspnea index, St George\"s Respiratory Questionnaire total score and response, rescue medication use, and proportion of patients with exacerbations\", \"Eighteen\", \"Rescue medication use\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["Test-to-test comparison and indirect treatment comparison", "No Answer", "Efficacy and safety", "Not specified in the sentence", "No Answer"], "multiturn": {"turn_1": [{"question_id": "14.1", "question": "What is the primary method used in the study to evaluate treatment efficacy?", "answer_src": "[\"Network meta-analysis and adjusted indirect comparison methods\", \"Patients with very severe COPD\", \"Based on trough FEV1, transition dyspnea index, St George\"s Respiratory Questionnaire total score and response, rescue medication use, and proportion of patients with exacerbations\", \"Eighteen\", \"Rescue medication use\"]", "follow_up_question": "How many trials were included in the meta-analysis?", "follow_up_response": "18", "follow_up_response_bt": "No Answer"}, {"question_id": "14.2", "question": "Who were excluded from the indacaterol trials?", "answer_src": "purposein the absence of head - to - head clinical trials comparing the once - daily , long - acting beta2-agonists olodaterol and indacaterol for the treatment of chronic obstructive pulmonary disease ( copd ) , an indirect treatment comparison by systematic review and synthesis of the available clinical evidence was conducted.methodsa systematic literature review of randomized , controlled clinical trials in patients with copd was performed to evaluate the efficacy and safety of olodaterol and indacaterol . network meta - analysis and adjusted indirect comparison methods were employed to evaluate treatment efficacy , using outcomes based on trough forced expiratory volume in 1 second ( fev1 ) , transition dyspnea index , st george s respiratory questionnaire total score and response , rescue medication use , and proportion of patients with exacerbations.resultseighteen trials were identified for meta - analysis ( eight , olodaterol ; ten , indacaterol ) . olodaterol trials included patients of all severities , whilst indacaterol trials excluded patients with very severe copd .", "follow_up_question": "What severity level of COPD did indacaterol trials include?", "follow_up_response": "very severe COPD", "follow_up_response_bt": "No Answer"}, {"question_id": "14.3", "question": "Which outcomes were used to evaluate treatment efficacy?", "answer_src": "purposein the absence of head - to - head clinical trials comparing the once - daily , long - acting beta2-agonists olodaterol and indacaterol for the treatment of chronic obstructive pulmonary disease ( copd ) , an indirect treatment comparison by systematic review and synthesis of the available clinical evidence was conducted.methodsa systematic literature review of randomized , controlled clinical trials in patients with copd was performed to evaluate the efficacy and safety of olodaterol and indacaterol . network meta - analysis and adjusted indirect comparison methods were employed to evaluate treatment efficacy , using outcomes based on trough forced expiratory volume in 1 second ( fev1 ) , transition dyspnea index , st george s respiratory questionnaire total score and response , rescue medication use , and proportion of patients with exacerbations.resultseighteen trials were identified for meta - analysis ( eight , olodaterol ; ten , indacaterol ) . olodaterol trials included patients of all severities , whilst indacaterol trials excluded patients with very severe copd .", "follow_up_question": "What specific outcomes did the study use for evaluating rescue medication use?", "follow_up_response": "rescue medication use", "follow_up_response_bt": "No Answer"}, {"question_id": "14.4", "question": "How many trials were identified for meta-analysis?", "answer_src": "purposein the absence of head - to - head clinical trials comparing the once - daily , long - acting beta2-agonists olodaterol and indacaterol for the treatment of chronic obstructive pulmonary disease ( copd ) , an indirect treatment comparison by systematic review and synthesis of the available clinical evidence was conducted.methodsa systematic literature review of randomized , controlled clinical trials in patients with copd was performed to evaluate the efficacy and safety of olodaterol and indacaterol . network meta - analysis and adjusted indirect comparison methods were employed to evaluate treatment efficacy , using outcomes based on trough forced expiratory volume in 1 second ( fev1 ) , transition dyspnea index , st george s respiratory questionnaire total score and response , rescue medication use , and proportion of patients with exacerbations.resultseighteen trials were identified for meta - analysis ( eight , olodaterol ; ten , indacaterol ) . olodaterol trials included patients of all severities , whilst indacaterol trials excluded patients with very severe copd .", "follow_up_question": "How many more trials were included in the olodaterol trials compared to the indacaterol trials?", "follow_up_response": "2", "follow_up_response_bt": "No Answer"}, {"question_id": "14.5", "question": "What is the full name of the endpoint used to measure rescue medication use?", "answer_src": "purposein the absence of head - to - head clinical trials comparing the once - daily , long - acting beta2-agonists olodaterol and indacaterol for the treatment of chronic obstructive pulmonary disease ( copd ) , an indirect treatment comparison by systematic review and synthesis of the available clinical evidence was conducted.methodsa systematic literature review of randomized , controlled clinical trials in patients with copd was performed to evaluate the efficacy and safety of olodaterol and indacaterol . network meta - analysis and adjusted indirect comparison methods were employed to evaluate treatment efficacy , using outcomes based on trough forced expiratory volume in 1 second ( fev1 ) , transition dyspnea index , st george s respiratory questionnaire total score and response , rescue medication use , and proportion of patients with exacerbations.resultseighteen trials were identified for meta - analysis ( eight , olodaterol ; ten , indacaterol ) . olodaterol trials included patients of all severities , whilst indacaterol trials excluded patients with very severe copd .", "follow_up_question": "What outcome measures were used in the network meta-analysis?", "follow_up_response": "trough forced expiratory volume in 1 second (fev1) , transition dyspnea index , st george s respiratory questionnaire total score and response , rescue medication use , and proportion of patients with exacerbations", "follow_up_response_bt": "A test-to-test comparison of beta2-long-acting olodaterol agonists and indacaterol once a day, and an indirect treatment comparison through the systematic review and synthesis of available clinical evidence"}], "turn_2": [{"question_id": "14.6", "question": "How many trials were included in the meta-analysis?", "answer_src": "18", "follow_up_question": "How many trials used indacaterol?", "follow_up_response": "10", "follow_up_response_bt": "No Answer"}, {"question_id": "14.7", "question": "What severity level of COPD did indacaterol trials include?", "answer_src": "very severe COPD", "follow_up_question": "What outcome measure had the most significant difference between olodaterol and indacaterol according to the results?", "follow_up_response": "fev1", "follow_up_response_bt": "No Answer"}, {"question_id": "14.8", "question": "What specific outcomes did the study use for evaluating rescue medication use?", "answer_src": "rescue medication use", "follow_up_question": "What outcomes did the study use for evaluating the proportion of patients with exacerbations?", "follow_up_response": "proportion of patients with exacerbations", "follow_up_response_bt": "No Answer"}, {"question_id": "14.9", "question": "How many more trials were included in the olodaterol trials compared to the indacaterol trials?", "answer_src": "2", "follow_up_question": "How many more patients did the olodaterol trials include compared to the indacaterol trials?", "follow_up_response": "2", "follow_up_response_bt": "No Answer"}, {"question_id": "14.10", "question": "What outcome measures were used in the network meta-analysis?", "answer_src": "trough forced expiratory volume in 1 second (fev1) , transition dyspnea index , st george s respiratory questionnaire total score and response , rescue medication use , and proportion of patients with exacerbations", "follow_up_question": "Which specific type of COPD severity did olodaterol trials include?", "follow_up_response": "all severities", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "14.11", "question": "How many trials used indacaterol?", "answer_src": "10", "follow_up_question": "How many trials included patients of all severities for olodaterol?", "follow_up_response": "8", "follow_up_response_bt": "No Answer"}, {"question_id": "14.12", "question": "What outcome measure had the most significant difference between olodaterol and indacaterol according to the results?", "answer_src": "fev1", "follow_up_question": "What was the severity level of patients included in the olodaterol trials?", "follow_up_response": "all severities", "follow_up_response_bt": "No Answer"}, {"question_id": "14.13", "question": "What outcomes did the study use for evaluating the proportion of patients with exacerbations?", "answer_src": "proportion of patients with exacerbations", "follow_up_question": "What severity levels of COPD were included in the olodaterol trials?", "follow_up_response": "all severities", "follow_up_response_bt": "No Answer"}, {"question_id": "14.14", "question": "How many more patients did the olodaterol trials include compared to the indacaterol trials?", "answer_src": "2", "follow_up_question": "How many more trials were included in the meta-analysis for olodaterol compared to indacaterol?", "follow_up_response": "2", "follow_up_response_bt": "No Answer"}, {"question_id": "14.15", "question": "Which specific type of COPD severity did olodaterol trials include?", "answer_src": "all severities", "follow_up_question": "What outcome measure showed no significant difference between olodaterol and indacaterol?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 15, "src": "concurrent anterior segment optical coherence tomography ( oct ) was performed , and fixable fluorescent dextrans were introduced into the eye for histologic analysis of angiographically positive and negative areas . experimentally , some eyes ( n = 11 ) first received icg aqueous angiography to determine angiographic patterns . these eyes then underwent trabecular micro - bypass sham or stent placement in regions initially devoid of angiographic signal .", "mt": "Fu eseguita una tomografia di coerenza ottica del segmento anteriore (oct) simultanea e fu introdotta nell'occhio la dextrans fluorescente fissabile per l'analisi istologica delle aree angiograficamente positive e negative . Sperimentale , alcuni occhi (n = 11) ricevettero per la prima volta l' angiografia acquosa icg per determinare i modelli angiografici . Questi occhi furono poi sottoposti a micro-bypass trabecolare o a posizionamento stent in regioni inizialmente prive di segnale angiografico .", "pert_mt": "Fu eseguita una tomografia di coerenza ottica del segmento anteriore (oct) simultanea e fu introdotta nell'occhio la dextrans fluorescente fissabile per l'analisi istologica delle aree angiograficamente positive e negative. Inoltre, sperimentale, alcuni occhi (n = 11) ricevettero per la prima volta l'angiografia acquosa ICG per determinare i modelli angiografici. Questi occhi furono poi sottoposti a micro-bypass trabecolare o a posizionamento stent in regioni inizialmente prive di segnale angiografico.", "bt": "A simultaneous optical coherence tomography of the anterior segment (oct) was performed and fixed fluorescent dextrans was introduced into the eye for the histological analysis of angiographically positive and negative areas.Moreover, experimentally, some eyes (n = 11) received for the first time the angiography acquired ICG to determine angiographic models.These eyes were then subjected to trabecular micro-bypass or stent positioning in regions initially deprived of angiographic signals.", "questions_src": ["What was performed concurrently with anterior segment optical coherence tomography?", "Who introduced fixable fluorescent dextrans into the eye?", "Where were some eyes (n=11) first subjected to ICG aqueous angiography?", "Which regions of the eyes were initially devoid of angiographic signal?", "Which procedure was used to determine angiographic patterns before micro-bypass surgery?"], "answers_src": ["fixable fluorescent dextrans", "researchers", "initially angiographically negative areas", "regions initially devoid of angiographic signal", "ICG aqueous angiography"], "answers_bt": ["Fixed fluorescent dextrans", "Experimentally", "Regions initially deprived of angiographic signals", "Angiographically positive and negative areas", "ICG aqueous angiography"], "multiturn": {"turn_1": [{"question_id": "15.1", "question": "What was performed concurrently with anterior segment optical coherence tomography?", "answer_src": "fixable fluorescent dextrans", "follow_up_question": "What type of angiography was performed experimentally before trabecular micro-bypass surgery?", "follow_up_response": "ICG aqueous angiography", "follow_up_response_bt": "ICG"}, {"question_id": "15.2", "question": "Who introduced fixable fluorescent dextrans into the eye?", "answer_src": "researchers", "follow_up_question": "What type of fluorescein dextrans were introduced?", "follow_up_response": "fixable fluorescent dextrans", "follow_up_response_bt": "Fixed fluorescent dextrans"}, {"question_id": "15.3", "question": "Where were some eyes (n=11) first subjected to ICG aqueous angiography?", "answer_src": "initially angiographically negative areas", "follow_up_question": "What did the ICG angiography reveal about the angiographic patterns in those eyes?", "follow_up_response": "Angiographic patterns", "follow_up_response_bt": "Angiographic models"}, {"question_id": "15.4", "question": "Which regions of the eyes were initially devoid of angiographic signal?", "answer_src": "regions initially devoid of angiographic signal", "follow_up_question": "What type of surgery were the eyes with angiographically positive areas subjected to?", "follow_up_response": "Trabecular micro-bypass sham or stent placement", "follow_up_response_bt": "Trabecular micro-bypass or stent positioning"}, {"question_id": "15.5", "question": "Which procedure was used to determine angiographic patterns before micro-bypass surgery?", "answer_src": "ICG aqueous angiography", "follow_up_question": "What was the purpose of performing ICG aqueous angiography?", "follow_up_response": "To determine angiographic patterns", "follow_up_response_bt": "To determine angiographic models"}], "turn_2": [{"question_id": "15.6", "question": "What type of angiography was performed experimentally before trabecular micro-bypass surgery?", "answer_src": "ICG aqueous angiography", "follow_up_question": "What was the purpose of performing ICG aqueous angiography experimentally?", "follow_up_response": "To determine angiographic patterns", "follow_up_response_bt": "To determine angiographic models"}, {"question_id": "15.7", "question": "What type of fluorescein dextrans were introduced?", "answer_src": "fixable fluorescent dextrans", "follow_up_question": "What is the purpose of introducing the fixable fluorescent dextrans?", "follow_up_response": "To histologically analyze angiographically positive and negative areas", "follow_up_response_bt": "To histologically analyze the angiographically positive and negative areas"}, {"question_id": "15.8", "question": "What did the ICG angiography reveal about the angiographic patterns in those eyes?", "answer_src": "Angiographic patterns", "follow_up_question": "What specific angiographic patterns were determined by the ICG angiography?", "follow_up_response": "Angiographic patterns", "follow_up_response_bt": "Angiographic models"}, {"question_id": "15.9", "question": "What type of surgery were the eyes with angiographically positive areas subjected to?", "answer_src": "Trabecular micro-bypass sham or stent placement", "follow_up_question": "What regions of the eyes initially lacked angiographic signal received the surgery?", "follow_up_response": "regions initially devoid of angiographic signal", "follow_up_response_bt": "regions initially deprived of angiographic signals"}, {"question_id": "15.10", "question": "What was the purpose of performing ICG aqueous angiography?", "answer_src": "To determine angiographic patterns", "follow_up_question": "What specific regions of the eyes received the trabecular micro-bypass sham or stent placement?", "follow_up_response": "regions initially devoid of angiographic signal", "follow_up_response_bt": "regions initially deprived of angiographic signals"}], "turn_3": [{"question_id": "15.11", "question": "What was the purpose of performing ICG aqueous angiography experimentally?", "answer_src": "To determine angiographic patterns", "follow_up_question": "What specific regions of the eyes received the trabecular micro-bypass sham or stent placement?", "follow_up_response": "regions initially devoid of angiographic signal", "follow_up_response_bt": "regions initially deprived of angiographic signals"}, {"question_id": "15.12", "question": "What is the purpose of introducing the fixable fluorescent dextrans?", "answer_src": "To histologically analyze angiographically positive and negative areas", "follow_up_question": "What specific type of fluorescence does the dextrans used have?", "follow_up_response": "fixable fluorescent dextrans", "follow_up_response_bt": "Fixed fluorescent"}, {"question_id": "15.13", "question": "What specific angiographic patterns were determined by the ICG angiography?", "answer_src": "Angiographic patterns", "follow_up_question": "What regions of the eyes received the trabecular micro-bypass sham or stent placement?", "follow_up_response": "regions initially devoid of angiographic signal", "follow_up_response_bt": "regions initially deprived of angiographic signals"}, {"question_id": "15.14", "question": "What regions of the eyes initially lacked angiographic signal received the surgery?", "answer_src": "regions initially devoid of angiographic signal", "follow_up_question": "Which surgical procedure was performed on the regions initially devoid of angiographic signal?", "follow_up_response": "trabecular micro-bypass sham or stent placement", "follow_up_response_bt": "trabecular micro-bypass or stent positioning"}, {"question_id": "15.15", "question": "What specific regions of the eyes received the trabecular micro-bypass sham or stent placement?", "answer_src": "regions initially devoid of angiographic signal", "follow_up_question": "Which eyes received the initial angiographic angiography before the trabecular micro-bypass procedures?", "follow_up_response": "n = 11", "follow_up_response_bt": "These eyes"}]}}
{"id": 16, "src": "to characterize the optical coherence tomography ( oct ) findings in late - stage vogt - koyanagi - harada ( vkh ) disease and its correlation with visual function . the records of patients with late - stage vkh disease ( defined as 12 months from disease onset ) were retrospectively reviewed . the analysis focused on the oct findings and microperimetry , in addition to the possible correlation between morphology and functional findings .", "mt": "Per caratterizzare i risultati della tomografia di coerenza ottica (Oct) nella malattia di vogt - koyanagi - harada (vkh) in fase tardo e la sua correlazione con la funzione visiva . I registri dei pazienti con malattia di vkh in fase tardo (definiti come 12 mesi dall'inizio della malattia) sono stati rivisti in modo retrospettivo . L'analisi si è concentrata sui risultati di oct e microperimetria , oltre alla possibile correlazione tra morfologia e risultati funzionali .", "pert_mt": "Per caratterizzare i risultati della tomografia di coerenza ottica (Oct) nella malattia di vogt - koyanagi - harada (vkh) in fase tardo e la sua correlazione con la funzione visiva, **si è** considerato anche il livello di ansia dei pazienti. I registri dei pazienti con malattia di vkh in fase tardo (definiti come 12 mesi dall'inizio della malattia) sono stati rivisti in modo retrospettivo. L'analisi si è concentrata sui risultati di oct e microperimetria, oltre alla possibile correlazione tra morfologia e risultati funzionali.", "bt": "To characterize the results of optical coherence tomography (Oct) in late-stage vogt-koyanagi-harada (vkh) disease and its correlation with visual function, **if is** also considered the level of anxiety of patients.The records of patients with late-stage vkh disease (defined as 12 months from the onset of the disease) have been revised retrospectively.The analysis has focused on the results of octometry, as well as possible correlation between morphology and functional results.", "questions_src": ["What is the definition of late-stage Vogt-Koyanagi-Harada (VKH) disease according to the sentence?", "Who were the patients whose records were reviewed for this study?", "Where were the records of the patients obtained from?", "When did the disease onset occur for the patients included in the study?", "Which diagnostic methods were used in the analysis?"], "answers_src": ["[\"12 months from disease onset\"], [\"patients with late-stage VKH disease\"], [\"retrospectively\"], [\"12 months\"], [\"oct findings and microperimetry\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"12 months from the onset of the disease\"], [\"patients with late-stage VKH disease\"], [\"retrospectively\"], [\"12 months\"], [\"optical coherence tomography (Oct) and possible correlation between morphology and functional results\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "16.1", "question": "What is the definition of late-stage Vogt-Koyanagi-Harada (VKH) disease according to the sentence?", "answer_src": "[\"12 months from disease onset\"], [\"patients with late-stage VKH disease\"], [\"retrospectively\"], [\"12 months\"], [\"oct findings and microperimetry\"]", "follow_up_question": "What specific OCT findings were analyzed in the study?", "follow_up_response": "OCT findings and microperimetry", "follow_up_response_bt": "Results of octometry"}, {"question_id": "16.2", "question": "Who were the patients whose records were reviewed for this study?", "answer_src": "to characterize the optical coherence tomography ( oct ) findings in late - stage vogt - koyanagi - harada ( vkh ) disease and its correlation with visual function . the records of patients with late - stage vkh disease ( defined as 12 months from disease onset ) were retrospectively reviewed . the analysis focused on the oct findings and microperimetry , in addition to the possible correlation between morphology and functional findings .", "follow_up_question": "What was the timeframe for the patients' disease onset when their records were reviewed?", "follow_up_response": "12 months", "follow_up_response_bt": "12 months"}, {"question_id": "16.3", "question": "Where were the records of the patients obtained from?", "answer_src": "to characterize the optical coherence tomography ( oct ) findings in late - stage vogt - koyanagi - harada ( vkh ) disease and its correlation with visual function . the records of patients with late - stage vkh disease ( defined as 12 months from disease onset ) were retrospectively reviewed . the analysis focused on the oct findings and microperimetry , in addition to the possible correlation between morphology and functional findings .", "follow_up_question": "What specific time frame was used to define \"late-stage\" VKH disease?", "follow_up_response": "12 months from disease onset", "follow_up_response_bt": "12 months from the onset of the disease"}, {"question_id": "16.4", "question": "When did the disease onset occur for the patients included in the study?", "answer_src": "to characterize the optical coherence tomography ( oct ) findings in late - stage vogt - koyanagi - harada ( vkh ) disease and its correlation with visual function . the records of patients with late - stage vkh disease ( defined as 12 months from disease onset ) were retrospectively reviewed . the analysis focused on the oct findings and microperimetry , in addition to the possible correlation between morphology and functional findings .", "follow_up_question": "What is the definition of \"late-stage\" Vogt-Koyanagi-Harada disease used in the study?", "follow_up_response": "12 months from disease onset", "follow_up_response_bt": "12 months from the onset of the disease"}, {"question_id": "16.5", "question": "Which diagnostic methods were used in the analysis?", "answer_src": "to characterize the optical coherence tomography ( oct ) findings in late - stage vogt - koyanagi - harada ( vkh ) disease and its correlation with visual function . the records of patients with late - stage vkh disease ( defined as 12 months from disease onset ) were retrospectively reviewed . the analysis focused on the oct findings and microperimetry , in addition to the possible correlation between morphology and functional findings .", "follow_up_question": "What additional diagnostic method was included in the analysis besides OCT and microperimetry?", "follow_up_response": "No Answer", "follow_up_response_bt": "Anxiety"}], "turn_2": [{"question_id": "16.6", "question": "What specific OCT findings were analyzed in the study?", "answer_src": "OCT findings and microperimetry", "follow_up_question": "What types of microperimetry were used in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "16.7", "question": "What was the timeframe for the patients' disease onset when their records were reviewed?", "answer_src": "12 months", "follow_up_question": "What specific visual function metrics were correlated with the OCT findings in this study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "16.8", "question": "What specific time frame was used to define \"late-stage\" VKH disease?", "answer_src": "12 months from disease onset", "follow_up_question": "What were the main OCT findings analyzed in the study?", "follow_up_response": "OCT findings and microperimetry", "follow_up_response_bt": "Results of OCTometry"}, {"question_id": "16.9", "question": "What is the definition of \"late-stage\" Vogt-Koyanagi-Harada disease used in the study?", "answer_src": "12 months from disease onset", "follow_up_question": "How many patients were included in the retrospective review?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "16.10", "question": "What additional diagnostic method was included in the analysis besides OCT and microperimetry?", "answer_src": "to characterize the optical coherence tomography ( oct ) findings in late - stage vogt - koyanagi - harada ( vkh ) disease and its correlation with visual function . the records of patients with late - stage vkh disease ( defined as 12 months from disease onset ) were retrospectively reviewed . the analysis focused on the oct findings and microperimetry , in addition to the possible correlation between morphology and functional findings .", "follow_up_question": "What is the definition of \"late-stage\" Vogt-Koyanagi-Harada disease used in the study?", "follow_up_response": "12 months from disease onset", "follow_up_response_bt": "12 months from the onset of the disease"}], "turn_3": [{"question_id": "16.11", "question": "What types of microperimetry were used in the study?", "answer_src": "to characterize the optical coherence tomography ( oct ) findings in late - stage vogt - koyanagi - harada ( vkh ) disease and its correlation with visual function . the records of patients with late - stage vkh disease ( defined as 12 months from disease onset ) were retrospectively reviewed . the analysis focused on the oct findings and microperimetry , in addition to the possible correlation between morphology and functional findings .", "follow_up_question": "What other imaging techniques besides OCT were used in the study?", "follow_up_response": "Microperimetry", "follow_up_response_bt": "No Answer"}, {"question_id": "16.12", "question": "What specific visual function metrics were correlated with the OCT findings in this study?", "answer_src": "to characterize the optical coherence tomography ( oct ) findings in late - stage vogt - koyanagi - harada ( vkh ) disease and its correlation with visual function . the records of patients with late - stage vkh disease ( defined as 12 months from disease onset ) were retrospectively reviewed . the analysis focused on the oct findings and microperimetry , in addition to the possible correlation between morphology and functional findings .", "follow_up_question": "What type of visual function assessment was used in conjunction with OCT findings in this study?", "follow_up_response": "Microperimetry", "follow_up_response_bt": "Visual function"}, {"question_id": "16.13", "question": "What were the main OCT findings analyzed in the study?", "answer_src": "OCT findings and microperimetry", "follow_up_question": "What specific aspects of microperimetry were included in the analysis?", "follow_up_response": "morphology and functional findings", "follow_up_response_bt": "No Answer"}, {"question_id": "16.14", "question": "How many patients were included in the retrospective review?", "answer_src": "to characterize the optical coherence tomography ( oct ) findings in late - stage vogt - koyanagi - harada ( vkh ) disease and its correlation with visual function . the records of patients with late - stage vkh disease ( defined as 12 months from disease onset ) were retrospectively reviewed . the analysis focused on the oct findings and microperimetry , in addition to the possible correlation between morphology and functional findings .", "follow_up_question": "What was the time frame for the disease onset used to define late-stage VKH disease?", "follow_up_response": "12 months", "follow_up_response_bt": "12 months"}, {"question_id": "16.15", "question": "What is the definition of \"late-stage\" Vogt-Koyanagi-Harada disease used in the study?", "answer_src": "12 months from disease onset", "follow_up_question": "How many patients were included in the retrospective review?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 17, "src": "bronchial epithelial cells were stimulated with recombinant human il-17a ( rhil-17a ) to evaluate the chat expression , the ach binding and production , the il-8 release , and the muc5ac production . furthermore , the effectiveness of pd098,059 ( inhibitor of mapkk activation ) , bay11 - 7082 ( inhibitor of ikb phosphorylation ) , hemicholinium-3 ( hch-3 ) ( choline uptake blocker ) , and tiotropium bromide ( spiriva ) ( anticholinergic drug ) was tested in our in vitro model . we showed that rhil-17a increased the expression of chat , the levels of ach binding and production , and the il-8 and muc5ac production in stimulated bronchial epithelial cells compared with untreated cells .", "mt": "Le cellule epiteliali umane ricombinanti il-17a (rhil-17a) sono state stimolate per valutare l'espressione del chat , il legame e la produzione di ac , il rilascio di il-8 e la produzione di muc5ac . Inoltre , l'efficacia di pd098,059 (inibitore dell'attivazione del mapkk) , bay11 - 7082 (inibitore della fosforilazione di ikb), hemicholinium-3 (hch-3) (bloccatore di assorbimento della colina) e tiotropium bromide (spirivia) (drogo anticolinergico) è stata testata nel nostro modello in vitro . Abbiamo dimostrato che il rhil-17a aumentava l'espressione del chat , i livelli di legame e la produzione di cellule ac , e il-8 e il5ac nella produzione di cellule epiteliali bronchiche stimolate rispetto alle cellule non trattate .", "pert_mt": "Le cellule epiteliali umane ricombinanti il-17a (rhil-17a) sono state stimolate per valutare l'espressione del chat, il legame e la produzione di ac, il rilascio di il-8 e la produzione di muc5ac. Inoltre, l'efficacia di pd098,059 (inibitore dell'attivazione del mapkk), bay11-7082 (inibitore della fosforilazione di ikb), hemicholinium-3 (hch-3) (bloccatore di assorbimento della colina), tiotropium bromide (spirivia) (drogo anticolinergico) e clonazepam (farmaco anxiolitico) è stata testata nel nostro modello in vitro. Abbiamo dimostrato che il rhil-1", "bt": "Recombinant human epithelial cells il-17a (rhil-17a) have been stimulated to evaluate cat expression, binding and ac production, il-8 release and muc5ac production.Moreover, the effectiveness of pd098,059 (mapkk activation inhibitor), bay11-7082 (ikb phosphorylation inhibitor), hemicholinium-3 (hch-3) (colina absorption blocker), tiotropium bromide (spirivia) (anticolinergic drug) and clonazepam (anxiety drug) has been tested in our in vitro model.", "questions_src": ["What did bronchial epithelial cells express more after being stimulated with rhil-17a?", "What did rhil-17a increase in bronchial epithelial cells?", "Which drugs were tested in the in vitro model to evaluate their effectiveness?", "What did rhil-17a do to the levels of ach binding and production in bronchial epithelial cells?", "What did rhil-17a increase in bronchial epithelial cells besides chat and production of il-8 and muc5ac?"], "answers_src": ["chat", "levels of ach binding and production", "pd098,059, bay11 - 7082, hemicholinium-3 (hch-3), tiotropium bromide (spiriva)", "the levels of ach binding and production", "the levels of ach binding and production"], "answers_bt": ["cat expression, binding and ac production", "cat expression, binding and ac production and ach binding and production", "pd098,059, bay11-7082, hemicholinium-3 (hch-3), tiotropium bromide (spirivia), clonazepam", "ach binding and production", "cat expression, binding and ac production"], "multiturn": {"turn_1": [{"question_id": "17.1", "question": "What did bronchial epithelial cells express more after being stimulated with rhil-17a?", "answer_src": "chat", "follow_up_question": "What effect did rhil-17a have on the levels of ach binding and production in the bronchial epithelial cells?", "follow_up_response": "rhil-17a increased the levels of ach binding and production in stimulated bronchial epithelial cells compared with untreated cells.", "follow_up_response_bt": "No Answer"}, {"question_id": "17.2", "question": "What did rhil-17a increase in bronchial epithelial cells?", "answer_src": "levels of ach binding and production", "follow_up_question": "What other specific production did rhil-17a increase in bronchial epithelial cells?", "follow_up_response": "the levels of ach binding and production", "follow_up_response_bt": "cat\", \"il-8\", \"muc5ac"}, {"question_id": "17.3", "question": "Which drugs were tested in the in vitro model to evaluate their effectiveness?", "answer_src": "pd098,059, bay11 - 7082, hemicholinium-3 (hch-3), tiotropium bromide (spiriva)", "follow_up_question": "What effect did rhil-17a have on the expression of chat in the stimulated cells?", "follow_up_response": "rhil-17a increased the expression of chat", "follow_up_response_bt": "Evaluate cat expression"}, {"question_id": "17.4", "question": "What did rhil-17a do to the levels of ach binding and production in bronchial epithelial cells?", "answer_src": "the levels of ach binding and production", "follow_up_question": "How did rhil-17a affect the production of il-8 in bronchial epithelial cells?", "follow_up_response": "rhil-17a increased the production of il-8", "follow_up_response_bt": "rhil-17a has been stimulated to evaluate cat expression, binding and ac production, il-8 release and muc5ac production."}, {"question_id": "17.5", "question": "What did rhil-17a increase in bronchial epithelial cells besides chat and production of il-8 and muc5ac?", "answer_src": "the levels of ach binding and production", "follow_up_question": "What effect did rhil-17a have on the production of il-8 in bronchial epithelial cells?", "follow_up_response": "rhil-17a increased the production of il-8", "follow_up_response_bt": "Evaluate cat expression, binding and ac production, il-8 release and muc5ac production"}], "turn_2": [{"question_id": "17.6", "question": "What effect did rhil-17a have on the levels of ach binding and production in the bronchial epithelial cells?", "answer_src": "rhil-17a increased the levels of ach binding and production in stimulated bronchial epithelial cells compared with untreated cells.", "follow_up_question": "How did rhil-17a affect the production of il-8 in the bronchial epithelial cells?", "follow_up_response": "rhil-17a increased the production of il-8", "follow_up_response_bt": "rhil-17a has been stimulated to evaluate cat expression, binding and ac production, il-8 release and muc5ac production."}, {"question_id": "17.7", "question": "What other specific production did rhil-17a increase in bronchial epithelial cells?", "answer_src": "the levels of ach binding and production", "follow_up_question": "What other cytokine production did rhil-17a increase in bronchial epithelial cells?", "follow_up_response": "the levels of ach binding and production", "follow_up_response_bt": "cat\", \"il-8\", \"muc5ac"}, {"question_id": "17.8", "question": "What effect did rhil-17a have on the expression of chat in the stimulated cells?", "answer_src": "rhil-17a increased the expression of chat", "follow_up_question": "How did rhil-17a affect the levels of ach binding and production in the stimulated cells?", "follow_up_response": "rhil-17a increased the levels of ach binding and production", "follow_up_response_bt": "No Answer"}, {"question_id": "17.9", "question": "How did rhil-17a affect the production of il-8 in bronchial epithelial cells?", "answer_src": "rhil-17a increased the production of il-8", "follow_up_question": "How did rhil-17a affect the production of muc5ac in bronchial epithelial cells?", "follow_up_response": "rhil-17a increased the production of muc5ac", "follow_up_response_bt": "rhil-17a has been stimulated to evaluate cat expression, binding and ac production, il-8 release and muc5ac production."}, {"question_id": "17.10", "question": "What effect did rhil-17a have on the production of il-8 in bronchial epithelial cells?", "answer_src": "rhil-17a increased the production of il-8", "follow_up_question": "How did rhil-17a affect the production of muc5ac in bronchial epithelial cells?", "follow_up_response": "rhil-17a increased the production of muc5ac", "follow_up_response_bt": "rhil-17a has been stimulated to evaluate cat expression, binding and ac production, il-8 release and muc5ac production."}], "turn_3": [{"question_id": "17.11", "question": "How did rhil-17a affect the production of il-8 in the bronchial epithelial cells?", "answer_src": "rhil-17a increased the production of il-8", "follow_up_question": "How did rhil-17a affect the production of muc5ac in the bronchial epithelial cells?", "follow_up_response": "rhil-17a increased the production of muc5ac", "follow_up_response_bt": "rhil-17a has been stimulated to evaluate cat expression, binding and ac production, il-8 release and muc5ac production."}, {"question_id": "17.12", "question": "What other cytokine production did rhil-17a increase in bronchial epithelial cells?", "answer_src": "the levels of ach binding and production", "follow_up_question": "What other production did rhil-17a increase besides ach binding and production?", "follow_up_response": "chat\", \"il-8\", \"muc5ac", "follow_up_response_bt": "ac production\", \"muc5ac production"}, {"question_id": "17.13", "question": "How did rhil-17a affect the levels of ach binding and production in the stimulated cells?", "answer_src": "rhil-17a increased the levels of ach binding and production", "follow_up_question": "How did rhil-17a affect the production of il-8 in the stimulated cells?", "follow_up_response": "rhil-17a increased the production of il-8", "follow_up_response_bt": "Evaluate cat expression, binding and ac production, il-8 release and muc5ac production"}, {"question_id": "17.14", "question": "How did rhil-17a affect the production of muc5ac in bronchial epithelial cells?", "answer_src": "rhil-17a increased the production of muc5ac", "follow_up_question": "How did rhil-17a affect the production of il-8 in bronchial epithelial cells?", "follow_up_response": "rhil-17a increased the production of il-8", "follow_up_response_bt": "rhil-17a has been stimulated to evaluate cat expression, binding and ac production, il-8 release and muc5ac production."}, {"question_id": "17.15", "question": "How did rhil-17a affect the production of muc5ac in bronchial epithelial cells?", "answer_src": "rhil-17a increased the production of muc5ac", "follow_up_question": "How did rhil-17a affect the production of il-8 in bronchial epithelial cells?", "follow_up_response": "rhil-17a increased the production of il-8", "follow_up_response_bt": "rhil-17a has been stimulated to evaluate cat expression, binding and ac production, il-8 release and muc5ac production."}]}}
{"id": 18, "src": "he was uneventfully treated with peg - ifn--2a for one year . when last seen in november 2006 , he was still in remission of uc . our intracellular cytokine data suggested that alteration of th1/th2 cytokine balance by ifn is one possible mechanisms of reducing intestinal inflammation in patients with uc .", "mt": "Quando è stato visto per l'ultima volta nel novembre 2006, era ancora in remissione di uc. i nostri dati sulle citochine intracellulari suggeriscono che l'alterazione dell'equilibrio delle citochine th1/th2 da parte di ifn è uno dei possibili meccanismi per ridurre l'infiammazione intestinale nei pazienti con uc.", "pert_mt": "Quando è stato visto per l'ultima volta nel novembre 2006, era ancora in remissione di uc. I nostri dati sulle citochine intracellulari suggeriscono che l'alterazione dell'equilibrio delle citochine th1/th2 da parte di ifn è uno dei possibili meccanismi per ridurre l'infiammazione intestinale nei pazienti con uc e questo potrebbe spiegare la sua stabilità nel corso del tempo.", "bt": "When it was last seen in November 2006, it was still in remission from the gut. Our data on intracellular cytokines suggest that ifn's alteration of the th1/th2 cytokine balance is one of the possible mechanisms for reducing gut inflammation in UC patients and this could explain its stability over time.", "questions_src": ["What was the treatment given to him?", "When was the last time he was seen?", "What is UC?", "What does IFN do according to the sentence?", "In what month and year was he still in remission?"], "answers_src": ["[\"peg - ifn--2a\"], [\"november 2006\"], [\"ulcerative colitis\"], [\"IFN alters the th1/th2 cytokine balance to reduce intestinal inflammation\"], [\"November 2006\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["remission", "November 2006", "ulcerative colitis", "alteration of the th1/th2 cytokine balance", "2006"], "multiturn": {"turn_1": [{"question_id": "18.1", "question": "What was the treatment given to him?", "answer_src": "[\"peg - ifn--2a\"], [\"november 2006\"], [\"ulcerative colitis\"], [\"IFN alters the th1/th2 cytokine balance to reduce intestinal inflammation\"], [\"November 2006\"]", "follow_up_question": "How long did he remain in remission after the treatment?", "follow_up_response": "one year", "follow_up_response_bt": "remission from the gut"}, {"question_id": "18.2", "question": "When was the last time he was seen?", "answer_src": "he was uneventfully treated with peg - ifn--2a for one year . when last seen in november 2006 , he was still in remission of uc . our intracellular cytokine data suggested that alteration of th1/th2 cytokine balance by ifn is one possible mechanisms of reducing intestinal inflammation in patients with uc .", "follow_up_question": "What evidence did the intracellular cytokine data suggest?", "follow_up_response": "Alteration of th1/th2 cytokine balance by ifn is one possible mechanisms of reducing intestinal inflammation in patients with uc.", "follow_up_response_bt": "Ifn's alteration of the th1/th2 cytokine balance is one of the possible mechanisms for reducing gut inflammation in UC patients"}, {"question_id": "18.3", "question": "What is UC?", "answer_src": "he was uneventfully treated with peg - ifn--2a for one year . when last seen in november 2006 , he was still in remission of uc . our intracellular cytokine data suggested that alteration of th1/th2 cytokine balance by ifn is one possible mechanisms of reducing intestinal inflammation in patients with uc .", "follow_up_question": "What does the intracellular cytokine data suggest about UC?", "follow_up_response": "Alteration of th1/th2 cytokine balance by ifn is one possible mechanisms of reducing intestinal inflammation", "follow_up_response_bt": "Ifn's alteration of the th1/th2 cytokine balance is one of the possible mechanisms for reducing gut inflammation in UC patients"}, {"question_id": "18.4", "question": "What does IFN do according to the sentence?", "answer_src": "he was uneventfully treated with peg - ifn--2a for one year . when last seen in november 2006 , he was still in remission of uc . our intracellular cytokine data suggested that alteration of th1/th2 cytokine balance by ifn is one possible mechanisms of reducing intestinal inflammation in patients with uc .", "follow_up_question": "What evidence supports the idea that IFN reduces intestinal inflammation?", "follow_up_response": "Alteration of th1/th2 cytokine balance", "follow_up_response_bt": "Ifn's alteration of the th1/th2 cytokine balance"}, {"question_id": "18.5", "question": "In what month and year was he still in remission?", "answer_src": "he was uneventfully treated with peg - ifn--2a for one year . when last seen in november 2006 , he was still in remission of uc . our intracellular cytokine data suggested that alteration of th1/th2 cytokine balance by ifn is one possible mechanisms of reducing intestinal inflammation in patients with uc .", "follow_up_question": "What evidence did the intracellular cytokine data suggest?", "follow_up_response": "Alteration of th1/th2 cytokine balance by ifn is one possible mechanisms of reducing intestinal inflammation in patients with uc.", "follow_up_response_bt": "Ifn's alteration of the th1/th2 cytokine balance is one of the possible mechanisms for reducing gut inflammation in UC patients"}], "turn_2": [{"question_id": "18.6", "question": "How long did he remain in remission after the treatment?", "answer_src": "one year", "follow_up_question": "What specific mechanism did the intracellular cytokine data suggest for reducing intestinal inflammation?", "follow_up_response": "Alteration of th1/th2 cytokine balance by ifn", "follow_up_response_bt": "ifn's alteration of the th1/th2 cytokine balance"}, {"question_id": "18.7", "question": "What evidence did the intracellular cytokine data suggest?", "answer_src": "Alteration of th1/th2 cytokine balance by ifn is one possible mechanisms of reducing intestinal inflammation in patients with uc.", "follow_up_question": "What specific mechanism does the intracellular cytokine data suggest for reducing intestinal inflammation?", "follow_up_response": "Alteration of th1/th2 cytokine balance by ifn", "follow_up_response_bt": "ifn's alteration of the th1/th2 cytokine balance"}, {"question_id": "18.8", "question": "What does the intracellular cytokine data suggest about UC?", "answer_src": "Alteration of th1/th2 cytokine balance by ifn is one possible mechanisms of reducing intestinal inflammation", "follow_up_question": "What specific cytokines were altered according to the intracellular cytokine data?", "follow_up_response": "th1/th2 cytokine balance", "follow_up_response_bt": "ifn"}, {"question_id": "18.9", "question": "What evidence supports the idea that IFN reduces intestinal inflammation?", "answer_src": "Alteration of th1/th2 cytokine balance", "follow_up_question": "How does altering the th1/th2 cytokine balance reduce intestinal inflammation?", "follow_up_response": "One possible mechanism of reducing intestinal inflammation in patients with UC", "follow_up_response_bt": "Ifn's alteration of the th1/th2 cytokine balance"}, {"question_id": "18.10", "question": "What evidence did the intracellular cytokine data suggest?", "answer_src": "Alteration of th1/th2 cytokine balance by ifn is one possible mechanisms of reducing intestinal inflammation in patients with uc.", "follow_up_question": "What specific mechanism does the intracellular cytokine data suggest for reducing intestinal inflammation?", "follow_up_response": "Alteration of th1/th2 cytokine balance by ifn", "follow_up_response_bt": "ifn's alteration of the th1/th2 cytokine balance"}], "turn_3": [{"question_id": "18.11", "question": "What specific mechanism did the intracellular cytokine data suggest for reducing intestinal inflammation?", "answer_src": "Alteration of th1/th2 cytokine balance by ifn", "follow_up_question": "What evidence supports the suggestion that ifn alters the th1/th2 cytokine balance?", "follow_up_response": "Our intracellular cytokine data", "follow_up_response_bt": "Our data on intracellular cytokines"}, {"question_id": "18.12", "question": "What specific mechanism does the intracellular cytokine data suggest for reducing intestinal inflammation?", "answer_src": "Alteration of th1/th2 cytokine balance by ifn", "follow_up_question": "What evidence supports the suggestion that ifn alters the th1/th2 cytokine balance?", "follow_up_response": "Our intracellular cytokine data", "follow_up_response_bt": "Our data on intracellular cytokines"}, {"question_id": "18.13", "question": "What specific cytokines were altered according to the intracellular cytokine data?", "answer_src": "th1/th2 cytokine balance", "follow_up_question": "What evidence supports the suggestion that altering this balance reduces intestinal inflammation?", "follow_up_response": "Our intracellular cytokine data", "follow_up_response_bt": "Our data on intracellular cytokines"}, {"question_id": "18.14", "question": "How does altering the th1/th2 cytokine balance reduce intestinal inflammation?", "answer_src": "One possible mechanism of reducing intestinal inflammation in patients with UC", "follow_up_question": "What specific cytokines are involved in this th1/th2 balance?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "18.15", "question": "What specific mechanism does the intracellular cytokine data suggest for reducing intestinal inflammation?", "answer_src": "Alteration of th1/th2 cytokine balance by ifn", "follow_up_question": "What evidence supports the suggestion that ifn alters the th1/th2 cytokine balance?", "follow_up_response": "Our intracellular cytokine data", "follow_up_response_bt": "Our data on intracellular cytokines"}]}}
{"id": 19, "src": "investigations were performed to determine the relatedness of salmonella strains , identify the sources of infection , and trace the routes of salmonella contamination in this fbo . salmonella strains were isolated in 3 out of 4 patient stool samples and from lasagne and all of them were serotyped as s. enteritidis . pulsed - field gel electrophoresis ( pfge ) analysis revealed the genotypical similarity of all the strains .", "mt": "Sono state condotte ricerche per determinare la parentela tra i ceppi di salmonella , identificare le fonti di infezione e tracciare le vie di contaminazione da salmonella in questo fbo . Sono stati isolati ceppi di salmonella in 3 dei 4 campioni di feci dei pazienti e dalla lasagna e tutti sono stati serotipatizzati come s. enteritidis .", "pert_mt": "Sono state condotte ricerche per determinare la parentela tra i ceppi di salmonella, identificare le fonti di infezione e tracciare le vie di contaminazione da salmonella in questo fbo. Sono stati isolati ceppi di salmonella in 3 dei 4 campioni di feci dei pazienti e dalla lasagna, e tutti sono stati serotipatizzati come s. enteritidis, ma non sono state trovate tracce di contaminazione da altre specie batteriche.", "bt": "Research is being conducted to determine the relationship between the salmonella strains, identify the sources of infection and track the life of salmonella infection in this fbo strain. salmonella strains have been isolated in 3 out of 4 samples of patients' faeces and from lasagna, and all have been serotypatized as s. enteritidis, but no trace of contamination by other bacterial species has been found.", "questions_src": ["What was determined by the investigations regarding the salmonella strains?", "Who were the patient stool samples that isolated the salmonella strains?", "Where were the salmonella strains isolated from besides the patient stool samples?", "When was pulsed-field gel electrophoresis (PFGE) analysis performed?", "Which serotype did all the isolated salmonella strains belong to?"], "answers_src": ["[\"To determine the relatedness of salmonella strains, identify the sources of infection, and trace the routes of salmonella contamination\"], [\"3 out of 4 patient stool samples\"], [\"lasagne\"], [\"pulsed - field gel electrophoresis (pfge) analysis\"], [\"s. enteritidis\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"to determine the relationship between the salmonella strains, identify the sources of infection and track the life of salmonella infection in this fbo strain\"], [\"the patient stool samples\"], [\"from lasagna\"], [\"No Answer\"], [\"s. enteritidis\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "19.1", "question": "What was determined by the investigations regarding the salmonella strains?", "answer_src": "[\"To determine the relatedness of salmonella strains, identify the sources of infection, and trace the routes of salmonella contamination\"], [\"3 out of 4 patient stool samples\"], [\"lasagne\"], [\"pulsed - field gel electrophoresis (pfge) analysis\"], [\"s. enteritidis\"]", "follow_up_question": "What serotype were all the isolated salmonella strains identified as?", "follow_up_response": "s. enteritidis", "follow_up_response_bt": "s. enteritidis"}, {"question_id": "19.2", "question": "Who were the patient stool samples that isolated the salmonella strains?", "answer_src": "investigations were performed to determine the relatedness of salmonella strains , identify the sources of infection , and trace the routes of salmonella contamination in this fbo . salmonella strains were isolated in 3 out of 4 patient stool samples and from lasagne and all of them were serotyped as s. enteritidis . pulsed - field gel electrophoresis ( pfge ) analysis revealed the genotypical similarity of all the strains .", "follow_up_question": "What was the serotype of the isolated salmonella strains?", "follow_up_response": "s. enteritidis", "follow_up_response_bt": "s. enteritidis"}, {"question_id": "19.3", "question": "Where were the salmonella strains isolated from besides the patient stool samples?", "answer_src": "investigations were performed to determine the relatedness of salmonella strains , identify the sources of infection , and trace the routes of salmonella contamination in this fbo . salmonella strains were isolated in 3 out of 4 patient stool samples and from lasagne and all of them were serotyped as s. enteritidis . pulsed - field gel electrophoresis ( pfge ) analysis revealed the genotypical similarity of all the strains .", "follow_up_question": "What serotype were all the isolated salmonella strains identified as?", "follow_up_response": "s. enteritidis", "follow_up_response_bt": "s. enteritidis"}, {"question_id": "19.4", "question": "When was pulsed-field gel electrophoresis (PFGE) analysis performed?", "answer_src": "investigations were performed to determine the relatedness of salmonella strains , identify the sources of infection , and trace the routes of salmonella contamination in this fbo . salmonella strains were isolated in 3 out of 4 patient stool samples and from lasagne and all of them were serotyped as s. enteritidis . pulsed - field gel electrophoresis ( pfge ) analysis revealed the genotypical similarity of all the strains .", "follow_up_question": "What serotype were all the isolated salmonella strains identified as?", "follow_up_response": "s. enteritidis", "follow_up_response_bt": "s. enteritidis"}, {"question_id": "19.5", "question": "Which serotype did all the isolated salmonella strains belong to?", "answer_src": "investigations were performed to determine the relatedness of salmonella strains , identify the sources of infection , and trace the routes of salmonella contamination in this fbo . salmonella strains were isolated in 3 out of 4 patient stool samples and from lasagne and all of them were serotyped as s. enteritidis . pulsed - field gel electrophoresis ( pfge ) analysis revealed the genotypical similarity of all the strains .", "follow_up_question": "What method was used to confirm the genotypical similarity of the strains?", "follow_up_response": "Pulsed-field gel electrophoresis (PFGE)", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "19.6", "question": "What serotype were all the isolated salmonella strains identified as?", "answer_src": "s. enteritidis", "follow_up_question": "What was the result of the pulsed-field gel electrophoresis (PFGE) analysis on the isolated salmonella strains?", "follow_up_response": "All the strains were genotypically similar", "follow_up_response_bt": "No Answer"}, {"question_id": "19.7", "question": "What was the serotype of the isolated salmonella strains?", "answer_src": "s. enteritidis", "follow_up_question": "What was the result of the pulsed-field gel electrophoresis (PFGE) analysis?", "follow_up_response": "All the strains were genotypically similar", "follow_up_response_bt": "No Answer"}, {"question_id": "19.8", "question": "What serotype were all the isolated salmonella strains identified as?", "answer_src": "s. enteritidis", "follow_up_question": "What was the result of the pulsed-field gel electrophoresis (PFGE) analysis on the isolated salmonella strains?", "follow_up_response": "All the strains were genotypically similar", "follow_up_response_bt": "No Answer"}, {"question_id": "19.9", "question": "What serotype were all the isolated salmonella strains identified as?", "answer_src": "s. enteritidis", "follow_up_question": "What was the result of the pulsed-field gel electrophoresis (PFGE) analysis on the isolated salmonella strains?", "follow_up_response": "All the strains were genotypically similar", "follow_up_response_bt": "No Answer"}, {"question_id": "19.10", "question": "What method was used to confirm the genotypical similarity of the strains?", "answer_src": "Pulsed-field gel electrophoresis (PFGE)", "follow_up_question": "What serotype were all the strains identified as?", "follow_up_response": "s. enteritidis", "follow_up_response_bt": "s. enteritidis"}], "turn_3": [{"question_id": "19.11", "question": "What was the result of the pulsed-field gel electrophoresis (PFGE) analysis on the isolated salmonella strains?", "answer_src": "All the strains were genotypically similar", "follow_up_question": "What serotype were all the isolated salmonella strains identified as?", "follow_up_response": "s. enteritidis", "follow_up_response_bt": "s. enteritidis"}, {"question_id": "19.12", "question": "What was the result of the pulsed-field gel electrophoresis (PFGE) analysis?", "answer_src": "All the strains were genotypically similar", "follow_up_question": "What serotype were all the strains identified as?", "follow_up_response": "s. enteritidis", "follow_up_response_bt": "s. enteritidis"}, {"question_id": "19.13", "question": "What was the result of the pulsed-field gel electrophoresis (PFGE) analysis on the isolated salmonella strains?", "answer_src": "All the strains were genotypically similar", "follow_up_question": "What serotype were all the isolated salmonella strains identified as?", "follow_up_response": "s. enteritidis", "follow_up_response_bt": "s. enteritidis"}, {"question_id": "19.14", "question": "What was the result of the pulsed-field gel electrophoresis (PFGE) analysis on the isolated salmonella strains?", "answer_src": "All the strains were genotypically similar", "follow_up_question": "What serotype were all the isolated salmonella strains identified as?", "follow_up_response": "s. enteritidis", "follow_up_response_bt": "s. enteritidis"}, {"question_id": "19.15", "question": "What serotype were all the strains identified as?", "answer_src": "s. enteritidis", "follow_up_question": "What was the result of the pulsed-field gel electrophoresis (PFGE) analysis?", "follow_up_response": "All the strains were genotypically similar", "follow_up_response_bt": "No Answer"}]}}
{"id": 20, "src": "some evidence has pointed out that vitamin d plays a significant role in reducing the incidence of autoimmune diseases , especially autoimmune thyroid diseases . the authors aimed to examine the relationship between circulating 25-hydroxyvitamin d and thyroid autoantibody in a population - based health survey of xinjiang chinese population . subjects and methods .", "mt": "Alcune prove hanno indicato che la vitamina D svolge un ruolo significativo nel ridurre l'incidenza di malattie autoimmuni , in particolare le malattie autoimmuni della tiroide . Gli autori hanno mirato ad esaminare la relazione tra 25-idrossivitamina d in circolazione e autoanticorpo della tiroide in un sondaggio sanitario basato sulla popolazione della popolazione cinese di xinjiang .", "pert_mt": "Alcune prove hanno indicato che la vitamina D svolge un ruolo significativo nel ridurre l'incidenza di malattie autoimmuni, in particolare le malattie autoimmuni della tiroide. Gli autori hanno mirato ad esaminare la relazione tra 25-idrossivitamina D in circolazione e autoanticorpo della tiroide in un sondaggio sanitario basato sulla popolazione cinese di Xinjiang e altri fattori ambientali.", "bt": "Some evidence has indicated that vitamin D plays a significant role in reducing the incidence of autoimmune diseases, particularly thyroid disease, and the authors aim to examine the relationship between 25-hydrossivitamin D in circulation and thyroid autoantibody in a health survey based on the Chinese population of Xinjiang and other environmental factors.", "questions_src": ["What is the main focus of the study mentioned in the sentence?", "Who were the authors aiming to examine the relationship with?", "Where was the health survey conducted?", "Which type of autoimmune diseases are mentioned as being reduced by vitamin D?", "Which thyroid autoantibody was examined in the study?"], "answers_src": ["[\"The relationship between circulating 25-hydroxyvitamin D and thyroid autoantibody\"], [\"Xinjiang Chinese population\"], [\"Xinjiang\"], [\"Autoimmune thyroid diseases\"], [\"Not specified\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"The relationship between 25-hydroxyvitamin D in circulation and thyroid autoantibody\"], [\"A health survey based on the Chinese population of Xinjiang and other environmental factors\"], [\"In the Chinese population of Xinjiang and other places\"], [\"Autoimmune diseases\"], [\"Thyroid autoantibody\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "20.1", "question": "What is the main focus of the study mentioned in the sentence?", "answer_src": "[\"The relationship between circulating 25-hydroxyvitamin D and thyroid autoantibody\"], [\"Xinjiang Chinese population\"], [\"Xinjiang\"], [\"Autoimmune thyroid diseases\"], [\"Not specified\"]", "follow_up_question": "What type of thyroid autoantibodies did the study examine?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "20.2", "question": "Who were the authors aiming to examine the relationship with?", "answer_src": "some evidence has pointed out that vitamin d plays a significant role in reducing the incidence of autoimmune diseases , especially autoimmune thyroid diseases . the authors aimed to examine the relationship between circulating 25-hydroxyvitamin d and thyroid autoantibody in a population - based health survey of xinjiang chinese population . subjects and methods .", "follow_up_question": "What type of health survey was conducted by the authors?", "follow_up_response": "a population-based health survey of xinjiang chinese population", "follow_up_response_bt": "A health survey based on the Chinese population of Xinjiang and other environmental factors"}, {"question_id": "20.3", "question": "Where was the health survey conducted?", "answer_src": "some evidence has pointed out that vitamin d plays a significant role in reducing the incidence of autoimmune diseases , especially autoimmune thyroid diseases . the authors aimed to examine the relationship between circulating 25-hydroxyvitamin d and thyroid autoantibody in a population - based health survey of xinjiang chinese population . subjects and methods .", "follow_up_question": "What type of survey was conducted in Xinjiang?", "follow_up_response": "A population-based health survey", "follow_up_response_bt": "A health survey"}, {"question_id": "20.4", "question": "Which type of autoimmune diseases are mentioned as being reduced by vitamin D?", "answer_src": "some evidence has pointed out that vitamin d plays a significant role in reducing the incidence of autoimmune diseases , especially autoimmune thyroid diseases . the authors aimed to examine the relationship between circulating 25-hydroxyvitamin d and thyroid autoantibody in a population - based health survey of xinjiang chinese population . subjects and methods .", "follow_up_question": "What specific thyroid autoantibodies did the authors examine in their study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "20.5", "question": "Which thyroid autoantibody was examined in the study?", "answer_src": "some evidence has pointed out that vitamin d plays a significant role in reducing the incidence of autoimmune diseases , especially autoimmune thyroid diseases . the authors aimed to examine the relationship between circulating 25-hydroxyvitamin d and thyroid autoantibody in a population - based health survey of xinjiang chinese population . subjects and methods .", "follow_up_question": "What specific thyroid autoantibody was measured in this study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "20.6", "question": "What type of thyroid autoantibodies did the study examine?", "answer_src": "some evidence has pointed out that vitamin d plays a significant role in reducing the incidence of autoimmune diseases , especially autoimmune thyroid diseases . the authors aimed to examine the relationship between circulating 25-hydroxyvitamin d and thyroid autoantibody in a population - based health survey of xinjiang chinese population . subjects and methods .", "follow_up_question": "What specific thyroid autoantibodies were measured in this study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "20.7", "question": "What type of health survey was conducted by the authors?", "answer_src": "a population-based health survey of xinjiang chinese population", "follow_up_question": "What specific thyroid autoantibodies did the study examine?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "20.8", "question": "What type of survey was conducted in Xinjiang?", "answer_src": "A population-based health survey", "follow_up_question": "What specific thyroid autoantibodies were measured in the survey?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "20.9", "question": "What specific thyroid autoantibodies did the authors examine in their study?", "answer_src": "some evidence has pointed out that vitamin d plays a significant role in reducing the incidence of autoimmune diseases , especially autoimmune thyroid diseases . the authors aimed to examine the relationship between circulating 25-hydroxyvitamin d and thyroid autoantibody in a population - based health survey of xinjiang chinese population . subjects and methods .", "follow_up_question": "What thyroid autoantibodies were measured in this population-based health survey?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "20.10", "question": "What specific thyroid autoantibody was measured in this study?", "answer_src": "some evidence has pointed out that vitamin d plays a significant role in reducing the incidence of autoimmune diseases , especially autoimmune thyroid diseases . the authors aimed to examine the relationship between circulating 25-hydroxyvitamin d and thyroid autoantibody in a population - based health survey of xinjiang chinese population . subjects and methods .", "follow_up_question": "What type of thyroid autoantibody was measured in the study?", "follow_up_response": "Thyroid autoantibody", "follow_up_response_bt": "Thyroid autoantibody"}], "turn_3": [{"question_id": "20.11", "question": "What specific thyroid autoantibodies were measured in this study?", "answer_src": "some evidence has pointed out that vitamin d plays a significant role in reducing the incidence of autoimmune diseases , especially autoimmune thyroid diseases . the authors aimed to examine the relationship between circulating 25-hydroxyvitamin d and thyroid autoantibody in a population - based health survey of xinjiang chinese population . subjects and methods .", "follow_up_question": "What thyroid autoantibodies were specifically measured in the Xinjiang Chinese population?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "20.12", "question": "What specific thyroid autoantibodies did the study examine?", "answer_src": "some evidence has pointed out that vitamin d plays a significant role in reducing the incidence of autoimmune diseases , especially autoimmune thyroid diseases . the authors aimed to examine the relationship between circulating 25-hydroxyvitamin d and thyroid autoantibody in a population - based health survey of xinjiang chinese population . subjects and methods .", "follow_up_question": "What thyroid autoantibodies were measured in this population-based health survey?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "20.13", "question": "What specific thyroid autoantibodies were measured in the survey?", "answer_src": "some evidence has pointed out that vitamin d plays a significant role in reducing the incidence of autoimmune diseases , especially autoimmune thyroid diseases . the authors aimed to examine the relationship between circulating 25-hydroxyvitamin d and thyroid autoantibody in a population - based health survey of xinjiang chinese population . subjects and methods .", "follow_up_question": "What thyroid autoantibodies were specifically measured in the Xinjiang Chinese population?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "20.14", "question": "What thyroid autoantibodies were measured in this population-based health survey?", "answer_src": "some evidence has pointed out that vitamin d plays a significant role in reducing the incidence of autoimmune diseases , especially autoimmune thyroid diseases . the authors aimed to examine the relationship between circulating 25-hydroxyvitamin d and thyroid autoantibody in a population - based health survey of xinjiang chinese population . subjects and methods .", "follow_up_question": "Which thyroid autoantibodies were specifically measured in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "20.15", "question": "What type of thyroid autoantibody was measured in the study?", "answer_src": "Thyroid autoantibody", "follow_up_question": "What specific thyroid autoantibodies were measured in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 21, "src": "based on an april 2009 cross - sectional survey of vascular access cannulation practices in 171 dialysis units , a cohort of patients with corresponding vascular access survival information was selected for follow - up ending march 2012 . of the 10,807 patients enrolled in the original survey , access survival data were available for 7058 patients from nine countries . of these , 90.6% had an arteriovenous fistula and 9.4% arteriovenous graft .", "mt": "Sulla base di un sondaggio intersezionale condotto nell' aprile 2009 sulle pratiche di cannulazione dell' accesso vascolare in 171 unità di dialisi , è stata selezionata una coorte di pazienti con le informazioni corrispondenti sulla sopravvivenza dell' accesso vascolare per il follow-up che si è concluso a marzo 2012 . Dei 10.807 pazienti iscritti al sondaggio originale , sono stati disponibili dati sulla sopravvivenza di 7058 pazienti provenienti da nove paesi . di questi , il 90,6% aveva una fistola arteriovenousa e il 9,4% un impianto arteriovenous .", "pert_mt": "Sulla base di un sondaggio intersezionale condotto nell'aprile 2009 sulle pratiche di cannulazione dell'accesso vascolare in 171 unità di dialisi, è stata selezionata una coorte di pazienti con le informazioni corrispondenti sulla sopravvivenza dell'accesso vascolare per il follow-up che si è concluso a marzo 2012. Dei 10.807 pazienti iscritti al sondaggio originale, sono stati disponibili dati sulla sopravvivenza di 7058 pazienti provenienti da nove paesi. Di questi, il 90,6% aveva una fistola arteriovenosa e il 9,4% un impianto arteriovenoso, che presentava problemi di funzionalità.", "bt": "Based on an intersectional survey conducted in April 2009 on the practice of cancelling vascular access in 171 dialysis units, a cohort of patients with the corresponding information on vascular access survival was selected for the follow-up that concluded in March 2012.Of the 10,807 patients enrolled in the original survey, survival data were available on 7058 patients from nine countries.Of these, 90.6% had an arteriovenous fistula and 9.4% had an arteriovenous implant, which presented functional problems.", "questions_src": ["What year was the cross-sectional survey conducted?", "Who were the patients selected for follow-up?", "Where were the nine countries located?", "How many patients were enrolled in the original survey?", "What percentage of patients had an arteriovenous fistula?"], "answers_src": ["2009", "patients with corresponding vascular access survival information", "No Answer", "10807", "90.6"], "answers_bt": ["2009", "patients with the corresponding information on vascular access survival", "No Answer", "10807", "90.6"], "multiturn": {"turn_1": [{"question_id": "21.1", "question": "What year was the cross-sectional survey conducted?", "answer_src": "2009", "follow_up_question": "In what percentage of cases did patients have arteriovenous grafts?", "follow_up_response": "9.4%", "follow_up_response_bt": "9.4%"}, {"question_id": "21.2", "question": "Who were the patients selected for follow-up?", "answer_src": "patients with corresponding vascular access survival information", "follow_up_question": "What percentage of the selected patients had an arteriovenous graft?", "follow_up_response": "9.4%", "follow_up_response_bt": "9.4%"}, {"question_id": "21.3", "question": "Where were the nine countries located?", "answer_src": "based on an april 2009 cross - sectional survey of vascular access cannulation practices in 171 dialysis units , a cohort of patients with corresponding vascular access survival information was selected for follow - up ending march 2012 . of the 10,807 patients enrolled in the original survey , access survival data were available for 7058 patients from nine countries . of these , 90.6% had an arteriovenous fistula and 9.4% arteriovenous graft .", "follow_up_question": "In what percentage of cases did patients have arteriovenous grafts?", "follow_up_response": "9.4%", "follow_up_response_bt": "9.4%"}, {"question_id": "21.4", "question": "How many patients were enrolled in the original survey?", "answer_src": "10807", "follow_up_question": "How many patients had an arteriovenous fistula?", "follow_up_response": "90.6%", "follow_up_response_bt": "90.6%"}, {"question_id": "21.5", "question": "What percentage of patients had an arteriovenous fistula?", "answer_src": "90.6", "follow_up_question": "What was the survival rate for patients with arteriovenous grafts?", "follow_up_response": "9.4%", "follow_up_response_bt": "9.4%"}], "turn_2": [{"question_id": "21.6", "question": "In what percentage of cases did patients have arteriovenous grafts?", "answer_src": "9.4%", "follow_up_question": "What was the survival rate for patients with arteriovenous fistulas?", "follow_up_response": "90.6%", "follow_up_response_bt": "90.6%"}, {"question_id": "21.7", "question": "What percentage of the selected patients had an arteriovenous graft?", "answer_src": "9.4%", "follow_up_question": "What was the average survival time for patients with arteriovenous fistulas?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "21.8", "question": "In what percentage of cases did patients have arteriovenous grafts?", "answer_src": "9.4%", "follow_up_question": "What was the survival rate for patients with arteriovenous fistulas?", "follow_up_response": "90.6%", "follow_up_response_bt": "90.6%"}, {"question_id": "21.9", "question": "How many patients had an arteriovenous fistula?", "answer_src": "90.6%", "follow_up_question": "What percentage of patients had an arteriovenous graft?", "follow_up_response": "9.4%", "follow_up_response_bt": "9.4%"}, {"question_id": "21.10", "question": "What was the survival rate for patients with arteriovenous grafts?", "answer_src": "9.4%", "follow_up_question": "What percentage of patients had arteriovenous fistulas?", "follow_up_response": "90.6%", "follow_up_response_bt": "90.6%"}], "turn_3": [{"question_id": "21.11", "question": "What was the survival rate for patients with arteriovenous fistulas?", "answer_src": "90.6%", "follow_up_question": "What was the survival rate for patients with arteriovenous grafts?", "follow_up_response": "9.4%", "follow_up_response_bt": "9.4%"}, {"question_id": "21.12", "question": "What was the average survival time for patients with arteriovenous fistulas?", "answer_src": "based on an april 2009 cross - sectional survey of vascular access cannulation practices in 171 dialysis units , a cohort of patients with corresponding vascular access survival information was selected for follow - up ending march 2012 . of the 10,807 patients enrolled in the original survey , access survival data were available for 7058 patients from nine countries . of these , 90.6% had an arteriovenous fistula and 9.4% arteriovenous graft .", "follow_up_question": "What percentage of patients with arteriovenous grafts had access survival data available?", "follow_up_response": "9.4%", "follow_up_response_bt": "9.4%"}, {"question_id": "21.13", "question": "What was the survival rate for patients with arteriovenous fistulas?", "answer_src": "90.6%", "follow_up_question": "What was the survival rate for patients with arteriovenous grafts?", "follow_up_response": "9.4%", "follow_up_response_bt": "9.4%"}, {"question_id": "21.14", "question": "What percentage of patients had an arteriovenous graft?", "answer_src": "9.4%", "follow_up_question": "What was the overall survival rate of the arteriovenous fistulas?", "follow_up_response": "90.6%", "follow_up_response_bt": "90.6%"}, {"question_id": "21.15", "question": "What percentage of patients had arteriovenous fistulas?", "answer_src": "90.6%", "follow_up_question": "What was the survival rate for patients with arteriovenous grafts?", "follow_up_response": "9.4%", "follow_up_response_bt": "9.4%"}]}}
{"id": 22, "src": "musculoskeletal disorders are among the most common problems affecting the elderly . the resulting loss of mobility and physical independence can be particularly devastating in this population . the aim of this article is to present some of the most frequent musculoskeletal disorders of the elderly , such as fractures , osteoporosis , osteoarthritis , microcrystal disorders , infections , and tumors .", "mt": "I disturbi muscolo-scheletrici sono tra i problemi più comuni che colpiscono gli anziani . La perdita di mobilità e di indipendenza fisica che ne deriva può essere particolarmente devastante in questa popolazione . L'obiettivo di questo articolo è quello di presentare alcuni dei disturbi muscolo-scheletrici più frequenti degli anziani , come fratture , osteoporosi , osteoartrite , disturbi dei microcristalli , infezioni e tumori .", "pert_mt": "I disturbi muscolo-scheletrici sono tra i problemi più comuni che colpiscono gli anziani. La perdita di mobilità e di indipendenza fisica che ne deriva può essere particolarmente devastante in questa popolazione. L'obiettivo di questo articolo è quello di presentare alcuni dei disturbi muscolo-scheletrici più frequenti degli anziani, come fratture, osteoporosi, osteoartrite, disturbi dei microcristalli, infezioni e tumori, e le loro complesse interazioni cliniche.", "bt": "Musculoskeletal disorders are among the most common problems affecting the elderly, and the resulting loss of mobility and physical independence can be particularly devastating in this population, with the aim of presenting some of the most common musculoskeletal disorders in the elderly, such as fracture, osteoporosis, osteoarthritis, microcrystalline disorders, infections and tumors, and their complex clinical interactions.", "questions_src": ["What are some of the most frequent musculoskeletal disorders of the elderly mentioned in the article?", "When can the loss of mobility and physical independence be particularly devastating for the elderly?", "Where can fractures commonly occur in the elderly?", "Who is the target audience of this article?", "Which conditions are discussed in the article that affect the elderly's musculoskeletal system?"], "answers_src": ["Fractures, osteoporosis, osteoarthritis, microcrystal disorders, infections, and tumors", "In this population", "No Answer", "The elderly", "Musculoskeletal disorders of the elderly"], "answers_bt": ["[\"Fracture, osteoporosis, osteoarthritis, microcrystalline disorders, infections and tumors\"], [\"In this population\"], [\"The musculoskeletal system\"], [\"The elderly\"], [\"Fracture, osteoporosis, osteoarthritis, microcrystalline disorders, infections and tumors\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "22.1", "question": "What are some of the most frequent musculoskeletal disorders of the elderly mentioned in the article?", "answer_src": "Fractures, osteoporosis, osteoarthritis, microcrystal disorders, infections, and tumors", "follow_up_question": "What percentage of the elderly population is affected by musculoskeletal disorders according to the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "22.2", "question": "When can the loss of mobility and physical independence be particularly devastating for the elderly?", "answer_src": "In this population", "follow_up_question": "What specific conditions does the article mention as causing these losses?", "follow_up_response": "Fractures, osteoporosis, osteoarthritis, microcrystal disorders, infections, and tumors", "follow_up_response_bt": "Fracture, osteoporosis, osteoarthritis, microcrystalline disorders, infections and tumors"}, {"question_id": "22.3", "question": "Where can fractures commonly occur in the elderly?", "answer_src": "musculoskeletal disorders are among the most common problems affecting the elderly . the resulting loss of mobility and physical independence can be particularly devastating in this population . the aim of this article is to present some of the most frequent musculoskeletal disorders of the elderly , such as fractures , osteoporosis , osteoarthritis , microcrystal disorders , infections , and tumors .", "follow_up_question": "What are some other musculoskeletal disorders discussed in the article besides fractures?", "follow_up_response": "osteoporosis\", \"osteoarthritis\", \"microcrystal disorders\", \"infections\", \"tumors", "follow_up_response_bt": "osteoporosis\", \"osteoarthritis\", \"microcrystalline disorders\", \"infections\", \"tumors"}, {"question_id": "22.4", "question": "Who is the target audience of this article?", "answer_src": "The elderly", "follow_up_question": "What specific musculoskeletal disorders does the article mention?", "follow_up_response": "fractures\", \"osteoporosis\", \"osteoarthritis\", \"microcrystal disorders\", \"infections\", \"tumors", "follow_up_response_bt": "fracture, osteoporosis, osteoarthritis, microcrystalline disorders, infections and tumors"}, {"question_id": "22.5", "question": "Which conditions are discussed in the article that affect the elderly's musculoskeletal system?", "answer_src": "Musculoskeletal disorders of the elderly", "follow_up_question": "What specific type of disorder does the article mention first?", "follow_up_response": "musculoskeletal disorders", "follow_up_response_bt": "Musculoskeletal disorders"}], "turn_2": [{"question_id": "22.6", "question": "What percentage of the elderly population is affected by musculoskeletal disorders according to the text?", "answer_src": "musculoskeletal disorders are among the most common problems affecting the elderly . the resulting loss of mobility and physical independence can be particularly devastating in this population . the aim of this article is to present some of the most frequent musculoskeletal disorders of the elderly , such as fractures , osteoporosis , osteoarthritis , microcrystal disorders , infections , and tumors .", "follow_up_question": "What specific types of musculoskeletal disorders does the article mention?", "follow_up_response": "fractures\", \"osteoporosis\", \"osteoarthritis\", \"microcrystal disorders\", \"infections\", \"tumors", "follow_up_response_bt": "fracture, osteoporosis, osteoarthritis, microcrystalline disorders, infections and tumors"}, {"question_id": "22.7", "question": "What specific conditions does the article mention as causing these losses?", "answer_src": "Fractures, osteoporosis, osteoarthritis, microcrystal disorders, infections, and tumors", "follow_up_question": "What percentage of the elderly population is affected by osteoporosis according to the article?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "22.8", "question": "What are some other musculoskeletal disorders discussed in the article besides fractures?", "answer_src": "osteoporosis\", \"osteoarthritis\", \"microcrystal disorders\", \"infections\", \"tumors", "follow_up_question": "What percentage of the elderly population is affected by osteoporosis according to the article?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "22.9", "question": "What specific musculoskeletal disorders does the article mention?", "answer_src": "fractures\", \"osteoporosis\", \"osteoarthritis\", \"microcrystal disorders\", \"infections\", \"tumors", "follow_up_question": "What percentage of the elderly population is affected by musculoskeletal disorders according to the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "22.10", "question": "What specific type of disorder does the article mention first?", "answer_src": "musculoskeletal disorders", "follow_up_question": "What is the first disorder mentioned in the article that leads to loss of mobility?", "follow_up_response": "fractures", "follow_up_response_bt": "Fracture"}], "turn_3": [{"question_id": "22.11", "question": "What specific types of musculoskeletal disorders does the article mention?", "answer_src": "fractures\", \"osteoporosis\", \"osteoarthritis\", \"microcrystal disorders\", \"infections\", \"tumors", "follow_up_question": "What percentage of the elderly population is affected by these disorders according to the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "22.12", "question": "What percentage of the elderly population is affected by osteoporosis according to the article?", "answer_src": "musculoskeletal disorders are among the most common problems affecting the elderly . the resulting loss of mobility and physical independence can be particularly devastating in this population . the aim of this article is to present some of the most frequent musculoskeletal disorders of the elderly , such as fractures , osteoporosis , osteoarthritis , microcrystal disorders , infections , and tumors .", "follow_up_question": "What other musculoskeletal disorder besides osteoporosis is discussed in the article?", "follow_up_response": "fractures\", \"osteoarthritis\", \"microcrystal disorders\", \"infections\", \"tumors", "follow_up_response_bt": "fracture\", \"osteoarthritis\", \"microcrystalline disorders\", \"infections\", \"tumors"}, {"question_id": "22.13", "question": "What percentage of the elderly population is affected by osteoporosis according to the article?", "answer_src": "musculoskeletal disorders are among the most common problems affecting the elderly . the resulting loss of mobility and physical independence can be particularly devastating in this population . the aim of this article is to present some of the most frequent musculoskeletal disorders of the elderly , such as fractures , osteoporosis , osteoarthritis , microcrystal disorders , infections , and tumors .", "follow_up_question": "What other musculoskeletal disorder besides osteoporosis is discussed in the article?", "follow_up_response": "fractures\", \"osteoarthritis\", \"microcrystal disorders\", \"infections\", \"tumors", "follow_up_response_bt": "fracture\", \"osteoarthritis\", \"microcrystalline disorders\", \"infections\", \"tumors"}, {"question_id": "22.14", "question": "What percentage of the elderly population is affected by musculoskeletal disorders according to the text?", "answer_src": "musculoskeletal disorders are among the most common problems affecting the elderly . the resulting loss of mobility and physical independence can be particularly devastating in this population . the aim of this article is to present some of the most frequent musculoskeletal disorders of the elderly , such as fractures , osteoporosis , osteoarthritis , microcrystal disorders , infections , and tumors .", "follow_up_question": "What specific types of musculoskeletal disorders does the article mention?", "follow_up_response": "fractures\", \"osteoporosis\", \"osteoarthritis\", \"microcrystal disorders\", \"infections\", \"tumors", "follow_up_response_bt": "fracture, osteoporosis, osteoarthritis, microcrystalline disorders, infections and tumors"}, {"question_id": "22.15", "question": "What is the first disorder mentioned in the article that leads to loss of mobility?", "answer_src": "fractures", "follow_up_question": "What percentage of musculoskeletal disorders discussed in the article affect the elderly specifically?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 23, "src": "food composition databases are limited for menaquinones and their presence in foods varies by region . dietary intakes of all forms of vitamin k vary widely among age groups and population subgroups . similarly , the utilization of vitamin k from different forms and food sources appear to vary , although our understanding of vitamin k is still rudimentary in light of new developments regarding the menaquinones .", "mt": "I database di composizione alimentare sono limitati per le menaquinoni e la loro presenza negli alimenti varia in base alla regione . L' assunzione di tutte le forme di vitamina k varia notevolmente tra i gruppi di età e i sottogruppi della popolazione . Allo stesso modo , l' utilizzo della vitamina k da diverse forme e fonti alimentari sembra variare , anche se la nostra comprensione della vitamina k è ancora rudimentale alla luce dei nuovi sviluppi relativi ai menaquinoni .", "pert_mt": "I database di composizione alimentare sono limitati per le menaquinoni e la loro presenza negli alimenti varia in base alla regione. L'assunzione di tutte le forme di vitamina K varia notevolmente tra i gruppi di età e i sottogruppi della popolazione. Allo stesso modo, l'utilizzo della vitamina K da diverse forme e fonti alimentari sembra variare, anche se la nostra comprensione della vitamina K è ancora rudimentale alla luce dei nuovi sviluppi relativi ai menaquinoni e questo aspetto richiede ulteriori ricerche.", "bt": "The food composition database is limited for menaquinones and their presence in foods varies by region. The intake of all forms of vitamin K varies greatly between age groups and subgroups of the population. Similarly, the use of vitamin K from various forms and food sources seems to vary, although our understanding of vitamin K is still rudimentary in light of new developments related to menaquinones and this aspect requires further research.", "questions_src": ["What are menaquinones used for in food composition databases?", "Who can have wide variations in dietary intakes of vitamin K?", "Where do the differences in vitamin K utilization come from?", "When was there a lack of understanding about vitamin K?", "Which forms of vitamin K are more prevalent in different food sources?"], "answers_src": ["Menakinones", "All age groups and population subgroups", "Different forms and food sources", "In the past", "All forms"], "answers_bt": ["The food composition database", "All age groups and subgroups of the population", "New developments related to menaquinones", "In light of new developments related to menaquinones", "Various forms and food sources"], "multiturn": {"turn_1": [{"question_id": "23.1", "question": "What are menaquinones used for in food composition databases?", "answer_src": "Menakinones", "follow_up_question": "What types of foods are menaquinones more commonly found in according to the text?", "follow_up_response": "menaquinones", "follow_up_response_bt": "menaquinones"}, {"question_id": "23.2", "question": "Who can have wide variations in dietary intakes of vitamin K?", "answer_src": "All age groups and population subgroups", "follow_up_question": "What factors contribute to the wide variations in dietary intakes of vitamin K?", "follow_up_response": "Age groups and population subgroups", "follow_up_response_bt": "Age groups and subgroups of the population"}, {"question_id": "23.3", "question": "Where do the differences in vitamin K utilization come from?", "answer_src": "Different forms and food sources", "follow_up_question": "How do the different forms of vitamin K affect its utilization?", "follow_up_response": "Although our understanding of vitamin K is still rudimentary, the utilization of vitamin K from different forms and food sources appear to vary", "follow_up_response_bt": "vitamin K from various forms and food sources"}, {"question_id": "23.4", "question": "When was there a lack of understanding about vitamin K?", "answer_src": "In the past", "follow_up_question": "What specific aspects of vitamin K's utilization were found to vary according to the text?", "follow_up_response": "the utilization of vitamin k from different forms and food sources", "follow_up_response_bt": "Age groups and subgroups of the population, forms and food sources"}, {"question_id": "23.5", "question": "Which forms of vitamin K are more prevalent in different food sources?", "answer_src": "All forms", "follow_up_question": "How many forms of vitamin K are mentioned in the text?", "follow_up_response": "2", "follow_up_response_bt": "2"}], "turn_2": [{"question_id": "23.6", "question": "What types of foods are menaquinones more commonly found in according to the text?", "answer_src": "menaquinones", "follow_up_question": "What regions have less data on menaquinones in foods according to the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "23.7", "question": "What factors contribute to the wide variations in dietary intakes of vitamin K?", "answer_src": "Age groups and population subgroups", "follow_up_question": "How do different forms of vitamin K affect its utilization?", "follow_up_response": "Although our understanding of vitamin K is still rudimentary, the utilization of vitamin K from different forms and food sources appear to vary", "follow_up_response_bt": "vitamin K from various forms and food sources"}, {"question_id": "23.8", "question": "How do the different forms of vitamin K affect its utilization?", "answer_src": "Although our understanding of vitamin K is still rudimentary, the utilization of vitamin K from different forms and food sources appear to vary", "follow_up_question": "What factors contribute to the variation in the utilization of vitamin K from different forms?", "follow_up_response": "The utilization of vitamin K from different forms and food sources", "follow_up_response_bt": "The use of vitamin K from various forms and food sources"}, {"question_id": "23.9", "question": "What specific aspects of vitamin K's utilization were found to vary according to the text?", "answer_src": "the utilization of vitamin k from different forms and food sources", "follow_up_question": "How does the utilization of vitamin K from different forms compare to its utilization from food sources?", "follow_up_response": "Although our understanding of vitamin K is still rudimentary, the utilization of vitamin K from different forms and food sources appear to vary", "follow_up_response_bt": "Although our understanding of vitamin K is still rudimentary, the use of vitamin K from various forms and food sources seems to vary."}, {"question_id": "23.10", "question": "How many forms of vitamin K are mentioned in the text?", "answer_src": "2", "follow_up_question": "What are the two forms of vitamin K mentioned in the text?", "follow_up_response": "menaquinones", "follow_up_response_bt": "menaquinones"}], "turn_3": [{"question_id": "23.11", "question": "What regions have less data on menaquinones in foods according to the text?", "answer_src": "food composition databases are limited for menaquinones and their presence in foods varies by region . dietary intakes of all forms of vitamin k vary widely among age groups and population subgroups . similarly , the utilization of vitamin k from different forms and food sources appear to vary , although our understanding of vitamin k is still rudimentary in light of new developments regarding the menaquinones .", "follow_up_question": "How does the text suggest our understanding of vitamin K is currently?", "follow_up_response": "still rudimentary", "follow_up_response_bt": "rudimentary"}, {"question_id": "23.12", "question": "How do different forms of vitamin K affect its utilization?", "answer_src": "Although our understanding of vitamin K is still rudimentary, the utilization of vitamin K from different forms and food sources appear to vary", "follow_up_question": "What factors contribute to the variation in the utilization of vitamin K from different forms?", "follow_up_response": "The utilization of vitamin K from different forms and food sources", "follow_up_response_bt": "The use of vitamin K from various forms and food sources"}, {"question_id": "23.13", "question": "What factors contribute to the variation in the utilization of vitamin K from different forms?", "answer_src": "The utilization of vitamin K from different forms and food sources", "follow_up_question": "How does the variation in utilization differ between different age groups?", "follow_up_response": "dietary intakes of all forms of vitamin k vary widely among age groups", "follow_up_response_bt": "The intake of all forms of vitamin K varies greatly between age groups"}, {"question_id": "23.14", "question": "How does the utilization of vitamin K from different forms compare to its utilization from food sources?", "answer_src": "Although our understanding of vitamin K is still rudimentary, the utilization of vitamin K from different forms and food sources appear to vary", "follow_up_question": "What factors contribute to the variation in the utilization of vitamin K from different forms?", "follow_up_response": "The utilization of vitamin K from different forms and food sources", "follow_up_response_bt": "The use of vitamin K from various forms and food sources"}, {"question_id": "23.15", "question": "What are the two forms of vitamin K mentioned in the text?", "answer_src": "menaquinones", "follow_up_question": "How do the dietary intakes of vitamin K differ between age groups and population subgroups?", "follow_up_response": "Dietary intakes of all forms of vitamin K vary widely among age groups and population subgroups.", "follow_up_response_bt": "The intake of all forms of vitamin K varies greatly between age groups and subgroups of the population"}]}}
{"id": 24, "src": "colesevelam may have some effect on glucose absorption , but likely via a different mechanism than -glucosidase inhibitors . colesevelam and metformin have similarities regarding hepatic glucose production , but divergent effects on gluconeogenesis versus glycogenolysis , suggesting differing mechanisms of drug action for improving glycemic control . colesevelam is thought to be a portal glucagon - like peptide-1 ( glp-1 ) secretagogue with primarily hepatic effects .", "mt": "Il colesevelam può avere qualche effetto sull'assorbimento del glucosio , ma probabilmente attraverso un meccanismo diverso dagli inibitori della -glucosidasi . Il colesevelam e la metformina hanno similitudini in materia di produzione di glucosio epatico , ma effetti divergenti sulla gluconeogenesi rispetto alla glycogenolysis , suggerendo meccanismi diversi di azione del farmaco per migliorare il controllo glicemico .", "pert_mt": "Il colesevelam può avere qualche effetto sull'assorbimento del glucosio, ma probabilmente attraverso un meccanismo diverso dagli inibitori della -glucosidasi. Il colesevelam e la metformina hanno similitudini in materia di produzione di glucosio epatico, ma effetti divergenti sulla gluconeogenesi rispetto alla glycogenolysis, suggerendo meccanismi diversi di azione del farmaco per migliorare il controllo glicemico e potenzialmente influenzando anche il metabolismo delle lipidi.", "bt": "Colesevelam may have some effect on glucose absorption, but probably through a different mechanism than the -glucosidase inhibitors.Colesevelam and metformin have similarities in liver glucose production, but divergent effects on gluconeogenesis compared to glycogenolysis, suggesting different mechanisms of action of the drug to improve glycemic control and potentially also affecting lipid metabolism.", "questions_src": ["What is colesevelam's primary mechanism of action compared to -glucosidase inhibitors?", "Who might colesevelam affect in terms of glucose absorption?", "Where does colesevelam have similar effects to metformin regarding hepatic glucose production?", "When was colesevelam first discovered or developed?", "Which other hormone does colesevelam act like according to the given information?"], "answers_src": ["a different mechanism", "some effect", "hepatic glucose production", "No Answer", "glucagon-like peptide-1 (GLP-1)"], "answers_bt": ["a different mechanism", "some effect", "the liver", "No Answer", "glycogen"], "multiturn": {"turn_1": [{"question_id": "24.1", "question": "What is colesevelam's primary mechanism of action compared to -glucosidase inhibitors?", "answer_src": "a different mechanism", "follow_up_question": "How does colesevelam differ from metformin in its effects on gluconeogenesis and glycogenolysis?", "follow_up_response": "colesevelam has divergent effects on gluconeogenesis versus glycogenolysis, suggesting differing mechanisms of drug action", "follow_up_response_bt": "Colesevelam has divergent effects on gluconeogenesis compared to glycogenolysis, while metformin does not provide information specifically about these processes."}, {"question_id": "24.2", "question": "Who might colesevelam affect in terms of glucose absorption?", "answer_src": "some effect", "follow_up_question": "what specific mechanism does colesevelam use for its effect on glucose absorption?", "follow_up_response": "but likely via a different mechanism than -glucosidase inhibitors", "follow_up_response_bt": "a different mechanism than the -glucosidase inhibitors"}, {"question_id": "24.3", "question": "Where does colesevelam have similar effects to metformin regarding hepatic glucose production?", "answer_src": "hepatic glucose production", "follow_up_question": "What are the differing effects of colesevelam on gluconeogenesis versus glycogenolysis compared to metformin?", "follow_up_response": "suggesting differing mechanisms of drug action for improving glycemic control", "follow_up_response_bt": "Different effects of colesevelam on gluconeogenesis compared to glycogenolysis"}, {"question_id": "24.4", "question": "When was colesevelam first discovered or developed?", "answer_src": "colesevelam may have some effect on glucose absorption , but likely via a different mechanism than -glucosidase inhibitors . colesevelam and metformin have similarities regarding hepatic glucose production , but divergent effects on gluconeogenesis versus glycogenolysis , suggesting differing mechanisms of drug action for improving glycemic control . colesevelam is thought to be a portal glucagon - like peptide-1 ( glp-1 ) secretagogue with primarily hepatic effects .", "follow_up_question": "What is colesevelam believed to primarily affect in the body?", "follow_up_response": "the liver", "follow_up_response_bt": "Glucose absorption"}, {"question_id": "24.5", "question": "Which other hormone does colesevelam act like according to the given information?", "answer_src": "glucagon-like peptide-1 (GLP-1)", "follow_up_question": "What are the primary effects of colesevelam on the liver?", "follow_up_response": "Primary effects of colesevelam on the liver", "follow_up_response_bt": "Similarities in liver glucose production"}], "turn_2": [{"question_id": "24.6", "question": "How does colesevelam differ from metformin in its effects on gluconeogenesis and glycogenolysis?", "answer_src": "colesevelam has divergent effects on gluconeogenesis versus glycogenolysis, suggesting differing mechanisms of drug action", "follow_up_question": "What specific hepatic effect is colesevelam believed to have based on the text?", "follow_up_response": "primarily hepatic effects", "follow_up_response_bt": "Liver glucose production"}, {"question_id": "24.7", "question": "what specific mechanism does colesevelam use for its effect on glucose absorption?", "answer_src": "but likely via a different mechanism than -glucosidase inhibitors", "follow_up_question": "what mechanism does colesevelam use that differs from -glucosidase inhibitors?", "follow_up_response": "a different mechanism", "follow_up_response_bt": "a different mechanism"}, {"question_id": "24.8", "question": "What are the differing effects of colesevelam on gluconeogenesis versus glycogenolysis compared to metformin?", "answer_src": "suggesting differing mechanisms of drug action for improving glycemic control", "follow_up_question": "How do colesevelam's effects on gluconeogenesis and glycogenolysis differ specifically from those of metformin?", "follow_up_response": "colesevelam has divergent effects on gluconeogenesis versus glycogenolysis, suggesting differing mechanisms of drug action for improving glycemic control", "follow_up_response_bt": "suggest different mechanisms of action"}, {"question_id": "24.9", "question": "What is colesevelam believed to primarily affect in the body?", "answer_src": "the liver", "follow_up_question": "What specific aspect of glucose metabolism does colesevelam primarily influence?", "follow_up_response": "primarily hepatic", "follow_up_response_bt": "Glucose absorption"}, {"question_id": "24.10", "question": "What are the primary effects of colesevelam on the liver?", "answer_src": "Primary effects of colesevelam on the liver", "follow_up_question": "How does colesevelam differ from metformin in its effects on gluconeogenesis and glycogenolysis?", "follow_up_response": "colesevelam has divergent effects on gluconeogenesis versus glycogenolysis, suggesting differing mechanisms of drug action", "follow_up_response_bt": "Colesevelam has divergent effects on gluconeogenesis compared to glycogenolysis, while metformin does not provide information specifically about these processes."}], "turn_3": [{"question_id": "24.11", "question": "What specific hepatic effect is colesevelam believed to have based on the text?", "answer_src": "primarily hepatic effects", "follow_up_question": "What are the primary effects of colesevelam on glycogenolysis and gluconeogenesis according to the text?", "follow_up_response": "divergent effects on gluconeogenesis versus glycogenolysis", "follow_up_response_bt": "Divergent effects on gluconeogenesis compared to glycogenolysis"}, {"question_id": "24.12", "question": "what mechanism does colesevelam use that differs from -glucosidase inhibitors?", "answer_src": "a different mechanism", "follow_up_question": "what specific mechanism does colesevelam use according to the text?", "follow_up_response": "portal glucagon - like peptide-1 (glp-1) secretagogue with primarily hepatic effects", "follow_up_response_bt": "a different mechanism than the -glucosidase inhibitors"}, {"question_id": "24.13", "question": "How do colesevelam's effects on gluconeogenesis and glycogenolysis differ specifically from those of metformin?", "answer_src": "colesevelam has divergent effects on gluconeogenesis versus glycogenolysis, suggesting differing mechanisms of drug action for improving glycemic control", "follow_up_question": "What specific hepatic effects does colesevelam have according to the text?", "follow_up_response": "primarily hepatic effects", "follow_up_response_bt": "Similarities in liver glucose production"}, {"question_id": "24.14", "question": "What specific aspect of glucose metabolism does colesevelam primarily influence?", "answer_src": "primarily hepatic", "follow_up_question": "What are the primary effects of colesevelam on glycogenolysis and gluconeogenesis?", "follow_up_response": "divergent effects on gluconeogenesis versus glycogenolysis", "follow_up_response_bt": "Divergent effects on gluconeogenesis compared to glycogenolysis"}, {"question_id": "24.15", "question": "How does colesevelam differ from metformin in its effects on gluconeogenesis and glycogenolysis?", "answer_src": "colesevelam has divergent effects on gluconeogenesis versus glycogenolysis, suggesting differing mechanisms of drug action", "follow_up_question": "What specific hepatic effect is colesevelam believed to have based on the text?", "follow_up_response": "primarily hepatic effects", "follow_up_response_bt": "Liver glucose production"}]}}
{"id": 25, "src": "purposeextracorporeal shock wave lithotripsy ( eswl ) has shown successful outcomes for ureteral stones . we investigated predictive factors for failure of eswl for treating ureteral stones.materials and methodsa total of 153 patients who underwent eswl between july 2006 and july 2009 for ureteral stones diagnosed by non - enhanced spiral computed tomography were divided into two groups : ( group a , stone size 10 mm ; and group b , stone size > 10 mm ) . the failure was defined as remnant stones > 4 mm .", "mt": "Abbiamo studiato i fattori predittivi per il fallimento di eswl per il trattamento di pietre ureterali.materiali e metodici sono stati utilizzati da un totale di 153 pazienti che hanno subito eswl tra luglio 2006 e luglio 2009 per le pietre ureterali diagnosticate con tomografia computerizzata a spirale non migliorata , e sono state suddivise in due gruppi: (gruppo a , dimensione di pietra 10 mm; e gruppo b , dimensione di pietra > 10 mm).", "pert_mt": "Abbiamo studiato i fattori predittivi per il fallimento di ESWL per il trattamento di pietre ureterali. I materiali e metodici sono stati utilizzati da un totale di 153 pazienti che hanno subito ESWL tra luglio 2006 e luglio 2009 per le pietre ureterali diagnosticate con tomografia computerizzata a spirale non migliorata, e sono state suddivise in due gruppi: (gruppo A, dimensione di pietra 10 mm; e gruppo B, dimensione di pietra > 10 mm).", "bt": "We studied the predictive factors for the failure of ESWL for the treatment of urethral stone, and the materials and methods were used by a total of 153 patients who had ESWL between July 2006 and July 2009 for urethral stone diagnosed with computed tomography with an unimproved spiral, and were divided into two groups: (group A, stone size 10 mm; and group B, stone size > 10 mm).", "questions_src": ["What is the name of the procedure used for ureteral stones?", "Who diagnosed the ureteral stones using non-enhanced spiral computed tomography?", "Where did the study take place (start and end months)?", "Which group had stones larger than 10 mm?", "When was the failure defined in terms of stone size?"], "answers_src": ["[\"purposeextracorporeal shock wave lithotripsy ( eswl )\"], [\"non - enhanced spiral computed tomography\"], [\"july 2006 and july 2009\"], [\"group b\"], [\"remnant stones > 4 mm\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["ESWL", "computed tomography", "July 2006 and July 2009", "Group B", "unimproved"], "multiturn": {"turn_1": [{"question_id": "25.1", "question": "What is the name of the procedure used for ureteral stones?", "answer_src": "[\"purposeextracorporeal shock wave lithotripsy ( eswl )\"], [\"non - enhanced spiral computed tomography\"], [\"july 2006 and july 2009\"], [\"group b\"], [\"remnant stones > 4 mm\"]", "follow_up_question": "What was the criterion for defining failure of ESWL in this study?", "follow_up_response": "Remnant stones > 4 mm", "follow_up_response_bt": "The failure of ESWL"}, {"question_id": "25.2", "question": "Who diagnosed the ureteral stones using non-enhanced spiral computed tomography?", "answer_src": "purposeextracorporeal shock wave lithotripsy ( eswl ) has shown successful outcomes for ureteral stones . we investigated predictive factors for failure of eswl for treating ureteral stones.materials and methodsa total of 153 patients who underwent eswl between july 2006 and july 2009 for ureteral stones diagnosed by non - enhanced spiral computed tomography were divided into two groups : ( group a , stone size 10 mm ; and group b , stone size > 10 mm ) . the failure was defined as remnant stones > 4 mm .", "follow_up_question": "What was the criterion for defining failure in this study?", "follow_up_response": "Remnant stones > 4 mm", "follow_up_response_bt": "The failure of ESWL"}, {"question_id": "25.3", "question": "Where did the study take place (start and end months)?", "answer_src": "purposeextracorporeal shock wave lithotripsy ( eswl ) has shown successful outcomes for ureteral stones . we investigated predictive factors for failure of eswl for treating ureteral stones.materials and methodsa total of 153 patients who underwent eswl between july 2006 and july 2009 for ureteral stones diagnosed by non - enhanced spiral computed tomography were divided into two groups : ( group a , stone size 10 mm ; and group b , stone size > 10 mm ) . the failure was defined as remnant stones > 4 mm .", "follow_up_question": "What was the criterion for defining failure in this study?", "follow_up_response": "Remnant stones > 4 mm", "follow_up_response_bt": "The failure of ESWL"}, {"question_id": "25.4", "question": "Which group had stones larger than 10 mm?", "answer_src": "purposeextracorporeal shock wave lithotripsy ( eswl ) has shown successful outcomes for ureteral stones . we investigated predictive factors for failure of eswl for treating ureteral stones.materials and methodsa total of 153 patients who underwent eswl between july 2006 and july 2009 for ureteral stones diagnosed by non - enhanced spiral computed tomography were divided into two groups : ( group a , stone size 10 mm ; and group b , stone size > 10 mm ) . the failure was defined as remnant stones > 4 mm .", "follow_up_question": "What was the criterion for defining failure in this study?", "follow_up_response": "Remnant stones > 4 mm", "follow_up_response_bt": "The failure of ESWL"}, {"question_id": "25.5", "question": "When was the failure defined in terms of stone size?", "answer_src": "purposeextracorporeal shock wave lithotripsy ( eswl ) has shown successful outcomes for ureteral stones . we investigated predictive factors for failure of eswl for treating ureteral stones.materials and methodsa total of 153 patients who underwent eswl between july 2006 and july 2009 for ureteral stones diagnosed by non - enhanced spiral computed tomography were divided into two groups : ( group a , stone size 10 mm ; and group b , stone size > 10 mm ) . the failure was defined as remnant stones > 4 mm .", "follow_up_question": "What was the criterion for defining remnant stones as failure?", "follow_up_response": "Remnant stones > 4 mm", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "25.6", "question": "What was the criterion for defining failure of ESWL in this study?", "answer_src": "Remnant stones > 4 mm", "follow_up_question": "What was the median stone size in each group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "25.7", "question": "What was the criterion for defining failure in this study?", "answer_src": "Remnant stones > 4 mm", "follow_up_question": "What was the median stone size in group B?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "25.8", "question": "What was the criterion for defining failure in this study?", "answer_src": "Remnant stones > 4 mm", "follow_up_question": "What was the median stone size in group B?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "25.9", "question": "What was the criterion for defining failure in this study?", "answer_src": "Remnant stones > 4 mm", "follow_up_question": "What was the median stone size in group B?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "25.10", "question": "What was the criterion for defining remnant stones as failure?", "answer_src": "Remnant stones > 4 mm", "follow_up_question": "What was the median stone size in group B?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "25.11", "question": "What was the median stone size in each group?", "answer_src": "purposeextracorporeal shock wave lithotripsy ( eswl ) has shown successful outcomes for ureteral stones . we investigated predictive factors for failure of eswl for treating ureteral stones.materials and methodsa total of 153 patients who underwent eswl between july 2006 and july 2009 for ureteral stones diagnosed by non - enhanced spiral computed tomography were divided into two groups : ( group a , stone size 10 mm ; and group b , stone size > 10 mm ) . the failure was defined as remnant stones > 4 mm .", "follow_up_question": "What was the cutoff stone size for defining failure in the study?", "follow_up_response": "10 mm", "follow_up_response_bt": "10 mm"}, {"question_id": "25.12", "question": "What was the median stone size in group B?", "answer_src": "purposeextracorporeal shock wave lithotripsy ( eswl ) has shown successful outcomes for ureteral stones . we investigated predictive factors for failure of eswl for treating ureteral stones.materials and methodsa total of 153 patients who underwent eswl between july 2006 and july 2009 for ureteral stones diagnosed by non - enhanced spiral computed tomography were divided into two groups : ( group a , stone size 10 mm ; and group b , stone size > 10 mm ) . the failure was defined as remnant stones > 4 mm .", "follow_up_question": "What was the cutoff stone size for group B?", "follow_up_response": "> 10 mm", "follow_up_response_bt": "> 10 mm"}, {"question_id": "25.13", "question": "What was the median stone size in group B?", "answer_src": "purposeextracorporeal shock wave lithotripsy ( eswl ) has shown successful outcomes for ureteral stones . we investigated predictive factors for failure of eswl for treating ureteral stones.materials and methodsa total of 153 patients who underwent eswl between july 2006 and july 2009 for ureteral stones diagnosed by non - enhanced spiral computed tomography were divided into two groups : ( group a , stone size 10 mm ; and group b , stone size > 10 mm ) . the failure was defined as remnant stones > 4 mm .", "follow_up_question": "What was the cutoff stone size for group B?", "follow_up_response": "> 10 mm", "follow_up_response_bt": "> 10 mm"}, {"question_id": "25.14", "question": "What was the median stone size in group B?", "answer_src": "purposeextracorporeal shock wave lithotripsy ( eswl ) has shown successful outcomes for ureteral stones . we investigated predictive factors for failure of eswl for treating ureteral stones.materials and methodsa total of 153 patients who underwent eswl between july 2006 and july 2009 for ureteral stones diagnosed by non - enhanced spiral computed tomography were divided into two groups : ( group a , stone size 10 mm ; and group b , stone size > 10 mm ) . the failure was defined as remnant stones > 4 mm .", "follow_up_question": "What was the cutoff stone size for group B?", "follow_up_response": "> 10 mm", "follow_up_response_bt": "> 10 mm"}, {"question_id": "25.15", "question": "What was the median stone size in group B?", "answer_src": "purposeextracorporeal shock wave lithotripsy ( eswl ) has shown successful outcomes for ureteral stones . we investigated predictive factors for failure of eswl for treating ureteral stones.materials and methodsa total of 153 patients who underwent eswl between july 2006 and july 2009 for ureteral stones diagnosed by non - enhanced spiral computed tomography were divided into two groups : ( group a , stone size 10 mm ; and group b , stone size > 10 mm ) . the failure was defined as remnant stones > 4 mm .", "follow_up_question": "What was the cutoff stone size for group B?", "follow_up_response": "> 10 mm", "follow_up_response_bt": "> 10 mm"}]}}
{"id": 26, "src": "multivariate cox proportional - hazards models were constructed to compare complication and revision tha risk among cohorts , adjusting for medical comorbidities , race , socioeconomic status , and hospital factors.resultsafter adjusting for patient and hospital factors , m - m bearings were associated with a higher risk of periprosthetic joint infection ( hazard ratio , 3.03 ; confidence interval , 1.029.09 ) when compared with c - c bearings ( 0.59% versus 0.32% , respectively ) . there were no other differences among bearing cohorts in the adjusted risk of revision tha or any other complication.conclusionsthe risk of short - term complication ( including dislocation ) and revision tha were similar among appropriately matched medicare tha patients regardless of bearing surface . hard - on - hard tha bearings are of questionable value in medicare patients , given the higher cost associated with their use and uncertain long - term benefits in older patients.level of evidencelevel ii , prognostic study .", "mt": "I modelli cox proporzionali ai rischi sono stati costruiti per confrontare complicazioni e rischi di revisione tra le coorte , adattandoli per le comorbilità mediche , la razza , lo stato socioeconomico e i fattori ospedalieri.in seguito all'aggiustamento per i fattori pazienti e ospedalieri , i cuscinetti m - m sono stati associati a un rischio maggiore di infezione articolare periprotetica (rischio di rischio , 3.03; intervallo di fiducia , 1.029.09) rispetto ai cuscinetti c - c (0,59% contro 0,32%, rispettivamente) . Non ci sono state altre differenze tra le coorte portanti nel rischio di revisione tha o in qualsiasi altra complicazione.conclusioneIl rischio di complicazioni a breve termine (comprese le dislocazioni) e i benefici della revisione tha erano simili tra i pazienti con ricorso alla medicina nonostante il costo di portare . - I cuscinetti a lungo termine sono questionabili , e il valore di uso di pazienti anziani è associato al livello di costo e il loro uso di medicina è stato valutato con un livello superiore ,", "pert_mt": "I modelli cox proporzionali ai rischi sono stati costruiti per confrontare complicazioni e rischi di revisione tra le coorte, adattandoli per le comorbilità medicale, la razza, lo stato socioeconomico e i fattori ospedalieri. In seguito all'aggiustamento per i fattori pazienti e ospedalieri, i cuscinetti m-m sono stati associati a un rischio maggiore di infezione articolare periprotetica (rischio relativo, 3.03; intervallo di fiducia, 1.02-9.09) rispetto ai cuscinetti c-c (0,59% contro 0,32%, rispettivamente). Non ci sono state altre differenze tra le coorte portanti nel rischio di revisione THA o in qualsiasi altra complicazione", "bt": "Risk-proportionate cox models were built to counter the complications and risks of revision between the cohort, adapting them to medical comorbidities, race, socioeconomic status and hospital factors.Following adjustment for patient and hospital factors, cuscinetti m-m were associated with a higher risk of periprotetic joint infection (relative risk, 3.03; confidence interval, 1.02-9.09) than cuscinetti c-c (0.59% versus 0.32%, respectively).There were no other differences between the cohort carrying risk of THA revision or in any other complication", "questions_src": ["What is the hazard ratio for m-m bearings compared to c-c bearings for periprosthetic joint infection?", "When did the results show that the risk of short-term complication and revision THA were similar among patients regardless of bearing surface?", "What was the percentage difference in revision THA between m-m and c-c bearings?", "Which factors were adjusted for in the multivariate Cox proportional hazards models?", "Who were the patients included in the study, according to the conclusion section?"], "answers_src": ["3.03", "No Answer", "0.27%", "Medical comorbidities, race, socioeconomic status, and hospital factors", "Medicare THA patients"], "answers_bt": ["3.03", "No Answer", "58%", "Patient and hospital factors", "No Answer"], "multiturn": {"turn_1": [{"question_id": "26.1", "question": "What is the hazard ratio for m-m bearings compared to c-c bearings for periprosthetic joint infection?", "answer_src": "3.03", "follow_up_question": "What is the adjusted risk of revision THA for m-m bearings compared to c-c bearings?", "follow_up_response": "3.03", "follow_up_response_bt": "3.03"}, {"question_id": "26.2", "question": "When did the results show that the risk of short-term complication and revision THA were similar among patients regardless of bearing surface?", "answer_src": "multivariate cox proportional - hazards models were constructed to compare complication and revision tha risk among cohorts , adjusting for medical comorbidities , race , socioeconomic status , and hospital factors.resultsafter adjusting for patient and hospital factors , m - m bearings were associated with a higher risk of periprosthetic joint infection ( hazard ratio , 3.03 ; confidence interval , 1.029.09 ) when compared with c - c bearings ( 0.59% versus 0.32% , respectively ) . there were no other differences among bearing cohorts in the adjusted risk of revision tha or any other complication.conclusionsthe risk of short - term complication ( including dislocation ) and revision tha were similar among appropriately matched medicare tha patients regardless of bearing surface . hard - on - hard tha bearings are of questionable value in medicare patients , given the higher cost associated with their use and uncertain long - term benefits in older patients.level of evidencelevel ii , prognostic study .", "follow_up_question": "What was the adjusted risk ratio for periprosthetic joint infection for m-m bearings compared to c-c bearings?", "follow_up_response": "3.03", "follow_up_response_bt": "3.03"}, {"question_id": "26.3", "question": "What was the percentage difference in revision THA between m-m and c-c bearings?", "answer_src": "0.27%", "follow_up_question": "What was the hazard ratio for periprosthetic joint infection between m-m and c-c bearings?", "follow_up_response": "3.03", "follow_up_response_bt": "3.03"}, {"question_id": "26.4", "question": "Which factors were adjusted for in the multivariate Cox proportional hazards models?", "answer_src": "Medical comorbidities, race, socioeconomic status, and hospital factors", "follow_up_question": "What was the adjusted hazard ratio for periprosthetic joint infection for m-m bearings compared to c-c bearings?", "follow_up_response": "3.03", "follow_up_response_bt": "3.03"}, {"question_id": "26.5", "question": "Who were the patients included in the study, according to the conclusion section?", "answer_src": "Medicare THA patients", "follow_up_question": "What was the primary finding regarding the risk of periprosthetic joint infection between m-m and c-c bearings?", "follow_up_response": "The risk of periprosthetic joint infection was higher for m-m bearings (hazard ratio, 3.03; confidence interval, 1.02-10.09) compared to c-c bearings (0.59% versus 0.32%).", "follow_up_response_bt": "cuscinetti m-m were associated with a higher risk of periprosthetic joint infection compared to cuscinetti c-c"}], "turn_2": [{"question_id": "26.6", "question": "What is the adjusted risk of revision THA for m-m bearings compared to c-c bearings?", "answer_src": "3.03", "follow_up_question": "What is the adjusted risk of periprosthetic joint infection for m-m bearings compared to c-c bearings?", "follow_up_response": "3.03", "follow_up_response_bt": "3.03"}, {"question_id": "26.7", "question": "What was the adjusted risk ratio for periprosthetic joint infection for m-m bearings compared to c-c bearings?", "answer_src": "3.03", "follow_up_question": "What was the adjusted risk of revision THA for m-m bearings compared to c-c bearings?", "follow_up_response": "3.03", "follow_up_response_bt": "3.03"}, {"question_id": "26.8", "question": "What was the hazard ratio for periprosthetic joint infection between m-m and c-c bearings?", "answer_src": "3.03", "follow_up_question": "What was the adjusted risk of revision THA for m-m bearings compared to c-c bearings?", "follow_up_response": "3.03", "follow_up_response_bt": "3.03"}, {"question_id": "26.9", "question": "What was the adjusted hazard ratio for periprosthetic joint infection for m-m bearings compared to c-c bearings?", "answer_src": "3.03", "follow_up_question": "What was the adjusted risk of revision THA for m-m bearings compared to c-c bearings?", "follow_up_response": "3.03", "follow_up_response_bt": "3.03"}, {"question_id": "26.10", "question": "What was the primary finding regarding the risk of periprosthetic joint infection between m-m and c-c bearings?", "answer_src": "The risk of periprosthetic joint infection was higher for m-m bearings (hazard ratio, 3.03; confidence interval, 1.02-10.09) compared to c-c bearings (0.59% versus 0.32%).", "follow_up_question": "What was the adjusted risk ratio for revision total hip arthroplasty between m-m and c-c bearings?", "follow_up_response": "3.03", "follow_up_response_bt": "3.03"}], "turn_3": [{"question_id": "26.11", "question": "What is the adjusted risk of periprosthetic joint infection for m-m bearings compared to c-c bearings?", "answer_src": "3.03", "follow_up_question": "What is the adjusted risk of revision THA for m-m bearings compared to c-c bearings?", "follow_up_response": "3.03", "follow_up_response_bt": "3.03"}, {"question_id": "26.12", "question": "What was the adjusted risk of revision THA for m-m bearings compared to c-c bearings?", "answer_src": "3.03", "follow_up_question": "What was the adjusted risk of periprosthetic joint infection for m-m bearings compared to c-c bearings?", "follow_up_response": "3.03", "follow_up_response_bt": "3.03"}, {"question_id": "26.13", "question": "What was the adjusted risk of revision THA for m-m bearings compared to c-c bearings?", "answer_src": "3.03", "follow_up_question": "What was the adjusted risk of periprosthetic joint infection for m-m bearings compared to c-c bearings?", "follow_up_response": "3.03", "follow_up_response_bt": "3.03"}, {"question_id": "26.14", "question": "What was the adjusted risk of revision THA for m-m bearings compared to c-c bearings?", "answer_src": "3.03", "follow_up_question": "What was the adjusted risk of periprosthetic joint infection for m-m bearings compared to c-c bearings?", "follow_up_response": "3.03", "follow_up_response_bt": "3.03"}, {"question_id": "26.15", "question": "What was the adjusted risk ratio for revision total hip arthroplasty between m-m and c-c bearings?", "answer_src": "3.03", "follow_up_question": "What was the adjusted risk of periprosthetic joint infection for m-m bearings compared to c-c bearings?", "follow_up_response": "3.03", "follow_up_response_bt": "3.03"}]}}
{"id": 27, "src": "the 21st century can not see the examination of health status of elderly , population , children and adolescents ; but not for females.current study are 1 ) to examine the health conditions ; 2 ) provide an epidemiological profile of changing health conditions in the last one half decade ( 2002 - 2007 ) ; 3 ) evaluate whether self - reported illness is a good measure of health status ; 4 ) compute the mean age of females having particular health conditions ; 5 ) calculate the mean age of being ill compared with those who are not ill ; and 6 ) assess the correlation between health status and income quintile.in 2002 , a subsample of 12,675 females was extracted from the sample of 25,018 respondents and for 2007 ; a subsample of 3,479 females was extracted from 6,783 respondents.there is reduction in the mean age of females reported being diagnosed with chronic illness such as diabetes mellitus ( 60.54 17.14 years ) ; hypertension ( 60.85 16.93 years ) and arthritis 59.72 15.41 years ) . the greatest decline in mean age of chronically ill diagnosed females was in arthritic cases ( by 7.41 years ) . concurrently , the mean age of females with unspecified health conditions fell by ( 33% , from 54.62 21.77 years in 2002 to 36.42 23.69 years in 2007).although healthy life expectancy for females at birth in jamaica was 66 years , improvements in their health status can not be neglected as there are shits in health conditions ( to diabetes mellitus ) as well as the decline in ages at which females are being diagnosed with particular chronic illnesses .", "mt": "Il 21 ° secolo non può vedere l'esame dello stato di salute degli anziani , della popolazione , dei bambini e degli adolescenti; ma non per le donne.lo studio attuale è 1 ) per esaminare le condizioni di salute; 2 ) fornire un profilo epidemiologico dei cambiamenti delle condizioni di salute negli ultimi mezzo decennio (2002 - 2007); 3 ) valutare se la malattia auto-rilevata è una buona misura dello stato di salute; 4 ) calcolare l'età media delle donne con particolari condizioni di salute; 5 ) calcolare l'età media di essere malate rispetto a quelli che non sono malati; e 6 ) valutare la correlazione tra lo stato di salute e il quintile di reddito.Nel 2002 , un sotto campione di 12.675 donne è stato estratto dal campione di 25.018 rispondenti e per il 2007; un medio di 3.479 donne è stato estratto da 6.783 ) .", "pert_mt": "Il 21 ° secolo non può vedere l'esame dello stato di salute degli anziani, della popolazione, dei bambini e degli adolescenti; ma non per le donne. Lo studio attuale è 1) per esaminare le condizioni di salute; 2) fornire un profilo epidemiologico dei cambiamenti delle condizioni di salute negli ultimi mezzo decennio (2002 - 2007); 3) valutare se la malattia auto-rilevata è una buona misura dello stato di salute; 4) calcolare l'età media delle donne con particolari condizioni di salute; 5) calcolare l'età media di essere malate rispetto a quelli che non sono malati; e 6) valutare la correlazione tra lo stato di salute e il quintile di reddito. Nel 2002", "bt": "The 21st century cannot see the examination of the health status of the elderly, the population, children and adolescents; but not for women.The current study is 1) to examine health conditions; 2) to provide an epidemiological profile of changes in health conditions over the past half decade (2002-2007); 3) to assess whether self-reported disease is a good measure of health status; 4) to calculate the average age of women with particular health conditions; 5) to calculate the average age of being sick compared to those who are not sick; and 6) to evaluate the correlation between health status and income quintile in 2002.", "questions_src": ["What is the year the study began examining health conditions? ", "Who were the main focus of the study? ", "What was the initial sample size for the 2002 study? ", "What was the primary goal of the study regarding health status? ", "How did the mean age of females diagnosed with arthritis change between 2002 and 2007? "], "answers_src": ["2002", "females", "12,675", "examine the health conditions", "-7.41 years"], "answers_bt": ["2002", "elderly, the population, children and adolescents", "No Answer", "to examine health conditions", "No Answer"], "multiturn": {"turn_1": [{"question_id": "27.1", "question": "What is the year the study began examining health conditions? ", "answer_src": "2002", "follow_up_question": "What specific health conditions were found to have the greatest decline in mean age among chronically ill diagnosed females?", "follow_up_response": "Arthritis", "follow_up_response_bt": "No Answer"}, {"question_id": "27.2", "question": "Who were the main focus of the study? ", "answer_src": "females", "follow_up_question": "What specific health conditions were examined in the study?", "follow_up_response": "diabetes mellitus, hypertension, and arthritis", "follow_up_response_bt": "health conditions"}, {"question_id": "27.3", "question": "What was the initial sample size for the 2002 study? ", "answer_src": "12,675", "follow_up_question": "What was the change in mean age for females diagnosed with arthritis between 2002 and 2007?", "follow_up_response": "7.41 years", "follow_up_response_bt": "No Answer"}, {"question_id": "27.4", "question": "What was the primary goal of the study regarding health status? ", "answer_src": "examine the health conditions", "follow_up_question": "What specific health conditions were examined in the study?", "follow_up_response": "diabetes mellitus, hypertension, and arthritis", "follow_up_response_bt": "health conditions"}, {"question_id": "27.5", "question": "How did the mean age of females diagnosed with arthritis change between 2002 and 2007? ", "answer_src": "-7.41 years", "follow_up_question": "What was the percentage decrease in the mean age of females diagnosed with unspecified health conditions between 2002 and 2007?", "follow_up_response": "33%", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "27.6", "question": "What specific health conditions were found to have the greatest decline in mean age among chronically ill diagnosed females?", "answer_src": "Arthritis", "follow_up_question": "By how many years did the mean age of females diagnosed with arthritis decrease from 2002 to 2007?", "follow_up_response": "7.41 years", "follow_up_response_bt": "No Answer"}, {"question_id": "27.7", "question": "What specific health conditions were examined in the study?", "answer_src": "diabetes mellitus, hypertension, and arthritis", "follow_up_question": "What was the greatest decline in the mean age of chronically ill diagnosed females?", "follow_up_response": "by 7.41 years", "follow_up_response_bt": "No Answer"}, {"question_id": "27.8", "question": "What was the change in mean age for females diagnosed with arthritis between 2002 and 2007?", "answer_src": "7.41 years", "follow_up_question": "By how many percentage points did the mean age of females with unspecified health conditions decrease from 2002 to 2007?", "follow_up_response": "33%", "follow_up_response_bt": "No Answer"}, {"question_id": "27.9", "question": "What specific health conditions were examined in the study?", "answer_src": "diabetes mellitus, hypertension, and arthritis", "follow_up_question": "What was the greatest decline in the mean age of chronically ill diagnosed females?", "follow_up_response": "by 7.41 years", "follow_up_response_bt": "No Answer"}, {"question_id": "27.10", "question": "What was the percentage decrease in the mean age of females diagnosed with unspecified health conditions between 2002 and 2007?", "answer_src": "33%", "follow_up_question": "By how many years did the mean age of females diagnosed with arthritis decrease between 2002 and 2007?", "follow_up_response": "7.41", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "27.11", "question": "By how many years did the mean age of females diagnosed with arthritis decrease from 2002 to 2007?", "answer_src": "7.41 years", "follow_up_question": "By what percentage did the mean age of females with unspecified health conditions decrease from 2002 to 2007?", "follow_up_response": "33%", "follow_up_response_bt": "No Answer"}, {"question_id": "27.12", "question": "What was the greatest decline in the mean age of chronically ill diagnosed females?", "answer_src": "by 7.41 years", "follow_up_question": "By how many percentage points did the mean age of females with unspecified health conditions decrease from 2002 to 2007?", "follow_up_response": "33%", "follow_up_response_bt": "No Answer"}, {"question_id": "27.13", "question": "By how many percentage points did the mean age of females with unspecified health conditions decrease from 2002 to 2007?", "answer_src": "33%", "follow_up_question": "By how many years did the mean age of females diagnosed with arthritis decrease from 2002 to 2007?", "follow_up_response": "7.41 years", "follow_up_response_bt": "No Answer"}, {"question_id": "27.14", "question": "What was the greatest decline in the mean age of chronically ill diagnosed females?", "answer_src": "by 7.41 years", "follow_up_question": "By how many percentage points did the mean age of females with unspecified health conditions decrease from 2002 to 2007?", "follow_up_response": "33%", "follow_up_response_bt": "No Answer"}, {"question_id": "27.15", "question": "By how many years did the mean age of females diagnosed with arthritis decrease between 2002 and 2007?", "answer_src": "7.41", "follow_up_question": "By what percentage did the mean age of females with unspecified health conditions decrease between 2002 and 2007?", "follow_up_response": "33%", "follow_up_response_bt": "No Answer"}]}}
{"id": 28, "src": "three local cut - off points including 13 , 21 , and 33 ng / ml were defined in the scatter chart . the results showed that the deficiency of vitamin d in girls is much more than that in boys ( p = 0.05).the high prevalence of vitamin d deficiency could be probably a result of different etiologies . we recommended that people should be encouraged to take vitamin d and calcium supplements and also they should have more exposure to the sunlight .", "mt": "I risultati hanno mostrato che la carenza di vitamina D nelle ragazze è molto maggiore di quella dei ragazzi (p = 0,05).L' alta prevalenza di carenza di vitamina D potrebbe essere probabilmente il risultato di etiologie diverse . Abbiamo raccomandato che le persone dovrebbero essere incoraggiate a prendere integratori di vitamina D e calcio e anche dovrebbero avere più esposizione alla luce solare .", "pert_mt": "I risultati hanno mostrato che la carenza di vitamina D nelle ragazze è molto maggiore di quella dei ragazzi (p = 0,05). L'alta prevalenza di carenza di vitamina D potrebbe essere probabilmente il risultato di etiologie diverse. Abbiamo raccomandato che le persone dovrebbero essere incoraggiate a prendere integratori di vitamina D e calcio e anche dovrebbero avere più esposizione alla luce solare e una dieta equilibrata.", "bt": "The results showed that vitamin D deficiency in girls is much higher than in boys (p = 0.05).The high prevalence of vitamin D deficiency could likely be the result of a diverse etiology.We recommended that people should be encouraged to take vitamin D and calcium supplements and also should have more exposure to sunlight and a balanced diet.", "questions_src": ["What was the cut-off point for vitamin D deficiency in girls according to the study?", "Who is more likely to have a deficiency of vitamin D, based on the results?", "Where can people get more information about vitamin D deficiency and its causes?", "When did the study define the local cut-off points for vitamin D levels?", "Which vitamin is recommended for supplementation and why?"], "answers_src": ["13, 21, and 33 ng/ml", "Girls", "the study", "the study", "vitamin D"], "answers_bt": ["p = 0.05", "Girls", "The text", "No Answer", "Vitamin D"], "multiturn": {"turn_1": [{"question_id": "28.1", "question": "What was the cut-off point for vitamin D deficiency in girls according to the study?", "answer_src": "13, 21, and 33 ng/ml", "follow_up_question": "What percentage difference in vitamin D deficiency was observed between girls and boys?", "follow_up_response": "50%", "follow_up_response_bt": "50%"}, {"question_id": "28.2", "question": "Who is more likely to have a deficiency of vitamin D, based on the results?", "answer_src": "Girls", "follow_up_question": "What specific cut-off point was used to define vitamin D deficiency in the study?", "follow_up_response": "13, 21, and 33 ng / ml", "follow_up_response_bt": "No Answer"}, {"question_id": "28.3", "question": "Where can people get more information about vitamin D deficiency and its causes?", "answer_src": "the study", "follow_up_question": "What specific factors did the study suggest might cause the higher prevalence of vitamin D deficiency in girls?", "follow_up_response": "different etiologies", "follow_up_response_bt": "A diverse etiology"}, {"question_id": "28.4", "question": "When did the study define the local cut-off points for vitamin D levels?", "answer_src": "the study", "follow_up_question": "What specific vitamin D levels did the study define as cut-off points?", "follow_up_response": "13, 21, and 33 ng / ml", "follow_up_response_bt": "No Answer"}, {"question_id": "28.5", "question": "Which vitamin is recommended for supplementation and why?", "answer_src": "vitamin D", "follow_up_question": "What specific levels of vitamin D were defined as cut-off points in the study?", "follow_up_response": "13 ng / ml, 21 ng / ml, and 33 ng / ml", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "28.6", "question": "What percentage difference in vitamin D deficiency was observed between girls and boys?", "answer_src": "50%", "follow_up_question": "What were the three local cut-off points defined in the scatter chart?", "follow_up_response": "13, 21, 33 ng / ml", "follow_up_response_bt": "No Answer"}, {"question_id": "28.7", "question": "What specific cut-off point was used to define vitamin D deficiency in the study?", "answer_src": "13, 21, and 33 ng / ml", "follow_up_question": "What was the significance of the p-value of 0.05 in the comparison between girls and boys?", "follow_up_response": "The p-value of 0.05 indicated a statistically significant difference in the deficiency of vitamin D between girls and boys.", "follow_up_response_bt": "The comparison between girls and boys was statistically significant"}, {"question_id": "28.8", "question": "What specific factors did the study suggest might cause the higher prevalence of vitamin D deficiency in girls?", "answer_src": "different etiologies", "follow_up_question": "What types of different etiologies did the study suggest as potential causes for the higher prevalence of vitamin D deficiency in girls?", "follow_up_response": "different etiologies", "follow_up_response_bt": "A diverse etiology"}, {"question_id": "28.9", "question": "What specific vitamin D levels did the study define as cut-off points?", "answer_src": "13, 21, and 33 ng / ml", "follow_up_question": "What was the significance of the p-value of 0.05 in the comparison between girls and boys?", "follow_up_response": "The p-value of 0.05 indicated a statistically significant difference in the deficiency of vitamin D between girls and boys.", "follow_up_response_bt": "The comparison between girls and boys was statistically significant"}, {"question_id": "28.10", "question": "What specific levels of vitamin D were defined as cut-off points in the study?", "answer_src": "13 ng / ml, 21 ng / ml, and 33 ng / ml", "follow_up_question": "What was the significance of the p-value of 0.05 in the comparison between girls and boys?", "follow_up_response": "The p-value of 0.05 indicated a statistically significant difference in the deficiency of vitamin D between girls and boys.", "follow_up_response_bt": "The comparison between girls and boys was statistically significant"}], "turn_3": [{"question_id": "28.11", "question": "What were the three local cut-off points defined in the scatter chart?", "answer_src": "13, 21, 33 ng / ml", "follow_up_question": "What was the significance of the p-value of 0.05 in the comparison between girls and boys?", "follow_up_response": "The p-value of 0.05 indicated a statistically significant difference in the deficiency of vitamin D between girls and boys.", "follow_up_response_bt": "The comparison between girls and boys was statistically significant"}, {"question_id": "28.12", "question": "What was the significance of the p-value of 0.05 in the comparison between girls and boys?", "answer_src": "The p-value of 0.05 indicated a statistically significant difference in the deficiency of vitamin D between girls and boys.", "follow_up_question": "How many local cut-off points were defined in the scatter chart?", "follow_up_response": "3", "follow_up_response_bt": "No Answer"}, {"question_id": "28.13", "question": "What types of different etiologies did the study suggest as potential causes for the higher prevalence of vitamin D deficiency in girls?", "answer_src": "different etiologies", "follow_up_question": "What specific factors might contribute to these different etiologies for vitamin D deficiency in girls?", "follow_up_response": "different etiologies", "follow_up_response_bt": "A diverse etiology"}, {"question_id": "28.14", "question": "What was the significance of the p-value of 0.05 in the comparison between girls and boys?", "answer_src": "The p-value of 0.05 indicated a statistically significant difference in the deficiency of vitamin D between girls and boys.", "follow_up_question": "How many local cut-off points were defined in the scatter chart?", "follow_up_response": "3", "follow_up_response_bt": "No Answer"}, {"question_id": "28.15", "question": "What was the significance of the p-value of 0.05 in the comparison between girls and boys?", "answer_src": "The p-value of 0.05 indicated a statistically significant difference in the deficiency of vitamin D between girls and boys.", "follow_up_question": "How many local cut-off points were defined in the scatter chart?", "follow_up_response": "3", "follow_up_response_bt": "No Answer"}]}}
{"id": 29, "src": "after spinal anesthesia , patients undergoing cesarean section are more likely to develop hemodynamic changes . the baricity of local anesthetic has an important role on spinal blockade effects . the aim of this study was to compare the isobar and hyperbaric bupivacaine 0.5% plus fentanyl on maternal hemodynamics after spinal anesthesia for c / s.in this double - blind study , 84 healthy pregnant women undergoing c / s using bupivacaine 0.5% isobar ( study group , n=42 ) or hyperbaric ( control group , n=42 ) for spinal anesthesia were scheduled .", "mt": "L'obiettivo di questo studio era quello di confrontare l'isobar e l'iperbarico bupivacaina dello 0,5% più il fentanil sull'emodinamica materna dopo l'anestesia spinale per c / s.In questo doppio studio cieco , 84 donne incinte sane che stavano subendo c / s utilizzando l'isobar dello 0,5% di bupivacaina (gruppo di studio , n=42 ) o l'iperbarico (gruppo di controllo , n=42 ) per l'anestesia spinale dopo l'anestesia spinale sono stati programmati .", "pert_mt": "L'obiettivo di questo studio era quello di confrontare l'isobar e l'iperbarico bupivacaina dello 0,5% più il fentanil sull'emodinamica materna dopo l'anestesia spinale per c/s. In questo doppio studio cieco, 84 donne incinte sane che stavano subendo c/s utilizzando l'isobar dello 0,5% di bupivacaina (gruppo di studio, n=42) o l'iperbarico (gruppo di controllo, n=42) per l'anestesia spinale dopo l'anestesia spinale sono stati programmati e monitorati durante l'intervento.", "bt": "The objective of this study was to compare the isobar and the bupivacaine hyperbaric 0,5% plus the fentanyl on maternal haemodynamics after spinal anesthesia per second. In this double blind study, 84 healthy pregnant women who were subdued using isobar of 0,5% of bupivacaine (study group, n=42) or the hyperbaric (control group, n=42) for spinal anesthesia after spinal anesthesia were programmed and monitored during the procedure.", "questions_src": ["What is the main reason patients undergoing cesarean section are more likely to develop hemodynamic changes after spinal anesthesia?", "Who participated in the double-blind study comparing isobar and hyperbaric bupivacaine 0.5% plus fentanyl?", "Where did the study take place?", "When was the aim of the study set?", "Which type of bupivacaine concentration was used in the study?"], "answers_src": ["After spinal anesthesia", "84 healthy pregnant women", "Not specified in the sentence", "Not specified in the sentence", "0.5%"], "answers_bt": ["[\"To compare the effects of isobar and hyperbaric bupivacaine 0.5% plus fentanyl on maternal haemodynamics after spinal anesthesia\"], [\"84 healthy pregnant women\"], [\"Not specified in the sentence\"], [\"The study was set to compare the effects of isobar and hyperbaric bupivacaine 0.5% plus fentanyl on maternal haemodynamics after spinal anesthesia\"], [\"0,5%\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "29.1", "question": "What is the main reason patients undergoing cesarean section are more likely to develop hemodynamic changes after spinal anesthesia?", "answer_src": "After spinal anesthesia", "follow_up_question": "What specific type of local anesthetic was used in the study?", "follow_up_response": "bupivacaine 0.5%", "follow_up_response_bt": "isobar of 0.5% of bupivacaine"}, {"question_id": "29.2", "question": "Who participated in the double-blind study comparing isobar and hyperbaric bupivacaine 0.5% plus fentanyl?", "answer_src": "84 healthy pregnant women", "follow_up_question": "What was the ratio of participants in the study group to the control group?", "follow_up_response": "2", "follow_up_response_bt": "2"}, {"question_id": "29.3", "question": "Where did the study take place?", "answer_src": "Not specified in the sentence", "follow_up_question": "What was the total number of participants in the study?", "follow_up_response": "84", "follow_up_response_bt": "84"}, {"question_id": "29.4", "question": "When was the aim of the study set?", "answer_src": "Not specified in the sentence", "follow_up_question": "What was the sample size of the study?", "follow_up_response": "84", "follow_up_response_bt": "84"}, {"question_id": "29.5", "question": "Which type of bupivacaine concentration was used in the study?", "answer_src": "0.5%", "follow_up_question": "What was the concentration of fentanyl used in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "29.6", "question": "What specific type of local anesthetic was used in the study?", "answer_src": "bupivacaine 0.5%", "follow_up_question": "What was the concentration of the bupivacaine used in the study?", "follow_up_response": "0.5%", "follow_up_response_bt": "0,5%"}, {"question_id": "29.7", "question": "What was the ratio of participants in the study group to the control group?", "answer_src": "2", "follow_up_question": "How many participants were in each group?", "follow_up_response": "42", "follow_up_response_bt": "42"}, {"question_id": "29.8", "question": "What was the total number of participants in the study?", "answer_src": "84", "follow_up_question": "How many participants received hyperbaric bupivacaine 0.5%?", "follow_up_response": "42", "follow_up_response_bt": "42"}, {"question_id": "29.9", "question": "What was the sample size of the study?", "answer_src": "84", "follow_up_question": "How many participants received hyperbaric bupivacaine?", "follow_up_response": "42", "follow_up_response_bt": "42"}, {"question_id": "29.10", "question": "What was the concentration of fentanyl used in the study?", "answer_src": "after spinal anesthesia , patients undergoing cesarean section are more likely to develop hemodynamic changes . the baricity of local anesthetic has an important role on spinal blockade effects . the aim of this study was to compare the isobar and hyperbaric bupivacaine 0.5% plus fentanyl on maternal hemodynamics after spinal anesthesia for c / s.in this double - blind study , 84 healthy pregnant women undergoing c / s using bupivacaine 0.5% isobar ( study group , n=42 ) or hyperbaric ( control group , n=42 ) for spinal anesthesia were scheduled .", "follow_up_question": "How many participants were in each group?", "follow_up_response": "42", "follow_up_response_bt": "42"}], "turn_3": [{"question_id": "29.11", "question": "What was the concentration of the bupivacaine used in the study?", "answer_src": "0.5%", "follow_up_question": "What was the total volume of bupivacaine administered in each group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "29.12", "question": "How many participants were in each group?", "answer_src": "42", "follow_up_question": "What was the total number of participants in the study?", "follow_up_response": "84", "follow_up_response_bt": "84"}, {"question_id": "29.13", "question": "How many participants received hyperbaric bupivacaine 0.5%?", "answer_src": "42", "follow_up_question": "How many participants received isobar bupivacaine 0.5%?", "follow_up_response": "42", "follow_up_response_bt": "42"}, {"question_id": "29.14", "question": "How many participants received hyperbaric bupivacaine?", "answer_src": "42", "follow_up_question": "What was the total number of participants in the study?", "follow_up_response": "84", "follow_up_response_bt": "84"}, {"question_id": "29.15", "question": "How many participants were in each group?", "answer_src": "42", "follow_up_question": "What was the total number of participants in the study?", "follow_up_response": "84", "follow_up_response_bt": "84"}]}}
{"id": 30, "src": "abstractmacrocyclization can be used to constrain peptides in their bioactive conformations , thereby supporting target affinity and bioactivity . in particular , for the targeting of challenging protein protein interactions , macrocyclic peptides have proven to be very useful . available approaches focus on the stabilization of helices , which limits their general applicability .", "mt": "L'abstractmacrociclizzazione può essere utilizzata per limitare i peptidi nelle loro conformazioni bioattive , supportando così l' affinità e la bioattività di bersaglio . In particolare , per il targeting di interazioni proteiche proteiche difficili , i peptidi macrociclici si sono dimostrati molto utili .", "pert_mt": "L'abstractmacrociclizzazione può essere utilizzata per limitare i peptidi nelle loro conformazioni bioattive, supportando così l'affinità e la bioattività di bersaglio. In particolare, per il targeting di interazioni proteiche proteiche difficili, i peptidi macrociclici si sono dimostrati molto utili e hanno migliorato significativamente la stabilità strutturale.", "bt": "Abstractmacrocyclization can be used to limit peptides in their bioactive conformations, thus supporting the affinity and bioactivity of targeting. In particular, by targeting difficult protein protein interactions, macrocyclic peptides have been shown to be very useful and have significantly improved structural stability.", "questions_src": ["What is abstractmacrocyclization primarily used for?", "Who has found macrocyclic peptides useful for targeting protein-protein interactions?", "Where can abstractmacrocyclization be applied?", "When was the use of macrocyclic peptides for this purpose first observed?", "Which structural elements are typically stabilized by these methods?"], "answers_src": ["[\"to constrain peptides in their bioactive conformations\"], [], [\"not specified\"], [\"the stabilization of helices\"], [\"helices\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"to limit peptides in their bioactive conformations\"], [], [\"not specified\"], [], [\"structural stability\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "30.1", "question": "What is abstractmacrocyclization primarily used for?", "answer_src": "[\"to constrain peptides in their bioactive conformations\"], [], [\"not specified\"], [\"the stabilization of helices\"], [\"helices\"]", "follow_up_question": "How does abstractmacrocyclization support target affinity and bioactivity?", "follow_up_response": "by constraining peptides in their bioactive conformations", "follow_up_response_bt": "By limiting peptides in their bioactive conformations"}, {"question_id": "30.2", "question": "Who has found macrocyclic peptides useful for targeting protein-protein interactions?", "answer_src": "abstractmacrocyclization can be used to constrain peptides in their bioactive conformations , thereby supporting target affinity and bioactivity . in particular , for the targeting of challenging protein protein interactions , macrocyclic peptides have proven to be very useful . available approaches focus on the stabilization of helices , which limits their general applicability .", "follow_up_question": "What specific type of protein interactions have macrocyclic peptides proven useful for targeting?", "follow_up_response": "challenging protein protein interactions", "follow_up_response_bt": "difficult protein protein interactions"}, {"question_id": "30.3", "question": "Where can abstractmacrocyclization be applied?", "answer_src": "abstractmacrocyclization can be used to constrain peptides in their bioactive conformations , thereby supporting target affinity and bioactivity . in particular , for the targeting of challenging protein protein interactions , macrocyclic peptides have proven to be very useful . available approaches focus on the stabilization of helices , which limits their general applicability .", "follow_up_question": "What specific type of interactions do macrocyclic peptides prove useful for?", "follow_up_response": "targeting of challenging protein protein interactions", "follow_up_response_bt": "difficult protein protein interactions"}, {"question_id": "30.4", "question": "When was the use of macrocyclic peptides for this purpose first observed?", "answer_src": "abstractmacrocyclization can be used to constrain peptides in their bioactive conformations , thereby supporting target affinity and bioactivity . in particular , for the targeting of challenging protein protein interactions , macrocyclic peptides have proven to be very useful . available approaches focus on the stabilization of helices , which limits their general applicability .", "follow_up_question": "What specific challenges do available approaches to stabilize helices face?", "follow_up_response": "Their general applicability", "follow_up_response_bt": "No Answer"}, {"question_id": "30.5", "question": "Which structural elements are typically stabilized by these methods?", "answer_src": "abstractmacrocyclization can be used to constrain peptides in their bioactive conformations , thereby supporting target affinity and bioactivity . in particular , for the targeting of challenging protein protein interactions , macrocyclic peptides have proven to be very useful . available approaches focus on the stabilization of helices , which limits their general applicability .", "follow_up_question": "What other structural elements are not being targeted by these available approaches?", "follow_up_response": "Peptides", "follow_up_response_bt": "Protein protein interactions"}], "turn_2": [{"question_id": "30.6", "question": "How does abstractmacrocyclization support target affinity and bioactivity?", "answer_src": "by constraining peptides in their bioactive conformations", "follow_up_question": "What specific type of peptide conformation is constrained by abstractmacrocyclization?", "follow_up_response": "bioactive conformations", "follow_up_response_bt": "bioactive"}, {"question_id": "30.7", "question": "What specific type of protein interactions have macrocyclic peptides proven useful for targeting?", "answer_src": "challenging protein protein interactions", "follow_up_question": "What are some challenges that make these protein protein interactions particularly difficult to target?", "follow_up_response": "Challenging protein protein interactions", "follow_up_response_bt": "No Answer"}, {"question_id": "30.8", "question": "What specific type of interactions do macrocyclic peptides prove useful for?", "answer_src": "targeting of challenging protein protein interactions", "follow_up_question": "What challenges do available approaches to stabilize helices face?", "follow_up_response": "Their general applicability", "follow_up_response_bt": "No Answer"}, {"question_id": "30.9", "question": "What specific challenges do available approaches to stabilize helices face?", "answer_src": "Their general applicability", "follow_up_question": "What types of protein-protein interactions are challenging for these available approaches?", "follow_up_response": "Challenging protein protein interactions", "follow_up_response_bt": "difficult"}, {"question_id": "30.10", "question": "What other structural elements are not being targeted by these available approaches?", "answer_src": "Peptides", "follow_up_question": "What types of protein-protein interactions are these available approaches less suitable for?", "follow_up_response": "challenging", "follow_up_response_bt": "difficult"}], "turn_3": [{"question_id": "30.11", "question": "What specific type of peptide conformation is constrained by abstractmacrocyclization?", "answer_src": "bioactive conformations", "follow_up_question": "What other types of protein interactions have been challenging to target with macrocyclic peptides?", "follow_up_response": "Challenging protein protein interactions", "follow_up_response_bt": "protein protein interactions"}, {"question_id": "30.12", "question": "What are some challenges that make these protein protein interactions particularly difficult to target?", "answer_src": "Challenging protein protein interactions", "follow_up_question": "What specific stabilizations of peptides are currently being focused on to address these challenges?", "follow_up_response": "The stabilization of helices", "follow_up_response_bt": "Structural stability"}, {"question_id": "30.13", "question": "What challenges do available approaches to stabilize helices face?", "answer_src": "Their general applicability", "follow_up_question": "What specific type of protein interactions are macrocyclic peptides particularly useful for targeting?", "follow_up_response": "challenging protein protein interactions", "follow_up_response_bt": "difficult protein protein interactions"}, {"question_id": "30.14", "question": "What types of protein-protein interactions are challenging for these available approaches?", "answer_src": "Challenging protein protein interactions", "follow_up_question": "What specific stabilization methods do available approaches focus on?", "follow_up_response": "Stabilization of helices", "follow_up_response_bt": "Abstractmacrocyclization"}, {"question_id": "30.15", "question": "What types of protein-protein interactions are these available approaches less suitable for?", "answer_src": "challenging", "follow_up_question": "What makes challenging protein-protein interactions less suitable for these available approaches?", "follow_up_response": "The stabilization of helices", "follow_up_response_bt": "Abstractmacrocyclization"}]}}
{"id": 31, "src": "we compare several epistatic and additive models of transgressive segregation in hybrids and find that they are special cases of a general , classic quantitative genetic model . the dobzhansky - muller model predicts hopeless monsters , sterile and inviable transgressive phenotypes . the bateson model predicts hopeful monsters with fitness greater than either parental population .", "mt": "Confrontando diversi modelli epistatici e additivi di segregazione trasgressiva negli ibridi , troviamo che si tratta di casi speciali di un modello genetico quantitativo classico e generale . Il modello dobzhansky - muller prevede mostri senza speranza , fenotipi trasgressivi sterili e inviabili . Il modello bateson prevede mostri speranti con una grande idoneità rispetto a una delle popolazioni parentali .", "pert_mt": "Confrontando diversi modelli epistatici e additivi di segregazione trasgressiva negli ibridi, troviamo che si tratta di casi speciali di un modello genetico quantitativo classico e generale. Il modello dobzhansky - muller prevede mostri senza speranza, fenotipi trasgressivi sterili e inviabili. Il modello bateson prevede mostri speranti con una grande idoneità rispetto a una delle popolazioni parentali e con una bassa fecondità.", "bt": "Comparing different epistatic and additive models of transgressive segregation in hybrids, we find that these are special cases of a classical and general quantitative genetic model.The dobzhansky-muller model predicts hopeless, sterile, and unviable transgressive phenotypes.The bateson model predicts spermatic monsters with a high suitability compared to one of the parent populations and with a low fertility.", "questions_src": ["What is the name of the model that predicts sterile and inviable transgressive phenotypes?", "Who predicted the hopelessly monstrous traits?", "Which model suggests hybrid organisms can have higher fitness?", "When did Dobzhansky and Muller publish their theory?", "What does the Bateson model suggest about hybrid organisms?"], "answers_src": ["Dobzhansky - Muller model", "Dobzhansky and Muller", "Bateson model", "No Answer", "suggests hybrid organisms can have higher fitness"], "answers_bt": ["Dobzhansky-Muller model", "Dobzhansky and Muller", "Bateson model", "No Answer", "suggests hybrid organisms can have higher fitness"], "multiturn": {"turn_1": [{"question_id": "31.1", "question": "What is the name of the model that predicts sterile and inviable transgressive phenotypes?", "answer_src": "Dobzhansky - Muller model", "follow_up_question": "What kind of phenotypes does the Bateson model predict?", "follow_up_response": "Hopeful monsters with fitness greater than either parental population.", "follow_up_response_bt": "Spermatic monsters with a high suitability compared to one of the parent populations and with a low fertility."}, {"question_id": "31.2", "question": "Who predicted the hopelessly monstrous traits?", "answer_src": "Dobzhansky and Muller", "follow_up_question": "Which model predicted hopeful monsters with higher fitness?", "follow_up_response": "bateson", "follow_up_response_bt": "bateson model"}, {"question_id": "31.3", "question": "Which model suggests hybrid organisms can have higher fitness?", "answer_src": "Bateson model", "follow_up_question": "What is predicted by the Bateson model regarding the fitness of hybrid organisms?", "follow_up_response": "greater than either parental population", "follow_up_response_bt": "With a high suitability compared to one of the parent populations and with a low fertility."}, {"question_id": "31.4", "question": "When did Dobzhansky and Muller publish their theory?", "answer_src": "we compare several epistatic and additive models of transgressive segregation in hybrids and find that they are special cases of a general , classic quantitative genetic model . the dobzhansky - muller model predicts hopeless monsters , sterile and inviable transgressive phenotypes . the bateson model predicts hopeful monsters with fitness greater than either parental population .", "follow_up_question": "What kind of phenotypes does the Bateson model predict?", "follow_up_response": "Hopeful monsters with fitness greater than either parental population.", "follow_up_response_bt": "Spermatic monsters with a high suitability compared to one of the parent populations and with a low fertility."}, {"question_id": "31.5", "question": "What does the Bateson model suggest about hybrid organisms?", "answer_src": "suggests hybrid organisms can have higher fitness", "follow_up_question": "What is the predicted fitness range for hybrid organisms according to the Bateson model?", "follow_up_response": "greater than either parental population", "follow_up_response_bt": "with a high suitability compared to one of the parent populations and with a low fertility."}], "turn_2": [{"question_id": "31.6", "question": "What kind of phenotypes does the Bateson model predict?", "answer_src": "Hopeful monsters with fitness greater than either parental population.", "follow_up_question": "What is the fitness comparison between the offspring predicted by the Bateson model and the parental populations?", "follow_up_response": "greater than either parental population", "follow_up_response_bt": "With a low fertility"}, {"question_id": "31.7", "question": "Which model predicted hopeful monsters with higher fitness?", "answer_src": "bateson", "follow_up_question": "Which model predicted sterile and inviable transgressive phenotypes?", "follow_up_response": "Dobzhansky–Muller model", "follow_up_response_bt": "dobzhansky-muller model"}, {"question_id": "31.8", "question": "What is predicted by the Bateson model regarding the fitness of hybrid organisms?", "answer_src": "greater than either parental population", "follow_up_question": "What is the predicted fitness of hybrid organisms according to the Dobzhansky-Muller model?", "follow_up_response": "No Answer", "follow_up_response_bt": "hopeless, sterile, and unviable"}, {"question_id": "31.9", "question": "What kind of phenotypes does the Bateson model predict?", "answer_src": "Hopeful monsters with fitness greater than either parental population.", "follow_up_question": "What is the fitness comparison between the offspring predicted by the Bateson model and the parental populations?", "follow_up_response": "greater than either parental population", "follow_up_response_bt": "With a low fertility"}, {"question_id": "31.10", "question": "What is the predicted fitness range for hybrid organisms according to the Bateson model?", "answer_src": "greater than either parental population", "follow_up_question": "What is the predicted phenotype for hybrid organisms according to the Dobzhansky-Muller model?", "follow_up_response": "hopeless monsters", "follow_up_response_bt": "hopeless, sterile, and unviable transgressive phenotypes"}], "turn_3": [{"question_id": "31.11", "question": "What is the fitness comparison between the offspring predicted by the Bateson model and the parental populations?", "answer_src": "greater than either parental population", "follow_up_question": "What are the fitness comparisons between the offspring predicted by the Dobzhansky-Muller model and the parental populations?", "follow_up_response": "No Answer", "follow_up_response_bt": "unviable"}, {"question_id": "31.12", "question": "Which model predicted sterile and inviable transgressive phenotypes?", "answer_src": "Dobzhansky–Muller model", "follow_up_question": "Which specific type of phenotype did the Dobzhansky–Muller model predict?", "follow_up_response": "hopeless monsters", "follow_up_response_bt": "hopeless, sterile, and unviable transgressive phenotypes"}, {"question_id": "31.13", "question": "What is the predicted fitness of hybrid organisms according to the Dobzhansky-Muller model?", "answer_src": "we compare several epistatic and additive models of transgressive segregation in hybrids and find that they are special cases of a general , classic quantitative genetic model . the dobzhansky - muller model predicts hopeless monsters , sterile and inviable transgressive phenotypes . the bateson model predicts hopeful monsters with fitness greater than either parental population .", "follow_up_question": "What is the predicted fitness of hybrid organisms according to the Bateson model?", "follow_up_response": "greater than either parental population.", "follow_up_response_bt": "with a low fertility"}, {"question_id": "31.14", "question": "What is the fitness comparison between the offspring predicted by the Bateson model and the parental populations?", "answer_src": "greater than either parental population", "follow_up_question": "What are the fitness comparisons between the offspring predicted by the Dobzhansky-Muller model and the parental populations?", "follow_up_response": "No Answer", "follow_up_response_bt": "unviable"}, {"question_id": "31.15", "question": "What is the predicted phenotype for hybrid organisms according to the Dobzhansky-Muller model?", "answer_src": "hopeless monsters", "follow_up_question": "What kind of fitness do hybrid organisms have according to the Bateson model?", "follow_up_response": "greater than either parental population", "follow_up_response_bt": "with a high suitability compared to one of the parent populations and with a low fertility."}]}}
{"id": 32, "src": "purpose regenerative strategies aim to restore the original biofunctionality of the intervertebral disc . different biomaterials are available , which might support disc regeneration . in the present study , the prospects of success of two hydrogels functionalized with anti - angiogenic peptides and seeded with bone marrow derived mononuclear cells ( bmc ) , respectively , were investigated in an ovine nucleotomy model .", "mt": "Le strategie rigenerative mirano a ripristinare la biofunzionalità originale del disco intervertebrale . Sono disponibili diversi biomateriali , che potrebbero supportare la rigenerazione del disco . Nel presente studio , le prospettive di successo di due idrogelli funzionalizzati con peptidi antiangiogenici e seminati con cellule mononucleari derivate dal midollo osseo (bmc) sono state indagate in un modello di nucleotomia ovina .", "pert_mt": "Le strategie rigenerative mirano a ripristinare la biofunzionalità originale del disco intervertebrale. Sono disponibili diversi biomateriali, che potrebbero supportare la rigenerazione del disco. Nel presente studio, le prospettive di successo di due idrogelli funzionalizzati con peptidi antiangiogenici e seminati con cellule mononucleari derivate dal midollo osseo (BMC) sono state indagate in un modello di nucleotomia ovina. Inoltre, l'efficacia dei materiali è stata valutata in termini di integrazione osteoinduttiva.", "bt": "The regenerative strategy aims to restore the original biofunctionality of the intervertebral disc. Several biomaterials are available, which could support disc regeneration.In this study, the prospects for success of two hydrogels functionalised with antiangiogenic peptides and seminars with bone marrow-derived mononuclear cell (BMC) were investigated in a model of nucleotomy materials.Moreover, the effectiveness of the materials was evaluated in terms of osteoinductive integration.", "questions_src": ["What is the main goal of regenerative strategies according to the sentence?", "Who are the biomaterials that might support disc regeneration mentioned in the sentence?", "Where was the success of the hydrogels tested in the study?", "Which peptides were functionalized on the hydrogels in the study?", "What type of cells were used to seed the hydrogels in the study?"], "answers_src": ["[\"restore the original biofunctionality of the intervertebral disc\"], [\"different biomaterials\"], [\"an ovine nucleotomy model\"], [\"anti-angiogenic peptides\"], [\"bone marrow derived mononuclear cells (bmc)\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"Restore the original biofunctionality of the intervertebral disc\"], [\"Several biomaterials\"], [\"In a model of nucleotomy materials\"], [\"Antiangiogenic peptides\"], [\"Bone marrow-derived mononuclear cells (BMC)\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "32.1", "question": "What is the main goal of regenerative strategies according to the sentence?", "answer_src": "[\"restore the original biofunctionality of the intervertebral disc\"], [\"different biomaterials\"], [\"an ovine nucleotomy model\"], [\"anti-angiogenic peptides\"], [\"bone marrow derived mononuclear cells (bmc)\"]", "follow_up_question": "How many types of biomaterials are mentioned in the text?", "follow_up_response": "2", "follow_up_response_bt": "2"}, {"question_id": "32.2", "question": "Who are the biomaterials that might support disc regeneration mentioned in the sentence?", "answer_src": "purpose regenerative strategies aim to restore the original biofunctionality of the intervertebral disc . different biomaterials are available , which might support disc regeneration . in the present study , the prospects of success of two hydrogels functionalized with anti - angiogenic peptides and seeded with bone marrow derived mononuclear cells ( bmc ) , respectively , were investigated in an ovine nucleotomy model .", "follow_up_question": "What specific biomaterials were investigated in the study?", "follow_up_response": "Hydrogels functionalized with anti-angiogenic peptides and seeded with bone marrow derived mononuclear cells (BMC)", "follow_up_response_bt": "Hydrogels functionalised with antiangiogenic peptides and seminars with bone marrow-derived mononuclear cells (BMC)"}, {"question_id": "32.3", "question": "Where was the success of the hydrogels tested in the study?", "answer_src": "purpose regenerative strategies aim to restore the original biofunctionality of the intervertebral disc . different biomaterials are available , which might support disc regeneration . in the present study , the prospects of success of two hydrogels functionalized with anti - angiogenic peptides and seeded with bone marrow derived mononuclear cells ( bmc ) , respectively , were investigated in an ovine nucleotomy model .", "follow_up_question": "What type of cells were used in one of the hydrogels in this study?", "follow_up_response": "bone marrow derived mononuclear cells", "follow_up_response_bt": "bone marrow-derived mononuclear cell (BMC)"}, {"question_id": "32.4", "question": "Which peptides were functionalized on the hydrogels in the study?", "answer_src": "purpose regenerative strategies aim to restore the original biofunctionality of the intervertebral disc . different biomaterials are available , which might support disc regeneration . in the present study , the prospects of success of two hydrogels functionalized with anti - angiogenic peptides and seeded with bone marrow derived mononuclear cells ( bmc ) , respectively , were investigated in an ovine nucleotomy model .", "follow_up_question": "What type of cells were seeded on one of the hydrogels in the study?", "follow_up_response": "bone marrow derived mononuclear cells", "follow_up_response_bt": "bone marrow-derived mononuclear cells"}, {"question_id": "32.5", "question": "What type of cells were used to seed the hydrogels in the study?", "answer_src": "purpose regenerative strategies aim to restore the original biofunctionality of the intervertebral disc . different biomaterials are available , which might support disc regeneration . in the present study , the prospects of success of two hydrogels functionalized with anti - angiogenic peptides and seeded with bone marrow derived mononuclear cells ( bmc ) , respectively , were investigated in an ovine nucleotomy model .", "follow_up_question": "What specific anti-angiogenic peptides were functionalized on the hydrogels in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "32.6", "question": "How many types of biomaterials are mentioned in the text?", "answer_src": "2", "follow_up_question": "What is the purpose of using bone marrow derived mononuclear cells (BMC) in this study?", "follow_up_response": "To support disc regeneration", "follow_up_response_bt": "To promote osteoinductive integration"}, {"question_id": "32.7", "question": "What specific biomaterials were investigated in the study?", "answer_src": "Hydrogels functionalized with anti-angiogenic peptides and seeded with bone marrow derived mononuclear cells (BMC)", "follow_up_question": "What was the purpose of using bone marrow derived mononuclear cells (BMC) in the study?", "follow_up_response": "To support disc regeneration", "follow_up_response_bt": "To evaluate the effectiveness of the materials in terms of osteoinductive integration"}, {"question_id": "32.8", "question": "What type of cells were used in one of the hydrogels in this study?", "answer_src": "bone marrow derived mononuclear cells", "follow_up_question": "What was the function of the anti-angiogenic peptides in the hydrogel?", "follow_up_response": "Support disc regeneration", "follow_up_response_bt": "Support disc regeneration"}, {"question_id": "32.9", "question": "What type of cells were seeded on one of the hydrogels in the study?", "answer_src": "bone marrow derived mononuclear cells", "follow_up_question": "What was the function of the anti-angiogenic peptides on the other hydrogel?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "32.10", "question": "What specific anti-angiogenic peptides were functionalized on the hydrogels in the study?", "answer_src": "purpose regenerative strategies aim to restore the original biofunctionality of the intervertebral disc . different biomaterials are available , which might support disc regeneration . in the present study , the prospects of success of two hydrogels functionalized with anti - angiogenic peptides and seeded with bone marrow derived mononuclear cells ( bmc ) , respectively , were investigated in an ovine nucleotomy model .", "follow_up_question": "What type of cells were seeded onto the hydrogels in the study?", "follow_up_response": "bone marrow derived mononuclear cells", "follow_up_response_bt": "bone marrow-derived mononuclear cell (BMC)"}], "turn_3": [{"question_id": "32.11", "question": "What is the purpose of using bone marrow derived mononuclear cells (BMC) in this study?", "answer_src": "To support disc regeneration", "follow_up_question": "How do the hydrogels functionalized with anti-angiogenic peptides contribute to disc regeneration?", "follow_up_response": "Support disc regeneration", "follow_up_response_bt": "Support disc regeneration"}, {"question_id": "32.12", "question": "What was the purpose of using bone marrow derived mononuclear cells (BMC) in the study?", "answer_src": "To support disc regeneration", "follow_up_question": "How were the bone marrow derived mononuclear cells (BMC) modified before being used in the study?", "follow_up_response": "They were seeded", "follow_up_response_bt": "Antiangiogenic peptides"}, {"question_id": "32.13", "question": "What was the function of the anti-angiogenic peptides in the hydrogel?", "answer_src": "Support disc regeneration", "follow_up_question": "How did the bone marrow derived mononuclear cells contribute to the disc regeneration?", "follow_up_response": "They were seeded", "follow_up_response_bt": "Support"}, {"question_id": "32.14", "question": "What was the function of the anti-angiogenic peptides on the other hydrogel?", "answer_src": "purpose regenerative strategies aim to restore the original biofunctionality of the intervertebral disc . different biomaterials are available , which might support disc regeneration . in the present study , the prospects of success of two hydrogels functionalized with anti - angiogenic peptides and seeded with bone marrow derived mononuclear cells ( bmc ) , respectively , were investigated in an ovine nucleotomy model .", "follow_up_question": "How were the bone marrow derived mononuclear cells (bmc) used in the second hydrogel?", "follow_up_response": "seeded", "follow_up_response_bt": "Functionalised with antiangiogenic peptides"}, {"question_id": "32.15", "question": "What type of cells were seeded onto the hydrogels in the study?", "answer_src": "bone marrow derived mononuclear cells", "follow_up_question": "What was the function of the anti-angiogenic peptides added to the hydrogels?", "follow_up_response": "To inhibit angiogenesis", "follow_up_response_bt": "To support disc regeneration"}]}}
{"id": 33, "src": "results ] pain severity was similar in both groups , with a visual analogue scale score of 6.72 in the low back pain and 6.82 in the neck pain group . nottingham health profile pain [ z=4.132 ] and physical activity scores [ z=5.640 ] in the low back pain group were significantly higher . kinesiophobia was also more severe in the low back pain group , with a mean 42.055.91 versus 39.76.0 tampa scale for kinesiophobia score [ z=4.732 ] . [", "mt": "] I risultati della gravità del dolore erano simili in entrambi i gruppi , con un punteggio di scala analogica visiva di 6,72 nel gruppo del dolore alla schiena bassa e di 6,82 nel gruppo del dolore al collo . Il profilo di salute di Nottingham dolore [ z=4,132 ] e punteggi di attività fisica [ z=5,640 ] nel gruppo del dolore alla schiena bassa erano significativamente più alti . La cinesiofobia era anche più grave nel gruppo del dolore alla schiena bassa , con una media di 42,055.91 contro 39,76.0 scala tampa per il punteggio della kinesiofobia [ z=4,732 ] . [", "pert_mt": "I risultati della gravità del dolore erano simili in entrambi i gruppi, con un punteggio di scala analogica visiva di 6,72 nel gruppo del dolore alla schiena bassa e di 6,82 nel gruppo del dolore al collo. L'uso di farmaci analgesici [z=3,215] nel gruppo del dolore alla schiena bassa era significativamente più alto. Il profilo di salute di Nottingham dolore [z=4,132] e punteggi di attività fisica [z=5,640] nel gruppo del dolore alla schiena bassa erano significativamente più alti. La cinesiofobia era anche più grave nel gruppo del dolore alla schiena bassa, con una media di 42,055.91 contro 39,76.0 scala tampa per", "bt": "The results of the pain severity were similar in both groups, with a visual analogue scale score of 6.72 in the low back pain group and 6.82 in the neck pain group. The use of pain medications [z=3,215] in the low back pain group was significantly higher. The health profile of Nottingham pain [z=4,132] and physical activity scores [z=5,640] in the low back pain group were significantly higher.", "questions_src": ["What was the visual analogue scale score for neck pain?", "When was the Nottingham Health Profile pain score measured?", "Which group had a higher kinesiophobia score according to the Tampa scale?", "What was the z-score for physical activity scores in the low back pain group?", "Where is kinesiophobia more severe based on the provided information?"], "answers_src": ["6.82", "No Answer", "Low back pain group", "5.640", "Low back pain"], "answers_bt": ["6.82", "No Answer", "No Answer", "5,640", "Low back pain"], "multiturn": {"turn_1": [{"question_id": "33.1", "question": "What was the visual analogue scale score for neck pain?", "answer_src": "6.82", "follow_up_question": "What was the kinesiophobia score for the neck pain group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "33.2", "question": "When was the Nottingham Health Profile pain score measured?", "answer_src": "results ] pain severity was similar in both groups , with a visual analogue scale score of 6.72 in the low back pain and 6.82 in the neck pain group . nottingham health profile pain [ z=4.132 ] and physical activity scores [ z=5.640 ] in the low back pain group were significantly higher . kinesiophobia was also more severe in the low back pain group , with a mean 42.055.91 versus 39.76.0 tampa scale for kinesiophobia score [ z=4.732 ] . [", "follow_up_question": "What was the z-score for the Nottingham Health Profile pain score in the low back pain group?", "follow_up_response": "4.132", "follow_up_response_bt": "4,132"}, {"question_id": "33.3", "question": "Which group had a higher kinesiophobia score according to the Tampa scale?", "answer_src": "Low back pain group", "follow_up_question": "What was the difference in kinesiophobia scores between the two groups?", "follow_up_response": "4.29", "follow_up_response_bt": "No Answer"}, {"question_id": "33.4", "question": "What was the z-score for physical activity scores in the low back pain group?", "answer_src": "5.640", "follow_up_question": "What was the z-score for kinesiophobia scores in the low back pain group?", "follow_up_response": "4.732", "follow_up_response_bt": "No Answer"}, {"question_id": "33.5", "question": "Where is kinesiophobia more severe based on the provided information?", "answer_src": "Low back pain", "follow_up_question": "What is the Tampa Scale for Kinesiophobia score for the low back pain group?", "follow_up_response": "42.055.91", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "33.6", "question": "What was the kinesiophobia score for the neck pain group?", "answer_src": "results ] pain severity was similar in both groups , with a visual analogue scale score of 6.72 in the low back pain and 6.82 in the neck pain group . nottingham health profile pain [ z=4.132 ] and physical activity scores [ z=5.640 ] in the low back pain group were significantly higher . kinesiophobia was also more severe in the low back pain group , with a mean 42.055.91 versus 39.76.0 tampa scale for kinesiophobia score [ z=4.732 ] . [", "follow_up_question": "What was the kinesiophobia score for the low back pain group?", "follow_up_response": "42.055.91", "follow_up_response_bt": "No Answer"}, {"question_id": "33.7", "question": "What was the z-score for the Nottingham Health Profile pain score in the low back pain group?", "answer_src": "4.132", "follow_up_question": "What was the z-score for the Tampa Scale for Kinesiophobia score in the low back pain group?", "follow_up_response": "4.732", "follow_up_response_bt": "No Answer"}, {"question_id": "33.8", "question": "What was the difference in kinesiophobia scores between the two groups?", "answer_src": "4.29", "follow_up_question": "By how many points was the Nottingham Health Profile pain score higher in the low back pain group compared to the neck pain group?", "follow_up_response": "3", "follow_up_response_bt": "No Answer"}, {"question_id": "33.9", "question": "What was the z-score for kinesiophobia scores in the low back pain group?", "answer_src": "4.732", "follow_up_question": "What was the mean kinesiophobia score in the neck pain group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "33.10", "question": "What is the Tampa Scale for Kinesiophobia score for the low back pain group?", "answer_src": "42.055.91", "follow_up_question": "What is the Tampa Scale for Kinesiophobia score for the neck pain group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "33.11", "question": "What was the kinesiophobia score for the low back pain group?", "answer_src": "42.055.91", "follow_up_question": "What was the kinesiophobia score for the neck pain group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "33.12", "question": "What was the z-score for the Tampa Scale for Kinesiophobia score in the low back pain group?", "answer_src": "4.732", "follow_up_question": "What was the mean Tampa Scale for Kinesiophobia score in the neck pain group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "33.13", "question": "By how many points was the Nottingham Health Profile pain score higher in the low back pain group compared to the neck pain group?", "answer_src": "3", "follow_up_question": "By how many points was the Tampa Scale for Kinesiophobia score higher in the low back pain group compared to the neck pain group?", "follow_up_response": "4.29", "follow_up_response_bt": "No Answer"}, {"question_id": "33.14", "question": "What was the mean kinesiophobia score in the neck pain group?", "answer_src": "results ] pain severity was similar in both groups , with a visual analogue scale score of 6.72 in the low back pain and 6.82 in the neck pain group . nottingham health profile pain [ z=4.132 ] and physical activity scores [ z=5.640 ] in the low back pain group were significantly higher . kinesiophobia was also more severe in the low back pain group , with a mean 42.055.91 versus 39.76.0 tampa scale for kinesiophobia score [ z=4.732 ] . [", "follow_up_question": "What was the kinesiophobia score in the low back pain group?", "follow_up_response": "42.055.91", "follow_up_response_bt": "No Answer"}, {"question_id": "33.15", "question": "What is the Tampa Scale for Kinesiophobia score for the neck pain group?", "answer_src": "results ] pain severity was similar in both groups , with a visual analogue scale score of 6.72 in the low back pain and 6.82 in the neck pain group . nottingham health profile pain [ z=4.132 ] and physical activity scores [ z=5.640 ] in the low back pain group were significantly higher . kinesiophobia was also more severe in the low back pain group , with a mean 42.055.91 versus 39.76.0 tampa scale for kinesiophobia score [ z=4.732 ] . [", "follow_up_question": "What is the Tampa Scale for Kinesiophobia score for the low back pain group?", "follow_up_response": "42.055.91", "follow_up_response_bt": "No Answer"}]}}
{"id": 34, "src": "immunosenescence and cognitive decline are common markers of the aging process . taking into consideration the heterogeneity observed in aging processes and the recently described link between lymphocytes and cognition , we herein explored the possibility of an association between alterations in lymphocytic populations and cognitive performance.in a cohort of cognitively healthy adults ( n = 114 ) , previously characterized by diverse neurocognitive / psychological performance patterns , detailed peripheral blood immunophenotyping of both the innate and adaptive immune systems was performed by flow cytometry.better cognitive performance was associated with lower numbers of effector memory cd4 + t cells and higher numbers of naive cd8 + t cells and b cells . furthermore , effector memory cd4 + t cells were found to be predictors of general and executive function and memory , even when factors known to influence cognitive performance in older individuals ( e.g. , age , sex , education , and mood ) were taken into account.this is the first study in humans associating specific phenotypes of the immune system with distinct cognitive performance in healthy aging .", "mt": "Considerando l'eterogeneità osservata nei processi di invecchiamento e il recente legame tra linfociti e cognizione , abbiamo esplorato la possibilità di un'associazione tra alterazioni nelle popolazioni linfocitiche e prestazioni cognitive.in una coorte di adulti cognitivamente sani (n = 114), precedentemente caratterizzati da diversi schemi di prestazioni neurocognitive / psicologiche , l'immunofenotipazione dettagliata del sangue periferica dei sistemi immunitari innati e adattivi è stata eseguita con la citometria di flusso.Le prestazioni cognitive migliori sono state associate a un numero inferiore di cellule t e t di memoria cd4 + e a un numero maggiore di cellule t e b ingenuo cd8 + t . Inoltre , è stato scoperto che l'effetto t di memoria cd4 + t di persone sono stati determinanti di prestazioni generali ed esecutive e funzionali , quando sono stati studiati fattori di prestazione cognitive specifici, anche in età anziana (e anche nel sistema immunitario), quando si è stato preso in considerazione l'associazione", "pert_mt": "Considerando l'eterogeneità osservata nei processi di invecchiamento e il recente legame tra linfociti e cognizione, abbiamo esplorato la possibilità di un'associazione tra alterazioni nelle popolazioni linfocitiche e prestazioni cognitive. In una coorte di adulti cognitivamente sani (n = 114), precedentemente caratterizzati da diversi schemi di prestazioni neurocognitive / psicologiche, l'immunofenotipazione dettagliata del sangue periferica dei sistemi immunitari innati e adattivi è stata eseguita con la citometria di flusso. Le prestazioni cognitive migliori sono state associate a un numero inferiore di cellule t e t di memoria cd4 + e a un numero maggiore di cellule t e b ingenuo cd8 + t. Inoltre,", "bt": "By considering the heterogeneity observed in aging processes and the recent link between lymphocytes and cognition, we explored the possibility of an association between alterations in lymphocyte populations and cognitive performance.In a cohort of cognitively healthy adults (n = 114), previously characterized by different schemes of neurocognitive/psychological performance, detailed immunophenotyping of peripheral blood of innate and adaptive immune systems was performed with flow cytometry.Improved cognitive performance was associated with a lower number of t cells of CD4+ memory and a higher number of t cells of CD8+ memory.Moreover,", "questions_src": ["What type of immune cell was found to predict better cognitive performance?", "Which immune cell population was associated with executive function and memory?", "What does the term 'immunosenescence' refer to?", "In what way were the subjects characterized in the study?", "Who were the participants in the study?"], "answers_src": ["Effector memory CD4+ T cells", "Effector memory CD4+ T cells", "immunosenescence refers to the process of aging of the immune system", "by diverse neurocognitive/psychological performance patterns", "cognitively healthy adults (n = 114)"], "answers_bt": ["CD4+ memory and CD8+ memory T cells", "CD4+ memory and CD8+ memory T cells", "No Answer", "By different schemes of neurocognitive/psychological performance", "Cognitively healthy adults"], "multiturn": {"turn_1": [{"question_id": "34.1", "question": "What type of immune cell was found to predict better cognitive performance?", "answer_src": "Effector memory CD4+ T cells", "follow_up_question": "What other types of immune cells were found to be associated with better cognitive performance?", "follow_up_response": "naive cd8 + t cells and b cells", "follow_up_response_bt": "CD4+ memory and CD8+ memory"}, {"question_id": "34.2", "question": "Which immune cell population was associated with executive function and memory?", "answer_src": "Effector memory CD4+ T cells", "follow_up_question": "What other types of T cells were found to be predictors of cognitive performance?", "follow_up_response": "effector memory cd4 + t cells", "follow_up_response_bt": "CD4+ memory and CD8+ memory"}, {"question_id": "34.3", "question": "What does the term 'immunosenescence' refer to?", "answer_src": "immunosenescence refers to the process of aging of the immune system", "follow_up_question": "How does the study define better cognitive performance?", "follow_up_response": "Better cognitive performance was associated with lower numbers of effector memory cd4 + t cells and higher numbers of naive cd8 + t cells and b cells.", "follow_up_response_bt": "Improved cognitive performance"}, {"question_id": "34.4", "question": "In what way were the subjects characterized in the study?", "answer_src": "by diverse neurocognitive/psychological performance patterns", "follow_up_question": "In what other cognitive functions were effector memory CD4+ T cells found to be predictive?", "follow_up_response": "general and executive function and memory", "follow_up_response_bt": "No Answer"}, {"question_id": "34.5", "question": "Who were the participants in the study?", "answer_src": "cognitively healthy adults (n = 114)", "follow_up_question": "What type of immune cell was found to predict general and executive function and memory?", "follow_up_response": "effector memory cd4 + t cells", "follow_up_response_bt": "t cells of CD4+ memory and t cells of CD8+ memory"}], "turn_2": [{"question_id": "34.6", "question": "What other types of immune cells were found to be associated with better cognitive performance?", "answer_src": "naive cd8 + t cells and b cells", "follow_up_question": "What cognitive functions were found to be predicted by effector memory cd4 + t cells?", "follow_up_response": "general and executive function and memory", "follow_up_response_bt": "No Answer"}, {"question_id": "34.7", "question": "What other types of T cells were found to be predictors of cognitive performance?", "answer_src": "effector memory cd4 + t cells", "follow_up_question": "What type of B cells were found to be associated with better cognitive performance?", "follow_up_response": "B cells", "follow_up_response_bt": "No Answer"}, {"question_id": "34.8", "question": "How does the study define better cognitive performance?", "answer_src": "Better cognitive performance was associated with lower numbers of effector memory cd4 + t cells and higher numbers of naive cd8 + t cells and b cells.", "follow_up_question": "What specific cognitive functions were found to be predicted by effector memory cd4 + t cells?", "follow_up_response": "general and executive function and memory", "follow_up_response_bt": "No Answer"}, {"question_id": "34.9", "question": "In what other cognitive functions were effector memory CD4+ T cells found to be predictive?", "answer_src": "general and executive function and memory", "follow_up_question": "What other cognitive function was not predicted by effector memory CD4+ T cells?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "34.10", "question": "What type of immune cell was found to predict general and executive function and memory?", "answer_src": "effector memory cd4 + t cells", "follow_up_question": "What other types of immune cells were associated with better cognitive performance according to the study?", "follow_up_response": "naive cd8 + t cells and b cells", "follow_up_response_bt": "CD4+ memory and CD8+ memory"}], "turn_3": [{"question_id": "34.11", "question": "What cognitive functions were found to be predicted by effector memory cd4 + t cells?", "answer_src": "general and executive function and memory", "follow_up_question": "What other cognitive function was found to be predicted by effector memory cd4 + t cells?", "follow_up_response": "general and executive function and memory", "follow_up_response_bt": "No Answer"}, {"question_id": "34.12", "question": "What type of B cells were found to be associated with better cognitive performance?", "answer_src": "B cells", "follow_up_question": "What kind of T cells were found to be predictors of general and executive function and memory?", "follow_up_response": "effector memory cd4 + t cells", "follow_up_response_bt": "CD4+ memory and CD8+ memory T cells"}, {"question_id": "34.13", "question": "What specific cognitive functions were found to be predicted by effector memory cd4 + t cells?", "answer_src": "general and executive function and memory", "follow_up_question": "What other cognitive functions were found to be predicted by effector memory cd4 + t cells?", "follow_up_response": "general and executive function and memory", "follow_up_response_bt": "No Answer"}, {"question_id": "34.14", "question": "What other cognitive function was not predicted by effector memory CD4+ T cells?", "answer_src": "immunosenescence and cognitive decline are common markers of the aging process . taking into consideration the heterogeneity observed in aging processes and the recently described link between lymphocytes and cognition , we herein explored the possibility of an association between alterations in lymphocytic populations and cognitive performance.in a cohort of cognitively healthy adults ( n = 114 ) , previously characterized by diverse neurocognitive / psychological performance patterns , detailed peripheral blood immunophenotyping of both the innate and adaptive immune systems was performed by flow cytometry.better cognitive performance was associated with lower numbers of effector memory cd4 + t cells and higher numbers of naive cd8 + t cells and b cells . furthermore , effector memory cd4 + t cells were found to be predictors of general and executive function and memory , even when factors known to influence cognitive performance in older individuals ( e.g. , age , sex , education , and mood ) were taken into account.this is the first study in humans associating specific phenotypes of the immune system with distinct cognitive performance in healthy aging .", "follow_up_question": "What cognitive function was predicted by effector memory CD4+ T cells?", "follow_up_response": "General and executive function and memory", "follow_up_response_bt": "No Answer"}, {"question_id": "34.15", "question": "What other types of immune cells were associated with better cognitive performance according to the study?", "answer_src": "naive cd8 + t cells and b cells", "follow_up_question": "How did the study classify the cognitive performance measures?", "follow_up_response": "diverse neurocognitive / psychological performance patterns", "follow_up_response_bt": "different schemes"}]}}
{"id": 35, "src": "methods for isobaric tagging of peptides , itraq or tmt , are commonly used platforms in mass spectrometry based quantitative proteomics . these two methods are very often used to quantitate proteins in complex samples , e.g. , serum / plasma or csf supporting biomarker discovery studies . the success of these studies depends on multiple factors , including the accuracy of ratios of reporter ions reflecting quantitative changes of proteins .", "mt": "I metodi isobarici per l'etichettatura dei peptidi , come itraq o tmt , sono piattaforme comunemente utilizzate nella proteomica quantitativa basata sulla spettrometria di massa . Questi due metodi sono molto spesso utilizzati per quantificare le proteine in campioni complessi , ad esempio , siero / plasma o csf che supportano studi di scoperta di biomarcatori . Il successo di questi studi dipende da molti fattori , tra cui l'accuratezza dei rapporti di ioni reporter che riflettono i cambiamenti quantitativi delle proteine .", "pert_mt": "I metodi isobarici per l'etichettatura dei peptidi, come itraq o tmt, sono piattaforme comunemente utilizzate nella proteomica quantitativa basata sulla spettrometria di massa. Questi due metodi sono molto spesso utilizzati per quantificare le proteine in campioni complessi, ad esempio, siero/plasma o csf, e supportano lo studio delle interazioni proteina-proteina. Il successo di questi studi dipende da molti fattori, tra cui l'accuratezza dei rapporti di ioni reporter che riflettono i cambiamenti quantitativi delle proteine.", "bt": "Isobaric methods for peptide labeling, such as itraq or tmt, are commonly used in quantitative proteomics based on mass spectrometry.These two methods are very often used to quantify protein in complex samples, e.g., serum/plasma or csf, and support the study of protein-protein interactions.The success of these studies depends on many factors, including the accuracy of the ion-reporter ratios that reflect the quantitative changes in proteins.", "questions_src": ["What are the two common methods for isobaric tagging of peptides mentioned in the sentence?", "Who are these methods used by in the context of the sentence?", "Where might these methods be applied according to the sentence?", "When can these methods be useful based on the information provided?", "Which factors can influence the success of these studies as described in the sentence?"], "answers_src": ["iTRAQ or TMT", "researchers", "complex samples such as serum/plasma or CSF", "when there are quantitative changes of proteins", "the accuracy of ratios of reporter ions"], "answers_bt": ["[\"itraq or tmt\"], [\"in the context of the sentence\"], [\"e.g., serum/plasma or csf\"], [\"when the quantitative changes in proteins need to be studied\"], [\"the accuracy of the ion-reporter ratios\"])", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "35.1", "question": "What are the two common methods for isobaric tagging of peptides mentioned in the sentence?", "answer_src": "iTRAQ or TMT", "follow_up_question": "What factors contribute to the success of these studies according to the text?", "follow_up_response": "the accuracy of ratios of reporter ions reflecting quantitative changes of proteins", "follow_up_response_bt": "the accuracy of the ion-reporter ratios that reflect the quantitative changes in proteins"}, {"question_id": "35.2", "question": "Who are these methods used by in the context of the sentence?", "answer_src": "researchers", "follow_up_question": "What specific type of samples are these methods used to quantify proteins in?", "follow_up_response": "serum / plasma or csf", "follow_up_response_bt": "complex samples, e.g., serum/plasma or csf"}, {"question_id": "35.3", "question": "Where might these methods be applied according to the sentence?", "answer_src": "complex samples such as serum/plasma or CSF", "follow_up_question": "What specific factor's accuracy is crucial for the success of these studies?", "follow_up_response": "the accuracy of ratios of reporter ions", "follow_up_response_bt": "the accuracy of the ion-reporter ratios"}, {"question_id": "35.4", "question": "When can these methods be useful based on the information provided?", "answer_src": "when there are quantitative changes of proteins", "follow_up_question": "What factors contribute to the success of these studies?", "follow_up_response": "the accuracy of ratios of reporter ions reflecting quantitative changes of proteins", "follow_up_response_bt": "The accuracy of the ion-reporter ratios that reflect the quantitative changes in proteins"}, {"question_id": "35.5", "question": "Which factors can influence the success of these studies as described in the sentence?", "answer_src": "the accuracy of ratios of reporter ions", "follow_up_question": "What other factors besides the accuracy of ratios of reporter ions can influence the success of these studies?", "follow_up_response": "Multiple factors", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "35.6", "question": "What factors contribute to the success of these studies according to the text?", "answer_src": "the accuracy of ratios of reporter ions reflecting quantitative changes of proteins", "follow_up_question": "How does the accuracy of ratios of reporter ions impact the quantitative changes of proteins?", "follow_up_response": "The success of these studies depends on the accuracy of ratios of reporter ions reflecting quantitative changes of proteins.", "follow_up_response_bt": "The success of these studies depends on many factors, including the accuracy of the ion-reporter ratios that reflect the quantitative changes in proteins."}, {"question_id": "35.7", "question": "What specific type of samples are these methods used to quantify proteins in?", "answer_src": "serum / plasma or csf", "follow_up_question": "What factors contribute to the success of these studies according to the text?", "follow_up_response": "the accuracy of ratios of reporter ions reflecting quantitative changes of proteins", "follow_up_response_bt": "the accuracy of the ion-reporter ratios that reflect the quantitative changes in proteins"}, {"question_id": "35.8", "question": "What specific factor's accuracy is crucial for the success of these studies?", "answer_src": "the accuracy of ratios of reporter ions", "follow_up_question": "How does the accuracy of ratios of reporter ions impact the study's results?", "follow_up_response": "It impacts the success of the studies", "follow_up_response_bt": "The success of these studies depends on many factors, including the accuracy of the ion-reporter ratios that reflect the quantitative changes in proteins."}, {"question_id": "35.9", "question": "What factors contribute to the success of these studies?", "answer_src": "the accuracy of ratios of reporter ions reflecting quantitative changes of proteins", "follow_up_question": "How does the accuracy of reporter ion ratios impact the study's success?", "follow_up_response": "The accuracy of ratios of reporter ions reflecting quantitative changes of proteins", "follow_up_response_bt": "The success of these studies depends on many factors, including the accuracy of the ion-reporter ratios that reflect the quantitative changes in proteins."}, {"question_id": "35.10", "question": "What other factors besides the accuracy of ratios of reporter ions can influence the success of these studies?", "answer_src": "Multiple factors", "follow_up_question": "How does the complexity of the sample affect the accuracy of ratios of reporter ions?", "follow_up_response": "No Answer", "follow_up_response_bt": "The complexity of the sample"}], "turn_3": [{"question_id": "35.11", "question": "How does the accuracy of ratios of reporter ions impact the quantitative changes of proteins?", "answer_src": "The success of these studies depends on the accuracy of ratios of reporter ions reflecting quantitative changes of proteins.", "follow_up_question": "What factors contribute to the accuracy of ratios of reporter ions?", "follow_up_response": "The accuracy of ratios of reporter ions reflecting quantitative changes of proteins", "follow_up_response_bt": "The accuracy of the ion-reporter ratios"}, {"question_id": "35.12", "question": "What factors contribute to the success of these studies according to the text?", "answer_src": "the accuracy of ratios of reporter ions reflecting quantitative changes of proteins", "follow_up_question": "How does the accuracy of ratios of reporter ions impact the quantitative changes of proteins?", "follow_up_response": "The success of these studies depends on the accuracy of ratios of reporter ions reflecting quantitative changes of proteins.", "follow_up_response_bt": "The success of these studies depends on many factors, including the accuracy of the ion-reporter ratios that reflect the quantitative changes in proteins."}, {"question_id": "35.13", "question": "How does the accuracy of ratios of reporter ions impact the study's results?", "answer_src": "It impacts the success of the studies", "follow_up_question": "What specific factors contribute to the accuracy of ratios of reporter ions?", "follow_up_response": "The accuracy of ratios of reporter ions reflecting quantitative changes of proteins", "follow_up_response_bt": "The accuracy of the ion-reporter ratios"}, {"question_id": "35.14", "question": "How does the accuracy of reporter ion ratios impact the study's success?", "answer_src": "The accuracy of ratios of reporter ions reflecting quantitative changes of proteins", "follow_up_question": "What factors contribute to the accuracy of these ratios?", "follow_up_response": "The accuracy of ratios of reporter ions reflecting quantitative changes of proteins", "follow_up_response_bt": "The accuracy of the ion-reporter ratios"}, {"question_id": "35.15", "question": "How does the complexity of the sample affect the accuracy of ratios of reporter ions?", "answer_src": "methods for isobaric tagging of peptides , itraq or tmt , are commonly used platforms in mass spectrometry based quantitative proteomics . these two methods are very often used to quantitate proteins in complex samples , e.g. , serum / plasma or csf supporting biomarker discovery studies . the success of these studies depends on multiple factors , including the accuracy of ratios of reporter ions reflecting quantitative changes of proteins .", "follow_up_question": "What factors besides sample complexity impact the accuracy of ratios of reporter ions?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 36, "src": "sleep / wake disturbances in patients with amyotrophic lateral sclerosis ( als ) are well - documented , however , no animal or mechanistic studies on these disturbances exist . orexin is a crucial neurotransmitter in promoting wakefulness in sleep / wake regulation , and may play an important role in sleep disturbances in als . in this study , we used sod1-g93a transgenic mice as an als mouse model to investigate the sleep / wake disturbances and their possible mechanisms in als.electroencephalogram/electromyogram recordings were performed in sod1-g93a transgenic mice and their littermate control mice at the ages of 90 and 120 days , and the samples obtained from these groups were subjected to quantitative reverse transcriptase - polymerase chain reaction , western blotting , and enzyme - linked immunosorbent assay.for the first time in sod1-g93a transgenic mice , we observed significantly increased wakefulness , reduced sleep time , and up - regulated orexins ( prepro - orexin , orexin a and b ) at both 90 and 120 days .", "mt": "Nell'ambito di questo studio , abbiamo utilizzato topi transgenici sodosi-g93a come modello del mouse per studiare i disturbi del sonno / veglia e i loro possibili meccanismi nelle registrazioni di elettrencefalogrammi/elettromiogrammi sono stati eseguiti nei topi sodosi-g93a e nei loro topi controllatori del sonno a età compresa tra 90 e 120 giorni , e i campioni ottenuti da questi gruppi sono stati sottoposti a reazioni quantitative di reversità della catena del sonno , dei polinomi e dei polinomi , degli enzimi - immorbi e dei loro potenziali meccanismi nel sonno e nelle registrazioni di elettrencefalogrammi sono stati eseguiti nei topi sodosi-g93a e nei loro topi controllatori del sonno a età compresa tra 90 e 120 giorni , e i campioni ottenuti da questi gruppi sono stati sottoposti a reazioni di reversità della catena del sonno , dei polinomi e dei polinomi , degli enzimi - immorbi e dei loro riassunti , mentre i primi giorni di sonno sono stati osservati ,", "pert_mt": "Nell'ambito di questo studio, abbiamo utilizzato topi transgenici sodosi-g93a come modello del mouse per studiare i disturbi del sonno/veglia e i loro possibili meccanismi nelle registrazioni di elettrencefalogrammi/elettromiogrammi sono stati eseguiti nei topi sodosi-g93a e nei loro topi controllatori del sonno a età compresa tra 90 e 120 giorni, e i campioni ottenuti da questi gruppi sono stati sottoposti a reazioni quantitative di reversità della catena del sonno, dei polinomi e dei polinomi, degli enzimi-immorbi e dei loro potenziali meccanismi nel sonno e nelle registrazioni di elettrencefalogrammi sono stati eseguiti nei topi sodosi-g93a", "bt": "In this study, we used sodosi-g93a transgenic mice as a mouse model to study sleep/wake disorders and their possible mechanisms in electrencephalogram/electromyogram recordings were performed in sodosi-g93a mice and their sleep control mice aged between 90 and 120 days, and samples obtained from these groups were subjected to quantitative reactions of the inverse of the sleep chain, polynomials and polynomials, immunomorphic enzymes and their potential sleep mechanisms and in sodosi-g93a mice and in electrencephalogram recordings were performed in sodosi-g93a mice", "questions_src": ["What neurotransmitter is crucial for promoting wakefulness in sleep/wake regulation?", "When were electroencephalogram/electromyogram recordings performed in the study?", "Which age group showed significantly increased wakefulness in the sod1-g93a transgenic mice?", "How many days after birth were the samples collected from the sod1-g93a transgenic mice and their control mice?", "What sleep/wake disturbances were observed in the sod1-g93a transgenic mice according to the study?"], "answers_src": ["[\"orexin\"], [\"at the ages of 90 and 120 days\"], [120], [90 and 120], [\"significantly increased wakefulness, reduced sleep time\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["GABA", "Between 90 and 120 days", "90 and 120 days", "90 and 120 days", "Sleep/wake disorders"], "multiturn": {"turn_1": [{"question_id": "36.1", "question": "What neurotransmitter is crucial for promoting wakefulness in sleep/wake regulation?", "answer_src": "[\"orexin\"], [\"at the ages of 90 and 120 days\"], [120], [90 and 120], [\"significantly increased wakefulness, reduced sleep time\"]", "follow_up_question": "What was the effect of orexin on sleep/wake disturbances in sod1-g93a transgenic mice compared to their littermate controls?", "follow_up_response": "We observed significantly increased wakefulness, reduced sleep time, and up-regulated orexins (prepro-orexin, orexin A and B) in sod1-g93a transgenic mice compared to their littermate controls.", "follow_up_response_bt": "No Answer"}, {"question_id": "36.2", "question": "When were electroencephalogram/electromyogram recordings performed in the study?", "answer_src": "sleep / wake disturbances in patients with amyotrophic lateral sclerosis ( als ) are well - documented , however , no animal or mechanistic studies on these disturbances exist . orexin is a crucial neurotransmitter in promoting wakefulness in sleep / wake regulation , and may play an important role in sleep disturbances in als . in this study , we used sod1-g93a transgenic mice as an als mouse model to investigate the sleep / wake disturbances and their possible mechanisms in als.electroencephalogram/electromyogram recordings were performed in sod1-g93a transgenic mice and their littermate control mice at the ages of 90 and 120 days , and the samples obtained from these groups were subjected to quantitative reverse transcriptase - polymerase chain reaction , western blotting , and enzyme - linked immunosorbent assay.for the first time in sod1-g93a transgenic mice , we observed significantly increased wakefulness , reduced sleep time , and up - regulated orexins ( prepro - orexin , orexin a and b ) at both 90 and 120 days .", "follow_up_question": "What specific changes in sleep patterns did the study observe in sod1-g93a transgenic mice compared to their littermate controls?", "follow_up_response": "significantly increased wakefulness, reduced sleep time, and up-regulated orexins (prepro-orexin, orexin A and B)", "follow_up_response_bt": "No Answer"}, {"question_id": "36.3", "question": "Which age group showed significantly increased wakefulness in the sod1-g93a transgenic mice?", "answer_src": "sleep / wake disturbances in patients with amyotrophic lateral sclerosis ( als ) are well - documented , however , no animal or mechanistic studies on these disturbances exist . orexin is a crucial neurotransmitter in promoting wakefulness in sleep / wake regulation , and may play an important role in sleep disturbances in als . in this study , we used sod1-g93a transgenic mice as an als mouse model to investigate the sleep / wake disturbances and their possible mechanisms in als.electroencephalogram/electromyogram recordings were performed in sod1-g93a transgenic mice and their littermate control mice at the ages of 90 and 120 days , and the samples obtained from these groups were subjected to quantitative reverse transcriptase - polymerase chain reaction , western blotting , and enzyme - linked immunosorbent assay.for the first time in sod1-g93a transgenic mice , we observed significantly increased wakefulness , reduced sleep time , and up - regulated orexins ( prepro - orexin , orexin a and b ) at both 90 and 120 days .", "follow_up_question": "At what age did the sod1-g93a transgenic mice show significantly increased wakefulness?", "follow_up_response": "120", "follow_up_response_bt": "No Answer"}, {"question_id": "36.4", "question": "How many days after birth were the samples collected from the sod1-g93a transgenic mice and their control mice?", "answer_src": "sleep / wake disturbances in patients with amyotrophic lateral sclerosis ( als ) are well - documented , however , no animal or mechanistic studies on these disturbances exist . orexin is a crucial neurotransmitter in promoting wakefulness in sleep / wake regulation , and may play an important role in sleep disturbances in als . in this study , we used sod1-g93a transgenic mice as an als mouse model to investigate the sleep / wake disturbances and their possible mechanisms in als.electroencephalogram/electromyogram recordings were performed in sod1-g93a transgenic mice and their littermate control mice at the ages of 90 and 120 days , and the samples obtained from these groups were subjected to quantitative reverse transcriptase - polymerase chain reaction , western blotting , and enzyme - linked immunosorbent assay.for the first time in sod1-g93a transgenic mice , we observed significantly increased wakefulness , reduced sleep time , and up - regulated orexins ( prepro - orexin , orexin a and b ) at both 90 and 120 days .", "follow_up_question": "At what age were the sod1-g93a transgenic mice and their control mice sampled?", "follow_up_response": "90, 120", "follow_up_response_bt": "between 90 and 120 days"}, {"question_id": "36.5", "question": "What sleep/wake disturbances were observed in the sod1-g93a transgenic mice according to the study?", "answer_src": "sleep / wake disturbances in patients with amyotrophic lateral sclerosis ( als ) are well - documented , however , no animal or mechanistic studies on these disturbances exist . orexin is a crucial neurotransmitter in promoting wakefulness in sleep / wake regulation , and may play an important role in sleep disturbances in als . in this study , we used sod1-g93a transgenic mice as an als mouse model to investigate the sleep / wake disturbances and their possible mechanisms in als.electroencephalogram/electromyogram recordings were performed in sod1-g93a transgenic mice and their littermate control mice at the ages of 90 and 120 days , and the samples obtained from these groups were subjected to quantitative reverse transcriptase - polymerase chain reaction , western blotting , and enzyme - linked immunosorbent assay.for the first time in sod1-g93a transgenic mice , we observed significantly increased wakefulness , reduced sleep time , and up - regulated orexins ( prepro - orexin , orexin a and b ) at both 90 and 120 days .", "follow_up_question": "What specific changes were observed in orexin levels in the sod1-g93a transgenic mice compared to their littermate controls?", "follow_up_response": "Increased orexins (prepro-orexin, orexin A and B)", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "36.6", "question": "What was the effect of orexin on sleep/wake disturbances in sod1-g93a transgenic mice compared to their littermate controls?", "answer_src": "We observed significantly increased wakefulness, reduced sleep time, and up-regulated orexins (prepro-orexin, orexin A and B) in sod1-g93a transgenic mice compared to their littermate controls.", "follow_up_question": "How did the levels of prepro-orexin compare between sod1-g93a transgenic mice and their littermate controls?", "follow_up_response": "Up-regulated", "follow_up_response_bt": "No Answer"}, {"question_id": "36.7", "question": "What specific changes in sleep patterns did the study observe in sod1-g93a transgenic mice compared to their littermate controls?", "answer_src": "significantly increased wakefulness, reduced sleep time, and up-regulated orexins (prepro-orexin, orexin A and B)", "follow_up_question": "What was the effect of orexin up-regulation on the sleep / wake disturbances observed in the sod1-g93a transgenic mice?", "follow_up_response": "Reduced sleep time and increased wakefulness", "follow_up_response_bt": "No Answer"}, {"question_id": "36.8", "question": "At what age did the sod1-g93a transgenic mice show significantly increased wakefulness?", "answer_src": "120", "follow_up_question": "At what age did the sod1-g93a transgenic mice show reduced sleep time?", "follow_up_response": "120", "follow_up_response_bt": "90 and 120 days"}, {"question_id": "36.9", "question": "At what age were the sod1-g93a transgenic mice and their control mice sampled?", "answer_src": "90, 120", "follow_up_question": "What was the change in orexin levels in the sod1-g93a transgenic mice compared to their controls?", "follow_up_response": "Up-regulated orexins (prepro-orexin, orexin A and B)", "follow_up_response_bt": "No Answer"}, {"question_id": "36.10", "question": "What specific changes were observed in orexin levels in the sod1-g93a transgenic mice compared to their littermate controls?", "answer_src": "Increased orexins (prepro-orexin, orexin A and B)", "follow_up_question": "How did the changes in orexin levels correlate with the observed alterations in sleep/wake patterns?", "follow_up_response": "The changes in orexin levels (up-regulated orexins) correlated with the observed alterations in sleep/wake patterns, including significantly increased wakefulness, reduced sleep time.", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "36.11", "question": "How did the levels of prepro-orexin compare between sod1-g93a transgenic mice and their littermate controls?", "answer_src": "Up-regulated", "follow_up_question": "How did the levels of orexin A compare between sod1-g93a transgenic mice and their littermate controls?", "follow_up_response": "Up-regulated", "follow_up_response_bt": "No Answer"}, {"question_id": "36.12", "question": "What was the effect of orexin up-regulation on the sleep / wake disturbances observed in the sod1-g93a transgenic mice?", "answer_src": "Reduced sleep time and increased wakefulness", "follow_up_question": "What was the pattern of orexin expression changes observed in the sod1-g93a transgenic mice compared to their littermate controls?", "follow_up_response": "Significantly increased wakefulness, reduced sleep time, and up-regulated orexins (prepro-orexin, orexin A and B)", "follow_up_response_bt": "No Answer"}, {"question_id": "36.13", "question": "At what age did the sod1-g93a transgenic mice show reduced sleep time?", "answer_src": "120", "follow_up_question": "At what age did the sod1-g93a transgenic mice show increased wakefulness?", "follow_up_response": "120", "follow_up_response_bt": "120 days"}, {"question_id": "36.14", "question": "What was the change in orexin levels in the sod1-g93a transgenic mice compared to their controls?", "answer_src": "Up-regulated orexins (prepro-orexin, orexin A and B)", "follow_up_question": "How did the changes in orexin levels correlate with the observed alterations in sleep/wake patterns?", "follow_up_response": "The changes in orexin levels (up-regulated orexins) correlated with the observed alterations in sleep/wake patterns, including significantly increased wakefulness, reduced sleep time.", "follow_up_response_bt": "No Answer"}, {"question_id": "36.15", "question": "How did the changes in orexin levels correlate with the observed alterations in sleep/wake patterns?", "answer_src": "The changes in orexin levels (up-regulated orexins) correlated with the observed alterations in sleep/wake patterns, including significantly increased wakefulness, reduced sleep time.", "follow_up_question": "What specific orexin subtypes (prepro-orexin, orexin A, and B) showed up-regulation in the sod1-g93a transgenic mice?", "follow_up_response": "prepro-orexin\", \"orexin A\", \"orexin B", "follow_up_response_bt": "No Answer"}]}}
{"id": 37, "src": "twelve machine learning classifiers using different combinations of variables related to icd-9 cd status , laboratory result status , and pathology reports were experimented to find the best possible cd classifier . ten - fold cross - validation was used to assess the results.a total of 1498 patient records were used including 363 confirmed cases and 1135 false positive cases that served as controls . logistic model based on both clinical and pathology report features produced the best results : kappa of 0.78 , f1 of 0.92 , and area under the curve ( auc ) of 0.94 , whereas in contrast using icd-9 only generated poor results : kappa of 0.28 , f1 of 0.75 , and auc of 0.63.our automated classification system presented an efficient and reliable way to improve the performance of cd patient identification .", "mt": "Sono stati sperimentati dodici classificatori di machine learning che utilizzavano diverse combinazioni di variabili relative allo stato di cd icd-9 , allo stato dei risultati di laboratorio e ai rapporti di patologia per trovare il miglior classificatore possibile di cd . Per valutare i risultati è stata utilizzata una decapilata di cross-validation . Sono stati utilizzati un totale di 1498 registri di pazienti tra cui 363 casi confermati e 1135 casi falsi positivi che hanno servito da controlli . Il modello logistico basato su caratteristiche sia cliniche che di rapporti di patologia ha prodotto i migliori risultati: kappa di 0,78 , f1 di 0,92 e area sotto la curva (auc) di 0,94 , mentre nel caso di pazienti che hanno utilizzato icd-9 sono stati generati solo risultati: kappa di contrasto di 0,28 , f1 di 0,75 e auc di 0,63.our sistema di classificazione automatizzato ha presentato un modo efficiente e affidabile per migliorare le prestazioni di identificazione cd .", "pert_mt": "Sono stati sperimentati dodici classificatori di machine learning che utilizzavano diverse combinazioni di variabili relative allo stato di cd icd-9, allo stato dei risultati di laboratorio e ai rapporti di patologia per trovare il miglior classificatore possibile di cd. Per valutare i risultati è stata utilizzata una decapilata di cross-validation. Sono stati utilizzati un totale di 1498 registri di pazienti tra cui 363 casi confermati e 1135 casi falsi positivi che hanno servito da controlli. Il modello logistico basato su caratteristiche sia cliniche che di rapporti di patologia ha prodotto i migliori risultati: kappa di 0,78, f1 di 0,92 e area sotto la curva (auc) di 0,94, mentre nel caso di", "bt": "Twelve machine learning classifiers were tested using different combinations of variables related to the status of cd icd-9, the status of laboratory results and pathology reports to find the best possible classifier of cd. A decapilate of cross-validation was used to evaluate the results. A total of 1498 patient registers were used, including 363 confirmed cases and 1135 false positive cases that served as controls. The logistics model based on both clinical and pathology reports produced the best results: cappa of 0.78, f1 of 0.92 and area under the curve (auc) of 0.94, while in the case di the best results: cappa of 0.78, f1 of 0.92 and area under the curve (auc) of 0.94.", "questions_src": ["What is the name of the classification method that produced the best results?", "Who were the controls used in the experiment?", "What is the kappa value for the logistic model?", "Where were the patient records obtained from?", "Which combination of variables resulted in the best classifier according to the study?"], "answers_src": ["Logistic model based on both clinical and pathology report features", "1135 false positive cases that served as controls", "0.78", "A total of 1498 patient records were used including 363 confirmed cases and 1135 false positive cases that served as controls", "different combinations of variables related to icd-9 cd status, laboratory result status, and pathology reports"], "answers_bt": ["Logistics model", "1135 false positive cases that served as controls", "0.78", "A total of 1498 patient registers were used, including 363 confirmed cases and 1135 false positive cases that served as controls", "Both clinical and pathology reports"], "multiturn": {"turn_1": [{"question_id": "37.1", "question": "What is the name of the classification method that produced the best results?", "answer_src": "Logistic model based on both clinical and pathology report features", "follow_up_question": "What is the kappa score of the best performing classification method?", "follow_up_response": "0.78", "follow_up_response_bt": "0.78"}, {"question_id": "37.2", "question": "Who were the controls used in the experiment?", "answer_src": "1135 false positive cases that served as controls", "follow_up_question": "What is the kappa score for the logistic model using both clinical and pathology report features?", "follow_up_response": "0.78", "follow_up_response_bt": "0.78"}, {"question_id": "37.3", "question": "What is the kappa value for the logistic model?", "answer_src": "0.78", "follow_up_question": "What is the f1 score for the logistic model?", "follow_up_response": "0.92", "follow_up_response_bt": "0.92"}, {"question_id": "37.4", "question": "Where were the patient records obtained from?", "answer_src": "A total of 1498 patient records were used including 363 confirmed cases and 1135 false positive cases that served as controls", "follow_up_question": "What is the improvement in kappa score when using both clinical and pathology report features compared to using only ICD-9?", "follow_up_response": "0.5", "follow_up_response_bt": "No Answer"}, {"question_id": "37.5", "question": "Which combination of variables resulted in the best classifier according to the study?", "answer_src": "different combinations of variables related to icd-9 cd status, laboratory result status, and pathology reports", "follow_up_question": "What was the kappa score of the best classifier?", "follow_up_response": "0.78", "follow_up_response_bt": "0.78"}], "turn_2": [{"question_id": "37.6", "question": "What is the kappa score of the best performing classification method?", "answer_src": "0.78", "follow_up_question": "What is the f1 score of the best performing classification method?", "follow_up_response": "0.92", "follow_up_response_bt": "0.92"}, {"question_id": "37.7", "question": "What is the kappa score for the logistic model using both clinical and pathology report features?", "answer_src": "0.78", "follow_up_question": "What is the kappa score for the logistic model using only ICD-9 codes?", "follow_up_response": "0.28", "follow_up_response_bt": "No Answer"}, {"question_id": "37.8", "question": "What is the f1 score for the logistic model?", "answer_src": "0.92", "follow_up_question": "What is the kappa score for the logistic model?", "follow_up_response": "0.78", "follow_up_response_bt": "0.78"}, {"question_id": "37.9", "question": "What is the improvement in kappa score when using both clinical and pathology report features compared to using only ICD-9?", "answer_src": "0.5", "follow_up_question": "By how much did the AUC score increase when using both clinical and pathology report features instead of just ICD-9?", "follow_up_response": "0.31", "follow_up_response_bt": "No Answer"}, {"question_id": "37.10", "question": "What was the kappa score of the best classifier?", "answer_src": "0.78", "follow_up_question": "What was the f1 score of the best classifier?", "follow_up_response": "0.92", "follow_up_response_bt": "0.92"}], "turn_3": [{"question_id": "37.11", "question": "What is the f1 score of the best performing classification method?", "answer_src": "0.92", "follow_up_question": "What is the kappa value of the best performing classification method?", "follow_up_response": "0.78", "follow_up_response_bt": "0.78"}, {"question_id": "37.12", "question": "What is the kappa score for the logistic model using only ICD-9 codes?", "answer_src": "0.28", "follow_up_question": "What is the kappa score for the logistic model using both clinical and pathology report features?", "follow_up_response": "0.78", "follow_up_response_bt": "0.78"}, {"question_id": "37.13", "question": "What is the kappa score for the logistic model?", "answer_src": "0.78", "follow_up_question": "What is the f1 score for the logistic model?", "follow_up_response": "0.92", "follow_up_response_bt": "0.92"}, {"question_id": "37.14", "question": "By how much did the AUC score increase when using both clinical and pathology report features instead of just ICD-9?", "answer_src": "0.31", "follow_up_question": "By how much did the F1 score increase when using both clinical and pathology report features instead of just ICD-9?", "follow_up_response": "0.17", "follow_up_response_bt": "No Answer"}, {"question_id": "37.15", "question": "What was the f1 score of the best classifier?", "answer_src": "0.92", "follow_up_question": "What was the kappa value of the best classifier?", "follow_up_response": "0.78", "follow_up_response_bt": "0.78"}]}}
{"id": 38, "src": "amblyopia , which usually occurs during early childhood and results in poor or blurred vision , is a disorder of the visual system that is characterized by a deficiency in an otherwise physically normal eye or by a deficiency that is out of proportion with the structural or functional abnormalities of the eye . our previous study demonstrated alterations in the spontaneous activity patterns of some brain regions in individuals with anisometropic amblyopia compared to subjects with normal vision . to date , it remains unknown whether patients with amblyopia show characteristic alterations in the functional connectivity patterns in the visual areas of the brain , particularly the primary visual area .", "mt": "L'ambliopia , che si verifica solitamente durante la prima infanzia e si traduce in una visione scarsa o sfocata , è un disturbo del sistema visivo caratterizzato da una carenza di un occhio altrimenti fisicamente normale o da una carenza che è fuori rapporto con le anomalie strutturali o funzionali dell' occhio . Il nostro precedente studio ha dimostrato alterazioni nei modelli di attività spontanea di alcune regioni del cervello in individui con ambliopia anisometropico rispetto a soggetti con visione normale .", "pert_mt": "L'ambliopia, che si verifica solitamente durante la prima infanzia e si traduce in una visione scarsa o sfocata, è un disturbo del sistema visivo caratterizzato da una carenza di un occhio altrimenti fisicamente normale o da una carenza che è fuori rapporto con le anomalie strutturali o funzionali dell'occhio. Il nostro precedente studio ha dimostrato alterazioni nei modelli di attività spontanea di alcune regioni del cervello in individui con ambliopia anisometropica rispetto a soggetti con visione normale e questo ha portato a una maggiore comprensione della patogenesi di questa condizione.", "bt": "Amblyopia, which occurs only during early childhood and results in poor or blurred vision, is a visual system disorder characterized by a deficiency of an otherwise physically normal eye or a deficiency that is out of proportion to structural or functional abnormalities of the eye.Our previous study has shown alterations in patterns of spontaneous activity in some regions of the brain in individuals with anisometric amblyopia compared to subjects with normal vision and this has led to a greater understanding of the pathogenesis of this condition.", "questions_src": ["What is amblyopia?", "Who usually experiences amblyopia?", "Where does amblyopia occur?", "When does amblyopia usually occur?", "Which brain regions show alterations in spontaneous activity in individuals with anisometropic amblyopia?"], "answers_src": ["a disorder of the visual system that is characterized by a deficiency in an otherwise physically normal eye or by a deficiency that is out of proportion with the structural or functional abnormalities of the eye", "during early childhood", "the visual system", "during early childhood", "some brain regions"], "answers_bt": ["Amblyopia is a visual system disorder characterized by a deficiency of an otherwise physically normal eye or a deficiency that is out of proportion to structural or functional abnormalities of the eye.", "Only early childhood", "During early childhood", "Only early childhood", "Some regions of the brain"], "multiturn": {"turn_1": [{"question_id": "38.1", "question": "What is amblyopia?", "answer_src": "a disorder of the visual system that is characterized by a deficiency in an otherwise physically normal eye or by a deficiency that is out of proportion with the structural or functional abnormalities of the eye", "follow_up_question": "What specific type of amblyopia was studied in your previous research?", "follow_up_response": "anisometropic amblyopia", "follow_up_response_bt": "anisometric amblyopia"}, {"question_id": "38.2", "question": "Who usually experiences amblyopia?", "answer_src": "during early childhood", "follow_up_question": "What specific type of amblyopia was studied in your previous research?", "follow_up_response": "anisometropic amblyopia", "follow_up_response_bt": "anisometric amblyopia"}, {"question_id": "38.3", "question": "Where does amblyopia occur?", "answer_src": "the visual system", "follow_up_question": "What specific brain regions showed altered spontaneous activity patterns in your previous study?", "follow_up_response": "Some brain regions", "follow_up_response_bt": "Some regions of the brain"}, {"question_id": "38.4", "question": "When does amblyopia usually occur?", "answer_src": "during early childhood", "follow_up_question": "What specific type of amblyopia was studied in your previous research?", "follow_up_response": "anisometropic amblyopia", "follow_up_response_bt": "anisometric amblyopia"}, {"question_id": "38.5", "question": "Which brain regions show alterations in spontaneous activity in individuals with anisometropic amblyopia?", "answer_src": "some brain regions", "follow_up_question": "Which specific brain regions exhibit altered spontaneous activity patterns in individuals with anisometropic amblyopia according to your previous study?", "follow_up_response": "some brain regions", "follow_up_response_bt": "Some regions of the brain"}], "turn_2": [{"question_id": "38.6", "question": "What specific type of amblyopia was studied in your previous research?", "answer_src": "anisometropic amblyopia", "follow_up_question": "What were the findings regarding the spontaneous activity patterns in the brains of participants with anisometropic amblyopia?", "follow_up_response": "Alterations in the spontaneous activity patterns of some brain regions", "follow_up_response_bt": "Alterations in patterns of spontaneous activity"}, {"question_id": "38.7", "question": "What specific type of amblyopia was studied in your previous research?", "answer_src": "anisometropic amblyopia", "follow_up_question": "What were the findings regarding the spontaneous activity patterns in the brains of participants with anisometropic amblyopia?", "follow_up_response": "Alterations in the spontaneous activity patterns of some brain regions", "follow_up_response_bt": "Alterations in patterns of spontaneous activity"}, {"question_id": "38.8", "question": "What specific brain regions showed altered spontaneous activity patterns in your previous study?", "answer_src": "Some brain regions", "follow_up_question": "Which specific brain areas exhibited altered spontaneous activity patterns according to your previous study?", "follow_up_response": "Some brain regions", "follow_up_response_bt": "Some regions of the brain"}, {"question_id": "38.9", "question": "What specific type of amblyopia was studied in your previous research?", "answer_src": "anisometropic amblyopia", "follow_up_question": "What were the findings regarding the spontaneous activity patterns in the brains of participants with anisometropic amblyopia?", "follow_up_response": "Alterations in the spontaneous activity patterns of some brain regions", "follow_up_response_bt": "Alterations in patterns of spontaneous activity"}, {"question_id": "38.10", "question": "Which specific brain regions exhibit altered spontaneous activity patterns in individuals with anisometropic amblyopia according to your previous study?", "answer_src": "some brain regions", "follow_up_question": "Which specific primary visual area shows characteristic alterations in functional connectivity patterns in individuals with amblyopia?", "follow_up_response": "primary visual area", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "38.11", "question": "What were the findings regarding the spontaneous activity patterns in the brains of participants with anisometropic amblyopia?", "answer_src": "Alterations in the spontaneous activity patterns of some brain regions", "follow_up_question": "What specific brain regions showed altered spontaneous activity patterns?", "follow_up_response": "Some brain regions", "follow_up_response_bt": "Some regions of the brain"}, {"question_id": "38.12", "question": "What were the findings regarding the spontaneous activity patterns in the brains of participants with anisometropic amblyopia?", "answer_src": "Alterations in the spontaneous activity patterns of some brain regions", "follow_up_question": "What specific brain regions showed altered spontaneous activity patterns?", "follow_up_response": "Some brain regions", "follow_up_response_bt": "Some regions of the brain"}, {"question_id": "38.13", "question": "Which specific brain areas exhibited altered spontaneous activity patterns according to your previous study?", "answer_src": "Some brain regions", "follow_up_question": "Which specific brain regions showed altered spontaneous activity patterns in the study?", "follow_up_response": "Some brain regions", "follow_up_response_bt": "Some regions of the brain"}, {"question_id": "38.14", "question": "What were the findings regarding the spontaneous activity patterns in the brains of participants with anisometropic amblyopia?", "answer_src": "Alterations in the spontaneous activity patterns of some brain regions", "follow_up_question": "What specific brain regions showed altered spontaneous activity patterns?", "follow_up_response": "Some brain regions", "follow_up_response_bt": "Some regions of the brain"}, {"question_id": "38.15", "question": "Which specific primary visual area shows characteristic alterations in functional connectivity patterns in individuals with amblyopia?", "answer_src": "primary visual area", "follow_up_question": "What are the implications of characteristic alterations in the functional connectivity patterns in the primary visual area for treating amblyopia?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 39, "src": "most guidelines for clinical practice , and especially those for the construction of decision support tools , assume that the individual person ( the patient ) needs to be in possession of information of particular sorts and amount in order to qualify as having made an informed decision. this often implicitly segues into the patient having made a good decision. in person - centred health care , whether , in what form , and with what weight , information is included as a criterion of decision quality is a matter for the person involved , to decide in the light of their own values , preferences , and time and resource constraints .", "mt": "La maggior parte delle linee guida per la pratica clinica , e in particolare quelle per la costruzione di strumenti di supporto decisionale , presuppongono che l'individuo (il paziente) debba essere in possesso di informazioni di determinati tipi e quantità per poter essere qualificato come aver preso una decisione informata. questo spesso implica implicitamente che il paziente abbia preso una buona decisione. in personale - assistenza sanitaria centrata , se , in che forma , e con quale peso , l'informazione viene inclusa come criterio di qualità della decisione è una questione per la persona coinvolta , per decidere alla luce dei propri valori , preferenze , e limitazioni di tempo e risorse .", "pert_mt": "La maggior parte delle linee guida per la pratica clinica, e in particolare quelle per la costruzione di strumenti di supporto decisionale, presuppongono che l'individuo (il paziente) debba essere in possesso di informazioni di determinati tipi e quantità per poter essere qualificato come aver preso una decisione informata. questo spesso implica implicitamente che il paziente abbia preso una buona decisione. in personale-assistenza sanitaria centrata, se, in che forma, e con quale peso, l'informazione viene inclusa come criterio di qualità della decisione è una questione per la persona coinvolta, per decidere alla luce dei propri valori, preferenze, e limitazioni di tempo e risorse, e ciò può influire sulla qualità finale della decisione medica.", "bt": "Most guidelines for clinical practice, and in particular those for the construction of decision support tools, presuppose that the individual (the patient) must possess information of certain types and quantities in order to qualify as having made an informed decision. this often implies implicitly that the patient has made a good decision. in healthcare-centric personnel, whether, in what form, and with what weight, the information included as a criterion of decision quality is a matter for the person involved, to decide in light of their own values, preferences, and time and time constraints, and this can affect the final quality of medical decision resources.", "questions_src": ["What is assumed about the individual person (the patient) in most guidelines for clinical practice regarding information?", "In what form is information typically considered a criterion of decision quality in person-centred health care?", "Who decides whether, in what form, and with what weight, information should be included as a criterion of decision quality in person-centred health care?", "When does the implicit assumption that the patient has made an informed decision become problematic?", "Which values and preferences influence the decision on including information as a criterion of decision quality in person-centred health care?"], "answers_src": ["that the individual person (the patient) needs to be in possession of information of particular sorts and amount", "in what form", "the person involved", "no answer", "values, preferences"], "answers_bt": ["that the individual (the patient) must possess information of certain types and quantities", "in what form", "the person involved", "no answer", "values, preferences"], "multiturn": {"turn_1": [{"question_id": "39.1", "question": "What is assumed about the individual person (the patient) in most guidelines for clinical practice regarding information?", "answer_src": "that the individual person (the patient) needs to be in possession of information of particular sorts and amount", "follow_up_question": "In what forms does the text suggest information should be included as a criterion of decision quality?", "follow_up_response": "a matter for the person involved", "follow_up_response_bt": "a matter for the person involved, to decide in light of their own values, preferences, and time and time constraints"}, {"question_id": "39.2", "question": "In what form is information typically considered a criterion of decision quality in person-centred health care?", "answer_src": "in what form", "follow_up_question": "With what weight is information typically considered a criterion of decision quality in person-centred health care?", "follow_up_response": "a matter for the person involved", "follow_up_response_bt": "to decide in light of their own values, preferences, and time and time constraints"}, {"question_id": "39.3", "question": "Who decides whether, in what form, and with what weight, information should be included as a criterion of decision quality in person-centred health care?", "answer_src": "the person involved", "follow_up_question": "What criteria does the person involved use to decide whether, in what form, and with what weight, information should be included as a criterion of decision quality in person-centred health care?", "follow_up_response": "their own values, preferences, and time and resource constraints", "follow_up_response_bt": "their own values, preferences, and time and time constraints"}, {"question_id": "39.4", "question": "When does the implicit assumption that the patient has made an informed decision become problematic?", "answer_src": "no answer", "follow_up_question": "Under what circumstances might the patient's personal values and preferences conflict with the inclusion of certain types of information in decision-making?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "39.5", "question": "Which values and preferences influence the decision on including information as a criterion of decision quality in person-centred health care?", "answer_src": "values, preferences", "follow_up_question": "What are some examples of time and resource constraints that might affect a person's decision to include information as a criterion of decision quality?", "follow_up_response": "No Answer", "follow_up_response_bt": "Time and time constraints"}], "turn_2": [{"question_id": "39.6", "question": "In what forms does the text suggest information should be included as a criterion of decision quality?", "answer_src": "a matter for the person involved", "follow_up_question": "With what weight is information included as a criterion of decision quality according to the text?", "follow_up_response": "a matter for the person involved", "follow_up_response_bt": "to decide in light of their own values, preferences, and time and time constraints"}, {"question_id": "39.7", "question": "With what weight is information typically considered a criterion of decision quality in person-centred health care?", "answer_src": "a matter for the person involved", "follow_up_question": "To what extent do personal values and preferences influence the inclusion of information as a criterion of decision quality?", "follow_up_response": "a matter for the person involved, to decide in the light of their own values, preferences, and time and resource constraints.", "follow_up_response_bt": "a matter for the person involved, to decide in light of their own values, preferences, and time and time constraints"}, {"question_id": "39.8", "question": "What criteria does the person involved use to decide whether, in what form, and with what weight, information should be included as a criterion of decision quality in person-centred health care?", "answer_src": "their own values, preferences, and time and resource constraints", "follow_up_question": "How do their values and preferences influence the weight given to information in person-centred health care?", "follow_up_response": "Whether, in what form, and with what weight, information is included as a criterion of decision quality is a matter for the person involved, to decide in the light of their own values, preferences, and time and resource constraints.", "follow_up_response_bt": "Their values and preferences"}, {"question_id": "39.9", "question": "Under what circumstances might the patient's personal values and preferences conflict with the inclusion of certain types of information in decision-making?", "answer_src": "most guidelines for clinical practice , and especially those for the construction of decision support tools , assume that the individual person ( the patient ) needs to be in possession of information of particular sorts and amount in order to qualify as having made an informed decision. this often implicitly segues into the patient having made a good decision. in person - centred health care , whether , in what form , and with what weight , information is included as a criterion of decision quality is a matter for the person involved , to decide in the light of their own values , preferences , and time and resource constraints .", "follow_up_question": "How does person-centred healthcare approach the inclusion of information in decision-making?", "follow_up_response": "Whether, in what form, and with what weight, information is included as a criterion of decision quality is a matter for the person involved", "follow_up_response_bt": "How person-centred healthcare approaches the inclusion of information in decision-making"}, {"question_id": "39.10", "question": "What are some examples of time and resource constraints that might affect a person's decision to include information as a criterion of decision quality?", "answer_src": "most guidelines for clinical practice , and especially those for the construction of decision support tools , assume that the individual person ( the patient ) needs to be in possession of information of particular sorts and amount in order to qualify as having made an informed decision. this often implicitly segues into the patient having made a good decision. in person - centred health care , whether , in what form , and with what weight , information is included as a criterion of decision quality is a matter for the person involved , to decide in the light of their own values , preferences , and time and resource constraints .", "follow_up_question": "What factors does the text suggest someone should consider when deciding whether to include information as a criterion of decision quality?", "follow_up_response": "their own values, preferences, and time and resource constraints", "follow_up_response_bt": "Their own values, preferences, and time and time constraints"}], "turn_3": [{"question_id": "39.11", "question": "With what weight is information included as a criterion of decision quality according to the text?", "answer_src": "a matter for the person involved", "follow_up_question": "whether information is included as a criterion of decision quality varies based on whom?", "follow_up_response": "the person involved", "follow_up_response_bt": "the person involved"}, {"question_id": "39.12", "question": "To what extent do personal values and preferences influence the inclusion of information as a criterion of decision quality?", "answer_src": "a matter for the person involved, to decide in the light of their own values, preferences, and time and resource constraints.", "follow_up_question": "What factors does the person involved consider when deciding what information to include as a criterion of decision quality?", "follow_up_response": "Their own values, preferences, and time and resource constraints", "follow_up_response_bt": "Their own values, preferences, and time and time constraints"}, {"question_id": "39.13", "question": "How do their values and preferences influence the weight given to information in person-centred health care?", "answer_src": "Whether, in what form, and with what weight, information is included as a criterion of decision quality is a matter for the person involved, to decide in the light of their own values, preferences, and time and resource constraints.", "follow_up_question": "What factors does the person involved consider when deciding the weight of information?", "follow_up_response": "Their own values, preferences, and time and resource constraints", "follow_up_response_bt": "Their own values, preferences, and time and time constraints"}, {"question_id": "39.14", "question": "How does person-centred healthcare approach the inclusion of information in decision-making?", "answer_src": "Whether, in what form, and with what weight, information is included as a criterion of decision quality is a matter for the person involved", "follow_up_question": "What factors do individuals consider when deciding how much weight to give information in person-centred healthcare?", "follow_up_response": "their own values, preferences, and time and resource constraints", "follow_up_response_bt": "Their own values, preferences, and time and time constraints"}, {"question_id": "39.15", "question": "What factors does the text suggest someone should consider when deciding whether to include information as a criterion of decision quality?", "answer_src": "their own values, preferences, and time and resource constraints", "follow_up_question": "What role do personal values play according to the text in determining whether information is a criterion of decision quality?", "follow_up_response": "to decide in the light of their own values, preferences, and time and resource constraints.", "follow_up_response_bt": "to decide in light of their own values, preferences, and time and time constraints"}]}}
{"id": 40, "src": "buccal cells are an important source of dna in epidemiological studies , but little is known about factors that influence amount and purity of dna . we assessed these factors in a self - administered buccal cell collection procedure , obtained with three cotton swabs . in 2,451 patients dna yield and in 1,033 patients dna purity was assessed .", "mt": "Le cellule bucali sono una fonte importante di DNA negli studi epidemiologici , ma poco è noto sui fattori che influenzano la quantità e la purezza del DNA . Questi fattori sono stati valutati in una procedura di raccolta di cellule bucali auto-somministrata , ottenuta con tre tamponi di cotone .", "pert_mt": "Le cellule bucali sono una fonte importante di DNA negli studi epidemiologici, ma poco è noto sui fattori che influenzano la quantità e la purezza del DNA. Questi fattori sono stati valutati in una procedura di raccolta di cellule bucali auto-somministrata, ottenuta con tre tamponi di cotone e l'uso di diversi solventi.", "bt": "Buccal cells are an important source of DNA in epidemiological studies, but little is known about the factors that influence the quantity and purity of DNA, which were evaluated in a self-administered buccal cell collection procedure, obtained with three cotton swabs and the use of several solvents.", "questions_src": ["What is an important source of DNA in epidemiological studies?", "When were the factors that influence amount and purity of DNA assessed?", "Which self-administered buccal cell collection procedure was used?", "How many cotton swabs were obtained for the study?", "In how many patients was DNA yield assessed?", "In how many patients was DNA purity assessed?"], "answers_src": ["Buccal cells", "In the study", "A self-administered buccal cell collection procedure", "Three", "2,451", "1,033"], "answers_bt": ["Buccal cells", "In a self-administered buccal cell collection procedure", "A self-administered buccal cell collection procedure", "Three", "Not specified", "Not specified"], "multiturn": {"turn_1": [{"question_id": "40.1", "question": "What is an important source of DNA in epidemiological studies?", "answer_src": "Buccal cells", "follow_up_question": "What percentage of patients had their DNA purity assessed?", "follow_up_response": "34.6%", "follow_up_response_bt": "No Answer"}, {"question_id": "40.2", "question": "When were the factors that influence amount and purity of DNA assessed?", "answer_src": "In the study", "follow_up_question": "What specific factors were assessed for DNA yield and purity?", "follow_up_response": "Amount and purity of", "follow_up_response_bt": "the quantity and purity of DNA"}, {"question_id": "40.3", "question": "Which self-administered buccal cell collection procedure was used?", "answer_src": "A self-administered buccal cell collection procedure", "follow_up_question": "What was the number of cotton swabs used in the collection procedure?", "follow_up_response": "3", "follow_up_response_bt": "3"}, {"question_id": "40.4", "question": "How many cotton swabs were obtained for the study?", "answer_src": "Three", "follow_up_question": "What was the total number of patients whose DNA yield was assessed?", "follow_up_response": "2451", "follow_up_response_bt": "No Answer"}, {"question_id": "40.5", "question": "In how many patients was DNA yield assessed?", "answer_src": "2,451", "follow_up_question": "In how many patients was DNA purity assessed?", "follow_up_response": "1033", "follow_up_response_bt": "No Answer"}, {"question_id": "40.6", "question": "In how many patients was DNA purity assessed?", "answer_src": "1,033", "follow_up_question": "How many more patients had their DNA yield assessed compared to those whose DNA purity was assessed?", "follow_up_response": "1,418", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "40.7", "question": "What percentage of patients had their DNA purity assessed?", "answer_src": "34.6%", "follow_up_question": "What was the average DNA yield among the patients whose DNA purity was assessed?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "40.8", "question": "What specific factors were assessed for DNA yield and purity?", "answer_src": "Amount and purity of", "follow_up_question": "How many patients had their DNA yield assessed?", "follow_up_response": "2451", "follow_up_response_bt": "No Answer"}, {"question_id": "40.9", "question": "What was the number of cotton swabs used in the collection procedure?", "answer_src": "3", "follow_up_question": "How many patients had their DNA purity assessed?", "follow_up_response": "1033", "follow_up_response_bt": "No Answer"}, {"question_id": "40.10", "question": "What was the total number of patients whose DNA yield was assessed?", "answer_src": "2451", "follow_up_question": "What was the DNA purity assessment done for the smallest number of patients?", "follow_up_response": "1,033 patients", "follow_up_response_bt": "No Answer"}, {"question_id": "40.11", "question": "In how many patients was DNA purity assessed?", "answer_src": "1033", "follow_up_question": "In how many patients was DNA yield assessed?", "follow_up_response": "2451", "follow_up_response_bt": "3"}, {"question_id": "40.12", "question": "How many more patients had their DNA yield assessed compared to those whose DNA purity was assessed?", "answer_src": "1,418", "follow_up_question": "How many patients did not have their DNA purity assessed?", "follow_up_response": "1418", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "40.13", "question": "What was the average DNA yield among the patients whose DNA purity was assessed?", "answer_src": "buccal cells are an important source of dna in epidemiological studies , but little is known about factors that influence amount and purity of dna . we assessed these factors in a self - administered buccal cell collection procedure , obtained with three cotton swabs . in 2,451 patients dna yield and in 1,033 patients dna purity was assessed .", "follow_up_question": "What was the DNA purity assessment done on the number of patients?", "follow_up_response": "1033", "follow_up_response_bt": "No Answer"}, {"question_id": "40.14", "question": "How many patients had their DNA yield assessed?", "answer_src": "2451", "follow_up_question": "How many more patients had their DNA yield assessed than their DNA purity?", "follow_up_response": "1,418", "follow_up_response_bt": "No Answer"}, {"question_id": "40.15", "question": "How many patients had their DNA purity assessed?", "answer_src": "1033", "follow_up_question": "How many patients had their DNA yield assessed?", "follow_up_response": "2451", "follow_up_response_bt": "No Answer"}, {"question_id": "40.16", "question": "What was the DNA purity assessment done for the smallest number of patients?", "answer_src": "1,033 patients", "follow_up_question": "For how many patients was DNA yield assessed?", "follow_up_response": "2451", "follow_up_response_bt": "No Answer"}, {"question_id": "40.17", "question": "In how many patients was DNA yield assessed?", "answer_src": "2451", "follow_up_question": "In how many patients was DNA purity assessed?", "follow_up_response": "1033", "follow_up_response_bt": "No Answer"}, {"question_id": "40.18", "question": "How many patients did not have their DNA purity assessed?", "answer_src": "1418", "follow_up_question": "How many patients had all their DNA yield and purity assessed?", "follow_up_response": "1033", "follow_up_response_bt": "No Answer"}]}}
{"id": 41, "src": "other measures were unaltered.conclusiondaily ingestion of 56 g of walnuts improves endothelial function in overweight adults with visceral adiposity . the addition of walnuts to the diet does not lead to weight gain . further study of the potential role of walnut intake in diabetes and cvd prevention is warranted .", "mt": "Altre misure non sono state modificate.in conclusione, l'ingestione giornaliera di 56 g di noci migliora la funzione endotheliale negli adulti in sovrappeso con adiposità viscerale . l'aggiunta di noci alla dieta non porta a un aumento di peso . è necessario ulteriore studio sul potenziale ruolo dell'assunzione di noci nel diabete e nella prevenzione dei cvd .", "pert_mt": "Altre misure non sono state modificate. In conclusione, l'ingestione giornaliera di 56 g di noci migliora la funzione endotheliale negli adulti in sovrappeso con adiposità viscerale. L'aggiunta di noci alla dieta non porta a un aumento di peso. È necessario ulteriore studio sul potenziale ruolo dell'assunzione di noci nel diabete e nella prevenzione dei cvd. Inoltre, le noci possono anche migliorare il colesterolo sierico.", "bt": "Other measures have not been modified.In conclusion, daily ingestion of 56 g of nutmeg improves endothelial function in overweight adults with visceral adiposity.Adding nutmeg to the diet does not lead to weight gain.Further study on the potential role of nutmeg intake in diabetes and the prevention of cardiovascular disease is needed.Moreover, nutmeg can also improve serum cholesterol.", "questions_src": ["What is the conclusion regarding daily walnut ingestion?", "Who are the target participants in the study?", "Where was the study conducted?", "When might further study be warranted?", "Which condition might walnut intake potentially prevent?"], "answers_src": ["[\"Daily ingestion of 56 g of walnuts improves endothelial function in overweight adults with visceral adiposity\"], [\"Overweight adults with visceral adiposity\"], [\"Further study of the potential role of walnut intake in diabetes and cvd prevention is warranted\"], [\"Diabetes and cvd\"], []", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["Daily ingestion of 56 g of nutmeg improves endothelial function in overweight adults with visceral adiposity.", "Overweight adults with visceral adiposity", "Not specified", "Further study on the potential role of nutmeg intake in diabetes and the prevention of cardiovascular disease is needed.", "Cardiovascular disease"], "multiturn": {"turn_1": [{"question_id": "41.1", "question": "What is the conclusion regarding daily walnut ingestion?", "answer_src": "[\"Daily ingestion of 56 g of walnuts improves endothelial function in overweight adults with visceral adiposity\"], [\"Overweight adults with visceral adiposity\"], [\"Further study of the potential role of walnut intake in diabetes and cvd prevention is warranted\"], [\"Diabetes and cvd\"], []", "follow_up_question": "How does the addition of walnuts to the diet affect body weight?", "follow_up_response": "does not lead to weight gain", "follow_up_response_bt": "No Answer"}, {"question_id": "41.2", "question": "Who are the target participants in the study?", "answer_src": "other measures were unaltered.conclusiondaily ingestion of 56 g of walnuts improves endothelial function in overweight adults with visceral adiposity . the addition of walnuts to the diet does not lead to weight gain . further study of the potential role of walnut intake in diabetes and cvd prevention is warranted .", "follow_up_question": "What specific health condition does the study suggest walnuts may help prevent?", "follow_up_response": "diabetes and cvd", "follow_up_response_bt": "No Answer"}, {"question_id": "41.3", "question": "Where was the study conducted?", "answer_src": "other measures were unaltered.conclusiondaily ingestion of 56 g of walnuts improves endothelial function in overweight adults with visceral adiposity . the addition of walnuts to the diet does not lead to weight gain . further study of the potential role of walnut intake in diabetes and cvd prevention is warranted .", "follow_up_question": "What specific health condition is the study suggesting walnut intake may help prevent?", "follow_up_response": "diabetes and cvd", "follow_up_response_bt": "cardiovascular disease"}, {"question_id": "41.4", "question": "When might further study be warranted?", "answer_src": "other measures were unaltered.conclusiondaily ingestion of 56 g of walnuts improves endothelial function in overweight adults with visceral adiposity . the addition of walnuts to the diet does not lead to weight gain . further study of the potential role of walnut intake in diabetes and cvd prevention is warranted .", "follow_up_question": "What conditions might warrant further study of walnut intake?", "follow_up_response": "diabetes and cvd", "follow_up_response_bt": "Diabetes and the prevention of cardiovascular disease"}, {"question_id": "41.5", "question": "Which condition might walnut intake potentially prevent?", "answer_src": "other measures were unaltered.conclusiondaily ingestion of 56 g of walnuts improves endothelial function in overweight adults with visceral adiposity . the addition of walnuts to the diet does not lead to weight gain . further study of the potential role of walnut intake in diabetes and cvd prevention is warranted .", "follow_up_question": "What other health conditions might walnut intake potentially prevent according to the study?", "follow_up_response": "diabetes and cvd", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "41.6", "question": "How does the addition of walnuts to the diet affect body weight?", "answer_src": "does not lead to weight gain", "follow_up_question": "What specific cardiovascular disease is suggested for further study?", "follow_up_response": "cvd", "follow_up_response_bt": "cardiovascular disease"}, {"question_id": "41.7", "question": "What specific health condition does the study suggest walnuts may help prevent?", "answer_src": "diabetes and cvd", "follow_up_question": "What evidence supports the claim that walnuts do not lead to weight gain?", "follow_up_response": "the addition of walnuts to the diet does not lead to weight gain", "follow_up_response_bt": "No Answer"}, {"question_id": "41.8", "question": "What specific health condition is the study suggesting walnut intake may help prevent?", "answer_src": "diabetes and cvd", "follow_up_question": "What evidence supports the claim that walnut intake does not lead to weight gain?", "follow_up_response": "the addition of walnuts to the diet does not lead to weight gain", "follow_up_response_bt": "Adding nutmeg to the diet does not lead to weight gain."}, {"question_id": "41.9", "question": "What conditions might warrant further study of walnut intake?", "answer_src": "diabetes and cvd", "follow_up_question": "What specific outcomes do the studies on walnut intake in diabetes and CVD prevention aim to investigate?", "follow_up_response": "further study of the potential role of walnut intake in diabetes and cvd prevention", "follow_up_response_bt": "No Answer"}, {"question_id": "41.10", "question": "What other health conditions might walnut intake potentially prevent according to the study?", "answer_src": "diabetes and cvd", "follow_up_question": "What evidence supports the claim that walnut intake does not lead to weight gain?", "follow_up_response": "the addition of walnuts to the diet does not lead to weight gain", "follow_up_response_bt": "Adding nutmeg to the diet does not lead to weight gain."}], "turn_3": [{"question_id": "41.11", "question": "What specific cardiovascular disease is suggested for further study?", "answer_src": "cvd", "follow_up_question": "What other health condition besides cardiovascular disease is suggested for further study?", "follow_up_response": "diabetes", "follow_up_response_bt": "diabetes"}, {"question_id": "41.12", "question": "What evidence supports the claim that walnuts do not lead to weight gain?", "answer_src": "the addition of walnuts to the diet does not lead to weight gain", "follow_up_question": "How does the text suggest walnuts may contribute to diabetes and CVD prevention?", "follow_up_response": "further study of the potential role of walnut intake in diabetes and cvd prevention is warranted.", "follow_up_response_bt": "Further study on the potential role of nutmeg intake in diabetes and the prevention of cardiovascular disease is needed."}, {"question_id": "41.13", "question": "What evidence supports the claim that walnut intake does not lead to weight gain?", "answer_src": "the addition of walnuts to the diet does not lead to weight gain", "follow_up_question": "How does the text suggest walnuts may contribute to diabetes prevention?", "follow_up_response": "Further study of the potential role of walnut intake in diabetes and CVD prevention is warranted.", "follow_up_response_bt": "No Answer"}, {"question_id": "41.14", "question": "What specific outcomes do the studies on walnut intake in diabetes and CVD prevention aim to investigate?", "answer_src": "further study of the potential role of walnut intake in diabetes and cvd prevention", "follow_up_question": "What aspects of diabetes and CVD prevention are specifically being investigated in these further studies?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "41.15", "question": "What evidence supports the claim that walnut intake does not lead to weight gain?", "answer_src": "the addition of walnuts to the diet does not lead to weight gain", "follow_up_question": "How does the text suggest walnuts may contribute to diabetes prevention?", "follow_up_response": "Further study of the potential role of walnut intake in diabetes and CVD prevention is warranted.", "follow_up_response_bt": "No Answer"}]}}
{"id": 42, "src": "health outcome and confounding data are at the individual level . ambient pm concentrations are inadequate surrogates for personal exposure because they are at the group level and comprise only a small proportion of personal exposure , they change over time , and they constitute only a small proportion of a life span . the strength of association and exposure - response relationships can not be determined because the ecologic group - level risks of pm2.5 are overestimated 150- to 300-fold based on an analogy with individual - level exposure to inhaled cigarette smoke .", "mt": "I risultati e i dati confondenti sono a livello individuale . Le concentrazioni di pm ambientali sono sostituti inadeguati per l'esposizione personale perché sono a livello di gruppo e comprendono solo una piccola percentuale di esposizione personale , cambiano nel tempo e costituiscono solo una piccola percentuale di durata della vita . La forza di associazione e l'esposizione - relazioni di risposta non possono essere determinate perché il gruppo ecologico - livelli di rischio di pm2.5 sono sopravvalutati da 150 a 300 volte sulla base di un'analogia con l'esposizione individuale - livello di salute al fumo di sigaretta inalato .", "pert_mt": "I risultati e i dati confondenti sono a livello individuale. Le concentrazioni di pm ambientali sono sostituti inadeguati per l'esposizione personale perché sono a livello di gruppo e comprendono solo una piccola percentuale di esposizione personale, cambiano nel tempo e costituiscono solo una piccola percentuale di durata della vita. La forza di associazione e l'esposizione-relazioni di risposta non possono essere determinate perché il gruppo ecologico-nivellamento dei livelli di rischio di pm2.5 è sovrastimato da 150 a 300 volte sulla base di un'analogia con l'esposizione individuale-nivellamento di salute al fumo di sigaretta inalato.", "bt": "The results and the conflicting data are at the individual level.Environmental PM concentrations are inadequate substitutes for personal exposure because they are at the group level and comprise only a small percentage of personal exposure, change over time and constitute only a small percentage of lifetime exposure.Association strength and exposure-response relationships cannot be determined because the ecological-leveling group of risk levels for pm2.5 is overestimated 150 to 300 times based on an analogy with the individual-leveling health exposure to inhaled cigarette smoke.", "questions_src": ["What is the primary reason ambient PM concentrations are inadequate surrogates for personal exposure?", "Who are the individuals whose risks of PM2.5 are overestimated by an analogy with individual-level exposure to inhaled cigarette smoke?", "Where do the ambient PM concentrations typically come from?", "When might the ambient PM concentrations change?", "Which type of exposure is being compared to the group-level risks of PM2.5?"], "answers_src": ["[\"They are at the group level and comprise only a small proportion of personal exposure\"], [\"Individuals\"], [\"Ambient PM concentrations typically come from the environment\"], [\"Over time\"], [\"Group-level risks of PM2.5\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["Environmental PM concentrations are at the group level and comprise only a small percentage of personal exposure, change over time and constitute only a small percentage of lifetime exposure", "Individuals", "Atmosphere", "Over time", "Individual-level exposure to inhaled cigarette smoke"], "multiturn": {"turn_1": [{"question_id": "42.1", "question": "What is the primary reason ambient PM concentrations are inadequate surrogates for personal exposure?", "answer_src": "[\"They are at the group level and comprise only a small proportion of personal exposure\"], [\"Individuals\"], [\"Ambient PM concentrations typically come from the environment\"], [\"Over time\"], [\"Group-level risks of PM2.5\"]", "follow_up_question": "How does the group-level risk of PM2.5 overestimate the individual-level exposure to PM2.5?", "follow_up_response": "150- to 300-fold", "follow_up_response_bt": "150 to 300 times"}, {"question_id": "42.2", "question": "Who are the individuals whose risks of PM2.5 are overestimated by an analogy with individual-level exposure to inhaled cigarette smoke?", "answer_src": "health outcome and confounding data are at the individual level . ambient pm concentrations are inadequate surrogates for personal exposure because they are at the group level and comprise only a small proportion of personal exposure , they change over time , and they constitute only a small proportion of a life span . the strength of association and exposure - response relationships can not be determined because the ecologic group - level risks of pm2.5 are overestimated 150- to 300-fold based on an analogy with individual - level exposure to inhaled cigarette smoke .", "follow_up_question": "What is the magnitude of the overestimation of ecologic group-level risks of PM2.5 based on individual-level exposure?", "follow_up_response": "150- to 300-fold", "follow_up_response_bt": "150 to 300 times"}, {"question_id": "42.3", "question": "Where do the ambient PM concentrations typically come from?", "answer_src": "health outcome and confounding data are at the individual level . ambient pm concentrations are inadequate surrogates for personal exposure because they are at the group level and comprise only a small proportion of personal exposure , they change over time , and they constitute only a small proportion of a life span . the strength of association and exposure - response relationships can not be determined because the ecologic group - level risks of pm2.5 are overestimated 150- to 300-fold based on an analogy with individual - level exposure to inhaled cigarette smoke .", "follow_up_question": "What is the main reason the ecologic group-level risks of PM2.5 are overestimated?", "follow_up_response": "An analogy with individual-level exposure to inhaled cigarette smoke", "follow_up_response_bt": "An analogy with the individual-leveling health exposure to inhaled cigarette smoke"}, {"question_id": "42.4", "question": "When might the ambient PM concentrations change?", "answer_src": "health outcome and confounding data are at the individual level . ambient pm concentrations are inadequate surrogates for personal exposure because they are at the group level and comprise only a small proportion of personal exposure , they change over time , and they constitute only a small proportion of a life span . the strength of association and exposure - response relationships can not be determined because the ecologic group - level risks of pm2.5 are overestimated 150- to 300-fold based on an analogy with individual - level exposure to inhaled cigarette smoke .", "follow_up_question": "What factor contributes to the overestimation of ecologic group-level risks of PM2.5?", "follow_up_response": "an analogy with individual-level exposure to inhaled cigarette smoke", "follow_up_response_bt": "An analogy with the individual-leveling health exposure to inhaled cigarette smoke"}, {"question_id": "42.5", "question": "Which type of exposure is being compared to the group-level risks of PM2.5?", "answer_src": "health outcome and confounding data are at the individual level . ambient pm concentrations are inadequate surrogates for personal exposure because they are at the group level and comprise only a small proportion of personal exposure , they change over time , and they constitute only a small proportion of a life span . the strength of association and exposure - response relationships can not be determined because the ecologic group - level risks of pm2.5 are overestimated 150- to 300-fold based on an analogy with individual - level exposure to inhaled cigarette smoke .", "follow_up_question": "What factor causes the overestimation of the ecologic group-level risks of PM2.5?", "follow_up_response": "An analogy with individual-level exposure to inhaled cigarette smoke", "follow_up_response_bt": "An analogy with the individual-leveling health exposure to inhaled cigarette smoke"}], "turn_2": [{"question_id": "42.6", "question": "How does the group-level risk of PM2.5 overestimate the individual-level exposure to PM2.5?", "answer_src": "150- to 300-fold", "follow_up_question": "What specific factors contribute to this overestimation?", "follow_up_response": "an analogy with individual - level exposure to inhaled cigarette smoke", "follow_up_response_bt": "an analogy with the individual-leveling health exposure to inhaled cigarette smoke"}, {"question_id": "42.7", "question": "What is the magnitude of the overestimation of ecologic group-level risks of PM2.5 based on individual-level exposure?", "answer_src": "150- to 300-fold", "follow_up_question": "By what factor do ecologic group-level risks of PM2.5 appear to be overestimated compared to individual-level exposure to inhaled cigarette smoke?", "follow_up_response": "150- to 300-fold", "follow_up_response_bt": "150 to 300 times"}, {"question_id": "42.8", "question": "What is the main reason the ecologic group-level risks of PM2.5 are overestimated?", "answer_src": "An analogy with individual-level exposure to inhaled cigarette smoke", "follow_up_question": "How does the analogy between individual-level exposure to inhaled cigarette smoke support the overestimation of ecologic group-level risks?", "follow_up_response": "The ecologic group-level risks of pm2.5 are overestimated 150- to 300-fold based on an analogy with individual-level exposure to inhaled cigarette smoke.", "follow_up_response_bt": "The analogy between individual-level exposure to inhaled cigarette smoke supports the overestimation of ecologic group-level risks 150 to 300 times."}, {"question_id": "42.9", "question": "What factor contributes to the overestimation of ecologic group-level risks of PM2.5?", "answer_src": "an analogy with individual-level exposure to inhaled cigarette smoke", "follow_up_question": "How does the analogy with individual-level exposure to inhaled cigarette smoke lead to the overestimation?", "follow_up_response": "The ecologic group-level risks of PM2.5 are overestimated 150- to 300-fold based on an analogy with individual-level exposure to inhaled cigarette smoke.", "follow_up_response_bt": "Based on an analogy with the individual-leveling health exposure to inhaled cigarette smoke"}, {"question_id": "42.10", "question": "What factor causes the overestimation of the ecologic group-level risks of PM2.5?", "answer_src": "An analogy with individual-level exposure to inhaled cigarette smoke", "follow_up_question": "How does the analogy between individual-level exposure to inhaled cigarette smoke contribute to the overestimation?", "follow_up_response": "The ecologic group-level risks of PM2.5 are overestimated 150- to 300-fold based on an analogy with individual-level exposure to inhaled cigarette smoke.", "follow_up_response_bt": "An analogy with the individual-leveling health exposure to inhaled cigarette smoke"}], "turn_3": [{"question_id": "42.11", "question": "What specific factors contribute to this overestimation?", "answer_src": "an analogy with individual - level exposure to inhaled cigarette smoke", "follow_up_question": "How does the analogy between individual-level exposure to inhaled cigarette smoke relate to the overestimation of ecologic group-level risks?", "follow_up_response": "The ecologic group-level risks of PM2.5 are overestimated 150- to 300-fold based on an analogy with individual-level exposure to inhaled cigarette smoke.", "follow_up_response_bt": "The analogy between individual-level exposure to inhaled cigarette smoke overestimates ecologic group-level risks by 150 to 300 times."}, {"question_id": "42.12", "question": "By what factor do ecologic group-level risks of PM2.5 appear to be overestimated compared to individual-level exposure to inhaled cigarette smoke?", "answer_src": "150- to 300-fold", "follow_up_question": "By what percentage does the strength of association between PM2.5 exposure and health outcomes appear to be underestimated based on the group-level data?", "follow_up_response": "150- to 300-fold", "follow_up_response_bt": "150 to 300 times"}, {"question_id": "42.13", "question": "How does the analogy between individual-level exposure to inhaled cigarette smoke support the overestimation of ecologic group-level risks?", "answer_src": "The ecologic group-level risks of pm2.5 are overestimated 150- to 300-fold based on an analogy with individual-level exposure to inhaled cigarette smoke.", "follow_up_question": "What specific factors contribute to the overestimation of 150- to 300-fold?", "follow_up_response": "An analogy with individual-level exposure to inhaled cigarette smoke", "follow_up_response_bt": "An analogy with the individual-leveling health exposure to inhaled cigarette smoke"}, {"question_id": "42.14", "question": "How does the analogy with individual-level exposure to inhaled cigarette smoke lead to the overestimation?", "answer_src": "The ecologic group-level risks of PM2.5 are overestimated 150- to 300-fold based on an analogy with individual-level exposure to inhaled cigarette smoke.", "follow_up_question": "What specific factors contribute to this 150- to 300-fold overestimation?", "follow_up_response": "an analogy with individual-level exposure to inhaled cigarette smoke", "follow_up_response_bt": "An analogy with the individual-leveling health exposure to inhaled cigarette smoke"}, {"question_id": "42.15", "question": "How does the analogy between individual-level exposure to inhaled cigarette smoke contribute to the overestimation?", "answer_src": "The ecologic group-level risks of PM2.5 are overestimated 150- to 300-fold based on an analogy with individual-level exposure to inhaled cigarette smoke.", "follow_up_question": "What specific factors lead to this 150- to 300-fold overestimation?", "follow_up_response": "an analogy with individual-level exposure to inhaled cigarette smoke", "follow_up_response_bt": "An analogy with the individual-leveling health exposure to inhaled cigarette smoke"}]}}
{"id": 43, "src": "objectivethe aim of this study was to evaluate the antimicrobial and fluoride releasing capacity of 3 bonding materials.material and methodsthirty nine specimens with standardized surface smoothness and dimensions were prepared . the antimicrobial capacity of the materials against s. mutans , l. casei and c. albicans was evaluated by determining the percentage of growth inhibition of these microorganisms in an inoculated medium , obtained by optical density readouts on a spectrophotometer . the potential to interfere in microbial growth on the surface of the studied materials was observed by means of scanning electron microscopy ( sem ) .", "mt": "L'obiettivo di questo studio era valutare la capacità di rilascio di antimicrobici e fluoruro di 3 materiali di legame.materiale e metodo furono preparati trenta nove campioni con un livello di liscia e dimensioni di superficie standardizzati . La capacità antimicrobica dei materiali contro s. mutans , l. casei e c. albicans fu valutata determinando la percentuale di inibizione della crescita di questi microrganismi in un mezzo inoculato , ottenuta con le letture di densità ottica su uno spettrotometro . Il potenziale di interferire nella crescita microbica sulla superficie dei materiali studiati fu osservato mediante la microscopia elettronica (sem .) di scansione .", "pert_mt": "L'obiettivo di questo studio era valutare la capacità di rilascio di antimicrobici e fluoruro di 3 materiali di legame. Materiale e metodo furono preparati trenta nove campioni con un livello di liscia e dimensioni di superficie standardizzati. La capacità antimicrobica dei materiali contro s. mutans, l. casei e c. albicans fu valutata determinando la percentuale di inibizione della crescita di questi microrganismi in un mezzo inoculato, ottenuta con le letture di densità ottica su uno spettrotometro. Il potenziale di interferire nella crescita microbica sulla superficie dei materiali studiati fu osservato mediante la microscopia elettronica (SEM) di scansione.", "bt": "The objective of this study was to evaluate the release capacity of antimicrobials and fluoride of 3 bond materials.The material and method prepared thirty-nine samples with a level of smoothness and standardized surface dimensions.The antimicrobial capacity of the materials against s. mutans, l. casei and c. albicans was evaluated by determining the percentage of inhibition of growth of these microorganisms in an inoculated medium, obtained by reading optical density on a spectrotometer.The potential to interfere with microbial growth on the surface of the materials studied was observed by means of scanning electron microscopy (SEM).", "questions_src": ["What is the main aim of the study?", "Who conducted the evaluation of the antimicrobial capacity?", "Where were the specimens prepared?", "When was the study conducted?", "Which microorganisms were tested for their growth inhibition?"], "answers_src": ["To evaluate the antimicrobial and fluoride releasing capacity of 3 bonding materials", "The study", "With standardized surface smoothness and dimensions", "No Answer", "S. mutans, L. casei, and C. albicans"], "answers_bt": ["To evaluate the release capacity of antimicrobials and fluoride of 3 bond materials", "The material and method", "Prepared thirty-nine samples", "The study", "s. mutans, l. casei and c. albicans"], "multiturn": {"turn_1": [{"question_id": "43.1", "question": "What is the main aim of the study?", "answer_src": "To evaluate the antimicrobial and fluoride releasing capacity of 3 bonding materials", "follow_up_question": "How many bonding materials were evaluated in the study?", "follow_up_response": "3", "follow_up_response_bt": "3"}, {"question_id": "43.2", "question": "Who conducted the evaluation of the antimicrobial capacity?", "answer_src": "The study", "follow_up_question": "What specific method was used to evaluate the antimicrobial capacity?", "follow_up_response": "Determining the percentage of growth inhibition of these microorganisms in an inoculated medium, obtained by optical density readouts on a spectrophotometer.", "follow_up_response_bt": "Scanning electron microscopy (SEM)"}, {"question_id": "43.3", "question": "Where were the specimens prepared?", "answer_src": "With standardized surface smoothness and dimensions", "follow_up_question": "What specific microorganisms were tested for their antimicrobial capacity?", "follow_up_response": "s. mutans, l. casei and c. albicans", "follow_up_response_bt": "s. mutans, l. casei and c. albicans"}, {"question_id": "43.4", "question": "When was the study conducted?", "answer_src": "objectivethe aim of this study was to evaluate the antimicrobial and fluoride releasing capacity of 3 bonding materials.material and methodsthirty nine specimens with standardized surface smoothness and dimensions were prepared . the antimicrobial capacity of the materials against s. mutans , l. casei and c. albicans was evaluated by determining the percentage of growth inhibition of these microorganisms in an inoculated medium , obtained by optical density readouts on a spectrophotometer . the potential to interfere in microbial growth on the surface of the studied materials was observed by means of scanning electron microscopy ( sem ) .", "follow_up_question": "What specific microorganisms were tested for their antimicrobial capacity?", "follow_up_response": "s. mutans, l. casei and c. albicans", "follow_up_response_bt": "s. mutans, l. casei and c. albicans"}, {"question_id": "43.5", "question": "Which microorganisms were tested for their growth inhibition?", "answer_src": "S. mutans, L. casei, and C. albicans", "follow_up_question": "Which scanning electron microscopy technique was used to observe the potential to interfere with microbial growth?", "follow_up_response": "sem", "follow_up_response_bt": "SEM"}], "turn_2": [{"question_id": "43.6", "question": "How many bonding materials were evaluated in the study?", "answer_src": "3", "follow_up_question": "What specific microorganisms were tested for their antimicrobial capacity?", "follow_up_response": "s. mutans, l. casei and c. albicans", "follow_up_response_bt": "s. mutans, l. casei and c. albicans"}, {"question_id": "43.7", "question": "What specific method was used to evaluate the antimicrobial capacity?", "answer_src": "Determining the percentage of growth inhibition of these microorganisms in an inoculated medium, obtained by optical density readouts on a spectrophotometer.", "follow_up_question": "How many different types of microorganisms were tested for their antimicrobial capacity?", "follow_up_response": "3", "follow_up_response_bt": "s. mutans, l. casei and c. albicans"}, {"question_id": "43.8", "question": "What specific microorganisms were tested for their antimicrobial capacity?", "answer_src": "s. mutans, l. casei and c. albicans", "follow_up_question": "What conditions were used to determine the percentage of growth inhibition?", "follow_up_response": "Standardized surface smoothness and dimensions", "follow_up_response_bt": "an inoculated medium, obtained by reading optical density on a spectrotometer"}, {"question_id": "43.9", "question": "What specific microorganisms were tested for their antimicrobial capacity?", "answer_src": "s. mutans, l. casei and c. albicans", "follow_up_question": "What conditions were used to determine the percentage of growth inhibition?", "follow_up_response": "Standardized surface smoothness and dimensions", "follow_up_response_bt": "an inoculated medium, obtained by reading optical density on a spectrotometer"}, {"question_id": "43.10", "question": "Which scanning electron microscopy technique was used to observe the potential to interfere with microbial growth?", "answer_src": "sem", "follow_up_question": "What specific microorganisms were tested for their antimicrobial capacity?", "follow_up_response": "s. mutans, l. casei and c. albicans", "follow_up_response_bt": "s. mutans, l. casei and c. albicans"}], "turn_3": [{"question_id": "43.11", "question": "What specific microorganisms were tested for their antimicrobial capacity?", "answer_src": "s. mutans, l. casei and c. albicans", "follow_up_question": "What conditions were used to determine the percentage of growth inhibition?", "follow_up_response": "Standardized surface smoothness and dimensions", "follow_up_response_bt": "an inoculated medium, obtained by reading optical density on a spectrotometer"}, {"question_id": "43.12", "question": "How many different types of microorganisms were tested for their antimicrobial capacity?", "answer_src": "3", "follow_up_question": "How many different bonding materials were evaluated in the study?", "follow_up_response": "3", "follow_up_response_bt": "3"}, {"question_id": "43.13", "question": "What conditions were used to determine the percentage of growth inhibition?", "answer_src": "Standardized surface smoothness and dimensions", "follow_up_question": "How many microorganisms were tested for their antimicrobial capacity?", "follow_up_response": "3", "follow_up_response_bt": "3"}, {"question_id": "43.14", "question": "What conditions were used to determine the percentage of growth inhibition?", "answer_src": "Standardized surface smoothness and dimensions", "follow_up_question": "How many microorganisms were tested for their antimicrobial capacity?", "follow_up_response": "3", "follow_up_response_bt": "3"}, {"question_id": "43.15", "question": "What specific microorganisms were tested for their antimicrobial capacity?", "answer_src": "s. mutans, l. casei and c. albicans", "follow_up_question": "What conditions were used to determine the percentage of growth inhibition?", "follow_up_response": "Standardized surface smoothness and dimensions", "follow_up_response_bt": "an inoculated medium, obtained by reading optical density on a spectrotometer"}]}}
{"id": 44, "src": "backgroundnuclear factor e2-related factor 2 ( nrf2 ) plays an anti - oxidative and phase ii detoxification function via its up - regulation on various antioxidant response elements ( are ) genes . nrf2 can protect both normal and cancer cells from damages of cell stress , thereby exerting a critical role in the development of cancer . the expression and significance of nrf2 in gastric cancer , however , has not been reported .", "mt": "Il fattore nucleare di fondo e2-relato 2 (nrf2 ) svolge una funzione antiossidativa e di disintossicazione di fase ii attraverso la sua regolazione su vari elementi di risposta antiossidante (sono) geni . nrf2 può proteggere sia le cellule normali che le cellule tumorali dai danni causati dallo stress cellulare , esercitando così un ruolo critico nello sviluppo del cancro .", "pert_mt": "Il fattore nucleare di fondo e2-relato 2 (nrf2) svolge una funzione antiossidativa e di disintossicazione di fase ii attraverso la sua regolazione su vari elementi di risposta antiossidante (sono) geni. nrf2 può proteggere sia le cellule normali che le cellule tumorali dai danni causati dallo stress cellulare, esercitando così un ruolo critico nello sviluppo del cancro e nella regolazione della crescita cellulare.", "bt": "The nuclear background factor e2-relato 2 (nrf2) performs an antioxidant and detoxification function of phase ii through its regulation on various elements of the antioxidant response (sone) gene. nrf2 can protect both normal cells and tumor cells from damage caused by cellular stress, thus playing a critical role in cancer development and in regulating cell growth.", "questions_src": ["What does Nrf2 play an anti-oxidative and phase II detoxification function through? ", "When can Nrf2 protect both normal and cancer cells from damage? ", "Which type of cancer has the expression and significance of Nrf2 not been reported for? "], "answers_src": ["via its up-regulation on various antioxidant response elements (ARE) genes", "from cell stress", "gastric cancer"], "answers_bt": ["its regulation on various elements of the antioxidant response (sone) gene", "Nrf2 can protect both normal and cancer cells from damage caused by cellular stress", "No Answer"], "multiturn": {"turn_1": [{"question_id": "44.1", "question": "What does Nrf2 play an anti-oxidative and phase II detoxification function through? ", "answer_src": "via its up-regulation on various antioxidant response elements (ARE) genes", "follow_up_question": "How many types of genes are regulated by Nrf2 according to the text?", "follow_up_response": "1", "follow_up_response_bt": "1"}, {"question_id": "44.2", "question": "When can Nrf2 protect both normal and cancer cells from damage? ", "answer_src": "from cell stress", "follow_up_question": "Under what conditions does Nrf2 protect cancer cells specifically?", "follow_up_response": "cell stress", "follow_up_response_bt": "cellular stress"}, {"question_id": "44.3", "question": "Which type of cancer has the expression and significance of Nrf2 not been reported for? ", "answer_src": "gastric cancer", "follow_up_question": "What specific mechanisms does Nrf2 use to protect cancer cells from damage?", "follow_up_response": "via its up-regulation on various antioxidant response elements (are) genes", "follow_up_response_bt": "Its regulation on various elements of the antioxidant response (Sone) gene"}], "turn_2": [{"question_id": "44.4", "question": "How many types of genes are regulated by Nrf2 according to the text?", "answer_src": "1", "follow_up_question": "How many types of functions does Nrf2 perform according to the text?", "follow_up_response": "2", "follow_up_response_bt": "2"}, {"question_id": "44.5", "question": "Under what conditions does Nrf2 protect cancer cells specifically?", "answer_src": "cell stress", "follow_up_question": "What types of cell stress does Nrf2 protect cancer cells from?", "follow_up_response": "cell stress", "follow_up_response_bt": "cellular stress"}, {"question_id": "44.6", "question": "What specific mechanisms does Nrf2 use to protect cancer cells from damage?", "answer_src": "via its up-regulation on various antioxidant response elements (are) genes", "follow_up_question": "How does Nrf2's up-regulation of ARE genes specifically contribute to its protective effects on cancer cells?", "follow_up_response": "Its anti-oxidative and phase II detoxification functions", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "44.7", "question": "How many types of functions does Nrf2 perform according to the text?", "answer_src": "2", "follow_up_question": "What are the two types of functions performed by Nrf2 mentioned in the text?", "follow_up_response": "Anti-oxidative and phase ii detoxification", "follow_up_response_bt": "Antioxidant and detoxification"}, {"question_id": "44.8", "question": "What types of cell stress does Nrf2 protect cancer cells from?", "answer_src": "cell stress", "follow_up_question": "What specific mechanisms does Nrf2 use to protect cancer cells from cell stress?", "follow_up_response": "via its up-regulation on various antioxidant response elements (are) genes", "follow_up_response_bt": "Its regulation on various elements of the antioxidant response (Sone) gene"}, {"question_id": "44.9", "question": "How does Nrf2's up-regulation of ARE genes specifically contribute to its protective effects on cancer cells?", "answer_src": "Its anti-oxidative and phase II detoxification functions", "follow_up_question": "What specific mechanisms do ARE genes use to provide protection against cell stress?", "follow_up_response": "up - regulation", "follow_up_response_bt": "No Answer"}]}}
{"id": 45, "src": "the cure rate in our series was 96.15% . the mean parathyroid gland weight was 2.05 3.03 g. none of the 41 patients in whom long - term follow - up was available , had recurrence of phpt.the profile of phpt is changing with older age at presentation , and emergence of renal stone disease and decline in overt skeletal disease as common presentation . the parathyroid weight in our study resembles that reported from developed countries .", "mt": "Il tasso di guarigione nella nostra serie era del 96,15% . il peso medio della ghiandola paratiroide era di 2,05 3,03 g. Nessuno dei 41 pazienti in cui era disponibile un follow-up a lungo termine aveva avuto una ricorrenza di phpt.il profilo di phpt sta cambiando con l'età in presentazione , e l'emergere di malattia renale e di calcoli renici e un calo della malattia scheletrica aperta come presentazione comune . il peso paratiroide nel nostro studio assomiglia a quello riportato dai paesi sviluppati .", "pert_mt": "Il tasso di guarigione nella nostra serie era del 96,15%. Il peso medio della ghiandola paratiroide era di 2,05-3,03 g. Nessuno dei 41 pazienti in cui era disponibile un follow-up a lungo termine aveva avuto una ricorrenza di PHPT. Il profilo di PHPT sta cambiando con l'età in presentazione, e l'emergere di malattie renali e di calcoli renici e un calo della malattia scheletrica aperta come presentazione comune. Il peso paratiroide nel nostro studio assomiglia a quello riportato dai paesi sviluppati.", "bt": "The average parathyroid gland weight was 2.05-3,03 g. None of the 41 patients who had long-term follow-up had had a recurrence of PHPT. The profile of PHPT is changing with age in presentation, and the emergence of kidney disease and kidney stones and a symptom of open-skeletal disease as a common presentation.", "questions_src": ["What is the cure rate in your series?", "What is the mean parathyroid gland weight in your study?", "How many patients had recurrence of PHPT in your long-term follow-up?", "At what age does the profile of PHPT typically change according to your findings?", "What is the trend in the presentation of PHPT with increasing age?"], "answers_src": ["96.15%", "2.05 3.03 g", "0", "older age", "emergence of renal stone disease and decline in overt skeletal disease"], "answers_bt": ["No Answer", "2.05-3,03 g", "0", "According to your findings, the profile of PHPT typically changes at an unspecified age", "The trend in the presentation of PHPT with increasing age"], "multiturn": {"turn_1": [{"question_id": "45.1", "question": "What is the cure rate in your series?", "answer_src": "96.15%", "follow_up_question": "How does the mean parathyroid gland weight compare to what is reported from developed countries?", "follow_up_response": "The mean parathyroid gland weight was 2.05 3.03 g, which resembles that reported from developed countries.", "follow_up_response_bt": "2.05-3,03 g"}, {"question_id": "45.2", "question": "What is the mean parathyroid gland weight in your study?", "answer_src": "2.05 3.03 g", "follow_up_question": "How does the mean parathyroid gland weight in your study compare to what is reported from developed countries?", "follow_up_response": "The mean parathyroid gland weight in our study (2.05 ± 3.03 g) resembles that reported from developed countries.", "follow_up_response_bt": "2.05-3.03 g"}, {"question_id": "45.3", "question": "How many patients had recurrence of PHPT in your long-term follow-up?", "answer_src": "0", "follow_up_question": "What percentage of patients in your study had a parathyroid gland weight between 2.05 g and 3.03 g?", "follow_up_response": "38.25", "follow_up_response_bt": "No Answer"}, {"question_id": "45.4", "question": "At what age does the profile of PHPT typically change according to your findings?", "answer_src": "older age", "follow_up_question": "What specific changes have you observed in the profile of PHPT with older age?", "follow_up_response": "Older age at presentation", "follow_up_response_bt": "The emergence of kidney disease and kidney stones and a symptom of open-skeletal disease"}, {"question_id": "45.5", "question": "What is the trend in the presentation of PHPT with increasing age?", "answer_src": "emergence of renal stone disease and decline in overt skeletal disease", "follow_up_question": "How does the parathyroid gland weight in this study compare to that reported from developed countries?", "follow_up_response": "The parathyroid weight in our study resembles that reported from developed countries.", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "45.6", "question": "How does the mean parathyroid gland weight compare to what is reported from developed countries?", "answer_src": "The mean parathyroid gland weight was 2.05 3.03 g, which resembles that reported from developed countries.", "follow_up_question": "What specific changes have been observed in the profile of PHPT according to the text?", "follow_up_response": "Older age at presentation, emergence of renal stone disease and decline in overt skeletal disease as common presentation", "follow_up_response_bt": "With age"}, {"question_id": "45.7", "question": "How does the mean parathyroid gland weight in your study compare to what is reported from developed countries?", "answer_src": "The mean parathyroid gland weight in our study (2.05 ± 3.03 g) resembles that reported from developed countries.", "follow_up_question": "What specific changes have been observed in the profile of PHPT with increasing age?", "follow_up_response": "Older age at presentation", "follow_up_response_bt": "With increasing age, the emergence of kidney disease and kidney stones and a symptom of open-skeletal disease as a common presentation."}, {"question_id": "45.8", "question": "What percentage of patients in your study had a parathyroid gland weight between 2.05 g and 3.03 g?", "answer_src": "38.25", "follow_up_question": "What was the average parathyroid gland weight in your study?", "follow_up_response": "2.05 3.03 g", "follow_up_response_bt": "2.05-3,03 g"}, {"question_id": "45.9", "question": "What specific changes have you observed in the profile of PHPT with older age?", "answer_src": "Older age at presentation", "follow_up_question": "How does the profile of PHPT change with the emergence of renal stone disease?", "follow_up_response": "With the emergence of renal stone disease", "follow_up_response_bt": "A symptom of open-skeletal disease"}, {"question_id": "45.10", "question": "How does the parathyroid gland weight in this study compare to that reported from developed countries?", "answer_src": "The parathyroid weight in our study resembles that reported from developed countries.", "follow_up_question": "What specific changes have been observed in the profile of PHPT according to the text?", "follow_up_response": "Older age at presentation, emergence of renal stone disease and decline in overt skeletal disease as common presentation", "follow_up_response_bt": "With age"}], "turn_3": [{"question_id": "45.11", "question": "What specific changes have been observed in the profile of PHPT according to the text?", "answer_src": "Older age at presentation, emergence of renal stone disease and decline in overt skeletal disease as common presentation", "follow_up_question": "How does the parathyroid gland weight in this study compare to that reported from developed countries?", "follow_up_response": "The parathyroid weight in our study resembles that reported from developed countries.", "follow_up_response_bt": "No Answer"}, {"question_id": "45.12", "question": "What specific changes have been observed in the profile of PHPT with increasing age?", "answer_src": "Older age at presentation", "follow_up_question": "How does the profile of PHPT change with the emergence of renal stone disease?", "follow_up_response": "With the emergence of renal stone disease", "follow_up_response_bt": "A symptom of open-skeletal disease"}, {"question_id": "45.13", "question": "What was the average parathyroid gland weight in your study?", "answer_src": "2.05 3.03 g", "follow_up_question": "How many standard deviations above the mean was the heaviest parathyroid gland in your study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "45.14", "question": "How does the profile of PHPT change with the emergence of renal stone disease?", "answer_src": "With the emergence of renal stone disease", "follow_up_question": "What other common presentation has been declining in your study?", "follow_up_response": "Overt skeletal disease", "follow_up_response_bt": "No Answer"}, {"question_id": "45.15", "question": "What specific changes have been observed in the profile of PHPT according to the text?", "answer_src": "Older age at presentation, emergence of renal stone disease and decline in overt skeletal disease as common presentation", "follow_up_question": "How does the parathyroid gland weight in this study compare to that reported from developed countries?", "follow_up_response": "The parathyroid weight in our study resembles that reported from developed countries.", "follow_up_response_bt": "No Answer"}]}}
{"id": 46, "src": "inhibition of sglt2 promotes glucose excretion and normalizes glycemia in animal models . first reports of specifically designed sglt2 inhibitors began to appear in the second half of the 1990s . several candidate sglt2 inhibitors are currently under development , with four in the later stages of clinical testing .", "mt": "L'inibizione di sglt2 promuove l'escretione di glucosio e normalizza la glicemia nei modelli animali . I primi rapporti di inibitori specificamente progettati di sglt2 iniziarono ad apparire nella seconda metà degli anni '90 .", "pert_mt": "L'inibizione di sglt2 promuove l'escretione di glucosio e normalizza la glicemia nei modelli animali. I primi rapporti di inibitori specificamente progettati di sglt2 iniziarono ad apparire nella seconda metà degli anni '90 e hanno portato a significative miglioramenti nel trattamento dei pazienti di diabete.", "bt": "Inhibition of sglt2 promotes the secretion of glucose and normalizes blood sugar in animal models.The first reports of specifically designed sglt2 inhibitors began to appear in the second half of the 1990s and led to significant improvements in the treatment of patients with diabetes.", "questions_src": ["What is inhibited by SGLT2?", "When did first reports of specifically designed SGLT2 inhibitors start appearing?", "Where are several candidate SGLT2 inhibitors currently being developed?", "Which SGLT2 inhibitors are in the later stages of clinical testing?", "What does SGLT2 inhibition promote in animal models?"], "answers_src": ["SGLT2", "Second half of the 1990s", "Currently", "Four", "Glucose excretion and normalizes glycemia"], "answers_bt": ["[\"SGLT2\"], [\"The second half of the 1990s\"], [\"No Answer\"], [\"No Answer\"], [\"The secretion of glucose and normalizes blood sugar\"]}", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "46.1", "question": "What is inhibited by SGLT2?", "answer_src": "SGLT2", "follow_up_question": "What role does SGLT2 inhibition play according to the text?", "follow_up_response": "promotes glucose excretion and normalizes glycemia", "follow_up_response_bt": "Promotes the secretion of glucose and normalizes blood sugar"}, {"question_id": "46.2", "question": "When did first reports of specifically designed SGLT2 inhibitors start appearing?", "answer_src": "Second half of the 1990s", "follow_up_question": "What were some of the later stages of clinical testing for SGLT2 inhibitors?", "follow_up_response": "Four", "follow_up_response_bt": "The second half of the 1990s"}, {"question_id": "46.3", "question": "Where are several candidate SGLT2 inhibitors currently being developed?", "answer_src": "Currently", "follow_up_question": "What is the current status of these four candidate SGLT2 inhibitors?", "follow_up_response": "They are in the later stages of clinical testing.", "follow_up_response_bt": "No Answer"}, {"question_id": "46.4", "question": "Which SGLT2 inhibitors are in the later stages of clinical testing?", "answer_src": "Four", "follow_up_question": "What are the four SGLT2 inhibitors currently in the later stages of clinical testing?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "46.5", "question": "What does SGLT2 inhibition promote in animal models?", "answer_src": "Glucose excretion and normalizes glycemia", "follow_up_question": "What specific action do SGLT2 inhibitors take to promote glucose excretion and normalize glycemia in animal models?", "follow_up_response": "inhibition", "follow_up_response_bt": "Inhibition"}], "turn_2": [{"question_id": "46.6", "question": "What role does SGLT2 inhibition play according to the text?", "answer_src": "promotes glucose excretion and normalizes glycemia", "follow_up_question": "How does SGLT2 inhibition normalize glycemia?", "follow_up_response": "promotes glucose excretion", "follow_up_response_bt": "promotes the secretion of glucose"}, {"question_id": "46.7", "question": "What were some of the later stages of clinical testing for SGLT2 inhibitors?", "answer_src": "Four", "follow_up_question": "Which SGLT2 inhibitor is not yet in the later stages of clinical testing?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "46.8", "question": "What is the current status of these four candidate SGLT2 inhibitors?", "answer_src": "They are in the later stages of clinical testing.", "follow_up_question": "What specific conditions are these inhibitors being tested for?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "46.9", "question": "What are the four SGLT2 inhibitors currently in the later stages of clinical testing?", "answer_src": "inhibition of sglt2 promotes glucose excretion and normalizes glycemia in animal models . first reports of specifically designed sglt2 inhibitors began to appear in the second half of the 1990s . several candidate sglt2 inhibitors are currently under development , with four in the later stages of clinical testing .", "follow_up_question": "What are the characteristics of these four SGLT2 inhibitors that make them suitable for later-stage clinical testing?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "46.10", "question": "What specific action do SGLT2 inhibitors take to promote glucose excretion and normalize glycemia in animal models?", "answer_src": "inhibition", "follow_up_question": "What mechanism do SGLT2 inhibitors use to promote glucose excretion?", "follow_up_response": "inhibition", "follow_up_response_bt": "Inhibition of SGLT2"}], "turn_3": [{"question_id": "46.11", "question": "How does SGLT2 inhibition normalize glycemia?", "answer_src": "promotes glucose excretion", "follow_up_question": "What mechanism does promoting glucose excretion have on glycemia?", "follow_up_response": "Inhibition of SGLT2", "follow_up_response_bt": "Promotes the secretion of glucose and normalizes blood sugar"}, {"question_id": "46.12", "question": "Which SGLT2 inhibitor is not yet in the later stages of clinical testing?", "answer_src": "inhibition of sglt2 promotes glucose excretion and normalizes glycemia in animal models . first reports of specifically designed sglt2 inhibitors began to appear in the second half of the 1990s . several candidate sglt2 inhibitors are currently under development , with four in the later stages of clinical testing .", "follow_up_question": "What are the current statuses of the other candidate SGLT2 inhibitors besides the four in the later stages of clinical testing?", "follow_up_response": "in the earlier stages of clinical testing", "follow_up_response_bt": "No Answer"}, {"question_id": "46.13", "question": "What specific conditions are these inhibitors being tested for?", "answer_src": "inhibition of sglt2 promotes glucose excretion and normalizes glycemia in animal models . first reports of specifically designed sglt2 inhibitors began to appear in the second half of the 1990s . several candidate sglt2 inhibitors are currently under development , with four in the later stages of clinical testing .", "follow_up_question": "What are the current stages of development for the four sglt2 inhibitors in later clinical testing?", "follow_up_response": "Later stages of clinical testing", "follow_up_response_bt": "No Answer"}, {"question_id": "46.14", "question": "What are the characteristics of these four SGLT2 inhibitors that make them suitable for later-stage clinical testing?", "answer_src": "inhibition of sglt2 promotes glucose excretion and normalizes glycemia in animal models . first reports of specifically designed sglt2 inhibitors began to appear in the second half of the 1990s . several candidate sglt2 inhibitors are currently under development , with four in the later stages of clinical testing .", "follow_up_question": "What specific properties do these four SGLT2 inhibitors have that make them suitable for later-stage clinical testing?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "46.15", "question": "What mechanism do SGLT2 inhibitors use to promote glucose excretion?", "answer_src": "inhibition", "follow_up_question": "What specific action do SGLT2 inhibitors take to inhibit SGLT2?", "follow_up_response": "promotes glucose excretion", "follow_up_response_bt": "Promotes the secretion of glucose"}]}}
{"id": 47, "src": "the spectacular improvement in long - term prognosis of patients with hematological malignancies since the 1980s , coupled with the subsequent improvement over the past decade in short- and mid - term survival in cases of critical illness , resulted in an increasing referral of such patients to the icu . a remaining question , however , is how these patients perform in the long term with regard to survival and quality of life . here we discuss the present multicenter study on survival beyond 1 year in critically ill patients with hematological malignancies .", "mt": "Il miglioramento spettacolare della prognosi a lungo termine dei pazienti con malignità ematologiche dagli anni '80 e il miglioramento successivo negli ultimi dieci anni nella sopravvivenza a breve e medio termine nei casi di malattia critica hanno portato ad un crescente rinvio di tali pazienti alle accoglienza medica .", "pert_mt": "Il miglioramento spettacolare della prognosi a lungo termine dei pazienti con malignità ematologiche dagli anni '80 e il miglioramento successivo negli ultimi dieci anni nella sopravvivenza a breve e medio termine nei casi di malattia critica hanno portato ad un crescente rinvio di tali pazienti alle accoglienza medica e alla terapia intensiva.", "bt": "The dramatic improvement in the long-term prognosis of patients with haematological malignancies since the 1980s and the successive improvement over the past decade in short and medium-term survival in critical disease cases have led to a growing shift of such patients to medical admission and intensive care.", "questions_src": ["What is the main focus of the present multicenter study?", "Who are the patients included in the study?", "Where was this study conducted?", "When was the study conducted?", "Which key outcomes are being evaluated in the study?"], "answers_src": ["Survival beyond 1 year in critically ill patients with hematological malignancies", "Patients with hematological malignancies", "Multicenter", "Present", "Survival and quality of life"], "answers_bt": ["The long-term prognosis of patients with haematological malignancies", "Patients with haematological malignancies", "Multicenter study", "Since the 1980s and over the past decade", "Short and medium-term survival"], "multiturn": {"turn_1": [{"question_id": "47.1", "question": "What is the main focus of the present multicenter study?", "answer_src": "Survival beyond 1 year in critically ill patients with hematological malignancies", "follow_up_question": "What specific outcomes are researchers investigating in this study?", "follow_up_response": "Survival and quality of life", "follow_up_response_bt": "No Answer"}, {"question_id": "47.2", "question": "Who are the patients included in the study?", "answer_src": "Patients with hematological malignancies", "follow_up_question": "What specific types of hematological malignancies are included in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "47.3", "question": "Where was this study conducted?", "answer_src": "Multicenter", "follow_up_question": "What were the primary outcomes of the study?", "follow_up_response": "Survival beyond 1 year", "follow_up_response_bt": "A growing shift of patients to medical admission and intensive care"}, {"question_id": "47.4", "question": "When was the study conducted?", "answer_src": "Present", "follow_up_question": "What is the primary focus of the present multicenter study?", "follow_up_response": "Survival beyond 1 year", "follow_up_response_bt": "No Answer"}, {"question_id": "47.5", "question": "Which key outcomes are being evaluated in the study?", "answer_src": "Survival and quality of life", "follow_up_question": "What specific time frame is being examined for survival in this study?", "follow_up_response": "1 year", "follow_up_response_bt": "The 1980s and the past decade"}], "turn_2": [{"question_id": "47.6", "question": "What specific outcomes are researchers investigating in this study?", "answer_src": "Survival and quality of life", "follow_up_question": "What types of hematological malignancies are included in this multicenter study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "47.7", "question": "What specific types of hematological malignancies are included in the study?", "answer_src": "the spectacular improvement in long - term prognosis of patients with hematological malignancies since the 1980s , coupled with the subsequent improvement over the past decade in short- and mid - term survival in cases of critical illness , resulted in an increasing referral of such patients to the icu . a remaining question , however , is how these patients perform in the long term with regard to survival and quality of life . here we discuss the present multicenter study on survival beyond 1 year in critically ill patients with hematological malignancies .", "follow_up_question": "What is the primary focus of the present multicenter study mentioned in the text?", "follow_up_response": "Survival beyond 1 year in critically ill patients with hematological malignancies", "follow_up_response_bt": "No Answer"}, {"question_id": "47.8", "question": "What were the primary outcomes of the study?", "answer_src": "Survival beyond 1 year", "follow_up_question": "What factors did the study investigate in relation to survival beyond 1 year?", "follow_up_response": "Long-term prognosis of patients with hematological malignancies and short- and mid-term survival in cases of critical illness", "follow_up_response_bt": "The dramatic improvement in the long-term prognosis of patients with haematological malignancies since the 1980s and the successive improvement over the past decade"}, {"question_id": "47.9", "question": "What is the primary focus of the present multicenter study?", "answer_src": "Survival beyond 1 year", "follow_up_question": "What specific hematological malignancies are included in this multicenter study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "47.10", "question": "What specific time frame is being examined for survival in this study?", "answer_src": "1 year", "follow_up_question": "What is the primary focus of the study regarding the patients' outcomes?", "follow_up_response": "Survival beyond 1 year", "follow_up_response_bt": "The long-term and short/medium-term survival"}], "turn_3": [{"question_id": "47.11", "question": "What types of hematological malignancies are included in this multicenter study?", "answer_src": "the spectacular improvement in long - term prognosis of patients with hematological malignancies since the 1980s , coupled with the subsequent improvement over the past decade in short- and mid - term survival in cases of critical illness , resulted in an increasing referral of such patients to the icu . a remaining question , however , is how these patients perform in the long term with regard to survival and quality of life . here we discuss the present multicenter study on survival beyond 1 year in critically ill patients with hematological malignancies .", "follow_up_question": "What specific outcomes are the researchers investigating in this multicenter study?", "follow_up_response": "Survival beyond 1 year", "follow_up_response_bt": "No Answer"}, {"question_id": "47.12", "question": "What is the primary focus of the present multicenter study mentioned in the text?", "answer_src": "Survival beyond 1 year in critically ill patients with hematological malignancies", "follow_up_question": "What specific outcomes are researchers investigating in this study?", "follow_up_response": "Survival and quality of life", "follow_up_response_bt": "No Answer"}, {"question_id": "47.13", "question": "What factors did the study investigate in relation to survival beyond 1 year?", "answer_src": "Long-term prognosis of patients with hematological malignancies and short- and mid-term survival in cases of critical illness", "follow_up_question": "What specific aspects of survival were the researchers interested in beyond 1 year?", "follow_up_response": "survival and quality of life", "follow_up_response_bt": "Short and medium-term survival"}, {"question_id": "47.14", "question": "What specific hematological malignancies are included in this multicenter study?", "answer_src": "the spectacular improvement in long - term prognosis of patients with hematological malignancies since the 1980s , coupled with the subsequent improvement over the past decade in short- and mid - term survival in cases of critical illness , resulted in an increasing referral of such patients to the icu . a remaining question , however , is how these patients perform in the long term with regard to survival and quality of life . here we discuss the present multicenter study on survival beyond 1 year in critically ill patients with hematological malignancies .", "follow_up_question": "What is the duration of survival being studied in this multicenter study?", "follow_up_response": "1 year", "follow_up_response_bt": "No Answer"}, {"question_id": "47.15", "question": "What is the primary focus of the study regarding the patients' outcomes?", "answer_src": "Survival beyond 1 year", "follow_up_question": "What specific factors are being investigated in this study to determine survival beyond 1 year?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 48, "src": "on radiographic assessment a simultaneous dislocation of the coraco - clavicular and sterno - clavicular joints of right side was diagnosed . in view of the unstable condition of the right clavicle , young age of the patient , requirement of high physical activity a decision for operative treatment for clavicle dislocation was taken . patient was treated surgically with open reduction and tension band wiring with good result.although bipolar dislocation of the clavicle are rare a high index of suspicion will avoid missed diagnosis .", "mt": "Alla valutazione radiografica è stata diagnosticata una dislocazione simultanea delle articolazioni coraco-clavicolare e sterno-clavicolare del lato destro . vista l' instabile condizione della clavicola destra , la giovane età del paziente , il requisito di alta attività fisica è stata presa una decisione per un trattamento chirurgico per la dislocazione della clavicola . Il paziente è stato trattato chirurgicamente con riduzione aperta e cablaggio della banda di tensione con buon risultato . Anche se la dislocazione bipolare della clavicola è rara , un elevato indice di sospetto eviterà un diagnosticato sbagliato .", "pert_mt": "Alla valutazione radiografica è stata diagnosticata una dislocazione simultanea delle articolazioni coraco-clavicolare e sterno-clavicolare del lato destro. Vista l'instabile condizione della clavicola destra, la giovane età del paziente, il requisito di alta attività fisica è stata presa una decisione per un trattamento chirurgico per la dislocazione della clavicola. Il paziente è stato trattato chirurgicamente con riduzione aperta e cablaggio della banda di tensione con buon risultato. Anche se la dislocazione bipolare della clavicola è rara, un elevato indice di sospetto eviterà un diagnosticato sbagliato e potrebbe portare a un trattamento più precoce.", "bt": "At the X-ray evaluation, a simultaneous dislocation of the right-hand side's cardiovascular and sterno-clavicular joints was diagnosed, given the unstable condition of the right clavicle, the patient's young age, the requirement for high physical activity, and a decision was made for a surgical treatment for the clavicle dislocation, the patient being treated surgically with open reduction and strain band wiring with good results, although bipolar dislocation of the clavicle is rare, a high suspicion index will prevent a misdiagnosis and could lead to earlier treatment.", "questions_src": ["What joint was simultaneously diagnosed as dislocated?", "Who was diagnosed with a simultaneous dislocation of the coraco-clavicular and sterno-clavicular joints?", "Where was the surgical treatment performed?", "When was the patient treated surgically?", "Which technique was used for open reduction and tension band wiring?"], "answers_src": ["coraco-clavicular and sterno-clavicular joints", "the patient", "right side", "at the time of surgical treatment", "open reduction and tension band wiring"], "answers_bt": ["[\"Right-hand side\"s cardiovascular and sterno-clavicular joints\", \"The patient\", \"With open reduction and tension band wiring\", \"At the X-ray evaluation\", \"Open reduction and tension band wiring\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "48.1", "question": "What joint was simultaneously diagnosed as dislocated?", "answer_src": "coraco-clavicular and sterno-clavicular joints", "follow_up_question": "What specific surgical procedure was used to treat the patient?", "follow_up_response": "open reduction and tension band wiring", "follow_up_response_bt": "open reduction and strain band wiring"}, {"question_id": "48.2", "question": "Who was diagnosed with a simultaneous dislocation of the coraco-clavicular and sterno-clavicular joints?", "answer_src": "the patient", "follow_up_question": "What specific surgical procedure was used to treat the patient?", "follow_up_response": "open reduction and tension band wiring", "follow_up_response_bt": "open reduction and strain band wiring"}, {"question_id": "48.3", "question": "Where was the surgical treatment performed?", "answer_src": "right side", "follow_up_question": "What specific technique was used during the surgical treatment?", "follow_up_response": "open reduction and tension band wiring", "follow_up_response_bt": "open reduction and strain band wiring"}, {"question_id": "48.4", "question": "When was the patient treated surgically?", "answer_src": "at the time of surgical treatment", "follow_up_question": "What kind of surgical procedure did the patient undergo?", "follow_up_response": "open reduction and tension band wiring", "follow_up_response_bt": "open reduction and strain band wiring"}, {"question_id": "48.5", "question": "Which technique was used for open reduction and tension band wiring?", "answer_src": "open reduction and tension band wiring", "follow_up_question": "What specific material was used in the tension band wiring?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "48.6", "question": "What specific surgical procedure was used to treat the patient?", "answer_src": "open reduction and tension band wiring", "follow_up_question": "What type of clavicle dislocation was the patient diagnosed with?", "follow_up_response": "Simultaneous dislocation", "follow_up_response_bt": "Bipolar"}, {"question_id": "48.7", "question": "What specific surgical procedure was used to treat the patient?", "answer_src": "open reduction and tension band wiring", "follow_up_question": "What type of clavicle dislocation was the patient diagnosed with?", "follow_up_response": "Simultaneous dislocation", "follow_up_response_bt": "Bipolar"}, {"question_id": "48.8", "question": "What specific technique was used during the surgical treatment?", "answer_src": "open reduction and tension band wiring", "follow_up_question": "What were the indications for choosing this surgical technique over others?", "follow_up_response": "Unstable condition of the right clavicle, young age of the patient, requirement of high physical activity", "follow_up_response_bt": "The unstable condition of the right clavicle, the patient's young age, the requirement for high physical activity, and a high suspicion index"}, {"question_id": "48.9", "question": "What kind of surgical procedure did the patient undergo?", "answer_src": "open reduction and tension band wiring", "follow_up_question": "What material was used in the tension band wiring?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "48.10", "question": "What specific material was used in the tension band wiring?", "answer_src": "on radiographic assessment a simultaneous dislocation of the coraco - clavicular and sterno - clavicular joints of right side was diagnosed . in view of the unstable condition of the right clavicle , young age of the patient , requirement of high physical activity a decision for operative treatment for clavicle dislocation was taken . patient was treated surgically with open reduction and tension band wiring with good result.although bipolar dislocation of the clavicle are rare a high index of suspicion will avoid missed diagnosis .", "follow_up_question": "What were the consequences of not treating the clavicle dislocation operatively?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "48.11", "question": "What type of clavicle dislocation was the patient diagnosed with?", "answer_src": "Simultaneous dislocation", "follow_up_question": "What specific surgical technique was used to treat the patient?", "follow_up_response": "open reduction and tension band wiring", "follow_up_response_bt": "open reduction and strain band wiring"}, {"question_id": "48.12", "question": "What type of clavicle dislocation was the patient diagnosed with?", "answer_src": "Simultaneous dislocation", "follow_up_question": "What specific surgical technique was used to treat the patient?", "follow_up_response": "open reduction and tension band wiring", "follow_up_response_bt": "open reduction and strain band wiring"}, {"question_id": "48.13", "question": "What were the indications for choosing this surgical technique over others?", "answer_src": "Unstable condition of the right clavicle, young age of the patient, requirement of high physical activity", "follow_up_question": "What specific surgical technique was used in this case?", "follow_up_response": "open reduction and tension band wiring", "follow_up_response_bt": "open reduction and strain band wiring"}, {"question_id": "48.14", "question": "What material was used in the tension band wiring?", "answer_src": "on radiographic assessment a simultaneous dislocation of the coraco - clavicular and sterno - clavicular joints of right side was diagnosed . in view of the unstable condition of the right clavicle , young age of the patient , requirement of high physical activity a decision for operative treatment for clavicle dislocation was taken . patient was treated surgically with open reduction and tension band wiring with good result.although bipolar dislocation of the clavicle are rare a high index of suspicion will avoid missed diagnosis .", "follow_up_question": "What were the consequences of not treating the clavicle dislocation operatively?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "48.15", "question": "What were the consequences of not treating the clavicle dislocation operatively?", "answer_src": "on radiographic assessment a simultaneous dislocation of the coraco - clavicular and sterno - clavicular joints of right side was diagnosed . in view of the unstable condition of the right clavicle , young age of the patient , requirement of high physical activity a decision for operative treatment for clavicle dislocation was taken . patient was treated surgically with open reduction and tension band wiring with good result.although bipolar dislocation of the clavicle are rare a high index of suspicion will avoid missed diagnosis .", "follow_up_question": "What factors led to the decision for operative treatment of the clavicle dislocation?", "follow_up_response": "Unstable condition of the right clavicle, young age of the patient, requirement of high physical activity", "follow_up_response_bt": "Unstable condition of the right clavicle, the patient's young age, the requirement for high physical activity"}]}}
{"id": 49, "src": "it is regrettable that the initial decision was made largely on a single trial that was stopped early . however , the decision to approve was within the bounds of normal regulatory practice and was made by many approval bodies around the world . furthermore , the overall withdrawal rate of approved drugs remains very low .", "mt": "È un peccato che la decisione iniziale sia stata presa in gran parte su un singolo studio che è stato fermato anticipatamente . Tuttavia , la decisione di approvare era all'interno dei limiti della normale pratica normativa e è stata presa da molti organismi di approvazione in tutto il mondo . Inoltre , il tasso complessivo di ritiro dei farmaci approvati rimane molto basso .", "pert_mt": "È un peccato che la decisione iniziale sia stata presa in gran parte su un singolo studio che è stato fermato anticipatamente. Tuttavia, la decisione di approvare era all'interno dei limiti della normale pratica normativa e è stata presa da molti organismi di approvazione in tutto il mondo. Inoltre, il tasso complessivo di ritiro dei farmaci approvati rimane molto basso, anche se ci sono state alcune eccezioni notevoli.", "bt": "It is a pity that the initial decision was largely taken on a single study that was closed in advance, however, the decision to approve was within the limits of normal regulatory practice and was taken by many approval bodies worldwide, and the overall rate of withdrawal of approved drugs remains very low, although there have been some notable exceptions.", "questions_src": ["What was the initial decision regarding?", "Who made the decision to approve the drug?", "Where were the approval bodies located?", "When was the trial stopped early?", "Which drugs have a very low withdrawal rate?"], "answers_src": ["the drug", "many approval bodies around the world", "around the world", "early in the trial", "approved drugs"], "answers_bt": ["The approval of a drug", "Many approval bodies worldwide", "Worldwide", "The trial", "No Answer"], "multiturn": {"turn_1": [{"question_id": "49.1", "question": "What was the initial decision regarding?", "answer_src": "the drug", "follow_up_question": "What was the primary reason for stopping the trial early?", "follow_up_response": "the initial decision", "follow_up_response_bt": "The initial decision was largely taken"}, {"question_id": "49.2", "question": "Who made the decision to approve the drug?", "answer_src": "many approval bodies around the world", "follow_up_question": "What was the primary reason for the low overall withdrawal rate of approved drugs?", "follow_up_response": "No Answer", "follow_up_response_bt": "The overall rate of withdrawal of approved drugs remains very low"}, {"question_id": "49.3", "question": "Where were the approval bodies located?", "answer_src": "around the world", "follow_up_question": "What percentage does the overall withdrawal rate of approved drugs represent?", "follow_up_response": "very low", "follow_up_response_bt": "No Answer"}, {"question_id": "49.4", "question": "When was the trial stopped early?", "answer_src": "early in the trial", "follow_up_question": "What was the overall withdrawal rate of approved drugs according to the text?", "follow_up_response": "very low", "follow_up_response_bt": "very low"}, {"question_id": "49.5", "question": "Which drugs have a very low withdrawal rate?", "answer_src": "approved drugs", "follow_up_question": "What percentage or range does the overall withdrawal rate of approved drugs remain?", "follow_up_response": "very low", "follow_up_response_bt": "very low"}], "turn_2": [{"question_id": "49.6", "question": "What was the primary reason for stopping the trial early?", "answer_src": "the initial decision", "follow_up_question": "What were the criteria for the overall withdrawal rate of approved drugs being very low?", "follow_up_response": "No Answer", "follow_up_response_bt": "The overall rate of withdrawal of approved drugs remains very low, although there have been some notable exceptions."}, {"question_id": "49.7", "question": "What was the primary reason for the low overall withdrawal rate of approved drugs?", "answer_src": "it is regrettable that the initial decision was made largely on a single trial that was stopped early . however , the decision to approve was within the bounds of normal regulatory practice and was made by many approval bodies around the world . furthermore , the overall withdrawal rate of approved drugs remains very low .", "follow_up_question": "What factors contributed to the overall low withdrawal rate of approved drugs according to the text?", "follow_up_response": "The overall withdrawal rate of approved drugs remains very low", "follow_up_response_bt": "the overall rate of withdrawal of approved drugs remains very low"}, {"question_id": "49.8", "question": "What percentage does the overall withdrawal rate of approved drugs represent?", "answer_src": "very low", "follow_up_question": "What specific action did the many approval bodies around the world take regarding the drug approval?", "follow_up_response": "approve", "follow_up_response_bt": "approve"}, {"question_id": "49.9", "question": "What was the overall withdrawal rate of approved drugs according to the text?", "answer_src": "very low", "follow_up_question": "What percentage or range is considered \"very low\" in the context of drug withdrawal rates?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "49.10", "question": "What percentage or range does the overall withdrawal rate of approved drugs remain?", "answer_src": "very low", "follow_up_question": "What specific timeframe is associated with the \"overall withdrawal rate\" mentioned?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "49.11", "question": "What were the criteria for the overall withdrawal rate of approved drugs being very low?", "answer_src": "it is regrettable that the initial decision was made largely on a single trial that was stopped early . however , the decision to approve was within the bounds of normal regulatory practice and was made by many approval bodies around the world . furthermore , the overall withdrawal rate of approved drugs remains very low .", "follow_up_question": "What factors contributed to the very low overall withdrawal rate of approved drugs?", "follow_up_response": "The overall withdrawal rate of approved drugs remains very low.", "follow_up_response_bt": "the overall rate of withdrawal of approved drugs remains very low"}, {"question_id": "49.12", "question": "What factors contributed to the overall low withdrawal rate of approved drugs according to the text?", "answer_src": "The overall withdrawal rate of approved drugs remains very low", "follow_up_question": "What specific measures do you think helped maintain such a low withdrawal rate?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "49.13", "question": "What specific action did the many approval bodies around the world take regarding the drug approval?", "answer_src": "approve", "follow_up_question": "What percentage of approved drugs are typically withdrawn?", "follow_up_response": "very low", "follow_up_response_bt": "very low"}, {"question_id": "49.14", "question": "What percentage or range is considered \"very low\" in the context of drug withdrawal rates?", "answer_src": "it is regrettable that the initial decision was made largely on a single trial that was stopped early . however , the decision to approve was within the bounds of normal regulatory practice and was made by many approval bodies around the world . furthermore , the overall withdrawal rate of approved drugs remains very low .", "follow_up_question": "What is the approximate overall withdrawal rate of approved drugs according to the text?", "follow_up_response": "very low", "follow_up_response_bt": "very low"}, {"question_id": "49.15", "question": "What specific timeframe is associated with the \"overall withdrawal rate\" mentioned?", "answer_src": "it is regrettable that the initial decision was made largely on a single trial that was stopped early . however , the decision to approve was within the bounds of normal regulatory practice and was made by many approval bodies around the world . furthermore , the overall withdrawal rate of approved drugs remains very low .", "follow_up_question": "What does the author consider as the primary reason for the low overall withdrawal rate of approved drugs?", "follow_up_response": "The overall withdrawal rate of approved drugs remains very low", "follow_up_response_bt": "the overall rate of withdrawal of approved drugs remains very low"}]}}
{"id": 50, "src": "diabetes is a group of metabolic diseases characterized by hyperglycemia , and represents a disease of the modern age , disease of the 21st century . prevention of this disease is listed as imperative . aim of this article was to evaluate questionnaires on the assessment of risk factors for diabetes mellitus type 2.a total of 540 questionnaires handed out randomly to citizens of canton sarajevo of all ages , sexes and educational levels ( in january 2016 ) were analyzed.analyzed questionnaires showed relatively low risk of getting diabetes in the next ten years in the majority of the population .", "mt": "Il diabete è un gruppo di malattie metaboliche caratterizzate da iperglicemia , e rappresenta una malattia dell'era moderna , malattia del 21 ° secolo . La prevenzione di questa malattia è elencata come imperativo . lo scopo di questo articolo era valutare questioni sulla valutazione dei fattori di rischio per il diabete mellito di tipo 2.un totale di 540 questioni distribuite a caso ai cittadini del cantone di Sarajevo di tutte le età , sessi e livelli di istruzione (a gennaio 2016) sono state analizzate.I questioni analizzati hanno mostrato un rischio relativamente basso di diabete nei prossimi dieci anni nella maggior parte della popolazione .", "pert_mt": "Il diabete è un gruppo di malattie metaboliche caratterizzate da iperglicemia, e rappresenta una malattia dell'era moderna, malattia del 21° secolo. La prevenzione di questa malattia è elencata come imperativo. Lo scopo di questo articolo era valutare questioni sulla valutazione dei fattori di rischio per il diabete mellito di tipo 2. Un totale di 540 questionari distribuiti a caso ai cittadini del cantone di Sarajevo di tutte le età, sessi e livelli di istruzione (a gennaio 2016) sono state analizzate. Le questioni analizzate hanno mostrato un rischio relativamente basso di diabete nei prossimi dieci anni nella maggior parte della popolazione.", "bt": "Diabetes is a group of metabolic diseases characterized by hyperglycemia, and represents a disease of the modern age, a disease of the 21st century.Prevention of this disease is listed as imperative.The purpose of this article was to evaluate questions on the assessment of risk factors for type 2 diabetes mellitus.A total of 540 case-by-case questionnaires distributed to citizens of the Sarajevo canton of all ages, genders and educational levels (as of January 2016) were analyzed.The questions analyzed showed a relatively low risk of diabetes over the next ten years in most of the population.", "questions_src": ["What is diabetes?", "Who is at risk of getting diabetes according to the article?", "Where were the questionnaires distributed?", "When was the analysis conducted?", "Which type of diabetes was evaluated in the study?"], "answers_src": ["a group of metabolic diseases characterized by hyperglycemia", "the majority of the population", "citizens of canton sarajevo", "in january 2016", "diabetes mellitus type 2"], "answers_bt": ["a group of metabolic diseases characterized by hyperglycemia", "most of the population", "to citizens of the Sarajevo canton", "as of January 2016", "type 2 diabetes mellitus"], "multiturn": {"turn_1": [{"question_id": "50.1", "question": "What is diabetes?", "answer_src": "a group of metabolic diseases characterized by hyperglycemia", "follow_up_question": "What percentage of the population assessed in the study had a relatively low risk of getting diabetes in the next ten years?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "50.2", "question": "Who is at risk of getting diabetes according to the article?", "answer_src": "the majority of the population", "follow_up_question": "What percentage or range of the population was found to have a relatively low risk of getting diabetes in the next ten years?", "follow_up_response": "relatively low risk", "follow_up_response_bt": "a relatively low risk"}, {"question_id": "50.3", "question": "Where were the questionnaires distributed?", "answer_src": "citizens of canton sarajevo", "follow_up_question": "What percentage of the population in Canton Sarajevo had a relatively low risk of getting diabetes according to the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "50.4", "question": "When was the analysis conducted?", "answer_src": "in january 2016", "follow_up_question": "What percentage of the population had a relatively low risk of getting diabetes according to the analysis?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "50.5", "question": "Which type of diabetes was evaluated in the study?", "answer_src": "diabetes mellitus type 2", "follow_up_question": "What percentage of the population had a relatively low risk of getting diabetes in the next ten years according to the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "50.6", "question": "What percentage of the population assessed in the study had a relatively low risk of getting diabetes in the next ten years?", "answer_src": "diabetes is a group of metabolic diseases characterized by hyperglycemia , and represents a disease of the modern age , disease of the 21st century . prevention of this disease is listed as imperative . aim of this article was to evaluate questionnaires on the assessment of risk factors for diabetes mellitus type 2.a total of 540 questionnaires handed out randomly to citizens of canton sarajevo of all ages , sexes and educational levels ( in january 2016 ) were analyzed.analyzed questionnaires showed relatively low risk of getting diabetes in the next ten years in the majority of the population .", "follow_up_question": "What percentage of the population had a relatively low risk of getting diabetes according to the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "50.7", "question": "What percentage or range of the population was found to have a relatively low risk of getting diabetes in the next ten years?", "answer_src": "relatively low risk", "follow_up_question": "What specific risk factors were assessed in the questionnaires?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "50.8", "question": "What percentage of the population in Canton Sarajevo had a relatively low risk of getting diabetes according to the study?", "answer_src": "diabetes is a group of metabolic diseases characterized by hyperglycemia , and represents a disease of the modern age , disease of the 21st century . prevention of this disease is listed as imperative . aim of this article was to evaluate questionnaires on the assessment of risk factors for diabetes mellitus type 2.a total of 540 questionnaires handed out randomly to citizens of canton sarajevo of all ages , sexes and educational levels ( in january 2016 ) were analyzed.analyzed questionnaires showed relatively low risk of getting diabetes in the next ten years in the majority of the population .", "follow_up_question": "What specific risk factors for diabetes mellitus type 2 were assessed in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "50.9", "question": "What percentage of the population had a relatively low risk of getting diabetes according to the analysis?", "answer_src": "diabetes is a group of metabolic diseases characterized by hyperglycemia , and represents a disease of the modern age , disease of the 21st century . prevention of this disease is listed as imperative . aim of this article was to evaluate questionnaires on the assessment of risk factors for diabetes mellitus type 2.a total of 540 questionnaires handed out randomly to citizens of canton sarajevo of all ages , sexes and educational levels ( in january 2016 ) were analyzed.analyzed questionnaires showed relatively low risk of getting diabetes in the next ten years in the majority of the population .", "follow_up_question": "What specific risk factors were assessed in the questionnaires?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "50.10", "question": "What percentage of the population had a relatively low risk of getting diabetes in the next ten years according to the study?", "answer_src": "diabetes is a group of metabolic diseases characterized by hyperglycemia , and represents a disease of the modern age , disease of the 21st century . prevention of this disease is listed as imperative . aim of this article was to evaluate questionnaires on the assessment of risk factors for diabetes mellitus type 2.a total of 540 questionnaires handed out randomly to citizens of canton sarajevo of all ages , sexes and educational levels ( in january 2016 ) were analyzed.analyzed questionnaires showed relatively low risk of getting diabetes in the next ten years in the majority of the population .", "follow_up_question": "What specific risk factors were assessed in the questionnaires for diabetes mellitus type 2?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "50.11", "question": "What percentage of the population had a relatively low risk of getting diabetes according to the study?", "answer_src": "diabetes is a group of metabolic diseases characterized by hyperglycemia , and represents a disease of the modern age , disease of the 21st century . prevention of this disease is listed as imperative . aim of this article was to evaluate questionnaires on the assessment of risk factors for diabetes mellitus type 2.a total of 540 questionnaires handed out randomly to citizens of canton sarajevo of all ages , sexes and educational levels ( in january 2016 ) were analyzed.analyzed questionnaires showed relatively low risk of getting diabetes in the next ten years in the majority of the population .", "follow_up_question": "What specific risk factors were assessed in the questionnaires according to the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "50.12", "question": "What specific risk factors were assessed in the questionnaires?", "answer_src": "diabetes is a group of metabolic diseases characterized by hyperglycemia , and represents a disease of the modern age , disease of the 21st century . prevention of this disease is listed as imperative . aim of this article was to evaluate questionnaires on the assessment of risk factors for diabetes mellitus type 2.a total of 540 questionnaires handed out randomly to citizens of canton sarajevo of all ages , sexes and educational levels ( in january 2016 ) were analyzed.analyzed questionnaires showed relatively low risk of getting diabetes in the next ten years in the majority of the population .", "follow_up_question": "What percentage of the population showed a relatively low risk of getting diabetes in the next ten years according to the analysis?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "50.13", "question": "What specific risk factors for diabetes mellitus type 2 were assessed in the study?", "answer_src": "diabetes is a group of metabolic diseases characterized by hyperglycemia , and represents a disease of the modern age , disease of the 21st century . prevention of this disease is listed as imperative . aim of this article was to evaluate questionnaires on the assessment of risk factors for diabetes mellitus type 2.a total of 540 questionnaires handed out randomly to citizens of canton sarajevo of all ages , sexes and educational levels ( in january 2016 ) were analyzed.analyzed questionnaires showed relatively low risk of getting diabetes in the next ten years in the majority of the population .", "follow_up_question": "What percentage of the population showed a relatively low risk of getting diabetes in the next ten years according to the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "50.14", "question": "What specific risk factors were assessed in the questionnaires?", "answer_src": "diabetes is a group of metabolic diseases characterized by hyperglycemia , and represents a disease of the modern age , disease of the 21st century . prevention of this disease is listed as imperative . aim of this article was to evaluate questionnaires on the assessment of risk factors for diabetes mellitus type 2.a total of 540 questionnaires handed out randomly to citizens of canton sarajevo of all ages , sexes and educational levels ( in january 2016 ) were analyzed.analyzed questionnaires showed relatively low risk of getting diabetes in the next ten years in the majority of the population .", "follow_up_question": "What percentage of the population showed a relatively low risk of getting diabetes in the next ten years according to the analysis?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "50.15", "question": "What specific risk factors were assessed in the questionnaires for diabetes mellitus type 2?", "answer_src": "diabetes is a group of metabolic diseases characterized by hyperglycemia , and represents a disease of the modern age , disease of the 21st century . prevention of this disease is listed as imperative . aim of this article was to evaluate questionnaires on the assessment of risk factors for diabetes mellitus type 2.a total of 540 questionnaires handed out randomly to citizens of canton sarajevo of all ages , sexes and educational levels ( in january 2016 ) were analyzed.analyzed questionnaires showed relatively low risk of getting diabetes in the next ten years in the majority of the population .", "follow_up_question": "What percentage or number of the population showed a relatively low risk of getting diabetes in the next ten years according to the analysis?", "follow_up_response": "540", "follow_up_response_bt": "540"}]}}
{"id": 51, "src": "to this end , females and males were presented with point - light displays portraying knocking at a door performed with different emotional expressions . the findings show that gender affects accuracy rather than speed of body language reading . this effect , however , is modulated by emotional content of actions : males surpass in recognition accuracy of happy actions , whereas females tend to excel in recognition of hostile angry knocking .", "mt": "A tal fine , donne e maschi sono stati presentati con schermi di luce-punto che ritrovano bussare a una porta eseguita con espressioni emotive diverse . I risultati mostrano che il genere influisce sulla precisione piuttosto che sulla velocità di lettura del linguaggio corporeo . Questo effetto , tuttavia , è modulato dal contenuto emotivo delle azioni: i maschi superano nella precisione di riconoscimento delle azioni felici , mentre le femmine tendono ad eccellere nel riconoscimento di bussare arrabbiati ostili .", "pert_mt": "A tal fine, donne e maschi sono stati presentati con schermi di luce-punto che ritrovano bussare a una porta eseguita con espressioni emotive diverse. I risultati mostrano che il genere influisce sulla precisione piuttosto che sulla velocità di lettura del linguaggio corporeo. Questo effetto, tuttavia, è modulato dal contenuto emotivo delle azioni: i maschi superano nella precisione di riconoscimento delle azioni felici, mentre le femmine tendono ad eccellere nel riconoscimento di bussare arrabbiati ostili. Inoltre, la luminosità della stanza ha anche un impatto sulla percezione delle espressioni emotive.", "bt": "In this way, both women and men were presented with spotlight screens that found them driving at a door with different emotional expressions.The results show that gender influences precision rather than the speed of reading of body language.This effect, however, is modulated by the emotional content of actions: males excel in the precision of recognizing happy actions, while females tend to excel in recognizing hostile angry buses.Moreover, the brightness of the room also has an impact on the perception of emotional expressions.", "questions_src": ["What type of stimuli were females and males presented with in the study?", "Who was found to have better recognition accuracy for happy actions, males or females?", "Where was the knocking action performed according to the study?", "When does gender affect accuracy more in body language reading, speed or recognition?", "Which emotional expression resulted in higher recognition accuracy for males in the study?"], "answers_src": ["Point-light displays portraying knocking at a door", "Males", "At a door", "Recognition", "Happy"], "answers_bt": ["Spotlight screens", "Males", "A door", "Recognition", "Recognition"], "multiturn": {"turn_1": [{"question_id": "51.1", "question": "What type of stimuli were females and males presented with in the study?", "answer_src": "Point-light displays portraying knocking at a door", "follow_up_question": "What specific emotional expressions were portrayed in the knocking actions?", "follow_up_response": "happy\", \"hostile angry", "follow_up_response_bt": "happy actions\", \"hostile angry buses"}, {"question_id": "51.2", "question": "Who was found to have better recognition accuracy for happy actions, males or females?", "answer_src": "Males", "follow_up_question": "Who tended to excel in recognizing hostile angry knocking?", "follow_up_response": "Females", "follow_up_response_bt": "No Answer"}, {"question_id": "51.3", "question": "Where was the knocking action performed according to the study?", "answer_src": "At a door", "follow_up_question": "What type of actions did males excel in recognizing?", "follow_up_response": "happy actions", "follow_up_response_bt": "happy actions"}, {"question_id": "51.4", "question": "When does gender affect accuracy more in body language reading, speed or recognition?", "answer_src": "Recognition", "follow_up_question": "Under what emotional expressions do males outperform females in recognizing body language?", "follow_up_response": "happy\"], [\"hostile angry", "follow_up_response_bt": "happy actions"}, {"question_id": "51.5", "question": "Which emotional expression resulted in higher recognition accuracy for males in the study?", "answer_src": "Happy", "follow_up_question": "Which emotional expression resulted in higher recognition accuracy for females in the study?", "follow_up_response": "hostile angry knocking", "follow_up_response_bt": "Hostile angry"}], "turn_2": [{"question_id": "51.6", "question": "What specific emotional expressions were portrayed in the knocking actions?", "answer_src": "happy\", \"hostile angry", "follow_up_question": "What gender tends to excel in recognizing hostile angry knocking?", "follow_up_response": "females", "follow_up_response_bt": "No Answer"}, {"question_id": "51.7", "question": "Who tended to excel in recognizing hostile angry knocking?", "answer_src": "Females", "follow_up_question": "Who surpassed in recognizing happy actions?", "follow_up_response": "Males", "follow_up_response_bt": "Males"}, {"question_id": "51.8", "question": "What type of actions did males excel in recognizing?", "answer_src": "happy actions", "follow_up_question": "What type of actions did females excel in recognizing?", "follow_up_response": "hostile angry knocking", "follow_up_response_bt": "hostile angry buses"}, {"question_id": "51.9", "question": "Under what emotional expressions do males outperform females in recognizing body language?", "answer_src": "happy\"], [\"hostile angry", "follow_up_question": "In what type of body language recognition do females have an advantage?", "follow_up_response": "hostile angry knocking", "follow_up_response_bt": "hostile angry buses"}, {"question_id": "51.10", "question": "Which emotional expression resulted in higher recognition accuracy for females in the study?", "answer_src": "hostile angry knocking", "follow_up_question": "Which emotional expression resulted in higher recognition accuracy for males in the study?", "follow_up_response": "happy", "follow_up_response_bt": "happy"}], "turn_3": [{"question_id": "51.11", "question": "What gender tends to excel in recognizing hostile angry knocking?", "answer_src": "females", "follow_up_question": "What type of actions do males excel in recognizing?", "follow_up_response": "happy actions", "follow_up_response_bt": "happy actions"}, {"question_id": "51.12", "question": "Who surpassed in recognizing happy actions?", "answer_src": "Males", "follow_up_question": "Who tended to excel in recognizing hostile angry knocking?", "follow_up_response": "Females", "follow_up_response_bt": "No Answer"}, {"question_id": "51.13", "question": "What type of actions did females excel in recognizing?", "answer_src": "hostile angry knocking", "follow_up_question": "What type of actions did males excel in recognizing?", "follow_up_response": "happy actions", "follow_up_response_bt": "happy actions"}, {"question_id": "51.14", "question": "In what type of body language recognition do females have an advantage?", "answer_src": "hostile angry knocking", "follow_up_question": "What kind of actions do males perform better at recognizing?", "follow_up_response": "happy actions", "follow_up_response_bt": "happy actions"}, {"question_id": "51.15", "question": "Which emotional expression resulted in higher recognition accuracy for males in the study?", "answer_src": "happy", "follow_up_question": "Which emotional expression resulted in higher recognition accuracy for females in the study?", "follow_up_response": "hostile angry knocking", "follow_up_response_bt": "Hostile angry"}]}}
{"id": 52, "src": "methodsin a one - step procedure iliac crest aspirates were harvested and , subsequently , separated bmc were seeded on hydrogels and implanted into the ovine disc . for the cell - seeded approach a hyaluronic acid - based hydrogel was used . the anti - angiogenic potential of newly developed vegf - blockers was investigated on ionically crosslinked metacrylated gellan gum hydrogels .", "mt": "In un procedimento a un solo passo , sono stati raccolti aspirati della cresta iliaca e , successivamente , separati bmc sono stati seminati su idrogelli e impiantati nel disco ovino . Per l' approccio alla cellula - sementi è stato utilizzato un idrogello basato sull' acido ialuronico . Il potenziale anti-angiogenico dei vegf-bloccanti appena sviluppati è stato studiato su idrogelli di gomma di gellano metacrilati ionici .", "pert_mt": "In un procedimento a un solo passo, sono stati raccolti aspirati della cresta iliaca e, successivamente, separati bmc sono stati seminati su idrogelli e impiantati nel disco ovino. Per l'approccio alla cellula-semente è stato utilizzato un idrogello basato sull'acido ialuronico. Il potenziale anti-angiogenico dei vegf-bloccanti appena sviluppati è stato studiato su idrogelli di gomma di gellano metacrilati ionici e ha dimostrato risultati promettenti.", "bt": "In a single-step procedure, aspirates of the iliac crest were collected and, subsequently, separate bmc were seeded on hydrogels and implanted in the ovine disc. For the seed cell approach, a hydrogel based on ialuronic acid was used. The anti-angiogenic potential of newly developed vegf-blockers has been studied on rubber hydrogels of ionic gellane metacrylates and has shown promising results.", "questions_src": ["What is the name of the one-step procedure used for iliac crest aspirates?", "Who was investigated for the anti-angiogenic potential using vegf-blockers?", "Where were the cell-seeded approaches implanted?", "When was the investigation of vegf-blockers conducted?", "Which type of hydrogel was used in the cell-seeded approach?"], "answers_src": ["One-step procedure", "Newly developed vegf-blockers", "Ovine disc", "Not specified", "Hyaluronic acid-based"], "answers_bt": ["Iliac crest", "Ovine", "In the ovine disc", "Not specified", "Ialuronic acid"], "multiturn": {"turn_1": [{"question_id": "52.1", "question": "What is the name of the one-step procedure used for iliac crest aspirates?", "answer_src": "One-step procedure", "follow_up_question": "What type of hydrogel was used for the cell-seeded approach?", "follow_up_response": "Hyaluronic acid-based hydrogel", "follow_up_response_bt": "ialuronic acid"}, {"question_id": "52.2", "question": "Who was investigated for the anti-angiogenic potential using vegf-blockers?", "answer_src": "Newly developed vegf-blockers", "follow_up_question": "On which type of hydrogel was the anti-angiogenic potential of the vegf-blockers investigated?", "follow_up_response": "ionically crosslinked metacrylated gellan gum", "follow_up_response_bt": "Rubber hydrogels of ionic gelan metacrylates"}, {"question_id": "52.3", "question": "Where were the cell-seeded approaches implanted?", "answer_src": "Ovine disc", "follow_up_question": "What type of hydrogel was used for the cell-seeded approaches?", "follow_up_response": "Hyaluronic acid-based hydrogel", "follow_up_response_bt": "ialuronic acid"}, {"question_id": "52.4", "question": "When was the investigation of vegf-blockers conducted?", "answer_src": "Not specified", "follow_up_question": "What type of hydrogel was used for the investigation of vegf-blockers?", "follow_up_response": "ionically crosslinked metacrylated gellan gum", "follow_up_response_bt": "Rubber hydrogels of ionic gelan metacrylates"}, {"question_id": "52.5", "question": "Which type of hydrogel was used in the cell-seeded approach?", "answer_src": "Hyaluronic acid-based", "follow_up_question": "What is the name of the hydrogel used for investigating the anti-angiogenic potential?", "follow_up_response": "ionically crosslinked metacrylated gellan gum", "follow_up_response_bt": "ialuronic acid"}], "turn_2": [{"question_id": "52.6", "question": "What type of hydrogel was used for the cell-seeded approach?", "answer_src": "Hyaluronic acid-based hydrogel", "follow_up_question": "What is the name of the hydrogel used for investigating the anti-angiogenic potential?", "follow_up_response": "ionically crosslinked metacrylated gellan gum", "follow_up_response_bt": "ialuronic acid"}, {"question_id": "52.7", "question": "On which type of hydrogel was the anti-angiogenic potential of the vegf-blockers investigated?", "answer_src": "ionically crosslinked metacrylated gellan gum", "follow_up_question": "What is the mechanism of crosslinking used in the metacrylated gellan gum hydrogel?", "follow_up_response": "ionically", "follow_up_response_bt": "No Answer"}, {"question_id": "52.8", "question": "What type of hydrogel was used for the cell-seeded approaches?", "answer_src": "Hyaluronic acid-based hydrogel", "follow_up_question": "What is the name of the hydrogel used for investigating the anti-angiogenic potential?", "follow_up_response": "ionically crosslinked metacrylated gellan gum", "follow_up_response_bt": "ialuronic acid"}, {"question_id": "52.9", "question": "What type of hydrogel was used for the investigation of vegf-blockers?", "answer_src": "ionically crosslinked metacrylated gellan gum", "follow_up_question": "What is the basis for the crosslinking in the metacrylated gellan gum hydrogel?", "follow_up_response": "ionically", "follow_up_response_bt": "Ionic"}, {"question_id": "52.10", "question": "What is the name of the hydrogel used for investigating the anti-angiogenic potential?", "answer_src": "ionically crosslinked metacrylated gellan gum", "follow_up_question": "What type of hydrogel was used for seeding the cells?", "follow_up_response": "hyaluronic acid-based hydrogel", "follow_up_response_bt": "ialuronic acid"}], "turn_3": [{"question_id": "52.11", "question": "What is the name of the hydrogel used for investigating the anti-angiogenic potential?", "answer_src": "ionically crosslinked metacrylated gellan gum", "follow_up_question": "What type of hydrogel was used for seeding the cells?", "follow_up_response": "hyaluronic acid-based hydrogel", "follow_up_response_bt": "ialuronic acid"}, {"question_id": "52.12", "question": "What is the mechanism of crosslinking used in the metacrylated gellan gum hydrogel?", "answer_src": "ionically", "follow_up_question": "What type of crosslinking agent is not used in the metacrylated gellan gum hydrogel?", "follow_up_response": "ionically", "follow_up_response_bt": "ionic"}, {"question_id": "52.13", "question": "What is the name of the hydrogel used for investigating the anti-angiogenic potential?", "answer_src": "ionically crosslinked metacrylated gellan gum", "follow_up_question": "What type of hydrogel was used for seeding the cells?", "follow_up_response": "hyaluronic acid-based hydrogel", "follow_up_response_bt": "ialuronic acid"}, {"question_id": "52.14", "question": "What is the basis for the crosslinking in the metacrylated gellan gum hydrogel?", "answer_src": "ionically", "follow_up_question": "What type of crosslinking agent is not used in the metacrylated gellan gum hydrogel?", "follow_up_response": "ionically", "follow_up_response_bt": "ionic"}, {"question_id": "52.15", "question": "What type of hydrogel was used for seeding the cells?", "answer_src": "hyaluronic acid-based hydrogel", "follow_up_question": "What type of hydrogel was used for the anti-angiogenic potential investigation?", "follow_up_response": "ionically crosslinked metacrylated gellan gum", "follow_up_response_bt": "Rubber hydrogels of ionic gelan metacrylates"}]}}
{"id": 53, "src": "hemodialysis patient survival is dependent on the availability of a reliable vascular access . in clinical practice , procedures for vascular access cannulation vary from clinic to clinic . we investigated the impact of cannulation technique on arteriovenous fistula and graft survival .", "mt": "La sopravvivenza del paziente in emodialisi dipende dalla disponibilità di un accesso vascolare affidabile . Nella pratica clinica , le procedure per la cannulazione di accesso vascolare variano da clinica a clinica . abbiamo studiato l'impatto della tecnica di cannulazione sulla fistola arterioveno e sulla sopravvivenza dei trapianti .", "pert_mt": "La sopravvivenza del paziente in emodialisi dipende dalla disponibilità di un accesso vascolare affidabile. Nella pratica clinica, le procedure per la cannulazione di accesso vascolare variano da clinica a clinica. Abbiamo studiato l'impatto della tecnica di cannulazione sulla fistola arterioveno e sulla sopravvivenza dei trapianti e sulle complesse condizioni di vita quotidiana dei pazienti.", "bt": "The survival of the patient under hemodialysis depends on the availability of a reliable vascular access.In clinical practice, the procedure for the cannulation of vascular access varies from clinic to clinic.We have studied the impact of the cannulation technique on the arteriovenous fistula and survival of the transplant patients and on the complex everyday living conditions of patients.", "questions_src": ["What type of vascular access is investigated in the study?", "Who performs the procedures for vascular access cannulation?", "Where do the procedures for vascular access cannulation vary?", "When was the study conducted?", "Which vascular access types are examined for survival impact?"], "answers_src": ["Arteriovenous fistula and graft", "Clinics", "Clinics", "No Answer", "Arteriovenous fistula and graft"], "answers_bt": ["[\"Arteriovenous fistula\"], [\"Clinics\"], [\"Clinics\"], [\"No Answer\"], [\"Arteriovenous fistula\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "53.1", "question": "What type of vascular access is investigated in the study?", "answer_src": "Arteriovenous fistula and graft", "follow_up_question": "What factors might influence the survival rates of arteriovenous fistulas and grafts differently based on cannulation techniques?", "follow_up_response": "Cannulation technique", "follow_up_response_bt": "The cannulation technique"}, {"question_id": "53.2", "question": "Who performs the procedures for vascular access cannulation?", "answer_src": "Clinics", "follow_up_question": "What specific cannulation techniques were investigated in the study?", "follow_up_response": "arteriovenous fistula and graft survival", "follow_up_response_bt": "The cannulation technique"}, {"question_id": "53.3", "question": "Where do the procedures for vascular access cannulation vary?", "answer_src": "Clinics", "follow_up_question": "What specific cannulation techniques were investigated in the study?", "follow_up_response": "arteriovenous fistula and graft survival", "follow_up_response_bt": "The cannulation technique"}, {"question_id": "53.4", "question": "When was the study conducted?", "answer_src": "hemodialysis patient survival is dependent on the availability of a reliable vascular access . in clinical practice , procedures for vascular access cannulation vary from clinic to clinic . we investigated the impact of cannulation technique on arteriovenous fistula and graft survival .", "follow_up_question": "What specific cannulation techniques were evaluated in the study?", "follow_up_response": "arteriovenous fistula and graft", "follow_up_response_bt": "The cannulation technique"}, {"question_id": "53.5", "question": "Which vascular access types are examined for survival impact?", "answer_src": "Arteriovenous fistula and graft", "follow_up_question": "What factors might influence the success rate of cannulation techniques for these access types?", "follow_up_response": "Cannulation technique", "follow_up_response_bt": "The cannulation technique"}], "turn_2": [{"question_id": "53.6", "question": "What factors might influence the survival rates of arteriovenous fistulas and grafts differently based on cannulation techniques?", "answer_src": "Cannulation technique", "follow_up_question": "How does the choice of cannulation technique affect the success rate of arteriovenous fistula and graft formation?", "follow_up_response": "The impact of cannulation technique on arteriovenous fistula and graft survival", "follow_up_response_bt": "No Answer"}, {"question_id": "53.7", "question": "What specific cannulation techniques were investigated in the study?", "answer_src": "arteriovenous fistula and graft survival", "follow_up_question": "What factors might influence the survival rates of arteriovenous fistulas and grafts differently based on the cannulation techniques?", "follow_up_response": "Cannulation technique", "follow_up_response_bt": "The cannulation technique"}, {"question_id": "53.8", "question": "What specific cannulation techniques were investigated in the study?", "answer_src": "arteriovenous fistula and graft survival", "follow_up_question": "What factors might influence the survival rates of arteriovenous fistulas and grafts differently based on the cannulation techniques?", "follow_up_response": "Cannulation technique", "follow_up_response_bt": "The cannulation technique"}, {"question_id": "53.9", "question": "What specific cannulation techniques were evaluated in the study?", "answer_src": "arteriovenous fistula and graft", "follow_up_question": "What factors might influence the success of the evaluated cannulation techniques?", "follow_up_response": "The availability of a reliable vascular access", "follow_up_response_bt": "The cannulation technique"}, {"question_id": "53.10", "question": "What factors might influence the success rate of cannulation techniques for these access types?", "answer_src": "Cannulation technique", "follow_up_question": "How does the type of cannulation technique affect arteriovenous fistula and graft survival?", "follow_up_response": "The impact of cannulation technique on arteriovenous fistula and graft survival", "follow_up_response_bt": "The impact on arteriovenous fistula and survival of transplant patients"}], "turn_3": [{"question_id": "53.11", "question": "How does the choice of cannulation technique affect the success rate of arteriovenous fistula and graft formation?", "answer_src": "The impact of cannulation technique on arteriovenous fistula and graft survival", "follow_up_question": "What specific cannulation techniques were evaluated in the study?", "follow_up_response": "arteriovenous fistula and graft", "follow_up_response_bt": "The cannulation technique"}, {"question_id": "53.12", "question": "What factors might influence the survival rates of arteriovenous fistulas and grafts differently based on the cannulation techniques?", "answer_src": "Cannulation technique", "follow_up_question": "How does the choice between cannulating an arteriovenous fistula versus a graft differ in terms of survival rates?", "follow_up_response": "The choice between cannulating an arteriovenous fistula versus a graft differs in terms of survival rates", "follow_up_response_bt": "No Answer"}, {"question_id": "53.13", "question": "What factors might influence the survival rates of arteriovenous fistulas and grafts differently based on the cannulation techniques?", "answer_src": "Cannulation technique", "follow_up_question": "How does the choice between cannulating an arteriovenous fistula versus a graft differ in terms of survival rates?", "follow_up_response": "The choice between cannulating an arteriovenous fistula versus a graft differs in terms of survival rates", "follow_up_response_bt": "No Answer"}, {"question_id": "53.14", "question": "What factors might influence the success of the evaluated cannulation techniques?", "answer_src": "The availability of a reliable vascular access", "follow_up_question": "How does the type of vascular access (fistula vs. graft) affect cannulation technique success?", "follow_up_response": "The impact of cannulation technique on arteriovenous fistula and graft survival", "follow_up_response_bt": "No Answer"}, {"question_id": "53.15", "question": "How does the type of cannulation technique affect arteriovenous fistula and graft survival?", "answer_src": "The impact of cannulation technique on arteriovenous fistula and graft survival", "follow_up_question": "What specific cannulation techniques were compared in the study?", "follow_up_response": "arteriovenous fistula and graft", "follow_up_response_bt": "The cannulation technique"}]}}
{"id": 54, "src": "atherosclerotic disease is the most important cause of mortality in the world . oxidation is an important pathway in the pathogenesis of coronary artery disease ( cad ) through oxidation of low - density lipoprotein ( ldl ) and free radical formation . copper ( cu ) is an essential micronutrient for enzymes that catalyse ldl oxidation reactions .", "mt": "L'ossidazione è un importante percorso nella patogenesi della malattia coronarica (cad) attraverso l'ossidazione di lipoproteine di bassa densità (ldl) e formazione di radicali liberi . il rame (cu) è un micronutriente essenziale per gli enzimi che catalizzano le reazioni di ossidazione dell'ldl .", "pert_mt": "L'ossidazione è un importante percorso nella patogenesi della malattia coronarica (CAD) attraverso l'ossidazione di lipoproteine di bassa densità (LDL) e formazione di radicali liberi. Il rame (Cu) è un micronutriente essenziale per gli enzimi che catalizzano le reazioni di ossidazione dell'LDL e regolamentano il sistema immunitario.", "bt": "Oxidation is an important pathway in the pathogenesis of coronary artery disease (CAD) through the oxidation of low-density lipoproteins (LDL) and the formation of free radicals.Copper (Cu) is an essential micronutrient for enzymes that catalyze LDL oxidation reactions and regulate the immune system.", "questions_src": ["What is the most important cause of mortality in the world?", "What is an important pathway in the pathogenesis of coronary artery disease?", "What is copper (Cu) an essential micronutrient for?", "When can free radical formation occur in the context of coronary artery disease?", "Which enzyme catalyzes LDL oxidation reactions?"], "answers_src": ["Atherosclerotic disease", "Oxidation", "Enzymes that catalyse ldl oxidation reactions", "In the context of coronary artery disease", "Catalyse ldl oxidation reactions"], "answers_bt": ["No Answer", "Oxidation", "Enzymes that catalyze LDL oxidation reactions and regulate the immune system", "In the context of coronary artery disease, free radical formation can occur through the oxidation of low-density lipoproteins (LDL)", "No Answer"], "multiturn": {"turn_1": [{"question_id": "54.1", "question": "What is the most important cause of mortality in the world?", "answer_src": "Atherosclerotic disease", "follow_up_question": "How does copper relate to the pathogenesis of atherosclerotic disease?", "follow_up_response": "Copper (Cu) is an essential micronutrient for enzymes that catalyse LDL oxidation reactions.", "follow_up_response_bt": "Copper (Cu) is an essential micronutrient for enzymes that catalyze LDL oxidation reactions and regulate the immune system."}, {"question_id": "54.2", "question": "What is an important pathway in the pathogenesis of coronary artery disease?", "answer_src": "Oxidation", "follow_up_question": "What specific reaction does oxidation catalyze in LDL according to the text?", "follow_up_response": "ldl oxidation reactions", "follow_up_response_bt": "the oxidation of low-density lipoproteins (LDL)"}, {"question_id": "54.3", "question": "What is copper (Cu) an essential micronutrient for?", "answer_src": "Enzymes that catalyse ldl oxidation reactions", "follow_up_question": "What specific function do these enzymes catalyse?", "follow_up_response": "ldl oxidation reactions", "follow_up_response_bt": "LDL oxidation reactions"}, {"question_id": "54.4", "question": "When can free radical formation occur in the context of coronary artery disease?", "answer_src": "In the context of coronary artery disease", "follow_up_question": "What specific enzyme's activity is copper (Cu) essential for in ldl oxidation reactions?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "54.5", "question": "Which enzyme catalyzes LDL oxidation reactions?", "answer_src": "Catalyse ldl oxidation reactions", "follow_up_question": "What are some examples of enzymes that catalyze LDL oxidation reactions?", "follow_up_response": "copper ( cu )", "follow_up_response_bt": "Cu"}], "turn_2": [{"question_id": "54.6", "question": "How does copper relate to the pathogenesis of atherosclerotic disease?", "answer_src": "Copper (Cu) is an essential micronutrient for enzymes that catalyse LDL oxidation reactions.", "follow_up_question": "What specific role do these enzymes play in the oxidation of LDL?", "follow_up_response": "They catalyse LDL oxidation reactions", "follow_up_response_bt": "They catalyze LDL oxidation reactions and regulate the immune system"}, {"question_id": "54.7", "question": "What specific reaction does oxidation catalyze in LDL according to the text?", "answer_src": "ldl oxidation reactions", "follow_up_question": "What enzymes are copper (Cu) essential for in this oxidation process?", "follow_up_response": "enzymes that catalyse ldl oxidation reactions", "follow_up_response_bt": "enzymes that catalyz[e] LDL oxidation reactions"}, {"question_id": "54.8", "question": "What specific function do these enzymes catalyse?", "answer_src": "ldl oxidation reactions", "follow_up_question": "What enzymes are copper (Cu) essential for?", "follow_up_response": "enzymes that catalyse ldl oxidation reactions", "follow_up_response_bt": "Enzymes that catalyze LDL oxidation reactions and regulate the immune system"}, {"question_id": "54.9", "question": "What specific enzyme's activity is copper (Cu) essential for in ldl oxidation reactions?", "answer_src": "atherosclerotic disease is the most important cause of mortality in the world . oxidation is an important pathway in the pathogenesis of coronary artery disease ( cad ) through oxidation of low - density lipoprotein ( ldl ) and free radical formation . copper ( cu ) is an essential micronutrient for enzymes that catalyse ldl oxidation reactions .", "follow_up_question": "Which specific enzymes' activity is copper (Cu) essential for in ldl oxidation reactions?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "54.10", "question": "What are some examples of enzymes that catalyze LDL oxidation reactions?", "answer_src": "copper ( cu )", "follow_up_question": "Which specific enzymes require copper (Cu) for their function in LDL oxidation?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "54.11", "question": "What specific role do these enzymes play in the oxidation of LDL?", "answer_src": "They catalyse LDL oxidation reactions", "follow_up_question": "How many such enzymes are mentioned in the text that catalyse LDL oxidation reactions?", "follow_up_response": "1", "follow_up_response_bt": "1"}, {"question_id": "54.12", "question": "What enzymes are copper (Cu) essential for in this oxidation process?", "answer_src": "enzymes that catalyse ldl oxidation reactions", "follow_up_question": "Which specific enzymes require copper (Cu) for their function in ldl oxidation?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "54.13", "question": "What enzymes are copper (Cu) essential for?", "answer_src": "enzymes that catalyse ldl oxidation reactions", "follow_up_question": "What specific ldl oxidation reaction is catalyzed by these enzymes?", "follow_up_response": "ldl oxidation reactions", "follow_up_response_bt": "No Answer"}, {"question_id": "54.14", "question": "Which specific enzymes' activity is copper (Cu) essential for in ldl oxidation reactions?", "answer_src": "atherosclerotic disease is the most important cause of mortality in the world . oxidation is an important pathway in the pathogenesis of coronary artery disease ( cad ) through oxidation of low - density lipoprotein ( ldl ) and free radical formation . copper ( cu ) is an essential micronutrient for enzymes that catalyse ldl oxidation reactions .", "follow_up_question": "Which enzymes' activity specifically is copper (Cu) essential for in ldl oxidation reactions?", "follow_up_response": "No Answer", "follow_up_response_bt": "enzymes that catalyze LDL oxidation reactions"}, {"question_id": "54.15", "question": "Which specific enzymes require copper (Cu) for their function in LDL oxidation?", "answer_src": "atherosclerotic disease is the most important cause of mortality in the world . oxidation is an important pathway in the pathogenesis of coronary artery disease ( cad ) through oxidation of low - density lipoprotein ( ldl ) and free radical formation . copper ( cu ) is an essential micronutrient for enzymes that catalyse ldl oxidation reactions .", "follow_up_question": "What specific enzymes are mentioned in the text as requiring copper (Cu) for their function in LDL oxidation?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 55, "src": "situs inversus totalis is a rare condition with a predicted incidence of one in 10,000 among the general population , the aetiologic factors for which are still not completely understood . in a patient with situs inversus totalis , not just the diagnosis of any acute abdomen pathology is difficult due to distorted anatomy and transposition of thoraco abdominal viscera but equally challenging is the anaesthetic management during the respective surgical procedure . we are reporting a patient who had situs inversus totalis and was operated for open cholecystectomy .", "mt": "In un paziente con sito inversus totalis , non solo la diagnosi di qualsiasi patologia acuta dell'addome è difficile a causa di anatomia distorta e trasposizione delle viscere abdominali toraciche , ma altrettanto impegnativa è la gestione anestetica durante la procedura chirurgica rispettiva . Stiamo riportando un paziente che ha avuto sito inversus totalis e che è stato operato per una colecistectomia aperta .", "pert_mt": "In un paziente con sito inversus totalis, non solo la diagnosi di qualsiasi patologia acuta dell'addome è difficile a causa di anatomia distorta e trasposizione delle viscere abdominali toraciche, ma altrettanto impegnativa è la gestione anestetica durante la procedura chirurgica rispettiva. Stiamo riportando un paziente che ha avuto sito inversus totalis e che è stato operato per una colecistectomia aperta, e il recupero postoperatorio è stato più lungo del previsto.", "bt": "In a patient with sito inversus totalis, not only is the diagnosis of any acute abdominal pathology difficult due to distorted anatomy and transposition of the abdominal viscera of the chest, but equally demanding is the management of anesthesia during the respective surgical procedure.We report a patient who had had sito inversus totalis and who was operated on for an open cholecistectomy, and the postoperative recovery was longer than expected.", "questions_src": ["What is the predicted incidence of situs inversus totalis among the general population?", "Who faces challenges in diagnosing acute abdomen pathologies in patients with situs inversus totalis?", "Where are the thoraco abdominal viscera transposed in a patient with situs inversus totalis?", "When might the anaesthetic management during surgical procedures be more challenging for patients with situs inversus totalis?", "Which diagnostic method is particularly difficult to use in patients with situs inversus totalis?"], "answers_src": ["one in 10,000", "the diagnosis of any acute abdomen pathology", "transposed", "during the respective surgical procedure", "any acute abdomen pathology"], "answers_bt": ["Not specified", "Patients with situs inversus totalis", "From the chest to the abdomen", "Anesthesia management during surgical procedures", "Diagnosis of acute abdominal pathology"], "multiturn": {"turn_1": [{"question_id": "55.1", "question": "What is the predicted incidence of situs inversus totalis among the general population?", "answer_src": "one in 10,000", "follow_up_question": "What specific thoraco-abdominal viscera are transposed in a patient with situs inversus totalis?", "follow_up_response": "thoraco abdominal viscera", "follow_up_response_bt": "abdominal viscera of the chest"}, {"question_id": "55.2", "question": "Who faces challenges in diagnosing acute abdomen pathologies in patients with situs inversus totalis?", "answer_src": "the diagnosis of any acute abdomen pathology", "follow_up_question": "What specific anatomical distortion makes diagnosing acute abdomen pathologies difficult in patients with situs inversus totalis?", "follow_up_response": "Distorted anatomy and transposition of thoraco-abdominal viscera", "follow_up_response_bt": "Distorted anatomy and transposition of the abdominal viscera of the chest"}, {"question_id": "55.3", "question": "Where are the thoraco abdominal viscera transposed in a patient with situs inversus totalis?", "answer_src": "transposed", "follow_up_question": "What specific thoraco abdominal viscera are typically transposed in situs inversus totalis?", "follow_up_response": "Liver and gallbladder", "follow_up_response_bt": "Abdominal viscera of the chest"}, {"question_id": "55.4", "question": "When might the anaesthetic management during surgical procedures be more challenging for patients with situs inversus totalis?", "answer_src": "during the respective surgical procedure", "follow_up_question": "What specific thoraco-abdominal viscera are transposed in a patient with situs inversus totalis?", "follow_up_response": "thoraco abdominal viscera", "follow_up_response_bt": "abdominal viscera of the chest"}, {"question_id": "55.5", "question": "Which diagnostic method is particularly difficult to use in patients with situs inversus totalis?", "answer_src": "any acute abdomen pathology", "follow_up_question": "What specific thoraco-abdominal organs are transposed in situs inversus totalis?", "follow_up_response": "thoracic and abdominal organs", "follow_up_response_bt": "Abdominal viscera"}], "turn_2": [{"question_id": "55.6", "question": "What specific thoraco-abdominal viscera are transposed in a patient with situs inversus totalis?", "answer_src": "thoraco abdominal viscera", "follow_up_question": "Which surgical procedure did the patient with situs inversus totalis undergo?", "follow_up_response": "open cholecystectomy", "follow_up_response_bt": "open cholecistectomy"}, {"question_id": "55.7", "question": "What specific anatomical distortion makes diagnosing acute abdomen pathologies difficult in patients with situs inversus totalis?", "answer_src": "Distorted anatomy and transposition of thoraco-abdominal viscera", "follow_up_question": "How does the transposition of thoraco-abdominal viscera specifically complicate the diagnosis of acute abdomen pathologies?", "follow_up_response": "not just the diagnosis of any acute abdomen pathology is difficult due to distorted anatomy and transposition of thoraco abdominal viscera", "follow_up_response_bt": "Due to distorted anatomy and transposition of the abdominal viscera of the chest"}, {"question_id": "55.8", "question": "What specific thoraco abdominal viscera are typically transposed in situs inversus totalis?", "answer_src": "Liver and gallbladder", "follow_up_question": "Which other organs might also be transposed in a case of situs inversus totalis?", "follow_up_response": "Thoraco abdominal viscera", "follow_up_response_bt": "Abdominal viscera"}, {"question_id": "55.9", "question": "What specific thoraco-abdominal viscera are transposed in a patient with situs inversus totalis?", "answer_src": "thoraco abdominal viscera", "follow_up_question": "Which surgical procedure did the patient with situs inversus totalis undergo?", "follow_up_response": "open cholecystectomy", "follow_up_response_bt": "open cholecistectomy"}, {"question_id": "55.10", "question": "What specific thoraco-abdominal organs are transposed in situs inversus totalis?", "answer_src": "thoracic and abdominal organs", "follow_up_question": "Which thoracic and abdominal organs are typically transposed in situs inversus totalis?", "follow_up_response": "thoracic and abdominal viscera", "follow_up_response_bt": "Abdominal viscera of the chest"}], "turn_3": [{"question_id": "55.11", "question": "Which surgical procedure did the patient with situs inversus totalis undergo?", "answer_src": "open cholecystectomy", "follow_up_question": "What anatomical challenges did the patient face during the open cholecystectomy due to their situs inversus totalis?", "follow_up_response": "distorted anatomy and transposition of thoraco abdominal viscera", "follow_up_response_bt": "Distorted anatomy and transposition of the abdominal viscera of the chest"}, {"question_id": "55.12", "question": "How does the transposition of thoraco-abdominal viscera specifically complicate the diagnosis of acute abdomen pathologies?", "answer_src": "not just the diagnosis of any acute abdomen pathology is difficult due to distorted anatomy and transposition of thoraco abdominal viscera", "follow_up_question": "What specific thoraco-abdominal viscera are transposed in situs inversus totalis?", "follow_up_response": "thoracic and abdominal organs", "follow_up_response_bt": "Abdominal viscera of the chest"}, {"question_id": "55.13", "question": "Which other organs might also be transposed in a case of situs inversus totalis?", "answer_src": "Thoraco abdominal viscera", "follow_up_question": "What specific thoraco abdominal viscera were transposed in this patient's case?", "follow_up_response": "No Answer", "follow_up_response_bt": "abdominal viscera of the chest"}, {"question_id": "55.14", "question": "Which surgical procedure did the patient with situs inversus totalis undergo?", "answer_src": "open cholecystectomy", "follow_up_question": "What anatomical challenges did the patient face during the open cholecystectomy due to their situs inversus totalis?", "follow_up_response": "distorted anatomy and transposition of thoraco abdominal viscera", "follow_up_response_bt": "Distorted anatomy and transposition of the abdominal viscera of the chest"}, {"question_id": "55.15", "question": "Which thoracic and abdominal organs are typically transposed in situs inversus totalis?", "answer_src": "thoracic and abdominal viscera", "follow_up_question": "What specific thoracic and abdominal organs are commonly transposed in situs inversus totalis?", "follow_up_response": "thoracic and abdominal viscera", "follow_up_response_bt": "Abdominal viscera of the chest"}]}}
{"id": 56, "src": "the optimal levels of these variables were quantified by the central composite design using rsm , for establishment of a significant mathematical model with a coefficient determination of r2 = 0.91 . the validation experimental was consistent with the prediction model . the optimum levels of process variables were temperature ( 36.56c ) , ph ( 7.27 ) , substrate concentration ( 3.55 g / l ) , inoculum size ( 3.69 ml ) , and agitation speed ( 194.44 rpm ) .", "mt": "I livelli ottimali di queste variabili sono stati quantificati dal progetto composto centrale utilizzando rsm , per stabilire un modello matematico significativo con una determinazione del coefficiente di r2 = 0,91 . La validazione sperimentale è stata coerente con il modello di previsione . I livelli ottimali di variabili di processo sono stati temperatura ( 36,56c) , ph ( 7,27), concentrazione di substrato ( 3,55 g / l), dimensione di inocolo ( 3,69 ml) e velocità di agitazione ( 194,44 rpm).", "pert_mt": "I livelli ottimali di queste variabili sono stati quantificati dal progetto composto centrale utilizzando rsm, per stabilire un modello matematico significativo con una determinazione del coefficiente di r2 = 0,91. La validazione sperimentale è stata coerente con il modello di previsione. I livelli ottimali di variabili di processo sono stati temperatura (36,56°C), pH (7,27), concentrazione di substrato (3,55 g/l), dimensione di inocolo (3,69 ml), velocità di agitazione (194,44 rpm), e durata della culturazione (48 ore).", "bt": "The optimal levels of these variables were quantified by the central composite project using rsm, to establish a significant mathematical model with a determination of the coefficient of r2 = 0.91.The experimental validation was consistent with the prediction model.The optimal levels of the process variables were temperature (36.56°C), pH (7.27), substrate concentration (3.55 g/l), inoculum size (3.69 ml), agitation speed (194.44 rpm), and culture duration (48 hours).", "questions_src": ["What was the coefficient determination value of R²?", "Who established a significant mathematical model?", "Where was the optimal levels of process variables quantified?", "When was the validation experimental consistent with the prediction model?", "Which process variable had an optimum level of 3.69 ml?"], "answers_src": ["0.91", "rsm", "the central composite design", "the validation experimental", "inoculum size"], "answers_bt": ["0.91", "The central composite project using rsm", "The central composite project using rsm", "The experiment", "Inoculum size"], "multiturn": {"turn_1": [{"question_id": "56.1", "question": "What was the coefficient determination value of R²?", "answer_src": "0.91", "follow_up_question": "What was the optimal temperature set for the process?", "follow_up_response": "36.56c", "follow_up_response_bt": "36.56°C"}, {"question_id": "56.2", "question": "Who established a significant mathematical model?", "answer_src": "rsm", "follow_up_question": "What is the coefficient determination of the significant mathematical model?", "follow_up_response": "0.91", "follow_up_response_bt": "0.91"}, {"question_id": "56.3", "question": "Where was the optimal levels of process variables quantified?", "answer_src": "the central composite design", "follow_up_question": "What was the coefficient determination value of the mathematical model?", "follow_up_response": "0.91", "follow_up_response_bt": "0.91"}, {"question_id": "56.4", "question": "When was the validation experimental consistent with the prediction model?", "answer_src": "the validation experimental", "follow_up_question": "What was the coefficient determination of r² for the significant mathematical model?", "follow_up_response": "0.91", "follow_up_response_bt": "0.91"}, {"question_id": "56.5", "question": "Which process variable had an optimum level of 3.69 ml?", "answer_src": "inoculum size", "follow_up_question": "What is the optimum temperature for the process?", "follow_up_response": "36.56c", "follow_up_response_bt": "36.56°C"}], "turn_2": [{"question_id": "56.6", "question": "What was the optimal temperature set for the process?", "answer_src": "36.56c", "follow_up_question": "What was the optimal substrate concentration set for the process?", "follow_up_response": "3.55 g / l", "follow_up_response_bt": "3.55 g/l"}, {"question_id": "56.7", "question": "What is the coefficient determination of the significant mathematical model?", "answer_src": "0.91", "follow_up_question": "What is the optimum temperature for the process?", "follow_up_response": "36.56c", "follow_up_response_bt": "36.56°C"}, {"question_id": "56.8", "question": "What was the coefficient determination value of the mathematical model?", "answer_src": "0.91", "follow_up_question": "What was the optimal temperature for the process?", "follow_up_response": "36.56c", "follow_up_response_bt": "36.56°C"}, {"question_id": "56.9", "question": "What was the coefficient determination of r² for the significant mathematical model?", "answer_src": "0.91", "follow_up_question": "What was the optimum temperature for the process?", "follow_up_response": "36.56c", "follow_up_response_bt": "36.56°C"}, {"question_id": "56.10", "question": "What is the optimum temperature for the process?", "answer_src": "36.56c", "follow_up_question": "What is the optimum substrate concentration for the process?", "follow_up_response": "3.55 g / l", "follow_up_response_bt": "3.55 g/l"}], "turn_3": [{"question_id": "56.11", "question": "What was the optimal substrate concentration set for the process?", "answer_src": "3.55 g / l", "follow_up_question": "What was the optimal temperature set for the process?", "follow_up_response": "36.56c", "follow_up_response_bt": "36.56°C"}, {"question_id": "56.12", "question": "What is the optimum temperature for the process?", "answer_src": "36.56c", "follow_up_question": "What is the optimum substrate concentration for the process?", "follow_up_response": "3.55 g / l", "follow_up_response_bt": "3.55 g/l"}, {"question_id": "56.13", "question": "What was the optimal temperature for the process?", "answer_src": "36.56c", "follow_up_question": "What was the optimal substrate concentration for the process?", "follow_up_response": "3.55 g / l", "follow_up_response_bt": "3.55 g/l"}, {"question_id": "56.14", "question": "What was the optimum temperature for the process?", "answer_src": "36.56c", "follow_up_question": "What was the optimum substrate concentration for the process?", "follow_up_response": "3.55 g / l", "follow_up_response_bt": "3.55 g/l"}, {"question_id": "56.15", "question": "What is the optimum substrate concentration for the process?", "answer_src": "3.55 g / l", "follow_up_question": "What is the optimum temperature for the process?", "follow_up_response": "36.56c", "follow_up_response_bt": "36.56°C"}]}}
{"id": 57, "src": "the aim of this study was to determine the frequency of pseudoprogression in a cohort of glioblastoma ( gbm ) patients following radiotherapy / temozolomide ( rt / tmz ) by comparing macdonald criterial to response assessment in neuro - oncology ( rano ) criteria . the impact on prognosis and survival analysis was also studied . materials and methods .", "mt": "Lo scopo di questo studio era quello di determinare la frequenza di pseudoprogressione in una coorte di pazienti con glioblastoma (gbm) che avevano seguito la radioterapia / temozolomide (rt / tmz) confrontando il criterio di Macdonald con la valutazione della risposta nei criteri neuro-oncologici ( rano).", "pert_mt": "Lo scopo di questo studio era quello di determinare la frequenza di pseudoprogressione in una coorte di pazienti con glioblastoma (gbm) che avevano seguito la radioterapia / temozolomide (rt / tmz), confrontando il criterio di Macdonald con la valutazione della risposta nei criteri neuro-oncologici (rANO), e considerando anche l'efficacia del trattamento.", "bt": "The purpose of this study was to determine the frequency of pseudoprogression in a cohort of glioblastoma (gbm) patients who had received radiation therapy/temozolomide (rt/tmz), by comparing Macdonald's criterion with the assessment of response to neuro-oncological criteria (rANO), and also considering the effectiveness of treatment.", "questions_src": ["What was the main goal of the study?", "Who were the participants in the study?", "Where was the study conducted?", "When did the study take place?", "Which criteria were used to assess response to treatment?"], "answers_src": ["To determine the frequency of pseudoprogression in a cohort of glioblastoma (GBM) patients following radiotherapy/temozolomide (RT/TMZ) by comparing MacDonald criteria to Response Assessment in Neuro-Oncology (RANO) criteria", "Glioblastoma (GBM) patients", "Not specified", "Not specified", "MacDonald criteria and Response Assessment in Neuro-Oncology (RANO) criteria"], "answers_bt": ["[\"To determine the frequency of pseudoprogression in a cohort of glioblastoma (gbm) patients who had received radiation therapy/temozolomide (rt/tmz)\", \"Glioblastoma (gbm) patients who had received radiation therapy/temozolomide (rt/tmz)\", \"No Answer\", \"No Answer\", \"Macdonald\"s criterion and the assessment of response to neuro-oncological criteria (rANO)\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "57.1", "question": "What was the main goal of the study?", "answer_src": "To determine the frequency of pseudoprogression in a cohort of glioblastoma (GBM) patients following radiotherapy/temozolomide (RT/TMZ) by comparing MacDonald criteria to Response Assessment in Neuro-Oncology (RANO) criteria", "follow_up_question": "How were the patients' responses assessed in this study?", "follow_up_response": "macdonald criterial to response assessment in neuro - oncology ( rano ) criteria", "follow_up_response_bt": "rANO"}, {"question_id": "57.2", "question": "Who were the participants in the study?", "answer_src": "Glioblastoma (GBM) patients", "follow_up_question": "What specific criteria did the study use to assess response?", "follow_up_response": "Macdonald criteria and Response Assessment in Neuro-Oncology (RANO) criteria", "follow_up_response_bt": "rANO"}, {"question_id": "57.3", "question": "Where was the study conducted?", "answer_src": "Not specified", "follow_up_question": "What were the two criteria used to assess response in the study?", "follow_up_response": "Macdonald criteria and RANO criteria", "follow_up_response_bt": "Macdonald's criterion and rANO"}, {"question_id": "57.4", "question": "When did the study take place?", "answer_src": "Not specified", "follow_up_question": "What were the primary endpoints of the study?", "follow_up_response": "To determine the frequency of pseudoprogression in a cohort of glioblastoma (gbm) patients following radiotherapy / temozolomide (rt / TMZ)", "follow_up_response_bt": "To determine the frequency of pseudoprogression"}, {"question_id": "57.5", "question": "Which criteria were used to assess response to treatment?", "answer_src": "MacDonald criteria and Response Assessment in Neuro-Oncology (RANO) criteria", "follow_up_question": "What is the difference between the MacDonald criteria and RANO criteria used in this study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "57.6", "question": "How were the patients' responses assessed in this study?", "answer_src": "macdonald criterial to response assessment in neuro - oncology ( rano ) criteria", "follow_up_question": "What is the difference between macdonald criterial and rano criteria?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "57.7", "question": "What specific criteria did the study use to assess response?", "answer_src": "Macdonald criteria and Response Assessment in Neuro-Oncology (RANO) criteria", "follow_up_question": "What is the difference between Macdonald criteria and RANO criteria according to the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "57.8", "question": "What were the two criteria used to assess response in the study?", "answer_src": "Macdonald criteria and RANO criteria", "follow_up_question": "What is the main difference between Macdonald criteria and RANO criteria according to the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "57.9", "question": "What were the primary endpoints of the study?", "answer_src": "To determine the frequency of pseudoprogression in a cohort of glioblastoma (gbm) patients following radiotherapy / temozolomide (rt / TMZ)", "follow_up_question": "How did the study define pseudoprogression in glioblastoma patients?", "follow_up_response": "MacDonald criteria to response assessment in neuro-oncology (RANO) criteria", "follow_up_response_bt": "Macdonald's criterion"}, {"question_id": "57.10", "question": "What is the difference between the MacDonald criteria and RANO criteria used in this study?", "answer_src": "the aim of this study was to determine the frequency of pseudoprogression in a cohort of glioblastoma ( gbm ) patients following radiotherapy / temozolomide ( rt / tmz ) by comparing macdonald criterial to response assessment in neuro - oncology ( rano ) criteria . the impact on prognosis and survival analysis was also studied . materials and methods .", "follow_up_question": "How did the study define pseudoprogression in the context of glioblastoma patients?", "follow_up_response": "MacDonald criteria to response assessment in neuro-oncology (RANO) criteria", "follow_up_response_bt": "Macdonald's criterion"}], "turn_3": [{"question_id": "57.11", "question": "What is the difference between macdonald criterial and rano criteria?", "answer_src": "the aim of this study was to determine the frequency of pseudoprogression in a cohort of glioblastoma ( gbm ) patients following radiotherapy / temozolomide ( rt / tmz ) by comparing macdonald criterial to response assessment in neuro - oncology ( rano ) criteria . the impact on prognosis and survival analysis was also studied . materials and methods .", "follow_up_question": "How did the study define pseudoprogression in the context of glioblastoma patients?", "follow_up_response": "MacDonald criteria to response assessment in neuro-oncology (RANO) criteria", "follow_up_response_bt": "Macdonald's criterion"}, {"question_id": "57.12", "question": "What is the difference between Macdonald criteria and RANO criteria according to the study?", "answer_src": "the aim of this study was to determine the frequency of pseudoprogression in a cohort of glioblastoma ( gbm ) patients following radiotherapy / temozolomide ( rt / tmz ) by comparing macdonald criterial to response assessment in neuro - oncology ( rano ) criteria . the impact on prognosis and survival analysis was also studied . materials and methods .", "follow_up_question": "How did the study define pseudoprogression in the context of glioblastoma patients?", "follow_up_response": "MacDonald criteria to response assessment in neuro-oncology (RANO) criteria", "follow_up_response_bt": "Macdonald's criterion"}, {"question_id": "57.13", "question": "What is the main difference between Macdonald criteria and RANO criteria according to the text?", "answer_src": "the aim of this study was to determine the frequency of pseudoprogression in a cohort of glioblastoma ( gbm ) patients following radiotherapy / temozolomide ( rt / tmz ) by comparing macdonald criterial to response assessment in neuro - oncology ( rano ) criteria . the impact on prognosis and survival analysis was also studied . materials and methods .", "follow_up_question": "How does the study plan to analyze the impact on prognosis and survival?", "follow_up_response": "was studied", "follow_up_response_bt": "No Answer"}, {"question_id": "57.14", "question": "How did the study define pseudoprogression in glioblastoma patients?", "answer_src": "MacDonald criteria to response assessment in neuro-oncology (RANO) criteria", "follow_up_question": "What were the key differences between the MacDonald criteria and RANO criteria used in this study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "57.15", "question": "How did the study define pseudoprogression in the context of glioblastoma patients?", "answer_src": "MacDonald criteria to response assessment in neuro-oncology (RANO) criteria", "follow_up_question": "What were the key differences between the MacDonald criteria and RANO criteria used in this study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 58, "src": "the first step in gene expression , transcription , is modulated by the interaction of transcription factors with their corresponding binding sites on the dna sequence . pscan is a software tool that scans a set of sequences ( e.g. promoters ) from co - regulated or co - expressed genes with motifs describing the binding specificity of known transcription factors and assesses which motifs are significantly over- or under - represented , providing thus hints on which transcription factors could be common regulators of the genes studied , together with the location of their candidate binding sites in the sequences . pscan does not resort to comparisons with orthologous sequences and experimental results show that it compares favorably to other tools for the same task in terms of false positive predictions and computation time .", "mt": "pscan è uno strumento software che scanna un insieme di sequenze (ad esempio promotori) da geni co-regolati o co-espressi con motivi che descrivono la specificità di legame di fattori di trascrizione noti e valuta quali motivi sono significativamente sovrapprezzati o sotto-representati , fornendo così indizi su quali fattori di trascrizione potrebbero essere comuni regolatori dei geni studiati , insieme alla posizione dei loro siti di legame candidati nei computer . pscan non fa paragoni con sequenze ortologiche e i risultati sperimentali mostrano che si confronta favorabilmente con altri strumenti per lo stesso compito in termini di previsioni false positive e tempo di ricorso .", "pert_mt": "pscan è uno strumento software che scanna un insieme di sequenze (ad esempio promotori) da geni co-regolati o co-espressi con motivi che descrivono la specificità di legame di fattori di trascrizione noti e valuta quali motivi sono significativamente sovrapprezzati o sotto-representati, fornendo così indizi su quali fattori di trascrizione potrebbero essere comuni regolatori dei geni studiati, insieme alla posizione dei loro siti di legame candidati nei computer. pscan non fa paragoni con sequenze ortologiche e i risultati sperimentali mostrano che si confronta favorabilmente con altri strumenti per lo stesso compito in termini di previsioni false positive e tempo di ricorso, ma non considera l'effetto delle varianti genetiche sui geni", "bt": "pscan is a software tool that scans a set of sequences (e.g. promoters) of genes that are co-regulated or co-expressed with motifs that describe the specificity of the binding of known transcription factors and which motifs are significantly over- or under-represented, thus providing clues as to which transcription factors may be common to the genes studied by regulators, along with the location of their candidate genes in these computers. pscan is not compared with ortho- sequences and experimental results show that if compared favorably with other tools for the same purpose in terms of false positive predictions and time of use, it does not consider the effect of genetic variants on genes.", "questions_src": ["What is the first step in gene expression?", "Who uses pscan to scan sequences?", "Where do you find the binding sites for transcription factors?", "When is pscan used in gene regulation studies?", "Which tool does pscan compare favorably to in terms of performance?"], "answers_src": ["[\"Transcription\"], [\"Researchers\"], [\"On the dna sequence\"], [\"In gene regulation studies\"], [\"Other tools\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"Scanning a set of sequences (e.g. promoters) of genes\"], [\"Researchers and scientists\"], [\"Motifs that describe the specificity of the binding of known transcription factors\"], [\"In gene regulation studies\"], [\"Other tools for the same purpose\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "58.1", "question": "What is the first step in gene expression?", "answer_src": "[\"Transcription\"], [\"Researchers\"], [\"On the dna sequence\"], [\"In gene regulation studies\"], [\"Other tools\"]", "follow_up_question": "How does PSCAN assess the significance of transcription factor binding sites?", "follow_up_response": "PSCAN assesses the significance of transcription factor binding sites by assessing which motifs are significantly over- or under-represented", "follow_up_response_bt": "It assesses the significance of transcription factor binding sites by determining which motifs are significantly over- or under-represented."}, {"question_id": "58.2", "question": "Who uses pscan to scan sequences?", "answer_src": "the first step in gene expression , transcription , is modulated by the interaction of transcription factors with their corresponding binding sites on the dna sequence . pscan is a software tool that scans a set of sequences ( e.g. promoters ) from co - regulated or co - expressed genes with motifs describing the binding specificity of known transcription factors and assesses which motifs are significantly over- or under - represented , providing thus hints on which transcription factors could be common regulators of the genes studied , together with the location of their candidate binding sites in the sequences . pscan does not resort to comparisons with orthologous sequences and experimental results show that it compares favorably to other tools for the same task in terms of false positive predictions and computation time .", "follow_up_question": "What types of sequences does pscan scan?", "follow_up_response": "a set of sequences ( e.g. promoters ) from co - regulated or co - expressed genes", "follow_up_response_bt": "a set of sequences (e.g. promoters) of genes"}, {"question_id": "58.3", "question": "Where do you find the binding sites for transcription factors?", "answer_src": "the first step in gene expression , transcription , is modulated by the interaction of transcription factors with their corresponding binding sites on the dna sequence . pscan is a software tool that scans a set of sequences ( e.g. promoters ) from co - regulated or co - expressed genes with motifs describing the binding specificity of known transcription factors and assesses which motifs are significantly over- or under - represented , providing thus hints on which transcription factors could be common regulators of the genes studied , together with the location of their candidate binding sites in the sequences . pscan does not resort to comparisons with orthologous sequences and experimental results show that it compares favorably to other tools for the same task in terms of false positive predictions and computation time .", "follow_up_question": "What information does PSCAN provide about the candidate binding sites?", "follow_up_response": "Hints on which transcription factors could be common regulators of the genes studied, together with the location of their candidate binding sites in the sequences.", "follow_up_response_bt": "Clues as to which transcription factors may be common to the genes studied by regulators, along with the location of their candidate genes"}, {"question_id": "58.4", "question": "When is pscan used in gene regulation studies?", "answer_src": "the first step in gene expression , transcription , is modulated by the interaction of transcription factors with their corresponding binding sites on the dna sequence . pscan is a software tool that scans a set of sequences ( e.g. promoters ) from co - regulated or co - expressed genes with motifs describing the binding specificity of known transcription factors and assesses which motifs are significantly over- or under - represented , providing thus hints on which transcription factors could be common regulators of the genes studied , together with the location of their candidate binding sites in the sequences . pscan does not resort to comparisons with orthologous sequences and experimental results show that it compares favorably to other tools for the same task in terms of false positive predictions and computation time .", "follow_up_question": "What types of sequences does pscan scan for gene regulation studies?", "follow_up_response": "promoters", "follow_up_response_bt": "a set of sequences (e.g. promoters)"}, {"question_id": "58.5", "question": "Which tool does pscan compare favorably to in terms of performance?", "answer_src": "the first step in gene expression , transcription , is modulated by the interaction of transcription factors with their corresponding binding sites on the dna sequence . pscan is a software tool that scans a set of sequences ( e.g. promoters ) from co - regulated or co - expressed genes with motifs describing the binding specificity of known transcription factors and assesses which motifs are significantly over- or under - represented , providing thus hints on which transcription factors could be common regulators of the genes studied , together with the location of their candidate binding sites in the sequences . pscan does not resort to comparisons with orthologous sequences and experimental results show that it compares favorably to other tools for the same task in terms of false positive predictions and computation time .", "follow_up_question": "What metrics do experimental results show pscan compares favorably to?", "follow_up_response": "other tools", "follow_up_response_bt": "false positive predictions and time of use"}], "turn_2": [{"question_id": "58.6", "question": "How does PSCAN assess the significance of transcription factor binding sites?", "answer_src": "PSCAN assesses the significance of transcription factor binding sites by assessing which motifs are significantly over- or under-represented", "follow_up_question": "What metrics does PSCAN use to determine if a motif is significantly over- or under-represented?", "follow_up_response": "False positive predictions and computation time", "follow_up_response_bt": "False positive predictions and time of use"}, {"question_id": "58.7", "question": "What types of sequences does pscan scan?", "answer_src": "a set of sequences ( e.g. promoters ) from co - regulated or co - expressed genes", "follow_up_question": "Which specific characteristics of the sequences do pscan use to identify potential transcription factor binding sites?", "follow_up_response": "motifs describing the binding specificity of known transcription factors", "follow_up_response_bt": "motifs that describe the specificity of the binding of known transcription factors"}, {"question_id": "58.8", "question": "What information does PSCAN provide about the candidate binding sites?", "answer_src": "Hints on which transcription factors could be common regulators of the genes studied, together with the location of their candidate binding sites in the sequences.", "follow_up_question": "What specific method does PSCAN use to identify candidate binding sites?", "follow_up_response": "motifs describing the binding specificity of known transcription factors", "follow_up_response_bt": "motifs that describe the specificity of the binding of known transcription factors"}, {"question_id": "58.9", "question": "What types of sequences does pscan scan for gene regulation studies?", "answer_src": "promoters", "follow_up_question": "Which specific characteristics of the sequences do pscan's motifs describe?", "follow_up_response": "binding specificity of known transcription factors", "follow_up_response_bt": "the specificity of the binding of known transcription factors"}, {"question_id": "58.10", "question": "What metrics do experimental results show pscan compares favorably to?", "answer_src": "other tools", "follow_up_question": "What aspects of comparison do experimental results show pscan compares favorably to?", "follow_up_response": "other tools", "follow_up_response_bt": "false positive predictions and time of use"}], "turn_3": [{"question_id": "58.11", "question": "What metrics does PSCAN use to determine if a motif is significantly over- or under-represented?", "answer_src": "False positive predictions and computation time", "follow_up_question": "What other metric does PSCAN use besides false positive predictions and computation time?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "58.12", "question": "Which specific characteristics of the sequences do pscan use to identify potential transcription factor binding sites?", "answer_src": "motifs describing the binding specificity of known transcription factors", "follow_up_question": "Which motifs does pscan assess as being significantly over- or under-represented?", "follow_up_response": "motifs describing the binding specificity of known transcription factors", "follow_up_response_bt": "motifs that describe the specificity of the binding of known transcription factors"}, {"question_id": "58.13", "question": "What specific method does PSCAN use to identify candidate binding sites?", "answer_src": "motifs describing the binding specificity of known transcription factors", "follow_up_question": "Which motifs does PSCAN assess for significant over- or under-representation?", "follow_up_response": "motifs describing the binding specificity of known transcription factors", "follow_up_response_bt": "motifs that describe the specificity of the binding of known transcription factors"}, {"question_id": "58.14", "question": "Which specific characteristics of the sequences do pscan's motifs describe?", "answer_src": "binding specificity of known transcription factors", "follow_up_question": "Which sequences does pscan scan for motif analysis?", "follow_up_response": "a set of sequences ( e.g. promoters ) from co - regulated or co - expressed genes", "follow_up_response_bt": "a set of sequences (e.g. promoters) of genes"}, {"question_id": "58.15", "question": "What aspects of comparison do experimental results show pscan compares favorably to?", "answer_src": "other tools", "follow_up_question": "What metric do experimental results show pscan compares favorably to other tools in?", "follow_up_response": "False positive predictions", "follow_up_response_bt": "False positive predictions and time of use"}]}}
{"id": 59, "src": "this analysis revealed substantial inhibition of erk phosphorylation , yet clinical evaluation did not show tumor regressions . at higher drug exposures afforded by a new amorphous drug formulation,4,5 greater than 80% inhibition of erk phosphorylation in the tumors of patients correlated with clinical response . indeed , the phase 1 clinical data revealed a remarkably high 81% response rate in metastatic melanoma patients treated at an oral dose of 960 mg twice daily.5 these data demonstrate that braf - mutant melanomas are highly dependent on b - raf kinase activity .", "mt": "Questa analisi ha rivelato una sostanziale inibizione della fosforilazione di erk , ma la valutazione clinica non ha mostrato regressioni tumorali . alle esposizioni più elevate dei farmaci fornite da una nuova formulazione di farmaci amorfi,4,5 più di 80% inibzione della fosforilazione di erk nei tumori dei pazienti correlati con la risposta clinica . Infatti, i dati clinici di fase 1 hanno rivelato un tasso di risposta notevolmente elevato dell'81% nei pazienti con melanoma metastatico trattati a una dose orale di 960 mg due volte al giorno.5 Questi dati kin dimostrano che i melanoma braf - mutanti sono fortemente dipendenti dall'attività della b - rafase .", "pert_mt": "Questa analisi ha rivelato una sostanziale inibizione della fosforilazione di erk, ma la valutazione clinica non ha mostrato regressioni tumorali. Alle esposizioni più elevate dei farmaci fornite da una nuova formulazione di farmaci amorfi,4,5 oltre il 80% inibizione della fosforilazione di erk nei tumori dei pazienti correlata con la risposta clinica. Infatti, i dati clinici di fase 1 hanno rivelato un tasso di risposta notevolmente elevato dell'81% nei pazienti con melanoma metastatico trattati a una dose orale di 960 mg due volte al giorno.5 Questi dati kin dimostrano che i melanoma braf-mutanti sono fortemente dipendenti dall'attività della b-rafase.", "bt": "This analysis revealed a substantial inhibition of erythematous phosphorylation, but the clinical evaluation did not show tumor regressions.The higher exposures of drugs provided by a new formulation of amorphous drugs,4,5 over 80% inhibition of erythematous phosphorylation in patients' tumors correlated with the clinical response.In fact, clinical data for phase 1 revealed a remarkably high response rate of 81% in patients with metastatic melanoma treated at an oral dose of 960 mg twice daily.5 These kinase data show that braf-mutant melanoma is strongly dependent on the activity of b-rafase.", "questions_src": ["What was the primary finding of the analysis regarding erk phosphorylation?", "Who showed a correlation between greater than 80% inhibition of erk phosphorylation and clinical response?", "Where were the tumors studied in the clinical trial?", "When was the phase 1 clinical data collected?", "Which type of cancer had a high response rate to the treatment mentioned in the study?"], "answers_src": ["Substantial inhibition of erk phosphorylation", "Patients", "In the tumors of patients", "Phase 1 clinical data", "Metastatic melanoma"], "answers_bt": ["[\"Substantial inhibition of erythematous phosphorylation\", \"Higher exposures of drugs provided by a new formulation of amorphous drugs,4,5\", \"Patients\" tumors\", \"Phase 1\", \"Metastatic melanoma\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "59.1", "question": "What was the primary finding of the analysis regarding erk phosphorylation?", "answer_src": "Substantial inhibition of erk phosphorylation", "follow_up_question": "What percentage of tumors showed clinical response at the highest drug exposure?", "follow_up_response": "81%", "follow_up_response_bt": "81%"}, {"question_id": "59.2", "question": "Who showed a correlation between greater than 80% inhibition of erk phosphorylation and clinical response?", "answer_src": "Patients", "follow_up_question": "What was the oral dose of the drug administered to achieve this response?", "follow_up_response": "960 mg", "follow_up_response_bt": "960 mg"}, {"question_id": "59.3", "question": "Where were the tumors studied in the clinical trial?", "answer_src": "In the tumors of patients", "follow_up_question": "What was the average drug exposure level associated with the clinical response?", "follow_up_response": "80%", "follow_up_response_bt": "80%"}, {"question_id": "59.4", "question": "When was the phase 1 clinical data collected?", "answer_src": "Phase 1 clinical data", "follow_up_question": "What was the oral dose of braf inhibitor used in the study?", "follow_up_response": "960 mg", "follow_up_response_bt": "960 mg"}, {"question_id": "59.5", "question": "Which type of cancer had a high response rate to the treatment mentioned in the study?", "answer_src": "Metastatic melanoma", "follow_up_question": "What was the average percentage of tumor regression observed in the clinical trials?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "59.6", "question": "What percentage of tumors showed clinical response at the highest drug exposure?", "answer_src": "81%", "follow_up_question": "At what oral dose were the 81% response rates observed in metastatic melanoma patients?", "follow_up_response": "960 mg", "follow_up_response_bt": "960 mg"}, {"question_id": "59.7", "question": "What was the oral dose of the drug administered to achieve this response?", "answer_src": "960 mg", "follow_up_question": "At what percentage of erk phosphorylation inhibition correlated with the 81% response rate?", "follow_up_response": "80%", "follow_up_response_bt": "80%"}, {"question_id": "59.8", "question": "What was the average drug exposure level associated with the clinical response?", "answer_src": "80%", "follow_up_question": "What was the oral dose of 960 mg twice daily used for?", "follow_up_response": "treated", "follow_up_response_bt": "treated at an oral dose of 960 mg twice daily"}, {"question_id": "59.9", "question": "What was the oral dose of braf inhibitor used in the study?", "answer_src": "960 mg", "follow_up_question": "At what percentage of erk phosphorylation inhibition correlated with a clinical response?", "follow_up_response": "greater than 80%", "follow_up_response_bt": "80%"}, {"question_id": "59.10", "question": "What was the average percentage of tumor regression observed in the clinical trials?", "answer_src": "this analysis revealed substantial inhibition of erk phosphorylation , yet clinical evaluation did not show tumor regressions . at higher drug exposures afforded by a new amorphous drug formulation,4,5 greater than 80% inhibition of erk phosphorylation in the tumors of patients correlated with clinical response . indeed , the phase 1 clinical data revealed a remarkably high 81% response rate in metastatic melanoma patients treated at an oral dose of 960 mg twice daily.5 these data demonstrate that braf - mutant melanomas are highly dependent on b - raf kinase activity .", "follow_up_question": "What was the oral dose of the drug associated with the 81% response rate?", "follow_up_response": "960 mg", "follow_up_response_bt": "960 mg"}], "turn_3": [{"question_id": "59.11", "question": "At what oral dose were the 81% response rates observed in metastatic melanoma patients?", "answer_src": "960 mg", "follow_up_question": "What was the percentage of tumors showing greater than 80% inhibition of erk phosphorylation?", "follow_up_response": "80%", "follow_up_response_bt": "80%"}, {"question_id": "59.12", "question": "At what percentage of erk phosphorylation inhibition correlated with the 81% response rate?", "answer_src": "80%", "follow_up_question": "What was the oral dose of 960 mg twice daily used in the clinical trial?", "follow_up_response": "metastatic melanoma patients", "follow_up_response_bt": "Patients with metastatic melanoma"}, {"question_id": "59.13", "question": "What was the oral dose of 960 mg twice daily used for?", "answer_src": "treated", "follow_up_question": "What was the phase 1 clinical data response rate?", "follow_up_response": "81%", "follow_up_response_bt": "81%"}, {"question_id": "59.14", "question": "At what percentage of erk phosphorylation inhibition correlated with a clinical response?", "answer_src": "greater than 80%", "follow_up_question": "What was the oral dose of the drug associated with the 81% response rate?", "follow_up_response": "960 mg", "follow_up_response_bt": "960 mg"}, {"question_id": "59.15", "question": "What was the oral dose of the drug associated with the 81% response rate?", "answer_src": "960 mg", "follow_up_question": "At what frequency was the 960 mg dose administered?", "follow_up_response": "twice daily", "follow_up_response_bt": "twice daily"}]}}
{"id": 60, "src": "pediatricsintroduction : the centers for disease control and prevention report that autism spectrum disorder ( asd ) now affects 1 in 88 children in the usa and 1 in 47 in utah . asd is 5 times more likely in boys with 1 in 54 boys identified nationally . more children will be diagnosed with asd this year than with aids , diabetes , and cancer combined .", "mt": "Introduzione pediatrica: i centri per il controllo e la prevenzione delle malattie riferiscono che il disturbo dello spettro autistico (asd) colpisce ora 1 bambino su 88 negli Stati Uniti e 1 bambino su 47 in Utah . l'asd è 5 volte più probabile nei ragazzi con 1 ragazzo su 54 identificato a livello nazionale .", "pert_mt": "Introduzione pediatrica: i centri per il controllo e la prevenzione delle malattie riferiscono che il disturbo dello spettro autistico (asd) colpisce ora 1 bambino su 88 negli Stati Uniti e 1 bambino su 47 in Utah. L'asd è 5 volte più probabile nei ragazzi, con 1 ragazzo su 54 identificato a livello nazionale, se confrontati con le altre regioni.", "bt": "Pediatric introduction: the centers for disease control and prevention report that autism spectrum disorder (asd) now affects 1 in 88 children in the united states and 1 in 47 children in utah asd is 5 times more likely in boys, with 1 in 54 boys nationally identified, compared to other regions.", "questions_src": ["What does the CDC report about autism spectrum disorder in the USA?", "Who is more likely to be diagnosed with ASD according to the sentence?", "Where is ASD more common compared to other states?", "When do you think the number of ASD diagnoses will exceed AIDS, diabetes, and cancer combined?", "Which condition is mentioned as affecting fewer children than ASD according to the sentence?"], "answers_src": ["Autism spectrum disorder now affects 1 in 88 children in the USA and 1 in 47 in Utah", "Boys", "Utah", "This year", "AIDS, diabetes, and cancer"], "answers_bt": ["Autism spectrum disorder now affects 1 in 88 children in the United States and 1 in 47 children in Utah", "Boys", "Utah", "No Answer", "AIDS, diabetes, and cancer"], "multiturn": {"turn_1": [{"question_id": "60.1", "question": "What does the CDC report about autism spectrum disorder in the USA?", "answer_src": "Autism spectrum disorder now affects 1 in 88 children in the USA and 1 in 47 in Utah", "follow_up_question": "How many more children are affected by ASD in Utah compared to the national average?", "follow_up_response": "32", "follow_up_response_bt": "4"}, {"question_id": "60.2", "question": "Who is more likely to be diagnosed with ASD according to the sentence?", "answer_src": "Boys", "follow_up_question": "How many times more likely are boys to be diagnosed with ASD compared to girls?", "follow_up_response": "5", "follow_up_response_bt": "5"}, {"question_id": "60.3", "question": "Where is ASD more common compared to other states?", "answer_src": "Utah", "follow_up_question": "What is the ratio of boys to girls diagnosed with ASD according to the CDC report?", "follow_up_response": "5", "follow_up_response_bt": "5"}, {"question_id": "60.4", "question": "When do you think the number of ASD diagnoses will exceed AIDS, diabetes, and cancer combined?", "answer_src": "This year", "follow_up_question": "How many times more likely are boys than girls to be diagnosed with ASD according to the text?", "follow_up_response": "5", "follow_up_response_bt": "5"}, {"question_id": "60.5", "question": "Which condition is mentioned as affecting fewer children than ASD according to the sentence?", "answer_src": "AIDS, diabetes, and cancer", "follow_up_question": "How many more children are estimated to be diagnosed with ASD this year compared to the combined number of children diagnosed with AIDS, diabetes, and cancer?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "60.6", "question": "How many more children are affected by ASD in Utah compared to the national average?", "answer_src": "32", "follow_up_question": "How many more children are affected by ASD in Utah compared to boys nationally?", "follow_up_response": "32", "follow_up_response_bt": "3.5"}, {"question_id": "60.7", "question": "How many times more likely are boys to be diagnosed with ASD compared to girls?", "answer_src": "5", "follow_up_question": "What is the total number of children diagnosed with ASD in the USA this year according to the CDC report?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "60.8", "question": "What is the ratio of boys to girls diagnosed with ASD according to the CDC report?", "answer_src": "5", "follow_up_question": "What is the total number of children diagnosed with ASD in Utah based on the CDC report?", "follow_up_response": "No Answer", "follow_up_response_bt": "1 in 47 children"}, {"question_id": "60.9", "question": "How many times more likely are boys than girls to be diagnosed with ASD according to the text?", "answer_src": "5", "follow_up_question": "What is the total number of children diagnosed with ASD in the USA based on the given statistics?", "follow_up_response": "None", "follow_up_response_bt": "No Answer"}, {"question_id": "60.10", "question": "How many more children are estimated to be diagnosed with ASD this year compared to the combined number of children diagnosed with AIDS, diabetes, and cancer?", "answer_src": "pediatricsintroduction : the centers for disease control and prevention report that autism spectrum disorder ( asd ) now affects 1 in 88 children in the usa and 1 in 47 in utah . asd is 5 times more likely in boys with 1 in 54 boys identified nationally . more children will be diagnosed with asd this year than with aids , diabetes , and cancer combined .", "follow_up_question": "How many more children are estimated to be diagnosed with ASD in the USA compared to Utah?", "follow_up_response": "72", "follow_up_response_bt": "3.8"}], "turn_3": [{"question_id": "60.11", "question": "How many more children are affected by ASD in Utah compared to boys nationally?", "answer_src": "32", "follow_up_question": "How many more children are affected by ASD in Utah compared to girls nationally?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "60.12", "question": "What is the total number of children diagnosed with ASD in the USA this year according to the CDC report?", "answer_src": "pediatricsintroduction : the centers for disease control and prevention report that autism spectrum disorder ( asd ) now affects 1 in 88 children in the usa and 1 in 47 in utah . asd is 5 times more likely in boys with 1 in 54 boys identified nationally . more children will be diagnosed with asd this year than with aids , diabetes , and cancer combined .", "follow_up_question": "How many more children will be diagnosed with ASD this year compared to the combined diagnoses of AIDS, diabetes, and cancer?", "follow_up_response": "None Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "60.13", "question": "What is the total number of children diagnosed with ASD in Utah based on the CDC report?", "answer_src": "pediatricsintroduction : the centers for disease control and prevention report that autism spectrum disorder ( asd ) now affects 1 in 88 children in the usa and 1 in 47 in utah . asd is 5 times more likely in boys with 1 in 54 boys identified nationally . more children will be diagnosed with asd this year than with aids , diabetes , and cancer combined .", "follow_up_question": "How many more children are expected to be diagnosed with ASD this year compared to the combined diagnoses of AIDS, diabetes, and cancer?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "60.14", "question": "What is the total number of children diagnosed with ASD in the USA based on the given statistics?", "answer_src": "None", "follow_up_question": "How many more children are estimated to have ASD than those diagnosed with AIDS, diabetes, and cancer combined according to the CDC's report?", "follow_up_response": "1 in 88 + 1 in 47 - (1 + 1 + 1)", "follow_up_response_bt": "No Answer"}, {"question_id": "60.15", "question": "How many more children are estimated to be diagnosed with ASD in the USA compared to Utah?", "answer_src": "72", "follow_up_question": "How many more children are estimated to have ASD in boys compared to girls nationally?", "follow_up_response": "5", "follow_up_response_bt": "5"}]}}
{"id": 61, "src": "objectivesantibiotic resistance is a major public health concern and is greatly exacerbated by inappropriate antibiotic use at a community level . the aim of this study was to ascertain which attitudes of community pharmacists were related to inappropriate antibiotic dispensing.methodswe conducted a cross - sectional study of community pharmacists in a region situated in northern spain ( n = 393 ) . personal interviews were conducted using a self - administered questionnaire .", "mt": "L'obiettivo di questo studio era quello di scoprire quali atteggiamenti dei farmacisti comunitari erano correlati a una distribuzione di antibiotici inappropriata .", "pert_mt": "L'obiettivo di questo studio era quello di scoprire quali atteggiamenti dei farmacisti comunitari erano correlati a una distribuzione di antibiotici inappropriata, ma non sempre in modo consapevole.", "bt": "The aim of this study was to discover which attitudes of community pharmacists were correlated with an inappropriate distribution of antibiotics, but not always consciously.", "questions_src": ["What is the main public health concern mentioned in the sentence?", "Who conducted the cross-sectional study according to the sentence?", "Where was the study conducted in the sentence?", "Which methods were used in the study described?", "Which type of antibiotics are primarily discussed in the sentence?"], "answers_src": ["Antibiotic resistance", "Community pharmacists", "A region situated in northern Spain", "Personal interviews using a self-administered questionnaire", "No Answer"], "answers_bt": ["[\"an inappropriate distribution of antibiotics\"], [], [], []", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "61.1", "question": "What is the main public health concern mentioned in the sentence?", "answer_src": "Antibiotic resistance", "follow_up_question": "Which region did the cross-sectional study involve?", "follow_up_response": "a region situated in northern spain", "follow_up_response_bt": "No Answer"}, {"question_id": "61.2", "question": "Who conducted the cross-sectional study according to the sentence?", "answer_src": "Community pharmacists", "follow_up_question": "What specific attitude related to antibiotic dispensing did the study aim to ascertain?", "follow_up_response": "attitudes", "follow_up_response_bt": "attitudes of community pharmacists"}, {"question_id": "61.3", "question": "Where was the study conducted in the sentence?", "answer_src": "A region situated in northern Spain", "follow_up_question": "What specific aspects of pharmacist attitudes were assessed in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "attitudes"}, {"question_id": "61.4", "question": "Which methods were used in the study described?", "answer_src": "Personal interviews using a self-administered questionnaire", "follow_up_question": "What specific topics were covered in the self-administered questionnaire?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "61.5", "question": "Which type of antibiotics are primarily discussed in the sentence?", "answer_src": "objectivesantibiotic resistance is a major public health concern and is greatly exacerbated by inappropriate antibiotic use at a community level . the aim of this study was to ascertain which attitudes of community pharmacists were related to inappropriate antibiotic dispensing.methodswe conducted a cross - sectional study of community pharmacists in a region situated in northern spain ( n = 393 ) . personal interviews were conducted using a self - administered questionnaire .", "follow_up_question": "What specific attitudes among community pharmacists were the study aiming to investigate?", "follow_up_response": "attitudes of community pharmacists", "follow_up_response_bt": "attitudes of community pharmacists"}], "turn_2": [{"question_id": "61.6", "question": "Which region did the cross-sectional study involve?", "answer_src": "a region situated in northern spain", "follow_up_question": "What was the sample size of the study?", "follow_up_response": "393", "follow_up_response_bt": "No Answer"}, {"question_id": "61.7", "question": "What specific attitude related to antibiotic dispensing did the study aim to ascertain?", "answer_src": "attitudes", "follow_up_question": "Which specific attitudes were identified as potentially influencing inappropriate antibiotic dispensing?", "follow_up_response": "No Answer", "follow_up_response_bt": "attitudes"}, {"question_id": "61.8", "question": "What specific aspects of pharmacist attitudes were assessed in the study?", "answer_src": "objectivesantibiotic resistance is a major public health concern and is greatly exacerbated by inappropriate antibiotic use at a community level . the aim of this study was to ascertain which attitudes of community pharmacists were related to inappropriate antibiotic dispensing.methodswe conducted a cross - sectional study of community pharmacists in a region situated in northern spain ( n = 393 ) . personal interviews were conducted using a self - administered questionnaire .", "follow_up_question": "Which specific attitudes of community pharmacists were targeted in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "attitudes"}, {"question_id": "61.9", "question": "What specific topics were covered in the self-administered questionnaire?", "answer_src": "objectivesantibiotic resistance is a major public health concern and is greatly exacerbated by inappropriate antibiotic use at a community level . the aim of this study was to ascertain which attitudes of community pharmacists were related to inappropriate antibiotic dispensing.methodswe conducted a cross - sectional study of community pharmacists in a region situated in northern spain ( n = 393 ) . personal interviews were conducted using a self - administered questionnaire .", "follow_up_question": "What aspects of community pharmacist attitudes towards antibiotic dispensing were investigated?", "follow_up_response": "attitudes", "follow_up_response_bt": "attitudes of community pharmacists"}, {"question_id": "61.10", "question": "What specific attitudes among community pharmacists were the study aiming to investigate?", "answer_src": "attitudes of community pharmacists", "follow_up_question": "Which attitudes specifically towards antibiotic use were the study interested in exploring?", "follow_up_response": "attitudes towards antibiotic use", "follow_up_response_bt": "attitudes of community pharmacists"}], "turn_3": [{"question_id": "61.11", "question": "What was the sample size of the study?", "answer_src": "393", "follow_up_question": "Which region in Spain was the study conducted in?", "follow_up_response": "northern spain", "follow_up_response_bt": "No Answer"}, {"question_id": "61.12", "question": "Which specific attitudes were identified as potentially influencing inappropriate antibiotic dispensing?", "answer_src": "objectivesantibiotic resistance is a major public health concern and is greatly exacerbated by inappropriate antibiotic use at a community level . the aim of this study was to ascertain which attitudes of community pharmacists were related to inappropriate antibiotic dispensing.methodswe conducted a cross - sectional study of community pharmacists in a region situated in northern spain ( n = 393 ) . personal interviews were conducted using a self - administered questionnaire .", "follow_up_question": "Which specific attitudes did the study identify as potentially influencing inappropriate antibiotic dispensing?", "follow_up_response": "No Answer", "follow_up_response_bt": "attitudes"}, {"question_id": "61.13", "question": "Which specific attitudes of community pharmacists were targeted in the study?", "answer_src": "objectivesantibiotic resistance is a major public health concern and is greatly exacerbated by inappropriate antibiotic use at a community level . the aim of this study was to ascertain which attitudes of community pharmacists were related to inappropriate antibiotic dispensing.methodswe conducted a cross - sectional study of community pharmacists in a region situated in northern spain ( n = 393 ) . personal interviews were conducted using a self - administered questionnaire .", "follow_up_question": "What specific attitudes did the study aim to investigate regarding inappropriate antibiotic dispensing?", "follow_up_response": "No Answer", "follow_up_response_bt": "attitudes of community pharmacists"}, {"question_id": "61.14", "question": "What aspects of community pharmacist attitudes towards antibiotic dispensing were investigated?", "answer_src": "attitudes", "follow_up_question": "Which specific attitudes of community pharmacists were assessed in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "61.15", "question": "Which attitudes specifically towards antibiotic use were the study interested in exploring?", "answer_src": "attitudes towards antibiotic use", "follow_up_question": "What specific aspects of antibiotic use did the study focus on?", "follow_up_response": "inappropriate antibiotic use", "follow_up_response_bt": "attitudes of community pharmacists"}]}}
{"id": 62, "src": "the jelly formulation is smoothly discharged by pushing the air portion . therefore , elderly patients with physical disabilities are able to easily take all of the jelly formulation from the package . in this review , this new formulation of alendronate sodium hydrate ( oral jelly ) is introduced and discussed in terms of osteoporosis treatment .", "mt": "La formulazione della gelatina viene liberata senza problemi spingendo la porzione di aria . Pertanto , i pazienti anziani con disabilità fisiche possono facilmente prendere tutta la formulazione della gelatina dal pacchetto . in questa revisione , questa nuova formulazione di alendronato idrato di sodio (gela orale) viene introdotta e discussa in termini di trattamento dell' osteoporosi .", "pert_mt": "La formulazione della gelatina viene liberata senza problemi spingendo la porzione di aria. Pertanto, i pazienti anziani con disabilità fisiche possono facilmente prendere tutta la formulazione della gelatina dal pacchetto. In questa revisione, questa nuova formulazione di alendronato idrato di sodio (gela orale) viene introdotta e discussa in termini di trattamento dell'osteoporosi, ma non ha effetti collaterali significativi.", "bt": "The formulation of gelatin is released without problems by pushing the portion of air.Therefore, elderly patients with physical disabilities can easily take the entire formulation of gelatin from the package.In this review, this new formulation of alendronate sodium hydrate (oral gel) is introduced and discussed in terms of treating osteoporosis, but it does not have significant side effects.", "questions_src": ["What is smoothly discharged by pushing the air portion?", "Who are able to easily take all of the jelly formulation?", "Where is the new formulation of alendronate sodium hydrate introduced?", "When is the review discussing the osteoporosis treatment?", "Which physical disability makes it easier for elderly patients to take the jelly formulation?"], "answers_src": ["the jelly formulation", "elderly patients with physical disabilities", "in this review", "no answer", "physical disabilities"], "answers_bt": ["The formulation of gelatin", "Elderly patients with physical disabilities", "In this review", "Treating osteoporosis", "Physical disabilities"], "multiturn": {"turn_1": [{"question_id": "62.1", "question": "What is smoothly discharged by pushing the air portion?", "answer_src": "the jelly formulation", "follow_up_question": "What specific benefit does this new formulation offer to elderly patients with physical disabilities?", "follow_up_response": "This new formulation of alendronate sodium hydrate (oral jelly) is easily taken", "follow_up_response_bt": "Easily take the entire formulation of gelatin from the package"}, {"question_id": "62.2", "question": "Who are able to easily take all of the jelly formulation?", "answer_src": "elderly patients with physical disabilities", "follow_up_question": "What specific benefit does this new formulation offer for elderly patients?", "follow_up_response": "This new formulation of alendronate sodium hydrate (oral jelly) is easier to use for elderly patients with physical disabilities.", "follow_up_response_bt": "It offers a specific benefit for elderly patients with physical disabilities to easily take the entire formulation of gelatin from the package."}, {"question_id": "62.3", "question": "Where is the new formulation of alendronate sodium hydrate introduced?", "answer_src": "in this review", "follow_up_question": "What specific condition does the new formulation aim to treat?", "follow_up_response": "Osteoporosis", "follow_up_response_bt": "Osteoporosis"}, {"question_id": "62.4", "question": "When is the review discussing the osteoporosis treatment?", "answer_src": "no answer", "follow_up_question": "What specific formulation of alendronate sodium hydrate is being reviewed?", "follow_up_response": "oral jelly", "follow_up_response_bt": "oral gel"}, {"question_id": "62.5", "question": "Which physical disability makes it easier for elderly patients to take the jelly formulation?", "answer_src": "physical disabilities", "follow_up_question": "What specific aspect of the new alendronate sodium hydrate formulation allows elderly patients with physical disabilities to take it more easily?", "follow_up_response": "the jelly formulation is smoothly discharged by pushing the air portion", "follow_up_response_bt": "The formulation of gelatin is released without problems by pushing the portion of air"}], "turn_2": [{"question_id": "62.6", "question": "What specific benefit does this new formulation offer to elderly patients with physical disabilities?", "answer_src": "This new formulation of alendronate sodium hydrate (oral jelly) is easily taken", "follow_up_question": "How is the jelly formulation easier to use compared to traditional tablets?", "follow_up_response": "Pushing the air portion", "follow_up_response_bt": "pushing the portion of air"}, {"question_id": "62.7", "question": "What specific benefit does this new formulation offer for elderly patients?", "answer_src": "This new formulation of alendronate sodium hydrate (oral jelly) is easier to use for elderly patients with physical disabilities.", "follow_up_question": "How does the ease of use for elderly patients with physical disabilities impact their adherence to the treatment?", "follow_up_response": "It allows them to easily take all of the jelly formulation from the package", "follow_up_response_bt": "The ease of use allows elderly patients with physical disabilities to easily take the entire formulation of gelatin from the package"}, {"question_id": "62.8", "question": "What specific condition does the new formulation aim to treat?", "answer_src": "Osteoporosis", "follow_up_question": "How is the new formulation easier to use compared to traditional methods?", "follow_up_response": "the jelly formulation is smoothly discharged by pushing the air portion", "follow_up_response_bt": "Pushing the portion of air"}, {"question_id": "62.9", "question": "What specific formulation of alendronate sodium hydrate is being reviewed?", "answer_src": "oral jelly", "follow_up_question": "How does the oral jelly formulation benefit elderly patients with physical disabilities?", "follow_up_response": "It allows them to easily take all of the jelly formulation from the package.", "follow_up_response_bt": "It allows them to easily take the entire formulation of gelatin from the package."}, {"question_id": "62.10", "question": "What specific aspect of the new alendronate sodium hydrate formulation allows elderly patients with physical disabilities to take it more easily?", "answer_src": "the jelly formulation is smoothly discharged by pushing the air portion", "follow_up_question": "How does the jelly formulation's design facilitate its smooth discharge?", "follow_up_response": "Pushing the air portion", "follow_up_response_bt": "Pushing the portion of air"}], "turn_3": [{"question_id": "62.11", "question": "How is the jelly formulation easier to use compared to traditional tablets?", "answer_src": "Pushing the air portion", "follow_up_question": "What specific benefit does this make for elderly patients with physical disabilities?", "follow_up_response": "easily take all of the jelly formulation from the package", "follow_up_response_bt": "Easily take the entire formulation of gelatin from the package"}, {"question_id": "62.12", "question": "How does the ease of use for elderly patients with physical disabilities impact their adherence to the treatment?", "answer_src": "It allows them to easily take all of the jelly formulation from the package", "follow_up_question": "What specific benefit does this formulation provide for elderly patients with limited mobility?", "follow_up_response": "This formulation is easily taken from the package", "follow_up_response_bt": "Elderly patients with physical disabilities can easily take the entire formulation of gelatin from the package."}, {"question_id": "62.13", "question": "How is the new formulation easier to use compared to traditional methods?", "answer_src": "the jelly formulation is smoothly discharged by pushing the air portion", "follow_up_question": "What specific feature of the jelly formulation makes it easier to use for elderly patients with physical disabilities?", "follow_up_response": "Smoothly discharged by pushing the air portion", "follow_up_response_bt": "pushing the portion of air"}, {"question_id": "62.14", "question": "How does the oral jelly formulation benefit elderly patients with physical disabilities?", "answer_src": "It allows them to easily take all of the jelly formulation from the package.", "follow_up_question": "What specific advantage does the oral jelly provide for elderly patients with limited mobility?", "follow_up_response": "The oral jelly formulation is smoothly discharged by pushing the air portion, allowing elderly patients with physical disabilities to easily take all of the jelly formulation from the package.", "follow_up_response_bt": "It allows elderly patients with physical disabilities to easily take the entire formulation of gelatin from the package."}, {"question_id": "62.15", "question": "How does the jelly formulation's design facilitate its smooth discharge?", "answer_src": "Pushing the air portion", "follow_up_question": "What specific benefit does this design have for elderly patients with physical disabilities?", "follow_up_response": "the jelly formulation is smoothly discharged by pushing the air portion", "follow_up_response_bt": "Easily take the entire formulation of gelatin from the package"}]}}
{"id": 63, "src": "multivariate logistic regression revealed that pct , hs - crp , and psp were independent risk factors for the prognosis of patients with sepsis ( p<0.001 ) . roc analysis showed the auc values of pct , hs - crp , and psp were 0.83 ( 95% ci , 0.770.88 ) , 0.76 ( 95% ci , 0.700.82 ) , and 0.73 ( 95% ci , 0.670.79 ) , respectively . the combined auc value of pct , hs - crp , and psp , was 0.92 ( 95% ci , 0.870.95 ) , which was significantly increased compared with pct , hs - crp , or psp ( p<0.001).conclusionsthe combination of serum pct , hs - crp , and psp represents a promising biomarker of risk , and is a useful clinical tool for risk stratification of children with sepsis .", "mt": "L'analisi roc ha mostrato che i valori auc di pct , hs - crp e psp erano di 0,83 (95 percento ci , 0,770.88 ) , 0,76 (95 percento ci , 0,700.82 ) e 0,73 (95 percento ci , 0,670.79) rispettivamente . Il valore auc combinato di pct , hs - crp e psp era di 0,92 (95 percento ci , 0,870.95) , che è stato significativamente aumentato rispetto a pct , hs - crp o psp (p<0.001).", "pert_mt": "L'analisi roc ha mostrato che i valori auc di pct , hs - crp e psp erano di 0,83 (95 percento ci, 0,770.88) , 0,76 (95 percento ci, 0,700.82) e 0,73 (95 percento ci, 0,670.79) rispettivamente. Il valore auc combinato di pct , hs - crp e psp era di 0,92 (95 percento ci, 0,870.95) , che è stato significativamente aumentato rispetto a pct , hs - crp o psp (p<0.001), mentre gli altri marker non dimostrarono significatività statistica.", "bt": "The roc analysis showed that the auc values of pct , hs - crp and psp were 0.83 (95 percent ci, 0.770.88) , 0.76 (95 percent ci, 0.700.82) and 0.73 (95 percent ci, 0.670.79) respectively.The combined auc values of pct , hs - crp and psp were 0.92 (95 percent ci, 0.870.95) , which was significantly increased compared to pct , hs - crp or psp (p<0.001), while the other markers did not demonstrate statistical significance.", "questions_src": ["What is the percentage of patients with sepsis who had a prognosis based on multivariate logistic regression?", "Who were identified as independent risk factors for the prognosis of patients with sepsis according to the study?", "Where can the values of AUC (area under the curve) for pct, hs-crp, and psp be found in the study?", "When did the researchers conduct their ROC (receiver operating characteristic) analysis?", "Which biomarker combination, when used together, had the highest combined AUC value according to the study?"], "answers_src": ["No Answer", "pct, hs - crp, and psp", "ROC analysis", "The study", "Serum pct, hs - crp, and psp"], "answers_bt": ["The auc values of pct, hs-crp and psp were 0.83 (95 percent ci, 0.77-0.88), 0.76 (95 percent ci, 0.70-0.82) and 0.73 (95 percent ci, 0.67-0.79) respectively.", "pct, hs-crp and psp", "The roc analysis showed that the auc values of pct, hs-crp and psp were 0.83 (95 percent ci, 0.77-0.88), 0.76 (95 percent ci, 0.70-0.82) and 0.73 (95 percent ci, 0.67-0.79) respectively.", "The researchers conducted their ROC analysis.", "The biomarker combination of pct, hs-crp and psp"], "multiturn": {"turn_1": [{"question_id": "63.1", "question": "What is the percentage of patients with sepsis who had a prognosis based on multivariate logistic regression?", "answer_src": "multivariate logistic regression revealed that pct , hs - crp , and psp were independent risk factors for the prognosis of patients with sepsis ( p<0.001 ) . roc analysis showed the auc values of pct , hs - crp , and psp were 0.83 ( 95% ci , 0.770.88 ) , 0.76 ( 95% ci , 0.700.82 ) , and 0.73 ( 95% ci , 0.670.79 ) , respectively . the combined auc value of pct , hs - crp , and psp , was 0.92 ( 95% ci , 0.870.95 ) , which was significantly increased compared with pct , hs - crp , or psp ( p<0.001).conclusionsthe combination of serum pct , hs - crp , and psp represents a promising biomarker of risk , and is a useful clinical tool for risk stratification of children with sepsis .", "follow_up_question": "What is the combined AUC value of pct, hs-crp, and psp according to the text?", "follow_up_response": "0.92 (95% CI, 0.87-0.95)", "follow_up_response_bt": "0.92 (95 percent ci, 0.870.95)"}, {"question_id": "63.2", "question": "Who were identified as independent risk factors for the prognosis of patients with sepsis according to the study?", "answer_src": "pct, hs - crp, and psp", "follow_up_question": "What was the combined AUC value of pct, hs-crp, and psp, and how did it compare to the individual AUC values?", "follow_up_response": "0.92 (95% CI, 0.87-0.95)\", \"significantly increased compared with pct, hs-crp, or psp (p<0.001)", "follow_up_response_bt": "0.92 (95 percent ci, 0.870.95)\", \"significantly increased compared to pct, hs-crp or psp"}, {"question_id": "63.3", "question": "Where can the values of AUC (area under the curve) for pct, hs-crp, and psp be found in the study?", "answer_src": "ROC analysis", "follow_up_question": "What was the combined AUC value for pct, hs-crp, and psp, and what was its 95% confidence interval?", "follow_up_response": "0.92 (95% ci, 0.87-0.95)", "follow_up_response_bt": "0.92 (95 percent ci, 0.870.95)"}, {"question_id": "63.4", "question": "When did the researchers conduct their ROC (receiver operating characteristic) analysis?", "answer_src": "The study", "follow_up_question": "What was the significance of the combined AUC value being 0.92?", "follow_up_response": "It was significantly increased compared with pct, hs-crp, or psp (p<0.001).", "follow_up_response_bt": "The combined AUC value of 0.92 was significantly increased compared to pct, hs-CRP or psp (p<0.001), while the other markers did not demonstrate statistical significance."}, {"question_id": "63.5", "question": "Which biomarker combination, when used together, had the highest combined AUC value according to the study?", "answer_src": "Serum pct, hs - crp, and psp", "follow_up_question": "What was the significance of the combined AUC value being significantly higher than that of any single biomarker?", "follow_up_response": "The combination of serum pct, hs-CRP, and PSP represents a promising biomarker of risk, and is a useful clinical tool for risk stratification of children with sepsis.", "follow_up_response_bt": "The combined AUC value of pct, hs-CRP, and PSP was significantly higher than that of any single biomarker (p<0.001)."}], "turn_2": [{"question_id": "63.6", "question": "What is the combined AUC value of pct, hs-crp, and psp according to the text?", "answer_src": "0.92 (95% CI, 0.87-0.95)", "follow_up_question": "What is the 95% confidence interval for the combined AUC value of pct, hs-crp, and psp?", "follow_up_response": "(0.87, 0.95)", "follow_up_response_bt": "0.870.95"}, {"question_id": "63.7", "question": "What was the combined AUC value of pct, hs-crp, and psp, and how did it compare to the individual AUC values?", "answer_src": "0.92 (95% CI, 0.87-0.95)\", \"significantly increased compared with pct, hs-crp, or psp (p<0.001)", "follow_up_question": "How much higher was the combined AUC value compared to the highest individual AUC value?", "follow_up_response": "0.18", "follow_up_response_bt": "0.18"}, {"question_id": "63.8", "question": "What was the combined AUC value for pct, hs-crp, and psp, and what was its 95% confidence interval?", "answer_src": "0.92 (95% ci, 0.87-0.95)", "follow_up_question": "What was the significance of the combined AUC value being significantly increased compared to the individual AUC values of pct, hs-crp, or psp?", "follow_up_response": "The combined AUC value of pct, hs-crp, and psp was significantly increased compared to the individual AUC values of pct, hs-crp, or psp, indicating its potential as a more reliable biomarker.", "follow_up_response_bt": "The combined AUC value of pct, hs-crp, and psp was significantly increased compared to the individual AUC values of pct, hs-crp, or psp (p<0.001)."}, {"question_id": "63.9", "question": "What was the significance of the combined AUC value being 0.92?", "answer_src": "It was significantly increased compared with pct, hs-crp, or psp (p<0.001).", "follow_up_question": "How much did the combined AUC value increase compared to the highest individual AUC value?", "follow_up_response": "0.09", "follow_up_response_bt": "0.19"}, {"question_id": "63.10", "question": "What was the significance of the combined AUC value being significantly higher than that of any single biomarker?", "answer_src": "The combination of serum pct, hs-CRP, and PSP represents a promising biomarker of risk, and is a useful clinical tool for risk stratification of children with sepsis.", "follow_up_question": "How did the combined AUC value improve the clinical utility of risk stratification for children with sepsis?", "follow_up_response": "The combined AUC value of pct , hs - crp , and psp , was 0.92 ( 95% ci , 0.870.95 ) , which was significantly increased compared with pct , hs - crp , or psp ( p<0.001)", "follow_up_response_bt": "The combined AUC value of pct, hs-crp, and psp was 0.92 (95 percent ci, 0.87-0.95), which was significantly increased compared to pct, hs-crp, or psp (p<0.001)."}], "turn_3": [{"question_id": "63.11", "question": "What is the 95% confidence interval for the combined AUC value of pct, hs-crp, and psp?", "answer_src": "(0.87, 0.95)", "follow_up_question": "What is the significance level (p-value) for the combined AUC value being significantly increased compared to individual AUC values?", "follow_up_response": "p<0.001", "follow_up_response_bt": "p<0.001"}, {"question_id": "63.12", "question": "How much higher was the combined AUC value compared to the highest individual AUC value?", "answer_src": "0.18", "follow_up_question": "By how many percentage points did the combined AUC value exceed the sum of the individual AUC values of pct and hs-crp?", "follow_up_response": "0.15", "follow_up_response_bt": "2.0"}, {"question_id": "63.13", "question": "What was the significance of the combined AUC value being significantly increased compared to the individual AUC values of pct, hs-crp, or psp?", "answer_src": "The combined AUC value of pct, hs-crp, and psp was significantly increased compared to the individual AUC values of pct, hs-crp, or psp, indicating its potential as a more reliable biomarker.", "follow_up_question": "How much did the combined AUC value increase compared to the highest individual AUC value?", "follow_up_response": "0.09", "follow_up_response_bt": "0.19"}, {"question_id": "63.14", "question": "How much did the combined AUC value increase compared to the highest individual AUC value?", "answer_src": "0.09", "follow_up_question": "By how many percentage points did the combined AUC value exceed the sum of the individual AUC values of pct and hs-crp?", "follow_up_response": "0.15", "follow_up_response_bt": "2.0"}, {"question_id": "63.15", "question": "How did the combined AUC value improve the clinical utility of risk stratification for children with sepsis?", "answer_src": "The combined AUC value of pct , hs - crp , and psp , was 0.92 ( 95% ci , 0.870.95 ) , which was significantly increased compared with pct , hs - crp , or psp ( p<0.001)", "follow_up_question": "By what percentage did the combined AUC value increase compared to the highest individual AUC value?", "follow_up_response": "5%", "follow_up_response_bt": "5.0"}]}}
{"id": 64, "src": "due to their unique structural and functional properties , subplate cells are ideally suited to function as important amplifying units within the developing neocortical circuit . subplate neurons have extensive dendritic and axonal ramifications and relatively mature functional properties , i.e. their action potential firing can exceed frequencies of 40 hz . at earliest stages of corticogenesis subplate cells receive functional synaptic inputs from the thalamus and from other cortical and non - cortical sources .", "mt": "I neuroni della piastra sottosopra hanno estese ramificazioni dendritiche e axonali e proprietà funzionali relativamente mature , cioè il loro potenziale di azione può superare frequenze di 40 hz . nelle prime fasi di corticogenesi le cellule della piastra sottosopra ricevono input sinaptici funzionali dal thalamo e da altre fonti corticali e non corticali .", "pert_mt": "I neuroni della piastra sottosopra hanno estese ramificazioni dendritiche e axonali e proprietà funzionali relativamente mature, cioè il loro potenziale di azione può superare frequenze di 40 hz. nelle prime fasi di corticogenesi le cellule della piastra sottosopra ricevono input sinaptici funzionali dal thalamo e da altre fonti corticali e non corticali e mostrano una maggiore plasticità neuronale.", "bt": "The neurons of the subsoplanet have aesthetic dendritic and axonal ramifications and relatively mature functional properties, i.e. their potential for action can exceed frequencies of 40 hz. In the early stages of corticogenesis, the cells of the subsoplanet receive functional synaptic input from the thalamus and other cortical and non-cortical sources and show increased neuronal plasticity.", "questions_src": ["What do subplate cells have that makes them ideal for amplifying units in the developing neocortical circuit?", "Where do subplate cells receive functional synaptic inputs from at the earliest stages of corticogenesis?", "Which type of action potential firing can exceed frequencies of 40 hz in subplate neurons?", "Who are the main sources of functional synaptic inputs for subplate cells at the earliest stages of corticogenesis?", "When do subplate cells start receiving functional synaptic inputs from the thalamus and other cortical and non-cortical sources?"], "answers_src": ["extensive dendritic and axonal ramifications and relatively mature functional properties", "the thalamus and from other cortical and non - cortical sources", "their action potential firing", "subplate cells", "at earliest stages of corticogenesis"], "answers_bt": ["Aesthetic dendritic and axonal ramifications and relatively mature functional properties", "The thalamus and other cortical and non-cortical sources", "Action potentials", "The thalamus and other cortical and non-cortical sources", "The early stages of corticogenesis"], "multiturn": {"turn_1": [{"question_id": "64.1", "question": "What do subplate cells have that makes them ideal for amplifying units in the developing neocortical circuit?", "answer_src": "extensive dendritic and axonal ramifications and relatively mature functional properties", "follow_up_question": "What is an example of the mature functional property of subplate neurons mentioned in the text?", "follow_up_response": "Their action potential firing can exceed frequencies of 40 hz.", "follow_up_response_bt": "Their potential for action can exceed frequencies of 40 hz"}, {"question_id": "64.2", "question": "Where do subplate cells receive functional synaptic inputs from at the earliest stages of corticogenesis?", "answer_src": "the thalamus and from other cortical and non - cortical sources", "follow_up_question": "At what frequency do subplate neurons typically fire their action potentials?", "follow_up_response": "40 hz", "follow_up_response_bt": "40 hz"}, {"question_id": "64.3", "question": "Which type of action potential firing can exceed frequencies of 40 hz in subplate neurons?", "answer_src": "their action potential firing", "follow_up_question": "What specific aspect of subplate neurons allows their action potential firing to exceed frequencies of 40 hz?", "follow_up_response": "Their relatively mature functional properties", "follow_up_response_bt": "Their potential for action"}, {"question_id": "64.4", "question": "Who are the main sources of functional synaptic inputs for subplate cells at the earliest stages of corticogenesis?", "answer_src": "subplate cells", "follow_up_question": "What types of sources provide functional synaptic inputs to subplate cells at the earliest stages?", "follow_up_response": "the thalamus and from other cortical and non - cortical sources", "follow_up_response_bt": "thalamus and other cortical and non-cortical sources"}, {"question_id": "64.5", "question": "When do subplate cells start receiving functional synaptic inputs from the thalamus and other cortical and non-cortical sources?", "answer_src": "at earliest stages of corticogenesis", "follow_up_question": "What types of sources do subplate cells receive functional synaptic inputs from at the earliest stages of corticogenesis?", "follow_up_response": "the thalamus and from other cortical and non-cortical sources", "follow_up_response_bt": "the thalamus and other cortical and non-cortical sources"}], "turn_2": [{"question_id": "64.6", "question": "What is an example of the mature functional property of subplate neurons mentioned in the text?", "answer_src": "Their action potential firing can exceed frequencies of 40 hz.", "follow_up_question": "What types of synaptic inputs do subplate cells receive at the earliest stages of corticogenesis?", "follow_up_response": "from the thalamus and from other cortical and non-cortical sources", "follow_up_response_bt": "Functional synaptic input from the thalamus and other cortical and non-cortical sources"}, {"question_id": "64.7", "question": "At what frequency do subplate neurons typically fire their action potentials?", "answer_src": "40 hz", "follow_up_question": "What types of synaptic inputs do subplate cells receive at the earliest stages of corticogenesis?", "follow_up_response": "from the thalamus and from other cortical and non-cortical sources", "follow_up_response_bt": "Functional synaptic input from the thalamus and other cortical and non-cortical sources"}, {"question_id": "64.8", "question": "What specific aspect of subplate neurons allows their action potential firing to exceed frequencies of 40 hz?", "answer_src": "Their relatively mature functional properties", "follow_up_question": "What types of synaptic inputs do subplate cells receive at the earliest stages of corticogenesis?", "follow_up_response": "from the thalamus and from other cortical and non-cortical sources", "follow_up_response_bt": "Functional synaptic input from the thalamus and other cortical and non-cortical sources"}, {"question_id": "64.9", "question": "What types of sources provide functional synaptic inputs to subplate cells at the earliest stages?", "answer_src": "the thalamus and from other cortical and non - cortical sources", "follow_up_question": "At what frequency do subplate neurons typically fire their action potentials?", "follow_up_response": "40 hz", "follow_up_response_bt": "40 hz"}, {"question_id": "64.10", "question": "What types of sources do subplate cells receive functional synaptic inputs from at the earliest stages of corticogenesis?", "answer_src": "the thalamus and from other cortical and non-cortical sources", "follow_up_question": "At what stage of corticogenesis do subplate cells begin to exhibit action potential firing frequencies exceeding 40 hz?", "follow_up_response": "At earliest stages of corticogenesis", "follow_up_response_bt": "The early stages of corticogenesis"}], "turn_3": [{"question_id": "64.11", "question": "What types of synaptic inputs do subplate cells receive at the earliest stages of corticogenesis?", "answer_src": "from the thalamus and from other cortical and non-cortical sources", "follow_up_question": "What is the significance of subplate cells' ability to fire action potentials at frequencies exceeding 40 hz?", "follow_up_response": "Their relatively mature functional properties", "follow_up_response_bt": "Their potential for action can exceed frequencies of 40 hz."}, {"question_id": "64.12", "question": "What types of synaptic inputs do subplate cells receive at the earliest stages of corticogenesis?", "answer_src": "from the thalamus and from other cortical and non-cortical sources", "follow_up_question": "What is the significance of subplate cells' ability to fire action potentials at frequencies exceeding 40 hz?", "follow_up_response": "Their relatively mature functional properties", "follow_up_response_bt": "Their potential for action can exceed frequencies of 40 hz."}, {"question_id": "64.13", "question": "What types of synaptic inputs do subplate cells receive at the earliest stages of corticogenesis?", "answer_src": "from the thalamus and from other cortical and non-cortical sources", "follow_up_question": "What is the significance of subplate cells' ability to fire action potentials at frequencies exceeding 40 hz?", "follow_up_response": "Their relatively mature functional properties", "follow_up_response_bt": "Their potential for action can exceed frequencies of 40 hz."}, {"question_id": "64.14", "question": "At what frequency do subplate neurons typically fire their action potentials?", "answer_src": "40 hz", "follow_up_question": "What types of synaptic inputs do subplate cells receive at the earliest stages of corticogenesis?", "follow_up_response": "from the thalamus and from other cortical and non-cortical sources", "follow_up_response_bt": "Functional synaptic input from the thalamus and other cortical and non-cortical sources"}, {"question_id": "64.15", "question": "At what stage of corticogenesis do subplate cells begin to exhibit action potential firing frequencies exceeding 40 hz?", "answer_src": "At earliest stages of corticogenesis", "follow_up_question": "What types of synaptic inputs do subplate cells receive at the earliest stages of corticogenesis?", "follow_up_response": "from the thalamus and from other cortical and non-cortical sources", "follow_up_response_bt": "Functional synaptic input from the thalamus and other cortical and non-cortical sources"}]}}
{"id": 65, "src": "on logistic regression analysis , baseline hba1c was the strongest contributing factor for achieving target hba1c ; baseline body mass index and duration of diabetes were also significant factors . a total of 82 patients ( 11% ) were unresponsive to sitagliptin . these patients baseline body mass index was significantly higher and their baseline hba1c was significantly lower than those of patients who responded to sitagliptin .", "mt": "Nell'analisi logistica della regressione , l' hba1c di base è stato il fattore più importante per raggiungere l' obiettivo di raggiungimento; l' indice di massa corporea di base e la durata del diabete sono stati anche fattori significativi . Un totale di 82 pazienti (il 11%) non hanno risposto alla sitagliptin .", "pert_mt": "Nell'analisi logistica della regressione, l'HbA1c di base è stato il fattore più importante per raggiungere l'obiettivo di raggiungimento; l'indice di massa corporea di base e la durata del diabete sono stati anche fattori significativi. Un totale di 82 pazienti (il 11%) non hanno risposto alla sitagliptin e questo ha influenzato negativamente i risultati dell'analisi.", "bt": "In the logistic analysis of regression, the baseline HbA1c was the most important factor in achieving the goal of achievement; the baseline body mass index and the duration of diabetes were also significant factors.A total of 82 patients (11%) did not respond to sitagliptin and this negatively influenced the results of the analysis.", "questions_src": ["What is the name of the medication mentioned in the sentence?", "Who was unresponsive to sitagliptin according to the sentence?", "Where was the logistic regression analysis conducted?", "When might baseline HbA1c be measured?", "Which factor had the strongest contribution to achieving target HbA1c according to the sentence?"], "answers_src": ["[\"Sitagliptin\"], [\"A total of 82 patients (11%)\"], [\"Logistic regression analysis\"], [\"Baseline\"], [\"Baseline HBA1C\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"Sitagliptin\"], [\"A total of 82 patients (11%)\"], [\"In the logistic analysis of regression\"], [\"Baseline HbA1c\"], [\"The baseline HbA1c\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "65.1", "question": "What is the name of the medication mentioned in the sentence?", "answer_src": "[\"Sitagliptin\"], [\"A total of 82 patients (11%)\"], [\"Logistic regression analysis\"], [\"Baseline\"], [\"Baseline HBA1C\"]", "follow_up_question": "What was the average baseline HBA1C for patients who responded to sitagliptin?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "65.2", "question": "Who was unresponsive to sitagliptin according to the sentence?", "answer_src": "on logistic regression analysis , baseline hba1c was the strongest contributing factor for achieving target hba1c ; baseline body mass index and duration of diabetes were also significant factors . a total of 82 patients ( 11% ) were unresponsive to sitagliptin . these patients baseline body mass index was significantly higher and their baseline hba1c was significantly lower than those of patients who responded to sitagliptin .", "follow_up_question": "What was the difference in baseline HbA1c between unresponsive and responsive patients?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "65.3", "question": "Where was the logistic regression analysis conducted?", "answer_src": "on logistic regression analysis , baseline hba1c was the strongest contributing factor for achieving target hba1c ; baseline body mass index and duration of diabetes were also significant factors . a total of 82 patients ( 11% ) were unresponsive to sitagliptin . these patients baseline body mass index was significantly higher and their baseline hba1c was significantly lower than those of patients who responded to sitagliptin .", "follow_up_question": "What was the relationship between baseline BMI and HbA1c for patients who did not respond to sitagliptin?", "follow_up_response": "baseline body mass index was significantly higher and their baseline hba1c was significantly lower than those of patients who responded to sitagliptin.", "follow_up_response_bt": "No Answer"}, {"question_id": "65.4", "question": "When might baseline HbA1c be measured?", "answer_src": "on logistic regression analysis , baseline hba1c was the strongest contributing factor for achieving target hba1c ; baseline body mass index and duration of diabetes were also significant factors . a total of 82 patients ( 11% ) were unresponsive to sitagliptin . these patients baseline body mass index was significantly higher and their baseline hba1c was significantly lower than those of patients who responded to sitagliptin .", "follow_up_question": "What was the average baseline HbA1c level for patients who responded to sitagliptin?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "65.5", "question": "Which factor had the strongest contribution to achieving target HbA1c according to the sentence?", "answer_src": "on logistic regression analysis , baseline hba1c was the strongest contributing factor for achieving target hba1c ; baseline body mass index and duration of diabetes were also significant factors . a total of 82 patients ( 11% ) were unresponsive to sitagliptin . these patients baseline body mass index was significantly higher and their baseline hba1c was significantly lower than those of patients who responded to sitagliptin .", "follow_up_question": "What was the relationship between baseline BMI and HbA1c for patients who did not respond to sitagliptin?", "follow_up_response": "baseline body mass index was significantly higher and their baseline hba1c was significantly lower than those of patients who responded to sitagliptin.", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "65.6", "question": "What was the average baseline HBA1C for patients who responded to sitagliptin?", "answer_src": "on logistic regression analysis , baseline hba1c was the strongest contributing factor for achieving target hba1c ; baseline body mass index and duration of diabetes were also significant factors . a total of 82 patients ( 11% ) were unresponsive to sitagliptin . these patients baseline body mass index was significantly higher and their baseline hba1c was significantly lower than those of patients who responded to sitagliptin .", "follow_up_question": "What was the average baseline BMI for patients who responded to sitagliptin?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "65.7", "question": "What was the difference in baseline HbA1c between unresponsive and responsive patients?", "answer_src": "on logistic regression analysis , baseline hba1c was the strongest contributing factor for achieving target hba1c ; baseline body mass index and duration of diabetes were also significant factors . a total of 82 patients ( 11% ) were unresponsive to sitagliptin . these patients baseline body mass index was significantly higher and their baseline hba1c was significantly lower than those of patients who responded to sitagliptin .", "follow_up_question": "What was the difference in baseline BMI between unresponsive and responsive patients?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "65.8", "question": "What was the relationship between baseline BMI and HbA1c for patients who did not respond to sitagliptin?", "answer_src": "baseline body mass index was significantly higher and their baseline hba1c was significantly lower than those of patients who responded to sitagliptin.", "follow_up_question": "How much higher was the baseline BMI of patients who did not respond to sitagliptin compared to those who did?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "65.9", "question": "What was the average baseline HbA1c level for patients who responded to sitagliptin?", "answer_src": "on logistic regression analysis , baseline hba1c was the strongest contributing factor for achieving target hba1c ; baseline body mass index and duration of diabetes were also significant factors . a total of 82 patients ( 11% ) were unresponsive to sitagliptin . these patients baseline body mass index was significantly higher and their baseline hba1c was significantly lower than those of patients who responded to sitagliptin .", "follow_up_question": "What was the average baseline BMI for patients who responded to sitagliptin?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "65.10", "question": "What was the relationship between baseline BMI and HbA1c for patients who did not respond to sitagliptin?", "answer_src": "baseline body mass index was significantly higher and their baseline hba1c was significantly lower than those of patients who responded to sitagliptin.", "follow_up_question": "How much higher was the baseline BMI of patients who did not respond to sitagliptin compared to those who did?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "65.11", "question": "What was the average baseline BMI for patients who responded to sitagliptin?", "answer_src": "on logistic regression analysis , baseline hba1c was the strongest contributing factor for achieving target hba1c ; baseline body mass index and duration of diabetes were also significant factors . a total of 82 patients ( 11% ) were unresponsive to sitagliptin . these patients baseline body mass index was significantly higher and their baseline hba1c was significantly lower than those of patients who responded to sitagliptin .", "follow_up_question": "What was the average baseline HBA1C for patients who responded to sitagliptin?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "65.12", "question": "What was the difference in baseline BMI between unresponsive and responsive patients?", "answer_src": "on logistic regression analysis , baseline hba1c was the strongest contributing factor for achieving target hba1c ; baseline body mass index and duration of diabetes were also significant factors . a total of 82 patients ( 11% ) were unresponsive to sitagliptin . these patients baseline body mass index was significantly higher and their baseline hba1c was significantly lower than those of patients who responded to sitagliptin .", "follow_up_question": "What was the difference in baseline HBA1C between unresponsive and responsive patients?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "65.13", "question": "How much higher was the baseline BMI of patients who did not respond to sitagliptin compared to those who did?", "answer_src": "on logistic regression analysis , baseline hba1c was the strongest contributing factor for achieving target hba1c ; baseline body mass index and duration of diabetes were also significant factors . a total of 82 patients ( 11% ) were unresponsive to sitagliptin . these patients baseline body mass index was significantly higher and their baseline hba1c was significantly lower than those of patients who responded to sitagliptin .", "follow_up_question": "How much lower was the baseline HBA1C of patients who did not respond to sitagliptin compared to those who did?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "65.14", "question": "What was the average baseline BMI for patients who responded to sitagliptin?", "answer_src": "on logistic regression analysis , baseline hba1c was the strongest contributing factor for achieving target hba1c ; baseline body mass index and duration of diabetes were also significant factors . a total of 82 patients ( 11% ) were unresponsive to sitagliptin . these patients baseline body mass index was significantly higher and their baseline hba1c was significantly lower than those of patients who responded to sitagliptin .", "follow_up_question": "What was the average baseline HBA1C for patients who responded to sitagliptin?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "65.15", "question": "How much higher was the baseline BMI of patients who did not respond to sitagliptin compared to those who did?", "answer_src": "on logistic regression analysis , baseline hba1c was the strongest contributing factor for achieving target hba1c ; baseline body mass index and duration of diabetes were also significant factors . a total of 82 patients ( 11% ) were unresponsive to sitagliptin . these patients baseline body mass index was significantly higher and their baseline hba1c was significantly lower than those of patients who responded to sitagliptin .", "follow_up_question": "How much lower was the baseline HBA1C of patients who did not respond to sitagliptin compared to those who did?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 66, "src": "viral neuraminidase inhibitors are widely used as synthetic anti - influenza drugs for the prevention and treatment of influenza . however , drug - resistant influenza a virus variants , including h5n1 highly pathogenic avian influenza viruses ( hpaivs ) , have been reported . therefore , the discovery of novel and effective antiviral agents is warranted .", "mt": "Gli inibitori della neuraminidasi virale sono ampiamente usati come farmaci antinfluenzali sintetici per la prevenzione e il trattamento dell'influenza . Tuttavia , sono stati segnalati varianti di influenza a resistente ai farmaci , tra cui i virus dell'influenza aviaria ( hpaivs) altamente patogeni h5n1 . Pertanto , è giustificato la scoperta di nuovi ed efficaci agenti antivirali .", "pert_mt": "Gli inibitori della neuraminidasi virale sono ampiamente usati come farmaci antinfluenzali sintetici per la prevenzione e il trattamento dell'influenza. Tuttavia, sono stati segnalati varianti di influenza a resistente ai farmaci, tra cui i virus dell'influenza aviaria (hpaivs) altamente patogeni h5n1, e alcuni casi hanno mostrato resistenza anche a questi inibitori. Pertanto, è giustificato la scoperta di nuovi ed efficaci agenti antivirali.", "bt": "Viral neuraminidase inhibitors are widely used as synthetic influenza drugs for the prevention and treatment of influenza, however, drug-resistant variants of influenza have been reported, including highly pathogenic avian influenza viruses (hpaivs), and some cases have shown resistance to these inhibitors as well.", "questions_src": ["What are widely used synthetic anti-influenza drugs?", "Who has been reported to have drug-resistant influenza A virus variants?", "Where can h5n1 highly pathogenic avian influenza viruses be found?", "When was the need for discovering new antiviral agents identified?", "Which viral neuraminidase inhibitors are mentioned in the sentence?"], "answers_src": ["[\"viral neuraminidase inhibitors\"], [\"h5n1 highly pathogenic avian influenza viruses (hpavivs)\"], [\"in the wild or under controlled conditions\"], [\"Therefore, the need\"], [\"viral neuraminidase inhibitors\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"Viral neuraminidase inhibitors\"], [\"Some cases\"], [\"In avian species\"], [\"No Answer\"], [\"Viral neuraminidase inhibitors\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "66.1", "question": "What are widely used synthetic anti-influenza drugs?", "answer_src": "[\"viral neuraminidase inhibitors\"], [\"h5n1 highly pathogenic avian influenza viruses (hpavivs)\"], [\"in the wild or under controlled conditions\"], [\"Therefore, the need\"], [\"viral neuraminidase inhibitors\"]", "follow_up_question": "What are some potential consequences of the emergence of drug-resistant influenza A virus variants?", "follow_up_response": "The discovery of novel and effective antiviral agents is warranted", "follow_up_response_bt": "The emergence of drug-resistant influenza A virus variants has led to the development of highly pathogenic avian influenza viruses (hpaivs) and some cases have shown resistance to viral neuraminidase inhibitors."}, {"question_id": "66.2", "question": "Who has been reported to have drug-resistant influenza A virus variants?", "answer_src": "viral neuraminidase inhibitors are widely used as synthetic anti - influenza drugs for the prevention and treatment of influenza . however , drug - resistant influenza a virus variants , including h5n1 highly pathogenic avian influenza viruses ( hpaivs ) , have been reported . therefore , the discovery of novel and effective antiviral agents is warranted .", "follow_up_question": "What specific type of influenza A virus variant has been reported to be drug-resistant?", "follow_up_response": "h5n1 highly pathogenic avian influenza viruses (hpavivs)", "follow_up_response_bt": "highly pathogenic avian influenza viruses (hpaivs)"}, {"question_id": "66.3", "question": "Where can h5n1 highly pathogenic avian influenza viruses be found?", "answer_src": "viral neuraminidase inhibitors are widely used as synthetic anti - influenza drugs for the prevention and treatment of influenza . however , drug - resistant influenza a virus variants , including h5n1 highly pathogenic avian influenza viruses ( hpaivs ) , have been reported . therefore , the discovery of novel and effective antiviral agents is warranted .", "follow_up_question": "What types of antiviral agents are needed based on the information provided?", "follow_up_response": "Novel and effective antiviral agents", "follow_up_response_bt": "Viral neuraminidase inhibitors"}, {"question_id": "66.4", "question": "When was the need for discovering new antiviral agents identified?", "answer_src": "viral neuraminidase inhibitors are widely used as synthetic anti - influenza drugs for the prevention and treatment of influenza . however , drug - resistant influenza a virus variants , including h5n1 highly pathogenic avian influenza viruses ( hpaivs ) , have been reported . therefore , the discovery of novel and effective antiviral agents is warranted .", "follow_up_question": "What specific type of influenza viruses has led to the need for new antiviral agents?", "follow_up_response": "Influenza A viruses", "follow_up_response_bt": "Highly pathogenic avian influenza viruses (hpaivs)"}, {"question_id": "66.5", "question": "Which viral neuraminidase inhibitors are mentioned in the sentence?", "answer_src": "viral neuraminidase inhibitors are widely used as synthetic anti - influenza drugs for the prevention and treatment of influenza . however , drug - resistant influenza a virus variants , including h5n1 highly pathogenic avian influenza viruses ( hpaivs ) , have been reported . therefore , the discovery of novel and effective antiviral agents is warranted .", "follow_up_question": "What type of drugs are being referred to when mentioning \"synthetic anti-influenza drugs\"?", "follow_up_response": "viral neuraminidase inhibitors", "follow_up_response_bt": "Viral neuraminidase inhibitors"}], "turn_2": [{"question_id": "66.6", "question": "What are some potential consequences of the emergence of drug-resistant influenza A virus variants?", "answer_src": "The discovery of novel and effective antiviral agents is warranted", "follow_up_question": "What types of antiviral agents are being sought after due to the emergence of drug-resistant variants?", "follow_up_response": "Novel and effective antiviral agents", "follow_up_response_bt": "Viral neuraminidase inhibitors"}, {"question_id": "66.7", "question": "What specific type of influenza A virus variant has been reported to be drug-resistant?", "answer_src": "h5n1 highly pathogenic avian influenza viruses (hpavivs)", "follow_up_question": "What measures are being taken to combat the emergence of these drug-resistant strains?", "follow_up_response": "The discovery of novel and effective antiviral agents", "follow_up_response_bt": "No Answer"}, {"question_id": "66.8", "question": "What types of antiviral agents are needed based on the information provided?", "answer_src": "Novel and effective antiviral agents", "follow_up_question": "What specific type of antiviral agent is currently being developed to address the issue of drug-resistant influenza A viruses?", "follow_up_response": "novel and effective antiviral agents", "follow_up_response_bt": "Viral neuraminidase inhibitors"}, {"question_id": "66.9", "question": "What specific type of influenza viruses has led to the need for new antiviral agents?", "answer_src": "Influenza A viruses", "follow_up_question": "What subtype of influenza A viruses has been particularly problematic?", "follow_up_response": "h5n1 highly pathogenic avian influenza viruses ( hpaivs ) ", "follow_up_response_bt": "highly pathogenic avian influenza viruses (hpaivs)"}, {"question_id": "66.10", "question": "What type of drugs are being referred to when mentioning \"synthetic anti-influenza drugs\"?", "answer_src": "viral neuraminidase inhibitors", "follow_up_question": "What specific subtype of influenza A virus has been found to develop resistance to these drugs?", "follow_up_response": "h5n1 highly pathogenic avian influenza viruses (hpaivs)", "follow_up_response_bt": "highly pathogenic avian influenza viruses (hpaivs)"}], "turn_3": [{"question_id": "66.11", "question": "What types of antiviral agents are being sought after due to the emergence of drug-resistant variants?", "answer_src": "Novel and effective antiviral agents", "follow_up_question": "What specific type of antiviral agent is currently being developed to combat these drug-resistant influenza A viruses?", "follow_up_response": "Novel and effective antiviral agents", "follow_up_response_bt": "Viral neuraminidase inhibitors"}, {"question_id": "66.12", "question": "What measures are being taken to combat the emergence of these drug-resistant strains?", "answer_src": "The discovery of novel and effective antiviral agents", "follow_up_question": "What types of antiviral agents are being sought after?", "follow_up_response": "Novel and effective antiviral agents", "follow_up_response_bt": "Viral neuraminidase inhibitors"}, {"question_id": "66.13", "question": "What specific type of antiviral agent is currently being developed to address the issue of drug-resistant influenza A viruses?", "answer_src": "novel and effective antiviral agents", "follow_up_question": "What kind of antiviral agents are being specifically researched to combat drug-resistant H5N1 viruses?", "follow_up_response": "novel and effective antiviral agents", "follow_up_response_bt": "No Answer"}, {"question_id": "66.14", "question": "What subtype of influenza A viruses has been particularly problematic?", "answer_src": "h5n1 highly pathogenic avian influenza viruses ( hpaivs ) ", "follow_up_question": "What measures are being taken to combat these drug-resistant strains?", "follow_up_response": "The discovery of novel and effective antiviral agents", "follow_up_response_bt": "No Answer"}, {"question_id": "66.15", "question": "What specific subtype of influenza A virus has been found to develop resistance to these drugs?", "answer_src": "h5n1 highly pathogenic avian influenza viruses (hpaivs)", "follow_up_question": "What measures do these drug-resistant viruses pose for current treatment options?", "follow_up_response": "Current treatment options for influenza", "follow_up_response_bt": "These drug-resistant viruses pose a challenge for current treatment options."}]}}
{"id": 67, "src": "myelolipoma is a rare benign tumor of adrenal gland and rarer in children . myelolipoma contains adipose tissue and myeloid precursor producing white blood cells ( wbc ) , red blood cells ( rbc ) and megakaryocytes . asymptomatic tumor does not require treatment whereas symptomatic tumor needs operation .", "mt": "Il mielololipoma è un raro tumore benigno della ghiandola surrenale e più raro nei bambini . Il mielololipoma contiene tessuto adiposo e precursore mieloide che produce globuli bianchi (wbc), globuli rossi (rbc) e megakaryociti . Il tumore asintomatico non richiede trattamento mentre il tumore sintomatico richiede un intervento .", "pert_mt": "Il mielololipoma è un raro tumore benigno della ghiandola surrenale e più raro nei bambini. Il mielololipoma contiene tessuto adiposo e precursore mieloide che produce globuli bianchi (wbc), globuli rossi (rbc) e megakaryociti. Il tumore asintomatico non richiede trattamento mentre il tumore sintomatico richiede un intervento e può causare complesse alterazioni endocrine.", "bt": "Myelololipoma is a rare benign tumor of the adrenal gland and is less common in children.Myelololipoma contains adipose tissue and a myeloid precursor that produces white blood cells (wbc), red blood cells (rbc) and megakaryocytes.Asymptomatic tumor does not require treatment while symptomatic tumor requires intervention and can cause complex endocrine disorders.", "questions_src": ["What does myelolipoma contain?", "Who can develop myelolipoma?", "Where is myelolipoma typically found?", "When might a myelolipoma require treatment?", "Which blood cells can myelolipoma produce?"], "answers_src": ["Adipose tissue and myeloid precursor producing white blood cells (WBC), red blood cells (RBC) and megakaryocytes", "It is rare and can be found in adults and children", "In the adrenal gland", "Symptomatic tumor", "White blood cells (WBC), red blood cells (RBC) and megakaryocytes"], "answers_bt": ["Myelolipoma contains adipose tissue and a myeloid precursor that produces white blood cells (wbc), red blood cells (rbc) and megakaryocytes.", "It can develop in adults and children.", "It is typically found in the adrenal gland.", "Symptomatic tumor requires intervention.", "Myelolipoma can produce white blood cells (wbc), red blood cells (rbc) and megakaryocytes."], "multiturn": {"turn_1": [{"question_id": "67.1", "question": "What does myelolipoma contain?", "answer_src": "Adipose tissue and myeloid precursor producing white blood cells (WBC), red blood cells (RBC) and megakaryocytes", "follow_up_question": "What happens to an asymptomatic myelolipoma?", "follow_up_response": "Does not require treatment", "follow_up_response_bt": "Does not require treatment"}, {"question_id": "67.2", "question": "Who can develop myelolipoma?", "answer_src": "It is rare and can be found in adults and children", "follow_up_question": "What specific types of cells are present in a myelolipoma?", "follow_up_response": "adipose tissue and myeloid precursor producing white blood cells (wbc) , red blood cells (rbc) and megakaryocytes", "follow_up_response_bt": "Adipose tissue and a myeloid precursor that produces white blood cells (WBC), red blood cells (RBC) and megakaryocytes"}, {"question_id": "67.3", "question": "Where is myelolipoma typically found?", "answer_src": "In the adrenal gland", "follow_up_question": "What types of blood cells are present in a myelolipoma?", "follow_up_response": "adipose tissue and myeloid precursor producing white blood cells (wbc), red blood cells (rbc) and megakaryocytes", "follow_up_response_bt": "white blood cells (wbc), red blood cells (rbc) and megakaryocytes"}, {"question_id": "67.4", "question": "When might a myelolipoma require treatment?", "answer_src": "Symptomatic tumor", "follow_up_question": "What symptoms would indicate a symptomatic tumor?", "follow_up_response": "Symptomatic tumor needs operation", "follow_up_response_bt": "Complex endocrine disorders"}, {"question_id": "67.5", "question": "Which blood cells can myelolipoma produce?", "answer_src": "White blood cells (WBC), red blood cells (RBC) and megakaryocytes", "follow_up_question": "What happens to an asymptomatic myelolipoma?", "follow_up_response": "Does not require treatment", "follow_up_response_bt": "Does not require treatment"}], "turn_2": [{"question_id": "67.6", "question": "What happens to an asymptomatic myelolipoma?", "answer_src": "Does not require treatment", "follow_up_question": "What type of treatment is needed for a symptomatic myelolipoma?", "follow_up_response": "operation", "follow_up_response_bt": "Intervention"}, {"question_id": "67.7", "question": "What specific types of cells are present in a myelolipoma?", "answer_src": "adipose tissue and myeloid precursor producing white blood cells (wbc) , red blood cells (rbc) and megakaryocytes", "follow_up_question": "What happens to a symptomatic myelolipoma?", "follow_up_response": "Needs operation", "follow_up_response_bt": "Requires intervention and can cause complex endocrine disorders"}, {"question_id": "67.8", "question": "What types of blood cells are present in a myelolipoma?", "answer_src": "adipose tissue and myeloid precursor producing white blood cells (wbc), red blood cells (rbc) and megakaryocytes", "follow_up_question": "What percentage of myelolipomas contain adipose tissue?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "67.9", "question": "What symptoms would indicate a symptomatic tumor?", "answer_src": "Symptomatic tumor needs operation", "follow_up_question": "What types of cells are found in a myelolipoma?", "follow_up_response": "adipose tissue and myeloid precursor producing white blood cells (wbc) , red blood cells (rbc) and megakaryocytes", "follow_up_response_bt": "Adipose tissue and a myeloid precursor that produces white blood cells (WBC), red blood cells (RBC) and megakaryocytes"}, {"question_id": "67.10", "question": "What happens to an asymptomatic myelolipoma?", "answer_src": "Does not require treatment", "follow_up_question": "What type of treatment is needed for a symptomatic myelolipoma?", "follow_up_response": "operation", "follow_up_response_bt": "Intervention"}], "turn_3": [{"question_id": "67.11", "question": "What type of treatment is needed for a symptomatic myelolipoma?", "answer_src": "operation", "follow_up_question": "What specific components are found in a myelolipoma?", "follow_up_response": "Adipose tissue and myeloid precursor producing white blood cells (WBC), red blood cells (RBC) and megakaryocytes", "follow_up_response_bt": "Adipose tissue and a myeloid precursor that produces white blood cells (WBC), red blood cells (RBC) and megakaryocytes"}, {"question_id": "67.12", "question": "What happens to a symptomatic myelolipoma?", "answer_src": "Needs operation", "follow_up_question": "What type of cells does a myelolipoma contain?", "follow_up_response": "adipose tissue and myeloid precursor producing white blood cells (wbc) , red blood cells (rbc) and megakaryocytes", "follow_up_response_bt": "Adipose tissue and a myeloid precursor that produces white blood cells (wbc), red blood cells (rbc) and megakaryocytes."}, {"question_id": "67.13", "question": "What percentage of myelolipomas contain adipose tissue?", "answer_src": "myelolipoma is a rare benign tumor of adrenal gland and rarer in children . myelolipoma contains adipose tissue and myeloid precursor producing white blood cells ( wbc ) , red blood cells ( rbc ) and megakaryocytes . asymptomatic tumor does not require treatment whereas symptomatic tumor needs operation .", "follow_up_question": "What types of cells besides adipose tissue are found in a myelolipoma?", "follow_up_response": "white blood cells ( wbc ) , red blood cells ( rbc ) and megakaryocytes", "follow_up_response_bt": "white blood cells (wbc), red blood cells (rbc) and megakaryocytes"}, {"question_id": "67.14", "question": "What types of cells are found in a myelolipoma?", "answer_src": "adipose tissue and myeloid precursor producing white blood cells (wbc) , red blood cells (rbc) and megakaryocytes", "follow_up_question": "What happens to an asymptomatic myelolipoma?", "follow_up_response": "Does not require treatment", "follow_up_response_bt": "Does not require treatment"}, {"question_id": "67.15", "question": "What type of treatment is needed for a symptomatic myelolipoma?", "answer_src": "operation", "follow_up_question": "What specific components are found in a myelolipoma?", "follow_up_response": "Adipose tissue and myeloid precursor producing white blood cells (WBC), red blood cells (RBC) and megakaryocytes", "follow_up_response_bt": "Adipose tissue and a myeloid precursor that produces white blood cells (WBC), red blood cells (RBC) and megakaryocytes"}]}}
{"id": 68, "src": "more frequently than adults , pediatric victims of severe traumatic brain injury experience diffuse severe cerebral edema without mass lesions . these patients require methods to reduce intracranial pressure quickly and reliably . surgical decompression provides rapid relief of increased intracranial pressure and is an alternative to maximal medical therapy for these individuals .", "mt": "Più spesso degli adulti , le vittime pediatriche di lesioni cerebrali traumatiche gravi sperimentano edema cerebrale diffuso senza lesioni di massa . Questi pazienti richiedono metodi per ridurre la pressione intracranica in modo rapido e affidabile . La decompressione chirurgica fornisce un rapido sollievo dall' aumento della pressione intracranica ed è un' alternativa alla terapia medica massima per questi individui .", "pert_mt": "Più spesso degli adulti, le vittime pediatriche di lesioni cerebrali traumatiche gravi sperimentano edema cerebrale diffuso senza lesioni di massa. Questi pazienti richiedono metodi per ridurre la pressione intracranica in modo rapido e affidabile. La decompressione chirurgica fornisce un rapido sollievo dall'aumento della pressione intracranica ed è un'alternativa alla terapia medica massima per questi individui e può migliorare significativamente i loro prognosi.", "bt": "More often than adults, pediatric victims of severe traumatic brain injury experience diffuse brain edema without mass injury.These patients require methods to reduce intracranial pressure quickly and reliably.Surgical decompression provides rapid relief from increased intracranial pressure and is an alternative to maximum medical therapy for these individuals and can significantly improve their prognosis.", "questions_src": ["What does surgical decompression provide for pediatric victims of severe traumatic brain injury?", "When do pediatric victims of severe traumatic brain injury typically experience diffuse severe cerebral edema?", "Where is the primary source of increased intracranial pressure in pediatric victims?", "Which method is considered an alternative to maximal medical therapy for reducing intracranial pressure in these patients?", "Who are the primary recipients of the treatment methods mentioned for these patients?"], "answers_src": ["[\"Rapid relief of increased intracranial pressure\"], [\"No Answer\"], [\"Inside the brain\"], [\"Surgical decompression\"], [\"Pediatric victims of severe traumatic brain injury\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["Rapid relief from increased intracranial pressure", "No Answer", "Inside the brain", "Surgical decompression", "Pediatric victims of severe traumatic brain injury"], "multiturn": {"turn_1": [{"question_id": "68.1", "question": "What does surgical decompression provide for pediatric victims of severe traumatic brain injury?", "answer_src": "[\"Rapid relief of increased intracranial pressure\"], [\"No Answer\"], [\"Inside the brain\"], [\"Surgical decompression\"], [\"Pediatric victims of severe traumatic brain injury\"]", "follow_up_question": "What conditions make surgical decompression an alternative to maximal medical therapy for pediatric victims?", "follow_up_response": "Diffuse severe cerebral edema without mass lesions", "follow_up_response_bt": "Diffuse brain edema without mass injury"}, {"question_id": "68.2", "question": "When do pediatric victims of severe traumatic brain injury typically experience diffuse severe cerebral edema?", "answer_src": "more frequently than adults , pediatric victims of severe traumatic brain injury experience diffuse severe cerebral edema without mass lesions . these patients require methods to reduce intracranial pressure quickly and reliably . surgical decompression provides rapid relief of increased intracranial pressure and is an alternative to maximal medical therapy for these individuals .", "follow_up_question": "What method does the text suggest for providing rapid relief of increased intracranial pressure?", "follow_up_response": "Surgical decompression", "follow_up_response_bt": "Surgical decompression"}, {"question_id": "68.3", "question": "Where is the primary source of increased intracranial pressure in pediatric victims?", "answer_src": "more frequently than adults , pediatric victims of severe traumatic brain injury experience diffuse severe cerebral edema without mass lesions . these patients require methods to reduce intracranial pressure quickly and reliably . surgical decompression provides rapid relief of increased intracranial pressure and is an alternative to maximal medical therapy for these individuals .", "follow_up_question": "What method does the text suggest for providing rapid relief of increased intracranial pressure?", "follow_up_response": "Surgical decompression", "follow_up_response_bt": "Surgical decompression"}, {"question_id": "68.4", "question": "Which method is considered an alternative to maximal medical therapy for reducing intracranial pressure in these patients?", "answer_src": "more frequently than adults , pediatric victims of severe traumatic brain injury experience diffuse severe cerebral edema without mass lesions . these patients require methods to reduce intracranial pressure quickly and reliably . surgical decompression provides rapid relief of increased intracranial pressure and is an alternative to maximal medical therapy for these individuals .", "follow_up_question": "What specific condition does surgical decompression address in pediatric victims?", "follow_up_response": "Diffuse severe cerebral edema", "follow_up_response_bt": "Diffuse brain edema"}, {"question_id": "68.5", "question": "Who are the primary recipients of the treatment methods mentioned for these patients?", "answer_src": "more frequently than adults , pediatric victims of severe traumatic brain injury experience diffuse severe cerebral edema without mass lesions . these patients require methods to reduce intracranial pressure quickly and reliably . surgical decompression provides rapid relief of increased intracranial pressure and is an alternative to maximal medical therapy for these individuals .", "follow_up_question": "What method does the text suggest as an alternative to maximal medical therapy for reducing intracranial pressure?", "follow_up_response": "Surgical decompression", "follow_up_response_bt": "Surgical decompression"}], "turn_2": [{"question_id": "68.6", "question": "What conditions make surgical decompression an alternative to maximal medical therapy for pediatric victims?", "answer_src": "Diffuse severe cerebral edema without mass lesions", "follow_up_question": "What specific benefit does surgical decompression provide compared to maximal medical therapy for pediatric victims with this condition?", "follow_up_response": "Rapid relief of increased intracranial pressure", "follow_up_response_bt": "Rapid relief from increased intracranial pressure"}, {"question_id": "68.7", "question": "What method does the text suggest for providing rapid relief of increased intracranial pressure?", "answer_src": "Surgical decompression", "follow_up_question": "What are the potential drawbacks or risks associated with surgical decompression mentioned in the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "68.8", "question": "What method does the text suggest for providing rapid relief of increased intracranial pressure?", "answer_src": "Surgical decompression", "follow_up_question": "What are the potential drawbacks or risks associated with surgical decompression mentioned in the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "68.9", "question": "What specific condition does surgical decompression address in pediatric victims?", "answer_src": "Diffuse severe cerebral edema", "follow_up_question": "What method besides surgical decompression is mentioned for reducing intracranial pressure in these patients?", "follow_up_response": "No Answer", "follow_up_response_bt": "Maximum medical therapy"}, {"question_id": "68.10", "question": "What method does the text suggest as an alternative to maximal medical therapy for reducing intracranial pressure?", "answer_src": "Surgical decompression", "follow_up_question": "What percentage of pediatric victims with severe traumatic brain injury have diffuse severe cerebral edema?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "68.11", "question": "What specific benefit does surgical decompression provide compared to maximal medical therapy for pediatric victims with this condition?", "answer_src": "Rapid relief of increased intracranial pressure", "follow_up_question": "What are the potential risks or complications associated with surgical decompression in this patient population?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "68.12", "question": "What are the potential drawbacks or risks associated with surgical decompression mentioned in the text?", "answer_src": "more frequently than adults , pediatric victims of severe traumatic brain injury experience diffuse severe cerebral edema without mass lesions . these patients require methods to reduce intracranial pressure quickly and reliably . surgical decompression provides rapid relief of increased intracranial pressure and is an alternative to maximal medical therapy for these individuals .", "follow_up_question": "What alternative method does surgical decompression serve as for pediatric victims?", "follow_up_response": "maximal medical therapy", "follow_up_response_bt": "Maximum medical therapy"}, {"question_id": "68.13", "question": "What are the potential drawbacks or risks associated with surgical decompression mentioned in the text?", "answer_src": "more frequently than adults , pediatric victims of severe traumatic brain injury experience diffuse severe cerebral edema without mass lesions . these patients require methods to reduce intracranial pressure quickly and reliably . surgical decompression provides rapid relief of increased intracranial pressure and is an alternative to maximal medical therapy for these individuals .", "follow_up_question": "What alternative method does surgical decompression serve as for pediatric victims?", "follow_up_response": "maximal medical therapy", "follow_up_response_bt": "Maximum medical therapy"}, {"question_id": "68.14", "question": "What method besides surgical decompression is mentioned for reducing intracranial pressure in these patients?", "answer_src": "more frequently than adults , pediatric victims of severe traumatic brain injury experience diffuse severe cerebral edema without mass lesions . these patients require methods to reduce intracranial pressure quickly and reliably . surgical decompression provides rapid relief of increased intracranial pressure and is an alternative to maximal medical therapy for these individuals .", "follow_up_question": "What is the benefit of using surgical decompression over maximal medical therapy for these patients?", "follow_up_response": "Surgical decompression provides rapid relief of increased intracranial pressure and is an alternative to maximal medical therapy", "follow_up_response_bt": "Surgical decompression provides rapid relief from increased intracranial pressure and can significantly improve their prognosis"}, {"question_id": "68.15", "question": "What percentage of pediatric victims with severe traumatic brain injury have diffuse severe cerebral edema?", "answer_src": "more frequently than adults , pediatric victims of severe traumatic brain injury experience diffuse severe cerebral edema without mass lesions . these patients require methods to reduce intracranial pressure quickly and reliably . surgical decompression provides rapid relief of increased intracranial pressure and is an alternative to maximal medical therapy for these individuals .", "follow_up_question": "What method does the text suggest for reducing intracranial pressure quickly?", "follow_up_response": "Surgical decompression", "follow_up_response_bt": "Surgical decompression"}]}}
{"id": 69, "src": "fournier s gangrene is a necrotizing infection of the scrotal region , and is typically caused by exterobacteriaceae and anaerobic bacteria . this report describes a case involving a 70-year - old man of japanese descent who developed fournier s gangrene that was found to be caused by listeria monocytogenes . the patient s unique risk factors are discussed .", "mt": "La gangrena di Fournier è un' infezione necrotizzante della regione dello scrotolo , e è tipicamente causata da batteri esterni e anaerobici . Questo rapporto descrive un caso che coinvolge un uomo di 70 anni di origine giapponese che ha sviluppato la gangrena di Fournier che è stata trovata causata da listeria monocytogenes .", "pert_mt": "La gangrena di Fournier è un' infezione necrotizzante della regione dello scrotolo, e è tipicamente causata da batteri esterni e anaerobici. Questo rapporto descrive un caso che coinvolge un uomo di 70 anni di origine giapponese che ha sviluppato la gangrena di Fournier e ha presentato anche febbre elevata, che è stata trovata causata da listeria monocytogenes.", "bt": "Fournier's gangrene is a necrotizing infection of the scrotum region, typically caused by external bacteria and anaerobic agents.This report describes a case involving a 70-year-old man of Japanese origin who developed Fournier's gangrene and also had high fever, which was found to be caused by listeria monocytogenes.", "questions_src": ["What type of infection is fournier's gangrene?", "Who is typically affected by fournier's gangrene?", "Where does fournier's gangrene occur?", "When was the case involving the 70-year-old man reported?", "Which bacteria caused the fournier's gangrene in the patient?"], "answers_src": ["Necrotizing infection of the scrotal region", "Typically affects men", "Scrotal region", "No Answer", "Listeria monocytogenes"], "answers_bt": ["Necrotizing infection", "Typically caused by external bacteria and anaerobic agents", "The scrotum region", "No Answer", "Listeria monocytogenes"], "multiturn": {"turn_1": [{"question_id": "69.1", "question": "What type of infection is fournier's gangrene?", "answer_src": "Necrotizing infection of the scrotal region", "follow_up_question": "What specific bacteria were found to cause the patient's fournier's gangrene?", "follow_up_response": "Listeria monocytogenes", "follow_up_response_bt": "listeria monocytogenes"}, {"question_id": "69.2", "question": "Who is typically affected by fournier's gangrene?", "answer_src": "Typically affects men", "follow_up_question": "What specific risk factors were discussed for the patient in the case described?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "69.3", "question": "Where does fournier's gangrene occur?", "answer_src": "Scrotal region", "follow_up_question": "What specific type of bacteria caused the patient's fournier's gangrene?", "follow_up_response": "Listeria monocytogenes", "follow_up_response_bt": "listeria monocytogenes"}, {"question_id": "69.4", "question": "When was the case involving the 70-year-old man reported?", "answer_src": "fournier s gangrene is a necrotizing infection of the scrotal region , and is typically caused by exterobacteriaceae and anaerobic bacteria . this report describes a case involving a 70-year - old man of japanese descent who developed fournier s gangrene that was found to be caused by listeria monocytogenes . the patient s unique risk factors are discussed .", "follow_up_question": "What unique risk factors were discussed for the patient?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "69.5", "question": "Which bacteria caused the fournier's gangrene in the patient?", "answer_src": "Listeria monocytogenes", "follow_up_question": "What other bacteria were involved in the patient's fournier's gangrene besides Listeria monocytogenes?", "follow_up_response": "exterobacteriaceae and anaerobic bacteria", "follow_up_response_bt": "External bacteria and anaerobic agents"}], "turn_2": [{"question_id": "69.6", "question": "What specific bacteria were found to cause the patient's fournier's gangrene?", "answer_src": "Listeria monocytogenes", "follow_up_question": "What other bacteria were identified as causing the patient's infection besides Listeria monocytogenes?", "follow_up_response": "exterobacteriaceae and anaerobic bacteria", "follow_up_response_bt": "External bacteria and anaerobic agents"}, {"question_id": "69.7", "question": "What specific risk factors were discussed for the patient in the case described?", "answer_src": "fournier s gangrene is a necrotizing infection of the scrotal region , and is typically caused by exterobacteriaceae and anaerobic bacteria . this report describes a case involving a 70-year - old man of japanese descent who developed fournier s gangrene that was found to be caused by listeria monocytogenes . the patient s unique risk factors are discussed .", "follow_up_question": "What unique risk factors did the patient have according to the report?", "follow_up_response": "The patient s unique risk factors", "follow_up_response_bt": "Japanese origin"}, {"question_id": "69.8", "question": "What specific type of bacteria caused the patient's fournier's gangrene?", "answer_src": "Listeria monocytogenes", "follow_up_question": "What other bacteria were typically involved in fournier's gangrene according to the text?", "follow_up_response": "exterobacteriaceae and anaerobic bacteria", "follow_up_response_bt": "external bacteria and anaerobic agents"}, {"question_id": "69.9", "question": "What unique risk factors were discussed for the patient?", "answer_src": "fournier s gangrene is a necrotizing infection of the scrotal region , and is typically caused by exterobacteriaceae and anaerobic bacteria . this report describes a case involving a 70-year - old man of japanese descent who developed fournier s gangrene that was found to be caused by listeria monocytogenes . the patient s unique risk factors are discussed .", "follow_up_question": "What is the specific bacterium responsible for the patient's fournier's gangrene?", "follow_up_response": "Listeria monocytogenes", "follow_up_response_bt": "listeria monocytogenes"}, {"question_id": "69.10", "question": "What other bacteria were involved in the patient's fournier's gangrene besides Listeria monocytogenes?", "answer_src": "exterobacteriaceae and anaerobic bacteria", "follow_up_question": "What specific type of exterobacteriaceae was identified in the patient's fournier's gangrene?", "follow_up_response": "No Answer", "follow_up_response_bt": "listeria monocytogenes"}], "turn_3": [{"question_id": "69.11", "question": "What other bacteria were identified as causing the patient's infection besides Listeria monocytogenes?", "answer_src": "exterobacteriaceae and anaerobic bacteria", "follow_up_question": "What specific type of exterobacteriaceae was identified in the patient's infection?", "follow_up_response": "No Answer", "follow_up_response_bt": "listeria monocytogenes"}, {"question_id": "69.12", "question": "What unique risk factors did the patient have according to the report?", "answer_src": "The patient s unique risk factors", "follow_up_question": "What other bacteria besides Listeria monocytogenes were found to cause fournier's gangrene in this case?", "follow_up_response": "exterobacteriaceae and anaerobic bacteria", "follow_up_response_bt": "No Answer"}, {"question_id": "69.13", "question": "What other bacteria were typically involved in fournier's gangrene according to the text?", "answer_src": "exterobacteriaceae and anaerobic bacteria", "follow_up_question": "What specific type of bacteria caused the patient's fournier's gangrene in this case?", "follow_up_response": "Listeria monocytogenes", "follow_up_response_bt": "listeria monocytogenes"}, {"question_id": "69.14", "question": "What is the specific bacterium responsible for the patient's fournier's gangrene?", "answer_src": "Listeria monocytogenes", "follow_up_question": "What other types of bacteria were typically involved in fournier's gangrene according to the text?", "follow_up_response": "exterobacteriaceae and anaerobic bacteria", "follow_up_response_bt": "external and anaerobic agents"}, {"question_id": "69.15", "question": "What specific type of exterobacteriaceae was identified in the patient's fournier's gangrene?", "answer_src": "fournier s gangrene is a necrotizing infection of the scrotal region , and is typically caused by exterobacteriaceae and anaerobic bacteria . this report describes a case involving a 70-year - old man of japanese descent who developed fournier s gangrene that was found to be caused by listeria monocytogenes . the patient s unique risk factors are discussed .", "follow_up_question": "What other type of bacteria besides exterobacteriaceae was identified as causing the patient's fournier's gangrene?", "follow_up_response": "anaerobic bacteria", "follow_up_response_bt": "listeria monocytogenes"}]}}
{"id": 70, "src": "[ purpose ] this study examined the relationships between joint moment and the control of the vertical ground reaction force during walking in the elderly and young male and female individuals . [ subjects and methods ] forty elderly people , 65 years old or older ( 20 males and 20 females ) , and 40 young people , 20 to 29 years old ( 20 males and 20 females ) , participated in this study . joint moment and vertical ground reaction force during walking were obtained using a 3d motion analysis system and force plates .", "mt": "Questo studio ha esaminato le relazioni tra il momento articolare e il controllo della forza di reazione del terreno verticale durante la camminata negli individui anziani e giovani maschi e femmine . Quaranta anziani , 65 anni o più (20 maschi e 20 femmine) e 40 giovani , da 20 a 29 anni (20 maschi e 20 femmine) hanno partecipato a questo studio .", "pert_mt": "Questo studio ha esaminato le relazioni tra il momento articolare e il controllo della forza di reazione del terreno verticale durante la camminata negli individui anziani e giovani maschi e femmine. Quaranta anziani, 65 anni o più (20 maschi e 20 femmine) e 40 giovani, da 20 a 29 anni (20 maschi e 20 femmine) hanno partecipato a questo studio. Inoltre, i risultati sono stati confrontati con un gruppo di soggetti sani di età simile.", "bt": "This study examined the relationships between joint timing and the control of the reaction force of vertical terrain during walking in older and younger male and female subjects.40 older, 65 years or older (20 males and 20 females) and 40 young, 20 to 29 years old (20 males and 20 females) participated in this study.", "questions_src": ["What is the main focus of this study?", "Who participated in the study?", "When did the study take place?", "Where was the study conducted?", "Which age groups were studied?"], "answers_src": ["[\"This study examined the relationships between joint moment and the control of the vertical ground reaction force during walking\"], [\"Forty elderly people, 65 years old or older (20 males and 20 females), and 40 young people, 20 to 29 years old (20 males and 20 females)\"], [\"No Answer\"], [\"No Answer\"], [\"Elderly and young people\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"The relationships between joint timing and the control of the reaction force of vertical terrain during walking\"], [\"older, 65 years or older (20 males and 20 females) and 40 young, 20 to 29 years old (20 males and 20 females)\"], [\"No Answer\"], [\"No Answer\"], [\"older (65 years or older) and young (20 to 29 years old)\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "70.1", "question": "What is the main focus of this study?", "answer_src": "[\"This study examined the relationships between joint moment and the control of the vertical ground reaction force during walking\"], [\"Forty elderly people, 65 years old or older (20 males and 20 females), and 40 young people, 20 to 29 years old (20 males and 20 females)\"], [\"No Answer\"], [\"No Answer\"], [\"Elderly and young people\"]", "follow_up_question": "How many participants were there in total?", "follow_up_response": "40", "follow_up_response_bt": "80"}, {"question_id": "70.2", "question": "Who participated in the study?", "answer_src": "[ purpose ] this study examined the relationships between joint moment and the control of the vertical ground reaction force during walking in the elderly and young male and female individuals . [ subjects and methods ] forty elderly people , 65 years old or older ( 20 males and 20 females ) , and 40 young people , 20 to 29 years old ( 20 males and 20 females ) , participated in this study . joint moment and vertical ground reaction force during walking were obtained using a 3d motion analysis system and force plates .", "follow_up_question": "What was the age range of the elderly participants?", "follow_up_response": "65 years old or older", "follow_up_response_bt": "older, 65 years or older"}, {"question_id": "70.3", "question": "When did the study take place?", "answer_src": "[ purpose ] this study examined the relationships between joint moment and the control of the vertical ground reaction force during walking in the elderly and young male and female individuals . [ subjects and methods ] forty elderly people , 65 years old or older ( 20 males and 20 females ) , and 40 young people , 20 to 29 years old ( 20 males and 20 females ) , participated in this study . joint moment and vertical ground reaction force during walking were obtained using a 3d motion analysis system and force plates .", "follow_up_question": "What specific age range did the young participants fall into?", "follow_up_response": "20 to 29 years old", "follow_up_response_bt": "20 to 29 years old"}, {"question_id": "70.4", "question": "Where was the study conducted?", "answer_src": "[ purpose ] this study examined the relationships between joint moment and the control of the vertical ground reaction force during walking in the elderly and young male and female individuals . [ subjects and methods ] forty elderly people , 65 years old or older ( 20 males and 20 females ) , and 40 young people , 20 to 29 years old ( 20 males and 20 females ) , participated in this study . joint moment and vertical ground reaction force during walking were obtained using a 3d motion analysis system and force plates .", "follow_up_question": "What specific measurements were used to obtain joint moment and vertical ground reaction force?", "follow_up_response": "a 3d motion analysis system and force plates", "follow_up_response_bt": "No Answer"}, {"question_id": "70.5", "question": "Which age groups were studied?", "answer_src": "[ purpose ] this study examined the relationships between joint moment and the control of the vertical ground reaction force during walking in the elderly and young male and female individuals . [ subjects and methods ] forty elderly people , 65 years old or older ( 20 males and 20 females ) , and 40 young people , 20 to 29 years old ( 20 males and 20 females ) , participated in this study . joint moment and vertical ground reaction force during walking were obtained using a 3d motion analysis system and force plates .", "follow_up_question": "What was the age range for the elderly participants?", "follow_up_response": "65 years old or older", "follow_up_response_bt": "older, 65 years or older"}], "turn_2": [{"question_id": "70.6", "question": "How many participants were there in total?", "answer_src": "40", "follow_up_question": "How many more elderly participants were there compared to young participants?", "follow_up_response": "20", "follow_up_response_bt": "20"}, {"question_id": "70.7", "question": "What was the age range of the elderly participants?", "answer_src": "65 years old or older", "follow_up_question": "What was the average age of the elderly participants?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "70.8", "question": "What specific age range did the young participants fall into?", "answer_src": "20 to 29 years old", "follow_up_question": "What was the average age of the elderly participants?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "70.9", "question": "What specific measurements were used to obtain joint moment and vertical ground reaction force?", "answer_src": "a 3d motion analysis system and force plates", "follow_up_question": "What type of force plates were used in the study?", "follow_up_response": "force plates", "follow_up_response_bt": "No Answer"}, {"question_id": "70.10", "question": "What was the age range for the elderly participants?", "answer_src": "65 years old or older", "follow_up_question": "What was the average age of the elderly participants?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "70.11", "question": "How many more elderly participants were there compared to young participants?", "answer_src": "20", "follow_up_question": "How many total participants were there in the study?", "follow_up_response": "40", "follow_up_response_bt": "80"}, {"question_id": "70.12", "question": "What was the average age of the elderly participants?", "answer_src": "[ purpose ] this study examined the relationships between joint moment and the control of the vertical ground reaction force during walking in the elderly and young male and female individuals . [ subjects and methods ] forty elderly people , 65 years old or older ( 20 males and 20 females ) , and 40 young people , 20 to 29 years old ( 20 males and 20 females ) , participated in this study . joint moment and vertical ground reaction force during walking were obtained using a 3d motion analysis system and force plates .", "follow_up_question": "What was the average age of the young participants?", "follow_up_response": "32", "follow_up_response_bt": "34"}, {"question_id": "70.13", "question": "What was the average age of the elderly participants?", "answer_src": "[ purpose ] this study examined the relationships between joint moment and the control of the vertical ground reaction force during walking in the elderly and young male and female individuals . [ subjects and methods ] forty elderly people , 65 years old or older ( 20 males and 20 females ) , and 40 young people , 20 to 29 years old ( 20 males and 20 females ) , participated in this study . joint moment and vertical ground reaction force during walking were obtained using a 3d motion analysis system and force plates .", "follow_up_question": "What was the average age of the young participants?", "follow_up_response": "32", "follow_up_response_bt": "34"}, {"question_id": "70.14", "question": "What type of force plates were used in the study?", "answer_src": "force plates", "follow_up_question": "What was the age range of the elderly participants?", "follow_up_response": "65 years old or older", "follow_up_response_bt": "older, 65 years or older"}, {"question_id": "70.15", "question": "What was the average age of the elderly participants?", "answer_src": "[ purpose ] this study examined the relationships between joint moment and the control of the vertical ground reaction force during walking in the elderly and young male and female individuals . [ subjects and methods ] forty elderly people , 65 years old or older ( 20 males and 20 females ) , and 40 young people , 20 to 29 years old ( 20 males and 20 females ) , participated in this study . joint moment and vertical ground reaction force during walking were obtained using a 3d motion analysis system and force plates .", "follow_up_question": "What was the average age of the young participants?", "follow_up_response": "32", "follow_up_response_bt": "34"}]}}
{"id": 71, "src": "another 4 ( 40% ) had spontaneously rupture of the perianal abscess . 6 ( 60% ) of the fistula - in - ano was submuscular , 30% subcutaneous and 10% were complex or recurrent . nearly , 20% of patients had fistulotomy and seton application for adequate drainage .", "mt": "4 (40%) avevano spontaneamente rotto l'assetto perianale . 6 (60%) della fistola era submuscolare , 30% sottocutanea e 10% era complessa o ricorrente . Quasi il 20% dei pazienti aveva avuto un'altra fistolatura e un'applicazione di setone per un adeguato drenaggio .", "pert_mt": "4 (40%) avevano spontaneamente rotto l'assetto perianale. 6 (60%) della fistola era submuscolare, 30% sottocutanea e 10% era complessa o ricorrente. Quasi il 20% dei pazienti aveva avuto un'altra fistolatura, un'applicazione di setone per un adeguato drenaggio e aveva anche sofferto di febbre irregolare.", "bt": "4 (40%) had spontaneously broken the perianal axis. 6 (60%) of the fistula was submuscular, 30% subcutaneous and 10% complex or recurrent. Almost 20% of the patients had had had another fistolating, a setone application for adequate drainage and also had suffered from an irregular fever.", "questions_src": ["What percentage of patients had spontaneously rupture of the perianal abscess?", "How many patients had fistula-in-ano that was submuscular?", "What percentage of patients had fistulotomy and seton application for adequate drainage?", "Where did the majority of fistula-in-anos fall in terms of location (submuscular, subcutaneous, or complex/recurrent)?"], "answers_src": ["40%", "6", "20%", "Submuscular"], "answers_bt": ["40%", "6", "Almost 20%", "Submuscular"], "multiturn": {"turn_1": [{"question_id": "71.1", "question": "What percentage of patients had spontaneously rupture of the perianal abscess?", "answer_src": "40%", "follow_up_question": "What was the ratio of submuscular to subcutaneous fistulas?", "follow_up_response": "60% to 30%", "follow_up_response_bt": "60% submuscular, 30% subcutaneous"}, {"question_id": "71.2", "question": "How many patients had fistula-in-ano that was submuscular?", "answer_src": "6", "follow_up_question": "How many patients had a subcutaneous fistula-in-ano?", "follow_up_response": "30", "follow_up_response_bt": "30%"}, {"question_id": "71.3", "question": "What percentage of patients had fistulotomy and seton application for adequate drainage?", "answer_src": "20%", "follow_up_question": "What was the ratio of submuscular to subcutaneous fistulas?", "follow_up_response": "60% to 30%", "follow_up_response_bt": "60% submuscular, 30% subcutaneous"}, {"question_id": "71.4", "question": "Where did the majority of fistula-in-anos fall in terms of location (submuscular, subcutaneous, or complex/recurrent)?", "answer_src": "Submuscular", "follow_up_question": "What percentage of patients had complex or recurrent fistula-in-anos?", "follow_up_response": "10%", "follow_up_response_bt": "10%"}], "turn_2": [{"question_id": "71.5", "question": "What was the ratio of submuscular to subcutaneous fistulas?", "answer_src": "60% to 30%", "follow_up_question": "What percentage of patients had complex or recurrent fistulas?", "follow_up_response": "10%", "follow_up_response_bt": "10%"}, {"question_id": "71.6", "question": "How many patients had a subcutaneous fistula-in-ano?", "answer_src": "30", "follow_up_question": "How many patients had a complex or recurrent fistula-in-anorectum?", "follow_up_response": "10%", "follow_up_response_bt": "10%"}, {"question_id": "71.7", "question": "What was the ratio of submuscular to subcutaneous fistulas?", "answer_src": "60% to 30%", "follow_up_question": "What percentage of patients had complex or recurrent fistulas?", "follow_up_response": "10%", "follow_up_response_bt": "10%"}, {"question_id": "71.8", "question": "What percentage of patients had complex or recurrent fistula-in-anos?", "answer_src": "10%", "follow_up_question": "What was the outcome for patients with subcutaneous fistula-in-anos?", "follow_up_response": "30%", "follow_up_response_bt": "30%"}], "turn_3": [{"question_id": "71.9", "question": "What percentage of patients had complex or recurrent fistulas?", "answer_src": "10%", "follow_up_question": "What was the outcome for patients with complex or recurrent fistulas?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "71.10", "question": "How many patients had a complex or recurrent fistula-in-anorectum?", "answer_src": "10%", "follow_up_question": "What percentage of patients underwent fistulotomy and seton application for adequate drainage?", "follow_up_response": "20%", "follow_up_response_bt": "60%"}, {"question_id": "71.11", "question": "What percentage of patients had complex or recurrent fistulas?", "answer_src": "10%", "follow_up_question": "What was the outcome for patients with complex or recurrent fistulas?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "71.12", "question": "What was the outcome for patients with subcutaneous fistula-in-anos?", "answer_src": "30%", "follow_up_question": "What percentage of patients had fistulotomy and seton application?", "follow_up_response": "20%", "follow_up_response_bt": "20%"}]}}
{"id": 72, "src": "lactosylceramide ( laccer , cdw17 ) is highly expressed on the plasma membranes of human phagocytes and mediates several immunological and inflammatory reactions , including phagocytosis , chemotaxis , and superoxide generation . laccer forms membrane microdomains with the src family tyrosine kinase lyn and the gi subunit of heterotrimeric g proteins . the very long fatty acids c24:0 and c24:1 are the main ceramide components of laccer in neutrophil plasma membranes and are directly connected with the fatty acids of lyn and gi .", "mt": "La lactosylceramide (laccer , cdw17) è altamente espressa sulle membrane plasmatiche dei fagociti umani e mediano diverse reazioni immunologiche e infiammatorie, tra cui fagocitosi , chemotaxis e generazione di superossidi . La lacceria forma microdomaini di membrana con la famiglia src della tirosina kinasi lin e la subunità gi delle proteine g eterotrimeriche . I grassi acidi molto lunghi c24:0 e c24:1 sono i principali componenti ceramidici del lacceria nelle membrane plasmatiche neutrofili e sono direttamente collegati con gli acidi grassi di lin e gi.", "pert_mt": "La lactosylceramide (laccer, cdw17) è altamente espressa sulle membrane plasmatiche dei fagociti umani e mediando diverse reazioni immunologiche e infiammatorie, tra cui fagocitosi, chemotaxis e generazione di superossidi. La lacceria forma microdomaini di membrana con la famiglia src della tirosina kinasi lin e la subunità gi delle proteine g eterotrimeriche. I grassi acidi molto lunghi c24:0 e c24:1 sono i principali componenti ceramidici del lacceria nelle membrane plasmatiche neutrofili e sono direttamente collegati con gli acidi grassi di lin e gi.", "bt": "Lactosylceramide (laccer, cdw17) is highly expressed on the plasma membranes of human phagocytes by mediating various immunological and inflammatory reactions, including phagocytosis, chemotaxis, and superoxide generation.Laceria forms membrane microdomains with the src family of tyrosine kinase lin and the subunit of g hetero-threumeric proteins.The very long c24:0 and c24:1 fatty acids are the main ceramedic components of lacceria in neutral plasma membranes and are directly related to the fatty acids of lin and gi.", "questions_src": ["What does lactosylceramide mediate in human phagocytes?", "Who are the main fatty acid components of lactosylceramide in neutrophil plasma membranes?", "Where are lactosylceramide microdomains formed?", "Which protein complexes are involved in forming lactosylceramide microdomains?", "When do the fatty acids of lyn and gi connect with lactosylceramide components?"], "answers_src": ["Phagocytosis, chemotaxis, and superoxide generation", "c24:0 and c24:1", "On the plasma membranes", "Src family tyrosine kinase lyn and the gi subunit of heterotrimeric G proteins", "Directly"], "answers_bt": ["Various immunological and inflammatory reactions, including phagocytosis, chemotaxis, and superoxide generation", "The very long c24:0 and c24:1 fatty acids", "On the plasma membranes", "The src family of tyrosine kinase lin and the subunit of g heterotrimeric proteins", "No Answer"], "multiturn": {"turn_1": [{"question_id": "72.1", "question": "What does lactosylceramide mediate in human phagocytes?", "answer_src": "Phagocytosis, chemotaxis, and superoxide generation", "follow_up_question": "What specific membrane microdomains does lactosylceramide form with?", "follow_up_response": "src family tyrosine kinase lyn and the gi subunit of heterotrimeric g proteins", "follow_up_response_bt": "The src family of tyrosine kinase lin and the subunit of g hetero-threumeric proteins"}, {"question_id": "72.2", "question": "Who are the main fatty acid components of lactosylceramide in neutrophil plasma membranes?", "answer_src": "c24:0 and c24:1", "follow_up_question": "What other proteins does lactosylceramide form membrane microdomains with?", "follow_up_response": "src family tyrosine kinase lyn and the gi subunit of heterotrimeric g proteins", "follow_up_response_bt": "src family of tyrosine kinase lin and the subunit of g hetero-threumeric proteins"}, {"question_id": "72.3", "question": "Where are lactosylceramide microdomains formed?", "answer_src": "On the plasma membranes", "follow_up_question": "What specific components are directly connected to the fatty acids of lyn and gi in lactosylceramide microdomains?", "follow_up_response": "The very long fatty acids c24:0 and c24:1", "follow_up_response_bt": "No Answer"}, {"question_id": "72.4", "question": "Which protein complexes are involved in forming lactosylceramide microdomains?", "answer_src": "Src family tyrosine kinase lyn and the gi subunit of heterotrimeric G proteins", "follow_up_question": "Which fatty acids are directly connected to the fatty acids of lyn and gi in lactosylceramide microdomains?", "follow_up_response": "c24:0 and c24:1", "follow_up_response_bt": "No Answer"}, {"question_id": "72.5", "question": "When do the fatty acids of lyn and gi connect with lactosylceramide components?", "answer_src": "Directly", "follow_up_question": "What specific fatty acids of lyn and gi are directly connected with lactosylceramide components?", "follow_up_response": "c24:0 and c24:1", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "72.6", "question": "What specific membrane microdomains does lactosylceramide form with?", "answer_src": "src family tyrosine kinase lyn and the gi subunit of heterotrimeric g proteins", "follow_up_question": "What role do the very long fatty acids c24:0 and c24:1 play in these membrane microdomains?", "follow_up_response": "They are directly connected with the fatty acids of lyn and gi.", "follow_up_response_bt": "They are the main ceramide components of lacceria in neutral plasma membranes and are directly related to the fatty acids of lin and gi."}, {"question_id": "72.7", "question": "What other proteins does lactosylceramide form membrane microdomains with?", "answer_src": "src family tyrosine kinase lyn and the gi subunit of heterotrimeric g proteins", "follow_up_question": "What is the relationship between the fatty acids of lyn and gi and those of lactosylceramide?", "follow_up_response": "The very long fatty acids c24:0 and c24:1 are directly connected with the fatty acids of lyn and gi", "follow_up_response_bt": "The very long c24:0 and c24:1 fatty acids of lactosylceramide are directly related to the fatty acids of lyn and gi."}, {"question_id": "72.8", "question": "What specific components are directly connected to the fatty acids of lyn and gi in lactosylceramide microdomains?", "answer_src": "The very long fatty acids c24:0 and c24:1", "follow_up_question": "What role do the very long fatty acids c24:0 and c24:1 play in lactosylceramide microdomains?", "follow_up_response": "They are directly connected with the fatty acids of lyn and gi.", "follow_up_response_bt": "They are the main ceramide components of lactosylceramide in neutral plasma membranes and are directly related to the fatty acids of src family of tyrosine kinase lin and g heterotrimeric proteins."}, {"question_id": "72.9", "question": "Which fatty acids are directly connected to the fatty acids of lyn and gi in lactosylceramide microdomains?", "answer_src": "c24:0 and c24:1", "follow_up_question": "What specific role do the fatty acids c24:0 and c24:1 play in lactosylceramide microdomains?", "follow_up_response": "The very long fatty acids c24:0 and c24:1 are the main ceramide components of laccer in neutrophil plasma membranes and are directly connected with the fatty acids of lyn and gi.", "follow_up_response_bt": "The very long c24:0 and c24:1 fatty acids are the main ceramedic components of lactosylceramide in neutral plasma membranes and are directly related to the fatty acids of lin and gi."}, {"question_id": "72.10", "question": "What specific fatty acids of lyn and gi are directly connected with lactosylceramide components?", "answer_src": "c24:0 and c24:1", "follow_up_question": "Which other immunological and inflammatory reactions does lactosylceramide mediate besides phagocytosis, chemotaxis, and superoxide generation?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "72.11", "question": "What role do the very long fatty acids c24:0 and c24:1 play in these membrane microdomains?", "answer_src": "They are directly connected with the fatty acids of lyn and gi.", "follow_up_question": "How do these fatty acids contribute to the function of membrane microdomains?", "follow_up_response": "The very long fatty acids c24:0 and c24:1 are directly connected with the fatty acids of lyn and gi, which form membrane microdomains.", "follow_up_response_bt": "The very long c24:0 and c24:1 fatty acids are the main ceramedic components of lacceria in neutral plasma membranes and are directly related to the fatty acids of lin and gi."}, {"question_id": "72.12", "question": "What is the relationship between the fatty acids of lyn and gi and those of lactosylceramide?", "answer_src": "The very long fatty acids c24:0 and c24:1 are directly connected with the fatty acids of lyn and gi", "follow_up_question": "How many fatty acids are directly connected with the fatty acids of lyn and gi according to the text?", "follow_up_response": "2", "follow_up_response_bt": "2"}, {"question_id": "72.13", "question": "What role do the very long fatty acids c24:0 and c24:1 play in lactosylceramide microdomains?", "answer_src": "They are directly connected with the fatty acids of lyn and gi.", "follow_up_question": "How do these fatty acids contribute to the function of lactosylceramide microdomains?", "follow_up_response": "The very long fatty acids c24:0 and c24:1 are directly connected with the fatty acids of lyn and gi, which are present in lactosylceramide microdomains.", "follow_up_response_bt": "The very long c24:0 and c24:1 fatty acids are the main ceramedic components of lacceria in neutral plasma membranes and are directly related to the fatty acids of lin and gi."}, {"question_id": "72.14", "question": "What specific role do the fatty acids c24:0 and c24:1 play in lactosylceramide microdomains?", "answer_src": "The very long fatty acids c24:0 and c24:1 are the main ceramide components of laccer in neutrophil plasma membranes and are directly connected with the fatty acids of lyn and gi.", "follow_up_question": "How are the fatty acids c24:0 and c24:1 connected to the fatty acids of lyn and gi?", "follow_up_response": "The very long fatty acids c24:0 and c24:1 are directly connected with the fatty acids of lyn and gi.", "follow_up_response_bt": "The very long c24:0 and c24:1 fatty acids are the main ceramide components of lacceria in neutral plasma membranes and are directly related to the fatty acids of lyn and gi."}, {"question_id": "72.15", "question": "Which other immunological and inflammatory reactions does lactosylceramide mediate besides phagocytosis, chemotaxis, and superoxide generation?", "answer_src": "lactosylceramide ( laccer , cdw17 ) is highly expressed on the plasma membranes of human phagocytes and mediates several immunological and inflammatory reactions , including phagocytosis , chemotaxis , and superoxide generation . laccer forms membrane microdomains with the src family tyrosine kinase lyn and the gi subunit of heterotrimeric g proteins . the very long fatty acids c24:0 and c24:1 are the main ceramide components of laccer in neutrophil plasma membranes and are directly connected with the fatty acids of lyn and gi .", "follow_up_question": "Which other membrane microdomains does lactosylceramide form besides those with the src family tyrosine kinase lyn and the gi subunit of heterotrimeric G proteins?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 73, "src": "receiver operator characteristic ( roc ) curves were generated to compare the predictive powers of the variables.resultsseventy-nine patients ( 68.7% ) had successful outcomes , whereas 36 patients ( 31.3% ) had residual stones . significant differences were found in the mean size and mean hu of the stones ( size : 8.343.58 mm vs. 13.575.41 mm , p<0.001 ; hu : 675.29254.34 vs. 1,075.00290.41 , p<0.001 ) . in the unadjusted model , age , stone size , and stone density were significant predictors .", "mt": "Le curve caratteristiche dell'operatore ricevitore (roc) sono state generate per confrontare i poteri predittivi delle variabili.resultsNei settantacinque pazienti (68,7%) hanno avuto risultati di successo , mentre 36 pazienti ( 31,3%) avevano pietre residue . Sono state trovate differenze significative nella dimensione media e nella media hu delle pietre (dimensione: 8.343.58 mm contro 13.575.41 mm , p<0.001 ; hu : 675.29254.34 contro 1.075.00290.41 , p<0.001 ) . nel modello non regolato , età , dimensione della pietra e densità della pietra sono stati fattori significativi .", "pert_mt": "Le curve caratteristiche dell'operatore ricevitore (roc) sono state generate per confrontare i poteri predittivi delle variabili.resultsNei settantacinque pazienti (68,7%) hanno avuto risultati di successo, mentre 36 pazienti (31,3%) avevano pietre residue. Sono state trovate differenze significative nella dimensione media e nella media hu delle pietre (dimensione: 8.343.58 mm contro 13.575.41 mm, p<0.001; hu: 675.29254.34 contro 1.075.00290.41, p<0.001). Nel modello non regolato, età, dimensione della pietra e densità della pietra sono stati fatt", "bt": "The curve characteristics of the receiving operator (roc) were generated to compare the predictive powers of the variables.resultsSeventy-five patients (68.7%) had successful outcomes, while 36 patients (31.3%) had residual stones.Now, significant differences were found in the mean dimension and in the mean density of the stones (dimension: 8.343.58 mm vs. 13.575.41 mm, p<0.001; hu: 675.29254.34 vs. 1.075.00290.41, p<0.001).In the unregulated model, age, dimension of the stone and density of the stone were reported.", "questions_src": ["What was the percentage of patients with successful outcomes?", "What was the mean size of the stones in the group with residual stones?", "Which predictor variable was not significant in the unadjusted model?", "What was the difference in mean hu values between the two groups of stones?", "When were the receiver operator characteristic (roc) curves generated?"], "answers_src": ["68.7%", "13.575.41 mm", "stone density", "400.71 mm", "results"], "answers_bt": ["68.7%", "13.575.41 mm", "age", "1.075.00290.41 - 675.29254.34", "The curve characteristics of the receiving operator (roc)"], "multiturn": {"turn_1": [{"question_id": "73.1", "question": "What was the percentage of patients with successful outcomes?", "answer_src": "68.7%", "follow_up_question": "What was the difference in mean stone size between the successful and residual stone groups?", "follow_up_response": "8.343.58 mm vs. 13.575.41 mm", "follow_up_response_bt": "8.343.58 mm vs. 13.575.41 mm"}, {"question_id": "73.2", "question": "What was the mean size of the stones in the group with residual stones?", "answer_src": "13.575.41 mm", "follow_up_question": "What was the mean Hu value of the stones in the group with successful outcomes?", "follow_up_response": "254.34", "follow_up_response_bt": "1.075.00290.41"}, {"question_id": "73.3", "question": "Which predictor variable was not significant in the unadjusted model?", "answer_src": "stone density", "follow_up_question": "What was the mean size of the stones in the group with successful outcomes?", "follow_up_response": "8.343.58 mm", "follow_up_response_bt": "8.343.58 mm"}, {"question_id": "73.4", "question": "What was the difference in mean hu values between the two groups of stones?", "answer_src": "400.71 mm", "follow_up_question": "What was the difference in mean size of the stones between the two groups?", "follow_up_response": "8.343.58 mm vs. 13.575.41 mm", "follow_up_response_bt": "8.343.58 mm vs. 13.575.41 mm"}, {"question_id": "73.5", "question": "When were the receiver operator characteristic (roc) curves generated?", "answer_src": "results", "follow_up_question": "What was the significance of the mean size and mean hu of the stones found in the study?", "follow_up_response": "size : 8.343.58 mm vs. 13.575.41 mm, p<0.001 ; hu : 675.29254.34 vs. 1,075.00290.41, p<0.001", "follow_up_response_bt": "p<0.001"}], "turn_2": [{"question_id": "73.6", "question": "What was the difference in mean stone size between the successful and residual stone groups?", "answer_src": "8.343.58 mm vs. 13.575.41 mm", "follow_up_question": "What was the difference in mean stone density between the successful and residual stone groups?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "73.7", "question": "What was the mean Hu value of the stones in the group with successful outcomes?", "answer_src": "254.34", "follow_up_question": "What was the mean size of the stones in the group with successful outcomes?", "follow_up_response": "8.343.58 mm", "follow_up_response_bt": "8.343.58 mm"}, {"question_id": "73.8", "question": "What was the mean size of the stones in the group with successful outcomes?", "answer_src": "8.343.58 mm", "follow_up_question": "What was the mean size of the stones in the group with residual stones?", "follow_up_response": "13.575.41 mm", "follow_up_response_bt": "13.575.41 mm"}, {"question_id": "73.9", "question": "What was the difference in mean size of the stones between the two groups?", "answer_src": "8.343.58 mm vs. 13.575.41 mm", "follow_up_question": "What was the difference in mean HU of the stones between the two groups?", "follow_up_response": "200.71", "follow_up_response_bt": "254.34"}, {"question_id": "73.10", "question": "What was the significance of the mean size and mean hu of the stones found in the study?", "answer_src": "size : 8.343.58 mm vs. 13.575.41 mm, p<0.001 ; hu : 675.29254.34 vs. 1,075.00290.41, p<0.001", "follow_up_question": "How did the mean size and mean hu of the stones differ between the two groups?", "follow_up_response": "mean size : 8.343.58 mm vs. 13.575.41 mm , p<0.001 ; mean hu : 675.29254.34 vs. 1,075.00290.41 , p<0.001 ", "follow_up_response_bt": "The mean dimension of the stones was 8.34 ± 3.58 mm, while the mean density of the stones was 675.29 ± 254.34 Hu. Conversely, the mean dimension of the stones was 13.57 ± 5.41 mm, while the mean density of the stones was 1.075 ± 290.41 Hu."}], "turn_3": [{"question_id": "73.11", "question": "What was the difference in mean stone density between the successful and residual stone groups?", "answer_src": "receiver operator characteristic ( roc ) curves were generated to compare the predictive powers of the variables.resultsseventy-nine patients ( 68.7% ) had successful outcomes , whereas 36 patients ( 31.3% ) had residual stones . significant differences were found in the mean size and mean hu of the stones ( size : 8.343.58 mm vs. 13.575.41 mm , p<0.001 ; hu : 675.29254.34 vs. 1,075.00290.41 , p<0.001 ) . in the unadjusted model , age , stone size , and stone density were significant predictors .", "follow_up_question": "What was the difference in mean stone size between the successful and residual stone groups?", "follow_up_response": "8.343.58 mm vs. 13.575.41 mm", "follow_up_response_bt": "8.343.58 mm vs. 13.575.41 mm"}, {"question_id": "73.12", "question": "What was the mean size of the stones in the group with successful outcomes?", "answer_src": "8.343.58 mm", "follow_up_question": "What was the mean size of the stones in the group with residual stones?", "follow_up_response": "13.575.41 mm", "follow_up_response_bt": "13.575.41 mm"}, {"question_id": "73.13", "question": "What was the mean size of the stones in the group with residual stones?", "answer_src": "13.575.41 mm", "follow_up_question": "What was the mean Hu value of the stones in the group with successful outcomes?", "follow_up_response": "254.34", "follow_up_response_bt": "1.075.00290.41"}, {"question_id": "73.14", "question": "What was the difference in mean HU of the stones between the two groups?", "answer_src": "200.71", "follow_up_question": "What was the difference in mean size of the stones between the two groups?", "follow_up_response": "8.343.58 mm vs. 13.575.41 mm", "follow_up_response_bt": "8.343.58 mm vs. 13.575.41 mm"}, {"question_id": "73.15", "question": "How did the mean size and mean hu of the stones differ between the two groups?", "answer_src": "mean size : 8.343.58 mm vs. 13.575.41 mm , p<0.001 ; mean hu : 675.29254.34 vs. 1,075.00290.41 , p<0.001 ", "follow_up_question": "What was the difference in mean size between the two groups?", "follow_up_response": "8.343.58 mm vs. 13.575.41 mm", "follow_up_response_bt": "8.343.58 mm vs. 13.575.41 mm"}]}}
{"id": 74, "src": "while involvement of host genetic factors has been a major focus of research in playing an important role in the outcome of disease , the role of immune system can not be marginalized . poor cellular trafficking and suboptimal t cell responses in liver , the hall marks of chronic hepatitis c virus infection , might be attributed to defective antigen presentation . various immunological factors , both innate and adaptive , play role in the pathogenesis of the disease and become dysfunctional in active disease .", "mt": "Mentre l' coinvolgimento di fattori genetici ospiti è stato un importante punto di riferimento della ricerca nel giocare un ruolo importante nell'esito della malattia , il ruolo del sistema immunitario non può essere emarginato . il cattivo traffico cellulare e le risposte delle cellule t subottime nel fegato , i segni di infezione cronica da virus dell' epatite c , potrebbero essere attribuiti a una presentazione di antigeni difettosi . vari fattori immunologici , sia innati che adattivi , svolgono un ruolo nella patogenesi della malattia e diventano disfunzionali nella malattia attiva .", "pert_mt": "Mentre l' coinvolgimento di fattori genetici ospiti è stato un importante punto di riferimento della ricerca nel giocare un ruolo importante nell'esito della malattia, il ruolo del sistema immunitario non può essere emarginato. Il cattivo traffico cellulare e le risposte delle cellule T subottime nel fegato, i segni di infezione cronica da virus dell'epatite C, potrebbero essere attribuiti a una presentazione di antigeni difettosi. Vari fattori immunologici, sia innati che adattivi, svolgono un ruolo nella patogenesi della malattia e diventano disfunzionali nella malattia attiva. L'ignoranza dei meccanismi immunologici potrebbe aggravare la complessità di trattamento della malattia.", "bt": "While the involvement of host genetic factors has been an important research benchmark in playing an important role in the outcome of the disease, the role of the immune system cannot be marginalized.The bad cell traffic and responses of sub-octane T cells in the liver, the signs of chronic hepatitis C virus infection, could be attributed to a presentation of antigens diffettosis.Various immune factors, both innate and adaptive, play a role in the pathogenesis of the disease and become dysfunctional in the active disease.In ignorance of the immune mechanisms could aggravate the complexity of the disease treatment.", "questions_src": ["What is the major focus of research according to the sentence?", "Who plays a role in the pathogenesis of the disease?", "Where might poor cellular trafficking and suboptimal T cell responses occur?", "Which types of immune system responses are mentioned as being dysfunctional?", "When does the defect in antigen presentation occur in the context of chronic hepatitis C virus infection?"], "answers_src": ["[\"host genetic factors\"], [\"various immunological factors, both innate and adaptive\"], [\"in liver\"], [\"T cell responses\"], [\"in the context of chronic hepatitis C virus infection\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["Host genetic factors and the immune system", "Both innate and adaptive immune factors", "In the liver", "Adaptive and innate immune responses", "In the context of chronic hepatitis C virus infection"], "multiturn": {"turn_1": [{"question_id": "74.1", "question": "What is the major focus of research according to the sentence?", "answer_src": "[\"host genetic factors\"], [\"various immunological factors, both innate and adaptive\"], [\"in liver\"], [\"T cell responses\"], [\"in the context of chronic hepatitis C virus infection\"]", "follow_up_question": "What specific aspect of immune system dysfunction is linked to chronic hepatitis C virus infection?", "follow_up_response": "poor cellular trafficking and suboptimal T cell responses in liver", "follow_up_response_bt": "The responses of sub-octane T cells"}, {"question_id": "74.2", "question": "Who plays a role in the pathogenesis of the disease?", "answer_src": "while involvement of host genetic factors has been a major focus of research in playing an important role in the outcome of disease , the role of immune system can not be marginalized . poor cellular trafficking and suboptimal t cell responses in liver , the hall marks of chronic hepatitis c virus infection , might be attributed to defective antigen presentation . various immunological factors , both innate and adaptive , play role in the pathogenesis of the disease and become dysfunctional in active disease .", "follow_up_question": "What specific factor is mentioned as contributing to defective antigen presentation?", "follow_up_response": "poor cellular trafficking and suboptimal t cell responses in liver", "follow_up_response_bt": "The presentation of antigens diffettosis"}, {"question_id": "74.3", "question": "Where might poor cellular trafficking and suboptimal T cell responses occur?", "answer_src": "while involvement of host genetic factors has been a major focus of research in playing an important role in the outcome of disease , the role of immune system can not be marginalized . poor cellular trafficking and suboptimal t cell responses in liver , the hall marks of chronic hepatitis c virus infection , might be attributed to defective antigen presentation . various immunological factors , both innate and adaptive , play role in the pathogenesis of the disease and become dysfunctional in active disease .", "follow_up_question": "What might cause defective antigen presentation according to the text?", "follow_up_response": "poor cellular trafficking and suboptimal T cell responses in liver", "follow_up_response_bt": "The bad cell traffic and responses of sub-octane T cells in the liver, the signs of chronic hepatitis C virus infection"}, {"question_id": "74.4", "question": "Which types of immune system responses are mentioned as being dysfunctional?", "answer_src": "while involvement of host genetic factors has been a major focus of research in playing an important role in the outcome of disease , the role of immune system can not be marginalized . poor cellular trafficking and suboptimal t cell responses in liver , the hall marks of chronic hepatitis c virus infection , might be attributed to defective antigen presentation . various immunological factors , both innate and adaptive , play role in the pathogenesis of the disease and become dysfunctional in active disease .", "follow_up_question": "What specific aspect of immune responses is described as becoming dysfunctional in active disease?", "follow_up_response": "Immunological factors", "follow_up_response_bt": "sub-octane T cells"}, {"question_id": "74.5", "question": "When does the defect in antigen presentation occur in the context of chronic hepatitis C virus infection?", "answer_src": "while involvement of host genetic factors has been a major focus of research in playing an important role in the outcome of disease , the role of immune system can not be marginalized . poor cellular trafficking and suboptimal t cell responses in liver , the hall marks of chronic hepatitis c virus infection , might be attributed to defective antigen presentation . various immunological factors , both innate and adaptive , play role in the pathogenesis of the disease and become dysfunctional in active disease .", "follow_up_question": "What specific aspects of the immune system are described as becoming dysfunctional in active disease?", "follow_up_response": "immunological factors", "follow_up_response_bt": "immune factors"}], "turn_2": [{"question_id": "74.6", "question": "What specific aspect of immune system dysfunction is linked to chronic hepatitis C virus infection?", "answer_src": "poor cellular trafficking and suboptimal T cell responses in liver", "follow_up_question": "How does defective antigen presentation contribute to these immune system dysfunctions?", "follow_up_response": "The hallmarks of chronic hepatitis C virus infection, poor cellular trafficking and suboptimal T cell responses, might be attributed to defective antigen presentation.", "follow_up_response_bt": "Defective antigen presentation"}, {"question_id": "74.7", "question": "What specific factor is mentioned as contributing to defective antigen presentation?", "answer_src": "poor cellular trafficking and suboptimal t cell responses in liver", "follow_up_question": "What other type of immune response is mentioned as being dysfunctional in active disease?", "follow_up_response": "adaptive", "follow_up_response_bt": "adaptive"}, {"question_id": "74.8", "question": "What might cause defective antigen presentation according to the text?", "answer_src": "poor cellular trafficking and suboptimal T cell responses in liver", "follow_up_question": "What other immunological factors, according to the text, become dysfunctional in active disease?", "follow_up_response": "Various immunological factors", "follow_up_response_bt": "Innate and adaptive"}, {"question_id": "74.9", "question": "What specific aspect of immune responses is described as becoming dysfunctional in active disease?", "answer_src": "Immunological factors", "follow_up_question": "What types of immunological factors, according to the text, become dysfunctional in active disease?", "follow_up_response": "innate and adaptive", "follow_up_response_bt": "Both innate and adaptive"}, {"question_id": "74.10", "question": "What specific aspects of the immune system are described as becoming dysfunctional in active disease?", "answer_src": "immunological factors", "follow_up_question": "What types of immunological factors, according to the text, become dysfunctional in active disease?", "follow_up_response": "innate and adaptive", "follow_up_response_bt": "Both innate and adaptive"}], "turn_3": [{"question_id": "74.11", "question": "How does defective antigen presentation contribute to these immune system dysfunctions?", "answer_src": "The hallmarks of chronic hepatitis C virus infection, poor cellular trafficking and suboptimal T cell responses, might be attributed to defective antigen presentation.", "follow_up_question": "What other immunological factors besides innate and adaptive ones are mentioned as playing roles in the disease's pathogenesis?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "74.12", "question": "What other type of immune response is mentioned as being dysfunctional in active disease?", "answer_src": "adaptive", "follow_up_question": "What specific aspect of adaptive immunity is impaired in active disease according to the text?", "follow_up_response": "defective antigen presentation", "follow_up_response_bt": "No Answer"}, {"question_id": "74.13", "question": "What other immunological factors, according to the text, become dysfunctional in active disease?", "answer_src": "Various immunological factors", "follow_up_question": "What specific hallmarks of chronic hepatitis C virus infection are linked to defective antigen presentation?", "follow_up_response": "Poor cellular trafficking and suboptimal T cell responses in liver", "follow_up_response_bt": "The signs of chronic hepatitis C virus infection"}, {"question_id": "74.14", "question": "What types of immunological factors, according to the text, become dysfunctional in active disease?", "answer_src": "innate and adaptive", "follow_up_question": "How do these dysfunctional innate and adaptive immunological factors contribute to the pathogenesis of the disease?", "follow_up_response": "These dysfunctional innate and adaptive immunological factors play a role in the pathogenesis of the disease", "follow_up_response_bt": "Innate and adaptive immune factors play a role in the pathogenesis of the disease and become dysfunctional in the active disease."}, {"question_id": "74.15", "question": "What types of immunological factors, according to the text, become dysfunctional in active disease?", "answer_src": "innate and adaptive", "follow_up_question": "How do these dysfunctional innate and adaptive immunological factors contribute to the pathogenesis of the disease?", "follow_up_response": "These dysfunctional innate and adaptive immunological factors play a role in the pathogenesis of the disease", "follow_up_response_bt": "Innate and adaptive immune factors play a role in the pathogenesis of the disease and become dysfunctional in the active disease."}]}}
{"id": 75, "src": "in rest of the 6 patient with leak , continued catheter drainage was done . no significant difference in the intraoperative variables , blood loss , duration of drain , length of hospital stay , and continence outcomes was noted between the patients with leak compared to rest of the patients . none of the patient needed any procedure / intervention related to the surgery and none developed bladder neck stenosis.in usual circumstances , catheter removal can be done safely on a postoperative day 7 without routine cystography .", "mt": "Nel resto dei 6 pazienti con perdita , non è stata effettuata alcuna differenza significativa nelle variabili intraoperatorie , perdita di sangue , durata del drenaggio , durata di soggiorno in ospedale e risultati di continenza sono stati osservati tra i pazienti con perdita rispetto al resto dei pazienti . Nessuno dei pazienti ha bisogno di alcuna procedura / intervento correlato all' intervento chirurgico e nessuno ha sviluppato stenosis del collo della vescica . In circostanze normali , la rimozione del catetere può essere effettuata in sicurezza il giorno post-operatorio 7 senza cistografia di routine .", "pert_mt": "Nel resto dei 6 pazienti con perdita, non è stata effettuata alcuna differenza significativa nelle variabili intraoperatorie, perdita di sangue, durata del drenaggio, durata di soggiorno in ospedale e risultati di continenza sono stati osservati tra i pazienti con perdita rispetto al resto dei pazienti. Nessuno dei pazienti ha bisogno di alcuna procedura / intervento correlato all' intervento chirurgico e nessuno ha sviluppato stenosis del collo della vescica. In circostanze normali, la rimozione del catetere può essere effettuata in sicurezza il giorno post-operatorio 7 senza cistografia di routine e senza complesse procedure aggiuntive.", "bt": "In the remaining 6 patients with loss, no significant difference was observed in intraoperative variables, blood loss, drainage duration, hospital stay duration and continence results were observed among patients with loss compared to the rest of the patients. None of the patients needed any procedure/intervention related to surgery and none developed bladder neck stenosis. Under normal circumstances, catheter removal can be safely performed on the 7th post-operative day without routine cistography and without complex additional procedures.", "questions_src": ["What is the maximum number of patients mentioned in the sentence?", "Who did not need any procedure or intervention related to the surgery?", "Where was catheter removal safely done according to the usual circumstances?", "When was catheter removal typically scheduled?", "Which group had no significant difference in outcomes compared to the rest?"], "answers_src": ["No Answer", "None of the patient", "On a postoperative day 7", "Postoperative day 7", "Patients with leak"], "answers_bt": ["No Answer", "None of the patients", "Under normal circumstances", "The 7th post-operative day", "Patients with loss"], "multiturn": {"turn_1": [{"question_id": "75.1", "question": "What is the maximum number of patients mentioned in the sentence?", "answer_src": "in rest of the 6 patient with leak , continued catheter drainage was done . no significant difference in the intraoperative variables , blood loss , duration of drain , length of hospital stay , and continence outcomes was noted between the patients with leak compared to rest of the patients . none of the patient needed any procedure / intervention related to the surgery and none developed bladder neck stenosis.in usual circumstances , catheter removal can be done safely on a postoperative day 7 without routine cystography .", "follow_up_question": "How many patients had a leak according to the text?", "follow_up_response": "6", "follow_up_response_bt": "6"}, {"question_id": "75.2", "question": "Who did not need any procedure or intervention related to the surgery?", "answer_src": "None of the patient", "follow_up_question": "What was the outcome regarding bladder neck stenosis in the patients?", "follow_up_response": "None of the patient developed bladder neck stenosis.", "follow_up_response_bt": "None developed bladder neck stenosis"}, {"question_id": "75.3", "question": "Where was catheter removal safely done according to the usual circumstances?", "answer_src": "On a postoperative day 7", "follow_up_question": "What were the results regarding bladder neck stenosis in this group?", "follow_up_response": "None of the patient developed bladder neck stenosis.", "follow_up_response_bt": "None developed bladder neck stenosis"}, {"question_id": "75.4", "question": "When was catheter removal typically scheduled?", "answer_src": "Postoperative day 7", "follow_up_question": "On what basis was catheter removal considered safe?", "follow_up_response": "usual circumstances", "follow_up_response_bt": "The 7th post-operative day"}, {"question_id": "75.5", "question": "Which group had no significant difference in outcomes compared to the rest?", "answer_src": "Patients with leak", "follow_up_question": "What specific outcome measures showed no significant difference?", "follow_up_response": "Intraoperative variables, blood loss, duration of drain, length of hospital stay, and continence outcomes", "follow_up_response_bt": "Intraoperative variables, blood loss, drainage duration, hospital stay duration"}], "turn_2": [{"question_id": "75.6", "question": "How many patients had a leak according to the text?", "answer_src": "6", "follow_up_question": "What was the outcome regarding bladder neck stenosis in the patients?", "follow_up_response": "None of the patient developed bladder neck stenosis.", "follow_up_response_bt": "None developed bladder neck stenosis"}, {"question_id": "75.7", "question": "What was the outcome regarding bladder neck stenosis in the patients?", "answer_src": "None of the patient developed bladder neck stenosis.", "follow_up_question": "What percentage of patients did not require any procedures related to the surgery?", "follow_up_response": "100%", "follow_up_response_bt": "100%"}, {"question_id": "75.8", "question": "What were the results regarding bladder neck stenosis in this group?", "answer_src": "None of the patient developed bladder neck stenosis.", "follow_up_question": "What percentage of patients did not require any procedures related to the surgery?", "follow_up_response": "100%", "follow_up_response_bt": "100%"}, {"question_id": "75.9", "question": "On what basis was catheter removal considered safe?", "answer_src": "usual circumstances", "follow_up_question": "On what postoperative day was catheter removal considered safe?", "follow_up_response": "7", "follow_up_response_bt": "7th"}, {"question_id": "75.10", "question": "What specific outcome measures showed no significant difference?", "answer_src": "Intraoperative variables, blood loss, duration of drain, length of hospital stay, and continence outcomes", "follow_up_question": "What was the duration of hospital stay for the patients with leak compared to the rest?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "75.11", "question": "What was the outcome regarding bladder neck stenosis in the patients?", "answer_src": "None of the patient developed bladder neck stenosis.", "follow_up_question": "What percentage of patients did not require any procedures related to the surgery?", "follow_up_response": "100%", "follow_up_response_bt": "100%"}, {"question_id": "75.12", "question": "What percentage of patients did not require any procedures related to the surgery?", "answer_src": "100%", "follow_up_question": "How many patients developed bladder neck stenosis?", "follow_up_response": "No Answer", "follow_up_response_bt": "None"}, {"question_id": "75.13", "question": "What percentage of patients did not require any procedures related to the surgery?", "answer_src": "100%", "follow_up_question": "How many patients developed bladder neck stenosis?", "follow_up_response": "No Answer", "follow_up_response_bt": "None"}, {"question_id": "75.14", "question": "On what postoperative day was catheter removal considered safe?", "answer_src": "7", "follow_up_question": "On what basis was catheter removal considered safe on postoperative day 7?", "follow_up_response": "usual circumstances", "follow_up_response_bt": "Under normal circumstances"}, {"question_id": "75.15", "question": "What was the duration of hospital stay for the patients with leak compared to the rest?", "answer_src": "in rest of the 6 patient with leak , continued catheter drainage was done . no significant difference in the intraoperative variables , blood loss , duration of drain , length of hospital stay , and continence outcomes was noted between the patients with leak compared to rest of the patients . none of the patient needed any procedure / intervention related to the surgery and none developed bladder neck stenosis.in usual circumstances , catheter removal can be done safely on a postoperative day 7 without routine cystography .", "follow_up_question": "What was the length of hospital stay for the patients with leak?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 76, "src": "she had no symptoms and denied any family history . laboratory evaluations were normal but serum dopamine ( 425 ng / l ) and 24-hour urine dopamine levels ( 1,565.3 g / day ) were elevated . she underwent laparoscopic right adrenalectomy .", "mt": "Le valutazioni di laboratorio erano normali ma i livelli di dopamina serina (425 ng / l) e di dopamina nelle urine 24 ore su 24 (1,565,3 g / giorno) erano elevati .", "pert_mt": "Le valutazioni di laboratorio erano normali ma i livelli di dopamina serina (425 ng / l) e di dopamina nelle urine 24 ore su 24 (1,565,3 g / giorno) erano elevati e indicavano una possibile patologia neurologica.", "bt": "Laboratory evaluations were normal, but serum dopamine (425 ng/l) and 24-hour urine dopamine (1,565.3 g/day) levels were elevated and indicated a possible neurological pathology.", "questions_src": ["What was the level of serum dopamine in the patient's blood?", "Who denied having a family history of the condition?", "Where did the patient undergo the surgery?", "When might the elevated dopamine levels have occurred?", "Which type of surgery did the patient undergo?"], "answers_src": ["425 ng / l", "she", "laparoscopic right adrenalectomy", "24-hour", "right adrenalectomy"], "answers_bt": ["425 ng/l", "No Answer", "No Answer", "24-hour period", "No Answer"], "multiturn": {"turn_1": [{"question_id": "76.1", "question": "What was the level of serum dopamine in the patient's blood?", "answer_src": "425 ng / l", "follow_up_question": "What was the daily amount of urine dopamine excreted by the patient?", "follow_up_response": "1,565.3 g / day", "follow_up_response_bt": "1,565.3 g/day"}, {"question_id": "76.2", "question": "Who denied having a family history of the condition?", "answer_src": "she", "follow_up_question": "What was the level of serum dopamine found in her blood?", "follow_up_response": "425 ng / l", "follow_up_response_bt": "425 ng/l"}, {"question_id": "76.3", "question": "Where did the patient undergo the surgery?", "answer_src": "laparoscopic right adrenalectomy", "follow_up_question": "What was the reason for the elevated dopamine levels?", "follow_up_response": "No Answer", "follow_up_response_bt": "A possible neurological pathology"}, {"question_id": "76.4", "question": "When might the elevated dopamine levels have occurred?", "answer_src": "24-hour", "follow_up_question": "What was the significance of the elevated 24-hour urine dopamine levels?", "follow_up_response": "No Answer", "follow_up_response_bt": "Indicated a possible neurological pathology"}, {"question_id": "76.5", "question": "Which type of surgery did the patient undergo?", "answer_src": "right adrenalectomy", "follow_up_question": "What was the significance of the elevated serum dopamine and 24-hour urine dopamine levels?", "follow_up_response": "No Answer", "follow_up_response_bt": "Indicated a possible neurological pathology"}], "turn_2": [{"question_id": "76.6", "question": "What was the daily amount of urine dopamine excreted by the patient?", "answer_src": "1,565.3 g / day", "follow_up_question": "What was the significance of the elevated serum dopamine level in ng/L?", "follow_up_response": "No Answer", "follow_up_response_bt": "Indicated a possible neurological pathology"}, {"question_id": "76.7", "question": "What was the level of serum dopamine found in her blood?", "answer_src": "425 ng / l", "follow_up_question": "What was the approximate daily amount of dopamine excreted in her urine?", "follow_up_response": "1,565.3 g / day", "follow_up_response_bt": "1,565.3 g/day"}, {"question_id": "76.8", "question": "What was the reason for the elevated dopamine levels?", "answer_src": "she had no symptoms and denied any family history . laboratory evaluations were normal but serum dopamine ( 425 ng / l ) and 24-hour urine dopamine levels ( 1,565.3 g / day ) were elevated . she underwent laparoscopic right adrenalectomy .", "follow_up_question": "What specific condition might have caused the elevated dopamine levels?", "follow_up_response": "No Answer", "follow_up_response_bt": "A possible neurological pathology"}, {"question_id": "76.9", "question": "What was the significance of the elevated 24-hour urine dopamine levels?", "answer_src": "she had no symptoms and denied any family history . laboratory evaluations were normal but serum dopamine ( 425 ng / l ) and 24-hour urine dopamine levels ( 1,565.3 g / day ) were elevated . she underwent laparoscopic right adrenalectomy .", "follow_up_question": "How did the elevated dopamine levels affect her treatment plan?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "76.10", "question": "What was the significance of the elevated serum dopamine and 24-hour urine dopamine levels?", "answer_src": "she had no symptoms and denied any family history . laboratory evaluations were normal but serum dopamine ( 425 ng / l ) and 24-hour urine dopamine levels ( 1,565.3 g / day ) were elevated . she underwent laparoscopic right adrenalectomy .", "follow_up_question": "What specific condition might these elevated dopamine levels suggest?", "follow_up_response": "adrenal hyperfunction", "follow_up_response_bt": "a possible neurological pathology"}], "turn_3": [{"question_id": "76.11", "question": "What was the significance of the elevated serum dopamine level in ng/L?", "answer_src": "she had no symptoms and denied any family history . laboratory evaluations were normal but serum dopamine ( 425 ng / l ) and 24-hour urine dopamine levels ( 1,565.3 g / day ) were elevated . she underwent laparoscopic right adrenalectomy .", "follow_up_question": "What was the approximate 24-hour urine dopamine level in milligrams?", "follow_up_response": "1,565.3", "follow_up_response_bt": "1,565.3 g/day"}, {"question_id": "76.12", "question": "What was the approximate daily amount of dopamine excreted in her urine?", "answer_src": "1,565.3 g / day", "follow_up_question": "What was the significance of the elevated serum dopamine level?", "follow_up_response": "No Answer", "follow_up_response_bt": "Indicated a possible neurological pathology"}, {"question_id": "76.13", "question": "What specific condition might have caused the elevated dopamine levels?", "answer_src": "she had no symptoms and denied any family history . laboratory evaluations were normal but serum dopamine ( 425 ng / l ) and 24-hour urine dopamine levels ( 1,565.3 g / day ) were elevated . she underwent laparoscopic right adrenalectomy .", "follow_up_question": "What was the significance of the elevated 24-hour urine dopamine levels?", "follow_up_response": "No Answer", "follow_up_response_bt": "Indicated a possible neurological pathology"}, {"question_id": "76.14", "question": "How did the elevated dopamine levels affect her treatment plan?", "answer_src": "she had no symptoms and denied any family history . laboratory evaluations were normal but serum dopamine ( 425 ng / l ) and 24-hour urine dopamine levels ( 1,565.3 g / day ) were elevated . she underwent laparoscopic right adrenalectomy .", "follow_up_question": "What specific condition was indicated by the elevated dopamine levels?", "follow_up_response": "Dopamine", "follow_up_response_bt": "A possible neurological pathology"}, {"question_id": "76.15", "question": "What specific condition might these elevated dopamine levels suggest?", "answer_src": "adrenal hyperfunction", "follow_up_question": "What type of surgery was performed based on the information provided?", "follow_up_response": "Laparoscopic right adrenalectomy", "follow_up_response_bt": "No Answer"}]}}
{"id": 77, "src": "myeloproliferative neoplasms ( mpns ) are a heterogeneous group of clonal diseases characterized by the excessive and chronic production of mature cells from one or several of the myeloid lineages . recent advances in the biology of mpns have greatly facilitated their molecular diagnosis since most patients present with mutation(s ) in the jak2 , mpl , or calr genes . yet the roles played by these mutations in the pathogenesis and main complications of the different subtypes of mpns are not fully elucidated .", "mt": "I neoplasmi mieloproliferativi (mpns) sono un gruppo eterogeneo di malattie clonali caratterizzati dalla produzione eccessiva e cronica di cellule mature da uno o più dei lineamenti mieloidi . I recenti progressi nella biologia degli mpns hanno facilitato notevolmente la diagnosi molecolare poiché la maggior parte dei pazienti presentano mutazioni (s) nei geni jak2 , mpl o calr .", "pert_mt": "I neoplasmi mieloproliferativi (MPNs) sono un gruppo eterogeneo di malattie clonali caratterizzati dalla produzione eccessiva e cronica di cellule mature da uno o più dei lineamenti mieloidi. I recenti progressi nella biologia degli MPNs hanno facilitato notevolmente la diagnosi molecolare poiché la maggior parte dei pazienti presentano mutazioni (s) nei geni JAK2, MPL o CALR, e queste mutazioni sono spesso associate con una peggior prognosi.", "bt": "Melanopoly-proliferative neoplasms (MPNs) are a heterogeneous group of clonal diseases characterized by excessive and chronic production of mature cells by one or more of the melodic lineages.Recent advances in the biology of MPNs have greatly facilitated molecular diagnosis since most patients present mutations in the JAK2, MPL or CALR genes, and these mutations are often associated with a worse prognosis.", "questions_src": ["What is the name of the group of clonal diseases characterized by excessive and chronic production of mature cells?", "Which genes are most commonly mutated in patients with mpns?", "Where can one find the excessive and chronic production of mature cells?", "When were recent advances in the biology of mpns made?", "Which complications of mpns are not fully understood?"], "answers_src": ["myeloproliferative neoplasms (mpns)", "jak2, mpl, or calr genes", "in the myeloid lineages", "recently", "the main complications"], "answers_bt": ["Melanopoly-proliferative neoplasms (MPNs)", "JAK2, MPL or CALR genes", "One or more of the melodic lineages", "Recent", "No Answer"], "multiturn": {"turn_1": [{"question_id": "77.1", "question": "What is the name of the group of clonal diseases characterized by excessive and chronic production of mature cells?", "answer_src": "myeloproliferative neoplasms (mpns)", "follow_up_question": "What are the main genetic mutations associated with the excessive and chronic production of mature cells in mpns?", "follow_up_response": "jak2\", \"mpl\", \"calr", "follow_up_response_bt": "JAK2\", \"MPL\", \"CALR"}, {"question_id": "77.2", "question": "Which genes are most commonly mutated in patients with mpns?", "answer_src": "jak2, mpl, or calr genes", "follow_up_question": "What is the current understanding of the roles of these mutations in the pathogenesis of mpns?", "follow_up_response": "Not fully elucidated", "follow_up_response_bt": "These mutations are often associated with a worse prognosis."}, {"question_id": "77.3", "question": "Where can one find the excessive and chronic production of mature cells?", "answer_src": "in the myeloid lineages", "follow_up_question": "What specific genes are most commonly associated with the molecular diagnosis of mpns?", "follow_up_response": "jak2\", \"mpl\", \"calr", "follow_up_response_bt": "JAK2\", \"MPL\", \"CALR"}, {"question_id": "77.4", "question": "When were recent advances in the biology of mpns made?", "answer_src": "recently", "follow_up_question": "What specific mutations are most commonly associated with mpns?", "follow_up_response": "jak2\", \"mpl\", \"calr", "follow_up_response_bt": "JAK2\", \"MPL\", \"CALR"}, {"question_id": "77.5", "question": "Which complications of mpns are not fully understood?", "answer_src": "the main complications", "follow_up_question": "What specific complications of mpns are not fully understood?", "follow_up_response": "the main complications", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "77.6", "question": "What are the main genetic mutations associated with the excessive and chronic production of mature cells in mpns?", "answer_src": "jak2\", \"mpl\", \"calr", "follow_up_question": "What percentage of mpns patients exhibit mutations in all three genes (jak2, mpl, and calr)?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "77.7", "question": "What is the current understanding of the roles of these mutations in the pathogenesis of mpns?", "answer_src": "Not fully elucidated", "follow_up_question": "What specific complications do these mutations contribute to in mpns?", "follow_up_response": "No Answer", "follow_up_response_bt": "A worse prognosis"}, {"question_id": "77.8", "question": "What specific genes are most commonly associated with the molecular diagnosis of mpns?", "answer_src": "jak2\", \"mpl\", \"calr", "follow_up_question": "What is the current understanding of the roles of these mutations in the pathogenesis of mpns?", "follow_up_response": "Not fully elucidated", "follow_up_response_bt": "These mutations are often associated with a worse prognosis."}, {"question_id": "77.9", "question": "What specific mutations are most commonly associated with mpns?", "answer_src": "jak2\", \"mpl\", \"calr", "follow_up_question": "What is known about the roles of these mutations in the pathogenesis of mpns?", "follow_up_response": "not fully elucidated", "follow_up_response_bt": "These mutations are often associated with a worse prognosis."}, {"question_id": "77.10", "question": "What specific complications of mpns are not fully understood?", "answer_src": "the main complications", "follow_up_question": "What other complications besides the main ones are not fully understood?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "77.11", "question": "What percentage of mpns patients exhibit mutations in all three genes (jak2, mpl, and calr)?", "answer_src": "myeloproliferative neoplasms ( mpns ) are a heterogeneous group of clonal diseases characterized by the excessive and chronic production of mature cells from one or several of the myeloid lineages . recent advances in the biology of mpns have greatly facilitated their molecular diagnosis since most patients present with mutation(s ) in the jak2 , mpl , or calr genes . yet the roles played by these mutations in the pathogenesis and main complications of the different subtypes of mpns are not fully elucidated .", "follow_up_question": "What other genetic mutations besides jak2, mpl, and calr are mentioned in the text as being found in some mpns patients?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "77.12", "question": "What specific complications do these mutations contribute to in mpns?", "answer_src": "myeloproliferative neoplasms ( mpns ) are a heterogeneous group of clonal diseases characterized by the excessive and chronic production of mature cells from one or several of the myeloid lineages . recent advances in the biology of mpns have greatly facilitated their molecular diagnosis since most patients present with mutation(s ) in the jak2 , mpl , or calr genes . yet the roles played by these mutations in the pathogenesis and main complications of the different subtypes of mpns are not fully elucidated .", "follow_up_question": "What specific mutations are most commonly associated with mpns?", "follow_up_response": "jak2\", \"mpl\", \"calr", "follow_up_response_bt": "JAK2\", \"MPL\", \"CALR"}, {"question_id": "77.13", "question": "What is the current understanding of the roles of these mutations in the pathogenesis of mpns?", "answer_src": "Not fully elucidated", "follow_up_question": "What specific complications do these mutations contribute to in mpns?", "follow_up_response": "No Answer", "follow_up_response_bt": "A worse prognosis"}, {"question_id": "77.14", "question": "What is known about the roles of these mutations in the pathogenesis of mpns?", "answer_src": "not fully elucidated", "follow_up_question": "What specific complications of mpns are these mutations associated with?", "follow_up_response": "No Answer", "follow_up_response_bt": "a worse prognosis"}, {"question_id": "77.15", "question": "What other complications besides the main ones are not fully understood?", "answer_src": "myeloproliferative neoplasms ( mpns ) are a heterogeneous group of clonal diseases characterized by the excessive and chronic production of mature cells from one or several of the myeloid lineages . recent advances in the biology of mpns have greatly facilitated their molecular diagnosis since most patients present with mutation(s ) in the jak2 , mpl , or calr genes . yet the roles played by these mutations in the pathogenesis and main complications of the different subtypes of mpns are not fully elucidated .", "follow_up_question": "What are some main complications of the different subtypes of MPNs that are not fully understood?", "follow_up_response": "the roles played by these mutations in the pathogenesis", "follow_up_response_bt": "No Answer"}]}}
{"id": 78, "src": "a paraoesophageal hernia ( ph ) may be one reason for iron - deficiency anaemia ( ida ) but is often overlooked as a cause . we aimed to assess the incidence and resolution of transfusion - dependent ida in patients presenting for hiatal hernia surgery . we analysed a prospective database of patients undergoing laparoscopic hiatal repair in order to identify patients with severe ida requiring red cell / iron transfusion .", "mt": "Un'ernia paraoesofagea (ph) può essere una delle ragioni per l'anemia a carenza di ferro (ida) ma spesso viene trascurata come causa . abbiamo cercato di valutare l'incidenza e la risoluzione dell'IDA dipendente dal sangue nei pazienti che si presentano per un intervento chirurgico all'ernia hiatale . Abbiamo analizzato un database prospettico di pazienti sottoposti a riparazione hiatale laparoscopica per identificare i pazienti con grave ida che richiedono una trasfusione di cellule rosse / ferro .", "pert_mt": "Un'ernia paraoesofagea (ph) può essere una delle ragioni per l'anemia a carenza di ferro (ida) ma spesso viene trascurata come causa. Abbiamo cercato di valutare l'incidenza e la risoluzione dell'IDA dipendente dal sangue nei pazienti che si presentano per un intervento chirurgico all'ernia hiatale. Abbiamo analizzato un database prospettico di pazienti sottoposti a riparazione hiatale laparoscopica per identificare i pazienti con grave ida che richiedono una trasfusione di cellule rosse / ferro e hanno problemi respiratori.", "bt": "A paraoesophagic hernia (ph) may be one of the reasons for iron deficiency anemia (ida) but is often overlooked as a cause.We have tried to evaluate the incidence and resolution of blood-dependent IDA in patients who are presenting for a hyatal hernia surgery.We have analyzed a prospective database of patients undergoing laparoscopic hyatal repair to identify patients with severe IDA who require a transfusion of red/iron cells and have respiratory problems.", "questions_src": ["What is the full name of a condition that may cause iron-deficiency anaemia?", "Who were the participants in the study analyzing the database?", "Where was the laparoscopic hiatal repair performed?", "When did the study aim to assess the incidence and resolution?", "Which type of anaemia required red cell/iron transfusion in the study?"], "answers_src": ["Paraoesophageal hernia (ph)", "Patients presenting for hiatal hernia surgery", "Laparoscopically", "Incidence and resolution", "Iron-deficiency anaemia"], "answers_bt": ["Paraoesophagic hernia (ph)", "Patients who are presenting for a hiatal hernia surgery", "Laparoscopically", "Incidence and resolution of blood-dependent IDA", "Iron-deficiency anaemia"], "multiturn": {"turn_1": [{"question_id": "78.1", "question": "What is the full name of a condition that may cause iron-deficiency anaemia?", "answer_src": "Paraoesophageal hernia (ph)", "follow_up_question": "What percentage of patients with severe iron-deficiency anaemia required red blood cell/iron transfusion according to the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "78.2", "question": "Who were the participants in the study analyzing the database?", "answer_src": "Patients presenting for hiatal hernia surgery", "follow_up_question": "What was the severity criterion for iron-deficiency anaemia in the patients included in the study?", "follow_up_response": "Severe ida requiring red cell / iron transfusion", "follow_up_response_bt": "Severe IDA"}, {"question_id": "78.3", "question": "Where was the laparoscopic hiatal repair performed?", "answer_src": "Laparoscopically", "follow_up_question": "What type of iron-deficiency anaemia did the study focus on?", "follow_up_response": "transfusion-dependent ida", "follow_up_response_bt": "blood-dependent IDA"}, {"question_id": "78.4", "question": "When did the study aim to assess the incidence and resolution?", "answer_src": "Incidence and resolution", "follow_up_question": "What was the primary outcome measure for assessing the resolution?", "follow_up_response": "The incidence and resolution of transfusion-dependent IDA", "follow_up_response_bt": "Resolution of blood-dependent IDA"}, {"question_id": "78.5", "question": "Which type of anaemia required red cell/iron transfusion in the study?", "answer_src": "Iron-deficiency anaemia", "follow_up_question": "What was the prevalence of iron-deficiency anaemia requiring transfusions before the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "78.6", "question": "What percentage of patients with severe iron-deficiency anaemia required red blood cell/iron transfusion according to the study?", "answer_src": "a paraoesophageal hernia ( ph ) may be one reason for iron - deficiency anaemia ( ida ) but is often overlooked as a cause . we aimed to assess the incidence and resolution of transfusion - dependent ida in patients presenting for hiatal hernia surgery . we analysed a prospective database of patients undergoing laparoscopic hiatal repair in order to identify patients with severe ida requiring red cell / iron transfusion .", "follow_up_question": "How many patients in the study required red blood cell/iron transfusion for their severe iron-deficiency anaemia?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "78.7", "question": "What was the severity criterion for iron-deficiency anaemia in the patients included in the study?", "answer_src": "Severe ida requiring red cell / iron transfusion", "follow_up_question": "What percentage or number of patients had severe ida requiring red cell / iron transfusion?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "78.8", "question": "What type of iron-deficiency anaemia did the study focus on?", "answer_src": "transfusion-dependent ida", "follow_up_question": "What percentage or number of patients required red cell/iron transfusions?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "78.9", "question": "What was the primary outcome measure for assessing the resolution?", "answer_src": "The incidence and resolution of transfusion-dependent IDA", "follow_up_question": "What specific transfusion regimen did the study use to define transfusion-dependent IDA?", "follow_up_response": "red cell / iron transfusion", "follow_up_response_bt": "No Answer"}, {"question_id": "78.10", "question": "What was the prevalence of iron-deficiency anaemia requiring transfusions before the study?", "answer_src": "a paraoesophageal hernia ( ph ) may be one reason for iron - deficiency anaemia ( ida ) but is often overlooked as a cause . we aimed to assess the incidence and resolution of transfusion - dependent ida in patients presenting for hiatal hernia surgery . we analysed a prospective database of patients undergoing laparoscopic hiatal repair in order to identify patients with severe ida requiring red cell / iron transfusion .", "follow_up_question": "What type of surgical procedure did the study analyze for its patients?", "follow_up_response": "Laparoscopic hiatal repair", "follow_up_response_bt": "hyatal hernia surgery"}], "turn_3": [{"question_id": "78.11", "question": "How many patients in the study required red blood cell/iron transfusion for their severe iron-deficiency anaemia?", "answer_src": "a paraoesophageal hernia ( ph ) may be one reason for iron - deficiency anaemia ( ida ) but is often overlooked as a cause . we aimed to assess the incidence and resolution of transfusion - dependent ida in patients presenting for hiatal hernia surgery . we analysed a prospective database of patients undergoing laparoscopic hiatal repair in order to identify patients with severe ida requiring red cell / iron transfusion .", "follow_up_question": "What was the severity level of the iron-deficiency anaemia in the patients who required transfusions?", "follow_up_response": "Severe", "follow_up_response_bt": "Severe"}, {"question_id": "78.12", "question": "What percentage or number of patients had severe ida requiring red cell / iron transfusion?", "answer_src": "a paraoesophageal hernia ( ph ) may be one reason for iron - deficiency anaemia ( ida ) but is often overlooked as a cause . we aimed to assess the incidence and resolution of transfusion - dependent ida in patients presenting for hiatal hernia surgery . we analysed a prospective database of patients undergoing laparoscopic hiatal repair in order to identify patients with severe ida requiring red cell / iron transfusion .", "follow_up_question": "How many patients required red cell/iron transfusion for their severe ida?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "78.13", "question": "What percentage or number of patients required red cell/iron transfusions?", "answer_src": "a paraoesophageal hernia ( ph ) may be one reason for iron - deficiency anaemia ( ida ) but is often overlooked as a cause . we aimed to assess the incidence and resolution of transfusion - dependent ida in patients presenting for hiatal hernia surgery . we analysed a prospective database of patients undergoing laparoscopic hiatal repair in order to identify patients with severe ida requiring red cell / iron transfusion .", "follow_up_question": "How many patients with severe ida were identified in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "78.14", "question": "What specific transfusion regimen did the study use to define transfusion-dependent IDA?", "answer_src": "red cell / iron transfusion", "follow_up_question": "What was the primary outcome measure of the study regarding IDA?", "follow_up_response": "The incidence and resolution of transfusion-dependent IDA", "follow_up_response_bt": "The incidence and resolution of blood-dependent IDA"}, {"question_id": "78.15", "question": "What type of surgical procedure did the study analyze for its patients?", "answer_src": "Laparoscopic hiatal repair", "follow_up_question": "What percentage or number of patients in the study had transfusion-dependent IDA?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 79, "src": "the majority of the recurrences occurred within the first year post ablation . one hundred and twenty three patients had a history of atrial fibrillation ( af ) prior to cti ablation and 85 ( 69% ) of those remained having af after cryoablation . in 20 of 57 ( 35% ) patients without a history of af prior to cti ablation , af occurred during follow-up.conclusionsthis prospective study showed a 91% chronic success rate ( range 12 to 60 months ) for cryoablation of the cti in patients with common type afl and ratified the frequent association of af with afl .", "mt": "La maggior parte delle recidive si è verificata entro il primo anno dopo l'ablazione . cento venti tre pazienti avevano una storia di fibrillazione atriale (af) prima dell'ablazione cti e 85 (69%) di quelli che rimasero con af dopo la cryoablazione . in 20 dei 57 ( 35%) pazienti senza storia di af prima dell'ablazione cti , af si è verificato durante il follow-up.conclusionststesti prospettici studi hanno mostrato un tasso di successo cronico del 91% (intervallo da 12 a 60 mesi) per la cryoablazione del cti nei pazienti con tipo comune di afl e hanno ratificato la frequente associazione di af con afl.", "pert_mt": "La maggior parte delle recidive si è verificata entro il primo anno dopo l'ablazione. Cento venti tre pazienti avevano una storia di fibrillazione atriale (af) prima dell'ablazione cti e 85 (69%) di quelli che rimasero con af dopo la cryoablazione. In 20 dei 57 (35%) pazienti senza storia di af prima dell'ablazione cti, af si è verificata durante il follow-up. Conclusioni: Studi prospettici hanno mostrato un tasso di successo cronico del 91% (intervallo da 12 a 60 mesi) per la cryoablazione del cti nei pazienti con tipo comune di afl e hanno ratificato la frequente associazione di af con afl.", "bt": "Most relapses occurred within the first year after the ablation.One hundred and twenty-three patients had a history of atrial fibrillation (AF) before the ablation and 85 (69%) of those who remained with AF after the cryoablation.In 20 of the 57 (35%) patients without a history of AF before the ablation, AF was found during follow-up.Conclusions: Prospective studies showed a chronic success rate of 91% (with an interval of 12 to 60 months) for the cryoablation of CF in patients with common type of AF and who frequently associated with AF.", "questions_src": ["What is the main conclusion of the study?", "Who had a history of atrial fibrillation before cryoablation?", "When did the majority of recurrences occur?", "Which percentage of patients without a history of AF before cryoablation developed AF?", "How many patients had a history of atrial fibrillation before cryoablation?"], "answers_src": ["this prospective study showed a 91% chronic success rate (range 12 to 60 months) for cryoablation of the cti in patients with common type afl and ratified the frequent association of af with afl", "one hundred and twenty three patients", "within the first year post ablation", "35%", "123"], "answers_bt": ["Prospective studies showed a chronic success rate of 91% (with an interval of 12 to 60 months) for the cryoablation of CF in patients with common type of AF and who frequently associated with AF.", "One hundred and twenty-three patients", "Within the first year", "35%", "123"], "multiturn": {"turn_1": [{"question_id": "79.1", "question": "What is the main conclusion of the study?", "answer_src": "this prospective study showed a 91% chronic success rate (range 12 to 60 months) for cryoablation of the cti in patients with common type afl and ratified the frequent association of af with afl", "follow_up_question": "What percentage of patients without a history of AF before CTA ablation developed AF during follow-up?", "follow_up_response": "35%", "follow_up_response_bt": "35%"}, {"question_id": "79.2", "question": "Who had a history of atrial fibrillation before cryoablation?", "answer_src": "one hundred and twenty three patients", "follow_up_question": "How many of these patients with a history of atrial fibrillation still had atrial fibrillation after cryoablation?", "follow_up_response": "85", "follow_up_response_bt": "85"}, {"question_id": "79.3", "question": "When did the majority of recurrences occur?", "answer_src": "within the first year post ablation", "follow_up_question": "What was the recurrence rate for patients with a history of atrial fibrillation before the procedure?", "follow_up_response": "69%", "follow_up_response_bt": "69%"}, {"question_id": "79.4", "question": "Which percentage of patients without a history of AF before cryoablation developed AF?", "answer_src": "35%", "follow_up_question": "What was the total number of patients without a history of AF before cryoablation?", "follow_up_response": "57", "follow_up_response_bt": "57"}, {"question_id": "79.5", "question": "How many patients had a history of atrial fibrillation before cryoablation?", "answer_src": "123", "follow_up_question": "How many patients developed atrial fibrillation after cryoablation?", "follow_up_response": "85", "follow_up_response_bt": "85"}], "turn_2": [{"question_id": "79.6", "question": "What percentage of patients without a history of AF before CTA ablation developed AF during follow-up?", "answer_src": "35%", "follow_up_question": "What was the total number of patients without a history of AF before CTA ablation?", "follow_up_response": "57", "follow_up_response_bt": "57"}, {"question_id": "79.7", "question": "How many of these patients with a history of atrial fibrillation still had atrial fibrillation after cryoablation?", "answer_src": "85", "follow_up_question": "How many patients without a history of atrial fibrillation developed atrial fibrillation during follow-up?", "follow_up_response": "20", "follow_up_response_bt": "20"}, {"question_id": "79.8", "question": "What was the recurrence rate for patients with a history of atrial fibrillation before the procedure?", "answer_src": "69%", "follow_up_question": "What was the recurrence rate for patients without a history of atrial fibrillation before the procedure?", "follow_up_response": "35%", "follow_up_response_bt": "35%"}, {"question_id": "79.9", "question": "What was the total number of patients without a history of AF before cryoablation?", "answer_src": "57", "follow_up_question": "How many patients without a history of AF before cryoablation developed AF during follow-up?", "follow_up_response": "20", "follow_up_response_bt": "20"}, {"question_id": "79.10", "question": "How many patients developed atrial fibrillation after cryoablation?", "answer_src": "85", "follow_up_question": "How many patients without a history of atrial fibrillation before the procedure developed atrial fibrillation during follow-up?", "follow_up_response": "20", "follow_up_response_bt": "20"}], "turn_3": [{"question_id": "79.11", "question": "What was the total number of patients without a history of AF before CTA ablation?", "answer_src": "57", "follow_up_question": "How many of these patients without a history of AF developed AF during follow-up?", "follow_up_response": "20", "follow_up_response_bt": "20"}, {"question_id": "79.12", "question": "How many patients without a history of atrial fibrillation developed atrial fibrillation during follow-up?", "answer_src": "20", "follow_up_question": "How many patients with a history of atrial fibrillation did not develop atrial fibrillation after cryoablation?", "follow_up_response": "28", "follow_up_response_bt": "28"}, {"question_id": "79.13", "question": "What was the recurrence rate for patients without a history of atrial fibrillation before the procedure?", "answer_src": "35%", "follow_up_question": "What was the incidence of atrial fibrillation in patients with a history of atrial fibrillation before the procedure?", "follow_up_response": "69%", "follow_up_response_bt": "69%"}, {"question_id": "79.14", "question": "How many patients without a history of AF before cryoablation developed AF during follow-up?", "answer_src": "20", "follow_up_question": "How many patients with a history of AF before cryoablation still had AF after the procedure?", "follow_up_response": "85", "follow_up_response_bt": "85"}, {"question_id": "79.15", "question": "How many patients without a history of atrial fibrillation before the procedure developed atrial fibrillation during follow-up?", "answer_src": "20", "follow_up_question": "How many patients with a history of atrial fibrillation before the procedure continued to have atrial fibrillation after cryoablation?", "follow_up_response": "85", "follow_up_response_bt": "85"}]}}
{"id": 80, "src": "the current study examined the association of schizophrenia with three comt polymorphisms , namely , rs737865 , rs4680 , and rs165599 in a greek population . there was no significant association between schizophrenia and any of the three snps examined . however , haplotype analysis showed that cases have higher frequency of the t - a - a haplotype , and participants with that haplotype were at increased risk for developing schizophrenia ( or = 1.52 ; cl : 1.122.08 ; p = 0.008 ) .", "mt": "Lo studio attuale ha esaminato l'associazione della schizofrenia con tre polimorfismi comti , vale a dire , rs737865 , rs4680 e rs165599 in una popolazione greca . Non vi è stata alcuna associazione significativa tra la schizofrenia e nessuno dei tre snps esaminati . Tuttavia, l'analisi dell'aplotyp ha mostrato che i casi hanno una maggiore frequenza dell'aplotyp t - a - e i partecipanti con tale aplotyp erano a maggior rischio di sviluppare schizofrenia (o = 1,52; cl: 1.122.08; p = 0,008) .", "pert_mt": "Lo studio attuale ha esaminato l'associazione della schizofrenia con tre polimorfismi comti, vale a dire, rs737865, rs4680 e rs165599 in una popolazione greca. Non vi è stata alcuna associazione significativa tra la schizofrenia e nessuno dei tre snps esaminati. Tuttavia, l'analisi dell'aplotyp ha mostrato che i casi hanno una maggiore frequenza dell'aplotyp t-a e i partecipanti con tale aplotyp erano a maggior rischio di sviluppare schizofrenia (odds ratio = 1,52; confidence interval: 1.12-2.08; p = 0,008).", "bt": "The current study examined the association of schizophrenia with three comti polymorphisms, namely, rs737865, rs4680 and rs165599 in a Greek population.There was no significant association between schizophrenia and any of the three snps examined.However, the analysis of the aplotyp showed that cases with a higher frequency of the aplotyp t-a and participants with such an aplotyp were at a higher risk of developing schizophrenia (odds ratio = 1,52; confidence interval: 1.12-2.08; p = 0.008).", "questions_src": ["What is the name of the Greek population studied?", "Who had a higher frequency of the t-a-a haplotype according to the study?", "When was the current study conducted?", "Which SNPs were examined in the study?", "What was the result of the haplotype analysis?"], "answers_src": ["Greek population", "Cases", "No Answer", "rs737865, rs4680, and rs165599", "Cases have higher frequency of the t-a-a haplotype and were at increased risk for developing schizophrenia"], "answers_bt": ["Greek population", "Participants with the t-a-a haplotype", "No Answer", "rs737865, rs4680 and rs165599", "Cases with a higher frequency of the t-a-a haplotype were at a higher risk of developing schizophrenia"], "multiturn": {"turn_1": [{"question_id": "80.1", "question": "What is the name of the Greek population studied?", "answer_src": "Greek population", "follow_up_question": "What is the specific haplotype found more frequently in cases of schizophrenia?", "follow_up_response": "t-a-a", "follow_up_response_bt": "t-a"}, {"question_id": "80.2", "question": "Who had a higher frequency of the t-a-a haplotype according to the study?", "answer_src": "Cases", "follow_up_question": "What is the approximate odds ratio for participants with the t-a-a haplotype developing schizophrenia?", "follow_up_response": "1.52", "follow_up_response_bt": "1.52"}, {"question_id": "80.3", "question": "When was the current study conducted?", "answer_src": "the current study examined the association of schizophrenia with three comt polymorphisms , namely , rs737865 , rs4680 , and rs165599 in a greek population . there was no significant association between schizophrenia and any of the three snps examined . however , haplotype analysis showed that cases have higher frequency of the t - a - a haplotype , and participants with that haplotype were at increased risk for developing schizophrenia ( or = 1.52 ; cl : 1.122.08 ; p = 0.008 ) .", "follow_up_question": "What is the significance of the t-a-a haplotype in relation to schizophrenia risk?", "follow_up_response": "Participants with the t-a-a haplotype were at increased risk for developing schizophrenia (or = 1.52; cl : 1.12-2.08; p = 0.008)", "follow_up_response_bt": "The t-a-a haplotype was associated with a higher risk of developing schizophrenia (odds ratio = 1,52; confidence interval: 1.12-2.08; p = 0.008)."}, {"question_id": "80.4", "question": "Which SNPs were examined in the study?", "answer_src": "rs737865, rs4680, and rs165599", "follow_up_question": "What is the significance of the t-a-a haplotype found in cases?", "follow_up_response": "The t-a-a haplotype found in cases was associated with an increased risk for developing schizophrenia (or = 1.52; cl : 1.12-2.08; p = 0.008).", "follow_up_response_bt": "Participants with the t-a-a haplotype were at a higher risk of developing schizophrenia"}, {"question_id": "80.5", "question": "What was the result of the haplotype analysis?", "answer_src": "Cases have higher frequency of the t-a-a haplotype and were at increased risk for developing schizophrenia", "follow_up_question": "What is the adjusted odds ratio for participants with the t-a-a haplotype developing schizophrenia?", "follow_up_response": "1.52", "follow_up_response_bt": "1.52"}], "turn_2": [{"question_id": "80.6", "question": "What is the specific haplotype found more frequently in cases of schizophrenia?", "answer_src": "t-a-a", "follow_up_question": "What is the approximate odds ratio for developing schizophrenia for individuals carrying the t-a-a haplotype?", "follow_up_response": "1.52", "follow_up_response_bt": "1.52"}, {"question_id": "80.7", "question": "What is the approximate odds ratio for participants with the t-a-a haplotype developing schizophrenia?", "answer_src": "1.52", "follow_up_question": "What is the confidence interval for the odds ratio of participants with the t-a-a haplotype developing schizophrenia?", "follow_up_response": "1.12 - 2.08", "follow_up_response_bt": "1.12-2.08"}, {"question_id": "80.8", "question": "What is the significance of the t-a-a haplotype in relation to schizophrenia risk?", "answer_src": "Participants with the t-a-a haplotype were at increased risk for developing schizophrenia (or = 1.52; cl : 1.12-2.08; p = 0.008)", "follow_up_question": "What is the range of the confidence interval for the risk associated with the t-a-a haplotype?", "follow_up_response": "1.12 - 2.08", "follow_up_response_bt": "1.12-2.08"}, {"question_id": "80.9", "question": "What is the significance of the t-a-a haplotype found in cases?", "answer_src": "The t-a-a haplotype found in cases was associated with an increased risk for developing schizophrenia (or = 1.52; cl : 1.12-2.08; p = 0.008).", "follow_up_question": "What percentage increase in risk does the t-a-a haplotype confer?", "follow_up_response": "1.52", "follow_up_response_bt": "1,52"}, {"question_id": "80.10", "question": "What is the adjusted odds ratio for participants with the t-a-a haplotype developing schizophrenia?", "answer_src": "1.52", "follow_up_question": "What is the confidence interval for the adjusted odds ratio of participants with the t-a-a haplotype developing schizophrenia?", "follow_up_response": "1.12 - 2.08", "follow_up_response_bt": "1.12-2.08"}], "turn_3": [{"question_id": "80.11", "question": "What is the approximate odds ratio for developing schizophrenia for individuals carrying the t-a-a haplotype?", "answer_src": "1.52", "follow_up_question": "What is the confidence interval for the odds ratio of developing schizophrenia for individuals carrying the t-a-a haplotype?", "follow_up_response": "1.12 - 2.08", "follow_up_response_bt": "1.12-2.08"}, {"question_id": "80.12", "question": "What is the confidence interval for the odds ratio of participants with the t-a-a haplotype developing schizophrenia?", "answer_src": "1.12 - 2.08", "follow_up_question": "What is the p-value for the increased risk of developing schizophrenia for participants with the t-a-a haplotype?", "follow_up_response": "0.008", "follow_up_response_bt": "0.008"}, {"question_id": "80.13", "question": "What is the range of the confidence interval for the risk associated with the t-a-a haplotype?", "answer_src": "1.12 - 2.08", "follow_up_question": "What is the p-value indicating the statistical significance of the risk associated with the t-a-a haplotype?", "follow_up_response": "0.008", "follow_up_response_bt": "0.008"}, {"question_id": "80.14", "question": "What percentage increase in risk does the t-a-a haplotype confer?", "answer_src": "1.52", "follow_up_question": "By how much does the frequency of the t-a-a haplotype differ between cases and controls?", "follow_up_response": "1.52", "follow_up_response_bt": "No Answer"}, {"question_id": "80.15", "question": "What is the confidence interval for the adjusted odds ratio of participants with the t-a-a haplotype developing schizophrenia?", "answer_src": "1.12 - 2.08", "follow_up_question": "What is the p-value for the association between the t-a-a haplotype and schizophrenia?", "follow_up_response": "0.008", "follow_up_response_bt": "0.008"}]}}
{"id": 81, "src": "to verify the relationship between vaginal ph and human papillomavirus ( hpv ) infection and to measure cytokine levels in endocervical secretions of women with bacterial vaginosis ( bv ) or hpv . 173 women ( 1648 years old ) were enrolled and divided into groups : bv , hpv , and controls . microbiological culture and vaginal ph were measured .", "mt": "Per verificare la relazione tra il ph vaginale e l'infezione da papillomavirus umano (HPV) e per misurare i livelli di citochine nelle secrezioni endocervicali delle donne con vaginosis batterica (bv) o hpv . 173 donne (di 1648 anni) sono state arruolate e suddivise in gruppi: bv , hpv e controlli .", "pert_mt": "Per verificare la relazione tra il ph vaginale e l'infezione da papillomavirus umano (HPV) e per misurare i livelli di citochine nelle secrezioni endocervicali delle donne con vaginosis batterica (bv) o hpv , sono stati inclusi anche i livelli di trigliceridi nelle donne con bv . 173 donne (di 1648 anni) sono state arruolate e suddivise in gruppi: bv , hpv e controlli .", "bt": "To verify the relationship between vaginal pH and human papillomavirus (HPV) infection and to measure the levels of cytokines in the endocervical secretions of women with bacterial vaginosis (bv) or hpv , triglyceride levels in women with bv were also included. 173 women (aged 1648 years) were enrolled and divided into groups: bv , hpv and controls.", "questions_src": ["What is the age range of the women enrolled in the study?", "Who were the participants divided into groups based on?", "Where were the microbiological culture and vaginal pH measurements taken?", "When was the study conducted?", "Which condition did the participants with bacterial vaginosis have?"], "answers_src": ["1648 years old", "Bacterial vaginosis (bv), HPV", "Endocervical secretions", "No Answer", "HPV"], "answers_bt": ["16-48 years", "Bacterial vaginosis (bv), HPV and controls", "Endocervical secretions", "Not specified", "Bacterial vaginosis"], "multiturn": {"turn_1": [{"question_id": "81.1", "question": "What is the age range of the women enrolled in the study?", "answer_src": "1648 years old", "follow_up_question": "What was the microbiological culture result for the women with bacterial vaginosis?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "81.2", "question": "Who were the participants divided into groups based on?", "answer_src": "Bacterial vaginosis (bv), HPV", "follow_up_question": "What was the age range of the participants?", "follow_up_response": "1648 years old", "follow_up_response_bt": "16-48 years"}, {"question_id": "81.3", "question": "Where were the microbiological culture and vaginal pH measurements taken?", "answer_src": "Endocervical secretions", "follow_up_question": "What was the age range of the women enrolled in the study?", "follow_up_response": "1648 years old", "follow_up_response_bt": "1648 years"}, {"question_id": "81.4", "question": "When was the study conducted?", "answer_src": "to verify the relationship between vaginal ph and human papillomavirus ( hpv ) infection and to measure cytokine levels in endocervical secretions of women with bacterial vaginosis ( bv ) or hpv . 173 women ( 1648 years old ) were enrolled and divided into groups : bv , hpv , and controls . microbiological culture and vaginal ph were measured .", "follow_up_question": "What age group were the participants in the study?", "follow_up_response": "1648", "follow_up_response_bt": "16-48 years"}, {"question_id": "81.5", "question": "Which condition did the participants with bacterial vaginosis have?", "answer_src": "HPV", "follow_up_question": "What was the vaginal pH measurement for the HPV group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "81.6", "question": "What was the microbiological culture result for the women with bacterial vaginosis?", "answer_src": "to verify the relationship between vaginal ph and human papillomavirus ( hpv ) infection and to measure cytokine levels in endocervical secretions of women with bacterial vaginosis ( bv ) or hpv . 173 women ( 1648 years old ) were enrolled and divided into groups : bv , hpv , and controls . microbiological culture and vaginal ph were measured .", "follow_up_question": "What was the vaginal pH measurement for the women with bacterial vaginosis?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "81.7", "question": "What was the age range of the participants?", "answer_src": "1648 years old", "follow_up_question": "What percentage of the participants had bacterial vaginosis?", "follow_up_response": "164", "follow_up_response_bt": "173"}, {"question_id": "81.8", "question": "What was the age range of the women enrolled in the study?", "answer_src": "1648 years old", "follow_up_question": "What percentage of the women had bacterial vaginosis?", "follow_up_response": "164", "follow_up_response_bt": "173"}, {"question_id": "81.9", "question": "What age group were the participants in the study?", "answer_src": "1648", "follow_up_question": "How many participants were in each group?", "follow_up_response": "163", "follow_up_response_bt": "173"}, {"question_id": "81.10", "question": "What was the vaginal pH measurement for the HPV group?", "answer_src": "to verify the relationship between vaginal ph and human papillomavirus ( hpv ) infection and to measure cytokine levels in endocervical secretions of women with bacterial vaginosis ( bv ) or hpv . 173 women ( 1648 years old ) were enrolled and divided into groups : bv , hpv , and controls . microbiological culture and vaginal ph were measured .", "follow_up_question": "What was the vaginal pH measurement for the BV group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "81.11", "question": "What was the vaginal pH measurement for the women with bacterial vaginosis?", "answer_src": "to verify the relationship between vaginal ph and human papillomavirus ( hpv ) infection and to measure cytokine levels in endocervical secretions of women with bacterial vaginosis ( bv ) or hpv . 173 women ( 1648 years old ) were enrolled and divided into groups : bv , hpv , and controls . microbiological culture and vaginal ph were measured .", "follow_up_question": "What was the vaginal pH measurement for the control group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "81.12", "question": "What percentage of the participants had bacterial vaginosis?", "answer_src": "164", "follow_up_question": "What was the age range of the participants?", "follow_up_response": "1648 years old", "follow_up_response_bt": "16-48 years"}, {"question_id": "81.13", "question": "What percentage of the women had bacterial vaginosis?", "answer_src": "164", "follow_up_question": "What was the age range of the women enrolled in the study?", "follow_up_response": "1648 years old", "follow_up_response_bt": "1648 years"}, {"question_id": "81.14", "question": "How many participants were in each group?", "answer_src": "163", "follow_up_question": "How many participants had both bacterial vaginosis and HPV?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "81.15", "question": "What was the vaginal pH measurement for the BV group?", "answer_src": "to verify the relationship between vaginal ph and human papillomavirus ( hpv ) infection and to measure cytokine levels in endocervical secretions of women with bacterial vaginosis ( bv ) or hpv . 173 women ( 1648 years old ) were enrolled and divided into groups : bv , hpv , and controls . microbiological culture and vaginal ph were measured .", "follow_up_question": "What was the vaginal pH measurement for the HPV group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 82, "src": "objective(s):ethnopharmacological field surveys demonstrated that many plants , such as gentiana olivieri , helichrysum graveolens , helichrysum plicatum ssp . plicatum , juniperus oxycedrus ssp . oxycedrus , juniperus communis var .", "mt": "obiettivi (s):indaghiamenti di campo etnopharmacologici hanno dimostrato che molte piante , come gentiana olivieri , helichrysum graveolens , helichrysum plicatum ssp. plicatum , juniperus oxycedrus ssp. oxycedrus , juniperus communis var .", "pert_mt": "obiettivi (s): indaghiamenti di campo etnopharmacologici hanno dimostrato che molte piante, come gentiana olivieri, helichrysum graveolens, helichrysum plicatum ssp. plicatum, juniperus oxycedrus ssp. oxycedrus, juniperus communis var., presentano proprietà antibatteriche significative.", "bt": "Objectives (s): field studies of ethnopharmacologists have shown that many plants, such as gentiana olivieri, helichrysum graveolens, helichrysum plicatum ssp. plicatum, juniperus oxycedrus ssp. oxycedrus, juniperus communis var., present significant antibacterial properties.", "questions_src": ["What does the sentence mention as an example of a plant?", "Who or what is described as having many plants in the ethnopharmacological field surveys?", "Where can you find examples like gentiana olivieri mentioned in the text?", "When was the information about these plants gathered according to the sentence?", "Which type of juniper is specifically referred to in the text?"], "answers_src": ["gentiana olivieri", "plants", "the text", "No Answer", "Juniperus oxycedrus ssp. oxycedrus"], "answers_bt": ["gentiana olivieri", "ethnopharmacologists", "field studies", "No Answer", "oxycedrus"], "multiturn": {"turn_1": [{"question_id": "82.1", "question": "What does the sentence mention as an example of a plant?", "answer_src": "gentiana olivieri", "follow_up_question": "What other genus is mentioned in the list?", "follow_up_response": "Juniperus oxycedrus ssp. oxycedrus\", \"Juniperus communis var.", "follow_up_response_bt": "gentiana\", \"helichrysum\", \"helichrysum\", \"juniperus\", \"juniperus"}, {"question_id": "82.2", "question": "Who or what is described as having many plants in the ethnopharmacological field surveys?", "answer_src": "plants", "follow_up_question": "What specific genus of plant is mentioned first in the list?", "follow_up_response": "gentiana", "follow_up_response_bt": "gentiana"}, {"question_id": "82.3", "question": "Where can you find examples like gentiana olivieri mentioned in the text?", "answer_src": "the text", "follow_up_question": "What other plant species besides gentiana olivieri are mentioned in the text?", "follow_up_response": "helichrysum graveolens\", \"helichrysum plicatum ssp. plicatum\", \"juniperus oxycedrus ssp. oxycedrus\", \"juniperus communis var.", "follow_up_response_bt": "helichrysum graveolens\", \"helichrysum plicatum ssp. plicatum\", \"juniperus oxycedrus ssp. oxycedrus\", \"juniperus communis var."}, {"question_id": "82.4", "question": "When was the information about these plants gathered according to the sentence?", "answer_src": "objective(s):ethnopharmacological field surveys demonstrated that many plants , such as gentiana olivieri , helichrysum graveolens , helichrysum plicatum ssp . plicatum , juniperus oxycedrus ssp . oxycedrus , juniperus communis var .", "follow_up_question": "What specific plants were included in the ethnopharmacological field surveys mentioned?", "follow_up_response": "gentiana olivieri\", \"helichrysum graveolens\", \"helichrysum plicatum ssp. plicatum\", \"juniperus oxycedrus ssp. oxycedrus\", \"juniperus communis var.", "follow_up_response_bt": "gentiana olivieri, helichrysum graveolens, helichrysum plicatum ssp. plicatum, juniperus oxycedrus ssp. oxycedrus, juniperus communis var."}, {"question_id": "82.5", "question": "Which type of juniper is specifically referred to in the text?", "answer_src": "Juniperus oxycedrus ssp. oxycedrus", "follow_up_question": "What other plant species besides gentiana olivieri are mentioned in the text?", "follow_up_response": "helichrysum graveolens\", \"helichrysum plicatum ssp. plicatum\", \"juniperus oxycedrus ssp. oxycedrus\", \"juniperus communis var.", "follow_up_response_bt": "helichrysum graveolens\", \"helichrysum plicatum ssp. plicatum\", \"juniperus oxycedrus ssp. oxycedrus\", \"juniperus communis var."}], "turn_2": [{"question_id": "82.6", "question": "What other genus is mentioned in the list?", "answer_src": "Juniperus oxycedrus ssp. oxycedrus\", \"Juniperus communis var.", "follow_up_question": "What specific species within the Juniperus genus are mentioned?", "follow_up_response": "Juniperus oxycedrus ssp. oxycedrus\", \"Juniperus communis var.", "follow_up_response_bt": "Juniperus oxycedrus ssp. oxycedrus\", \"Juniperus communis var."}, {"question_id": "82.7", "question": "What specific genus of plant is mentioned first in the list?", "answer_src": "gentiana", "follow_up_question": "What species within the Gentiana genus is mentioned first?", "follow_up_response": "Gentiana olivieri", "follow_up_response_bt": "gentiana olivieri"}, {"question_id": "82.8", "question": "What other plant species besides gentiana olivieri are mentioned in the text?", "answer_src": "helichrysum graveolens\", \"helichrysum plicatum ssp. plicatum\", \"juniperus oxycedrus ssp. oxycedrus\", \"juniperus communis var.", "follow_up_question": "What is the specific subspecies designation for juniperus oxycedrus ssp. oxycedrus?", "follow_up_response": "oxycedrus", "follow_up_response_bt": "oxycedrus"}, {"question_id": "82.9", "question": "What specific plants were included in the ethnopharmacological field surveys mentioned?", "answer_src": "gentiana olivieri\", \"helichrysum graveolens\", \"helichrysum plicatum ssp. plicatum\", \"juniperus oxycedrus ssp. oxycedrus\", \"juniperus communis var.", "follow_up_question": "What is the commonality among the plants listed in the ethnopharmacological field surveys?", "follow_up_response": "Many plants", "follow_up_response_bt": "significant antibacterial properties"}, {"question_id": "82.10", "question": "What other plant species besides gentiana olivieri are mentioned in the text?", "answer_src": "helichrysum graveolens\", \"helichrysum plicatum ssp. plicatum\", \"juniperus oxycedrus ssp. oxycedrus\", \"juniperus communis var.", "follow_up_question": "What is the specific subspecies designation for juniperus oxycedrus ssp. oxycedrus?", "follow_up_response": "oxycedrus", "follow_up_response_bt": "oxycedrus"}], "turn_3": [{"question_id": "82.11", "question": "What specific species within the Juniperus genus are mentioned?", "answer_src": "Juniperus oxycedrus ssp. oxycedrus\", \"Juniperus communis var.", "follow_up_question": "What is the difference between Juniperus oxycedrus ssp. oxycedrus and Juniperus communis var.?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "82.12", "question": "What species within the Gentiana genus is mentioned first?", "answer_src": "Gentiana olivieri", "follow_up_question": "What other plant species besides Gentiana olivieri are listed?", "follow_up_response": "helichrysum graveolens\", \"helichrysum plicatum ssp. plicatum\", \"juniperus oxycedrus ssp. oxycedrus\", \"juniperus communis var.", "follow_up_response_bt": "helichrysum graveolens\", \"helichrysum plicatum ssp. plicatum\", \"juniperus oxycedrus ssp. oxycedrus\", \"juniperus communis var."}, {"question_id": "82.13", "question": "What is the specific subspecies designation for juniperus oxycedrus ssp. oxycedrus?", "answer_src": "oxycedrus", "follow_up_question": "What other plant species were identified in the ethnopharmacological field surveys?", "follow_up_response": "gentiana olivieri\", \"helichrysum graveolens\", \"helichrysum plicatum ssp. plicatum\", \"juniperus oxycedrus ssp. oxycedrus\", \"juniperus communis var.", "follow_up_response_bt": "gentiana olivieri, helichrysum graveolens, helichrysum plicatum ssp. plicatum, juniperus oxycedrus ssp. oxycedrus, juniperus communis var."}, {"question_id": "82.14", "question": "What is the commonality among the plants listed in the ethnopharmacological field surveys?", "answer_src": "Many plants", "follow_up_question": "What other plant genus is mentioned besides Juniperus?", "follow_up_response": "gentiana\", \"helichrysum\", \"plicatum\", \"oxycedrus\", \"communis", "follow_up_response_bt": "gentiana olivieri\", \"helichrysum graveolens\", \"helichrysum plicatum ssp. plicatum"}, {"question_id": "82.15", "question": "What is the specific subspecies designation for juniperus oxycedrus ssp. oxycedrus?", "answer_src": "oxycedrus", "follow_up_question": "What other plant species were identified in the ethnopharmacological field surveys?", "follow_up_response": "gentiana olivieri\", \"helichrysum graveolens\", \"helichrysum plicatum ssp. plicatum\", \"juniperus oxycedrus ssp. oxycedrus\", \"juniperus communis var.", "follow_up_response_bt": "gentiana olivieri, helichrysum graveolens, helichrysum plicatum ssp. plicatum, juniperus oxycedrus ssp. oxycedrus, juniperus communis var."}]}}
{"id": 83, "src": "neuroendocrine tumor metastases to the liver can mimic primary hepatocellular carcinoma ( hcc ) on imaging , cytology , and core biopsy . we present a case study along with the literature review of a patient who presented as a solitary liver mass mimicking hcc and subsequently underwent a partial hepatectomy . the histopathology and immunohistochemisrty of the resected specimen revealed metastatic neuroendocrine carcinoma .", "mt": "Le metastasi di tumori neuroendocrini nel fegato possono imitare il carcinoma epatocellulare primario (hcc) su imaging , citologia e biopsia del nucleo . Vi presentiamo un caso di studio insieme alla revisione della letteratura di un paziente che si è presentato come un solitario massa epatica imitando l'hcc e successivamente sottoposto ad una parte di hepatectomia .", "pert_mt": "Le metastasi di tumori neuroendocrini nel fegato possono imitare il carcinoma epatocellulare primario (hcc) su imaging, citologia e biopsia del nucleo. Vi presentiamo un caso di studio insieme alla revisione della letteratura di un paziente che si è presentato come un solitario massa epatica imitando l'hcc e successivamente sottoposto ad una parte di hepatectomia e ha mostrato sintomi gastrointestinali.", "bt": "Metastases of neuroendocrine tumors in the liver can mimic primary hepatocellular carcinoma (hcc) in imaging, cytology and nucleus biopsy.We present a case study together with a review of the literature of a patient who was presented as a solitary liver mass mimicking hcc and subsequently subjected to a portion of hepatectomy and showed gastrointestinal symptoms.", "questions_src": ["What type of tumor was initially suspected in the patient's liver mass?", "When did the patient undergo the partial hepatectomy?", "Where was the metastatic neuroendocrine carcinoma initially detected?", "Which imaging or biopsy method was used to initially suspect the liver mass?", "Who performed the histopathology and immunohistochemistry on the resected specimen?"], "answers_src": ["Primary hepatocellular carcinoma (hcc)", "No Answer", "The liver", "Imaging, cytology, and core biopsy", "No Answer"], "answers_bt": ["Metastatic neuroendocrine carcinoma", "No Answer", "In the liver", "Imaging and cytology", "Not specified in the text"], "multiturn": {"turn_1": [{"question_id": "83.1", "question": "What type of tumor was initially suspected in the patient's liver mass?", "answer_src": "Primary hepatocellular carcinoma (hcc)", "follow_up_question": "What evidence supported the initial suspicion of hepatocellular carcinoma?", "follow_up_response": "Imaging, cytology, and core biopsy", "follow_up_response_bt": "Imaging, cytology and nucleus biopsy"}, {"question_id": "83.2", "question": "When did the patient undergo the partial hepatectomy?", "answer_src": "neuroendocrine tumor metastases to the liver can mimic primary hepatocellular carcinoma ( hcc ) on imaging , cytology , and core biopsy . we present a case study along with the literature review of a patient who presented as a solitary liver mass mimicking hcc and subsequently underwent a partial hepatectomy . the histopathology and immunohistochemisrty of the resected specimen revealed metastatic neuroendocrine carcinoma .", "follow_up_question": "What was the histopathology and immunohistochemistry of the resected specimen?", "follow_up_response": "revealed metastatic neuroendocrine carcinoma", "follow_up_response_bt": "No Answer"}, {"question_id": "83.3", "question": "Where was the metastatic neuroendocrine carcinoma initially detected?", "answer_src": "The liver", "follow_up_question": "What were the initial diagnostic tests that suggested the liver mass might be primary hepatocellular carcinoma?", "follow_up_response": "Imaging, cytology, and core biopsy", "follow_up_response_bt": "Imaging, cytology and nucleus biopsy"}, {"question_id": "83.4", "question": "Which imaging or biopsy method was used to initially suspect the liver mass?", "answer_src": "Imaging, cytology, and core biopsy", "follow_up_question": "What type of imaging was primarily used to differentiate between the liver mass and primary HCC?", "follow_up_response": "Imaging", "follow_up_response_bt": "No Answer"}, {"question_id": "83.5", "question": "Who performed the histopathology and immunohistochemistry on the resected specimen?", "answer_src": "neuroendocrine tumor metastases to the liver can mimic primary hepatocellular carcinoma ( hcc ) on imaging , cytology , and core biopsy . we present a case study along with the literature review of a patient who presented as a solitary liver mass mimicking hcc and subsequently underwent a partial hepatectomy . the histopathology and immunohistochemisrty of the resected specimen revealed metastatic neuroendocrine carcinoma .", "follow_up_question": "What did the histopathology and immunohistochemistry reveal about the resected specimen?", "follow_up_response": "Metastatic neuroendocrine carcinoma", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "83.6", "question": "What evidence supported the initial suspicion of hepatocellular carcinoma?", "answer_src": "Imaging, cytology, and core biopsy", "follow_up_question": "What specific imaging findings were inconsistent with hepatocellular carcinoma?", "follow_up_response": "neuroendocrine tumor metastases", "follow_up_response_bt": "Metastases of neuroendocrine tumors"}, {"question_id": "83.7", "question": "What was the histopathology and immunohistochemistry of the resected specimen?", "answer_src": "revealed metastatic neuroendocrine carcinoma", "follow_up_question": "What were the initial symptoms or diagnostic findings that led to the suspicion of hepatocellular carcinoma?", "follow_up_response": "A solitary liver mass", "follow_up_response_bt": "Gastrointestinal symptoms"}, {"question_id": "83.8", "question": "What were the initial diagnostic tests that suggested the liver mass might be primary hepatocellular carcinoma?", "answer_src": "Imaging, cytology, and core biopsy", "follow_up_question": "What imaging findings were particularly misleading in this case?", "follow_up_response": "Imaging", "follow_up_response_bt": "Metastases of neuroendocrine tumors"}, {"question_id": "83.9", "question": "What type of imaging was primarily used to differentiate between the liver mass and primary HCC?", "answer_src": "Imaging", "follow_up_question": "What specific imaging feature helped differentiate the neuroendocrine carcinoma from primary HCC?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "83.10", "question": "What did the histopathology and immunohistochemistry reveal about the resected specimen?", "answer_src": "Metastatic neuroendocrine carcinoma", "follow_up_question": "What were the initial symptoms or clinical presentation that led to the suspicion of hepatocellular carcinoma?", "follow_up_response": "A solitary liver mass", "follow_up_response_bt": "Gastrointestinal symptoms"}], "turn_3": [{"question_id": "83.11", "question": "What specific imaging findings were inconsistent with hepatocellular carcinoma?", "answer_src": "neuroendocrine tumor metastases", "follow_up_question": "What were the results of the core biopsy?", "follow_up_response": "metastatic neuroendocrine carcinoma", "follow_up_response_bt": "No Answer"}, {"question_id": "83.12", "question": "What were the initial symptoms or diagnostic findings that led to the suspicion of hepatocellular carcinoma?", "answer_src": "A solitary liver mass", "follow_up_question": "What was the final diagnosis after histopathology and immunohistochemistry?", "follow_up_response": "Metastatic neuroendocrine carcinoma", "follow_up_response_bt": "No Answer"}, {"question_id": "83.13", "question": "What imaging findings were particularly misleading in this case?", "answer_src": "Imaging", "follow_up_question": "What type of imaging was most likely misinterpreted as hepatocellular carcinoma?", "follow_up_response": "neuroendocrine tumor metastases", "follow_up_response_bt": "Metastases of neuroendocrine tumors"}, {"question_id": "83.14", "question": "What specific imaging feature helped differentiate the neuroendocrine carcinoma from primary HCC?", "answer_src": "neuroendocrine tumor metastases to the liver can mimic primary hepatocellular carcinoma ( hcc ) on imaging , cytology , and core biopsy . we present a case study along with the literature review of a patient who presented as a solitary liver mass mimicking hcc and subsequently underwent a partial hepatectomy . the histopathology and immunohistochemisrty of the resected specimen revealed metastatic neuroendocrine carcinoma .", "follow_up_question": "How did the immunohistochemistry results contribute to the diagnosis?", "follow_up_response": "Metastatic neuroendocrine carcinoma", "follow_up_response_bt": "No Answer"}, {"question_id": "83.15", "question": "What were the initial symptoms or clinical presentation that led to the suspicion of hepatocellular carcinoma?", "answer_src": "A solitary liver mass", "follow_up_question": "What diagnostic test initially suggested the possibility of neuroendocrine carcinoma rather than hepatocellular carcinoma?", "follow_up_response": "Imaging, cytology, and core biopsy", "follow_up_response_bt": "Imaging, cytology and nucleus biopsy"}]}}
{"id": 84, "src": "hypophosphatasia is a congenital disease characterized by deficiency of serum and tissue non - specific alkaline phosphatase activity . the disease occurs due to mutations in the liver / bone / kidney alkaline phosphatase gene . six clinical forms of hypophosphatasia are recognized .", "mt": "L'ipofosfatasia è una malattia congenita caratterizzata da carenza di attività alcalina di fosfatasi alcelica non specifica del siero e dei tessuti . La malattia si verifica a causa di mutazioni nel gene alcalino fosfatasi epatico / osseo / renale . Sono riconosciute sei forme cliniche di ipofosfatasia .", "pert_mt": "L'ipofosfatasia è una malattia congenita caratterizzata da carenza di attività alcalina di fosfatasi alcelica non specifica del siero e dei tessiti. La malattia si verifica a causa di mutazioni nel gene alcalino fosfatasi epatico / osseo / renale. Sono riconosciute sei forme cliniche di ipofosfatasia e queste influenzano significativamente lo sviluppo osseo.", "bt": "Hypophosphatosis is a congenital disease characterized by a lack of alkaline activity of non-specific alcelic phosphatase of the liver and tissues.The disease occurs due to mutations in the hepatic/osseo/renal alkaline phosphatase gene.Six clinical forms of hypophosphatosis are recognized and these significantly influence bone development.", "questions_src": ["What is hypophosphatasia?", "Where can mutations in hypophosphatasia occur?", "Which gene is associated with mutations causing hypophosphatasia?", "When does hypophosphatasia typically develop?", "Which clinical forms of hypophosphatasia are recognized?"], "answers_src": ["[\"hypophosphatasia is a congenital disease characterized by deficiency of serum and tissue non-specific alkaline phosphatase activity\"], [\"the liver/bone/kidney alkaline phosphatase gene\"], [\"the liver/bone/kidney alkaline phosphatase gene\"], [\"hypophosphatasia typically develops congenitally\"], [\"six clinical forms of hypophosphatasia\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["Hypophosphatasia is a congenital disease characterized by a lack of alkaline activity of non-specific alcelic phosphatase of the liver and tissues.", "In the liver and tissues", "The hepatic/osseo/renal alkaline phosphatase gene", "Typically develops congenitally", "Six clinical forms"], "multiturn": {"turn_1": [{"question_id": "84.1", "question": "What is hypophosphatasia?", "answer_src": "[\"hypophosphatasia is a congenital disease characterized by deficiency of serum and tissue non-specific alkaline phosphatase activity\"], [\"the liver/bone/kidney alkaline phosphatase gene\"], [\"the liver/bone/kidney alkaline phosphatase gene\"], [\"hypophosphatasia typically develops congenitally\"], [\"six clinical forms of hypophosphatasia\"]", "follow_up_question": "What are the six clinical forms of hypophosphatasia?", "follow_up_response": "No Answer", "follow_up_response_bt": "Six clinical forms"}, {"question_id": "84.2", "question": "Where can mutations in hypophosphatasia occur?", "answer_src": "hypophosphatasia is a congenital disease characterized by deficiency of serum and tissue non - specific alkaline phosphatase activity . the disease occurs due to mutations in the liver / bone / kidney alkaline phosphatase gene . six clinical forms of hypophosphatasia are recognized .", "follow_up_question": "What are the three specific locations where mutations in the liver / bone / kidney alkaline phosphatase gene can occur?", "follow_up_response": "Liver\", \"Bone\", \"Kidney", "follow_up_response_bt": "The liver, bone, and kidney"}, {"question_id": "84.3", "question": "Which gene is associated with mutations causing hypophosphatasia?", "answer_src": "hypophosphatasia is a congenital disease characterized by deficiency of serum and tissue non - specific alkaline phosphatase activity . the disease occurs due to mutations in the liver / bone / kidney alkaline phosphatase gene . six clinical forms of hypophosphatasia are recognized .", "follow_up_question": "What are the six clinical forms of hypophosphatasia?", "follow_up_response": "No Answer", "follow_up_response_bt": "Six clinical forms"}, {"question_id": "84.4", "question": "When does hypophosphatasia typically develop?", "answer_src": "hypophosphatasia is a congenital disease characterized by deficiency of serum and tissue non - specific alkaline phosphatase activity . the disease occurs due to mutations in the liver / bone / kidney alkaline phosphatase gene . six clinical forms of hypophosphatasia are recognized .", "follow_up_question": "What are the causes of hypophosphatasia?", "follow_up_response": "Mutations in the liver / bone / kidney alkaline phosphatase gene", "follow_up_response_bt": "Mutations in the hepatic/osseo/renal alkaline phosphatase gene"}, {"question_id": "84.5", "question": "Which clinical forms of hypophosphatasia are recognized?", "answer_src": "hypophosphatasia is a congenital disease characterized by deficiency of serum and tissue non - specific alkaline phosphatase activity . the disease occurs due to mutations in the liver / bone / kidney alkaline phosphatase gene . six clinical forms of hypophosphatasia are recognized .", "follow_up_question": "What are the six clinical forms of hypophosphatasia?", "follow_up_response": "No Answer", "follow_up_response_bt": "Six clinical forms"}], "turn_2": [{"question_id": "84.6", "question": "What are the six clinical forms of hypophosphatasia?", "answer_src": "hypophosphatasia is a congenital disease characterized by deficiency of serum and tissue non - specific alkaline phosphatase activity . the disease occurs due to mutations in the liver / bone / kidney alkaline phosphatase gene . six clinical forms of hypophosphatasia are recognized .", "follow_up_question": "What are the six recognized clinical forms of hypophosphatasia?", "follow_up_response": "No Answer", "follow_up_response_bt": "Six clinical forms"}, {"question_id": "84.7", "question": "What are the three specific locations where mutations in the liver / bone / kidney alkaline phosphatase gene can occur?", "answer_src": "Liver\", \"Bone\", \"Kidney", "follow_up_question": "What are the six recognized clinical forms of hypophosphatasia?", "follow_up_response": "No Answer", "follow_up_response_bt": "Six clinical forms"}, {"question_id": "84.8", "question": "What are the six clinical forms of hypophosphatasia?", "answer_src": "hypophosphatasia is a congenital disease characterized by deficiency of serum and tissue non - specific alkaline phosphatase activity . the disease occurs due to mutations in the liver / bone / kidney alkaline phosphatase gene . six clinical forms of hypophosphatasia are recognized .", "follow_up_question": "What are the six recognized clinical forms of hypophosphatasia?", "follow_up_response": "No Answer", "follow_up_response_bt": "Six clinical forms"}, {"question_id": "84.9", "question": "What are the causes of hypophosphatasia?", "answer_src": "Mutations in the liver / bone / kidney alkaline phosphatase gene", "follow_up_question": "How many clinical forms of hypophosphatasia are recognized?", "follow_up_response": "six", "follow_up_response_bt": "Six"}, {"question_id": "84.10", "question": "What are the six clinical forms of hypophosphatasia?", "answer_src": "hypophosphatasia is a congenital disease characterized by deficiency of serum and tissue non - specific alkaline phosphatase activity . the disease occurs due to mutations in the liver / bone / kidney alkaline phosphatase gene . six clinical forms of hypophosphatasia are recognized .", "follow_up_question": "What are the six recognized clinical forms of hypophosphatasia?", "follow_up_response": "No Answer", "follow_up_response_bt": "Six clinical forms"}], "turn_3": [{"question_id": "84.11", "question": "What are the six recognized clinical forms of hypophosphatasia?", "answer_src": "hypophosphatasia is a congenital disease characterized by deficiency of serum and tissue non - specific alkaline phosphatase activity . the disease occurs due to mutations in the liver / bone / kidney alkaline phosphatase gene . six clinical forms of hypophosphatasia are recognized .", "follow_up_question": "What are the six recognized clinical forms of hypophosphatasia?", "follow_up_response": "No Answer", "follow_up_response_bt": "Six clinical forms"}, {"question_id": "84.12", "question": "What are the six recognized clinical forms of hypophosphatasia?", "answer_src": "hypophosphatasia is a congenital disease characterized by deficiency of serum and tissue non - specific alkaline phosphatase activity . the disease occurs due to mutations in the liver / bone / kidney alkaline phosphatase gene . six clinical forms of hypophosphatasia are recognized .", "follow_up_question": "What are the six recognized clinical forms of hypophosphatasia?", "follow_up_response": "No Answer", "follow_up_response_bt": "Six clinical forms"}, {"question_id": "84.13", "question": "What are the six recognized clinical forms of hypophosphatasia?", "answer_src": "hypophosphatasia is a congenital disease characterized by deficiency of serum and tissue non - specific alkaline phosphatase activity . the disease occurs due to mutations in the liver / bone / kidney alkaline phosphatase gene . six clinical forms of hypophosphatasia are recognized .", "follow_up_question": "What are the six recognized clinical forms of hypophosphatasia?", "follow_up_response": "No Answer", "follow_up_response_bt": "Six clinical forms"}, {"question_id": "84.14", "question": "How many clinical forms of hypophosphatasia are recognized?", "answer_src": "six", "follow_up_question": "What are the clinical forms of hypophosphatasia recognized?", "follow_up_response": "Six clinical forms", "follow_up_response_bt": "Six clinical forms"}, {"question_id": "84.15", "question": "What are the six recognized clinical forms of hypophosphatasia?", "answer_src": "hypophosphatasia is a congenital disease characterized by deficiency of serum and tissue non - specific alkaline phosphatase activity . the disease occurs due to mutations in the liver / bone / kidney alkaline phosphatase gene . six clinical forms of hypophosphatasia are recognized .", "follow_up_question": "What are the six recognized clinical forms of hypophosphatasia?", "follow_up_response": "No Answer", "follow_up_response_bt": "Six clinical forms"}]}}
{"id": 85, "src": "misclassification of bmi categories was assessed by weighted cohen s kappa and bland altman plot.resultson average , the two measurements were taken 8 months apart , and self - reported weight increased by 0.6 kg ( p<0.05 ) , and bmi by 0.2 kg / m2 ( p<0.05 ) . the distribution of bmi categories did not differ between self - reported and measured values . there was substantial agreement between self - reported values and those measured by medical staff ( weighted kappa 0.73 ) .", "mt": "La classificazione erronea delle categorie bmi è stata valutata con il peso ponderato di cohen s kappa e del plot altman bland.resultson average , le due misurazioni sono state prese a 8 mesi di distanza , e il peso auto-rilevato è aumentato di 0,6 kg (p<0,05) e il peso auto-rilevato di 0,2 kg / m2 (p<0,05) . La distribuzione delle categorie bmi non differì tra i valori auto-rilevati e misurati .", "pert_mt": "La classificazione erronea delle categorie bmi è stata valutata con il peso ponderato di cohen s kappa e del plot altman bland. Risultati, in media, le due misurazioni sono state prese a 8 mesi di distanza, e il peso auto-rilevato è aumentato di 0,6 kg (p<0,05) e il peso auto-rilevato di 0,2 kg / m2 (p<0,05). La distribuzione delle categorie bmi non differì tra i valori auto-rilevati e misurati.", "bt": "The wrong classification of the bmi categories was assessed using the weighted weight of the cohen s kappa and the plot altman bland.The results, on average, were taken eight months apart, and the self-relevant weight increased by 0.6 kg (p<0.05) and the self-relevant weight by 0.2 kg/m2 (p<0.05).", "questions_src": ["What was the average time interval between the two measurements?", "Who reported the increase in weight and BMI?", "Where was the agreement between self-reported values and medical staff measurements based on?", "When was the misclassification of BMI categories assessed?", "Which statistical measure was used to assess the agreement between self-reported and measured values?"], "answers_src": ["[\"8 months\", \"Self - reported\", \"Medical staff\", \"Weight and BMI\", \"Cohen\"s kappa\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"Eight months\", \"Self-relevant\", \"Cohen\"s kappa and plot altman bland\", \"Not explicitly mentioned\", \"Cohen\"s kappa and plot altman bland\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "85.1", "question": "What was the average time interval between the two measurements?", "answer_src": "[\"8 months\", \"Self - reported\", \"Medical staff\", \"Weight and BMI\", \"Cohen\"s kappa\"]", "follow_up_question": "What was the significance of the substantial agreement between self-reported values and those measured by medical staff according to the weighted kappa value?", "follow_up_response": "The substantial agreement between self-reported values and those measured by medical staff had a weighted kappa value of 0.73, which indicates substantial agreement.", "follow_up_response_bt": "No Answer"}, {"question_id": "85.2", "question": "Who reported the increase in weight and BMI?", "answer_src": "misclassification of bmi categories was assessed by weighted cohen s kappa and bland altman plot.resultson average , the two measurements were taken 8 months apart , and self - reported weight increased by 0.6 kg ( p<0.05 ) , and bmi by 0.2 kg / m2 ( p<0.05 ) . the distribution of bmi categories did not differ between self - reported and measured values . there was substantial agreement between self - reported values and those measured by medical staff ( weighted kappa 0.73 ) .", "follow_up_question": "How much did the self-reported weight increase?", "follow_up_response": "0.6 kg", "follow_up_response_bt": "0.6 kg"}, {"question_id": "85.3", "question": "Where was the agreement between self-reported values and medical staff measurements based on?", "answer_src": "misclassification of bmi categories was assessed by weighted cohen s kappa and bland altman plot.resultson average , the two measurements were taken 8 months apart , and self - reported weight increased by 0.6 kg ( p<0.05 ) , and bmi by 0.2 kg / m2 ( p<0.05 ) . the distribution of bmi categories did not differ between self - reported and measured values . there was substantial agreement between self - reported values and those measured by medical staff ( weighted kappa 0.73 ) .", "follow_up_question": "What was the value of the weighted kappa for the agreement between self-reported values and those measured by medical staff?", "follow_up_response": "0.73", "follow_up_response_bt": "No Answer"}, {"question_id": "85.4", "question": "When was the misclassification of BMI categories assessed?", "answer_src": "misclassification of bmi categories was assessed by weighted cohen s kappa and bland altman plot.resultson average , the two measurements were taken 8 months apart , and self - reported weight increased by 0.6 kg ( p<0.05 ) , and bmi by 0.2 kg / m2 ( p<0.05 ) . the distribution of bmi categories did not differ between self - reported and measured values . there was substantial agreement between self - reported values and those measured by medical staff ( weighted kappa 0.73 ) .", "follow_up_question": "What was the average difference in BMI between self-reported and measured values?", "follow_up_response": "0.2 kg / m2", "follow_up_response_bt": "0.4 kg/m2"}, {"question_id": "85.5", "question": "Which statistical measure was used to assess the agreement between self-reported and measured values?", "answer_src": "misclassification of bmi categories was assessed by weighted cohen s kappa and bland altman plot.resultson average , the two measurements were taken 8 months apart , and self - reported weight increased by 0.6 kg ( p<0.05 ) , and bmi by 0.2 kg / m2 ( p<0.05 ) . the distribution of bmi categories did not differ between self - reported and measured values . there was substantial agreement between self - reported values and those measured by medical staff ( weighted kappa 0.73 ) .", "follow_up_question": "What was the value of the weighted kappa for the agreement between self-reported and measured values?", "follow_up_response": "0.73", "follow_up_response_bt": "0.6 kg (p<0.05) and the self-relevant weight by 0.2 kg/m2 (p<0.05)"}], "turn_2": [{"question_id": "85.6", "question": "What was the significance of the substantial agreement between self-reported values and those measured by medical staff according to the weighted kappa value?", "answer_src": "The substantial agreement between self-reported values and those measured by medical staff had a weighted kappa value of 0.73, which indicates substantial agreement.", "follow_up_question": "How many BMI categories did the study find did not differ between self-reported and measured values?", "follow_up_response": "1", "follow_up_response_bt": "No Answer"}, {"question_id": "85.7", "question": "How much did the self-reported weight increase?", "answer_src": "0.6 kg", "follow_up_question": "By how much did the self-reported BMI increase?", "follow_up_response": "0.2 kg / m2", "follow_up_response_bt": "0.6 kg"}, {"question_id": "85.8", "question": "What was the value of the weighted kappa for the agreement between self-reported values and those measured by medical staff?", "answer_src": "0.73", "follow_up_question": "What was the average difference in BMI between self-reported and measured values?", "follow_up_response": "0.2 kg / m2", "follow_up_response_bt": "0.4 kg/m2"}, {"question_id": "85.9", "question": "What was the average difference in BMI between self-reported and measured values?", "answer_src": "0.2 kg / m2", "follow_up_question": "What was the average difference in self-reported weight between the two measurements?", "follow_up_response": "0.6 kg", "follow_up_response_bt": "0.8 kg"}, {"question_id": "85.10", "question": "What was the value of the weighted kappa for the agreement between self-reported and measured values?", "answer_src": "0.73", "follow_up_question": "What was the average difference in BMI between self-reported and measured values?", "follow_up_response": "0.2 kg / m2", "follow_up_response_bt": "0.4 kg/m2"}], "turn_3": [{"question_id": "85.11", "question": "How many BMI categories did the study find did not differ between self-reported and measured values?", "answer_src": "1", "follow_up_question": "What was the average difference in BMI between self-reported and measured values?", "follow_up_response": "0.2 kg / m2", "follow_up_response_bt": "0.4 kg/m2"}, {"question_id": "85.12", "question": "By how much did the self-reported BMI increase?", "answer_src": "0.2 kg / m2", "follow_up_question": "By what percentage did the self-reported weight increase?", "follow_up_response": "6%", "follow_up_response_bt": "6%"}, {"question_id": "85.13", "question": "What was the average difference in BMI between self-reported and measured values?", "answer_src": "0.2 kg / m2", "follow_up_question": "What was the average difference in self-reported weight between the two measurements?", "follow_up_response": "0.6 kg", "follow_up_response_bt": "0.8 kg"}, {"question_id": "85.14", "question": "What was the average difference in self-reported weight between the two measurements?", "answer_src": "0.6 kg", "follow_up_question": "What was the average difference in self-reported BMI between the two measurements?", "follow_up_response": "0.2 kg / m2", "follow_up_response_bt": "0.8 kg"}, {"question_id": "85.15", "question": "What was the average difference in BMI between self-reported and measured values?", "answer_src": "0.2 kg / m2", "follow_up_question": "What was the average difference in self-reported weight between the two measurements?", "follow_up_response": "0.6 kg", "follow_up_response_bt": "0.8 kg"}]}}
{"id": 86, "src": "an attempt has been made to review the bioavailability complications and clinical therapeutics of poorly water soluble drug : cinnarizine . the interest of writing this paper is to summarize the pharmacokinetic limitations of drug with special focus on strategies to improvise bioavailability along with effectiveness of novel dosage forms to circumvent the obstacle . the paper provides insight to the approaches to overcome low and erratic bioavailability of cinnarizine by cyclodextrin complexes and novel dosage forms : self - nanoemulsifying systems and buoyant microparticulates .", "mt": "Si è tentato di rivedere le complicazioni di biodisponibilità e le terapie cliniche della droga scarsamente solubile in acqua: la cinnarizina . l'interesse di scrivere questo articolo è quello di riassumere le limitazioni farmacocinetiche della droga con particolare attenzione alle strategie per migliorare la biodisponibilità insieme all'efficacia di nuove forme di dosaggio per eludere l'ostacolo . Il documento fornisce informazioni sui metodi per superare la bassa e errata biodisponibilità della cinnarizina da complessi ciclodestrinosi e nuove forme di dosaggio: sistemi auto-nanoemulsificanti e microparticulati galleggianti .", "pert_mt": "Si è tentato di rivedere le complicazioni di biodisponibilità e le terapie cliniche della droga scarsamente solubile in acqua: la cinnarizina. L'interesse di scrivere questo articolo è quello di riassumere le limitazioni farmacocinetiche della droga con particolare attenzione alle strategie per migliorare la biodisponibilità insieme all'efficacia di nuove forme di dosaggio per eludere l'ostacolo e ridurre i costi dei trattamenti. Il documento fornisce informazioni sui metodi per superare la bassa e errata biodisponibilità della cinnarizina da complessi ciclodestrinosi e nuove forme di dosaggio: sistemi auto-nanoemulsificanti e microparticulati galleggianti.", "bt": "The purpose of this article is to summarize the pharmacokinetic limitations of the drug, with particular attention to strategies to improve bioavailability along with the effectiveness of new dosage forms to bypass the obstacle and reduce treatment costs.The paper provides information on methods to overcome the low and incorrect bioavailability of cinnarizine and cyclodestrinosis and new dosage forms: auto-nanoemulsific systems and floating microparticles.", "questions_src": ["What is the name of the drug reviewed in the paper?", "When was the attempt made to review the bioavailability complications?", "Who is the target audience for the insights provided in the paper?", "Where can one find information about cyclodextrin complexes used to improve bioavailability?", "Which novel dosage form is discussed in the paper to enhance the bioavailability of cinnarizine?"], "answers_src": ["Cinnarizine", "an attempt has been made", "researchers and pharmaceutical scientists", "cyclodextrin complexes", "self-nanoemulsifying systems"], "answers_bt": ["cinnarizine", "No Answer", "researchers and clinicians", "cyclodestrinosis", "auto-nanoemulsific systems"], "multiturn": {"turn_1": [{"question_id": "86.1", "question": "What is the name of the drug reviewed in the paper?", "answer_src": "Cinnarizine", "follow_up_question": "What strategies does the paper suggest to improve the bioavailability of cinnarizine?", "follow_up_response": "cyclodextrin complexes and novel dosage forms", "follow_up_response_bt": "strategies to improve bioavailability"}, {"question_id": "86.2", "question": "When was the attempt made to review the bioavailability complications?", "answer_src": "an attempt has been made", "follow_up_question": "What strategies does the paper suggest to improve the bioavailability of cinnarizine?", "follow_up_response": "cyclodextrin complexes and novel dosage forms", "follow_up_response_bt": "strategies to improve bioavailability"}, {"question_id": "86.3", "question": "Who is the target audience for the insights provided in the paper?", "answer_src": "researchers and pharmaceutical scientists", "follow_up_question": "What specific pharmacokinetic limitations does the paper highlight for cinnarizine?", "follow_up_response": "Pharmacokinetic limitations", "follow_up_response_bt": "low and incorrect bioavailability"}, {"question_id": "86.4", "question": "Where can one find information about cyclodextrin complexes used to improve bioavailability?", "answer_src": "cyclodextrin complexes", "follow_up_question": "What are some examples of novel dosage forms discussed in the paper?", "follow_up_response": "Self-nanoemulsifying systems and buoyant microparticulates", "follow_up_response_bt": "auto-nanoemulsific systems and floating microparticles"}, {"question_id": "86.5", "question": "Which novel dosage form is discussed in the paper to enhance the bioavailability of cinnarizine?", "answer_src": "self-nanoemulsifying systems", "follow_up_question": "What are the other strategies mentioned in the paper to improve the bioavailability of cinnarizine?", "follow_up_response": "cyclodextrin complexes and novel dosage forms : self-nanoemulsifying systems and buoyant microparticulates", "follow_up_response_bt": "auto-nanoemulsific systems and floating microparticles"}], "turn_2": [{"question_id": "86.6", "question": "What strategies does the paper suggest to improve the bioavailability of cinnarizine?", "answer_src": "cyclodextrin complexes and novel dosage forms", "follow_up_question": "What are some examples of novel dosage forms discussed in the paper?", "follow_up_response": "Self-nanoemulsifying systems and buoyant microparticulates", "follow_up_response_bt": "auto-nanoemulsific systems and floating microparticles"}, {"question_id": "86.7", "question": "What strategies does the paper suggest to improve the bioavailability of cinnarizine?", "answer_src": "cyclodextrin complexes and novel dosage forms", "follow_up_question": "What are some examples of novel dosage forms discussed in the paper?", "follow_up_response": "Self-nanoemulsifying systems and buoyant microparticulates", "follow_up_response_bt": "auto-nanoemulsific systems and floating microparticles"}, {"question_id": "86.8", "question": "What specific pharmacokinetic limitations does the paper highlight for cinnarizine?", "answer_src": "Pharmacokinetic limitations", "follow_up_question": "What strategies does the paper suggest to improve the bioavailability of cinnarizine?", "follow_up_response": "cyclodextrin complexes and novel dosage forms", "follow_up_response_bt": "strategies to improve bioavailability"}, {"question_id": "86.9", "question": "What are some examples of novel dosage forms discussed in the paper?", "answer_src": "Self-nanoemulsifying systems and buoyant microparticulates", "follow_up_question": "What is the main pharmacokinetic limitation addressed in the paper regarding cinnarizine?", "follow_up_response": "Pharmacokinetic limitations", "follow_up_response_bt": "Low and incorrect bioavailability"}, {"question_id": "86.10", "question": "What are the other strategies mentioned in the paper to improve the bioavailability of cinnarizine?", "answer_src": "cyclodextrin complexes and novel dosage forms : self-nanoemulsifying systems and buoyant microparticulates", "follow_up_question": "What are some examples of novel dosage forms discussed in the paper?", "follow_up_response": "Self-nanoemulsifying systems and buoyant microparticulates", "follow_up_response_bt": "auto-nanoemulsific systems and floating microparticles"}], "turn_3": [{"question_id": "86.11", "question": "What are some examples of novel dosage forms discussed in the paper?", "answer_src": "Self-nanoemulsifying systems and buoyant microparticulates", "follow_up_question": "What is the main pharmacokinetic limitation addressed in the paper regarding cinnarizine?", "follow_up_response": "Pharmacokinetic limitations", "follow_up_response_bt": "Low and incorrect bioavailability"}, {"question_id": "86.12", "question": "What are some examples of novel dosage forms discussed in the paper?", "answer_src": "Self-nanoemulsifying systems and buoyant microparticulates", "follow_up_question": "What is the main pharmacokinetic limitation addressed in the paper regarding cinnarizine?", "follow_up_response": "Pharmacokinetic limitations", "follow_up_response_bt": "Low and incorrect bioavailability"}, {"question_id": "86.13", "question": "What strategies does the paper suggest to improve the bioavailability of cinnarizine?", "answer_src": "cyclodextrin complexes and novel dosage forms", "follow_up_question": "What are some examples of novel dosage forms discussed in the paper?", "follow_up_response": "Self-nanoemulsifying systems and buoyant microparticulates", "follow_up_response_bt": "auto-nanoemulsific systems and floating microparticles"}, {"question_id": "86.14", "question": "What is the main pharmacokinetic limitation addressed in the paper regarding cinnarizine?", "answer_src": "Pharmacokinetic limitations", "follow_up_question": "What strategies does the paper suggest to improve the bioavailability of cinnarizine?", "follow_up_response": "cyclodextrin complexes and novel dosage forms", "follow_up_response_bt": "strategies to improve bioavailability"}, {"question_id": "86.15", "question": "What are some examples of novel dosage forms discussed in the paper?", "answer_src": "Self-nanoemulsifying systems and buoyant microparticulates", "follow_up_question": "What is the main pharmacokinetic limitation addressed in the paper regarding cinnarizine?", "follow_up_response": "Pharmacokinetic limitations", "follow_up_response_bt": "Low and incorrect bioavailability"}]}}
{"id": 87, "src": "there were 18 and 15 cases of disc herniation at l5/s1 and l4/5 levels , respectively . four weeks following the procedure , 13 patients reported improvement in symptoms , and 14 remained symptomatically the same and subsequently had open microdiscectomy.nucleoplasty has been shown to be a safe and minimal - access procedure . less than half of our selected cohort of patients reported symptomatic improvement at 1-month follow - up .", "mt": "Sono stati registrati 18 e 15 casi di ernia a disco ai livelli di l5/s1 e l4/5 rispettivamente . quattro settimane dopo la procedura , 13 pazienti hanno riportato miglioramenti nei sintomi , e 14 sono rimasti sintomaticamente gli stessi e successivamente hanno avuto una microdiscectomy.nucleoplasty aperta è stato dimostrato essere una procedura sicura e minima - accesso . meno della metà della nostra coorte selezionata di pazienti ha riportato miglioramento sintomatico al 1 mese di follow-up .", "pert_mt": "Sono stati registrati 18 e 15 casi di ernia a disco ai livelli di l5/s1 e l4/5 rispettivamente. Quattro settimane dopo la procedura, 13 pazienti hanno riportato miglioramenti nei sintomi, e 14 sono rimasti sintomaticamente gli stessi e successivamente hanno avuto una microdiscectomia. La nucleoplasty aperta è stata dimostrata essere una procedura sicura e minima-accesso. Meno della metà della nostra coorte selezionata di pazienti ha riportato miglioramento sintomatico al 1 mese di follow-up.", "bt": "There were 18 and 15 cases of hernia at the levels of l5/s1 and l4/5 respectively, and four weeks after the procedure, 13 patients reported improvements in symptoms, and 14 were symptomatically left with the same and subsequently had a microdiscectomy.Open nucleoplasty has been shown to be a safe and minimally accessible procedure.Less than half of our selected cohort of patients reported symptomatic improvement at 1 month of follow-up.", "questions_src": ["What level of the spine had 18 cases of disc herniation?", "Who reported improvement in symptoms after the procedure?", "Where was the procedure performed?", "When did the patients report improvement in symptoms?", "Which type of procedure is shown to be safe and minimal-access?"], "answers_src": ["L5/S1 and L4/5 levels", "Four weeks following the procedure, 13 patients", "Not specified in the sentence", "Four weeks following the procedure", "Nucleoplasty"], "answers_bt": ["l5/s1", "13 patients", "Open nucleoplasty", "Four weeks after the procedure", "Open nucleoplasty"], "multiturn": {"turn_1": [{"question_id": "87.1", "question": "What level of the spine had 18 cases of disc herniation?", "answer_src": "L5/S1 and L4/5 levels", "follow_up_question": "How many patients remained symptomatically the same after four weeks?", "follow_up_response": "14", "follow_up_response_bt": "14"}, {"question_id": "87.2", "question": "Who reported improvement in symptoms after the procedure?", "answer_src": "Four weeks following the procedure, 13 patients", "follow_up_question": "How many patients remained symptomatically the same and subsequently had open microdiscectomy?", "follow_up_response": "14", "follow_up_response_bt": "14"}, {"question_id": "87.3", "question": "Where was the procedure performed?", "answer_src": "Not specified in the sentence", "follow_up_question": "What percentage of patients reported symptomatic improvement at 1-month follow-up?", "follow_up_response": "less than 50%", "follow_up_response_bt": "Less than 50%"}, {"question_id": "87.4", "question": "When did the patients report improvement in symptoms?", "answer_src": "Four weeks following the procedure", "follow_up_question": "What was the percentage of patients who reported symptomatic improvement at one-month follow-up?", "follow_up_response": "less than 50%", "follow_up_response_bt": "Less than 50%"}, {"question_id": "87.5", "question": "Which type of procedure is shown to be safe and minimal-access?", "answer_src": "Nucleoplasty", "follow_up_question": "What percentage of the selected cohort reported symptomatic improvement at 1-month follow-up?", "follow_up_response": "less than 50%", "follow_up_response_bt": "Less than 50%"}], "turn_2": [{"question_id": "87.6", "question": "How many patients remained symptomatically the same after four weeks?", "answer_src": "14", "follow_up_question": "How many patients had an open microdiscectomy?", "follow_up_response": "14", "follow_up_response_bt": "14"}, {"question_id": "87.7", "question": "How many patients remained symptomatically the same and subsequently had open microdiscectomy?", "answer_src": "14", "follow_up_question": "How many patients did not report any improvement in symptoms four weeks after the procedure?", "follow_up_response": "1", "follow_up_response_bt": "1"}, {"question_id": "87.8", "question": "What percentage of patients reported symptomatic improvement at 1-month follow-up?", "answer_src": "less than 50%", "follow_up_question": "What was the overall success rate of nucleoplasty as a minimal-access procedure based on the 1-month follow-up results?", "follow_up_response": "less than 50%", "follow_up_response_bt": "Less than 50%"}, {"question_id": "87.9", "question": "What was the percentage of patients who reported symptomatic improvement at one-month follow-up?", "answer_src": "less than 50%", "follow_up_question": "What was the percentage of patients who did not report any symptomatic improvement at one-month follow-up?", "follow_up_response": "50%", "follow_up_response_bt": "Less than 50%"}, {"question_id": "87.10", "question": "What percentage of the selected cohort reported symptomatic improvement at 1-month follow-up?", "answer_src": "less than 50%", "follow_up_question": "What was the overall success rate of nucleoplasty as a minimal-access procedure based on the 1-month follow-up results?", "follow_up_response": "less than 50%", "follow_up_response_bt": "Less than 50%"}], "turn_3": [{"question_id": "87.11", "question": "How many patients had an open microdiscectomy?", "answer_src": "14", "follow_up_question": "How many patients reported improvement in symptoms at four weeks?", "follow_up_response": "13", "follow_up_response_bt": "13"}, {"question_id": "87.12", "question": "How many patients did not report any improvement in symptoms four weeks after the procedure?", "answer_src": "1", "follow_up_question": "How many patients underwent open microdiscectomy?", "follow_up_response": "14", "follow_up_response_bt": "14"}, {"question_id": "87.13", "question": "What was the overall success rate of nucleoplasty as a minimal-access procedure based on the 1-month follow-up results?", "answer_src": "less than 50%", "follow_up_question": "What percentage of patients did not experience any symptomatic improvement at 1-month follow-up?", "follow_up_response": "50%", "follow_up_response_bt": "Less than 50%"}, {"question_id": "87.14", "question": "What was the percentage of patients who did not report any symptomatic improvement at one-month follow-up?", "answer_src": "50%", "follow_up_question": "What was the total number of patients who did not experience symptomatic improvement at one-month follow-up?", "follow_up_response": "5", "follow_up_response_bt": "11"}, {"question_id": "87.15", "question": "What was the overall success rate of nucleoplasty as a minimal-access procedure based on the 1-month follow-up results?", "answer_src": "less than 50%", "follow_up_question": "What percentage of patients did not experience any symptomatic improvement at 1-month follow-up?", "follow_up_response": "50%", "follow_up_response_bt": "Less than 50%"}]}}
{"id": 88, "src": "in the present study , the antioxidant activity of successive leaf extracts of dracaena reflexa was investigated using the scavenging activity on 1,1-diphenyl-2-picrylhydrazyl and reducing power by ferric reducing antioxidant power assay . methanol extract was found potent in both the assays . ic50 values of 1,1-diphenyl-2-picrylhydrazyl assay for methanol extract was 0.97 mg / ml and ferric reducing antioxidant power value for the same is 1.19 .", "mt": "Nel presente studio , l'attività antiossidante di estratti di foglia successive di dracaena reflexa è stata studiata utilizzando l'attività di scavenging su 1,1-diphenyl-2-picrylhydrazyl e riducendo la potenza riducendo il ferro per ridurre il potere di antiossidante . L'estratto di metanolo è stato trovato potente in entrambi gli esami . I valori ic50 di 1,1-diphenyl-2-picrylhydrazyl per l'estratto di metanolo sono stati 0,97 mg / ml e il valore di potenza di antiossidante riducente per lo stesso è 1,19 .", "pert_mt": "Nel presente studio, l'attività antiossidante di estratti di foglia successive di dracaena reflexa è stata studiata utilizzando l'attività di scavenging su 1,1-diphenyl-2-picrylhydrazyl e riducendo la potenza riducendo il ferro per ridurre il potere di antiossidante. Inoltre, l'estratto di acetone è stato trovato potente in entrambi gli esami. I valori ic50 di 1,1-diphenyl-2-picrylhydrazyl per l'estratto di acetone sono stati 0,97 mg/ml e il valore di potenza di antiossidante riducente per lo stesso è 1,19.", "bt": "In the present study, the antioxidant activity of successive dracaena reflex leaf extracts was studied using the scavenging activity of 1,1-diphenyl-2-picrylhydrazyl and reducing potency by reducing iron to reduce antioxidant potency.Moreover, acetone extract was found to be potent in both trials.The ic50 values of 1,1-diphenyl-2-picrylhydrazyl for acetone extract were 0.97 mg/ml and the reducing antioxidant potency value for the same was 1.19.", "questions_src": ["What was the main method used to investigate the antioxidant activity of Dracaena reflexa leaf extracts?", "Who found that the methanol extract was potent in both assays?", "Where was the investigation conducted in the present study?", "When were the IC50 values measured for the 1,1-diphenyl-2-picrylhydrazyl assay?", "Which assay had an IC50 value of 1.19 for the methanol extract?"], "answers_src": ["Scavenging activity on 1,1-diphenyl-2-picrylhydrazyl and reducing power by ferric reducing antioxidant power assay", "Methanol extract", "in the present study", "in the present study", "Ferric reducing antioxidant power"], "answers_bt": ["Scavenging activity of 1,1-diphenyl-2-picrylhydrazyl and reducing potency by reducing iron to reduce antioxidant potency", "No Answer", "The present study", "In the present study", "Reducing antioxidant potency"], "multiturn": {"turn_1": [{"question_id": "88.1", "question": "What was the main method used to investigate the antioxidant activity of Dracaena reflexa leaf extracts?", "answer_src": "Scavenging activity on 1,1-diphenyl-2-picrylhydrazyl and reducing power by ferric reducing antioxidant power assay", "follow_up_question": "What was the IC50 value for the methanol extract in the 1,1-diphenyl-2-picrylhydrazyl assay?", "follow_up_response": "0.97 mg / ml", "follow_up_response_bt": "No Answer"}, {"question_id": "88.2", "question": "Who found that the methanol extract was potent in both assays?", "answer_src": "Methanol extract", "follow_up_question": "What was the IC50 value of the methanol extract in the 1,1-diphenyl-2-picrylhydrazyl assay?", "follow_up_response": "0.97 mg / ml", "follow_up_response_bt": "No Answer"}, {"question_id": "88.3", "question": "Where was the investigation conducted in the present study?", "answer_src": "in the present study", "follow_up_question": "What was the IC50 value for the ferric reducing antioxidant power assay in the methanol extract?", "follow_up_response": "1.19", "follow_up_response_bt": "No Answer"}, {"question_id": "88.4", "question": "When were the IC50 values measured for the 1,1-diphenyl-2-picrylhydrazyl assay?", "answer_src": "in the present study", "follow_up_question": "For which specific extract was the IC50 value of 0.97 mg/ml measured in the 1,1-diphenyl-2-picrylhydrazyl assay?", "follow_up_response": "methanol extract", "follow_up_response_bt": "acetone"}, {"question_id": "88.5", "question": "Which assay had an IC50 value of 1.19 for the methanol extract?", "answer_src": "Ferric reducing antioxidant power", "follow_up_question": "What was the IC50 value for the methanol extract in the 1,1-diphenyl-2-picrylhydrazyl assay?", "follow_up_response": "0.97 mg / ml", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "88.6", "question": "What was the IC50 value for the methanol extract in the 1,1-diphenyl-2-picrylhydrazyl assay?", "answer_src": "0.97 mg / ml", "follow_up_question": "What was the ferric reducing antioxidant power value for the methanol extract?", "follow_up_response": "1.19", "follow_up_response_bt": "No Answer"}, {"question_id": "88.7", "question": "What was the IC50 value of the methanol extract in the 1,1-diphenyl-2-picrylhydrazyl assay?", "answer_src": "0.97 mg / ml", "follow_up_question": "What was the ferric reducing antioxidant power value for the methanol extract?", "follow_up_response": "1.19", "follow_up_response_bt": "No Answer"}, {"question_id": "88.8", "question": "What was the IC50 value for the ferric reducing antioxidant power assay in the methanol extract?", "answer_src": "1.19", "follow_up_question": "What was the IC50 value for the 1,1-diphenyl-2-picrylhydrazyl assay in the methanol extract?", "follow_up_response": "0.97 mg / ml", "follow_up_response_bt": "No Answer"}, {"question_id": "88.9", "question": "For which specific extract was the IC50 value of 0.97 mg/ml measured in the 1,1-diphenyl-2-picrylhydrazyl assay?", "answer_src": "methanol extract", "follow_up_question": "What was the IC50 value for the ferric reducing antioxidant power assay?", "follow_up_response": "1.19", "follow_up_response_bt": "1.19"}, {"question_id": "88.10", "question": "What was the IC50 value for the methanol extract in the 1,1-diphenyl-2-picrylhydrazyl assay?", "answer_src": "0.97 mg / ml", "follow_up_question": "What was the ferric reducing antioxidant power value for the methanol extract?", "follow_up_response": "1.19", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "88.11", "question": "What was the ferric reducing antioxidant power value for the methanol extract?", "answer_src": "1.19", "follow_up_question": "What was the IC50 value for the methanol extract in the 1,1-diphenyl-2-picrylhydrazyl assay?", "follow_up_response": "0.97 mg / ml", "follow_up_response_bt": "No Answer"}, {"question_id": "88.12", "question": "What was the ferric reducing antioxidant power value for the methanol extract?", "answer_src": "1.19", "follow_up_question": "What was the IC50 value for the methanol extract in the 1,1-diphenyl-2-picrylhydrazyl assay?", "follow_up_response": "0.97 mg / ml", "follow_up_response_bt": "No Answer"}, {"question_id": "88.13", "question": "What was the IC50 value for the 1,1-diphenyl-2-picrylhydrazyl assay in the methanol extract?", "answer_src": "0.97 mg / ml", "follow_up_question": "What was the ferric reducing antioxidant power value for the methanol extract?", "follow_up_response": "1.19", "follow_up_response_bt": "No Answer"}, {"question_id": "88.14", "question": "What was the IC50 value for the ferric reducing antioxidant power assay?", "answer_src": "1.19", "follow_up_question": "What was the IC50 value for the 1,1-diphenyl-2-picrylhydrazyl assay?", "follow_up_response": "0.97 mg / ml", "follow_up_response_bt": "0.97 mg/ml"}, {"question_id": "88.15", "question": "What was the ferric reducing antioxidant power value for the methanol extract?", "answer_src": "1.19", "follow_up_question": "What was the IC50 value for the methanol extract in the 1,1-diphenyl-2-picrylhydrazyl assay?", "follow_up_response": "0.97 mg / ml", "follow_up_response_bt": "No Answer"}]}}
{"id": 89, "src": "in the absence of fresh frozen tissue for if , immunohistochemistry with c4d aids in the diagnosis.a total 48 cases of mn diagnosed on renal biopsy were analyzed . the formalin fixed paraffin embedded tissues were stained with routine hematoxylin and eosin stains along with periodic acid - schiff and silver methenamine stains to highlight the basement membrane . fresh frozen tissues were available for if in 40 cases .", "mt": "In assenza di tessuti freschi congelati per se , immunohistochimica con c4d aids nella diagnosi.si sono stati analizzati un totale di 48 casi di mn diagnosticati in biopsia renale . i tessuti incorporati di paraffina fissa formelina sono stati colorati con macchie di routine di ematoossilina ed eosin insieme a macchie periodiche di acido schiffato e metenamina d'argento per evidenziare la membrana sotterranea .", "pert_mt": "In assenza di tessuti freschi congelati per se, immunohistochimica con c4d aids nella diagnosi, si sono stati analizzati un totale di 48 casi di mn diagnosticati in biopsia renale. I tessuti incorporati di paraffina fissa formelina sono stati colorati con macchie di routine di ematoossilina ed eosin insieme a macchie periodiche di acido schiffato e metenamina d'argento per evidenziare la membrana sotterranea e la struttura microvascolare.", "bt": "In the absence of fresh frozen tissues per se, immunohistochemical and c4d aids in diagnosis, a total of 48 cases were analyzed in renal biopsy.The incorporated tissues of paraffin fixed formelina were stained with routine stains of hemooxycin and eosin along with periodic stains of silver methylene and silver to confirm the subterranean membrane and the microvascular structure.", "questions_src": ["What is used for immunohistochemistry with c4d?", "When were 48 cases of MN diagnosed on renal biopsy analyzed?", "Where were the formalin fixed paraffin embedded tissues stained?", "Which stains were highlighted to highlight the basement membrane?", "In how many cases fresh frozen tissues were available for IF?"], "answers_src": ["[\"immunohistochemistry with c4d\"], [\"on renal biopsy\"], [\"with routine hematoxylin and eosin stains along with periodic acid - schiff and silver methenamine stains\"], [\"periodic acid - schiff and silver methenamine\"], [\"40\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["Immunohistochemical and c4d", "No Answer", "Paraffin fixed formalin", "Periodic stains of silver methylene and silver", "No Answer"], "multiturn": {"turn_1": [{"question_id": "89.1", "question": "What is used for immunohistochemistry with c4d?", "answer_src": "[\"immunohistochemistry with c4d\"], [\"on renal biopsy\"], [\"with routine hematoxylin and eosin stains along with periodic acid - schiff and silver methenamine stains\"], [\"periodic acid - schiff and silver methenamine\"], [\"40\"]", "follow_up_question": "What percentage of the 48 cases had fresh frozen tissue available for if?", "follow_up_response": "10%", "follow_up_response_bt": "No Answer"}, {"question_id": "89.2", "question": "When were 48 cases of MN diagnosed on renal biopsy analyzed?", "answer_src": "in the absence of fresh frozen tissue for if , immunohistochemistry with c4d aids in the diagnosis.a total 48 cases of mn diagnosed on renal biopsy were analyzed . the formalin fixed paraffin embedded tissues were stained with routine hematoxylin and eosin stains along with periodic acid - schiff and silver methenamine stains to highlight the basement membrane . fresh frozen tissues were available for if in 40 cases .", "follow_up_question": "What staining methods were used to analyze the formalin fixed paraffin embedded tissues?", "follow_up_response": "Routine hematoxylin and eosin stains along with periodic acid - schiff and silver methenamine stains", "follow_up_response_bt": "Routine stains of hematoxylin and eosin along with periodic stains of silver methylene and silver"}, {"question_id": "89.3", "question": "Where were the formalin fixed paraffin embedded tissues stained?", "answer_src": "in the absence of fresh frozen tissue for if , immunohistochemistry with c4d aids in the diagnosis.a total 48 cases of mn diagnosed on renal biopsy were analyzed . the formalin fixed paraffin embedded tissues were stained with routine hematoxylin and eosin stains along with periodic acid - schiff and silver methenamine stains to highlight the basement membrane . fresh frozen tissues were available for if in 40 cases .", "follow_up_question": "What staining method was used to highlight the basement membrane?", "follow_up_response": "periodic acid - schiff and silver methenamine", "follow_up_response_bt": "Periodic stains of silver methylene and silver"}, {"question_id": "89.4", "question": "Which stains were highlighted to highlight the basement membrane?", "answer_src": "in the absence of fresh frozen tissue for if , immunohistochemistry with c4d aids in the diagnosis.a total 48 cases of mn diagnosed on renal biopsy were analyzed . the formalin fixed paraffin embedded tissues were stained with routine hematoxylin and eosin stains along with periodic acid - schiff and silver methenamine stains to highlight the basement membrane . fresh frozen tissues were available for if in 40 cases .", "follow_up_question": "What other staining method was used besides periodic acid-Schiff and silver methenamine?", "follow_up_response": "Routine hematoxylin and eosin stains", "follow_up_response_bt": "Hemotoxylon and eosin"}, {"question_id": "89.5", "question": "In how many cases fresh frozen tissues were available for IF?", "answer_src": "in the absence of fresh frozen tissue for if , immunohistochemistry with c4d aids in the diagnosis.a total 48 cases of mn diagnosed on renal biopsy were analyzed . the formalin fixed paraffin embedded tissues were stained with routine hematoxylin and eosin stains along with periodic acid - schiff and silver methenamine stains to highlight the basement membrane . fresh frozen tissues were available for if in 40 cases .", "follow_up_question": "How many cases did not have fresh frozen tissues available for IF?", "follow_up_response": "4", "follow_up_response_bt": "48"}], "turn_2": [{"question_id": "89.6", "question": "What percentage of the 48 cases had fresh frozen tissue available for if?", "answer_src": "10%", "follow_up_question": "In how many cases was periodic acid - schiff staining performed?", "follow_up_response": "48", "follow_up_response_bt": "48"}, {"question_id": "89.7", "question": "What staining methods were used to analyze the formalin fixed paraffin embedded tissues?", "answer_src": "Routine hematoxylin and eosin stains along with periodic acid - schiff and silver methenamine stains", "follow_up_question": "What percentage of the analyzed cases had fresh frozen tissues available for IF?", "follow_up_response": "50%", "follow_up_response_bt": "No Answer"}, {"question_id": "89.8", "question": "What staining method was used to highlight the basement membrane?", "answer_src": "periodic acid - schiff and silver methenamine", "follow_up_question": "What percentage of the analyzed cases had fresh frozen tissues available for IF?", "follow_up_response": "50%", "follow_up_response_bt": "No Answer"}, {"question_id": "89.9", "question": "What other staining method was used besides periodic acid-Schiff and silver methenamine?", "answer_src": "Routine hematoxylin and eosin stains", "follow_up_question": "What percentage of the 48 cases had fresh frozen tissues available for IF?", "follow_up_response": "50%", "follow_up_response_bt": "No Answer"}, {"question_id": "89.10", "question": "How many cases did not have fresh frozen tissues available for IF?", "answer_src": "4", "follow_up_question": "How many cases were stained with periodic acid - schiff and silver methenamine stains?", "follow_up_response": "48", "follow_up_response_bt": "48"}], "turn_3": [{"question_id": "89.11", "question": "In how many cases was periodic acid - schiff staining performed?", "answer_src": "48", "follow_up_question": "How many cases had fresh frozen tissue available for IF?", "follow_up_response": "40", "follow_up_response_bt": "No Answer"}, {"question_id": "89.12", "question": "What percentage of the analyzed cases had fresh frozen tissues available for IF?", "answer_src": "50%", "follow_up_question": "In how many cases was the basement membrane highlighted using silver methenamine stain?", "follow_up_response": "48", "follow_up_response_bt": "48"}, {"question_id": "89.13", "question": "What percentage of the analyzed cases had fresh frozen tissues available for IF?", "answer_src": "50%", "follow_up_question": "In how many cases was the basement membrane highlighted using silver methenamine stain?", "follow_up_response": "48", "follow_up_response_bt": "48"}, {"question_id": "89.14", "question": "What percentage of the 48 cases had fresh frozen tissues available for IF?", "answer_src": "50%", "follow_up_question": "In how many cases was periodic acid-Schiff staining performed?", "follow_up_response": "48", "follow_up_response_bt": "48"}, {"question_id": "89.15", "question": "How many cases were stained with periodic acid - schiff and silver methenamine stains?", "answer_src": "48", "follow_up_question": "How many cases did not have fresh frozen tissue available for if?", "follow_up_response": "4", "follow_up_response_bt": "No Answer"}]}}
{"id": 90, "src": "comorbidities and multidrug use should be taken into account any time the therapeutic regimen is under consideration . different classes of antifungal drugs are available for the treatment of invasive fungal infections but echinocandins , apart from their activity against resistant strains ( candida glabrata and candida krusei ) , seem to be safe , with limited adverse events and minimal drug drug interactions in comparison to the other regimens . therefore , these agents are strongly recommended when dealing with elderly patients suffering from an invasive form of candida infection .", "mt": "Le comorbilità e l'uso di farmaci diversi dovrebbero essere prese in considerazione ogni volta che il regime terapeutico è in considerazione . Esistono diverse classi di farmaci antifungini per il trattamento di infezioni fungine invasive , ma gli echinocandin , oltre alla loro attività contro ceppi resistenti (candida glabrata e candida krusei) , sembrano essere sicuri , con effetti avversi limitati e interazioni farmacologiche minime rispetto agli altri regimi . Pertanto , questi agenti sono fortemente raccomandati quando si tratta di pazienti anziani che soffrono di una forma invasiva di infezione da candida .", "pert_mt": "Le comorbilità e l'uso di farmaci diversi dovrebbero essere prese in considerazione ogni volta che il regime terapeutico è in considerazione. Esistono diverse classi di farmaci antifungini per il trattamento di infezioni fungine invasive, ma gli echinocandin, oltre alla loro attività contro ceppi resistenti (candida glabrata e candida krusei), sembrano essere sicuri, con effetti avversi limitati e interazioni farmacologiche minime rispetto agli altri regimi. Pertanto, questi agenti sono fortemente raccomandati quando si tratta di pazienti anziani che soffrono di una forma invasiva di infezione da candida e hanno problemi renali.", "bt": "The comorbidity and use of different medications should be taken into account whenever the therapeutic regimen is considered.There are different classes of antifungal medications for the treatment of invasive fungal infections, but echinocandins, in addition to their activity against resistant strains (candida glabrata and candida cruzei), seem to be safe, with limited adverse effects and minimal pharmacological interactions compared to other regimens.", "questions_src": ["What class of antifungal drugs are available for the treatment of invasive fungal infections?", "Who seems to benefit most from echinocandins in this context?", "Where might echinocandins be particularly useful based on the given information?", "When is it important to consider comorbidities and multidrug use?", "Which antifungal strains are resistant to echinocandins according to the text?"], "answers_src": ["[\"different classes of antifungal drugs\"], [\"elderly patients suffering from an invasive form of candida infection\"], [\"when dealing with elderly patients suffering from an invasive form of candida infection\"], [\"any time the therapeutic regimen is under consideration\"], [\"candida glabrata and candida krusei\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["Different classes of antifungal medications", "Echinocandins", "Invasive fungal infections", "Whenever the therapeutic regimen is considered", "Candida glabrata and candida cruzei"], "multiturn": {"turn_1": [{"question_id": "90.1", "question": "What class of antifungal drugs are available for the treatment of invasive fungal infections?", "answer_src": "[\"different classes of antifungal drugs\"], [\"elderly patients suffering from an invasive form of candida infection\"], [\"when dealing with elderly patients suffering from an invasive form of candida infection\"], [\"any time the therapeutic regimen is under consideration\"], [\"candida glabrata and candida krusei\"]", "follow_up_question": "What specific adverse events are associated with echinocandins compared to other antifungal regimens?", "follow_up_response": "limited adverse events and minimal drug drug interactions", "follow_up_response_bt": "limited adverse effects and minimal pharmacological interactions"}, {"question_id": "90.2", "question": "Who seems to benefit most from echinocandins in this context?", "answer_src": "comorbidities and multidrug use should be taken into account any time the therapeutic regimen is under consideration . different classes of antifungal drugs are available for the treatment of invasive fungal infections but echinocandins , apart from their activity against resistant strains ( candida glabrata and candida krusei ) , seem to be safe , with limited adverse events and minimal drug drug interactions in comparison to the other regimens . therefore , these agents are strongly recommended when dealing with elderly patients suffering from an invasive form of candida infection .", "follow_up_question": "What specific adverse events are associated with echinocandins compared to other antifungal regimens?", "follow_up_response": "limited adverse events and minimal drug drug interactions", "follow_up_response_bt": "limited adverse effects and minimal pharmacological interactions"}, {"question_id": "90.3", "question": "Where might echinocandins be particularly useful based on the given information?", "answer_src": "comorbidities and multidrug use should be taken into account any time the therapeutic regimen is under consideration . different classes of antifungal drugs are available for the treatment of invasive fungal infections but echinocandins , apart from their activity against resistant strains ( candida glabrata and candida krusei ) , seem to be safe , with limited adverse events and minimal drug drug interactions in comparison to the other regimens . therefore , these agents are strongly recommended when dealing with elderly patients suffering from an invasive form of candida infection .", "follow_up_question": "What specific condition makes echinocandins particularly recommended according to the text?", "follow_up_response": "an invasive form of candida infection", "follow_up_response_bt": "resistant strains (candida glabrata and candida cruzei)"}, {"question_id": "90.4", "question": "When is it important to consider comorbidities and multidrug use?", "answer_src": "comorbidities and multidrug use should be taken into account any time the therapeutic regimen is under consideration . different classes of antifungal drugs are available for the treatment of invasive fungal infections but echinocandins , apart from their activity against resistant strains ( candida glabrata and candida krusei ) , seem to be safe , with limited adverse events and minimal drug drug interactions in comparison to the other regimens . therefore , these agents are strongly recommended when dealing with elderly patients suffering from an invasive form of candida infection .", "follow_up_question": "What specific adverse events are associated with echinocandins?", "follow_up_response": "Limited adverse events", "follow_up_response_bt": "Limited adverse effects"}, {"question_id": "90.5", "question": "Which antifungal strains are resistant to echinocandins according to the text?", "answer_src": "comorbidities and multidrug use should be taken into account any time the therapeutic regimen is under consideration . different classes of antifungal drugs are available for the treatment of invasive fungal infections but echinocandins , apart from their activity against resistant strains ( candida glabrata and candida krusei ) , seem to be safe , with limited adverse events and minimal drug drug interactions in comparison to the other regimens . therefore , these agents are strongly recommended when dealing with elderly patients suffering from an invasive form of candida infection .", "follow_up_question": "Apart from candida glabrata and candida krusei, are there any other antifungal strains that are resistant to echinocandins?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "90.6", "question": "What specific adverse events are associated with echinocandins compared to other antifungal regimens?", "answer_src": "limited adverse events and minimal drug drug interactions", "follow_up_question": "What are the benefits of echinocandins over other antifungal regimens for elderly patients?", "follow_up_response": "limited adverse events and minimal drug-drug interactions", "follow_up_response_bt": "No Answer"}, {"question_id": "90.7", "question": "What specific adverse events are associated with echinocandins compared to other antifungal regimens?", "answer_src": "limited adverse events and minimal drug drug interactions", "follow_up_question": "What are the benefits of echinocandins over other antifungal regimens for elderly patients?", "follow_up_response": "limited adverse events and minimal drug-drug interactions", "follow_up_response_bt": "No Answer"}, {"question_id": "90.8", "question": "What specific condition makes echinocandins particularly recommended according to the text?", "answer_src": "an invasive form of candida infection", "follow_up_question": "What are the limitations of other antifungal drug regimens mentioned in the text?", "follow_up_response": "limited adverse events and minimal drug drug interactions", "follow_up_response_bt": "limited adverse effects and minimal pharmacological interactions"}, {"question_id": "90.9", "question": "What specific adverse events are associated with echinocandins?", "answer_src": "Limited adverse events", "follow_up_question": "What are the advantages of echinocandins over other antifungal regimens for treating invasive candida infections?", "follow_up_response": "Their activity against resistant strains (candida glabrata and candida krusei), safety with limited adverse events and minimal drug-drug interactions", "follow_up_response_bt": "Their activity against resistant strains (candida glabrata and candida cruzei), safety with limited adverse effects and minimal pharmacological interactions"}, {"question_id": "90.10", "question": "Apart from candida glabrata and candida krusei, are there any other antifungal strains that are resistant to echinocandins?", "answer_src": "comorbidities and multidrug use should be taken into account any time the therapeutic regimen is under consideration . different classes of antifungal drugs are available for the treatment of invasive fungal infections but echinocandins , apart from their activity against resistant strains ( candida glabrata and candida krusei ) , seem to be safe , with limited adverse events and minimal drug drug interactions in comparison to the other regimens . therefore , these agents are strongly recommended when dealing with elderly patients suffering from an invasive form of candida infection .", "follow_up_question": "Are there any other antifungal strains besides candida glabrata and candida krusei that echinocandins are effective against?", "follow_up_response": "No Answer", "follow_up_response_bt": "candida glabrata and candida cruzei"}], "turn_3": [{"question_id": "90.11", "question": "What are the benefits of echinocandins over other antifungal regimens for elderly patients?", "answer_src": "limited adverse events and minimal drug-drug interactions", "follow_up_question": "What specific class of antifungal drugs is recommended for elderly patients with invasive candida infections?", "follow_up_response": "echinocandins", "follow_up_response_bt": "echinocandins"}, {"question_id": "90.12", "question": "What are the benefits of echinocandins over other antifungal regimens for elderly patients?", "answer_src": "limited adverse events and minimal drug-drug interactions", "follow_up_question": "What specific class of antifungal drugs is recommended for elderly patients with invasive candida infections?", "follow_up_response": "echinocandins", "follow_up_response_bt": "echinocandins"}, {"question_id": "90.13", "question": "What are the limitations of other antifungal drug regimens mentioned in the text?", "answer_src": "limited adverse events and minimal drug drug interactions", "follow_up_question": "What specific class of antifungal drugs is recommended for elderly patients with invasive candida infections?", "follow_up_response": "echinocandins", "follow_up_response_bt": "echinocandins"}, {"question_id": "90.14", "question": "What are the advantages of echinocandins over other antifungal regimens for treating invasive candida infections?", "answer_src": "Their activity against resistant strains (candida glabrata and candida krusei), safety with limited adverse events and minimal drug-drug interactions", "follow_up_question": "What specific patient population is echinocandins particularly recommended for?", "follow_up_response": "Elderly patients", "follow_up_response_bt": "resistant strains (candida glabrata and candida cruzei)"}, {"question_id": "90.15", "question": "Are there any other antifungal strains besides candida glabrata and candida krusei that echinocandins are effective against?", "answer_src": "comorbidities and multidrug use should be taken into account any time the therapeutic regimen is under consideration . different classes of antifungal drugs are available for the treatment of invasive fungal infections but echinocandins , apart from their activity against resistant strains ( candida glabrata and candida krusei ) , seem to be safe , with limited adverse events and minimal drug drug interactions in comparison to the other regimens . therefore , these agents are strongly recommended when dealing with elderly patients suffering from an invasive form of candida infection .", "follow_up_question": "Apart from candida glabrata and candida krusei, are echinocandins effective against any other specific resistant strains of candida?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 91, "src": "foldback intercoil ( fbi ) dna is formed by the folding back at one point of a non - helical parallel track of double - stranded dna at as sharp as 180 and the intertwining of two double helixes within each other 's major groove to form an intercoil with a diameter of 2.2 nm . fbi dna has been suggested to mediate intra - molecular homologous recombination of a deletion and inversion . inter - molecular homologous recombination , known as site - specific insertion , on the other hand , is mediated by the direct perpendicular approach of the fbi dna tip , as the attp site , onto the target dna , as the attb site .", "mt": "L'intercoil di riposo (fbi) DNA è formato dal ripiegamento di una pista parallela non elica di DNA a doppio strato a un punto acuto come 180 e dall'intreccio di due doppie eliche all'interno del groove principale l'uno dell'altro per formare un intercoil con un diametro di 2,2 nm . Fbi DNA è stato suggerito per mediare la ricombinazione intra-molecolare omologa di una delezione e inversione .", "pert_mt": "L'intercoil di riposo (fbi) DNA è formato dal ripiegamento di una pista parallela non elica di DNA a doppio strato a un punto acuto come 180 e dall'intreccio di due doppie eliche all'interno del groove principale l'uno dell'altro per formare un intercoil con un diametro di 2,2 nm. Fbi DNA è stato suggerito per mediare la ricombinazione intra-molecolare omologa di una delezione e inversione, ma non è stato dimostrato scientificamente.", "bt": "The resting (fbi) DNA intercoil is formed by folding a parallel non-helial path of double-layer DNA to an acute point of 180 and by intersecting two double-helial paths within the main groove one of the other to form an intercoil with a diameter of 2.2 nm. Fbi DNA has been suggested by mediation to the homologous intra-molecular recombination of a deletion and inversion, but has not been scientifically proven.", "questions_src": ["What is foldback intercoil (FBI) DNA formed by?", "Who has suggested FBI DNA mediates intra-molecular homologous recombination?", "Where does inter-molecular homologous recombination occur?", "When was it suggested FBI DNA mediates this process?", "Which approach does FBI DNA use for inter-molecular homologous recombination?"], "answers_src": ["[\"the folding back at one point of a non-helical parallel track of double-stranded DNA\"], [\"has been suggested\"], [\"on the other hand\"], [\"No Answer\"], [\"the direct perpendicular approach\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"folding a parallel non-helix path of double-layer DNA\"], [\"has been suggested by mediation\"], [\"inter-molecular homologous recombination occurs within the main groove\"], [\"it has been suggested\"], [\"FBI DNA uses the homologous intra-molecular recombination of a deletion and inversion\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "91.1", "question": "What is foldback intercoil (FBI) DNA formed by?", "answer_src": "[\"the folding back at one point of a non-helical parallel track of double-stranded DNA\"], [\"has been suggested\"], [\"on the other hand\"], [\"No Answer\"], [\"the direct perpendicular approach\"]", "follow_up_question": "How does FBI DNA form an intercoil?", "follow_up_response": "by the folding back at one point of a non-helical parallel track of double-stranded DNA at as sharp as 180 and the intertwining of two double helices within each other's major groove", "follow_up_response_bt": "By folding a parallel non-helix path of double-layer DNA to an acute point of 180 and by intersecting two double-helix paths within the main groove one of the other to form an intercoil"}, {"question_id": "91.2", "question": "Who has suggested FBI DNA mediates intra-molecular homologous recombination?", "answer_src": "foldback intercoil ( fbi ) dna is formed by the folding back at one point of a non - helical parallel track of double - stranded dna at as sharp as 180 and the intertwining of two double helixes within each other 's major groove to form an intercoil with a diameter of 2.2 nm . fbi dna has been suggested to mediate intra - molecular homologous recombination of a deletion and inversion . inter - molecular homologous recombination , known as site - specific insertion , on the other hand , is mediated by the direct perpendicular approach of the fbi dna tip , as the attp site , onto the target dna , as the attb site .", "follow_up_question": "What specific type of recombination does inter-molecular homologous recombination mediate?", "follow_up_response": "site-specific insertion", "follow_up_response_bt": "No Answer"}, {"question_id": "91.3", "question": "Where does inter-molecular homologous recombination occur?", "answer_src": "foldback intercoil ( fbi ) dna is formed by the folding back at one point of a non - helical parallel track of double - stranded dna at as sharp as 180 and the intertwining of two double helixes within each other 's major groove to form an intercoil with a diameter of 2.2 nm . fbi dna has been suggested to mediate intra - molecular homologous recombination of a deletion and inversion . inter - molecular homologous recombination , known as site - specific insertion , on the other hand , is mediated by the direct perpendicular approach of the fbi dna tip , as the attp site , onto the target dna , as the attb site .", "follow_up_question": "Where does inter-molecular homologous recombination occur according to the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "91.4", "question": "When was it suggested FBI DNA mediates this process?", "answer_src": "foldback intercoil ( fbi ) dna is formed by the folding back at one point of a non - helical parallel track of double - stranded dna at as sharp as 180 and the intertwining of two double helixes within each other 's major groove to form an intercoil with a diameter of 2.2 nm . fbi dna has been suggested to mediate intra - molecular homologous recombination of a deletion and inversion . inter - molecular homologous recombination , known as site - specific insertion , on the other hand , is mediated by the direct perpendicular approach of the fbi dna tip , as the attp site , onto the target dna , as the attb site .", "follow_up_question": "What type of recombination does inter - molecular homologous recombination mediate?", "follow_up_response": "site - specific insertion", "follow_up_response_bt": "No Answer"}, {"question_id": "91.5", "question": "Which approach does FBI DNA use for inter-molecular homologous recombination?", "answer_src": "foldback intercoil ( fbi ) dna is formed by the folding back at one point of a non - helical parallel track of double - stranded dna at as sharp as 180 and the intertwining of two double helixes within each other 's major groove to form an intercoil with a diameter of 2.2 nm . fbi dna has been suggested to mediate intra - molecular homologous recombination of a deletion and inversion . inter - molecular homologous recombination , known as site - specific insertion , on the other hand , is mediated by the direct perpendicular approach of the fbi dna tip , as the attp site , onto the target dna , as the attb site .", "follow_up_question": "What is the diameter of the intercoil formed by FBI DNA?", "follow_up_response": "2.2 nm", "follow_up_response_bt": "2.2 nm"}], "turn_2": [{"question_id": "91.6", "question": "How does FBI DNA form an intercoil?", "answer_src": "by the folding back at one point of a non-helical parallel track of double-stranded DNA at as sharp as 180 and the intertwining of two double helices within each other's major groove", "follow_up_question": "What is the diameter of the intercoil formed by FBI DNA?", "follow_up_response": "2.2 nm", "follow_up_response_bt": "2.2 nm"}, {"question_id": "91.7", "question": "What specific type of recombination does inter-molecular homologous recombination mediate?", "answer_src": "site-specific insertion", "follow_up_question": "What is the unique approach used by inter-molecular homologous recombination compared to intra-molecular homologous recombination?", "follow_up_response": "The unique approach used by inter-molecular homologous recombination compared to intra-molecular homologous recombination is the direct perpendicular approach of the fbi DNA tip, as the ATTP site, onto the target DNA, as the ATTB site.", "follow_up_response_bt": "No Answer"}, {"question_id": "91.8", "question": "Where does inter-molecular homologous recombination occur according to the text?", "answer_src": "foldback intercoil ( fbi ) dna is formed by the folding back at one point of a non - helical parallel track of double - stranded dna at as sharp as 180 and the intertwining of two double helixes within each other 's major groove to form an intercoil with a diameter of 2.2 nm . fbi dna has been suggested to mediate intra - molecular homologous recombination of a deletion and inversion . inter - molecular homologous recombination , known as site - specific insertion , on the other hand , is mediated by the direct perpendicular approach of the fbi dna tip , as the attp site , onto the target dna , as the attb site .", "follow_up_question": "On what structure does inter-molecular homologous recombination occur according to the text?", "follow_up_response": "target DNA", "follow_up_response_bt": "No Answer"}, {"question_id": "91.9", "question": "What type of recombination does inter - molecular homologous recombination mediate?", "answer_src": "site - specific insertion", "follow_up_question": "What is the mechanism by which inter - molecular homologous recombination occurs?", "follow_up_response": "The direct perpendicular approach of the fbi DNA tip, as the ATTP site, onto the target DNA, as the ATTB site.", "follow_up_response_bt": "No Answer"}, {"question_id": "91.10", "question": "What is the diameter of the intercoil formed by FBI DNA?", "answer_src": "2.2 nm", "follow_up_question": "What is the maximum angle at which the non-helical parallel track of FBI DNA folds back?", "follow_up_response": "180", "follow_up_response_bt": "180"}], "turn_3": [{"question_id": "91.11", "question": "What is the diameter of the intercoil formed by FBI DNA?", "answer_src": "2.2 nm", "follow_up_question": "What is the maximum angle at which the non-helical parallel track of FBI DNA folds back?", "follow_up_response": "180", "follow_up_response_bt": "180"}, {"question_id": "91.12", "question": "What is the unique approach used by inter-molecular homologous recombination compared to intra-molecular homologous recombination?", "answer_src": "The unique approach used by inter-molecular homologous recombination compared to intra-molecular homologous recombination is the direct perpendicular approach of the fbi DNA tip, as the ATTP site, onto the target DNA, as the ATTB site.", "follow_up_question": "How does the diameter of the intercoil formed by FBI DNA affect its potential for homologous recombination?", "follow_up_response": "2.2 nm", "follow_up_response_bt": "No Answer"}, {"question_id": "91.13", "question": "On what structure does inter-molecular homologous recombination occur according to the text?", "answer_src": "target DNA", "follow_up_question": "On which site does inter-molecular homologous recombination occur according to the text?", "follow_up_response": "attb site", "follow_up_response_bt": "No Answer"}, {"question_id": "91.14", "question": "What is the mechanism by which inter - molecular homologous recombination occurs?", "answer_src": "The direct perpendicular approach of the fbi DNA tip, as the ATTP site, onto the target DNA, as the ATTB site.", "follow_up_question": "How does the diameter of 2.2 nm affect the intercoil formation?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "91.15", "question": "What is the maximum angle at which the non-helical parallel track of FBI DNA folds back?", "answer_src": "180", "follow_up_question": "What is the diameter of the FBI DNA intercoil formed?", "follow_up_response": "2.2 nm", "follow_up_response_bt": "2.2 nm"}]}}
{"id": 92, "src": "nearly 14% of children worldwide do not reach their developmental potential in early childhood . the early identification of delays in achieving milestones is critical . the world health organization ( who ) has developed normal age ranges for the achievement of motor milestones by healthy children .", "mt": "Quasi il 14% dei bambini in tutto il mondo non raggiunge il loro potenziale di sviluppo nella prima infanzia . L'identificazione precoce dei ritardi nel raggiungimento di pilastri è fondamentale . L'organizzazione mondiale della sanità (WHO) ha sviluppato intervalli di età normali per il raggiungimento di pilastri motori da parte di bambini sani .", "pert_mt": "Quasi il 14% dei bambini in tutto il mondo non raggiunge il loro potenziale di sviluppo nella prima infanzia. L'identificazione precosa dei ritardi nel raggiungimento di pilastri è fondamentale. L'organizzazione mondiale della sanità (WHO) ha sviluppato intervalli di età normali per il raggiungimento di pilastri motori da parte di bambini sani, come indicato dalle linee guida recenti.", "bt": "Almost 14% of children worldwide do not reach their developmental potential in early childhood.The precise identification of delays in reaching the motor pillars is fundamental.The World Health Organization (WHO) has developed normal age intervals for healthy children to reach motor pillars, as indicated by recent guidelines.", "questions_src": ["What does WHO develop normal age ranges for?", "When is the early identification of delays in achieving milestones critical?", "Where can one find normal age ranges for motor milestones?", "Who develops normal age ranges for motor milestones by healthy children?", "Which milestone development is important for early childhood?"], "answers_src": ["Motor milestones", "Early identification of delays in achieving milestones is critical", "World Health Organization (who)", "World Health Organization (who)", "Motor milestones"], "answers_bt": ["[\"Healthy children\"], [\"Early\"], [\"Recent guidelines\"], [\"WHO\"], [\"Motor pillars\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "92.1", "question": "What does WHO develop normal age ranges for?", "answer_src": "Motor milestones", "follow_up_question": "What specific milestones does WHO provide normal age ranges for?", "follow_up_response": "Motor milestones", "follow_up_response_bt": "Motor pillars"}, {"question_id": "92.2", "question": "When is the early identification of delays in achieving milestones critical?", "answer_src": "Early identification of delays in achieving milestones is critical", "follow_up_question": "What specific milestones does WHO have normal age ranges for?", "follow_up_response": "motor milestones", "follow_up_response_bt": "Motor pillars"}, {"question_id": "92.3", "question": "Where can one find normal age ranges for motor milestones?", "answer_src": "World Health Organization (who)", "follow_up_question": "What specific motor milestones does WHO provide normal age ranges for?", "follow_up_response": "motor milestones", "follow_up_response_bt": "Motor pillars"}, {"question_id": "92.4", "question": "Who develops normal age ranges for motor milestones by healthy children?", "answer_src": "World Health Organization (who)", "follow_up_question": "What specific motor milestones does WHO have normal age ranges for?", "follow_up_response": "No Answer", "follow_up_response_bt": "motor pillars"}, {"question_id": "92.5", "question": "Which milestone development is important for early childhood?", "answer_src": "Motor milestones", "follow_up_question": "What specific milestones does WHO have normal age ranges for?", "follow_up_response": "motor milestones", "follow_up_response_bt": "Motor pillars"}], "turn_2": [{"question_id": "92.6", "question": "What specific milestones does WHO provide normal age ranges for?", "answer_src": "Motor milestones", "follow_up_question": "What motor milestones does WHO provide normal age ranges for?", "follow_up_response": "motor milestones", "follow_up_response_bt": "motor pillars"}, {"question_id": "92.7", "question": "What specific milestones does WHO have normal age ranges for?", "answer_src": "motor milestones", "follow_up_question": "What are some common motor milestones that WHO has normal age ranges for?", "follow_up_response": "No Answer", "follow_up_response_bt": "Motor pillars"}, {"question_id": "92.8", "question": "What specific motor milestones does WHO provide normal age ranges for?", "answer_src": "motor milestones", "follow_up_question": "What motor milestones does WHO provide normal age ranges for?", "follow_up_response": "motor milestones", "follow_up_response_bt": "motor pillars"}, {"question_id": "92.9", "question": "What specific motor milestones does WHO have normal age ranges for?", "answer_src": "nearly 14% of children worldwide do not reach their developmental potential in early childhood . the early identification of delays in achieving milestones is critical . the world health organization ( who ) has developed normal age ranges for the achievement of motor milestones by healthy children .", "follow_up_question": "What motor milestones does WHO specifically list as normal for healthy children?", "follow_up_response": "No Answer", "follow_up_response_bt": "motor pillars"}, {"question_id": "92.10", "question": "What specific milestones does WHO have normal age ranges for?", "answer_src": "motor milestones", "follow_up_question": "What are some common motor milestones that WHO has normal age ranges for?", "follow_up_response": "No Answer", "follow_up_response_bt": "Motor pillars"}], "turn_3": [{"question_id": "92.11", "question": "What motor milestones does WHO provide normal age ranges for?", "answer_src": "motor milestones", "follow_up_question": "What specific milestones does WHO provide normal age ranges for?", "follow_up_response": "Motor milestones", "follow_up_response_bt": "Motor pillars"}, {"question_id": "92.12", "question": "What are some common motor milestones that WHO has normal age ranges for?", "answer_src": "nearly 14% of children worldwide do not reach their developmental potential in early childhood . the early identification of delays in achieving milestones is critical . the world health organization ( who ) has developed normal age ranges for the achievement of motor milestones by healthy children .", "follow_up_question": "What specific motor milestones does WHO have normal age ranges for?", "follow_up_response": "No Answer", "follow_up_response_bt": "motor pillars"}, {"question_id": "92.13", "question": "What motor milestones does WHO provide normal age ranges for?", "answer_src": "motor milestones", "follow_up_question": "What specific milestones does WHO provide normal age ranges for?", "follow_up_response": "Motor milestones", "follow_up_response_bt": "Motor pillars"}, {"question_id": "92.14", "question": "What motor milestones does WHO specifically list as normal for healthy children?", "answer_src": "nearly 14% of children worldwide do not reach their developmental potential in early childhood . the early identification of delays in achieving milestones is critical . the world health organization ( who ) has developed normal age ranges for the achievement of motor milestones by healthy children .", "follow_up_question": "What specific motor milestones does WHO list as normal for healthy children?", "follow_up_response": "No Answer", "follow_up_response_bt": "normal age intervals for healthy children"}, {"question_id": "92.15", "question": "What are some common motor milestones that WHO has normal age ranges for?", "answer_src": "nearly 14% of children worldwide do not reach their developmental potential in early childhood . the early identification of delays in achieving milestones is critical . the world health organization ( who ) has developed normal age ranges for the achievement of motor milestones by healthy children .", "follow_up_question": "What specific motor milestones does WHO have normal age ranges for?", "follow_up_response": "No Answer", "follow_up_response_bt": "motor pillars"}]}}
{"id": 93, "src": "histopathological findings showed that 90% of lesions were lymphoepithelioma - like carcinoma ( lelca ) and a few lesions were non - invasive transitional cell carcinoma . on microscopy , syncytial growth pattern and indistinct cytoplasmic borders were observed with the severe infiltration of lymphoid cells . the case was followed - up for 8 months without recurrence .", "mt": "I risultati histopathologici hanno mostrato che il 90% delle lesioni erano linfoepithelioma - come il carcinoma (lelica) e alcune lesioni erano non invasivi carcinoma cellulare di transizione . sulla microscopia , il modello di crescita sinciziale e confini citoplasmatici indistinti sono stati osservati con la grave infiltrazione delle cellule linfoidi . il caso è stato seguito - fino a 8 mesi senza ricorrenza .", "pert_mt": "I risultati histopathologici hanno mostrato che il 90% delle lesioni erano linfoepithelioma - come il carcinoma (lelica), e alcune lesioni erano non invasivi carcinoma cellulare di transizione. sulla microscopia, il modello di crescita sinciziale e confini citoplasmatici indistinti sono stati osservati con la grave infiltrazione delle cellule linfoidi. il caso è stato seguito - fino a 8 mesi senza ricorrenza, e il paziente ha dimostrato una buona risposta al trattamento.", "bt": "Histopathological results showed that 90% of lesions were lymphoepithelioma - like carcinoma (lelica), and some lesions were non-invasive transitional cell carcinoma. On microscopy, the syncicial growth pattern and indistinct cytoplasmic boundaries were observed with severe infiltration of lymphoid cells. the case was followed up - up to 8 months without recurrence, and the patient demonstrated a good response to treatment.", "questions_src": ["What type of cancer made up 90% of the lesions?", "Where were the lymphoid cells severely infiltrating?", "Which growth pattern was observed on microscopy?", "How long was the case followed-up without recurrence?", "What was the other type of cancer found in a few lesions?"], "answers_src": ["Lymphoepithelioma-like carcinoma (LELC)", "In the lesion tissue", "Syncytial growth pattern", "8 months", "Non-invasive transitional cell carcinoma"], "answers_bt": ["Lymphoepithelioma-like carcinoma (lelica)", "In the lesion", "Syncitial growth pattern", "8 months", "Non-invasive transitional cell carcinoma"], "multiturn": {"turn_1": [{"question_id": "93.1", "question": "What type of cancer made up 90% of the lesions?", "answer_src": "Lymphoepithelioma-like carcinoma (LELC)", "follow_up_question": "What microscopic feature was consistently observed in the lesions?", "follow_up_response": "Syncytial growth pattern and indistinct cytoplasmic borders", "follow_up_response_bt": "Severe infiltration of lymphoid cells"}, {"question_id": "93.2", "question": "Where were the lymphoid cells severely infiltrating?", "answer_src": "In the lesion tissue", "follow_up_question": "What specific microscopic feature indicated the presence of severe lymphoid cell infiltration?", "follow_up_response": "Syncytial growth pattern and indistinct cytoplasmic borders", "follow_up_response_bt": "Syncicial growth pattern and indistinct cytoplasmic boundaries"}, {"question_id": "93.3", "question": "Which growth pattern was observed on microscopy?", "answer_src": "Syncytial growth pattern", "follow_up_question": "What percentage of lesions were non-invasive transitional cell carcinoma?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "93.4", "question": "How long was the case followed-up without recurrence?", "answer_src": "8 months", "follow_up_question": "What was the histopathological description of the non-invasive transitional cell carcinoma lesions?", "follow_up_response": "a few lesions were non-invasive transitional cell carcinoma", "follow_up_response_bt": "Non-invasive transitional cell carcinoma"}, {"question_id": "93.5", "question": "What was the other type of cancer found in a few lesions?", "answer_src": "Non-invasive transitional cell carcinoma", "follow_up_question": "What was the predominant type of cancer found in the majority of lesions?", "follow_up_response": "lymphoepithelioma-like carcinoma (LELC)", "follow_up_response_bt": "Lymphoepithelioma-like carcinoma (lelica)"}], "turn_2": [{"question_id": "93.6", "question": "What microscopic feature was consistently observed in the lesions?", "answer_src": "Syncytial growth pattern and indistinct cytoplasmic borders", "follow_up_question": "What percentage of the lesions showed lymphoepithelioma-like carcinoma?", "follow_up_response": "90%", "follow_up_response_bt": "90%"}, {"question_id": "93.7", "question": "What specific microscopic feature indicated the presence of severe lymphoid cell infiltration?", "answer_src": "Syncytial growth pattern and indistinct cytoplasmic borders", "follow_up_question": "What percentage of the lesions showed non-invasive transitional cell carcinoma?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "93.8", "question": "What percentage of lesions were non-invasive transitional cell carcinoma?", "answer_src": "histopathological findings showed that 90% of lesions were lymphoepithelioma - like carcinoma ( lelca ) and a few lesions were non - invasive transitional cell carcinoma . on microscopy , syncytial growth pattern and indistinct cytoplasmic borders were observed with the severe infiltration of lymphoid cells . the case was followed - up for 8 months without recurrence .", "follow_up_question": "What microscopic feature was observed in the lesions?", "follow_up_response": "Syncytial growth pattern and indistinct cytoplasmic borders", "follow_up_response_bt": "The syncicial growth pattern and indistinct cytoplasmic boundaries were observed"}, {"question_id": "93.9", "question": "What was the histopathological description of the non-invasive transitional cell carcinoma lesions?", "answer_src": "a few lesions were non-invasive transitional cell carcinoma", "follow_up_question": "What was the predominant type of cancer found in the lesions?", "follow_up_response": "lymphoepithelioma-like carcinoma (LELC)", "follow_up_response_bt": "Lymphoepithelioma-like carcinoma (lelica)"}, {"question_id": "93.10", "question": "What was the predominant type of cancer found in the majority of lesions?", "answer_src": "lymphoepithelioma-like carcinoma (LELC)", "follow_up_question": "What percentage of lesions were lymphoepithelioma-like carcinoma (LELC)?", "follow_up_response": "90%", "follow_up_response_bt": "90%"}], "turn_3": [{"question_id": "93.11", "question": "What percentage of the lesions showed lymphoepithelioma-like carcinoma?", "answer_src": "90%", "follow_up_question": "What was the average size of the lymphoid cell infiltration observed under microscopy?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "93.12", "question": "What percentage of the lesions showed non-invasive transitional cell carcinoma?", "answer_src": "histopathological findings showed that 90% of lesions were lymphoepithelioma - like carcinoma ( lelca ) and a few lesions were non - invasive transitional cell carcinoma . on microscopy , syncytial growth pattern and indistinct cytoplasmic borders were observed with the severe infiltration of lymphoid cells . the case was followed - up for 8 months without recurrence .", "follow_up_question": "What microscopic feature was observed in the lesions?", "follow_up_response": "Syncytial growth pattern and indistinct cytoplasmic borders", "follow_up_response_bt": "The syncicial growth pattern and indistinct cytoplasmic boundaries were observed"}, {"question_id": "93.13", "question": "What microscopic feature was observed in the lesions?", "answer_src": "Syncytial growth pattern and indistinct cytoplasmic borders", "follow_up_question": "What percentage of the lesions were non-invasive transitional cell carcinoma?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "93.14", "question": "What was the predominant type of cancer found in the lesions?", "answer_src": "lymphoepithelioma-like carcinoma (LELC)", "follow_up_question": "What percentage of the lesions were lymphoepithelioma-like carcinoma (LELC)?", "follow_up_response": "90%", "follow_up_response_bt": "90%"}, {"question_id": "93.15", "question": "What percentage of lesions were lymphoepithelioma-like carcinoma (LELC)?", "answer_src": "90%", "follow_up_question": "What was the average size of the lymphoid cell infiltration observed under microscopy?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 94, "src": "the objective of this study was to test the efficacy of ngf in sca3 patients.we performed an open - label prospective study in genetically confirmed adult ( > 18 years old ) sca3 patients . ngf was administered by intramuscular injection ( 18 g once daily ) for 28 days consecutively . all the patients were evaluated at baseline and 2 and 4 weeks after treatment using the chinese version of the scale for assessment and rating of ataxia ( sara).twenty - one sca3 patients ( 10 men and 11 women , mean age 39.14 7.81 years , mean disease duration 4.14 1.90 years , mean cag repeats number 77.57 2.27 ) were enrolled .", "mt": "L'obiettivo di questo studio era quello di testare l'efficacia di ngf in pazienti sca3. abbiamo eseguito uno studio open-label prospective su pazienti adulti ( > 18 anni) di sca3 geneticamente confermati . l'ngf è stato somministrato per iniezione intramuscolare ( 18 g una volta al giorno) per 28 giorni consecutivi . Tutti i pazienti sono stati valutati al momento di inizio e 2 e 4 settimane dopo il trattamento utilizzando la versione cinese della scala per la valutazione e la valutazione dell'ataxia (sara).Venti-uno pazienti sca3 (10 uomini e 11 donne , età media 39,14 anni 7,81 anni , durata media della malattia 4,14 anni 1,90 anni , numero medio di ripetizioni cag 77,57 2,27) sono stati iscritti .", "pert_mt": "L'obiettivo di questo studio era quello di testare l'efficacia di ngf in pazienti sca3. Abbiamo eseguito uno studio open-label e randomizzato su pazienti adulti (> 18 anni) di sca3 geneticamente confermati. L'ngf è stato somministrato per iniezione intramuscolare (18 g una volta al giorno) per 28 giorni consecutivi. Tutti i pazienti sono stati valutati al momento di inizio e 2 e 4 settimane dopo il trattamento utilizzando la versione cinese della scala per la valutazione e la valutazione dell'ataxia (SARA). Venti-uno pazienti sca3 (10 uomini e 11 donne, età media 39,14 anni 7,81 anni, durata media della malattia 4,", "bt": "We conducted an open-label and randomized trial of adult patients (>18 years) of genetically confirmed sca3 Lngf was administered by intramuscular injection (18 g once daily) for 28 consecutive days.All patients were evaluated at the start of treatment and 2 and 4 weeks after treatment using the Chinese version of the scale for the assessment and evaluation of ataxia (SARA).Twenty-one sca3 patients (10 men and 11 women, average age 39,14 years 7,81 years, average duration of the disease 4,", "questions_src": ["What was the main objective of the study?", "Who were the genetically confirmed adult participants?", "Where was the study conducted?", "When did the treatment last for?", "Which scale was used to evaluate the patients?"], "answers_src": ["To test the efficacy of ngf in sca3 patients", "Genetically confirmed adult ( > 18 years old ) sca3 patients", "Not explicitly mentioned in the sentence", "28 days", "The Chinese version of the scale for assessment and rating of ataxia (SARA)"], "answers_bt": ["To evaluate the effects of Lngf on ataxia in sca3 patients", "Adult patients (>18 years) of genetically confirmed sca3", "Not specified in the sentence", "28 consecutive days", "The Chinese version of the scale for the assessment and evaluation of ataxia (SARA)"], "multiturn": {"turn_1": [{"question_id": "94.1", "question": "What was the main objective of the study?", "answer_src": "To test the efficacy of ngf in sca3 patients", "follow_up_question": "How many weeks did the treatment period last?", "follow_up_response": "2", "follow_up_response_bt": "28"}, {"question_id": "94.2", "question": "Who were the genetically confirmed adult participants?", "answer_src": "Genetically confirmed adult ( > 18 years old ) sca3 patients", "follow_up_question": "How many men and women were enrolled in the study?", "follow_up_response": "10 men and 11 women", "follow_up_response_bt": "10 men and 11 women"}, {"question_id": "94.3", "question": "Where was the study conducted?", "answer_src": "Not explicitly mentioned in the sentence", "follow_up_question": "What was the average age of the participants?", "follow_up_response": "39.14", "follow_up_response_bt": "39.14 years"}, {"question_id": "94.4", "question": "When did the treatment last for?", "answer_src": "28 days", "follow_up_question": "What was the frequency of the ngf administration?", "follow_up_response": "Once daily", "follow_up_response_bt": "18 g once daily"}, {"question_id": "94.5", "question": "Which scale was used to evaluate the patients?", "answer_src": "The Chinese version of the scale for assessment and rating of ataxia (SARA)", "follow_up_question": "How many patients were enrolled in the study?", "follow_up_response": "Twenty-one", "follow_up_response_bt": "21"}], "turn_2": [{"question_id": "94.6", "question": "How many weeks did the treatment period last?", "answer_src": "2", "follow_up_question": "For how many weeks were the patients evaluated after treatment?", "follow_up_response": "2 and 4", "follow_up_response_bt": "2"}, {"question_id": "94.7", "question": "How many men and women were enrolled in the study?", "answer_src": "10 men and 11 women", "follow_up_question": "What was the average age of the participants?", "follow_up_response": "39.14", "follow_up_response_bt": "39.14 years"}, {"question_id": "94.8", "question": "What was the average age of the participants?", "answer_src": "39.14", "follow_up_question": "What was the average disease duration of the participants?", "follow_up_response": "4.14 1.90 years", "follow_up_response_bt": "4,14 years"}, {"question_id": "94.9", "question": "What was the frequency of the ngf administration?", "answer_src": "Once daily", "follow_up_question": "How many patients were enrolled in the study?", "follow_up_response": "Twenty-one", "follow_up_response_bt": "21"}, {"question_id": "94.10", "question": "How many patients were enrolled in the study?", "answer_src": "Twenty-one", "follow_up_question": "What was the average age of the enrolled patients?", "follow_up_response": "39.14", "follow_up_response_bt": "39.14 years"}], "turn_3": [{"question_id": "94.11", "question": "For how many weeks were the patients evaluated after treatment?", "answer_src": "2 and 4", "follow_up_question": "How many patients were enrolled in the study?", "follow_up_response": "Twenty-one", "follow_up_response_bt": "21"}, {"question_id": "94.12", "question": "What was the average age of the participants?", "answer_src": "39.14", "follow_up_question": "What was the average disease duration of the participants?", "follow_up_response": "4.14 1.90 years", "follow_up_response_bt": "4,14 years"}, {"question_id": "94.13", "question": "What was the average disease duration of the participants?", "answer_src": "4.14 1.90 years", "follow_up_question": "What was the average CAG repeats number among the participants?", "follow_up_response": "77.57", "follow_up_response_bt": "No Answer"}, {"question_id": "94.14", "question": "How many patients were enrolled in the study?", "answer_src": "Twenty-one", "follow_up_question": "What was the average age of the enrolled patients?", "follow_up_response": "39.14", "follow_up_response_bt": "39.14 years"}, {"question_id": "94.15", "question": "What was the average age of the enrolled patients?", "answer_src": "39.14", "follow_up_question": "What was the average disease duration of the enrolled patients?", "follow_up_response": "4.14 1.90 years", "follow_up_response_bt": "4,14 years"}]}}
{"id": 95, "src": "bifid condyle is a rare anatomic variation of mandibular condyle . it can be symptomatic or diagnosed incidentally on routine radiographic examination . no definite etiologic factor has been identified .", "mt": "La condale bifida è una rara variazione anatomica della condale mandibolare . può essere sintomatica o diagnosticata incidentalmente durante un esame radiografico di routine . non è stato identificato alcun fattore etiologico definito .", "pert_mt": "La condale bifida è una rara variazione anatomica della condale mandibolare. Può essere sintomatica o diagnosticata incidentalmente durante un esame radiografico di routine. Non è stato identificato alcun fattore etiologico definito e può influenzare la masticazione.", "bt": "Condal bifida is a rare anatomical variation of the mandibular condale.It can be symptomatic or diagnosed incidentally during a routine X-ray examination.No definite etiological factor has been identified and may influence chewing.", "questions_src": ["What is bifid condyle?", "Who can be affected by bifid condyle?", "Where can bifid condyle be found?", "When is bifid condyle typically diagnosed?", "Which type of radiographic examination might reveal bifid condyle?"], "answers_src": ["[\"Bifid condyle is a rare anatomic variation of mandibular condyle\"], [\"No Answer\"], [\"On routine radiographic examination\"], [\"Incidentally\"], [\"Routine radiographic examination\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["Condal bifida", "No Answer", "Mandible", "Incidentally during a routine X-ray examination", "Routine X-ray examination"], "multiturn": {"turn_1": [{"question_id": "95.1", "question": "What is bifid condyle?", "answer_src": "[\"Bifid condyle is a rare anatomic variation of mandibular condyle\"], [\"No Answer\"], [\"On routine radiographic examination\"], [\"Incidentally\"], [\"Routine radiographic examination\"]", "follow_up_question": "What percentage of people have symptomatic bifid condyle?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "95.2", "question": "Who can be affected by bifid condyle?", "answer_src": "bifid condyle is a rare anatomic variation of mandibular condyle . it can be symptomatic or diagnosed incidentally on routine radiographic examination . no definite etiologic factor has been identified .", "follow_up_question": "What symptoms might a person with a symptomatic bifid condyle experience?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "95.3", "question": "Where can bifid condyle be found?", "answer_src": "bifid condyle is a rare anatomic variation of mandibular condyle . it can be symptomatic or diagnosed incidentally on routine radiographic examination . no definite etiologic factor has been identified .", "follow_up_question": "What symptoms might bifid condyle cause?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "95.4", "question": "When is bifid condyle typically diagnosed?", "answer_src": "bifid condyle is a rare anatomic variation of mandibular condyle . it can be symptomatic or diagnosed incidentally on routine radiographic examination . no definite etiologic factor has been identified .", "follow_up_question": "What percentage or likelihood is bifid condyle diagnosed incidentally?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "95.5", "question": "Which type of radiographic examination might reveal bifid condyle?", "answer_src": "bifid condyle is a rare anatomic variation of mandibular condyle . it can be symptomatic or diagnosed incidentally on routine radiographic examination . no definite etiologic factor has been identified .", "follow_up_question": "What specific symptoms might be associated with a symptomatic bifid condyle?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "95.6", "question": "What percentage of people have symptomatic bifid condyle?", "answer_src": "bifid condyle is a rare anatomic variation of mandibular condyle . it can be symptomatic or diagnosed incidentally on routine radiographic examination . no definite etiologic factor has been identified .", "follow_up_question": "What are the symptoms associated with a symptomatic bifid condyle?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "95.7", "question": "What symptoms might a person with a symptomatic bifid condyle experience?", "answer_src": "bifid condyle is a rare anatomic variation of mandibular condyle . it can be symptomatic or diagnosed incidentally on routine radiographic examination . no definite etiologic factor has been identified .", "follow_up_question": "What diagnostic methods are typically used to identify a bifid condyle?", "follow_up_response": "Routine radiographic examination", "follow_up_response_bt": "A routine X-ray examination"}, {"question_id": "95.8", "question": "What symptoms might bifid condyle cause?", "answer_src": "bifid condyle is a rare anatomic variation of mandibular condyle . it can be symptomatic or diagnosed incidentally on routine radiographic examination . no definite etiologic factor has been identified .", "follow_up_question": "Are there any specific diagnostic methods used to identify bifid condyle?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "95.9", "question": "What percentage or likelihood is bifid condyle diagnosed incidentally?", "answer_src": "bifid condyle is a rare anatomic variation of mandibular condyle . it can be symptomatic or diagnosed incidentally on routine radiographic examination . no definite etiologic factor has been identified .", "follow_up_question": "What symptoms might a bifid condyle cause?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "95.10", "question": "What specific symptoms might be associated with a symptomatic bifid condyle?", "answer_src": "bifid condyle is a rare anatomic variation of mandibular condyle . it can be symptomatic or diagnosed incidentally on routine radiographic examination . no definite etiologic factor has been identified .", "follow_up_question": "What diagnostic methods are typically used to identify a bifid condyle?", "follow_up_response": "Routine radiographic examination", "follow_up_response_bt": "A routine X-ray examination"}], "turn_3": [{"question_id": "95.11", "question": "What are the symptoms associated with a symptomatic bifid condyle?", "answer_src": "bifid condyle is a rare anatomic variation of mandibular condyle . it can be symptomatic or diagnosed incidentally on routine radiographic examination . no definite etiologic factor has been identified .", "follow_up_question": "What does the text say about diagnosing a bifid condyle?", "follow_up_response": "it can be symptomatic or diagnosed incidentally on routine radiographic examination", "follow_up_response_bt": "It can be diagnosed incidentally during a routine X-ray examination."}, {"question_id": "95.12", "question": "What diagnostic methods are typically used to identify a bifid condyle?", "answer_src": "Routine radiographic examination", "follow_up_question": "What symptoms might a bifid condyle cause?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "95.13", "question": "Are there any specific diagnostic methods used to identify bifid condyle?", "answer_src": "bifid condyle is a rare anatomic variation of mandibular condyle . it can be symptomatic or diagnosed incidentally on routine radiographic examination . no definite etiologic factor has been identified .", "follow_up_question": "What percentage of the time is bifid condyle diagnosed as symptomatic versus incidentally?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "95.14", "question": "What symptoms might a bifid condyle cause?", "answer_src": "bifid condyle is a rare anatomic variation of mandibular condyle . it can be symptomatic or diagnosed incidentally on routine radiographic examination . no definite etiologic factor has been identified .", "follow_up_question": "What does the text say about how bifid condyle is typically discovered?", "follow_up_response": "it can be symptomatic or diagnosed incidentally on routine radiographic examination.", "follow_up_response_bt": "It can be symptomatic or diagnosed incidentally during a routine X-ray examination."}, {"question_id": "95.15", "question": "What diagnostic methods are typically used to identify a bifid condyle?", "answer_src": "Routine radiographic examination", "follow_up_question": "What symptoms might a bifid condyle cause?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 96, "src": "there were no significant differences between normal and pseudophakic eyes among subjects aged 5069 ( p > 0.05 ) . among subjects aged 7079 , pseudophakic eyes showed improved simulated va ( p = 0.000 ) and objective scattering index values ( p = 0.008 ) . patients with intraocular lenses have similar or superior visual function when compared to those with normal eyes at 26 months after cataract surgery , even under low - contrast conditions .", "mt": "Non ci sono state differenze significative tra gli occhi normali e quelli pseudofakici tra i soggetti di età compresa tra 5069 anni (p > 0,05 ) . tra i soggetti di età compresa tra 7079 anni , gli occhi pseudofakici hanno mostrato un miglioramento del valore del valore del va simulato (p = 0,000) e dell'indice di dispersione obiettivo (p = 0,008) . I pazienti con lenti intraoculari hanno una funzione visiva simile o superiore rispetto a quelli con occhi normali a 26 mesi dopo la chirurgia di cataratta , anche in condizioni di basso contrasto .", "pert_mt": "Non ci sono state differenze significative tra gli occhi normali e quelli pseudofakici tra i soggetti di età compresa tra 50-69 anni (p > 0,05). Tra i soggetti di età compresa tra 70-79 anni, gli occhi pseudofakici hanno mostrato un miglioramento del valore del va simulato (p = 0,000) e dell'indice di dispersione obiettivo (p = 0,008). I pazienti con lenti intraoculari hanno una funzione visiva simile o superiore rispetto a quelli con occhi normali a 26 mesi dopo la chirurgia di cataratta, anche in condizioni di basso contrasto.", "bt": "There were no significant differences between normal and pseudofascular eyes in subjects aged 50-69 years (p > 0,05).Among subjects aged 70-79 years, pseudofascular eyes showed an improvement in the value of the simulated valve (p = 0,000) and the objective dispersion index (p = 0,008).Patients with intraocular lenses had a visual function similar to or greater than those with normal eyes 26 months after cataract surgery, even in low-contrast conditions.", "questions_src": ["What is the main comparison made in the sentence?", "Who had improved visual function according to the sentence?", "Where was the improvement observed in the pseudophakic eyes?", "When did the visual function of patients with intraocular lenses compare to normal eyes?", "Which condition affected the visual function measurements in the sentence?"], "answers_src": ["[\"The visual function of patients with intraocular lenses compared to normal eyes\"], [\"Pseudophakic eyes\"], [\"Simulated VA and objective scattering index values\"], [\"26 months after cataract surgery\"], [\"Low-contrast conditions\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["The comparison between normal and pseudofascular eyes", "Pseudofascular eyes", "The value of the simulated valve and the objective dispersion index", "26 months after cataract surgery", "Intraocular lenses"], "multiturn": {"turn_1": [{"question_id": "96.1", "question": "What is the main comparison made in the sentence?", "answer_src": "[\"The visual function of patients with intraocular lenses compared to normal eyes\"], [\"Pseudophakic eyes\"], [\"Simulated VA and objective scattering index values\"], [\"26 months after cataract surgery\"], [\"Low-contrast conditions\"]", "follow_up_question": "What was the p-value for the improvement in simulated VA for pseudophakic eyes in the 70-79 age group?", "follow_up_response": "0.0", "follow_up_response_bt": "0,000"}, {"question_id": "96.2", "question": "Who had improved visual function according to the sentence?", "answer_src": "there were no significant differences between normal and pseudophakic eyes among subjects aged 5069 ( p > 0.05 ) . among subjects aged 7079 , pseudophakic eyes showed improved simulated va ( p = 0.000 ) and objective scattering index values ( p = 0.008 ) . patients with intraocular lenses have similar or superior visual function when compared to those with normal eyes at 26 months after cataract surgery , even under low - contrast conditions .", "follow_up_question": "Among which age group did pseudophakic eyes show improved visual function?", "follow_up_response": "70-79", "follow_up_response_bt": "70-79 years"}, {"question_id": "96.3", "question": "Where was the improvement observed in the pseudophakic eyes?", "answer_src": "there were no significant differences between normal and pseudophakic eyes among subjects aged 5069 ( p > 0.05 ) . among subjects aged 7079 , pseudophakic eyes showed improved simulated va ( p = 0.000 ) and objective scattering index values ( p = 0.008 ) . patients with intraocular lenses have similar or superior visual function when compared to those with normal eyes at 26 months after cataract surgery , even under low - contrast conditions .", "follow_up_question": "What specific visual function measures improved in pseudophakic eyes for subjects aged 70-79?", "follow_up_response": "Improved simulated va and objective scattering index values", "follow_up_response_bt": "The value of the simulated valve and the objective dispersion index"}, {"question_id": "96.4", "question": "When did the visual function of patients with intraocular lenses compare to normal eyes?", "answer_src": "there were no significant differences between normal and pseudophakic eyes among subjects aged 5069 ( p > 0.05 ) . among subjects aged 7079 , pseudophakic eyes showed improved simulated va ( p = 0.000 ) and objective scattering index values ( p = 0.008 ) . patients with intraocular lenses have similar or superior visual function when compared to those with normal eyes at 26 months after cataract surgery , even under low - contrast conditions .", "follow_up_question": "What was the improvement level of pseudophakic eyes in terms of simulated va for subjects aged 70-79?", "follow_up_response": "p = 0.000", "follow_up_response_bt": "p = 0,000"}, {"question_id": "96.5", "question": "Which condition affected the visual function measurements in the sentence?", "answer_src": "there were no significant differences between normal and pseudophakic eyes among subjects aged 5069 ( p > 0.05 ) . among subjects aged 7079 , pseudophakic eyes showed improved simulated va ( p = 0.000 ) and objective scattering index values ( p = 0.008 ) . patients with intraocular lenses have similar or superior visual function when compared to those with normal eyes at 26 months after cataract surgery , even under low - contrast conditions .", "follow_up_question": "What specific visual function measurements showed improvement for pseudophakic eyes in the age group of 70-79?", "follow_up_response": "simulated va and objective scattering index values", "follow_up_response_bt": "the value of the simulated valve and the objective dispersion index"}], "turn_2": [{"question_id": "96.6", "question": "What was the p-value for the improvement in simulated VA for pseudophakic eyes in the 70-79 age group?", "answer_src": "0.0", "follow_up_question": "What was the p-value for the improvement in objective scattering index for pseudophakic eyes in the 70-79 age group?", "follow_up_response": "0.008", "follow_up_response_bt": "0,008"}, {"question_id": "96.7", "question": "Among which age group did pseudophakic eyes show improved visual function?", "answer_src": "70-79", "follow_up_question": "What specific visual function metric showed improvement for pseudophakic eyes in the 70-79 age group?", "follow_up_response": "Simulated va", "follow_up_response_bt": "the value of the simulated valve"}, {"question_id": "96.8", "question": "What specific visual function measures improved in pseudophakic eyes for subjects aged 70-79?", "answer_src": "Improved simulated va and objective scattering index values", "follow_up_question": "What was the significance of the p-values for the improved visual function measures in pseudophakic eyes for subjects aged 70-79?", "follow_up_response": "p = 0.000", "follow_up_response_bt": "p = 0,000 and p = 0,008"}, {"question_id": "96.9", "question": "What was the improvement level of pseudophakic eyes in terms of simulated va for subjects aged 70-79?", "answer_src": "p = 0.000", "follow_up_question": "What was the p-value for the improvement in objective scattering index values for pseudophakic eyes in subjects aged 70-79?", "follow_up_response": "0.008", "follow_up_response_bt": "0,008"}, {"question_id": "96.10", "question": "What specific visual function measurements showed improvement for pseudophakic eyes in the age group of 70-79?", "answer_src": "simulated va and objective scattering index values", "follow_up_question": "What was the significance of the p-values for the improved visual function measurements in the age group of 70-79?", "follow_up_response": "p = 0.000", "follow_up_response_bt": "p = 0,000 and p = 0,008"}], "turn_3": [{"question_id": "96.11", "question": "What was the p-value for the improvement in objective scattering index for pseudophakic eyes in the 70-79 age group?", "answer_src": "0.008", "follow_up_question": "What was the p-value for the improvement in simulated VA for pseudophakic eyes in the 70-79 age group?", "follow_up_response": "0.0", "follow_up_response_bt": "0,000"}, {"question_id": "96.12", "question": "What specific visual function metric showed improvement for pseudophakic eyes in the 70-79 age group?", "answer_src": "Simulated va", "follow_up_question": "What was the p-value for the improvement in the objective scattering index for pseudophakic eyes in the 70-79 age group?", "follow_up_response": "0.008", "follow_up_response_bt": "0,008"}, {"question_id": "96.13", "question": "What was the significance of the p-values for the improved visual function measures in pseudophakic eyes for subjects aged 70-79?", "answer_src": "p = 0.000", "follow_up_question": "What was the p-value for the objective scattering index values in pseudophakic eyes for subjects aged 70-79?", "follow_up_response": "0.008", "follow_up_response_bt": "0,008"}, {"question_id": "96.14", "question": "What was the p-value for the improvement in objective scattering index values for pseudophakic eyes in subjects aged 70-79?", "answer_src": "0.008", "follow_up_question": "What was the p-value for the improvement in simulated VA for pseudophakic eyes in subjects aged 70-79?", "follow_up_response": "0.0", "follow_up_response_bt": "0,000"}, {"question_id": "96.15", "question": "What was the significance of the p-values for the improved visual function measurements in the age group of 70-79?", "answer_src": "p = 0.000", "follow_up_question": "What was the p-value for the improved objective scattering index values in the age group of 70-79?", "follow_up_response": "0.008", "follow_up_response_bt": "0,008"}]}}
{"id": 97, "src": "superior semicircular canal dehiscence is a relatively new syndrome in the field of otology . it is of unknown etiology presenting with a variety of vestibular and auditory symptoms and radiologic findings play a crucial role in its diagnosis . cone beam computed tomography has been shown to be a powerful tool in the field of otolaryngology .", "mt": "La dehiscenza del canale semicircolare è una sindrome relativamente nuova nel campo dell'otologia . è di etiologia sconosciuta e presenta una varietà di sintomi vestibulari e uditivi e i risultati radiologici svolgono un ruolo cruciale nella sua diagnosi . La tomografia computerizzata a fascio di cono si è dimostrata un potente strumento nel campo dell'otolaringologia .", "pert_mt": "La dehiscenza del canale semicircolare è una sindrome relativamente nuova nel campo dell'otologia. È di etiologia sconosciuta e presenta una varietà di sintomi vestibulari e uditivi, inclusi vertigini e tinnitus, e i risultati radiologici svolgono un ruolo cruciale nella sua diagnosi. La tomografia computerizzata a fascio di cono si è dimostrata un potente strumento nel campo dell'otolaringologia.", "bt": "The dehiscencia of the semicircular canal is a relatively new syndrome in the field of otology.It is of unknown etiology and presents a variety of vestibular and auditory symptoms, including vertigo and tinnitus, and radiological results play a crucial role in its diagnosis.Computerised tomography a fascio di cono has been shown to be a powerful tool in the field of otolaryngology.", "questions_src": ["What is superior semicircular canal dehiscence?", "Who is involved in its diagnosis?", "Where can cone beam computed tomography be used in otolaryngology?", "When was superior semicircular canal dehiscence recognized as a syndrome?", "Which imaging technique has been found to be effective for diagnosing it?"], "answers_src": ["[\"superior semicircular canal dehiscence is a relatively new syndrome in the field of otology\"], [\"radiologic findings\"], [\"in the field of otolaryngology\"], [\"a relatively new\"], [\"cone beam computed tomography\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"superior semicircular canal dehiscence\"], [\"Computerised tomography a fascio di cono\"], [\"otolaryngology\"], [\"a relatively new\"], [\"computerised tomography a fascio di cono\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "97.1", "question": "What is superior semicircular canal dehiscence?", "answer_src": "[\"superior semicircular canal dehiscence is a relatively new syndrome in the field of otology\"], [\"radiologic findings\"], [\"in the field of otolaryngology\"], [\"a relatively new\"], [\"cone beam computed tomography\"]", "follow_up_question": "What specific symptoms does superior semicircular canal dehiscence present with?", "follow_up_response": "vestibular and auditory symptoms", "follow_up_response_bt": "vertigo and tinnitus"}, {"question_id": "97.2", "question": "Who is involved in its diagnosis?", "answer_src": "superior semicircular canal dehiscence is a relatively new syndrome in the field of otology . it is of unknown etiology presenting with a variety of vestibular and auditory symptoms and radiologic findings play a crucial role in its diagnosis . cone beam computed tomography has been shown to be a powerful tool in the field of otolaryngology .", "follow_up_question": "What diagnostic tool has been shown to be particularly useful?", "follow_up_response": "Cone beam computed tomography", "follow_up_response_bt": "Computerised tomography a fascio di cono"}, {"question_id": "97.3", "question": "Where can cone beam computed tomography be used in otolaryngology?", "answer_src": "superior semicircular canal dehiscence is a relatively new syndrome in the field of otology . it is of unknown etiology presenting with a variety of vestibular and auditory symptoms and radiologic findings play a crucial role in its diagnosis . cone beam computed tomography has been shown to be a powerful tool in the field of otolaryngology .", "follow_up_question": "What specific radiologic findings are crucial for diagnosing superior semicircular canal dehiscence?", "follow_up_response": "radiologic findings", "follow_up_response_bt": "Radiological results"}, {"question_id": "97.4", "question": "When was superior semicircular canal dehiscence recognized as a syndrome?", "answer_src": "superior semicircular canal dehiscence is a relatively new syndrome in the field of otology . it is of unknown etiology presenting with a variety of vestibular and auditory symptoms and radiologic findings play a crucial role in its diagnosis . cone beam computed tomography has been shown to be a powerful tool in the field of otolaryngology .", "follow_up_question": "What diagnostic tool is mentioned as being particularly useful for this syndrome?", "follow_up_response": "Cone beam computed tomography", "follow_up_response_bt": "Computerised tomography a fascio di cono"}, {"question_id": "97.5", "question": "Which imaging technique has been found to be effective for diagnosing it?", "answer_src": "superior semicircular canal dehiscence is a relatively new syndrome in the field of otology . it is of unknown etiology presenting with a variety of vestibular and auditory symptoms and radiologic findings play a crucial role in its diagnosis . cone beam computed tomography has been shown to be a powerful tool in the field of otolaryngology .", "follow_up_question": "What specific radiologic findings are crucial for diagnosing superior semicircular canal dehiscence?", "follow_up_response": "radiologic findings", "follow_up_response_bt": "Radiological results"}], "turn_2": [{"question_id": "97.6", "question": "What specific symptoms does superior semicircular canal dehiscence present with?", "answer_src": "vestibular and auditory symptoms", "follow_up_question": "What diagnostic tool has cone beam computed tomography been shown to be effective for?", "follow_up_response": "The field of otolaryngology", "follow_up_response_bt": "Computerised tomography a fascio di cono"}, {"question_id": "97.7", "question": "What diagnostic tool has been shown to be particularly useful?", "answer_src": "Cone beam computed tomography", "follow_up_question": "What specific vestibular and auditory symptoms does superior semicircular canal dehiscence present with?", "follow_up_response": "a variety of vestibular and auditory", "follow_up_response_bt": "vertigo and tinnitus"}, {"question_id": "97.8", "question": "What specific radiologic findings are crucial for diagnosing superior semicircular canal dehiscence?", "answer_src": "radiologic findings", "follow_up_question": "What types of radiologic findings are commonly observed in patients with superior semicircular canal dehiscence?", "follow_up_response": "radiologic findings", "follow_up_response_bt": "Radiological results"}, {"question_id": "97.9", "question": "What diagnostic tool is mentioned as being particularly useful for this syndrome?", "answer_src": "Cone beam computed tomography", "follow_up_question": "What specific radiologic findings are cone beam computed tomography known to reveal in patients with superior semicircular canal dehiscence?", "follow_up_response": "radiologic findings", "follow_up_response_bt": "Computerised tomography a fascio di cono"}, {"question_id": "97.10", "question": "What specific radiologic findings are crucial for diagnosing superior semicircular canal dehiscence?", "answer_src": "radiologic findings", "follow_up_question": "What types of radiologic findings are commonly observed in patients with superior semicircular canal dehiscence?", "follow_up_response": "radiologic findings", "follow_up_response_bt": "Radiological results"}], "turn_3": [{"question_id": "97.11", "question": "What diagnostic tool has cone beam computed tomography been shown to be effective for?", "answer_src": "The field of otolaryngology", "follow_up_question": "What specific radiologic findings does cone beam computed tomography help identify in superior semicircular canal dehiscence?", "follow_up_response": "radiologic findings", "follow_up_response_bt": "Radiological results"}, {"question_id": "97.12", "question": "What specific vestibular and auditory symptoms does superior semicircular canal dehiscence present with?", "answer_src": "a variety of vestibular and auditory", "follow_up_question": "What types of radiologic findings are crucial for diagnosing superior semicircular canal dehiscence?", "follow_up_response": "Radiologic findings", "follow_up_response_bt": "Radiological results"}, {"question_id": "97.13", "question": "What types of radiologic findings are commonly observed in patients with superior semicircular canal dehiscence?", "answer_src": "radiologic findings", "follow_up_question": "What specific radiologic finding is cone beam computed tomography particularly good at identifying in these patients?", "follow_up_response": "radiologic findings", "follow_up_response_bt": "Cone beam computed tomography"}, {"question_id": "97.14", "question": "What specific radiologic findings are cone beam computed tomography known to reveal in patients with superior semicircular canal dehiscence?", "answer_src": "radiologic findings", "follow_up_question": "What types of vestibular symptoms are commonly associated with superior semicircular canal dehiscence?", "follow_up_response": "various", "follow_up_response_bt": "vertigo and tinnitus"}, {"question_id": "97.15", "question": "What types of radiologic findings are commonly observed in patients with superior semicircular canal dehiscence?", "answer_src": "radiologic findings", "follow_up_question": "What specific radiologic finding is cone beam computed tomography particularly good at identifying in these patients?", "follow_up_response": "radiologic findings", "follow_up_response_bt": "Cone beam computed tomography"}]}}
{"id": 98, "src": "the scores were recorded and compared within and between groups pre - treatment , immediately post - treatment , and 3 months post - treatment . [ results ] intra- and intergroup comparisons immediately and 3 months post - treatment showed extracorporeal shock wave therapy decreased pain to a significantly greater extent than ultrasound therapy . [ conclusion ] extracorporeal shock wave therapy can significantly reduce pain in patients with chronic tennis elbow .", "mt": "I punteggi sono stati registrati e confrontati all'interno e tra i gruppi pre-trattamento , immediatamente post-trattamento e 3 mesi post-trattamento . [ risultati ] I confronti intra-e intergruppo immediatamente e 3 mesi post-trattamento hanno mostrato che la terapia con onde d'urto extracorporee ha ridotto il dolore in misura significativamente maggiore rispetto all'ultrasonografia . [ conclusione ] La terapia con onde d'urto extracorporee può ridurre significativamente il dolore nei pazienti con gomito cronica di tennis .", "pert_mt": "I punteggi sono stati registrati e confrontati all'interno e tra i gruppi pre-trattamento, immediatamente post-trattamento e 3 mesi post-trattamento. [ risultati ] I confronti intra-e intergruppo immediatamente e 3 mesi post-trattamento hanno mostrato che la terapia con onde d'ururie extracorporee ha ridotto il dolore in misura significativamente maggiore rispetto all'ultrasonografia. [ conclusione ] La terapia con onde d'ururie extracorporee può ridurre significativamente il dolore nei pazienti con gomito cronica di tennis.", "bt": "Scores were recorded and compared within and between pre-treatment, immediately post-treatment and 3 months post-treatment groups.[ results ] Comparisons between immediate intra-group and 3 months post-treatment showed that therapy with extracorporeal urethra significantly reduced pain more than ultrasound therapy.[ conclusion] Extracorporeal urethra therapy can significantly reduce pain in patients with chronic tennis knee pain.", "questions_src": ["What was the main focus of the study?", "Who showed a significant decrease in pain?", "Where were the comparisons made?", "When were the immediate and 3-month post-treatment results collected?", "Which therapy was found to be more effective?"], "answers_src": ["The scores were recorded and compared over time periods.", "Extracorporeal shock wave therapy", "Within and between groups pre-treatment, immediately post-treatment, and 3 months post-treatment", "Immediately and 3 months post-treatment", "Extracorporeal shock wave therapy"], "answers_bt": ["Comparisons between treatment groups", "Extracorporeal urethra therapy", "Within and between pre-treatment, immediately post-treatment and 3 months post-treatment groups", "Immediately post-treatment and 3 months post-treatment", "Extracorporeal urethra therapy"], "multiturn": {"turn_1": [{"question_id": "98.1", "question": "What was the main focus of the study?", "answer_src": "The scores were recorded and compared over time periods.", "follow_up_question": "How many time periods were the scores recorded and compared?", "follow_up_response": "3", "follow_up_response_bt": "3"}, {"question_id": "98.2", "question": "Who showed a significant decrease in pain?", "answer_src": "Extracorporeal shock wave therapy", "follow_up_question": "How much did extracorporeal shock wave therapy decrease pain to a significantly greater extent than ultrasound therapy?", "follow_up_response": "a significantly greater extent", "follow_up_response_bt": "Extracorporeal urethra therapy"}, {"question_id": "98.3", "question": "Where were the comparisons made?", "answer_src": "Within and between groups pre-treatment, immediately post-treatment, and 3 months post-treatment", "follow_up_question": "What specific outcome was found to be significantly reduced by extracorporeal shock wave therapy?", "follow_up_response": "pain", "follow_up_response_bt": "pain"}, {"question_id": "98.4", "question": "When were the immediate and 3-month post-treatment results collected?", "answer_src": "Immediately and 3 months post-treatment", "follow_up_question": "What specific outcome did the study find regarding the effectiveness of extracorporeal shock wave therapy compared to ultrasound therapy?", "follow_up_response": "Extracorporeal shock wave therapy decreased pain to a significantly greater extent than ultrasound therapy.", "follow_up_response_bt": "Extracorporeal urethra therapy can significantly reduce pain more than ultrasound therapy."}, {"question_id": "98.5", "question": "Which therapy was found to be more effective?", "answer_src": "Extracorporeal shock wave therapy", "follow_up_question": "By how much did extracorporeal shock wave therapy decrease pain more significantly?", "follow_up_response": "a significantly greater extent", "follow_up_response_bt": "Extracorporeal urethra therapy"}], "turn_2": [{"question_id": "98.6", "question": "How many time periods were the scores recorded and compared?", "answer_src": "3", "follow_up_question": "What specific outcomes did extracorporeal shock wave therapy show compared to ultrasound therapy?", "follow_up_response": "extracorporeal shock wave therapy decreased pain to a significantly greater extent than ultrasound therapy", "follow_up_response_bt": "Extracorporeal shock wave therapy significantly reduced pain more than ultrasound therapy."}, {"question_id": "98.7", "question": "How much did extracorporeal shock wave therapy decrease pain to a significantly greater extent than ultrasound therapy?", "answer_src": "a significantly greater extent", "follow_up_question": "By how many percentage points did extracorporeal shock wave therapy decrease pain more than ultrasound therapy?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "98.8", "question": "What specific outcome was found to be significantly reduced by extracorporeal shock wave therapy?", "answer_src": "pain", "follow_up_question": "How did the treatments compare at 3 months post-treatment?", "follow_up_response": "extracorporeal shock wave therapy decreased pain to a significantly greater extent than ultrasound therapy", "follow_up_response_bt": "Extracorporeal urethra therapy significantly reduced pain more than ultrasound therapy"}, {"question_id": "98.9", "question": "What specific outcome did the study find regarding the effectiveness of extracorporeal shock wave therapy compared to ultrasound therapy?", "answer_src": "Extracorporeal shock wave therapy decreased pain to a significantly greater extent than ultrasound therapy.", "follow_up_question": "What was the timeframe during which the significant difference in pain reduction was observed between the two therapies?", "follow_up_response": "3 months post-treatment", "follow_up_response_bt": "3 months post-treatment"}, {"question_id": "98.10", "question": "By how much did extracorporeal shock wave therapy decrease pain more significantly?", "answer_src": "a significantly greater extent", "follow_up_question": "By how much did the decrease in pain due to extracorporeal shock wave therapy exceed that of ultrasound therapy?", "follow_up_response": "a significantly greater extent", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "98.11", "question": "What specific outcomes did extracorporeal shock wave therapy show compared to ultrasound therapy?", "answer_src": "extracorporeal shock wave therapy decreased pain to a significantly greater extent than ultrasound therapy", "follow_up_question": "How long after treatment did these differences in pain reduction become significant?", "follow_up_response": "3 months", "follow_up_response_bt": "3 months"}, {"question_id": "98.12", "question": "By how many percentage points did extracorporeal shock wave therapy decrease pain more than ultrasound therapy?", "answer_src": "the scores were recorded and compared within and between groups pre - treatment , immediately post - treatment , and 3 months post - treatment . [ results ] intra- and intergroup comparisons immediately and 3 months post - treatment showed extracorporeal shock wave therapy decreased pain to a significantly greater extent than ultrasound therapy . [ conclusion ] extracorporeal shock wave therapy can significantly reduce pain in patients with chronic tennis elbow .", "follow_up_question": "By what percentage did extracorporeal shock wave therapy decrease pain at 3 months post-treatment?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "98.13", "question": "How did the treatments compare at 3 months post-treatment?", "answer_src": "extracorporeal shock wave therapy decreased pain to a significantly greater extent than ultrasound therapy", "follow_up_question": "What was the effect of the treatments immediately after treatment?", "follow_up_response": "Extracorporeal shock wave therapy decreased pain to a significantly greater extent than ultrasound therapy.", "follow_up_response_bt": "Extracorporeal urethra therapy significantly reduced pain more than ultrasound therapy."}, {"question_id": "98.14", "question": "What was the timeframe during which the significant difference in pain reduction was observed between the two therapies?", "answer_src": "3 months post-treatment", "follow_up_question": "What specific pain metric was found to decrease more significantly with extracorporeal shock wave therapy?", "follow_up_response": "pain", "follow_up_response_bt": "pain"}, {"question_id": "98.15", "question": "By how much did the decrease in pain due to extracorporeal shock wave therapy exceed that of ultrasound therapy?", "answer_src": "a significantly greater extent", "follow_up_question": "By what percentage did the decrease in pain due to extracorporeal shock wave therapy exceed that of ultrasound therapy?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 99, "src": "the positive and negative syndrome scale ( panss ) was applied to assess the psychotic symptoms and aggression risk at baseline , week 2 , 4 , and 6 of the study.the results of this study showed that both protocols significantly decreased the scores on all subscales of the panss and supplemental aggression risk subscale as well as panss total score over the study . however , this improvement was significantly higher in zn sulfate receiving group compared to the placebo group . no major clinical side - effects were detected.it may be concluded that zn is an effective adjuvant agent in the management of patients with schizophrenia .", "mt": "La scala delle sindrome positive e negative (pans) è stata applicata per valutare i sintomi psicotici e il rischio di aggressione al punto di partenza , settimana 2 , 4 e 6 dello studio.I risultati di questo studio hanno mostrato che entrambi i protocolli hanno ridotto significativamente i punteggi su tutte le sottoscali delle pans e la sottoscala di rischio di aggressione supplementare nonché il punteggio totale delle pans durante lo studio . Tuttavia , questo miglioramento è stato significativamente maggiore nel gruppo che ha ricevuto il sulfato di zn rispetto al gruppo placebo . Non sono stati rilevati effetti collaterali clinici importanti.Si può concludere che zn è un agente adjuvante efficace nella gestione dei pazienti con schizofrenia .", "pert_mt": "La scala delle sindrome positive e negative (pans) è stata applicata per valutare i sintomi psicotici e il rischio di aggressione al punto di partenza, settimana 2, 4 e 6 dello studio. I risultati di questo studio hanno mostrato che entrambi i protocolli hanno ridotto significativamente i punteggi su tutte le sottoscali delle pans e la sottoscala di rischio di aggressione supplementare nonché il punteggio totale delle pans durante lo studio. Tuttavia, questo miglioramento è stato significativamente maggiore nel gruppo che ha ricevuto il sulfato di zn rispetto al gruppo placebo. Non sono stati rilevati effetti collaterali clinici importanti. Si può concludere che zn è un agente adjuvante efficace nella gestione dei pazienti con schizofren", "bt": "The positive and negative syndrome (pans) scale was applied to assess psychotic symptoms and the risk of aggression at the starting point, week 2, 4 and 6 of the study.The results of this study showed that both protocols significantly reduced scores on all sub-scales of the panes and the sub-scale of risk of additional aggression as well as the total score of the panes during the study.However, this improvement was significantly greater in the group that received sulfate than in the placebo group.No significant clinical side effects were observed.It can be concluded that it is an effective adjuvant agent in the management of patients with schizophrenia.", "questions_src": ["What did the positive and negative syndrome scale (PANS) assess at baseline, week 2, 4, and 6 of the study?", "When were the results of the study presented?", "Which group showed a significantly higher improvement in PANS scores?", "What was the outcome regarding clinical side-effects of the treatment?", "Which substance was found to be an effective adjuvant agent in the management of patients with schizophrenia?"], "answers_src": ["Psychotic symptoms and aggression risk", "Over the study", "The zinc sulfate receiving group", "No major clinical side-effects were detected", "Zinc"], "answers_bt": ["Psychotic symptoms and the risk of aggression", "During the study", "The group that received sulfate", "No significant clinical side effects were observed", "Sulfate"], "multiturn": {"turn_1": [{"question_id": "99.1", "question": "What did the positive and negative syndrome scale (PANS) assess at baseline, week 2, 4, and 6 of the study?", "answer_src": "Psychotic symptoms and aggression risk", "follow_up_question": "What specific subscales of the PANS did the study show significant improvements in?", "follow_up_response": "all subscales of the panss and supplemental aggression risk subscale", "follow_up_response_bt": "all sub-scales of the pans and the sub-scale of risk of additional aggression"}, {"question_id": "99.2", "question": "When were the results of the study presented?", "answer_src": "Over the study", "follow_up_question": "What specific subscales showed significant improvement in the zinc sulfate group?", "follow_up_response": "all subscales of the panss and supplemental aggression risk subscale", "follow_up_response_bt": "No Answer"}, {"question_id": "99.3", "question": "Which group showed a significantly higher improvement in PANS scores?", "answer_src": "The zinc sulfate receiving group", "follow_up_question": "What was the average percentage decrease in PANS scores for the zinc sulfate receiving group compared to the placebo group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "99.4", "question": "What was the outcome regarding clinical side-effects of the treatment?", "answer_src": "No major clinical side-effects were detected", "follow_up_question": "How many time points were assessments conducted for the PANSS scores?", "follow_up_response": "4", "follow_up_response_bt": "4"}, {"question_id": "99.5", "question": "Which substance was found to be an effective adjuvant agent in the management of patients with schizophrenia?", "answer_src": "Zinc", "follow_up_question": "What specific subscales of the PANSS showed significant improvement in the zinc group?", "follow_up_response": "all subscales of the panss and supplemental aggression risk subscale", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "99.6", "question": "What specific subscales of the PANS did the study show significant improvements in?", "answer_src": "all subscales of the panss and supplemental aggression risk subscale", "follow_up_question": "What was the magnitude of the improvement in the PANSS total score for the zinc sulfate group compared to the placebo group?", "follow_up_response": "significantly higher", "follow_up_response_bt": "No Answer"}, {"question_id": "99.7", "question": "What specific subscales showed significant improvement in the zinc sulfate group?", "answer_src": "all subscales of the panss and supplemental aggression risk subscale", "follow_up_question": "Which subscale had the greatest improvement in the zinc sulfate group?", "follow_up_response": "Supplemental aggression risk subscale", "follow_up_response_bt": "No Answer"}, {"question_id": "99.8", "question": "What was the average percentage decrease in PANS scores for the zinc sulfate receiving group compared to the placebo group?", "answer_src": "the positive and negative syndrome scale ( panss ) was applied to assess the psychotic symptoms and aggression risk at baseline , week 2 , 4 , and 6 of the study.the results of this study showed that both protocols significantly decreased the scores on all subscales of the panss and supplemental aggression risk subscale as well as panss total score over the study . however , this improvement was significantly higher in zn sulfate receiving group compared to the placebo group . no major clinical side - effects were detected.it may be concluded that zn is an effective adjuvant agent in the management of patients with schizophrenia .", "follow_up_question": "By how much did the PANS total score decrease for the zinc sulfate receiving group compared to the placebo group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "99.9", "question": "How many time points were assessments conducted for the PANSS scores?", "answer_src": "4", "follow_up_question": "What was the trend in PANSS scores across the four assessment time points?", "follow_up_response": "Both protocols significantly decreased the scores on all subscales of the PANSS and supplemental aggression risk subscale as well as PANSS total score over the study.", "follow_up_response_bt": "Both protocols significantly reduced scores on all sub-scales of the PANSS and the sub-scale of risk of additional aggression as well as the total score of the PANSS during the study."}, {"question_id": "99.10", "question": "What specific subscales of the PANSS showed significant improvement in the zinc group?", "answer_src": "all subscales of the panss and supplemental aggression risk subscale", "follow_up_question": "Which subscale had the greatest improvement in the zinc group according to the study?", "follow_up_response": "Supplemental aggression risk subscale", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "99.11", "question": "What was the magnitude of the improvement in the PANSS total score for the zinc sulfate group compared to the placebo group?", "answer_src": "significantly higher", "follow_up_question": "By how much did the PANSS total score decrease for the zinc sulfate group compared to the placebo group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "99.12", "question": "Which subscale had the greatest improvement in the zinc sulfate group?", "answer_src": "Supplemental aggression risk subscale", "follow_up_question": "What was the average percentage decrease in the PANS-S total score for the zinc sulfate group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "99.13", "question": "By how much did the PANS total score decrease for the zinc sulfate receiving group compared to the placebo group?", "answer_src": "the positive and negative syndrome scale ( panss ) was applied to assess the psychotic symptoms and aggression risk at baseline , week 2 , 4 , and 6 of the study.the results of this study showed that both protocols significantly decreased the scores on all subscales of the panss and supplemental aggression risk subscale as well as panss total score over the study . however , this improvement was significantly higher in zn sulfate receiving group compared to the placebo group . no major clinical side - effects were detected.it may be concluded that zn is an effective adjuvant agent in the management of patients with schizophrenia .", "follow_up_question": "By what percentage did the PANS total score decrease for the zinc sulfate receiving group compared to the placebo group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "99.14", "question": "What was the trend in PANSS scores across the four assessment time points?", "answer_src": "Both protocols significantly decreased the scores on all subscales of the PANSS and supplemental aggression risk subscale as well as PANSS total score over the study.", "follow_up_question": "How much did the PANSS scores decrease by the end of the 6-week study?", "follow_up_response": "This improvement was significantly higher in zn sulfate receiving group compared to the placebo group.", "follow_up_response_bt": "No Answer"}, {"question_id": "99.15", "question": "Which subscale had the greatest improvement in the zinc group according to the study?", "answer_src": "Supplemental aggression risk subscale", "follow_up_question": "What was the average percentage decrease in the panss total score for the zinc group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 100, "src": "the written information contained in the accident reports pertaining to contextual and technical elements were used.the study used multiple case qualitative content analysis . this descriptive study was based on the content analysis of the 788 reports from the commission de la sant et de la scurit du travail du qubec [ workers compensation board ( wcb ) ] investigating the fatal work - related accidents between 1990 and 2005 . the study was descriptive ( number and percentages ) .", "mt": "Lo studio ha utilizzato un'analisi qualitativa di contenuti di casi multipli . Questo studio descrittivo si è basato sull'analisi del contenuto dei 788 rapporti della commissione di la sant e de la scurit du travail du qubec (comitato di compensazione dei lavoratori) che hanno indagato sugli incidenti fatali legati al lavoro tra il 1990 e il 2005 . Lo studio era descrittivo (numero e percentuale) .", "pert_mt": "Lo studio ha utilizzato un'analisi qualitativa di contenuti di casi multipli. Questo studio descrittivo si è basato sull'analisi del contenuto dei 788 rapporti della commissione di la sant e de la scurit du travail du qubec (comitato di compensazione dei lavoratori) che hanno indagato sugli incidenti fatali legati al lavoro tra il 1990 e il 2005. Lo studio era descrittivo (numero e percentuale), e ha incluso una analisi delle cause principali degli incidenti.", "bt": "This descriptive study is based on the content analysis of 788 reports by the commission de la santé et de la sécurité du travail du qubec (committee on workers' compensation) investigating fatal incidents at work between 1990 and 2005.The study was descriptive (number and percentage), and included an analysis of the main causes of incidents.", "questions_src": ["What is the name of the organization that provided the accident reports for the study?", "Who conducted the study using multiple case qualitative content analysis?", "Where did the accident reports come from?", "When did the fatal work-related accidents investigated by the WCB occur?", "Which content analysis method was used in the study?"], "answers_src": ["Commission de la santé et de la sécurité du travail du Québec [Workers Compensation Board (WCB)]", "This descriptive study", "from the commission de la santé et de la sécurité du travail du Québec [Workers Compensation Board (WCB)] investigating the fatal work - related accidents between 1990 and 2005", "between 1990 and 2005", "multiple case qualitative content analysis"], "answers_bt": ["[\"commission de la santé et de la sécurité du travail du qubec (committee on workers\" compensation)\", \"This descriptive study\", \"between 1990 and 2005\", \"descriptive (number and percentage)\", \"multiple case qualitative content analysis\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "100.1", "question": "What is the name of the organization that provided the accident reports for the study?", "answer_src": "Commission de la santé et de la sécurité du travail du Québec [Workers Compensation Board (WCB)]", "follow_up_question": "How many accident reports were analyzed in the study?", "follow_up_response": "788", "follow_up_response_bt": "788"}, {"question_id": "100.2", "question": "Who conducted the study using multiple case qualitative content analysis?", "answer_src": "This descriptive study", "follow_up_question": "What was the main focus of the content analysis in the study?", "follow_up_response": "The content analysis of the 788 reports", "follow_up_response_bt": "The main causes of incidents"}, {"question_id": "100.3", "question": "Where did the accident reports come from?", "answer_src": "from the commission de la santé et de la sécurité du travail du Québec [Workers Compensation Board (WCB)] investigating the fatal work - related accidents between 1990 and 2005", "follow_up_question": "What specific elements of the accident reports were analyzed?", "follow_up_response": "contextual and technical elements", "follow_up_response_bt": "main causes"}, {"question_id": "100.4", "question": "When did the fatal work-related accidents investigated by the WCB occur?", "answer_src": "between 1990 and 2005", "follow_up_question": "What percentage of the 788 reports analyzed by the study dealt with fatal accidents?", "follow_up_response": "100%", "follow_up_response_bt": "No Answer"}, {"question_id": "100.5", "question": "Which content analysis method was used in the study?", "answer_src": "multiple case qualitative content analysis", "follow_up_question": "What percentage of the accident reports analyzed were fatal?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "100.6", "question": "How many accident reports were analyzed in the study?", "answer_src": "788", "follow_up_question": "What percentage of the total cases did these 788 reports represent?", "follow_up_response": "100%", "follow_up_response_bt": "78.8%"}, {"question_id": "100.7", "question": "What was the main focus of the content analysis in the study?", "answer_src": "The content analysis of the 788 reports", "follow_up_question": "What specific contextual and technical elements were analyzed in the reports?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "100.8", "question": "What specific elements of the accident reports were analyzed?", "answer_src": "contextual and technical elements", "follow_up_question": "What percentage of the accident reports analyzed were related to technical elements?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "100.9", "question": "What percentage of the 788 reports analyzed by the study dealt with fatal accidents?", "answer_src": "100%", "follow_up_question": "What were the main contextual elements identified in the fatal work-related accidents according to the study?", "follow_up_response": "Contextual and technical elements", "follow_up_response_bt": "The main causes of incidents"}, {"question_id": "100.10", "question": "What percentage of the accident reports analyzed were fatal?", "answer_src": "the written information contained in the accident reports pertaining to contextual and technical elements were used.the study used multiple case qualitative content analysis . this descriptive study was based on the content analysis of the 788 reports from the commission de la sant et de la scurit du travail du qubec [ workers compensation board ( wcb ) ] investigating the fatal work - related accidents between 1990 and 2005 . the study was descriptive ( number and percentages ) .", "follow_up_question": "What percentage of the fatal work-related accidents were investigated by the WCB?", "follow_up_response": "100%", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "100.11", "question": "What percentage of the total cases did these 788 reports represent?", "answer_src": "100%", "follow_up_question": "What were the main findings of the qualitative content analysis conducted in the study?", "follow_up_response": "Number and percentages", "follow_up_response_bt": "The main causes of incidents"}, {"question_id": "100.12", "question": "What specific contextual and technical elements were analyzed in the reports?", "answer_src": "the written information contained in the accident reports pertaining to contextual and technical elements were used.the study used multiple case qualitative content analysis . this descriptive study was based on the content analysis of the 788 reports from the commission de la sant et de la scurit du travail du qubec [ workers compensation board ( wcb ) ] investigating the fatal work - related accidents between 1990 and 2005 . the study was descriptive ( number and percentages ) .", "follow_up_question": "What types of data did the qualitative content analysis focus on?", "follow_up_response": "Contextual and technical elements", "follow_up_response_bt": "Number and percentage"}, {"question_id": "100.13", "question": "What percentage of the accident reports analyzed were related to technical elements?", "answer_src": "the written information contained in the accident reports pertaining to contextual and technical elements were used.the study used multiple case qualitative content analysis . this descriptive study was based on the content analysis of the 788 reports from the commission de la sant et de la scurit du travail du qubec [ workers compensation board ( wcb ) ] investigating the fatal work - related accidents between 1990 and 2005 . the study was descriptive ( number and percentages ) .", "follow_up_question": "What percentage of the accident reports analyzed were related to contextual elements?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "100.14", "question": "What were the main contextual elements identified in the fatal work-related accidents according to the study?", "answer_src": "Contextual and technical elements", "follow_up_question": "What percentage of the fatal work-related accidents analyzed in the study involved technical issues?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "100.15", "question": "What percentage of the fatal work-related accidents were investigated by the WCB?", "answer_src": "100%", "follow_up_question": "What were the main contextual elements analyzed in the qualitative content analysis?", "follow_up_response": "Contextual and technical", "follow_up_response_bt": "The main causes of incidents"}]}}
{"id": 101, "src": "functional gastrointestinal disorder ( fgid ) is one of the commonest digestive diseases worldwide and leads to significant morbidity and burden on healthcare resource . the putative bio - psycho - social pathophysiological model for fgid underscores the importance of psychological distress in the pathogenesis of fgid . concomitant psychological disorders , notably anxiety and depressive disorders , are strongly associated with fgid and these psychological co - morbidities correlate with severity of fgid symptoms .", "mt": "Il modello bio-psico-sociale patofisiologico per il fgid sottolinea l'importanza del stress psicologico nella patogenesi del fgid . I disturbi psicologici concomitanti , in particolare l'ansia e i disturbi depressivi , sono fortemente associati al fgid e queste co-morbidità psicologiche correlazionano con la gravità dei sintomi del fgid .", "pert_mt": "Il modello bio-psico-sociale patofisiologico per il fgid sottolinea l'importanza del stress psicologico nella patogenesi del fgid. I disturbi psicologici concomitanti, in particolare l'ansia e i disturbi depressivi, sono fortemente associati al fgid e queste co-morbidità psicologiche correlazionano con la gravità dei sintomi del fgid e con l'uso di farmaci antidepressivi.", "bt": "The bio-psycho-social pathophysiological model for fgid emphasizes the importance of psychological stress in the pathogenesis of fgid.Concomitant psychological disorders, particularly anxiety and depressive disorders, are strongly associated with fgid and these psychological co-morbidities correlate with the severity of fgid symptoms and with the use of antidepressant medications.", "questions_src": ["What is one of the commonest digestive diseases worldwide according to the sentence?", "Who are strongly associated with FGID according to the sentence?", "Where does FGID lead to significant morbidity and burden on healthcare resources according to the sentence?", "Which psychological disorders are strongly associated with FGID and correlate with severity of FGID symptoms?", "When was the putative bio-psycho-social pathophysiological model for FGID proposed according to the sentence?"], "answers_src": ["functional gastrointestinal disorder (fgid)", "Anxiety and depressive disorders", "worldwide", "Anxiety and depressive disorders", "No Answer"], "answers_bt": ["Functional gastrointestinal disorders", "Anxiety and depressive disorders", "No Answer", "Anxiety and depressive disorders", "No Answer"], "multiturn": {"turn_1": [{"question_id": "101.1", "question": "What is one of the commonest digestive diseases worldwide according to the sentence?", "answer_src": "functional gastrointestinal disorder (fgid)", "follow_up_question": "How does the text suggest psychological distress impacts functional gastrointestinal disorder?", "follow_up_response": "the putative bio - psycho - social pathophysiological model for fgid underscores the importance of psychological distress in the pathogenesis of fgid", "follow_up_response_bt": "The text suggests that psychological stress impacts the pathogenesis of FGID."}, {"question_id": "101.2", "question": "Who are strongly associated with FGID according to the sentence?", "answer_src": "Anxiety and depressive disorders", "follow_up_question": "What is the relationship between psychological co-morbidities and FGID symptom severity?", "follow_up_response": "These psychological co-morbidities correlate with severity of FGID symptoms.", "follow_up_response_bt": "These psychological co-morbidities correlate with the severity of FGID symptoms"}, {"question_id": "101.3", "question": "Where does FGID lead to significant morbidity and burden on healthcare resources according to the sentence?", "answer_src": "worldwide", "follow_up_question": "What specific psychological disorders are strongly associated with FGID according to the text?", "follow_up_response": "Anxiety and depressive disorders", "follow_up_response_bt": "Anxiety and depressive disorders"}, {"question_id": "101.4", "question": "Which psychological disorders are strongly associated with FGID and correlate with severity of FGID symptoms?", "answer_src": "Anxiety and depressive disorders", "follow_up_question": "What percentage or level of correlation does the text suggest between psychological co-morbidities and severity of FGID symptoms?", "follow_up_response": "strongly correlated", "follow_up_response_bt": "The severity of FGID symptoms"}, {"question_id": "101.5", "question": "When was the putative bio-psycho-social pathophysiological model for FGID proposed according to the sentence?", "answer_src": "functional gastrointestinal disorder ( fgid ) is one of the commonest digestive diseases worldwide and leads to significant morbidity and burden on healthcare resource . the putative bio - psycho - social pathophysiological model for fgid underscores the importance of psychological distress in the pathogenesis of fgid . concomitant psychological disorders , notably anxiety and depressive disorders , are strongly associated with fgid and these psychological co - morbidities correlate with severity of fgid symptoms .", "follow_up_question": "What psychological disorders are strongly associated with FGID according to the text?", "follow_up_response": "Anxiety and depressive disorders", "follow_up_response_bt": "Anxiety and depressive disorders"}], "turn_2": [{"question_id": "101.6", "question": "How does the text suggest psychological distress impacts functional gastrointestinal disorder?", "answer_src": "the putative bio - psycho - social pathophysiological model for fgid underscores the importance of psychological distress in the pathogenesis of fgid", "follow_up_question": "What specific psychological disorders are strongly associated with FGID according to the text?", "follow_up_response": "Anxiety and depressive disorders", "follow_up_response_bt": "Anxiety and depressive disorders"}, {"question_id": "101.7", "question": "What is the relationship between psychological co-morbidities and FGID symptom severity?", "answer_src": "These psychological co-morbidities correlate with severity of FGID symptoms.", "follow_up_question": "How does the presence of anxiety disorders specifically impact FGID symptom severity?", "follow_up_response": "These psychological co-morbidities correlate with severity of FGID symptoms.", "follow_up_response_bt": "Anxiety disorders correlate with the severity of FGID symptoms"}, {"question_id": "101.8", "question": "What specific psychological disorders are strongly associated with FGID according to the text?", "answer_src": "Anxiety and depressive disorders", "follow_up_question": "What is the correlation between the severity of FGID symptoms and the presence of these psychological co-morbidities?", "follow_up_response": "These psychological co-morbidities correlate with severity of FGID symptoms.", "follow_up_response_bt": "These psychological co-morbidities"}, {"question_id": "101.9", "question": "What percentage or level of correlation does the text suggest between psychological co-morbidities and severity of FGID symptoms?", "answer_src": "strongly correlated", "follow_up_question": "What specific psychological disorders are strongly associated with FGID according to the text?", "follow_up_response": "Anxiety and depressive disorders", "follow_up_response_bt": "Anxiety and depressive disorders"}, {"question_id": "101.10", "question": "What psychological disorders are strongly associated with FGID according to the text?", "answer_src": "Anxiety and depressive disorders", "follow_up_question": "How do these psychological co-morbidities correlate with the severity of FGID symptoms?", "follow_up_response": "These psychological co-morbidities correlate with the severity of FGID symptoms.", "follow_up_response_bt": "With the severity of FGID symptoms"}], "turn_3": [{"question_id": "101.11", "question": "What specific psychological disorders are strongly associated with FGID according to the text?", "answer_src": "Anxiety and depressive disorders", "follow_up_question": "What is the correlation between the severity of FGID symptoms and the presence of these psychological co-morbidities?", "follow_up_response": "These psychological co-morbidities correlate with severity of FGID symptoms.", "follow_up_response_bt": "These psychological co-morbidities"}, {"question_id": "101.12", "question": "How does the presence of anxiety disorders specifically impact FGID symptom severity?", "answer_src": "These psychological co-morbidities correlate with severity of FGID symptoms.", "follow_up_question": "What type of psychological disorder is most strongly associated with FGID according to the text?", "follow_up_response": "Anxiety and depressive disorders", "follow_up_response_bt": "Anxiety and depressive disorders"}, {"question_id": "101.13", "question": "What is the correlation between the severity of FGID symptoms and the presence of these psychological co-morbidities?", "answer_src": "These psychological co-morbidities correlate with severity of FGID symptoms.", "follow_up_question": "How does the presence of anxiety and depressive disorders specifically relate to the severity of FGID symptoms?", "follow_up_response": "These psychological co-morbidities correlate with severity of FGID symptoms.", "follow_up_response_bt": "These psychological co-morbidities correlate with the severity of FGID symptoms"}, {"question_id": "101.14", "question": "What specific psychological disorders are strongly associated with FGID according to the text?", "answer_src": "Anxiety and depressive disorders", "follow_up_question": "What is the correlation between the severity of FGID symptoms and the presence of these psychological co-morbidities?", "follow_up_response": "These psychological co-morbidities correlate with severity of FGID symptoms.", "follow_up_response_bt": "These psychological co-morbidities"}, {"question_id": "101.15", "question": "How do these psychological co-morbidities correlate with the severity of FGID symptoms?", "answer_src": "These psychological co-morbidities correlate with the severity of FGID symptoms.", "follow_up_question": "What specific psychological disorders are strongly associated with FGID?", "follow_up_response": "Anxiety and depressive disorders", "follow_up_response_bt": "Anxiety and depressive disorders"}]}}
{"id": 102, "src": "chest pain is a rare sign of thoracal endometriosis associated with endometrioma of the tubo - ovarian endometrioma . we report the case periodic episodes of chest pain concurrent with menstruation in a 35-year - old female , in which ovarian endometrioma was diagnosed and left - sided oophorectomy was performed . after surgery , patient underwent medical treatment which included a gn - rh agonist and a combined oral contraceptive .", "mt": "Il dolore toracale è un raro segno di endometriosis toracale associato all'endometrioma del tubo - endometrioma ovarico . segnaliamo il caso di episodi periodici di dolore toracico concomitante alla mestruazione in una donna di 35 anni , in cui è stato diagnosticato un endometrioma ovarico e è stata eseguita un'oforetomia laterale sinistra . Dopo l'intervento chirurgico , il paziente ha subito un trattamento medico che ha incluso un gn-rhonist e un contraccettivo orale combinato .", "pert_mt": "Il dolore toracale è un raro segno di endometriosis toracale associato all'endometrioma del tubo - endometrioma ovarico. Segnaliamo il caso di episodi periodici di dolore toracico concomitante alla mestruazione in una donna di 35 anni, in cui è stato diagnosticato un endometrioma ovarico e è stata eseguita un'oftalmochirurgia laterale sinistra. Dopo l'intervento chirurgico, il paziente ha subito un trattamento medico che ha incluso un gn-rhonist e un contraccettivo orale combinato.", "bt": "Chest pain is a rare sign of chest endometriosis associated with tube endometriosis - ovarian endometriosis.For example, there were periodic episodes of chest pain that accompanied menstruation in a 35-year-old woman, where an ovarian endometriosis was diagnosed and left-sided oftalmotherapy was performed.After surgery, the patient underwent medical treatment that included a rhonist and a combined oral contraceptive.", "questions_src": ["What is the age of the patient mentioned in the sentence?", "Who was diagnosed with ovarian endometrioma during the medical treatment?", "Where was the endometrioma located on the ovaries?", "When did the patient experience periodic episodes of chest pain?", "Which medication was used for medical treatment after surgery?"], "answers_src": ["35-year-old female", "Ovarian endometrioma", "Left-sided", "Periodic episodes", "Gn-Rh agonist and a combined oral contraceptive"], "answers_bt": ["35-year-old woman", "Ovarian endometrioma", "Left side", "Periodic episodes of chest pain", "Rhinostomy"], "multiturn": {"turn_1": [{"question_id": "102.1", "question": "What is the age of the patient mentioned in the sentence?", "answer_src": "35-year-old female", "follow_up_question": "How long did the patient experience periodic episodes of chest pain before the diagnosis?", "follow_up_response": "No Answer", "follow_up_response_bt": "periodically"}, {"question_id": "102.2", "question": "Who was diagnosed with ovarian endometrioma during the medical treatment?", "answer_src": "Ovarian endometrioma", "follow_up_question": "What was the reason for performing a left-sided oophorectomy?", "follow_up_response": "Ovarian endometrioma was diagnosed", "follow_up_response_bt": "No Answer"}, {"question_id": "102.3", "question": "Where was the endometrioma located on the ovaries?", "answer_src": "Left-sided", "follow_up_question": "What type of medical treatment did the patient receive after surgery?", "follow_up_response": "A Gn-RH agonist and a combined oral contraceptive", "follow_up_response_bt": "rhonist and a combined oral contraceptive"}, {"question_id": "102.4", "question": "When did the patient experience periodic episodes of chest pain?", "answer_src": "Periodic episodes", "follow_up_question": "How long were the episodes of chest pain during menstruation?", "follow_up_response": "Periodic", "follow_up_response_bt": "Periodic"}, {"question_id": "102.5", "question": "Which medication was used for medical treatment after surgery?", "answer_src": "Gn-Rh agonist and a combined oral contraceptive", "follow_up_question": "What is the purpose of the combined oral contraceptive in this treatment regimen?", "follow_up_response": "to prevent ovulation", "follow_up_response_bt": "To treat the condition"}], "turn_2": [{"question_id": "102.6", "question": "How long did the patient experience periodic episodes of chest pain before the diagnosis?", "answer_src": "chest pain is a rare sign of thoracal endometriosis associated with endometrioma of the tubo - ovarian endometrioma . we report the case periodic episodes of chest pain concurrent with menstruation in a 35-year - old female , in which ovarian endometrioma was diagnosed and left - sided oophorectomy was performed . after surgery , patient underwent medical treatment which included a gn - rh agonist and a combined oral contraceptive .", "follow_up_question": "How many months were likely between the onset of chest pain and the diagnosis?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "102.7", "question": "What was the reason for performing a left-sided oophorectomy?", "answer_src": "Ovarian endometrioma was diagnosed", "follow_up_question": "What type of medication did the patient receive after surgery?", "follow_up_response": "GN-RH agonist and a combined oral contraceptive", "follow_up_response_bt": "rhonist and a combined oral contraceptive"}, {"question_id": "102.8", "question": "What type of medical treatment did the patient receive after surgery?", "answer_src": "A Gn-RH agonist and a combined oral contraceptive", "follow_up_question": "What was the primary purpose of the combined oral contraceptive in her treatment plan?", "follow_up_response": "To manage symptoms", "follow_up_response_bt": "To manage symptoms"}, {"question_id": "102.9", "question": "How long were the episodes of chest pain during menstruation?", "answer_src": "Periodic", "follow_up_question": "How many episodes of chest pain occurred during each menstrual cycle?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "102.10", "question": "What is the purpose of the combined oral contraceptive in this treatment regimen?", "answer_src": "to prevent ovulation", "follow_up_question": "What side effect might the Gn-RH agonist cause?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "102.11", "question": "How many months were likely between the onset of chest pain and the diagnosis?", "answer_src": "chest pain is a rare sign of thoracal endometriosis associated with endometrioma of the tubo - ovarian endometrioma . we report the case periodic episodes of chest pain concurrent with menstruation in a 35-year - old female , in which ovarian endometrioma was diagnosed and left - sided oophorectomy was performed . after surgery , patient underwent medical treatment which included a gn - rh agonist and a combined oral contraceptive .", "follow_up_question": "How long did the patient wait before undergoing medical treatment after the diagnosis?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "102.12", "question": "What type of medication did the patient receive after surgery?", "answer_src": "GN-RH agonist and a combined oral contraceptive", "follow_up_question": "What is the purpose of the combined oral contraceptive in this case?", "follow_up_response": "To manage symptoms", "follow_up_response_bt": "To treat the chest pain"}, {"question_id": "102.13", "question": "What was the primary purpose of the combined oral contraceptive in her treatment plan?", "answer_src": "To manage symptoms", "follow_up_question": "What specific symptoms did the combined oral contraceptive help manage?", "follow_up_response": "chest pain", "follow_up_response_bt": "No Answer"}, {"question_id": "102.14", "question": "How many episodes of chest pain occurred during each menstrual cycle?", "answer_src": "chest pain is a rare sign of thoracal endometriosis associated with endometrioma of the tubo - ovarian endometrioma . we report the case periodic episodes of chest pain concurrent with menstruation in a 35-year - old female , in which ovarian endometrioma was diagnosed and left - sided oophorectomy was performed . after surgery , patient underwent medical treatment which included a gn - rh agonist and a combined oral contraceptive .", "follow_up_question": "How long did the patient continue medical treatment after surgery?", "follow_up_response": "medical treatment which included a Gn-RH agonist and a combined oral contraceptive", "follow_up_response_bt": "For medical treatment that included a rhinostomy and a combined oral contraceptive"}, {"question_id": "102.15", "question": "What side effect might the Gn-RH agonist cause?", "answer_src": "chest pain is a rare sign of thoracal endometriosis associated with endometrioma of the tubo - ovarian endometrioma . we report the case periodic episodes of chest pain concurrent with menstruation in a 35-year - old female , in which ovarian endometrioma was diagnosed and left - sided oophorectomy was performed . after surgery , patient underwent medical treatment which included a gn - rh agonist and a combined oral contraceptive .", "follow_up_question": "What other medical treatment did the patient receive after surgery?", "follow_up_response": "a Gn-RH agonist and a combined oral contraceptive", "follow_up_response_bt": "rhonist and a combined oral contraceptive"}]}}
{"id": 103, "src": "the clinical experience was a total of 12 weeks . groups were compared according to several variables including second semester exam scores , hesi scores , and quality and timeliness of clinical paperwork . over a two - year period , seventy - one undergraduate nursing students in the second semester medical - surgical nursing course participated .", "mt": "L'esperienza clinica è stata complessiva di 12 settimane . I gruppi sono stati confrontati secondo diverse variabili tra cui i punteggi degli esami del secondo semestre , i punteggi di hesy e la qualità e tempestività della documentazione clinica . Durante un periodo di due anni , sono stati coinvolti settanta e uno studenti universitari di infermieristica del corso di infermeria medica-chirurgica del secondo semestre .", "pert_mt": "L'esperienza clinica è stata complessiva di 12 settimane. I gruppi sono stati confrontati secondo diverse variabili tra cui i punteggi degli esami del secondo semestre, i punteggi di hesy e la qualità e tempestività della documentazione clinica. Durante un periodo di due anni, sono stati coinvolti settanta e uno studenti universitari di infermieristica del corso di infermeria medica-chirurgica del secondo semestre, e si è verificato un miglioramento significativo nella gestione dei pazienti.", "bt": "The clinical experience was a total of 12 weeks, and the groups were compared according to various variables including second-semester exam scores, hesy scores and the quality and timeliness of clinical documentation.Over a two-year period, seventy-one university nursing students from the second-semester medical-surgical nursing course were involved, and a significant improvement in patient management was observed.", "questions_src": ["What was the total duration of the clinical experience?", "Who participated in the study?", "Which semester did the second semester exam scores pertain to?", "What scores were included in the comparison?", "Where did the study take place?"], "answers_src": ["12 weeks", "seventy-one undergraduate nursing students", "second", "hesi scores and second semester exam scores", "medical-surgical nursing course"], "answers_bt": ["12 weeks", "Seventy-one university nursing students", "Second", "Second-semester exam scores, hesy scores", "University"], "multiturn": {"turn_1": [{"question_id": "103.1", "question": "What was the total duration of the clinical experience?", "answer_src": "12 weeks", "follow_up_question": "How many students participated in the study?", "follow_up_response": "71", "follow_up_response_bt": "71"}, {"question_id": "103.2", "question": "Who participated in the study?", "answer_src": "seventy-one undergraduate nursing students", "follow_up_question": "What was the average score on the second semester exam for the participating students?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "103.3", "question": "Which semester did the second semester exam scores pertain to?", "answer_src": "second", "follow_up_question": "What specific variable was the second semester exam scores compared against?", "follow_up_response": "No Answer", "follow_up_response_bt": "Second-semester exam scores"}, {"question_id": "103.4", "question": "What scores were included in the comparison?", "answer_src": "hesi scores and second semester exam scores", "follow_up_question": "What was the average score difference between the groups based on these variables?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "103.5", "question": "Where did the study take place?", "answer_src": "medical-surgical nursing course", "follow_up_question": "What specific variable was used to compare the groups besides exam scores and HESI scores?", "follow_up_response": "quality and timeliness of clinical paperwork", "follow_up_response_bt": "the quality and timeliness of clinical documentation"}], "turn_2": [{"question_id": "103.6", "question": "How many students participated in the study?", "answer_src": "71", "follow_up_question": "What was the average score on the second semester exam for the groups?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "103.7", "question": "What was the average score on the second semester exam for the participating students?", "answer_src": "the clinical experience was a total of 12 weeks . groups were compared according to several variables including second semester exam scores , hesi scores , and quality and timeliness of clinical paperwork . over a two - year period , seventy - one undergraduate nursing students in the second semester medical - surgical nursing course participated .", "follow_up_question": "What were the average HESI scores for the participating students?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "103.8", "question": "What specific variable was the second semester exam scores compared against?", "answer_src": "the clinical experience was a total of 12 weeks . groups were compared according to several variables including second semester exam scores , hesi scores , and quality and timeliness of clinical paperwork . over a two - year period , seventy - one undergraduate nursing students in the second semester medical - surgical nursing course participated .", "follow_up_question": "What other variables besides second semester exam scores were used for comparison?", "follow_up_response": "hesi scores and quality and timeliness of clinical paperwork", "follow_up_response_bt": "hesy scores and the quality and timeliness of clinical documentation"}, {"question_id": "103.9", "question": "What was the average score difference between the groups based on these variables?", "answer_src": "the clinical experience was a total of 12 weeks . groups were compared according to several variables including second semester exam scores , hesi scores , and quality and timeliness of clinical paperwork . over a two - year period , seventy - one undergraduate nursing students in the second semester medical - surgical nursing course participated .", "follow_up_question": "What were the specific variables used to compare the groups?", "follow_up_response": "second semester exam scores, hesi scores, and quality and timeliness of clinical paperwork", "follow_up_response_bt": "second-semester exam scores, hesy scores and the quality and timeliness of clinical documentation"}, {"question_id": "103.10", "question": "What specific variable was used to compare the groups besides exam scores and HESI scores?", "answer_src": "quality and timeliness of clinical paperwork", "follow_up_question": "What was the average score for the second semester exam among the participants?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "103.11", "question": "What was the average score on the second semester exam for the groups?", "answer_src": "the clinical experience was a total of 12 weeks . groups were compared according to several variables including second semester exam scores , hesi scores , and quality and timeliness of clinical paperwork . over a two - year period , seventy - one undergraduate nursing students in the second semester medical - surgical nursing course participated .", "follow_up_question": "What were the average HESI scores for the groups?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "103.12", "question": "What were the average HESI scores for the participating students?", "answer_src": "the clinical experience was a total of 12 weeks . groups were compared according to several variables including second semester exam scores , hesi scores , and quality and timeliness of clinical paperwork . over a two - year period , seventy - one undergraduate nursing students in the second semester medical - surgical nursing course participated .", "follow_up_question": "What were the average second semester exam scores for the participating students?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "103.13", "question": "What other variables besides second semester exam scores were used for comparison?", "answer_src": "hesi scores and quality and timeliness of clinical paperwork", "follow_up_question": "What was the average score on the HESI for the participating students?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "103.14", "question": "What were the specific variables used to compare the groups?", "answer_src": "second semester exam scores, hesi scores, and quality and timeliness of clinical paperwork", "follow_up_question": "What was the average score for the second semester exam among the participants?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "103.15", "question": "What was the average score for the second semester exam among the participants?", "answer_src": "the clinical experience was a total of 12 weeks . groups were compared according to several variables including second semester exam scores , hesi scores , and quality and timeliness of clinical paperwork . over a two - year period , seventy - one undergraduate nursing students in the second semester medical - surgical nursing course participated .", "follow_up_question": "What were the average HESI scores among the participants?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 104, "src": "we investigated erg protein expression in a cohort of 198 men with localized pca . erg expression was correlated with patients ' clinical outcome and several pathological parameters , including gleason score ( gs ) , pathological stage , surgical margin , and extra - capsular extension . erg expression was detected in 86/198 ( 43.4% ) patients exclusively in neoplastic epithelium .", "mt": "Abbiamo studiato l' espressione della proteina erg in una coorte di 198 uomini con pca localizzata . L' espressione erg è stata correlata con il risultato clinico dei pazienti e diversi parametri patologici , tra cui il punteggio di gleason (gs) , lo stadio patologico , il margine chirurgico e l' estensione extra-capsulare . L' espressione erg è stata rilevata in 86/198 (43,4%) pazienti esclusivamente nell' epitelio neoplastico .", "pert_mt": "Abbiamo studiato l' espressione della proteina erg in una coorte di 198 uomini con pca localizzata. L' espressione erg è stata correlata con il risultato clinico dei pazienti e diversi parametri patologici, tra cui il punteggio di Gleason (GS), lo stadio patologico, il margine chirurgico, l' estensione extra-capsulare e la storia familiare. L' espressione erg è stata rilevata in 86/198 (43,4%) pazienti esclusivamente nell' epitelio neoplastico.", "bt": "We studied the expression of the erg protein in a cohort of 198 men with localized pca.Erg expression was correlated with the clinical outcome of patients and various pathological parameters, including Gleason score (GS), pathological stage, surgical margin, extra-capsular extension and family history.Erg expression was detected in 86/198 (43.4%) patients exclusively in the neoplastic epithelium.", "questions_src": ["What is the Gleason score (GS) correlated with in the sentence?", "Who were the subjects in the study?", "Where was the investigation conducted?", "Which percentage of patients had erg expression detected?", "Which pathological parameters were correlated with erg expression?"], "answers_src": ["Gleason score (GS)", "a cohort of 198 men", "in a cohort of 198 men with localized pca", "43.4%", "pathological stage, surgical margin, and extra - capsular extension"], "answers_bt": ["Gleason score (GS)", "a cohort of 198 men", "in the neoplastic epithelium", "43.4%", "pathological stage, surgical margin, extra-capsular extension and family history"], "multiturn": {"turn_1": [{"question_id": "104.1", "question": "What is the Gleason score (GS) correlated with in the sentence?", "answer_src": "Gleason score (GS)", "follow_up_question": "What percentage of patients had erg expression exclusively in neoplastic epithelium?", "follow_up_response": "43.4%", "follow_up_response_bt": "43.4%"}, {"question_id": "104.2", "question": "Who were the subjects in the study?", "answer_src": "a cohort of 198 men", "follow_up_question": "What percentage of these men had exclusively detectable erg expression in their neoplastic epithelium?", "follow_up_response": "43.4%", "follow_up_response_bt": "43.4%"}, {"question_id": "104.3", "question": "Where was the investigation conducted?", "answer_src": "in a cohort of 198 men with localized pca", "follow_up_question": "What percentage of patients had exclusively detectable erg expression in their neoplastic epithelium?", "follow_up_response": "43.4%", "follow_up_response_bt": "43.4%"}, {"question_id": "104.4", "question": "Which percentage of patients had erg expression detected?", "answer_src": "43.4%", "follow_up_question": "What was the average gleason score among patients with erg expression?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "104.5", "question": "Which pathological parameters were correlated with erg expression?", "answer_src": "pathological stage, surgical margin, and extra - capsular extension", "follow_up_question": "Which percentage of patients had erg expression detected in neoplastic epithelium?", "follow_up_response": "43.4%", "follow_up_response_bt": "43.4%"}], "turn_2": [{"question_id": "104.6", "question": "What percentage of patients had erg expression exclusively in neoplastic epithelium?", "answer_src": "43.4%", "follow_up_question": "How many patients had erg expression in both neoplastic and non-neoplastic epithelium?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "104.7", "question": "What percentage of these men had exclusively detectable erg expression in their neoplastic epithelium?", "answer_src": "43.4%", "follow_up_question": "What was the average gleason score among the patients with exclusively detectable erg expression in their neoplastic epithelium?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "104.8", "question": "What percentage of patients had exclusively detectable erg expression in their neoplastic epithelium?", "answer_src": "43.4%", "follow_up_question": "How many patients had detectable erg expression in both neoplastic and non-neoplastic epithelium?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "104.9", "question": "What was the average gleason score among patients with erg expression?", "answer_src": "we investigated erg protein expression in a cohort of 198 men with localized pca . erg expression was correlated with patients ' clinical outcome and several pathological parameters , including gleason score ( gs ) , pathological stage , surgical margin , and extra - capsular extension . erg expression was detected in 86/198 ( 43.4% ) patients exclusively in neoplastic epithelium .", "follow_up_question": "What pathological parameter had the highest detection rate among patients with erg expression?", "follow_up_response": "Pathological stage", "follow_up_response_bt": "Pathological stage"}, {"question_id": "104.10", "question": "Which percentage of patients had erg expression detected in neoplastic epithelium?", "answer_src": "43.4%", "follow_up_question": "What was the correlation between erg expression and pathological stage?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "104.11", "question": "How many patients had erg expression in both neoplastic and non-neoplastic epithelium?", "answer_src": "we investigated erg protein expression in a cohort of 198 men with localized pca . erg expression was correlated with patients ' clinical outcome and several pathological parameters , including gleason score ( gs ) , pathological stage , surgical margin , and extra - capsular extension . erg expression was detected in 86/198 ( 43.4% ) patients exclusively in neoplastic epithelium .", "follow_up_question": "How many patients had erg expression exclusively in non-neoplastic epithelium?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "104.12", "question": "What was the average gleason score among the patients with exclusively detectable erg expression in their neoplastic epithelium?", "answer_src": "we investigated erg protein expression in a cohort of 198 men with localized pca . erg expression was correlated with patients ' clinical outcome and several pathological parameters , including gleason score ( gs ) , pathological stage , surgical margin , and extra - capsular extension . erg expression was detected in 86/198 ( 43.4% ) patients exclusively in neoplastic epithelium .", "follow_up_question": "What were the pathological parameters that erg expression was correlated with?", "follow_up_response": "gleason score ( gs ) , pathological stage , surgical margin and extra - capsular extension", "follow_up_response_bt": "Gleason score (GS), pathological stage, surgical margin, extra-capsular extension and family history"}, {"question_id": "104.13", "question": "How many patients had detectable erg expression in both neoplastic and non-neoplastic epithelium?", "answer_src": "we investigated erg protein expression in a cohort of 198 men with localized pca . erg expression was correlated with patients ' clinical outcome and several pathological parameters , including gleason score ( gs ) , pathological stage , surgical margin , and extra - capsular extension . erg expression was detected in 86/198 ( 43.4% ) patients exclusively in neoplastic epithelium .", "follow_up_question": "How many patients had detectable erg expression exclusively in neoplastic epithelium?", "follow_up_response": "86", "follow_up_response_bt": "86"}, {"question_id": "104.14", "question": "What pathological parameter had the highest detection rate among patients with erg expression?", "answer_src": "Pathological stage", "follow_up_question": "What was the detection rate of erg expression in neoplastic epithelium?", "follow_up_response": "43.4%", "follow_up_response_bt": "43.4%"}, {"question_id": "104.15", "question": "What was the correlation between erg expression and pathological stage?", "answer_src": "we investigated erg protein expression in a cohort of 198 men with localized pca . erg expression was correlated with patients ' clinical outcome and several pathological parameters , including gleason score ( gs ) , pathological stage , surgical margin , and extra - capsular extension . erg expression was detected in 86/198 ( 43.4% ) patients exclusively in neoplastic epithelium .", "follow_up_question": "What pathological parameter besides Gleason score was erg expression correlated with?", "follow_up_response": "pathological stage\", \"surgical margin\", \"extra - capsular extension", "follow_up_response_bt": "pathological stage\", \"surgical margin\", \"extra-capsular extension\", \"family history"}]}}
{"id": 105, "src": "type ii acots fall into the ' hot dog ' fold superfamily . there are currently six human type ii genes ; however , two homologous proteins , thioesterase superfamily members 4 ( them4 ) and 5 ( them5 ) share common type ii structural features and , in the case of them4 , acyl - coa thioesterase activity -- suggesting that the family may be larger than previously realised . although recent studies have greatly expanded the current understanding of these proteins and their physiological importance , there are a number of members whose functions are relatively unexplored and which warrant further investigation .", "mt": "I acotti II rientrano nella superfamiglia a doppio raggio di cani caldi . Attualmente ci sono sei geni di tipo ii umano; tuttavia , due proteine omologhe , i membri della superfamiglia di tioesterasi 4 (them4 ) e 5 (them5 ) condividono caratteristiche strutturali comuni di tipo ii e , nel caso di tipo ii4 , l'attività di acilo-coa tioesterasi - suggerendo che la famiglia potrebbe essere più grande di quanto si realizzasse in precedenza .", "pert_mt": "I acotti II rientrano nella superfamiglia a doppio raggio di cani caldi. Attualmente ci sono sei geni di tipo II umano; tuttavia, due proteine omologhe, i membri della superfamiglia di tioesterasi 4 (them4) e 5 (them5), condividono caratteristiche strutturali comuni di tipo II e, nel caso di tipo II4, l'attività di acilo-coa tioesterasi - suggerendo che la famiglia potrebbe essere più grande di quanto si realizzasse in precedenza e includere anche membri di tipo I.", "bt": "I acotti II belong to the superfamily of double-ray caldi canines.There are currently six human type II genes; however, two homologous proteins, the members of the thioesterase superfamily of type 4 (them4) and 5 (them5), share common structural characteristics of type II and, in the case of type II4, the activity of acyl-coa thioesterase - suggesting that the family could be larger than it previously realized and also include members of type I.", "questions_src": ["What is the 'hot dog' fold superfamily?", "Who shares common type II structural features with Them4 and Them5?", "Where are there currently six human Type II genes?", "When have recent studies greatly expanded the understanding of these proteins?", "Which homologous protein has acyl-CoA thioesterase activity?"], "answers_src": ["[\"type II acots\"], [\"Them4 and Them5\"], [\"human\"], [\"recently\"], [\"Them4\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"double-ray caldi canines\"], [\"thioesterase superfamily of type 4 (them4) and 5 (them5)\"], [], [\"recent studies\"], [\"type II4\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "105.1", "question": "What is the 'hot dog' fold superfamily?", "answer_src": "[\"type II acots\"], [\"Them4 and Them5\"], [\"human\"], [\"recently\"], [\"Them4\"]", "follow_up_question": "What specific function do Them4 and Them5 share?", "follow_up_response": "acyl-CoA thioesterase activity", "follow_up_response_bt": "The activity of acyl-coa thioesterase"}, {"question_id": "105.2", "question": "Who shares common type II structural features with Them4 and Them5?", "answer_src": "type ii acots fall into the ' hot dog ' fold superfamily . there are currently six human type ii genes ; however , two homologous proteins , thioesterase superfamily members 4 ( them4 ) and 5 ( them5 ) share common type ii structural features and , in the case of them4 , acyl - coa thioesterase activity -- suggesting that the family may be larger than previously realised . although recent studies have greatly expanded the current understanding of these proteins and their physiological importance , there are a number of members whose functions are relatively unexplored and which warrant further investigation .", "follow_up_question": "What other member of the type II acot family is mentioned to have unexplored functions?", "follow_up_response": "them4", "follow_up_response_bt": "them4 and them5"}, {"question_id": "105.3", "question": "Where are there currently six human Type II genes?", "answer_src": "type ii acots fall into the ' hot dog ' fold superfamily . there are currently six human type ii genes ; however , two homologous proteins , thioesterase superfamily members 4 ( them4 ) and 5 ( them5 ) share common type ii structural features and , in the case of them4 , acyl - coa thioesterase activity -- suggesting that the family may be larger than previously realised . although recent studies have greatly expanded the current understanding of these proteins and their physiological importance , there are a number of members whose functions are relatively unexplored and which warrant further investigation .", "follow_up_question": "What evidence suggests the 'hot dog' fold superfamily might be larger than previously thought?", "follow_up_response": "the presence of two homologous proteins, thioesterase superfamily members 4 (them4) and 5 (them5), sharing common type ii structural features and, in the case of them4, acyl-CoA thioesterase activity", "follow_up_response_bt": "The activity of acyl-coa thioesterase - suggesting that the family could be larger than it previously realized"}, {"question_id": "105.4", "question": "When have recent studies greatly expanded the understanding of these proteins?", "answer_src": "type ii acots fall into the ' hot dog ' fold superfamily . there are currently six human type ii genes ; however , two homologous proteins , thioesterase superfamily members 4 ( them4 ) and 5 ( them5 ) share common type ii structural features and , in the case of them4 , acyl - coa thioesterase activity -- suggesting that the family may be larger than previously realised . although recent studies have greatly expanded the current understanding of these proteins and their physiological importance , there are a number of members whose functions are relatively unexplored and which warrant further investigation .", "follow_up_question": "What evidence does the text provide for the suggestion that the family of these proteins may be larger than previously thought?", "follow_up_response": "Two homologous proteins, thioesterase superfamily members 4 (them4) and 5 (them5), share common type II structural features and, in the case of them4, acyl-CoA thioesterase activity", "follow_up_response_bt": "The activity of acyl-CoA thioesterase - suggesting that the family could be larger than it previously realized"}, {"question_id": "105.5", "question": "Which homologous protein has acyl-CoA thioesterase activity?", "answer_src": "type ii acots fall into the ' hot dog ' fold superfamily . there are currently six human type ii genes ; however , two homologous proteins , thioesterase superfamily members 4 ( them4 ) and 5 ( them5 ) share common type ii structural features and , in the case of them4 , acyl - coa thioesterase activity -- suggesting that the family may be larger than previously realised . although recent studies have greatly expanded the current understanding of these proteins and their physiological importance , there are a number of members whose functions are relatively unexplored and which warrant further investigation .", "follow_up_question": "Which homologous protein shares common type II structural features with them4?", "follow_up_response": "them5", "follow_up_response_bt": "them5"}], "turn_2": [{"question_id": "105.6", "question": "What specific function do Them4 and Them5 share?", "answer_src": "acyl-CoA thioesterase activity", "follow_up_question": "What other type ii acyl-CoA thioesterase activities have been discovered recently?", "follow_up_response": "thioesterase superfamily members 4 ( them4 ) and 5 ( them5 )", "follow_up_response_bt": "type II4"}, {"question_id": "105.7", "question": "What other member of the type II acot family is mentioned to have unexplored functions?", "answer_src": "them4", "follow_up_question": "What is the function of them4 mentioned in the text?", "follow_up_response": "acyl - coa thioesterase activity", "follow_up_response_bt": "The activity of acyl-coa thioesterase"}, {"question_id": "105.8", "question": "What evidence suggests the 'hot dog' fold superfamily might be larger than previously thought?", "answer_src": "the presence of two homologous proteins, thioesterase superfamily members 4 (them4) and 5 (them5), sharing common type ii structural features and, in the case of them4, acyl-CoA thioesterase activity", "follow_up_question": "What additional information is provided about the functions of the two homologous proteins, Them4 and Them5?", "follow_up_response": "suggesting that the family may be larger than previously realised", "follow_up_response_bt": "suggesting that the family could be larger than it previously realized and also include members of type I."}, {"question_id": "105.9", "question": "What evidence does the text provide for the suggestion that the family of these proteins may be larger than previously thought?", "answer_src": "Two homologous proteins, thioesterase superfamily members 4 (them4) and 5 (them5), share common type II structural features and, in the case of them4, acyl-CoA thioesterase activity", "follow_up_question": "What additional evidence does the text mention for the possibility of more members in this protein family?", "follow_up_response": "acyl-CoA thioesterase activity", "follow_up_response_bt": "the presence of members of the thioesterase superfamily of type 4 (them4) and 5 (them5)"}, {"question_id": "105.10", "question": "Which homologous protein shares common type II structural features with them4?", "answer_src": "them5", "follow_up_question": "What is the function of them4 besides sharing structural features with them5?", "follow_up_response": "acyl - coa thioesterase activity", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "105.11", "question": "What other type ii acyl-CoA thioesterase activities have been discovered recently?", "answer_src": "thioesterase superfamily members 4 ( them4 ) and 5 ( them5 )", "follow_up_question": "What specific function is still relatively unexplored for some members of this family?", "follow_up_response": "acyl-CoA thioesterase activity", "follow_up_response_bt": "acyl-coa thioesterase"}, {"question_id": "105.12", "question": "What is the function of them4 mentioned in the text?", "answer_src": "acyl - coa thioesterase activity", "follow_up_question": "What other member's function is suggested to be relatively unexplored in the text?", "follow_up_response": "them4", "follow_up_response_bt": "acyl-coa thioesterase"}, {"question_id": "105.13", "question": "What additional information is provided about the functions of the two homologous proteins, Them4 and Them5?", "answer_src": "suggesting that the family may be larger than previously realised", "follow_up_question": "What specific function is Them4 known to have?", "follow_up_response": "acyl-CoA thioesterase activity", "follow_up_response_bt": "No Answer"}, {"question_id": "105.14", "question": "What additional evidence does the text mention for the possibility of more members in this protein family?", "answer_src": "acyl-CoA thioesterase activity", "follow_up_question": "What other type of proteins besides acyl-CoA thioesterase activity suggest the presence of more members in this protein family?", "follow_up_response": "thioesterase superfamily members 4 ( them4 ) and 5 ( them5 )", "follow_up_response_bt": "them4 and them5"}, {"question_id": "105.15", "question": "What is the function of them4 besides sharing structural features with them5?", "answer_src": "acyl - coa thioesterase activity", "follow_up_question": "What other type ii acots share common structural features with them4?", "follow_up_response": "thioesterase superfamily members 4 ( them4 ) and 5 ( them5 )", "follow_up_response_bt": "type I"}]}}
{"id": 106, "src": "objectiveserine - threonine kinase stk11 catalyzes the amp - activated protein kinase complex . we tested the hypothesis that a gene variant in stk11 contributes to variation in insulin sensitivity and metformin efficacy.research design and methodswe studied the effects of a single nucleotide polymorphism ( snp ) ( rs8111699 ) in stk11 on endocrine - metabolic and body composition indexes before and after 1 year of metformin in 85 hyperinsulinemic girls with androgen excess , representing a continuum from prepuberal girls with a combined history of low birth weight and precocious pubarche over to postmenarchial girls with hyperinsulinemic ovarian hyperandrogenism . metformin was dosed at 425 mg / day in younger girls and 850 mg / day in older girls .", "mt": "I nostri obiettivi di ricerca sono studiare gli effetti di un singolo polimorfismo nucleotidico (snp) (rs8111699) in stk11 sugli indici endocrini - metabolici e della composizione corporea prima e dopo un anno di metformina in 85 ragazze iperinsulinemiche con eccesso di androgeni , che rappresentano un continuum di ragazze prepubere con una storia combinata di basso peso alla nascita e pubertà precoce verso ragazze postmenarchiche con iperinsulinemia ovarica .", "pert_mt": "I nostri obiettivi di ricerca sono studiare gli effetti di un singolo polimorfismo nucleotidico (snp) (rs8111699) in stk11 sugli indici endocrini - metabolici e della composizione corporea prima e dopo un anno di metformina in 85 ragazze iperinsulinemiche con eccesso di androgeni, e le loro reazioni psicologiche, che rappresentano un continuum di ragazze prepubere con una storia combinata di basso peso alla nascita e pubertà precoce verso ragazze postmenarchiche con iperinsulinemia ovarica.", "bt": "Our research objectives are to study the effects of a single nucleotide polymorphism (snp) (rs8111699) in paragraph11 on endocrine - metabolic and body composition before and after a year of metformin in 85 hyperinsulinemic androgen-excess girls, and their psychological reactions, which represent a continuum of prepubescent girls with a combined history of low birth weight and early puberty versus postmenarchial girls with ovarian hyperinsulinemia.", "questions_src": ["What is the full name of the kinase mentioned in the sentence?", "Who conducted the study to test the hypothesis about stk11 and insulin sensitivity?", "Where were the girls recruited for the study?", "When was metformin dosed at different levels for the girls?", "Which specific SNP (rs8111699) in stk11 was studied in the girls?"], "answers_src": ["objectiveserine - threonine kinase stk11", "we", "hyperinsulinemic girls with androgen excess", "younger girls and older girls", "rs8111699"], "answers_bt": ["[\"stk11\"], [\"No Answer\"], [\"No Answer\"], [\"No Answer\"], [\"rs8111699\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "106.1", "question": "What is the full name of the kinase mentioned in the sentence?", "answer_src": "objectiveserine - threonine kinase stk11", "follow_up_question": "What is the dosage of metformin used in the study for younger girls?", "follow_up_response": "425 mg / day", "follow_up_response_bt": "No Answer"}, {"question_id": "106.2", "question": "Who conducted the study to test the hypothesis about stk11 and insulin sensitivity?", "answer_src": "we", "follow_up_question": "What was the primary endpoint measured in the study?", "follow_up_response": "Metformin efficacy", "follow_up_response_bt": "No Answer"}, {"question_id": "106.3", "question": "Where were the girls recruited for the study?", "answer_src": "hyperinsulinemic girls with androgen excess", "follow_up_question": "What specific condition characterized the girls with androgen excess?", "follow_up_response": "representing a continuum from prepuberal girls with a combined history of low birth weight and precocious pubarche over to postmenarchial girls with hyperinsulinemic ovarian hyperandrogenism", "follow_up_response_bt": "Hyperinsulinemic"}, {"question_id": "106.4", "question": "When was metformin dosed at different levels for the girls?", "answer_src": "younger girls and older girls", "follow_up_question": "At what age range did the older girls start receiving the higher metformin dose?", "follow_up_response": "older", "follow_up_response_bt": "No Answer"}, {"question_id": "106.5", "question": "Which specific SNP (rs8111699) in stk11 was studied in the girls?", "answer_src": "rs8111699", "follow_up_question": "What was the dosage of metformin used in the study for younger and older girls?", "follow_up_response": "425 mg / day in younger girls and 850 mg / day in older girls.", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "106.6", "question": "What is the dosage of metformin used in the study for younger girls?", "answer_src": "425 mg / day", "follow_up_question": "What were the endocrine-metabolic and body composition indexes measured before and after the 1-year metformin treatment?", "follow_up_response": "Endocrine-metabolic and body composition indexes", "follow_up_response_bt": "Endocrine - metabolic and body composition"}, {"question_id": "106.7", "question": "What was the primary endpoint measured in the study?", "answer_src": "Metformin efficacy", "follow_up_question": "What were the two groups of girls studied in the research?", "follow_up_response": "prepuberal girls with a combined history of low birth weight and precocious pubarche and postmenarchial girls with hyperinsulinemic ovarian hyperandrogenism", "follow_up_response_bt": "Hyperinsulinemic androgen-excess girls"}, {"question_id": "106.8", "question": "What specific condition characterized the girls with androgen excess?", "answer_src": "representing a continuum from prepuberal girls with a combined history of low birth weight and precocious pubarche over to postmenarchial girls with hyperinsulinemic ovarian hyperandrogenism", "follow_up_question": "What is the dosage of metformin used in the study for younger and older girls?", "follow_up_response": "425 mg / day in younger girls and 850 mg / day in older girls.", "follow_up_response_bt": "No Answer"}, {"question_id": "106.9", "question": "At what age range did the older girls start receiving the higher metformin dose?", "answer_src": "older", "follow_up_question": "In which age group did the younger girls receive the lower metformin dose?", "follow_up_response": "Younger girls", "follow_up_response_bt": "No Answer"}, {"question_id": "106.10", "question": "What was the dosage of metformin used in the study for younger and older girls?", "answer_src": "425 mg / day in younger girls and 850 mg / day in older girls.", "follow_up_question": "How many girls were included in the study?", "follow_up_response": "85", "follow_up_response_bt": "85"}], "turn_3": [{"question_id": "106.11", "question": "What were the endocrine-metabolic and body composition indexes measured before and after the 1-year metformin treatment?", "answer_src": "Endocrine-metabolic and body composition indexes", "follow_up_question": "What specific indexes were used to assess insulin sensitivity?", "follow_up_response": "endocrine - metabolic and body composition", "follow_up_response_bt": "No Answer"}, {"question_id": "106.12", "question": "What were the two groups of girls studied in the research?", "answer_src": "prepuberal girls with a combined history of low birth weight and precocious pubarche and postmenarchial girls with hyperinsulinemic ovarian hyperandrogenism", "follow_up_question": "How many girls were studied in total?", "follow_up_response": "85", "follow_up_response_bt": "85"}, {"question_id": "106.13", "question": "What is the dosage of metformin used in the study for younger and older girls?", "answer_src": "425 mg / day in younger girls and 850 mg / day in older girls.", "follow_up_question": "How many girls were included in the study?", "follow_up_response": "85", "follow_up_response_bt": "85"}, {"question_id": "106.14", "question": "In which age group did the younger girls receive the lower metformin dose?", "answer_src": "Younger girls", "follow_up_question": "How many girls were part of the study?", "follow_up_response": "85", "follow_up_response_bt": "85"}, {"question_id": "106.15", "question": "How many girls were included in the study?", "answer_src": "85", "follow_up_question": "How many of these girls had a history of low birth weight?", "follow_up_response": "85", "follow_up_response_bt": "85"}]}}
{"id": 107, "src": "development of novel biomaterials for drug delivery which forms a part of the so called novel drug delivery systems has always been exhilarating . mechanical evaluation of polymer based topical gels , which would be subjected to load or stress during its application , is inevitable.rheological characterization was done by studying viscosity and yielding . rheological modeling was also carried out.the viscosity and yield stress were inversely dependent on the eugenol concentration .", "mt": "Lo sviluppo di nuovi biomateriali per la consegna di farmaci che fanno parte dei cosiddetti nuovi sistemi di consegna di farmaci è sempre stato eccitante . La valutazione meccanica dei gel topici a base di polimeri , che sarebbero stati sottoposti a carico o stress durante la sua applicazione , è inevitabile.La caratterizzazione reologica è stata fatta studiando la viscosità e la resa . È stato anche effettuato un modellaggio reologico.La viscosità e la resa stress sono stati inversamente dipendenti dalla concentrazione di eugenolo .", "pert_mt": "Lo sviluppo di nuovi biomateriali per la consegna di farmaci che fanno parte dei cosiddetti nuovi sistemi di consegna di farmaci è sempre stato eccitante. La valutazione meccanica dei gel topici a base di polimeri, che sarebbero stati sottoposti a carico o stress durante la sua applicazione, è inevitabile. La caratterizzazione reologica è stata fatta studiando la viscosità e la resa. È stato anche effettuato un modellaggio reologico. La viscosità e la resa stress sono stati inversamente dipendenti dalla concentrazione di eugenolo e hanno influenzato la durata della liberazione del farmaco.", "bt": "The development of new biomaterials for drug delivery that are part of the so-called new drug delivery systems has always been exciting.The mechanical evaluation of topical polymer-based gels, which would have been subjected to load or stress during their application, is inevitable.The rheological characterization was done by studying viscosity and yield.A rheological modeling was also carried out.Viscosity and yield stress were inversely dependent on the concentration of eugenol and influenced the duration of drug release.", "questions_src": ["What material was studied in the mechanical evaluation of topical gels?", "When was rheological characterization conducted?", "Which factors were inversely dependent on eugenol concentration?", "Where might this research be applied in the field of drug delivery systems?", "Who typically carries out rheological modeling studies?"], "answers_src": ["Polymer", "Rheological characterization was done by studying viscosity and yielding.", "Viscosity and yield stress", "In the field of drug delivery systems", "Rheological modeling was also carried out."], "answers_bt": ["Topical polymer-based gels", "During their application", "Viscosity and yield stress", "In the field of drug delivery systems", "Researchers"], "multiturn": {"turn_1": [{"question_id": "107.1", "question": "What material was studied in the mechanical evaluation of topical gels?", "answer_src": "Polymer", "follow_up_question": "What relationship exists between viscosity and eugenol concentration?", "follow_up_response": "the viscosity and yield stress were inversely dependent on the eugenol concentration.", "follow_up_response_bt": "Viscosity and yield stress were inversely dependent on the concentration of eugenol"}, {"question_id": "107.2", "question": "When was rheological characterization conducted?", "answer_src": "Rheological characterization was done by studying viscosity and yielding.", "follow_up_question": "What was the relationship between viscosity and eugenol concentration?", "follow_up_response": "the viscosity and yield stress were inversely dependent on the eugenol concentration.", "follow_up_response_bt": "Viscosity and yield stress were inversely dependent on the concentration of eugenol"}, {"question_id": "107.3", "question": "Which factors were inversely dependent on eugenol concentration?", "answer_src": "Viscosity and yield stress", "follow_up_question": "What was the effect of increasing eugenol concentration on viscosity?", "follow_up_response": "Viscosity and yielding were inversely dependent on the eugenol concentration.", "follow_up_response_bt": "Viscosity and yield stress were inversely dependent on the concentration of eugenol"}, {"question_id": "107.4", "question": "Where might this research be applied in the field of drug delivery systems?", "answer_src": "In the field of drug delivery systems", "follow_up_question": "What factors affect the viscosity and yield stress of the polymer-based topical gels?", "follow_up_response": "Eugenol concentration", "follow_up_response_bt": "The concentration of eugenol"}, {"question_id": "107.5", "question": "Who typically carries out rheological modeling studies?", "answer_src": "Rheological modeling was also carried out.", "follow_up_question": "What relationship exists between viscosity and yield stress based on the eugenol concentration?", "follow_up_response": "the viscosity and yield stress were inversely dependent on the eugenol concentration.", "follow_up_response_bt": "Viscosity and yield stress were inversely dependent on the concentration of eugenol"}], "turn_2": [{"question_id": "107.6", "question": "What relationship exists between viscosity and eugenol concentration?", "answer_src": "the viscosity and yield stress were inversely dependent on the eugenol concentration.", "follow_up_question": "How does eugenol concentration affect the yield stress?", "follow_up_response": "eugenol concentration and yield stress are inversely dependent", "follow_up_response_bt": "Eugenol concentration influences the yield stress"}, {"question_id": "107.7", "question": "What was the relationship between viscosity and eugenol concentration?", "answer_src": "the viscosity and yield stress were inversely dependent on the eugenol concentration.", "follow_up_question": "How did the yield stress change as the eugenol concentration increased?", "follow_up_response": "the yield stress was inversely dependent on the eugenol concentration.", "follow_up_response_bt": "Inversely"}, {"question_id": "107.8", "question": "What was the effect of increasing eugenol concentration on viscosity?", "answer_src": "Viscosity and yielding were inversely dependent on the eugenol concentration.", "follow_up_question": "How did the yield stress change as eugenol concentration increased?", "follow_up_response": "the yield stress was inversely dependent on the eugenol concentration.", "follow_up_response_bt": "Inversely"}, {"question_id": "107.9", "question": "What factors affect the viscosity and yield stress of the polymer-based topical gels?", "answer_src": "Eugenol concentration", "follow_up_question": "How does eugenol concentration specifically influence the viscosity and yield stress of the polymer-based topical gels?", "follow_up_response": "Viscosity and yield stress were inversely dependent on the eugenol concentration.", "follow_up_response_bt": "Eugenol concentration influences the viscosity and yield stress of the polymer-based topical gels, with viscosity and yield stress being inversely dependent on the concentration of eugenol."}, {"question_id": "107.10", "question": "What relationship exists between viscosity and yield stress based on the eugenol concentration?", "answer_src": "the viscosity and yield stress were inversely dependent on the eugenol concentration.", "follow_up_question": "How does the eugenol concentration affect the viscosity and yield stress of the polymer-based topical gels?", "follow_up_response": "The viscosity and yield stress are inversely dependent on the eugenol concentration.", "follow_up_response_bt": "The eugenol concentration inversely depends on the viscosity and yield stress of the polymer-based topical gels."}], "turn_3": [{"question_id": "107.11", "question": "How does eugenol concentration affect the yield stress?", "answer_src": "eugenol concentration and yield stress are inversely dependent", "follow_up_question": "How does eugenol concentration affect viscosity?", "follow_up_response": "Viscosity and yielding were inversely dependent on the eugenol concentration.", "follow_up_response_bt": "Eugenol concentration inversely affects viscosity."}, {"question_id": "107.12", "question": "How did the yield stress change as the eugenol concentration increased?", "answer_src": "the yield stress was inversely dependent on the eugenol concentration.", "follow_up_question": "What was the effect of increasing eugenol concentration on viscosity?", "follow_up_response": "Viscosity and yielding were inversely dependent on the eugenol concentration.", "follow_up_response_bt": "Viscosity and yield stress were inversely dependent on the concentration of eugenol"}, {"question_id": "107.13", "question": "How did the yield stress change as eugenol concentration increased?", "answer_src": "the yield stress was inversely dependent on the eugenol concentration.", "follow_up_question": "What was the effect of increasing eugenol concentration on viscosity?", "follow_up_response": "Viscosity and yielding were inversely dependent on the eugenol concentration.", "follow_up_response_bt": "Viscosity and yield stress were inversely dependent on the concentration of eugenol"}, {"question_id": "107.14", "question": "How does eugenol concentration specifically influence the viscosity and yield stress of the polymer-based topical gels?", "answer_src": "Viscosity and yield stress were inversely dependent on the eugenol concentration.", "follow_up_question": "What is the range of eugenol concentrations used in the rheological characterization?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "107.15", "question": "How does the eugenol concentration affect the viscosity and yield stress of the polymer-based topical gels?", "answer_src": "The viscosity and yield stress are inversely dependent on the eugenol concentration.", "follow_up_question": "What is the range of eugenol concentrations used in the rheological characterization?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 108, "src": "parasite lactate dehydrogenase ( pldh ) is extensively employed as malaria rapid diagnostic tests ( rdts ) . moreover , it is a well - known drug target candidate . however , the genetic diversity of this gene might influence performance of rdt kits and its drug target candidacy .", "mt": "Il parassita lattato-deidrogenasi (pldh) è ampiamente utilizzato come test diagnostici rapidi per la malaria (rdts). Inoltre , è un noto candidato di bersaglio di farmaci . Tuttavia , la diversità genetica di questo gene potrebbe influenzare la performance dei kit rdt e la sua candidatura di bersaglio di farmaci .", "pert_mt": "Il parassita lattato-deidrogenasi (pldh) è ampiamente utilizzato come test diagnostici rapidi per la malaria (rdts). Inoltre, è un noto candidato di bersaglio di farmaci. Tuttavia, la diversità genetica di questo gene potrebbe influenzare la performance dei kit rdt e la sua candidatura di bersaglio di farmaci e la necessità di ulteriori studi.", "bt": "The lattato-dehydrogenase parasite (pldh) is widely used as a rapid diagnostic test for malaria (rdts) and is also a known target candidate for drug targets, however, the genetic diversity of this gene could influence the performance of the rdt kit and its target candidate for drug targets and the need for further studies.", "questions_src": ["What is extensively employed as malaria rapid diagnostic tests (RDTs)?", "What is a well-known drug target candidate?", "What genetic diversity might influence performance of RDT kits and its drug target candidacy?"], "answers_src": ["parasite lactate dehydrogenase (pldh)", "parasite lactate dehydrogenase (pldh)", "the genetic diversity of this gene"], "answers_bt": ["The lattato-dehydrogenase parasite (pldh)", "The lattato-dehydrogenase parasite (pldh)", "The genetic diversity of the pldh gene"], "multiturn": {"turn_1": [{"question_id": "108.1", "question": "What is extensively employed as malaria rapid diagnostic tests (RDTs)?", "answer_src": "parasite lactate dehydrogenase (pldh)", "follow_up_question": "How does genetic diversity affect the performance of RDT kits using pldh?", "follow_up_response": "It might influence the performance of RDT kits", "follow_up_response_bt": "The genetic diversity of this gene could influence the performance of the RDT kit"}, {"question_id": "108.2", "question": "What is a well-known drug target candidate?", "answer_src": "parasite lactate dehydrogenase (pldh)", "follow_up_question": "How does genetic diversity affect the performance of RDT kits targeting parasite lactate dehydrogenase?", "follow_up_response": "It might influence the performance of RDT kits", "follow_up_response_bt": "The genetic diversity of the pldh gene could influence the performance of the RDT kit"}, {"question_id": "108.3", "question": "What genetic diversity might influence performance of RDT kits and its drug target candidacy?", "answer_src": "the genetic diversity of this gene", "follow_up_question": "How does genetic diversity affect the performance of RDT kits?", "follow_up_response": "It might influence performance of rdt kits", "follow_up_response_bt": "The genetic diversity of the pldh gene could influence the performance of the RDT kit"}], "turn_2": [{"question_id": "108.4", "question": "How does genetic diversity affect the performance of RDT kits using pldh?", "answer_src": "It might influence the performance of RDT kits", "follow_up_question": "What specific aspects of RDT kit performance could be affected by genetic diversity?", "follow_up_response": "Performance of RDT kits", "follow_up_response_bt": "The genetic diversity of the pldh gene"}, {"question_id": "108.5", "question": "How does genetic diversity affect the performance of RDT kits targeting parasite lactate dehydrogenase?", "answer_src": "It might influence the performance of RDT kits", "follow_up_question": "What specific aspects of genetic diversity could influence the performance of RDT kits?", "follow_up_response": "The genetic diversity of this gene", "follow_up_response_bt": "The genetic diversity of the pldh gene"}, {"question_id": "108.6", "question": "How does genetic diversity affect the performance of RDT kits?", "answer_src": "It might influence performance of rdt kits", "follow_up_question": "What specific aspects of genetic diversity could influence RDT kit performance?", "follow_up_response": "The genetic diversity of this gene", "follow_up_response_bt": "The genetic diversity of this gene"}], "turn_3": [{"question_id": "108.7", "question": "What specific aspects of RDT kit performance could be affected by genetic diversity?", "answer_src": "Performance of RDT kits", "follow_up_question": "How might genetic diversity affect the performance of RDT kits?", "follow_up_response": "It might influence the performance of RDT kits", "follow_up_response_bt": "The genetic diversity of the pldh gene could influence the performance of the RDT kit"}, {"question_id": "108.8", "question": "What specific aspects of genetic diversity could influence the performance of RDT kits?", "answer_src": "The genetic diversity of this gene", "follow_up_question": "How might genetic diversity affect the specificity of RDT kits?", "follow_up_response": "It might influence the performance of RDT kits", "follow_up_response_bt": "The genetic diversity of the pldh gene could influence the performance of the RDT kit"}, {"question_id": "108.9", "question": "What specific aspects of genetic diversity could influence RDT kit performance?", "answer_src": "The genetic diversity of this gene", "follow_up_question": "How might genetic diversity affect the specificity of RDT kits?", "follow_up_response": "It might influence the performance of RDT kits", "follow_up_response_bt": "The genetic diversity of the pldh gene could influence the performance of the RDT kit"}]}}
{"id": 109, "src": "beryllium was released into the air from routine operations and three accidental fires at the rocky flats plant ( rfp ) in colorado from 1958 to 1989 . we evaluated environmental monitoring data and developed estimates of airborne concentrations and their uncertainties and calculated lifetime cancer risks and risks of chronic beryllium disease to hypothetical receptors . this article discusses exposure - response relationships for lung cancer and chronic beryllium disease .", "mt": "Il berillio è stato rilasciato nell'aria da operazioni di routine e da tre incendi accidentali presso l' impianto rocky flats (rfp) del Colorado dal 1958 al 1989 . Abbiamo valutato i dati di monitoraggio ambientale e sviluppato stime delle concentrazioni e delle loro incertezze nell'aria e calcolato i rischi di cancro e i rischi di malattia cronica del berillio ai recettori ipotetici . Questo articolo discute le relazioni di esposizione-risposta per il cancro ai polmoni e la malattia cronica del berillio .", "pert_mt": "Il berillio è stato rilasciato nell'aria da operazioni di routine e da tre incendi accidentali presso l' impianto rocky flats (rfp) del Colorado dal 1958 al 1989. Abbiamo valutato i dati di monitoraggio ambientale e sviluppato stime delle concentrazioni e他们的暴露与肺癌和berillio慢性病之间的关系。", "bt": "Il berillio was released in the area of routine operations and three accidental fires at the rocky flats plant (rfp) in colorado from 1958 to 1989. we evaluated environmental monitoring data and developed estimates of concentrations and their exposure to the relationship between lung cancer and berillium chronic disease.", "questions_src": ["What year did beryllium releases begin at Rocky Flats Plant?", "Who conducted the evaluation of environmental monitoring data?", "Where were the three accidental fires mentioned?", "Which health conditions were estimated to be affected by beryllium exposure?", "When did the risk calculations for chronic beryllium disease start?"], "answers_src": ["1958", "We", "Colorado", "Lung cancer and chronic beryllium disease", "1989"], "answers_bt": ["1958", "we", "colorado", "lung cancer and berillium chronic disease", "1989"], "multiturn": {"turn_1": [{"question_id": "109.1", "question": "What year did beryllium releases begin at Rocky Flats Plant?", "answer_src": "1958", "follow_up_question": "In what year did the last accidental fire occur at Rocky Flats Plant?", "follow_up_response": "1989", "follow_up_response_bt": "1989"}, {"question_id": "109.2", "question": "Who conducted the evaluation of environmental monitoring data?", "answer_src": "We", "follow_up_question": "What specific types of risks were calculated?", "follow_up_response": "risks of chronic beryllium disease", "follow_up_response_bt": "No Answer"}, {"question_id": "109.3", "question": "Where were the three accidental fires mentioned?", "answer_src": "Colorado", "follow_up_question": "What specific years did the three accidental fires occur?", "follow_up_response": "1958 to 1989", "follow_up_response_bt": "1958 to 1989"}, {"question_id": "109.4", "question": "Which health conditions were estimated to be affected by beryllium exposure?", "answer_src": "Lung cancer and chronic beryllium disease", "follow_up_question": "What is the time period over which beryllium was released into the air?", "follow_up_response": "From 1958 to 1989", "follow_up_response_bt": "1958 to 1989"}, {"question_id": "109.5", "question": "When did the risk calculations for chronic beryllium disease start?", "answer_src": "1989", "follow_up_question": "When were the lifetime cancer risk calculations conducted?", "follow_up_response": "1958 to 1989", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "109.6", "question": "In what year did the last accidental fire occur at Rocky Flats Plant?", "answer_src": "1989", "follow_up_question": "What were the estimated lifetime cancer risks for the hypothetical receptors?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "109.7", "question": "What specific types of risks were calculated?", "answer_src": "risks of chronic beryllium disease", "follow_up_question": "Exposure-response relationships were discussed for which type of cancer?", "follow_up_response": "Lung cancer", "follow_up_response_bt": "Lung cancer"}, {"question_id": "109.8", "question": "What specific years did the three accidental fires occur?", "answer_src": "1958 to 1989", "follow_up_question": "What were the estimated airborne concentrations during these periods?", "follow_up_response": "Lifetime cancer risks and risks of chronic beryllium disease to hypothetical receptors", "follow_up_response_bt": "No Answer"}, {"question_id": "109.9", "question": "What is the time period over which beryllium was released into the air?", "answer_src": "From 1958 to 1989", "follow_up_question": "What specific activities at the Rocky Flats Plant led to beryllium release into the air?", "follow_up_response": "Routine operations and three accidental fires", "follow_up_response_bt": "Il berillio was released in the area of routine operations and three accidental fires"}, {"question_id": "109.10", "question": "When were the lifetime cancer risk calculations conducted?", "answer_src": "1958 to 1989", "follow_up_question": "What specific types of health risks were estimated in the study?", "follow_up_response": "Lifetime cancer risks and risks of chronic beryllium disease", "follow_up_response_bt": "Lung cancer and berillium chronic disease"}], "turn_3": [{"question_id": "109.11", "question": "What were the estimated lifetime cancer risks for the hypothetical receptors?", "answer_src": "beryllium was released into the air from routine operations and three accidental fires at the rocky flats plant ( rfp ) in colorado from 1958 to 1989 . we evaluated environmental monitoring data and developed estimates of airborne concentrations and their uncertainties and calculated lifetime cancer risks and risks of chronic beryllium disease to hypothetical receptors . this article discusses exposure - response relationships for lung cancer and chronic beryllium disease .", "follow_up_question": "What were the estimated risks of chronic beryllium disease for the hypothetical receptors?", "follow_up_response": "risks of chronic beryllium disease", "follow_up_response_bt": "No Answer"}, {"question_id": "109.12", "question": "Exposure-response relationships were discussed for which type of cancer?", "answer_src": "Lung cancer", "follow_up_question": "What other health condition's risk was assessed in the study?", "follow_up_response": "chronic beryllium disease", "follow_up_response_bt": "Lung cancer"}, {"question_id": "109.13", "question": "What were the estimated airborne concentrations during these periods?", "answer_src": "Lifetime cancer risks and risks of chronic beryllium disease to hypothetical receptors", "follow_up_question": "What specific lung cancer risk levels were calculated?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "109.14", "question": "What specific activities at the Rocky Flats Plant led to beryllium release into the air?", "answer_src": "Routine operations and three accidental fires", "follow_up_question": "What were the time periods during which these activities occurred?", "follow_up_response": "1958 to 1989", "follow_up_response_bt": "1958 to 1989"}, {"question_id": "109.15", "question": "What specific types of health risks were estimated in the study?", "answer_src": "Lifetime cancer risks and risks of chronic beryllium disease", "follow_up_question": "What types of lung cancer risks were considered in the study?", "follow_up_response": "Lifetime cancer risks", "follow_up_response_bt": "No Answer"}]}}
{"id": 110, "src": "in addition , all video - documented areas of peeling on the retinal surface were evaluated postoperatively using an additional focal 2 microperimetry . retinal sensitivity and bcva were correlated with morphological changes ( ez and elm ) in the foveal region and in regions of membrane peeling . overall , bcva increased from 0.6 ( 0.2 ) to 0.2 ( 0.2 ) logmar after 6 months with an increase in retinal sensitivity ( 17.9 2.7 db to 26.8 3.1 db , p < 0.01 ) .", "mt": "Inoltre, tutte le aree di peeling documentate in video sulla superficie della retina sono state valutate postoperativamente utilizzando un'ulteriore microperimetria focale 2 . La sensibilità della retina e la bcva sono correlate con cambiamenti morfologici (ez e elm) nella regione foveale e nelle regioni di peeling della membrana . Nel complesso , la bcva è aumentata da 0,6 (0,2 ) a 0,2 (0,2 ) logmar dopo 6 mesi con un aumento della sensibilità della retina ( 17,9 2,7 db a 26,8 3.1 db , p < 0,01).", "pert_mt": "Inoltre, tutte le aree di peeling documentate in video sulla superficie della retina sono state valutate postoperativamente utilizzando un'ulteriore microperimetria focale 2. La sensibilità della retina e la bcva sono correlate con cambiamenti morfologici (ez e elm) nella regione foveale e nelle regioni di peeling della membrana. Nel complesso, la bcva è aumentata da 0,6 (0,2) a 0,9 (0,3) logmar dopo 6 mesi con un aumento della sensibilità della retina (17,9 2,7 db a 26,8 3,1 db, p < 0,01).", "bt": "In addition, all peeling areas documented in video on the retina surface were evaluated postoperatively using additional focal microperimetry 2.The sensitivity of the retina and the bcva are correlated with morphological changes (e.g. elm) in the foveal region and peeling regions of the membrane.In total, the bcva increased from 0.6 (0.2) to 0.9 (0.3) logmar after 6 months with an increase in the sensitivity of the retina (17.9 2.7 db to 26.8 3.1 db, p < 0,01).", "questions_src": ["What was the initial BCVA measurement before the treatment?", "Who performed the evaluation of retinal sensitivity postoperatively?", "Where was the focal 2 microperimetry used?", "When did the BCVA measurement increase by 0.4 logmar?", "Which regions had an increase in retinal sensitivity after the treatment?"], "answers_src": ["0.6 (0.2)", "an additional focal 2 microperimetry", "the retinal surface", "after 6 months", "the foveal region and in regions of membrane peeling"], "answers_bt": ["0.6 (0.2)", "Additional focal microperimetry", "On the retina surface", "After 6 months", "Peeling regions of the membrane"], "multiturn": {"turn_1": [{"question_id": "110.1", "question": "What was the initial BCVA measurement before the treatment?", "answer_src": "0.6 (0.2)", "follow_up_question": "What was the change in BCVA after 6 months?", "follow_up_response": "0.2 ( 0.2 ) logmar", "follow_up_response_bt": "From 0.6 (0.2) to 0.9 (0.3) logmar"}, {"question_id": "110.2", "question": "Who performed the evaluation of retinal sensitivity postoperatively?", "answer_src": "an additional focal 2 microperimetry", "follow_up_question": "What was the change in retinal sensitivity measured in decibels (dB) before and after 6 months?", "follow_up_response": "17.9 2.7 db to 26.8 3.1 db", "follow_up_response_bt": "17.9 2.7 db to 26.8 3.1 db"}, {"question_id": "110.3", "question": "Where was the focal 2 microperimetry used?", "answer_src": "the retinal surface", "follow_up_question": "What was the change in retinal sensitivity measured in decibels (dB) before and after 6 months?", "follow_up_response": "17.9 2.7 db to 26.8 3.1 db", "follow_up_response_bt": "17.9 2.7 db to 26.8 3.1 db"}, {"question_id": "110.4", "question": "When did the BCVA measurement increase by 0.4 logmar?", "answer_src": "after 6 months", "follow_up_question": "By how many dB did retinal sensitivity increase?", "follow_up_response": "17.9", "follow_up_response_bt": "18.9"}, {"question_id": "110.5", "question": "Which regions had an increase in retinal sensitivity after the treatment?", "answer_src": "the foveal region and in regions of membrane peeling", "follow_up_question": "What was the change in retinal sensitivity in the foveal region?", "follow_up_response": "17.9 2.7 db to 26.8 3.1 db", "follow_up_response_bt": "17.9 2.7 db to 26.8 3.1 db"}], "turn_2": [{"question_id": "110.6", "question": "What was the change in BCVA after 6 months?", "answer_src": "0.2 ( 0.2 ) logmar", "follow_up_question": "What was the change in retinal sensitivity after 6 months?", "follow_up_response": "17.9 2.7 db to 26.8 3.1 db", "follow_up_response_bt": "17.9 2.7 db to 26.8 3.1 db"}, {"question_id": "110.7", "question": "What was the change in retinal sensitivity measured in decibels (dB) before and after 6 months?", "answer_src": "17.9 2.7 db to 26.8 3.1 db", "follow_up_question": "By how many decibels did retinal sensitivity increase specifically in the foveal region?", "follow_up_response": "17.9", "follow_up_response_bt": "26.8 3.1 db"}, {"question_id": "110.8", "question": "What was the change in retinal sensitivity measured in decibels (dB) before and after 6 months?", "answer_src": "17.9 2.7 db to 26.8 3.1 db", "follow_up_question": "By how many decibels did retinal sensitivity increase specifically in the foveal region?", "follow_up_response": "17.9", "follow_up_response_bt": "26.8 3.1 db"}, {"question_id": "110.9", "question": "By how many dB did retinal sensitivity increase?", "answer_src": "17.9", "follow_up_question": "By what percentage did retinal sensitivity increase?", "follow_up_response": "17.9", "follow_up_response_bt": "17.9"}, {"question_id": "110.10", "question": "What was the change in retinal sensitivity in the foveal region?", "answer_src": "17.9 2.7 db to 26.8 3.1 db", "follow_up_question": "What was the change in BCVA in the foveal region?", "follow_up_response": "0.6 (0.2) to 0.2 (0.2) logmar", "follow_up_response_bt": "0.3"}], "turn_3": [{"question_id": "110.11", "question": "What was the change in retinal sensitivity after 6 months?", "answer_src": "17.9 2.7 db to 26.8 3.1 db", "follow_up_question": "By how many decibels did retinal sensitivity increase?", "follow_up_response": "17.9", "follow_up_response_bt": "17.9, 2.7, 26.8, 3.1"}, {"question_id": "110.12", "question": "By how many decibels did retinal sensitivity increase specifically in the foveal region?", "answer_src": "17.9", "follow_up_question": "By how many decibels did retinal sensitivity increase in regions of membrane peeling?", "follow_up_response": "17.9", "follow_up_response_bt": "17.9 2.7 db to 26.8 3.1 db"}, {"question_id": "110.13", "question": "By how many decibels did retinal sensitivity increase specifically in the foveal region?", "answer_src": "17.9", "follow_up_question": "By how many decibels did retinal sensitivity increase in regions of membrane peeling?", "follow_up_response": "17.9", "follow_up_response_bt": "17.9 2.7 db to 26.8 3.1 db"}, {"question_id": "110.14", "question": "By what percentage did retinal sensitivity increase?", "answer_src": "17.9", "follow_up_question": "By how many dB did retinal sensitivity increase at the foveal region?", "follow_up_response": "17.9", "follow_up_response_bt": "17.9"}, {"question_id": "110.15", "question": "What was the change in BCVA in the foveal region?", "answer_src": "0.6 (0.2) to 0.2 (0.2) logmar", "follow_up_question": "What was the change in retinal sensitivity in the foveal region?", "follow_up_response": "17.9 2.7 db to 26.8 3.1 db", "follow_up_response_bt": "17.9 2.7 db to 26.8 3.1 db"}]}}
{"id": 111, "src": "45 male c57bl/6j mice ( mean weight 27 g ) were anesthetized with ketamine / xylazine . animals were subjected to a weight drop closed traumatic brain injury ( wd - tbi ) , a femoral fracture and hemorrhagic shock ( fx - sh ) . animals were subdivided into wd - tbi , fx - sh and combined trauma ( co - tx ) groups .", "mt": "45 topi maschi c57bl/6j (peso medio 27 g) sono stati anestetizzati con ketamina / xilasiene . Gli animali sono stati sottoposti a un calo di peso chiuso traumatico lesione cerebrale (wd - tbi), una frattura femorale e shock emorragico (fx - sh) . Gli animali sono stati suddivisi in gruppi di trauma combinato (co - tx) e di trauma combinato (wd - tbi , fx - sh).", "pert_mt": "45 topi maschi c57bl/6j (peso medio 27 g) sono stati anestetizzati con ketamina / xilasiene. Gli animali sono stati sottoposti a un calo di peso chiuso traumatico lesione cerebrale (wd - tbi), una frattura femorale e shock emorragico (fx - sh). Gli animali sono stati suddivisi in gruppi di trauma combinato (co - tx), trauma combinato (wd - tbi), trauma combinato (fx - sh), e trauma combinato (shock emorragico).", "bt": "Topical maschi c57bl/6j (mean weight 27 g) were anesthetized with ketamine/xilasiene.The animals were subjected to a closed-weight trauma trauma (fx-sh), a femoral fracture and hemorrhagic shock (fx-sh).The animals were divided into groups of combined trauma (co-sh), combined trauma (wd-tbi), combined trauma (fx-sh), and combined trauma (hemocratic shock).", "questions_src": ["What was the mean weight of the mice in grams?", "Who administered the anesthesia to the mice?", "Where were the mice housed before the experiment?", "When was the experiment conducted?", "Which group received both weight drop closed traumatic brain injury and femoral fracture injuries?"], "answers_src": ["27 g", "ketamine / xylazine", "c57bl/6j mice", "No Answer", "combined trauma (co-tx)"], "answers_bt": ["27 g", "ketamine/xilasiene", "Topical maschi c57bl/6j", "No Answer", "combined trauma (wd-tbi)"], "multiturn": {"turn_1": [{"question_id": "111.1", "question": "What was the mean weight of the mice in grams?", "answer_src": "27 g", "follow_up_question": "What is the total number of mice used in the study?", "follow_up_response": "45", "follow_up_response_bt": "No Answer"}, {"question_id": "111.2", "question": "Who administered the anesthesia to the mice?", "answer_src": "ketamine / xylazine", "follow_up_question": "What was the total number of mice used in the study?", "follow_up_response": "45", "follow_up_response_bt": "No Answer"}, {"question_id": "111.3", "question": "Where were the mice housed before the experiment?", "answer_src": "c57bl/6j mice", "follow_up_question": "What was the average weight of the mice?", "follow_up_response": "27 g", "follow_up_response_bt": "27 g"}, {"question_id": "111.4", "question": "When was the experiment conducted?", "answer_src": "45 male c57bl/6j mice ( mean weight 27 g ) were anesthetized with ketamine / xylazine . animals were subjected to a weight drop closed traumatic brain injury ( wd - tbi ) , a femoral fracture and hemorrhagic shock ( fx - sh ) . animals were subdivided into wd - tbi , fx - sh and combined trauma ( co - tx ) groups .", "follow_up_question": "What type of injury did the mice receive in the wd-tbi group?", "follow_up_response": "Weight drop closed traumatic brain injury", "follow_up_response_bt": "Weighted-decortication traumatic brain injury"}, {"question_id": "111.5", "question": "Which group received both weight drop closed traumatic brain injury and femoral fracture injuries?", "answer_src": "combined trauma (co-tx)", "follow_up_question": "Which animals in the combined trauma group also experienced hemorrhagic shock?", "follow_up_response": "No Answer", "follow_up_response_bt": "The animals in the combined trauma (hemorrhagic shock) group"}], "turn_2": [{"question_id": "111.6", "question": "What is the total number of mice used in the study?", "answer_src": "45", "follow_up_question": "How many mice received only the weight drop closed traumatic brain injury?", "follow_up_response": "45", "follow_up_response_bt": "No Answer"}, {"question_id": "111.7", "question": "What was the total number of mice used in the study?", "answer_src": "45", "follow_up_question": "How many mice received only the weight drop closed traumatic brain injury?", "follow_up_response": "45", "follow_up_response_bt": "No Answer"}, {"question_id": "111.8", "question": "What was the average weight of the mice?", "answer_src": "27 g", "follow_up_question": "What was the total weight of the 45 mice?", "follow_up_response": "1365", "follow_up_response_bt": "No Answer"}, {"question_id": "111.9", "question": "What type of injury did the mice receive in the wd-tbi group?", "answer_src": "Weight drop closed traumatic brain injury", "follow_up_question": "What was the mean weight of the mice in the study?", "follow_up_response": "27 g", "follow_up_response_bt": "27 g"}, {"question_id": "111.10", "question": "Which animals in the combined trauma group also experienced hemorrhagic shock?", "answer_src": "45 male c57bl/6j mice ( mean weight 27 g ) were anesthetized with ketamine / xylazine . animals were subjected to a weight drop closed traumatic brain injury ( wd - tbi ) , a femoral fracture and hemorrhagic shock ( fx - sh ) . animals were subdivided into wd - tbi , fx - sh and combined trauma ( co - tx ) groups .", "follow_up_question": "In which other condition did the combined trauma group experience a femoral fracture?", "follow_up_response": "No Answer", "follow_up_response_bt": "combined trauma (wd-tbi)"}], "turn_3": [{"question_id": "111.11", "question": "How many mice received only the weight drop closed traumatic brain injury?", "answer_src": "45", "follow_up_question": "How many mice received both femoral fractures and hemorrhagic shock?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "111.12", "question": "How many mice received only the weight drop closed traumatic brain injury?", "answer_src": "45", "follow_up_question": "How many mice received both femoral fractures and hemorrhagic shock?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "111.13", "question": "What was the total weight of the 45 mice?", "answer_src": "1365", "follow_up_question": "What was the average weight of each mouse?", "follow_up_response": "27 g", "follow_up_response_bt": "27 g"}, {"question_id": "111.14", "question": "What was the mean weight of the mice in the study?", "answer_src": "27 g", "follow_up_question": "What is the total number of mice in the study?", "follow_up_response": "45", "follow_up_response_bt": "No Answer"}, {"question_id": "111.15", "question": "In which other condition did the combined trauma group experience a femoral fracture?", "answer_src": "45 male c57bl/6j mice ( mean weight 27 g ) were anesthetized with ketamine / xylazine . animals were subjected to a weight drop closed traumatic brain injury ( wd - tbi ) , a femoral fracture and hemorrhagic shock ( fx - sh ) . animals were subdivided into wd - tbi , fx - sh and combined trauma ( co - tx ) groups .", "follow_up_question": "What type of injury did the combined trauma group receive?", "follow_up_response": "closed traumatic brain injury ( wd - tbi ) and femoral fracture and hemorrhagic shock ( fx - sh )", "follow_up_response_bt": "Combined trauma"}]}}
{"id": 112, "src": "objectivea review of the literature on coccygectomy and our patients was performed to assess the effectiveness of coccygectomy for chronic refractory coccygodynia.methodsan english language pubmed search was conducted with the terms \" coccygodynia \" and \" coccygectomy \" from january 1980 to january 2012 . we retrospectively reviewed the medical records and performed telephone questionnaire on 61 patients who underwent coccygectomy at ucdmc between 1997 and 2009.resultsthere were 28 case series from 1980 to 2012 for a total of 742 patients who underwent coccygectomy following failed conservative management . the mean age ranged from 26.4 to 52.8 years .", "mt": "Una revisione della letteratura sulla coccygectomy e dei nostri pazienti è stata eseguita per valutare l'efficacia della coccygectomy per la coccygodynia refrattoria cronica.La ricerca obiettiva in lingua inglese è stata condotta con i termini \"coccygodynia\" e \"coccygectomy\" da gennaio 1980 a gennaio 2012 . Abbiamo esaminato retrospettivamente i registri medici e eseguito un questionario telefonico su 61 pazienti che hanno subito la coccygectomy a ucdmc tra il 1997 e il 2009.I risultati sono stati 28 serie di casi dal 1980 al 2012 per un totale di 742 pazienti che hanno subito una coccygectomy fallita dopo la gestione conservatrice . l'età media è stata compresa tra il 26,4 e il 52,8 anni .", "pert_mt": "Una revisione della letteratura sulla coccygectomy e dei nostri pazienti è stata eseguita per valutare l'efficacia della coccygectomy per la coccygodynia refrattoria cronica. La ricerca obiettiva in lingua inglese è stata condotta con i termini \"coccygodynia\" e \"coccygectomy\" da gennaio 1980 a gennaio 2012. Abbiamo esaminato retrospettivamente i registri medici e eseguito un questionario telefonico su 61 pazienti che hanno subito la coccygectomy a UCDMC tra il 1997 e il 2009. I risultati sono stati 28 serie di casi dal 1980 al 2012 per un totale di 742 pazienti che hanno sub", "bt": "Objective research in English was conducted with the terms \"coccygodynia\" and \"coccygectomy\" from January 1980 to January 2012.We retrospectively reviewed medical records and conducted a telephone questionnaire of 61 patients who had coccygectomy at UCDMC between 1997 and 2009.The results were 28 series of cases from 1980 to 2012 for a total of 742 patients who had sub-species.", "questions_src": ["What is the main topic of the objective of your study?", "Who were the patients included in your retrospective review?", "Where was the data primarily collected from?", "When did the literature review cover?", "Which method was used to assess the outcomes?"], "answers_src": ["[\"Coccygectomy for chronic refractory coccygodynia\"], [\"61 patients who underwent coccygectomy at UCDMC between 1997 and 2009\"], [\"PubMed search\"], [\"January 1980 to January 2012\"], [\"Telephone questionnaire\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["Objective research in English", "61 patients who had coccygectomy at UCDMC", "Medical records and telephone questionnaire", "January 1980 to January 2012", "Telephone questionnaire"], "multiturn": {"turn_1": [{"question_id": "112.1", "question": "What is the main topic of the objective of your study?", "answer_src": "[\"Coccygectomy for chronic refractory coccygodynia\"], [\"61 patients who underwent coccygectomy at UCDMC between 1997 and 2009\"], [\"PubMed search\"], [\"January 1980 to January 2012\"], [\"Telephone questionnaire\"]", "follow_up_question": "What is the range of ages for the patients included in the retrospective review?", "follow_up_response": "26.4 to 52.8 years", "follow_up_response_bt": "No Answer"}, {"question_id": "112.2", "question": "Who were the patients included in your retrospective review?", "answer_src": "objectivea review of the literature on coccygectomy and our patients was performed to assess the effectiveness of coccygectomy for chronic refractory coccygodynia.methodsan english language pubmed search was conducted with the terms \" coccygodynia \" and \" coccygectomy \" from january 1980 to january 2012 . we retrospectively reviewed the medical records and performed telephone questionnaire on 61 patients who underwent coccygectomy at ucdmc between 1997 and 2009.resultsthere were 28 case series from 1980 to 2012 for a total of 742 patients who underwent coccygectomy following failed conservative management . the mean age ranged from 26.4 to 52.8 years .", "follow_up_question": "What was the age range of the patients included in your retrospective review?", "follow_up_response": "26.4 to 52.8 years", "follow_up_response_bt": "No Answer"}, {"question_id": "112.3", "question": "Where was the data primarily collected from?", "answer_src": "objectivea review of the literature on coccygectomy and our patients was performed to assess the effectiveness of coccygectomy for chronic refractory coccygodynia.methodsan english language pubmed search was conducted with the terms \" coccygodynia \" and \" coccygectomy \" from january 1980 to january 2012 . we retrospectively reviewed the medical records and performed telephone questionnaire on 61 patients who underwent coccygectomy at ucdmc between 1997 and 2009.resultsthere were 28 case series from 1980 to 2012 for a total of 742 patients who underwent coccygectomy following failed conservative management . the mean age ranged from 26.4 to 52.8 years .", "follow_up_question": "What was the time frame for the English language PubMed search?", "follow_up_response": "January 1980 to January 2012", "follow_up_response_bt": "January 1980 to January 2012"}, {"question_id": "112.4", "question": "When did the literature review cover?", "answer_src": "objectivea review of the literature on coccygectomy and our patients was performed to assess the effectiveness of coccygectomy for chronic refractory coccygodynia.methodsan english language pubmed search was conducted with the terms \" coccygodynia \" and \" coccygectomy \" from january 1980 to january 2012 . we retrospectively reviewed the medical records and performed telephone questionnaire on 61 patients who underwent coccygectomy at ucdmc between 1997 and 2009.resultsthere were 28 case series from 1980 to 2012 for a total of 742 patients who underwent coccygectomy following failed conservative management . the mean age ranged from 26.4 to 52.8 years .", "follow_up_question": "What is the range of ages for the patients included in the case series?", "follow_up_response": "26.4 to 52.8 years", "follow_up_response_bt": "No Answer"}, {"question_id": "112.5", "question": "Which method was used to assess the outcomes?", "answer_src": "objectivea review of the literature on coccygectomy and our patients was performed to assess the effectiveness of coccygectomy for chronic refractory coccygodynia.methodsan english language pubmed search was conducted with the terms \" coccygodynia \" and \" coccygectomy \" from january 1980 to january 2012 . we retrospectively reviewed the medical records and performed telephone questionnaire on 61 patients who underwent coccygectomy at ucdmc between 1997 and 2009.resultsthere were 28 case series from 1980 to 2012 for a total of 742 patients who underwent coccygectomy following failed conservative management . the mean age ranged from 26.4 to 52.8 years .", "follow_up_question": "How many patients were included in the retrospective review?", "follow_up_response": "61", "follow_up_response_bt": "742"}], "turn_2": [{"question_id": "112.6", "question": "What is the range of ages for the patients included in the retrospective review?", "answer_src": "26.4 to 52.8 years", "follow_up_question": "What was the total number of patients included in the case series studies?", "follow_up_response": "742", "follow_up_response_bt": "742"}, {"question_id": "112.7", "question": "What was the age range of the patients included in your retrospective review?", "answer_src": "26.4 to 52.8 years", "follow_up_question": "What was the total number of patients included in the case series studies?", "follow_up_response": "742", "follow_up_response_bt": "742"}, {"question_id": "112.8", "question": "What was the time frame for the English language PubMed search?", "answer_src": "January 1980 to January 2012", "follow_up_question": "What was the mean age range of the patients included in the retrospective review?", "follow_up_response": "26.4 to 52.8 years", "follow_up_response_bt": "No Answer"}, {"question_id": "112.9", "question": "What is the range of ages for the patients included in the case series?", "answer_src": "26.4 to 52.8 years", "follow_up_question": "What was the total number of patients included in the case series?", "follow_up_response": "742", "follow_up_response_bt": "742"}, {"question_id": "112.10", "question": "How many patients were included in the retrospective review?", "answer_src": "61", "follow_up_question": "What was the range of ages for the patients included in the retrospective review?", "follow_up_response": "26.4 to 52.8 years", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "112.11", "question": "What was the total number of patients included in the case series studies?", "answer_src": "742", "follow_up_question": "What was the average age of the patients in the case series studies?", "follow_up_response": "34.6", "follow_up_response_bt": "No Answer"}, {"question_id": "112.12", "question": "What was the total number of patients included in the case series studies?", "answer_src": "742", "follow_up_question": "What was the average age of the patients in the case series studies?", "follow_up_response": "34.6", "follow_up_response_bt": "No Answer"}, {"question_id": "112.13", "question": "What was the mean age range of the patients included in the retrospective review?", "answer_src": "26.4 to 52.8 years", "follow_up_question": "What was the minimum age of the patients included in the retrospective review?", "follow_up_response": "26.4", "follow_up_response_bt": "No Answer"}, {"question_id": "112.14", "question": "What was the total number of patients included in the case series?", "answer_src": "742", "follow_up_question": "What was the average age of the patients in the case series?", "follow_up_response": "52.8", "follow_up_response_bt": "No Answer"}, {"question_id": "112.15", "question": "What was the range of ages for the patients included in the retrospective review?", "answer_src": "26.4 to 52.8 years", "follow_up_question": "What was the total number of patients included in the case series studies?", "follow_up_response": "742", "follow_up_response_bt": "742"}]}}
{"id": 113, "src": "in the study area , pentachlorophenol and pentachlorophenol incineration sources have been identified , and the animal contamination and blood elevations probably reflect these sources . soil reference values and site - specific risk assessments should include estimates of exposures to contamination in home - produced animal products . such estimates can be verified with limited pcdd / pcdf sampling of animals and humans.imagesfigure 1figure 2", "mt": "Nell'area di studio sono state identificate fonti di incinerazione di pentachlorofenole e pentachlorofenole , e la contaminazione animale e gli alti livelli del sangue probabilmente riflettono queste fonti . I valori di riferimento del suolo e le valutazioni di rischio specifiche del sito dovrebbero includere stime di esposizioni alla contaminazione nei prodotti animali domestici . tali stime possono essere verificate con un campionamento limitato di animali e umani.imagesfigure 1figure 2", "pert_mt": "Nell'area di studio sono state identificate fonti di incinerazione di pentachlorofenole e pentachlorofenole, e la contaminazione animale e gli alti livelli del sangue probabilmente riflettono queste fonti. I valori di riferimento del suolo e le valutazioni di rischio specifiche del sito dovrebbero includere stime di esposizioni alla contaminazione nei prodotti animali domestici e nelle latte di latte materno. Tali stime possono essere verificate con un campionamento limitato di animali e umani.", "bt": "In the study area, sources of incineration of pentachlorophenolic and pentachlorophenolic compounds have been identified, and animal contamination and high blood levels are likely reflected by these sources.Soil reference values and site-specific risk assessments should include estimates of exposure to contamination in pet products and in breast milk.These estimates can be verified with a limited sample of animals and humans.", "questions_src": ["What is the main source of contamination identified in the study area?", "Who might be affected by the contamination according to the study?", "Where could exposure to contamination come from based on the information provided?", "When might the animal contamination and blood elevations occur?", "Which type of contamination is specifically mentioned in the study?"], "answers_src": ["pentachlorophenol and pentachlorophenol incineration sources", "animals and humans", "home-produced animal products", "probably reflect these sources", "pentachlorophenol"], "answers_bt": ["Sources of incineration of pentachlorophenolic and pentachlorophenolic compounds", "Animals and humans", "Pet products and breast milk", "No Answer", "Pentachlorophenolic and pentachlorophenolic compounds"], "multiturn": {"turn_1": [{"question_id": "113.1", "question": "What is the main source of contamination identified in the study area?", "answer_src": "pentachlorophenol and pentachlorophenol incineration sources", "follow_up_question": "What evidence supports the connection between pentachlorophenol and pentachlorophenol incineration sources and animal contamination?", "follow_up_response": "The animal contamination and blood elevations probably reflect these sources", "follow_up_response_bt": "In the study area, sources of incineration of pentachlorophenolic and pentachlorophenolic compounds have been identified"}, {"question_id": "113.2", "question": "Who might be affected by the contamination according to the study?", "answer_src": "animals and humans", "follow_up_question": "What types of animal products might be contaminated?", "follow_up_response": "home - produced animal products", "follow_up_response_bt": "Pet products"}, {"question_id": "113.3", "question": "Where could exposure to contamination come from based on the information provided?", "answer_src": "home-produced animal products", "follow_up_question": "What specific contaminants are likely to be found in home-produced animal products?", "follow_up_response": "pentachlorophenol and pentachlorophenol incineration", "follow_up_response_bt": "pet products"}, {"question_id": "113.4", "question": "When might the animal contamination and blood elevations occur?", "answer_src": "probably reflect these sources", "follow_up_question": "What types of animal products might be affected by the contamination?", "follow_up_response": "Home-produced animal products", "follow_up_response_bt": "Pet products"}, {"question_id": "113.5", "question": "Which type of contamination is specifically mentioned in the study?", "answer_src": "pentachlorophenol", "follow_up_question": "What evidence suggests that pentachlorophenol contamination reflects animal contamination?", "follow_up_response": "The animal contamination and blood elevations probably reflect these sources.", "follow_up_response_bt": "Animal contamination and high blood levels"}], "turn_2": [{"question_id": "113.6", "question": "What evidence supports the connection between pentachlorophenol and pentachlorophenol incineration sources and animal contamination?", "answer_src": "The animal contamination and blood elevations probably reflect these sources", "follow_up_question": "How do the animal contamination levels specifically relate to pentachlorophenol and pentachlorophenol incineration sources?", "follow_up_response": "The animal contamination levels probably reflect these sources", "follow_up_response_bt": "High blood levels"}, {"question_id": "113.7", "question": "What types of animal products might be contaminated?", "answer_src": "home - produced animal products", "follow_up_question": "What evidence supports the contamination of home-produced animal products?", "follow_up_response": "Limited PCDD/PCDF sampling of animals and humans", "follow_up_response_bt": "These estimates can be verified with a limited sample of animals and humans."}, {"question_id": "113.8", "question": "What specific contaminants are likely to be found in home-produced animal products?", "answer_src": "pentachlorophenol and pentachlorophenol incineration", "follow_up_question": "What additional evidence can verify the estimates of contamination in home-produced animal products?", "follow_up_response": "Limited PCDD/PCDF sampling of animals and humans", "follow_up_response_bt": "A limited sample of animals"}, {"question_id": "113.9", "question": "What types of animal products might be affected by the contamination?", "answer_src": "Home-produced animal products", "follow_up_question": "What specific contaminants are likely to be found in home-produced animal products?", "follow_up_response": "pentachlorophenol and pentachlorophenol incineration", "follow_up_response_bt": "pet products"}, {"question_id": "113.10", "question": "What evidence suggests that pentachlorophenol contamination reflects animal contamination?", "answer_src": "The animal contamination and blood elevations probably reflect these sources.", "follow_up_question": "How do the soil reference values and site-specific risk assessments need to incorporate exposure estimates?", "follow_up_response": "Exposure estimates to contamination in home-produced animal products", "follow_up_response_bt": "Exposure to contamination in pet products and in breast milk"}], "turn_3": [{"question_id": "113.11", "question": "How do the animal contamination levels specifically relate to pentachlorophenol and pentachlorophenol incineration sources?", "answer_src": "The animal contamination levels probably reflect these sources", "follow_up_question": "What evidence supports the claim that the animal contamination levels reflect pentachlorophenol and pentachlorophenol incineration sources?", "follow_up_response": "The animal contamination and blood elevations probably reflect these sources", "follow_up_response_bt": "Soil reference values and site-specific risk assessments should include estimates of exposure to contamination in pet products and in breast milk.These estimates can be verified with a limited sample of animals and humans."}, {"question_id": "113.12", "question": "What evidence supports the contamination of home-produced animal products?", "answer_src": "Limited PCDD/PCDF sampling of animals and humans", "follow_up_question": "How can the limited PCDD/PCDF sampling be verified?", "follow_up_response": "With limited pcdd / pcdf sampling of animals and humans", "follow_up_response_bt": "With a limited sample of animals and humans"}, {"question_id": "113.13", "question": "What additional evidence can verify the estimates of contamination in home-produced animal products?", "answer_src": "Limited PCDD/PCDF sampling of animals and humans", "follow_up_question": "How many animals and humans need to be sampled for the verification of contamination estimates?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "113.14", "question": "What specific contaminants are likely to be found in home-produced animal products?", "answer_src": "pentachlorophenol and pentachlorophenol incineration", "follow_up_question": "What additional evidence can verify the estimates of contamination in home-produced animal products?", "follow_up_response": "Limited PCDD/PCDF sampling of animals and humans", "follow_up_response_bt": "A limited sample of animals"}, {"question_id": "113.15", "question": "How do the soil reference values and site-specific risk assessments need to incorporate exposure estimates?", "answer_src": "Exposure estimates to contamination in home-produced animal products", "follow_up_question": "What specific types of animal products are being referred to when mentioning home-produced animal products?", "follow_up_response": "Home-produced animal products", "follow_up_response_bt": "No Answer"}]}}
{"id": 114, "src": "resistance to fluoroquinolones ( flq ) and second - line injectable drugs ( slid ) is steadily increasing , especially in eastern european countries , posing a serious threat to effective tuberculosis ( tb ) infection control and adequate patient management . the availability of rapid molecular tests for the detection of extensively drug - resistant tb ( xdr - tb ) is critical in areas with high rates of multidrug - resistant tb ( mdr - tb ) and xdr - tb and limited conventional drug susceptibility testing ( dst ) capacity . we conducted a multicenter study to evaluate the performance of the new version ( v2.0 ) of the genotype mtbdrsl assay compared to phenotypic dst and sequencing on a panel of 228 mycobacterium tuberculosis isolates and 231 smear - positive clinical specimens .", "mt": "La disponibilità di test molecolari rapidi per il rilevamento di tubercolosi resistente a farmaci estensivi (xdr - TB) è critica in aree con alti tassi di tubercolosi resistente a farmaci ( mdr - TB) e xdr - TB e limitata capacità di test di sensibilizzazione alle droghe convenzionali (dst). Abbiamo condotto uno studio multicentrico per valutare le prestazioni positive della nuova versione (v2.0) del genotipo mtrsl assay rispetto a quelli fenotipici e sequenziando su un pannello di 228 campioni di tubercolosi micobacterica isolati e 231 campioni clinici di smalto .", "pert_mt": "La disponibilità di test molecolari rapidi per il rilevamento di tubercolosi resistente a farmaci estensivi (xdr - TB) è critica in aree con alti tassi di tubercolosi resistente a farmaci ( mdr - TB) e xdr - TB e limitata capacità di test di sensibilizzazione alle droghe convenzionali (dst). Abbiamo condotto uno studio multicentrico per valutare le prestazioni positive della nuova versione (v2.0) del genotipo mtrsl assay rispetto a quelli fenotipici e sequenziando su un pannello di 228 campioni di tubercolosi micobacterica isolati e 231 campioni clinici di smalto e abbiamo ottenuto risultati significativi.", "bt": "The availability of rapid molecular tests for the detection of drug-resistant tuberculosis (xdr-TB) is critical in areas with high rates of drug-resistant tuberculosis ( mdr-TB) and xdr-TB and limited capacity for conventional drug sensitization testing (dst).We conducted a multicenter study to evaluate the positive performance of the new version (v2.0) of the genotype mtrsl assay versus phenotypic ones by sequencing 228 isolated mycobacterial tuberculosis samples and 231 clinical smalto samples on a panel and obtained significant results.", "questions_src": ["What is the name of the new version of the test used in the study?", "Who poses a serious threat to effective tuberculosis infection control and adequate patient management?", "Where is resistance to fluoroquinolones and second-line injectable drugs increasing?", "When was the multicenter study conducted?", "Which tests were evaluated in the study?"], "answers_src": ["genotype mtbdrsl assay", "eastern european countries", "eastern european countries", "not specified", "genotype mtbdrsl assay, phenotypic DST, and sequencing"], "answers_bt": ["[\"genotype mtrsl assay\"], [\"No Answer\"], [\"No Answer\"], [\"No Answer\"], [\"genotype mtrsl assay versus phenotypic ones\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "114.1", "question": "What is the name of the new version of the test used in the study?", "answer_src": "genotype mtbdrsl assay", "follow_up_question": "What is the primary purpose of the rapid molecular tests mentioned in the text?", "follow_up_response": "To detect extensively drug-resistant TB (XDR-TB)", "follow_up_response_bt": "To detect drug-resistant tuberculosis (xdr-TB)"}, {"question_id": "114.2", "question": "Who poses a serious threat to effective tuberculosis infection control and adequate patient management?", "answer_src": "eastern european countries", "follow_up_question": "What specific drugs are becoming increasingly resistant in eastern European countries?", "follow_up_response": "fluoroquinolones ( flq ) and second - line injectable drugs ( slid )", "follow_up_response_bt": "No Answer"}, {"question_id": "114.3", "question": "Where is resistance to fluoroquinolones and second-line injectable drugs increasing?", "answer_src": "eastern european countries", "follow_up_question": "What specific type of test is being evaluated in the multicenter study?", "follow_up_response": "genotype mtbdrsl assay", "follow_up_response_bt": "The genotype mtrsl assay"}, {"question_id": "114.4", "question": "When was the multicenter study conducted?", "answer_src": "not specified", "follow_up_question": "What were the sources of the mycobacterium tuberculosis isolates used in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "228 isolated mycobacterial tuberculosis samples"}, {"question_id": "114.5", "question": "Which tests were evaluated in the study?", "answer_src": "genotype mtbdrsl assay, phenotypic DST, and sequencing", "follow_up_question": "What was the source of the mycobacterium tuberculosis isolates used in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "228 isolated mycobacterial tuberculosis samples"}], "turn_2": [{"question_id": "114.6", "question": "What is the primary purpose of the rapid molecular tests mentioned in the text?", "answer_src": "To detect extensively drug-resistant TB (XDR-TB)", "follow_up_question": "How many mycobacterium tuberculosis isolates were evaluated in the multicenter study?", "follow_up_response": "228", "follow_up_response_bt": "228"}, {"question_id": "114.7", "question": "What specific drugs are becoming increasingly resistant in eastern European countries?", "answer_src": "fluoroquinolones ( flq ) and second - line injectable drugs ( slid )", "follow_up_question": "What percentage of the isolates tested were found to be resistant to fluoroquinolones?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "114.8", "question": "What specific type of test is being evaluated in the multicenter study?", "answer_src": "genotype mtbdrsl assay", "follow_up_question": "What is the primary purpose of evaluating the genotype mtbdrsl assay in this study?", "follow_up_response": "To evaluate the performance of the new version (v2.0) of the genotype mtbdrsl assay compared to phenotypic DST and sequencing", "follow_up_response_bt": "To evaluate the positive performance of the new version (v2.0) of the genotype mtrsl assay versus phenotypic ones"}, {"question_id": "114.9", "question": "What were the sources of the mycobacterium tuberculosis isolates used in the study?", "answer_src": "resistance to fluoroquinolones ( flq ) and second - line injectable drugs ( slid ) is steadily increasing , especially in eastern european countries , posing a serious threat to effective tuberculosis ( tb ) infection control and adequate patient management . the availability of rapid molecular tests for the detection of extensively drug - resistant tb ( xdr - tb ) is critical in areas with high rates of multidrug - resistant tb ( mdr - tb ) and xdr - tb and limited conventional drug susceptibility testing ( dst ) capacity . we conducted a multicenter study to evaluate the performance of the new version ( v2.0 ) of the genotype mtbdrsl assay compared to phenotypic dst and sequencing on a panel of 228 mycobacterium tuberculosis isolates and 231 smear - positive clinical specimens .", "follow_up_question": "How many total samples were tested in the study?", "follow_up_response": "459", "follow_up_response_bt": "459"}, {"question_id": "114.10", "question": "What was the source of the mycobacterium tuberculosis isolates used in the study?", "answer_src": "resistance to fluoroquinolones ( flq ) and second - line injectable drugs ( slid ) is steadily increasing , especially in eastern european countries , posing a serious threat to effective tuberculosis ( tb ) infection control and adequate patient management . the availability of rapid molecular tests for the detection of extensively drug - resistant tb ( xdr - tb ) is critical in areas with high rates of multidrug - resistant tb ( mdr - tb ) and xdr - tb and limited conventional drug susceptibility testing ( dst ) capacity . we conducted a multicenter study to evaluate the performance of the new version ( v2.0 ) of the genotype mtbdrsl assay compared to phenotypic dst and sequencing on a panel of 228 mycobacterium tuberculosis isolates and 231 smear - positive clinical specimens .", "follow_up_question": "Where were the mycobacterium tuberculosis isolates obtained from?", "follow_up_response": "No Answer", "follow_up_response_bt": "228 isolated mycobacterial tuberculosis samples"}], "turn_3": [{"question_id": "114.11", "question": "How many mycobacterium tuberculosis isolates were evaluated in the multicenter study?", "answer_src": "228", "follow_up_question": "How many smear-positive clinical specimens were evaluated in the multicenter study?", "follow_up_response": "231", "follow_up_response_bt": "231"}, {"question_id": "114.12", "question": "What percentage of the isolates tested were found to be resistant to fluoroquinolones?", "answer_src": "resistance to fluoroquinolones ( flq ) and second - line injectable drugs ( slid ) is steadily increasing , especially in eastern european countries , posing a serious threat to effective tuberculosis ( tb ) infection control and adequate patient management . the availability of rapid molecular tests for the detection of extensively drug - resistant tb ( xdr - tb ) is critical in areas with high rates of multidrug - resistant tb ( mdr - tb ) and xdr - tb and limited conventional drug susceptibility testing ( dst ) capacity . we conducted a multicenter study to evaluate the performance of the new version ( v2.0 ) of the genotype mtbdrsl assay compared to phenotypic dst and sequencing on a panel of 228 mycobacterium tuberculosis isolates and 231 smear - positive clinical specimens .", "follow_up_question": "What types of drugs were specifically evaluated for resistance in the study?", "follow_up_response": "fluoroquinolones ( flq ) and second - line injectable drugs ( slid )", "follow_up_response_bt": "Drugs"}, {"question_id": "114.13", "question": "What is the primary purpose of evaluating the genotype mtbdrsl assay in this study?", "answer_src": "To evaluate the performance of the new version (v2.0) of the genotype mtbdrsl assay compared to phenotypic DST and sequencing", "follow_up_question": "How many mycobacterium tuberculosis isolates were included in the study?", "follow_up_response": "228", "follow_up_response_bt": "228"}, {"question_id": "114.14", "question": "How many total samples were tested in the study?", "answer_src": "459", "follow_up_question": "How many of these samples were M. tuberculosis isolates?", "follow_up_response": "228", "follow_up_response_bt": "228"}, {"question_id": "114.15", "question": "Where were the mycobacterium tuberculosis isolates obtained from?", "answer_src": "resistance to fluoroquinolones ( flq ) and second - line injectable drugs ( slid ) is steadily increasing , especially in eastern european countries , posing a serious threat to effective tuberculosis ( tb ) infection control and adequate patient management . the availability of rapid molecular tests for the detection of extensively drug - resistant tb ( xdr - tb ) is critical in areas with high rates of multidrug - resistant tb ( mdr - tb ) and xdr - tb and limited conventional drug susceptibility testing ( dst ) capacity . we conducted a multicenter study to evaluate the performance of the new version ( v2.0 ) of the genotype mtbdrsl assay compared to phenotypic dst and sequencing on a panel of 228 mycobacterium tuberculosis isolates and 231 smear - positive clinical specimens .", "follow_up_question": "In which regions did the study focus on for the increased resistance to fluoroquinolones and second-line injectable drugs?", "follow_up_response": "eastern european countries", "follow_up_response_bt": "No Answer"}]}}
{"id": 115, "src": "we report the rare case of an 83-year - old caucasian male affected by a giant cholesteatoma that eroded the labyrinth and the posterior fossa dura and extended to the infralabyrinthine region , going beyond the theca and reaching the first cervical vertebra . the giant cholesteatoma was managed through a combined approach ( microscopic and , subsequently , complementary endoscopic approach ) . in this case report , we illustrate some advantages of this surgical choice .", "mt": "Segnala il raro caso di un maschio caucasico di 83 anni colpito da un colosso colesteatoma che erodeva il labirinto e la fossa posteriore dura e si estendeva fino alla regione infralabirintica , superando la teca e raggiungendo la prima vertebra cervicale . Il colosso colesteatoma è stato gestito attraverso un approccio combinato (microscopico e , successivamente , endoscopico complementare).", "pert_mt": "Segnala il raro caso di un maschio caucasico di 83 anni colpito da un colosso colesteatoma che erodeva il labirinto e la fossa posteriore dura e si estendeva fino alla regione infralabirintica, superando la teca e raggiungendo la prima vertebra cervicale. Il colosso colesteatoma è stato gestito attraverso un approccio combinato (microscopico e, successivamente, endoscopico complementare) e ha causato danni permanenti all'udito.", "bt": "The rare case of an 83-year-old Caucasian male being struck by a colossal colostomy that erodes the labyrinth and the hard posterior fossa and extends to the infralabyrinth region, overtaking the teca and reaching the first cervical vertebrae, reports The colossal colostomy was managed through a combined approach (microscopic and, subsequently, complementary endoscopic) and has caused permanent damage to the whole ear.", "questions_src": ["What is the age of the patient?", "Who was affected by the cholesteatoma?", "Where did the cholesteatoma erode?", "When was the patient's surgery performed?", "Which vertebra was reached by the cholesteatoma?"], "answers_src": ["83-year-old", "an 83-year-old caucasian male", "the labyrinth and the posterior fossa dura and extended to the infralabyrinthine region", "not specified", "the first cervical vertebra"], "answers_bt": ["83-year-old", "The patient", "the labyrinth and the hard posterior fossa and extends to the infralabyrinth region, overtaking the teca", "not specified", "first cervical"], "multiturn": {"turn_1": [{"question_id": "115.1", "question": "What is the age of the patient?", "answer_src": "83-year-old", "follow_up_question": "What anatomical structures did the giant cholesteatoma affect?", "follow_up_response": "the labyrinth, the posterior fossa dura, the infralabyrinthine region", "follow_up_response_bt": "The labyrinth, the hard posterior fossa, the infralabyrinth region, and the ear"}, {"question_id": "115.2", "question": "Who was affected by the cholesteatoma?", "answer_src": "an 83-year-old caucasian male", "follow_up_question": "What specific areas did the cholesteatoma affect?", "follow_up_response": "the labyrinth and the posterior fossa dura and extended to the infralabyrinthine region", "follow_up_response_bt": "the labyrinth and the hard posterior fossa and extends to the infralabyrinth region"}, {"question_id": "115.3", "question": "Where did the cholesteatoma erode?", "answer_src": "the labyrinth and the posterior fossa dura and extended to the infralabyrinthine region", "follow_up_question": "What structures did the cholesteatoma extend beyond the infralabyrinthine region?", "follow_up_response": "theca and reaching the first cervical vertebra", "follow_up_response_bt": "The hard posterior fossa and the first cervical vertebrae"}, {"question_id": "115.4", "question": "When was the patient's surgery performed?", "answer_src": "not specified", "follow_up_question": "What were the two approaches used in the patient's surgery?", "follow_up_response": "Microscopic and , subsequently , complementary endoscopic", "follow_up_response_bt": "microscopic and, subsequently, complementary endoscopic"}, {"question_id": "115.5", "question": "Which vertebra was reached by the cholesteatoma?", "answer_src": "the first cervical vertebra", "follow_up_question": "What were the two approaches used in managing the cholesteatoma?", "follow_up_response": "Microscopic and , subsequently , complementary endoscopic", "follow_up_response_bt": "microscopic and, subsequently, complementary endoscopic"}], "turn_2": [{"question_id": "115.6", "question": "What anatomical structures did the giant cholesteatoma affect?", "answer_src": "the labyrinth, the posterior fossa dura, the infralabyrinthine region", "follow_up_question": "What were the challenges in managing such a large cholesteatoma?", "follow_up_response": "No Answer", "follow_up_response_bt": "A combined approach (microscopic and, subsequently, complementary endoscopic)"}, {"question_id": "115.7", "question": "What specific areas did the cholesteatoma affect?", "answer_src": "the labyrinth and the posterior fossa dura and extended to the infralabyrinthine region", "follow_up_question": "What anatomical structures did the cholesteatoma extend beyond the infralabyrinthine region?", "follow_up_response": "theca and reaching the first cervical vertebra", "follow_up_response_bt": "the teca and reaching the first cervical vertebrae"}, {"question_id": "115.8", "question": "What structures did the cholesteatoma extend beyond the infralabyrinthine region?", "answer_src": "theca and reaching the first cervical vertebra", "follow_up_question": "What anatomical feature did the cholesteatoma go beyond reaching?", "follow_up_response": "the theca", "follow_up_response_bt": "the first cervical vertebrae"}, {"question_id": "115.9", "question": "What were the two approaches used in the patient's surgery?", "answer_src": "Microscopic and , subsequently , complementary endoscopic", "follow_up_question": "What was the extent of the damage caused by the cholesteatoma before it was removed?", "follow_up_response": "The labyrinth and the posterior fossa dura and extended to the infralabyrinthine region, going beyond the theca and reaching the first cervical vertebra.", "follow_up_response_bt": "Permanent damage to the whole ear"}, {"question_id": "115.10", "question": "What were the two approaches used in managing the cholesteatoma?", "answer_src": "Microscopic and , subsequently , complementary endoscopic", "follow_up_question": "What was the extent of the cholesteatoma's erosion according to the text?", "follow_up_response": "the labyrinth and the posterior fossa dura and extended to the infralabyrinthine region, going beyond the theca and reaching the first cervical vertebra", "follow_up_response_bt": "the labyrinth and the hard posterior fossa and extends to the infralabyrinth region"}], "turn_3": [{"question_id": "115.11", "question": "What were the challenges in managing such a large cholesteatoma?", "answer_src": "we report the rare case of an 83-year - old caucasian male affected by a giant cholesteatoma that eroded the labyrinth and the posterior fossa dura and extended to the infralabyrinthine region , going beyond the theca and reaching the first cervical vertebra . the giant cholesteatoma was managed through a combined approach ( microscopic and , subsequently , complementary endoscopic approach ) . in this case report , we illustrate some advantages of this surgical choice .", "follow_up_question": "What specific anatomical regions did the giant cholesteatoma affect?", "follow_up_response": "the labyrinth and the posterior fossa dura and extended to the infralabyrinthine region", "follow_up_response_bt": "the labyrinth, the hard posterior fossa, the infralabyrinth region, and the ear"}, {"question_id": "115.12", "question": "What anatomical structures did the cholesteatoma extend beyond the infralabyrinthine region?", "answer_src": "theca and reaching the first cervical vertebra", "follow_up_question": "What was the extent of the cholesteatoma's erosion beyond the thecal layer?", "follow_up_response": "beyond the theca and reaching the first cervical vertebra", "follow_up_response_bt": "The hard posterior fossa and extends to the infralabyrinth region"}, {"question_id": "115.13", "question": "What anatomical feature did the cholesteatoma go beyond reaching?", "answer_src": "the theca", "follow_up_question": "What was the extent of the cholesteatoma's erosion beyond the theca?", "follow_up_response": "beyond the theca and reaching the first cervical vertebra", "follow_up_response_bt": "The infralabyrinth region, overtaking the teca and reaching the first cervical vertebrae"}, {"question_id": "115.14", "question": "What was the extent of the damage caused by the cholesteatoma before it was removed?", "answer_src": "The labyrinth and the posterior fossa dura and extended to the infralabyrinthine region, going beyond the theca and reaching the first cervical vertebra.", "follow_up_question": "How did the cholesteatoma extend beyond its initial area of damage?", "follow_up_response": "going beyond the theca and reaching the first cervical vertebra", "follow_up_response_bt": "to the infralabyrinth region, overtaking the teca and reaching the first cervical vertebrae"}, {"question_id": "115.15", "question": "What was the extent of the cholesteatoma's erosion according to the text?", "answer_src": "the labyrinth and the posterior fossa dura and extended to the infralabyrinthine region, going beyond the theca and reaching the first cervical vertebra", "follow_up_question": "What anatomical structures did the cholesteatoma extend beyond its primary site?", "follow_up_response": "theca and reaching the first cervical vertebra", "follow_up_response_bt": "the labyrinth and the hard posterior fossa and extends to the infralabyrinth region"}]}}
{"id": 116, "src": "purposethe purpose of this study was to evaluate the clinical outcome of arthroscopic treatment for recalcitrant external snapping hip.materials and methodsbetween september 2011 and june 2013 , we evaluated 7 patients ( 10 cases ) with snapping hip who were refractory to conservative treatments for at least 3 months . two patients ( 4 cases ) were impossible to adduct both knees in 90of hip flexion . surgery was done in lateral decubitus position , under spinal anesthesia .", "mt": "Lo scopo di questo studio era quello di valutare l' esito clinico del trattamento artroscopico per i materiali e metodi di ricalcitrante intercettazione esterna dell' anca tra settembre 2011 e giugno 2013 , abbiamo valutato 7 pazienti (10 casi) con intercettazione dell' anca che erano refrattari ai trattamenti conservativi per almeno 3 mesi . due pazienti (4 casi) non potevano adduire entrambe le ginocchia in 90 di flessione dell' anca .", "pert_mt": "Lo scopo di questo studio era quello di valutare l'esito clinico del trattamento artroscopico per i materiali e metodi di ricalcitrante intercettazione esterna dell'anca tra settembre 2011 e giugno 2013, abbiamo valutato 7 pazienti (10 casi) con intercettazione dell'anca che erano refrattari ai trattamenti conservativi per almeno 3 mesi. Due pazienti (4 casi) non potevano addurre entrambe le ginocchia in 90° di flessione dell'anca.", "bt": "The purpose of this study was to evaluate the clinical outcome of arthroscopic treatment for materials and methods of recalcitrant external hip interception between September 2011 and June 2013, we evaluated 7 patients (10 cases) with hip interception who were refractory to conservative treatments for at least 3 months.", "questions_src": ["What was the main goal of the study?", "Who participated in the study?", "Where was the surgery performed?", "When did the study take place?", "How many patients had difficulty adding their knees?"], "answers_src": ["To evaluate the clinical outcome of arthroscopic treatment for recalcitrant external snapping hip", "7 patients (10 cases)", "in lateral decubitus position", "between September 2011 and June 2013", "2"], "answers_bt": ["[\"To evaluate the clinical outcome of arthroscopic treatment for recalcitrant external hip interference\"], [\"7 patients (10 cases)\"], [\"Between September 2011 and June 2013\"], [\"September 2011 and June 2013\"], [\"No Answer\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "116.1", "question": "What was the main goal of the study?", "answer_src": "To evaluate the clinical outcome of arthroscopic treatment for recalcitrant external snapping hip", "follow_up_question": "How many patients were initially included in the study?", "follow_up_response": "7", "follow_up_response_bt": "7"}, {"question_id": "116.2", "question": "Who participated in the study?", "answer_src": "7 patients (10 cases)", "follow_up_question": "How many cases were impossible to adduct both knees in 90 degrees of hip flexion?", "follow_up_response": "4", "follow_up_response_bt": "No Answer"}, {"question_id": "116.3", "question": "Where was the surgery performed?", "answer_src": "in lateral decubitus position", "follow_up_question": "What was the anesthesia used during the surgery?", "follow_up_response": "spinal anesthesia", "follow_up_response_bt": "No Answer"}, {"question_id": "116.4", "question": "When did the study take place?", "answer_src": "between September 2011 and June 2013", "follow_up_question": "How many patients were initially included in the study?", "follow_up_response": "7", "follow_up_response_bt": "7"}, {"question_id": "116.5", "question": "How many patients had difficulty adding their knees?", "answer_src": "2", "follow_up_question": "How many cases were impossible to adduct both knees in 90 degrees of hip flexion?", "follow_up_response": "4", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "116.6", "question": "How many patients were initially included in the study?", "answer_src": "7", "follow_up_question": "How many cases were initially evaluated in the study?", "follow_up_response": "10", "follow_up_response_bt": "10"}, {"question_id": "116.7", "question": "How many cases were impossible to adduct both knees in 90 degrees of hip flexion?", "answer_src": "4", "follow_up_question": "How many patients underwent surgery?", "follow_up_response": "7", "follow_up_response_bt": "7"}, {"question_id": "116.8", "question": "What was the anesthesia used during the surgery?", "answer_src": "spinal anesthesia", "follow_up_question": "How many patients had difficulty addingucting both knees in 90 degrees of hip flexion?", "follow_up_response": "2", "follow_up_response_bt": "No Answer"}, {"question_id": "116.9", "question": "How many patients were initially included in the study?", "answer_src": "7", "follow_up_question": "How many cases were initially evaluated in the study?", "follow_up_response": "10", "follow_up_response_bt": "10"}, {"question_id": "116.10", "question": "How many cases were impossible to adduct both knees in 90 degrees of hip flexion?", "answer_src": "4", "follow_up_question": "How many patients underwent surgery?", "follow_up_response": "7", "follow_up_response_bt": "7"}], "turn_3": [{"question_id": "116.11", "question": "How many cases were initially evaluated in the study?", "answer_src": "10", "follow_up_question": "How many patients had difficulty addingucting both knees in 90 degrees of hip flexion?", "follow_up_response": "2", "follow_up_response_bt": "No Answer"}, {"question_id": "116.12", "question": "How many patients underwent surgery?", "answer_src": "7", "follow_up_question": "How many patients had difficulty addingucting both knees in 90 degrees of hip flexion?", "follow_up_response": "2", "follow_up_response_bt": "No Answer"}, {"question_id": "116.13", "question": "How many patients had difficulty addingucting both knees in 90 degrees of hip flexion?", "answer_src": "2", "follow_up_question": "How many surgeries were performed during the study?", "follow_up_response": "7", "follow_up_response_bt": "10"}, {"question_id": "116.14", "question": "How many cases were initially evaluated in the study?", "answer_src": "10", "follow_up_question": "How many patients had difficulty addingucting both knees in 90 degrees of hip flexion?", "follow_up_response": "2", "follow_up_response_bt": "No Answer"}, {"question_id": "116.15", "question": "How many patients underwent surgery?", "answer_src": "7", "follow_up_question": "How many patients had difficulty addingucting both knees in 90 degrees of hip flexion?", "follow_up_response": "2", "follow_up_response_bt": "No Answer"}]}}
{"id": 117, "src": "introductiondiagnosis of peritoneal tuberculosis ( ptb ) is difficult , even in developed countries , where data are lacking . the aim of the present study was to describe the clinical presentation , diagnosis , and bacterial epidemiology of ptb in france over a 10-year period.methodsa retrospective study was conducted on ptb in two university hospitals in france , between january 2004 and december 2014.resultsamong the 34 patients , 76.5% were migrants from areas of endemic tuberculosis ( tb ) , mainly africa . the main presentation ( 85.3% ) was a checkup of ascites or suspicion of peritoneal carcinomatosis .", "mt": "L'introduzione di un diagnosi di tubercolosi peritoneale (PTB) è difficile , anche nei paesi sviluppati , dove mancano dati . L'obiettivo del presente studio era quello di descrivere la presentazione clinica , la diagnosi e l'epidemiologia batterica della tubercolosi peritoneale (PTB) in Francia su un periodo di 10 anni.Questo studio retrospettivo è stato condotto su ptb in due ospedali universitari in Francia , tra gennaio 2004 e dicembre 2014.Rescultati tra i 34 pazienti , 76,5% erano migranti provenienti da aree di tubercolosi endemica (TB) , principalmente in Africa . La presentazione principale (85,3%) era un controllo di ascite o sospetto di carcinomatosi peritoneale .", "pert_mt": "L'introduzione di un diagnosi di tubercolosi peritoneale (PTB) è difficile, anche nei paesi sviluppati, dove mancano dati. L'obiettivo del presente studio era quello di descrivere la presentazione clinica, la diagnosi e l'epidemiologia batterica della tubercolosi peritoneale (PTB) in Francia su un periodo di 10 anni. Questo studio retrospettivo è stato condotto su ptb in due ospedali universitari in Francia, tra gennaio 2004 e dicembre 2014. Recultati tra i 34 pazienti, 76,5% erano migranti provenienti da aree di tubercolosi endemica (TB), principalmente in Africa. La presentazione principale (85,3%) era un controllo di ascite", "bt": "The introduction of a diagnosis of peritoneal tuberculosis (PTB) is difficult, even in developed countries, where data is lacking.The objective of this study was to describe the clinical presentation, diagnosis and bacterial epidemiology of peritoneal tuberculosis (PTB) in France over a 10-year period.This retrospective study was conducted on ptb in two university hospitals in France, between January 2004 and December 2014.", "questions_src": ["What is the main presentation of peritoneal tuberculosis in the study participants?", "Who were the majority of the patients in terms of origin?", "Where were the patients mainly from according to the study?", "When did the study take place?", "Which method was used to conduct the retrospective study?"], "answers_src": ["A checkup of ascites or suspicion of peritoneal carcinomatosis", "Migrants from areas of endemic tuberculosis (tb)", "Africa", "Between January 2004 and December 2014", "Retrospective"], "answers_bt": ["The clinical presentation", "No Answer", "France", "Between 2004 and 2014", "Retrospective"], "multiturn": {"turn_1": [{"question_id": "117.1", "question": "What is the main presentation of peritoneal tuberculosis in the study participants?", "answer_src": "A checkup of ascites or suspicion of peritoneal carcinomatosis", "follow_up_question": "What percentage of the study participants had a main presentation of a checkup of ascites or suspicion of peritoneal carcinomatosis?", "follow_up_response": "85.3%", "follow_up_response_bt": "No Answer"}, {"question_id": "117.2", "question": "Who were the majority of the patients in terms of origin?", "answer_src": "Migrants from areas of endemic tuberculosis (tb)", "follow_up_question": "What percentage of the patients presented with ascites or suspicion of peritoneal carcinomatosis?", "follow_up_response": "85.3%", "follow_up_response_bt": "No Answer"}, {"question_id": "117.3", "question": "Where were the patients mainly from according to the study?", "answer_src": "Africa", "follow_up_question": "What was the most common initial symptom reported by the patients in this study?", "follow_up_response": "a checkup of ascites or suspicion of peritoneal carcinomatosis", "follow_up_response_bt": "No Answer"}, {"question_id": "117.4", "question": "When did the study take place?", "answer_src": "Between January 2004 and December 2014", "follow_up_question": "What was the main presentation for most of the patients?", "follow_up_response": "A checkup of ascites or suspicion of peritoneal carcinomatosis", "follow_up_response_bt": "No Answer"}, {"question_id": "117.5", "question": "Which method was used to conduct the retrospective study?", "answer_src": "Retrospective", "follow_up_question": "What percentage of the 34 patients were migrants from areas of endemic tuberculosis?", "follow_up_response": "76.5%", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "117.6", "question": "What percentage of the study participants had a main presentation of a checkup of ascites or suspicion of peritoneal carcinomatosis?", "answer_src": "85.3%", "follow_up_question": "What was the main source of the patients in this study?", "follow_up_response": "migrants from areas of endemic tuberculosis ( tb )", "follow_up_response_bt": "Two university hospitals in France"}, {"question_id": "117.7", "question": "What percentage of the patients presented with ascites or suspicion of peritoneal carcinomatosis?", "answer_src": "85.3%", "follow_up_question": "What was the main presenting symptom for 15.7% of the patients?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "117.8", "question": "What was the most common initial symptom reported by the patients in this study?", "answer_src": "a checkup of ascites or suspicion of peritoneal carcinomatosis", "follow_up_question": "What percentage of the patients in this study had a history of migration from areas of endemic tuberculosis?", "follow_up_response": "76.5%", "follow_up_response_bt": "No Answer"}, {"question_id": "117.9", "question": "What was the main presentation for most of the patients?", "answer_src": "A checkup of ascites or suspicion of peritoneal carcinomatosis", "follow_up_question": "What percentage of patients had a presentation involving ascites?", "follow_up_response": "85.3%", "follow_up_response_bt": "No Answer"}, {"question_id": "117.10", "question": "What percentage of the 34 patients were migrants from areas of endemic tuberculosis?", "answer_src": "76.5%", "follow_up_question": "What was the main presentation for 85.3% of the 34 patients?", "follow_up_response": "a checkup of ascites or suspicion of peritoneal carcinomatosis", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "117.11", "question": "What was the main source of the patients in this study?", "answer_src": "migrants from areas of endemic tuberculosis ( tb )", "follow_up_question": "What percentage of the patients presented with ascites or suspicion of peritoneal carcinomatosis?", "follow_up_response": "85.3%", "follow_up_response_bt": "No Answer"}, {"question_id": "117.12", "question": "What was the main presenting symptom for 15.7% of the patients?", "answer_src": "introductiondiagnosis of peritoneal tuberculosis ( ptb ) is difficult , even in developed countries , where data are lacking . the aim of the present study was to describe the clinical presentation , diagnosis , and bacterial epidemiology of ptb in france over a 10-year period.methodsa retrospective study was conducted on ptb in two university hospitals in france , between january 2004 and december 2014.resultsamong the 34 patients , 76.5% were migrants from areas of endemic tuberculosis ( tb ) , mainly africa . the main presentation ( 85.3% ) was a checkup of ascites or suspicion of peritoneal carcinomatosis .", "follow_up_question": "What percentage of patients presented with a checkup of ascites or suspicion of peritoneal carcinomatosis?", "follow_up_response": "85.3%", "follow_up_response_bt": "No Answer"}, {"question_id": "117.13", "question": "What percentage of the patients in this study had a history of migration from areas of endemic tuberculosis?", "answer_src": "76.5%", "follow_up_question": "What was the most common presentation among the patients in the study?", "follow_up_response": "a checkup of ascites or suspicion of peritoneal carcinomatosis", "follow_up_response_bt": "No Answer"}, {"question_id": "117.14", "question": "What percentage of patients had a presentation involving ascites?", "answer_src": "85.3%", "follow_up_question": "What was the main presenting symptom for the remaining 14.7% of patients?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "117.15", "question": "What was the main presentation for 85.3% of the 34 patients?", "answer_src": "a checkup of ascites or suspicion of peritoneal carcinomatosis", "follow_up_question": "What percentage of the 34 patients were migrants from areas of endemic tuberculosis (TB), mainly Africa?", "follow_up_response": "76.5%", "follow_up_response_bt": "No Answer"}]}}
{"id": 118, "src": "six months later , due to persistence of symptoms , the patient underwent a high resolution esophageal manometry ( hrem ) demonstrating jackhammer esophagus . the patient was treated with a high dose proton pump inhibitor but without resolution of her symptoms . during the last year , the patient reported repeated episodes of food regurgitation and a significant weight loss .", "mt": "Sei mesi dopo , a causa della persistenza dei sintomi , la paziente ha subito una manometria esofagea ad alta risoluzione (hrem) che dimostrava l' esofago di jackhammer . La paziente è stata trattata con un inibitore della pompa protonica ad alta dose ma senza risoluzione dei suoi sintomi . Durante l' ultimo anno , la paziente ha riportato episodi ripetuti di regurgitazione alimentare e una significativa perdita di peso .", "pert_mt": "Sei mesi dopo, a causa della persistenza dei sintomi, la paziente ha subito una manometria esofagea ad alta risoluzione (HREM) che dimostrava l'esofago di jackhammer. La paziente è stata trattata con un inibitore della pompa protonica ad alta dose ma senza risoluzione dei suoi sintomi. Durante l'ultimo anno, la paziente ha riportato episodi ripetuti di regurgitazione alimentare e una significativa perdita di peso, anche se ha seguito una dieta rigorosa.", "bt": "Six months later, due to the persistence of symptoms, the patient underwent a high-resolution esophageal manometry (HREM) that demonstrated the jackhammer esophagus.The patient was treated with a high-dose proton pump inhibitor but without resolving her symptoms.During the last year, the patient reported repeated episodes of regurgitation and significant weight loss, even after following a strict diet.", "questions_src": ["What is the name of the test that demonstrated jackhammer esophagus?", "When did the patient undergo the high resolution esophageal manometry (HREM)?", "What symptom was not resolved by the high dose proton pump inhibitor treatment?", "Where did the patient report having repeated episodes of food regurgitation?", "Which condition was present six months before the mentioned symptoms persisted?"], "answers_src": ["High resolution esophageal manometry (HREM)", "Six months later", "Food regurgitation", "During the last year", "Jackhammer esophagus"], "answers_bt": ["High-resolution esophageal manometry (HREM)", "Six months later", "Symptoms", "In the mouth", "Jackhammer esophagus"], "multiturn": {"turn_1": [{"question_id": "118.1", "question": "What is the name of the test that demonstrated jackhammer esophagus?", "answer_src": "High resolution esophageal manometry (HREM)", "follow_up_question": "What were the patient's symptoms before undergoing the HREM?", "follow_up_response": "persistence of symptoms", "follow_up_response_bt": "The persistence of symptoms"}, {"question_id": "118.2", "question": "When did the patient undergo the high resolution esophageal manometry (HREM)?", "answer_src": "Six months later", "follow_up_question": "What were the symptoms that prompted the patient to undergo the HREM?", "follow_up_response": "persistence of symptoms", "follow_up_response_bt": "The persistence of symptoms"}, {"question_id": "118.3", "question": "What symptom was not resolved by the high dose proton pump inhibitor treatment?", "answer_src": "Food regurgitation", "follow_up_question": "What other change did the patient experience besides the weight loss?", "follow_up_response": "Repeated episodes of food regurgitation", "follow_up_response_bt": "Repeated episodes of regurgitation"}, {"question_id": "118.4", "question": "Where did the patient report having repeated episodes of food regurgitation?", "answer_src": "During the last year", "follow_up_question": "What significant weight loss did the patient experience?", "follow_up_response": "a significant weight loss", "follow_up_response_bt": "even after following a strict diet"}, {"question_id": "118.5", "question": "Which condition was present six months before the mentioned symptoms persisted?", "answer_src": "Jackhammer esophagus", "follow_up_question": "What were the symptoms that persisted six months before the patient underwent the hrem?", "follow_up_response": "persistence of symptoms", "follow_up_response_bt": "the persistence of symptoms"}], "turn_2": [{"question_id": "118.6", "question": "What were the patient's symptoms before undergoing the HREM?", "answer_src": "persistence of symptoms", "follow_up_question": "What specific symptoms did the patient report experiencing during the last year?", "follow_up_response": "repeated episodes of food regurgitation and a significant weight loss", "follow_up_response_bt": "Repeated episodes of regurgitation and significant weight loss"}, {"question_id": "118.7", "question": "What were the symptoms that prompted the patient to undergo the HREM?", "answer_src": "persistence of symptoms", "follow_up_question": "What specific symptom led to the patient's repeated episodes of food regurgitation?", "follow_up_response": "Persistence of symptoms", "follow_up_response_bt": "No Answer"}, {"question_id": "118.8", "question": "What other change did the patient experience besides the weight loss?", "answer_src": "Repeated episodes of food regurgitation", "follow_up_question": "What specific treatment did the patient receive for the food regurgitation?", "follow_up_response": "High dose proton pump inhibitor", "follow_up_response_bt": "A high-dose proton pump inhibitor"}, {"question_id": "118.9", "question": "What significant weight loss did the patient experience?", "answer_src": "a significant weight loss", "follow_up_question": "How many episodes of food regurgitation did the patient report in the last year?", "follow_up_response": "repeated", "follow_up_response_bt": "Repeated"}, {"question_id": "118.10", "question": "What were the symptoms that persisted six months before the patient underwent the hrem?", "answer_src": "persistence of symptoms", "follow_up_question": "What specific symptom led to the patient's decision to undergo the hrem?", "follow_up_response": "Persistence of symptoms", "follow_up_response_bt": "The persistence of symptoms"}], "turn_3": [{"question_id": "118.11", "question": "What specific symptoms did the patient report experiencing during the last year?", "answer_src": "repeated episodes of food regurgitation and a significant weight loss", "follow_up_question": "What is the significance of the high resolution esophageal manometry (HREM) findings in this case?", "follow_up_response": "Jackhammer esophagus", "follow_up_response_bt": "The jackhammer esophagus"}, {"question_id": "118.12", "question": "What specific symptom led to the patient's repeated episodes of food regurgitation?", "answer_src": "Persistence of symptoms", "follow_up_question": "What were the symptoms that persisted leading to the patient's food regurgitation?", "follow_up_response": "No Answer", "follow_up_response_bt": "The persistence of symptoms"}, {"question_id": "118.13", "question": "What specific treatment did the patient receive for the food regurgitation?", "answer_src": "High dose proton pump inhibitor", "follow_up_question": "What were the patient's symptoms before she started the high dose proton pump inhibitor?", "follow_up_response": "repeated episodes of food regurgitation and a significant weight loss", "follow_up_response_bt": "repeated episodes of regurgitation and significant weight loss"}, {"question_id": "118.14", "question": "How many episodes of food regurgitation did the patient report in the last year?", "answer_src": "repeated", "follow_up_question": "How many significant weight loss episodes did the patient report in the last year?", "follow_up_response": "1", "follow_up_response_bt": "One"}, {"question_id": "118.15", "question": "What specific symptom led to the patient's decision to undergo the hrem?", "answer_src": "Persistence of symptoms", "follow_up_question": "What were the specific symptoms that the patient reported during the last year?", "follow_up_response": "Repeated episodes of food regurgitation and significant weight loss", "follow_up_response_bt": "Repeated episodes of regurgitation and significant weight loss"}]}}
{"id": 119, "src": "the failure to identify a retinal break during surgery was associated with a lower rate of retinal reattachment , worse final visual acuity , and a higher rate of re - operation ( p = 0.002 , p = 0.02 , and p = 0.002 , respectively ) . the location of the identified retinal break was more common in the superotemporal quadrant than in the other quadrants.conclusionsthe inability to identify a retinal break during surgery was associated with a poor final outcome . other factors were less important for the functional and anatomic success in patients with pseudophakic rds .", "mt": "La mancanza di identificazione di una rottura della retina durante l'intervento chirurgico è stata associata ad un tasso inferiore di riattaccamento della retina , una peggiore acuità visiva finale e ad un tasso più elevato di rioperazione (p = 0,002 , p = 0,02 e p = 0,002 , rispettivamente) . La posizione della rottura della retina identificata era più comune nel quadrante superotemporale rispetto agli altri quadranti.conclusioni.L'incapacità di identificare una rottura della retina durante l'intervento chirurgico è stata associata ad un risultato finale scadente . Altri fattori erano meno importanti per il successo funzionale e anatomico nei pazienti con rds pseudofakici .", "pert_mt": "La mancanza di identificazione di una rottura della retina durante l'intervento chirurgico è stata associata ad un tasso inferiore di riattaccamento della retina, una peggiore acuità visiva finale e ad un tasso più elevato di rioperazione (p = 0,002, p = 0,02 e p = 0,002, rispettivamente). La posizione della rottura della retina identificata era più comune nel quadrante superotemporale rispetto agli altri quadranti. Conclusioni: L'incapacità di identificare una rottura della retina durante l'intervento chirurgico è stata associata ad un risultato finale scadente. Altri fattori erano meno importanti per il successo funzionale e anatomico nei pazienti con retinopatie pseudofakiche.", "bt": "The lack of identification of a retinal rupture during surgery was associated with a lower rate of retinal reattachment, a worse final visual acuity and a higher rate of reoperation (p = 0.002, p = 0.02 and p = 0.002, respectively).The location of the identified retinal rupture was more common in the supertemporal quadrant than in other quadrants.Conclusions: The inability to identify a retinal rupture during surgery was associated with a poor final result.Other factors were less important for functional and anatomical success in patients with pseudopathic retinopathy.", "questions_src": ["What is the location of the identified retinal break?", "What is associated with a poor final outcome?", "What is the significance of the lower rate of retinal reattachment?", "What does the term 'pseudophakic RDS' refer to?", "What percentage is statistically significant at p = 0.002?"], "answers_src": ["the superotemporal quadrant", "the failure to identify a retinal break during surgery", "a lower rate of retinal reattachment", "pseudophakic retinal detachment syndrome", "2%"], "answers_bt": ["[\"supertemporal quadrant\", \"The lack of identification of a retinal rupture during surgery\", \"A lower rate of retinal reattachment\", \"\"pseudophakic retinopathy\"\", \"2\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "119.1", "question": "What is the location of the identified retinal break?", "answer_src": "the superotemporal quadrant", "follow_up_question": "What was the impact on the rate of re-operation?", "follow_up_response": "a higher rate of re-operation", "follow_up_response_bt": "a higher rate of reoperation"}, {"question_id": "119.2", "question": "What is associated with a poor final outcome?", "answer_src": "the failure to identify a retinal break during surgery", "follow_up_question": "What specific factor was found to have a lower rate of retinal reattachment?", "follow_up_response": "the failure to identify a retinal break during surgery", "follow_up_response_bt": "The lack of identification of a retinal rupture"}, {"question_id": "119.3", "question": "What is the significance of the lower rate of retinal reattachment?", "answer_src": "a lower rate of retinal reattachment", "follow_up_question": "What specific factor contributed to the lower rate of retinal reattachment?", "follow_up_response": "the failure to identify a retinal break during surgery", "follow_up_response_bt": "The lack of identification of a retinal rupture"}, {"question_id": "119.4", "question": "What does the term 'pseudophakic RDS' refer to?", "answer_src": "pseudophakic retinal detachment syndrome", "follow_up_question": "What percentage difference in reoperation rate was observed between surgeries where a retinal break was not identified and those where it was?", "follow_up_response": "0.002", "follow_up_response_bt": "0.002"}, {"question_id": "119.5", "question": "What percentage is statistically significant at p = 0.002?", "answer_src": "2%", "follow_up_question": "What was the worst final visual acuity result associated with?", "follow_up_response": "the failure to identify a retinal break during surgery", "follow_up_response_bt": "The inability to identify a retinal rupture during surgery"}], "turn_2": [{"question_id": "119.6", "question": "What was the impact on the rate of re-operation?", "answer_src": "a higher rate of re-operation", "follow_up_question": "What was the impact on the final visual acuity?", "follow_up_response": "worse final visual acuity", "follow_up_response_bt": "worse final visual acuity"}, {"question_id": "119.7", "question": "What specific factor was found to have a lower rate of retinal reattachment?", "answer_src": "the failure to identify a retinal break during surgery", "follow_up_question": "What was the worst final visual acuity associated with?", "follow_up_response": "the failure to identify a retinal break during surgery", "follow_up_response_bt": "The inability to identify a retinal rupture during surgery"}, {"question_id": "119.8", "question": "What specific factor contributed to the lower rate of retinal reattachment?", "answer_src": "the failure to identify a retinal break during surgery", "follow_up_question": "What was the impact on visual acuity in patients where a retinal break was not identified?", "follow_up_response": "worse final visual acuity", "follow_up_response_bt": "a worse final visual acuity"}, {"question_id": "119.9", "question": "What percentage difference in reoperation rate was observed between surgeries where a retinal break was not identified and those where it was?", "answer_src": "0.002", "follow_up_question": "What was the difference in the rate of retinal reattachment between surgeries where a retinal break was not identified and those where it was?", "follow_up_response": "a lower rate of retinal reattachment", "follow_up_response_bt": "a lower rate of retinal reattachment"}, {"question_id": "119.10", "question": "What was the worst final visual acuity result associated with?", "answer_src": "the failure to identify a retinal break during surgery", "follow_up_question": "What was the p-value associated with the worse final visual acuity?", "follow_up_response": "0.02", "follow_up_response_bt": "0.02"}], "turn_3": [{"question_id": "119.11", "question": "What was the impact on the final visual acuity?", "answer_src": "worse final visual acuity", "follow_up_question": "what was the impact on the rate of re-operation?", "follow_up_response": "a higher rate of re-operation", "follow_up_response_bt": "a higher rate of reoperation"}, {"question_id": "119.12", "question": "What was the worst final visual acuity associated with?", "answer_src": "the failure to identify a retinal break during surgery", "follow_up_question": "What was the p-value associated with the worse final visual acuity?", "follow_up_response": "0.02", "follow_up_response_bt": "0.02"}, {"question_id": "119.13", "question": "What was the impact on visual acuity in patients where a retinal break was not identified?", "answer_src": "worse final visual acuity", "follow_up_question": "what was the difference in visual acuity between patients where a retinal break was identified versus those where it was not?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "119.14", "question": "What was the difference in the rate of retinal reattachment between surgeries where a retinal break was not identified and those where it was?", "answer_src": "a lower rate of retinal reattachment", "follow_up_question": "What was the difference in the rate of re-operation between these two groups?", "follow_up_response": "0.002", "follow_up_response_bt": "0.002"}, {"question_id": "119.15", "question": "What was the p-value associated with the worse final visual acuity?", "answer_src": "0.02", "follow_up_question": "What was the p-value associated with the higher rate of re-operation?", "follow_up_response": "0.002", "follow_up_response_bt": "0.002"}]}}
{"id": 120, "src": "we reviewed a cohort of patients with previously untreated locoregional advanced head and neck squamous cell carcinoma ( hnscc ) who received a uniform chemoradiotherapy regimen . retrospective review was performed of 105 patients with stage iii or iv hnscc treated at greater baltimore medical center from 2000 to 2007 . radiation included 125 cgy twice daily for a total 70 gy to the primary site .", "mt": "Abbiamo esaminato una coorte di pazienti con carcinoma a cellule squamose della testa e del collo avanzato locoregionale (hnscc) non trattati in precedenza che hanno ricevuto un regime chimoradioterapico uniforme . La revisione retrospettiva è stata eseguita su 105 pazienti con hnscc di stadio iii o iv trattati al centro medico di Greater Baltimore dal 2000 al 2007 . La radiazione comprendeva 125 cgy due volte al giorno per un totale di 70 gy al sito primario .", "pert_mt": "Abbiamo esaminato una coorte di pazienti con carcinoma a cellule squamose della testa e del collo avanzato locoregionale (hnscc) non trattati in precedenza che hanno ricevuto un regime chimoradioterapico uniforme. La revisione retrospettiva è stata eseguita su 105 pazienti con hnscc di stadio iii o iv trattati al centro medico di Greater Baltimore dal 2000 al 2007. La radiazione comprendeva 125 cgy due volte al giorno per un totale di 70 gy al sito primario e ha causato effetti collaterali significativi.", "bt": "We examined a cohort of patients with advanced locoregional test and neck squamous cell carcinoma (hnscc) who had not previously been treated with a uniform chimoradiotherapeutic regimen, and conducted a retrospective review of 105 patients with stage iii or iv hnscc at Greater Baltimore Medical Center from 2000 to 2007, including 125 cgy twice daily for a total of 70 gy at the primary site, and caused significant side effects.", "questions_src": ["What year did the treatment start?", "Who were the patients in the study?", "Where was the treatment provided?", "What type of cancer did the patients have?", "Which stage of cancer was included in the study?"], "answers_src": ["2000 to 2007", "patients with previously untreated locoregional advanced head and neck squamous cell carcinoma", "greater baltimore medical center", "head and neck squamous cell carcinoma", "stage iii or iv"], "answers_bt": ["2000 to 2007", "patients with advanced locoregional test and neck squamous cell carcinoma", "Greater Baltimore Medical Center", "locoregional test and neck squamous cell carcinoma", "stage iii or iv"], "multiturn": {"turn_1": [{"question_id": "120.1", "question": "What year did the treatment start?", "answer_src": "2000 to 2007", "follow_up_question": "In what years were patients with stage III or IV HNSCC treated?", "follow_up_response": "2000 to 2007", "follow_up_response_bt": "2000 to 2007"}, {"question_id": "120.2", "question": "Who were the patients in the study?", "answer_src": "patients with previously untreated locoregional advanced head and neck squamous cell carcinoma", "follow_up_question": "What was the treatment regimen provided to the patients?", "follow_up_response": "Uniform chemoradiotherapy regimen", "follow_up_response_bt": "Uniform chemo-radiotherapeutic regimen"}, {"question_id": "120.3", "question": "Where was the treatment provided?", "answer_src": "greater baltimore medical center", "follow_up_question": "What was the total dose of radiation delivered?", "follow_up_response": "70 gy", "follow_up_response_bt": "70 gy"}, {"question_id": "120.4", "question": "What type of cancer did the patients have?", "answer_src": "head and neck squamous cell carcinoma", "follow_up_question": "What was the treatment duration for the radiation therapy?", "follow_up_response": "70 gy", "follow_up_response_bt": "70 gy"}, {"question_id": "120.5", "question": "Which stage of cancer was included in the study?", "answer_src": "stage iii or iv", "follow_up_question": "What was the total dose of radiation delivered to the primary site?", "follow_up_response": "70 gy", "follow_up_response_bt": "70 gy"}], "turn_2": [{"question_id": "120.6", "question": "In what years were patients with stage III or IV HNSCC treated?", "answer_src": "2000 to 2007", "follow_up_question": "What was the total dose of radiation delivered to the primary site for each patient?", "follow_up_response": "70 cgy", "follow_up_response_bt": "70 gy"}, {"question_id": "120.7", "question": "What was the treatment regimen provided to the patients?", "answer_src": "Uniform chemoradiotherapy regimen", "follow_up_question": "How many patients were included in the study?", "follow_up_response": "105", "follow_up_response_bt": "105"}, {"question_id": "120.8", "question": "What was the total dose of radiation delivered?", "answer_src": "70 gy", "follow_up_question": "How many times per day was the radiation delivered?", "follow_up_response": "twice", "follow_up_response_bt": "twice daily"}, {"question_id": "120.9", "question": "What was the treatment duration for the radiation therapy?", "answer_src": "70 gy", "follow_up_question": "How many days did each radiation session last?", "follow_up_response": "2", "follow_up_response_bt": "2"}, {"question_id": "120.10", "question": "What was the total dose of radiation delivered to the primary site?", "answer_src": "70 gy", "follow_up_question": "How many patients were in the cohort?", "follow_up_response": "105", "follow_up_response_bt": "105"}], "turn_3": [{"question_id": "120.11", "question": "What was the total dose of radiation delivered to the primary site for each patient?", "answer_src": "70 cgy", "follow_up_question": "How many patients had stage iv hnscc according to the study?", "follow_up_response": "105", "follow_up_response_bt": "105"}, {"question_id": "120.12", "question": "How many patients were included in the study?", "answer_src": "105", "follow_up_question": "What was the total radiation dose delivered to the primary site for each patient?", "follow_up_response": "70 cgy", "follow_up_response_bt": "70 gy"}, {"question_id": "120.13", "question": "How many times per day was the radiation delivered?", "answer_src": "twice", "follow_up_question": "How long did each radiation session last?", "follow_up_response": "2 days", "follow_up_response_bt": "2 hours"}, {"question_id": "120.14", "question": "How many days did each radiation session last?", "answer_src": "2", "follow_up_question": "How many total radiation sessions were administered to each patient?", "follow_up_response": "35", "follow_up_response_bt": "125"}, {"question_id": "120.15", "question": "How many patients were in the cohort?", "answer_src": "105", "follow_up_question": "How many patients had stage iii hnscc?", "follow_up_response": "53", "follow_up_response_bt": "105"}]}}
{"id": 121, "src": "liver metastases from colorectal carcinoma commonly form nodular lesions in the liver parenchyma . we report a case of liver metastasis from rectal adenocarcinoma that extended predominantly into the bile duct . a 62-year - old japanese man underwent low anterior resection for rectal adenocarcinoma 9 years ago .", "mt": "Le metastasi epatiche del carcinoma corretto generalmente formano lesioni nodulari nel parenchima epatico . segnaliamo un caso di metastasi epatiche da adenocarcinoma rettale che si estendeva prevalentemente nel dutto biliare . un uomo giapponese di 62 anni ha subito una resezione anteriore bassa per adenocarcinoma rettale 9 anni fa .", "pert_mt": "Le metastasi epatiche del carcinoma corretto generalmente formano lesioni nodulari nel parenchima epatico. Segnaliamo un caso di metastasi epatiche da adenocarcinoma rettale che si estendeva prevalentemente nel dutto biliare. Un uomo giapponese di 62 anni ha subito una resezione anteriore bassa per adenocarcinoma rettale 9 anni fa e presentava anche sintomi gastrointestinali.", "bt": "The hepatic metastasis of corretto carcinoma usually forms nodal lesions in the parenchima hepatica.We have reported a case of hepatic metastasis of adenocarcinoma rettale that extends predominantly in the bile duct.A 62-year-old Japanese man underwent a low anterior resection for adenocarcinoma rettale 9 years ago and also had gastrointestinal symptoms.", "questions_src": ["What type of cancer was the patient initially diagnosed with?", "Where did the metastatic lesions primarily occur in the liver?", "How long had the patient been alive before this liver metastasis was detected?"], "answers_src": ["Rectal adenocarcinoma", "Bile duct", "9 years"], "answers_bt": ["Adenocarcinoma rettale", "In the bile duct", "9 years"], "multiturn": {"turn_1": [{"question_id": "121.1", "question": "What type of cancer was the patient initially diagnosed with?", "answer_src": "Rectal adenocarcinoma", "follow_up_question": "What surgical procedure did the patient undergo 9 years ago?", "follow_up_response": "Low anterior resection", "follow_up_response_bt": "Low anterior resection"}, {"question_id": "121.2", "question": "Where did the metastatic lesions primarily occur in the liver?", "answer_src": "Bile duct", "follow_up_question": "What was the primary surgical procedure performed on the patient 9 years ago?", "follow_up_response": "Low anterior resection", "follow_up_response_bt": "Low anterior resection"}, {"question_id": "121.3", "question": "How long had the patient been alive before this liver metastasis was detected?", "answer_src": "9 years", "follow_up_question": "How many years after the rectal adenocarcinoma surgery did the liver metastasis occur?", "follow_up_response": "9", "follow_up_response_bt": "9"}], "turn_2": [{"question_id": "121.4", "question": "What surgical procedure did the patient undergo 9 years ago?", "answer_src": "Low anterior resection", "follow_up_question": "What type of cancer was found in the rectum 9 years ago?", "follow_up_response": "Rectal adenocarcinoma", "follow_up_response_bt": "Adenocarcinoma rettale"}, {"question_id": "121.5", "question": "What was the primary surgical procedure performed on the patient 9 years ago?", "answer_src": "Low anterior resection", "follow_up_question": "What type of cancer did the patient have 9 years ago?", "follow_up_response": "Rectal adenocarcinoma", "follow_up_response_bt": "Adenocarcinoma rettale"}, {"question_id": "121.6", "question": "How many years after the rectal adenocarcinoma surgery did the liver metastasis occur?", "answer_src": "9", "follow_up_question": "How long was the patient asymptomatic before the diagnosis of liver metastasis?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "121.7", "question": "What type of cancer was found in the rectum 9 years ago?", "answer_src": "Rectal adenocarcinoma", "follow_up_question": "What was the location of the primary tumor 9 years ago?", "follow_up_response": "rectal adenocarcinoma", "follow_up_response_bt": "Adenocarcinoma rettale"}, {"question_id": "121.8", "question": "What type of cancer did the patient have 9 years ago?", "answer_src": "Rectal adenocarcinoma", "follow_up_question": "What was the surgical procedure used 9 years ago?", "follow_up_response": "Low anterior resection", "follow_up_response_bt": "Low anterior resection"}, {"question_id": "121.9", "question": "How long was the patient asymptomatic before the diagnosis of liver metastasis?", "answer_src": "liver metastases from colorectal carcinoma commonly form nodular lesions in the liver parenchyma . we report a case of liver metastasis from rectal adenocarcinoma that extended predominantly into the bile duct . a 62-year - old japanese man underwent low anterior resection for rectal adenocarcinoma 9 years ago .", "follow_up_question": "How long after his initial surgery did the patient develop liver metastasis?", "follow_up_response": "9 years", "follow_up_response_bt": "No Answer"}]}}
{"id": 122, "src": "drug - eluting stents ( des ) are considered the treatment of choice for most patients with obstructive coronary artery disease when percutaneous intervention ( pci ) is feasible . however , stent thrombosis seems to occur more frequently with des and occasionally is associated with resistance to anti - platelet drugs . we have experienced a case of recurrent stent thrombosis in a patient with clopidogrel resistance .", "mt": "- gli stenti di eluting (des) sono considerati il trattamento di scelta per la maggior parte dei pazienti con malattia coronarica ostrutiva quando è fattibile un intervento percutaneo (pci). tuttavia , la trombosi dello stent sembra verificarsi più frequentemente con des e occasionalmente è associata a resistenza ai farmaci antipiastronetici . abbiamo sperimentato un caso di trombosi dello stent ricorrente in un paziente con resistenza al clopidogrel .", "pert_mt": "- gli stenti di eluting (des) sono considerati il trattamento di scelta per la maggior parte dei pazienti con malattia coronarica ostrutiva quando è fattibile un intervento percutaneo (pci). tuttavia , la trombosi dello stent sembra verificarsi più frequentemente con des e occasionalmente è associata a resistenza ai farmaci antipiastronetici, anche se questo non è sempre facilmente rilevabile clinicamente. abbiamo sperimentato un caso di trombosi dello stent ricorrente in un paziente con resistenza al clopidogrel .", "bt": "- eluting stents (des) are considered the treatment of choice for most patients with obstructive coronary disease when a percutaneous procedure (PCI) is feasible. however, stent thrombosis appears to occur more frequently with des and occasionally is associated with resistance to anti-piastronetic drugs, although this is not always easily detectable clinically. we have experienced a case of recurrent stent thrombosis in a patient with clopidogrel resistance.", "questions_src": ["What type of stents are considered the treatment of choice for most patients with obstructive coronary artery disease?", "Where do doctors usually prefer to use percutaneous intervention (PCI) over stents?", "Who is often affected by stent thrombosis, according to the passage?", "When might a patient experience clopidogrel resistance?", "Which drug is sometimes ineffective in treating resistance to anti-platelet drugs?"], "answers_src": ["drug - eluting stents (des)", "when percutaneous intervention (PCI) is feasible", "patients", "with stent thrombosis", "clopidogrel"], "answers_bt": ["eluting stents (des)", "when a percutaneous procedure (PCI) is feasible", "most patients with obstructive coronary disease", "not specified in the passage", "clopidogrel"], "multiturn": {"turn_1": [{"question_id": "122.1", "question": "What type of stents are considered the treatment of choice for most patients with obstructive coronary artery disease?", "answer_src": "drug - eluting stents (des)", "follow_up_question": "What is the cause of stent thrombosis in patients treated with drug-eluting stents?", "follow_up_response": "stent thrombosis seems to occur more frequently with des and occasionally is associated with resistance to anti-platelet drugs", "follow_up_response_bt": "stent thrombosis appears to occur more frequently with des and occasionally is associated with resistance to anti-piastronetic drugs"}, {"question_id": "122.2", "question": "Where do doctors usually prefer to use percutaneous intervention (PCI) over stents?", "answer_src": "when percutaneous intervention (PCI) is feasible", "follow_up_question": "What specific complication did the patient experience with DES?", "follow_up_response": "stent thrombosis", "follow_up_response_bt": "stent thrombosis"}, {"question_id": "122.3", "question": "Who is often affected by stent thrombosis, according to the passage?", "answer_src": "patients", "follow_up_question": "What is the cause of stent thrombosis in some patients?", "follow_up_response": "stent thrombosis seems to occur more frequently with des and occasionally is associated with resistance to anti-platelet drugs", "follow_up_response_bt": "stent thrombosis appears to occur more frequently with des and occasionally is associated with resistance to anti-piastronetic drugs"}, {"question_id": "122.4", "question": "When might a patient experience clopidogrel resistance?", "answer_src": "with stent thrombosis", "follow_up_question": "What factors contribute to clopidogrel resistance in patients with stent thrombosis?", "follow_up_response": "No Answer", "follow_up_response_bt": "Clopidogrel resistance"}, {"question_id": "122.5", "question": "Which drug is sometimes ineffective in treating resistance to anti-platelet drugs?", "answer_src": "clopidogrel", "follow_up_question": "What is clopidogrel resistance and how does it affect the patient in this case?", "follow_up_response": "Clopidogrel resistance is a condition where the patient's blood vessels do not respond to clopidogrel, leading to recurrent stent thrombosis.", "follow_up_response_bt": "Clopidogrel resistance is associated with increased risk of stent thrombosis, which occurred in a patient in this case despite being treated with antiplatelet drugs."}], "turn_2": [{"question_id": "122.6", "question": "What is the cause of stent thrombosis in patients treated with drug-eluting stents?", "answer_src": "stent thrombosis seems to occur more frequently with des and occasionally is associated with resistance to anti-platelet drugs", "follow_up_question": "What type of anti-platelet drug was ineffective in this particular case?", "follow_up_response": "clopidogrel", "follow_up_response_bt": "clopidogrel"}, {"question_id": "122.7", "question": "What specific complication did the patient experience with DES?", "answer_src": "stent thrombosis", "follow_up_question": "What type of anti-platelet drug was ineffective in this patient?", "follow_up_response": "clopidogrel", "follow_up_response_bt": "clopidogrel"}, {"question_id": "122.8", "question": "What is the cause of stent thrombosis in some patients?", "answer_src": "stent thrombosis seems to occur more frequently with des and occasionally is associated with resistance to anti-platelet drugs", "follow_up_question": "What type of anti-platelet drug was ineffective in this particular case?", "follow_up_response": "clopidogrel", "follow_up_response_bt": "clopidogrel"}, {"question_id": "122.9", "question": "What factors contribute to clopidogrel resistance in patients with stent thrombosis?", "answer_src": "drug - eluting stents ( des ) are considered the treatment of choice for most patients with obstructive coronary artery disease when percutaneous intervention ( pci ) is feasible . however , stent thrombosis seems to occur more frequently with des and occasionally is associated with resistance to anti - platelet drugs . we have experienced a case of recurrent stent thrombosis in a patient with clopidogrel resistance .", "follow_up_question": "What type of stents were used in the case described?", "follow_up_response": "drug - eluting stents ( des )", "follow_up_response_bt": "eluting stents"}, {"question_id": "122.10", "question": "What is clopidogrel resistance and how does it affect the patient in this case?", "answer_src": "Clopidogrel resistance is a condition where the patient's blood vessels do not respond to clopidogrel, leading to recurrent stent thrombosis.", "follow_up_question": "How common is clopidogrel resistance in patients with des?", "follow_up_response": "occasionally", "follow_up_response_bt": "occasionally"}], "turn_3": [{"question_id": "122.11", "question": "What type of anti-platelet drug was ineffective in this particular case?", "answer_src": "clopidogrel", "follow_up_question": "What other factors might contribute to the patient's clopidogrel resistance?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "122.12", "question": "What type of anti-platelet drug was ineffective in this patient?", "answer_src": "clopidogrel", "follow_up_question": "What other factors might contribute to the patient's clopidogrel resistance?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "122.13", "question": "What type of anti-platelet drug was ineffective in this particular case?", "answer_src": "clopidogrel", "follow_up_question": "What other factors might contribute to the patient's clopidogrel resistance?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "122.14", "question": "What type of stents were used in the case described?", "answer_src": "drug - eluting stents ( des )", "follow_up_question": "What was the mechanism of clopidogrel resistance in this case?", "follow_up_response": "No Answer", "follow_up_response_bt": "clopidogrel resistance"}, {"question_id": "122.15", "question": "How common is clopidogrel resistance in patients with des?", "answer_src": "occasionally", "follow_up_question": "What percentage or number of patients with des experience clopidogrel resistance?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 123, "src": "the mean hemoglobin level of the 25 patients at baseline was 9.6 g / dl ( median , 9.9 g / dl ; range , 6.9 g / dl 10.9 g / dl ) . the mean change in hemoglobin level for the 15 patients who completed at least 9 treatments was 1.7 g / dl ( median , 1.1 g / dl ; range , 1.9 g / dl to 3.2 g / dl ) ; it reached 2.1 g / dl ( median , 1.3 g / dl ; range , 0.2 g / dl to 4.6 g / dl ; p = 0.0007 ) for the 14 patients who completed all 12 weekly treatments . five ( 20.0% ) patients were transfused and considered as treatment failures .", "mt": "Il livello medio di emoglobina dei 25 pazienti al punto di partenza era di 9,6 g / dl (mediano , 9,9 g / dl; gamma , 6,9 g / dl 10,9 g / dl) . il cambiamento medio del livello di emoglobina per i 15 pazienti che hanno completato almeno 9 trattamenti è stato di 1,7 g / dl (mediano , 1,1 g / dl; gamma , 1,9 g / dl a 3,2 g / dl) ; ha raggiunto 2,1 g / dl (mediano , 1,3 g / dl; gamma , 0,2 g / dl a 4,6 g / dl; p = 0,0007 ) per i 14 pazienti che hanno completato tutti e 12 trattamenti settimanali . cinque ( 20,0%) pazienti sono stati trasfusi e considerati come fallimenti del trattamento .", "pert_mt": "Il livello medio di emoglobina dei 25 pazienti al punto di partenza era di 9,6 g / dl (mediano, 9,9 g / dl; gamma, 6,9 g / dl 10,9 g / dl). Il cambiamento medio del livello di emoglobina per i 15 pazienti che hanno completato almeno 9 trattamenti è stato di 1,7 g / dl (mediano, 1,1 g / dl; gamma, 1,9 g / dl a 3,2 g / dl); ha raggiunto 2,1 g / dl (mediano, 1,3 g / dl; gamma, 0,2 g / dl a 4,6 g / dl; p = 0,0007) per i 14 pazienti che hanno completato tutti e 12 trattamenti settiman", "bt": "The mean change in hemoglobin level for 15 patients who completed at least nine treatments was 1.7 g/dL (median, 1.1 g/dL; gamma, 1.9 g/dL to 3.2 g/dL); it reached 2.1 g/dL (median, 1.3 g/dL; gamma, 0,2 g/dL to 4.6 g/dL; p = 0.0007) for 14 patients who completed all 12 treatments.", "questions_src": ["What was the mean hemoglobin level at baseline?", "Who completed at least 9 treatments?", "Where were the patients located?", "When did the changes occur?", "Which group had a mean change in hemoglobin level of 2.1 g/dl?"], "answers_src": ["9.6 g / dl", "15 patients", "No Answer", "No Answer", "14 patients"], "answers_bt": ["1.7 g/dL (median, 1.1 g/dL)", "15 patients", "No Answer", "At least 9 treatments", "14 patients who completed all 12 treatments"], "multiturn": {"turn_1": [{"question_id": "123.1", "question": "What was the mean hemoglobin level at baseline?", "answer_src": "9.6 g / dl", "follow_up_question": "What was the median hemoglobin level at baseline?", "follow_up_response": "9.9 g / dl", "follow_up_response_bt": "1.1 g/dL"}, {"question_id": "123.2", "question": "Who completed at least 9 treatments?", "answer_src": "15 patients", "follow_up_question": "How many patients completed all 12 weekly treatments?", "follow_up_response": "14", "follow_up_response_bt": "14"}, {"question_id": "123.3", "question": "Where were the patients located?", "answer_src": "the mean hemoglobin level of the 25 patients at baseline was 9.6 g / dl ( median , 9.9 g / dl ; range , 6.9 g / dl 10.9 g / dl ) . the mean change in hemoglobin level for the 15 patients who completed at least 9 treatments was 1.7 g / dl ( median , 1.1 g / dl ; range , 1.9 g / dl to 3.2 g / dl ) ; it reached 2.1 g / dl ( median , 1.3 g / dl ; range , 0.2 g / dl to 4.6 g / dl ; p = 0.0007 ) for the 14 patients who completed all 12 weekly treatments . five ( 20.0% ) patients were transfused and considered as treatment failures .", "follow_up_question": "What was the minimum and maximum change in hemoglobin level for the patients who completed all 12 weekly treatments?", "follow_up_response": "0.2 g / dl to 4.6 g / dl", "follow_up_response_bt": "0.2 g/dL to 4.6 g/dL"}, {"question_id": "123.4", "question": "When did the changes occur?", "answer_src": "the mean hemoglobin level of the 25 patients at baseline was 9.6 g / dl ( median , 9.9 g / dl ; range , 6.9 g / dl 10.9 g / dl ) . the mean change in hemoglobin level for the 15 patients who completed at least 9 treatments was 1.7 g / dl ( median , 1.1 g / dl ; range , 1.9 g / dl to 3.2 g / dl ) ; it reached 2.1 g / dl ( median , 1.3 g / dl ; range , 0.2 g / dl to 4.6 g / dl ; p = 0.0007 ) for the 14 patients who completed all 12 weekly treatments . five ( 20.0% ) patients were transfused and considered as treatment failures .", "follow_up_question": "How much higher was the mean change in hemoglobin level for the 14 patients who completed all 12 weekly treatments compared to those who completed at least 9 treatments?", "follow_up_response": "0.4", "follow_up_response_bt": "0.4"}, {"question_id": "123.5", "question": "Which group had a mean change in hemoglobin level of 2.1 g/dl?", "answer_src": "14 patients", "follow_up_question": "What was the median change in hemoglobin level for the group that reached 2.1 g/dl?", "follow_up_response": "1.3 g / dl", "follow_up_response_bt": "1.3 g/dL"}], "turn_2": [{"question_id": "123.6", "question": "What was the median hemoglobin level at baseline?", "answer_src": "9.9 g / dl", "follow_up_question": "What was the median hemoglobin level for the patients who completed at least 9 treatments?", "follow_up_response": "1.1 g / dl", "follow_up_response_bt": "1.1 g/dL"}, {"question_id": "123.7", "question": "How many patients completed all 12 weekly treatments?", "answer_src": "14", "follow_up_question": "What was the median change in hemoglobin level for the patients who completed all 12 weekly treatments?", "follow_up_response": "1.3 g / dl", "follow_up_response_bt": "1.3 g/dL"}, {"question_id": "123.8", "question": "What was the minimum and maximum change in hemoglobin level for the patients who completed all 12 weekly treatments?", "answer_src": "0.2 g / dl to 4.6 g / dl", "follow_up_question": "What was the median change in hemoglobin level for the patients who completed all 12 weekly treatments?", "follow_up_response": "1.3 g / dl", "follow_up_response_bt": "1.3 g/dL"}, {"question_id": "123.9", "question": "How much higher was the mean change in hemoglobin level for the 14 patients who completed all 12 weekly treatments compared to those who completed at least 9 treatments?", "answer_src": "0.4", "follow_up_question": "By how many grams per deciliter did the mean change in hemoglobin level increase for the 14 patients who completed all 12 weekly treatments compared to their baseline?", "follow_up_response": "2.1", "follow_up_response_bt": "0.4"}, {"question_id": "123.10", "question": "What was the median change in hemoglobin level for the group that reached 2.1 g/dl?", "answer_src": "1.3 g / dl", "follow_up_question": "What was the range of hemoglobin level changes for the group that reached 2.1 g/dl?", "follow_up_response": "0.2 g / dl to 4.6 g / dl", "follow_up_response_bt": "gamma, 0.2 g/dL to 4.6 g/dL"}], "turn_3": [{"question_id": "123.11", "question": "What was the median hemoglobin level for the patients who completed at least 9 treatments?", "answer_src": "1.1 g / dl", "follow_up_question": "What was the range of hemoglobin levels for the patients who completed all 12 treatments?", "follow_up_response": "0.2 g / dl to 4.6 g / dl", "follow_up_response_bt": "0.2 g/dL to 4.6 g/dL"}, {"question_id": "123.12", "question": "What was the median change in hemoglobin level for the patients who completed all 12 weekly treatments?", "answer_src": "1.3 g / dl", "follow_up_question": "What was the range of hemoglobin level changes for the patients who completed all 12 weekly treatments?", "follow_up_response": "range , 0.2 g / dl to 4.6 g / dl", "follow_up_response_bt": "gamma, 0,2 g/dL to 4.6 g/dL"}, {"question_id": "123.13", "question": "What was the median change in hemoglobin level for the patients who completed all 12 weekly treatments?", "answer_src": "1.3 g / dl", "follow_up_question": "What was the range of hemoglobin level changes for the patients who completed all 12 weekly treatments?", "follow_up_response": "range , 0.2 g / dl to 4.6 g / dl", "follow_up_response_bt": "gamma, 0,2 g/dL to 4.6 g/dL"}, {"question_id": "123.14", "question": "By how many grams per deciliter did the mean change in hemoglobin level increase for the 14 patients who completed all 12 weekly treatments compared to their baseline?", "answer_src": "2.1", "follow_up_question": "By what percentage did the mean change in hemoglobin level for the 14 patients who completed all 12 weekly treatments exceed their baseline?", "follow_up_response": "13.0%", "follow_up_response_bt": "No Answer"}, {"question_id": "123.15", "question": "What was the range of hemoglobin level changes for the group that reached 2.1 g/dl?", "answer_src": "0.2 g / dl to 4.6 g / dl", "follow_up_question": "What was the median hemoglobin level change for the group that reached 2.1 g/dl?", "follow_up_response": "1.3 g / dl", "follow_up_response_bt": "1.3 g/dL"}]}}
{"id": 124, "src": "overall 86.9% of respondents felt that the proposed hierarchical nature of injuries was appropriate , and 77.8% of respondents agreed that that the risk of neurologic injury is highest in a vertical fracture through the foramen . almost 80% of respondents felt that the separation of injuries based on the integrity of l5s1 facet was appropriate , and 83.8% of surgeons agreed that a nondisplaced sacral u fracture is a clinically relevant entity . conclusion this study determines the global perspective on controversial areas in the injury patterns of sacral fractures and demonstrates that the development of a comprehensive and universally accepted sacral classification is possible .", "mt": "In generale , l' 86,9% degli intervistati ritiene che la proposta di natura gerarchica delle lesioni sia appropriata , e il 77,8% degli intervistati concorda che il rischio di lesioni neurologiche è più alto in una frattura verticale attraverso il forame . Quasi l 80% degli intervistati ritiene che la separazione delle lesioni sulla base dell' integrità del lato l5s1 sia appropriata , e l 83,8% dei chirurghi ritiene che una frattura sacral u non dislocata sia un' entità clinicamente rilevante . Questo studio determina la prospettiva globale sulle aree controverse nei modelli di lesioni delle fratture sacrali e dimostra che è possibile sviluppare una classificazione sacral completa e universalmente accettata .", "pert_mt": "In generale, l'86,9% degli intervistati ritiene che la proposta di natura gerarchica delle lesioni sia appropriata, e il 77,8% degli intervistati concorda che il rischio di lesioni neurologiche è più alto in una frattura verticale attraverso il forame. Quasi l 80% degli intervistati ritiene che la separazione delle lesioni sulla base dell' integrità del lato l5s1 sia appropriata, e l 83,8% dei chirurghi ritiene che una frattura sacrale non dislocata sia un' entità clinicamente rilevante. Questo studio determina la prospettiva globale sulle aree controverse nei modelli di lesioni delle fratture sacrali e dimostra che è possibile sviluppare una classificazione sac", "bt": "In general, 86.9% of respondents believe that the proposed hierarchical nature of injury is appropriate, and 77.8% of respondents agree that the risk of neurological injury is higher in a vertical fracture through the foramen.Nearly 80% of respondents believe that the separation of lesions based on the integrity of the l5s1 side is appropriate, and 83.8% of surgeons believe that a non-dislocated sacral fracture is a clinically relevant entity.This study determines the overall perspective on the controversial areas in the models of sacral fracture injuries and shows that it is possible to develop a classification.", "questions_src": ["What percentage of respondents felt that the proposed hierarchical nature of injuries was appropriate?", "When did the study determine the global perspective on controversial areas in the injury patterns of sacral fractures?", "Which type of fracture is considered clinically relevant by 83.8% of surgeons?", "What percentage of respondents agreed that a nondisplaced sacral U fracture is a clinically relevant entity?", "Where do most respondents believe the risk of neurologic injury is highest, according to the study?"], "answers_src": ["86.9%", "No Answer", "sacral U fracture", "83.8%", "a vertical fracture through the foramen"], "answers_bt": ["86.9%", "This study", "non-dislocated sacral", "83.8%", "through the foramen"], "multiturn": {"turn_1": [{"question_id": "124.1", "question": "What percentage of respondents felt that the proposed hierarchical nature of injuries was appropriate?", "answer_src": "86.9%", "follow_up_question": "What percentage of respondents agreed that the risk of neurologic injury is highest in a vertical fracture through the foramen?", "follow_up_response": "77.8%", "follow_up_response_bt": "77.8%"}, {"question_id": "124.2", "question": "When did the study determine the global perspective on controversial areas in the injury patterns of sacral fractures?", "answer_src": "overall 86.9% of respondents felt that the proposed hierarchical nature of injuries was appropriate , and 77.8% of respondents agreed that that the risk of neurologic injury is highest in a vertical fracture through the foramen . almost 80% of respondents felt that the separation of injuries based on the integrity of l5s1 facet was appropriate , and 83.8% of surgeons agreed that a nondisplaced sacral u fracture is a clinically relevant entity . conclusion this study determines the global perspective on controversial areas in the injury patterns of sacral fractures and demonstrates that the development of a comprehensive and universally accepted sacral classification is possible .", "follow_up_question": "What percentage of respondents agreed that a nondisplaced sacral U fracture is a clinically relevant entity?", "follow_up_response": "83.8%", "follow_up_response_bt": "83.8%"}, {"question_id": "124.3", "question": "Which type of fracture is considered clinically relevant by 83.8% of surgeons?", "answer_src": "sacral U fracture", "follow_up_question": "What percentage of respondents felt that the separation of injuries based on the integrity of L5S1 facet was appropriate?", "follow_up_response": "80%", "follow_up_response_bt": "80%"}, {"question_id": "124.4", "question": "What percentage of respondents agreed that a nondisplaced sacral U fracture is a clinically relevant entity?", "answer_src": "83.8%", "follow_up_question": "What percentage of surgeons felt that the separation of injuries based on the integrity of L5-S1 facet was appropriate?", "follow_up_response": "80%", "follow_up_response_bt": "83.8%"}, {"question_id": "124.5", "question": "Where do most respondents believe the risk of neurologic injury is highest, according to the study?", "answer_src": "a vertical fracture through the foramen", "follow_up_question": "What percentage of respondents agreed with this statement?", "follow_up_response": "86.9%", "follow_up_response_bt": "86.9%"}], "turn_2": [{"question_id": "124.6", "question": "What percentage of respondents agreed that the risk of neurologic injury is highest in a vertical fracture through the foramen?", "answer_src": "77.8%", "follow_up_question": "What percentage of respondents felt that the separation of injuries based on the integrity of L5S1 facet was appropriate?", "follow_up_response": "80%", "follow_up_response_bt": "80%"}, {"question_id": "124.7", "question": "What percentage of respondents agreed that a nondisplaced sacral U fracture is a clinically relevant entity?", "answer_src": "83.8%", "follow_up_question": "What percentage of surgeons felt that the separation of injuries based on the integrity of L5-S1 facet was appropriate?", "follow_up_response": "80%", "follow_up_response_bt": "83.8%"}, {"question_id": "124.8", "question": "What percentage of respondents felt that the separation of injuries based on the integrity of L5S1 facet was appropriate?", "answer_src": "80%", "follow_up_question": "What percentage of surgeons agreed that a nondisplaced sacral U fracture is a clinically relevant entity?", "follow_up_response": "83.8%", "follow_up_response_bt": "83.8%"}, {"question_id": "124.9", "question": "What percentage of surgeons felt that the separation of injuries based on the integrity of L5-S1 facet was appropriate?", "answer_src": "80%", "follow_up_question": "What percentage of respondents agreed with the statement that a nondisplaced sacral U fracture is a clinically relevant entity?", "follow_up_response": "83.8%", "follow_up_response_bt": "83.8%"}, {"question_id": "124.10", "question": "What percentage of respondents agreed with this statement?", "answer_src": "86.9%", "follow_up_question": "What percentage of respondents felt that the risk of neurologic injury is highest in a vertical fracture through the foramen?", "follow_up_response": "77.8%", "follow_up_response_bt": "77.8%"}], "turn_3": [{"question_id": "124.11", "question": "What percentage of respondents felt that the separation of injuries based on the integrity of L5S1 facet was appropriate?", "answer_src": "80%", "follow_up_question": "What percentage of surgeons agreed that a nondisplaced sacral U fracture is a clinically relevant entity?", "follow_up_response": "83.8%", "follow_up_response_bt": "83.8%"}, {"question_id": "124.12", "question": "What percentage of surgeons felt that the separation of injuries based on the integrity of L5-S1 facet was appropriate?", "answer_src": "80%", "follow_up_question": "What percentage of respondents agreed with the statement that a nondisplaced sacral U fracture is a clinically relevant entity?", "follow_up_response": "83.8%", "follow_up_response_bt": "83.8%"}, {"question_id": "124.13", "question": "What percentage of surgeons agreed that a nondisplaced sacral U fracture is a clinically relevant entity?", "answer_src": "83.8%", "follow_up_question": "What percentage of respondents felt that the separation of injuries based on the integrity of L5S1 facet was appropriate?", "follow_up_response": "80%", "follow_up_response_bt": "80%"}, {"question_id": "124.14", "question": "What percentage of respondents agreed with the statement that a nondisplaced sacral U fracture is a clinically relevant entity?", "answer_src": "83.8%", "follow_up_question": "What percentage of respondents felt that the separation of injuries based on the integrity of L5-S1 facet was appropriate?", "follow_up_response": "80%", "follow_up_response_bt": "80%"}, {"question_id": "124.15", "question": "What percentage of respondents felt that the risk of neurologic injury is highest in a vertical fracture through the foramen?", "answer_src": "77.8%", "follow_up_question": "What percentage of respondents felt that the separation of injuries based on the integrity of L5S1 facet was appropriate?", "follow_up_response": "80%", "follow_up_response_bt": "80%"}]}}
{"id": 125, "src": "the metsy was defined according to the revised national cholesterol education program third adult treatment panel . all probable predictive models and their predictive performance were provided using leave - one - out cross - validated logistic regression and the receiver operation characteristic curve methods . multiple linear regression was performed to assess factors associated with the cmetsys.the study population consisted of 8313 persons ( 49.9% male , mean age 38.54 15.86 years ) .", "mt": "La metsy è stata definita secondo il programma nazionale di educazione del colesterolo rivisto terzo pannello di trattamento per adulti . Tutti i modelli predittivi probabili e le loro prestazioni predittive sono stati forniti utilizzando il congedo - one - out cross-validated logistic regression e i metodi di curva caratteristica dell'operazione del ricevitore .", "pert_mt": "La metsy è stata definita secondo il programma nazionale di educazione del colesterolo rivisto terzo pannello di trattamento per adulti. Tutti i modelli predittivi probabili e le loro prestazioni predittive sono stati forniti utilizzando il congedo-one-out cross-validated logistic regression e i metodi di curva caratteristica dell'operazione del ricevitore, ma non tutti i pazienti hanno risposto positivamente a questi metodi.", "bt": "The metsy was defined according to the National Cholesterol Education Program and the third panel of adult treatment, and all probable predictive models and their predictive performance were provided using congedo-one-out cross-validated logistic regression and the curve methods characteristic of the recipient's operation, but not all patients responded positively to these methods.", "questions_src": ["What is the full name of the program that defined the metsy?", "Who were the participants in the study, and what percentage were male?", "Where was the study conducted?", "When did the study conclude?", "Which statistical method was used to assess factors associated with cmetsys?"], "answers_src": ["National cholesterol education program third adult treatment panel", "8313 persons, 49.9% male", "Not specified", "Not specified", "Multiple linear regression"], "answers_bt": ["National Cholesterol Education Program and the third panel of adult treatment", "No Answer", "No Answer", "No Answer", "congedo-one-out cross-validated logistic regression"], "multiturn": {"turn_1": [{"question_id": "125.1", "question": "What is the full name of the program that defined the metsy?", "answer_src": "National cholesterol education program third adult treatment panel", "follow_up_question": "What was the primary method used to provide the predictive performance of the models?", "follow_up_response": "leave-one-out cross-validated logistic regression and the receiver operation characteristic curve methods", "follow_up_response_bt": "congedo-one-out cross-validated logistic regression and the curve methods"}, {"question_id": "125.2", "question": "Who were the participants in the study, and what percentage were male?", "answer_src": "8313 persons, 49.9% male", "follow_up_question": "What was the average age of the study participants?", "follow_up_response": "38.54 15.86 years", "follow_up_response_bt": "No Answer"}, {"question_id": "125.3", "question": "Where was the study conducted?", "answer_src": "Not specified", "follow_up_question": "What was the mean age of the study participants?", "follow_up_response": "38.54 15.86 years", "follow_up_response_bt": "No Answer"}, {"question_id": "125.4", "question": "When did the study conclude?", "answer_src": "Not specified", "follow_up_question": "What was the average age of the study participants?", "follow_up_response": "38.54 15.86 years", "follow_up_response_bt": "No Answer"}, {"question_id": "125.5", "question": "Which statistical method was used to assess factors associated with cmetsys?", "answer_src": "Multiple linear regression", "follow_up_question": "What was the sample size of the study population?", "follow_up_response": "8313", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "125.6", "question": "What was the primary method used to provide the predictive performance of the models?", "answer_src": "leave-one-out cross-validated logistic regression and the receiver operation characteristic curve methods", "follow_up_question": "What is the mean age of the study population?", "follow_up_response": "38.54 15.86 years", "follow_up_response_bt": "No Answer"}, {"question_id": "125.7", "question": "What was the average age of the study participants?", "answer_src": "38.54 15.86 years", "follow_up_question": "What was the percentage of males in the study population?", "follow_up_response": "49.9%", "follow_up_response_bt": "No Answer"}, {"question_id": "125.8", "question": "What was the mean age of the study participants?", "answer_src": "38.54 15.86 years", "follow_up_question": "What was the percentage of males in the study population?", "follow_up_response": "49.9%", "follow_up_response_bt": "No Answer"}, {"question_id": "125.9", "question": "What was the average age of the study participants?", "answer_src": "38.54 15.86 years", "follow_up_question": "What was the percentage of males in the study population?", "follow_up_response": "49.9%", "follow_up_response_bt": "No Answer"}, {"question_id": "125.10", "question": "What was the sample size of the study population?", "answer_src": "8313", "follow_up_question": "What was the average age of the study population?", "follow_up_response": "38.54 15.86 years", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "125.11", "question": "What is the mean age of the study population?", "answer_src": "38.54 15.86 years", "follow_up_question": "What is the percentage of males in the study population?", "follow_up_response": "49.9%", "follow_up_response_bt": "No Answer"}, {"question_id": "125.12", "question": "What was the percentage of males in the study population?", "answer_src": "49.9%", "follow_up_question": "What was the average age of the study population?", "follow_up_response": "38.54 15.86 years", "follow_up_response_bt": "No Answer"}, {"question_id": "125.13", "question": "What was the percentage of males in the study population?", "answer_src": "49.9%", "follow_up_question": "What was the average age of the study population?", "follow_up_response": "38.54 15.86 years", "follow_up_response_bt": "No Answer"}, {"question_id": "125.14", "question": "What was the percentage of males in the study population?", "answer_src": "49.9%", "follow_up_question": "What was the average age of the study population?", "follow_up_response": "38.54 15.86 years", "follow_up_response_bt": "No Answer"}, {"question_id": "125.15", "question": "What was the average age of the study population?", "answer_src": "38.54 15.86 years", "follow_up_question": "What was the percentage of males in the study population?", "follow_up_response": "49.9%", "follow_up_response_bt": "No Answer"}]}}
{"id": 126, "src": "introductioncare coordination is an important aspect of nursing care especially for elderly patients admitted to an acute care setting . in singapore care coordination and transitional care nursing is a new concept of care nevertheless important but unexplored.aim/objectivesthe objective of this paper is to explore the characteristics of elderly patients receiving care coordination , determine care gaps and intervention during home visit and telephonic review.research design and samplinga designed questionnaire was used to collect information on the patient s demography , social and clinical profile and determine post discharge activities using eric coleman s four pillars tool . a pilot study of ten questionnaires was conducted .", "mt": "L'introduzione del coordinamento dei cure è un aspetto importante dell'assistenza infermieristica, in particolare per i pazienti anziani ammessi in un ambiente di cura acuta . in Singapore il coordinamento dei cure e l'assistenza transitorio è un nuovo concetto di cura comunque importante ma inesplorato.obiettivo/obiettivoL'obiettivo di questo documento è quello di esplorare le caratteristiche dei pazienti anziani che ricevono il coordinamento dei cure, determinare le lacune nel trattamento e l'intervento durante la visita a casa e la revisione telefonica.Il progetto di ricerca e il campionamento del questionario progettato sono stati utilizzati per raccogliere informazioni sulla demografia del paziente , sul profilo sociale e clinico e determinare il post-discarico utilizzando lo strumento di quattro pilastri dell'attività di Eric Coleman .", "pert_mt": "L'introduzione del coordinamento dei cure è un aspetto importante dell'assistenza infermieristica, in particolare per i pazienti anziani ammessi in un ambiente di cura acuta. In Singapore il coordinamento dei cure e l'assistenza transitoria è un nuovo concetto di cura, comunque importante ma inesplorato. Obiettivo: L'obiettivo di questo documento è quello di esplorare le caratteristiche dei pazienti anziani che ricevono il coordinamento dei cure, determinare le lacune nel trattamento e l'intervento durante la visita a casa e la revisione telefonica. Il progetto di ricerca e il campionamento del questionario progettato sono stati utilizzati per raccogliere informazioni sulla demografia del paziente, sul profilo sociale e clinico e determinare il post-discarico utilizzando lo", "bt": "The introduction of treatment coordination is an important aspect of nursing care, especially for elderly patients admitted to an acute care setting.In Singapore, treatment coordination and transient care is a new concept of care, however important but unexplored.The objective: The purpose of this paper is to explore the characteristics of elderly patients receiving treatment coordination, to determine the gaps in treatment and intervention during the home visit and telephone review.The research project and sample of the proposed question were used to gather information on patient demography, social and clinical profile and to determine the post-discharge using the lo", "questions_src": ["What is the aim of the paper?", "Who are the elderly patients being explored in the research?", "Where was the pilot study conducted?", "When were the ten questionnaires administered?", "Which tool was used to assess post-discharge activities?"], "answers_src": ["[\"To explore the characteristics of elderly patients receiving care coordination, determine care gaps and intervention during home visit and telephonic review.\", \"Elderly patients\", \"Ten questionnaires\", \"Not specified\", \"Eric Coleman\"s four pillars tool\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["To explore the characteristics of elderly patients receiving treatment coordination and to determine the gaps in treatment and intervention during the home visit and telephone review", "Elderly patients", "Singapore", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "126.1", "question": "What is the aim of the paper?", "answer_src": "[\"To explore the characteristics of elderly patients receiving care coordination, determine care gaps and intervention during home visit and telephonic review.\", \"Elderly patients\", \"Ten questionnaires\", \"Not specified\", \"Eric Coleman\"s four pillars tool\"]", "follow_up_question": "What specific demographic information does the questionnaire collect?", "follow_up_response": "patient's demography", "follow_up_response_bt": "No Answer"}, {"question_id": "126.2", "question": "Who are the elderly patients being explored in the research?", "answer_src": "introductioncare coordination is an important aspect of nursing care especially for elderly patients admitted to an acute care setting . in singapore care coordination and transitional care nursing is a new concept of care nevertheless important but unexplored.aim/objectivesthe objective of this paper is to explore the characteristics of elderly patients receiving care coordination , determine care gaps and intervention during home visit and telephonic review.research design and samplinga designed questionnaire was used to collect information on the patient s demography , social and clinical profile and determine post discharge activities using eric coleman s four pillars tool . a pilot study of ten questionnaires was conducted .", "follow_up_question": "What demographic information does the questionnaire collect about the elderly patients?", "follow_up_response": "patient's demography", "follow_up_response_bt": "patient demography"}, {"question_id": "126.3", "question": "Where was the pilot study conducted?", "answer_src": "introductioncare coordination is an important aspect of nursing care especially for elderly patients admitted to an acute care setting . in singapore care coordination and transitional care nursing is a new concept of care nevertheless important but unexplored.aim/objectivesthe objective of this paper is to explore the characteristics of elderly patients receiving care coordination , determine care gaps and intervention during home visit and telephonic review.research design and samplinga designed questionnaire was used to collect information on the patient s demography , social and clinical profile and determine post discharge activities using eric coleman s four pillars tool . a pilot study of ten questionnaires was conducted .", "follow_up_question": "What tool was used to determine post-discharge activities?", "follow_up_response": "Eric Coleman's four pillars tool", "follow_up_response_bt": "No Answer"}, {"question_id": "126.4", "question": "When were the ten questionnaires administered?", "answer_src": "introductioncare coordination is an important aspect of nursing care especially for elderly patients admitted to an acute care setting . in singapore care coordination and transitional care nursing is a new concept of care nevertheless important but unexplored.aim/objectivesthe objective of this paper is to explore the characteristics of elderly patients receiving care coordination , determine care gaps and intervention during home visit and telephonic review.research design and samplinga designed questionnaire was used to collect information on the patient s demography , social and clinical profile and determine post discharge activities using eric coleman s four pillars tool . a pilot study of ten questionnaires was conducted .", "follow_up_question": "What tool was used to determine post-discharge activities?", "follow_up_response": "Eric Coleman's four pillars tool", "follow_up_response_bt": "No Answer"}, {"question_id": "126.5", "question": "Which tool was used to assess post-discharge activities?", "answer_src": "introductioncare coordination is an important aspect of nursing care especially for elderly patients admitted to an acute care setting . in singapore care coordination and transitional care nursing is a new concept of care nevertheless important but unexplored.aim/objectivesthe objective of this paper is to explore the characteristics of elderly patients receiving care coordination , determine care gaps and intervention during home visit and telephonic review.research design and samplinga designed questionnaire was used to collect information on the patient s demography , social and clinical profile and determine post discharge activities using eric coleman s four pillars tool . a pilot study of ten questionnaires was conducted .", "follow_up_question": "What demographic information did the questionnaire collect?", "follow_up_response": "patient's demography", "follow_up_response_bt": "patient demography"}], "turn_2": [{"question_id": "126.6", "question": "What specific demographic information does the questionnaire collect?", "answer_src": "patient's demography", "follow_up_question": "What clinical profile aspects are included in the questionnaire?", "follow_up_response": "social and clinical", "follow_up_response_bt": "No Answer"}, {"question_id": "126.7", "question": "What demographic information does the questionnaire collect about the elderly patients?", "answer_src": "patient's demography", "follow_up_question": "What clinical profile aspects are included in the questionnaire?", "follow_up_response": "social and clinical", "follow_up_response_bt": "No Answer"}, {"question_id": "126.8", "question": "What tool was used to determine post-discharge activities?", "answer_src": "Eric Coleman's four pillars tool", "follow_up_question": "What demographic information did the questionnaire collect about the patients?", "follow_up_response": "patient's demography", "follow_up_response_bt": "patient demography"}, {"question_id": "126.9", "question": "What tool was used to determine post-discharge activities?", "answer_src": "Eric Coleman's four pillars tool", "follow_up_question": "What demographic information did the questionnaire collect about the patients?", "follow_up_response": "patient's demography", "follow_up_response_bt": "patient demography"}, {"question_id": "126.10", "question": "What demographic information did the questionnaire collect?", "answer_src": "patient's demography", "follow_up_question": "What clinical profile details were collected according to the questionnaire?", "follow_up_response": "social and clinical profile", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "126.11", "question": "What clinical profile aspects are included in the questionnaire?", "answer_src": "social and clinical", "follow_up_question": "What demographic information does the questionnaire include?", "follow_up_response": "patient's demography", "follow_up_response_bt": "No Answer"}, {"question_id": "126.12", "question": "What clinical profile aspects are included in the questionnaire?", "answer_src": "social and clinical", "follow_up_question": "What demographic information does the questionnaire include?", "follow_up_response": "patient's demography", "follow_up_response_bt": "No Answer"}, {"question_id": "126.13", "question": "What demographic information did the questionnaire collect about the patients?", "answer_src": "patient's demography", "follow_up_question": "what clinical profile details were collected using eric coleman's four pillars tool?", "follow_up_response": "post discharge activities", "follow_up_response_bt": "No Answer"}, {"question_id": "126.14", "question": "What demographic information did the questionnaire collect about the patients?", "answer_src": "patient's demography", "follow_up_question": "what clinical profile details were collected using eric coleman's four pillars tool?", "follow_up_response": "post discharge activities", "follow_up_response_bt": "No Answer"}, {"question_id": "126.15", "question": "What clinical profile details were collected according to the questionnaire?", "answer_src": "social and clinical profile", "follow_up_question": "What specific post-discharge activities were assessed using Eric Coleman's four pillars tool?", "follow_up_response": "determine post discharge activities", "follow_up_response_bt": "No Answer"}]}}
{"id": 127, "src": "fundamental problems with personality disorders ( pd ) diagnostic system in the previous version of dsm , led to the revision of dsm . therefore , a multidimensional system has been proposed for diagnosis of personality disorder features in dsm-5 . in the dimensional approach of dsm-5 , personality disorders diagnosis is based on levels of personality functioning ( criteria a ) and personality trait domains ( criteria b).the purpose of this study was firstly , to examine the dsm-5 levels of personality functioning in antisocial and borderline personality disorders , and second , to explore which levels of personality functioning in patients with antisocial and borderline personality disorders can better predicted severity than others.this study had a cross sectional design .", "mt": "I problemi fondamentali con il sistema diagnostico dei disturbi della personalità ( pd) nella versione precedente di dsm , hanno portato alla revisione di dsm . Pertanto , è stato proposto un sistema multidimensionale per la diagnosi delle caratteristiche del disturbo della personalità in dsm-5 . nell'approccio dimensionale di dsm-5 , la diagnosi dei disturbi della personalità si basa sui livelli di funzionalità della personalità (criteri a) e domini di tratti della personalità (criteri b).Lo scopo di questo studio era , in primo luogo , di esaminare i livelli di funzionalità di dsm-5 nei disturbi della personalità antisociale e frontali , e , in secondo luogo , di esplorare quali livelli di funzionalità della personalità nei pazienti con disturbi della personalità antisociale e frontali possono prevedere meglio la gravità rispetto ad altri.Questo studio aveva un disegno cross-sectional .", "pert_mt": "I problemi fondamentali con il sistema diagnostico dei disturbi della personalità (pd) nella versione precedente di dsm, hanno portato alla revisione di dsm. Pertanto, è stato proposto un sistema multidimensionale per la diagnosi delle caratteristiche del disturbo della personalità in dsm-5. Nell'approccio dimensionale di dsm-5, la diagnosi dei disturbi della personalità si basa sui livelli di funzionalità della personalità (criteri a) e domini di tratti della personalità (criteri b). Lo scopo di questo studio era, in primo luogo, di esaminare i livelli di funzionalità di dsm-5 nei disturbi della personalità antisociale e frontali, e, in secondo luogo, di esplorare quali livelli di funzionalità della personalità nei pazienti", "bt": "The fundamental problems with the DSM diagnostic system (pd) in the previous version of dsm led to the revision of dsm. Therefore, a multidimensional system for diagnosing the characteristics of DSM-5 was proposed.In the DSM-5 dimensional approach, the diagnosis of personality disorders is based on levels of personality function (criteria a) and domains of personality traits (criteria b).The purpose of this study was, first, to examine the levels of dsm-5 function in patients with antisocial borderline personality disorders, and, second, to explore what levels of personality function in patients.", "questions_src": ["What did the previous version of DSM have fundamental problems with regarding personality disorders?", "When was the revision of DSM due to these fundamental problems?", "Which system has been proposed for diagnosing personality disorder features in DSM-5?", "What are the two main criteria used for diagnosis of personality disorders in DSM-5?", "Who conducted the study examining DSM-5 levels of personality functioning in antisocial and borderline personality disorders?"], "answers_src": ["fundamental problems with personality disorders diagnostic system", "not specified", "multidimensional system", "levels of personality functioning and personality trait domains", "not specified"], "answers_bt": ["The fundamental problems with the DSM diagnostic system (pd)", "Therefore, a multidimensional system for diagnosing the characteristics of DSM-5 was proposed", "A multidimensional system", "Levels of personality function (criteria a) and domains of personality traits (criteria b)", "Not specified in the sentence"], "multiturn": {"turn_1": [{"question_id": "127.1", "question": "What did the previous version of DSM have fundamental problems with regarding personality disorders?", "answer_src": "fundamental problems with personality disorders diagnostic system", "follow_up_question": "Which specific aspects of the personality disorders diagnostic system were found to have fundamental problems?", "follow_up_response": "Personality disorders diagnostic system", "follow_up_response_bt": "The fundamental problems with the DSM diagnostic system (pd)"}, {"question_id": "127.2", "question": "When was the revision of DSM due to these fundamental problems?", "answer_src": "not specified", "follow_up_question": "Which personality disorders were examined in terms of their levels of personality functioning in this study?", "follow_up_response": "Antisocial and borderline personality disorders", "follow_up_response_bt": "Antisocial borderline personality disorders"}, {"question_id": "127.3", "question": "Which system has been proposed for diagnosing personality disorder features in DSM-5?", "answer_src": "multidimensional system", "follow_up_question": "Which personality disorder diagnoses were examined in terms of their levels of personality functioning in this study?", "follow_up_response": "antisocial and borderline personality disorders", "follow_up_response_bt": "antisocial borderline personality disorders"}, {"question_id": "127.4", "question": "What are the two main criteria used for diagnosis of personality disorders in DSM-5?", "answer_src": "levels of personality functioning and personality trait domains", "follow_up_question": "Which level of personality functioning was examined in the study for patients with antisocial personality disorder?", "follow_up_response": "levels of personality functioning", "follow_up_response_bt": "levels of dsm-5 function"}, {"question_id": "127.5", "question": "Who conducted the study examining DSM-5 levels of personality functioning in antisocial and borderline personality disorders?", "answer_src": "not specified", "follow_up_question": "Which personality disorders were examined in the study regarding DSM-5 levels of personality functioning?", "follow_up_response": "Antisocial and borderline personality disorders", "follow_up_response_bt": "Antisocial borderline personality disorders"}], "turn_2": [{"question_id": "127.6", "question": "Which specific aspects of the personality disorders diagnostic system were found to have fundamental problems?", "answer_src": "Personality disorders diagnostic system", "follow_up_question": "What were the two specific criteria used in the dimensional approach of DSM-5 for diagnosing personality disorders?", "follow_up_response": "levels of personality functioning (criteria a) and personality trait domains (criteria b)", "follow_up_response_bt": "Levels of personality function (criteria a) and domains of personality traits (criteria b)"}, {"question_id": "127.7", "question": "Which personality disorders were examined in terms of their levels of personality functioning in this study?", "answer_src": "Antisocial and borderline personality disorders", "follow_up_question": "Which level of personality functioning was found to better predict severity in patients with antisocial and borderline personality disorders according to this study?", "follow_up_response": "levels of personality functioning", "follow_up_response_bt": "levels of dsm-5 function"}, {"question_id": "127.8", "question": "Which personality disorder diagnoses were examined in terms of their levels of personality functioning in this study?", "answer_src": "antisocial and borderline personality disorders", "follow_up_question": "Which level of personality functioning was found to better predict severity in patients with antisocial and borderline personality disorders according to this study?", "follow_up_response": "levels of personality functioning", "follow_up_response_bt": "levels of dsm-5 function"}, {"question_id": "127.9", "question": "Which level of personality functioning was examined in the study for patients with antisocial personality disorder?", "answer_src": "levels of personality functioning", "follow_up_question": "Which level of personality functioning was examined in the study for patients with borderline personality disorder?", "follow_up_response": "levels of personality functioning", "follow_up_response_bt": "levels of dsm-5 function"}, {"question_id": "127.10", "question": "Which personality disorders were examined in the study regarding DSM-5 levels of personality functioning?", "answer_src": "Antisocial and borderline personality disorders", "follow_up_question": "Which level of personality functioning in the study was found to better predict severity in patients with antisocial and borderline personality disorders?", "follow_up_response": "levels of personality functioning", "follow_up_response_bt": "levels of dsm-5 function"}], "turn_3": [{"question_id": "127.11", "question": "What were the two specific criteria used in the dimensional approach of DSM-5 for diagnosing personality disorders?", "answer_src": "levels of personality functioning (criteria a) and personality trait domains (criteria b)", "follow_up_question": "Which level of personality functioning was examined in this study for patients with antisocial personality disorder?", "follow_up_response": "levels of personality functioning", "follow_up_response_bt": "levels of dsm-5 function"}, {"question_id": "127.12", "question": "Which level of personality functioning was found to better predict severity in patients with antisocial and borderline personality disorders according to this study?", "answer_src": "levels of personality functioning", "follow_up_question": "Which levels of personality functioning were examined in this study for antisocial and borderline personality disorders?", "follow_up_response": "levels of personality functioning", "follow_up_response_bt": "levels of personality function"}, {"question_id": "127.13", "question": "Which level of personality functioning was found to better predict severity in patients with antisocial and borderline personality disorders according to this study?", "answer_src": "levels of personality functioning", "follow_up_question": "Which levels of personality functioning were examined in this study for antisocial and borderline personality disorders?", "follow_up_response": "levels of personality functioning", "follow_up_response_bt": "levels of personality function"}, {"question_id": "127.14", "question": "Which level of personality functioning was examined in the study for patients with borderline personality disorder?", "answer_src": "levels of personality functioning", "follow_up_question": "Which levels of personality functioning were examined in the study for patients with antisocial personality disorder?", "follow_up_response": "levels of personality functioning", "follow_up_response_bt": "levels of personality function (criteria a)"}, {"question_id": "127.15", "question": "Which level of personality functioning in the study was found to better predict severity in patients with antisocial and borderline personality disorders?", "answer_src": "levels of personality functioning", "follow_up_question": "Which levels of personality functioning were examined in the study for antisocial and borderline personality disorders?", "follow_up_response": "levels of personality functioning", "follow_up_response_bt": "levels of personality function"}]}}
{"id": 128, "src": "based on a 28-day survival , the sepsis was further divided into the survivors ' and nonsurvivors ' groups . serum strem-1 , scd163 , pct , crp , and wbc counts were tested on days 1 , 3 , 5 , 7 , 10 , and 14 . on the icu admission , the sepsis group displayed higher levels of strem-1 , scd163 , pct , and crp than the sirs group ( p < 0.05 ) .", "mt": "Sulla base di una sopravvivenza di 28 giorni , la sepsis è stata ulteriormente suddivisa in gruppi di sopravvissuti e non sopravvissuti . I numeri seriali di strem-1 , scd163 , pct , crp e wbc sono stati testati ai giorni 1 , 3 , 5 , 7 , 10 e 14 .", "pert_mt": "Sulla base di una sopravvivenza di 28 giorni, la sepsis è stata ulteriormente suddivisa in gruppi di sopravvissuti e non sopravvissuti. I numeri seriali di strem-1, scd163, pct, crp e wbc sono stati testati ai giorni 1, 3, 5, 7, 10, 14 e dei pazienti non guariti.", "bt": "Based on a 28-day survival, sepsis was further divided into groups of survivors and non-survivors.Serial numbers of strem-1, scd163, pct, crp and wbc were tested on days 1, 3, 5, 7, 10, 14 e of non-cured patients.", "questions_src": ["What is the name of the test that was tested on days 1, 3, 5, 7, 10, and 14?", "Who had higher levels of strem-1, scd163, pct, and crp on ICU admission, the sepsis group or the SIRS group?", "Where was the survival study conducted for the sepsis groups?", "When were the tests on strem-1, scd163, pct, and crp conducted?", "Which group had a lower level of serum strem-1, scd163, pct, and crp on day 1?"], "answers_src": ["serum strem-1, scd163, pct, and crp", "the sepsis group", "on a 28-day survival", "on days 1, 3, 5, 7, 10, and 14", "the SIRS group"], "answers_bt": ["wbc", "No Answer", "No Answer", "Days 1, 3, 5, 7, 10, and 14", "No Answer"], "multiturn": {"turn_1": [{"question_id": "128.1", "question": "What is the name of the test that was tested on days 1, 3, 5, 7, 10, and 14?", "answer_src": "serum strem-1, scd163, pct, and crp", "follow_up_question": "What was the difference in levels of these tests between the sepsis group and the SIRS group at ICU admission?", "follow_up_response": "strem-1, scd163, pct, and crp", "follow_up_response_bt": "No Answer"}, {"question_id": "128.2", "question": "Who had higher levels of strem-1, scd163, pct, and crp on ICU admission, the sepsis group or the SIRS group?", "answer_src": "the sepsis group", "follow_up_question": "On which day did the sepsis group first show significantly higher levels of strem-1 compared to the SIRS group?", "follow_up_response": "1", "follow_up_response_bt": "No Answer"}, {"question_id": "128.3", "question": "Where was the survival study conducted for the sepsis groups?", "answer_src": "on a 28-day survival", "follow_up_question": "What was the difference in levels of strem-1 between the sepsis and SIRS groups at ICU admission?", "follow_up_response": "higher", "follow_up_response_bt": "No Answer"}, {"question_id": "128.4", "question": "When were the tests on strem-1, scd163, pct, and crp conducted?", "answer_src": "on days 1, 3, 5, 7, 10, and 14", "follow_up_question": "On which day did the sepsis group first show higher levels of strem-1 compared to the SIRS group?", "follow_up_response": "Day 3", "follow_up_response_bt": "No Answer"}, {"question_id": "128.5", "question": "Which group had a lower level of serum strem-1, scd163, pct, and crp on day 1?", "answer_src": "the SIRS group", "follow_up_question": "On which day did the sepsis group show significantly higher levels of strem-1, scd163, pct, and crp compared to the SIRS group?", "follow_up_response": "14", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "128.6", "question": "What was the difference in levels of these tests between the sepsis group and the SIRS group at ICU admission?", "answer_src": "strem-1, scd163, pct, and crp", "follow_up_question": "What was the level of strem-1 at ICU admission for the sepsis group?", "follow_up_response": "higher levels", "follow_up_response_bt": "No Answer"}, {"question_id": "128.7", "question": "On which day did the sepsis group first show significantly higher levels of strem-1 compared to the SIRS group?", "answer_src": "1", "follow_up_question": "On which day did the sepsis group first show significantly higher levels of pct compared to the SIRS group?", "follow_up_response": "14", "follow_up_response_bt": "No Answer"}, {"question_id": "128.8", "question": "What was the difference in levels of strem-1 between the sepsis and SIRS groups at ICU admission?", "answer_src": "higher", "follow_up_question": "What was the trend in strem-1 levels over time for the sepsis group?", "follow_up_response": "Higher levels", "follow_up_response_bt": "No Answer"}, {"question_id": "128.9", "question": "On which day did the sepsis group first show higher levels of strem-1 compared to the SIRS group?", "answer_src": "Day 3", "follow_up_question": "On which other biomarker did the sepsis group show higher levels compared to the SIRS group on day 3?", "follow_up_response": "scd163", "follow_up_response_bt": "No Answer"}, {"question_id": "128.10", "question": "On which day did the sepsis group show significantly higher levels of strem-1, scd163, pct, and crp compared to the SIRS group?", "answer_src": "14", "follow_up_question": "On which day did the SIRS group show significantly higher levels of strem-1, scd163, pct, and crp compared to the sepsis group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "128.11", "question": "What was the level of strem-1 at ICU admission for the sepsis group?", "answer_src": "higher levels", "follow_up_question": "What was the level of pct at ICU admission for the sepsis group?", "follow_up_response": "higher levels", "follow_up_response_bt": "No Answer"}, {"question_id": "128.12", "question": "On which day did the sepsis group first show significantly higher levels of pct compared to the SIRS group?", "answer_src": "14", "follow_up_question": "On which day did the sepsis group first show significantly higher levels of strem-1 compared to the SIRS group?", "follow_up_response": "1", "follow_up_response_bt": "No Answer"}, {"question_id": "128.13", "question": "What was the trend in strem-1 levels over time for the sepsis group?", "answer_src": "Higher levels", "follow_up_question": "How did strem-1 levels compare between the sepsis and sirs groups at ICU admission?", "follow_up_response": "higher", "follow_up_response_bt": "No Answer"}, {"question_id": "128.14", "question": "On which other biomarker did the sepsis group show higher levels compared to the SIRS group on day 3?", "answer_src": "scd163", "follow_up_question": "On which other biomarker did the sepsis group show higher levels compared to the SIRS group on day 7?", "follow_up_response": "wbc counts", "follow_up_response_bt": "No Answer"}, {"question_id": "128.15", "question": "On which day did the SIRS group show significantly higher levels of strem-1, scd163, pct, and crp compared to the sepsis group?", "answer_src": "based on a 28-day survival , the sepsis was further divided into the survivors ' and nonsurvivors ' groups . serum strem-1 , scd163 , pct , crp , and wbc counts were tested on days 1 , 3 , 5 , 7 , 10 , and 14 . on the icu admission , the sepsis group displayed higher levels of strem-1 , scd163 , pct , and crp than the sirs group ( p < 0.05 ) .", "follow_up_question": "On which day did the sepsis group show higher levels of strem-1, scd163, pct, and crp compared to the SIRS group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 129, "src": "the patients age ranged from 16 - 37 years old ( mean age 21.587.23 years ) . the most prevalent observed clinical signs were pain and redness . three samples reported as sterile .", "mt": "I pazienti avevano età compresa tra 16 e 37 anni (età media 21,587,23 anni). i segni clinici più frequenti sono stati dolore e rossorezza . tre campioni sono stati segnalati come sterili .", "pert_mt": "I pazienti avevano età compresa tra 16 e 37 anni (età media 21,587,23 anni). I segni clinici più frequenti sono stati dolore e rossorezza, ed emicranie. Tre campioni sono stati segnalati come sterili.", "bt": "The patients were aged between 16 and 37 years (mean age 21,587.23 years).The most frequent clinical signs were pain and rossorezza, and migraine.Three samples were reported as sterile.", "questions_src": ["What was the mean age of the patients in the sentence?", "Who were the most prevalent observed clinical signs mentioned?", "Where were the ages of the patients mentioned?", "When did the observation take place according to the sentence?", "Which samples were reported as sterile?"], "answers_src": ["21.587.23 years", "Pain and redness", "16 - 37 years old", "No Answer", "Three samples"], "answers_bt": ["21,587.23 years", "Pain and rossorezza and migraine", "between 16 and 37 years", "No Answer", "Three"], "multiturn": {"turn_1": [{"question_id": "129.1", "question": "What was the mean age of the patients in the sentence?", "answer_src": "21.587.23 years", "follow_up_question": "What was the range of ages for the patients?", "follow_up_response": "16 - 37 years old", "follow_up_response_bt": "16 and 37 years"}, {"question_id": "129.2", "question": "Who were the most prevalent observed clinical signs mentioned?", "answer_src": "Pain and redness", "follow_up_question": "What was the range of ages for the patients?", "follow_up_response": "16 - 37 years old", "follow_up_response_bt": "16 and 37 years"}, {"question_id": "129.3", "question": "Where were the ages of the patients mentioned?", "answer_src": "16 - 37 years old", "follow_up_question": "What was the average age of the patients?", "follow_up_response": "21.587.23 years", "follow_up_response_bt": "21.587.23 years"}, {"question_id": "129.4", "question": "When did the observation take place according to the sentence?", "answer_src": "the patients age ranged from 16 - 37 years old ( mean age 21.587.23 years ) . the most prevalent observed clinical signs were pain and redness . three samples reported as sterile .", "follow_up_question": "What was the range of ages observed in the study?", "follow_up_response": "16 - 37 years old", "follow_up_response_bt": "16 and 37 years"}, {"question_id": "129.5", "question": "Which samples were reported as sterile?", "answer_src": "Three samples", "follow_up_question": "What was the average age of the patients?", "follow_up_response": "21.587.23 years", "follow_up_response_bt": "21.587.23 years"}], "turn_2": [{"question_id": "129.6", "question": "What was the range of ages for the patients?", "answer_src": "16 - 37 years old", "follow_up_question": "What was the average age of the patients?", "follow_up_response": "21.587.23 years", "follow_up_response_bt": "21.587.23 years"}, {"question_id": "129.7", "question": "What was the range of ages for the patients?", "answer_src": "16 - 37 years old", "follow_up_question": "What was the average age of the patients?", "follow_up_response": "21.587.23 years", "follow_up_response_bt": "21.587.23 years"}, {"question_id": "129.8", "question": "What was the average age of the patients?", "answer_src": "21.587.23 years", "follow_up_question": "What was the range of ages for the patients?", "follow_up_response": "16 - 37 years old", "follow_up_response_bt": "16 and 37 years"}, {"question_id": "129.9", "question": "What was the range of ages observed in the study?", "answer_src": "16 - 37 years old", "follow_up_question": "What was the average age of the patients in the study?", "follow_up_response": "21.587.23 years", "follow_up_response_bt": "21.587.23 years"}, {"question_id": "129.10", "question": "What was the average age of the patients?", "answer_src": "21.587.23 years", "follow_up_question": "What was the range of ages for the patients?", "follow_up_response": "16 - 37 years old", "follow_up_response_bt": "16 and 37 years"}], "turn_3": [{"question_id": "129.11", "question": "What was the average age of the patients?", "answer_src": "21.587.23 years", "follow_up_question": "What was the range of ages for the patients?", "follow_up_response": "16 - 37 years old", "follow_up_response_bt": "16 and 37 years"}, {"question_id": "129.12", "question": "What was the average age of the patients?", "answer_src": "21.587.23 years", "follow_up_question": "What was the range of ages for the patients?", "follow_up_response": "16 - 37 years old", "follow_up_response_bt": "16 and 37 years"}, {"question_id": "129.13", "question": "What was the range of ages for the patients?", "answer_src": "16 - 37 years old", "follow_up_question": "What was the average age of the patients?", "follow_up_response": "21.587.23 years", "follow_up_response_bt": "21.587.23 years"}, {"question_id": "129.14", "question": "What was the average age of the patients in the study?", "answer_src": "21.587.23 years", "follow_up_question": "What was the range of ages for the patients in the study?", "follow_up_response": "16 - 37 years old", "follow_up_response_bt": "16 and 37 years"}, {"question_id": "129.15", "question": "What was the range of ages for the patients?", "answer_src": "16 - 37 years old", "follow_up_question": "What was the average age of the patients?", "follow_up_response": "21.587.23 years", "follow_up_response_bt": "21.587.23 years"}]}}
{"id": 130, "src": "chromosome 22q13.3 deletion syndrome is a well - recognized cause of global developmental delay , while duplication of the same chromosome is a rare occurrence . the presence of both abnormalities in the same family has never been reported , to our knowledge . we report a rare occurrence of 22q13.3 duplication and 22q13.3 deletion in siblings , as a consequence of a mother 's inversion on her 22nd chromosome ( p13;q13.32 ) .", "mt": "La sindrome di delezione del cromosoma 22q13.3 è una causa ben nota di ritardo dello sviluppo globale , mentre la duplicazione dello stesso cromosoma è una rara circostanza . La presenza di entrambe le anomalie nella stessa famiglia non è mai stata segnalata , a nostra conoscenza . segnaliamo una rara circostanza di duplicazione del 22q13.3 e di delezione del 22q13.3 nei fratelli , come conseguenza dell'inversione di una madre sul suo 22 ° cromosoma (p13;q13.32).", "pert_mt": "La sindrome di delezione del cromosoma 22q13.3 è una causa ben nota di ritardo dello sviluppo globale, mentre la duplicazione dello stesso cromosoma è una rara circostanza. La presenza di entrambe le anomalie nella stessa famiglia non è mai stata segnalata, a nostra conoscenza. Segnaliamo una rara circostanza di duplicazione del 22q13.3 e di delezione del 22q13.3 nei fratelli, come conseguenza dell'inversione di una madre sul suo 22° cromosoma (p13;q13.32), e questo caso mostra un pattern interessante di ereditarietà.", "bt": "The syndrome of chromosome deletion 22q13.3 is a well-known cause of delayed global development, while the duplication of the same chromosome is a rare occurrence.The presence of both abnormalities in the same family has never been reported, to our knowledge.We are reporting a rare occurrence of 22q13.3 duplication and 22q13.3 deletion in siblings, as a result of a mother's inversion on her 22° chromosome (p13;q13.32), and this case shows an interesting pattern of heredity.", "questions_src": ["What is the name of the genetic condition mentioned in the sentence?", "Who experienced a duplication of chromosome 22q13.3?", "Where does the inversion occur on the mother's chromosome?", "When did the mother have this inversion?", "Which siblings were found to have both abnormalities?"], "answers_src": ["chromosome 22q13.3 deletion syndrome", "the siblings", "p13;q13.32", "on her 22nd chromosome", "the siblings"], "answers_bt": ["Chromosome deletion 22q13.3 and 22q13.3 duplication", "The mother", "On the p13 segment", "Not specified in the sentence", "The siblings"], "multiturn": {"turn_1": [{"question_id": "130.1", "question": "What is the name of the genetic condition mentioned in the sentence?", "answer_src": "chromosome 22q13.3 deletion syndrome", "follow_up_question": "What specific type of genetic change was observed in the siblings?", "follow_up_response": "22q13.3 duplication and 22q13.3 deletion", "follow_up_response_bt": "22q13.3 duplication and 22q13.3 deletion"}, {"question_id": "130.2", "question": "Who experienced a duplication of chromosome 22q13.3?", "answer_src": "the siblings", "follow_up_question": "What specific type of genetic abnormality did the siblings have?", "follow_up_response": "22q13.3 duplication and 22q13.3 deletion", "follow_up_response_bt": "22q13.3 duplication and 22q13.3 deletion"}, {"question_id": "130.3", "question": "Where does the inversion occur on the mother's chromosome?", "answer_src": "p13;q13.32", "follow_up_question": "What is the significance of this inversion in the context of the siblings' genetic conditions?", "follow_up_response": "This inversion on her 22nd chromosome (p13;q13.32) is the cause of both the 22q13.3 duplication and the 22q13.3 deletion in the siblings.", "follow_up_response_bt": "This inversion on her 22° chromosome (p13;q13.32) is significant as it resulted in both a 22q13.3 duplication and a 22q13.3 deletion in the siblings."}, {"question_id": "130.4", "question": "When did the mother have this inversion?", "answer_src": "on her 22nd chromosome", "follow_up_question": "What specific region of chromosome 22 was affected by the inversion?", "follow_up_response": "p13;q13.32", "follow_up_response_bt": "p13;q13.32"}, {"question_id": "130.5", "question": "Which siblings were found to have both abnormalities?", "answer_src": "the siblings", "follow_up_question": "What was the cause of the presence of both abnormalities in these siblings?", "follow_up_response": "a mother 's inversion on her 22nd chromosome ( p13;q13.32 )", "follow_up_response_bt": "A mother's inversion on her 22° chromosome (p13;q13.32)"}], "turn_2": [{"question_id": "130.6", "question": "What specific type of genetic change was observed in the siblings?", "answer_src": "22q13.3 duplication and 22q13.3 deletion", "follow_up_question": "What is the chromosomal location of the genetic changes observed in the siblings?", "follow_up_response": "22q13.3", "follow_up_response_bt": "22q13.3"}, {"question_id": "130.7", "question": "What specific type of genetic abnormality did the siblings have?", "answer_src": "22q13.3 duplication and 22q13.3 deletion", "follow_up_question": "What was the cause of the inversion on the mother's 22nd chromosome?", "follow_up_response": "A mother's inversion on her 22nd chromosome (p13;q13.32)", "follow_up_response_bt": "A mother's inversion on her 22° chromosome (p13;q13.32)"}, {"question_id": "130.8", "question": "What is the significance of this inversion in the context of the siblings' genetic conditions?", "answer_src": "This inversion on her 22nd chromosome (p13;q13.32) is the cause of both the 22q13.3 duplication and the 22q13.3 deletion in the siblings.", "follow_up_question": "How many total copies of chromosome 22 do the affected siblings have?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "130.9", "question": "What specific region of chromosome 22 was affected by the inversion?", "answer_src": "p13;q13.32", "follow_up_question": "What was the consequence of the mother's inversion on her 22nd chromosome?", "follow_up_response": "a mother 's inversion on her 22nd chromosome ( p13 ; q13.32 ) ", "follow_up_response_bt": "An interesting pattern of heredity"}, {"question_id": "130.10", "question": "What was the cause of the presence of both abnormalities in these siblings?", "answer_src": "a mother 's inversion on her 22nd chromosome ( p13;q13.32 )", "follow_up_question": "What specific part of the chromosome was inverted?", "follow_up_response": "p13;q13.32", "follow_up_response_bt": "p13;q13.32"}], "turn_3": [{"question_id": "130.11", "question": "What is the chromosomal location of the genetic changes observed in the siblings?", "answer_src": "22q13.3", "follow_up_question": "What specific type of genetic change was observed in one of the siblings?", "follow_up_response": "22q13.3 duplication and 22q13.3 deletion", "follow_up_response_bt": "22q13.3 duplication and 22q13.3 deletion"}, {"question_id": "130.12", "question": "What was the cause of the inversion on the mother's 22nd chromosome?", "answer_src": "A mother's inversion on her 22nd chromosome (p13;q13.32)", "follow_up_question": "What specific genetic material was affected by the inversion?", "follow_up_response": "chromosome 22q13.3", "follow_up_response_bt": "22° chromosome (p13;q13.32)"}, {"question_id": "130.13", "question": "How many total copies of chromosome 22 do the affected siblings have?", "answer_src": "chromosome 22q13.3 deletion syndrome is a well - recognized cause of global developmental delay , while duplication of the same chromosome is a rare occurrence . the presence of both abnormalities in the same family has never been reported , to our knowledge . we report a rare occurrence of 22q13.3 duplication and 22q13.3 deletion in siblings , as a consequence of a mother 's inversion on her 22nd chromosome ( p13;q13.32 ) .", "follow_up_question": "What specific chromosomal region was inverted in the mother's 22nd chromosome?", "follow_up_response": "p13;q13.32", "follow_up_response_bt": "p13;q13.32"}, {"question_id": "130.14", "question": "What was the consequence of the mother's inversion on her 22nd chromosome?", "answer_src": "a mother 's inversion on her 22nd chromosome ( p13 ; q13.32 ) ", "follow_up_question": "What specific genetic material was duplicated and deleted in the siblings due to the mother's inversion?", "follow_up_response": "chromosome 22q13.3", "follow_up_response_bt": "chromosome 22q13.3"}, {"question_id": "130.15", "question": "What specific part of the chromosome was inverted?", "answer_src": "p13;q13.32", "follow_up_question": "What is the significance of this inversion in causing the two abnormalities in the siblings?", "follow_up_response": "A mother's inversion on her 22nd chromosome (p13;q13.32)", "follow_up_response_bt": "A mother's inversion on her 22° chromosome (p13;q13.32)"}]}}
{"id": 131, "src": "in rb group , 14 patients ( 93.3% ) had cad ( p<0.001 ) and 13 patients ( 86.7% ) presented with ami ( p<0.001 ) . on the aspect of cad type and reversibility of avb , 13/15 ( 86.7% ) patients of ami , 0/2 ( 0% ) of unstable angina , and 1/41 ( 2.4% ) of stable angina had reversible avb.conclusionavb in patients with ami is usually reversible . therefore , permanent pacemaker implantation should be delayed in cases of ami .", "mt": "Nel gruppo rb , 14 pazienti (93.3%) avevano avv (p<0.001 ) e 13 pazienti (86.7%) avevano avv (p<0.001 ) presentato ami (p<0.001) . sull'aspetto del tipo di cad e della reversibilità di avv , 13/15 (86.7%) pazienti di ami , 0/2 (0%) di angina instabile , e 1/41 (2.4%) di angina stabile avevano avv.conclusionav reversible in pazienti con ami è di solito reversibile . Pertanto, l'implementazione di un pacemaker permanente dovrebbe essere ritardata nei casi di ami .", "pert_mt": "Nel gruppo rb, 14 pazienti (93.3%) avevano avv (p<0.001) e 13 pazienti (86.7%) avevano avv (p<0.001) presentato ami (p<0.001). Sull'aspetto del tipo di caduta e della reversibilità dell'avv, 13/15 (86.7%) pazienti di ami, 0/2 (0%) di angina instabile, e 1/41 (2.4%) di angina stabile avevano avv. Conclusion: l'implementazione di un pacemaker permanente dovrebbe essere ritardata nei casi di ami.", "bt": "In the rb group, 14 patients (93.3%) had avv (p<0.001) and 13 patients (86.7%) had avv (p<0.001) presented ami (p<0.001).On the type of stroke and the reversibility of the AVV, 13/15 (86.7%) patients had amy, 0/2 (0%) had unstable angina, and 1/41 (2.4%) had stable angina.", "questions_src": ["What is the percentage of patients with CAD in the RB group?", "Who had a 100% reversal rate of AVB in patients with unstable angina?", "When was the conclusion reached about AVB in patients with AMI?", "Where can you find information about the percentage of patients with AMI presenting with reversible AVB?", "Which type of angina had no patients with reversible AVB according to the study?"], "answers_src": ["93.3%", "No Answer", "No Answer", "13/15 (86.7%) patients of AMI", "Unstable angina"], "answers_bt": ["86.7%", "No Answer", "No Answer", "15/13 (100%) patients had a 100% reversal rate of AVB", "Stable angina"], "multiturn": {"turn_1": [{"question_id": "131.1", "question": "What is the percentage of patients with CAD in the RB group?", "answer_src": "93.3%", "follow_up_question": "What percentage of patients with AMI had reversible AVB?", "follow_up_response": "2.4%", "follow_up_response_bt": "86.7%"}, {"question_id": "131.2", "question": "Who had a 100% reversal rate of AVB in patients with unstable angina?", "answer_src": "in rb group , 14 patients ( 93.3% ) had cad ( p<0.001 ) and 13 patients ( 86.7% ) presented with ami ( p<0.001 ) . on the aspect of cad type and reversibility of avb , 13/15 ( 86.7% ) patients of ami , 0/2 ( 0% ) of unstable angina , and 1/41 ( 2.4% ) of stable angina had reversible avb.conclusionavb in patients with ami is usually reversible . therefore , permanent pacemaker implantation should be delayed in cases of ami .", "follow_up_question": "What percentage of patients with stable angina in the RB group had reversible AVB?", "follow_up_response": "2.4%", "follow_up_response_bt": "No Answer"}, {"question_id": "131.3", "question": "When was the conclusion reached about AVB in patients with AMI?", "answer_src": "in rb group , 14 patients ( 93.3% ) had cad ( p<0.001 ) and 13 patients ( 86.7% ) presented with ami ( p<0.001 ) . on the aspect of cad type and reversibility of avb , 13/15 ( 86.7% ) patients of ami , 0/2 ( 0% ) of unstable angina , and 1/41 ( 2.4% ) of stable angina had reversible avb.conclusionavb in patients with ami is usually reversible . therefore , permanent pacemaker implantation should be delayed in cases of ami .", "follow_up_question": "What percentage of patients with unstable angina had reversible AVB?", "follow_up_response": "0%", "follow_up_response_bt": "No Answer"}, {"question_id": "131.4", "question": "Where can you find information about the percentage of patients with AMI presenting with reversible AVB?", "answer_src": "13/15 (86.7%) patients of AMI", "follow_up_question": "What percentage of patients with unstable angina had reversible AVB?", "follow_up_response": "0%", "follow_up_response_bt": "No Answer"}, {"question_id": "131.5", "question": "Which type of angina had no patients with reversible AVB according to the study?", "answer_src": "Unstable angina", "follow_up_question": "How many patients with stable angina had reversible AVB according to the study?", "follow_up_response": "2.4%", "follow_up_response_bt": "2.4%"}], "turn_2": [{"question_id": "131.6", "question": "What percentage of patients with AMI had reversible AVB?", "answer_src": "2.4%", "follow_up_question": "What was the percentage of patients with unstable angina who had reversible AVB?", "follow_up_response": "0%", "follow_up_response_bt": "No Answer"}, {"question_id": "131.7", "question": "What percentage of patients with stable angina in the RB group had reversible AVB?", "answer_src": "2.4%", "follow_up_question": "What was the percentage of patients with unstable angina in the RB group who had reversible AVB?", "follow_up_response": "0%", "follow_up_response_bt": "0%"}, {"question_id": "131.8", "question": "What percentage of patients with unstable angina had reversible AVB?", "answer_src": "0%", "follow_up_question": "What percentage of patients with stable angina had reversible AVB?", "follow_up_response": "2.4%", "follow_up_response_bt": "No Answer"}, {"question_id": "131.9", "question": "What percentage of patients with unstable angina had reversible AVB?", "answer_src": "0%", "follow_up_question": "What percentage of patients with stable angina had reversible AVB?", "follow_up_response": "2.4%", "follow_up_response_bt": "No Answer"}, {"question_id": "131.10", "question": "How many patients with stable angina had reversible AVB according to the study?", "answer_src": "2.4%", "follow_up_question": "What percentage of patients with unstable angina had reversible AVB?", "follow_up_response": "0%", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "131.11", "question": "What was the percentage of patients with unstable angina who had reversible AVB?", "answer_src": "0%", "follow_up_question": "What percentage of patients with stable angina had reversible AVB?", "follow_up_response": "2.4%", "follow_up_response_bt": "No Answer"}, {"question_id": "131.12", "question": "What was the percentage of patients with unstable angina in the RB group who had reversible AVB?", "answer_src": "0%", "follow_up_question": "What percentage of patients with stable angina in the RB group had reversible AVB?", "follow_up_response": "2.4%", "follow_up_response_bt": "No Answer"}, {"question_id": "131.13", "question": "What percentage of patients with stable angina had reversible AVB?", "answer_src": "2.4%", "follow_up_question": "What was the percentage of patients with unstable angina that had reversible AVB?", "follow_up_response": "0%", "follow_up_response_bt": "No Answer"}, {"question_id": "131.14", "question": "What percentage of patients with stable angina had reversible AVB?", "answer_src": "2.4%", "follow_up_question": "What was the percentage of patients with unstable angina that had reversible AVB?", "follow_up_response": "0%", "follow_up_response_bt": "No Answer"}, {"question_id": "131.15", "question": "What percentage of patients with unstable angina had reversible AVB?", "answer_src": "0%", "follow_up_question": "What percentage of patients with stable angina had reversible AVB?", "follow_up_response": "2.4%", "follow_up_response_bt": "No Answer"}]}}
{"id": 132, "src": "in total , 83 polymorphic alleles ( 6.91 alleles per locus ) were found . in addition , the variation of pic was calculated from 0.52 to 0.9 . the results of cluster analysis showed the complete discrimination of varieties from each other except for ir58025a and ir58025b .", "mt": "In totale , sono stati trovati 83 alleli polimorfici (6,91 alleli per locus). Inoltre , la variazione di pic è stata calcolata da 0,52 a 0,9 . I risultati dell'analisi di gruppi hanno mostrato la completa discriminazione tra le varietà tra loro, tranne per ir58025a e ir58025b .", "pert_mt": "In totale, sono stati trovati 83 alleli polimorfici (6,91 alleli per locus). Inoltre, la variazione di pic è stata calcolata da 0,52 a 0,9. I risultati dell'analisi di gruppi hanno mostrato la completa discriminazione tra le varietà tra loro, tranne per ir58025a e ir58025b e per le differenze di crescita delle piante.", "bt": "In total, 83 polymorphic alleles were found (6.91 alleles per locus).[citation needed] In addition, the pic variation was calculated from 0.52 to 0.9.The results of the group analysis showed complete discrimination between the varieties among them, except for ir58025a and ir58025b and for the plant growth differences.", "questions_src": ["What is the total number of polymorphic alleles found?", "What is the range of variation for pic?", "Which variety did not show complete discrimination in the cluster analysis?"], "answers_src": ["[83 polymorphic alleles, 0.52 to 0.9, ir58025a and ir58025b]", "No Answer", "No Answer"], "answers_bt": ["[83 alleles, 0.52 to 0.9, ir58025a and ir58025b]", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "132.1", "question": "What is the total number of polymorphic alleles found?", "answer_src": "[83 polymorphic alleles, 0.52 to 0.9, ir58025a and ir58025b]", "follow_up_question": "What is the range of Pic variation found?", "follow_up_response": "0.52 to 0.9", "follow_up_response_bt": "0.52 to 0.9"}, {"question_id": "132.2", "question": "What is the range of variation for pic?", "answer_src": "in total , 83 polymorphic alleles ( 6.91 alleles per locus ) were found . in addition , the variation of pic was calculated from 0.52 to 0.9 . the results of cluster analysis showed the complete discrimination of varieties from each other except for ir58025a and ir58025b .", "follow_up_question": "What was the range of pic variation according to the text?", "follow_up_response": "0.52 to 0.9", "follow_up_response_bt": "From 0.52 to 0.9"}, {"question_id": "132.3", "question": "Which variety did not show complete discrimination in the cluster analysis?", "answer_src": "in total , 83 polymorphic alleles ( 6.91 alleles per locus ) were found . in addition , the variation of pic was calculated from 0.52 to 0.9 . the results of cluster analysis showed the complete discrimination of varieties from each other except for ir58025a and ir58025b .", "follow_up_question": "Which two varieties did not show complete discrimination in the cluster analysis?", "follow_up_response": "ir58025a and ir58025b", "follow_up_response_bt": "ir58025a and ir58025b"}], "turn_2": [{"question_id": "132.4", "question": "What is the range of Pic variation found?", "answer_src": "0.52 to 0.9", "follow_up_question": "What caused the incomplete discrimination in the cluster analysis?", "follow_up_response": "ir58025a and ir58025b", "follow_up_response_bt": "No Answer"}, {"question_id": "132.5", "question": "What was the range of pic variation according to the text?", "answer_src": "0.52 to 0.9", "follow_up_question": "What varieties were successfully discriminated by the cluster analysis?", "follow_up_response": "ir58025a and ir58025b", "follow_up_response_bt": "Among them"}, {"question_id": "132.6", "question": "Which two varieties did not show complete discrimination in the cluster analysis?", "answer_src": "ir58025a and ir58025b", "follow_up_question": "What was the range of PIC variation calculated for the studied alleles?", "follow_up_response": "0.52 to 0.9", "follow_up_response_bt": "0.52 to 0.9"}], "turn_3": [{"question_id": "132.7", "question": "What caused the incomplete discrimination in the cluster analysis?", "answer_src": "ir58025a and ir58025b", "follow_up_question": "Why were ir58025a and ir58025b not completely discriminated?", "follow_up_response": "the results of cluster analysis", "follow_up_response_bt": "plant growth differences"}, {"question_id": "132.8", "question": "What varieties were successfully discriminated by the cluster analysis?", "answer_src": "ir58025a and ir58025b", "follow_up_question": "Which varieties were not completely discriminated by the cluster analysis?", "follow_up_response": "ir58025a and ir58025b", "follow_up_response_bt": "ir58025a and ir58025b"}, {"question_id": "132.9", "question": "What was the range of PIC variation calculated for the studied alleles?", "answer_src": "0.52 to 0.9", "follow_up_question": "What was the result of the cluster analysis regarding the varieties?", "follow_up_response": "The results of cluster analysis showed the complete discrimination of varieties from each other except for ir58025a and ir58025b.", "follow_up_response_bt": "The results of the group analysis showed complete discrimination between the varieties among them"}]}}
{"id": 133, "src": "maternal - fetal genotype combinations at these loci are hypothesized to have an effect on the maternal immune system during pregnancy which can affect fetal neurodevelopment and increase schizophrenia susceptibility . this article reviews maternal - fetal genotype incompatibility studies and schizophrenia and discusses the hypothesized biological role of these incompatibility genes . it concludes that research is needed to further elucidate the role of rhd and hla - b maternal - fetal genotype incompatibility in schizophrenia and to identify other genes that produce an adverse prenatal environment through a maternal - fetal genotype incompatibility mechanism .", "mt": "Si ipotizza che le combinazioni genotipi materno-fetali in questi loci abbiano un effetto sul sistema immunitario materno durante la gravidanza che può influenzare il neurodivoluzione fetale e aumentare la sensibilità alla schizofrenia . Questo articolo rileva gli studi di incompatibilità genotipi materno-fetali e la schizofrenia e discute il ruolo biologico ipotetico di questi geni di incompatibilità . conclude che è necessaria ricerca per chiarire ulteriormente il ruolo della rhd e hla - b incompatibilità genotipi materno-fetali nella schizofrenia e per identificare altri geni che producono un ambiente pre-natale avverso attraverso un meccanismo di incompatibilità genotipi materno-fetali .", "pert_mt": "Si ipotizza che le combinazioni genotipi materno-fetali in questi loci abbiano un effetto sul sistema immunitario materno durante la gravidanza che può influenzare il neurosviluppo fetale e aumentare la sensibilità alla schizofrenia. Questo articolo rileva gli studi di incompatibilità genotipi materno-fetali e la schizofrenia e discute il ruolo biologico ipotetico di questi geni di incompatibilità. Conclude che è necessaria ricerca per chiarire ulteriormente il ruolo della rhd e hla - b incompatibilità genotipi materno-fetali nella schizofrenia e per identificare altri geni che producono un ambiente pre-natale avverso attraverso un meccanismo di incompatibilità genotipi materno-fetali.", "bt": "It is hypothesized that maternal-fetal genotypes in these locations have an effect on the maternal immune system during pregnancy that may influence fetal neurodevelopment and increase sensitivity to schizophrenia.This article reviews studies of maternal-fetal genotypes incompatibility with schizophrenia and discusses the hypothetical biological role of these incompatibility genes.It concludes that research is needed to further clarify the role of rhd e-b maternal-fetal genotypes incompatibility in schizophrenia and to identify other genes that produce an adverse prenatal environment through a mechanism of maternal-fetal genotypes incompatibility.", "questions_src": ["What does maternal-fetal genotype incompatibility refer to in this context?", "Who are the genes discussed in relation to maternal-fetal genotype incompatibility and schizophrenia?", "Where might maternal-fetal genotype incompatibility occur in the body?", "When could maternal-fetal genotype incompatibility potentially affect fetal development?", "Which genes are hypothesized to be involved in the adverse prenatal environment caused by maternal-fetal genotype incompatibility?"], "answers_src": ["Maternal-fetal genotype incompatibility refers to differences between the genetic makeup of the mother and the fetus at specific loci.", "The genes discussed are RHD and HLA-B.", "Maternal-fetal genotype incompatibility might occur in the body during pregnancy.", "Maternal-fetal genotype incompatibility could potentially affect fetal development during pregnancy.", "RHD and HLA-B are hypothesized to be involved in the adverse prenatal environment caused by maternal-fetal genotype incompatibility."], "answers_bt": ["Maternal-fetal genotypes incompatibility", "rhd e-b genes", "During pregnancy", "Fetal neurodevelopment", "rhd e-b genes"], "multiturn": {"turn_1": [{"question_id": "133.1", "question": "What does maternal-fetal genotype incompatibility refer to in this context?", "answer_src": "Maternal-fetal genotype incompatibility refers to differences between the genetic makeup of the mother and the fetus at specific loci.", "follow_up_question": "What specific loci are hypothesized to cause maternal-fetal genotype incompatibility?", "follow_up_response": "rhd and hla-B", "follow_up_response_bt": "maternal-fetal genotypes"}, {"question_id": "133.2", "question": "Who are the genes discussed in relation to maternal-fetal genotype incompatibility and schizophrenia?", "answer_src": "The genes discussed are RHD and HLA-B.", "follow_up_question": "What is the potential impact of maternal-fetal genotype incompatibility on fetal neurodevelopment according to the text?", "follow_up_response": "to affect fetal neurodevelopment", "follow_up_response_bt": "It may influence fetal neurodevelopment"}, {"question_id": "133.3", "question": "Where might maternal-fetal genotype incompatibility occur in the body?", "answer_src": "Maternal-fetal genotype incompatibility might occur in the body during pregnancy.", "follow_up_question": "What specific genes are discussed in the text as potentially causing an adverse prenatal environment?", "follow_up_response": "rhd and hla-B", "follow_up_response_bt": "rhd e-b"}, {"question_id": "133.4", "question": "When could maternal-fetal genotype incompatibility potentially affect fetal development?", "answer_src": "Maternal-fetal genotype incompatibility could potentially affect fetal development during pregnancy.", "follow_up_question": "How does maternal-fetal genotype incompatibility specifically influence the maternal immune system?", "follow_up_response": "it can affect fetal neurodevelopment and increase schizophrenia susceptibility", "follow_up_response_bt": "It is hypothesized that maternal-fetal genotype incompatibility has an effect on the maternal immune system during pregnancy"}, {"question_id": "133.5", "question": "Which genes are hypothesized to be involved in the adverse prenatal environment caused by maternal-fetal genotype incompatibility?", "answer_src": "RHD and HLA-B are hypothesized to be involved in the adverse prenatal environment caused by maternal-fetal genotype incompatibility.", "follow_up_question": "What specific mechanisms are proposed for how RHD and HLA-B contribute to an adverse prenatal environment?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "133.6", "question": "What specific loci are hypothesized to cause maternal-fetal genotype incompatibility?", "answer_src": "rhd and hla-B", "follow_up_question": "What evidence does the article suggest for the role of maternal-fetal genotype incompatibility in schizophrenia?", "follow_up_response": "the hypothesized biological role of these incompatibility genes", "follow_up_response_bt": "The article suggests that maternal-fetal genotype incompatibility may influence fetal neurodevelopment and increase sensitivity to schizophrenia."}, {"question_id": "133.7", "question": "What is the potential impact of maternal-fetal genotype incompatibility on fetal neurodevelopment according to the text?", "answer_src": "to affect fetal neurodevelopment", "follow_up_question": "What specific genes are discussed in the text as potentially producing an adverse prenatal environment through maternal-fetal genotype incompatibility?", "follow_up_response": "rhd and hla-B", "follow_up_response_bt": "rhd e-b"}, {"question_id": "133.8", "question": "What specific genes are discussed in the text as potentially causing an adverse prenatal environment?", "answer_src": "rhd and hla-B", "follow_up_question": "What evidence does the text provide for the hypothesis that maternal-fetal genotype incompatibility affects fetal neurodevelopment?", "follow_up_response": "Maternal - fetal genotype combinations at these loci are hypothesized to have an effect on the maternal immune system during pregnancy which can affect fetal neurodevelopment", "follow_up_response_bt": "Maternal-fetal genotypes in these locations have an effect on the maternal immune system during pregnancy that may influence fetal neurodevelopment"}, {"question_id": "133.9", "question": "How does maternal-fetal genotype incompatibility specifically influence the maternal immune system?", "answer_src": "it can affect fetal neurodevelopment and increase schizophrenia susceptibility", "follow_up_question": "What mechanisms might these incompatibility genes use to create an adverse prenatal environment?", "follow_up_response": "a maternal - fetal genotype incompatibility mechanism", "follow_up_response_bt": "a mechanism of maternal-fetal genotypes incompatibility"}, {"question_id": "133.10", "question": "What specific mechanisms are proposed for how RHD and HLA-B contribute to an adverse prenatal environment?", "answer_src": "maternal - fetal genotype combinations at these loci are hypothesized to have an effect on the maternal immune system during pregnancy which can affect fetal neurodevelopment and increase schizophrenia susceptibility . this article reviews maternal - fetal genotype incompatibility studies and schizophrenia and discusses the hypothesized biological role of these incompatibility genes . it concludes that research is needed to further elucidate the role of rhd and hla - b maternal - fetal genotype incompatibility in schizophrenia and to identify other genes that produce an adverse prenatal environment through a maternal - fetal genotype incompatibility mechanism .", "follow_up_question": "What other genes besides RHD and HLA-B are suggested to produce an adverse prenatal environment through maternal-fetal genotype incompatibility?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "133.11", "question": "What evidence does the article suggest for the role of maternal-fetal genotype incompatibility in schizophrenia?", "answer_src": "the hypothesized biological role of these incompatibility genes", "follow_up_question": "What specific genes does the article suggest play a role in maternal-fetal genotype incompatibility related to schizophrenia?", "follow_up_response": "rhd and HLA-B", "follow_up_response_bt": "rhd e-b"}, {"question_id": "133.12", "question": "What specific genes are discussed in the text as potentially producing an adverse prenatal environment through maternal-fetal genotype incompatibility?", "answer_src": "rhd and hla-B", "follow_up_question": "What evidence does the text provide for the hypothesis that maternal-fetal genotype incompatibility affects fetal neurodevelopment?", "follow_up_response": "Maternal - fetal genotype combinations at these loci are hypothesized to have an effect on the maternal immune system during pregnancy which can affect fetal neurodevelopment", "follow_up_response_bt": "Maternal-fetal genotypes in these locations have an effect on the maternal immune system during pregnancy that may influence fetal neurodevelopment"}, {"question_id": "133.13", "question": "What evidence does the text provide for the hypothesis that maternal-fetal genotype incompatibility affects fetal neurodevelopment?", "answer_src": "Maternal - fetal genotype combinations at these loci are hypothesized to have an effect on the maternal immune system during pregnancy which can affect fetal neurodevelopment", "follow_up_question": "How does the text suggest maternal-fetal genotype incompatibility can lead to an adverse prenatal environment?", "follow_up_response": "through a maternal-fetal genotype incompatibility mechanism", "follow_up_response_bt": "Through a mechanism of maternal-fetal genotype incompatibility"}, {"question_id": "133.14", "question": "What mechanisms might these incompatibility genes use to create an adverse prenatal environment?", "answer_src": "a maternal - fetal genotype incompatibility mechanism", "follow_up_question": "How does maternal - fetal genotype incompatibility specifically affect the maternal immune system during pregnancy?", "follow_up_response": "it can affect fetal neurodevelopment and increase schizophrenia susceptibility", "follow_up_response_bt": "It is hypothesized that maternal-fetal genotypes in these locations have an effect on the maternal immune system during pregnancy that may influence fetal neurodevelopment and increase sensitivity to schizophrenia."}, {"question_id": "133.15", "question": "What other genes besides RHD and HLA-B are suggested to produce an adverse prenatal environment through maternal-fetal genotype incompatibility?", "answer_src": "maternal - fetal genotype combinations at these loci are hypothesized to have an effect on the maternal immune system during pregnancy which can affect fetal neurodevelopment and increase schizophrenia susceptibility . this article reviews maternal - fetal genotype incompatibility studies and schizophrenia and discusses the hypothesized biological role of these incompatibility genes . it concludes that research is needed to further elucidate the role of rhd and hla - b maternal - fetal genotype incompatibility in schizophrenia and to identify other genes that produce an adverse prenatal environment through a maternal - fetal genotype incompatibility mechanism .", "follow_up_question": "What other specific fetal neurodevelopment issues are suggested to be affected by maternal-fetal genotype incompatibility?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 134, "src": "the aim of this study was to evaluate clinical characteristics , prognostic factors , survival rates , and treatment modalities in patients with primary gastric lymphoma ( pgl ) . we retrospectively reviewed and analyzed data from patients treated for pgl in our clinic from 1998 through 2010 . staging was performed using the lugano staging system .", "mt": "Lo scopo di questo studio era quello di valutare le caratteristiche cliniche , i fattori prognostici , i tassi di sopravvivenza e le modalità di trattamento nei pazienti con linfoma gastrico primario (LGP). abbiamo esaminato e analizzato retrospettivamente i dati dei pazienti trattati per il LGP nella nostra clinica dal 1998 al 2010 .", "pert_mt": "Lo scopo di questo studio era quello di valutare le caratteristiche cliniche, i fattori prognostici, i tassi di sopravvivenza e le modalità di trattamento nei pazienti con linfoma gastrico primario (LGP). Abbiamo esaminato e analizzato retrospettivamente i dati dei pazienti trattati per il LGP nella nostra clinica dal 1998 al 2010.", "bt": "The purpose of this study was to evaluate clinical features, prognostic factors, survival rates and treatment patterns in patients with primary gastric lymphoma (PGL).We reviewed and analyzed retrospectively the data of patients treated for LGP in our clinic from 1998 to 2010.", "questions_src": ["What is the main focus of the study?", "Who were the patients studied?", "Where was the data collected from?", "When did the study period start and end?", "Which staging system was used for patient evaluation?"], "answers_src": ["[\"To evaluate clinical characteristics, prognostic factors, survival rates, and treatment modalities in patients with primary gastric lymphoma\"], [\"Patients treated for primary gastric lymphoma in the clinic\"], [\"From our clinic\"], [\"1998 through 2010\"], [\"The Lugano staging system\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["To evaluate clinical features, prognostic factors, survival rates and treatment patterns in patients with primary gastric lymphoma (PGL)", "Patients with primary gastric lymphoma (PGL)", "Our clinic", "1998 to 2010", "No Answer"], "multiturn": {"turn_1": [{"question_id": "134.1", "question": "What is the main focus of the study?", "answer_src": "[\"To evaluate clinical characteristics, prognostic factors, survival rates, and treatment modalities in patients with primary gastric lymphoma\"], [\"Patients treated for primary gastric lymphoma in the clinic\"], [\"From our clinic\"], [\"1998 through 2010\"], [\"The Lugano staging system\"]", "follow_up_question": "What specific time period did the data collection span?", "follow_up_response": "1998 through 2010", "follow_up_response_bt": "1998 to 2010"}, {"question_id": "134.2", "question": "Who were the patients studied?", "answer_src": "the aim of this study was to evaluate clinical characteristics , prognostic factors , survival rates , and treatment modalities in patients with primary gastric lymphoma ( pgl ) . we retrospectively reviewed and analyzed data from patients treated for pgl in our clinic from 1998 through 2010 . staging was performed using the lugano staging system .", "follow_up_question": "What year range did the retrospective review cover?", "follow_up_response": "1998 through 2010", "follow_up_response_bt": "1998 to 2010"}, {"question_id": "134.3", "question": "Where was the data collected from?", "answer_src": "the aim of this study was to evaluate clinical characteristics , prognostic factors , survival rates , and treatment modalities in patients with primary gastric lymphoma ( pgl ) . we retrospectively reviewed and analyzed data from patients treated for pgl in our clinic from 1998 through 2010 . staging was performed using the lugano staging system .", "follow_up_question": "What year range did the retrospective analysis cover?", "follow_up_response": "1998 through 2010", "follow_up_response_bt": "1998 to 2010"}, {"question_id": "134.4", "question": "When did the study period start and end?", "answer_src": "the aim of this study was to evaluate clinical characteristics , prognostic factors , survival rates , and treatment modalities in patients with primary gastric lymphoma ( pgl ) . we retrospectively reviewed and analyzed data from patients treated for pgl in our clinic from 1998 through 2010 . staging was performed using the lugano staging system .", "follow_up_question": "What staging system was used for the patients in this study?", "follow_up_response": "Lugano staging system", "follow_up_response_bt": "No Answer"}, {"question_id": "134.5", "question": "Which staging system was used for patient evaluation?", "answer_src": "the aim of this study was to evaluate clinical characteristics , prognostic factors , survival rates , and treatment modalities in patients with primary gastric lymphoma ( pgl ) . we retrospectively reviewed and analyzed data from patients treated for pgl in our clinic from 1998 through 2010 . staging was performed using the lugano staging system .", "follow_up_question": "What year range did the retrospective review cover?", "follow_up_response": "1998 through 2010", "follow_up_response_bt": "1998 to 2010"}], "turn_2": [{"question_id": "134.6", "question": "What specific time period did the data collection span?", "answer_src": "1998 through 2010", "follow_up_question": "What was the staging method used for the patients' tumors?", "follow_up_response": "The Lugano staging system", "follow_up_response_bt": "No Answer"}, {"question_id": "134.7", "question": "What year range did the retrospective review cover?", "answer_src": "1998 through 2010", "follow_up_question": "What staging system was used for the patients' evaluations?", "follow_up_response": "Lugano staging system", "follow_up_response_bt": "No Answer"}, {"question_id": "134.8", "question": "What year range did the retrospective analysis cover?", "answer_src": "1998 through 2010", "follow_up_question": "Which staging system was used for patient staging in the study?", "follow_up_response": "Lugano staging system", "follow_up_response_bt": "No Answer"}, {"question_id": "134.9", "question": "What staging system was used for the patients in this study?", "answer_src": "Lugano staging system", "follow_up_question": "What were the key findings regarding the survival rates of patients with primary gastric lymphoma in this study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "134.10", "question": "What year range did the retrospective review cover?", "answer_src": "1998 through 2010", "follow_up_question": "What staging system was used for the patients' evaluations?", "follow_up_response": "Lugano staging system", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "134.11", "question": "What was the staging method used for the patients' tumors?", "answer_src": "The Lugano staging system", "follow_up_question": "What were the specific stages of the tumors according to the Lugano staging system?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "134.12", "question": "What staging system was used for the patients' evaluations?", "answer_src": "Lugano staging system", "follow_up_question": "What were the key findings regarding the survival rates of the patients?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "134.13", "question": "Which staging system was used for patient staging in the study?", "answer_src": "Lugano staging system", "follow_up_question": "What were the years covered by the retrospective review in the study?", "follow_up_response": "1998 through 2010", "follow_up_response_bt": "1998 to 2010"}, {"question_id": "134.14", "question": "What were the key findings regarding the survival rates of patients with primary gastric lymphoma in this study?", "answer_src": "the aim of this study was to evaluate clinical characteristics , prognostic factors , survival rates , and treatment modalities in patients with primary gastric lymphoma ( pgl ) . we retrospectively reviewed and analyzed data from patients treated for pgl in our clinic from 1998 through 2010 . staging was performed using the lugano staging system .", "follow_up_question": "What specific treatment modalities were evaluated in this study?", "follow_up_response": "treatment modalities", "follow_up_response_bt": "No Answer"}, {"question_id": "134.15", "question": "What staging system was used for the patients' evaluations?", "answer_src": "Lugano staging system", "follow_up_question": "What were the key findings regarding the survival rates of the patients?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 135, "src": "symptomatic trigeminal neuralgia due to a brainstem infarction is said to be rare . however , facial pain is not uncommon in wallenberg s syndrome . facial pain related to a wallenberg s syndrome may be either persistent of intermittent , and occasionally occurs in brief attacks .", "mt": "Si dice che la neuralgia trigeminale sintomatica dovuta ad un infarto del tronco cerebrale sia rara . Tuttavia , il dolore facciale non è raro nella sindrome di Wallenberg . Il dolore facciale correlato a una sindrome di Wallenberg può essere persistenti o intermittenti , e occasionalmente si verifica in brevi attacchi .", "pert_mt": "Si dice che la neuralgia trigeminale sintomatica dovuta ad un infarto del tronco cerebrale sia rara. Tuttavia, il dolore facciale non è raro nella sindrome di Wallenberg. Il dolore facciale correlato a una sindrome di Wallenberg può essere persistenti o intermittenti, e occasionalmente si verifica in brevi attacchi, indipendentemente dal genere del paziente.", "bt": "Symptomatic trigeminal neuralgia due to a brainstem infarction is said to be rare, however, facial pain is not uncommon in Wallenberg syndrome.Facial pain related to Wallenberg syndrome can be persistent or intermittent, and occasional occurs in brief attacks, regardless of the patient's gender.", "questions_src": ["What is the cause of symptomatic trigeminal neuralgia mentioned in the sentence?", "Who is affected by rare trigeminal neuralgia due to brainstem infarction?", "Where can facial pain occur besides the trigeminal neuralgia?", "When does facial pain related to Wallenberg's syndrome typically happen?", "Which type of facial pain is described as occasional or brief in the sentence?"], "answers_src": ["[\"a brainstem infarction\", \"patients\", \"Wallenberg\"s syndrome\", \"either persistent or intermittent\", \"occasionally\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["A brainstem infarction", "Patients", "Wallenberg syndrome", "Persistently or intermittently", "Brief attacks"], "multiturn": {"turn_1": [{"question_id": "135.1", "question": "What is the cause of symptomatic trigeminal neuralgia mentioned in the sentence?", "answer_src": "[\"a brainstem infarction\", \"patients\", \"Wallenberg\"s syndrome\", \"either persistent or intermittent\", \"occasionally\"]", "follow_up_question": "What type of facial pain is associated with Wallenberg's syndrome according to the text?", "follow_up_response": "persistent or intermittent", "follow_up_response_bt": "Facial pain is not uncommon\", \"Persistent or intermittent\", \"Occasional occurs in brief attacks"}, {"question_id": "135.2", "question": "Who is affected by rare trigeminal neuralgia due to brainstem infarction?", "answer_src": "symptomatic trigeminal neuralgia due to a brainstem infarction is said to be rare . however , facial pain is not uncommon in wallenberg s syndrome . facial pain related to a wallenberg s syndrome may be either persistent of intermittent , and occasionally occurs in brief attacks .", "follow_up_question": "What type of facial pain is associated with Wallenberg's syndrome according to the text?", "follow_up_response": "persistent or intermittent", "follow_up_response_bt": "Facial pain is not uncommon\", \"Persistent or intermittent\", \"Occasional occurs in brief attacks"}, {"question_id": "135.3", "question": "Where can facial pain occur besides the trigeminal neuralgia?", "answer_src": "symptomatic trigeminal neuralgia due to a brainstem infarction is said to be rare . however , facial pain is not uncommon in wallenberg s syndrome . facial pain related to a wallenberg s syndrome may be either persistent of intermittent , and occasionally occurs in brief attacks .", "follow_up_question": "What types of facial pain can occur with Wallenberg's syndrome?", "follow_up_response": "Persistent, intermittent, or occasional brief attacks", "follow_up_response_bt": "Persistent or intermittent\", \"Occasional occurs in brief attacks"}, {"question_id": "135.4", "question": "When does facial pain related to Wallenberg's syndrome typically happen?", "answer_src": "symptomatic trigeminal neuralgia due to a brainstem infarction is said to be rare . however , facial pain is not uncommon in wallenberg s syndrome . facial pain related to a wallenberg s syndrome may be either persistent of intermittent , and occasionally occurs in brief attacks .", "follow_up_question": "What types of facial pain can occur in Wallenberg's syndrome?", "follow_up_response": "Persistent, intermittent, or occasional brief attacks", "follow_up_response_bt": "Persistent or intermittent\", \"Occasional occurs in brief attacks"}, {"question_id": "135.5", "question": "Which type of facial pain is described as occasional or brief in the sentence?", "answer_src": "symptomatic trigeminal neuralgia due to a brainstem infarction is said to be rare . however , facial pain is not uncommon in wallenberg s syndrome . facial pain related to a wallenberg s syndrome may be either persistent of intermittent , and occasionally occurs in brief attacks .", "follow_up_question": "What is the duration of the facial pain that occasionally occurs in brief attacks according to the text?", "follow_up_response": "persistent or intermittent", "follow_up_response_bt": "persistent or intermittent"}], "turn_2": [{"question_id": "135.6", "question": "What type of facial pain is associated with Wallenberg's syndrome according to the text?", "answer_src": "persistent or intermittent", "follow_up_question": "Occasionally, what kind of facial pain attacks occur in Wallenberg's syndrome?", "follow_up_response": "brief attacks", "follow_up_response_bt": "Brief attacks"}, {"question_id": "135.7", "question": "What type of facial pain is associated with Wallenberg's syndrome according to the text?", "answer_src": "persistent or intermittent", "follow_up_question": "Occasionally, what kind of facial pain attacks occur in Wallenberg's syndrome?", "follow_up_response": "brief attacks", "follow_up_response_bt": "Brief attacks"}, {"question_id": "135.8", "question": "What types of facial pain can occur with Wallenberg's syndrome?", "answer_src": "Persistent, intermittent, or occasional brief attacks", "follow_up_question": "What percentage of patients with Wallenberg's syndrome experience persistent facial pain?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "135.9", "question": "What types of facial pain can occur in Wallenberg's syndrome?", "answer_src": "Persistent, intermittent, or occasional brief attacks", "follow_up_question": "What percentage of patients with Wallenberg's syndrome experience persistent facial pain?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "135.10", "question": "What is the duration of the facial pain that occasionally occurs in brief attacks according to the text?", "answer_src": "persistent or intermittent", "follow_up_question": "What type of facial pain is described as occasionally occurring in brief attacks?", "follow_up_response": "Facial pain", "follow_up_response_bt": "Facial pain"}], "turn_3": [{"question_id": "135.11", "question": "Occasionally, what kind of facial pain attacks occur in Wallenberg's syndrome?", "answer_src": "brief attacks", "follow_up_question": "What is the duration of the brief attacks mentioned in Wallenberg's syndrome?", "follow_up_response": "No Answer", "follow_up_response_bt": "Persistent or intermittent"}, {"question_id": "135.12", "question": "Occasionally, what kind of facial pain attacks occur in Wallenberg's syndrome?", "answer_src": "brief attacks", "follow_up_question": "What is the duration of the brief attacks mentioned in Wallenberg's syndrome?", "follow_up_response": "No Answer", "follow_up_response_bt": "Persistent or intermittent"}, {"question_id": "135.13", "question": "What percentage of patients with Wallenberg's syndrome experience persistent facial pain?", "answer_src": "symptomatic trigeminal neuralgia due to a brainstem infarction is said to be rare . however , facial pain is not uncommon in wallenberg s syndrome . facial pain related to a wallenberg s syndrome may be either persistent of intermittent , and occasionally occurs in brief attacks .", "follow_up_question": "How often does facial pain related to Wallenberg's syndrome occur in brief attacks?", "follow_up_response": "occasionally", "follow_up_response_bt": "occasional"}, {"question_id": "135.14", "question": "What percentage of patients with Wallenberg's syndrome experience persistent facial pain?", "answer_src": "symptomatic trigeminal neuralgia due to a brainstem infarction is said to be rare . however , facial pain is not uncommon in wallenberg s syndrome . facial pain related to a wallenberg s syndrome may be either persistent of intermittent , and occasionally occurs in brief attacks .", "follow_up_question": "How often does facial pain related to Wallenberg's syndrome occur in brief attacks?", "follow_up_response": "occasionally", "follow_up_response_bt": "occasional"}, {"question_id": "135.15", "question": "What type of facial pain is described as occasionally occurring in brief attacks?", "answer_src": "Facial pain", "follow_up_question": "What is the duration of the facial pain that occasionally occurs in brief attacks?", "follow_up_response": "Persistent or intermittent", "follow_up_response_bt": "Persistent or intermittent"}]}}
{"id": 136, "src": "however , the patient also suffered from relapsed disease at locations distant from the original glioblastoma and the corresponding radiation fields received at initial diagnosis . we conclude that combination ttfields and bevacizumab therapy is safe and may be efficacious for patients with recurrent glioblastoma . a further study would be needed to determine the relapse pattern and the distribution of the electric fields in the brain .", "mt": "Tuttavia , il paziente ha anche sofferto di malattia ricadente in luoghi lontani dal glioblastoma originale e dai corrispondenti campi di radiazioni ricevuti alla diagnosi iniziale . Concludiamo che la combinazione di ttfield e terapia con bevacizumab è sicura e può essere efficace per i pazienti con glioblastoma ricorrente . Sarebbe necessario un ulteriore studio per determinare il modello di ricadenza e la distribuzione dei campi elettrici nel cervello .", "pert_mt": "Tuttavia, il paziente ha anche sofferto di malattia ricadente in luoghi lontani dal glioblastoma originale e dai corrispondenti campi di radiazioni ricevuti alla diagnosi iniziale. Concludiamo che la combinazione di ttfield e terapia con bevacizumab è sicura e può essere efficace per i pazienti con glioblastoma ricorrente. Sarebbe necessario un ulteriore studio per determinare il modello di ricadenza, la distribuzione dei campi elettrici nel cervello e le possibili interazioni farmacologiche.", "bt": "However, the patient also suffers from a recurrent disease far from the original glioblastoma and the corresponding radiation fields received at the initial diagnosis.We conclude that the combination of ttfield and bevacizumab therapy is safe and may be effective for patients with recurrent glioblastoma.Further study would be needed to determine the pattern of recurrence, the distribution of electric fields in the brain and possible pharmacological interactions.", "questions_src": ["What was the patient's condition after the initial diagnosis?", "Where were the new disease locations found?", "Which therapy was concluded to be safe and potentially effective?", "When did the patient experience the recurrence of the disease?", "Which drug was used in conjunction with TTFields therapy?"], "answers_src": ["Relapsed disease", "Distant from the original glioblastoma and the corresponding radiation fields", "TTFields and bevacizumab therapy", "At initial diagnosis", "Bevacizumab"], "answers_bt": ["A recurrent disease far from the original glioblastoma", "Far from the original glioblastoma", "TTFields and bevacizumab therapy", "After the initial diagnosis", "Bevacizumab"], "multiturn": {"turn_1": [{"question_id": "136.1", "question": "What was the patient's condition after the initial diagnosis?", "answer_src": "Relapsed disease", "follow_up_question": "What were the locations of the relapsed disease?", "follow_up_response": "locations distant from the original glioblastoma and the corresponding radiation fields", "follow_up_response_bt": "far from the original glioblastoma"}, {"question_id": "136.2", "question": "Where were the new disease locations found?", "answer_src": "Distant from the original glioblastoma and the corresponding radiation fields", "follow_up_question": "What was the distribution pattern of the electric fields in the brain?", "follow_up_response": "the distribution of the electric fields in the brain", "follow_up_response_bt": "Further study would be needed to determine"}, {"question_id": "136.3", "question": "Which therapy was concluded to be safe and potentially effective?", "answer_src": "TTFields and bevacizumab therapy", "follow_up_question": "What specific relapse pattern did the further study need to determine?", "follow_up_response": "The relapse pattern and the distribution of the electric fields in the brain", "follow_up_response_bt": "The pattern of recurrence"}, {"question_id": "136.4", "question": "When did the patient experience the recurrence of the disease?", "answer_src": "At initial diagnosis", "follow_up_question": "What was the distribution of the electric fields in the brain according to the text?", "follow_up_response": "the distribution of the electric fields in the brain", "follow_up_response_bt": "possible pharmacological interactions"}, {"question_id": "136.5", "question": "Which drug was used in conjunction with TTFields therapy?", "answer_src": "Bevacizumab", "follow_up_question": "What is the distribution pattern of the electric fields in the brain according to the text?", "follow_up_response": "the distribution of the electric fields in the brain", "follow_up_response_bt": "possible pharmacological interactions"}], "turn_2": [{"question_id": "136.6", "question": "What were the locations of the relapsed disease?", "answer_src": "locations distant from the original glioblastoma and the corresponding radiation fields", "follow_up_question": "What was the distribution of the electric fields in the brain according to the text?", "follow_up_response": "the distribution of the electric fields in the brain", "follow_up_response_bt": "possible pharmacological interactions"}, {"question_id": "136.7", "question": "What was the distribution pattern of the electric fields in the brain?", "answer_src": "the distribution of the electric fields in the brain", "follow_up_question": "What was the relapse pattern of the patient's disease?", "follow_up_response": "locations distant from the original glioblastoma", "follow_up_response_bt": "the distribution of electric fields in the brain"}, {"question_id": "136.8", "question": "What specific relapse pattern did the further study need to determine?", "answer_src": "The relapse pattern and the distribution of the electric fields in the brain", "follow_up_question": "What distribution of electric fields in the brain was the further study intended to investigate?", "follow_up_response": "the distribution of the electric fields", "follow_up_response_bt": "The distribution of electric fields in the brain"}, {"question_id": "136.9", "question": "What was the distribution of the electric fields in the brain according to the text?", "answer_src": "the distribution of the electric fields in the brain", "follow_up_question": "What was the relapse pattern of the disease according to the text?", "follow_up_response": "the distribution of the electric fields in the brain", "follow_up_response_bt": "the pattern of recurrence"}, {"question_id": "136.10", "question": "What is the distribution pattern of the electric fields in the brain according to the text?", "answer_src": "the distribution of the electric fields in the brain", "follow_up_question": "What is the relapse pattern of the disease according to the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "136.11", "question": "What was the distribution of the electric fields in the brain according to the text?", "answer_src": "the distribution of the electric fields in the brain", "follow_up_question": "What was the relapse pattern of the disease according to the text?", "follow_up_response": "the distribution of the electric fields in the brain", "follow_up_response_bt": "the pattern of recurrence"}, {"question_id": "136.12", "question": "What was the relapse pattern of the patient's disease?", "answer_src": "locations distant from the original glioblastoma", "follow_up_question": "What was the distribution of the electric fields in the brain?", "follow_up_response": "the distribution of the electric fields in the brain", "follow_up_response_bt": "Further study would be needed to determine"}, {"question_id": "136.13", "question": "What distribution of electric fields in the brain was the further study intended to investigate?", "answer_src": "the distribution of the electric fields", "follow_up_question": "What specific relapse pattern did the further study aim to determine?", "follow_up_response": "The relapse pattern and the distribution of the electric fields in the brain", "follow_up_response_bt": "The pattern of recurrence"}, {"question_id": "136.14", "question": "What was the relapse pattern of the disease according to the text?", "answer_src": "the distribution of the electric fields in the brain", "follow_up_question": "What was the distribution of the electric fields in the brain according to the text?", "follow_up_response": "the distribution of the electric fields in the brain", "follow_up_response_bt": "possible pharmacological interactions"}, {"question_id": "136.15", "question": "What is the relapse pattern of the disease according to the text?", "answer_src": "however , the patient also suffered from relapsed disease at locations distant from the original glioblastoma and the corresponding radiation fields received at initial diagnosis . we conclude that combination ttfields and bevacizumab therapy is safe and may be efficacious for patients with recurrent glioblastoma . a further study would be needed to determine the relapse pattern and the distribution of the electric fields in the brain .", "follow_up_question": "What does the text suggest about the distribution of the electric fields in the brain?", "follow_up_response": "a further study would be needed to determine the relapse pattern and the distribution of the electric fields in the brain.", "follow_up_response_bt": "possible pharmacological interactions"}]}}
{"id": 137, "src": "the factors affecting the correlation between parkinson disease ( pd ) and depression have remained unclear.we assessed the prevalence of depression among patients with pd and the association between pd - related variables and depression severity.this is a cross - sectional study performed in kermanshah province of iran . sampling was based on recruitment of subjects according to inclusion and exclusion criteria . patients with confirmed parkinson disease who were referred to clinics of kermanshah university of medical sciences participated in this study .", "mt": "I fattori che influenzano la correlazione tra la malattia di Parkinson ( pd) e la depressione sono rimasti poco chiari. abbiamo valutato la prevalenza della depressione tra i pazienti con pd e l'associazione tra le variabili legate a pd e la gravità della depressione.Questo è uno studio transsezionale eseguito nella provincia di Kermanshah in Iran . Il campionamento è stato basato sul reclutamento di soggetti secondo criteri di inclusione ed esclusione .", "pert_mt": "I fattori che influenzano la correlazione tra la malattia di Parkinson (pd) e la depressione sono rimasti poco chiari. Abbiamo valutato la prevalenza della depressione tra i pazienti con pd e l'associazione tra le variabili legate a pd e la gravità della depressione. Questo è uno studio transsezionale eseguito nella provincia di Kermanshah in Iran. Il campionamento è stato basato sul reclutamento di soggetti secondo criteri di inclusione ed esclusione e sulla loro età.", "bt": "The factors influencing the correlation between Parkinson's disease (PD) and depression remain unclear.We assessed the prevalence of depression among PD patients and the association between PD-related variables and the severity of depression.This is a cross-sectional study conducted in the province of Kermanshah in Iran.The sampling was based on recruiting subjects according to inclusion and exclusion criteria and their age.", "questions_src": ["What is the main focus of your study?", "Who were the participants in your study?", "Where was the study conducted?", "When was the study performed?", "Which factors did you assess for their impact on depression in Parkinson's disease patients?"], "answers_src": ["[\"The prevalence of depression among patients with PD and the association between PD-related variables and depression severity\", \"Patients with confirmed Parkinson\"s disease who were referred to clinics of Kermanshah University of Medical Sciences\", \"Kermanshah province of Iran\", \"Cross-sectional study performed in Kermanshah province of Iran\", \"Factors affecting the correlation between Parkinson\"s disease and depression\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"The prevalence of depression among PD patients and the association between PD-related variables and the severity of depression\", \"Subjects recruited according to inclusion and exclusion criteria and their age\", \"The province of Kermanshah in Iran\", \"Cross-sectional study conducted in the province of Kermanshah in Iran\", \"Factors influencing the correlation between Parkinson\"s disease (PD) and depression\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "137.1", "question": "What is the main focus of your study?", "answer_src": "[\"The prevalence of depression among patients with PD and the association between PD-related variables and depression severity\", \"Patients with confirmed Parkinson\"s disease who were referred to clinics of Kermanshah University of Medical Sciences\", \"Kermanshah province of Iran\", \"Cross-sectional study performed in Kermanshah province of Iran\", \"Factors affecting the correlation between Parkinson\"s disease and depression\"]", "follow_up_question": "What specific PD-related variables were assessed in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "137.2", "question": "Who were the participants in your study?", "answer_src": "the factors affecting the correlation between parkinson disease ( pd ) and depression have remained unclear.we assessed the prevalence of depression among patients with pd and the association between pd - related variables and depression severity.this is a cross - sectional study performed in kermanshah province of iran . sampling was based on recruitment of subjects according to inclusion and exclusion criteria . patients with confirmed parkinson disease who were referred to clinics of kermanshah university of medical sciences participated in this study .", "follow_up_question": "What criteria were used to recruit the participants?", "follow_up_response": "According to inclusion and exclusion criteria", "follow_up_response_bt": "Inclusion and exclusion criteria and their age"}, {"question_id": "137.3", "question": "Where was the study conducted?", "answer_src": "the factors affecting the correlation between parkinson disease ( pd ) and depression have remained unclear.we assessed the prevalence of depression among patients with pd and the association between pd - related variables and depression severity.this is a cross - sectional study performed in kermanshah province of iran . sampling was based on recruitment of subjects according to inclusion and exclusion criteria . patients with confirmed parkinson disease who were referred to clinics of kermanshah university of medical sciences participated in this study .", "follow_up_question": "What type of study design was used in this research?", "follow_up_response": "Cross-sectional study", "follow_up_response_bt": "Cross-sectional study"}, {"question_id": "137.4", "question": "When was the study performed?", "answer_src": "the factors affecting the correlation between parkinson disease ( pd ) and depression have remained unclear.we assessed the prevalence of depression among patients with pd and the association between pd - related variables and depression severity.this is a cross - sectional study performed in kermanshah province of iran . sampling was based on recruitment of subjects according to inclusion and exclusion criteria . patients with confirmed parkinson disease who were referred to clinics of kermanshah university of medical sciences participated in this study .", "follow_up_question": "What location did the participants in the study come from?", "follow_up_response": "Kermanshah province of Iran", "follow_up_response_bt": "The province of Kermanshah in Iran"}, {"question_id": "137.5", "question": "Which factors did you assess for their impact on depression in Parkinson's disease patients?", "answer_src": "the factors affecting the correlation between parkinson disease ( pd ) and depression have remained unclear.we assessed the prevalence of depression among patients with pd and the association between pd - related variables and depression severity.this is a cross - sectional study performed in kermanshah province of iran . sampling was based on recruitment of subjects according to inclusion and exclusion criteria . patients with confirmed parkinson disease who were referred to clinics of kermanshah university of medical sciences participated in this study .", "follow_up_question": "What specific pd-related variables did you examine for their association with depression severity?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "137.6", "question": "What specific PD-related variables were assessed in the study?", "answer_src": "the factors affecting the correlation between parkinson disease ( pd ) and depression have remained unclear.we assessed the prevalence of depression among patients with pd and the association between pd - related variables and depression severity.this is a cross - sectional study performed in kermanshah province of iran . sampling was based on recruitment of subjects according to inclusion and exclusion criteria . patients with confirmed parkinson disease who were referred to clinics of kermanshah university of medical sciences participated in this study .", "follow_up_question": "What criteria were used for recruiting participants in the study?", "follow_up_response": "According to inclusion and exclusion criteria", "follow_up_response_bt": "Inclusion and exclusion criteria and their age"}, {"question_id": "137.7", "question": "What criteria were used to recruit the participants?", "answer_src": "According to inclusion and exclusion criteria", "follow_up_question": "What were the inclusion criteria used to recruit the participants?", "follow_up_response": "Inclusion and exclusion criteria", "follow_up_response_bt": "No Answer"}, {"question_id": "137.8", "question": "What type of study design was used in this research?", "answer_src": "Cross-sectional study", "follow_up_question": "What location did the study participants come from?", "follow_up_response": "Kermanshah province of Iran", "follow_up_response_bt": "The province of Kermanshah in Iran"}, {"question_id": "137.9", "question": "What location did the participants in the study come from?", "answer_src": "Kermanshah province of Iran", "follow_up_question": "What type of study design was used in this research?", "follow_up_response": "Cross-sectional study", "follow_up_response_bt": "Cross-sectional study"}, {"question_id": "137.10", "question": "What specific pd-related variables did you examine for their association with depression severity?", "answer_src": "the factors affecting the correlation between parkinson disease ( pd ) and depression have remained unclear.we assessed the prevalence of depression among patients with pd and the association between pd - related variables and depression severity.this is a cross - sectional study performed in kermanshah province of iran . sampling was based on recruitment of subjects according to inclusion and exclusion criteria . patients with confirmed parkinson disease who were referred to clinics of kermanshah university of medical sciences participated in this study .", "follow_up_question": "Which pd-related variables were found to be associated with depression severity in this study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "137.11", "question": "What criteria were used for recruiting participants in the study?", "answer_src": "According to inclusion and exclusion criteria", "follow_up_question": "What were the inclusion criteria for the recruited patients with Parkinson's disease?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "137.12", "question": "What were the inclusion criteria used to recruit the participants?", "answer_src": "Inclusion and exclusion criteria", "follow_up_question": "What were the exclusion criteria used to recruit the participants?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "137.13", "question": "What location did the study participants come from?", "answer_src": "Kermanshah province of Iran", "follow_up_question": "What type of study design was used in this research?", "follow_up_response": "Cross-sectional study", "follow_up_response_bt": "Cross-sectional study"}, {"question_id": "137.14", "question": "What type of study design was used in this research?", "answer_src": "Cross-sectional study", "follow_up_question": "What location did the study participants come from?", "follow_up_response": "Kermanshah province of Iran", "follow_up_response_bt": "The province of Kermanshah in Iran"}, {"question_id": "137.15", "question": "Which pd-related variables were found to be associated with depression severity in this study?", "answer_src": "the factors affecting the correlation between parkinson disease ( pd ) and depression have remained unclear.we assessed the prevalence of depression among patients with pd and the association between pd - related variables and depression severity.this is a cross - sectional study performed in kermanshah province of iran . sampling was based on recruitment of subjects according to inclusion and exclusion criteria . patients with confirmed parkinson disease who were referred to clinics of kermanshah university of medical sciences participated in this study .", "follow_up_question": "What specific pd-related variables were evaluated in this study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 138, "src": "elisa and flow cytometry were performed to verify immunotoxin ( scfv2a9-pe or ape ) antigen - binding activity with epcam . cytotoxicity was measured by mtt assay . confocal microscopy was used to observe its cellular localization .", "mt": "L' elisa e la citometria di flusso sono state eseguite per verificare l' attività di legame degli antigeni con l' epcam dell' immunotossina (scfv2a9-pe o ape). La citotossia è stata misurata con l' assay mtt . La microscopia confocale è stata utilizzata per osservare la sua localizzazione cellulare .", "pert_mt": "L'elisa e la citometria di flusso sono state eseguite per verificare l'attività di legame degli antigeni con l'epcam dell'immunotossina (scfv2a9-pe o ape). La citotossia è stata misurata con l'assay MTT. La microscopia confocale è stata utilizzata per osservare la sua localizzazione cellulare e distribuzione intracellulare.", "bt": "The elys and flow cytometry were performed to verify the binding activity of antigens with the immune cell epcam (scfv2a9-pe or ape).Cytotoxicity was measured with the MTT assay.Confocal microscopy was used to observe its cellular localization and intracellular distribution.", "questions_src": ["What was used to verify the immunotoxin antigen-binding activity?", "Who performed elisa and flow cytometry?", "Where was confocal microscopy used?", "When was the mtt assay conducted?", "Which antigen-binding activity was verified?"], "answers_src": ["elisa and flow cytometry", "elisa and flow cytometry", "confocal microscopy", "mtt assay", "immunotoxin ( scfv2a9-pe or ape )"], "answers_bt": ["elys and flow cytometry", "No Answer", "To observe its cellular localization and intracellular distribution", "To measure cytotoxicity", "The immunotoxin antigen-binding activity"], "multiturn": {"turn_1": [{"question_id": "138.1", "question": "What was used to verify the immunotoxin antigen-binding activity?", "answer_src": "elisa and flow cytometry", "follow_up_question": "What specific type of immunotoxin was verified using ELISA and flow cytometry?", "follow_up_response": "immunotoxin (scfv2a9-pe or ape)", "follow_up_response_bt": "scfv2a9-pe or ape"}, {"question_id": "138.2", "question": "Who performed elisa and flow cytometry?", "answer_src": "elisa and flow cytometry", "follow_up_question": "What type of assay was used to measure cytotoxicity?", "follow_up_response": "mtt assay", "follow_up_response_bt": "MTT assay"}, {"question_id": "138.3", "question": "Where was confocal microscopy used?", "answer_src": "confocal microscopy", "follow_up_question": "What specific property of the immunotoxin was observed using confocal microscopy?", "follow_up_response": "Its cellular localization", "follow_up_response_bt": "Its cellular localization and intracellular distribution"}, {"question_id": "138.4", "question": "When was the mtt assay conducted?", "answer_src": "mtt assay", "follow_up_question": "What type of assay was used to measure cytotoxicity?", "follow_up_response": "mtt assay", "follow_up_response_bt": "MTT assay"}, {"question_id": "138.5", "question": "Which antigen-binding activity was verified?", "answer_src": "immunotoxin ( scfv2a9-pe or ape )", "follow_up_question": "What type of assay was used to measure cytotoxicity?", "follow_up_response": "mtt assay", "follow_up_response_bt": "MTT assay"}], "turn_2": [{"question_id": "138.6", "question": "What specific type of immunotoxin was verified using ELISA and flow cytometry?", "answer_src": "immunotoxin (scfv2a9-pe or ape)", "follow_up_question": "What was the purpose of performing the MTT assay?", "follow_up_response": "To measure cytotoxicity", "follow_up_response_bt": "To measure cytotoxicity"}, {"question_id": "138.7", "question": "What type of assay was used to measure cytotoxicity?", "answer_src": "mtt assay", "follow_up_question": "What cell type was the cytotoxicity assay conducted on?", "follow_up_response": "epcam", "follow_up_response_bt": "immune cell epcam"}, {"question_id": "138.8", "question": "What specific property of the immunotoxin was observed using confocal microscopy?", "answer_src": "Its cellular localization", "follow_up_question": "What cellular structures were found to express the antigen bound by the immunotoxin?", "follow_up_response": "epcam", "follow_up_response_bt": "epcam"}, {"question_id": "138.9", "question": "What type of assay was used to measure cytotoxicity?", "answer_src": "mtt assay", "follow_up_question": "What cell type was the cytotoxicity assay conducted on?", "follow_up_response": "epcam", "follow_up_response_bt": "immune cell epcam"}, {"question_id": "138.10", "question": "What type of assay was used to measure cytotoxicity?", "answer_src": "mtt assay", "follow_up_question": "What cell type was the cytotoxicity assay conducted on?", "follow_up_response": "epcam", "follow_up_response_bt": "immune cell epcam"}], "turn_3": [{"question_id": "138.11", "question": "What was the purpose of performing the MTT assay?", "answer_src": "To measure cytotoxicity", "follow_up_question": "How was the cytotoxicity measured?", "follow_up_response": "by mtt assay", "follow_up_response_bt": "With the MTT assay."}, {"question_id": "138.12", "question": "What cell type was the cytotoxicity assay conducted on?", "answer_src": "epcam", "follow_up_question": "What method was used to observe the cellular localization of the immunotoxin?", "follow_up_response": "confocal microscopy", "follow_up_response_bt": "Confocal microscopy"}, {"question_id": "138.13", "question": "What cellular structures were found to express the antigen bound by the immunotoxin?", "answer_src": "epcam", "follow_up_question": "What specific type of cells were targeted by the immunotoxin in the study?", "follow_up_response": "epcam", "follow_up_response_bt": "immune cell epcam"}, {"question_id": "138.14", "question": "What cell type was the cytotoxicity assay conducted on?", "answer_src": "epcam", "follow_up_question": "What method was used to observe the cellular localization of the immunotoxin?", "follow_up_response": "confocal microscopy", "follow_up_response_bt": "Confocal microscopy"}, {"question_id": "138.15", "question": "What cell type was the cytotoxicity assay conducted on?", "answer_src": "epcam", "follow_up_question": "What method was used to observe the cellular localization of the immunotoxin?", "follow_up_response": "confocal microscopy", "follow_up_response_bt": "Confocal microscopy"}]}}
{"id": 139, "src": "lack of hybridization to consensus- and variant - oligos indicates a new allele . detection of unknown variants in heterozygous samples depends upon fluorimetric analysis of signal intensity based on the principle that homozygous samples generate twice the amount of signal . this method can identify unknown snp in heterozygous conditions with a sensitivity of 82% and specificity of 90% .", "mt": "La rilevazione di varianti sconosciute nei campioni eterogeni dipende dall'analisi fluorimetrica dell'intensità del segnale basata sul principio che i campioni omosigoti generano il doppio della quantità del segnale . Questo metodo può identificare snp sconosciuta in condizioni eterogeni con una sensibilità dell'82% e una specificità del 90% .", "pert_mt": "La rilevazione di varianti sconosciute nei campioni eterogeni dipende dall'analisi fluorimetrica dell'intensità del segnale basata sul principio che i campioni omosigoti generano il doppio della quantità del segnale. Questo metodo può identificare SNP sconosciuti in condizioni eterogeni con una sensibilità dell'82% e una specificità del 90%.", "bt": "The detection of unknown variants in heterogeneous samples depends on a fluorimetric analysis of signal intensity based on the principle that homosigotide samples generate twice the amount of signal.This method can identify unknown SNPs under heterogeneous conditions with a sensitivity of 82% and a specificity of 90%.", "questions_src": ["What does the lack of hybridization to consensus- and variant - oligos indicate?", "Who generates twice the amount of signal in homozygous samples?", "Where is fluorimetric analysis based?", "When does detection of unknown variants depend upon?", "Which method has a sensitivity of 82% and specificity of 90%?"], "answers_src": ["A new allele", "Homozygous samples", "Fluorimetric analysis", "Detection of unknown variants depends upon fluorimetric analysis of signal intensity", "This method"], "answers_bt": ["No Answer", "homosigotide samples", "fluorimetric analysis", "The detection of unknown variants in heterogeneous samples depends on a fluorimetric analysis of signal intensity based on the principle that homosigotide samples generate twice the amount of signal.", "The method"], "multiturn": {"turn_1": [{"question_id": "139.1", "question": "What does the lack of hybridization to consensus- and variant - oligos indicate?", "answer_src": "A new allele", "follow_up_question": "What percentage of SNP identifications in heterozygous conditions is this method considered sensitive for?", "follow_up_response": "82", "follow_up_response_bt": "82"}, {"question_id": "139.2", "question": "Who generates twice the amount of signal in homozygous samples?", "answer_src": "Homozygous samples", "follow_up_question": "What is the sensitivity of identifying unknown SNPs in heterozygous conditions using this method?", "follow_up_response": "82%", "follow_up_response_bt": "82%"}, {"question_id": "139.3", "question": "Where is fluorimetric analysis based?", "answer_src": "Fluorimetric analysis", "follow_up_question": "What principle does fluorimetric analysis rely on for detecting unknown SNPs?", "follow_up_response": "the principle that homozygous samples generate twice the amount of signal", "follow_up_response_bt": "The principle that homosigotide samples generate twice the amount of signal"}, {"question_id": "139.4", "question": "When does detection of unknown variants depend upon?", "answer_src": "Detection of unknown variants depends upon fluorimetric analysis of signal intensity", "follow_up_question": "What is the principle used by the fluorimetric analysis?", "follow_up_response": "Fluorimetric analysis of signal intensity based on the principle that homozygous samples generate twice the amount of signal.", "follow_up_response_bt": "The principle that homosigotide samples generate twice the amount of signal"}, {"question_id": "139.5", "question": "Which method has a sensitivity of 82% and specificity of 90%?", "answer_src": "This method", "follow_up_question": "What type of samples does this method identify unknown SNPs in?", "follow_up_response": "heterozygous conditions", "follow_up_response_bt": "heterogeneous samples"}], "turn_2": [{"question_id": "139.6", "question": "What percentage of SNP identifications in heterozygous conditions is this method considered sensitive for?", "answer_src": "82", "follow_up_question": "What is the specificity of this method for identifying SNP in heterozygous conditions?", "follow_up_response": "90%", "follow_up_response_bt": "90%"}, {"question_id": "139.7", "question": "What is the sensitivity of identifying unknown SNPs in heterozygous conditions using this method?", "answer_src": "82%", "follow_up_question": "What is the specificity of identifying unknown SNPs in heterozygous conditions using this method?", "follow_up_response": "90%", "follow_up_response_bt": "90%"}, {"question_id": "139.8", "question": "What principle does fluorimetric analysis rely on for detecting unknown SNPs?", "answer_src": "the principle that homozygous samples generate twice the amount of signal", "follow_up_question": "How does the sensitivity of the method compare to its specificity?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "139.9", "question": "What is the principle used by the fluorimetric analysis?", "answer_src": "Fluorimetric analysis of signal intensity based on the principle that homozygous samples generate twice the amount of signal.", "follow_up_question": "What is the sensitivity of identifying unknown SNPs in heterozygous conditions?", "follow_up_response": "82%", "follow_up_response_bt": "82%"}, {"question_id": "139.10", "question": "What type of samples does this method identify unknown SNPs in?", "answer_src": "heterozygous conditions", "follow_up_question": "What is the sensitivity of identifying unknown SNPs in heterozygous conditions?", "follow_up_response": "82%", "follow_up_response_bt": "82%"}], "turn_3": [{"question_id": "139.11", "question": "What is the specificity of this method for identifying SNP in heterozygous conditions?", "answer_src": "90%", "follow_up_question": "What is the sensitivity of this method for identifying SNP in heterozygous conditions?", "follow_up_response": "82%", "follow_up_response_bt": "82%"}, {"question_id": "139.12", "question": "What is the specificity of identifying unknown SNPs in heterozygous conditions using this method?", "answer_src": "90%", "follow_up_question": "What is the sensitivity of identifying unknown SNPs in heterozygous conditions using this method?", "follow_up_response": "82%", "follow_up_response_bt": "82%"}, {"question_id": "139.13", "question": "How does the sensitivity of the method compare to its specificity?", "answer_src": "lack of hybridization to consensus- and variant - oligos indicates a new allele . detection of unknown variants in heterozygous samples depends upon fluorimetric analysis of signal intensity based on the principle that homozygous samples generate twice the amount of signal . this method can identify unknown snp in heterozygous conditions with a sensitivity of 82% and specificity of 90% .", "follow_up_question": "What is the difference between the sensitivity and specificity of the method?", "follow_up_response": "18%", "follow_up_response_bt": "No Answer"}, {"question_id": "139.14", "question": "What is the sensitivity of identifying unknown SNPs in heterozygous conditions?", "answer_src": "82%", "follow_up_question": "What is the specificity of identifying unknown SNPs in heterozygous conditions?", "follow_up_response": "90%", "follow_up_response_bt": "90%"}, {"question_id": "139.15", "question": "What is the sensitivity of identifying unknown SNPs in heterozygous conditions?", "answer_src": "82%", "follow_up_question": "What is the specificity of identifying unknown SNPs in heterozygous conditions?", "follow_up_response": "90%", "follow_up_response_bt": "90%"}]}}
{"id": 140, "src": "american trypanosomiasis or chagas disease is a debilitating disease representing an important social problem that affects , approximately , 10 million people in the world . the main aggravating factor of this situation is the lack of an effective drug to treat the different stages of this disease . in this context , the search for trypanocidal substances isolated from plants , synthetic or semi synthetic molecules , is an important strategy .", "mt": "La trypanosomiasi o malattia di Chagas è una malattia debilitante americana che rappresenta un importante problema sociale che colpisce circa 10 milioni di persone nel mondo . Il principale fattore aggravante di questa situazione è la mancanza di un farmaco efficace per trattare le diverse fasi di questa malattia . In questo contesto , la ricerca di sostanze trypanocidali isolate dalle piante , molecole sintetiche o semisintetiche , è una strategia importante .", "pert_mt": "La trypanosomiasi o malattia di Chagas è una malattia debilitante americana che rappresenta un importante problema sociale che colpisce circa 10 milioni di persone nel mondo. L'uso di farmaci esistenti, il principale fattore aggravante di questa situazione, è la mancanza di un farmaco efficace per trattare le diverse fasi di questa malattia. In questo contesto, la ricerca di sostanze trypanocidali isolate dalle piante, molecole sintetiche o semisintetiche, è una strategia importante.", "bt": "Trypanosomiasis or Chagas disease is a debilitating American disease that represents a major social problem affecting about 10 million people worldwide.The use of existing drugs, the main aggravating factor of this situation, is the lack of an effective drug to treat the various stages of this disease.In this context, the search for trypanocidal substances isolated from plants, synthetic or semisynthetic molecules, is an important strategy.", "questions_src": ["What is the name of the disease described in the sentence?", "Who is affected by American trypanosomiasis according to the sentence?", "Where can the disease be found based on the information provided?", "When might treatment for the disease become more effective with the discovery of new substances?", "Which type of substances is being researched as potential treatments for the disease?"], "answers_src": ["American trypanosomiasis or chagas disease", "approximately 10 million people in the world", "the world", "not specified, but it implies when new substances are discovered", "trypanocidal substances isolated from plants, synthetic or semi synthetic molecules"], "answers_bt": ["Trypanosomiasis or Chagas disease", "about 10 million people worldwide", "worldwide", "with the discovery of new substances", "trypanocidal substances isolated from plants, synthetic or semisynthetic molecules"], "multiturn": {"turn_1": [{"question_id": "140.1", "question": "What is the name of the disease described in the sentence?", "answer_src": "American trypanosomiasis or chagas disease", "follow_up_question": "What percentage of the world's population does American trypanosomiasis or chagas disease affect?", "follow_up_response": "approximately 10 million people", "follow_up_response_bt": "About 10 million people"}, {"question_id": "140.2", "question": "Who is affected by American trypanosomiasis according to the sentence?", "answer_src": "approximately 10 million people in the world", "follow_up_question": "What percentage does the previous sentence indicate as affected by American trypanosomiasis?", "follow_up_response": "\"10%\",", "follow_up_response_bt": "10 million"}, {"question_id": "140.3", "question": "Where can the disease be found based on the information provided?", "answer_src": "the world", "follow_up_question": "What percentage of the world's population does it affect?", "follow_up_response": "approximately 10 million people", "follow_up_response_bt": "About 10 million people"}, {"question_id": "140.4", "question": "When might treatment for the disease become more effective with the discovery of new substances?", "answer_src": "not specified, but it implies when new substances are discovered", "follow_up_question": "What type of substances is the search focusing on for trypanocidal effects?", "follow_up_response": "Plants, synthetic or semi-synthetic molecules", "follow_up_response_bt": "Plants, synthetic or semisynthetic molecules"}, {"question_id": "140.5", "question": "Which type of substances is being researched as potential treatments for the disease?", "answer_src": "trypanocidal substances isolated from plants, synthetic or semi synthetic molecules", "follow_up_question": "What percentage of the affected population is estimated to have the disease?", "follow_up_response": "approximately 10 million people", "follow_up_response_bt": "About 10 million people"}], "turn_2": [{"question_id": "140.6", "question": "What percentage of the world's population does American trypanosomiasis or chagas disease affect?", "answer_src": "approximately 10 million people", "follow_up_question": "How many countries are affected by American trypanosomiasis or chagas disease according to the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "140.7", "question": "What percentage does the previous sentence indicate as affected by American trypanosomiasis?", "answer_src": "\"10%\",", "follow_up_question": "What specific stage of the disease is the lack of an effective drug to treat mentioned in the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "various stages"}, {"question_id": "140.8", "question": "What percentage of the world's population does it affect?", "answer_src": "approximately 10 million people", "follow_up_question": "How many countries are affected by american trypanosomiasis?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "140.9", "question": "What type of substances is the search focusing on for trypanocidal effects?", "answer_src": "Plants, synthetic or semi-synthetic molecules", "follow_up_question": "What percentage of the affected population lives in Latin America?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "140.10", "question": "What percentage of the affected population is estimated to have the disease?", "answer_src": "approximately 10 million people", "follow_up_question": "How many people does the estimated 10 million represent as a proportion of the global population?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "140.11", "question": "How many countries are affected by American trypanosomiasis or chagas disease according to the text?", "answer_src": "american trypanosomiasis or chagas disease is a debilitating disease representing an important social problem that affects , approximately , 10 million people in the world . the main aggravating factor of this situation is the lack of an effective drug to treat the different stages of this disease . in this context , the search for trypanocidal substances isolated from plants , synthetic or semi synthetic molecules , is an important strategy .", "follow_up_question": "What is the main aggravating factor mentioned in the text for the situation affecting people with American trypanosomiasis or chagas disease?", "follow_up_response": "the lack of an effective drug to treat the different stages of this disease", "follow_up_response_bt": "The lack of an effective drug to treat the various stages of this disease"}, {"question_id": "140.12", "question": "What specific stage of the disease is the lack of an effective drug to treat mentioned in the text?", "answer_src": "american trypanosomiasis or chagas disease is a debilitating disease representing an important social problem that affects , approximately , 10 million people in the world . the main aggravating factor of this situation is the lack of an effective drug to treat the different stages of this disease . in this context , the search for trypanocidal substances isolated from plants , synthetic or semi synthetic molecules , is an important strategy .", "follow_up_question": "What type of substances is the text suggesting as a potential solution for treating american trypanosomiasis?", "follow_up_response": "trypanocidal substances isolated from plants, synthetic or semi synthetic molecules", "follow_up_response_bt": "trypanocidal substances"}, {"question_id": "140.13", "question": "How many countries are affected by american trypanosomiasis?", "answer_src": "american trypanosomiasis or chagas disease is a debilitating disease representing an important social problem that affects , approximately , 10 million people in the world . the main aggravating factor of this situation is the lack of an effective drug to treat the different stages of this disease . in this context , the search for trypanocidal substances isolated from plants , synthetic or semi synthetic molecules , is an important strategy .", "follow_up_question": "How many different stages of chagas disease are mentioned as needing treatment?", "follow_up_response": "different stages", "follow_up_response_bt": "No Answer"}, {"question_id": "140.14", "question": "What percentage of the affected population lives in Latin America?", "answer_src": "american trypanosomiasis or chagas disease is a debilitating disease representing an important social problem that affects , approximately , 10 million people in the world . the main aggravating factor of this situation is the lack of an effective drug to treat the different stages of this disease . in this context , the search for trypanocidal substances isolated from plants , synthetic or semi synthetic molecules , is an important strategy .", "follow_up_question": "What is the main aggravating factor of the situation affecting the affected population?", "follow_up_response": "the lack of an effective drug to treat the different stages of this disease", "follow_up_response_bt": "The lack of an effective drug to treat the various stages of this disease"}, {"question_id": "140.15", "question": "How many people does the estimated 10 million represent as a proportion of the global population?", "answer_src": "american trypanosomiasis or chagas disease is a debilitating disease representing an important social problem that affects , approximately , 10 million people in the world . the main aggravating factor of this situation is the lack of an effective drug to treat the different stages of this disease . in this context , the search for trypanocidal substances isolated from plants , synthetic or semi synthetic molecules , is an important strategy .", "follow_up_question": "What percentage of these 10 million people are affected by the different stages of chagas disease?", "follow_up_response": "10%\", \"No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 141, "src": "of the 168 participants , 31.0% were classified as normal weight ( bmi = 18.524.9 kg / m2 ) , 36.3% were classified as overweight ( bmi = 25.029.9 kg / m2 ) , and 32.7% were classified as obese , classes i and ii ( bmi = 3039.9 kg / m2 ) . there were no significant differences among bmi groups on t25fw and 6mw , cw , spatiotemporal gait parameters , msws-12 , or daily step and movement counts . the prevalence of overweight and obesity in this sample was almost 70% , but there was not a consistent nor significant impact of bmi on outcomes of mobility .", "mt": "Dei 168 partecipanti , il 31,0% è stato classificato come peso normale (bmi = 18,524.9 kg / m2), il 36,3% è stato classificato come sovrappeso (bmi = 25,029.9 kg / m2), e il 32,7% è stato classificato come obeso , classi i e ii (bmi = 3039.9 kg / m2). Non ci sono state differenze significative tra i gruppi bmi sui parametri di t25fw e 6mw , cw , parametri di camminata spaziotemporale , msws-12 o conteggi giornalieri . La prevalenza di sovrappeso e obesità in questo campione è stata di quasi il 70% , ma non c'è stato un impatto coerente né significativo di bmi sui risultati della mobilità .", "pert_mt": "Dei 168 partecipanti, il 31,0% è stato classificato come peso normale (bmi = 18,524.9 kg / m2), il 36,3% è stato classificato come sovrappeso (bmi = 25,029.9 kg / m2), e il 32,7% è stato classificato come obeso, classi I e II (bmi = 3039.9 kg / m2). Non ci sono state differenze significative tra i gruppi bmi sui parametri di t25fw e 6mw, cw, parametri di camminata spaziotemporale, msws-12 o conteggi giornalieri. La prevalenza di sovrappeso e obesità in questo campione è stata di quasi il 70%, ma non c", "bt": "Among 168 participants, 31.0% were classified as normal weight (bmi = 18.524.9 kg / m2), 36.3% were classified as overweight (bmi = 25.029.9 kg / m2), and 32.7% were classified as obese, class I and II (bmi = 3039.9 kg / m2).There were no significant differences between the groups of bmi based on the parameters of t25fw and 6mw, cw, parameters of spaziotemporal walking, msws-12 or daily counts.The prevalence of obesity and obesity in this sample was almost 70%, but not c", "questions_src": ["What percentage of participants were classified as normal weight?", "What range of BMI defines overweight?", "What range of BMI defines obesity?", "How many participants had a BMI between 25.0 and 29.9?", "What is the name of the questionnaire that measured mobility outcomes?"], "answers_src": ["31.0%", "25.0 - 29.9 kg/m²", "30.0 - 39.9 kg/m²", "No Answer", "MSWS-12"], "answers_bt": ["31.0%", "25.0 - 29.9 kg/m²", "30 - 39.9 kg/m²", "No Answer", "6MWT"], "multiturn": {"turn_1": [{"question_id": "141.1", "question": "What percentage of participants were classified as normal weight?", "answer_src": "31.0%", "follow_up_question": "What was the combined percentage of participants classified as overweight or obese?", "follow_up_response": "70.0%", "follow_up_response_bt": "68.7"}, {"question_id": "141.2", "question": "What range of BMI defines overweight?", "answer_src": "25.0 - 29.9 kg/m²", "follow_up_question": "What is the range of BMI that defines obesity in this study?", "follow_up_response": "30-39.9 kg/m²", "follow_up_response_bt": "30–39.9 kg / m2"}, {"question_id": "141.3", "question": "What range of BMI defines obesity?", "answer_src": "30.0 - 39.9 kg/m²", "follow_up_question": "What percentage of participants had a BMI within the obesity range?", "follow_up_response": "32.7%", "follow_up_response_bt": "32.7%"}, {"question_id": "141.4", "question": "How many participants had a BMI between 25.0 and 29.9?", "answer_src": "of the 168 participants , 31.0% were classified as normal weight ( bmi = 18.524.9 kg / m2 ) , 36.3% were classified as overweight ( bmi = 25.029.9 kg / m2 ) , and 32.7% were classified as obese , classes i and ii ( bmi = 3039.9 kg / m2 ) . there were no significant differences among bmi groups on t25fw and 6mw , cw , spatiotemporal gait parameters , msws-12 , or daily step and movement counts . the prevalence of overweight and obesity in this sample was almost 70% , but there was not a consistent nor significant impact of bmi on outcomes of mobility .", "follow_up_question": "How many participants were classified as obese?", "follow_up_response": "32.7%", "follow_up_response_bt": "32.7"}, {"question_id": "141.5", "question": "What is the name of the questionnaire that measured mobility outcomes?", "answer_src": "MSWS-12", "follow_up_question": "What percentage of participants had a BMI classification of obesity (classes i and ii)?", "follow_up_response": "32.7%", "follow_up_response_bt": "32.7%"}], "turn_2": [{"question_id": "141.6", "question": "What was the combined percentage of participants classified as overweight or obese?", "answer_src": "70.0%", "follow_up_question": "What was the average BMI range for the participants classified as overweight?", "follow_up_response": "25.0 - 29.9 kg / m2", "follow_up_response_bt": "25.0 - 29.9 kg / m2"}, {"question_id": "141.7", "question": "What is the range of BMI that defines obesity in this study?", "answer_src": "30-39.9 kg/m²", "follow_up_question": "What percentage of participants had a BMI within the obesity range defined in the study?", "follow_up_response": "32.7%", "follow_up_response_bt": "32.7%"}, {"question_id": "141.8", "question": "What percentage of participants had a BMI within the obesity range?", "answer_src": "32.7%", "follow_up_question": "What was the total percentage of participants classified as overweight or obese?", "follow_up_response": "70.0%", "follow_up_response_bt": "68.7"}, {"question_id": "141.9", "question": "How many participants were classified as obese?", "answer_src": "32.7%", "follow_up_question": "What percentage of participants had a BMI between 30 and 39.9 kg/m²?", "follow_up_response": "32.7%", "follow_up_response_bt": "32.7%"}, {"question_id": "141.10", "question": "What percentage of participants had a BMI classification of obesity (classes i and ii)?", "answer_src": "32.7%", "follow_up_question": "What was the total percentage of participants classified as normal weight or overweight?", "follow_up_response": "67.3", "follow_up_response_bt": "67.3"}], "turn_3": [{"question_id": "141.11", "question": "What was the average BMI range for the participants classified as overweight?", "answer_src": "25.0 - 29.9 kg / m2", "follow_up_question": "What was the average BMI range for the participants classified as obese?", "follow_up_response": "30-39.9 kg / m2", "follow_up_response_bt": "bmi = 3039.9 kg / m2"}, {"question_id": "141.12", "question": "What percentage of participants had a BMI within the obesity range defined in the study?", "answer_src": "32.7%", "follow_up_question": "What was the total percentage of participants classified as overweight or obese according to the study?", "follow_up_response": "70.0%", "follow_up_response_bt": "32.7%"}, {"question_id": "141.13", "question": "What was the total percentage of participants classified as overweight or obese?", "answer_src": "70.0%", "follow_up_question": "What was the average BMI range for the participants classified as overweight?", "follow_up_response": "25.0 - 29.9 kg / m2", "follow_up_response_bt": "25.0 - 29.9 kg / m2"}, {"question_id": "141.14", "question": "What percentage of participants had a BMI between 30 and 39.9 kg/m²?", "answer_src": "32.7%", "follow_up_question": "What was the average BMI range for the participants classified as obese?", "follow_up_response": "30-39.9 kg / m2", "follow_up_response_bt": "bmi = 3039.9 kg / m2"}, {"question_id": "141.15", "question": "What was the total percentage of participants classified as normal weight or overweight?", "answer_src": "67.3", "follow_up_question": "What was the combined percentage of participants classified as overweight or obese?", "follow_up_response": "70.0%", "follow_up_response_bt": "68.7"}]}}
{"id": 142, "src": "triatoma brasiliensis sensu lato ( s.l . ) , the main vector of chagas disease in northeastern brazil , is a species complex comprising four species , one with two subspecies ( t. brasiliensis brasiliensis , t. brasiliensis macromelasoma , t. juazeirensis , t. sherlocki , and t. melanica ) , and each taxon displaying distinct ecological requirements . in order to evaluate the genetic relationships among nine t. brasiliensis s.l .", "mt": "Triatoma brasiliensis sensu lato (s.l. ) , il principale vettore della malattia di Chagas nel nord-est del Brasile , è un complesso di specie composto da quattro specie , una con due sottospecie (t. brasiliensis brasiliensis , t. brasiliensis macromelasoma , t. juazeirensis , t. sherlocki e t. melanica) e ciascun taxone con requisiti ecologici distinti .", "pert_mt": "Triatoma brasiliensis sensu lato (s.l. ), il principale vettore della malattia di Chagas nel nord-est del Brasile, è un complesso di specie composto da quattro specie, una con due sottospecie (t. brasiliensis brasiliensis, t. brasiliensis macromelasoma, t. juazeirensis, t. sherlocki e t. melanica), e ciascun taxone con requisiti ecologici distinti e distribuzione geografica specifica.", "bt": "Triatoma brasiliensis sensu lato (s.l. ), the main vector of Chagas disease in northeastern Brazil, is a species complex composed of four species, one with two subspecies (t. brasiliensis brasiliensis, t. brasiliensis macromelasoma, t. juazeirensis, t. sherlocki and t. melanica), and each taxon with distinct ecological requirements and specific geographical distribution.", "questions_src": ["What is the main vector of Chagas disease in northeastern Brazil?", "Which species is part of the T. brasiliensis sensu lato species complex?", "Where does T. brasiliensis brasiliensis live?", "When was the genetic evaluation of T. brasiliensis s.l. conducted?", "Which subspecies of T. brasiliensis are there?"], "answers_src": ["Triatoma brasiliensis sensu lato", "T. brasiliensis brasiliensis, T. brasiliensis macromelasoma, T. juazeirensis, T. sherlocki, and T. melanica", "No Answer", "No Answer", "Two"], "answers_bt": ["[\"Triatoma brasiliensis sensu lato (s.l.)\"], [\"T. brasiliensis brasiliensis, t. brasiliensis macromelasoma, t. juazeirensis, t. sherlocki and t. melanica\"], [\"Northeastern Brazil\"], [\"No Answer\"], [\"T. brasiliensis brasiliensis, t. brasiliensis macromelasoma\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "142.1", "question": "What is the main vector of Chagas disease in northeastern Brazil?", "answer_src": "Triatoma brasiliensis sensu lato", "follow_up_question": "What other species are included in the species complex of Triatoma brasiliensis sensu lato?", "follow_up_response": "t. brasiliensis brasiliensis, t. brasiliensis macromelasoma, t. juazeirensis, t. sherlocki, and t. melanica", "follow_up_response_bt": "t. brasiliensis brasiliensis, t. brasiliensis macromelasoma, t. juazeirensis, t. sherlocki and t. melanica"}, {"question_id": "142.2", "question": "Which species is part of the T. brasiliensis sensu lato species complex?", "answer_src": "T. brasiliensis brasiliensis, T. brasiliensis macromelasoma, T. juazeirensis, T. sherlocki, and T. melanica", "follow_up_question": "What are the distinct ecological requirements displayed by each taxon within the T. brasiliensis sensu lato species complex?", "follow_up_response": "Each taxon displays distinct ecological requirements", "follow_up_response_bt": "No Answer"}, {"question_id": "142.3", "question": "Where does T. brasiliensis brasiliensis live?", "answer_src": "triatoma brasiliensis sensu lato ( s.l . ) , the main vector of chagas disease in northeastern brazil , is a species complex comprising four species , one with two subspecies ( t. brasiliensis brasiliensis , t. brasiliensis macromelasoma , t. juazeirensis , t. sherlocki , and t. melanica ) , and each taxon displaying distinct ecological requirements . in order to evaluate the genetic relationships among nine t. brasiliensis s.l .", "follow_up_question": "Where does T. brasiliensis macromelasoma live?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "142.4", "question": "When was the genetic evaluation of T. brasiliensis s.l. conducted?", "answer_src": "triatoma brasiliensis sensu lato ( s.l . ) , the main vector of chagas disease in northeastern brazil , is a species complex comprising four species , one with two subspecies ( t. brasiliensis brasiliensis , t. brasiliensis macromelasoma , t. juazeirensis , t. sherlocki , and t. melanica ) , and each taxon displaying distinct ecological requirements . in order to evaluate the genetic relationships among nine t. brasiliensis s.l .", "follow_up_question": "What specific genetic relationships were evaluated among the nine T. brasiliensis s.l.?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "142.5", "question": "Which subspecies of T. brasiliensis are there?", "answer_src": "Two", "follow_up_question": "How many subspecies are there in total within the T. brasiliensis species complex?", "follow_up_response": "2", "follow_up_response_bt": "2"}], "turn_2": [{"question_id": "142.6", "question": "What other species are included in the species complex of Triatoma brasiliensis sensu lato?", "answer_src": "t. brasiliensis brasiliensis, t. brasiliensis macromelasoma, t. juazeirensis, t. sherlocki, and t. melanica", "follow_up_question": "What are the distinct ecological requirements displayed by each taxon within the species complex?", "follow_up_response": "Distinct ecological requirements", "follow_up_response_bt": "No Answer"}, {"question_id": "142.7", "question": "What are the distinct ecological requirements displayed by each taxon within the T. brasiliensis sensu lato species complex?", "answer_src": "Each taxon displays distinct ecological requirements", "follow_up_question": "How many distinct ecological requirements do the four species within the T. brasiliensis sensu lato species complex display?", "follow_up_response": "4", "follow_up_response_bt": "4"}, {"question_id": "142.8", "question": "Where does T. brasiliensis macromelasoma live?", "answer_src": "triatoma brasiliensis sensu lato ( s.l . ) , the main vector of chagas disease in northeastern brazil , is a species complex comprising four species , one with two subspecies ( t. brasiliensis brasiliensis , t. brasiliensis macromelasoma , t. juazeirensis , t. sherlocki , and t. melanica ) , and each taxon displaying distinct ecological requirements . in order to evaluate the genetic relationships among nine t. brasiliensis s.l .", "follow_up_question": "Where does T. brasiliensis juazeirensis live?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "142.9", "question": "What specific genetic relationships were evaluated among the nine T. brasiliensis s.l.?", "answer_src": "triatoma brasiliensis sensu lato ( s.l . ) , the main vector of chagas disease in northeastern brazil , is a species complex comprising four species , one with two subspecies ( t. brasiliensis brasiliensis , t. brasiliensis macromelasoma , t. juazeirensis , t. sherlocki , and t. melanica ) , and each taxon displaying distinct ecological requirements . in order to evaluate the genetic relationships among nine t. brasiliensis s.l .", "follow_up_question": "What specific nine taxa were evaluated for genetic relationships?", "follow_up_response": "t. brasiliensis brasiliensis\", \"t. brasiliensis macromelasoma\", \"t. juazeirensis\", \"t. sherlocki\", \"t. melanica", "follow_up_response_bt": "t. brasiliensis brasiliensis, t. brasiliensis macromelasoma, t. juazeirensis, t. sherlocki and t. melanica"}, {"question_id": "142.10", "question": "How many subspecies are there in total within the T. brasiliensis species complex?", "answer_src": "2", "follow_up_question": "How many species are included in the T. brasiliensis species complex?", "follow_up_response": "4", "follow_up_response_bt": "4"}], "turn_3": [{"question_id": "142.11", "question": "What are the distinct ecological requirements displayed by each taxon within the species complex?", "answer_src": "Distinct ecological requirements", "follow_up_question": "What specific ecological requirement does t. brasiliensis brasiliensis have?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "142.12", "question": "How many distinct ecological requirements do the four species within the T. brasiliensis sensu lato species complex display?", "answer_src": "4", "follow_up_question": "How many species are included in the T. brasiliensis sensu lato species complex?", "follow_up_response": "4", "follow_up_response_bt": "4"}, {"question_id": "142.13", "question": "Where does T. brasiliensis juazeirensis live?", "answer_src": "triatoma brasiliensis sensu lato ( s.l . ) , the main vector of chagas disease in northeastern brazil , is a species complex comprising four species , one with two subspecies ( t. brasiliensis brasiliensis , t. brasiliensis macromelasoma , t. juazeirensis , t. sherlocki , and t. melanica ) , and each taxon displaying distinct ecological requirements . in order to evaluate the genetic relationships among nine t. brasiliensis s.l .", "follow_up_question": "What are the five other species included in the species complex besides T. brasiliensis juazeirensis?", "follow_up_response": "T. brasiliensis macromelasoma\", \"T. sherlocki\", \"T. melanica", "follow_up_response_bt": "t. brasiliensis brasiliensis\", \"t. brasiliensis macromelasoma\", \"t. sherlocki\", \"t. melanica"}, {"question_id": "142.14", "question": "What specific nine taxa were evaluated for genetic relationships?", "answer_src": "t. brasiliensis brasiliensis\", \"t. brasiliensis macromelasoma\", \"t. juazeirensis\", \"t. sherlocki\", \"t. melanica", "follow_up_question": "Which of the nine taxa evaluated are known vectors of Chagas disease?", "follow_up_response": "triatoma brasiliensis sensu lato (s.l.)", "follow_up_response_bt": "Triatoma brasiliensis sensu lato"}, {"question_id": "142.15", "question": "How many species are included in the T. brasiliensis species complex?", "answer_src": "4", "follow_up_question": "How many subspecies are there within T. brasiliensis brasiliensis?", "follow_up_response": "2", "follow_up_response_bt": "2"}]}}
{"id": 143, "src": "skin - lightening is an aesthetic practice of global concern . by adopting a biopsycho - social approach , we consider the interplay between the biological , psychological and social factors that underpin the circulation and consumption of skin lighteners in south africa . this paper reflects on biological aspects of skin lightening , interpersonal relationships , individual beliefs and expectations about the maintenance of health and well being that informs cosmetic practices .", "mt": "- il bricicolo della pelle è una pratica estetica di preoccupazione globale . adottando un approccio biopsicoso-sociale , consideriamo l'interazione tra i fattori biologici , psicologici e sociali che sostengono la circolazione e il consumo di bricicolanti della pelle in Sudafrica . Questo documento riflette sugli aspetti biologici del bricicolo della pelle , le relazioni interpersonali , le credenze individuali e le aspettative sul mantenimento della salute e del benessere che informano le pratiche cosmetiche .", "pert_mt": "Il bricicolo della pelle è una pratica estetica di preoccupazione globale. Adottando un approccio biopsicoso-sociale, consideriamo l'interazione tra i fattori biologici, psicologici e sociali che sostengono la circolazione e il consumo di bricicolanti della pelle in Sudafrica. Questo documento riflette sugli aspetti biologici del bricicolo della pelle, le relazioni interpersonali, le credenze individuali e le aspettative sul mantenimento della salute e del benessere che informano le pratiche cosmetiche, e come queste pratiche influenzano la salute mentale della popolazione.", "bt": "Skin briqueting is an aesthetic practice of global concern. adopting a biopsycho-social approach, we consider the interaction between biological, psychological and social factors that support the circulation and consumption of skin briqueting in South Africa.This paper reflects on the biological aspects of skin briqueting, interpersonal relationships, individual beliefs and expectations about health and well-being that inform cosmetic practices, and how these practices influence the mental health of the population.", "questions_src": ["What does skin-lightening refer to?", "Who is affected by the practice of skin-lightening globally?", "Where does the paper focus on biological aspects of skin-lightening?", "When did you hear about the biopsychosocial approach to skin-lightening?", "Which factors does the paper explore in relation to skin-lightening in South Africa?"], "answers_src": ["An aesthetic practice", "Global concern", "South Africa", "No Answer", "Biological, psychological, and social"], "answers_bt": ["Skin briqueting", "The population", "South Africa", "No Answer", "Biological, psychological, and social"], "multiturn": {"turn_1": [{"question_id": "143.1", "question": "What does skin-lightening refer to?", "answer_src": "An aesthetic practice", "follow_up_question": "What biological aspects does the paper reflect on?", "follow_up_response": "biological aspects of skin lightening", "follow_up_response_bt": "The biological aspects of skin briqueting"}, {"question_id": "143.2", "question": "Who is affected by the practice of skin-lightening globally?", "answer_src": "Global concern", "follow_up_question": "What biological aspects does the paper reflect on?", "follow_up_response": "biological aspects of skin lightening", "follow_up_response_bt": "The biological aspects of skin briqueting"}, {"question_id": "143.3", "question": "Where does the paper focus on biological aspects of skin-lightening?", "answer_src": "South Africa", "follow_up_question": "What biological aspects of skin-lightening does the paper discuss?", "follow_up_response": "The biological aspects of skin lightening", "follow_up_response_bt": "biological"}, {"question_id": "143.4", "question": "When did you hear about the biopsychosocial approach to skin-lightening?", "answer_src": "skin - lightening is an aesthetic practice of global concern . by adopting a biopsycho - social approach , we consider the interplay between the biological , psychological and social factors that underpin the circulation and consumption of skin lighteners in south africa . this paper reflects on biological aspects of skin lightening , interpersonal relationships , individual beliefs and expectations about the maintenance of health and well being that informs cosmetic practices .", "follow_up_question": "What biological aspects does the paper reflect on?", "follow_up_response": "biological aspects of skin lightening", "follow_up_response_bt": "The biological aspects of skin briqueting"}, {"question_id": "143.5", "question": "Which factors does the paper explore in relation to skin-lightening in South Africa?", "answer_src": "Biological, psychological, and social", "follow_up_question": "How does the paper define \"cosmetic practices\" in the context of skin-lightening?", "follow_up_response": "The maintenance of health and well-being", "follow_up_response_bt": "The biological aspects of skin briqueting, interpersonal relationships, individual beliefs and expectations about health and well-being that inform cosmetic practices"}], "turn_2": [{"question_id": "143.6", "question": "What biological aspects does the paper reflect on?", "answer_src": "biological aspects of skin lightening", "follow_up_question": "What specific biological factors are discussed regarding skin lightening?", "follow_up_response": "biological", "follow_up_response_bt": "No Answer"}, {"question_id": "143.7", "question": "What biological aspects does the paper reflect on?", "answer_src": "biological aspects of skin lightening", "follow_up_question": "What specific biological factors are discussed regarding skin lightening?", "follow_up_response": "biological", "follow_up_response_bt": "No Answer"}, {"question_id": "143.8", "question": "What biological aspects of skin-lightening does the paper discuss?", "answer_src": "The biological aspects of skin lightening", "follow_up_question": "How do individual beliefs and expectations about health and well-being influence cosmetic practices discussed in the paper?", "follow_up_response": "Individual beliefs and expectations about the maintenance of health and well-being", "follow_up_response_bt": "Inform cosmetic practices"}, {"question_id": "143.9", "question": "What biological aspects does the paper reflect on?", "answer_src": "biological aspects of skin lightening", "follow_up_question": "What specific biological factors are discussed regarding skin lightening?", "follow_up_response": "biological", "follow_up_response_bt": "No Answer"}, {"question_id": "143.10", "question": "How does the paper define \"cosmetic practices\" in the context of skin-lightening?", "answer_src": "The maintenance of health and well-being", "follow_up_question": "What specific biological aspect of skin-lightening does the paper focus on?", "follow_up_response": "biological", "follow_up_response_bt": "biological"}], "turn_3": [{"question_id": "143.11", "question": "What specific biological factors are discussed regarding skin lightening?", "answer_src": "biological", "follow_up_question": "What biological aspects of skin lightening are explored in the paper?", "follow_up_response": "The biological aspects of skin lightening", "follow_up_response_bt": "Biological aspects"}, {"question_id": "143.12", "question": "What specific biological factors are discussed regarding skin lightening?", "answer_src": "biological", "follow_up_question": "What biological aspects of skin lightening are explored in the paper?", "follow_up_response": "The biological aspects of skin lightening", "follow_up_response_bt": "Biological aspects"}, {"question_id": "143.13", "question": "How do individual beliefs and expectations about health and well-being influence cosmetic practices discussed in the paper?", "answer_src": "Individual beliefs and expectations about the maintenance of health and well-being", "follow_up_question": "What specific beliefs and expectations are highlighted regarding the maintenance of health and well-being?", "follow_up_response": "individual beliefs and expectations about the maintenance of health and well-being", "follow_up_response_bt": "individual beliefs and expectations about health and well-being"}, {"question_id": "143.14", "question": "What specific biological factors are discussed regarding skin lightening?", "answer_src": "biological", "follow_up_question": "What biological aspects of skin lightening are explored in the paper?", "follow_up_response": "The biological aspects of skin lightening", "follow_up_response_bt": "Biological aspects"}, {"question_id": "143.15", "question": "What specific biological aspect of skin-lightening does the paper focus on?", "answer_src": "biological", "follow_up_question": "What psychological factors does the paper explore in relation to skin-lightening practices?", "follow_up_response": "psychological", "follow_up_response_bt": "Individual beliefs and expectations about health and well-being"}]}}
{"id": 144, "src": "similar codes were grouped into categories , and broader themes were developed from these categories . four themes were identified : social network and relationships ; interactions with agencies ; recognition of role ; and time for oneself . by identifying what affects carers ' quality of life , an appropriate choice can be made when selecting instruments for future carer research .", "mt": "I codici sono stati raggruppati in categorie simili e sono stati sviluppati temi più ampi da queste categorie . Sono stati identificati quattro temi: social network e relazioni; interazioni con le agenzie; riconoscimento del ruolo; e tempo per se stesso . identificando ciò che influenza la qualità della vita dei caregiver , una scelta appropriata può essere fatta quando si selezionano strumenti per la ricerca futura dei caregiver .", "pert_mt": "I codici sono stati raggruppati in categorie simili e sono stati sviluppati temi più ampi da queste categorie. Sono stati identificati quattro temi: social network e relazioni; interazioni con le agenzie; riconoscimento del ruolo; e tempo per se stesso. Identificando ciò che influenza la qualità della vita dei caregiver, una scelta appropriata può essere fatta quando si selezionano strumenti per la ricerca futura dei caregiver, e questo può migliorare significativamente l'efficacia delle interviste.", "bt": "The codes have been grouped into similar categories and broader themes have been developed from these categories.Four themes have been identified: social networking and relationships; interactions with agencies; role recognition; and time for itself.By identifying what influences caregivers' quality of life, an appropriate choice can be made when selecting tools for future caregiver research, and this can significantly improve the effectiveness of interviews.", "questions_src": ["What were four themes identified in the study?", "Who is the primary focus of the identified themes?", "Where was the process of grouping similar codes into categories conducted?", "When can an appropriate choice be made regarding carer research instruments?", "Which aspects of carers' quality of life were affected by the identified themes?"], "answers_src": ["[\"Social network and relationships, interactions with agencies, recognition of role, and time for oneself\"], [\"Carers\"], [\"In the study\"], [\"After identifying what affects carers\" quality of life\"], [\"Social network and relationships, interactions with agencies, recognition of role, and time for oneself\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["Social networking and relationships, interactions with agencies, role recognition, and time for itself", "Caregivers", "In the study", "When an appropriate choice can be made regarding carer research instruments", "Social networking and relationships, interactions with agencies, role recognition, and time for itself"], "multiturn": {"turn_1": [{"question_id": "144.1", "question": "What were four themes identified in the study?", "answer_src": "[\"Social network and relationships, interactions with agencies, recognition of role, and time for oneself\"], [\"Carers\"], [\"In the study\"], [\"After identifying what affects carers\" quality of life\"], [\"Social network and relationships, interactions with agencies, recognition of role, and time for oneself\"]", "follow_up_question": "How many themes were identified in the study?", "follow_up_response": "Four", "follow_up_response_bt": "Four"}, {"question_id": "144.2", "question": "Who is the primary focus of the identified themes?", "answer_src": "similar codes were grouped into categories , and broader themes were developed from these categories . four themes were identified : social network and relationships ; interactions with agencies ; recognition of role ; and time for oneself . by identifying what affects carers ' quality of life , an appropriate choice can be made when selecting instruments for future carer research .", "follow_up_question": "What specific aspects do the identified themes address regarding carers' quality of life?", "follow_up_response": "social network and relationships\", \"interactions with agencies\", \"recognition of role\", \"time for oneself", "follow_up_response_bt": "social networking and relationships\", \"interactions with agencies\", \"role recognition\", \"time for itself"}, {"question_id": "144.3", "question": "Where was the process of grouping similar codes into categories conducted?", "answer_src": "similar codes were grouped into categories , and broader themes were developed from these categories . four themes were identified : social network and relationships ; interactions with agencies ; recognition of role ; and time for oneself . by identifying what affects carers ' quality of life , an appropriate choice can be made when selecting instruments for future carer research .", "follow_up_question": "What specific aspects did the study identify as affecting carers' quality of life?", "follow_up_response": "social network and relationships\", \"interactions with agencies\", \"recognition of role\", \"time for oneself", "follow_up_response_bt": "social networking and relationships\", \"interactions with agencies\", \"role recognition\", \"time for itself"}, {"question_id": "144.4", "question": "When can an appropriate choice be made regarding carer research instruments?", "answer_src": "similar codes were grouped into categories , and broader themes were developed from these categories . four themes were identified : social network and relationships ; interactions with agencies ; recognition of role ; and time for oneself . by identifying what affects carers ' quality of life , an appropriate choice can be made when selecting instruments for future carer research .", "follow_up_question": "What specific aspects of carers' quality of life were identified?", "follow_up_response": "social network and relationships\", \"interactions with agencies\", \"recognition of role\", \"time for oneself", "follow_up_response_bt": "social networking and relationships\", \"interactions with agencies\", \"role recognition\", \"time for itself"}, {"question_id": "144.5", "question": "Which aspects of carers' quality of life were affected by the identified themes?", "answer_src": "similar codes were grouped into categories , and broader themes were developed from these categories . four themes were identified : social network and relationships ; interactions with agencies ; recognition of role ; and time for oneself . by identifying what affects carers ' quality of life , an appropriate choice can be made when selecting instruments for future carer research .", "follow_up_question": "What specific theme relates to interactions with agencies?", "follow_up_response": "interactions with agencies", "follow_up_response_bt": "interactions with agencies"}], "turn_2": [{"question_id": "144.6", "question": "How many themes were identified in the study?", "answer_src": "Four", "follow_up_question": "What specific theme related to interactions with agencies was identified?", "follow_up_response": "interactions with agencies", "follow_up_response_bt": "interactions with agencies"}, {"question_id": "144.7", "question": "What specific aspects do the identified themes address regarding carers' quality of life?", "answer_src": "social network and relationships\", \"interactions with agencies\", \"recognition of role\", \"time for oneself", "follow_up_question": "How many specific aspects did the identified themes address regarding carers' quality of life?", "follow_up_response": "4", "follow_up_response_bt": "4"}, {"question_id": "144.8", "question": "What specific aspects did the study identify as affecting carers' quality of life?", "answer_src": "social network and relationships\", \"interactions with agencies\", \"recognition of role\", \"time for oneself", "follow_up_question": "Which theme was not directly related to interactions with agencies?", "follow_up_response": "Recognition of role\", \"Time for oneself", "follow_up_response_bt": "Role recognition and time for itself"}, {"question_id": "144.9", "question": "What specific aspects of carers' quality of life were identified?", "answer_src": "social network and relationships\", \"interactions with agencies\", \"recognition of role\", \"time for oneself", "follow_up_question": "What instrument is suggested for future carer research based on the identified aspects?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "144.10", "question": "What specific theme relates to interactions with agencies?", "answer_src": "interactions with agencies", "follow_up_question": "What kind of recognition does the third identified theme focus on?", "follow_up_response": "Recognition of role", "follow_up_response_bt": "role recognition"}], "turn_3": [{"question_id": "144.11", "question": "What specific theme related to interactions with agencies was identified?", "answer_src": "interactions with agencies", "follow_up_question": "What kind of recognition did the identified themes focus on?", "follow_up_response": "Recognition of role", "follow_up_response_bt": "role recognition"}, {"question_id": "144.12", "question": "How many specific aspects did the identified themes address regarding carers' quality of life?", "answer_src": "4", "follow_up_question": "What are all four identified themes addressing carers' quality of life?", "follow_up_response": "social network and relationships\", \"interactions with agencies\", \"recognition of role\", \"time for oneself", "follow_up_response_bt": "social networking and relationships\", \"interactions with agencies\", \"role recognition\", \"time for itself"}, {"question_id": "144.13", "question": "Which theme was not directly related to interactions with agencies?", "answer_src": "Recognition of role\", \"Time for oneself", "follow_up_question": "What specific aspects of social network and relationships were identified?", "follow_up_response": "social network and relationships", "follow_up_response_bt": "social networking and relationships"}, {"question_id": "144.14", "question": "What instrument is suggested for future carer research based on the identified aspects?", "answer_src": "similar codes were grouped into categories , and broader themes were developed from these categories . four themes were identified : social network and relationships ; interactions with agencies ; recognition of role ; and time for oneself . by identifying what affects carers ' quality of life , an appropriate choice can be made when selecting instruments for future carer research .", "follow_up_question": "What specific aspect of carers' quality of life does the theme \"time for oneself\" relate to?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "144.15", "question": "What kind of recognition does the third identified theme focus on?", "answer_src": "Recognition of role", "follow_up_question": "What specific aspects of their role do carers recognize according to this theme?", "follow_up_response": "Recognition of role", "follow_up_response_bt": "Role recognition"}]}}
{"id": 145, "src": "pancreatic cell failure leads to diabetes development . during disease progression , cells adapt their secretory capacity to compensate the elevated glycaemia and the peripheral insulin resistance . this compensatory mechanism involves a fine - tuned regulation to modulate the endoplasmic reticulum ( er ) capacity and quality control to prevent unfolded proinsulin accumulation , a major protein synthetized within the cell .", "mt": "Durante la progressione della malattia , le cellule adattano la loro capacità secretoriale per compensare l' elevata glicemia e la resistenza all' insulina periferica . Questo meccanismo compensativo prevede una regolazione fine-tuned per modulare la capacità e il controllo della qualità del reticolo endoplasmico (er) per prevenire l' accumulo di proinsulina , una delle principali proteine sintetizzate all'interno della cellula .", "pert_mt": "Durante la progressione della malattia, le cellule adattano la loro capacità secretoriale per compensare l'elevata glicemia e la resistenza all'insulina periferica e la diminuzione dell'attività enzimatica. Questo meccanismo compensativo prevede una regolazione fine-tuned per modulare la capacità e il controllo della qualità del reticolo endoplasmico (ER) per prevenire l'accumulo di proinsulina, una delle principali proteine sintetizzate all'interno della cellula.", "bt": "During disease progression, cells adapt their secretory capacity to compensate for high blood sugar and peripheral insulin resistance and decreased enzyme activity, and this compensatory mechanism involves fine-tuned regulation to modulate the capacity and quality control of the endoplasmic reticulum (ER) to prevent the buildup of proinsulin, one of the main proteins synthesized within the cell.", "questions_src": ["What does pancreatic cell failure lead to?", "When does disease progression occur in diabetes?", "Where is the major protein synthesized within the cell?", "Which mechanism involves a fine-tuned regulation of the endoplasmic reticulum capacity?", "Which type of insulin resistance is mentioned in the sentence?"], "answers_src": ["Diabetes development", "During disease progression", "Within the cell", "A fine-tuned regulation to modulate the endoplasmic reticulum (er) capacity and quality control", "Peripheral"], "answers_bt": ["Pancreatic cell failure leads to uncontrolled blood sugar levels and insulin resistance", "Disease progression occurs during the adaptation of cells to high blood sugar and peripheral insulin resistance", "Within the cell", "Fine-tuned regulation of the endoplasmic reticulum capacity", "Peripheral insulin resistance"], "multiturn": {"turn_1": [{"question_id": "145.1", "question": "What does pancreatic cell failure lead to?", "answer_src": "Diabetes development", "follow_up_question": "How does the pancreas adapt its secretory capacity during disease progression?", "follow_up_response": "to compensate the elevated glycaemia and the peripheral insulin resistance", "follow_up_response_bt": "To compensate for high blood sugar and peripheral insulin resistance and decreased enzyme activity"}, {"question_id": "145.2", "question": "When does disease progression occur in diabetes?", "answer_src": "During disease progression", "follow_up_question": "What mechanisms do cells use to adapt their secretory capacity during disease progression?", "follow_up_response": "This compensatory mechanism involves a fine - tuned regulation to modulate the endoplasmic reticulum (er) capacity and quality control", "follow_up_response_bt": "This compensatory mechanism involves fine-tuned regulation to modulate the capacity and quality control of the endoplasmic reticulum (ER) to prevent the buildup of proinsulin, one of the main proteins synthesized within the cell."}, {"question_id": "145.3", "question": "Where is the major protein synthesized within the cell?", "answer_src": "Within the cell", "follow_up_question": "What specific process does the cell use to prevent unfolded proinsulin accumulation?", "follow_up_response": "a fine - tuned regulation to modulate the endoplasmic reticulum ( er ) capacity and quality control", "follow_up_response_bt": "fine-tuned regulation to modulate the capacity and quality control of the endoplasmic reticulum (ER)"}, {"question_id": "145.4", "question": "Which mechanism involves a fine-tuned regulation of the endoplasmic reticulum capacity?", "answer_src": "A fine-tuned regulation to modulate the endoplasmic reticulum (er) capacity and quality control", "follow_up_question": "What is the purpose of this fine-tuned regulation?", "follow_up_response": "To prevent unfolded proinsulin accumulation", "follow_up_response_bt": "To prevent the buildup of proinsulin"}, {"question_id": "145.5", "question": "Which type of insulin resistance is mentioned in the sentence?", "answer_src": "Peripheral", "follow_up_question": "How does the pancreas adapt its secretory capacity to compensate for peripheral insulin resistance?", "follow_up_response": "This compensatory mechanism involves a fine-tuned regulation to modulate the endoplasmic reticulum (ER) capacity and quality control to prevent unfolded proinsulin accumulation, a major protein synthesized within the cell.", "follow_up_response_bt": "This compensatory mechanism involves fine-tuned regulation to modulate the capacity and quality control of the endoplasmic reticulum (ER) to prevent the buildup of proinsulin"}], "turn_2": [{"question_id": "145.6", "question": "How does the pancreas adapt its secretory capacity during disease progression?", "answer_src": "to compensate the elevated glycaemia and the peripheral insulin resistance", "follow_up_question": "How does the pancreas regulate endoplasmic reticulum capacity to prevent unfolded proinsulin accumulation?", "follow_up_response": "a fine - tuned regulation", "follow_up_response_bt": "No Answer"}, {"question_id": "145.7", "question": "What mechanisms do cells use to adapt their secretory capacity during disease progression?", "answer_src": "This compensatory mechanism involves a fine - tuned regulation to modulate the endoplasmic reticulum (er) capacity and quality control", "follow_up_question": "How does the endoplasmic reticulum (ER) capacity and quality control specifically help prevent unfolded proinsulin accumulation?", "follow_up_response": "A fine-tuned regulation helps prevent unfolded proinsulin accumulation", "follow_up_response_bt": "Fine-tuned regulation"}, {"question_id": "145.8", "question": "What specific process does the cell use to prevent unfolded proinsulin accumulation?", "answer_src": "a fine - tuned regulation to modulate the endoplasmic reticulum ( er ) capacity and quality control", "follow_up_question": "How does the regulation of endoplasmic reticulum (ER) capacity and quality control specifically prevent unfolded proinsulin accumulation?", "follow_up_response": "A fine-tuned regulation to modulate the endoplasmic reticulum (ER) capacity and quality control", "follow_up_response_bt": "Fine-tuned regulation"}, {"question_id": "145.9", "question": "What is the purpose of this fine-tuned regulation?", "answer_src": "To prevent unfolded proinsulin accumulation", "follow_up_question": "How does preventing unfolded proinsulin accumulation benefit the cells?", "follow_up_response": "Preventing unfolded proinsulin accumulation prevents its major protein synthesis within the cell", "follow_up_response_bt": "Preventing unfolded proinsulin accumulation benefits the cells by allowing fine-tuned regulation to modulate the capacity and quality control of the endoplasmic reticulum (ER)"}, {"question_id": "145.10", "question": "How does the pancreas adapt its secretory capacity to compensate for peripheral insulin resistance?", "answer_src": "This compensatory mechanism involves a fine-tuned regulation to modulate the endoplasmic reticulum (ER) capacity and quality control to prevent unfolded proinsulin accumulation, a major protein synthesized within the cell.", "follow_up_question": "What specific proteins are targeted by the fine-tuned regulation to prevent unfolded proinsulin accumulation?", "follow_up_response": "No Answer", "follow_up_response_bt": "proinsulin"}], "turn_3": [{"question_id": "145.11", "question": "How does the pancreas regulate endoplasmic reticulum capacity to prevent unfolded proinsulin accumulation?", "answer_src": "a fine - tuned regulation", "follow_up_question": "What specific mechanisms are involved in this fine - tuned regulation?", "follow_up_response": "A fine - tuned regulation to modulate the endoplasmic reticulum (er) capacity and quality control", "follow_up_response_bt": "Fine-tuned regulation"}, {"question_id": "145.12", "question": "How does the endoplasmic reticulum (ER) capacity and quality control specifically help prevent unfolded proinsulin accumulation?", "answer_src": "A fine-tuned regulation helps prevent unfolded proinsulin accumulation", "follow_up_question": "What specific mechanisms are involved in this fine-tuned regulation?", "follow_up_response": "A fine - tuned regulation to modulate the endoplasmic reticulum ( er ) capacity and quality control", "follow_up_response_bt": "Fine-tuned regulation"}, {"question_id": "145.13", "question": "How does the regulation of endoplasmic reticulum (ER) capacity and quality control specifically prevent unfolded proinsulin accumulation?", "answer_src": "A fine-tuned regulation to modulate the endoplasmic reticulum (ER) capacity and quality control", "follow_up_question": "What specific mechanisms are involved in modulating the ER capacity?", "follow_up_response": "A fine - tuned regulation", "follow_up_response_bt": "Fine-tuned regulation"}, {"question_id": "145.14", "question": "How does preventing unfolded proinsulin accumulation benefit the cells?", "answer_src": "Preventing unfolded proinsulin accumulation prevents its major protein synthesis within the cell", "follow_up_question": "What specific mechanisms do cells use to regulate the endoplasmic reticulum capacity and quality control?", "follow_up_response": "a fine - tuned regulation", "follow_up_response_bt": "fine-tuned regulation"}, {"question_id": "145.15", "question": "What specific proteins are targeted by the fine-tuned regulation to prevent unfolded proinsulin accumulation?", "answer_src": "pancreatic cell failure leads to diabetes development . during disease progression , cells adapt their secretory capacity to compensate the elevated glycaemia and the peripheral insulin resistance . this compensatory mechanism involves a fine - tuned regulation to modulate the endoplasmic reticulum ( er ) capacity and quality control to prevent unfolded proinsulin accumulation , a major protein synthetized within the cell .", "follow_up_question": "What aspect of endoplasmic reticulum (ER) capacity and quality control is specifically regulated to prevent unfolded proinsulin accumulation?", "follow_up_response": "a fine - tuned regulation", "follow_up_response_bt": "fine-tuned regulation"}]}}
{"id": 146, "src": "mitochondrial genomes often contain large amounts of plastid dna ( ptdna)-derived sequences ( mtpts ) . it has been suggested that the intercompartmental transfer of ptdna is greatly reduced in species with only a single plastid per cell ( monoplastidic ) as compared with those with many plastids per cell ( polyplastidic ) . this hypothesis has not been applied to the movement of dna from plastids to mitochondria .", "mt": "I genomi mitocondriali spesso contengono grandi quantità di sequenze di plastide DNA (ptdna) derivate (mtpts) . è stato suggerito che il trasferimento intercompartimentale di ptdna è notevolmente ridotto nelle specie con solo un singolo plastide per cellula (monoplastidico) rispetto a quelle con molti plastide per cellula (polyplastidico).", "pert_mt": "I genomi mitocondriali spesso contengono grandi quantità di sequenze di plastide DNA (ptdna) derivate (mtpts). È stato suggerito che il trasferimento intercompartimentale di ptdna è notevolmente ridotto nelle specie con solo un singolo plastide per cellula (monoplastidico) rispetto a quelle con molti plastide per cellula (polyplastidico), ma questo non si verifica nel caso delle specie endosimbiotiche.", "bt": "Mitochondrial genomes often contain large quantities of DNA-derived plastids (ptdna) sequences (mtpts).It has been suggested that the intercompartmental transfer of ptdna is significantly reduced in species with only one single plastids per cell (monoplastidical) compared to those with many plastids per cell (polyplastidical), but this does not occur in endosymbiotic species.", "questions_src": ["What does mitochondrial DNA often contain?", "Who suggests that intercompartmental transfer of plastid DNA is reduced?", "Where do these reductions occur?", "When was this hypothesis first suggested?", "Which type of cells have many plastids per cell?"], "answers_src": ["Large amounts of plastid DNA (ptDNA)-derived sequences", "It has been suggested", "In species with only a single plastid per cell and those with many plastids per cell", "This hypothesis has not been applied", "Polyplastidic"], "answers_bt": ["Large quantities of DNA-derived plastids (ptdna) sequences", "It has been suggested", "In species with only one single plastids per cell and polyplastidical", "No Answer", "Polyplastidical"], "multiturn": {"turn_1": [{"question_id": "146.1", "question": "What does mitochondrial DNA often contain?", "answer_src": "Large amounts of plastid DNA (ptDNA)-derived sequences", "follow_up_question": "What specific type of sequences are these plastid DNA-derived sequences?", "follow_up_response": "mtpts", "follow_up_response_bt": "mtpts"}, {"question_id": "146.2", "question": "Who suggests that intercompartmental transfer of plastid DNA is reduced?", "answer_src": "It has been suggested", "follow_up_question": "What evidence supports the reduction in intercompartmental transfer in monoplastidic species?", "follow_up_response": "The intercompartmental transfer of ptdna is greatly reduced in species with only a single plastid per cell (monoplastidic) as compared with those with many plastids per cell (polyplastidic)", "follow_up_response_bt": "It has been suggested that the intercompartmental transfer of ptdna is significantly reduced in species with only one single plastids per cell (monoplastidical) compared to those with many plastids per cell (polyplastidical), but this does not occur in endosymbiotic species."}, {"question_id": "146.3", "question": "Where do these reductions occur?", "answer_src": "In species with only a single plastid per cell and those with many plastids per cell", "follow_up_question": "What is the difference between monoplastidic and polyplastidic species?", "follow_up_response": "Species with only a single plastid per cell (monoplastidic) as compared with those with many plastids per cell (polyplastidic)", "follow_up_response_bt": "Monoplastidic species have only one plastid per cell, while polyplastidic species have many plastids per cell."}, {"question_id": "146.4", "question": "When was this hypothesis first suggested?", "answer_src": "This hypothesis has not been applied", "follow_up_question": "What evidence supports the reduction in intercompartmental transfer in monoplastidic species?", "follow_up_response": "The intercompartmental transfer of ptdna is greatly reduced in species with only a single plastid per cell (monoplastidic) as compared with those with many plastids per cell (polyplastidic)", "follow_up_response_bt": "It has been suggested that the intercompartmental transfer of ptdna is significantly reduced in species with only one single plastids per cell (monoplastidical) compared to those with many plastids per cell (polyplastidical), but this does not occur in endosymbiotic species."}, {"question_id": "146.5", "question": "Which type of cells have many plastids per cell?", "answer_src": "Polyplastidic", "follow_up_question": "What evidence supports the hypothesis that intercompartmental transfer of plastid DNA is greater in polyplastidic cells?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "146.6", "question": "What specific type of sequences are these plastid DNA-derived sequences?", "answer_src": "mtpts", "follow_up_question": "What are the implications of the presence of mtpts in monoplastidic species?", "follow_up_response": "The intercompartmental transfer of ptdna is greatly reduced", "follow_up_response_bt": "The intercompartmental transfer of ptdna is significantly reduced"}, {"question_id": "146.7", "question": "What evidence supports the reduction in intercompartmental transfer in monoplastidic species?", "answer_src": "The intercompartmental transfer of ptdna is greatly reduced in species with only a single plastid per cell (monoplastidic) as compared with those with many plastids per cell (polyplastidic)", "follow_up_question": "How does the presence of multiple plastids in polyplastidic species affect the intercompartmental transfer of ptdna?", "follow_up_response": "It is greatly reduced", "follow_up_response_bt": "Significantly reduced"}, {"question_id": "146.8", "question": "What is the difference between monoplastidic and polyplastidic species?", "answer_src": "Species with only a single plastid per cell (monoplastidic) as compared with those with many plastids per cell (polyplastidic)", "follow_up_question": "How does the presence of multiple plastids affect the intercompartmental transfer of plastid DNA?", "follow_up_response": "It has been suggested that the intercompartmental transfer of ptdna is greatly reduced in species with only a single plastid per cell (monoplastidic) as compared with those with many plastids per cell (polyplastidic)", "follow_up_response_bt": "The intercompartmental transfer of ptdna is significantly reduced in species with only one single plastids per cell (monoplastidical) compared to those with many plastids per cell (polyplastidical)"}, {"question_id": "146.9", "question": "What evidence supports the reduction in intercompartmental transfer in monoplastidic species?", "answer_src": "The intercompartmental transfer of ptdna is greatly reduced in species with only a single plastid per cell (monoplastidic) as compared with those with many plastids per cell (polyplastidic)", "follow_up_question": "How does the presence of multiple plastids in polyplastidic species affect the intercompartmental transfer of ptdna?", "follow_up_response": "It is greatly reduced", "follow_up_response_bt": "Significantly reduced"}, {"question_id": "146.10", "question": "What evidence supports the hypothesis that intercompartmental transfer of plastid DNA is greater in polyplastidic cells?", "answer_src": "mitochondrial genomes often contain large amounts of plastid dna ( ptdna)-derived sequences ( mtpts ) . it has been suggested that the intercompartmental transfer of ptdna is greatly reduced in species with only a single plastid per cell ( monoplastidic ) as compared with those with many plastids per cell ( polyplastidic ) . this hypothesis has not been applied to the movement of dna from plastids to mitochondria .", "follow_up_question": "How does the presence of multiple plastids in cells relate to the presence of mtpts in mitochondrial genomes?", "follow_up_response": "The presence of many plastids per cell reduces the intercompartmental transfer of ptdna, which in turn affects the presence of mtpts in mitochondrial genomes.", "follow_up_response_bt": "The presence of multiple plastids in cells reduces the intercompartmental transfer of ptdna, which in turn affects the presence of mtpts in mitochondrial genomes."}], "turn_3": [{"question_id": "146.11", "question": "What are the implications of the presence of mtpts in monoplastidic species?", "answer_src": "The intercompartmental transfer of ptdna is greatly reduced", "follow_up_question": "How does the reduction in ptdna transfer affect the accumulation of mtpts in monoplastidic species?", "follow_up_response": "It reduces the accumulation of mtpts", "follow_up_response_bt": "Significantly reduced"}, {"question_id": "146.12", "question": "How does the presence of multiple plastids in polyplastidic species affect the intercompartmental transfer of ptdna?", "answer_src": "It is greatly reduced", "follow_up_question": "What evidence supports the reduction in intercompartmental transfer in monoplastidic species?", "follow_up_response": "The intercompartmental transfer of ptdna is greatly reduced in species with only a single plastid per cell (monoplastidic) as compared with those with many plastids per cell (polyplastidic)", "follow_up_response_bt": "It has been suggested that the intercompartmental transfer of ptdna is significantly reduced in species with only one single plastids per cell (monoplastidical) compared to those with many plastids per cell (polyplastidical), but this does not occur in endosymbiotic species."}, {"question_id": "146.13", "question": "How does the presence of multiple plastids affect the intercompartmental transfer of plastid DNA?", "answer_src": "It has been suggested that the intercompartmental transfer of ptdna is greatly reduced in species with only a single plastid per cell (monoplastidic) as compared with those with many plastids per cell (polyplastidic)", "follow_up_question": "What evidence supports the reduction in intercompartmental transfer in monoplastidic species?", "follow_up_response": "The intercompartmental transfer of ptdna is greatly reduced in species with only a single plastid per cell (monoplastidic) as compared with those with many plastids per cell (polyplastidic)", "follow_up_response_bt": "It has been suggested that the intercompartmental transfer of ptdna is significantly reduced in species with only one single plastids per cell (monoplastidical) compared to those with many plastids per cell (polyplastidical), but this does not occur in endosymbiotic species."}, {"question_id": "146.14", "question": "How does the presence of multiple plastids in polyplastidic species affect the intercompartmental transfer of ptdna?", "answer_src": "It is greatly reduced", "follow_up_question": "What evidence supports the reduction in intercompartmental transfer in monoplastidic species?", "follow_up_response": "The intercompartmental transfer of ptdna is greatly reduced in species with only a single plastid per cell (monoplastidic) as compared with those with many plastids per cell (polyplastidic)", "follow_up_response_bt": "It has been suggested that the intercompartmental transfer of ptdna is significantly reduced in species with only one single plastids per cell (monoplastidical) compared to those with many plastids per cell (polyplastidical), but this does not occur in endosymbiotic species."}, {"question_id": "146.15", "question": "How does the presence of multiple plastids in cells relate to the presence of mtpts in mitochondrial genomes?", "answer_src": "The presence of many plastids per cell reduces the intercompartmental transfer of ptdna, which in turn affects the presence of mtpts in mitochondrial genomes.", "follow_up_question": "What evidence supports the hypothesis that monoplastidic species have fewer mtpts than polyplastidic species?", "follow_up_response": "The intercompartmental transfer of ptdna is greatly reduced in species with only a single plastid per cell (monoplastidic) as compared with those with many plastids per cell (polyplastidic)", "follow_up_response_bt": "This does not occur in endosymbiotic species."}]}}
{"id": 147, "src": "many research studies report the healing effects of aloe vera , thyroid hormone cream and silver sulfadiazine . however , the effects of these therapeutic agents are not well understood and have not been compared in one study . this study aimed at investigating the effects of topical application of an aloe vera gel , a thyroid hormone cream and a silver sulfadiazine cream on the healing of skin wounds surgically induced in wistar rats for determining the treatment of choice .", "mt": "Molti studi di ricerca riportano gli effetti curativi dell' aloe vera , della crema ormonale tiroidea e della sulfadiazina d'argento . Tuttavia , gli effetti di questi agenti terapeutici non sono ben compresi e non sono stati confrontati in un solo studio . Questo studio mirava a indagare sugli effetti dell'applicazione topica di un gel di aloe vera , di una crema ormonale tiroidea e di una crema sulfadiazina d'argento sulla guarigione delle ferite cutanee chirurgicamente indotte nei ratti wistar per determinare il trattamento di scelta .", "pert_mt": "Molti studi di ricerca riportano gli effetti curativi dell' aloe vera , della crema ormonale tiroidea e della sulfadiazina d'argento . Tuttavia , gli effetti di questi agenti terapeutici non sono ben compresi e non sono stati confrontati in un solo studio . Questo studio mirava a indagare sugli effetti dell'applicazione topica di un gel di aloe vera , di una crema ormonale tiroidea e di una crema sulfadiazina d'argento sulla guarigione delle ferite cutanee chirurgicamente indotte nei ratti wistar per determinare il trattamento di scelta . Inoltre, i risultati sono stati valutati in termini di riduzione della inflamazione.", "bt": "Many research studies report the healing effects of aloe vera , thyroid hormone cream and silver sulfadiazine , however, the effects of these therapeutic agents are not well understood and have not been compared in a single study this study sought to investigate the effects of topical application of a gel of aloe vera , thyroid hormone cream and silver sulfadiazine cream on the healing of surgically induced skin wounds in the rat wistar to determine the treatment of choice. additionally, the results were evaluated in terms of reducing inflammation.", "questions_src": ["What is the name of the study that investigated the effects of topical application of aloe vera gel, thyroid hormone cream, and silver sulfadiazine cream on skin wounds in rats?", "When were the skin wounds surgically induced in the study?", "Where were the wistar rats used in the study obtained from?", "Which two substances had their healing effects compared in the study?", "Which cream was applied topically to the skin wounds in the study?"], "answers_src": ["[\"This study\"], [\"In rats\"], [\"From a source not specified\"], [\"Aloe vera gel and thyroid hormone cream\"], [\"Silver sulfadiazine cream\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["No Answer", "Surgically induced", "Wistar", "Thyroid hormone cream and silver sulfadiazine", "Aloe vera gel"], "multiturn": {"turn_1": [{"question_id": "147.1", "question": "What is the name of the study that investigated the effects of topical application of aloe vera gel, thyroid hormone cream, and silver sulfadiazine cream on skin wounds in rats?", "answer_src": "[\"This study\"], [\"In rats\"], [\"From a source not specified\"], [\"Aloe vera gel and thyroid hormone cream\"], [\"Silver sulfadiazine cream\"]", "follow_up_question": "What type of skin wounds were surgically induced in the rats for this study?", "follow_up_response": "skin wounds", "follow_up_response_bt": "surgically induced skin wounds"}, {"question_id": "147.2", "question": "When were the skin wounds surgically induced in the study?", "answer_src": "many research studies report the healing effects of aloe vera , thyroid hormone cream and silver sulfadiazine . however , the effects of these therapeutic agents are not well understood and have not been compared in one study . this study aimed at investigating the effects of topical application of an aloe vera gel , a thyroid hormone cream and a silver sulfadiazine cream on the healing of skin wounds surgically induced in wistar rats for determining the treatment of choice .", "follow_up_question": "For how long were the skin wounds surgically induced in the study?", "follow_up_response": "for 7 days", "follow_up_response_bt": "Not specified"}, {"question_id": "147.3", "question": "Where were the wistar rats used in the study obtained from?", "answer_src": "many research studies report the healing effects of aloe vera , thyroid hormone cream and silver sulfadiazine . however , the effects of these therapeutic agents are not well understood and have not been compared in one study . this study aimed at investigating the effects of topical application of an aloe vera gel , a thyroid hormone cream and a silver sulfadiazine cream on the healing of skin wounds surgically induced in wistar rats for determining the treatment of choice .", "follow_up_question": "What type of skin wounds were surgically induced in the wistar rats?", "follow_up_response": "skin wounds", "follow_up_response_bt": "surgically induced skin wounds"}, {"question_id": "147.4", "question": "Which two substances had their healing effects compared in the study?", "answer_src": "many research studies report the healing effects of aloe vera , thyroid hormone cream and silver sulfadiazine . however , the effects of these therapeutic agents are not well understood and have not been compared in one study . this study aimed at investigating the effects of topical application of an aloe vera gel , a thyroid hormone cream and a silver sulfadiazine cream on the healing of skin wounds surgically induced in wistar rats for determining the treatment of choice .", "follow_up_question": "What type of skin wounds were used in the study?", "follow_up_response": "skin wounds surgically induced in wistar rats", "follow_up_response_bt": "surgically induced skin wounds"}, {"question_id": "147.5", "question": "Which cream was applied topically to the skin wounds in the study?", "answer_src": "many research studies report the healing effects of aloe vera , thyroid hormone cream and silver sulfadiazine . however , the effects of these therapeutic agents are not well understood and have not been compared in one study . this study aimed at investigating the effects of topical application of an aloe vera gel , a thyroid hormone cream and a silver sulfadiazine cream on the healing of skin wounds surgically induced in wistar rats for determining the treatment of choice .", "follow_up_question": "What type of cream was applied with the aloe vera gel?", "follow_up_response": "Thyroid hormone cream", "follow_up_response_bt": "Thyroid hormone cream"}], "turn_2": [{"question_id": "147.6", "question": "What type of skin wounds were surgically induced in the rats for this study?", "answer_src": "skin wounds", "follow_up_question": "What was the purpose of comparing the three therapeutic agents?", "follow_up_response": "To investigate the effects of topical application of an aloe vera gel, a thyroid hormone cream, and a silver sulfadiazine cream on the healing of skin wounds surgically induced in Wistar rats", "follow_up_response_bt": "To determine the treatment of choice"}, {"question_id": "147.7", "question": "For how long were the skin wounds surgically induced in the study?", "answer_src": "for 7 days", "follow_up_question": "What type of skin wounds were surgically induced in the study?", "follow_up_response": "skin wounds surgically induced in wistar rats", "follow_up_response_bt": "surgically induced skin wounds"}, {"question_id": "147.8", "question": "What type of skin wounds were surgically induced in the wistar rats?", "answer_src": "skin wounds", "follow_up_question": "What was the purpose of the study regarding the aloe vera gel?", "follow_up_response": "Investigating the effects of topical application of an aloe vera gel", "follow_up_response_bt": "To investigate the effects of topical application of a gel of aloe vera, thyroid hormone cream and silver sulfadiazine cream on the healing of surgically induced skin wounds in the rat wistar"}, {"question_id": "147.9", "question": "What type of skin wounds were used in the study?", "answer_src": "skin wounds surgically induced in wistar rats", "follow_up_question": "What surgical method was used to induce the skin wounds?", "follow_up_response": "surgically", "follow_up_response_bt": "surgically induced"}, {"question_id": "147.10", "question": "What type of cream was applied with the aloe vera gel?", "answer_src": "Thyroid hormone cream", "follow_up_question": "What specific concentration of thyroid hormone cream was used in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "147.11", "question": "What was the purpose of comparing the three therapeutic agents?", "answer_src": "To investigate the effects of topical application of an aloe vera gel, a thyroid hormone cream, and a silver sulfadiazine cream on the healing of skin wounds surgically induced in Wistar rats", "follow_up_question": "What type of skin wounds were used in the study?", "follow_up_response": "skin wounds surgically induced in wistar rats", "follow_up_response_bt": "surgically induced skin wounds"}, {"question_id": "147.12", "question": "What type of skin wounds were surgically induced in the study?", "answer_src": "skin wounds surgically induced in wistar rats", "follow_up_question": "What was the purpose of comparing the three therapeutic agents?", "follow_up_response": "To investigate the effects of topical application of an aloe vera gel, a thyroid hormone cream, and a silver sulfadiazine cream on the healing of skin wounds surgically induced in Wistar rats", "follow_up_response_bt": "To determine the treatment of choice"}, {"question_id": "147.13", "question": "What was the purpose of the study regarding the aloe vera gel?", "answer_src": "Investigating the effects of topical application of an aloe vera gel", "follow_up_question": "What specific skin wounds were used in the study?", "follow_up_response": "skin wounds surgically induced in wistar rats", "follow_up_response_bt": "surgically induced skin wounds in the rat wistar"}, {"question_id": "147.14", "question": "What surgical method was used to induce the skin wounds?", "answer_src": "surgically", "follow_up_question": "What type of skin wounds were the rats subjected to?", "follow_up_response": "skin wounds surgically induced", "follow_up_response_bt": "surgically induced skin wounds"}, {"question_id": "147.15", "question": "What specific concentration of thyroid hormone cream was used in the study?", "answer_src": "many research studies report the healing effects of aloe vera , thyroid hormone cream and silver sulfadiazine . however , the effects of these therapeutic agents are not well understood and have not been compared in one study . this study aimed at investigating the effects of topical application of an aloe vera gel , a thyroid hormone cream and a silver sulfadiazine cream on the healing of skin wounds surgically induced in wistar rats for determining the treatment of choice .", "follow_up_question": "What type of skin wounds were surgically induced in the Wistar rats?", "follow_up_response": "skin wounds", "follow_up_response_bt": "surgically induced skin wounds"}]}}
{"id": 148, "src": "two groups of prosthesis had been implanted : harris - galante ii ( hgii ) in 15 and versys - trilogy ( v - t ) in 37 hips , both from zimmer company . the patients were assessed clinically , radiographically and with harris hip score , sf36 , womac , and mactar questionnaires , with 65 months ( 26 - 136 ) mean follow-up.all the v - t prostheses had survived well . eight of hg ii were revised by the last follow - up in 19 - 102 months .", "mt": "I pazienti sono stati valutati clinicamente , radiograficamente e con il punteggio dell' anca di Harris , sf36 , womac e questionari di mactar , con un follow-up medio di 65 mesi (26 - 136).Tutti i protesi v - t erano sopravvissuti bene . Otto di hg ii sono stati rivisti dall' ultimo follow-up in 19 - 102 mesi .", "pert_mt": "I pazienti sono stati valutati clinicamente, radiograficamente e con il punteggio dell'anca di Harris, sf36, womac e questionari di mactar, con un follow-up medio di 65 mesi (26 - 136). Tutti i protesi v-t erano sopravvissute bene. Otto di hg ii sono stati rivisti dall'ultimo follow-up in 19 - 102 mesi. Le revisioni hanno rilevato miglioramenti significativi nella mobilità dei pazienti.", "bt": "Patients were evaluated clinically, x-rays and with Harris's spine score, sf36, and mactar questionnaires, with an average follow-up of 65 months (26 - 136).All v-t prosthetics had survived well. Otto di hg ii was reviewed for the last follow-up at 19 - 102 months.", "questions_src": ["What was the name of the prosthesis that was implanted in 15 hips?", "Who performed the revisions on the Harris-Galante II prostheses?", "Where did all the Versys-Trilogy prostheses survive well?", "When was the mean follow-up period for the study?", "Which questionnaire was not used to assess the patients?"], "answers_src": ["Harris-Galante II", "Not specified in the sentence", "all the V-T prostheses", "65 months (26 - 136)", "Mactar"], "answers_bt": ["[\"Otto di hg ii\"], [], [\"65 months (26 - 136)\"], [\"mactar questionnaires\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "148.1", "question": "What was the name of the prosthesis that was implanted in 15 hips?", "answer_src": "Harris-Galante II", "follow_up_question": "How many more v-t prostheses were revised compared to hg ii prostheses?", "follow_up_response": "23", "follow_up_response_bt": "No Answer"}, {"question_id": "148.2", "question": "Who performed the revisions on the Harris-Galante II prostheses?", "answer_src": "Not specified in the sentence", "follow_up_question": "How many months after the initial implantation did the revisions start occurring?", "follow_up_response": "19 - 102 months", "follow_up_response_bt": "No Answer"}, {"question_id": "148.3", "question": "Where did all the Versys-Trilogy prostheses survive well?", "answer_src": "all the V-T prostheses", "follow_up_question": "How many months was the longest survival time for the Versys-Trilogy prostheses?", "follow_up_response": "136", "follow_up_response_bt": "136"}, {"question_id": "148.4", "question": "When was the mean follow-up period for the study?", "answer_src": "65 months (26 - 136)", "follow_up_question": "What was the average time from implantation to revision for the hgii prostheses?", "follow_up_response": "19 - 102 months", "follow_up_response_bt": "19 - 102 months"}, {"question_id": "148.5", "question": "Which questionnaire was not used to assess the patients?", "answer_src": "Mactar", "follow_up_question": "Which patient group had a longer mean follow-up time?", "follow_up_response": "19 - 102 months", "follow_up_response_bt": "19 - 102 months"}], "turn_2": [{"question_id": "148.6", "question": "How many more v-t prostheses were revised compared to hg ii prostheses?", "answer_src": "23", "follow_up_question": "How many more months did the average follow-up last for v-t prostheses compared to hg ii prostheses?", "follow_up_response": "36", "follow_up_response_bt": "91"}, {"question_id": "148.7", "question": "How many months after the initial implantation did the revisions start occurring?", "answer_src": "19 - 102 months", "follow_up_question": "For how many months was the longest revision delay observed?", "follow_up_response": "102", "follow_up_response_bt": "136"}, {"question_id": "148.8", "question": "How many months was the longest survival time for the Versys-Trilogy prostheses?", "answer_src": "136", "follow_up_question": "How many more months did it take for an average patient with HGII prostheses to be revised compared to the longest survival time of V-T prostheses?", "follow_up_response": "37", "follow_up_response_bt": "102 - 65"}, {"question_id": "148.9", "question": "What was the average time from implantation to revision for the hgii prostheses?", "answer_src": "19 - 102 months", "follow_up_question": "What was the average survival time for the vt prostheses?", "follow_up_response": "65 months", "follow_up_response_bt": "65 months"}, {"question_id": "148.10", "question": "Which patient group had a longer mean follow-up time?", "answer_src": "19 - 102 months", "follow_up_question": "What was the mean follow-up time for the hgii group?", "follow_up_response": "26 - 102 months", "follow_up_response_bt": "65 months"}], "turn_3": [{"question_id": "148.11", "question": "How many more months did the average follow-up last for v-t prostheses compared to hg ii prostheses?", "answer_src": "36", "follow_up_question": "By how many months was the average follow-up shorter for hg ii prostheses compared to v-t prostheses?", "follow_up_response": "31", "follow_up_response_bt": "No Answer"}, {"question_id": "148.12", "question": "For how many months was the longest revision delay observed?", "answer_src": "102", "follow_up_question": "For what percentage of patients with hgii prostheses did revision occur within 2 years?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "148.13", "question": "How many more months did it take for an average patient with HGII prostheses to be revised compared to the longest survival time of V-T prostheses?", "answer_src": "37", "follow_up_question": "How many more patients with HGII prostheses were revised compared to those with V-T prostheses?", "follow_up_response": "8", "follow_up_response_bt": "No Answer"}, {"question_id": "148.14", "question": "What was the average survival time for the vt prostheses?", "answer_src": "65 months", "follow_up_question": "What was the average survival time for the hgii prostheses?", "follow_up_response": "19 - 102 months", "follow_up_response_bt": "19 - 102 months"}, {"question_id": "148.15", "question": "What was the mean follow-up time for the hgii group?", "answer_src": "26 - 102 months", "follow_up_question": "What was the range of follow-up time for the hgii group?", "follow_up_response": "19 - 102 months", "follow_up_response_bt": "26 - 136"}]}}
{"id": 149, "src": "a latent content analysis was used to explore the characteristics and dynamics of social and sexual relationships.resultswe found dominant masculine ideals characterised by overt economic power and multiple sexual partners . reasons for large concurrent sexual networks were the perception that women were too empowered , could not be trusted , and lack of control over women . existing masculine norms encourage concurrent sexual networks , ignoring the high risk of hiv transmission .", "mt": "Un'analisi di contenuti latenti è stata utilizzata per esplorare le caratteristiche e le dinamiche delle relazioni sociali e sessuali.resultswe ha trovato ideali maschili dominanti caratterizzati da potere economico ovverto e più partner sessuali . le ragioni per le grandi reti sessuali concorrenti sono state la percezione che le donne erano troppo responsabilizzate , non potevano essere fidate , e la mancanza di controllo sulle donne .", "pert_mt": "Un'analisi di contenuti latenti è stata utilizzata per esplorare le caratteristiche e le dinamiche她们的关系和社会性关系中的主导男性理想特征被描述为拥有经济权力和多个性伴侣。大型性网络竞争的原因包括认为女性过于责任感强、不可信赖以及缺乏对女性的控制。", "bt": "An analysis of latent content has been used to explore the characteristics and dynamics of male ideals dominating their relationships and social relationships.The ideal characteristics of men are described as having economic power and multiple sexual partners.The reasons for the competition in the large sex network include the perception that women are overly responsible, unreliable, and lack of control over women.", "questions_src": ["What type of analysis was used in the study?", "Where were dominant masculine ideals characterized?", "Who perceived that women were too empowered?", "When did the study find evidence of concurrent sexual networks?", "Which norms encourage the formation of concurrent sexual networks?"], "answers_src": ["Latent content analysis", "In social and sexual relationships", "Women", "In the results", "Existing masculine norms"], "answers_bt": ["[\"An analysis of latent content\"], [\"Their relationships and social relationships\"], [\"No Answer\"], [\"No Answer\"], [\"The perception that women are overly responsible, unreliable, and lack of control over women\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "149.1", "question": "What type of analysis was used in the study?", "answer_src": "Latent content analysis", "follow_up_question": "What did the study find about dominant masculine ideals?", "follow_up_response": "Dominant masculine ideals characterised by overt economic power and multiple sexual partners.", "follow_up_response_bt": "Male ideals dominate their relationships and social relationships.\", \"The ideal characteristics of men are described as having economic power and multiple sexual partners.\", \"The reasons for the competition in the large sex network include the perception that women are overly responsible, unreliable, and lack of control over women."}, {"question_id": "149.2", "question": "Where were dominant masculine ideals characterized?", "answer_src": "In social and sexual relationships", "follow_up_question": "What specific traits did dominant masculine ideals include?", "follow_up_response": "overt economic power and multiple sexual partners", "follow_up_response_bt": "economic power and multiple sexual partners"}, {"question_id": "149.3", "question": "Who perceived that women were too empowered?", "answer_src": "Women", "follow_up_question": "What were the reasons given for the perception that women were too empowered?", "follow_up_response": "could not be trusted", "follow_up_response_bt": "No Answer"}, {"question_id": "149.4", "question": "When did the study find evidence of concurrent sexual networks?", "answer_src": "In the results", "follow_up_question": "What factors did the study identify as reasons for the existence of concurrent sexual networks?", "follow_up_response": "The perception that women were too empowered, could not be trusted, and lack of control over women", "follow_up_response_bt": "The perception that women are overly responsible, unreliable, and lack of control over women"}, {"question_id": "149.5", "question": "Which norms encourage the formation of concurrent sexual networks?", "answer_src": "Existing masculine norms", "follow_up_question": "What specific risks do these norms ignore?", "follow_up_response": "high risk of hiv transmission", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "149.6", "question": "What did the study find about dominant masculine ideals?", "answer_src": "Dominant masculine ideals characterised by overt economic power and multiple sexual partners.", "follow_up_question": "What does the study suggest is the reason for large concurrent sexual networks?", "follow_up_response": "The perception that women were too empowered, could not be trusted, and lack of control over women", "follow_up_response_bt": "The perception that women are overly responsible, unreliable, and lack of control over women"}, {"question_id": "149.7", "question": "What specific traits did dominant masculine ideals include?", "answer_src": "overt economic power and multiple sexual partners", "follow_up_question": "What factors contributed to the perception that women were too empowered?", "follow_up_response": "The perception that women were too empowered", "follow_up_response_bt": "The perception that women are overly responsible, unreliable, and lack of control over women"}, {"question_id": "149.8", "question": "What were the reasons given for the perception that women were too empowered?", "answer_src": "could not be trusted", "follow_up_question": "What factors did existing masculine norms ignore?", "follow_up_response": "the high risk of hiv transmission", "follow_up_response_bt": "No Answer"}, {"question_id": "149.9", "question": "What factors did the study identify as reasons for the existence of concurrent sexual networks?", "answer_src": "The perception that women were too empowered, could not be trusted, and lack of control over women", "follow_up_question": "What does the text suggest is the underlying reason for these existing masculine norms that encourage concurrent sexual networks?", "follow_up_response": "Ignoring the high risk of HIV transmission", "follow_up_response_bt": "The perception that women are overly responsible, unreliable, and lack of control over women"}, {"question_id": "149.10", "question": "What specific risks do these norms ignore?", "answer_src": "high risk of hiv transmission", "follow_up_question": "What measures does the text suggest to mitigate the high risk of HIV transmission?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "149.11", "question": "What does the study suggest is the reason for large concurrent sexual networks?", "answer_src": "The perception that women were too empowered, could not be trusted, and lack of control over women", "follow_up_question": "What specific existing masculine norm encourages concurrent sexual networks according to the study?", "follow_up_response": "existing masculine norms", "follow_up_response_bt": "The perception that women are overly responsible, unreliable, and lack of control over women"}, {"question_id": "149.12", "question": "What factors contributed to the perception that women were too empowered?", "answer_src": "The perception that women were too empowered", "follow_up_question": "Why did the authors consider this perception problematic?", "follow_up_response": "The high risk of HIV transmission", "follow_up_response_bt": "The perception that women are overly responsible, unreliable, and lack of control over women"}, {"question_id": "149.13", "question": "What factors did existing masculine norms ignore?", "answer_src": "the high risk of hiv transmission", "follow_up_question": "What other risks did existing masculine norms ignore?", "follow_up_response": "high risk of hiv transmission", "follow_up_response_bt": "No Answer"}, {"question_id": "149.14", "question": "What does the text suggest is the underlying reason for these existing masculine norms that encourage concurrent sexual networks?", "answer_src": "Ignoring the high risk of HIV transmission", "follow_up_question": "What specific factors do the text mention as contributing to the perception that women are too empowered?", "follow_up_response": "perception that women were too empowered", "follow_up_response_bt": "No Answer"}, {"question_id": "149.15", "question": "What measures does the text suggest to mitigate the high risk of HIV transmission?", "answer_src": "a latent content analysis was used to explore the characteristics and dynamics of social and sexual relationships.resultswe found dominant masculine ideals characterised by overt economic power and multiple sexual partners . reasons for large concurrent sexual networks were the perception that women were too empowered , could not be trusted , and lack of control over women . existing masculine norms encourage concurrent sexual networks , ignoring the high risk of hiv transmission .", "follow_up_question": "How do existing masculine norms contribute to the formation of large concurrent sexual networks?", "follow_up_response": "Existing masculine norms encourage concurrent sexual networks, ignoring the high risk of HIV transmission.", "follow_up_response_bt": "The reasons for the competition in the large sex network include the perception that women are overly responsible, unreliable, and lack of control over women."}]}}
{"id": 150, "src": "a higher level of this cytokine was also found in patients with obesity suffering from t2 dm . a positive correlation was present between il-6 and tnf- concentrations . only did the il-6 level correlate with the concentration of crp in serum.conclusionsthe study confirmed that increased inflammatory cytokines lead to the persistence of inflammation in obese subjects .", "mt": "Un livello più elevato di questa citochina è stato anche trovato in pazienti obesi affetti da t2 dm . una correlazione positiva è stata presente tra il-6 e tnf- concentrazioni . solo il livello di il-6 correlazione con la concentrazione di crp nel siero.conclusioni dello studio ha confermato che l'aumento delle citochine infiammatorie porta alla persistenza dell'infiammazione nei soggetti obesi .", "pert_mt": "Un livello più elevato di questa citochina è stato anche trovato in pazienti obesi affetti da t2 dm. Una correlazione positiva è stata presente tra il-6 e tnf-concentrazioni. Solo il livello di il-6 correlazione con la concentrazione di crp nel siero. Conclusioni dello studio hanno confermato che l'aumento delle citochine infiammatorie porta alla persistenza dell'infiammazione nei soggetti obesi e questo effetto è stato più marcato in pazienti con un indice di massa corporea alto.", "bt": "A higher level of this cytokine was also found in obese patients with t2 dm. A positive correlation was found between il-6 and tnf-concentrations. Only the level of il-6 correlated with the concentration of crp in serum.The study's conclusions confirmed that increased inflammatory cytokines lead to persistence of inflammation in obese subjects and this effect was more pronounced in patients with a high body mass index.", "questions_src": ["What is the name of the cytokine mentioned in the sentence?", "Who suffered from t2 dm according to the sentence?", "Where can the concentrations of IL-6 and TNF be found?", "When was a positive correlation observed between IL-6 and TNF?", "Which inflammatory marker showed a correlation with CRP concentration in serum?"], "answers_src": ["[\"IL-6\"], [\"patients\"], [\"serum\"], [\"in the study\"], [\"IL-6\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"IL-6\"], [\"obese patients\"], [\"serum\"], [\"in the study\"], [\"IL-6\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "150.1", "question": "What is the name of the cytokine mentioned in the sentence?", "answer_src": "[\"IL-6\"], [\"patients\"], [\"serum\"], [\"in the study\"], [\"IL-6\"]", "follow_up_question": "What other cytokine had a positive correlation with IL-6 according to the text?", "follow_up_response": "TNF", "follow_up_response_bt": "TNF"}, {"question_id": "150.2", "question": "Who suffered from t2 dm according to the sentence?", "answer_src": "a higher level of this cytokine was also found in patients with obesity suffering from t2 dm . a positive correlation was present between il-6 and tnf- concentrations . only did the il-6 level correlate with the concentration of crp in serum.conclusionsthe study confirmed that increased inflammatory cytokines lead to the persistence of inflammation in obese subjects .", "follow_up_question": "What other inflammatory cytokine had a positive correlation with IL-6 according to the text?", "follow_up_response": "TNF", "follow_up_response_bt": "TNF"}, {"question_id": "150.3", "question": "Where can the concentrations of IL-6 and TNF be found?", "answer_src": "a higher level of this cytokine was also found in patients with obesity suffering from t2 dm . a positive correlation was present between il-6 and tnf- concentrations . only did the il-6 level correlate with the concentration of crp in serum.conclusionsthe study confirmed that increased inflammatory cytokines lead to the persistence of inflammation in obese subjects .", "follow_up_question": "What other inflammatory cytokine's concentration is mentioned to correlate with IL-6 in serum?", "follow_up_response": "TNF-", "follow_up_response_bt": "crp"}, {"question_id": "150.4", "question": "When was a positive correlation observed between IL-6 and TNF?", "answer_src": "a higher level of this cytokine was also found in patients with obesity suffering from t2 dm . a positive correlation was present between il-6 and tnf- concentrations . only did the il-6 level correlate with the concentration of crp in serum.conclusionsthe study confirmed that increased inflammatory cytokines lead to the persistence of inflammation in obese subjects .", "follow_up_question": "What other inflammatory cytokine's concentration correlated with IL-6 in serum?", "follow_up_response": "CRP", "follow_up_response_bt": "crp"}, {"question_id": "150.5", "question": "Which inflammatory marker showed a correlation with CRP concentration in serum?", "answer_src": "a higher level of this cytokine was also found in patients with obesity suffering from t2 dm . a positive correlation was present between il-6 and tnf- concentrations . only did the il-6 level correlate with the concentration of crp in serum.conclusionsthe study confirmed that increased inflammatory cytokines lead to the persistence of inflammation in obese subjects .", "follow_up_question": "What other inflammatory marker besides IL-6 showed a correlation with CRP concentration in serum?", "follow_up_response": "TNF-", "follow_up_response_bt": "TNF"}], "turn_2": [{"question_id": "150.6", "question": "What other cytokine had a positive correlation with IL-6 according to the text?", "answer_src": "TNF", "follow_up_question": "What was the relationship between IL-6 and CRP in serum as described in the text?", "follow_up_response": "There was a positive correlation between IL-6 and TNF concentrations, and only the IL-6 level correlated with the concentration of CRP in serum.", "follow_up_response_bt": "A positive correlation was found between IL-6 and TNF-concentrations, and only the level of IL-6 correlated with the concentration of CRP in serum."}, {"question_id": "150.7", "question": "What other inflammatory cytokine had a positive correlation with IL-6 according to the text?", "answer_src": "TNF", "follow_up_question": "What was the relationship between IL-6 and CRP in serum as described in the text?", "follow_up_response": "There was a positive correlation between IL-6 and TNF concentrations, and only the IL-6 level correlated with the concentration of CRP in serum.", "follow_up_response_bt": "A positive correlation was found between IL-6 and TNF-concentrations, and only the level of IL-6 correlated with the concentration of CRP in serum."}, {"question_id": "150.8", "question": "What other inflammatory cytokine's concentration is mentioned to correlate with IL-6 in serum?", "answer_src": "TNF-", "follow_up_question": "What is the relationship between CRP and IL-6 concentration according to the study?", "follow_up_response": "Only the IL-6 level correlated with the concentration of CRP in serum.", "follow_up_response_bt": "Only the level of IL-6 correlated with the concentration of CRP in serum."}, {"question_id": "150.9", "question": "What other inflammatory cytokine's concentration correlated with IL-6 in serum?", "answer_src": "CRP", "follow_up_question": "What was the relationship between IL-6 and CRP concentrations according to the text?", "follow_up_response": "A positive correlation was present between IL-6 and TNF- concentrations.", "follow_up_response_bt": "A positive correlation was found between IL-6 and TNF-concentrations"}, {"question_id": "150.10", "question": "What other inflammatory marker besides IL-6 showed a correlation with CRP concentration in serum?", "answer_src": "TNF-", "follow_up_question": "What was the relationship between IL-6 and TNF concentrations according to the text?", "follow_up_response": "A positive correlation was present between IL-6 and TNF concentrations.", "follow_up_response_bt": "A positive correlation was found"}], "turn_3": [{"question_id": "150.11", "question": "What was the relationship between IL-6 and CRP in serum as described in the text?", "answer_src": "There was a positive correlation between IL-6 and TNF concentrations, and only the IL-6 level correlated with the concentration of CRP in serum.", "follow_up_question": "How did the concentration of CRP in serum relate to the other cytokines mentioned in the text?", "follow_up_response": "Only the IL-6 level correlated with the concentration of CRP in serum.", "follow_up_response_bt": "Only the level of IL-6 correlated with the concentration of CRP in serum."}, {"question_id": "150.12", "question": "What was the relationship between IL-6 and CRP in serum as described in the text?", "answer_src": "There was a positive correlation between IL-6 and TNF concentrations, and only the IL-6 level correlated with the concentration of CRP in serum.", "follow_up_question": "How did the concentration of CRP in serum relate to the other cytokines mentioned in the text?", "follow_up_response": "Only the IL-6 level correlated with the concentration of CRP in serum.", "follow_up_response_bt": "Only the level of IL-6 correlated with the concentration of CRP in serum."}, {"question_id": "150.13", "question": "What is the relationship between CRP and IL-6 concentration according to the study?", "answer_src": "Only the IL-6 level correlated with the concentration of CRP in serum.", "follow_up_question": "What other cytokine had a positive correlation with TNF- concentrations?", "follow_up_response": "IL-6", "follow_up_response_bt": "il-6"}, {"question_id": "150.14", "question": "What was the relationship between IL-6 and CRP concentrations according to the text?", "answer_src": "A positive correlation was present between IL-6 and TNF- concentrations.", "follow_up_question": "What was the relationship between IL-6 and CRP concentrations?", "follow_up_response": "There was a positive correlation between IL-6 and TNF concentrations.", "follow_up_response_bt": "A positive correlation"}, {"question_id": "150.15", "question": "What was the relationship between IL-6 and TNF concentrations according to the text?", "answer_src": "A positive correlation was present between IL-6 and TNF concentrations.", "follow_up_question": "What was the relationship between IL-6 and CRP concentrations in serum according to the text?", "follow_up_response": "Only the IL-6 level correlated with the concentration of CRP in serum.", "follow_up_response_bt": "Only the level of IL-6 correlated with the concentration of CRP in serum according to the text."}]}}
{"id": 151, "src": "introductionthe spleen is a highly vascular organ and is in close proximity to many potential primary sites such as the stomach , breast , pancreas and colon . it is however an unusual site for metastatic disease . the reasons for this are not fully understood at the present time .", "mt": "L'introduzione del milzo è un organo altamente vascolare ed è in prossimità di molti potenziali siti primari come lo stomaco , il seno , il pancreas e il colon . Tuttavia è un sito insolito per malattie metastatiche . Le ragioni di questo non sono ancora pienamente comprese al momento .", "pert_mt": "L'introduzione del milzo è un organo altamente vascolare ed è in prossimità di molti potenziali siti primari come lo stomaco, il seno, il pancreas e il colon. Tuttavia è un sito insolito per malattie metastatiche. Le ragioni di questo non sono ancora pienamente comprese al momento e includono anche fattori geneticici.", "bt": "The introduction of the spleen is a highly vascular organ and is in close proximity to many potential primary sites such as the stomach, breast, pancreas and colon, but it is an unusual site for metastatic disease, for which the reasons are not yet fully understood at this time and include genetic factors.", "questions_src": ["What is the spleen's main function?", "Who are the common primary sites of metastatic disease according to the sentence?", "Where is the spleen located in relation to the stomach?", "When was the sentence written?", "Which organ is mentioned as being unusual for metastatic disease?"], "answers_src": ["a highly vascular organ and is in close proximity to many potential primary sites such as the stomach, breast, pancreas and colon", "the stomach, breast, pancreas and colon", "in close proximity", "No Answer", "the spleen"], "answers_bt": ["highly vascular organ", "the stomach, breast, pancreas and colon", "in close proximity", "No Answer", "the spleen"], "multiturn": {"turn_1": [{"question_id": "151.1", "question": "What is the spleen's main function?", "answer_src": "a highly vascular organ and is in close proximity to many potential primary sites such as the stomach, breast, pancreas and colon", "follow_up_question": "What other organs are mentioned as potential primary sites for the spleen?", "follow_up_response": "the stomach, breast, pancreas and colon", "follow_up_response_bt": "stomach, breast, pancreas and colon"}, {"question_id": "151.2", "question": "Who are the common primary sites of metastatic disease according to the sentence?", "answer_src": "the stomach, breast, pancreas and colon", "follow_up_question": "What percentage of metastatic diseases originate from these common primary sites?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "151.3", "question": "Where is the spleen located in relation to the stomach?", "answer_src": "in close proximity", "follow_up_question": "What other organs are mentioned as being in close proximity to the spleen besides the stomach?", "follow_up_response": "breast\", \"pancreas\", \"colon", "follow_up_response_bt": "breast\", \"pancreas\", \"colon"}, {"question_id": "151.4", "question": "When was the sentence written?", "answer_src": "introductionthe spleen is a highly vascular organ and is in close proximity to many potential primary sites such as the stomach , breast , pancreas and colon . it is however an unusual site for metastatic disease . the reasons for this are not fully understood at the present time .", "follow_up_question": "What does the text say about the reasons for the spleen being an unusual site for metastatic disease?", "follow_up_response": "The reasons for this are not fully understood at the present time.", "follow_up_response_bt": "for which the reasons are not yet fully understood at this time and include genetic factors."}, {"question_id": "151.5", "question": "Which organ is mentioned as being unusual for metastatic disease?", "answer_src": "the spleen", "follow_up_question": "What other organs are listed as potential primary sites for the spleen?", "follow_up_response": "the stomach, breast, pancreas and colon", "follow_up_response_bt": "the stomach, breast, pancreas and colon"}], "turn_2": [{"question_id": "151.6", "question": "What other organs are mentioned as potential primary sites for the spleen?", "answer_src": "the stomach, breast, pancreas and colon", "follow_up_question": "What percentage of splenic metastases originate from these primary sites according to the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "151.7", "question": "What percentage of metastatic diseases originate from these common primary sites?", "answer_src": "introductionthe spleen is a highly vascular organ and is in close proximity to many potential primary sites such as the stomach , breast , pancreas and colon . it is however an unusual site for metastatic disease . the reasons for this are not fully understood at the present time .", "follow_up_question": "What other organs besides the stomach, breast, pancreas, and colon are mentioned as potential primary sites for the spleen?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "151.8", "question": "What other organs are mentioned as being in close proximity to the spleen besides the stomach?", "answer_src": "breast\", \"pancreas\", \"colon", "follow_up_question": "What percentage of splenic metastases originate from the stomach according to the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "151.9", "question": "What does the text say about the reasons for the spleen being an unusual site for metastatic disease?", "answer_src": "The reasons for this are not fully understood at the present time.", "follow_up_question": "What specific organs are mentioned as potential primary sites for the spleen?", "follow_up_response": "the stomach, breast, pancreas and colon", "follow_up_response_bt": "stomach, breast, pancreas and colon"}, {"question_id": "151.10", "question": "What other organs are listed as potential primary sites for the spleen?", "answer_src": "the stomach, breast, pancreas and colon", "follow_up_question": "What percentage of splenic metastases originate from these listed organs?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "151.11", "question": "What percentage of splenic metastases originate from these primary sites according to the text?", "answer_src": "introductionthe spleen is a highly vascular organ and is in close proximity to many potential primary sites such as the stomach , breast , pancreas and colon . it is however an unusual site for metastatic disease . the reasons for this are not fully understood at the present time .", "follow_up_question": "What other organs besides the stomach, breast, pancreas, and colon are mentioned as potential primary sites for the spleen?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "151.12", "question": "What other organs besides the stomach, breast, pancreas, and colon are mentioned as potential primary sites for the spleen?", "answer_src": "introductionthe spleen is a highly vascular organ and is in close proximity to many potential primary sites such as the stomach , breast , pancreas and colon . it is however an unusual site for metastatic disease . the reasons for this are not fully understood at the present time .", "follow_up_question": "What other organs besides the stomach, breast, pancreas, and colon are mentioned as potential primary sites for the spleen in the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "151.13", "question": "What percentage of splenic metastases originate from the stomach according to the text?", "answer_src": "introductionthe spleen is a highly vascular organ and is in close proximity to many potential primary sites such as the stomach , breast , pancreas and colon . it is however an unusual site for metastatic disease . the reasons for this are not fully understood at the present time .", "follow_up_question": "What other organs besides the stomach are mentioned as potential primary sites for the spleen?", "follow_up_response": "breast\", \"pancreas\", \"colon", "follow_up_response_bt": "breast, pancreas and colon"}, {"question_id": "151.14", "question": "What specific organs are mentioned as potential primary sites for the spleen?", "answer_src": "the stomach, breast, pancreas and colon", "follow_up_question": "What percentage of splenic metastases originate from these primary sites according to the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "151.15", "question": "What percentage of splenic metastases originate from these listed organs?", "answer_src": "introductionthe spleen is a highly vascular organ and is in close proximity to many potential primary sites such as the stomach , breast , pancreas and colon . it is however an unusual site for metastatic disease . the reasons for this are not fully understood at the present time .", "follow_up_question": "What other organs besides the stomach, breast, pancreas, and colon are mentioned as potential primary sites for the spleen?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 152, "src": "it is known that the brain adaptively recalibrates itself to small ( 100 ms ) auditory visual ( av ) temporal asynchronies so as to maintain intersensory temporal coherence . here we explored whether spatial disparity between a sound and light affects av temporal recalibration . participants were exposed to a train of asynchronous av stimulus pairs ( sound - first or light - first ) with sounds and lights emanating from either the same or a different location .", "mt": "È noto che il cervello si ricalibra in modo adattativo a piccole (100 ms) assincroni visive uditive (av) temporali per mantenere la coerenza temporale intersensibile . Qui abbiamo esplorato se la disparità spaziale tra un suono e una luce influisce sulla ricalibrazione temporale . I partecipanti sono stati esposti a un treno di coppie di stimoli assincroni av (suono - prima o luce - prima) con suoni e luci che emanavano dalla stessa o da un luogo diverso .", "pert_mt": "È noto che il cervello si ricalibra in modo adattativo a piccole (100 ms) assincroni visive uditive (av) temporali per mantenere la coerenza temporale intersensibile. Qui abbiamo esplorato se la disparità spaziale tra un suono e una luce influisce sulla ricalibrazione temporale. I partecipanti sono stati esposti a un treno di coppie di stimuli assincroni av (suono - prima o luce - prima) con suoni e luci che emanavano dalla stessa o da un luogo diverso e questo ha influenzato significativamente i risultati dell'esperimento.", "bt": "It has been noted that the brain recalibrates itself adaptively to small (100 ms) temporal visual auditory (AV) signals to maintain intersensitive temporal coherence.We have explored whether the spatial disparity between sound and light influences the temporal recalibration.The participants were exposed to a train of pairs of synchronous av (sound - prima or light - prima) stimuli with sounds and lights emanating from the same or a different place and this significantly influenced the results of the experiment.", "questions_src": ["What type of stimulus pairs did participants receive?", "Where did the sounds and lights originate from?", "How was the temporal recalibration measured?", "Which location did the stimuli come from?", "What was the duration of the auditory visual asynchronies?"], "answers_src": ["Asynchronous av stimulus pairs (sound-first or light-first)", "From either the same or a different location", "Measured by maintaining intersensory temporal coherence", "From either the same or a different location", "100 ms"], "answers_bt": ["Synchronous AV (sound-light) stimuli", "From the same or a different place", "By measuring the temporal recalibration", "From the same or a different place", "100 ms"], "multiturn": {"turn_1": [{"question_id": "152.1", "question": "What type of stimulus pairs did participants receive?", "answer_src": "Asynchronous av stimulus pairs (sound-first or light-first)", "follow_up_question": "What was the spatial relationship between the sound and light stimuli?", "follow_up_response": "from either the same or a different location", "follow_up_response_bt": "The sound and light emanated from the same or a different place"}, {"question_id": "152.2", "question": "Where did the sounds and lights originate from?", "answer_src": "From either the same or a different location", "follow_up_question": "What was the effect of the different locations on the av temporal recalibration?", "follow_up_response": "Spatial disparity between a sound and light affects av temporal recalibration", "follow_up_response_bt": "The spatial disparity between sound and light influenced the temporal recalibration"}, {"question_id": "152.3", "question": "How was the temporal recalibration measured?", "answer_src": "Measured by maintaining intersensory temporal coherence", "follow_up_question": "What specific type of spatial disparity was manipulated in the experiment?", "follow_up_response": "Different location", "follow_up_response_bt": "The spatial disparity between sound and light"}, {"question_id": "152.4", "question": "Which location did the stimuli come from?", "answer_src": "From either the same or a different location", "follow_up_question": "What was the spatial disparity when the sound and light came from the same location?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "152.5", "question": "What was the duration of the auditory visual asynchronies?", "answer_src": "100 ms", "follow_up_question": "How many locations did the sounds and lights emanate from?", "follow_up_response": "Same, Different", "follow_up_response_bt": "Same or a different place"}], "turn_2": [{"question_id": "152.6", "question": "What was the spatial relationship between the sound and light stimuli?", "answer_src": "from either the same or a different location", "follow_up_question": "How many different locations were used for the sound and light stimuli?", "follow_up_response": "2", "follow_up_response_bt": "2"}, {"question_id": "152.7", "question": "What was the effect of the different locations on the av temporal recalibration?", "answer_src": "Spatial disparity between a sound and light affects av temporal recalibration", "follow_up_question": "How did the order of sound and light presentation influence the av temporal recalibration?", "follow_up_response": "Whether sound or light was presented first", "follow_up_response_bt": "The order of sound and light presentation significantly influenced the results of the experiment."}, {"question_id": "152.8", "question": "What specific type of spatial disparity was manipulated in the experiment?", "answer_src": "Different location", "follow_up_question": "What was the duration of the asynchronous av stimulus pairs?", "follow_up_response": "100 ms", "follow_up_response_bt": "No Answer"}, {"question_id": "152.9", "question": "What was the spatial disparity when the sound and light came from the same location?", "answer_src": "it is known that the brain adaptively recalibrates itself to small ( 100 ms ) auditory visual ( av ) temporal asynchronies so as to maintain intersensory temporal coherence . here we explored whether spatial disparity between a sound and light affects av temporal recalibration . participants were exposed to a train of asynchronous av stimulus pairs ( sound - first or light - first ) with sounds and lights emanating from either the same or a different location .", "follow_up_question": "What was the spatial disparity when the sound and light came from different locations?", "follow_up_response": "Different", "follow_up_response_bt": "The spatial disparity"}, {"question_id": "152.10", "question": "How many locations did the sounds and lights emanate from?", "answer_src": "Same, Different", "follow_up_question": "In how many pairs of stimuli was the sound presented first?", "follow_up_response": "No Answer", "follow_up_response_bt": "0"}], "turn_3": [{"question_id": "152.11", "question": "How many different locations were used for the sound and light stimuli?", "answer_src": "2", "follow_up_question": "How many different types of stimulus pairs were presented to the participants?", "follow_up_response": "2", "follow_up_response_bt": "2"}, {"question_id": "152.12", "question": "How did the order of sound and light presentation influence the av temporal recalibration?", "answer_src": "Whether sound or light was presented first", "follow_up_question": "How did the spatial disparity between the sound and light presentation affect the av temporal recalibration?", "follow_up_response": "Whether spatial disparity between the sound and light presentation affects av temporal recalibration was explored", "follow_up_response_bt": "This significantly influenced the results of the experiment."}, {"question_id": "152.13", "question": "What was the duration of the asynchronous av stimulus pairs?", "answer_src": "100 ms", "follow_up_question": "How many locations did the sounds and lights emanate from?", "follow_up_response": "Same, Different", "follow_up_response_bt": "Same or a different place"}, {"question_id": "152.14", "question": "What was the spatial disparity when the sound and light came from different locations?", "answer_src": "Different", "follow_up_question": "What was the effect of different locations on the participants' ability to detect temporal asynchronies?", "follow_up_response": "Spatial disparity between a sound and light affects av temporal recalibration", "follow_up_response_bt": "The spatial disparity between sound and light influenced the temporal recalibration"}, {"question_id": "152.15", "question": "In how many pairs of stimuli was the sound presented first?", "answer_src": "it is known that the brain adaptively recalibrates itself to small ( 100 ms ) auditory visual ( av ) temporal asynchronies so as to maintain intersensory temporal coherence . here we explored whether spatial disparity between a sound and light affects av temporal recalibration . participants were exposed to a train of asynchronous av stimulus pairs ( sound - first or light - first ) with sounds and lights emanating from either the same or a different location .", "follow_up_question": "How many pairs of stimuli had the sound and light emanating from the same location?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 153, "src": "three - way anova was used to compare the factors implant length , crown height , and implant system ( = 0.05 ) . the results showed that implant length was a statistically significant factor for both axial and nonaxial loading . the 13 mm prosthetic crown did not result in statistically significant differences in stress distribution between the implant systems and implant lengths studied , regardless of load type ( p > 0.05 ) .", "mt": "Il tri-way anova è stato utilizzato per confrontare i fattori lunghezza dell'impianto , altezza della corona e sistema di impianto ( = 0,05 ) . I risultati hanno mostrato che la lunghezza dell'impianto era un fattore statisticamente significativo per il carico sia axiale che non axiale . La corona protetica da 13 mm non ha portato a differenze statisticamente significative nella distribuzione dello stress tra i sistemi di impianto e le lunghezze degli impianti studiati , indipendentemente dal tipo di carico (p > 0,05).", "pert_mt": "Il tri-way anova è stato utilizzato per confrontare i fattori lunghezza dell'impianto, altezza della corona e sistema di impianto (p = 0,05). I risultati hanno mostrato che la lunghezza dell'impianto era un fattore statisticamente significativo per il carico sia axiale che non axiale. La corona protetica da 13 mm non ha portato a differenze statisticamente significative nella distribuzione dello stress tra i sistemi di impianto e le lunghezze degli impianti studiati, indipendentemente dal tipo di carico (p > 0,05).", "bt": "The new tri-way was used to compare the factors of the length of the implant, the height of the crown and the implant system (p = 0,05).The results showed that the length of the implant was a statistically significant factor for both axial and non-axial load.The 13 mm protective crown did not result in a statistically significant difference in the distribution of stress between the implant systems and the length of the implants studied, regardless of the type of load (p > 0,05).", "questions_src": ["What was used to compare the factors implant length, crown height, and implant system?", "Who showed that implant length was a statistically significant factor for both axial and nonaxial loading?", "Where did the 13 mm prosthetic crown not result in statistically significant differences in stress distribution?", "When were three-way ANOVA tests conducted?", "Which load types were considered in the study?"], "answers_src": ["three - way anova", "the results", "implant systems and implant lengths studied", "the study", "both axial and nonaxial"], "answers_bt": ["The new tri-way", "The results", "The implant systems and the length of the implants studied", "The new tri-way was used to compare the factors", "Axial and non-axial"], "multiturn": {"turn_1": [{"question_id": "153.1", "question": "What was used to compare the factors implant length, crown height, and implant system?", "answer_src": "three - way anova", "follow_up_question": "What was the outcome regarding the 13 mm prosthetic crown for axial and nonaxial loading?", "follow_up_response": "statistically significant differences", "follow_up_response_bt": "No Answer"}, {"question_id": "153.2", "question": "Who showed that implant length was a statistically significant factor for both axial and nonaxial loading?", "answer_src": "the results", "follow_up_question": "What specific implant length demonstrated statistical significance for both types of loading?", "follow_up_response": "13 mm", "follow_up_response_bt": "13 mm"}, {"question_id": "153.3", "question": "Where did the 13 mm prosthetic crown not result in statistically significant differences in stress distribution?", "answer_src": "implant systems and implant lengths studied", "follow_up_question": "What was the outcome regarding stress distribution for the 13 mm prosthetic crown under axial loading?", "follow_up_response": "statistically significant differences", "follow_up_response_bt": "No Answer"}, {"question_id": "153.4", "question": "When were three-way ANOVA tests conducted?", "answer_src": "the study", "follow_up_question": "What was the outcome regarding the 13 mm prosthetic crown?", "follow_up_response": "the 13 mm prosthetic crown did not result in statistically significant differences", "follow_up_response_bt": "The 13 mm protective crown did not result in a statistically significant difference in the distribution of stress between the implant systems and the length of the implants studied, regardless of the type of load"}, {"question_id": "153.5", "question": "Which load types were considered in the study?", "answer_src": "both axial and nonaxial", "follow_up_question": "What was the average stress distribution for the 13 mm prosthetic crown across the implant systems?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "153.6", "question": "What was the outcome regarding the 13 mm prosthetic crown for axial and nonaxial loading?", "answer_src": "statistically significant differences", "follow_up_question": "What was the outcome for the 13 mm prosthetic crown regarding stress distribution between the implant systems?", "follow_up_response": "no statistically significant differences", "follow_up_response_bt": "No Answer"}, {"question_id": "153.7", "question": "What specific implant length demonstrated statistical significance for both types of loading?", "answer_src": "13 mm", "follow_up_question": "What was the outcome for the 13 mm prosthetic crown regarding stress distribution differences between implant systems?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "153.8", "question": "What was the outcome regarding stress distribution for the 13 mm prosthetic crown under axial loading?", "answer_src": "statistically significant differences", "follow_up_question": "What was the outcome regarding stress distribution for the 13 mm prosthetic crown under nonaxial loading?", "follow_up_response": "statistically significant differences", "follow_up_response_bt": "There was no statistically significant difference in the distribution of stress"}, {"question_id": "153.9", "question": "What was the outcome regarding the 13 mm prosthetic crown?", "answer_src": "the 13 mm prosthetic crown did not result in statistically significant differences", "follow_up_question": "Were there any statistically significant differences in stress distribution between the implant systems with a 13 mm prosthetic crown?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "153.10", "question": "What was the average stress distribution for the 13 mm prosthetic crown across the implant systems?", "answer_src": "three - way anova was used to compare the factors implant length , crown height , and implant system ( = 0.05 ) . the results showed that implant length was a statistically significant factor for both axial and nonaxial loading . the 13 mm prosthetic crown did not result in statistically significant differences in stress distribution between the implant systems and implant lengths studied , regardless of load type ( p > 0.05 ) .", "follow_up_question": "What was the outcome regarding the stress distribution for the 13 mm prosthetic crown under axial loading?", "follow_up_response": "statistically significant differences", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "153.11", "question": "What was the outcome for the 13 mm prosthetic crown regarding stress distribution between the implant systems?", "answer_src": "no statistically significant differences", "follow_up_question": "What was the outcome for the 13 mm prosthetic crown regarding stress distribution between the axial and nonaxial loads?", "follow_up_response": "statistically significant differences", "follow_up_response_bt": "No Answer"}, {"question_id": "153.12", "question": "What was the outcome for the 13 mm prosthetic crown regarding stress distribution differences between implant systems?", "answer_src": "three - way anova was used to compare the factors implant length , crown height , and implant system ( = 0.05 ) . the results showed that implant length was a statistically significant factor for both axial and nonaxial loading . the 13 mm prosthetic crown did not result in statistically significant differences in stress distribution between the implant systems and implant lengths studied , regardless of load type ( p > 0.05 ) .", "follow_up_question": "What was the outcome for the 13 mm prosthetic crown regarding nonaxial loading stress distribution?", "follow_up_response": "statistically significant differences", "follow_up_response_bt": "no statistically significant difference"}, {"question_id": "153.13", "question": "What was the outcome regarding stress distribution for the 13 mm prosthetic crown under nonaxial loading?", "answer_src": "statistically significant differences", "follow_up_question": "What was the outcome regarding stress distribution for the 13 mm prosthetic crown under axial loading?", "follow_up_response": "statistically significant differences", "follow_up_response_bt": "No Answer"}, {"question_id": "153.14", "question": "Were there any statistically significant differences in stress distribution between the implant systems with a 13 mm prosthetic crown?", "answer_src": "three - way anova was used to compare the factors implant length , crown height , and implant system ( = 0.05 ) . the results showed that implant length was a statistically significant factor for both axial and nonaxial loading . the 13 mm prosthetic crown did not result in statistically significant differences in stress distribution between the implant systems and implant lengths studied , regardless of load type ( p > 0.05 ) .", "follow_up_question": "Was there a statistically significant difference in stress distribution between the different implant systems when using a 13 mm prosthetic crown?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "153.15", "question": "What was the outcome regarding the stress distribution for the 13 mm prosthetic crown under axial loading?", "answer_src": "statistically significant differences", "follow_up_question": "What was the outcome regarding the stress distribution for the 13 mm prosthetic crown under nonaxial loading?", "follow_up_response": "statistically significant differences", "follow_up_response_bt": "There was no statistically significant difference in the distribution of stress"}]}}
{"id": 154, "src": "head and neck squamous cell carcinomas are among the most common neoplasms worldwide and characterized by local tumor aggressiveness , high rate of early recurrences , development of metastasis , and second primary cancers . despite modern therapeutic strategies and sophisticated surgical management , overall survival - rates remained largely unchanged over the last decades . thus , the need for novel treatment options for this tumor entity is undeniable .", "mt": "I carcinomi a cellule squamose della testa e del collo sono tra i tumori più comuni in tutto il mondo e sono caratterizzati da aggressività tumorale locale , elevato tasso di ricorrenze precoci , sviluppo di metastasi e tumori secondari primari . Nonostante le moderne strategie terapeutiche e la gestione chirurgica sofisticata , i tassi di sopravvivenza complessivi sono rimasti in gran parte invariati negli ultimi decenni .", "pert_mt": "I carcinomi a cellule squamose della testa e del collo sono tra i tumori più comuni in tutto il mondo e sono caratterizzati da aggressività tumorale locale, elevato tasso di ricorrenze precoci, sviluppo di metastasi e tumori secondari primari. Nonostante le moderne strategie terapeutiche e la gestione chirurgica sofisticata, i tassi di sopravvivenza complessivi sono rimasti in gran parte invariati negli ultimi decenni e questo malgrado le cure palliative intensive.", "bt": "T-cell and cervical squamous cell carcinomas are among the most common tumors worldwide and are characterized by local tumor aggressiveness, high rates of premature recurrence, development of metastases and primary secondary tumors.Despite modern therapeutic strategies and sophisticated surgical management, overall survival rates have remained largely unchanged over the past few decades and this despite intensive palliative care.", "questions_src": ["What are head and neck squamous cell carcinomas characterized by?", "When did overall survival rates remain largely unchanged?", "Where can second primary cancers develop?", "Which strategy has not significantly improved survival rates?", "Who is affected by these neoplasms worldwide?"], "answers_src": ["local tumor aggressiveness, high rate of early recurrences, development of metastasis, and second primary cancers", "over the last decades", "anywhere in the body", "modern therapeutic strategies and sophisticated surgical management", "worldwide"], "answers_bt": ["Local tumor aggressiveness, high rates of premature recurrence, development of metastases and primary secondary tumors", "No Answer", "Primary and secondary tumors", "Modern therapeutic strategies", "T-cell and cervical squamous cell carcinomas"], "multiturn": {"turn_1": [{"question_id": "154.1", "question": "What are head and neck squamous cell carcinomas characterized by?", "answer_src": "local tumor aggressiveness, high rate of early recurrences, development of metastasis, and second primary cancers", "follow_up_question": "What percentage or timeframe does the text suggest overall survival rates have remained unchanged?", "follow_up_response": "over the last decades", "follow_up_response_bt": "No Answer"}, {"question_id": "154.2", "question": "When did overall survival rates remain largely unchanged?", "answer_src": "over the last decades", "follow_up_question": "What factors contribute to the local tumor aggressiveness of head and neck squamous cell carcinomas?", "follow_up_response": "local tumor aggressiveness", "follow_up_response_bt": "Local tumor aggressiveness"}, {"question_id": "154.3", "question": "Where can second primary cancers develop?", "answer_src": "anywhere in the body", "follow_up_question": "What are some of the challenges in treating head and neck squamous cell carcinomas?", "follow_up_response": "Local tumor aggressiveness, high rate of early recurrences, development of metastasis, and second primary cancers", "follow_up_response_bt": "Local tumor aggressiveness, high rates of premature recurrence, development of metastases and primary secondary tumors"}, {"question_id": "154.4", "question": "Which strategy has not significantly improved survival rates?", "answer_src": "modern therapeutic strategies and sophisticated surgical management", "follow_up_question": "What specific type of cancer is primarily discussed in the text?", "follow_up_response": "head and neck squamous cell carcinomas", "follow_up_response_bt": "T-cell and cervical squamous cell carcinomas"}, {"question_id": "154.5", "question": "Who is affected by these neoplasms worldwide?", "answer_src": "worldwide", "follow_up_question": "What specific types of neoplasms are referred to as head and neck squamous cell carcinomas?", "follow_up_response": "head and neck squamous cell carcinomas", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "154.6", "question": "What percentage or timeframe does the text suggest overall survival rates have remained unchanged?", "answer_src": "over the last decades", "follow_up_question": "What specific treatments were described as not being sufficient to improve overall survival rates?", "follow_up_response": "modern therapeutic strategies and sophisticated surgical management", "follow_up_response_bt": "intensive palliative care"}, {"question_id": "154.7", "question": "What factors contribute to the local tumor aggressiveness of head and neck squamous cell carcinomas?", "answer_src": "local tumor aggressiveness", "follow_up_question": "What specific type of metastasis do these tumors commonly develop?", "follow_up_response": "development of metastasis", "follow_up_response_bt": "development of metastases"}, {"question_id": "154.8", "question": "What are some of the challenges in treating head and neck squamous cell carcinomas?", "answer_src": "Local tumor aggressiveness, high rate of early recurrences, development of metastasis, and second primary cancers", "follow_up_question": "What measures are described in the text as not being sufficient to improve overall survival rates?", "follow_up_response": "modern therapeutic strategies and sophisticated surgical management", "follow_up_response_bt": "intensive palliative care"}, {"question_id": "154.9", "question": "What specific type of cancer is primarily discussed in the text?", "answer_src": "head and neck squamous cell carcinomas", "follow_up_question": "What challenges do current therapeutic strategies face according to the text?", "follow_up_response": "local tumor aggressiveness, high rate of early recurrences, development of metastasis, and second primary cancers", "follow_up_response_bt": "Maintaining overall survival rates"}, {"question_id": "154.10", "question": "What specific types of neoplasms are referred to as head and neck squamous cell carcinomas?", "answer_src": "head and neck squamous cell carcinomas", "follow_up_question": "What percentage of all neoplasms worldwide are head and neck squamous cell carcinomas?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "154.11", "question": "What specific treatments were described as not being sufficient to improve overall survival rates?", "answer_src": "modern therapeutic strategies and sophisticated surgical management", "follow_up_question": "What kind of tumors are head and neck squamous cell carcinomas?", "follow_up_response": "neoplasms", "follow_up_response_bt": "No Answer"}, {"question_id": "154.12", "question": "What specific type of metastasis do these tumors commonly develop?", "answer_src": "development of metastasis", "follow_up_question": "What other complication besides metastasis does the text mention developing in these tumors?", "follow_up_response": "second primary cancers", "follow_up_response_bt": "development of metastases and primary secondary tumors"}, {"question_id": "154.13", "question": "What measures are described in the text as not being sufficient to improve overall survival rates?", "answer_src": "modern therapeutic strategies and sophisticated surgical management", "follow_up_question": "What specific challenges do these measures face according to the text?", "follow_up_response": "local tumor aggressiveness, high rate of early recurrences, development of metastasis, and second primary cancers", "follow_up_response_bt": "local tumor aggressiveness, high rates of premature recurrence, development of metastases and primary secondary tumors"}, {"question_id": "154.14", "question": "What challenges do current therapeutic strategies face according to the text?", "answer_src": "local tumor aggressiveness, high rate of early recurrences, development of metastasis, and second primary cancers", "follow_up_question": "What factors contribute to the high rate of early recurrences mentioned in the text?", "follow_up_response": "local tumor aggressiveness , high rate of early recurrences , development of metastasis , and second primary cancers", "follow_up_response_bt": "Local tumor aggressiveness, high rates of premature recurrence, development of metastases and primary secondary tumors"}, {"question_id": "154.15", "question": "What percentage of all neoplasms worldwide are head and neck squamous cell carcinomas?", "answer_src": "head and neck squamous cell carcinomas are among the most common neoplasms worldwide and characterized by local tumor aggressiveness , high rate of early recurrences , development of metastasis , and second primary cancers . despite modern therapeutic strategies and sophisticated surgical management , overall survival - rates remained largely unchanged over the last decades . thus , the need for novel treatment options for this tumor entity is undeniable .", "follow_up_question": "What characteristic of head and neck squamous cell carcinomas is characterized as \"local tumor aggressiveness\"?", "follow_up_response": "local tumor aggressiveness", "follow_up_response_bt": "Local tumor aggressiveness"}]}}
{"id": 155, "src": "for this purpose , formalin - fixed and paraffin - embedded sections obtained from 15 normal ( at autopsy ) donors and 12 men with prostate cancer were analyzed by immunohistochemistry . about 40% of both normal and tumor prostate samples resulted spanx positive . signals were exclusively within the nucleus in normal prostate cells , whereas both nuclear and cytoplasmic positivity was observed in tumor cells .", "mt": "A tal fine , le sezioni forminali - fisse e paraffine - incorporate ottenute da 15 donatori normali (all'autopsia) e da 12 uomini con cancro alla prostata sono state analizzate con immunohistochimia . Circa il 40% dei campioni di prostata normale e tumorale hanno ottenuto risultati spande positivi . I segnali erano esclusivamente all'interno del nucleo nelle cellule prostatiche normali , mentre sia la positività nucleare che quella citoplasmica è stata osservata nelle cellule tumorali .", "pert_mt": "A tal fine, le sezioni formali - fisse e paraffine - incorporate ottenute da 15 donatori normali (all'autopsia) e da 12 uomini con cancro alla prostata sono state analizzate con immunohistochimia. Circa il 40% dei campioni di prostata normale e tumorale hanno ottenuto risultati spande positivi. I segnali erano esclusivamente all'interno del nucleo nelle cellule prostatiche normali, mentre sia la positività nucleare che quella citoplasmica è stata osservata nelle cellule tumorali e nelle cellule staminali prostatiche.", "bt": "Finally, the formal sections - fisse and paraffin - incorporated from 15 normal donors (all autopsies) and 12 men with prostate cancer were analyzed with immunohistochemistry.About 40% of the normal prostate and tumor samples had positive spande results.The signals were exclusively inside the nucleus in normal prostate cells, while both nuclear and cytoplasmic positivity was observed in tumor cells and prostate stem cells.", "questions_src": ["What is the main method used to analyze the samples?", "Who provided the prostate cancer samples for analysis?", "Where were the normal sections obtained from?", "When was the study conducted?", "Which type of positivity was observed in tumor cells?"], "answers_src": ["[\"Immunohistochemistry\"], [\"Men with prostate cancer\"], [\"Normal (at autopsy) donors\"], [\"At autopsy\"], [\"Both nuclear and cytoplasmic\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["Immunohistochemistry", "12 men with prostate cancer", "from 15 normal donors (all autopsies)", "Not specified in the sentence", "Both nuclear and cytoplasmic"], "multiturn": {"turn_1": [{"question_id": "155.1", "question": "What is the main method used to analyze the samples?", "answer_src": "[\"Immunohistochemistry\"], [\"Men with prostate cancer\"], [\"Normal (at autopsy) donors\"], [\"At autopsy\"], [\"Both nuclear and cytoplasmic\"]", "follow_up_question": "What percentage of tumor prostate samples were spanx positive?", "follow_up_response": "40%", "follow_up_response_bt": "40%"}, {"question_id": "155.2", "question": "Who provided the prostate cancer samples for analysis?", "answer_src": "for this purpose , formalin - fixed and paraffin - embedded sections obtained from 15 normal ( at autopsy ) donors and 12 men with prostate cancer were analyzed by immunohistochemistry . about 40% of both normal and tumor prostate samples resulted spanx positive . signals were exclusively within the nucleus in normal prostate cells , whereas both nuclear and cytoplasmic positivity was observed in tumor cells .", "follow_up_question": "What percentage of tumor prostate samples showed spanx positivity?", "follow_up_response": "40%", "follow_up_response_bt": "40%"}, {"question_id": "155.3", "question": "Where were the normal sections obtained from?", "answer_src": "for this purpose , formalin - fixed and paraffin - embedded sections obtained from 15 normal ( at autopsy ) donors and 12 men with prostate cancer were analyzed by immunohistochemistry . about 40% of both normal and tumor prostate samples resulted spanx positive . signals were exclusively within the nucleus in normal prostate cells , whereas both nuclear and cytoplasmic positivity was observed in tumor cells .", "follow_up_question": "What percentage of tumor prostate samples showed spanx positivity?", "follow_up_response": "40%", "follow_up_response_bt": "40%"}, {"question_id": "155.4", "question": "When was the study conducted?", "answer_src": "for this purpose , formalin - fixed and paraffin - embedded sections obtained from 15 normal ( at autopsy ) donors and 12 men with prostate cancer were analyzed by immunohistochemistry . about 40% of both normal and tumor prostate samples resulted spanx positive . signals were exclusively within the nucleus in normal prostate cells , whereas both nuclear and cytoplasmic positivity was observed in tumor cells .", "follow_up_question": "What percentage of tumor prostate samples showed spanx positivity?", "follow_up_response": "40%", "follow_up_response_bt": "40%"}, {"question_id": "155.5", "question": "Which type of positivity was observed in tumor cells?", "answer_src": "for this purpose , formalin - fixed and paraffin - embedded sections obtained from 15 normal ( at autopsy ) donors and 12 men with prostate cancer were analyzed by immunohistochemistry . about 40% of both normal and tumor prostate samples resulted spanx positive . signals were exclusively within the nucleus in normal prostate cells , whereas both nuclear and cytoplasmic positivity was observed in tumor cells .", "follow_up_question": "What was the percentage of tumor prostate samples that resulted spanx positive?", "follow_up_response": "40%", "follow_up_response_bt": "40%"}], "turn_2": [{"question_id": "155.6", "question": "What percentage of tumor prostate samples were spanx positive?", "answer_src": "40%", "follow_up_question": "What percentage of normal prostate samples were spanx positive?", "follow_up_response": "40%", "follow_up_response_bt": "40%"}, {"question_id": "155.7", "question": "What percentage of tumor prostate samples showed spanx positivity?", "answer_src": "40%", "follow_up_question": "What was the distribution of spanx positivity in normal prostate cells?", "follow_up_response": "Signals were exclusively within the nucleus", "follow_up_response_bt": "Exclusively inside the nucleus"}, {"question_id": "155.8", "question": "What percentage of tumor prostate samples showed spanx positivity?", "answer_src": "40%", "follow_up_question": "What was the distribution of spanx positivity in normal prostate cells?", "follow_up_response": "Signals were exclusively within the nucleus", "follow_up_response_bt": "Exclusively inside the nucleus"}, {"question_id": "155.9", "question": "What percentage of tumor prostate samples showed spanx positivity?", "answer_src": "40%", "follow_up_question": "What was the distribution of spanx positivity in normal prostate cells?", "follow_up_response": "Signals were exclusively within the nucleus", "follow_up_response_bt": "Exclusively inside the nucleus"}, {"question_id": "155.10", "question": "What was the percentage of tumor prostate samples that resulted spanx positive?", "answer_src": "40%", "follow_up_question": "What percentage of normal prostate samples resulted spanx positive?", "follow_up_response": "40%", "follow_up_response_bt": "40%"}], "turn_3": [{"question_id": "155.11", "question": "What percentage of normal prostate samples were spanx positive?", "answer_src": "40%", "follow_up_question": "What percentage of tumor prostate samples were spanx positive?", "follow_up_response": "40%", "follow_up_response_bt": "40%"}, {"question_id": "155.12", "question": "What was the distribution of spanx positivity in normal prostate cells?", "answer_src": "Signals were exclusively within the nucleus", "follow_up_question": "What percentage of tumor prostate samples showed spanx positivity?", "follow_up_response": "40%", "follow_up_response_bt": "40%"}, {"question_id": "155.13", "question": "What was the distribution of spanx positivity in normal prostate cells?", "answer_src": "Signals were exclusively within the nucleus", "follow_up_question": "What percentage of tumor prostate samples showed spanx positivity?", "follow_up_response": "40%", "follow_up_response_bt": "40%"}, {"question_id": "155.14", "question": "What was the distribution of spanx positivity in normal prostate cells?", "answer_src": "Signals were exclusively within the nucleus", "follow_up_question": "What percentage of tumor prostate samples showed spanx positivity?", "follow_up_response": "40%", "follow_up_response_bt": "40%"}, {"question_id": "155.15", "question": "What percentage of normal prostate samples resulted spanx positive?", "answer_src": "40%", "follow_up_question": "What percentage of tumor prostate samples resulted spanx positive?", "follow_up_response": "40%", "follow_up_response_bt": "40%"}]}}
{"id": 156, "src": "in the latest year , and also in 2013 , salmonella was the most frequently detected causative agent in foodborne outbreaks ( fbos ) reported in europe . as indicated in efsa report ( 2015 ) the serotypes mostly associated to fbos are s. typhimurium and enteritidis ; while salmonella typhimurium is generally associated with the consumption of contaminated pork and beef , fbos due to salmonella enteritidis are linked to eggs and poultry meat . in this study it is described the investigation of a domestic fbo involving four adults and linked to homemade lasagne .", "mt": "Nell'ultimo anno , e anche nel 2013, la salmonella è stata l' agente causante più frequentemente rilevato negli epidemie alimentari (fbos) segnalati in Europa . Come indicato nel rapporto efsa (2015), i serotipi più associati a fbos sono s. typhimurium e enteritidis; mentre la salmonella typhimurium è generalmente associata al consumo di carne di maiale e di manzo contaminata , le fbos dovute a salmonella enteritidis sono legate ad uova e carne di pollame . in questo studio si descrive l'indagine di un fbo domestico che coinvolge quattro adulti e legato alla lasagna fatta in casa .", "pert_mt": "Nell'ultimo anno, e anche nel 2013, la salmonella è stata l'agente causante più frequentemente rilevato negli epidemie alimentari (fbos) segnalati in Europa. Come indicato nel rapporto efsa (2015), i serotipi più associati a fbos sono s. typhimurium e enteritidis; mentre la salmonella typhimurium è generalmente associata al consumo di carne di maiale e di manzo contaminata, le fbos dovute a salmonella enteritidis sono legate ad uova e prodotti di pollame. In questo studio si descrive l'indagine di un fbo domestico che coinvolge quattro adulti e legato alla lasagna fatta in casa.", "bt": "In the last year, and even in 2013, salmonella has been the most frequently detected causative agent in the food epidemics (fbos) reported in Europe.As indicated in the efsa report (2015), the serotypes most associated with fbos are s. typhimurium e enteritidis; while salmonella typhimurium is generally associated with consumption of contaminated pork and beef, fbos due to salmonella enteritidis are related to eggs and poultry products.In this study, siagna describes the investigation of a domestic fbo involving four adults and related to homemade lasso.", "questions_src": ["What is the most frequently detected causative agent in foodborne outbreaks reported in Europe according to the latest year and 2013 data? ", "Which serotypes are mostly associated with foodborne outbreaks as indicated in the EFSA report of 2015? ", "Which Salmonella serotype is generally associated with the consumption of contaminated pork and beef as mentioned in the study? ", "Which Salmonella serotype is linked to eggs and poultry meat in foodborne outbreaks, as stated in the study? ", "In what type of dish was a domestic foodborne outbreak involving four adults linked to, according to the study? "], "answers_src": ["[\"Salmonella\"], [\"s. typhimurium and enteritidis\"], [\"typhimurium\"], [\"enteritidis\"], [\"homemade lasagne\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["Salmonella", "s. typhimurium and e. enteritidis", "salmonella typhimurium", "salmonella enteritidis", "homemade lasso"], "multiturn": {"turn_1": [{"question_id": "156.1", "question": "What is the most frequently detected causative agent in foodborne outbreaks reported in Europe according to the latest year and 2013 data? ", "answer_src": "[\"Salmonella\"], [\"s. typhimurium and enteritidis\"], [\"typhimurium\"], [\"enteritidis\"], [\"homemade lasagne\"]", "follow_up_question": "Which specific serotype of Salmonella is generally associated with the consumption of contaminated pork and beef?", "follow_up_response": "salmonella typhimurium", "follow_up_response_bt": "salmonella typhimurium"}, {"question_id": "156.2", "question": "Which serotypes are mostly associated with foodborne outbreaks as indicated in the EFSA report of 2015? ", "answer_src": "in the latest year , and also in 2013 , salmonella was the most frequently detected causative agent in foodborne outbreaks ( fbos ) reported in europe . as indicated in efsa report ( 2015 ) the serotypes mostly associated to fbos are s. typhimurium and enteritidis ; while salmonella typhimurium is generally associated with the consumption of contaminated pork and beef , fbos due to salmonella enteritidis are linked to eggs and poultry meat . in this study it is described the investigation of a domestic fbo involving four adults and linked to homemade lasagne .", "follow_up_question": "What specific food items are linked to foodborne outbreaks caused by Salmonella enteritidis according to the text?", "follow_up_response": "eggs and poultry meat", "follow_up_response_bt": "eggs and poultry products"}, {"question_id": "156.3", "question": "Which Salmonella serotype is generally associated with the consumption of contaminated pork and beef as mentioned in the study? ", "answer_src": "in the latest year , and also in 2013 , salmonella was the most frequently detected causative agent in foodborne outbreaks ( fbos ) reported in europe . as indicated in efsa report ( 2015 ) the serotypes mostly associated to fbos are s. typhimurium and enteritidis ; while salmonella typhimurium is generally associated with the consumption of contaminated pork and beef , fbos due to salmonella enteritidis are linked to eggs and poultry meat . in this study it is described the investigation of a domestic fbo involving four adults and linked to homemade lasagne .", "follow_up_question": "Which food item is fbos due to salmonella enteritidis linked to according to the study?", "follow_up_response": "eggs and poultry meat", "follow_up_response_bt": "eggs and poultry products"}, {"question_id": "156.4", "question": "Which Salmonella serotype is linked to eggs and poultry meat in foodborne outbreaks, as stated in the study? ", "answer_src": "in the latest year , and also in 2013 , salmonella was the most frequently detected causative agent in foodborne outbreaks ( fbos ) reported in europe . as indicated in efsa report ( 2015 ) the serotypes mostly associated to fbos are s. typhimurium and enteritidis ; while salmonella typhimurium is generally associated with the consumption of contaminated pork and beef , fbos due to salmonella enteritidis are linked to eggs and poultry meat . in this study it is described the investigation of a domestic fbo involving four adults and linked to homemade lasagne .", "follow_up_question": "What type of meat is salmonella typhimurium generally associated with in foodborne outbreaks?", "follow_up_response": "contaminated pork and beef", "follow_up_response_bt": "contaminated pork and beef"}, {"question_id": "156.5", "question": "In what type of dish was a domestic foodborne outbreak involving four adults linked to, according to the study? ", "answer_src": "in the latest year , and also in 2013 , salmonella was the most frequently detected causative agent in foodborne outbreaks ( fbos ) reported in europe . as indicated in efsa report ( 2015 ) the serotypes mostly associated to fbos are s. typhimurium and enteritidis ; while salmonella typhimurium is generally associated with the consumption of contaminated pork and beef , fbos due to salmonella enteritidis are linked to eggs and poultry meat . in this study it is described the investigation of a domestic fbo involving four adults and linked to homemade lasagne .", "follow_up_question": "What type of meat is salmonella typhimurium generally associated with in foodborne outbreaks?", "follow_up_response": "contaminated pork and beef", "follow_up_response_bt": "contaminated pork and beef"}], "turn_2": [{"question_id": "156.6", "question": "Which specific serotype of Salmonella is generally associated with the consumption of contaminated pork and beef?", "answer_src": "salmonella typhimurium", "follow_up_question": "Which type of meat is not typically linked to foodborne outbreaks caused by Salmonella enteritidis?", "follow_up_response": "pork and beef", "follow_up_response_bt": "contaminated pork and beef"}, {"question_id": "156.7", "question": "What specific food items are linked to foodborne outbreaks caused by Salmonella enteritidis according to the text?", "answer_src": "eggs and poultry meat", "follow_up_question": "What percentage of the outbreak in the study involving homemade lasagne was attributed to Salmonella enteritidis?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "156.8", "question": "Which food item is fbos due to salmonella enteritidis linked to according to the study?", "answer_src": "eggs and poultry meat", "follow_up_question": "Which other food item besides eggs and poultry meat can fbos due to salmonella enteritidis be linked to?", "follow_up_response": "Poultry meat", "follow_up_response_bt": "Poultry products"}, {"question_id": "156.9", "question": "What type of meat is salmonella typhimurium generally associated with in foodborne outbreaks?", "answer_src": "contaminated pork and beef", "follow_up_question": "What specific food item is fbos due to salmonella enteritidis linked to in this study?", "follow_up_response": "eggs and poultry meat", "follow_up_response_bt": "eggs and poultry products"}, {"question_id": "156.10", "question": "What type of meat is salmonella typhimurium generally associated with in foodborne outbreaks?", "answer_src": "contaminated pork and beef", "follow_up_question": "What specific food item is fbos due to salmonella enteritidis linked to in this study?", "follow_up_response": "eggs and poultry meat", "follow_up_response_bt": "eggs and poultry products"}], "turn_3": [{"question_id": "156.11", "question": "Which type of meat is not typically linked to foodborne outbreaks caused by Salmonella enteritidis?", "answer_src": "pork and beef", "follow_up_question": "What specific food item is linked to foodborne outbreaks caused by Salmonella enteritidis?", "follow_up_response": "eggs and poultry meat", "follow_up_response_bt": "eggs and poultry products"}, {"question_id": "156.12", "question": "What percentage of the outbreak in the study involving homemade lasagne was attributed to Salmonella enteritidis?", "answer_src": "in the latest year , and also in 2013 , salmonella was the most frequently detected causative agent in foodborne outbreaks ( fbos ) reported in europe . as indicated in efsa report ( 2015 ) the serotypes mostly associated to fbos are s. typhimurium and enteritidis ; while salmonella typhimurium is generally associated with the consumption of contaminated pork and beef , fbos due to salmonella enteritidis are linked to eggs and poultry meat . in this study it is described the investigation of a domestic fbo involving four adults and linked to homemade lasagne .", "follow_up_question": "What type of food was linked to fbos caused by Salmonella enteritidis according to the text?", "follow_up_response": "eggs and poultry meat", "follow_up_response_bt": "eggs and poultry products"}, {"question_id": "156.13", "question": "Which other food item besides eggs and poultry meat can fbos due to salmonella enteritidis be linked to?", "answer_src": "Poultry meat", "follow_up_question": "Homemade lasagne as part of the domestic fbo involved in this study, was it prepared using ingredients that were likely contaminated with which type of salmonella?", "follow_up_response": "salmonella enteritidis", "follow_up_response_bt": "salmonella enteritidis"}, {"question_id": "156.14", "question": "What specific food item is fbos due to salmonella enteritidis linked to in this study?", "answer_src": "eggs and poultry meat", "follow_up_question": "What percentage of fbos involving salmonella were linked to eggs and poultry meat according to EFSA report (2015)?", "follow_up_response": "9.0%", "follow_up_response_bt": "9.0%"}, {"question_id": "156.15", "question": "What specific food item is fbos due to salmonella enteritidis linked to in this study?", "answer_src": "eggs and poultry meat", "follow_up_question": "What percentage of fbos involving salmonella were linked to eggs and poultry meat according to EFSA report (2015)?", "follow_up_response": "9.0%", "follow_up_response_bt": "9.0%"}]}}
{"id": 157, "src": "we have developed a specific monoclonal antibody against 6-oxo - m1dg and have incorporated this antibody into a procedure for the immunoaffinity isolation of 6-oxo - m1dg from biological matrices . the purified analyte is quantified by lc - ms / ms using a stable isotope - labeled analogue ( [ 15n5]-6-oxo - m1dg ) as an internal standard . healthy male sprague dawley rats excreted 6-oxo - m1dg at a rate of 3501893 fmol / kgd in feces .", "mt": "Abbiamo sviluppato un anticorpo monoclonale specifico contro il 6-oxo - m1dg e abbiamo incorporato questo anticorpo in una procedura per l'isolamento di immunoafinità del 6-oxo - m1dg dalle matrici biologiche . L'analista purificato è quantificato da lc - ms / ms utilizzando un analogo stabilizzato da isotopo ([ 15n5]-6-oxo - m1dg) come standard interno . Ratti da dawley sani di maschio di sprague hanno escreto il 6-oxo - m1dg a un tasso di 3501893 fmol / kgd nelle feci .", "pert_mt": "Abbiamo sviluppato un anticorpo monoclonale specifico contro il 6-oxo - m1dg e abbiamo incorporato questo anticorpo in una procedura per l'isolamento di immunoafinità del 6-oxo - m1dg dalle matrici biologiche. Inoltre, l'analista purificato è quantificato da lc - ms / ms utilizzando un analogo stabilizzato da isotopo ([ 15n5]-6-oxo - m1dg) come standard interno. Ratti da dawley sani di maschio di sprague hanno escreto il 6-oxo - m1dg a un tasso di 3501893 fmol / kgd nelle feci.", "bt": "We developed a specific monoclonal antibody against the 6-oxo - m1dg and incorporated this antibody into a procedure for isolating the immunoaffection of the 6-oxo - m1dg from biological matrices.Moreover, the purified analyst quantified the lc - ms / ms using a stabilized analog of the isotope ([15n5]-6-oxo - m1dg) as the internal standard.Rats and dawley of male sprague have a 6-oxo - m1dg scrotum at a rate of 3501893 fmol / kgd in feces.", "questions_src": ["What is the name of the internal standard used to quantify the purified analyte?", "Who has developed the specific monoclonal antibody?", "Where was the 6-oxo-m1dg quantified?", "How much 6-oxo-m1dg did healthy male sprague dawley rats excrete in feces per kilogram per day?", "Which method was used for the immunoaffinity isolation of 6-oxo-m1dg?"], "answers_src": ["[15N5]-6-oxo-m1dg", "we have developed a specific monoclonal antibody", "lc-ms/ms", "3501893", "a procedure for the immunoaffinity isolation"], "answers_bt": ["[15N5]-6-oxo-m1dg", "We", "lc-ms/ms", "3501893", "a procedure"], "multiturn": {"turn_1": [{"question_id": "157.1", "question": "What is the name of the internal standard used to quantify the purified analyte?", "answer_src": "[15N5]-6-oxo-m1dg", "follow_up_question": "What is the daily excretion rate of 6-oxo-m1dg in feces for healthy male Sprague-Dawley rats?", "follow_up_response": "3501893 fmol / kgd", "follow_up_response_bt": "3501893 fmol / kgd"}, {"question_id": "157.2", "question": "Who has developed the specific monoclonal antibody?", "answer_src": "we have developed a specific monoclonal antibody", "follow_up_question": "What is the name of the internal standard used for quantification?", "follow_up_response": "[15N5]-6-oxo-m1dg", "follow_up_response_bt": "[15n5]-6-oxo - m1dg"}, {"question_id": "157.3", "question": "Where was the 6-oxo-m1dg quantified?", "answer_src": "lc-ms/ms", "follow_up_question": "What is the unit of measurement used for the excretion rate of 6-oxo-m1dg?", "follow_up_response": "fmol / kgd", "follow_up_response_bt": "fmol / kgd"}, {"question_id": "157.4", "question": "How much 6-oxo-m1dg did healthy male sprague dawley rats excrete in feces per kilogram per day?", "answer_src": "3501893", "follow_up_question": "What was the total amount of 6-oxo-m1dg excreted by the rats in feces over a week?", "follow_up_response": "3501893 fmol / kgd", "follow_up_response_bt": "No Answer"}, {"question_id": "157.5", "question": "Which method was used for the immunoaffinity isolation of 6-oxo-m1dg?", "answer_src": "a procedure for the immunoaffinity isolation", "follow_up_question": "What is the concentration of 6-oxo-m1dg excreted by healthy male Sprague-Dawley rats per kilogram of body weight per day?", "follow_up_response": "3501893 fmol / kgd", "follow_up_response_bt": "3501893 fmol / kgd"}], "turn_2": [{"question_id": "157.6", "question": "What is the daily excretion rate of 6-oxo-m1dg in feces for healthy male Sprague-Dawley rats?", "answer_src": "3501893 fmol / kgd", "follow_up_question": "What is the molecular weight of 6-oxo-m1dg based on the information provided?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "157.7", "question": "What is the name of the internal standard used for quantification?", "answer_src": "[15N5]-6-oxo-m1dg", "follow_up_question": "What is the daily excretion rate of 6-oxo-m1dg in feces for healthy male Sprague-Dawley rats?", "follow_up_response": "3501893 fmol / kgd", "follow_up_response_bt": "3501893 fmol / kgd"}, {"question_id": "157.8", "question": "What is the unit of measurement used for the excretion rate of 6-oxo-m1dg?", "answer_src": "fmol / kgd", "follow_up_question": "What is the total amount of 6-oxo-m1dg excreted by one kilogram of rat body mass over a day?", "follow_up_response": "3501893 fmol", "follow_up_response_bt": "3501893 fmol / kgd"}, {"question_id": "157.9", "question": "What was the total amount of 6-oxo-m1dg excreted by the rats in feces over a week?", "answer_src": "3501893 fmol / kgd", "follow_up_question": "How many times more fmol of 6-oxo-m1dg was excreted per day compared to per kilogram?", "follow_up_response": "3501893", "follow_up_response_bt": "3501893"}, {"question_id": "157.10", "question": "What is the concentration of 6-oxo-m1dg excreted by healthy male Sprague-Dawley rats per kilogram of body weight per day?", "answer_src": "3501893 fmol / kgd", "follow_up_question": "What is the unit of measurement used to express the excretion rate of 6-oxo-m1dg?", "follow_up_response": "fmol / kgd", "follow_up_response_bt": "fmol / kgd"}], "turn_3": [{"question_id": "157.11", "question": "What is the molecular weight of 6-oxo-m1dg based on the information provided?", "answer_src": "we have developed a specific monoclonal antibody against 6-oxo - m1dg and have incorporated this antibody into a procedure for the immunoaffinity isolation of 6-oxo - m1dg from biological matrices . the purified analyte is quantified by lc - ms / ms using a stable isotope - labeled analogue ( [ 15n5]-6-oxo - m1dg ) as an internal standard . healthy male sprague dawley rats excreted 6-oxo - m1dg at a rate of 3501893 fmol / kgd in feces .", "follow_up_question": "How much 6-oxo-m1dg did one kilogram of healthy male Sprague-Dawley rat excrete per day?", "follow_up_response": "3501893 fmol", "follow_up_response_bt": "3501893 fmol / kgd"}, {"question_id": "157.12", "question": "What is the daily excretion rate of 6-oxo-m1dg in feces for healthy male Sprague-Dawley rats?", "answer_src": "3501893 fmol / kgd", "follow_up_question": "What is the molecular weight of 6-oxo-m1dg based on the information provided?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "157.13", "question": "What is the total amount of 6-oxo-m1dg excreted by one kilogram of rat body mass over a day?", "answer_src": "3501893 fmol", "follow_up_question": "What is the concentration of 6-oxo-m1dg in feces per gram of rat body mass?", "follow_up_response": "3501893 fmol / kgd", "follow_up_response_bt": "3501893 fmol / kg"}, {"question_id": "157.14", "question": "How many times more fmol of 6-oxo-m1dg was excreted per day compared to per kilogram?", "answer_src": "3501893", "follow_up_question": "What was the total amount of 6-oxo-m1dg excreted in feces over a week?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "157.15", "question": "What is the unit of measurement used to express the excretion rate of 6-oxo-m1dg?", "answer_src": "fmol / kgd", "follow_up_question": "What is the total amount of 6-oxo-m1dg excreted by one kilogram of rat body mass over a day?", "follow_up_response": "3501893 fmol", "follow_up_response_bt": "3501893 fmol / kgd"}]}}
{"id": 158, "src": "the analyses were repeated using the national equations . both the atlantic and the national equations yielded corrected obesity estimates that were significantly more accurate than those based on self - report . the results provide some evidence of the generalizability of the national equations to atypical regions of canada .", "mt": "Le analisi sono state ripetute utilizzando le equazioni nazionali . Sia le equazioni nazionali che quelle atlantiche hanno prodotto stime corrette di obesità che erano significativamente più accurate di quelle basate su auto-riporto . I risultati forniscono alcune prove della generalizzabilità delle equazioni nazionali per le regioni atipiche del Canada .", "pert_mt": "Le analisi sono state ripetute utilizzando le equazioni nazionali. Sia le equazioni nazionali che quelle atlantiche hanno prodotto stime corrette di obesità che erano significativamente più accurate di quelle basate su auto-riporto. Inoltre, i risultati forniscono alcune prove della generalizzabilità delle equazioni nazionali per le regioni atipiche del Canada.", "bt": "Both the national and Atlantic equations produced correct estimates of obesity that were significantly more accurate than those based on self-reporting, and the results provide some evidence of the generalizability of the national equations for the atypical regions of Canada.", "questions_src": ["What were repeated in the analyses?", "Who yielded corrected obesity estimates?", "Where were the atlantic and national equations used?", "When did the results provide evidence?", "Which equations provided more accurate results?"], "answers_src": ["the national equations", "both the atlantic and the national equations", "atypical regions of canada", "nowhere specifically mentioned", "the national equations"], "answers_bt": ["the national and Atlantic equations", "Both the national and Atlantic equations", "atypical regions of Canada", "nowhere specifically mentioned", "the national and Atlantic equations"], "multiturn": {"turn_1": [{"question_id": "158.1", "question": "What were repeated in the analyses?", "answer_src": "the national equations", "follow_up_question": "How did the national equations compare to the atlantic equations in terms of accuracy?", "follow_up_response": "the national equations yielded corrected obesity estimates that were significantly more accurate than those based on self-report", "follow_up_response_bt": "correct estimates of obesity that were significantly more accurate"}, {"question_id": "158.2", "question": "Who yielded corrected obesity estimates?", "answer_src": "both the atlantic and the national equations", "follow_up_question": "What was the level of accuracy improvement for the corrected obesity estimates?", "follow_up_response": "significantly more accurate", "follow_up_response_bt": "Significantly more accurate"}, {"question_id": "158.3", "question": "Where were the atlantic and national equations used?", "answer_src": "atypical regions of canada", "follow_up_question": "What specific regions of Canada were considered atypical?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "158.4", "question": "When did the results provide evidence?", "answer_src": "nowhere specifically mentioned", "follow_up_question": "What regions of Canada were found to have generalizable national equations?", "follow_up_response": "atypical regions of canada", "follow_up_response_bt": "atypical"}, {"question_id": "158.5", "question": "Which equations provided more accurate results?", "answer_src": "the national equations", "follow_up_question": "How did the national equations improve the accuracy compared to self-reporting?", "follow_up_response": "Corrected obesity estimates", "follow_up_response_bt": "The national equations produced correct estimates of obesity that were significantly more accurate than those based on self-reporting"}], "turn_2": [{"question_id": "158.6", "question": "How did the national equations compare to the atlantic equations in terms of accuracy?", "answer_src": "the national equations yielded corrected obesity estimates that were significantly more accurate than those based on self-report", "follow_up_question": "What specific regions of Canada were found to have generalizable national equations?", "follow_up_response": "atypical regions of canada", "follow_up_response_bt": "atypical regions"}, {"question_id": "158.7", "question": "What was the level of accuracy improvement for the corrected obesity estimates?", "answer_src": "significantly more accurate", "follow_up_question": "How much more accurate were the corrected obesity estimates compared to the self-report estimates?", "follow_up_response": "significantly more accurate", "follow_up_response_bt": "significantly"}, {"question_id": "158.8", "question": "What specific regions of Canada were considered atypical?", "answer_src": "the analyses were repeated using the national equations . both the atlantic and the national equations yielded corrected obesity estimates that were significantly more accurate than those based on self - report . the results provide some evidence of the generalizability of the national equations to atypical regions of canada .", "follow_up_question": "What regions besides the Atlantic were found to have generalizable national equations?", "follow_up_response": "No Answer", "follow_up_response_bt": "the atypical regions of Canada"}, {"question_id": "158.9", "question": "What regions of Canada were found to have generalizable national equations?", "answer_src": "atypical regions of canada", "follow_up_question": "What specific national equations were used for these atypical regions?", "follow_up_response": "the national equations", "follow_up_response_bt": "Both the national and Atlantic equations"}, {"question_id": "158.10", "question": "How did the national equations improve the accuracy compared to self-reporting?", "answer_src": "Corrected obesity estimates", "follow_up_question": "What specific regions of Canada were found to have generalizable national equations?", "follow_up_response": "atypical regions of canada", "follow_up_response_bt": "atypical regions"}], "turn_3": [{"question_id": "158.11", "question": "What specific regions of Canada were found to have generalizable national equations?", "answer_src": "atypical regions of canada", "follow_up_question": "What were the corrected obesity estimates based on the national equations?", "follow_up_response": "corrected obesity estimates", "follow_up_response_bt": "corrected obesity estimates"}, {"question_id": "158.12", "question": "How much more accurate were the corrected obesity estimates compared to the self-report estimates?", "answer_src": "significantly more accurate", "follow_up_question": "By how much did the corrected obesity estimates improve over the self-report estimates?", "follow_up_response": "some evidence", "follow_up_response_bt": "significantly"}, {"question_id": "158.13", "question": "What regions besides the Atlantic were found to have generalizable national equations?", "answer_src": "the analyses were repeated using the national equations . both the atlantic and the national equations yielded corrected obesity estimates that were significantly more accurate than those based on self - report . the results provide some evidence of the generalizability of the national equations to atypical regions of canada .", "follow_up_question": "What regions besides the Atlantic were found to have generalizable national equations according to the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "atypical regions of Canada"}, {"question_id": "158.14", "question": "What specific national equations were used for these atypical regions?", "answer_src": "the national equations", "follow_up_question": "How many regions of Canada were considered atypical in this study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "158.15", "question": "What specific regions of Canada were found to have generalizable national equations?", "answer_src": "atypical regions of canada", "follow_up_question": "What were the corrected obesity estimates based on the national equations?", "follow_up_response": "corrected obesity estimates", "follow_up_response_bt": "corrected obesity estimates"}]}}
{"id": 159, "src": "in consequence , each agonist muscle fiber is stimulated by an agonist neuron , while an antagonist muscle fiber is unstimulated by a pause and step from the antagonist neuron . it is concluded that the neural network is constrained by a minimum duration of the agonist pulse and that the most dominant factor in determining the saccade magnitude is the number of active neurons for the small saccades . for the large saccades , however , the duration of agonist burst firing significantly affects the control of saccades .", "mt": "Di conseguenza , ogni fibra muscolare agonista è stimolata da un neurone agonista , mentre una fibra muscolare antagonista è non stimolata da una pausa e un passo dal neurone antagonista . Si conclude che la rete neurale è limitata da una durata minima del pulso agonista e che il fattore più dominante nel determinare la grandezza del sacchato è il numero di neuroni attivi per i piccoli sacchati .", "pert_mt": "Di conseguenza, ogni fibra muscolare agonista è stimolata da un neurone agonista, mentre una fibra muscolare antagonista è non stimolata da una pausa e un passo dal neurone antagonista. Si conclude che la rete neurale è limitata da una durata minima del pulso agonista e che il fattore più dominante nel determinare la grandezza del sacchato è il numero di neuroni attivi per i piccoli sacchati, indipendentemente dalla frequenza cardiacia.", "bt": "As a result, each agonist muscle fiber is stimulated by an agonist neuron, while an antagonist muscle fiber is not stimulated by a pause and a step from the antagonist neuron.It is concluded that the neural network is limited by a minimum duration of the agonist pulse and that the most dominant factor in determining the size of the sacchato and the number of active neurons for small sacchats, regardless of cardiac frequency, is determined.", "questions_src": ["What does each agonist muscle fiber rely on for stimulation?", "Who pauses and steps to unstimulate antagonist muscle fibers?", "Where does the neural network have a minimum duration constraint?", "When is the most dominant factor in small saccade magnitude determined?", "Which factor significantly affects large saccade control?"], "answers_src": ["an agonist neuron", "an antagonist neuron", "the neural network", "the number of active neurons", "the duration of agonist burst firing"], "answers_bt": ["an agonist neuron", "an antagonist neuron", "the neural network", "regardless of cardiac frequency", "the minimum duration of the agonist pulse"], "multiturn": {"turn_1": [{"question_id": "159.1", "question": "What does each agonist muscle fiber rely on for stimulation?", "answer_src": "an agonist neuron", "follow_up_question": "What role does the antagonist neuron play in muscle fiber stimulation?", "follow_up_response": "an antagonist muscle fiber is unstimulated", "follow_up_response_bt": "It is not stimulated"}, {"question_id": "159.2", "question": "Who pauses and steps to unstimulate antagonist muscle fibers?", "answer_src": "an antagonist neuron", "follow_up_question": "What is the effect of the duration of the agonist burst firing on large saccades?", "follow_up_response": "The duration of agonist burst firing significantly affects the control of saccades.", "follow_up_response_bt": "No Answer"}, {"question_id": "159.3", "question": "Where does the neural network have a minimum duration constraint?", "answer_src": "the neural network", "follow_up_question": "What is the minimum duration constraint in the neural network?", "follow_up_response": "A minimum duration of the agonist pulse", "follow_up_response_bt": "A minimum duration of the agonist pulse"}, {"question_id": "159.4", "question": "When is the most dominant factor in small saccade magnitude determined?", "answer_src": "the number of active neurons", "follow_up_question": "How does the duration of the agonist burst firing affect large saccades?", "follow_up_response": "The duration of agonist burst firing significantly affects the control of saccades.", "follow_up_response_bt": "No Answer"}, {"question_id": "159.5", "question": "Which factor significantly affects large saccade control?", "answer_src": "the duration of agonist burst firing", "follow_up_question": "How does the duration of agonist burst firing affect large saccade control?", "follow_up_response": "Significantly", "follow_up_response_bt": "It is concluded that the neural network is limited by a minimum duration of the agonist pulse"}], "turn_2": [{"question_id": "159.6", "question": "What role does the antagonist neuron play in muscle fiber stimulation?", "answer_src": "an antagonist muscle fiber is unstimulated", "follow_up_question": "How does the duration of the agonist pulse affect saccade magnitude for large saccades?", "follow_up_response": "The duration of agonist burst firing significantly affects the control of saccades.", "follow_up_response_bt": "No Answer"}, {"question_id": "159.7", "question": "What is the effect of the duration of the agonist burst firing on large saccades?", "answer_src": "The duration of agonist burst firing significantly affects the control of saccades.", "follow_up_question": "How does the duration of agonist burst firing differ between small and large saccades?", "follow_up_response": "The duration of agonist burst firing significantly affects the control of saccades for large saccades, while for small saccades, the most dominant factor is the number of active neurons.", "follow_up_response_bt": "No Answer"}, {"question_id": "159.8", "question": "What is the minimum duration constraint in the neural network?", "answer_src": "A minimum duration of the agonist pulse", "follow_up_question": "How does the duration of the agonist pulse affect saccades for large saccades?", "follow_up_response": "The duration of agonist burst firing significantly affects the control of saccades.", "follow_up_response_bt": "No Answer"}, {"question_id": "159.9", "question": "How does the duration of the agonist burst firing affect large saccades?", "answer_src": "The duration of agonist burst firing significantly affects the control of saccades.", "follow_up_question": "What is the relationship between the duration of the agonist burst firing and the control of large saccades?", "follow_up_response": "The duration of agonist burst firing significantly affects the control of saccades.", "follow_up_response_bt": "No Answer"}, {"question_id": "159.10", "question": "How does the duration of agonist burst firing affect large saccade control?", "answer_src": "Significantly", "follow_up_question": "What is the relationship between the duration of agonist burst firing and small saccade control?", "follow_up_response": "the duration of agonist burst firing significantly affects the control of saccades", "follow_up_response_bt": "The most dominant factor in determining the size of the saccade and the number of active neurons for small saccades, regardless of cardiac frequency, is the duration of the agonist pulse."}], "turn_3": [{"question_id": "159.11", "question": "How does the duration of the agonist pulse affect saccade magnitude for large saccades?", "answer_src": "The duration of agonist burst firing significantly affects the control of saccades.", "follow_up_question": "How does the number of active neurons influence saccade magnitude for large saccades?", "follow_up_response": "The duration of agonist burst firing significantly affects the control of saccades.", "follow_up_response_bt": "No Answer"}, {"question_id": "159.12", "question": "How does the duration of agonist burst firing differ between small and large saccades?", "answer_src": "The duration of agonist burst firing significantly affects the control of saccades for large saccades, while for small saccades, the most dominant factor is the number of active neurons.", "follow_up_question": "How does the number of active neurons for small saccades compare to the duration of agonist burst firing for large saccades?", "follow_up_response": "the most dominant factor in determining the saccade magnitude is the number of active neurons for the small saccades, while for the large saccades, the duration of agonist burst firing significantly affects the control of saccades.", "follow_up_response_bt": "No Answer"}, {"question_id": "159.13", "question": "How does the duration of the agonist pulse affect saccades for large saccades?", "answer_src": "The duration of agonist burst firing significantly affects the control of saccades.", "follow_up_question": "What is the relationship between the number of active neurons and saccade magnitude for large saccades?", "follow_up_response": "the duration of agonist burst firing significantly affects the control of saccades", "follow_up_response_bt": "No Answer"}, {"question_id": "159.14", "question": "What is the relationship between the duration of the agonist burst firing and the control of large saccades?", "answer_src": "The duration of agonist burst firing significantly affects the control of saccades.", "follow_up_question": "How does the number of active neurons influence the control of small saccades?", "follow_up_response": "The most dominant factor", "follow_up_response_bt": "The most dominant factor in determining the size of the sacchato and the number of active neurons for small sacchats, regardless of cardiac frequency"}, {"question_id": "159.15", "question": "What is the relationship between the duration of agonist burst firing and small saccade control?", "answer_src": "the duration of agonist burst firing significantly affects the control of saccades", "follow_up_question": "How does the number of active neurons influence the control of large saccades?", "follow_up_response": "The duration of agonist burst firing", "follow_up_response_bt": "No Answer"}]}}
{"id": 160, "src": "nearly , 50% of the patients were farmers , 30% businessmen and 20% were civil servant . 7 ( 70% ) of these patients presented with fournier 's gangrene within 4 weeks of development of fistula - in - ano and the rest within 8 weeks . 4 ( 40% ) of these patients had inadequate drainage of their perianal abscess and 2 ( 20% ) had incision and drainage .", "mt": "Il 50% dei pazienti erano agricoltori , il 30% uomini d'affari e il 20% funzionari pubblici . 7 (70%) di questi pazienti presentavano gangrena di fournier entro 4 settimane dallo sviluppo della fistola e il resto entro 8 settimane . 4 (40%) di questi pazienti avevano un drenaggio insufficiente del loro assesso perianale e 2 (20%) avevano incisione e drenaggio .", "pert_mt": "Il 50% dei pazienti erano agricoltori, il 30% uomini d'affari e il 20% funzionari pubblici. 7 (70%) di questi pazienti presentavano gangrena di Fournier entro 4 settimane dallo sviluppo della fistola e il resto entro 8 settimane. 4 (40%) di questi pazienti avevano un drenaggio insufficiente del loro assesso perianale e 2 (20%) avevano incisione e drenaggio e complessivi problemi di salute.", "bt": "50% of the patients were farmers, 30% were businessmen and 20% were civil servants. 7 (70%) of these patients had Fournier's gangrene within 4 weeks of developing the fistula and the rest within 8 weeks. 4 (40%) of these patients had insufficient drainage of their perianal axis and 2 (20%) had incisions and drainage and overall health problems.", "questions_src": ["What percentage of the patients were farmers?", "When did 70% of the patients present with Fournier's gangrene?", "Which group made up 30% of the patients?", "How many patients had inadequate drainage of their perianal abscess?", "Which condition affected 20% of the patients?"], "answers_src": ["50%", "Within 4 weeks", "businessmen", "4", "incision and drainage"], "answers_bt": ["50%", "Within 4 weeks", "businessmen", "4", "Overall health problems"], "multiturn": {"turn_1": [{"question_id": "160.1", "question": "What percentage of the patients were farmers?", "answer_src": "50%", "follow_up_question": "What was the total percentage of patients who developed Fournier's gangrene within 4 weeks?", "follow_up_response": "70%", "follow_up_response_bt": "70%"}, {"question_id": "160.2", "question": "When did 70% of the patients present with Fournier's gangrene?", "answer_src": "Within 4 weeks", "follow_up_question": "When did the remaining 30% of the patients present with Fournier's gangrene?", "follow_up_response": "within 8 weeks", "follow_up_response_bt": "within 8 weeks"}, {"question_id": "160.3", "question": "Which group made up 30% of the patients?", "answer_src": "businessmen", "follow_up_question": "How many patients presented with Fournier's gangrene within 4 weeks?", "follow_up_response": "7", "follow_up_response_bt": "7"}, {"question_id": "160.4", "question": "How many patients had inadequate drainage of their perianal abscess?", "answer_src": "4", "follow_up_question": "How many patients had incision and drainage?", "follow_up_response": "2", "follow_up_response_bt": "2"}, {"question_id": "160.5", "question": "Which condition affected 20% of the patients?", "answer_src": "incision and drainage", "follow_up_question": "Which percentage of patients had inadequate drainage of their perianal abscess?", "follow_up_response": "20%", "follow_up_response_bt": "20%"}], "turn_2": [{"question_id": "160.6", "question": "What was the total percentage of patients who developed Fournier's gangrene within 4 weeks?", "answer_src": "70%", "follow_up_question": "What was the total percentage of patients who developed Fournier's gangrene within 8 weeks?", "follow_up_response": "20%", "follow_up_response_bt": "30"}, {"question_id": "160.7", "question": "When did the remaining 30% of the patients present with Fournier's gangrene?", "answer_src": "within 8 weeks", "follow_up_question": "What percentage of the patients had inadequate drainage of their perianal abscess?", "follow_up_response": "20%", "follow_up_response_bt": "20%"}, {"question_id": "160.8", "question": "How many patients presented with Fournier's gangrene within 4 weeks?", "answer_src": "7", "follow_up_question": "How many patients presented with Fournier's gangrene within 8 weeks?", "follow_up_response": "2", "follow_up_response_bt": "2"}, {"question_id": "160.9", "question": "How many patients had incision and drainage?", "answer_src": "2", "follow_up_question": "How many patients had inadequate drainage of their perianal abscess?", "follow_up_response": "2", "follow_up_response_bt": "2"}, {"question_id": "160.10", "question": "Which percentage of patients had inadequate drainage of their perianal abscess?", "answer_src": "20%", "follow_up_question": "What was the total percentage of patients who had inadequate drainage of their perianal abscess?", "follow_up_response": "20%", "follow_up_response_bt": "20%"}], "turn_3": [{"question_id": "160.11", "question": "What was the total percentage of patients who developed Fournier's gangrene within 8 weeks?", "answer_src": "20%", "follow_up_question": "What was the percentage of patients who did not have adequate drainage of their perianal abscess?", "follow_up_response": "60%, 30%, 10%", "follow_up_response_bt": "20%"}, {"question_id": "160.12", "question": "What percentage of the patients had inadequate drainage of their perianal abscess?", "answer_src": "20%", "follow_up_question": "What was the total number of patients who had inadequate drainage of their perianal abscess?", "follow_up_response": "2", "follow_up_response_bt": "2"}, {"question_id": "160.13", "question": "How many patients presented with Fournier's gangrene within 8 weeks?", "answer_src": "2", "follow_up_question": "How many patients had inadequate drainage of their perianal abscess?", "follow_up_response": "2", "follow_up_response_bt": "2"}, {"question_id": "160.14", "question": "How many patients had inadequate drainage of their perianal abscess?", "answer_src": "2", "follow_up_question": "How many patients had incision and drainage?", "follow_up_response": "2", "follow_up_response_bt": "2"}, {"question_id": "160.15", "question": "What was the total percentage of patients who had inadequate drainage of their perianal abscess?", "answer_src": "20%", "follow_up_question": "What was the total percentage of patients who had incision and drainage?", "follow_up_response": "20%", "follow_up_response_bt": "20%"}]}}
{"id": 161, "src": "using 64-channel multidetector row computed tomographic angiography ( mdcta ) , we evaluated morphological features of the major systemic vessels in micropigs and compared our results to published human data . the main vasculature of the animals was similar to that of humans , except for the iliac arterial system . however , diameters of the major systemic vessels were significantly different between micropigs and humans .", "mt": "Usando la riga di 64 canali di multi-detettore di tomografia computarizzata (mdcta) abbiamo valutato le caratteristiche morfologiche dei principali vasi sistemici nei micro-cinnoni e confrontato i nostri risultati con i dati umani pubblicati . La vasculatura principale degli animali era simile a quella degli esseri umani , tranne che per il sistema iatico arterioso . Tuttavia , i diametri dei principali vasi sistemici erano significativamente diversi tra i micro-cinnoni e gli esseri umani .", "pert_mt": "Usando la riga di 64 canali di multi-detettore di tomografia computarizzata (MDCTA) abbiamo valutato le caratteristiche morfologiche dei principali vasi sistemici nei micro-cinnoni e confrontato i nostri risultati con i dati umani pubblicati. La vasculatura principale degli animali era simile a quella degli esseri umani, tranne che per il sistema iatico arterioso. Tuttavia, i diametri dei principali vasi sistemici erano significativamente diversi tra i micro-cinnoni e gli esseri umani, indipendentemente dal genere degli animali utilizzati.", "bt": "Using the 64-channel line of multi-detector computed tomography (MDCTA) scanners, we evaluated the morphological characteristics of the main systemic vessels in these micro-cinnons and compared our results with published human data.The main animal vasculature was similar to that of humans, except for the arterial system.However, the diameters of the main systemic vessels were significantly different between micro-cinnons and humans, regardless of the sex of the animals used.", "questions_src": ["What is the full name of the imaging technique used in the study?", "Who were the subjects of the study?", "Where was the study conducted?", "When was the study performed?", "Which vascular system of the animals was different from humans?"], "answers_src": ["64-channel multidetector row computed tomographic angiography (mdcta)", "micropigs", "not specified", "not specified", "iliac arterial system"], "answers_bt": ["Multi-detector computed tomography (MDCTA)", "Micro-cinnons", "Not specified", "Not specified", "Arterial"], "multiturn": {"turn_1": [{"question_id": "161.1", "question": "What is the full name of the imaging technique used in the study?", "answer_src": "64-channel multidetector row computed tomographic angiography (mdcta)", "follow_up_question": "How do the diameters of the major systemic vessels differ between micropigs and humans?", "follow_up_response": "Significantly different", "follow_up_response_bt": "Significantly different"}, {"question_id": "161.2", "question": "Who were the subjects of the study?", "answer_src": "micropigs", "follow_up_question": "What were the key differences found between the diameters of the major systemic vessels in micropigs and humans?", "follow_up_response": "Diameters", "follow_up_response_bt": "The diameters of the main systemic vessels were significantly different between micro-cinnons and humans, regardless of the sex of the animals used."}, {"question_id": "161.3", "question": "Where was the study conducted?", "answer_src": "not specified", "follow_up_question": "What were the specific differences found in the diameters of the major systemic vessels between micropigs and humans?", "follow_up_response": "Significantly different", "follow_up_response_bt": "The diameters"}, {"question_id": "161.4", "question": "When was the study performed?", "answer_src": "not specified", "follow_up_question": "What is the main difference found between the diameters of the major systemic vessels in micropigs and humans?", "follow_up_response": "Diameters", "follow_up_response_bt": "Significantly different"}, {"question_id": "161.5", "question": "Which vascular system of the animals was different from humans?", "answer_src": "iliac arterial system", "follow_up_question": "What was the average diameter difference found between micropigs and humans in the major systemic vessels?", "follow_up_response": "Significantly different", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "161.6", "question": "How do the diameters of the major systemic vessels differ between micropigs and humans?", "answer_src": "Significantly different", "follow_up_question": "What is the average percentage difference in diameters between micropigs and humans?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "161.7", "question": "What were the key differences found between the diameters of the major systemic vessels in micropigs and humans?", "answer_src": "Diameters", "follow_up_question": "How did the diameters of the major systemic vessels in micropigs compare specifically to those in humans?", "follow_up_response": "Significantly different", "follow_up_response_bt": "significantly different"}, {"question_id": "161.8", "question": "What were the specific differences found in the diameters of the major systemic vessels between micropigs and humans?", "answer_src": "Significantly different", "follow_up_question": "What were the specific major systemic vessels whose diameters showed significant differences?", "follow_up_response": "the major systemic vessels", "follow_up_response_bt": "The main systemic vessels"}, {"question_id": "161.9", "question": "What is the main difference found between the diameters of the major systemic vessels in micropigs and humans?", "answer_src": "Diameters", "follow_up_question": "How much larger or smaller were the diameters of the major systemic vessels in micropigs compared to humans?", "follow_up_response": "significantly different", "follow_up_response_bt": "significantly different"}, {"question_id": "161.10", "question": "What was the average diameter difference found between micropigs and humans in the major systemic vessels?", "answer_src": "Significantly different", "follow_up_question": "What was the range of diameter differences found between micropigs and humans in the major systemic vessels?", "follow_up_response": "Significantly different", "follow_up_response_bt": "Significantly different"}], "turn_3": [{"question_id": "161.11", "question": "What is the average percentage difference in diameters between micropigs and humans?", "answer_src": "using 64-channel multidetector row computed tomographic angiography ( mdcta ) , we evaluated morphological features of the major systemic vessels in micropigs and compared our results to published human data . the main vasculature of the animals was similar to that of humans , except for the iliac arterial system . however , diameters of the major systemic vessels were significantly different between micropigs and humans .", "follow_up_question": "What were the specific major systemic vessels found to have significantly different diameters between micropigs and humans?", "follow_up_response": "the major systemic vessels", "follow_up_response_bt": "main systemic vessels"}, {"question_id": "161.12", "question": "How did the diameters of the major systemic vessels in micropigs compare specifically to those in humans?", "answer_src": "Significantly different", "follow_up_question": "What was the average percentage difference in vessel diameters between micropigs and humans?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "161.13", "question": "What were the specific major systemic vessels whose diameters showed significant differences?", "answer_src": "the major systemic vessels", "follow_up_question": "What were the specific major systemic vessels whose diameters showed significant differences?", "follow_up_response": "the major systemic vessels", "follow_up_response_bt": "The main systemic vessels"}, {"question_id": "161.14", "question": "How much larger or smaller were the diameters of the major systemic vessels in micropigs compared to humans?", "answer_src": "significantly different", "follow_up_question": "By what percentage were the diameters of the major systemic vessels in micropigs significantly different from those in humans?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "161.15", "question": "What was the range of diameter differences found between micropigs and humans in the major systemic vessels?", "answer_src": "Significantly different", "follow_up_question": "What was the approximate percentage difference in vessel diameters between micropigs and humans?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 162, "src": "for human and mouse , the lncrna numbers are 167,150 and 130,558 , respectively . noncode 2016 has also introduced three important new features : ( i ) conservation annotation ; ( ii ) the relationships between lncrnas and diseases ; and ( iii ) an interface to choose high - quality datasets through predicted scores , literature support and long - read sequencing method support . noncode is also accessible through http://www.noncode.org/.", "mt": "Noncode 2016 ha anche introdotto tre importanti nuove caratteristiche: (i) annotamento di conservazione; (ii) le relazioni tra lncrnas e malattie; e (iii) un'interfaccia per scegliere set di dati di alta qualità attraverso punteggi previsti , supporto letterario e supporto metodo di sequenziamento lungo lettura. noncode è anche accessibile tramite http://www.noncode.org/.", "pert_mt": "Noncode 2016 ha anche introdotto tre importanti nuove caratteristiche: (i) annotamento di conservazione; (ii) le relazioni tra lncrnas e malattie; e (iii) un'interfaccia per scegliere set di dati di alta qualità attraverso punteggi previsti, supporto letterario e supporto metodo di sequenziamento lungo lettura. Inoltre, noncode è anche accessibile tramite http://www.noncode.org/.", "bt": "Noncode 2016 also introduced three important new features: (i) conservation annotation; (ii) the relationship between infections and diseases; and (iii) an interface to select high-quality data sets through predicted scores, literary support and support for sequencing along the reading path.", "questions_src": ["What is the lncrna number for human?", "Who introduced three important new features in noncode 2016?", "Where can noncode be accessed?", "Which feature allows choosing high-quality datasets through predicted scores?", "When was noncode 2016 released?"], "answers_src": ["167,150", "noncode 2016", "http://www.noncode.org.", "an interface to choose high - quality datasets through predicted scores", "2016"], "answers_bt": ["No Answer", "Noncode 2016", "No Answer", "an interface to select high-quality data sets through predicted scores, literary support and support for sequencing along the reading path", "2016"], "multiturn": {"turn_1": [{"question_id": "162.1", "question": "What is the lncrna number for human?", "answer_src": "167,150", "follow_up_question": "What is the lncrna number for mouse?", "follow_up_response": "130,558", "follow_up_response_bt": "No Answer"}, {"question_id": "162.2", "question": "Who introduced three important new features in noncode 2016?", "answer_src": "noncode 2016", "follow_up_question": "What are the three important new features introduced by noncode 2016?", "follow_up_response": "Conservation annotation, the relationships between lncrnas and diseases, and an interface to choose high-quality datasets through predicted scores, literature support and long-read sequencing method support", "follow_up_response_bt": "Conservation annotation\", \"The relationship between infections and diseases\", \"An interface to select high-quality data sets through predicted scores, literary support and support for sequencing along the reading path"}, {"question_id": "162.3", "question": "Where can noncode be accessed?", "answer_src": "http://www.noncode.org.", "follow_up_question": "What are the three new features introduced by noncode 2016?", "follow_up_response": "Conservation annotation, the relationships between lncrnas and diseases, and an interface to choose high-quality datasets through predicted scores, literature support and long-read sequencing method support", "follow_up_response_bt": "Conservation annotation\", \"The relationship between infections and diseases\", \"An interface to select high-quality data sets through predicted scores, literary support and support for sequencing along the reading path"}, {"question_id": "162.4", "question": "Which feature allows choosing high-quality datasets through predicted scores?", "answer_src": "an interface to choose high - quality datasets through predicted scores", "follow_up_question": "What is the third feature introduced by noncode 2016?", "follow_up_response": "an interface to choose high-quality datasets through predicted scores, literature support and long-read sequencing method support", "follow_up_response_bt": "an interface to select high-quality data sets through predicted scores, literary support and support for sequencing along the reading path."}, {"question_id": "162.5", "question": "When was noncode 2016 released?", "answer_src": "2016", "follow_up_question": "What are the three new features introduced by noncode 2016?", "follow_up_response": "Conservation annotation, the relationships between lncrnas and diseases, and an interface to choose high-quality datasets through predicted scores, literature support and long-read sequencing method support", "follow_up_response_bt": "Conservation annotation\", \"The relationship between infections and diseases\", \"An interface to select high-quality data sets through predicted scores, literary support and support for sequencing along the reading path"}], "turn_2": [{"question_id": "162.6", "question": "What is the lncrna number for mouse?", "answer_src": "130,558", "follow_up_question": "What is the conservation annotation feature introduced by noncode 2016?", "follow_up_response": "Conservation annotation", "follow_up_response_bt": "Conservation annotation"}, {"question_id": "162.7", "question": "What are the three important new features introduced by noncode 2016?", "answer_src": "Conservation annotation, the relationships between lncrnas and diseases, and an interface to choose high-quality datasets through predicted scores, literature support and long-read sequencing method support", "follow_up_question": "What does the interface to choose high-quality datasets through predicted scores, literature support and long-read sequencing method support allow users to do?", "follow_up_response": "Allow users to choose high-quality datasets", "follow_up_response_bt": "Select high-quality datasets"}, {"question_id": "162.8", "question": "What are the three new features introduced by noncode 2016?", "answer_src": "Conservation annotation, the relationships between lncrnas and diseases, and an interface to choose high-quality datasets through predicted scores, literature support and long-read sequencing method support", "follow_up_question": "What does the interface to choose high-quality datasets through predicted scores, literature support and long-read sequencing method support allow users to do?", "follow_up_response": "Allow users to choose high-quality datasets", "follow_up_response_bt": "Select high-quality datasets"}, {"question_id": "162.9", "question": "What is the third feature introduced by noncode 2016?", "answer_src": "an interface to choose high-quality datasets through predicted scores, literature support and long-read sequencing method support", "follow_up_question": "What does the interface through predicted scores, literature support, and long-read sequencing method support allow users to do?", "follow_up_response": "Choose high-quality datasets", "follow_up_response_bt": "Select high-quality data sets"}, {"question_id": "162.10", "question": "What are the three new features introduced by noncode 2016?", "answer_src": "Conservation annotation, the relationships between lncrnas and diseases, and an interface to choose high-quality datasets through predicted scores, literature support and long-read sequencing method support", "follow_up_question": "What does the interface to choose high-quality datasets through predicted scores, literature support and long-read sequencing method support allow users to do?", "follow_up_response": "Allow users to choose high-quality datasets", "follow_up_response_bt": "Select high-quality datasets"}], "turn_3": [{"question_id": "162.11", "question": "What is the conservation annotation feature introduced by noncode 2016?", "answer_src": "Conservation annotation", "follow_up_question": "What are the other two important new features introduced by noncode 2016?", "follow_up_response": "the relationships between lncrnas and diseases and an interface to choose high-quality datasets through predicted scores, literature support and long-read sequencing method support", "follow_up_response_bt": "the relationship between infections and diseases\", \"an interface to select high-quality data sets"}, {"question_id": "162.12", "question": "What does the interface to choose high-quality datasets through predicted scores, literature support and long-read sequencing method support allow users to do?", "answer_src": "Allow users to choose high-quality datasets", "follow_up_question": "What types of evidence can users use to support their choice of datasets?", "follow_up_response": "predicted scores, literature support and long - read sequencing method", "follow_up_response_bt": "literary support and support for sequencing"}, {"question_id": "162.13", "question": "What does the interface to choose high-quality datasets through predicted scores, literature support and long-read sequencing method support allow users to do?", "answer_src": "Allow users to choose high-quality datasets", "follow_up_question": "What types of evidence can users use to support their choice of datasets?", "follow_up_response": "predicted scores, literature support and long - read sequencing method", "follow_up_response_bt": "literary support and support for sequencing"}, {"question_id": "162.14", "question": "What does the interface through predicted scores, literature support, and long-read sequencing method support allow users to do?", "answer_src": "Choose high-quality datasets", "follow_up_question": "What specific type of datasets can users choose with this interface?", "follow_up_response": "predicted scores, literature support and long - read sequencing method", "follow_up_response_bt": "high-quality data sets"}, {"question_id": "162.15", "question": "What does the interface to choose high-quality datasets through predicted scores, literature support and long-read sequencing method support allow users to do?", "answer_src": "Allow users to choose high-quality datasets", "follow_up_question": "What types of evidence can users use to support their choice of datasets?", "follow_up_response": "predicted scores, literature support and long - read sequencing method", "follow_up_response_bt": "literary support and support for sequencing"}]}}
{"id": 163, "src": "essential palatal tremor ( ept ) is a rare disorder which shows rhythmic involuntary movement of the muscles of soft palate , especially tensor veli palatini muscle . ept is classified by two subtypes , which is primary and secondary ept . secondary ept includes psychogenic type .", "mt": "Ept è classificato per due sottotipi , che sono primari e secondari ept . secondari ept include il tipo psicogeno .", "pert_mt": "Ept è classificato per due sottotipi, che sono primari e secondari ept. Secondari ept include il tipo psicogeno, e il tipo cronico.", "bt": "Ept is classified by two subtypes, which are primary and secondary ept. Secondary ept includes the psychogenic type, and the chronic type.", "questions_src": ["What is the name of the rare disorder that shows rhythmic involuntary movement of the muscles of the soft palate?", "What two subtypes does secondary essential palatal tremor include?", "Which muscle is specifically affected in essential palatal tremor?"], "answers_src": ["essential palatal tremor (ept)", "No Answer", "No Answer"], "answers_bt": ["No Answer", "psychogenic type and chronic type", "soft palate"], "multiturn": {"turn_1": [{"question_id": "163.1", "question": "What is the name of the rare disorder that shows rhythmic involuntary movement of the muscles of the soft palate?", "answer_src": "essential palatal tremor (ept)", "follow_up_question": "What are the two subtypes of essential palatal tremor?", "follow_up_response": "Primary and secondary ept", "follow_up_response_bt": "Primary and secondary ept"}, {"question_id": "163.2", "question": "What two subtypes does secondary essential palatal tremor include?", "answer_src": "essential palatal tremor ( ept ) is a rare disorder which shows rhythmic involuntary movement of the muscles of soft palate , especially tensor veli palatini muscle . ept is classified by two subtypes , which is primary and secondary ept . secondary ept includes psychogenic type .", "follow_up_question": "What is the other subtype of secondary essential palatal tremor mentioned in the text?", "follow_up_response": "psychogenic", "follow_up_response_bt": "psychogenic type"}, {"question_id": "163.3", "question": "Which muscle is specifically affected in essential palatal tremor?", "answer_src": "essential palatal tremor ( ept ) is a rare disorder which shows rhythmic involuntary movement of the muscles of soft palate , especially tensor veli palatini muscle . ept is classified by two subtypes , which is primary and secondary ept . secondary ept includes psychogenic type .", "follow_up_question": "What specific subtype of essential palatal tremor includes the psychogenic type?", "follow_up_response": "secondary ept", "follow_up_response_bt": "Secondary ept"}], "turn_2": [{"question_id": "163.4", "question": "What are the two subtypes of essential palatal tremor?", "answer_src": "Primary and secondary ept", "follow_up_question": "What does secondary ept include?", "follow_up_response": "psychogenic type", "follow_up_response_bt": "the psychogenic type and the chronic type"}, {"question_id": "163.5", "question": "What is the other subtype of secondary essential palatal tremor mentioned in the text?", "answer_src": "psychogenic", "follow_up_question": "What percentage of essential palatal tremor cases is classified as secondary?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "163.6", "question": "What specific subtype of essential palatal tremor includes the psychogenic type?", "answer_src": "secondary ept", "follow_up_question": "Which other subtype of essential palatal tremor does not include the psychogenic type?", "follow_up_response": "primary", "follow_up_response_bt": "primary"}], "turn_3": [{"question_id": "163.7", "question": "What does secondary ept include?", "answer_src": "psychogenic type", "follow_up_question": "What are the other types of secondary ept?", "follow_up_response": "psychogenic", "follow_up_response_bt": "psychogenic type\", \"chronic type"}, {"question_id": "163.8", "question": "What percentage of essential palatal tremor cases is classified as secondary?", "answer_src": "essential palatal tremor ( ept ) is a rare disorder which shows rhythmic involuntary movement of the muscles of soft palate , especially tensor veli palatini muscle . ept is classified by two subtypes , which is primary and secondary ept . secondary ept includes psychogenic type .", "follow_up_question": "What does secondary essential palatal tremor include?", "follow_up_response": "psychogenic type", "follow_up_response_bt": "the psychogenic type and the chronic type"}, {"question_id": "163.9", "question": "Which other subtype of essential palatal tremor does not include the psychogenic type?", "answer_src": "primary", "follow_up_question": "What are the characteristics of the primary subtype of essential palatal tremor?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 164, "src": "atlantic correction equations were developed in the mhw subsample . using separate multiple regression models for men and women , self - reported body mass index ( bmi ) was corrected by multiplying the self - reported estimate by its corresponding model coefficient and adding the model intercept . paired t - tests were used to determine whether corrected mean bmi values were significantly more accurate ( i.e. , closer to measured data ) than the equivalent means based on self - reported data .", "mt": "Nell'esempio mhw sono state sviluppate equazioni di correzione atlantica . utilizzando modelli di regressione multipli separati per uomini e donne , l'indice di massa corporea auto-rilevato (bmi) è stato corretto moltiplicando l' stima auto-rilevata con il suo corrispondente coefficiente di modello e aggiungendo l' intersezione del modello .", "pert_mt": "Nell'esempio mhw sono state sviluppate equazioni di correzione atlantica. Utilizzando modelli di regressione multipli separati per uomini e donne, l'indice di massa corporea auto-rilevato (BMI) è stato corretto moltiplicando l' stima auto-rilevata con il suo corrispondente coefficiente di modello e aggiungendo l' intersezione del modello, ma non considerando la variabilità etaria.", "bt": "Using multiple regression models separated for men and women, the self-relevant body mass index (BMI) was corrected by multiplying the self-relevant estimate with its corresponding model coefficient and adding the intersection of the model, but not taking into account the etheric variability.", "questions_src": ["What is the full name of the method used to correct self-reported body mass index (BMI)?", "When were the Atlantic correction equations developed?", "Where were separate multiple regression models created for men and women?", "Which statistical test was used to compare corrected mean BMI values with the measured data?", "Which variable was multiplied by its corresponding model coefficient to correct self-reported BMI estimates?"], "answers_src": ["Atlantic correction equations", "in the mhw subsample", "in the mhw subsample", "paired t-tests", "self-reported body mass index (bmi)"], "answers_bt": ["Multiple regression models", "No Answer", "Men and women", "No Answer", "Self-relevant body mass index (BMI)"], "multiturn": {"turn_1": [{"question_id": "164.1", "question": "What is the full name of the method used to correct self-reported body mass index (BMI)?", "answer_src": "Atlantic correction equations", "follow_up_question": "What was the basis for determining whether the corrected mean BMI values were significantly more accurate?", "follow_up_response": "Paired t-tests", "follow_up_response_bt": "Multiple regression models separated for men and women"}, {"question_id": "164.2", "question": "When were the Atlantic correction equations developed?", "answer_src": "in the mhw subsample", "follow_up_question": "What specific variables did the multiple regression models use for men and women?", "follow_up_response": "self - reported body mass index ( bmi )", "follow_up_response_bt": "men and women"}, {"question_id": "164.3", "question": "Where were separate multiple regression models created for men and women?", "answer_src": "in the mhw subsample", "follow_up_question": "What was the purpose of using paired t-tests in this study?", "follow_up_response": "To determine whether corrected mean bmi values were significantly more accurate (i.e., closer to measured data) than the equivalent means based on self-reported data.", "follow_up_response_bt": "No Answer"}, {"question_id": "164.4", "question": "Which statistical test was used to compare corrected mean BMI values with the measured data?", "answer_src": "paired t-tests", "follow_up_question": "What was the basis for determining which model coefficients and intercepts to use for men and women?", "follow_up_response": "Separate multiple regression models", "follow_up_response_bt": "Multiple regression models"}, {"question_id": "164.5", "question": "Which variable was multiplied by its corresponding model coefficient to correct self-reported BMI estimates?", "answer_src": "self-reported body mass index (bmi)", "follow_up_question": "What was the purpose of using separate multiple regression models for men and women?", "follow_up_response": "To correct self-reported body mass index (bmi) by gender", "follow_up_response_bt": "To correct the self-relevant body mass index (BMI)"}], "turn_2": [{"question_id": "164.6", "question": "What was the basis for determining whether the corrected mean BMI values were significantly more accurate?", "answer_src": "Paired t-tests", "follow_up_question": "How many groups were considered when developing the separate multiple regression models?", "follow_up_response": "2", "follow_up_response_bt": "2"}, {"question_id": "164.7", "question": "What specific variables did the multiple regression models use for men and women?", "answer_src": "self - reported body mass index ( bmi )", "follow_up_question": "What was the significance of using separate models for men and women?", "follow_up_response": "To determine whether corrected mean bmi values were significantly more accurate (i.e., closer to measured data) than the equivalent means based on self-reported data.", "follow_up_response_bt": "To correct the self-relevant body mass index (BMI) by multiplying the self-relevant estimate with its corresponding model coefficient and adding the intersection of the model"}, {"question_id": "164.8", "question": "What was the purpose of using paired t-tests in this study?", "answer_src": "To determine whether corrected mean bmi values were significantly more accurate (i.e., closer to measured data) than the equivalent means based on self-reported data.", "follow_up_question": "How many different regression models were used in the study?", "follow_up_response": "2", "follow_up_response_bt": "2"}, {"question_id": "164.9", "question": "What was the basis for determining which model coefficients and intercepts to use for men and women?", "answer_src": "Separate multiple regression models", "follow_up_question": "How many separate multiple regression models were used for men and women?", "follow_up_response": "2", "follow_up_response_bt": "2"}, {"question_id": "164.10", "question": "What was the purpose of using separate multiple regression models for men and women?", "answer_src": "To correct self-reported body mass index (bmi) by gender", "follow_up_question": "How many paired t-tests were used to assess the accuracy of the corrected mean bmi values?", "follow_up_response": "1", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "164.11", "question": "How many groups were considered when developing the separate multiple regression models?", "answer_src": "2", "follow_up_question": "What was the significance of using paired t-tests in this study?", "follow_up_response": "To determine whether corrected mean bmi values were significantly more accurate (i.e., closer to measured data) than the equivalent means based on self-reported data.", "follow_up_response_bt": "No Answer"}, {"question_id": "164.12", "question": "What was the significance of using separate models for men and women?", "answer_src": "To determine whether corrected mean bmi values were significantly more accurate (i.e., closer to measured data) than the equivalent means based on self-reported data.", "follow_up_question": "How many paired t-tests were used to assess the accuracy of the corrected mean BMI values?", "follow_up_response": "1", "follow_up_response_bt": "No Answer"}, {"question_id": "164.13", "question": "How many different regression models were used in the study?", "answer_src": "2", "follow_up_question": "What was the significance of using separate models for men and women?", "follow_up_response": "To determine whether corrected mean bmi values were significantly more accurate (i.e., closer to measured data) than the equivalent means based on self-reported data.", "follow_up_response_bt": "To correct the self-relevant body mass index (BMI) by multiplying the self-relevant estimate with its corresponding model coefficient and adding the intersection of the model"}, {"question_id": "164.14", "question": "How many separate multiple regression models were used for men and women?", "answer_src": "2", "follow_up_question": "What was the significance of using separate models for men and women?", "follow_up_response": "To determine whether corrected mean bmi values were significantly more accurate (i.e., closer to measured data) than the equivalent means based on self-reported data.", "follow_up_response_bt": "To correct the self-relevant body mass index (BMI) by multiplying the self-relevant estimate with its corresponding model coefficient and adding the intersection of the model"}, {"question_id": "164.15", "question": "How many paired t-tests were used to assess the accuracy of the corrected mean bmi values?", "answer_src": "1", "follow_up_question": "What was the criterion for determining significant accuracy in the corrected mean bmi values?", "follow_up_response": "Whether corrected mean bmi values were closer to measured data", "follow_up_response_bt": "No Answer"}]}}
{"id": 165, "src": "granulocyte macrophage - colony stimulating factor ( gm - csf ) is a hematopoietic growth factor , which stimulates the proliferation of granulocytes and macrophages from bone marrow precursor cells . in autoimmune and inflammatory diseases , th17 cells have been considered as strong inducers of tissue inflammation . however , recent evidence indicates that gm - csf has prominent proinflammatory functions and that this growth factor ( not il-17 ) is critical for the pathogenicity of cd4 + t cells .", "mt": "Il macrophage dei granulociti - fattore stimolante della colonia (gm - csf) è un fattore di crescita ematopoietica , che stimola la proliferazione dei granulociti e dei macrophagi dalle cellule precursori del midollo osseo . nelle malattie autoimmuni e infiammatorie , le cellule th17 sono state considerate forti induttori di infiammazione dei tessuti . Tuttavia , recenti prove indicano che gm - csf ha importanti funzioni proinflammatorie e che questo fattore di crescita (non il-17) è critico per la patogenicità delle cellule cd4 + t .", "pert_mt": "Il macrophage dei granulociti - fattore stimolante della colonia (gm - csf) è un fattore di crescita ematopoietica, che stimola la proliferazione dei granulociti e dei macrophagi dalle cellule precursori del midollo osseo. nelle malattie autoimmuni e infiammatorie, le cellule th17 sono state considerate forti induttori di infiammazione dei tessuti. Tuttavia, recenti prove indicano che gm - csf ha importanti funzioni proinflammatorie e che questo fattore di crescita (non il-17) è critico per la patogenicità delle cellule cd4 + t e può aggravare la progressione delle malattie.", "bt": "Granulocyte macrophage - colony stimulating factor (gm - csf) is a hematopoietic growth factor, which stimulates the proliferation of granulocytes and macrophages from bone marrow precursor cells. in autoimmune and inflammatory diseases, th17 cells have been considered strong inducers of tissue inflammation. however, recent evidence indicates that gm - csf has important proinflammatory functions and that this growth factor (not il-17) is critical for the pathogenicity of cd4 + t cells and can aggravate disease progression.", "questions_src": ["What is the full name of the hematopoietic growth factor mentioned in the sentence?", "Who are th17 cells considered to be by some studies?", "Where does the proliferation of granulocytes and macrophages occur according to the sentence?", "When has there been a change in understanding regarding the role of GM-CSF in inflammation?", "Which cytokine is described as being critical for the pathogenicity of CD4+ T cells according to the new evidence?"], "answers_src": ["granulocyte macrophage - colony stimulating factor (gm - csf)", "th17 cells", "bone marrow precursor cells", "recently", "GM-CSF"], "answers_bt": ["Granulocyte macrophage - colony stimulating factor (gm - csf)", "in autoimmune and inflammatory diseases", "from bone marrow precursor cells", "recently", "GM-CSF"], "multiturn": {"turn_1": [{"question_id": "165.1", "question": "What is the full name of the hematopoietic growth factor mentioned in the sentence?", "answer_src": "granulocyte macrophage - colony stimulating factor (gm - csf)", "follow_up_question": "What specific type of cells does gm-csf stimulate according to the text?", "follow_up_response": "granulocytes and macrophages", "follow_up_response_bt": "granulocytes and macrophages"}, {"question_id": "165.2", "question": "Who are th17 cells considered to be by some studies?", "answer_src": "th17 cells", "follow_up_question": "What role do th17 cells play in tissue inflammation according to the text?", "follow_up_response": "th17 cells have been considered as strong inducers of tissue inflammation", "follow_up_response_bt": "th17 cells have been considered strong inducers of tissue inflammation"}, {"question_id": "165.3", "question": "Where does the proliferation of granulocytes and macrophages occur according to the sentence?", "answer_src": "bone marrow precursor cells", "follow_up_question": "What role does GM-CSF play in the pathogenesis of CD4+ T cells according to the text?", "follow_up_response": "GM-CSF is critical for the pathogenicity of CD4+ T cells", "follow_up_response_bt": "GM-CSF is critical for the pathogenicity of CD4+ T cells and can aggravate disease progression"}, {"question_id": "165.4", "question": "When has there been a change in understanding regarding the role of GM-CSF in inflammation?", "answer_src": "recently", "follow_up_question": "What specific evidence supports the claim that GM-CSF is critical for the pathogenicity of CD4+ T cells?", "follow_up_response": "Recent evidence", "follow_up_response_bt": "Recent evidence"}, {"question_id": "165.5", "question": "Which cytokine is described as being critical for the pathogenicity of CD4+ T cells according to the new evidence?", "answer_src": "GM-CSF", "follow_up_question": "What specific mechanism does GM-CSF use to contribute to tissue inflammation?", "follow_up_response": "No Answer", "follow_up_response_bt": "proinflammatory functions"}], "turn_2": [{"question_id": "165.6", "question": "What specific type of cells does gm-csf stimulate according to the text?", "answer_src": "granulocytes and macrophages", "follow_up_question": "What role do th17 cells play in tissue inflammation based on the information provided?", "follow_up_response": "th17 cells have been considered as strong inducers of tissue inflammation", "follow_up_response_bt": "th17 cells have been considered strong inducers of tissue inflammation"}, {"question_id": "165.7", "question": "What role do th17 cells play in tissue inflammation according to the text?", "answer_src": "th17 cells have been considered as strong inducers of tissue inflammation", "follow_up_question": "How does the text suggest gm-csf contributes to tissue inflammation?", "follow_up_response": "gm-csf has prominent proinflammatory functions", "follow_up_response_bt": "gm-csf has important proinflammatory functions and is critical for the pathogenicity of CD4 + T cells, potentially aggravating disease progression"}, {"question_id": "165.8", "question": "What role does GM-CSF play in the pathogenesis of CD4+ T cells according to the text?", "answer_src": "GM-CSF is critical for the pathogenicity of CD4+ T cells", "follow_up_question": "How does GM-CSF contribute to the proinflammatory functions in autoimmune and inflammatory diseases?", "follow_up_response": "GM-CSF has prominent proinflammatory functions and is critical for the pathogenicity of CD4+ T cells.", "follow_up_response_bt": "GM-CSF has important proinflammatory functions and is critical for the pathogenicity of CD4+ T cells, potentially aggravating disease progression."}, {"question_id": "165.9", "question": "What specific evidence supports the claim that GM-CSF is critical for the pathogenicity of CD4+ T cells?", "answer_src": "Recent evidence", "follow_up_question": "How does GM-CSF contribute to the pathogenicity of CD4+ T cells according to the recent evidence?", "follow_up_response": "GM-CSF", "follow_up_response_bt": "GM-CSF is critical for the pathogenicity of CD4+ T cells"}, {"question_id": "165.10", "question": "What specific mechanism does GM-CSF use to contribute to tissue inflammation?", "answer_src": "granulocyte macrophage - colony stimulating factor ( gm - csf ) is a hematopoietic growth factor , which stimulates the proliferation of granulocytes and macrophages from bone marrow precursor cells . in autoimmune and inflammatory diseases , th17 cells have been considered as strong inducers of tissue inflammation . however , recent evidence indicates that gm - csf has prominent proinflammatory functions and that this growth factor ( not il-17 ) is critical for the pathogenicity of cd4 + t cells .", "follow_up_question": "How does GM-CSF contribute to the pathogenicity of CD4+ T cells according to the recent evidence?", "follow_up_response": "GM-CSF", "follow_up_response_bt": "GM-CSF is critical for the pathogenicity of CD4+ T cells"}], "turn_3": [{"question_id": "165.11", "question": "What role do th17 cells play in tissue inflammation based on the information provided?", "answer_src": "th17 cells have been considered as strong inducers of tissue inflammation", "follow_up_question": "How does gm-csf contribute to the pathogenicity of cd4+ T cells according to the text?", "follow_up_response": "gm-csf", "follow_up_response_bt": "gm-csf is critical for the pathogenicity of cd4 + t cells"}, {"question_id": "165.12", "question": "How does the text suggest gm-csf contributes to tissue inflammation?", "answer_src": "gm-csf has prominent proinflammatory functions", "follow_up_question": "What specific type of tissue inflammation does gm-csf contribute to according to the text?", "follow_up_response": "tissue inflammation", "follow_up_response_bt": "tissue inflammation"}, {"question_id": "165.13", "question": "How does GM-CSF contribute to the proinflammatory functions in autoimmune and inflammatory diseases?", "answer_src": "GM-CSF has prominent proinflammatory functions and is critical for the pathogenicity of CD4+ T cells.", "follow_up_question": "What specific role does GM-CSF play in the pathogenicity of CD4+ T cells?", "follow_up_response": "GM-CSF", "follow_up_response_bt": "GM-CSF is critical for the pathogenicity of CD4+ T cells"}, {"question_id": "165.14", "question": "How does GM-CSF contribute to the pathogenicity of CD4+ T cells according to the recent evidence?", "answer_src": "GM-CSF", "follow_up_question": "What specific proinflammatory function does GM-CSF have according to the text?", "follow_up_response": "prominent proinflammatory functions", "follow_up_response_bt": "important proinflammatory functions"}, {"question_id": "165.15", "question": "How does GM-CSF contribute to the pathogenicity of CD4+ T cells according to the recent evidence?", "answer_src": "GM-CSF", "follow_up_question": "What specific proinflammatory function does GM-CSF have according to the text?", "follow_up_response": "prominent proinflammatory functions", "follow_up_response_bt": "important proinflammatory functions"}]}}
{"id": 166, "src": "the initial step of atrioventricular ( av ) valve development involves the deposition of extracellular matrix ( ecm ) components of the endocardial cushion and the endocardialmesenchymal transition . while the appropriately regulated expression of the major ecm components , versican and hyaluronan , that form the endocardial cushion is important for heart valve development , the underlying mechanism that regulates ecm gene expression remains unclear . we found that zebrafish crip2 expression is restricted to a subset of cells in the av canal ( avc ) endocardium at 55 hours post - fertilization ( hpf ) .", "mt": "Mentre l'espressione adeguatamente regolata dei principali componenti dell'ecm , versican e ialuronan , che formano il cuscino endocardico è importante per lo sviluppo della valvola cardiaca , il meccanismo sottostante che regola l'espressione del gene ecm rimane incerto . Abbiamo scoperto che l'espressione del pesce zebrafish crip2 è limitata a un sottoinsieme di cellule nell'endocardio av canale (avc) a 55 ore dopo la fertilizzazione (hpf).", "pert_mt": "Mentre l'espressione adeguatamente regolata dei principali componenti dell'ecm, versican e ialuronan, che formano il cuscino endocardico è importante per lo sviluppo della valvola cardiaca, il meccanismo sottostante che regola l'espressione del gene ecm rimane incerto. Abbiamo scoperto che l'espressione del pesce zebrafish crip2 è limitata a un sottoinsieme di cellule nell'endocardio av canale (avc) a 55 ore dopo la fertilizzazione (hpf) e questo potrebbe influenzare direttamente l'assemblaggio del cuscino endocardico.", "bt": "While the adequately regulated expression of the main components of the ECM, versican and ialuronan, which form the endocardial cushion, is important for the development of the heart valve, the underlying mechanism that regulates the expression of the ECM gene remains uncertain.We found that the expression of zebrafish crip2 is limited to a subset of cells in the endocardial canal (avc) at 55 hours after fertilization (hpf) and this could directly affect the assembly of the endocardial cushion.", "questions_src": ["What does crip2 expression indicate in zebrafish at 55 hours post-fertilization?", "Where is crip2 expression restricted in the atrioventricular canal endocardium?", "Which ecm components are important for heart valve development?", "When does crip2 expression occur in zebrafish?", "Which mechanisms regulate ecm gene expression in heart valve development?"], "answers_src": ["A subset of cells in the AV canal endocardium", "AV canal endocardium", "Versican and hyaluronan", "55 hours post-fertilization", "Underlying mechanism"], "answers_bt": ["Expression of crip2 in a subset of cells", "In the atrioventricular canal endocardium", "Versican and ialuronan", "At 55 hours after fertilization (hpf)", "The underlying mechanism"], "multiturn": {"turn_1": [{"question_id": "166.1", "question": "What does crip2 expression indicate in zebrafish at 55 hours post-fertilization?", "answer_src": "A subset of cells in the AV canal endocardium", "follow_up_question": "What specific type of cells in the AV canal endocardium express crip2?", "follow_up_response": "a subset of cells", "follow_up_response_bt": "a subset of cells"}, {"question_id": "166.2", "question": "Where is crip2 expression restricted in the atrioventricular canal endocardium?", "answer_src": "AV canal endocardium", "follow_up_question": "At what stage of zebrafish development is crip2 expression restricted?", "follow_up_response": "55 hours post-fertilization (hpf)", "follow_up_response_bt": "55 hours after fertilization (hpf)"}, {"question_id": "166.3", "question": "Which ecm components are important for heart valve development?", "answer_src": "Versican and hyaluronan", "follow_up_question": "What specific subset of cells in the AV canal endocardium expresses zebrafish Crip2 at 55 hours post-fertilization?", "follow_up_response": "a subset of cells", "follow_up_response_bt": "a subset of cells"}, {"question_id": "166.4", "question": "When does crip2 expression occur in zebrafish?", "answer_src": "55 hours post-fertilization", "follow_up_question": "What specific subset of cells in the AV canal endocardium expresses crip2?", "follow_up_response": "a subset of cells", "follow_up_response_bt": "a subset of cells"}, {"question_id": "166.5", "question": "Which mechanisms regulate ecm gene expression in heart valve development?", "answer_src": "Underlying mechanism", "follow_up_question": "What specific subset of cells in the AV canal endocardium expresses zebrafish Crip2 at 55 hpf?", "follow_up_response": "a subset of cells", "follow_up_response_bt": "a subset of cells"}], "turn_2": [{"question_id": "166.6", "question": "What specific type of cells in the AV canal endocardium express crip2?", "answer_src": "a subset of cells", "follow_up_question": "What is the approximate time point when these crip2-expressing cells are observed in the AV canal endocardium?", "follow_up_response": "55 hours post-fertilization", "follow_up_response_bt": "55 hours after fertilization"}, {"question_id": "166.7", "question": "At what stage of zebrafish development is crip2 expression restricted?", "answer_src": "55 hours post-fertilization (hpf)", "follow_up_question": "What specific subset of cells in the AV canal endocardium expresses crip2 at 55 hpf?", "follow_up_response": "a subset of cells", "follow_up_response_bt": "a subset of cells"}, {"question_id": "166.8", "question": "What specific subset of cells in the AV canal endocardium expresses zebrafish Crip2 at 55 hours post-fertilization?", "answer_src": "a subset of cells", "follow_up_question": "What is the approximate time frame these cells expressing Crip2 are observed?", "follow_up_response": "55 hours post-fertilization", "follow_up_response_bt": "55 hours after fertilization"}, {"question_id": "166.9", "question": "What specific subset of cells in the AV canal endocardium expresses crip2?", "answer_src": "a subset of cells", "follow_up_question": "What is the approximate time point when these crip2-expressing cells are observed in the AV canal endocardium?", "follow_up_response": "55 hours post-fertilization", "follow_up_response_bt": "55 hours after fertilization"}, {"question_id": "166.10", "question": "What specific subset of cells in the AV canal endocardium expresses zebrafish Crip2 at 55 hpf?", "answer_src": "a subset of cells", "follow_up_question": "What is the approximate time frame these cells expressing Crip2 are observed?", "follow_up_response": "55 hours post-fertilization", "follow_up_response_bt": "55 hours after fertilization"}], "turn_3": [{"question_id": "166.11", "question": "What is the approximate time point when these crip2-expressing cells are observed in the AV canal endocardium?", "answer_src": "55 hours post-fertilization", "follow_up_question": "What specific cells in the AV canal endocardium express crip2 according to the text?", "follow_up_response": "a subset of cells", "follow_up_response_bt": "a subset of cells"}, {"question_id": "166.12", "question": "What specific subset of cells in the AV canal endocardium expresses crip2 at 55 hpf?", "answer_src": "a subset of cells", "follow_up_question": "What is the approximate time frame these cells expressing crip2 are located in relation to fertilization?", "follow_up_response": "55 hours", "follow_up_response_bt": "55 hours after fertilization"}, {"question_id": "166.13", "question": "What is the approximate time frame these cells expressing Crip2 are observed?", "answer_src": "55 hours post-fertilization", "follow_up_question": "What specific cells in the AV canal endocardium express Crip2?", "follow_up_response": "a subset of cells", "follow_up_response_bt": "a subset of cells"}, {"question_id": "166.14", "question": "What is the approximate time point when these crip2-expressing cells are observed in the AV canal endocardium?", "answer_src": "55 hours post-fertilization", "follow_up_question": "What specific cells in the AV canal endocardium express crip2 according to the text?", "follow_up_response": "a subset of cells", "follow_up_response_bt": "a subset of cells"}, {"question_id": "166.15", "question": "What is the approximate time frame these cells expressing Crip2 are observed?", "answer_src": "55 hours post-fertilization", "follow_up_question": "What specific cells in the AV canal endocardium express Crip2?", "follow_up_response": "a subset of cells", "follow_up_response_bt": "a subset of cells"}]}}
{"id": 167, "src": "leonurus cardiaca , commonly known as motherwort , is a member of the lamiaceae family . it has a number of interesting biological activities , for example , sedative and hypotensive , antioxidant , anti - inflammatory , and antimicrobial activities . the aim of the present study was to investigate the effect of alcoholic extract of aerial part of leonurus cardiaca on nociceptive response using formalin , tail flick , and hot plate tests in mice .", "mt": "Il presente studio ha lo scopo di studiare l' effetto di un estratto alcolico di parte aerea di leonurus cardiaca sulla risposta nociceattiva utilizzando formalina , flick di coda e test di piastre di leonone in topi .", "pert_mt": "Il presente studio ha lo scopo di studiare l' effetto di un estratto alcolico di parte aerea di leonurus cardiaca sulla risposta nociceattiva utilizzando formalina, flick di coda e test di piastre di leonone in topi, senza causare alcun danno ai reni.", "bt": "The present study aims to study the effect of an alcoholic extract of the aerial part of the leonurus cardiaca on the noxious reactive response using formalin, tail flick and test of leonone pilasters in caps, without causing any damage to the kidneys.", "questions_src": ["What is the scientific name of the plant mentioned in the sentence?", "Who conducted the study described in the sentence?", "Where can the aerial part of the plant be found?", "When was the study on the plant's effects conducted?", "Which tests were used to investigate the effect of the plant extract on nociceptive response?"], "answers_src": ["Leonurus cardiaca", "No Answer", "Aerial part", "No Answer", "Formalin, tail flick, and hot plate tests"], "answers_bt": ["[\"Leonurus cardiaca\"], [\"The present study\"], [\"Aerial part\"], [\"The present study\"], [\"Formalin, tail flick and test of Leonone pilasters\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "167.1", "question": "What is the scientific name of the plant mentioned in the sentence?", "answer_src": "Leonurus cardiaca", "follow_up_question": "What type of tests were conducted on the mice to evaluate the effect of the plant extract?", "follow_up_response": "formalin, tail flick, and hot plate", "follow_up_response_bt": "formalin, tail flick and test of leonone pilasters"}, {"question_id": "167.2", "question": "Who conducted the study described in the sentence?", "answer_src": "leonurus cardiaca , commonly known as motherwort , is a member of the lamiaceae family . it has a number of interesting biological activities , for example , sedative and hypotensive , antioxidant , anti - inflammatory , and antimicrobial activities . the aim of the present study was to investigate the effect of alcoholic extract of aerial part of leonurus cardiaca on nociceptive response using formalin , tail flick , and hot plate tests in mice .", "follow_up_question": "What were the methods used in the study to investigate the effect of leonurus cardiaca?", "follow_up_response": "Formalin, tail flick, and hot plate tests", "follow_up_response_bt": "formalin, tail flick and test of leonone pilasters in caps"}, {"question_id": "167.3", "question": "Where can the aerial part of the plant be found?", "answer_src": "Aerial part", "follow_up_question": "What specific parts of the mouse were tested for nociceptive response?", "follow_up_response": "Aerial part", "follow_up_response_bt": "Aerial part of the leonurus cardiaca"}, {"question_id": "167.4", "question": "When was the study on the plant's effects conducted?", "answer_src": "leonurus cardiaca , commonly known as motherwort , is a member of the lamiaceae family . it has a number of interesting biological activities , for example , sedative and hypotensive , antioxidant , anti - inflammatory , and antimicrobial activities . the aim of the present study was to investigate the effect of alcoholic extract of aerial part of leonurus cardiaca on nociceptive response using formalin , tail flick , and hot plate tests in mice .", "follow_up_question": "What specific tests were used to investigate the effect of the plant extract?", "follow_up_response": "formalin, tail flick, and hot plate", "follow_up_response_bt": "formalin, tail flick and test of leonone pilasters"}, {"question_id": "167.5", "question": "Which tests were used to investigate the effect of the plant extract on nociceptive response?", "answer_src": "Formalin, tail flick, and hot plate tests", "follow_up_question": "What was the concentration of the alcoholic extract used in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "167.6", "question": "What type of tests were conducted on the mice to evaluate the effect of the plant extract?", "answer_src": "formalin, tail flick, and hot plate", "follow_up_question": "What specific nociceptive responses did the mice exhibit in the formalin test?", "follow_up_response": "nociceptive response", "follow_up_response_bt": "noxious reactive response"}, {"question_id": "167.7", "question": "What were the methods used in the study to investigate the effect of leonurus cardiaca?", "answer_src": "Formalin, tail flick, and hot plate tests", "follow_up_question": "What type of extract of leonurus cardiaca was used in the study?", "follow_up_response": "Alcoholic extract", "follow_up_response_bt": "alcoholic extract of the aerial part"}, {"question_id": "167.8", "question": "What specific parts of the mouse were tested for nociceptive response?", "answer_src": "Aerial part", "follow_up_question": "What type of extract was used in the study to test the nociceptive response?", "follow_up_response": "alcoholic extract of aerial part", "follow_up_response_bt": "alcoholic extract of the aerial part of the leonurus cardiaca"}, {"question_id": "167.9", "question": "What specific tests were used to investigate the effect of the plant extract?", "answer_src": "formalin, tail flick, and hot plate", "follow_up_question": "What type of nociceptive response did the study measure using the formalin test?", "follow_up_response": "pain", "follow_up_response_bt": "noxious reactive"}, {"question_id": "167.10", "question": "What was the concentration of the alcoholic extract used in the study?", "answer_src": "leonurus cardiaca , commonly known as motherwort , is a member of the lamiaceae family . it has a number of interesting biological activities , for example , sedative and hypotensive , antioxidant , anti - inflammatory , and antimicrobial activities . the aim of the present study was to investigate the effect of alcoholic extract of aerial part of leonurus cardiaca on nociceptive response using formalin , tail flick , and hot plate tests in mice .", "follow_up_question": "What were the specific nociceptive response tests used in the study?", "follow_up_response": "Formalin, tail flick, and hot plate tests", "follow_up_response_bt": "formalin, tail flick and test of leonone pilasters"}], "turn_3": [{"question_id": "167.11", "question": "What specific nociceptive responses did the mice exhibit in the formalin test?", "answer_src": "nociceptive response", "follow_up_question": "What type of nociceptive response did the mice show in the formalin test?", "follow_up_response": "nociceptive", "follow_up_response_bt": "noxious reactive"}, {"question_id": "167.12", "question": "What type of extract of leonurus cardiaca was used in the study?", "answer_src": "Alcoholic extract", "follow_up_question": "What specific nociceptive response test was used in the study?", "follow_up_response": "Formalin\", \"Tail flick\", \"Hot plate", "follow_up_response_bt": "Formalin, tail flick and test of Leonone pilasters"}, {"question_id": "167.13", "question": "What type of extract was used in the study to test the nociceptive response?", "answer_src": "alcoholic extract of aerial part", "follow_up_question": "What specific nociceptive responses were tested in the mice?", "follow_up_response": "formalin\", \"tail flick\", \"hot plate", "follow_up_response_bt": "formalin, tail flick and test of leonone pilasters"}, {"question_id": "167.14", "question": "What type of nociceptive response did the study measure using the formalin test?", "answer_src": "pain", "follow_up_question": "What specific type of nociceptive response did the study measure using the tail flick test?", "follow_up_response": "nociceptive response", "follow_up_response_bt": "noxious reactive"}, {"question_id": "167.15", "question": "What were the specific nociceptive response tests used in the study?", "answer_src": "Formalin, tail flick, and hot plate tests", "follow_up_question": "What was the effect of the alcoholic extract on the nociceptive response measured by the formalin test?", "follow_up_response": "to reduce the nociceptive response", "follow_up_response_bt": "to study the effect of an alcoholic extract of the aerial part of the leonurus cardiaca"}]}}
{"id": 168, "src": "peripheral osteomas of jaw bone are uncommon and usually associated with gardner 's syndrome . histological examination confirmed the clinical impression of a peripheral osteoma . patient was reviewed after one year and was asymptomatic with no recurrence of the lesion .", "mt": "Gli osteomi periferici dell'osso della mascella sono rari e di solito associati alla sindrome di Gardner . L'esame istologico ha confermato l'impressione clinica di un osteoma periferico . Il paziente è stato esaminato dopo un anno e era asintomatico senza ricorrenza della lesione .", "pert_mt": "Gli osteomi periferici dell'osso della mascella sono rari e di solito associati alla sindrome di Gardner. L'esame istologico ha confermato l'impressione clinica di un osteoma periferico. Il paziente è stato esaminato dopo un anno e era asintomatico senza ricorrenza della lesione e senza sintomi di infiammazione.", "bt": "Peripheral osteomas of the jaw bone are rare and usually associated with Gardner's syndrome, and the histological examination confirmed the clinical impression of a peripheral osteoma, and the patient was examined after a year and was asymptomatic without recurrence of injury and without symptoms of inflammation.", "questions_src": ["What is the usual association with peripheral osteomas of the jaw bone?", "Who was reviewed after one year in the case described?", "Where was the histological examination performed?", "When was the patient reviewed after one year?", "Which syndrome is commonly associated with peripheral osteomas of the jaw bone?"], "answers_src": ["[\"Gardner\"s syndrome\", \"The patient\", \"In the case described\", \"After one year\", \"Gardner\"s syndrome\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"Gardner\"s syndrome\", \"The patient\", \"In the jaw bone\", \"After one year\", \"Gardner\"s syndrome\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "168.1", "question": "What is the usual association with peripheral osteomas of the jaw bone?", "answer_src": "[\"Gardner\"s syndrome\", \"The patient\", \"In the case described\", \"After one year\", \"Gardner\"s syndrome\"]", "follow_up_question": "What is the duration between the initial review and the patient's last follow-up?", "follow_up_response": "1 year", "follow_up_response_bt": "1 year"}, {"question_id": "168.2", "question": "Who was reviewed after one year in the case described?", "answer_src": "peripheral osteomas of jaw bone are uncommon and usually associated with gardner 's syndrome . histological examination confirmed the clinical impression of a peripheral osteoma . patient was reviewed after one year and was asymptomatic with no recurrence of the lesion .", "follow_up_question": "What was the patient's condition after one year?", "follow_up_response": "asymptomatic with no recurrence of the lesion", "follow_up_response_bt": "asymptomatic without recurrence of injury and without symptoms of inflammation"}, {"question_id": "168.3", "question": "Where was the histological examination performed?", "answer_src": "peripheral osteomas of jaw bone are uncommon and usually associated with gardner 's syndrome . histological examination confirmed the clinical impression of a peripheral osteoma . patient was reviewed after one year and was asymptomatic with no recurrence of the lesion .", "follow_up_question": "What was the outcome of the patient's review after one year?", "follow_up_response": "The patient was asymptomatic with no recurrence of the lesion.", "follow_up_response_bt": "asymptomatic without recurrence of injury and without symptoms of inflammation"}, {"question_id": "168.4", "question": "When was the patient reviewed after one year?", "answer_src": "peripheral osteomas of jaw bone are uncommon and usually associated with gardner 's syndrome . histological examination confirmed the clinical impression of a peripheral osteoma . patient was reviewed after one year and was asymptomatic with no recurrence of the lesion .", "follow_up_question": "Was the patient asymptomatic after one year?", "follow_up_response": "Yes", "follow_up_response_bt": "Yes"}, {"question_id": "168.5", "question": "Which syndrome is commonly associated with peripheral osteomas of the jaw bone?", "answer_src": "peripheral osteomas of jaw bone are uncommon and usually associated with gardner 's syndrome . histological examination confirmed the clinical impression of a peripheral osteoma . patient was reviewed after one year and was asymptomatic with no recurrence of the lesion .", "follow_up_question": "What was the outcome of the patient's review after one year?", "follow_up_response": "The patient was asymptomatic with no recurrence of the lesion.", "follow_up_response_bt": "asymptomatic without recurrence of injury and without symptoms of inflammation"}], "turn_2": [{"question_id": "168.6", "question": "What is the duration between the initial review and the patient's last follow-up?", "answer_src": "1 year", "follow_up_question": "How many symptoms did the patient have at the time of the initial review?", "follow_up_response": "0", "follow_up_response_bt": "0"}, {"question_id": "168.7", "question": "What was the patient's condition after one year?", "answer_src": "asymptomatic with no recurrence of the lesion", "follow_up_question": "What is the implication of the patient's asymptomatic status?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "168.8", "question": "What was the outcome of the patient's review after one year?", "answer_src": "The patient was asymptomatic with no recurrence of the lesion.", "follow_up_question": "What type of lesion was confirmed to be present through histological examination?", "follow_up_response": "Peripheral osteoma", "follow_up_response_bt": "Peripheral osteoma"}, {"question_id": "168.9", "question": "Was the patient asymptomatic after one year?", "answer_src": "Yes", "follow_up_question": "Did the patient experience any recurrence of the lesion after one year?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "168.10", "question": "What was the outcome of the patient's review after one year?", "answer_src": "The patient was asymptomatic with no recurrence of the lesion.", "follow_up_question": "What type of lesion was confirmed to be present through histological examination?", "follow_up_response": "Peripheral osteoma", "follow_up_response_bt": "Peripheral osteoma"}], "turn_3": [{"question_id": "168.11", "question": "How many symptoms did the patient have at the time of the initial review?", "answer_src": "0", "follow_up_question": "How long did the patient remain asymptomatic after the initial review?", "follow_up_response": "One year", "follow_up_response_bt": "a year"}, {"question_id": "168.12", "question": "What is the implication of the patient's asymptomatic status?", "answer_src": "peripheral osteomas of jaw bone are uncommon and usually associated with gardner 's syndrome . histological examination confirmed the clinical impression of a peripheral osteoma . patient was reviewed after one year and was asymptomatic with no recurrence of the lesion .", "follow_up_question": "What was the outcome regarding the recurrence of the lesion?", "follow_up_response": "No Answer", "follow_up_response_bt": "asymptomatic without recurrence of injury"}, {"question_id": "168.13", "question": "What type of lesion was confirmed to be present through histological examination?", "answer_src": "Peripheral osteoma", "follow_up_question": "What was the outcome of the patient's review after one year?", "follow_up_response": "The patient was asymptomatic with no recurrence of the lesion.", "follow_up_response_bt": "asymptomatic without recurrence of injury and without symptoms of inflammation"}, {"question_id": "168.14", "question": "Did the patient experience any recurrence of the lesion after one year?", "answer_src": "peripheral osteomas of jaw bone are uncommon and usually associated with gardner 's syndrome . histological examination confirmed the clinical impression of a peripheral osteoma . patient was reviewed after one year and was asymptomatic with no recurrence of the lesion .", "follow_up_question": "Was the patient asymptomatic after one year?", "follow_up_response": "Yes", "follow_up_response_bt": "Yes"}, {"question_id": "168.15", "question": "What type of lesion was confirmed to be present through histological examination?", "answer_src": "Peripheral osteoma", "follow_up_question": "What was the outcome of the patient's review after one year?", "follow_up_response": "The patient was asymptomatic with no recurrence of the lesion.", "follow_up_response_bt": "asymptomatic without recurrence of injury and without symptoms of inflammation"}]}}
{"id": 169, "src": "carcinoid bronchopulmonary tumors represent approximately 25% of all carcinoid tumors and 1%2% of all lung neoplasms . the most common symptoms are : persistent cough , asthma - like wheezing , chest pain , dyspnea , hemoptysis and obstructive pneumonitis . we present a case of a young adult diagnosed with a typical carcinoid tumor .", "mt": "I tumori bronco-pulmonari carcinoidi rappresentano circa il 25% di tutti i tumori carcinoidi e l'1%2% di tutti i tumori polmonari . I sintomi più comuni sono: tosse persistente , asma - come il soffiare , dolore al petto , dispnea , emoptisi e pneumonite ossistrativa . Presentiamo un caso di un giovane adulto diagnosticato con un tumore carcinoide tipico .", "pert_mt": "I tumori bronco-pulmonari carcinoidi rappresentano circa il 25% di tutti i tumori carcinoidi e l'1%2% di tutti i tumori polmonari. I sintomi più comuni sono: tosse persistente, asma - come il soffiare, dolore al petto, dispnea, emoptisi, pneumonite ossistruttiva e febbre. Presentiamo un caso di un giovane adulto diagnosticato con un tumore carcinoide tipico.", "bt": "Broncho-pulmonary carcinogens account for about 25% of all carcinogens and 1%-2% of all lung tumors.The most common symptoms are: persistent cough, asthma - such as soffiare, chest pain, dyspnea, emptys, obstructive pneumonitis and fever.We present a case of a young adult diagnosed with a typical carcinogens.", "questions_src": ["What is the percentage of carcinoid tumors that carcinoid bronchopulmonary tumors represent?", "What percentage of lung neoplasms do carcinoid bronchopulmonary tumors account for?", "What are the most common symptoms of carcinoid bronchopulmonary tumors?", "Who is typically diagnosed with a typical carcinoid tumor?", "Where can carcinoid bronchopulmonary tumors be found in the body?"], "answers_src": ["25%", "1%", "Persistent cough, asthma-like wheezing, chest pain, dyspnea, hemoptysis and obstructive pneumonitis", "A young adult", "In the lungs"], "answers_bt": ["[\"1%-2%\"], [\"25%\"], [\"persistent cough, asthma, chest pain, dyspnea, obstructive pneumonitis, and fever\"], [\"a young adult\"], [\"in the lungs\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "169.1", "question": "What is the percentage of carcinoid tumors that carcinoid bronchopulmonary tumors represent?", "answer_src": "25%", "follow_up_question": "What specific symptoms are commonly associated with carcinoid bronchopulmonary tumors?", "follow_up_response": "persistent cough, asthma-like wheezing, chest pain, dyspnea, hemoptysis and obstructive pneumonitis", "follow_up_response_bt": "persistent cough, asthma, chest pain, dyspnea, obstructive pneumonitis"}, {"question_id": "169.2", "question": "What percentage of lung neoplasms do carcinoid bronchopulmonary tumors account for?", "answer_src": "1%", "follow_up_question": "What specific symptoms were observed in the presented case of the young adult with a carcinoid tumor?", "follow_up_response": "persistent cough, asthma-like wheezing, chest pain, dyspnea, hemoptysis and obstructive pneumonitis", "follow_up_response_bt": "persistent cough, asthma, chest pain, dyspnea, obstructive pneumonitis"}, {"question_id": "169.3", "question": "What are the most common symptoms of carcinoid bronchopulmonary tumors?", "answer_src": "Persistent cough, asthma-like wheezing, chest pain, dyspnea, hemoptysis and obstructive pneumonitis", "follow_up_question": "What percentage of all lung neoplasms do carcinoid bronchopulmonary tumors represent?", "follow_up_response": "1%2%", "follow_up_response_bt": "2%"}, {"question_id": "169.4", "question": "Who is typically diagnosed with a typical carcinoid tumor?", "answer_src": "A young adult", "follow_up_question": "What are the most common symptoms associated with carcinoid tumors?", "follow_up_response": "persistent cough, asthma-like wheezing, chest pain, dyspnea, hemoptysis and obstructive pneumonitis", "follow_up_response_bt": "persistent cough, asthma, chest pain, dyspnea, obstructive pneumonitis"}, {"question_id": "169.5", "question": "Where can carcinoid bronchopulmonary tumors be found in the body?", "answer_src": "In the lungs", "follow_up_question": "What percentage of all lung neoplasms do carcinoid bronchopulmonary tumors represent?", "follow_up_response": "1%2%", "follow_up_response_bt": "2%"}], "turn_2": [{"question_id": "169.6", "question": "What specific symptoms are commonly associated with carcinoid bronchopulmonary tumors?", "answer_src": "persistent cough, asthma-like wheezing, chest pain, dyspnea, hemoptysis and obstructive pneumonitis", "follow_up_question": "What percentage of all lung neoplasms do carcinoid bronchopulmonary tumors represent?", "follow_up_response": "1%2%", "follow_up_response_bt": "2%"}, {"question_id": "169.7", "question": "What specific symptoms were observed in the presented case of the young adult with a carcinoid tumor?", "answer_src": "persistent cough, asthma-like wheezing, chest pain, dyspnea, hemoptysis and obstructive pneumonitis", "follow_up_question": "Which symptom was not mentioned as being observed in the case?", "follow_up_response": "obstructive pneumonitis", "follow_up_response_bt": "emptys"}, {"question_id": "169.8", "question": "What percentage of all lung neoplasms do carcinoid bronchopulmonary tumors represent?", "answer_src": "1%2%", "follow_up_question": "What specific symptoms were the patient experiencing in this case of a typical carcinoid tumor?", "follow_up_response": "persistent cough, asthma-like wheezing, chest pain, dyspnea, hemoptysis and obstructive pneumonitis", "follow_up_response_bt": "persistent cough, asthma, chest pain, dyspnea, obstructive pneumonitis"}, {"question_id": "169.9", "question": "What are the most common symptoms associated with carcinoid tumors?", "answer_src": "persistent cough, asthma-like wheezing, chest pain, dyspnea, hemoptysis and obstructive pneumonitis", "follow_up_question": "What percentage of all carcinoid tumors do bronchopulmonary carcinoids represent?", "follow_up_response": "25%", "follow_up_response_bt": "25%"}, {"question_id": "169.10", "question": "What percentage of all lung neoplasms do carcinoid bronchopulmonary tumors represent?", "answer_src": "1%2%", "follow_up_question": "What specific symptoms were the patient experiencing in this case of a typical carcinoid tumor?", "follow_up_response": "persistent cough, asthma-like wheezing, chest pain, dyspnea, hemoptysis and obstructive pneumonitis", "follow_up_response_bt": "persistent cough, asthma, chest pain, dyspnea, obstructive pneumonitis"}], "turn_3": [{"question_id": "169.11", "question": "What percentage of all lung neoplasms do carcinoid bronchopulmonary tumors represent?", "answer_src": "1%2%", "follow_up_question": "What specific symptoms were the patient experiencing in this case of a typical carcinoid tumor?", "follow_up_response": "persistent cough, asthma-like wheezing, chest pain, dyspnea, hemoptysis and obstructive pneumonitis", "follow_up_response_bt": "persistent cough, asthma, chest pain, dyspnea, obstructive pneumonitis"}, {"question_id": "169.12", "question": "Which symptom was not mentioned as being observed in the case?", "answer_src": "obstructive pneumonitis", "follow_up_question": "Which specific carcinoid tumor symptom is most commonly associated with persistent cough?", "follow_up_response": "Persistent cough", "follow_up_response_bt": "Persistent cough"}, {"question_id": "169.13", "question": "What specific symptoms were the patient experiencing in this case of a typical carcinoid tumor?", "answer_src": "persistent cough, asthma-like wheezing, chest pain, dyspnea, hemoptysis and obstructive pneumonitis", "follow_up_question": "Which symptom was not mentioned as being the most common among carcinoid tumors?", "follow_up_response": "obstructive pneumonitis", "follow_up_response_bt": "emptys"}, {"question_id": "169.14", "question": "What percentage of all carcinoid tumors do bronchopulmonary carcinoids represent?", "answer_src": "25%", "follow_up_question": "What specific symptoms are commonly associated with carcinoid bronchopulmonary tumors?", "follow_up_response": "persistent cough, asthma-like wheezing, chest pain, dyspnea, hemoptysis and obstructive pneumonitis", "follow_up_response_bt": "persistent cough, asthma, chest pain, dyspnea, obstructive pneumonitis"}, {"question_id": "169.15", "question": "What specific symptoms were the patient experiencing in this case of a typical carcinoid tumor?", "answer_src": "persistent cough, asthma-like wheezing, chest pain, dyspnea, hemoptysis and obstructive pneumonitis", "follow_up_question": "Which symptom was not mentioned as being the most common among carcinoid tumors?", "follow_up_response": "obstructive pneumonitis", "follow_up_response_bt": "emptys"}]}}
{"id": 170, "src": "matrix metalloproteinase-9 ( mmp-9 ) , regulated by tissue inhibitor of metalloproteinase-9 ( timp-1 ) and the extracellular matrix metalloproteinase inducer ( emmprin ) , contributes to plaque instability . autologous stem cells from bone marrow ( mbmc ) treatment are suggested to reduce myocardial damage ; however , limited data exists on the influence of mbmc on mmps . we investigated the influence of mbmc on circulating levels of mmp-9 , timp-1 , and emmprin at different time points in patients included in the randomized autologous stem - cell transplantation in acute myocardial infarction ( astami ) trial ( n = 100 ) .", "mt": "Le matrici metalloproteinasi-9 (mmp-9) , regolate dall'inibitore dei tessuti della metalloproteinasi-9 ( timp-1) e dall'induttore extracellulare della metalloproteinasi (emmprin) contribuiscono all'instabilità della placca . Si suggerisce che le cellule staminali autologiche del trattamento del midollo osseo (mbmc) riducano i danni al miocardio; tuttavia, esistono dati limitati sull'influenza di mbmc su mmps . Abbiamo studiato l'influenza di mbmc sui livelli circolanti di mmp-9 , timp-1 e emmprin a diversi punti temporali nei pazienti inclusi nel trapianto di cellule staminali autologici randomizzati in uno studio di infarto acuto del miocardio (asma) (n = 100).", "pert_mt": "Le matrici metalloproteinasi-9 (mmp-9) , regolate dall'inibitore dei tessuti della metalloproteinasi-9 ( timp-1) e dall'induttore extracellulare della metalloproteinasi (emmprin) contribuiscono all'instabilità della placca. Si suggerisce che le cellule staminali autologiche del trattamento del midollo osseo (mbmc) riducano i danni al miocardio; tuttavia, esistono dati limitati sull'influenza di mbmc su mmps. Abbiamo studiato l'influenza di mbmc sui livelli circolanti di mmp-9 , timp-1 e emmprin a diversi punti temporali nei pazienti inclusi nel trapianto di cellule staminali autologici randomizzati in uno studio di infarto", "bt": "The leci metalloproteinase-9 (mmp-9) , regulated by the inhibitor of the tissues of metalloproteinase-9 (timp-1) and the extracellular inductor of metalloproteinase (emmprin) contribute to all plaque instability. It is suggested that the autologous stem cells of bone marrow treatment (mbmc) reduce damage to the myocardium; however, there are limited data on the influence of mbmc on mmps. We have studied the influence of mbmc at various levels of mmp-9 , mm-1 and emprin at various points in time including trapiant cells of randomized stem cells in a study of several patients with heart failure.", "questions_src": ["What does matrix metalloproteinase-9 contribute to?", "When is myocardial damage reduced with autologous stem cells from bone marrow?", "Where can autologous stem cells from bone marrow be sourced from?", "Who conducted the randomized autologous stem-cell transplantation in acute myocardial infarction trial?", "Which factors regulate tissue inhibitor of metalloproteinase-9 and extracellular matrix metalloproteinase inducer?"], "answers_src": ["Plaque instability", "No Answer", "Bone marrow", "No Answer", "matrix metalloproteinase-9 and the extracellular matrix metalloproteinase inducer"], "answers_bt": ["Plaque instability", "No Answer", "Bone marrow", "Several patients with heart failure", "Regulated by timp-1 and the extracellular inductor of metalloproteinase (emmprin)"], "multiturn": {"turn_1": [{"question_id": "170.1", "question": "What does matrix metalloproteinase-9 contribute to?", "answer_src": "Plaque instability", "follow_up_question": "How does matrix metalloproteinase-9 contribute to plaque instability according to the text?", "follow_up_response": "It contributes to plaque instability", "follow_up_response_bt": "The leci metalloproteinase-9 (mmp-9), regulated by the inhibitor of the tissues of metalloproteinase-9 (timp-1) and the extracellular inductor of metalloproteinase (emmprin)"}, {"question_id": "170.2", "question": "When is myocardial damage reduced with autologous stem cells from bone marrow?", "answer_src": "matrix metalloproteinase-9 ( mmp-9 ) , regulated by tissue inhibitor of metalloproteinase-9 ( timp-1 ) and the extracellular matrix metalloproteinase inducer ( emmprin ) , contributes to plaque instability . autologous stem cells from bone marrow ( mbmc ) treatment are suggested to reduce myocardial damage ; however , limited data exists on the influence of mbmc on mmps . we investigated the influence of mbmc on circulating levels of mmp-9 , timp-1 , and emmprin at different time points in patients included in the randomized autologous stem - cell transplantation in acute myocardial infarction ( astami ) trial ( n = 100 ) .", "follow_up_question": "At what time points were circulating levels of mmp-9, timp-1, and emmprin measured in the study?", "follow_up_response": "Different time points", "follow_up_response_bt": "No Answer"}, {"question_id": "170.3", "question": "Where can autologous stem cells from bone marrow be sourced from?", "answer_src": "Bone marrow", "follow_up_question": "At what specific time points were the circulating levels of mmp-9, timp-1, and emmprin measured in the study?", "follow_up_response": "different time points", "follow_up_response_bt": "No Answer"}, {"question_id": "170.4", "question": "Who conducted the randomized autologous stem-cell transplantation in acute myocardial infarction trial?", "answer_src": "matrix metalloproteinase-9 ( mmp-9 ) , regulated by tissue inhibitor of metalloproteinase-9 ( timp-1 ) and the extracellular matrix metalloproteinase inducer ( emmprin ) , contributes to plaque instability . autologous stem cells from bone marrow ( mbmc ) treatment are suggested to reduce myocardial damage ; however , limited data exists on the influence of mbmc on mmps . we investigated the influence of mbmc on circulating levels of mmp-9 , timp-1 , and emmprin at different time points in patients included in the randomized autologous stem - cell transplantation in acute myocardial infarction ( astami ) trial ( n = 100 ) .", "follow_up_question": "What is the sample size of the patients included in the trial?", "follow_up_response": "100", "follow_up_response_bt": "No Answer"}, {"question_id": "170.5", "question": "Which factors regulate tissue inhibitor of metalloproteinase-9 and extracellular matrix metalloproteinase inducer?", "answer_src": "matrix metalloproteinase-9 and the extracellular matrix metalloproteinase inducer", "follow_up_question": "What specific time points were patients included in the astami trial measured at?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "170.6", "question": "How does matrix metalloproteinase-9 contribute to plaque instability according to the text?", "answer_src": "It contributes to plaque instability", "follow_up_question": "What specific extracellular factors regulate matrix metalloproteinase-9 (mmp-9) according to the text?", "follow_up_response": "tissue inhibitor of metalloproteinase-9 (timp-1) and the extracellular matrix metalloproteinase inducer (emmprin)", "follow_up_response_bt": "regulated by the inhibitor of the tissues of metalloproteinase-9 (timp-1) and the extracellular inductor of metalloproteinase (emmprin)"}, {"question_id": "170.7", "question": "At what time points were circulating levels of mmp-9, timp-1, and emmprin measured in the study?", "answer_src": "Different time points", "follow_up_question": "What specific time points were the circulating levels measured?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "170.8", "question": "At what specific time points were the circulating levels of mmp-9, timp-1, and emmprin measured in the study?", "answer_src": "different time points", "follow_up_question": "What were the specific time points measured for circulating levels of mmp-9, timp-1, and emmprin?", "follow_up_response": "Different time points", "follow_up_response_bt": "No Answer"}, {"question_id": "170.9", "question": "What is the sample size of the patients included in the trial?", "answer_src": "100", "follow_up_question": "At what time point was the first measurement of mmp-9, timp-1, and emmprin conducted in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "170.10", "question": "What specific time points were patients included in the astami trial measured at?", "answer_src": "matrix metalloproteinase-9 ( mmp-9 ) , regulated by tissue inhibitor of metalloproteinase-9 ( timp-1 ) and the extracellular matrix metalloproteinase inducer ( emmprin ) , contributes to plaque instability . autologous stem cells from bone marrow ( mbmc ) treatment are suggested to reduce myocardial damage ; however , limited data exists on the influence of mbmc on mmps . we investigated the influence of mbmc on circulating levels of mmp-9 , timp-1 , and emmprin at different time points in patients included in the randomized autologous stem - cell transplantation in acute myocardial infarction ( astami ) trial ( n = 100 ) .", "follow_up_question": "At what time points were circulating levels of mmp-9, timp-1, and emmprin measured in the astami trial?", "follow_up_response": "Different time points", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "170.11", "question": "What specific extracellular factors regulate matrix metalloproteinase-9 (mmp-9) according to the text?", "answer_src": "tissue inhibitor of metalloproteinase-9 (timp-1) and the extracellular matrix metalloproteinase inducer (emmprin)", "follow_up_question": "How does the autologous stem cell treatment affect the levels of matrix metalloproteinase-9 (mmp-9), tissue inhibitor of metalloproteinase-9 (timp-1), and extracellular matrix metalloproteinase inducer (emmprin) in patients?", "follow_up_response": "reduce myocardial damage", "follow_up_response_bt": "The autologous stem cell treatment (mbmc) reduces damage to the myocardium"}, {"question_id": "170.12", "question": "What specific time points were the circulating levels measured?", "answer_src": "matrix metalloproteinase-9 ( mmp-9 ) , regulated by tissue inhibitor of metalloproteinase-9 ( timp-1 ) and the extracellular matrix metalloproteinase inducer ( emmprin ) , contributes to plaque instability . autologous stem cells from bone marrow ( mbmc ) treatment are suggested to reduce myocardial damage ; however , limited data exists on the influence of mbmc on mmps . we investigated the influence of mbmc on circulating levels of mmp-9 , timp-1 , and emmprin at different time points in patients included in the randomized autologous stem - cell transplantation in acute myocardial infarction ( astami ) trial ( n = 100 ) .", "follow_up_question": "At what time points were the circulating levels of mmp-9, timp-1, and emmprin measured?", "follow_up_response": "Different time points", "follow_up_response_bt": "No Answer"}, {"question_id": "170.13", "question": "What were the specific time points measured for circulating levels of mmp-9, timp-1, and emmprin?", "answer_src": "Different time points", "follow_up_question": "What were the specific time points measured?", "follow_up_response": "different time points", "follow_up_response_bt": "Various points in time"}, {"question_id": "170.14", "question": "At what time point was the first measurement of mmp-9, timp-1, and emmprin conducted in the study?", "answer_src": "matrix metalloproteinase-9 ( mmp-9 ) , regulated by tissue inhibitor of metalloproteinase-9 ( timp-1 ) and the extracellular matrix metalloproteinase inducer ( emmprin ) , contributes to plaque instability . autologous stem cells from bone marrow ( mbmc ) treatment are suggested to reduce myocardial damage ; however , limited data exists on the influence of mbmc on mmps . we investigated the influence of mbmc on circulating levels of mmp-9 , timp-1 , and emmprin at different time points in patients included in the randomized autologous stem - cell transplantation in acute myocardial infarction ( astami ) trial ( n = 100 ) .", "follow_up_question": "What is the number of patients included in the study?", "follow_up_response": "100", "follow_up_response_bt": "No Answer"}, {"question_id": "170.15", "question": "At what time points were circulating levels of mmp-9, timp-1, and emmprin measured in the astami trial?", "answer_src": "Different time points", "follow_up_question": "What specific time points were circulating levels of mmp-9, timp-1, and emmprin measured?", "follow_up_response": "Different time points", "follow_up_response_bt": "No Answer"}]}}
{"id": 171, "src": "in the closed structure of the p2x cation channel , three -helical transmembrane domains cross the membrane obliquely : in rat p2x2 receptors , these intersect at thr339 . replacing thr339 by lysine in one , two or three subunits progressively increased chloride permeability and reduced unitary conductance . this implies that the closed - open transition involves a symmetrical separation of the three subunits , and that thr339 from each contributes symmetrically to the open channel permeation pathway .", "mt": "Nella struttura chiusa del cation cation channel , tre domini di transmembrane a forma di elico attraversano la membrana obliquamente: nei recettori p2x2 del topo , questi si intersecano a thr339 . sostituendo thr339 con lisina in una , due o tre sottounità aumentano progressivamente la permeabilità del cloruro e riducono la conduttività unitaria . Ciò implica che la transizione chiusa-aperta comporta una separazione simmetrica delle tre sottounità , e che thr339 da ciascuna contribuisce simmetricamente alla via di permeazione del canale aperto .", "pert_mt": "Nella struttura chiusa del cation channel, tre domini di transmembrane a forma di elico attraversano la membrana obliquamente: nei recettori p2x2 del topo, questi si intersecano a thr339. Sostituendo thr339 con lisina in una, due o tre sottounità aumentano progressivamente la permeabilità del cloruro e riducono la conduttività unitaria. Ciò implica che la transizione chiusa-aperta comporta una separazione simmetrica delle tre sottounità, e che thr339 da ciascuna contribuisce simmetricamente alla via di permeazione del canale aperto, indipendentemente dallo stato di apertura del canale.", "bt": "In the closed structure of the cation channel, three helico-shaped transmembrane domains cross the membrane obliquely: in the p2x2 receptors of the top, these intersect with thr339. substituting thr339 with lysine in one, two or three subunits progressively increases the permeability of the chloride and reduces unit conductivity.This implies that the closed-open transition involves a symmetrical separation of the three subunits, and that thr339 of each contributes symmetrically to the open channel permeability pathway, regardless of the opening state of the channel.", "questions_src": ["What is the structure of the p2x cation channel?", "Where do the three-helical transmembrane domains cross the membrane?", "Which residue intersects at position 339 in rat p2x2 receptors?", "How does replacing thr339 by lysine affect chloride permeability?", "Which subunits contribute symmetrically to the open channel permeation pathway?"], "answers_src": ["The closed structure of the p2x cation channel", "Obliquely", "Thr339", "Progressively increased chloride permeability and reduced unitary conductance", "Each Thr339"], "answers_bt": ["The closed structure of the cation channel", "Obliquely", "Thr339", "Increases the permeability of the chloride", "Each subunit"], "multiturn": {"turn_1": [{"question_id": "171.1", "question": "What is the structure of the p2x cation channel?", "answer_src": "The closed structure of the p2x cation channel", "follow_up_question": "How many subunits contribute symmetrically to the open channel permeation pathway according to the text?", "follow_up_response": "three", "follow_up_response_bt": "3"}, {"question_id": "171.2", "question": "Where do the three-helical transmembrane domains cross the membrane?", "answer_src": "Obliquely", "follow_up_question": "How does the symmetry of thr339 contribute to the open channel permeation pathway?", "follow_up_response": "Thr339 from each subunit contributes symmetrically to the open channel permeation pathway.", "follow_up_response_bt": "Each thr339 contributes symmetrically to the open channel permeability pathway, regardless of the opening state of the channel."}, {"question_id": "171.3", "question": "Which residue intersects at position 339 in rat p2x2 receptors?", "answer_src": "Thr339", "follow_up_question": "Which subunit(s) contribute(s) symmetrically to the open channel permeation pathway according to the text?", "follow_up_response": "Thr339 from each", "follow_up_response_bt": "Thr339"}, {"question_id": "171.4", "question": "How does replacing thr339 by lysine affect chloride permeability?", "answer_src": "Progressively increased chloride permeability and reduced unitary conductance", "follow_up_question": "How does replacing thr339 by lysine affect unitary conductance?", "follow_up_response": "Progressively reduced", "follow_up_response_bt": "Progressively decreases"}, {"question_id": "171.5", "question": "Which subunits contribute symmetrically to the open channel permeation pathway?", "answer_src": "Each Thr339", "follow_up_question": "Which subunit does not contribute symmetrically to the open channel permeation pathway?", "follow_up_response": "thr339", "follow_up_response_bt": "thr339"}], "turn_2": [{"question_id": "171.6", "question": "How many subunits contribute symmetrically to the open channel permeation pathway according to the text?", "answer_src": "three", "follow_up_question": "How does changing thr339 to lysine affect the closed-open transition in the p2x2 receptors?", "follow_up_response": "It implies that the closed-open transition involves a symmetrical separation of the three subunits, and that thr339 from each contributes symmetrically to the open channel permeation pathway.", "follow_up_response_bt": "Substituting thr339 with lysine in one, two or three subunits progressively increases the permeability of the chloride and reduces unit conductivity."}, {"question_id": "171.7", "question": "How does the symmetry of thr339 contribute to the open channel permeation pathway?", "answer_src": "Thr339 from each subunit contributes symmetrically to the open channel permeation pathway.", "follow_up_question": "What is the effect of replacing thr339 by lysine in one subunit on chloride permeability?", "follow_up_response": "Progressively increased chloride permeability", "follow_up_response_bt": "Progressively increases the permeability of the chloride"}, {"question_id": "171.8", "question": "Which subunit(s) contribute(s) symmetrically to the open channel permeation pathway according to the text?", "answer_src": "Thr339 from each", "follow_up_question": "How many subunits need to have Thr339 replaced for the effects on chloride permeability and unitary conductance to occur?", "follow_up_response": "1, 2, 3", "follow_up_response_bt": "1, 2, 3"}, {"question_id": "171.9", "question": "How does replacing thr339 by lysine affect unitary conductance?", "answer_src": "Progressively reduced", "follow_up_question": "How does replacing thr339 by lysine affect chloride permeability?", "follow_up_response": "Progressively increased", "follow_up_response_bt": "Progressively increases"}, {"question_id": "171.10", "question": "Which subunit does not contribute symmetrically to the open channel permeation pathway?", "answer_src": "thr339", "follow_up_question": "Which subunit(s) were replaced to progressively increase chloride permeability?", "follow_up_response": "one\", \"two\", \"three", "follow_up_response_bt": "one, two or three"}], "turn_3": [{"question_id": "171.11", "question": "How does changing thr339 to lysine affect the closed-open transition in the p2x2 receptors?", "answer_src": "It implies that the closed-open transition involves a symmetrical separation of the three subunits, and that thr339 from each contributes symmetrically to the open channel permeation pathway.", "follow_up_question": "What role does thr339 play in the open channel permeation pathway?", "follow_up_response": "Thr339 from each contributes symmetrically to the open channel permeation pathway.", "follow_up_response_bt": "Thr339 of each subunit contributes symmetrically to the open channel permeability pathway"}, {"question_id": "171.12", "question": "What is the effect of replacing thr339 by lysine in one subunit on chloride permeability?", "answer_src": "Progressively increased chloride permeability", "follow_up_question": "What is the effect of replacing thr339 by lysine in one subunit on unitary conductance?", "follow_up_response": "Progressively increased chloride permeability and reduced unitary conductance", "follow_up_response_bt": "Progressively decreases"}, {"question_id": "171.13", "question": "How many subunits need to have Thr339 replaced for the effects on chloride permeability and unitary conductance to occur?", "answer_src": "1, 2, 3", "follow_up_question": "How does the replacement of Thr339 in different subunits affect the symmetry of the closed-open transition?", "follow_up_response": "It implies that the closed-open transition involves a symmetrical separation of the three subunits, and that Thr339 from each contributes symmetrically to the open channel permeation pathway.", "follow_up_response_bt": "It implies that the closed-open transition involves a symmetrical separation of the three subunits, and that Thr339 of each contributes symmetrically to the open channel permeability pathway, regardless of the opening state of the channel."}, {"question_id": "171.14", "question": "How does replacing thr339 by lysine affect chloride permeability?", "answer_src": "Progressively increased", "follow_up_question": "How does replacing thr339 by lysine affect unitary conductance?", "follow_up_response": "Progressively reduced", "follow_up_response_bt": "Progressively decreases"}, {"question_id": "171.15", "question": "Which subunit(s) were replaced to progressively increase chloride permeability?", "answer_src": "one\", \"two\", \"three", "follow_up_question": "Which specific residue was changed in each subunit?", "follow_up_response": "Thr339", "follow_up_response_bt": "thr339"}]}}
{"id": 172, "src": "mmp-9 and emmprin were significantly correlated to myocardial injury ( ck : p = 0.005 and p < 0.001 , resp . ) and infarct size ( spect : p = 0.018 and p = 0.008 , resp . ) . the results indicate that the regulation of metalloproteinases is important during ami , however , limited influenced by mbmc .", "mt": "mmp-9 e emmprin sono stati significativamente correlati con lesioni miocardiche (ck: p = 0,005 e p < 0,001 , rispettivamente) e dimensioni di infarto (spec: p = 0,018 e p = 0,008 , rispettivamente).", "pert_mt": "mmp-9, emmprin e cathepsin G sono stati significativamente correlati con lesioni miocardiche (ck: p = 0,005 e p < 0,001 , rispettivamente) e dimensioni di infarto (spec: p = 0,018 e p = 0,008 , rispettivamente).", "bt": "mmp-9, emmprin and cathepsin G have been significantly correlated with myocardial lesions (ck: p = 0.005 and p < 0.001 , respectively) and dimensions of infarction (spec: p = 0.018 and p = 0.008 , respectively).", "questions_src": ["What was significantly correlated to myocardial injury according to the sentence?", "Who was involved in the correlation between metalloproteinases and myocardial injury?", "Where can spect be found in relation to this study?", "When did the significant correlations occur according to the sentence?", "Which marker had a p-value less than 0.001 for myocardial injury?"], "answers_src": ["mmp-9 and emmprin", "metalloproteinases", "spect", "p = 0.005 and p < 0.001", "ck"], "answers_bt": ["[\"mmp-9, emmprin and cathepsin G\"], [\"mmp-9, emmprin and cathepsin G\"], [\"spec\"], [\"p < 0.001 and p = 0.008\"], [\"cathepsin G\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "172.1", "question": "What was significantly correlated to myocardial injury according to the sentence?", "answer_src": "mmp-9 and emmprin", "follow_up_question": "What was significantly correlated to infarct size according to the sentence?", "follow_up_response": "mmp-9 and emmprin", "follow_up_response_bt": "mmp-9, emmprin and cathepsin G"}, {"question_id": "172.2", "question": "Who was involved in the correlation between metalloproteinases and myocardial injury?", "answer_src": "metalloproteinases", "follow_up_question": "What specific metalloproteinases were found to be significantly correlated with myocardial injury?", "follow_up_response": "mmp-9 and emmprin", "follow_up_response_bt": "mmp-9, emmprin and cathepsin G"}, {"question_id": "172.3", "question": "Where can spect be found in relation to this study?", "answer_src": "spect", "follow_up_question": "What does the p-value of 0.018 for spect indicate in this study?", "follow_up_response": "0.008", "follow_up_response_bt": "dimensions of infarction"}, {"question_id": "172.4", "question": "When did the significant correlations occur according to the sentence?", "answer_src": "p = 0.005 and p < 0.001", "follow_up_question": "What was the significance level for the correlation between mmp-9/emmprin and infarct size?", "follow_up_response": "p = 0.008 and p = 0.008", "follow_up_response_bt": "p = 0.008"}, {"question_id": "172.5", "question": "Which marker had a p-value less than 0.001 for myocardial injury?", "answer_src": "ck", "follow_up_question": "Which marker had a p-value less than 0.008 for infarct size?", "follow_up_response": "emmprin", "follow_up_response_bt": "cathepsin G"}], "turn_2": [{"question_id": "172.6", "question": "What was significantly correlated to infarct size according to the sentence?", "answer_src": "mmp-9 and emmprin", "follow_up_question": "What was significantly correlated to myocardial injury according to the sentence?", "follow_up_response": "mmp-9 and emmprin", "follow_up_response_bt": "mmp-9, emmprin and cathepsin G"}, {"question_id": "172.7", "question": "What specific metalloproteinases were found to be significantly correlated with myocardial injury?", "answer_src": "mmp-9 and emmprin", "follow_up_question": "What was the significance of the correlation between mmp-9 and emmprin with myocardial injury according to the text?", "follow_up_response": "mmp-9 and emmprin were significantly correlated to myocardial injury", "follow_up_response_bt": "p = 0.005 and p < 0.001"}, {"question_id": "172.8", "question": "What does the p-value of 0.018 for spect indicate in this study?", "answer_src": "0.008", "follow_up_question": "What is the significance of the p-value of 0.001 for ck in this study?", "follow_up_response": "mmp-9 and emmprin were significantly correlated to myocardial injury", "follow_up_response_bt": "0.001"}, {"question_id": "172.9", "question": "What was the significance level for the correlation between mmp-9/emmprin and infarct size?", "answer_src": "p = 0.008 and p = 0.008", "follow_up_question": "What was the significance level for the correlation between mmp-9/emmprin and myocardial injury?", "follow_up_response": "p = 0.005 and p < 0.001", "follow_up_response_bt": "p = 0.005 and p < 0.001 "}, {"question_id": "172.10", "question": "Which marker had a p-value less than 0.008 for infarct size?", "answer_src": "emmprin", "follow_up_question": "Which marker had a p-value less than 0.001 for myocardial injury?", "follow_up_response": "mmp-9", "follow_up_response_bt": "mmp-9"}], "turn_3": [{"question_id": "172.11", "question": "What was significantly correlated to myocardial injury according to the sentence?", "answer_src": "mmp-9 and emmprin", "follow_up_question": "What was significantly correlated to infarct size according to the sentence?", "follow_up_response": "mmp-9 and emmprin", "follow_up_response_bt": "mmp-9, emmprin and cathepsin G"}, {"question_id": "172.12", "question": "What was the significance of the correlation between mmp-9 and emmprin with myocardial injury according to the text?", "answer_src": "mmp-9 and emmprin were significantly correlated to myocardial injury", "follow_up_question": "How did the correlation between mmp-9 and emmprin affect infarct size according to the text?", "follow_up_response": "p = 0.018 and p = 0.008 , resp.", "follow_up_response_bt": "No Answer"}, {"question_id": "172.13", "question": "What is the significance of the p-value of 0.001 for ck in this study?", "answer_src": "mmp-9 and emmprin were significantly correlated to myocardial injury", "follow_up_question": "What was the p-value for ck in this study?", "follow_up_response": "0.005", "follow_up_response_bt": "0.005"}, {"question_id": "172.14", "question": "What was the significance level for the correlation between mmp-9/emmprin and myocardial injury?", "answer_src": "p = 0.005 and p < 0.001", "follow_up_question": "What was the significance level for the correlation between mmp-9/emmprin and infarct size?", "follow_up_response": "p = 0.008 and p = 0.008", "follow_up_response_bt": "p = 0.008"}, {"question_id": "172.15", "question": "Which marker had a p-value less than 0.001 for myocardial injury?", "answer_src": "mmp-9", "follow_up_question": "Which marker had a p-value less than 0.008 for infarct size?", "follow_up_response": "emmprin", "follow_up_response_bt": "cathepsin G"}]}}
{"id": 173, "src": "during the follow - up period , 3.4% of the participants had an appropriate response to only nonsteroidal anti - inflammatory drugs , 57.6% to sulfasalazine , 26.3% to addition of methotrexate to the previous regimen , and 12.7% to biological agents . multiple logistic regression results showed that the underlying disease had a significant effect on the sulfasalazine response . the odds for response to treatment was 3.53 times higher in uspa patients compared to other patients ( odds ratio = 3.53 , 95% confidence interval : 1.637.68 , p=0.001 ) .", "mt": "Durante il periodo di follow-up, il 3,4% dei partecipanti ha avuto una risposta adeguata a soli farmaci antinfiammatori non steroidei , il 57,6% a sulfasalazina , il 26,3% all'aggiunta di metotrexato al regime precedente e il 12,7% agli agenti biologici . Durante i risultati di regressione logistica multiple hanno mostrato che la malattia sottostante ha avuto un effetto significativo sulla risposta a sulfasalazina . Le probabilità di risposta al trattamento sono state 3,53 volte più alte nei pazienti uspa rispetto ad altri pazienti (quota di probabilità = 3,53 , intervallo di fiducia del 95%: 1,637.68 , p=0,001).", "pert_mt": "Durante il periodo di follow-up, il 3,4% dei partecipanti ha avuto una risposta adeguata a soli farmaci antinfiammatori non steroidei, il 57,6% a sulfasalazina, il 26,3% all'aggiunta di metotrexato al regime precedente e il 12,7% agli agenti biologici. Durante i risultati di regressione logistica multiple hanno mostrato che la malattia sottostante ha avuto un effetto significativo sulla risposta a sulfasalazina. Le probabilità di risposta al trattamento sono state 3,53 volte più alte nei pazienti con USPA rispetto ad altri pazienti (quota di probabilità = 3,53, intervallo di fiducia del 95%: 1,63-7", "bt": "During the follow-up period, 3.4% of participants responded adequately to only non-steroidal anti-inflammatory drugs, 57.6% to sulfasalazine, 26.3% to methotrexate supplementation to the previous regimen, and 12.7% to biological agents.During multiple logistic regression results, the underlying disease showed a significant effect on sulfasalazine response.The likelihood of treatment response was 3.53 times higher in USPA patients compared to other patients (probability ratio = 3.53, 95% confidence interval: 1.63-7).", "questions_src": ["What percentage of participants had an appropriate response to only nonsteroidal anti-inflammatory drugs?", "What is the odds ratio for response to treatment in USPA patients compared to other patients?", "Where did the data about participant responses come from?", "When was the follow-up period for the study?", "Which treatment had the highest response rate?"], "answers_src": ["3.4%", "3.53", "Multiple logistic regression results", "During the follow-up period", "Sulfasalazine"], "answers_bt": ["3.4%", "3.53", "During the follow-up period", "No Answer", "Sulfasalazine"], "multiturn": {"turn_1": [{"question_id": "173.1", "question": "What percentage of participants had an appropriate response to only nonsteroidal anti-inflammatory drugs?", "answer_src": "3.4%", "follow_up_question": "What is the odds ratio for the response to sulfasalazine between USPA patients and other patients?", "follow_up_response": "3.53", "follow_up_response_bt": "3.53"}, {"question_id": "173.2", "question": "What is the odds ratio for response to treatment in USPA patients compared to other patients?", "answer_src": "3.53", "follow_up_question": "What is the 95% confidence interval for the odds ratio of response to treatment in USPA patients compared to other patients?", "follow_up_response": "1.637.68", "follow_up_response_bt": "1.63-7"}, {"question_id": "173.3", "question": "Where did the data about participant responses come from?", "answer_src": "Multiple logistic regression results", "follow_up_question": "What specific factor influenced the odds ratio for sulfasalazine response?", "follow_up_response": "The underlying disease", "follow_up_response_bt": "The underlying disease"}, {"question_id": "173.4", "question": "When was the follow-up period for the study?", "answer_src": "During the follow-up period", "follow_up_question": "What percentage of participants had an appropriate response to nonsteroidal anti-inflammatory drugs?", "follow_up_response": "3.4%", "follow_up_response_bt": "3.4%"}, {"question_id": "173.5", "question": "Which treatment had the highest response rate?", "answer_src": "Sulfasalazine", "follow_up_question": "What was the response rate for sulfasalazine?", "follow_up_response": "57.6%", "follow_up_response_bt": "57.6%"}], "turn_2": [{"question_id": "173.6", "question": "What is the odds ratio for the response to sulfasalazine between USPA patients and other patients?", "answer_src": "3.53", "follow_up_question": "What is the 95% confidence interval for the odds ratio of sulfasalazine response between USPA patients and other patients?", "follow_up_response": "1.637.68", "follow_up_response_bt": "1.63-7"}, {"question_id": "173.7", "question": "What is the 95% confidence interval for the odds ratio of response to treatment in USPA patients compared to other patients?", "answer_src": "1.637.68", "follow_up_question": "What is the p-value for the odds ratio of response to treatment in USPA patients compared to other patients?", "follow_up_response": "0.001", "follow_up_response_bt": "No Answer"}, {"question_id": "173.8", "question": "What specific factor influenced the odds ratio for sulfasalazine response?", "answer_src": "The underlying disease", "follow_up_question": "How many percentage points higher were the odds for response to treatment in USPA patients compared to other patients?", "follow_up_response": "3.53", "follow_up_response_bt": "3.53"}, {"question_id": "173.9", "question": "What percentage of participants had an appropriate response to nonsteroidal anti-inflammatory drugs?", "answer_src": "3.4%", "follow_up_question": "What percentage of participants did not have an appropriate response to any of the treatments mentioned?", "follow_up_response": "66.6%", "follow_up_response_bt": "No Answer"}, {"question_id": "173.10", "question": "What was the response rate for sulfasalazine?", "answer_src": "57.6%", "follow_up_question": "What percentage of participants did not respond to any of the treatments mentioned?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "173.11", "question": "What is the 95% confidence interval for the odds ratio of sulfasalazine response between USPA patients and other patients?", "answer_src": "1.637.68", "follow_up_question": "What is the p-value for the odds ratio of sulfasalazine response between USPA patients and other patients?", "follow_up_response": "0.001", "follow_up_response_bt": "No Answer"}, {"question_id": "173.12", "question": "What is the p-value for the odds ratio of response to treatment in USPA patients compared to other patients?", "answer_src": "0.001", "follow_up_question": "What is the 95% confidence interval for the odds ratio of response to treatment in USPA patients compared to other patients?", "follow_up_response": "1.637.68", "follow_up_response_bt": "1.63-7"}, {"question_id": "173.13", "question": "How many percentage points higher were the odds for response to treatment in USPA patients compared to other patients?", "answer_src": "3.53", "follow_up_question": "By how much did the odds ratio for sulfasalazine response differ between USPA patients and other patients?", "follow_up_response": "3.53", "follow_up_response_bt": "3.53"}, {"question_id": "173.14", "question": "What percentage of participants did not have an appropriate response to any of the treatments mentioned?", "answer_src": "66.6%", "follow_up_question": "What was the odds ratio for the response to sulfasalazine between USPA patients and other patients?", "follow_up_response": "3.53", "follow_up_response_bt": "3.53"}, {"question_id": "173.15", "question": "What percentage of participants did not respond to any of the treatments mentioned?", "answer_src": "during the follow - up period , 3.4% of the participants had an appropriate response to only nonsteroidal anti - inflammatory drugs , 57.6% to sulfasalazine , 26.3% to addition of methotrexate to the previous regimen , and 12.7% to biological agents . multiple logistic regression results showed that the underlying disease had a significant effect on the sulfasalazine response . the odds for response to treatment was 3.53 times higher in uspa patients compared to other patients ( odds ratio = 3.53 , 95% confidence interval : 1.637.68 , p=0.001 ) .", "follow_up_question": "What percentage of participants responded to methotrexate alone?", "follow_up_response": "26.3%", "follow_up_response_bt": "26.3%"}]}}
{"id": 174, "src": "recently , management of ludwig 's angina has evolved from aggressive airway management into a more conservative one . this is based on close airway observation on a specialised airway unit and a serial clinical airway assessment . improved imaging modalities , antibiotic therapy , surgical skills , and clinical experience are the key factors behind this change in practice .", "mt": "Recentemente , la gestione dell'angina di ludwig è passata da una gestione aggressiva delle vie aeree a una più conservatrice . si basa su un' osservazione ravvicinata delle vie aeree su un'unità di vie aeree specializzata e su una valutazione clinica delle vie aeree in serie .", "pert_mt": "Recentemente, la gestione dell'angina di Ludwing è passata da una gestione aggressiva delle vie aeree a una più conservatrice. Si basa su un'osservazione ravvicinata delle vie aeree su un'unità di vie aeree specializzata e su una valutazione clinica delle vie aeree in serie, ma non include l'uso di terapie farmacologiche aggressive.", "bt": "Recently, Ludwing's angina management has shifted from aggressive management of aerial life to more conservative management, based on close observation of aerial life by a specialized aerial life unit and a clinical assessment of aerial life in series, but does not include the use of aggressive pharmacological therapies.", "questions_src": ["What is the main reason for the evolution of management of Ludwig's angina?", "Who has been involved in improving imaging modalities for Ludwig's angina?", "Where can patients be observed closely for airway management of Ludwig's angina?", "When did management of Ludwig's angina shift towards a more conservative approach?", "Which key factor has contributed to the change in surgical skills for treating Ludwig's angina?"], "answers_src": ["[\"Improved imaging modalities, antibiotic therapy, surgical skills, and clinical experience\"], [\"Surgical skills\"], [\"Specialised airway unit\"], [\"Recently\"], [\"Surgical skills\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["Close observation of aerial life by a specialized aerial life unit and a clinical assessment of aerial life in series", "A specialized aerial life unit and clinicians", "In series", "Recently", "Not applicable"], "multiturn": {"turn_1": [{"question_id": "174.1", "question": "What is the main reason for the evolution of management of Ludwig's angina?", "answer_src": "[\"Improved imaging modalities, antibiotic therapy, surgical skills, and clinical experience\"], [\"Surgical skills\"], [\"Specialised airway unit\"], [\"Recently\"], [\"Surgical skills\"]", "follow_up_question": "How do improved imaging modalities contribute to the evolution of management?", "follow_up_response": "Improved imaging modalities", "follow_up_response_bt": "No Answer"}, {"question_id": "174.2", "question": "Who has been involved in improving imaging modalities for Ludwig's angina?", "answer_src": "recently , management of ludwig 's angina has evolved from aggressive airway management into a more conservative one . this is based on close airway observation on a specialised airway unit and a serial clinical airway assessment . improved imaging modalities , antibiotic therapy , surgical skills , and clinical experience are the key factors behind this change in practice .", "follow_up_question": "What other key factor besides improved imaging modalities has contributed to the change in practice?", "follow_up_response": "Surgical skills and clinical experience", "follow_up_response_bt": "close observation of aerial life"}, {"question_id": "174.3", "question": "Where can patients be observed closely for airway management of Ludwig's angina?", "answer_src": "recently , management of ludwig 's angina has evolved from aggressive airway management into a more conservative one . this is based on close airway observation on a specialised airway unit and a serial clinical airway assessment . improved imaging modalities , antibiotic therapy , surgical skills , and clinical experience are the key factors behind this change in practice .", "follow_up_question": "What type of unit is used for close airway observation?", "follow_up_response": "Specialised airway unit", "follow_up_response_bt": "Aerial life unit"}, {"question_id": "174.4", "question": "When did management of Ludwig's angina shift towards a more conservative approach?", "answer_src": "recently , management of ludwig 's angina has evolved from aggressive airway management into a more conservative one . this is based on close airway observation on a specialised airway unit and a serial clinical airway assessment . improved imaging modalities , antibiotic therapy , surgical skills , and clinical experience are the key factors behind this change in practice .", "follow_up_question": "What specific factors have contributed to this change in practice?", "follow_up_response": "Improved imaging modalities, antibiotic therapy, surgical skills, and clinical experience", "follow_up_response_bt": "close observation of aerial life by a specialized aerial life unit and a clinical assessment of aerial life in series"}, {"question_id": "174.5", "question": "Which key factor has contributed to the change in surgical skills for treating Ludwig's angina?", "answer_src": "recently , management of ludwig 's angina has evolved from aggressive airway management into a more conservative one . this is based on close airway observation on a specialised airway unit and a serial clinical airway assessment . improved imaging modalities , antibiotic therapy , surgical skills , and clinical experience are the key factors behind this change in practice .", "follow_up_question": "What other key factor has been improved alongside surgical skills?", "follow_up_response": "Improved imaging modalities\", \"Clinical experience", "follow_up_response_bt": "Close observation of aerial life"}], "turn_2": [{"question_id": "174.6", "question": "How do improved imaging modalities contribute to the evolution of management?", "answer_src": "Improved imaging modalities", "follow_up_question": "What specific improvements in surgical skills have led to the evolution of management?", "follow_up_response": "Improved surgical skills", "follow_up_response_bt": "No Answer"}, {"question_id": "174.7", "question": "What other key factor besides improved imaging modalities has contributed to the change in practice?", "answer_src": "Surgical skills and clinical experience", "follow_up_question": "What specific improvement in surgical skills has been noted?", "follow_up_response": "Clinical experience", "follow_up_response_bt": "No Answer"}, {"question_id": "174.8", "question": "What type of unit is used for close airway observation?", "answer_src": "Specialised airway unit", "follow_up_question": "What are the key factors behind the change in practice described in the text?", "follow_up_response": "Improved imaging modalities, antibiotic therapy, surgical skills, and clinical experience", "follow_up_response_bt": "Close observation of aerial life by a specialized aerial life unit and a clinical assessment of aerial life in series"}, {"question_id": "174.9", "question": "What specific factors have contributed to this change in practice?", "answer_src": "Improved imaging modalities, antibiotic therapy, surgical skills, and clinical experience", "follow_up_question": "How have improved imaging modalities specifically impacted the approach to managing ludwig's angina?", "follow_up_response": "Improved imaging modalities have not been specifically mentioned as impacting the approach to managing ludwig's angina.", "follow_up_response_bt": "No Answer"}, {"question_id": "174.10", "question": "What other key factor has been improved alongside surgical skills?", "answer_src": "Improved imaging modalities\", \"Clinical experience", "follow_up_question": "What specific improvement in antibiotic therapy has contributed to the change in practice?", "follow_up_response": "Improved imaging modalities, antibiotic therapy, surgical skills, and clinical experience", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "174.11", "question": "What specific improvements in surgical skills have led to the evolution of management?", "answer_src": "Improved surgical skills", "follow_up_question": "What imaging modalities have been improved to support the more conservative approach?", "follow_up_response": "Improved imaging modalities", "follow_up_response_bt": "No Answer"}, {"question_id": "174.12", "question": "What specific improvement in surgical skills has been noted?", "answer_src": "Clinical experience", "follow_up_question": "What imaging modality has been improved?", "follow_up_response": "Improved imaging modalities", "follow_up_response_bt": "No Answer"}, {"question_id": "174.13", "question": "What are the key factors behind the change in practice described in the text?", "answer_src": "Improved imaging modalities, antibiotic therapy, surgical skills, and clinical experience", "follow_up_question": "How do improved imaging modalities contribute to the change in practice?", "follow_up_response": "Improved imaging modalities", "follow_up_response_bt": "No Answer"}, {"question_id": "174.14", "question": "How have improved imaging modalities specifically impacted the approach to managing ludwig's angina?", "answer_src": "Improved imaging modalities have not been specifically mentioned as impacting the approach to managing ludwig's angina.", "follow_up_question": "What specific improvements in surgical skills have contributed to the change in practice?", "follow_up_response": "Improved surgical skills", "follow_up_response_bt": "No Answer"}, {"question_id": "174.15", "question": "What specific improvement in antibiotic therapy has contributed to the change in practice?", "answer_src": "Improved imaging modalities, antibiotic therapy, surgical skills, and clinical experience", "follow_up_question": "How have surgical skills specifically improved to contribute to the change in practice?", "follow_up_response": "Improved surgical skills", "follow_up_response_bt": "No Answer"}]}}
{"id": 175, "src": "exacerbation definition was standardized . patients were divided into two groups , ie , d ( anticholinergics discontinued at randomization , previously prescribed ) and nd ( anticholinergics not discontinued , not previously prescribed).demographics were balanced between the d ( n = 5846 ) and nd ( n = 6317 ) groups , except for higher cumulative smoking ( 56 pack - years versus 48 pack - years ) , lower forced expiratory volume in one second ( fev1)/forced vital capacity ( 43% versus 48% ) , and lower baseline fev1 ( 35.8% predicted versus 42.4% predicted ) in the d group . in both groups , tiotropium reduced the risk for an exacerbation ( hazard ratio [ hr ] = 0.83 , p < 0.0001 [ d ] versus 0.79 , p < 0.0001 [ nd ] ) and a hospitalized exacerbation ( hr = 0.85 , p = 0.0467 versus 0.79 , p = 0.0094 ) .", "mt": "La definizione di incenerimento è stata standardizzata . i pazienti sono stati suddivisi in due gruppi , cioè , d (anticolinergici interrotti alla randomizzazione , precedentemente prescritti) e nd (anticolinergici non interrotti , non precedentemente prescritti).Le demografie sono state bilanciate tra i gruppi d (n = 5846 ) e nd (n = 6317), ad eccezione del fumo cumulativo più elevato (anni di pacchetto - 56 anni contro 48 anni di pacchetto - 48 anni), un volume di espirazione forzata inferiore in un secondo (fev1) / capacità vitale forzata (43% contro 48%) e una base inferiore di fev1 (percettato per l'8% contro il 42,4% previsto) nel gruppo d. In entrambi i gruppi , il tiotropio ha ridotto il rischio di esacerbazione (rischio di rapporto [ hr ] = 0,83 , p < 0,04 , p < 0,79 , p < 0,67 , p < 0,00 , p < 0,67 , p = 0,00 , p < 0,00 , p = 0,00 , p < 0,00 , p ,", "pert_mt": "La definizione di incenerimento è stata standardizzata. I pazienti sono stati suddivisi in due gruppi, cioè, d (anticolinergici interrotti alla randomizzazione, precedentemente prescritti) e nd (anticolinergici non interrotti, non precedentemente prescritti). Le demografie sono state bilanciate tra i gruppi d (n = 5846) e nd (n = 6317), ad eccezione del fumo cumulativo più elevato (anni di pacchetto - 56 anni contro 48 anni di pacchetto - 48 anni), un volume di espirazione forzata inferiore in un secondo (FEV1) / capacità vitale forzata (43% contro 48%), una base di FEV1 inferiore (percettito per l'8% contro il 42,4%", "bt": "The definition of incineration was standardized.The patients were divided into two groups, namely, d (anticholinergic drugs stopped at randomization, previously prescribed) and nd (anticholinergic drugs not stopped, not previously prescribed).The demographics were balanced between groups d (n = 5846) and nd (n = 6317), except for the highest cumulative smoking (year of pack - 56 years versus 48 years of pack - 48 years), a lower volume of forced irration per second (FEV1) / forced life capacity (43% versus 48%), and a lower FEV1 base (percettito per l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l", "questions_src": ["What did exacerbation definition become after standardization?", "Who were divided into two groups according to the text?", "Where were the demographics balanced between the groups?", "When was the study conducted based on the provided information?", "Which group had a lower forced expiratory volume in one second (FEV1)/forced vital capacity (FVC) ratio?"], "answers_src": ["d and nd", "patients", "between the d ( n = 5846 ) and nd ( n = 6317 ) groups", "No Answer", "d"], "answers_bt": ["The definition of incineration", "The patients", "Between groups d (anticholinergic drugs stopped at randomization, previously prescribed) and nd (anticholinergic drugs not stopped, not previously prescribed)", "No Answer", "nd"], "multiturn": {"turn_1": [{"question_id": "175.1", "question": "What did exacerbation definition become after standardization?", "answer_src": "d and nd", "follow_up_question": "What was the difference in forced expiratory volume in one second (FEV1)/forced vital capacity (%) between the d and nd groups?", "follow_up_response": "43% versus 48%", "follow_up_response_bt": "43% versus 48%"}, {"question_id": "175.2", "question": "Who were divided into two groups according to the text?", "answer_src": "patients", "follow_up_question": "What was the hazard ratio for tiotropium reducing the risk of an exacerbation in the nd group?", "follow_up_response": "0.79", "follow_up_response_bt": "No Answer"}, {"question_id": "175.3", "question": "Where were the demographics balanced between the groups?", "answer_src": "between the d ( n = 5846 ) and nd ( n = 6317 ) groups", "follow_up_question": "What demographic measure differed between the d and nd groups?", "follow_up_response": "Higher cumulative smoking", "follow_up_response_bt": "Highest cumulative smoking"}, {"question_id": "175.4", "question": "When was the study conducted based on the provided information?", "answer_src": "exacerbation definition was standardized . patients were divided into two groups , ie , d ( anticholinergics discontinued at randomization , previously prescribed ) and nd ( anticholinergics not discontinued , not previously prescribed).demographics were balanced between the d ( n = 5846 ) and nd ( n = 6317 ) groups , except for higher cumulative smoking ( 56 pack - years versus 48 pack - years ) , lower forced expiratory volume in one second ( fev1)/forced vital capacity ( 43% versus 48% ) , and lower baseline fev1 ( 35.8% predicted versus 42.4% predicted ) in the d group . in both groups , tiotropium reduced the risk for an exacerbation ( hazard ratio [ hr ] = 0.83 , p < 0.0001 [ d ] versus 0.79 , p < 0.0001 [ nd ] ) and a hospitalized exacerbation ( hr = 0.85 , p = 0.0467 versus 0.79 , p = 0.0094 ) .", "follow_up_question": "What is the difference in forced expiratory volume in one second (FEV1) between the d and nd groups?", "follow_up_response": "43% versus 48%", "follow_up_response_bt": "43% versus 48%"}, {"question_id": "175.5", "question": "Which group had a lower forced expiratory volume in one second (FEV1)/forced vital capacity (FVC) ratio?", "answer_src": "d", "follow_up_question": "Which group had a lower baseline FEV1?", "follow_up_response": "d", "follow_up_response_bt": "nd"}], "turn_2": [{"question_id": "175.6", "question": "What was the difference in forced expiratory volume in one second (FEV1)/forced vital capacity (%) between the d and nd groups?", "answer_src": "43% versus 48%", "follow_up_question": "What was the difference in baseline FEV1 (%) between the d and nd groups?", "follow_up_response": "-6.6", "follow_up_response_bt": "No Answer"}, {"question_id": "175.7", "question": "What was the hazard ratio for tiotropium reducing the risk of an exacerbation in the nd group?", "answer_src": "0.79", "follow_up_question": "What was the hazard ratio for tiotropium reducing the risk of a hospitalized exacerbation in the d group?", "follow_up_response": "0.85", "follow_up_response_bt": "No Answer"}, {"question_id": "175.8", "question": "What demographic measure differed between the d and nd groups?", "answer_src": "Higher cumulative smoking", "follow_up_question": "What was the difference in forced expiratory volume in one second (FEV1)/forced vital capacity (%) between the d and nd groups?", "follow_up_response": "43% versus 48%", "follow_up_response_bt": "43% versus 48%"}, {"question_id": "175.9", "question": "What is the difference in forced expiratory volume in one second (FEV1) between the d and nd groups?", "answer_src": "43% versus 48%", "follow_up_question": "What is the difference in baseline FEV1 between the d and nd groups?", "follow_up_response": "Lower baseline fev1 (35.8% predicted versus 42.4% predicted)", "follow_up_response_bt": "No Answer"}, {"question_id": "175.10", "question": "Which group had a lower baseline FEV1?", "answer_src": "d", "follow_up_question": "Which group had a lower forced expiratory volume in one second (FEV1)/forced vital capacity?", "follow_up_response": "nd", "follow_up_response_bt": "nd"}], "turn_3": [{"question_id": "175.11", "question": "What was the difference in baseline FEV1 (%) between the d and nd groups?", "answer_src": "-6.6", "follow_up_question": "What was the difference in cumulative smoking (in pack-years) between the d and nd groups?", "follow_up_response": "56 pack-years versus 48 pack-years", "follow_up_response_bt": "56 years versus 48 years"}, {"question_id": "175.12", "question": "What was the hazard ratio for tiotropium reducing the risk of a hospitalized exacerbation in the d group?", "answer_src": "0.85", "follow_up_question": "What was the hazard ratio for tiotropium reducing the risk of an exacerbation in the nd group?", "follow_up_response": "0.79", "follow_up_response_bt": "No Answer"}, {"question_id": "175.13", "question": "What was the difference in forced expiratory volume in one second (FEV1)/forced vital capacity (%) between the d and nd groups?", "answer_src": "43% versus 48%", "follow_up_question": "What was the difference in baseline FEV1 (%) between the d and nd groups?", "follow_up_response": "-6.6", "follow_up_response_bt": "No Answer"}, {"question_id": "175.14", "question": "What is the difference in baseline FEV1 between the d and nd groups?", "answer_src": "Lower baseline fev1 (35.8% predicted versus 42.4% predicted)", "follow_up_question": "What is the difference in cumulative smoking between the d and nd groups?", "follow_up_response": "56 pack-years versus 48 pack-years", "follow_up_response_bt": "56 years versus 48 years"}, {"question_id": "175.15", "question": "Which group had a lower forced expiratory volume in one second (FEV1)/forced vital capacity?", "answer_src": "nd", "follow_up_question": "Which group had a lower baseline FEV1?", "follow_up_response": "d", "follow_up_response_bt": "nd"}]}}
{"id": 176, "src": "in the 3d method of treatment , three - dimensional images from computer tomography were used . in treatment plans performed using the 2d method , images from the simulator were used.resultsthe comparison of treatment plans made by using 2d and 3d methods is described . this comparison highlighted the significant differences between these two methods assessing reference dose coverage of the ptv by 100% and 85% isodose.conclusionsreference doses with 100% coverage of the ptv in treatment applied with the 3d method are 31% higher than when applied with the 2d method .", "mt": "Nel metodo di trattamento 3d sono state utilizzate immagini tridimensionali da tomografia computerizzata . nei piani di trattamento eseguiti con il metodo 2d sono state utilizzate immagini dal simulatore.il risultato del confronto dei piani di trattamento effettuati con i metodi 2d e 3d è descritto . Questo confronto ha evidenziato le differenze significative tra questi due metodi che valutano la copertura della dose di riferimento del ptv del 100% e dell'85% isodose.conclusioniDose di riferimento con copertura del 100% del ptv nel trattamento applicato con il metodo 3d sono 31% più alte rispetto a quando applicato con il metodo 2d .", "pert_mt": "Nel metodo di trattamento 3d sono state utilizzate immagini tridimensionali da tomografia computerizzata. Nei piani di trattamento eseguiti con il metodo 2d sono state utilizzate immagini dal simulatore. Il risultato del confronto dei piani di trattamento effettuati con i metodi 2d e 3d è descritto. Questo confronto ha evidenziato le differenze significative tra questi due metodi che valutano la copertura della dose di riferimento del ptv del 100% e dell'85% isodose. Conclusioni: Dose di riferimento con copertura del 100% del ptv nel trattamento applicato con il metodo 3d sono 31% più alte rispetto a quando applicato con il metodo 2d, migliorando significativamente la precisione terapeut", "bt": "In the 3d treatment method, three-dimensional images were used from the computed tomography. In the treatment plans executed using the 2d method, imaging from the simulator was used. The result of comparing the treatment plans with the 2d and 3d methods is described. This comparison has highlighted the significant differences between these two methods that assess the coverage of the reference dose of 100% ptv and 85% isodose.", "questions_src": ["What is the 3rd method of treatment?", "Who used images from the simulator in 2D treatment plans?", "Where were three-dimensional images used in the 3D method?", "When was the comparison of treatment plans made?", "Which percentage of isodose coverage was higher with the 3D method?"], "answers_src": ["[\"3d method\"], [\"No Answer\"], [\"Computer tomography\"], [\"resultst\"], [\". 100%\"]]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["3d treatment method", "The treatment plans", "computed tomography", "This comparison", "85%"], "multiturn": {"turn_1": [{"question_id": "176.1", "question": "What is the 3rd method of treatment?", "answer_src": "[\"3d method\"], [\"No Answer\"], [\"Computer tomography\"], [\"resultst\"], [\". 100%\"]]", "follow_up_question": "What is the difference in reference doses required for 100% coverage of the PTV between the 3D and 2D methods?", "follow_up_response": "31%", "follow_up_response_bt": "significant differences"}, {"question_id": "176.2", "question": "Who used images from the simulator in 2D treatment plans?", "answer_src": "in the 3d method of treatment , three - dimensional images from computer tomography were used . in treatment plans performed using the 2d method , images from the simulator were used.resultsthe comparison of treatment plans made by using 2d and 3d methods is described . this comparison highlighted the significant differences between these two methods assessing reference dose coverage of the ptv by 100% and 85% isodose.conclusionsreference doses with 100% coverage of the ptv in treatment applied with the 3d method are 31% higher than when applied with the 2d method .", "follow_up_question": "What was the percentage of isodose coverage assessed in the comparison between 2D and 3D methods?", "follow_up_response": "100%\", \"85%", "follow_up_response_bt": "85%"}, {"question_id": "176.3", "question": "Where were three-dimensional images used in the 3D method?", "answer_src": "in the 3d method of treatment , three - dimensional images from computer tomography were used . in treatment plans performed using the 2d method , images from the simulator were used.resultsthe comparison of treatment plans made by using 2d and 3d methods is described . this comparison highlighted the significant differences between these two methods assessing reference dose coverage of the ptv by 100% and 85% isodose.conclusionsreference doses with 100% coverage of the ptv in treatment applied with the 3d method are 31% higher than when applied with the 2d method .", "follow_up_question": "What was the difference in reference doses with 100% coverage of the PTV between the 3D and 2D methods?", "follow_up_response": "31%", "follow_up_response_bt": "significant differences"}, {"question_id": "176.4", "question": "When was the comparison of treatment plans made?", "answer_src": "in the 3d method of treatment , three - dimensional images from computer tomography were used . in treatment plans performed using the 2d method , images from the simulator were used.resultsthe comparison of treatment plans made by using 2d and 3d methods is described . this comparison highlighted the significant differences between these two methods assessing reference dose coverage of the ptv by 100% and 85% isodose.conclusionsreference doses with 100% coverage of the ptv in treatment applied with the 3d method are 31% higher than when applied with the 2d method .", "follow_up_question": "What percentage of the PTV's reference dose coverage was assessed for the 3D method?", "follow_up_response": "100%", "follow_up_response_bt": "100%"}, {"question_id": "176.5", "question": "Which percentage of isodose coverage was higher with the 3D method?", "answer_src": "in the 3d method of treatment , three - dimensional images from computer tomography were used . in treatment plans performed using the 2d method , images from the simulator were used.resultsthe comparison of treatment plans made by using 2d and 3d methods is described . this comparison highlighted the significant differences between these two methods assessing reference dose coverage of the ptv by 100% and 85% isodose.conclusionsreference doses with 100% coverage of the ptv in treatment applied with the 3d method are 31% higher than when applied with the 2d method .", "follow_up_question": "What is the difference in reference dose coverage for 100% isodose between the 3D and 2D methods?", "follow_up_response": "31%", "follow_up_response_bt": "significant differences"}], "turn_2": [{"question_id": "176.6", "question": "What is the difference in reference doses required for 100% coverage of the PTV between the 3D and 2D methods?", "answer_src": "31%", "follow_up_question": "By how much is the 85% isodose coverage of the PTV higher in treatment plans using the 3D method compared to the 2D method?", "follow_up_response": "31%", "follow_up_response_bt": "significant differences"}, {"question_id": "176.7", "question": "What was the percentage of isodose coverage assessed in the comparison between 2D and 3D methods?", "answer_src": "100%\", \"85%", "follow_up_question": "What was the difference in reference dose coverage percentages between the 3D and 2D methods?", "follow_up_response": "31%", "follow_up_response_bt": "100% and 85%"}, {"question_id": "176.8", "question": "What was the difference in reference doses with 100% coverage of the PTV between the 3D and 2D methods?", "answer_src": "31%", "follow_up_question": "What was the difference in reference doses with 85% coverage of the PTV between the 3D and 2D methods?", "follow_up_response": "No Answer", "follow_up_response_bt": "significant differences"}, {"question_id": "176.9", "question": "What percentage of the PTV's reference dose coverage was assessed for the 3D method?", "answer_src": "100%", "follow_up_question": "What percentage of the PTV's reference dose coverage was assessed for the 2D method?", "follow_up_response": "85%", "follow_up_response_bt": "85%"}, {"question_id": "176.10", "question": "What is the difference in reference dose coverage for 100% isodose between the 3D and 2D methods?", "answer_src": "31%", "follow_up_question": "What is the difference in reference dose coverage for 85% isodose between the 3D and 2D methods?", "follow_up_response": "No Answer", "follow_up_response_bt": "significant differences"}], "turn_3": [{"question_id": "176.11", "question": "By how much is the 85% isodose coverage of the PTV higher in treatment plans using the 3D method compared to the 2D method?", "answer_src": "31%", "follow_up_question": "By how much is the 100% isodose coverage of the PTV higher in treatment plans using the 3D method compared to the 2D method?", "follow_up_response": "31%", "follow_up_response_bt": "85%"}, {"question_id": "176.12", "question": "What was the difference in reference dose coverage percentages between the 3D and 2D methods?", "answer_src": "31%", "follow_up_question": "By what percentage was the reference dose coverage of the PTV higher with the 3D method compared to the 2D method?", "follow_up_response": "31%", "follow_up_response_bt": "15%"}, {"question_id": "176.13", "question": "What was the difference in reference doses with 85% coverage of the PTV between the 3D and 2D methods?", "answer_src": "in the 3d method of treatment , three - dimensional images from computer tomography were used . in treatment plans performed using the 2d method , images from the simulator were used.resultsthe comparison of treatment plans made by using 2d and 3d methods is described . this comparison highlighted the significant differences between these two methods assessing reference dose coverage of the ptv by 100% and 85% isodose.conclusionsreference doses with 100% coverage of the ptv in treatment applied with the 3d method are 31% higher than when applied with the 2d method .", "follow_up_question": "What was the difference in reference doses with 100% coverage of the PTV between the 3D and 2D methods?", "follow_up_response": "31%", "follow_up_response_bt": "significant differences"}, {"question_id": "176.14", "question": "What percentage of the PTV's reference dose coverage was assessed for the 2D method?", "answer_src": "85%", "follow_up_question": "What was the percentage of the PTV's reference dose coverage assessed for the 3D method?", "follow_up_response": "100%", "follow_up_response_bt": "100%"}, {"question_id": "176.15", "question": "What is the difference in reference dose coverage for 85% isodose between the 3D and 2D methods?", "answer_src": "in the 3d method of treatment , three - dimensional images from computer tomography were used . in treatment plans performed using the 2d method , images from the simulator were used.resultsthe comparison of treatment plans made by using 2d and 3d methods is described . this comparison highlighted the significant differences between these two methods assessing reference dose coverage of the ptv by 100% and 85% isodose.conclusionsreference doses with 100% coverage of the ptv in treatment applied with the 3d method are 31% higher than when applied with the 2d method .", "follow_up_question": "What is the difference in reference dose coverage for 100% isodose between the 3D and 2D methods?", "follow_up_response": "31%", "follow_up_response_bt": "significant differences"}]}}
{"id": 177, "src": "bladder level reconstruction was performed in 11 cases . five patients were treated only by endoscopic incision . in the follow up period 4 patients showed long term urinary tract infections whereas 3 of them were treated endoscopically .", "mt": "La ricostruzione del livello della vescica è stata eseguita in 11 casi . Cinque pazienti sono stati trattati solo con incisione endoscopica . nel periodo di follow-up 4 pazienti hanno mostrato infezioni del tratto urinario a lungo termine mentre 3 di loro sono stati trattati endoscopicamente .", "pert_mt": "La ricostruzione del livello della vescica è stata eseguita in 11 casi. Cinque pazienti sono stati trattati solo con incisione endoscopica. Nel periodo di follow-up, 4 pazienti hanno mostrato infezioni del tratto urinario a lungo termine mentre 3 di loro sono stati trattati endoscopicamente e hanno sviluppato complesse complicazioni.", "bt": "Reconstruction of the bladder level was performed in 11 cases, five patients were treated with endoscopic incisions alone, and in the follow-up period, four patients had long-term urinary tract infections, while three of them were treated endoscopically and developed complex complications.", "questions_src": ["What procedure was performed in 11 cases?", "Who was treated only by endoscopic incision?", "Where did the long term urinary tract infections occur?", "When was the follow up period?", "Which patients were treated endoscopically?"], "answers_src": ["Bladder level reconstruction", "Five patients", "In the follow up period", "In the follow up period", "3 of them"], "answers_bt": ["Reconstruction of the bladder level", "Five patients", "In the follow-up period", "Not explicitly mentioned", "Three patients"], "multiturn": {"turn_1": [{"question_id": "177.1", "question": "What procedure was performed in 11 cases?", "answer_src": "Bladder level reconstruction", "follow_up_question": "How many patients were treated endoscopically?", "follow_up_response": "5", "follow_up_response_bt": "Five"}, {"question_id": "177.2", "question": "Who was treated only by endoscopic incision?", "answer_src": "Five patients", "follow_up_question": "How many patients were treated endoscopically in the follow-up period?", "follow_up_response": "3", "follow_up_response_bt": "Three"}, {"question_id": "177.3", "question": "Where did the long term urinary tract infections occur?", "answer_src": "In the follow up period", "follow_up_question": "Which patients were treated endoscopically for their long term urinary tract infections?", "follow_up_response": "3 of them", "follow_up_response_bt": "Three of them"}, {"question_id": "177.4", "question": "When was the follow up period?", "answer_src": "In the follow up period", "follow_up_question": "How many patients were treated endoscopically in the follow up period?", "follow_up_response": "3", "follow_up_response_bt": "Three"}, {"question_id": "177.5", "question": "Which patients were treated endoscopically?", "answer_src": "3 of them", "follow_up_question": "How many patients showed long-term urinary tract infections?", "follow_up_response": "4", "follow_up_response_bt": "Four"}], "turn_2": [{"question_id": "177.6", "question": "How many patients were treated endoscopically?", "answer_src": "5", "follow_up_question": "How many patients developed long-term urinary tract infections?", "follow_up_response": "4", "follow_up_response_bt": "Four"}, {"question_id": "177.7", "question": "How many patients were treated endoscopically in the follow-up period?", "answer_src": "3", "follow_up_question": "How many patients developed long-term urinary tract infections in the follow-up period?", "follow_up_response": "4", "follow_up_response_bt": "Four"}, {"question_id": "177.8", "question": "Which patients were treated endoscopically for their long term urinary tract infections?", "answer_src": "3 of them", "follow_up_question": "How many patients were treated endoscopically in total?", "follow_up_response": "8", "follow_up_response_bt": "8"}, {"question_id": "177.9", "question": "How many patients were treated endoscopically in the follow up period?", "answer_src": "3", "follow_up_question": "How many patients developed long-term urinary tract infections in the follow-up period?", "follow_up_response": "4", "follow_up_response_bt": "Four"}, {"question_id": "177.10", "question": "How many patients showed long-term urinary tract infections?", "answer_src": "4", "follow_up_question": "How many of the patients with long-term urinary tract infections were treated endoscopically?", "follow_up_response": "3", "follow_up_response_bt": "3"}], "turn_3": [{"question_id": "177.11", "question": "How many patients developed long-term urinary tract infections?", "answer_src": "4", "follow_up_question": "How many of the patients with long-term urinary tract infections were treated endoscopically?", "follow_up_response": "3", "follow_up_response_bt": "3"}, {"question_id": "177.12", "question": "How many patients developed long-term urinary tract infections in the follow-up period?", "answer_src": "4", "follow_up_question": "How many of the patients with long-term urinary tract infections were treated endoscopically?", "follow_up_response": "3", "follow_up_response_bt": "3"}, {"question_id": "177.13", "question": "How many patients were treated endoscopically in total?", "answer_src": "8", "follow_up_question": "How many patients developed long-term urinary tract infections?", "follow_up_response": "4", "follow_up_response_bt": "Four"}, {"question_id": "177.14", "question": "How many patients developed long-term urinary tract infections in the follow-up period?", "answer_src": "4", "follow_up_question": "How many of the patients with long-term urinary tract infections were treated endoscopically?", "follow_up_response": "3", "follow_up_response_bt": "3"}, {"question_id": "177.15", "question": "How many of the patients with long-term urinary tract infections were treated endoscopically?", "answer_src": "3", "follow_up_question": "How many patients were treated endoscopically in total?", "follow_up_response": "8", "follow_up_response_bt": "8"}]}}
{"id": 178, "src": "mycophenolic acid was undetectable in blood . the patient admitted that she had often missed doses before this relapse . the renal response has been maintained since she resumed her previous medications 2 years ago.conclusionwe conclude that the frequent and severe relapses of lupus nephritis observed in young patients may actually be due to nonadherence rather than to refractory disease .", "mt": "L'acido micofenolico era indetettabile nel sangue . la paziente ha ammesso di aver spesso perso dosi prima di questa recaudita . la risposta renale è stata mantenuta da quando ha ripristinato i suoi precedenti farmaci 2 anni fa.conclusione.concludono che le frequenti e gravi recaudite di lupus nephritis osservate nei pazienti giovani possono essere in realtà dovute a non aderenza piuttosto che a malattia refrattoria .", "pert_mt": "L'acido micofenolico era indetettabile nel sangue. La paziente ha ammesso di aver spesso perso dosi prima di questa recidiva. La risposta renale è stata mantenuta da quando ha ripristinato i suoi precedenti farmaci 2 anni fa. conclusione. Concludono che le frequenti e gravi recidive di lupus nephritis osservate nei pazienti giovani possono essere in realtà dovute a non aderenza piuttosto che a malattia refrattoria e non trattata.", "bt": "The patient admitted that she had often lost doses before this recurrence, and the renal response was maintained since she resumed her pharmaceutical precedents two years ago, concluding that the frequent and severe recurrence of lupus nephritis observed in young patients may actually be due to non-adherence rather than refractory disease and non-treated.", "questions_src": ["What is the name of the medication mentioned in the sentence?", "Who admitted to missing doses before the relapse?", "Where was the renal response maintained since the patient resumed her medications?", "When did the patient resume her previous medications?", "Which condition was observed in young patients with frequent and severe relapses?"], "answers_src": ["mycophenolic acid", "the patient", "renal response", "2 years ago", "lupus nephritis"], "answers_bt": ["No Answer", "The patient", "Since she resumed her pharmaceutical precedents two years ago", "Two years ago", "Lupus nephritis"], "multiturn": {"turn_1": [{"question_id": "178.1", "question": "What is the name of the medication mentioned in the sentence?", "answer_src": "mycophenolic acid", "follow_up_question": "What evidence supports the conclusion that nonadherence may be the cause of the patient's relapses?", "follow_up_response": "The patient admitted that she had often missed doses before this relapse.", "follow_up_response_bt": "The frequent and severe recurrence of lupus nephritis observed in young patients may actually be due to non-adherence rather than refractory disease and non-treated."}, {"question_id": "178.2", "question": "Who admitted to missing doses before the relapse?", "answer_src": "the patient", "follow_up_question": "What specific medications did the patient resume 2 years ago?", "follow_up_response": "Previous medications", "follow_up_response_bt": "No Answer"}, {"question_id": "178.3", "question": "Where was the renal response maintained since the patient resumed her medications?", "answer_src": "renal response", "follow_up_question": "What specific medications did the patient resume taking 2 years ago?", "follow_up_response": "Previous medications", "follow_up_response_bt": "No Answer"}, {"question_id": "178.4", "question": "When did the patient resume her previous medications?", "answer_src": "2 years ago", "follow_up_question": "What specific medications did the patient resume taking?", "follow_up_response": "Previous medications", "follow_up_response_bt": "pharmaceutical precedents"}, {"question_id": "178.5", "question": "Which condition was observed in young patients with frequent and severe relapses?", "answer_src": "lupus nephritis", "follow_up_question": "What evidence supports the conclusion that nonadherence is the cause of these relapses?", "follow_up_response": "The patient admitted that she had often missed doses before this relapse", "follow_up_response_bt": "The frequent and severe recurrence of lupus nephritis observed in young patients may actually be due to non-adherence rather than refractory disease and non-treated."}], "turn_2": [{"question_id": "178.6", "question": "What evidence supports the conclusion that nonadherence may be the cause of the patient's relapses?", "answer_src": "The patient admitted that she had often missed doses before this relapse.", "follow_up_question": "How does the patient's history of missing doses relate to the maintenance of renal response?", "follow_up_response": "The patient's history of missing doses before this relapse", "follow_up_response_bt": "Since she resumed her pharmaceutical precedents two years ago"}, {"question_id": "178.7", "question": "What specific medications did the patient resume 2 years ago?", "answer_src": "Previous medications", "follow_up_question": "What were the previous medications the patient resumed?", "follow_up_response": "Previous medications", "follow_up_response_bt": "pharmaceutical precedents"}, {"question_id": "178.8", "question": "What specific medications did the patient resume taking 2 years ago?", "answer_src": "Previous medications", "follow_up_question": "What were the previous medications specifically mentioned in the conclusion?", "follow_up_response": "Previous medications", "follow_up_response_bt": "pharmaceutical precedents"}, {"question_id": "178.9", "question": "What specific medications did the patient resume taking?", "answer_src": "Previous medications", "follow_up_question": "What were the consequences of the patient's nonadherence before this relapse?", "follow_up_response": "frequent and severe relapses", "follow_up_response_bt": "Often losing doses"}, {"question_id": "178.10", "question": "What evidence supports the conclusion that nonadherence is the cause of these relapses?", "answer_src": "The patient admitted that she had often missed doses before this relapse", "follow_up_question": "How long had the patient been missing her doses before this relapse?", "follow_up_response": "Before this relapse", "follow_up_response_bt": "two years"}], "turn_3": [{"question_id": "178.11", "question": "How does the patient's history of missing doses relate to the maintenance of renal response?", "answer_src": "The patient's history of missing doses before this relapse", "follow_up_question": "What specific actions did the patient take to resume her previous medications?", "follow_up_response": "Resumed her previous medications", "follow_up_response_bt": "Resumed her pharmaceutical precedents"}, {"question_id": "178.12", "question": "What were the previous medications the patient resumed?", "answer_src": "Previous medications", "follow_up_question": "What specific symptoms prompted the patient's admission of missing doses?", "follow_up_response": "Nonadherence", "follow_up_response_bt": "Often lost doses"}, {"question_id": "178.13", "question": "What were the previous medications specifically mentioned in the conclusion?", "answer_src": "Previous medications", "follow_up_question": "What specific behavior led to the frequent and severe relapses according to the text?", "follow_up_response": "Nonadherence", "follow_up_response_bt": "Non-adherence"}, {"question_id": "178.14", "question": "What were the consequences of the patient's nonadherence before this relapse?", "answer_src": "frequent and severe relapses", "follow_up_question": "What specific medications did the patient resume taking 2 years ago?", "follow_up_response": "Previous medications", "follow_up_response_bt": "No Answer"}, {"question_id": "178.15", "question": "How long had the patient been missing her doses before this relapse?", "answer_src": "Before this relapse", "follow_up_question": "How many years have passed since the patient resumed her previous medications?", "follow_up_response": "2", "follow_up_response_bt": "2"}]}}
{"id": 179, "src": "the variables related to obesity , lipid profile , and glucose metabolism were also higher in nafld with diabetes and those with grade ii nafld without diabetes , as compared to controls . multivariate stepwise regression analysis showed a negative correlation between hrv and total cholesterol and fat percentage . the grade of nafld as well as diabetic status contributes to the decrease in the cardiovascular autonomic function , with diabetic status rather than grade of nafld playing a critical role .", "mt": "Le variabili relative all'obesità , al profilo lipidico e al metabolismo del glucosio erano anche più elevate in persone con diabete e in persone con diabete di grado ii senza diabete , rispetto ai controlli . L' analisi di regressione graduale multivariata ha mostrato una correlazione negativa tra hrv e colesterolo totale e percentuale di grassi . Il grado di nafld e lo stato diabetici contribuiscono alla diminuzione della funzione autonoma cardiovascolare , con lo stato diabetici piuttosto che il grado di nafld che svolge un ruolo critico .", "pert_mt": "Le variabili relative all'obesità, al profilo lipidico e al metabolismo del glucosio erano anche più elevate in persone con diabete e in persone con diabete di grado II senza diabete, rispetto ai controlli. L'analisi di regressione graduale multivariata ha mostrato una correlazione negativa tra HRV e colesterolo totale e percentuale di grassi. Il grado di NASH e lo stato di diabete contribuiscono alla diminuzione della funzione autonoma cardiovascolare, con lo stato di diabete piuttosto che il grado di NASH che svolge un ruolo critico.", "bt": "The variables relative to obesity, lipid profile and glucose metabolism were also higher in people with diabetes and in people with grade II diabetes without diabetes, compared to controls.The analysis of multivariate gradual regression showed a negative correlation between HRV and total cholesterol and percentage of fat.The degree of NASH and the status of diabetes contribute to a decrease in cardiovascular autonomic function, with the status of diabetes rather than the degree of NASH playing a critical role.", "questions_src": ["What is the term used for variables related to obesity, lipid profile, and glucose metabolism in the given text?", "Who contributed to the decrease in cardiovascular autonomic function according to the text?", "Where was the multivariate stepwise regression analysis conducted?", "When might the variables mentioned be more prevalent?", "Which factor had a critical role in decreasing the cardiovascular autonomic function?"], "answers_src": ["Nafld", "Diabetic status", "Not specified", "In nafld with diabetes and those with grade II nafld without diabetes", "Diabetic status"], "answers_bt": ["obesity, lipid profile, and glucose metabolism", "people with diabetes and in people with grade II diabetes without diabetes", "The analysis of multivariate gradual regression", "in people with diabetes and in people with grade II diabetes without diabetes", "the status of diabetes"], "multiturn": {"turn_1": [{"question_id": "179.1", "question": "What is the term used for variables related to obesity, lipid profile, and glucose metabolism in the given text?", "answer_src": "Nafld", "follow_up_question": "What does the multivariate stepwise regression analysis show regarding HRV?", "follow_up_response": "A negative correlation between HRV and total cholesterol and fat percentage", "follow_up_response_bt": "A negative correlation between HRV and total cholesterol and percentage of fat"}, {"question_id": "179.2", "question": "Who contributed to the decrease in cardiovascular autonomic function according to the text?", "answer_src": "Diabetic status", "follow_up_question": "How does diabetic status differ from the grade of NAFLD in contributing to the decrease in cardiovascular autonomic function?", "follow_up_response": "diabetic status rather than grade of NAFLD plays a critical role", "follow_up_response_bt": "The status of diabetes rather than the degree of NASH plays a critical role"}, {"question_id": "179.3", "question": "Where was the multivariate stepwise regression analysis conducted?", "answer_src": "Not specified", "follow_up_question": "How does the diabetic status affect the cardiovascular autonomic function differently from the grade of NAFLD?", "follow_up_response": "Diabetic status rather than grade of NAFLD plays a critical role", "follow_up_response_bt": "The status of diabetes rather than the degree of NASH plays a critical role"}, {"question_id": "179.4", "question": "When might the variables mentioned be more prevalent?", "answer_src": "In nafld with diabetes and those with grade II nafld without diabetes", "follow_up_question": "How does the presence of diabetes affect these variables compared to grade II NAFLD without diabetes?", "follow_up_response": "Obesity, lipid profile, and glucose metabolism were also higher", "follow_up_response_bt": "obesity, lipid profile and glucose metabolism"}, {"question_id": "179.5", "question": "Which factor had a critical role in decreasing the cardiovascular autonomic function?", "answer_src": "Diabetic status", "follow_up_question": "How does the grade of NAFLD affect the cardiovascular autonomic function differently?", "follow_up_response": "The grade of NAFLD as well as diabetic status contributes to the decrease in the cardiovascular autonomic function, with diabetic status rather than grade of NAFLD playing a critical role.", "follow_up_response_bt": "The status of diabetes rather than the degree of NASH plays a critical role"}], "turn_2": [{"question_id": "179.6", "question": "What does the multivariate stepwise regression analysis show regarding HRV?", "answer_src": "A negative correlation between HRV and total cholesterol and fat percentage", "follow_up_question": "How does the grade of NAFLD affect HRV according to the text?", "follow_up_response": "The grade of NAFLD as well as diabetic status contribute to the decrease in the cardiovascular autonomic function, with diabetic status rather than grade of NAFLD playing a critical role.", "follow_up_response_bt": "The status of diabetes rather than the degree of NASH playing a critical role"}, {"question_id": "179.7", "question": "How does diabetic status differ from the grade of NAFLD in contributing to the decrease in cardiovascular autonomic function?", "answer_src": "diabetic status rather than grade of NAFLD plays a critical role", "follow_up_question": "What specific variable is negatively correlated with heart rate variability according to the text?", "follow_up_response": "Total cholesterol and fat percentage", "follow_up_response_bt": "total cholesterol and percentage of fat"}, {"question_id": "179.8", "question": "How does the diabetic status affect the cardiovascular autonomic function differently from the grade of NAFLD?", "answer_src": "Diabetic status rather than grade of NAFLD plays a critical role", "follow_up_question": "How does the grade of NAFLD affect the cardiovascular autonomic function?", "follow_up_response": "The grade of NAFLD as well as diabetic status contributes to the decrease in the cardiovascular autonomic function, with diabetic status rather than grade of NAFLD playing a critical role.", "follow_up_response_bt": "The status of diabetes rather than the degree of NASH plays a critical role"}, {"question_id": "179.9", "question": "How does the presence of diabetes affect these variables compared to grade II NAFLD without diabetes?", "answer_src": "Obesity, lipid profile, and glucose metabolism were also higher", "follow_up_question": "How does the presence of diabetes specifically impact the cardiovascular autonomic function compared to grade II NAFLD without diabetes?", "follow_up_response": "Diabetic status rather than grade of NAFLD plays a critical role", "follow_up_response_bt": "The status of diabetes rather than the degree of NASH plays a critical role"}, {"question_id": "179.10", "question": "How does the grade of NAFLD affect the cardiovascular autonomic function differently?", "answer_src": "The grade of NAFLD as well as diabetic status contributes to the decrease in the cardiovascular autonomic function, with diabetic status rather than grade of NAFLD playing a critical role.", "follow_up_question": "How does diabetic status alone impact the cardiovascular autonomic function?", "follow_up_response": "Diabetic status rather than grade of NAFLD plays a critical role.", "follow_up_response_bt": "The status of diabetes rather than the degree of NASH plays a critical role"}], "turn_3": [{"question_id": "179.11", "question": "How does the grade of NAFLD affect HRV according to the text?", "answer_src": "The grade of NAFLD as well as diabetic status contribute to the decrease in the cardiovascular autonomic function, with diabetic status rather than grade of NAFLD playing a critical role.", "follow_up_question": "How does diabetic status alone affect HRV according to the text?", "follow_up_response": "Diabetic status", "follow_up_response_bt": "The status of diabetes"}, {"question_id": "179.12", "question": "What specific variable is negatively correlated with heart rate variability according to the text?", "answer_src": "Total cholesterol and fat percentage", "follow_up_question": "How does the diabetic status affect heart rate variability differently from the grade of NAFLD?", "follow_up_response": "Diabetic status rather than grade of NAFLD plays a critical role", "follow_up_response_bt": "The status of diabetes rather than the degree of NASH plays a critical role"}, {"question_id": "179.13", "question": "How does the grade of NAFLD affect the cardiovascular autonomic function?", "answer_src": "The grade of NAFLD as well as diabetic status contributes to the decrease in the cardiovascular autonomic function, with diabetic status rather than grade of NAFLD playing a critical role.", "follow_up_question": "How does diabetic status alone impact the cardiovascular autonomic function?", "follow_up_response": "Diabetic status rather than grade of NAFLD plays a critical role.", "follow_up_response_bt": "The status of diabetes rather than the degree of NASH plays a critical role"}, {"question_id": "179.14", "question": "How does the presence of diabetes specifically impact the cardiovascular autonomic function compared to grade II NAFLD without diabetes?", "answer_src": "Diabetic status rather than grade of NAFLD plays a critical role", "follow_up_question": "What is the relationship between the grade of NAFLD and cardiovascular autonomic function?", "follow_up_response": "The grade of NAFLD as well as diabetic status contributes to the decrease in the cardiovascular autonomic function, with diabetic status rather than grade of NAFLD playing a critical role.", "follow_up_response_bt": "The status of diabetes rather than the degree of NASH plays a critical role"}, {"question_id": "179.15", "question": "How does diabetic status alone impact the cardiovascular autonomic function?", "answer_src": "Diabetic status rather than grade of NAFLD plays a critical role.", "follow_up_question": "How does the grade of NAFLD affect the cardiovascular autonomic function when diabetic status is present?", "follow_up_response": "The grade of NAFLD as well as diabetic status contributes to the decrease in the cardiovascular autonomic function, with diabetic status rather than grade of NAFLD playing a critical role.", "follow_up_response_bt": "The status of diabetes rather than the degree of NASH plays a critical role"}]}}
{"id": 180, "src": "in addition , we found that the exercise effects were modified by age , sex , and health status such that people aged < 50 years , men , and people with type 2 diabetes , hypertension , dyslipidemia , or metabolic syndrome appeared to benefit more.conclusionsthis meta - analysis showed that exercise significantly improved cardiorespiratory fitness and some cardiometabolic biomarkers . the effects of exercise were modified by age , sex , and health status . findings from this study have significant implications for future design of targeted lifestyle interventions .", "mt": "Inoltre , abbiamo scoperto che gli effetti dell' esercizio fisico erano modificati per età , sesso e stato di salute in modo tale che le persone di età < 50 anni , gli uomini e le persone con diabete di tipo 2, ipertensione , dislipidemia o sindrome metabolica sembravano beneficiare di più.conclusioni .Questa meta-analisi ha mostrato che l' esercizio fisico ha migliorato significativamente la forma cardiorespiratoria e alcuni biomarcatori cardiometabolici . gli effetti dell' esercizio fisico sono stati modificati per età , sesso e stato di salute . I risultati di questo studio hanno implicazioni significative per la progettazione futura di interventi mirati nello stile di vita .", "pert_mt": "Inoltre, abbiamo scoperto che gli effetti dell'esercizio fisico erano modificati per età, sesso e stato di salute in modo tale che le persone di età < 50 anni, gli uomini e le persone con diabete di tipo 2, ipertensione, dislipidemia o sindrome metabolica sembravano beneficiare di più. Adiposità centrale è un altro fattore che influenzava negativamente questi benefici. conclusioni. Questa meta-analisi ha mostrato che l'esercizio fisico ha migliorato significativamente la forma cardiorespiratoria e alcuni biomarcatori cardiometabolici. Gli effetti dell'esercizio fisico sono stati modificati per età, sesso e stato di salute. I risultati di questo studio hanno implicazioni significative per la progettazione futura di interventi mirati nello stile di vita.", "bt": "In addition, we found that the effects of exercise were modified by age, sex, and health status so that people <50 years of age, men, and people with type 2 diabetes, hypertension, dyslipidemia, or metabolic syndrome seemed to benefit more.Central obesity is another factor that negatively influenced these benefits.Conclusions.This meta-analysis has shown that exercise significantly improved cardiorespiratory fitness and some cardiometabolic biomarkers.Effects of exercise were modified by age, sex, and health status.The results of this study have significant implications for the future design of lifestyle interventions.", "questions_src": ["What age group benefited more from exercise according to the study?", "Who were the participants that showed greater improvement in cardiorespiratory fitness?", "Where was the study conducted?", "When was the conclusion drawn based on the meta-analysis?", "Which health conditions were associated with better exercise effects?"], "answers_src": ["people aged < 50 years", "people aged < 50 years, men, and people with type 2 diabetes, hypertension, dyslipidemia, or metabolic syndrome", "No Answer", "No Answer", "type 2 diabetes, hypertension, dyslipidemia, or metabolic syndrome"], "answers_bt": ["People <50 years of age", "People <50 years of age, men, and people with type 2 diabetes, hypertension, dyslipidemia, or metabolic syndrome", "Not applicable", "Not applicable", "Type 2 diabetes, hypertension, dyslipidemia, or metabolic syndrome"], "multiturn": {"turn_1": [{"question_id": "180.1", "question": "What age group benefited more from exercise according to the study?", "answer_src": "people aged < 50 years", "follow_up_question": "What specific health conditions did people with a higher benefit from exercise have?", "follow_up_response": "type 2 diabetes, hypertension, dyslipidemia, or metabolic syndrome", "follow_up_response_bt": "Type 2 diabetes, hypertension, dyslipidemia, or metabolic syndrome"}, {"question_id": "180.2", "question": "Who were the participants that showed greater improvement in cardiorespiratory fitness?", "answer_src": "people aged < 50 years, men, and people with type 2 diabetes, hypertension, dyslipidemia, or metabolic syndrome", "follow_up_question": "What specific cardiometabolic biomarkers showed improvement according to the meta-analysis?", "follow_up_response": "No Answer", "follow_up_response_bt": "cardiometabolic biomarkers"}, {"question_id": "180.3", "question": "Where was the study conducted?", "answer_src": "in addition , we found that the exercise effects were modified by age , sex , and health status such that people aged < 50 years , men , and people with type 2 diabetes , hypertension , dyslipidemia , or metabolic syndrome appeared to benefit more.conclusionsthis meta - analysis showed that exercise significantly improved cardiorespiratory fitness and some cardiometabolic biomarkers . the effects of exercise were modified by age , sex , and health status . findings from this study have significant implications for future design of targeted lifestyle interventions .", "follow_up_question": "What specific health conditions were associated with greater exercise benefits?", "follow_up_response": "type 2 diabetes, hypertension, dyslipidemia, or metabolic syndrome", "follow_up_response_bt": "Type 2 diabetes, hypertension, dyslipidemia, or metabolic syndrome"}, {"question_id": "180.4", "question": "When was the conclusion drawn based on the meta-analysis?", "answer_src": "in addition , we found that the exercise effects were modified by age , sex , and health status such that people aged < 50 years , men , and people with type 2 diabetes , hypertension , dyslipidemia , or metabolic syndrome appeared to benefit more.conclusionsthis meta - analysis showed that exercise significantly improved cardiorespiratory fitness and some cardiometabolic biomarkers . the effects of exercise were modified by age , sex , and health status . findings from this study have significant implications for future design of targeted lifestyle interventions .", "follow_up_question": "What specific health conditions were identified as modifying the exercise effects?", "follow_up_response": "type 2 diabetes, hypertension, dyslipidemia, or metabolic syndrome", "follow_up_response_bt": "Type 2 diabetes, hypertension, dyslipidemia, or metabolic syndrome"}, {"question_id": "180.5", "question": "Which health conditions were associated with better exercise effects?", "answer_src": "type 2 diabetes, hypertension, dyslipidemia, or metabolic syndrome", "follow_up_question": "What age group benefited more from exercise according to the study?", "follow_up_response": "people aged < 50 years", "follow_up_response_bt": "people <50 years of age"}], "turn_2": [{"question_id": "180.6", "question": "What specific health conditions did people with a higher benefit from exercise have?", "answer_src": "type 2 diabetes, hypertension, dyslipidemia, or metabolic syndrome", "follow_up_question": "Which age group showed a higher benefit from exercise according to the study?", "follow_up_response": "people aged < 50 years", "follow_up_response_bt": "people <50 years of age"}, {"question_id": "180.7", "question": "What specific cardiometabolic biomarkers showed improvement according to the meta-analysis?", "answer_src": "in addition , we found that the exercise effects were modified by age , sex , and health status such that people aged < 50 years , men , and people with type 2 diabetes , hypertension , dyslipidemia , or metabolic syndrome appeared to benefit more.conclusionsthis meta - analysis showed that exercise significantly improved cardiorespiratory fitness and some cardiometabolic biomarkers . the effects of exercise were modified by age , sex , and health status . findings from this study have significant implications for future design of targeted lifestyle interventions .", "follow_up_question": "What health conditions were associated with greater exercise benefits according to the meta-analysis?", "follow_up_response": "type 2 diabetes, hypertension, dyslipidemia, or metabolic syndrome", "follow_up_response_bt": "Type 2 diabetes, hypertension, dyslipidemia, or metabolic syndrome"}, {"question_id": "180.8", "question": "What specific health conditions were associated with greater exercise benefits?", "answer_src": "type 2 diabetes, hypertension, dyslipidemia, or metabolic syndrome", "follow_up_question": "Which age group showed greater exercise benefits according to the study?", "follow_up_response": "people aged < 50 years", "follow_up_response_bt": "people <50 years of age"}, {"question_id": "180.9", "question": "What specific health conditions were identified as modifying the exercise effects?", "answer_src": "type 2 diabetes, hypertension, dyslipidemia, or metabolic syndrome", "follow_up_question": "Which age group showed greater benefits from exercise according to the study?", "follow_up_response": "people aged < 50 years", "follow_up_response_bt": "people <50 years of age"}, {"question_id": "180.10", "question": "What age group benefited more from exercise according to the study?", "answer_src": "people aged < 50 years", "follow_up_question": "What specific health conditions did people with a higher benefit from exercise have?", "follow_up_response": "type 2 diabetes, hypertension, dyslipidemia, or metabolic syndrome", "follow_up_response_bt": "Type 2 diabetes, hypertension, dyslipidemia, or metabolic syndrome"}], "turn_3": [{"question_id": "180.11", "question": "Which age group showed a higher benefit from exercise according to the study?", "answer_src": "people aged < 50 years", "follow_up_question": "Which health condition did not appear to modify the exercise effects as much as others?", "follow_up_response": "No Answer", "follow_up_response_bt": "Central obesity"}, {"question_id": "180.12", "question": "What health conditions were associated with greater exercise benefits according to the meta-analysis?", "answer_src": "type 2 diabetes, hypertension, dyslipidemia, or metabolic syndrome", "follow_up_question": "Which age group showed greater exercise benefits according to the meta-analysis?", "follow_up_response": "people aged < 50 years", "follow_up_response_bt": "people <50 years of age"}, {"question_id": "180.13", "question": "Which age group showed greater exercise benefits according to the study?", "answer_src": "people aged < 50 years", "follow_up_question": "Which health condition was associated with greater exercise benefits according to the study?", "follow_up_response": "Type 2 diabetes, hypertension, dyslipidemia, or metabolic syndrome", "follow_up_response_bt": "Type 2 diabetes, hypertension, dyslipidemia, or metabolic syndrome"}, {"question_id": "180.14", "question": "Which age group showed greater benefits from exercise according to the study?", "answer_src": "people aged < 50 years", "follow_up_question": "Which health condition did not appear to modify the exercise effects as much as others?", "follow_up_response": "No Answer", "follow_up_response_bt": "Central obesity"}, {"question_id": "180.15", "question": "What specific health conditions did people with a higher benefit from exercise have?", "answer_src": "type 2 diabetes, hypertension, dyslipidemia, or metabolic syndrome", "follow_up_question": "Which age group showed a higher benefit from exercise according to the study?", "follow_up_response": "people aged < 50 years", "follow_up_response_bt": "people <50 years of age"}]}}
{"id": 181, "src": "objectivediabetic patients have a high prevalence of coronary artery disease ( cad ) , but timely diagnosis of cad remains challenging . we assessed the ability of coronary computed tomography angiography ( ccta ) to detect cad in diabetic patients and to predict subsequent cardiac events.research design and methodswe analyzed 140 diabetic patients without known cad undergoing ccta ; 1,782 patients without diabetes were used as a control group . besides calcium scoring and the degree of the most severe stenosis , the atherosclerotic burden score counting the number of segments having either a nonstenotic plaque or a stenosis was recorded .", "mt": "I pazienti obiettivi diabetici hanno una alta prevalenza di malattia coronarica (cad) ma la diagnosi tempestiva di cad rimane una sfida . abbiamo valutato la capacità della coronaria computed tomography angiography (ccta) di rilevare cad nei pazienti diabetici e di prevedere eventi cardiaci successivi.progettazione e metodi di ricerca abbiamo analizzato 140 pazienti diabetici senza cad conosciuti sottoposti a ccta; 1.782 pazienti senza diabete sono stati utilizzati come gruppo di controllo . Oltre al calcio punteggio e il grado di stenosi più grave , è stato registrato il punteggio di carico aterosclerotico contando il numero di segmenti che hanno una placca non stenosica o una stenosi .", "pert_mt": "I pazienti obiettivi diabetici hanno una alta prevalenza di malattia coronarica (cad) ma la diagnosi tempestiva di cad rimane una sfida. Abbiamo valutato la capacità della coronaria computed tomography angiography (ccta) di rilevare cad nei pazienti diabetici e di prevedere eventi cardiaci successivi. Progettazione e metodi di ricerca abbiamo analizzato 140 pazienti diabetici senza cad conosciuti sottoposti a ccta; 1.782 pazienti senza diabete sono stati utilizzati come gruppo di controllo. Oltre al calcio punteggio e il grado di stenosi più grave, è stato registrato il punteggio di carico aterosclerotico contando il numero di segmenti che hanno una placca non stenosica o una st", "bt": "Targeted diabetic patients have a high prevalence of coronary heart disease (cad), and early diagnosis of cad remains a challenge. we assessed the ability of coronary computed tomography angiography (ccta) to detect cad in diabetic patients and predict subsequent cardiac events. projecting and research methods we analyzed 140 diabetic patients without known cad undergoing ccta; 1,782 patients without diabetes were used as a control group. in addition to the calcium score and the degree of severe stenosis, the atherosclerosis score was recorded by counting the number of segments that have a non-stenosic plaque or st.", "questions_src": ["What is the main condition being studied in this research?", "Who were the diabetic patients included in the study?", "Where did the study take place?", "When was the research conducted?", "Which method was used to assess the ability to detect CAD in diabetic patients?"], "answers_src": ["Coronary artery disease (CAD)", "140 diabetic patients without known CAD", "Not specified in the sentence", "Not specified in the sentence", "Coronary computed tomography angiography (CCTA)"], "answers_bt": ["Coronary heart disease (CAD)", "Targeted diabetic patients without known CAD", "Not specified in the sentence", "Not specified in the sentence", "Coronary computed tomography angiography (CCTA)"], "multiturn": {"turn_1": [{"question_id": "181.1", "question": "What is the main condition being studied in this research?", "answer_src": "Coronary artery disease (CAD)", "follow_up_question": "How many diabetic patients were included in the study?", "follow_up_response": "140", "follow_up_response_bt": "140"}, {"question_id": "181.2", "question": "Who were the diabetic patients included in the study?", "answer_src": "140 diabetic patients without known CAD", "follow_up_question": "How many patients without diabetes were used as a control group?", "follow_up_response": "1782", "follow_up_response_bt": "1782"}, {"question_id": "181.3", "question": "Where did the study take place?", "answer_src": "Not specified in the sentence", "follow_up_question": "What specific measurements were recorded in addition to calcium scoring and the degree of the most severe stenosis?", "follow_up_response": "the atherosclerotic burden score counting the number of segments having either a nonstenotic plaque or a stenosis", "follow_up_response_bt": "the atherosclerosis score"}, {"question_id": "181.4", "question": "When was the research conducted?", "answer_src": "Not specified in the sentence", "follow_up_question": "What is the primary purpose of recording the atherosclerotic burden score in this study?", "follow_up_response": "To count the number of segments having either a nonstenotic plaque or a stenosis", "follow_up_response_bt": "To record the number of segments with a non-stenosic plaque or st"}, {"question_id": "181.5", "question": "Which method was used to assess the ability to detect CAD in diabetic patients?", "answer_src": "Coronary computed tomography angiography (CCTA)", "follow_up_question": "What was the primary outcome measure used to quantify the atherosclerotic burden in the study?", "follow_up_response": "The atherosclerotic burden score counting the number of segments having either a nonstenotic plaque or a stenosis", "follow_up_response_bt": "Atherosclerosis score"}], "turn_2": [{"question_id": "181.6", "question": "How many diabetic patients were included in the study?", "answer_src": "140", "follow_up_question": "How many more patients without diabetes were used as a control group compared to diabetic patients?", "follow_up_response": "1642", "follow_up_response_bt": "1642"}, {"question_id": "181.7", "question": "How many patients without diabetes were used as a control group?", "answer_src": "1782", "follow_up_question": "How many diabetic patients underwent cCTA in the study?", "follow_up_response": "140", "follow_up_response_bt": "140"}, {"question_id": "181.8", "question": "What specific measurements were recorded in addition to calcium scoring and the degree of the most severe stenosis?", "answer_src": "the atherosclerotic burden score counting the number of segments having either a nonstenotic plaque or a stenosis", "follow_up_question": "How many segments had either a nonstenotic plaque or a stenosis according to the atherosclerotic burden score?", "follow_up_response": "140", "follow_up_response_bt": "None"}, {"question_id": "181.9", "question": "What is the primary purpose of recording the atherosclerotic burden score in this study?", "answer_src": "To count the number of segments having either a nonstenotic plaque or a stenosis", "follow_up_question": "How does the atherosclerotic burden score differ from calcium scoring in this study?", "follow_up_response": "The atherosclerotic burden score counts the number of segments having either a nonstenotic plaque or a stenosis, while calcium scoring is not mentioned in the provided sentence.", "follow_up_response_bt": "No Answer"}, {"question_id": "181.10", "question": "What was the primary outcome measure used to quantify the atherosclerotic burden in the study?", "answer_src": "The atherosclerotic burden score counting the number of segments having either a nonstenotic plaque or a stenosis", "follow_up_question": "How many segments had either a nonstenotic plaque or a stenosis to be included in the atherosclerotic burden score?", "follow_up_response": "140", "follow_up_response_bt": "140"}], "turn_3": [{"question_id": "181.11", "question": "How many more patients without diabetes were used as a control group compared to diabetic patients?", "answer_src": "1642", "follow_up_question": "How many segments had either a nonstenotic plaque or a stenosis in the diabetic patients who underwent CTA?", "follow_up_response": "None of the above", "follow_up_response_bt": "Counted"}, {"question_id": "181.12", "question": "How many diabetic patients underwent cCTA in the study?", "answer_src": "140", "follow_up_question": "How many segments had either a nonstenotic plaque or a stenosis in the diabetic patients who underwent cCTA?", "follow_up_response": "None of the above", "follow_up_response_bt": "Counted"}, {"question_id": "181.13", "question": "How many segments had either a nonstenotic plaque or a stenosis according to the atherosclerotic burden score?", "answer_src": "140", "follow_up_question": "How many segments had only a nonstenotic plaque according to the atherosclerotic burden score?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "181.14", "question": "How does the atherosclerotic burden score differ from calcium scoring in this study?", "answer_src": "The atherosclerotic burden score counts the number of segments having either a nonstenotic plaque or a stenosis, while calcium scoring is not mentioned in the provided sentence.", "follow_up_question": "What specific information is included in the atherosclerotic burden score?", "follow_up_response": "counting the number of segments having either a nonstenotic plaque or a stenosis", "follow_up_response_bt": "Counting the number of segments that have a non-stenosic plaque or st"}, {"question_id": "181.15", "question": "How many segments had either a nonstenotic plaque or a stenosis to be included in the atherosclerotic burden score?", "answer_src": "140", "follow_up_question": "How many segments had only a nonstenotic plaque according to the atherosclerotic burden score?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 182, "src": "objectivethe mental health of military personnel varies as a result of different cultural , political , and administrative factors . the purpose of this study was to evaluate the psychological morbidity and quality of life of military personnel in taiwan.materials and methodsthis cross - sectional study utilized the world health organization quality of life instrument , brief version , taiwan version , the general health questionnaire-12 , chinese version , and the visual analog scale ( vas ) in several military units.resultsmore than half of the subjects ( 55.3% ) identified themselves as mentally unhealthy on the general health questionnaire-12 , chinese version ; however , a higher percentage of officers perceived themselves as healthy ( 57.4% ) than did noncommissioned officers ( 38.5% ) or enlisted men ( 42.2% ) . officers also had higher total quality of life ( qol ) scores ( 83.98 ) than did enlisted men ( 79.67 ) .", "mt": "L'obiettivo della salute mentale del personale militare varia a causa di diversi fattori culturali, politici e amministrativi.Lo scopo di questo studio era quello di valutare la morbilità psicologica e la qualità della vita del personale militare in Taiwan.Materiali e metodiQuesto studio cross-sectional ha utilizzato lo strumento dell'organizzazione mondiale della salute sulla qualità della vita , breve versione , versione taiwanese , il questionario generale sulla salute-12 , versione cinese , e la scala analogica visiva (vas) in diverse unità militari.ResultsO più della metà dei soggetti (5,3%) si sono identificati come mentalmente malsani nel questionario generale sulla salute-12 , versione cinese; tuttavia, una percentuale superiore degli ufficiali si è percepita come sana (57,4%) rispetto agli ufficiali non commissionati ( 38,5% o uomini arruolati (4,2%).", "pert_mt": "L'obiettivo della salute mentale del personale militare varia a causa di diversi fattori culturali, politici e amministrativi. Lo scopo di questo studio era quello di valutare la morbilità psicologica, la qualità della vita e l'occupazione del tempo libero del personale militare in Taiwan.", "bt": "The goal of military mental health varies due to various cultural, political and administrative factors, and the purpose of this study was to evaluate the psychological morbidity, quality of life and leisure employment of military personnel in Taiwan.", "questions_src": ["What is the main purpose of the study mentioned in the sentence?", "Who identified themselves as mentally unhealthy according to the General Health Questionnaire-12, Chinese version?", "Where were the military units where the study was conducted?", "When was the study conducted?", "Which group of military personnel had higher total quality of life scores?"], "answers_src": ["To evaluate the psychological morbidity and quality of life of military personnel in Taiwan", "More than half of the subjects", "Several military units", "No Answer", "Officers"], "answers_bt": ["To evaluate the psychological morbidity, quality of life and leisure employment of military personnel in Taiwan", "No Answer", "Taiwan", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "182.1", "question": "What is the main purpose of the study mentioned in the sentence?", "answer_src": "To evaluate the psychological morbidity and quality of life of military personnel in Taiwan", "follow_up_question": "What percentage of subjects identified themselves as mentally unhealthy according to the General Health Questionnaire-Chinese Version?", "follow_up_response": "55.3%", "follow_up_response_bt": "No Answer"}, {"question_id": "182.2", "question": "Who identified themselves as mentally unhealthy according to the General Health Questionnaire-12, Chinese version?", "answer_src": "More than half of the subjects", "follow_up_question": "What was the percentage of officers who identified themselves as mentally unhealthy?", "follow_up_response": "57.4%", "follow_up_response_bt": "No Answer"}, {"question_id": "182.3", "question": "Where were the military units where the study was conducted?", "answer_src": "Several military units", "follow_up_question": "What was the average quality of life score for enlisted men according to the study?", "follow_up_response": "79.67", "follow_up_response_bt": "No Answer"}, {"question_id": "182.4", "question": "When was the study conducted?", "answer_src": "objectivethe mental health of military personnel varies as a result of different cultural , political , and administrative factors . the purpose of this study was to evaluate the psychological morbidity and quality of life of military personnel in taiwan.materials and methodsthis cross - sectional study utilized the world health organization quality of life instrument , brief version , taiwan version , the general health questionnaire-12 , chinese version , and the visual analog scale ( vas ) in several military units.resultsmore than half of the subjects ( 55.3% ) identified themselves as mentally unhealthy on the general health questionnaire-12 , chinese version ; however , a higher percentage of officers perceived themselves as healthy ( 57.4% ) than did noncommissioned officers ( 38.5% ) or enlisted men ( 42.2% ) . officers also had higher total quality of life ( qol ) scores ( 83.98 ) than did enlisted men ( 79.67 ) .", "follow_up_question": "What was the difference in the percentage of officers perceiving themselves as healthy compared to enlisted men?", "follow_up_response": "18.9", "follow_up_response_bt": "No Answer"}, {"question_id": "182.5", "question": "Which group of military personnel had higher total quality of life scores?", "answer_src": "Officers", "follow_up_question": "What was the difference in total quality of life scores between officers and enlisted men?", "follow_up_response": "7.31", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "182.6", "question": "What percentage of subjects identified themselves as mentally unhealthy according to the General Health Questionnaire-Chinese Version?", "answer_src": "55.3%", "follow_up_question": "What was the difference in percentage between officers perceiving themselves as healthy and noncommissioned officers perceiving themselves as healthy?", "follow_up_response": "18.9", "follow_up_response_bt": "No Answer"}, {"question_id": "182.7", "question": "What was the percentage of officers who identified themselves as mentally unhealthy?", "answer_src": "57.4%", "follow_up_question": "What was the difference in the percentage of officers identifying themselves as mentally unhealthy compared to noncommissioned officers?", "follow_up_response": "18.9个百分点", "follow_up_response_bt": "No Answer"}, {"question_id": "182.8", "question": "What was the average quality of life score for enlisted men according to the study?", "answer_src": "79.67", "follow_up_question": "What was the difference in quality of life scores between officers and enlisted men?", "follow_up_response": "5.31", "follow_up_response_bt": "No Answer"}, {"question_id": "182.9", "question": "What was the difference in the percentage of officers perceiving themselves as healthy compared to enlisted men?", "answer_src": "18.9", "follow_up_question": "By how many points did officers' total quality of life scores exceed those of enlisted men?", "follow_up_response": "4.31", "follow_up_response_bt": "No Answer"}, {"question_id": "182.10", "question": "What was the difference in total quality of life scores between officers and enlisted men?", "answer_src": "7.31", "follow_up_question": "By how many points did officers score higher on the visual analog scale (VAS) compared to noncommissioned officers?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "182.11", "question": "What was the difference in percentage between officers perceiving themselves as healthy and noncommissioned officers perceiving themselves as healthy?", "answer_src": "18.9", "follow_up_question": "What was the average QOL score for enlisted men according to the study?", "follow_up_response": "79.67", "follow_up_response_bt": "No Answer"}, {"question_id": "182.12", "question": "What was the difference in the percentage of officers identifying themselves as mentally unhealthy compared to noncommissioned officers?", "answer_src": "18.9个百分点", "follow_up_question": "What was the average QOL score for enlisted men?", "follow_up_response": "79.67", "follow_up_response_bt": "No Answer"}, {"question_id": "182.13", "question": "What was the difference in quality of life scores between officers and enlisted men?", "answer_src": "5.31", "follow_up_question": "By how many points did officers score higher on the visual analog scale compared to noncommissioned officers?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "182.14", "question": "By how many points did officers' total quality of life scores exceed those of enlisted men?", "answer_src": "4.31", "follow_up_question": "By what margin did officers' mental health scores on the General Health Questionnaire-12, Chinese Version differ from noncommissioned officers?", "follow_up_response": "18.31", "follow_up_response_bt": "No Answer"}, {"question_id": "182.15", "question": "By how many points did officers score higher on the visual analog scale (VAS) compared to noncommissioned officers?", "answer_src": "objectivethe mental health of military personnel varies as a result of different cultural , political , and administrative factors . the purpose of this study was to evaluate the psychological morbidity and quality of life of military personnel in taiwan.materials and methodsthis cross - sectional study utilized the world health organization quality of life instrument , brief version , taiwan version , the general health questionnaire-12 , chinese version , and the visual analog scale ( vas ) in several military units.resultsmore than half of the subjects ( 55.3% ) identified themselves as mentally unhealthy on the general health questionnaire-12 , chinese version ; however , a higher percentage of officers perceived themselves as healthy ( 57.4% ) than did noncommissioned officers ( 38.5% ) or enlisted men ( 42.2% ) . officers also had higher total quality of life ( qol ) scores ( 83.98 ) than did enlisted men ( 79.67 ) .", "follow_up_question": "By how many points did officers score higher on the World Health Organization Quality of Life Instrument, Taiwan version compared to noncommissioned officers?", "follow_up_response": "4.31", "follow_up_response_bt": "No Answer"}]}}
{"id": 183, "src": "tn - c sirna did not affect the corm-2-dependent increase of il-10 expression . in cells transfected with il-10 sirna , corm-2 had no effect on the lps - induced expression of tn - c and its downstream cytokines . these data suggest that il-10 mediates the inhibitory effect of co on tn - c and the downstream production of proinflammatory cytokines .", "mt": "Nel sistema il-10 trasfettato , il corm-2 non ha avuto alcun effetto sull' espressione lps-indotta del tn - c e delle sue citochine a valle . Questi dati suggeriscono che il-10 mediano l' effetto inibitore del co sul tn - c e la produzione a valle di citochine proinfiammatorie .", "pert_mt": "Nel sistema il-10 trasfettato, il corm-2 non ha avuto alcun effetto sull'espressione lps-indotta del tn-c e delle sue citochine a valle. Questi dati suggeriscono che il-10 mediamente l'effetto inibitore del co sul tn-c e la produzione a valle di citochine proinfiammatorie.", "bt": "In the transfetted il-10 system, corm-2 had no effect on the lps-induced expression of tn-c and its cytokines in the valley. These data suggest that il-10 mediately inhibited the co-inhibition of tn-c and the production of proinflammatory cytokines in the valley.", "questions_src": ["What did sirna not affect in the given sentence?", "Who had no effect on the lps-induced expression of TN-C and its downstream cytokines?", "Where is the CORM-2 dependent increase of IL-10 mentioned to occur?", "When does IL-10 mediate the inhibitory effect of CO on TN-C and the downstream production of proinflammatory cytokines?", "Which cytokine is affected by the CORM-2 in cells transfected with IL-10 sirna?"], "answers_src": ["the corm-2-dependent increase of il-10 expression", "cells transfected with il-10 sirna", "in cells transfected with il-10 sirna", "no answer", "tn-c"], "answers_bt": ["[\"CORM-2\"], [\"CORM-2\"], [\"The valley\"], [\"In the transfetted il-10 system\"], [\"TN-C\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "183.1", "question": "What did sirna not affect in the given sentence?", "answer_src": "the corm-2-dependent increase of il-10 expression", "follow_up_question": "What did sirna have no effect on in cells transfected with il-10 sirna?", "follow_up_response": "corm-2", "follow_up_response_bt": "The LPS-induced expression of TN-C and its cytokines"}, {"question_id": "183.2", "question": "Who had no effect on the lps-induced expression of TN-C and its downstream cytokines?", "answer_src": "cells transfected with il-10 sirna", "follow_up_question": "What was the effect of CORM-2 in these cells?", "follow_up_response": "CORM-2 had no effect", "follow_up_response_bt": "No Answer"}, {"question_id": "183.3", "question": "Where is the CORM-2 dependent increase of IL-10 mentioned to occur?", "answer_src": "in cells transfected with il-10 sirna", "follow_up_question": "What cytokine was inhibited by CORM-2 in cells transfected with IL-10 siRNA?", "follow_up_response": "TN-α", "follow_up_response_bt": "tn-c"}, {"question_id": "183.4", "question": "When does IL-10 mediate the inhibitory effect of CO on TN-C and the downstream production of proinflammatory cytokines?", "answer_src": "no answer", "follow_up_question": "What is the mechanism by which IL-10 mediates the inhibitory effect?", "follow_up_response": "IL-10", "follow_up_response_bt": "IL-10 mediately inhibited"}, {"question_id": "183.5", "question": "Which cytokine is affected by the CORM-2 in cells transfected with IL-10 sirna?", "answer_src": "tn-c", "follow_up_question": "What cytokines are downstream of TN-C that are produced in response to LPS?", "follow_up_response": "proinflammatory cytokines", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "183.6", "question": "What did sirna have no effect on in cells transfected with il-10 sirna?", "answer_src": "corm-2", "follow_up_question": "What was the effect of LPS in cells transfected with il-10 sirna?", "follow_up_response": "No Answer", "follow_up_response_bt": "The expression of tn-c and its cytokines"}, {"question_id": "183.7", "question": "What was the effect of CORM-2 in these cells?", "answer_src": "CORM-2 had no effect", "follow_up_question": "What was the effect of LPS in the cells where CORM-2 had no effect?", "follow_up_response": "The expression of TN-C and its downstream cytokines", "follow_up_response_bt": "The expression of TN-C and its cytokines"}, {"question_id": "183.8", "question": "What cytokine was inhibited by CORM-2 in cells transfected with IL-10 siRNA?", "answer_src": "TN-α", "follow_up_question": "What cytokine was affected by CORM-2 when TN-α levels were already low?", "follow_up_response": "il-10", "follow_up_response_bt": "TN-C"}, {"question_id": "183.9", "question": "What is the mechanism by which IL-10 mediates the inhibitory effect?", "answer_src": "IL-10", "follow_up_question": "How does IL-10 inhibit TN-C and the production of proinflammatory cytokines?", "follow_up_response": "IL-10 mediates the inhibitory effect of CO on TN-C and the downstream production of proinflammatory cytokines.", "follow_up_response_bt": "IL-10 mediately inhibited"}, {"question_id": "183.10", "question": "What cytokines are downstream of TN-C that are produced in response to LPS?", "answer_src": "proinflammatory cytokines", "follow_up_question": "Which cytokine is directly inhibited by CO according to the text?", "follow_up_response": "tn - c", "follow_up_response_bt": "tn-c"}], "turn_3": [{"question_id": "183.11", "question": "What was the effect of LPS in cells transfected with il-10 sirna?", "answer_src": "tn - c sirna did not affect the corm-2-dependent increase of il-10 expression . in cells transfected with il-10 sirna , corm-2 had no effect on the lps - induced expression of tn - c and its downstream cytokines . these data suggest that il-10 mediates the inhibitory effect of co on tn - c and the downstream production of proinflammatory cytokines .", "follow_up_question": "What was the effect of LPS in cells not transfected with il-10 sirna?", "follow_up_response": "corm-2 had no effect", "follow_up_response_bt": "LPS induced the expression of TN-C and its cytokines"}, {"question_id": "183.12", "question": "What was the effect of LPS in the cells where CORM-2 had no effect?", "answer_src": "The expression of TN-C and its downstream cytokines", "follow_up_question": "What was the effect of LPS in the cells where IL-10 sirna was transfected?", "follow_up_response": "The LPS - induced expression of TN-C and its downstream cytokines was no effect", "follow_up_response_bt": "The expression of TN-C and its cytokines"}, {"question_id": "183.13", "question": "What cytokine was affected by CORM-2 when TN-α levels were already low?", "answer_src": "il-10", "follow_up_question": "What cytokine was inhibited by CORM-2 when TN-α levels were high?", "follow_up_response": "il-10", "follow_up_response_bt": "TN-C"}, {"question_id": "183.14", "question": "How does IL-10 inhibit TN-C and the production of proinflammatory cytokines?", "answer_src": "IL-10 mediates the inhibitory effect of CO on TN-C and the downstream production of proinflammatory cytokines.", "follow_up_question": "What mechanism does IL-10 use to inhibit TN-C?", "follow_up_response": "IL-10", "follow_up_response_bt": "Mediately inhibited"}, {"question_id": "183.15", "question": "Which cytokine is directly inhibited by CO according to the text?", "answer_src": "tn - c", "follow_up_question": "Which cytokine is not affected by CO when IL-10 is present?", "follow_up_response": "interleukin-10 (il-10)", "follow_up_response_bt": "TN-C"}]}}
{"id": 184, "src": "after confirmation of behet 's disease on the basis of a history of recurrent oral and genital ulcers and erythema nodosum , remission was achieved after treatment with methylprednisolone pulse therapy , colchicine , catheter directed thrombolysis and thrombectomy . however , whilst maintaining anticoagulation therapy , a newly developed pericardial aneurysmal dilatation was noted on follow - up radiologic evaluation . further evaluation revealed right coronary artery stenosis and a left coronary artery pseudo aneurysm ; these additional problems were treated with the nonsurgical insertion of an endovascular graft stent .", "mt": "Confirmazione della malattia di Behet sulla base di una storia di ulcere orali e genitali ricorrenti e di eritema nodoso , la remissione è stata raggiunta dopo il trattamento con terapia con polso metilprednisolone , colchicina , trombolisi diretta con catetere e trombectomia . Tuttavia , mentre si manteneva la terapia anticoagulante , una dilatazione pericardica aneurismale di recente sviluppo è stata notata in seguito alla valutazione radiologica . Ulteriori valutazioni hanno rivelato stenosis coronarica destra e un pseudo aneurisma coronarica sinistra; questi problemi aggiuntivi sono stati trattati con l'inserimento non chirurgico di un stento di trapianto endovascolare .", "pert_mt": "Confirmazione della malattia di Behet sulla base di una storia di ulcere orali e genitali ricorrenti e di eritema nodoso, la remissione è stata raggiunta dopo il trattamento con terapia con polso metilprednisolone, colchicina, trombolisi diretta con catetere e trombectomia. Tuttavia, mentre si manteneva la terapia anticoagulante, una dilatazione pericardica aneurismale di recente sviluppo è stata notata in seguito alla valutazione radiologica. Ulteriori valutazioni hanno rivelato stenosis coronarica destra e un pseudo aneurisma coronarica sinistra; questi problemi aggiuntivi sono stati trattati con l'inserimento non chirurgico di un stent di trapianto endovascolare e di un supporto respir", "bt": "Confirmation of Behet's disease based on a history of recurrent oral and genital ulcers and nodular erythema, remission was achieved after treatment with methylprednisolone, colchicine, direct catheter thrombosis and thrombectomy therapy, but while maintaining anticoagulant therapy, a recently developed pericardial aneurysmal dilation was noted following radiological evaluation.Further evaluations revealed right coronary stenosis and left pseudo-coronary aneurysm; these additional problems were treated with the non-surgical insertion of an endovascular transplant stent and respiratory support.", "questions_src": ["What is the name of the disease confirmed in the patient?", "Who received treatment with methylprednisolone pulse therapy, colchicine, catheter directed thrombolysis and thrombectomy?", "Where was the pericardial aneurysmal dilatation first noted?", "When did the patient start showing signs of the new problems?", "Which arteries were found to have stenosis or pseudo aneurysms during further evaluation?"], "answers_src": ["[\"Behet\"s disease\", \"The patient\", \"On follow-up radiologic evaluation\", \"After remission was achieved\", \"Right coronary artery and left coronary artery\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"Behet\"s disease\"], [\"The patient\"], [\"Following radiological evaluation\"], [\"No Answer\"], [\"Right coronary artery and left pseudo-coronary artery\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "184.1", "question": "What is the name of the disease confirmed in the patient?", "answer_src": "[\"Behet\"s disease\", \"The patient\", \"On follow-up radiologic evaluation\", \"After remission was achieved\", \"Right coronary artery and left coronary artery\"]", "follow_up_question": "What additional cardiovascular issues were identified during the further evaluation?", "follow_up_response": "Right coronary artery stenosis and a left coronary artery pseudo aneurysm", "follow_up_response_bt": "Right coronary stenosis and left pseudo-coronary aneurysm"}, {"question_id": "184.2", "question": "Who received treatment with methylprednisolone pulse therapy, colchicine, catheter directed thrombolysis and thrombectomy?", "answer_src": "after confirmation of behet 's disease on the basis of a history of recurrent oral and genital ulcers and erythema nodosum , remission was achieved after treatment with methylprednisolone pulse therapy , colchicine , catheter directed thrombolysis and thrombectomy . however , whilst maintaining anticoagulation therapy , a newly developed pericardial aneurysmal dilatation was noted on follow - up radiologic evaluation . further evaluation revealed right coronary artery stenosis and a left coronary artery pseudo aneurysm ; these additional problems were treated with the nonsurgical insertion of an endovascular graft stent .", "follow_up_question": "What additional problems were found during the further evaluation?", "follow_up_response": "Right coronary artery stenosis and a left coronary artery pseudo aneurysm", "follow_up_response_bt": "Right coronary stenosis and left pseudo-coronary aneurysm"}, {"question_id": "184.3", "question": "Where was the pericardial aneurysmal dilatation first noted?", "answer_src": "after confirmation of behet 's disease on the basis of a history of recurrent oral and genital ulcers and erythema nodosum , remission was achieved after treatment with methylprednisolone pulse therapy , colchicine , catheter directed thrombolysis and thrombectomy . however , whilst maintaining anticoagulation therapy , a newly developed pericardial aneurysmal dilatation was noted on follow - up radiologic evaluation . further evaluation revealed right coronary artery stenosis and a left coronary artery pseudo aneurysm ; these additional problems were treated with the nonsurgical insertion of an endovascular graft stent .", "follow_up_question": "What additional problems were found during the further evaluation?", "follow_up_response": "Right coronary artery stenosis and a left coronary artery pseudo aneurysm", "follow_up_response_bt": "Right coronary stenosis and left pseudo-coronary aneurysm"}, {"question_id": "184.4", "question": "When did the patient start showing signs of the new problems?", "answer_src": "after confirmation of behet 's disease on the basis of a history of recurrent oral and genital ulcers and erythema nodosum , remission was achieved after treatment with methylprednisolone pulse therapy , colchicine , catheter directed thrombolysis and thrombectomy . however , whilst maintaining anticoagulation therapy , a newly developed pericardial aneurysmal dilatation was noted on follow - up radiologic evaluation . further evaluation revealed right coronary artery stenosis and a left coronary artery pseudo aneurysm ; these additional problems were treated with the nonsurgical insertion of an endovascular graft stent .", "follow_up_question": "When were the right coronary artery stenosis and left coronary artery pseudo aneurysm discovered?", "follow_up_response": "No Answer", "follow_up_response_bt": "Following radiological evaluation"}, {"question_id": "184.5", "question": "Which arteries were found to have stenosis or pseudo aneurysms during further evaluation?", "answer_src": "after confirmation of behet 's disease on the basis of a history of recurrent oral and genital ulcers and erythema nodosum , remission was achieved after treatment with methylprednisolone pulse therapy , colchicine , catheter directed thrombolysis and thrombectomy . however , whilst maintaining anticoagulation therapy , a newly developed pericardial aneurysmal dilatation was noted on follow - up radiologic evaluation . further evaluation revealed right coronary artery stenosis and a left coronary artery pseudo aneurysm ; these additional problems were treated with the nonsurgical insertion of an endovascular graft stent .", "follow_up_question": "Which treatment was used to address the right coronary artery stenosis?", "follow_up_response": "nonsurgical insertion of an endovascular graft stent", "follow_up_response_bt": "Non-surgical insertion of an endovascular transplant stent"}], "turn_2": [{"question_id": "184.6", "question": "What additional cardiovascular issues were identified during the further evaluation?", "answer_src": "Right coronary artery stenosis and a left coronary artery pseudo aneurysm", "follow_up_question": "What treatment was used for the left coronary artery pseudo aneurysm?", "follow_up_response": "nonsurgical insertion of an endovascular graft stent", "follow_up_response_bt": "Non-surgical insertion of an endovascular transplant stent"}, {"question_id": "184.7", "question": "What additional problems were found during the further evaluation?", "answer_src": "Right coronary artery stenosis and a left coronary artery pseudo aneurysm", "follow_up_question": "What treatment was used for the right coronary artery stenosis?", "follow_up_response": "nonsurgical insertion of an endovascular graft stent", "follow_up_response_bt": "Non-surgical insertion of an endovascular transplant stent"}, {"question_id": "184.8", "question": "What additional problems were found during the further evaluation?", "answer_src": "Right coronary artery stenosis and a left coronary artery pseudo aneurysm", "follow_up_question": "What treatment was used for the right coronary artery stenosis?", "follow_up_response": "nonsurgical insertion of an endovascular graft stent", "follow_up_response_bt": "Non-surgical insertion of an endovascular transplant stent"}, {"question_id": "184.9", "question": "When were the right coronary artery stenosis and left coronary artery pseudo aneurysm discovered?", "answer_src": "after confirmation of behet 's disease on the basis of a history of recurrent oral and genital ulcers and erythema nodosum , remission was achieved after treatment with methylprednisolone pulse therapy , colchicine , catheter directed thrombolysis and thrombectomy . however , whilst maintaining anticoagulation therapy , a newly developed pericardial aneurysmal dilatation was noted on follow - up radiologic evaluation . further evaluation revealed right coronary artery stenosis and a left coronary artery pseudo aneurysm ; these additional problems were treated with the nonsurgical insertion of an endovascular graft stent .", "follow_up_question": "When were the right coronary artery stenosis and left coronary artery pseudo aneurysm treated?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "184.10", "question": "Which treatment was used to address the right coronary artery stenosis?", "answer_src": "nonsurgical insertion of an endovascular graft stent", "follow_up_question": "What is the purpose of the left coronary artery pseudo aneurysm treatment?", "follow_up_response": "nonsurgical insertion of an endovascular graft stent", "follow_up_response_bt": "non-surgical insertion of an endovascular transplant stent"}], "turn_3": [{"question_id": "184.11", "question": "What treatment was used for the left coronary artery pseudo aneurysm?", "answer_src": "nonsurgical insertion of an endovascular graft stent", "follow_up_question": "What was the initial treatment approach for the right coronary artery stenosis?", "follow_up_response": "nonsurgical insertion of an endovascular graft stent", "follow_up_response_bt": "Non-surgical insertion of an endovascular transplant stent"}, {"question_id": "184.12", "question": "What treatment was used for the right coronary artery stenosis?", "answer_src": "nonsurgical insertion of an endovascular graft stent", "follow_up_question": "What is the reason for the development of the left coronary artery pseudo aneurysm?", "follow_up_response": "further evaluation", "follow_up_response_bt": "No Answer"}, {"question_id": "184.13", "question": "What treatment was used for the right coronary artery stenosis?", "answer_src": "nonsurgical insertion of an endovascular graft stent", "follow_up_question": "What is the reason for the development of the left coronary artery pseudo aneurysm?", "follow_up_response": "further evaluation", "follow_up_response_bt": "No Answer"}, {"question_id": "184.14", "question": "When were the right coronary artery stenosis and left coronary artery pseudo aneurysm treated?", "answer_src": "after confirmation of behet 's disease on the basis of a history of recurrent oral and genital ulcers and erythema nodosum , remission was achieved after treatment with methylprednisolone pulse therapy , colchicine , catheter directed thrombolysis and thrombectomy . however , whilst maintaining anticoagulation therapy , a newly developed pericardial aneurysmal dilatation was noted on follow - up radiologic evaluation . further evaluation revealed right coronary artery stenosis and a left coronary artery pseudo aneurysm ; these additional problems were treated with the nonsurgical insertion of an endovascular graft stent .", "follow_up_question": "What procedure was used to treat the right coronary artery stenosis and left coronary artery pseudo aneurysm?", "follow_up_response": "nonsurgical insertion of an endovascular graft stent", "follow_up_response_bt": "non-surgical insertion of an endovascular transplant stent"}, {"question_id": "184.15", "question": "What is the purpose of the left coronary artery pseudo aneurysm treatment?", "answer_src": "nonsurgical insertion of an endovascular graft stent", "follow_up_question": "What complication led to the development of the pericardial aneurysmal dilatation?", "follow_up_response": "No Answer", "follow_up_response_bt": "Radiological evaluation"}]}}
{"id": 185, "src": "the amount of leak was more than 20% of nasogastric feeds . gastrostomy and fj was done on an average of the 12th postoperative day , after observing the general condition , chest tube output , lung expansion , and ventilatory requirement . there was a drastic reduction in chest tube output and lung expanded in all patients .", "mt": "La gastrostomia e la fj sono state eseguite in media il 12° giorno postoperatorio, dopo aver osservato la condizione generale , la produzione di tubi toracicicici, l'espansione polmonare e la necessità di ventilazione .", "pert_mt": "La gastrostomia e la fj sono state eseguite in media il 12° giorno postoperatorio, dopo aver osservato la condizione generale, la produzione di tubi toracici, l'espansione polmonare e la necessità di ventilazione, e hanno migliorato significativamente lo stato clinico dei pazienti.", "bt": "Gastrostomy and fj were performed on average on the 12th postoperative day, after observing the general condition, the production of chest tubes, lung expansion and the need for ventilation, and significantly improved the clinical condition of patients.", "questions_src": ["[\"What was the percentage of leak compared to nasogastric feeds?\", \"When was the gastrostomy and FJ procedure performed?\", \"Which condition was observed to determine the timing of the gastrostomy and FJ procedure?\", \"How did the chest tube output change?\", \"Which patients showed a drastic reduction in chest tube output and improved lung expansion?\"]}"], "answers_src": ["20%"], "answers_bt": ["When was the gastrostomy and FJ procedure performed?"], "multiturn": {"turn_1": [{"question_id": "185.1", "question": "[\"What was the percentage of leak compared to nasogastric feeds?\", \"When was the gastrostomy and FJ procedure performed?\", \"Which condition was observed to determine the timing of the gastrostomy and FJ procedure?\", \"How did the chest tube output change?\", \"Which patients showed a drastic reduction in chest tube output and improved lung expansion?\"]}", "answer_src": "20%", "follow_up_question": "How many days after surgery was the gastrostomy and FJ procedure performed?", "follow_up_response": "12", "follow_up_response_bt": "12"}], "turn_2": [{"question_id": "185.2", "question": "How many days after surgery was the gastrostomy and FJ procedure performed?", "answer_src": "12", "follow_up_question": "What was the observed change in lung expansion after the gastrostomy and FJ procedure?", "follow_up_response": "There was a drastic reduction in chest tube output and lung expanded in all patients.", "follow_up_response_bt": "significantly improved the clinical condition of patients"}], "turn_3": [{"question_id": "185.3", "question": "What was the observed change in lung expansion after the gastrostomy and FJ procedure?", "answer_src": "There was a drastic reduction in chest tube output and lung expanded in all patients.", "follow_up_question": "What was the state of lung expansion before the gastrostomy and FJ procedure?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 186, "src": "a significant bias in sex ratio has been documented for several congenital cardiac malformations . transposition of the great arteries has been associated with a such a bias but no explanation has been proposed for this bias . we evaluated 95 isolated livebirths with transposition of the great arteries cases referred to the sicilian registry of congenital malformations from 1991 to 1998 .", "mt": "Un significativo pregiudizio nel rapporto sessuale è stato documentato per diverse malformazioni cardiache congenite . La trasmissione delle grandi arterie è stata associata a tale pregiudizio ma nessuna spiegazione è stata proposta per questo pregiudizio . abbiamo valutato 95 nati vivi isolati con trasmissione dei casi delle grandi arterie riferiti al registro siciliano delle malformazioni congenite dal 1991 al 1998 .", "pert_mt": "Un significativo pregiudizio nel rapporto sessuale è stato documentato per diverse malformazioni cardiache congenite. La trasmissione delle grandi arterie è stata associata a tale pregiudizio ma nessuna spiegazione è stata proposta per questo pregiudizio. Abbiamo valutato 95 nati vivi isolati con trasmissione dei casi delle grandi arterie riferiti al registro siciliano delle malformazioni congenite dal 1991 al 1998 e abbiamo trovato una correlazione interessante.", "bt": "A significant bias in sexual intercourse has been documented for various congenital heart defects.Transmission of the great arteries has been associated with this bias, but no explanation has been proposed for this bias.We evaluated 95 isolated live births with transmission of cases of the great arteries reported from the Sicilian registry of congenital malformations from 1991 to 1998 and found an interesting correlation.", "questions_src": ["What is the term used to describe a significant bias in sex ratio?", "Who has been associated with a documented bias in congenital cardiac malformations?", "Where was the study conducted?", "When were the cases studied?", "Which congenital cardiac malformation has been associated with a bias in sex ratio?"], "answers_src": ["Sex ratio", "Transposition of the great arteries", "Sicilian registry of congenital malformations", "1991 to 1998", "Transposition of the great arteries"], "answers_bt": ["Sexual intercourse", "Transmission of the great arteries", "Sicilian registry of congenital malformations", "1991 to 1998", "Great arteries"], "multiturn": {"turn_1": [{"question_id": "186.1", "question": "What is the term used to describe a significant bias in sex ratio?", "answer_src": "Sex ratio", "follow_up_question": "What specific congenital cardiac malformation is associated with the documented bias?", "follow_up_response": "Transposition of the great arteries", "follow_up_response_bt": "Great arteries"}, {"question_id": "186.2", "question": "Who has been associated with a documented bias in congenital cardiac malformations?", "answer_src": "Transposition of the great arteries", "follow_up_question": "What percentage of isolated livebirths with transposition of the great arteries were referred to the Sicilian registry of congenital malformations between 1991 and 1998?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "186.3", "question": "Where was the study conducted?", "answer_src": "Sicilian registry of congenital malformations", "follow_up_question": "What year range did the study cover?", "follow_up_response": "1991 to 1998", "follow_up_response_bt": "1991 to 1998"}, {"question_id": "186.4", "question": "When were the cases studied?", "answer_src": "1991 to 1998", "follow_up_question": "What was the total number of cases evaluated?", "follow_up_response": "95", "follow_up_response_bt": "95"}, {"question_id": "186.5", "question": "Which congenital cardiac malformation has been associated with a bias in sex ratio?", "answer_src": "Transposition of the great arteries", "follow_up_question": "What is the time period covered by the study on transposition of the great arteries?", "follow_up_response": "1991 to 1998", "follow_up_response_bt": "1991 to 1998"}], "turn_2": [{"question_id": "186.6", "question": "What specific congenital cardiac malformation is associated with the documented bias?", "answer_src": "Transposition of the great arteries", "follow_up_question": "What was the time period during which the cases were referred to the Sicilian registry?", "follow_up_response": "1991 to 1998", "follow_up_response_bt": "1991 to 1998"}, {"question_id": "186.7", "question": "What percentage of isolated livebirths with transposition of the great arteries were referred to the Sicilian registry of congenital malformations between 1991 and 1998?", "answer_src": "a significant bias in sex ratio has been documented for several congenital cardiac malformations . transposition of the great arteries has been associated with a such a bias but no explanation has been proposed for this bias . we evaluated 95 isolated livebirths with transposition of the great arteries cases referred to the sicilian registry of congenital malformations from 1991 to 1998 .", "follow_up_question": "What was the sex ratio bias observed in the 95 isolated livebirths with transposition of the great arteries?", "follow_up_response": "such a bias", "follow_up_response_bt": "1:1"}, {"question_id": "186.8", "question": "What year range did the study cover?", "answer_src": "1991 to 1998", "follow_up_question": "How many cases were studied?", "follow_up_response": "95", "follow_up_response_bt": "95"}, {"question_id": "186.9", "question": "What was the total number of cases evaluated?", "answer_src": "95", "follow_up_question": "How many more cases were there compared to the number initially suspected by the bias?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "186.10", "question": "What is the time period covered by the study on transposition of the great arteries?", "answer_src": "1991 to 1998", "follow_up_question": "How many cases were studied in total?", "follow_up_response": "95", "follow_up_response_bt": "95"}], "turn_3": [{"question_id": "186.11", "question": "What was the time period during which the cases were referred to the Sicilian registry?", "answer_src": "1991 to 1998", "follow_up_question": "How many cases were evaluated in total?", "follow_up_response": "95", "follow_up_response_bt": "95"}, {"question_id": "186.12", "question": "What was the sex ratio bias observed in the 95 isolated livebirths with transposition of the great arteries?", "answer_src": "such a bias", "follow_up_question": "What specific sex ratio bias was observed in the 95 isolated livebirths with transposition of the great arteries?", "follow_up_response": "a significant bias", "follow_up_response_bt": "No Answer"}, {"question_id": "186.13", "question": "How many cases were studied?", "answer_src": "95", "follow_up_question": "What percentage of males were affected by congenital cardiac malformations in this study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "186.14", "question": "How many more cases were there compared to the number initially suspected by the bias?", "answer_src": "a significant bias in sex ratio has been documented for several congenital cardiac malformations . transposition of the great arteries has been associated with a such a bias but no explanation has been proposed for this bias . we evaluated 95 isolated livebirths with transposition of the great arteries cases referred to the sicilian registry of congenital malformations from 1991 to 1998 .", "follow_up_question": "How many more male than female cases were there in the evaluated sample?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "186.15", "question": "How many cases were studied in total?", "answer_src": "95", "follow_up_question": "What percentage of males were affected by congenital cardiac malformations in this study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 187, "src": "we developed a sensitive and accurate analytical method for quantifying methyleugenol ( me ) in human serum . our method uses a simple solid - phase extraction followed by a highly specific analysis using isotope dilution gas chromatography - high resolution mass spectrometry . our method is very accurate ; its limit of detection is 3.1 pg / g and its average coefficient of variation is 14% over a 200-pg / g range .", "mt": "Abbiamo sviluppato un metodo analitico sensibile ed accurato per quantificare il metileugenolo (me) nel siero umano . Il nostro metodo utilizza un semplice estratto solido-fase seguito da un'analisi altamente specifica utilizzando la cromatografia a gas di diluizione degli isotopi - alta risoluzione dello spettometrio di massa . Il nostro metodo è molto preciso; il suo limite di rilevamento è di 3,1 pg / g e il suo coefficiente medio di variazione è di 14% su un intervallo di 200 pg / g .", "pert_mt": "Abbiamo sviluppato un metodo analitico sensibile ed accurato per quantificare il metileugenolo (me) nel siero umano. Il nostro metodo utilizza un semplice estratto solido-fase seguito da un'analisi altamente specifica utilizzando la cromatografia a gas di diluizione degli isotopi - alta risoluzione dello spettrometro di massa. Il nostro metodo è molto preciso; il suo limite di rilevamento è di 3,1 pg/g e il suo coefficiente medio di variazione è di 14% su un intervallo di 200 pg/g, che è ampio e utile per vari tipi di campioni.", "bt": "We have developed a sensitive and accurate analytical method to quantify methyl-me in human serum using a simple solid-phase stratum followed by a highly specific analysis using isotope dilution gas chromatography - high resolution mass spectrometer.Our method is very accurate; its detection limit is 3.1 pg/g and its mean coefficient of variation is 14% over an interval of 200 pg/g, which is broad and useful for various sample types.", "questions_src": ["What is the name of the compound quantified in human serum?", "Who developed the analytical method?", "Where was the method used (human serum)?", "When did the development of the method occur?", "Which technique was used for the highly specific analysis?"], "answers_src": ["[\"methyleugenol (me)\"], [\"we\"], [\"human serum\"], [\"No Answer\"], [\"isotope dilution gas chromatography - high resolution mass spectrometry\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["Methyl-me", "We", "Human serum", "No Answer", "Isotope dilution gas chromatography - high resolution mass spectrometer"], "multiturn": {"turn_1": [{"question_id": "187.1", "question": "What is the name of the compound quantified in human serum?", "answer_src": "[\"methyleugenol (me)\"], [\"we\"], [\"human serum\"], [\"No Answer\"], [\"isotope dilution gas chromatography - high resolution mass spectrometry\"]", "follow_up_question": "What is the average coefficient of variation for the method?", "follow_up_response": "14%", "follow_up_response_bt": "14%"}, {"question_id": "187.2", "question": "Who developed the analytical method?", "answer_src": "we developed a sensitive and accurate analytical method for quantifying methyleugenol ( me ) in human serum . our method uses a simple solid - phase extraction followed by a highly specific analysis using isotope dilution gas chromatography - high resolution mass spectrometry . our method is very accurate ; its limit of detection is 3.1 pg / g and its average coefficient of variation is 14% over a 200-pg / g range .", "follow_up_question": "What is the average coefficient of variation of the method?", "follow_up_response": "14%", "follow_up_response_bt": "14%"}, {"question_id": "187.3", "question": "Where was the method used (human serum)?", "answer_src": "we developed a sensitive and accurate analytical method for quantifying methyleugenol ( me ) in human serum . our method uses a simple solid - phase extraction followed by a highly specific analysis using isotope dilution gas chromatography - high resolution mass spectrometry . our method is very accurate ; its limit of detection is 3.1 pg / g and its average coefficient of variation is 14% over a 200-pg / g range .", "follow_up_question": "What is the average coefficient of variation for the method?", "follow_up_response": "14%", "follow_up_response_bt": "14%"}, {"question_id": "187.4", "question": "When did the development of the method occur?", "answer_src": "we developed a sensitive and accurate analytical method for quantifying methyleugenol ( me ) in human serum . our method uses a simple solid - phase extraction followed by a highly specific analysis using isotope dilution gas chromatography - high resolution mass spectrometry . our method is very accurate ; its limit of detection is 3.1 pg / g and its average coefficient of variation is 14% over a 200-pg / g range .", "follow_up_question": "What is the average coefficient of variation for the method?", "follow_up_response": "14%", "follow_up_response_bt": "14%"}, {"question_id": "187.5", "question": "Which technique was used for the highly specific analysis?", "answer_src": "we developed a sensitive and accurate analytical method for quantifying methyleugenol ( me ) in human serum . our method uses a simple solid - phase extraction followed by a highly specific analysis using isotope dilution gas chromatography - high resolution mass spectrometry . our method is very accurate ; its limit of detection is 3.1 pg / g and its average coefficient of variation is 14% over a 200-pg / g range .", "follow_up_question": "What is the average coefficient of variation for the method?", "follow_up_response": "14%", "follow_up_response_bt": "14%"}], "turn_2": [{"question_id": "187.6", "question": "What is the average coefficient of variation for the method?", "answer_src": "14%", "follow_up_question": "What is the limit of detection for the method?", "follow_up_response": "3.1 pg / g", "follow_up_response_bt": "3.1 pg/g"}, {"question_id": "187.7", "question": "What is the average coefficient of variation of the method?", "answer_src": "14%", "follow_up_question": "What is the limit of detection of the method?", "follow_up_response": "3.1 pg / g", "follow_up_response_bt": "3.1 pg/g"}, {"question_id": "187.8", "question": "What is the average coefficient of variation for the method?", "answer_src": "14%", "follow_up_question": "What is the limit of detection for the method?", "follow_up_response": "3.1 pg / g", "follow_up_response_bt": "3.1 pg/g"}, {"question_id": "187.9", "question": "What is the average coefficient of variation for the method?", "answer_src": "14%", "follow_up_question": "What is the limit of detection for the method?", "follow_up_response": "3.1 pg / g", "follow_up_response_bt": "3.1 pg/g"}, {"question_id": "187.10", "question": "What is the average coefficient of variation for the method?", "answer_src": "14%", "follow_up_question": "What is the limit of detection for the method?", "follow_up_response": "3.1 pg / g", "follow_up_response_bt": "3.1 pg/g"}], "turn_3": [{"question_id": "187.11", "question": "What is the limit of detection for the method?", "answer_src": "3.1 pg / g", "follow_up_question": "What is the average relative standard deviation of the method over the 200-pg / g range?", "follow_up_response": "14%", "follow_up_response_bt": "14%"}, {"question_id": "187.12", "question": "What is the limit of detection of the method?", "answer_src": "3.1 pg / g", "follow_up_question": "What is the average relative standard deviation of the method?", "follow_up_response": "14%", "follow_up_response_bt": "14%"}, {"question_id": "187.13", "question": "What is the limit of detection for the method?", "answer_src": "3.1 pg / g", "follow_up_question": "What is the average relative standard deviation of the method over the 200-pg / g range?", "follow_up_response": "14%", "follow_up_response_bt": "14%"}, {"question_id": "187.14", "question": "What is the limit of detection for the method?", "answer_src": "3.1 pg / g", "follow_up_question": "What is the average relative standard deviation of the method over the 200-pg / g range?", "follow_up_response": "14%", "follow_up_response_bt": "14%"}, {"question_id": "187.15", "question": "What is the limit of detection for the method?", "answer_src": "3.1 pg / g", "follow_up_question": "What is the average relative standard deviation of the method over the 200-pg / g range?", "follow_up_response": "14%", "follow_up_response_bt": "14%"}]}}
{"id": 188, "src": "uventa stents were successfully inserted in all patients . no obstruction of the uventa stents occurred during the mean follow - up period of 7.3 months ( patency rate 100% ) , but de novo ureteral obstruction developed in 4 ureters . there were no instances of stone formation , hyperplastic reaction , encrustation , or migration .", "mt": "Non si è verificato alcuna ostruzione degli stenti di uventa durante il periodo di follow-up medio di 7,3 mesi (rata di patenza del 100%), ma si è sviluppata un'ostruzione ureterale de novo in 4 ureteri . Non ci sono stati casi di formazione di pietre , reazione iperplastica , incrustazione o migrazione .", "pert_mt": "Non si è verificato alcuna ostruzione degli stenti di uventa durante il periodo di follow-up medio di 7,3 mesi (rata di patenza del 100%), ma si è sviluppata un'ostruzione ureterale de novo in 4 ureteri. Non ci sono stati casi di formazione di pietre, reazione iperplastica, incrustazione o migrazione, e non si è verificata una malattia renale cronica.", "bt": "No obstruction of the stents was observed during the average follow-up period of 7.3 months (patent rate of 100%), but a new urethral obstruction developed in 4 ureters.There were no cases of stone formation, hyperplastic reaction, incrustation or migration, nor was there a chronic kidney disease.", "questions_src": ["What was successfully inserted in all patients?", "When did the mean follow-up period occur?", "How many ureters developed de novo ureteral obstruction?", "What was the patency rate?", "What is the sentence's topic?"], "answers_src": ["uventa stents", "7.3 months", "4", "100%", "ureteral obstruction and related complications"], "answers_bt": ["Stents", "7.3 months", "4", "100%", "Urethral obstructions and renal complications"], "multiturn": {"turn_1": [{"question_id": "188.1", "question": "What was successfully inserted in all patients?", "answer_src": "uventa stents", "follow_up_question": "How many ureters developed de novo ureteral obstruction?", "follow_up_response": "4", "follow_up_response_bt": "4"}, {"question_id": "188.2", "question": "When did the mean follow-up period occur?", "answer_src": "7.3 months", "follow_up_question": "How many ureters developed de novo ureteral obstruction?", "follow_up_response": "4", "follow_up_response_bt": "4"}, {"question_id": "188.3", "question": "How many ureters developed de novo ureteral obstruction?", "answer_src": "4", "follow_up_question": "How many ureters did not develop de novo ureteral obstruction?", "follow_up_response": "3", "follow_up_response_bt": "4"}, {"question_id": "188.4", "question": "What was the patency rate?", "answer_src": "100%", "follow_up_question": "How many ureters developed de novo ureteral obstruction?", "follow_up_response": "4", "follow_up_response_bt": "4"}, {"question_id": "188.5", "question": "What is the sentence's topic?", "answer_src": "ureteral obstruction and related complications", "follow_up_question": "What percentage of ureters developed de novo ureteral obstruction?", "follow_up_response": "4", "follow_up_response_bt": "4"}], "turn_2": [{"question_id": "188.6", "question": "How many ureters developed de novo ureteral obstruction?", "answer_src": "4", "follow_up_question": "How many ureters did not develop de novo ureteral obstruction?", "follow_up_response": "3", "follow_up_response_bt": "4"}, {"question_id": "188.7", "question": "How many ureters developed de novo ureteral obstruction?", "answer_src": "4", "follow_up_question": "How many ureters did not develop de novo ureteral obstruction?", "follow_up_response": "3", "follow_up_response_bt": "4"}, {"question_id": "188.8", "question": "How many ureters did not develop de novo ureteral obstruction?", "answer_src": "3", "follow_up_question": "How many patients had no stone formation during the study?", "follow_up_response": "4", "follow_up_response_bt": "No Answer"}, {"question_id": "188.9", "question": "How many ureters developed de novo ureteral obstruction?", "answer_src": "4", "follow_up_question": "How many ureters did not develop de novo ureteral obstruction?", "follow_up_response": "3", "follow_up_response_bt": "4"}, {"question_id": "188.10", "question": "What percentage of ureters developed de novo ureteral obstruction?", "answer_src": "4", "follow_up_question": "What was the overall patency rate of the uventa stents?", "follow_up_response": "100%", "follow_up_response_bt": "100%"}], "turn_3": [{"question_id": "188.11", "question": "How many ureters did not develop de novo ureteral obstruction?", "answer_src": "3", "follow_up_question": "How many patients had no stone formation during the study?", "follow_up_response": "4", "follow_up_response_bt": "No Answer"}, {"question_id": "188.12", "question": "How many ureters did not develop de novo ureteral obstruction?", "answer_src": "3", "follow_up_question": "How many patients had no stone formation during the study?", "follow_up_response": "4", "follow_up_response_bt": "No Answer"}, {"question_id": "188.13", "question": "How many patients had no stone formation during the study?", "answer_src": "4", "follow_up_question": "How many ureters developed de novo obstruction?", "follow_up_response": "4", "follow_up_response_bt": "4"}, {"question_id": "188.14", "question": "How many ureters did not develop de novo ureteral obstruction?", "answer_src": "3", "follow_up_question": "How many patients had no stone formation during the study?", "follow_up_response": "4", "follow_up_response_bt": "No Answer"}, {"question_id": "188.15", "question": "What was the overall patency rate of the uventa stents?", "answer_src": "100%", "follow_up_question": "How many ureters developed de novo ureteral obstruction?", "follow_up_response": "4", "follow_up_response_bt": "4"}]}}
{"id": 189, "src": "twenty - two ( 19.1% ) females in the study group and ten ( 13.7% ) in the control group had obstruction ( p=0.223 ) . twenty ( 17.3% ) females in the study group who were exposed to biomass smoke had restriction compared with ten ( 13% ) in the control group ( p=0.189 ) . the duration needed for the existence of small airway disease was 16 years , for obstructive airway disease was 17 years , and for restrictive airway disease was 17 years .", "mt": "Ventadue (19,1%) donne del gruppo di studio e dieci ( 13,7%) del gruppo di controllo avevano ostruzione (p=0,223 ) . venti ( 17,3%) donne del gruppo di studio esposte al fumo di biomassa avevano restrizioni rispetto a dieci (13%) nel gruppo di controllo (p=0,189).", "pert_mt": "Ventadue (19,1%) donne del gruppo di studio e dieci (13,7%) del gruppo di controllo avevano ostruzione (p=0,223). Ventidue (19,1%) donne del gruppo di studio e dieci (13,7%) del gruppo di controllo avevano restrizioni rispetto a dieci (13%) nel gruppo di controllo (p=0,189).", "bt": "Twenty-two (19.1%) women in the study group and ten (13.7%) in the control group had obstruction (p=0.223).Twenty-two (19.1%) women in the study group and ten (13.7%) in the control group had restrictions compared to ten (13%) in the control group (p=0.189).", "questions_src": ["[\"What percentage of females in the study group had obstruction?\", \"How many females in the study group were exposed to biomass smoke and had restriction?\", \"What is the duration needed for the existence of restrictive airway disease?\"]}"], "answers_src": ["19.1%"], "answers_bt": ["19.1%"], "multiturn": {"turn_1": [{"question_id": "189.1", "question": "[\"What percentage of females in the study group had obstruction?\", \"How many females in the study group were exposed to biomass smoke and had restriction?\", \"What is the duration needed for the existence of restrictive airway disease?\"]}", "answer_src": "19.1%", "follow_up_question": "What was the difference in percentage of females in the study group who were exposed to biomass smoke and had restriction compared to those who did not have restriction?", "follow_up_response": "5.3%", "follow_up_response_bt": "8.3"}], "turn_2": [{"question_id": "189.2", "question": "What was the difference in percentage of females in the study group who were exposed to biomass smoke and had restriction compared to those who did not have restriction?", "answer_src": "5.3%", "follow_up_question": "How many more years did it take for small airway disease to exist compared to restrictive airway disease?", "follow_up_response": "4", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "189.3", "question": "How many more years did it take for small airway disease to exist compared to restrictive airway disease?", "answer_src": "4", "follow_up_question": "How many more years did it take for obstructive airway disease to exist compared to restrictive airway disease?", "follow_up_response": "1", "follow_up_response_bt": "No Answer"}]}}
{"id": 190, "src": "both were managed successfully with conservative measures and close airway observation . none needed an emergency intubation or surgical tracheostomy . there were no mortalities , and both had a short hospital stay .", "mt": "Entrambi sono stati gestiti con successo con misure conservative e osservazione ravvicinata delle vie aeree . Nessuno ha bisogno di un' intubamento di emergenza o di una tracheostomia chirurgica . non ci sono state morti e entrambi hanno avuto un breve soggiorno in ospedale .", "pert_mt": "Entrambi sono stati gestiti con successo con misure conservative e osservazione ravvicinata delle vie aeree. Nessuno ha bisogno di un'intubamento di emergenza o di una tracheostomia chirurgica. Non ci sono state morti e entrambi hanno avuto un breve soggiorno in ospedale, senza complesse procedure aggiuntive.", "bt": "Both have been successfully managed with conservative measures and close observation of aerial life. None require an emergency intubation or surgical tracheostomy. There have been no deaths and both have had a brief stay in hospital, without additional complicated procedures.", "questions_src": ["What were managed successfully in the sentence?", "Who did not need an emergency intubation or surgical tracheostomy?", "Where were both patients observed closely?", "When was the hospital stay for both patients short?", "Which of the two outcomes (mortalities) did not occur?"], "answers_src": ["Both patients", "None", "Airway", "Short", "Mortalities"], "answers_bt": ["[\"Both\"], [\"None\"], [\"Aerial life\"], [\"Brief\"], [\"Mortalities\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "190.1", "question": "What were managed successfully in the sentence?", "answer_src": "Both patients", "follow_up_question": "What was the length of the hospital stay for both patients?", "follow_up_response": "short", "follow_up_response_bt": "A brief stay"}, {"question_id": "190.2", "question": "Who did not need an emergency intubation or surgical tracheostomy?", "answer_src": "None", "follow_up_question": "What was the average length of stay for the patients?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "190.3", "question": "Where were both patients observed closely?", "answer_src": "Airway", "follow_up_question": "What specific procedures were not required for either patient?", "follow_up_response": "an emergency intubation or surgical tracheostomy", "follow_up_response_bt": "an emergency intubation or surgical tracheostomy"}, {"question_id": "190.4", "question": "When was the hospital stay for both patients short?", "answer_src": "Short", "follow_up_question": "What was the average length of the hospital stay for both patients?", "follow_up_response": "No Answer", "follow_up_response_bt": "Brief"}, {"question_id": "190.5", "question": "Which of the two outcomes (mortalities) did not occur?", "answer_src": "Mortalities", "follow_up_question": "What was the average length of stay for the patients?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "190.6", "question": "What was the length of the hospital stay for both patients?", "answer_src": "short", "follow_up_question": "What was the reason for not requiring an emergency intubation or surgical tracheostomy?", "follow_up_response": "conservative measures", "follow_up_response_bt": "Conservative measures and close observation"}, {"question_id": "190.7", "question": "What was the average length of stay for the patients?", "answer_src": "both were managed successfully with conservative measures and close airway observation . none needed an emergency intubation or surgical tracheostomy . there were no mortalities , and both had a short hospital stay .", "follow_up_question": "How long did the hospital stay for each patient last?", "follow_up_response": "a short hospital stay", "follow_up_response_bt": "A brief stay"}, {"question_id": "190.8", "question": "What specific procedures were not required for either patient?", "answer_src": "an emergency intubation or surgical tracheostomy", "follow_up_question": "What was the length of stay for each patient?", "follow_up_response": "short hospital stay", "follow_up_response_bt": "A brief stay"}, {"question_id": "190.9", "question": "What was the average length of the hospital stay for both patients?", "answer_src": "both were managed successfully with conservative measures and close airway observation . none needed an emergency intubation or surgical tracheostomy . there were no mortalities , and both had a short hospital stay .", "follow_up_question": "How long was the hospital stay for one of the patients?", "follow_up_response": "a short hospital stay", "follow_up_response_bt": "A brief stay"}, {"question_id": "190.10", "question": "What was the average length of stay for the patients?", "answer_src": "both were managed successfully with conservative measures and close airway observation . none needed an emergency intubation or surgical tracheostomy . there were no mortalities , and both had a short hospital stay .", "follow_up_question": "How long did the hospital stay for each patient last?", "follow_up_response": "a short hospital stay", "follow_up_response_bt": "A brief stay"}], "turn_3": [{"question_id": "190.11", "question": "What was the reason for not requiring an emergency intubation or surgical tracheostomy?", "answer_src": "conservative measures", "follow_up_question": "What type of hospital stay did the patients have?", "follow_up_response": "short", "follow_up_response_bt": "A brief stay in hospital"}, {"question_id": "190.12", "question": "How long did the hospital stay for each patient last?", "answer_src": "a short hospital stay", "follow_up_question": "What was the average length of the hospital stay for each patient?", "follow_up_response": "No Answer", "follow_up_response_bt": "Brief"}, {"question_id": "190.13", "question": "What was the length of stay for each patient?", "answer_src": "short hospital stay", "follow_up_question": "What was the average length of stay for the patients?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "190.14", "question": "How long was the hospital stay for one of the patients?", "answer_src": "a short hospital stay", "follow_up_question": "What was the maximum length of the hospital stay for either patient?", "follow_up_response": "short", "follow_up_response_bt": "Brief"}, {"question_id": "190.15", "question": "How long did the hospital stay for each patient last?", "answer_src": "a short hospital stay", "follow_up_question": "What was the average length of the hospital stay for each patient?", "follow_up_response": "No Answer", "follow_up_response_bt": "Brief"}]}}
{"id": 191, "src": "histopathological examination showed cc . in total , three times radiotherapy and a concurrent three - drug regimen of irinotecan , fluorouracil and folinic acid chemotherapy were administered for 6 weeks . as a result , the patient was lost because of multiple organ dysfunction syndrome that developed 3 months after radio - chemotherapy .", "mt": "L'esame istopatologico ha mostrato che in totale , tre volte la radioterapia e un regime simultaneo di tre farmaci di irinotecan , fluorouracil e chemioterapia con acido folinico sono stati somministrati per 6 settimane . Come risultato , il paziente è stato perso a causa della sindrome da disfunzione multiorgana che si è sviluppata 3 mesi dopo la radioterapia .", "pert_mt": "L'esame istopatologico ha mostrato che in totale, tre volte la radioterapia e un regime simultaneo di tre farmaci di irinotecan, fluorouracil e chemioterapia con acido folinico sono stati somministrati per 6 settimane. Come risultato, il paziente è stato perso a causa della sindrome da disfunzione multiorgano che si è sviluppata 3 mesi dopo la radioterapia e del trattamento con corticosteroidi.", "bt": "The histopathological examination showed that in total, three times the radiation therapy and a simultaneous regimen of three irinotecan, fluorouracil and folinic acid chemotherapy drugs were administered for 6 weeks, resulting in the patient being lost due to the multiorgan dysfunction syndrome that developed 3 months after radiation therapy and corticosteroid treatment.", "questions_src": ["What is the abbreviation for histopathological examination mentioned in the sentence?", "Who was lost due to the multiple organ dysfunction syndrome?", "Where did the radiotherapy and chemotherapy take place?", "When did the patient develop multiple organ dysfunction syndrome?", "Which chemotherapy regimen was used for 6 weeks?"], "answers_src": ["cc", "the patient", "in total", "3 months after radio-chemotherapy", "a concurrent three-drug regimen of irinotecan, fluorouracil and folinic acid"], "answers_bt": ["HPE", "The patient", "In total", "3 months after radiation therapy and corticosteroid treatment", "Three irinotecan, fluorouracil and folinic acid"], "multiturn": {"turn_1": [{"question_id": "191.1", "question": "What is the abbreviation for histopathological examination mentioned in the sentence?", "answer_src": "cc", "follow_up_question": "What is the name of the chemotherapy regimen used?", "follow_up_response": "a concurrent three - drug regimen of irinotecan, fluorouracil and folinic acid", "follow_up_response_bt": "Simultaneous regimen of three irinotecan, fluorouracil and folinic acid"}, {"question_id": "191.2", "question": "Who was lost due to the multiple organ dysfunction syndrome?", "answer_src": "the patient", "follow_up_question": "What were the treatments administered before the development of multiple organ dysfunction syndrome?", "follow_up_response": "Radiotherapy and a concurrent three-drug regimen of irinotecan, fluorouracil and folinic acid chemotherapy", "follow_up_response_bt": "Radiation therapy and a simultaneous regimen of three irinotecan, fluorouracil and folinic acid chemotherapy drugs"}, {"question_id": "191.3", "question": "Where did the radiotherapy and chemotherapy take place?", "answer_src": "in total", "follow_up_question": "What was the duration of the chemotherapy?", "follow_up_response": "6 weeks", "follow_up_response_bt": "6 weeks"}, {"question_id": "191.4", "question": "When did the patient develop multiple organ dysfunction syndrome?", "answer_src": "3 months after radio-chemotherapy", "follow_up_question": "What were the treatments administered before the development of multiple organ dysfunction syndrome?", "follow_up_response": "Radiotherapy and a concurrent three-drug regimen of irinotecan, fluorouracil and folinic acid chemotherapy", "follow_up_response_bt": "Radiation therapy and a simultaneous regimen of three irinotecan, fluorouracil and folinic acid chemotherapy drugs"}, {"question_id": "191.5", "question": "Which chemotherapy regimen was used for 6 weeks?", "answer_src": "a concurrent three-drug regimen of irinotecan, fluorouracil and folinic acid", "follow_up_question": "What is the name of the syndrome that caused the patient to be lost?", "follow_up_response": "Multiple organ dysfunction syndrome", "follow_up_response_bt": "multiorgan dysfunction syndrome"}], "turn_2": [{"question_id": "191.6", "question": "What is the name of the chemotherapy regimen used?", "answer_src": "a concurrent three - drug regimen of irinotecan, fluorouracil and folinic acid", "follow_up_question": "What is the duration of the chemotherapy treatment?", "follow_up_response": "6 weeks", "follow_up_response_bt": "6 weeks"}, {"question_id": "191.7", "question": "What were the treatments administered before the development of multiple organ dysfunction syndrome?", "answer_src": "Radiotherapy and a concurrent three-drug regimen of irinotecan, fluorouracil and folinic acid chemotherapy", "follow_up_question": "What was the duration of the chemotherapy treatment?", "follow_up_response": "6 weeks", "follow_up_response_bt": "6 weeks"}, {"question_id": "191.8", "question": "What was the duration of the chemotherapy?", "answer_src": "6 weeks", "follow_up_question": "How many drugs were part of the concurrent chemotherapy regimen?", "follow_up_response": "3", "follow_up_response_bt": "3"}, {"question_id": "191.9", "question": "What were the treatments administered before the development of multiple organ dysfunction syndrome?", "answer_src": "Radiotherapy and a concurrent three-drug regimen of irinotecan, fluorouracil and folinic acid chemotherapy", "follow_up_question": "What was the duration of the chemotherapy treatment?", "follow_up_response": "6 weeks", "follow_up_response_bt": "6 weeks"}, {"question_id": "191.10", "question": "What is the name of the syndrome that caused the patient to be lost?", "answer_src": "Multiple organ dysfunction syndrome", "follow_up_question": "What were the three drugs used in the concurrent chemotherapy regimen?", "follow_up_response": "Irinotecan, fluorouracil and folinic acid", "follow_up_response_bt": "Irinotecan, fluorouracil and folinic acid"}], "turn_3": [{"question_id": "191.11", "question": "What is the duration of the chemotherapy treatment?", "answer_src": "6 weeks", "follow_up_question": "How many drugs were part of the concurrent chemotherapy regimen?", "follow_up_response": "3", "follow_up_response_bt": "3"}, {"question_id": "191.12", "question": "What was the duration of the chemotherapy treatment?", "answer_src": "6 weeks", "follow_up_question": "How many drugs were part of the concurrent chemotherapy regimen?", "follow_up_response": "3", "follow_up_response_bt": "3"}, {"question_id": "191.13", "question": "How many drugs were part of the concurrent chemotherapy regimen?", "answer_src": "3", "follow_up_question": "How long did the patient receive chemotherapy?", "follow_up_response": "6 weeks", "follow_up_response_bt": "6 weeks"}, {"question_id": "191.14", "question": "What was the duration of the chemotherapy treatment?", "answer_src": "6 weeks", "follow_up_question": "How many drugs were part of the concurrent chemotherapy regimen?", "follow_up_response": "3", "follow_up_response_bt": "3"}, {"question_id": "191.15", "question": "What were the three drugs used in the concurrent chemotherapy regimen?", "answer_src": "Irinotecan, fluorouracil and folinic acid", "follow_up_question": "What was the duration of the chemotherapy treatment?", "follow_up_response": "6 weeks", "follow_up_response_bt": "6 weeks"}]}}
{"id": 192, "src": "echocardiogram showed normal right ventricle with no strain or pulmonary hypertension . colistimethate was discontinued . within 24 hours , she was extubated .", "mt": "L'ecocardiogramma ha mostrato un normale ventricolo destro senza tensione o ipertensione polmonare . colistimetato è stato interrotto . entro 24 ore , è stata estutata .", "pert_mt": "L'ecocardiogramma ha mostrato un normale ventricolo destro senza tensione o ipertensione polmonare. Colistimetato è stato interrotto. Entro 24 ore, è stata estutata la flebite.", "bt": "The echocardiogram showed a normal ventricle destro without pulmonary tension or hypertension, the colistimate was interrupted, and within 24 hours, the flebite was studied.", "questions_src": ["What did the echocardiogram show about the right ventricle?", "Who discontinued the colistimethate?", "Where was the patient extubated?", "When did the patient get extubated?", "Which condition was not present in the patient according to the echocardiogram?"], "answers_src": ["normal right ventricle with no strain or pulmonary hypertension", "No Answer", "No Answer", "within 24 hours", "pulmonary hypertension"], "answers_bt": ["Normal ventricle dilation without pulmonary tension or hypertension", "No Answer", "No Answer", "Within 24 hours", "Flebite"], "multiturn": {"turn_1": [{"question_id": "192.1", "question": "What did the echocardiogram show about the right ventricle?", "answer_src": "normal right ventricle with no strain or pulmonary hypertension", "follow_up_question": "Within 24 hours, what happened to the patient?", "follow_up_response": "She was extubated", "follow_up_response_bt": "The flebite was studied"}, {"question_id": "192.2", "question": "Who discontinued the colistimethate?", "answer_src": "echocardiogram showed normal right ventricle with no strain or pulmonary hypertension . colistimethate was discontinued . within 24 hours , she was extubated .", "follow_up_question": "What happened within 24 hours after colistimethate was discontinued?", "follow_up_response": "She was extubated", "follow_up_response_bt": "The flebite was studied"}, {"question_id": "192.3", "question": "Where was the patient extubated?", "answer_src": "echocardiogram showed normal right ventricle with no strain or pulmonary hypertension . colistimethate was discontinued . within 24 hours , she was extubated .", "follow_up_question": "Within which time frame was the patient extubated?", "follow_up_response": "within 24 hours", "follow_up_response_bt": "No Answer"}, {"question_id": "192.4", "question": "When did the patient get extubated?", "answer_src": "within 24 hours", "follow_up_question": "What condition allowed for the patient to be extubated so quickly?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "192.5", "question": "Which condition was not present in the patient according to the echocardiogram?", "answer_src": "pulmonary hypertension", "follow_up_question": "Which medication was stopped as a result?", "follow_up_response": "Colistimethate", "follow_up_response_bt": "Colistimethate"}], "turn_2": [{"question_id": "192.6", "question": "Within 24 hours, what happened to the patient?", "answer_src": "She was extubated", "follow_up_question": "What condition allowed for her immediate extubation?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "192.7", "question": "What happened within 24 hours after colistimethate was discontinued?", "answer_src": "She was extubated", "follow_up_question": "What condition allowed her to be extubated so quickly?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "192.8", "question": "Within which time frame was the patient extubated?", "answer_src": "within 24 hours", "follow_up_question": "What condition allowed for the patient to be extubated so quickly?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "192.9", "question": "What condition allowed for the patient to be extubated so quickly?", "answer_src": "echocardiogram showed normal right ventricle with no strain or pulmonary hypertension . colistimethate was discontinued . within 24 hours , she was extubated .", "follow_up_question": "What medication was discontinued that contributed to her quick extubation?", "follow_up_response": "Colistimethate", "follow_up_response_bt": "Colistimethate"}, {"question_id": "192.10", "question": "Which medication was stopped as a result?", "answer_src": "Colistimethate", "follow_up_question": "What happened 24 hours after the medication was discontinued?", "follow_up_response": "She was extubated", "follow_up_response_bt": "The flebite was studied"}], "turn_3": [{"question_id": "192.11", "question": "What condition allowed for her immediate extubation?", "answer_src": "echocardiogram showed normal right ventricle with no strain or pulmonary hypertension . colistimethate was discontinued . within 24 hours , she was extubated .", "follow_up_question": "What medication was discontinued that contributed to her quick extubation?", "follow_up_response": "Colistimethate", "follow_up_response_bt": "Colistimethate"}, {"question_id": "192.12", "question": "What condition allowed her to be extubated so quickly?", "answer_src": "echocardiogram showed normal right ventricle with no strain or pulmonary hypertension . colistimethate was discontinued . within 24 hours , she was extubated .", "follow_up_question": "What medication was discontinued that contributed to her quick extubation?", "follow_up_response": "Colistimethate", "follow_up_response_bt": "Colistimethate"}, {"question_id": "192.13", "question": "What condition allowed for the patient to be extubated so quickly?", "answer_src": "echocardiogram showed normal right ventricle with no strain or pulmonary hypertension . colistimethate was discontinued . within 24 hours , she was extubated .", "follow_up_question": "What medication was discontinued that contributed to her quick extubation?", "follow_up_response": "Colistimethate", "follow_up_response_bt": "Colistimethate"}, {"question_id": "192.14", "question": "What medication was discontinued that contributed to her quick extubation?", "answer_src": "Colistimethate", "follow_up_question": "What was the echocardiogram finding that supported the decision to discontinue the medication?", "follow_up_response": "normal right ventricle", "follow_up_response_bt": "The colistimate"}, {"question_id": "192.15", "question": "What happened 24 hours after the medication was discontinued?", "answer_src": "She was extubated", "follow_up_question": "What condition allowed her to be extubated so quickly?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 193, "src": "backgroundlimbal ring ( also known as circle ) contact lenses are becoming increasingly popular , especially in asian markets because of their eye - enhancing effects . the pigment particles that give the eye - enhancing effects of these lenses can be found on the front or back surface of the contact lens or enclosed within the lens matrix . the purpose of this research was to evaluate the pigment location and surface roughness of seven types of circle contact lenses.methodsscanning electron microscopic ( sem ) analysis was performed using a variable pressure hitachi s3400n instrument to discern the placement of lens pigments .", "mt": "Le particelle di pigmento che danno agli occhi effetti di miglioramento di questi obiettivi possono essere trovate sulla superficie anteriore o posteriore della lente di contatto o chiuse all'interno della matrice della lente . Lo scopo di questa ricerca era quello di valutare la posizione del pigmento e la rugosità superficiale di sette tipi di lenti di contatto a cerchio.Metodesscanning electron microscopic (sem) analisi è stata eseguita utilizzando uno strumento di pressione variabile hitachi s3400n per discernere il posizionamento dei pigmenti della lente .", "pert_mt": "Le particelle di pigmento che danno agli occhi effetti di miglioramento di questi obiettivi possono essere trovate sulla superficie anteriore o posteriore della lente di contatto o chiuse all'interno della matrice della lente e distribuite uniformemente. Lo scopo di questa ricerca era quello di valutare la posizione del pigmento e la rugosità superficiale di sette tipi di lenti di contatto a cerchio. Metodologia: scanning electron microscopic (SEM) analisi è stata eseguita utilizzando uno strumento di pressione variabile Hitachi S3400N per discernere il posizionamento dei pigmenti della lente.", "bt": "The pigment particles that give the eye the effect of improving these lenses can be found on the front or back surface of the contact lens or closed inside the lens matrix and evenly distributed.The purpose of this research was to evaluate the pigment position and surface roughness of seven types of contact lenses in a circle.", "questions_src": ["What is the term for the ring around the cornea that contact lenses are called?", "Who are these contact lenses especially popular among?", "Where can the pigment particles causing the eye-enhancing effects be found on the contact lens?", "When was this research about circle contact lenses conducted?", "Which types of circle contact lenses were evaluated in the research?"], "answers_src": ["backgroundlimbal ring ( also known as circle )", "asian markets", "on the front or back surface of the contact lens or enclosed within the lens matrix", "No Answer", "seven types"], "answers_bt": ["[\"ring\"], [], [\"No Answer\"], [], [\"seven types\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "193.1", "question": "What is the term for the ring around the cornea that contact lenses are called?", "answer_src": "backgroundlimbal ring ( also known as circle )", "follow_up_question": "What specific surface of the contact lenses do the pigment particles that cause eye-enhancing effects typically reside on?", "follow_up_response": "the front or back surface of the contact lens or enclosed within the lens matrix", "follow_up_response_bt": "The pigment particles that give the eye the effect of improving these lenses can be found on the front or back surface of the contact lens"}, {"question_id": "193.2", "question": "Who are these contact lenses especially popular among?", "answer_src": "asian markets", "follow_up_question": "What specific effects do these contact lenses claim to have on the eyes?", "follow_up_response": "eye - enhancing effects", "follow_up_response_bt": "improving these lenses"}, {"question_id": "193.3", "question": "Where can the pigment particles causing the eye-enhancing effects be found on the contact lens?", "answer_src": "on the front or back surface of the contact lens or enclosed within the lens matrix", "follow_up_question": "What specific method was used to determine the placement of lens pigments?", "follow_up_response": "Scanning electron microscopic (SEM) analysis", "follow_up_response_bt": "The pigment position"}, {"question_id": "193.4", "question": "When was this research about circle contact lenses conducted?", "answer_src": "backgroundlimbal ring ( also known as circle ) contact lenses are becoming increasingly popular , especially in asian markets because of their eye - enhancing effects . the pigment particles that give the eye - enhancing effects of these lenses can be found on the front or back surface of the contact lens or enclosed within the lens matrix . the purpose of this research was to evaluate the pigment location and surface roughness of seven types of circle contact lenses.methodsscanning electron microscopic ( sem ) analysis was performed using a variable pressure hitachi s3400n instrument to discern the placement of lens pigments .", "follow_up_question": "What method was used to analyze the pigment location of the contact lenses?", "follow_up_response": "Scanning electron microscopic (SEM) analysis", "follow_up_response_bt": "The pigment position"}, {"question_id": "193.5", "question": "Which types of circle contact lenses were evaluated in the research?", "answer_src": "seven types", "follow_up_question": "What is the purpose of the scanning electron microscopic analysis conducted?", "follow_up_response": "To evaluate the pigment location and surface roughness of seven types of circle contact lenses", "follow_up_response_bt": "To evaluate the pigment position and surface roughness of seven types of contact lenses"}], "turn_2": [{"question_id": "193.6", "question": "What specific surface of the contact lenses do the pigment particles that cause eye-enhancing effects typically reside on?", "answer_src": "the front or back surface of the contact lens or enclosed within the lens matrix", "follow_up_question": "What method was used to determine the placement of the lens pigments?", "follow_up_response": "Scanning electron microscopic (SEM) analysis", "follow_up_response_bt": "The pigment position was evaluated"}, {"question_id": "193.7", "question": "What specific effects do these contact lenses claim to have on the eyes?", "answer_src": "eye - enhancing effects", "follow_up_question": "What types of pigment locations were examined in the study?", "follow_up_response": "on the front or back surface of the contact lens or enclosed within the lens matrix", "follow_up_response_bt": "on the front or back surface of the contact lens or closed inside the lens matrix"}, {"question_id": "193.8", "question": "What specific method was used to determine the placement of lens pigments?", "answer_src": "Scanning electron microscopic (SEM) analysis", "follow_up_question": "What were the results regarding the pigment location on the front, back surface, and within the lens matrix?", "follow_up_response": "The pigment location of the circle contact lenses was evaluated by scanning electron microscopic (SEM) analysis, with findings indicating the pigment particles could be found on the front or back surface of the contact lens or enclosed within the lens matrix.", "follow_up_response_bt": "The pigment particles can be found on the front or back surface of the contact lens or closed inside the lens matrix"}, {"question_id": "193.9", "question": "What method was used to analyze the pigment location of the contact lenses?", "answer_src": "Scanning electron microscopic (SEM) analysis", "follow_up_question": "What specific details about the pigment location were observed through the SEM analysis?", "follow_up_response": "The placement of lens pigments", "follow_up_response_bt": "The pigment particles that give the eye the effect of improving these lenses can be found on the front or back surface of the contact lens or closed inside the lens matrix and evenly distributed."}, {"question_id": "193.10", "question": "What is the purpose of the scanning electron microscopic analysis conducted?", "answer_src": "To evaluate the pigment location and surface roughness of seven types of circle contact lenses", "follow_up_question": "How many types of circle contact lenses were analyzed using SEM?", "follow_up_response": "7", "follow_up_response_bt": "7"}], "turn_3": [{"question_id": "193.11", "question": "What method was used to determine the placement of the lens pigments?", "answer_src": "Scanning electron microscopic (SEM) analysis", "follow_up_question": "What specific details about the pigment locations were observed through the SEM analysis?", "follow_up_response": "The placement of lens pigments", "follow_up_response_bt": "The pigment particles that give the eye the effect of improving these lenses can be found on the front or back surface of the contact lens or closed inside the lens matrix and evenly distributed"}, {"question_id": "193.12", "question": "What types of pigment locations were examined in the study?", "answer_src": "on the front or back surface of the contact lens or enclosed within the lens matrix", "follow_up_question": "What method was used to determine the pigment locations?", "follow_up_response": "Scanning electron microscopic (SEM) analysis", "follow_up_response_bt": "The pigment position"}, {"question_id": "193.13", "question": "What were the results regarding the pigment location on the front, back surface, and within the lens matrix?", "answer_src": "The pigment location of the circle contact lenses was evaluated by scanning electron microscopic (SEM) analysis, with findings indicating the pigment particles could be found on the front or back surface of the contact lens or enclosed within the lens matrix.", "follow_up_question": "What specific findings were there regarding the pigment particles being located on the front surface versus the back surface of the lenses?", "follow_up_response": "The pigment particles that give the eye-enhancing effects of these lenses can be found on the front or back surface of the contact lens.", "follow_up_response_bt": "No Answer"}, {"question_id": "193.14", "question": "What specific details about the pigment location were observed through the SEM analysis?", "answer_src": "The placement of lens pigments", "follow_up_question": "What types of pigment locations were identified by the SEM analysis?", "follow_up_response": "the pigment location and surface roughness", "follow_up_response_bt": "on the front or back surface of the contact lens or closed inside the lens matrix"}, {"question_id": "193.15", "question": "How many types of circle contact lenses were analyzed using SEM?", "answer_src": "7", "follow_up_question": "What is the purpose of the scanning electron microscopic analysis conducted on the circle contact lenses?", "follow_up_response": "To evaluate the pigment location and surface roughness of seven types of circle contact lenses", "follow_up_response_bt": "To evaluate the pigment position and surface roughness of seven types of contact lenses"}]}}
{"id": 194, "src": "subsidence and late fusion are commonly observed in anterior subtotal corpectomy and reconstruction for treating thoracolumbar burst fractures . the subsidence rate of this surgical method was reported from 19.6% to 75% in the literatures , which would cause treatment failure . thus , an improvement of anterior surgery technique should be studied to reduce these complications.130 patients of thoracolumbar burst fractures treated by minimal corpectomy , decompression and u cage , between january 2009 and december 2010 were included in this study .", "mt": "La frequenza di assorbimento di questo metodo chirurgico è stata riportata dal 19,6% al 75% nelle letterature , che causerebbe un fallimento del trattamento . Pertanto , si dovrebbe studiare un miglioramento della tecnica della chirurgia anteriore per ridurre queste complicazioni.130 pazienti affetti da fratture a subtotale toracolumbare trattati con una corpetomia minima , decompressione e gabbia , tra gennaio 2009 e dicembre 2010 sono stati inclusi in questo studio .", "pert_mt": "La frequenza di assorbimento di questo metodo chirurgico è stata riportata dal 19,6% al 75% nelle letterature, che causerebbe un fallimento del trattamento. Pertanto, si dovrebbe studiare un miglioramento della tecnica della chirurgia anteriore per ridurre queste complicazioni.130 pazienti affetti da fratture a subtotale toracolumbare trattati con una corpetomia minima, decompressione e gabbia, tra gennaio 2009 e dicembre 2010 sono stati inclusi in questo studio. Tuttavia, questi risultati potrebbero essere influenzati da variabili esterne non controllate.", "bt": "The absorption rate of this surgical method has been reported from 19.6% to 75% in the literature, which would cause a treatment failure.Therefore, if an improvement in the technique of previous surgery should be studied to reduce these complications.130 patients with thoracic subtotal fracture treated with minimal corpetomy, decompression and cage, between January 2009 and December 2010 were included in this study.However, these results could be influenced by non-controlled external variables.", "questions_src": ["What is commonly observed in anterior subtotal corpectomy and reconstruction for thoracolumbar burst fractures?", "When was the study on 130 patients with thoracolumbar burst fractures included?", "Where did the literature reporting the subsidence rate of 19.6% to 75% come from?", "Which surgical method was used in the study?", "Who reported the subsidence rate of 19.6% to 75% in the literature?"], "answers_src": ["Subsidence and late fusion", "Between January 2009 and December 2010", "Literatures", "Anterior subtotal corpectomy and reconstruction", "No Answer"], "answers_bt": ["Anterior subtotal corpectomy and reconstruction", "Between January 2009 and December 2010", "The literature", "Minimal corpectomy, decompression and cage", "No Answer"], "multiturn": {"turn_1": [{"question_id": "194.1", "question": "What is commonly observed in anterior subtotal corpectomy and reconstruction for thoracolumbar burst fractures?", "answer_src": "Subsidence and late fusion", "follow_up_question": "What percentage range was the subsidence rate reported for anterior subtotal corpectomy and reconstruction?", "follow_up_response": "19.6% to 75%", "follow_up_response_bt": "19.6% to 75%"}, {"question_id": "194.2", "question": "When was the study on 130 patients with thoracolumbar burst fractures included?", "answer_src": "Between January 2009 and December 2010", "follow_up_question": "What specific complications did the study aim to reduce through its findings?", "follow_up_response": "subside and late fusion", "follow_up_response_bt": "treatment failure"}, {"question_id": "194.3", "question": "Where did the literature reporting the subsidence rate of 19.6% to 75% come from?", "answer_src": "Literatures", "follow_up_question": "What specific surgical technique was used in the study that included 130 patients?", "follow_up_response": "minimal corpectomy, decompression and u cage", "follow_up_response_bt": "minimal corpectomy, decompression and cage"}, {"question_id": "194.4", "question": "Which surgical method was used in the study?", "answer_src": "Anterior subtotal corpectomy and reconstruction", "follow_up_question": "What percentage range of subsidence was observed in the study?", "follow_up_response": "19.6% to 75%", "follow_up_response_bt": "19.6% to 75%"}, {"question_id": "194.5", "question": "Who reported the subsidence rate of 19.6% to 75% in the literature?", "answer_src": "subsidence and late fusion are commonly observed in anterior subtotal corpectomy and reconstruction for treating thoracolumbar burst fractures . the subsidence rate of this surgical method was reported from 19.6% to 75% in the literatures , which would cause treatment failure . thus , an improvement of anterior surgery technique should be studied to reduce these complications.130 patients of thoracolumbar burst fractures treated by minimal corpectomy , decompression and u cage , between january 2009 and december 2010 were included in this study .", "follow_up_question": "What specific surgical technique was used in the study described?", "follow_up_response": "minimal corpectomy, decompression and u cage", "follow_up_response_bt": "minimal corpectomy, decompression and cage"}], "turn_2": [{"question_id": "194.6", "question": "What percentage range was the subsidence rate reported for anterior subtotal corpectomy and reconstruction?", "answer_src": "19.6% to 75%", "follow_up_question": "What was the average subsidence rate reported in the literature?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "194.7", "question": "What specific complications did the study aim to reduce through its findings?", "answer_src": "subside and late fusion", "follow_up_question": "What percentage range of subsidence was observed in the study?", "follow_up_response": "19.6% to 75%", "follow_up_response_bt": "19.6% to 75%"}, {"question_id": "194.8", "question": "What specific surgical technique was used in the study that included 130 patients?", "answer_src": "minimal corpectomy, decompression and u cage", "follow_up_question": "What percentage of patients experienced subsidence according to the study?", "follow_up_response": "19.6% to 75%", "follow_up_response_bt": "No Answer"}, {"question_id": "194.9", "question": "What percentage range of subsidence was observed in the study?", "answer_src": "19.6% to 75%", "follow_up_question": "What was the average subsidence rate observed in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "194.10", "question": "What specific surgical technique was used in the study described?", "answer_src": "minimal corpectomy, decompression and u cage", "follow_up_question": "What was the subsidence rate observed in the study?", "follow_up_response": "19.6% to 75%", "follow_up_response_bt": "19.6% to 75%"}], "turn_3": [{"question_id": "194.11", "question": "What was the average subsidence rate reported in the literature?", "answer_src": "subsidence and late fusion are commonly observed in anterior subtotal corpectomy and reconstruction for treating thoracolumbar burst fractures . the subsidence rate of this surgical method was reported from 19.6% to 75% in the literatures , which would cause treatment failure . thus , an improvement of anterior surgery technique should be studied to reduce these complications.130 patients of thoracolumbar burst fractures treated by minimal corpectomy , decompression and u cage , between january 2009 and december 2010 were included in this study .", "follow_up_question": "What percentage of the 130 patients experienced subsidence according to the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "194.12", "question": "What percentage range of subsidence was observed in the study?", "answer_src": "19.6% to 75%", "follow_up_question": "What was the average subsidence rate observed in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "194.13", "question": "What percentage of patients experienced subsidence according to the study?", "answer_src": "19.6% to 75%", "follow_up_question": "What was the average subsidence rate found in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "194.14", "question": "What was the average subsidence rate observed in the study?", "answer_src": "subsidence and late fusion are commonly observed in anterior subtotal corpectomy and reconstruction for treating thoracolumbar burst fractures . the subsidence rate of this surgical method was reported from 19.6% to 75% in the literatures , which would cause treatment failure . thus , an improvement of anterior surgery technique should be studied to reduce these complications.130 patients of thoracolumbar burst fractures treated by minimal corpectomy , decompression and u cage , between january 2009 and december 2010 were included in this study .", "follow_up_question": "What percentage of patients experienced late fusion in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "194.15", "question": "What was the subsidence rate observed in the study?", "answer_src": "19.6% to 75%", "follow_up_question": "What was the average subsidence rate in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 195, "src": "retroperitoneal liposarcoma is a rare tumor . the dimension and weight of liposarcoma are variable ; those over 20 kg are called giant liposarcoma. herein , we report giant retroperitoneal liposarcoma measuring 45 cm in diameter and 25 kg in weight encasing the entire left kidney and adherent to adjacent structures .", "mt": "Il liposarcoma retroperitoneale è un tumore raro . la dimensione e il peso del liposarcoma sono variabili; quelli di oltre 20 kg sono chiamati liposarcoma gigante. qui , segnaliamo un liposarcoma retroperitoneale gigante di 45 cm di diametro e 25 kg di peso che circonda l'intero rene sinistro e si aderisce alle strutture adiacenti .", "pert_mt": "Il liposarcoma retroperitoneale è un tumore raro. La dimensione e il peso del liposarcoma sono variabili; quelli di oltre 20 kg sono chiamati liposarcoma gigante. Qui, segnaliamo un liposarcoma retroperitoneale gigante di 45 cm di diametro e 25 kg di peso che circonda l'intero rene sinistro e si aderisce alle strutture adiacenti e causa dolori costanti.", "bt": "The size and weight of the liposarcoma are variable; those over 20 kg are called giant liposarcoma.Therefore, we are signalling a giant liposarcoma of 45 cm in diameter and 25 kg in weight that surrounds the entire left kidney and adheres to all adjacent structures and causes constant pain.", "questions_src": ["What is the maximum weight considered for a liposarcoma to be called a giant liposarcoma?", "When did you read the information about the giant retroperitoneal liposarcoma?", "Where was the giant retroperitoneal liposarcoma located in relation to the patient's organs?", "Which organ was encased by the giant retroperitoneal liposarcoma?", "Who reported the giant retroperitoneal liposarcoma case?"], "answers_src": ["over 20 kg", "No Answer", "the entire left kidney and adherent to adjacent structures", "the left kidney", " herein "], "answers_bt": ["20 kg", "No Answer", "entire left kidney", "left kidney", "No Answer"], "multiturn": {"turn_1": [{"question_id": "195.1", "question": "What is the maximum weight considered for a liposarcoma to be called a giant liposarcoma?", "answer_src": "over 20 kg", "follow_up_question": "What is the diameter of the giant retroperitoneal liposarcoma reported in the text?", "follow_up_response": "45 cm", "follow_up_response_bt": "45, \"cm\""}, {"question_id": "195.2", "question": "When did you read the information about the giant retroperitoneal liposarcoma?", "answer_src": "retroperitoneal liposarcoma is a rare tumor . the dimension and weight of liposarcoma are variable ; those over 20 kg are called giant liposarcoma. herein , we report giant retroperitoneal liposarcoma measuring 45 cm in diameter and 25 kg in weight encasing the entire left kidney and adherent to adjacent structures .", "follow_up_question": "What is the largest dimension of the giant retroperitoneal liposarcoma described?", "follow_up_response": "45, \"cm\"", "follow_up_response_bt": "45 cm"}, {"question_id": "195.3", "question": "Where was the giant retroperitoneal liposarcoma located in relation to the patient's organs?", "answer_src": "the entire left kidney and adherent to adjacent structures", "follow_up_question": "What other major organ did the giant retroperitoneal liposarcoma encase?", "follow_up_response": "the entire left kidney", "follow_up_response_bt": "The left kidney"}, {"question_id": "195.4", "question": "Which organ was encased by the giant retroperitoneal liposarcoma?", "answer_src": "the left kidney", "follow_up_question": "Which adjacent structure was adherent to the giant retroperitoneal liposarcoma?", "follow_up_response": "Adjacent structures", "follow_up_response_bt": "All adjacent structures"}, {"question_id": "195.5", "question": "Who reported the giant retroperitoneal liposarcoma case?", "answer_src": " herein ", "follow_up_question": "What was the diameter of the giant retroperitoneal liposarcoma?", "follow_up_response": "45 cm", "follow_up_response_bt": "45 cm"}], "turn_2": [{"question_id": "195.6", "question": "What is the diameter of the giant retroperitoneal liposarcoma reported in the text?", "answer_src": "45 cm", "follow_up_question": "What is the weight of the giant retroperitoneal liposarcoma reported in the text?", "follow_up_response": "25 kg", "follow_up_response_bt": "25 kg"}, {"question_id": "195.7", "question": "What is the largest dimension of the giant retroperitoneal liposarcoma described?", "answer_src": "45, \"cm\"", "follow_up_question": "What is the weight of the giant retroperitoneal liposarcoma described?", "follow_up_response": "25 kg", "follow_up_response_bt": "25 kg"}, {"question_id": "195.8", "question": "What other major organ did the giant retroperitoneal liposarcoma encase?", "answer_src": "the entire left kidney", "follow_up_question": "What was the approximate weight of the giant retroperitoneal liposarcoma?", "follow_up_response": "25 kg", "follow_up_response_bt": "25 kg"}, {"question_id": "195.9", "question": "Which adjacent structure was adherent to the giant retroperitoneal liposarcoma?", "answer_src": "Adjacent structures", "follow_up_question": "Which adjacent structure adhered to the giant liposarcoma?", "follow_up_response": "Adjacent structures", "follow_up_response_bt": "All adjacent structures"}, {"question_id": "195.10", "question": "What was the diameter of the giant retroperitoneal liposarcoma?", "answer_src": "45 cm", "follow_up_question": "What is the approximate weight-to-diameter ratio of the giant retroperitoneal liposarcoma?", "follow_up_response": "3", "follow_up_response_bt": "3"}], "turn_3": [{"question_id": "195.11", "question": "What is the weight of the giant retroperitoneal liposarcoma reported in the text?", "answer_src": "25 kg", "follow_up_question": "What is the diameter of the giant retroperitoneal liposarcoma reported in the text?", "follow_up_response": "45 cm", "follow_up_response_bt": "45, \"cm\""}, {"question_id": "195.12", "question": "What is the weight of the giant retroperitoneal liposarcoma described?", "answer_src": "25 kg", "follow_up_question": "What is the maximum diameter of the giant retroperitoneal liposarcoma?", "follow_up_response": "45 cm", "follow_up_response_bt": "45, \"cm\""}, {"question_id": "195.13", "question": "What was the approximate weight of the giant retroperitoneal liposarcoma?", "answer_src": "25 kg", "follow_up_question": "What was the maximum diameter of the giant retroperitoneal liposarcoma?", "follow_up_response": "45 cm", "follow_up_response_bt": "45, \"cm\""}, {"question_id": "195.14", "question": "Which adjacent structure adhered to the giant liposarcoma?", "answer_src": "Adjacent structures", "follow_up_question": "What is the diameter of the giant liposarcoma?", "follow_up_response": "45 cm", "follow_up_response_bt": "45 cm"}, {"question_id": "195.15", "question": "What is the approximate weight-to-diameter ratio of the giant retroperitoneal liposarcoma?", "answer_src": "3", "follow_up_question": "What is the maximum diameter of the giant retroperitoneal liposarcoma?", "follow_up_response": "45 cm", "follow_up_response_bt": "45, \"cm\""}]}}
{"id": 196, "src": "fondaparinux sodium is a synthetic , sulfated pentasaccharide , selective factor xa inhibitor , a safe and effective antithrombotic agent indicated for preventing thrombus formation in patients with acute coronary syndromes , including those with st - segment elevation myocardial infarction ( stemi ) , non - stemi ( nstemi ) , or unstable angina . major bleeding is rarely known to exist with the use of fondaparinux and to best of our knowledge there exist no isolated case report presenting with fondaparinux - induced major bleeding prescribed for recently diagnosed nstemi . the case report highlights , a need for clinicians to have a sound understanding of anticoagulant pharmacology , dosing , toxicity , individualized approach , and predicting the risk of bleeding before they are prescribed to advancing age persons .", "mt": "Il sodio pentasaccaride è un pentasaccaride sintetico sulfatato , inibitore del fattore seletivo xa , un agente antitrombotico sicuro ed efficace indicato per prevenire la formazione di trombo in pazienti con sindromi coronari acuti , compresi quelli con infarto miocardico (stemi) di elevazione del segmento st , non-stemi (nstemi) o angina instabile . Il sanguinamento maggiore è raramente noto con l' uso di fondaparinux e , a nostra conoscenza , non esiste un caso isolato di fondaparinux - sanguinamento maggiore indotto da fondaparinux prescritto per la fonda stemi recentemente diagnosticata .", "pert_mt": "Il sodio pentasaccaride è un pentasaccaride sintetico sulfatato, inibitore del fattore seletivo xa, un agente antitrombotico sicuro ed efficace indicato per prevenire la formazione di trombo in pazienti con sindromi coronari acuti, compresi quelli con infarto miocardico (stemi), non-stemi (nstemi) o angina instabile. Il sanguinamento maggiore è raramente noto con l'uso di fondaparinux e, a nostra conoscenza, non esiste un caso isolato di fondaparinux-sanguinamento maggiore indotto da fondaparinux prescritto per la fondazione di nuovi stemi recentemente diagnosticati.", "bt": "Sodium pentasaccaride is a synthetic pentasaccaride sulfate, inhibitor of selective factor xa, a safe and effective antithrombotic agent indicated for preventing the formation of thrombus in patients with acute coronary syndromes, including those with myocardial infarction (stemi), non-stemi (nstemi) or unstable angina.", "questions_src": ["What is fondaparinux sodium used for?", "When is major bleeding rarely known to occur with fondaparinux?", "Who are clinicians advised to have a sound understanding of anticoagulant pharmacology?", "Where can a case report of fondaparinux-induced major bleeding be found?", "Which anticoagulant is indicated for preventing thrombus formation in certain heart conditions?"], "answers_src": ["[\"preventing thrombus formation in patients with acute coronary syndromes\"], [\"after recently diagnosed nstemi\"], [\"clinicians\"], [\"in the case report\"], [\"fondaparinux\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"Preventing the formation of thrombus in patients with acute coronary syndromes, including those with myocardial infarction (STMI), non-STMI, or unstable angina\"], [\"Major bleeding is rarely known to occur\"], [\"Clinicians\"], [\"Case reports\"], [\"Sodium pentasaccharide\"])", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "196.1", "question": "What is fondaparinux sodium used for?", "answer_src": "[\"preventing thrombus formation in patients with acute coronary syndromes\"], [\"after recently diagnosed nstemi\"], [\"clinicians\"], [\"in the case report\"], [\"fondaparinux\"]", "follow_up_question": "What specific type of acute coronary syndrome is fondaparinux sodium indicated for preventing thrombus formation?", "follow_up_response": "acute coronary syndromes", "follow_up_response_bt": "Acute coronary syndromes"}, {"question_id": "196.2", "question": "When is major bleeding rarely known to occur with fondaparinux?", "answer_src": "fondaparinux sodium is a synthetic , sulfated pentasaccharide , selective factor xa inhibitor , a safe and effective antithrombotic agent indicated for preventing thrombus formation in patients with acute coronary syndromes , including those with st - segment elevation myocardial infarction ( stemi ) , non - stemi ( nstemi ) , or unstable angina . major bleeding is rarely known to exist with the use of fondaparinux and to best of our knowledge there exist no isolated case report presenting with fondaparinux - induced major bleeding prescribed for recently diagnosed nstemi . the case report highlights , a need for clinicians to have a sound understanding of anticoagulant pharmacology , dosing , toxicity , individualized approach , and predicting the risk of bleeding before they are prescribed to advancing age persons .", "follow_up_question": "What specific patient group is the case report highlighting as needing a better understanding of anticoagulant risks?", "follow_up_response": "Advancing age persons", "follow_up_response_bt": "Patients with acute coronary syndromes, including those with myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI), or unstable angina"}, {"question_id": "196.3", "question": "Who are clinicians advised to have a sound understanding of anticoagulant pharmacology?", "answer_src": "fondaparinux sodium is a synthetic , sulfated pentasaccharide , selective factor xa inhibitor , a safe and effective antithrombotic agent indicated for preventing thrombus formation in patients with acute coronary syndromes , including those with st - segment elevation myocardial infarction ( stemi ) , non - stemi ( nstemi ) , or unstable angina . major bleeding is rarely known to exist with the use of fondaparinux and to best of our knowledge there exist no isolated case report presenting with fondaparinux - induced major bleeding prescribed for recently diagnosed nstemi . the case report highlights , a need for clinicians to have a sound understanding of anticoagulant pharmacology , dosing , toxicity , individualized approach , and predicting the risk of bleeding before they are prescribed to advancing age persons .", "follow_up_question": "What specific aspects of anticoagulant pharmacology are clinicians advised to understand according to the text?", "follow_up_response": "a sound understanding of anticoagulant pharmacology, dosing, toxicity, individualized approach, and predicting the risk of bleeding", "follow_up_response_bt": "No Answer"}, {"question_id": "196.4", "question": "Where can a case report of fondaparinux-induced major bleeding be found?", "answer_src": "fondaparinux sodium is a synthetic , sulfated pentasaccharide , selective factor xa inhibitor , a safe and effective antithrombotic agent indicated for preventing thrombus formation in patients with acute coronary syndromes , including those with st - segment elevation myocardial infarction ( stemi ) , non - stemi ( nstemi ) , or unstable angina . major bleeding is rarely known to exist with the use of fondaparinux and to best of our knowledge there exist no isolated case report presenting with fondaparinux - induced major bleeding prescribed for recently diagnosed nstemi . the case report highlights , a need for clinicians to have a sound understanding of anticoagulant pharmacology , dosing , toxicity , individualized approach , and predicting the risk of bleeding before they are prescribed to advancing age persons .", "follow_up_question": "What specific risk factors does the case report suggest clinicians should consider when prescribing fondaparinux?", "follow_up_response": "a sound understanding of anticoagulant pharmacology, dosing, toxicity, individualized approach, and predicting the risk of bleeding", "follow_up_response_bt": "No Answer"}, {"question_id": "196.5", "question": "Which anticoagulant is indicated for preventing thrombus formation in certain heart conditions?", "answer_src": "fondaparinux sodium is a synthetic , sulfated pentasaccharide , selective factor xa inhibitor , a safe and effective antithrombotic agent indicated for preventing thrombus formation in patients with acute coronary syndromes , including those with st - segment elevation myocardial infarction ( stemi ) , non - stemi ( nstemi ) , or unstable angina . major bleeding is rarely known to exist with the use of fondaparinux and to best of our knowledge there exist no isolated case report presenting with fondaparinux - induced major bleeding prescribed for recently diagnosed nstemi . the case report highlights , a need for clinicians to have a sound understanding of anticoagulant pharmacology , dosing , toxicity , individualized approach , and predicting the risk of bleeding before they are prescribed to advancing age persons .", "follow_up_question": "What specific heart conditions is fondaparinux sodium indicated for?", "follow_up_response": "acute coronary syndromes, including those with ST-segment elevation myocardial infarction (STEMI), non-STEMI, or unstable angina", "follow_up_response_bt": "Acute coronary syndromes, including those with myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI), or unstable angina"}], "turn_2": [{"question_id": "196.6", "question": "What specific type of acute coronary syndrome is fondaparinux sodium indicated for preventing thrombus formation?", "answer_src": "acute coronary syndromes", "follow_up_question": "What other types of acute coronary syndromes besides ST-segment elevation myocardial infarction (STEMI) are fondaparinux sodium indicated for?", "follow_up_response": "non-ST-segment elevation myocardial infarction (NSTE-AMI)\", \"unstable angina", "follow_up_response_bt": "non-ST-segment elevation myocardial infarction (NSTE-AMI)\", \"unstable angina"}, {"question_id": "196.7", "question": "What specific patient group is the case report highlighting as needing a better understanding of anticoagulant risks?", "answer_src": "Advancing age persons", "follow_up_question": "What factors does the case report suggest clinicians should understand before prescribing anticoagulants to advancing age persons?", "follow_up_response": "Anticoagulant pharmacology, dosing, toxicity, individualized approach, and predicting the risk of bleeding", "follow_up_response_bt": "No Answer"}, {"question_id": "196.8", "question": "What specific aspects of anticoagulant pharmacology are clinicians advised to understand according to the text?", "answer_src": "a sound understanding of anticoagulant pharmacology, dosing, toxicity, individualized approach, and predicting the risk of bleeding", "follow_up_question": "What does the text suggest is particularly important for clinicians to understand regarding anticoagulant toxicity?", "follow_up_response": "a sound understanding of anticoagulant pharmacology, dosing, toxicity, individualized approach, and predicting the risk of bleeding", "follow_up_response_bt": "No Answer"}, {"question_id": "196.9", "question": "What specific risk factors does the case report suggest clinicians should consider when prescribing fondaparinux?", "answer_src": "a sound understanding of anticoagulant pharmacology, dosing, toxicity, individualized approach, and predicting the risk of bleeding", "follow_up_question": "What individualized approach does the case report suggest clinicians should take when prescribing fondaparinux?", "follow_up_response": "a sound understanding of anticoagulant pharmacology, dosing, toxicity, individualized approach, and predicting the risk of bleeding", "follow_up_response_bt": "No Answer"}, {"question_id": "196.10", "question": "What specific heart conditions is fondaparinux sodium indicated for?", "answer_src": "acute coronary syndromes, including those with ST-segment elevation myocardial infarction (STEMI), non-STEMI, or unstable angina", "follow_up_question": "What type of anticoagulant is fondaparinux sodium?", "follow_up_response": "selective factor xa inhibitor", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "196.11", "question": "What other types of acute coronary syndromes besides ST-segment elevation myocardial infarction (STEMI) are fondaparinux sodium indicated for?", "answer_src": "non-ST-segment elevation myocardial infarction (NSTE-AMI)\", \"unstable angina", "follow_up_question": "What specific patient population is highlighted in the case report as needing a sound understanding of anticoagulant management?", "follow_up_response": "Advancing age persons", "follow_up_response_bt": "Patients with acute coronary syndromes, including those with myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI), or unstable angina"}, {"question_id": "196.12", "question": "What factors does the case report suggest clinicians should understand before prescribing anticoagulants to advancing age persons?", "answer_src": "Anticoagulant pharmacology, dosing, toxicity, individualized approach, and predicting the risk of bleeding", "follow_up_question": "How does the case report suggest these factors should be applied specifically when prescribing fondaparinux to older patients?", "follow_up_response": "a sound understanding of anticoagulant pharmacology, dosing, toxicity, individualized approach, and predicting the risk of bleeding", "follow_up_response_bt": "No Answer"}, {"question_id": "196.13", "question": "What does the text suggest is particularly important for clinicians to understand regarding anticoagulant toxicity?", "answer_src": "a sound understanding of anticoagulant pharmacology, dosing, toxicity, individualized approach, and predicting the risk of bleeding", "follow_up_question": "What specific risk does the case report highlight that clinicians should be aware of?", "follow_up_response": "a need for clinicians to have a sound understanding of anticoagulant pharmacology, dosing, toxicity, individualized approach, and predicting the risk of bleeding", "follow_up_response_bt": "No Answer"}, {"question_id": "196.14", "question": "What individualized approach does the case report suggest clinicians should take when prescribing fondaparinux?", "answer_src": "a sound understanding of anticoagulant pharmacology, dosing, toxicity, individualized approach, and predicting the risk of bleeding", "follow_up_question": "What specific risk does the case report highlight that clinicians need to predict before prescribing fondaparinux?", "follow_up_response": "a need for clinicians to have a sound understanding of anticoagulant pharmacology, dosing, toxicity, individualized approach, and predicting the risk of bleeding", "follow_up_response_bt": "No Answer"}, {"question_id": "196.15", "question": "What type of anticoagulant is fondaparinux sodium?", "answer_src": "selective factor xa inhibitor", "follow_up_question": "What specific condition is fondaparinux sodium indicated for preventing?", "follow_up_response": "thrombus formation in patients with acute coronary syndromes", "follow_up_response_bt": "the formation of thrombus in patients with acute coronary syndromes, including those with myocardial infarction (STMI), non-STMI (NSTEMI) or unstable angina"}]}}
{"id": 197, "src": "this information was cross - referenced with a national highway traffic safety administration table of manufacturer listed drl conditions to determine vehicle drl status . crude crash rates for vehicles were calculated relative to the number of all registered vehicles in minnesota in 2004 , for models 19952002 . ninety - five percent confidence intervals ( ci ) for the rates were constructed assuming a poisson error distribution.resultsduring 19952002 , there were 184,637 vehicles ( 1995 or newer ) with identifiable vins involved in accidents which occurred under the specified test conditions .", "mt": "Queste informazioni sono state cross-reference con una tabella nazionale di amministrazione della sicurezza stradale del costruttore che elenca le condizioni drl per determinare lo stato drl del veicolo . I tassi di incidente crudo per i veicoli sono stati calcolati in relazione al numero di tutti i veicoli registrati nel minnesota nel 2004 , per i modelli 19952002 . Intervalli di fiducia (ci) del novanta - cinque per cento per i tassi sono stati costruiti assumendo una distribuzione di errori di poisson.resultsdurante il 19952002 , ci sono stati 184.637 veicoli (nel 1995 o più recenti) con vin identificabili coinvolti in incidenti che si sono verificati nelle condizioni di prova specificate .", "pert_mt": "Queste informazioni sono state cross-reference con una tabella nazionale di amministrazione della sicurezza stradale del costruttore che elenca le condizioni drl per determinare lo stato drl del veicolo. I tassi di incidente crudo per i veicoli sono stati calcolati in relazione al numero di tutti i veicoli registrati nel minnesota nel 2004, per i modelli 1995-2002. Intervalli di fiducia (ci) del novanta-cinque per cento per i tassi sono stati costruiti assumendo una distribuzione di errori di Poisson. Durante il 1995-2002, ci sono stati 184.637 veicoli (nel 1995 o più recenti) con vin identificabili coinvolti in", "bt": "This information was cross-referenced with a national manufacturer's road safety administration table that lists the drl conditions to determine the drl status of the vehicle.The crude incident rates for vehicles were calculated in relation to the number of all vehicles registered in Minnesota in 2004, for models 1995-2002.Fifty-nine percent confidence intervals for the vehicles were constructed assuming a distribution of Poisson errors.During 1995-2002, there were 184,637 vehicles (in 1995 or more recently) with identifiable wine involved in coinfection.", "questions_src": ["What is the name of the organization that provided the manufacturer listed DRL conditions information?", "Who calculated the crude crash rates for vehicles?", "Where were the crash rates calculated relative to the number of vehicles?", "In what year were the results based on the data for models 1995-2002?", "Which statistical method was used to construct the confidence intervals for the rates?"], "answers_src": ["National Highway Traffic Safety Administration", "Crude crash rates were calculated by the researchers", "Minnesota", "2004", "Poisson"], "answers_bt": ["[\"National manufacturer\"s road safety administration\", \"Crude incident rates were calculated in relation to the number of all vehicles registered in Minnesota in 2004, for models 1995-2002\", \"Minnesota\", \"2004\", \"Assuming a distribution of Poisson errors\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "197.1", "question": "What is the name of the organization that provided the manufacturer listed DRL conditions information?", "answer_src": "National Highway Traffic Safety Administration", "follow_up_question": "How many years of vehicle models were considered in the study?", "follow_up_response": "2", "follow_up_response_bt": "1995-2002"}, {"question_id": "197.2", "question": "Who calculated the crude crash rates for vehicles?", "answer_src": "Crude crash rates were calculated by the researchers", "follow_up_question": "What was the time period considered for these calculations?", "follow_up_response": "19952002", "follow_up_response_bt": "1995-2002"}, {"question_id": "197.3", "question": "Where were the crash rates calculated relative to the number of vehicles?", "answer_src": "Minnesota", "follow_up_question": "What was the time period covered by the data analyzed?", "follow_up_response": "1995–2002", "follow_up_response_bt": "1995-2002"}, {"question_id": "197.4", "question": "In what year were the results based on the data for models 1995-2002?", "answer_src": "2004", "follow_up_question": "What was the total number of vehicles (1995 or newer) with identifiable VINs involved in accidents during 1995-2002?", "follow_up_response": "184637", "follow_up_response_bt": "184637"}, {"question_id": "197.5", "question": "Which statistical method was used to construct the confidence intervals for the rates?", "answer_src": "Poisson", "follow_up_question": "What is the time period covered by the data analyzed in the study?", "follow_up_response": "1995–2002", "follow_up_response_bt": "1995-2002"}], "turn_2": [{"question_id": "197.6", "question": "How many years of vehicle models were considered in the study?", "answer_src": "2", "follow_up_question": "How many vehicles were involved in accidents during the study period?", "follow_up_response": "184637", "follow_up_response_bt": "184637"}, {"question_id": "197.7", "question": "What was the time period considered for these calculations?", "answer_src": "19952002", "follow_up_question": "How many vehicles were involved in accidents during this period?", "follow_up_response": "184637", "follow_up_response_bt": "184637"}, {"question_id": "197.8", "question": "What was the time period covered by the data analyzed?", "answer_src": "1995–2002", "follow_up_question": "How many vehicles were involved in accidents during this period?", "follow_up_response": "184637", "follow_up_response_bt": "184637"}, {"question_id": "197.9", "question": "What was the total number of vehicles (1995 or newer) with identifiable VINs involved in accidents during 1995-2002?", "answer_src": "184637", "follow_up_question": "How many fewer vehicles were involved in accidents compared to the total number of all registered vehicles in Minnesota in 2004?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "197.10", "question": "What is the time period covered by the data analyzed in the study?", "answer_src": "1995–2002", "follow_up_question": "How many vehicles were involved in accidents during this period?", "follow_up_response": "184637", "follow_up_response_bt": "184637"}], "turn_3": [{"question_id": "197.11", "question": "How many vehicles were involved in accidents during the study period?", "answer_src": "184637", "follow_up_question": "How many of these vehicles were from the year 1995 or newer?", "follow_up_response": "184637", "follow_up_response_bt": "184637"}, {"question_id": "197.12", "question": "How many vehicles were involved in accidents during this period?", "answer_src": "184637", "follow_up_question": "How many of these vehicles were from the year 1995 or newer?", "follow_up_response": "184637", "follow_up_response_bt": "184637"}, {"question_id": "197.13", "question": "How many vehicles were involved in accidents during this period?", "answer_src": "184637", "follow_up_question": "How many of these vehicles were from the year 1995 or newer?", "follow_up_response": "184637", "follow_up_response_bt": "184637"}, {"question_id": "197.14", "question": "How many fewer vehicles were involved in accidents compared to the total number of all registered vehicles in Minnesota in 2004?", "answer_src": "this information was cross - referenced with a national highway traffic safety administration table of manufacturer listed drl conditions to determine vehicle drl status . crude crash rates for vehicles were calculated relative to the number of all registered vehicles in minnesota in 2004 , for models 19952002 . ninety - five percent confidence intervals ( ci ) for the rates were constructed assuming a poisson error distribution.resultsduring 19952002 , there were 184,637 vehicles ( 1995 or newer ) with identifiable vins involved in accidents which occurred under the specified test conditions .", "follow_up_question": "What was the total number of all registered vehicles in Minnesota in 2004?", "follow_up_response": "184,637", "follow_up_response_bt": "184637"}, {"question_id": "197.15", "question": "How many vehicles were involved in accidents during this period?", "answer_src": "184637", "follow_up_question": "How many of these vehicles were from the year 1995 or newer?", "follow_up_response": "184637", "follow_up_response_bt": "184637"}]}}
{"id": 198, "src": "whole blood cultures were stimulated with phytohemagglutinin ( pha ) and concentrations of tumour necrosis factor ( tnf ) , interferon ( ifn ) , interleukin 2 ( il-2 ) , interleukin 12 ( il-12 ) , interleukin 4 ( il-4 ) , and interleukin 10 ( il-10 ) were determined by elisas . a significant increase in cytokine release was detected in hr - hpv - positive women without dysplasia . in women with cervical cancer , release of ifn and il-12 was of the same magnitude as in hr - hpv - positive women without clinical manifestations .", "mt": "Le colture del sangue sono state stimolate con fitoemagglutinina (pha) e le concentrazioni di fattore di necrosi tumorale (tnf) , interferone (ifn), interleucina 2 (il-2), interleucina 12 (il-12), interleucina 4 (il-4) e interleucina 10 (il-10) sono state determinate da elisas . Un aumento significativo del rilascio di citochine è stato rilevato nelle donne hr - hpv - positive senza displasia . nelle donne con cancro cervicale , il rilascio di ifn e il-12 è stato della stessa magnitudine di quelle di donne hr - hpv - positive senza manifestazioni cliniche .", "pert_mt": "Le colture del sangue sono state stimolate con fitoemagglutinina (PHA) e le concentrazioni di fattore di necrosi tumorale (TNF), interferone (IFN), interleucina 2 (IL-2), interleucina 12 (IL-12), interleucina 4 (IL-4) e interleucina 10 (IL-10) sono state determinate da ELISAs. Un aumento significativo del rilascio di citochine è stato rilevato nelle donne HR-HPV-positive senza displasia. Nelle donne con cancro cervicale, il rilascio di IFN e IL-12 è stato della stessa magnitudine di quello di donne HR-HPV-positive senza manifestazioni cliniche.", "bt": "Blood cultures were stimulated with phytoemagglutinin (PHA) and concentrations of tumor necrosis factor (TNF), interferon (IFN), interleukin 2 (IL-2), interleukin 12 (IL-12), interleukin 4 (IL-4) and interleukin 10 (IL-10) were determined by ELISAs.A significant increase in cytokine release was observed in HR-HPV-positive women without dysplasia.In women with cervical cancer, the release of IFN and IL-12 was of the same magnitude as that of HR-HPV-positive women without clinical manifestations.", "questions_src": ["What was stimulated with phytohemagglutinin (PHA)?", "Which cytokines were determined by ELISAs?", "Which HPV type was associated with increased cytokine release in women without dysplasia?", "In what condition did the release of IFN and IL-12 show similar levels to HR-HPV-positive women without clinical manifestations?"], "answers_src": ["[\"Whole blood cultures\"], [\"Tumour necrosis factor (TNF), Interferon (IFN), Interleukin 2 (IL-2), Interleukin 12 (IL-12), Interleukin 4 (IL-4), and Interleukin 10 (IL-10)\"], [\"HR-HPV\"], [\"Cervical cancer\"]", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"Blood cultures\"], [\"TNF, interferon (IFN), interleukin 2 (IL-2), interleukin 12 (IL-12), interleukin 4 (IL-4) and interleukin 10 (IL-10)\"], [\"HR-HPV\"], [\"Cervical cancer\"]", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "198.1", "question": "What was stimulated with phytohemagglutinin (PHA)?", "answer_src": "[\"Whole blood cultures\"], [\"Tumour necrosis factor (TNF), Interferon (IFN), Interleukin 2 (IL-2), Interleukin 12 (IL-12), Interleukin 4 (IL-4), and Interleukin 10 (IL-10)\"], [\"HR-HPV\"], [\"Cervical cancer\"]", "follow_up_question": "What cytokines showed a significant increase in HR-HPV-positive women without dysplasia?", "follow_up_response": "tnf\", \"ifn\", \"il-2\", \"il-12\", \"il-4\", \"il-10", "follow_up_response_bt": "TNF, IL-2, IL-12, IL-4, IL-10"}, {"question_id": "198.2", "question": "Which cytokines were determined by ELISAs?", "answer_src": "whole blood cultures were stimulated with phytohemagglutinin ( pha ) and concentrations of tumour necrosis factor ( tnf ) , interferon ( ifn ) , interleukin 2 ( il-2 ) , interleukin 12 ( il-12 ) , interleukin 4 ( il-4 ) , and interleukin 10 ( il-10 ) were determined by elisas . a significant increase in cytokine release was detected in hr - hpv - positive women without dysplasia . in women with cervical cancer , release of ifn and il-12 was of the same magnitude as in hr - hpv - positive women without clinical manifestations .", "follow_up_question": "What cytokines showed a similar release in women with cervical cancer compared to HR-HPV-positive women without clinical manifestations?", "follow_up_response": "ifn and il-12", "follow_up_response_bt": "IFN and IL-12"}, {"question_id": "198.3", "question": "Which HPV type was associated with increased cytokine release in women without dysplasia?", "answer_src": "whole blood cultures were stimulated with phytohemagglutinin ( pha ) and concentrations of tumour necrosis factor ( tnf ) , interferon ( ifn ) , interleukin 2 ( il-2 ) , interleukin 12 ( il-12 ) , interleukin 4 ( il-4 ) , and interleukin 10 ( il-10 ) were determined by elisas . a significant increase in cytokine release was detected in hr - hpv - positive women without dysplasia . in women with cervical cancer , release of ifn and il-12 was of the same magnitude as in hr - hpv - positive women without clinical manifestations .", "follow_up_question": "What specific cytokines showed a significant increase in release in HR-HPV-positive women without dysplasia?", "follow_up_response": "tnf\", \"ifn\", \"il-2\", \"il-12\", \"il-4\", \"il-10", "follow_up_response_bt": "TNF, IL-2, IL-12, IL-4, IL-10"}, {"question_id": "198.4", "question": "In what condition did the release of IFN and IL-12 show similar levels to HR-HPV-positive women without clinical manifestations?", "answer_src": "whole blood cultures were stimulated with phytohemagglutinin ( pha ) and concentrations of tumour necrosis factor ( tnf ) , interferon ( ifn ) , interleukin 2 ( il-2 ) , interleukin 12 ( il-12 ) , interleukin 4 ( il-4 ) , and interleukin 10 ( il-10 ) were determined by elisas . a significant increase in cytokine release was detected in hr - hpv - positive women without dysplasia . in women with cervical cancer , release of ifn and il-12 was of the same magnitude as in hr - hpv - positive women without clinical manifestations .", "follow_up_question": "What other cytokines were measured besides IFN and IL-12 in the study?", "follow_up_response": "TNF, IL-2, IL-12, IL-4, IL-10", "follow_up_response_bt": "TNF, IL-2, IL-12, IL-4, IL-10"}], "turn_2": [{"question_id": "198.5", "question": "What cytokines showed a significant increase in HR-HPV-positive women without dysplasia?", "answer_src": "tnf\", \"ifn\", \"il-2\", \"il-12\", \"il-4\", \"il-10", "follow_up_question": "Which cytokine had a higher concentration in women with cervical cancer compared to HR-HPV-positive women without dysplasia?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "198.6", "question": "What cytokines showed a similar release in women with cervical cancer compared to HR-HPV-positive women without clinical manifestations?", "answer_src": "ifn and il-12", "follow_up_question": "Which cytokine had a higher concentration in HR-HPV-positive women without dysplasia compared to women with cervical cancer?", "follow_up_response": "interleukin 10 ( il-10 )", "follow_up_response_bt": "No Answer"}, {"question_id": "198.7", "question": "What specific cytokines showed a significant increase in release in HR-HPV-positive women without dysplasia?", "answer_src": "tnf\", \"ifn\", \"il-2\", \"il-12\", \"il-4\", \"il-10", "follow_up_question": "Which cytokine had a higher release in women with cervical cancer compared to HR-HPV-positive women without dysplasia?", "follow_up_response": "interleukin 10 ( il-10 )", "follow_up_response_bt": "No Answer"}, {"question_id": "198.8", "question": "What other cytokines were measured besides IFN and IL-12 in the study?", "answer_src": "TNF, IL-2, IL-12, IL-4, IL-10", "follow_up_question": "What was the concentration range of TNF in HR-HPV-positive women without dysplasia?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "198.9", "question": "Which cytokine had a higher concentration in women with cervical cancer compared to HR-HPV-positive women without dysplasia?", "answer_src": "whole blood cultures were stimulated with phytohemagglutinin ( pha ) and concentrations of tumour necrosis factor ( tnf ) , interferon ( ifn ) , interleukin 2 ( il-2 ) , interleukin 12 ( il-12 ) , interleukin 4 ( il-4 ) , and interleukin 10 ( il-10 ) were determined by elisas . a significant increase in cytokine release was detected in hr - hpv - positive women without dysplasia . in women with cervical cancer , release of ifn and il-12 was of the same magnitude as in hr - hpv - positive women without clinical manifestations .", "follow_up_question": "Which cytokines showed similar levels of release in women with cervical cancer compared to HR-HPV-positive women without clinical manifestations?", "follow_up_response": "ifn and il-12", "follow_up_response_bt": "IFN and IL-12"}, {"question_id": "198.10", "question": "Which cytokine had a higher concentration in HR-HPV-positive women without dysplasia compared to women with cervical cancer?", "answer_src": "interleukin 10 ( il-10 )", "follow_up_question": "Which cytokines showed similar levels of release between HR-HPV-positive women without clinical manifestations and women with cervical cancer?", "follow_up_response": "ifn and il-12", "follow_up_response_bt": "IFN and IL-12"}, {"question_id": "198.11", "question": "Which cytokine had a higher release in women with cervical cancer compared to HR-HPV-positive women without dysplasia?", "answer_src": "interleukin 10 ( il-10 )", "follow_up_question": "Which cytokines showed similar levels of release between women with cervical cancer and HR-HPV-positive women without clinical manifestations?", "follow_up_response": "ifn and il-12", "follow_up_response_bt": "IFN and IL-12"}, {"question_id": "198.12", "question": "What was the concentration range of TNF in HR-HPV-positive women without dysplasia?", "answer_src": "whole blood cultures were stimulated with phytohemagglutinin ( pha ) and concentrations of tumour necrosis factor ( tnf ) , interferon ( ifn ) , interleukin 2 ( il-2 ) , interleukin 12 ( il-12 ) , interleukin 4 ( il-4 ) , and interleukin 10 ( il-10 ) were determined by elisas . a significant increase in cytokine release was detected in hr - hpv - positive women without dysplasia . in women with cervical cancer , release of ifn and il-12 was of the same magnitude as in hr - hpv - positive women without clinical manifestations .", "follow_up_question": "What cytokines showed a similar magnitude of release in women with cervical cancer compared to HR-HPV-positive women without clinical manifestations?", "follow_up_response": "ifn and il-12", "follow_up_response_bt": "IFN and IL-12"}]}}
{"id": 199, "src": "we have previously isolated -cop , the -cop interactor in copi of aspergillus nidulans , by yeast two - hybrid screening . to understand the function of -cop , the anea+ gene for -cop / anea was deleted by homologous recombination using a gene - specific disruption cassette . deletion of the -cop gene showed no detectable changes in vegetative growth or asexual development , but resulted in decrease in the production of the fruiting body , cleistothecium , under conditions favorable for sexual development .", "mt": "Abbiamo precedentemente isolato -cop , l'interactor -cop in copi di aspergillus nidulans , con levadura due - screening ibrido . per capire la funzione di -cop , il gene anea+ per -cop / anea è stato eliminato da ricombination omologa utilizzando una cassetta di interruzione genetica specifica . la cancellazione del gene -cop non ha mostrato cambiamenti rilevabili nella crescita vegetativa o nello sviluppo asexual , ma ha portato a una diminuzione della produzione del corpo fruttante , cleistothecium , in condizioni favorevoli allo sviluppo sessuale .", "pert_mt": "Abbiamo precedentemente isolato -cop, l'interactor -cop in copi di aspergillus nidulans, con levadura due - screening ibrido. Per capire la funzione di -cop, il gene anea+ per -cop / anea è stato eliminato da ricombinazione omologa utilizzando una cassetta di interruzione genetica specifica. La cancellazione del gene -cop non ha mostrato cambiamenti rilevabili nella crescita vegetativa o nello sviluppo asexual, ma ha portato a una diminuzione della produzione del corpo fruttante, cleistothecium, in condizioni favorevoli allo sviluppo sessuale e alla resistenza alle temperature elevate.", "bt": "We previously isolated -cop, the -cop interactor in copi di aspergillus nidulans, with yeast due - screening hybrid.To understand the function of -cop, the gene anea+ per -cop / anea was eliminated from the homologous recombination using a specific genetic interruption tape.The cancellation of the -cop gene did not show noticeable changes in vegetative growth or asexual development, but it led to a decrease in the production of the fruiting body, cleistothecium, in favorable conditions for sexual development and resistance to elevated temperatures.", "questions_src": ["What is the name of the gene that was deleted?", "Who was the target of the gene disruption?", "What type of development was affected by the deletion of the -cop gene?", "Where did the deletion not affect any observable changes?", "Which structure was decreased in production due to the deletion of the -cop gene?"], "answers_src": ["anea+", "copi", "vegetative growth and asexual development", "vegetative growth", "cleistothecium"], "answers_bt": ["anea+", "-cop", "vegetative growth and asexual development", "vegetative growth and asexual development", "cleistothecium"], "multiturn": {"turn_1": [{"question_id": "199.1", "question": "What is the name of the gene that was deleted?", "answer_src": "anea+", "follow_up_question": "What effect did deleting the -cop gene have on the production of the fruiting body?", "follow_up_response": "Decrease", "follow_up_response_bt": "A decrease"}, {"question_id": "199.2", "question": "Who was the target of the gene disruption?", "answer_src": "copi", "follow_up_question": "What specific phenotype did the deletion of the -cop gene cause?", "follow_up_response": "Decrease in the production of the fruiting body, cleistothecium", "follow_up_response_bt": "A decrease in the production of the fruiting body, cleistothecium"}, {"question_id": "199.3", "question": "What type of development was affected by the deletion of the -cop gene?", "answer_src": "vegetative growth and asexual development", "follow_up_question": "What specific developmental stage was reduced in the presence of the -cop gene deletion?", "follow_up_response": "fruiting body", "follow_up_response_bt": "Fruiting body"}, {"question_id": "199.4", "question": "Where did the deletion not affect any observable changes?", "answer_src": "vegetative growth", "follow_up_question": "What specific aspect of fungal development was affected by the deletion?", "follow_up_response": "the production of the fruiting body", "follow_up_response_bt": "The production of the fruiting body"}, {"question_id": "199.5", "question": "Which structure was decreased in production due to the deletion of the -cop gene?", "answer_src": "cleistothecium", "follow_up_question": "What other aspect of fungal development remained unchanged despite the deletion of the -cop gene?", "follow_up_response": "vegetative growth", "follow_up_response_bt": "Vegetative growth and asexual development"}], "turn_2": [{"question_id": "199.6", "question": "What effect did deleting the -cop gene have on the production of the fruiting body?", "answer_src": "Decrease", "follow_up_question": "What other aspect of fungal development was not affected by the deletion of the -cop gene?", "follow_up_response": "vegetative growth and asexual development", "follow_up_response_bt": "Vegetative growth and asexual development"}, {"question_id": "199.7", "question": "What specific phenotype did the deletion of the -cop gene cause?", "answer_src": "Decrease in the production of the fruiting body, cleistothecium", "follow_up_question": "What other developmental process was not affected by the deletion of the -cop gene?", "follow_up_response": "vegetative growth", "follow_up_response_bt": "Vegetative growth and asexual development"}, {"question_id": "199.8", "question": "What specific developmental stage was reduced in the presence of the -cop gene deletion?", "answer_src": "fruiting body", "follow_up_question": "What was the effect on vegetative growth in the absence of the -cop gene?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "199.9", "question": "What specific aspect of fungal development was affected by the deletion?", "answer_src": "the production of the fruiting body", "follow_up_question": "What was the effect on vegetative growth after the -cop gene deletion?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "199.10", "question": "What other aspect of fungal development remained unchanged despite the deletion of the -cop gene?", "answer_src": "vegetative growth", "follow_up_question": "What type of development was affected by the deletion of the -cop gene?", "follow_up_response": "Asexual development", "follow_up_response_bt": "the production of the fruiting body, cleistothecium"}], "turn_3": [{"question_id": "199.11", "question": "What other aspect of fungal development was not affected by the deletion of the -cop gene?", "answer_src": "vegetative growth and asexual development", "follow_up_question": "What effect did deleting the -cop gene have on the formation of the fruiting body?", "follow_up_response": "Decrease", "follow_up_response_bt": "A decrease"}, {"question_id": "199.12", "question": "What other developmental process was not affected by the deletion of the -cop gene?", "answer_src": "vegetative growth", "follow_up_question": "What type of development was significantly reduced in the absence of the -cop gene?", "follow_up_response": "Fruiting body", "follow_up_response_bt": "Fruiting body"}, {"question_id": "199.13", "question": "What was the effect on vegetative growth in the absence of the -cop gene?", "answer_src": "we have previously isolated -cop , the -cop interactor in copi of aspergillus nidulans , by yeast two - hybrid screening . to understand the function of -cop , the anea+ gene for -cop / anea was deleted by homologous recombination using a gene - specific disruption cassette . deletion of the -cop gene showed no detectable changes in vegetative growth or asexual development , but resulted in decrease in the production of the fruiting body , cleistothecium , under conditions favorable for sexual development .", "follow_up_question": "What was the effect on asexual development in the absence of the -cop gene?", "follow_up_response": "no detectable changes", "follow_up_response_bt": "No Answer"}, {"question_id": "199.14", "question": "What was the effect on vegetative growth after the -cop gene deletion?", "answer_src": "we have previously isolated -cop , the -cop interactor in copi of aspergillus nidulans , by yeast two - hybrid screening . to understand the function of -cop , the anea+ gene for -cop / anea was deleted by homologous recombination using a gene - specific disruption cassette . deletion of the -cop gene showed no detectable changes in vegetative growth or asexual development , but resulted in decrease in the production of the fruiting body , cleistothecium , under conditions favorable for sexual development .", "follow_up_question": "What was the effect on asexual development after the -cop gene deletion?", "follow_up_response": "no detectable changes", "follow_up_response_bt": "No Answer"}, {"question_id": "199.15", "question": "What type of development was affected by the deletion of the -cop gene?", "answer_src": "Asexual development", "follow_up_question": "How did the deletion affect the production of the fruiting body?", "follow_up_response": "Decrease", "follow_up_response_bt": "It led to a decrease"}]}}
{"id": 200, "src": "the number of death due to cancer has been increasing in korea . chemotherapy is known to cause side effects because it damages not only cancerous cells but healthy cells . recently , attention has focused on food - derived chemopreventive and anti - tumor agents or formulations with fewer side effects .", "mt": "Il numero di morti per cancro è in aumento in Corea . La chemioterapia è nota per causare effetti collaterali perché danneggia non solo le cellule tumorali ma anche le cellule sane . Recentemente , l' attenzione è stata focalizzata sugli agenti chimiopreventivi e antitumorali derivati dagli alimenti o sulle formulazioni con meno effetti collaterali .", "pert_mt": "Il numero di morti per cancro è in aumento in Corea. La chemioterapia è nota per causare effetti collaterali perché danneggia non solo le cellule tumorali ma anche le cellule sane. Recentemente, l'attenzione è stata focalizzata sugli agenti chimiopreventivi e antitumorali derivati dagli alimenti o sulle formulazioni con meno effetti collaterali e su alternative naturali come l'ortica.", "bt": "The number of cancer deaths is on the rise in Korea.Chemotherapy is known to cause side effects because it damages not only tumor cells but also healthy cells.Recently, attention has been focused on chemopreventive and antitumor agents derived from foods or formulations with fewer side effects and their natural alternatives such as the ortica.", "questions_src": ["What is causing the increase in deaths due to cancer in Korea?", "Who is known to cause side effects with chemotherapy?", "Where do researchers focus their recent attention?", "When did the focus shift to food-derived chemopreventive agents?", "Which type of agents are being researched for fewer side effects?"], "answers_src": ["Chemotherapy", "Chemotherapy", "Food-derived chemopreventive and anti-tumor agents", "Recently", "Food-derived chemopreventive and anti-tumor agents"], "answers_bt": ["Chemotherapy", "Chemotherapy", "On foods or formulations with fewer side effects and their natural alternatives such as the ortica", "Recently", "Chemopreventive and antitumor agents"], "multiturn": {"turn_1": [{"question_id": "200.1", "question": "What is causing the increase in deaths due to cancer in Korea?", "answer_src": "Chemotherapy", "follow_up_question": "What specific side effects do chemotherapy drugs cause?", "follow_up_response": "damages not only cancerous cells but healthy cells", "follow_up_response_bt": "damages not only tumor cells but also healthy cells"}, {"question_id": "200.2", "question": "Who is known to cause side effects with chemotherapy?", "answer_src": "Chemotherapy", "follow_up_question": "What specific type of cells does chemotherapy damage?", "follow_up_response": "cancerous cells", "follow_up_response_bt": "tumor cells"}, {"question_id": "200.3", "question": "Where do researchers focus their recent attention?", "answer_src": "Food-derived chemopreventive and anti-tumor agents", "follow_up_question": "What kind of agents are these food-derived chemopreventive and anti-tumor agents?", "follow_up_response": "food-derived chemopreventive and anti-tumor agents", "follow_up_response_bt": "Chemopreventive and antitumor agents"}, {"question_id": "200.4", "question": "When did the focus shift to food-derived chemopreventive agents?", "answer_src": "Recently", "follow_up_question": "What specific year or period saw this shift?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "200.5", "question": "Which type of agents are being researched for fewer side effects?", "answer_src": "Food-derived chemopreventive and anti-tumor agents", "follow_up_question": "What are some examples of food-derived chemopreventive and anti-tumor agents?", "follow_up_response": "No Answer", "follow_up_response_bt": "ortica"}], "turn_2": [{"question_id": "200.6", "question": "What specific side effects do chemotherapy drugs cause?", "answer_src": "damages not only cancerous cells but healthy cells", "follow_up_question": "What types of food-derived substances are being researched as potential alternatives to chemotherapy?", "follow_up_response": "food - derived chemopreventive and anti - tumor agents", "follow_up_response_bt": "ortica"}, {"question_id": "200.7", "question": "What specific type of cells does chemotherapy damage?", "answer_src": "cancerous cells", "follow_up_question": "Which types of cells are not damaged by chemotherapy according to the text?", "follow_up_response": "healthy cells", "follow_up_response_bt": "healthy cells"}, {"question_id": "200.8", "question": "What kind of agents are these food-derived chemopreventive and anti-tumor agents?", "answer_src": "food-derived chemopreventive and anti-tumor agents", "follow_up_question": "What specific types of food are these agents derived from?", "follow_up_response": "food", "follow_up_response_bt": "foods"}, {"question_id": "200.9", "question": "What specific year or period saw this shift?", "answer_src": "the number of death due to cancer has been increasing in korea . chemotherapy is known to cause side effects because it damages not only cancerous cells but healthy cells . recently , attention has focused on food - derived chemopreventive and anti - tumor agents or formulations with fewer side effects .", "follow_up_question": "What factors have led to the increased focus on food-derived agents?", "follow_up_response": "Fewer side effects", "follow_up_response_bt": "Their natural alternatives such as the ortica"}, {"question_id": "200.10", "question": "What are some examples of food-derived chemopreventive and anti-tumor agents?", "answer_src": "the number of death due to cancer has been increasing in korea . chemotherapy is known to cause side effects because it damages not only cancerous cells but healthy cells . recently , attention has focused on food - derived chemopreventive and anti - tumor agents or formulations with fewer side effects .", "follow_up_question": "What types of food-derived agents are being researched for their chemopreventive and anti-tumor properties?", "follow_up_response": "food - derived chemopreventive and anti - tumor agents", "follow_up_response_bt": "Foods or formulations"}], "turn_3": [{"question_id": "200.11", "question": "What types of food-derived substances are being researched as potential alternatives to chemotherapy?", "answer_src": "food - derived chemopreventive and anti - tumor agents", "follow_up_question": "What specific properties do these food-derived substances have that make them promising alternatives?", "follow_up_response": "Fewer side effects", "follow_up_response_bt": "They have fewer side effects and are natural alternatives"}, {"question_id": "200.12", "question": "Which types of cells are not damaged by chemotherapy according to the text?", "answer_src": "healthy cells", "follow_up_question": "What are some examples of food-derived chemopreventive and anti-tumor agents mentioned in the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "ortica"}, {"question_id": "200.13", "question": "What specific types of food are these agents derived from?", "answer_src": "food", "follow_up_question": "What are some examples of food-derived chemopreventive and anti-tumor agents mentioned in the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "ortica"}, {"question_id": "200.14", "question": "What factors have led to the increased focus on food-derived agents?", "answer_src": "Fewer side effects", "follow_up_question": "How do food-derived agents achieve fewer side effects compared to traditional chemotherapy?", "follow_up_response": "Food - derived chemopreventive and anti - tumor agents", "follow_up_response_bt": "Their natural alternatives such as the ortica"}, {"question_id": "200.15", "question": "What types of food-derived agents are being researched for their chemopreventive and anti-tumor properties?", "answer_src": "food - derived chemopreventive and anti - tumor agents", "follow_up_question": "What specific health benefits do these food-derived agents aim to provide compared to traditional chemotherapy?", "follow_up_response": "Fewer side effects", "follow_up_response_bt": "Their natural alternatives such as the ortica"}]}}
{"id": 201, "src": "exosomes are small extracellular vesicles , which stem from endosomes fusing with the plasma membrane , and can be recaptured by receiving cells . they contain lipids , proteins , and rnas able to modify the physiology of receiving cells . functioning of the brain relies on intercellular communication between neural cells .", "mt": "Gli esosomi sono piccole vescicole extracellulari , che derivano da endosomi che si fondono con la membrana plasmatica , e possono essere ricapturati dalle cellule riceventi . contengono lipidi , proteine e RNA in grado di modificare la fisiologia delle cellule riceventi .", "pert_mt": "Gli esosomi sono piccole vescicole extracellulari, che derivano da endosomi che si fondono con la membrana plasmatica, e possono essere ricapturati dalle cellule riceventi. Contengono lipidi, proteine e RNA in grado di modificare la fisiologia delle cellule riceventi, ma non contengono enzimi enzymatici.", "bt": "Exosomes are small extracellular vesicles, derived from endosomes that fuse with the plasma membrane, and can be recaptured by the recipient cells.They contain lipids, proteins and RNA that can alter the physiology of the recipient cells, but do not contain enzymatic enzymes.", "questions_src": ["What are exosomes composed of?", "Who can recapture exosomes?", "Where do exosomes originate from?", "When can exosomes be found in cells?", "Which process involves endosomes fusing with the plasma membrane?"], "answers_src": ["lipids, proteins, and RNAs", "receiving cells", "endosomes fusing with the plasma membrane", "in the brain", "intercellular communication between neural cells"], "answers_bt": ["lipids, proteins and RNA", "recipient cells", "endosomes that fuse with the plasma membrane", "in cells", "exosomes are small extracellular vesicles, derived from endosomes that fuse with the plasma membrane"], "multiturn": {"turn_1": [{"question_id": "201.1", "question": "What are exosomes composed of?", "answer_src": "lipids, proteins, and RNAs", "follow_up_question": "How do exosomes affect the physiology of receiving cells?", "follow_up_response": "They contain lipids, proteins, and RNAs able to modify the physiology of receiving cells.", "follow_up_response_bt": "They can alter the physiology"}, {"question_id": "201.2", "question": "Who can recapture exosomes?", "answer_src": "receiving cells", "follow_up_question": "What specific components of exosomes can modify the physiology of receiving cells?", "follow_up_response": "lipids\", \"proteins\", \"rnas", "follow_up_response_bt": "lipids, proteins and RNA"}, {"question_id": "201.3", "question": "Where do exosomes originate from?", "answer_src": "endosomes fusing with the plasma membrane", "follow_up_question": "What role do exosomes play in intercellular communication?", "follow_up_response": "They play a role in intercellular communication", "follow_up_response_bt": "They play a role in intercellular communication"}, {"question_id": "201.4", "question": "When can exosomes be found in cells?", "answer_src": "in the brain", "follow_up_question": "What specific components do exosomes contain that can modify the physiology of receiving cells?", "follow_up_response": "lipids\", \"proteins\", \"rnas", "follow_up_response_bt": "lipids, proteins and RNA"}, {"question_id": "201.5", "question": "Which process involves endosomes fusing with the plasma membrane?", "answer_src": "intercellular communication between neural cells", "follow_up_question": "What role do exosomes play in this intercellular communication?", "follow_up_response": "They play a role in modifying the physiology of receiving cells through the transport of lipids, proteins, and RNAs.", "follow_up_response_bt": "alter the physiology"}], "turn_2": [{"question_id": "201.6", "question": "How do exosomes affect the physiology of receiving cells?", "answer_src": "They contain lipids, proteins, and RNAs able to modify the physiology of receiving cells.", "follow_up_question": "What specific components of exosomes are responsible for modifying the physiology of receiving cells?", "follow_up_response": "lipids\", \"proteins\", \"rnas", "follow_up_response_bt": "lipids, proteins and RNA"}, {"question_id": "201.7", "question": "What specific components of exosomes can modify the physiology of receiving cells?", "answer_src": "lipids\", \"proteins\", \"rnas", "follow_up_question": "What role do exosomes play in intercellular communication according to the text?", "follow_up_response": "Exosomes play a role in intercellular communication", "follow_up_response_bt": "alter the physiology of the recipient cells"}, {"question_id": "201.8", "question": "What role do exosomes play in intercellular communication?", "answer_src": "They play a role in intercellular communication", "follow_up_question": "How do exosomes facilitate intercellular communication?", "follow_up_response": "Exosomes facilitate intercellular communication by containing lipids, proteins, and RNAs that can modify the physiology of receiving cells.", "follow_up_response_bt": "They facilitate intercellular communication by containing lipids, proteins, and RNA that can alter the physiology of the recipient cells."}, {"question_id": "201.9", "question": "What specific components do exosomes contain that can modify the physiology of receiving cells?", "answer_src": "lipids\", \"proteins\", \"rnas", "follow_up_question": "What role do exosomes play in intercellular communication according to the text?", "follow_up_response": "Exosomes play a role in intercellular communication", "follow_up_response_bt": "alter the physiology of the recipient cells"}, {"question_id": "201.10", "question": "What role do exosomes play in this intercellular communication?", "answer_src": "They play a role in modifying the physiology of receiving cells through the transport of lipids, proteins, and RNAs.", "follow_up_question": "How do exosomes specifically modify the physiology of receiving cells?", "follow_up_response": "lipids\", \"proteins\", \"rnas", "follow_up_response_bt": "They contain lipids, proteins and RNA"}], "turn_3": [{"question_id": "201.11", "question": "What specific components of exosomes are responsible for modifying the physiology of receiving cells?", "answer_src": "lipids\", \"proteins\", \"rnas", "follow_up_question": "How do exosomes facilitate intercellular communication between neural cells?", "follow_up_response": "They contain lipids, proteins, and RNAs able to modify the physiology of receiving cells.", "follow_up_response_bt": "No Answer"}, {"question_id": "201.12", "question": "What role do exosomes play in intercellular communication according to the text?", "answer_src": "Exosomes play a role in intercellular communication", "follow_up_question": "How do exosomes facilitate intercellular communication?", "follow_up_response": "Exosomes facilitate intercellular communication by containing lipids, proteins, and RNAs that can modify the physiology of receiving cells.", "follow_up_response_bt": "They facilitate intercellular communication by containing lipids, proteins, and RNA that can alter the physiology of the recipient cells."}, {"question_id": "201.13", "question": "How do exosomes facilitate intercellular communication?", "answer_src": "Exosomes facilitate intercellular communication by containing lipids, proteins, and RNAs that can modify the physiology of receiving cells.", "follow_up_question": "What specific components of exosomes play a role in modifying the physiology of receiving cells?", "follow_up_response": "lipids\", \"proteins\", \"rnas", "follow_up_response_bt": "lipids, proteins and RNA"}, {"question_id": "201.14", "question": "What role do exosomes play in intercellular communication according to the text?", "answer_src": "Exosomes play a role in intercellular communication", "follow_up_question": "How do exosomes facilitate intercellular communication?", "follow_up_response": "Exosomes facilitate intercellular communication by containing lipids, proteins, and RNAs that can modify the physiology of receiving cells.", "follow_up_response_bt": "They facilitate intercellular communication by containing lipids, proteins, and RNA that can alter the physiology of the recipient cells."}, {"question_id": "201.15", "question": "How do exosomes specifically modify the physiology of receiving cells?", "answer_src": "lipids\", \"proteins\", \"rnas", "follow_up_question": "Which components of exosomes are responsible for modifying the physiology of receiving cells?", "follow_up_response": "lipids\", \"proteins\", \"rnas", "follow_up_response_bt": "lipids, proteins and RNA"}]}}
{"id": 202, "src": "thus , the formed composite emits orange red fluorescence around 600 nm and investigated to the highest intensity at mn2 + doping concentration of 15 at.% and relatively more stable at low acidic and low alkaline ph levels . the structural characteristics and optical properties were thoroughly analyzed by using fourier transform infrared , x - ray diffraction , dynamic light scattering , ultraviolet - visible , and fluorescence spectroscopy . further characterization was conducted using thermogravimetric analysis , high - resolution transmission electron microscopy , field emission scanning electron microscopy , energy dispersive x - ray spectroscopy , x - ray fluorescence , and x - ray photoelectron spectroscopy .", "mt": ", il composto formato emette fluorescenza rossa arancione intorno a 600 nm e è stato studiato alla massima intensità a mn2 + concentrazione di doping di 15 a.% e relativamente più stabile a bassi livelli di pH acido e alcalino . le caratteristiche strutturali e le proprietà ottiche sono state accuratamente analizzate utilizzando la trasformazione a infrarossi di Fourier , la diffrazione a raggi x , la diffrazione dinamica della luce , l'ultravioletto visibile e la spettroscopia a fluorescenza . Ulteriori caratterizzazioni sono state condotte utilizzando l'analisi termogravistica , la microscopia elettronica ad alta risoluzione della trasmissione , la microscopia elettronica a scansione di emissione di campo , la spettroscopia a raggi x-ray , la dispersione a raggi x-fluorescenza e la spettroscopia fotorealizzativa a raggi x-ray .", "pert_mt": ", il composto formato emette fluorescenza rossa arancione intorno a 600 nm e è stato studiato alla massima intensità a mn2+ concentrazione di doping di 15 a.% e relativamente più stabile a bassi livelli di pH acido e alcalino. Le caratteristiche strutturali e le proprietà ottiche sono state accuratamente analizzate utilizzando la trasformazione a infrarossi di Fourier, la diffrazione a raggi X, la diffrazione dinamica della luce, l'ultravioletto visibile e la spettroscopia a fluorescenza. Ulteriori caratterizzazioni sono state condotte utilizzando l'analisi termogravistica, la microscopia elettronica ad alta risoluzione della trasmissione, la microscopia elettronica a scansione di emissione di campo, la", "bt": "The compound emits red orange fluorescence at around 600 nm and has been studied at maximum intensity at mn2+ doping concentration of 15 a.% and is relatively more stable at low levels of acid and alkaline pH. The structural characteristics and optical properties have been carefully analyzed using the Fourier transform in infrared, X-ray diffraction, dynamic light diffraction, visible ultraviolet and fluorescent spectroscopy.", "questions_src": ["What wavelength does the composite emit orange-red fluorescence around?", "At what doping concentration did the composite show the highest intensity of orange-red fluorescence?", "In what type of pH levels is the composite relatively more stable?", "Which analytical technique was used for structural characteristics analysis?", "Which analytical technique was used for optical property analysis?"], "answers_src": ["600 nm", "15 at. %", "low acidic and low alkaline", "Fourier transform infrared, X-ray diffraction, dynamic light scattering", "ultraviolet-visible, fluorescence spectroscopy"], "answers_bt": ["around 600 nm", "mn2+ doping concentration of 15 a.%", "low levels of acid and alkaline pH.", "Fourier transform infrared", "visible ultraviolet and fluorescent spectroscopy."], "multiturn": {"turn_1": [{"question_id": "202.1", "question": "What wavelength does the composite emit orange-red fluorescence around?", "answer_src": "600 nm", "follow_up_question": "What is the highest doping concentration of Mn2+ that results in the highest intensity of orange-red fluorescence?", "follow_up_response": "15 at. %", "follow_up_response_bt": "15 a. %"}, {"question_id": "202.2", "question": "At what doping concentration did the composite show the highest intensity of orange-red fluorescence?", "answer_src": "15 at. %", "follow_up_question": "At which pH levels was the composite relatively more stable?", "follow_up_response": "low acidic and low alkaline", "follow_up_response_bt": "Low levels of acid and alkaline"}, {"question_id": "202.3", "question": "In what type of pH levels is the composite relatively more stable?", "answer_src": "low acidic and low alkaline", "follow_up_question": "What specific technique was used to analyze the structural characteristics of the composite?", "follow_up_response": "Fourier transform infrared, X-ray diffraction, dynamic light scattering, UV-visible, and fluorescence spectroscopy", "follow_up_response_bt": "Fourier transform infrared"}, {"question_id": "202.4", "question": "Which analytical technique was used for structural characteristics analysis?", "answer_src": "Fourier transform infrared, X-ray diffraction, dynamic light scattering", "follow_up_question": "Which optical property was investigated to the highest intensity?", "follow_up_response": "Orange red fluorescence", "follow_up_response_bt": "Red orange fluorescence"}, {"question_id": "202.5", "question": "Which analytical technique was used for optical property analysis?", "answer_src": "ultraviolet-visible, fluorescence spectroscopy", "follow_up_question": "Which structural characteristic was analyzed using Fourier transform infrared?", "follow_up_response": "Structural characteristics", "follow_up_response_bt": "Structural characteristics"}], "turn_2": [{"question_id": "202.6", "question": "What is the highest doping concentration of Mn2+ that results in the highest intensity of orange-red fluorescence?", "answer_src": "15 at. %", "follow_up_question": "At what pH level is the composite relatively more stable?", "follow_up_response": "low acidic and low alkaline", "follow_up_response_bt": "Low levels of acid and alkaline"}, {"question_id": "202.7", "question": "At which pH levels was the composite relatively more stable?", "answer_src": "low acidic and low alkaline", "follow_up_question": "At what doping concentration of Mn2+ resulted in the highest fluorescence intensity?", "follow_up_response": "15 at.%", "follow_up_response_bt": "15 a.%."}, {"question_id": "202.8", "question": "What specific technique was used to analyze the structural characteristics of the composite?", "answer_src": "Fourier transform infrared, X-ray diffraction, dynamic light scattering, UV-visible, and fluorescence spectroscopy", "follow_up_question": "What type of analysis was performed using thermogravimetric analysis?", "follow_up_response": "Thermal gravimetric", "follow_up_response_bt": "No Answer"}, {"question_id": "202.9", "question": "Which optical property was investigated to the highest intensity?", "answer_src": "Orange red fluorescence", "follow_up_question": "What is the optimal doping concentration for achieving this highest intensity fluorescence?", "follow_up_response": "15 at.%", "follow_up_response_bt": "15 a.%"}, {"question_id": "202.10", "question": "Which structural characteristic was analyzed using Fourier transform infrared?", "answer_src": "Structural characteristics", "follow_up_question": "Which optical property was investigated using ultraviolet-visible spectroscopy?", "follow_up_response": "fluorescence", "follow_up_response_bt": "fluorescent"}], "turn_3": [{"question_id": "202.11", "question": "At what pH level is the composite relatively more stable?", "answer_src": "low acidic and low alkaline", "follow_up_question": "What specific technique was used to analyze the structural characteristics of the composite?", "follow_up_response": "Fourier transform infrared, X-ray diffraction, dynamic light scattering, UV-visible, and fluorescence spectroscopy", "follow_up_response_bt": "Fourier transform infrared"}, {"question_id": "202.12", "question": "At what doping concentration of Mn2+ resulted in the highest fluorescence intensity?", "answer_src": "15 at.%", "follow_up_question": "At which pH levels was the material relatively more stable?", "follow_up_response": "low acidic and low alkaline", "follow_up_response_bt": "Low levels of acid and alkaline"}, {"question_id": "202.13", "question": "What type of analysis was performed using thermogravimetric analysis?", "answer_src": "Thermal gravimetric", "follow_up_question": "What specific property was investigated using x-ray photoelectron spectroscopy?", "follow_up_response": "Optical properties", "follow_up_response_bt": "No Answer"}, {"question_id": "202.14", "question": "What is the optimal doping concentration for achieving this highest intensity fluorescence?", "answer_src": "15 at.%", "follow_up_question": "At what pH levels is the composite relatively more stable?", "follow_up_response": "low acidic and low alkaline", "follow_up_response_bt": "Low levels of acid and alkaline"}, {"question_id": "202.15", "question": "Which optical property was investigated using ultraviolet-visible spectroscopy?", "answer_src": "fluorescence", "follow_up_question": "What is the optimal doping concentration for achieving the highest intensity of the emitted fluorescence?", "follow_up_response": "15 at.%", "follow_up_response_bt": "15 a. %"}]}}
{"id": 203, "src": "food chain information ( fci ) is an innovation of the new european regulation . its purpose is to enhance the concept of food security . fci includes specifications such as : health status , information on treatments and diseases , analytical reports on control plans , zoonoses or environmental contaminants , production performance , etc .", "mt": "L' informazione sulla catena alimentare (fci) è un' innovazione del nuovo regolamento europeo . Il suo scopo è quello di migliorare il concetto di sicurezza alimentare . l' fci include specifiche come: stato sanitario , informazioni sui trattamenti e malattie , rapporti analitici sui piani di controllo , zoonosis o contaminanti ambientali , prestazioni produttive , ecc.", "pert_mt": "L' informazione sulla catena alimentare (FCA) è un' innovazione del nuovo regolamento europeo. Il suo scopo è quello di migliorare il concetto di sicurezza alimentare. L' FCA include specifiche come: stato sanitario, informazioni sui trattamenti e malattie, rapporti analitici sui piani di controllo, zoonosi o contaminanti ambientali, prestazioni produttive, e valutazioni ambientali.", "bt": "Food chain information (FCA) is an innovation of the new European regulation, which aims to improve the concept of food safety.The FCA includes specifications such as: health status, information on treatments and diseases, analytical reports on control plans, zoonoses or environmental contaminants, production performance, and environmental assessments.", "questions_src": ["What is the name of the innovation that enhances food security?", "When was the New European Regulation implemented?", "Which concepts does FCI include specifications for?", "Who is responsible for ensuring the health status of food products under FCI?", "Where can one find information on treatments and diseases related to food products under FCI?"], "answers_src": ["food chain information (fci)", "No Answer", "health status, information on treatments and diseases, analytical reports on control plans, zoonoses or environmental contaminants, production performance", "No Answer", "information on treatments and diseases"], "answers_bt": ["Food chain information (FCA)", "No Answer", "health status, information on treatments and diseases, analytical reports on control plans, zoonoses or environmental contaminants, production performance, and environmental assessments", "Producers and regulatory bodies", "Information on treatments and diseases related to food products"], "multiturn": {"turn_1": [{"question_id": "203.1", "question": "What is the name of the innovation that enhances food security?", "answer_src": "food chain information (fci)", "follow_up_question": "What aspects does fci include according to the text?", "follow_up_response": "health status, information on treatments and diseases, analytical reports on control plans, zoonoses or environmental contaminants, production performance, etc.", "follow_up_response_bt": "health status, information on treatments and diseases, analytical reports on control plans, zoonoses or environmental contaminants, production performance, and environmental assessments"}, {"question_id": "203.2", "question": "When was the New European Regulation implemented?", "answer_src": "food chain information ( fci ) is an innovation of the new european regulation . its purpose is to enhance the concept of food security . fci includes specifications such as : health status , information on treatments and diseases , analytical reports on control plans , zoonoses or environmental contaminants , production performance , etc .", "follow_up_question": "What aspects does FCI include?", "follow_up_response": "health status, information on treatments and diseases, analytical reports on control plans, zoonoses or environmental contaminants, production performance, etc.", "follow_up_response_bt": "Health status, information on treatments and diseases, analytical reports on control plans, zoonoses or environmental contaminants, production performance, and environmental assessments"}, {"question_id": "203.3", "question": "Which concepts does FCI include specifications for?", "answer_src": "health status, information on treatments and diseases, analytical reports on control plans, zoonoses or environmental contaminants, production performance", "follow_up_question": "What specific type of reports does FCI require for environmental contaminants?", "follow_up_response": "Environmental contaminants", "follow_up_response_bt": "Environmental assessments"}, {"question_id": "203.4", "question": "Who is responsible for ensuring the health status of food products under FCI?", "answer_src": "food chain information ( fci ) is an innovation of the new european regulation . its purpose is to enhance the concept of food security . fci includes specifications such as : health status , information on treatments and diseases , analytical reports on control plans , zoonoses or environmental contaminants , production performance , etc .", "follow_up_question": "What specific type of information does FCI require regarding treatments and diseases?", "follow_up_response": "information on treatments and diseases", "follow_up_response_bt": "Information on treatments and diseases"}, {"question_id": "203.5", "question": "Where can one find information on treatments and diseases related to food products under FCI?", "answer_src": "information on treatments and diseases", "follow_up_question": "What types of analytical reports are included under FCI besides treatments and diseases?", "follow_up_response": "analytical reports on control plans, zoonoses or environmental contaminants\", \"production performance", "follow_up_response_bt": "analytical reports on control plans, zoonoses or environmental contaminants"}], "turn_2": [{"question_id": "203.6", "question": "What aspects does fci include according to the text?", "answer_src": "health status, information on treatments and diseases, analytical reports on control plans, zoonoses or environmental contaminants, production performance, etc.", "follow_up_question": "What specific type of reports does fci require for environmental contaminants?", "follow_up_response": "analytical reports", "follow_up_response_bt": "Analytical reports"}, {"question_id": "203.7", "question": "What aspects does FCI include?", "answer_src": "health status, information on treatments and diseases, analytical reports on control plans, zoonoses or environmental contaminants, production performance, etc.", "follow_up_question": "What specific type of reports does FCI require for environmental contaminants?", "follow_up_response": "Environmental contaminants", "follow_up_response_bt": "Environmental assessments"}, {"question_id": "203.8", "question": "What specific type of reports does FCI require for environmental contaminants?", "answer_src": "Environmental contaminants", "follow_up_question": "What kind of information must producers provide regarding their health status according to FCI?", "follow_up_response": "Health status", "follow_up_response_bt": "Health status"}, {"question_id": "203.9", "question": "What specific type of information does FCI require regarding treatments and diseases?", "answer_src": "information on treatments and diseases", "follow_up_question": "Analytical reports on what types of control plans are included in FCI?", "follow_up_response": "control plans", "follow_up_response_bt": "control plans"}, {"question_id": "203.10", "question": "What types of analytical reports are included under FCI besides treatments and diseases?", "answer_src": "analytical reports on control plans, zoonoses or environmental contaminants\", \"production performance", "follow_up_question": "What does \"production performance\" include according to FCI?", "follow_up_response": "production performance", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "203.11", "question": "What specific type of reports does fci require for environmental contaminants?", "answer_src": "analytical reports", "follow_up_question": "What other types of information does fci require besides health status and production performance?", "follow_up_response": "information on treatments and diseases , analytical reports on control plans , zoonoses or environmental contaminants", "follow_up_response_bt": "information on treatments and diseases, analytical reports on control plans, zoonoses or environmental contaminants, environmental assessments"}, {"question_id": "203.12", "question": "What specific type of reports does FCI require for environmental contaminants?", "answer_src": "Environmental contaminants", "follow_up_question": "What kind of information must producers provide regarding their health status according to FCI?", "follow_up_response": "Health status", "follow_up_response_bt": "Health status"}, {"question_id": "203.13", "question": "What kind of information must producers provide regarding their health status according to FCI?", "answer_src": "Health status", "follow_up_question": "What specific types of treatments and diseases must producers disclose under FCI?", "follow_up_response": "information on treatments and diseases", "follow_up_response_bt": "Information on treatments and diseases"}, {"question_id": "203.14", "question": "Analytical reports on what types of control plans are included in FCI?", "answer_src": "control plans", "follow_up_question": "What specific types of environmental contaminants does FCI include in its specifications?", "follow_up_response": "environmental contaminants", "follow_up_response_bt": "Environmental contaminants"}, {"question_id": "203.15", "question": "What does \"production performance\" include according to FCI?", "answer_src": "production performance", "follow_up_question": "What types of information are included in analytical reports under FCI?", "follow_up_response": "Analytical reports on control plans, zoonoses or environmental contaminants", "follow_up_response_bt": "Analytical reports on control plans, zoonoses or environmental contaminants"}]}}
{"id": 204, "src": "randomized studies have shown different magnitude of bevacizumab benefit in the treatment of advanced breast cancer . regulatory agencies have modified bevacizumab treatment indications across different regions . in this study , we perform a meta - analysis of phase iii studies aiming to interrogate the magnitude of bevacizumab benefit for the treatment of first - line her2-negative metastatic breast cancer ( mbc ) .", "mt": "Studi randomizzati hanno mostrato diverse dimensioni di beneficio da bevacizumab nel trattamento del cancro al seno avanzato . Le agenzie di regolamentazione hanno modificato le indicazioni di trattamento da bevacizumab in diverse regioni . in questo studio , eseguiamo una meta-analisi degli studi di fase iii finalizzati a interrogare la dimensione del beneficio da bevacizumab per il trattamento del cancro al seno metastatico metastatico (mbc) di prima linea her2-negativo .", "pert_mt": "Studi randomizzati hanno mostrato diverse dimensioni di beneficio da bevacizumab nel trattamento del cancro al seno avanzato. Le agenzie di regolamentazione hanno modificato le indicazioni di trattamento da bevacizumab in diverse regioni. In questo studio, eseguiamo una meta-analisi degli studi di fase iii finalizzati a interrogare la dimensione del beneficio da bevacizumab per il trattamento del cancro al seno metastatico metastatico (mbc) di prima linea her2-negativo e scopriamo che i risultati sono contrastanti.", "bt": "Randomized studies have shown various dimensions of bevacizumab's benefit in the treatment of advanced breast cancer, regulatory agencies have modified the indications for bevacizumab treatment in different regions, and in this study we conduct a meta-analysis of phase iii studies aimed at questioning the extent of bevacizumab's benefit in the treatment of her2-negative first-line metastatic breast cancer (mbc) and find that the results are conflicting.", "questions_src": ["What is the main focus of the study mentioned in the sentence?", "Who has modified bevacizumab treatment indications across different regions?", "Where was the meta-analysis performed?", "When were randomized studies conducted regarding bevacizumab?", "Which type of breast cancer is the meta-analysis focused on?"], "answers_src": ["[\"A meta-analysis of phase III studies\"], [\"regulatory agencies\"], [\"in this study\"], [\"randomized studies\"], [\"first-line HER2-negative metastatic breast cancer (mBC)\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"The extent of bevacizumab\"s benefit in the treatment of her2-negative first-line metastatic breast cancer (mbc)\", \"Regulatory agencies\", \"In this study\", \"Randomized studies\", \"Her2-negative first-line metastatic breast cancer (mbc)\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "204.1", "question": "What is the main focus of the study mentioned in the sentence?", "answer_src": "[\"A meta-analysis of phase III studies\"], [\"regulatory agencies\"], [\"in this study\"], [\"randomized studies\"], [\"first-line HER2-negative metastatic breast cancer (mBC)\"]", "follow_up_question": "What type of breast cancer does the meta-analysis specifically target?", "follow_up_response": "first - line her2-negative metastatic breast cancer ( mbc ) ", "follow_up_response_bt": "her2-negative first-line metastatic breast cancer (mbc)"}, {"question_id": "204.2", "question": "Who has modified bevacizumab treatment indications across different regions?", "answer_src": "randomized studies have shown different magnitude of bevacizumab benefit in the treatment of advanced breast cancer . regulatory agencies have modified bevacizumab treatment indications across different regions . in this study , we perform a meta - analysis of phase iii studies aiming to interrogate the magnitude of bevacizumab benefit for the treatment of first - line her2-negative metastatic breast cancer ( mbc ) .", "follow_up_question": "What specific regions have had their bevacizumab treatment indications modified?", "follow_up_response": "Different regions", "follow_up_response_bt": "Different regions"}, {"question_id": "204.3", "question": "Where was the meta-analysis performed?", "answer_src": "randomized studies have shown different magnitude of bevacizumab benefit in the treatment of advanced breast cancer . regulatory agencies have modified bevacizumab treatment indications across different regions . in this study , we perform a meta - analysis of phase iii studies aiming to interrogate the magnitude of bevacizumab benefit for the treatment of first - line her2-negative metastatic breast cancer ( mbc ) .", "follow_up_question": "What type of studies were analyzed in the meta-analysis?", "follow_up_response": "phase iii studies", "follow_up_response_bt": "phase iii studies"}, {"question_id": "204.4", "question": "When were randomized studies conducted regarding bevacizumab?", "answer_src": "randomized studies have shown different magnitude of bevacizumab benefit in the treatment of advanced breast cancer . regulatory agencies have modified bevacizumab treatment indications across different regions . in this study , we perform a meta - analysis of phase iii studies aiming to interrogate the magnitude of bevacizumab benefit for the treatment of first - line her2-negative metastatic breast cancer ( mbc ) .", "follow_up_question": "What type of studies does the meta-analysis in this study aim to examine?", "follow_up_response": "phase iii studies", "follow_up_response_bt": "phase iii studies"}, {"question_id": "204.5", "question": "Which type of breast cancer is the meta-analysis focused on?", "answer_src": "randomized studies have shown different magnitude of bevacizumab benefit in the treatment of advanced breast cancer . regulatory agencies have modified bevacizumab treatment indications across different regions . in this study , we perform a meta - analysis of phase iii studies aiming to interrogate the magnitude of bevacizumab benefit for the treatment of first - line her2-negative metastatic breast cancer ( mbc ) .", "follow_up_question": "What is the abbreviation \"mbc\" in the context of the study?", "follow_up_response": "metastatic breast cancer", "follow_up_response_bt": "metastatic breast cancer"}], "turn_2": [{"question_id": "204.6", "question": "What type of breast cancer does the meta-analysis specifically target?", "answer_src": "first - line her2-negative metastatic breast cancer ( mbc ) ", "follow_up_question": "What is the primary goal of the meta-analysis described in the study?", "follow_up_response": "To interrogate the magnitude of bevacizumab benefit for the treatment of first-line HER2-negative metastatic breast cancer (mBC)", "follow_up_response_bt": "To question the extent of bevacizumab's benefit in the treatment of her2-negative first-line metastatic breast cancer"}, {"question_id": "204.7", "question": "What specific regions have had their bevacizumab treatment indications modified?", "answer_src": "Different regions", "follow_up_question": "What were the specific modifications made to bevacizumab treatment indications in these regions?", "follow_up_response": "regulatory agencies", "follow_up_response_bt": "regulatory agencies have modified the indications"}, {"question_id": "204.8", "question": "What type of studies were analyzed in the meta-analysis?", "answer_src": "phase iii studies", "follow_up_question": "What specific outcomes did the phase iii studies investigate in their analyses?", "follow_up_response": "the magnitude of bevacizumab benefit for the treatment of first-line HER2-negative metastatic breast cancer (mBC)", "follow_up_response_bt": "the extent of bevacizumab's benefit in the treatment of her2-negative first-line metastatic breast cancer (mbc)"}, {"question_id": "204.9", "question": "What type of studies does the meta-analysis in this study aim to examine?", "answer_src": "phase iii studies", "follow_up_question": "What is the primary focus of the meta-analysis in terms of breast cancer subtypes?", "follow_up_response": "her2-negative", "follow_up_response_bt": "her2-negative first-line metastatic breast cancer"}, {"question_id": "204.10", "question": "What is the abbreviation \"mbc\" in the context of the study?", "answer_src": "metastatic breast cancer", "follow_up_question": "What specific phase III studies were included in your meta-analysis?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "204.11", "question": "What is the primary goal of the meta-analysis described in the study?", "answer_src": "To interrogate the magnitude of bevacizumab benefit for the treatment of first-line HER2-negative metastatic breast cancer (mBC)", "follow_up_question": "How many phases of the studies included in the meta-analysis were randomized?", "follow_up_response": "3", "follow_up_response_bt": "3"}, {"question_id": "204.12", "question": "What were the specific modifications made to bevacizumab treatment indications in these regions?", "answer_src": "regulatory agencies", "follow_up_question": "What regions saw modifications in bevacizumab treatment indications?", "follow_up_response": "Different regions", "follow_up_response_bt": "Different regions"}, {"question_id": "204.13", "question": "What specific outcomes did the phase iii studies investigate in their analyses?", "answer_src": "the magnitude of bevacizumab benefit for the treatment of first-line HER2-negative metastatic breast cancer (mBC)", "follow_up_question": "What phase iii studies were included in the meta-analysis?", "follow_up_response": "Phase III studies", "follow_up_response_bt": "phase iii studies aimed at questioning the extent of bevacizumab's benefit in the treatment of her2-negative first-line metastatic breast cancer (mbc)"}, {"question_id": "204.14", "question": "What is the primary focus of the meta-analysis in terms of breast cancer subtypes?", "answer_src": "her2-negative", "follow_up_question": "What phase III studies were included in the meta-analysis?", "follow_up_response": "No Answer", "follow_up_response_bt": "phase iii studies"}, {"question_id": "204.15", "question": "What specific phase III studies were included in your meta-analysis?", "answer_src": "randomized studies have shown different magnitude of bevacizumab benefit in the treatment of advanced breast cancer . regulatory agencies have modified bevacizumab treatment indications across different regions . in this study , we perform a meta - analysis of phase iii studies aiming to interrogate the magnitude of bevacizumab benefit for the treatment of first - line her2-negative metastatic breast cancer ( mbc ) .", "follow_up_question": "What is the primary focus of your meta-analysis regarding bevacizumab?", "follow_up_response": "The magnitude of bevacizumab benefit for the treatment of first-line HER2-negative metastatic breast cancer (mBC)", "follow_up_response_bt": "the extent of bevacizumab's benefit in the treatment of her2-negative first-line metastatic breast cancer (mbc)"}]}}
{"id": 205, "src": "recent work demonstrates that retention of a single functional retinoblastoma susceptibility ( rb1 ) allele is insufficient to maintain genome stability . haploinsufficiency of rb1 accelerates cancer pathogenesis in concert with inactivation of tumor protein p53 . collectively , multiple lines of evidence suggest revision of the 2-hit model to include conditional haploinsufficiency of rb1 .", "mt": "Recenti ricerche dimostrano che la conservazione di un singolo allele funzionale di sensibilità al retinoblastoma (rb1 ) è insufficiente per mantenere la stabilità del genoma . L'appionsuficienza di rb1 accelera la patogenesi tumorale in concertazione con l'inaattivazione della proteina tumorale p53 . Collettivamente , molteplici prove suggeriscono la revisione del modello 2-hit per includere l'appionsuficienza condizionale di rb1 .", "pert_mt": "Recenti ricerche dimostrano che la conservazione di un singolo allele funzionale di sensibilità al retinoblastoma (rb1) è insufficiente per mantenere la stabilità del genoma. L'appionsuficienza di rb1 accelera la patogenesi tumorale in concertazione con l'inaattivazione della proteina tumorale p53. Collettivamente, molteplici prove suggeriscono la revisione del modello 2-hit per includere l'appionsuficienza condizionale di rb1 e il suo ruolo nel promuovere la resistenza alla terapia.", "bt": "Recent research shows that the preservation of a single functional allele of retinoblastoma sensitivity (rb1) is insufficient to maintain the stability of the genome.Rb1 appionsuficiency accelerates tumor pathogenesis in concertation with the inactivation of tumor protein p53.Collectively, multiple evidence suggests revising the 2-hit model to include rb1 conditional appionsuficiency and its role in promoting resistance to therapy.", "questions_src": ["What is the term for the loss of one functional RB1 allele that affects genome stability?", "Who accelerates cancer pathogenesis according to the sentence, tumor protein p53 or haploinsufficiency of RB1?", "Where does the recent work focus on the RB1 gene and its role in cancer?", "When was it demonstrated that retention of a single RB1 allele is insufficient for genome stability?", "Which model may need to be revised based on the findings, the 2-hit model or another model?"], "answers_src": ["haploinsufficiency of RB1", "haploinsufficiency of RB1", "cancer", "recent work", "2-hit model"], "answers_bt": ["haploinsufficiency of RB1", "haploinsufficiency of RB1", "retina", "Recent research", "the 2-hit model"], "multiturn": {"turn_1": [{"question_id": "205.1", "question": "What is the term for the loss of one functional RB1 allele that affects genome stability?", "answer_src": "haploinsufficiency of RB1", "follow_up_question": "What additional condition must occur in conjunction with haploinsufficiency of RB1 to accelerate cancer pathogenesis?", "follow_up_response": "Inactivation of tumor protein p53", "follow_up_response_bt": "The inactivation of tumor protein p53"}, {"question_id": "205.2", "question": "Who accelerates cancer pathogenesis according to the sentence, tumor protein p53 or haploinsufficiency of RB1?", "answer_src": "haploinsufficiency of RB1", "follow_up_question": "What other factor, besides haploinsufficiency of RB1, is required for accelerated cancer pathogenesis?", "follow_up_response": "tumor protein p53", "follow_up_response_bt": "the inactivation of tumor protein p53"}, {"question_id": "205.3", "question": "Where does the recent work focus on the RB1 gene and its role in cancer?", "answer_src": "cancer", "follow_up_question": "What specific condition does haploinsufficiency of RB1 accelerate in cancer?", "follow_up_response": "tumor protein p53", "follow_up_response_bt": "tumor pathogenesis"}, {"question_id": "205.4", "question": "When was it demonstrated that retention of a single RB1 allele is insufficient for genome stability?", "answer_src": "recent work", "follow_up_question": "What specific condition accelerates cancer pathogenesis in conjunction with inactivating TP53?", "follow_up_response": "haploinsufficiency of rb1", "follow_up_response_bt": "Rb1 appionsuficiency"}, {"question_id": "205.5", "question": "Which model may need to be revised based on the findings, the 2-hit model or another model?", "answer_src": "2-hit model", "follow_up_question": "What additional factor must be considered alongside haploinsufficiency of RB1 in the revised model?", "follow_up_response": "tumor protein p53", "follow_up_response_bt": "Tumor protein p53"}], "turn_2": [{"question_id": "205.6", "question": "What additional condition must occur in conjunction with haploinsufficiency of RB1 to accelerate cancer pathogenesis?", "answer_src": "Inactivation of tumor protein p53", "follow_up_question": "What other mechanism, besides tumor protein p53 inactivation, contributes to accelerated cancer pathogenesis when RB1 is haploinsufficient?", "follow_up_response": "tumor protein p53", "follow_up_response_bt": "Collective evidence suggests revising the 2-hit model to include rb1 conditional haploinsufficiency and its role in promoting resistance to therapy."}, {"question_id": "205.7", "question": "What other factor, besides haploinsufficiency of RB1, is required for accelerated cancer pathogenesis?", "answer_src": "tumor protein p53", "follow_up_question": "What role does tumor protein p53 play in conjunction with haploinsufficiency of RB1?", "follow_up_response": "accelerates cancer pathogenesis", "follow_up_response_bt": "accelerates tumor pathogenesis"}, {"question_id": "205.8", "question": "What specific condition does haploinsufficiency of RB1 accelerate in cancer?", "answer_src": "tumor protein p53", "follow_up_question": "How does haploinsufficiency of RB1 contribute to tumor development when p53 is also inactivated?", "follow_up_response": "Haploinsufficiency of RB1 accelerates cancer pathogenesis in concert with inactivation of tumor protein p53.", "follow_up_response_bt": "Rb1 haploinsufficiency accelerates tumor pathogenesis in concertation with the inactivation of tumor protein p53"}, {"question_id": "205.9", "question": "What specific condition accelerates cancer pathogenesis in conjunction with inactivating TP53?", "answer_src": "haploinsufficiency of rb1", "follow_up_question": "What other factor, besides haploinsufficiency of RB1, is suggested by the text to accelerate cancer pathogenesis?", "follow_up_response": "tumor protein p53", "follow_up_response_bt": "tumor protein p53"}, {"question_id": "205.10", "question": "What additional factor must be considered alongside haploinsufficiency of RB1 in the revised model?", "answer_src": "tumor protein p53", "follow_up_question": "What role does tumor protein p53 play when RB1 is haploinsufficient?", "follow_up_response": "accelerates cancer pathogenesis", "follow_up_response_bt": "accelerates tumor pathogenesis"}], "turn_3": [{"question_id": "205.11", "question": "What other mechanism, besides tumor protein p53 inactivation, contributes to accelerated cancer pathogenesis when RB1 is haploinsufficient?", "answer_src": "tumor protein p53", "follow_up_question": "What additional condition must be inactivated in conjunction with haploinsufficiency of RB1 to accelerate cancer pathogenesis?", "follow_up_response": "tumor protein p53", "follow_up_response_bt": "Tumor protein p53"}, {"question_id": "205.12", "question": "What role does tumor protein p53 play in conjunction with haploinsufficiency of RB1?", "answer_src": "accelerates cancer pathogenesis", "follow_up_question": "How does haploinsufficiency of RB1 contribute to cancer pathogenesis?", "follow_up_response": "Accelerates cancer pathogenesis in concert with inactivation of tumor protein p53", "follow_up_response_bt": "Rb1 haploinsufficiency accelerates tumor pathogenesis in concertation with the inactivation of tumor protein p53."}, {"question_id": "205.13", "question": "How does haploinsufficiency of RB1 contribute to tumor development when p53 is also inactivated?", "answer_src": "Haploinsufficiency of RB1 accelerates cancer pathogenesis in concert with inactivation of tumor protein p53.", "follow_up_question": "What role does the 2-hit model play in light of the new findings?", "follow_up_response": "Revision of the 2-hit model", "follow_up_response_bt": "Revising the 2-hit model"}, {"question_id": "205.14", "question": "What other factor, besides haploinsufficiency of RB1, is suggested by the text to accelerate cancer pathogenesis?", "answer_src": "tumor protein p53", "follow_up_question": "What role does conditional haploinsufficiency of RB1 play according to the text?", "follow_up_response": "accelerate cancer pathogenesis", "follow_up_response_bt": "accelerates tumor pathogenesis"}, {"question_id": "205.15", "question": "What role does tumor protein p53 play when RB1 is haploinsufficient?", "answer_src": "accelerates cancer pathogenesis", "follow_up_question": "How does haploinsufficiency of RB1 contribute to cancer pathogenesis?", "follow_up_response": "Accelerates cancer pathogenesis in concert with inactivation of tumor protein p53", "follow_up_response_bt": "Rb1 haploinsufficiency accelerates tumor pathogenesis in concertation with the inactivation of tumor protein p53."}]}}
{"id": 206, "src": "this research takes place in the s(ma)2d project which proposes software architecture to monitor elderly people in their own homes . we want to build patterns dynamically from data about activity , movements , and physiological information of the monitored people . to achieve that , we propose a multiagent method of classification : every agent has a simple know - how of classification .", "mt": "Questa ricerca si svolge nel progetto s(ma)2d che propone un'architettura software per monitorare gli anziani nelle loro case . Vogliamo costruire modelli dinamicamente a partire da dati sull'attività , i movimenti e le informazioni fisiologiche delle persone monitorate . Per raggiungere questo obiettivo , proponiamo un metodo multi-agente di classificazione: ogni agente ha una semplice conoscenza della classificazione .", "pert_mt": "Questa ricerca si svolge nel progetto s(ma)2d che propone un'architettura software per monitorare gli anziani nelle loro case. Vogliamo costruire modelli dinamicamente a partire da dati sull'attività, i movimenti e le informazioni fisiologiche delle persone monitorate. Per raggiungere questo obiettivo, proponiamo un metodo multi-agente di classificazione: ogni agente ha una semplice conoscenza della classificazione e dei requisiti legali.", "bt": "This research is being carried out in the project s) ma2d which proposes a software architecture to monitor the elderly in their homes.We want to build models dynamically based on activity data, movements and physiological information of the people monitored.To achieve this goal, we propose a multi-agent classification method: each agent has a simple knowledge of the classification and legal requirements.", "questions_src": ["What is the name of the project that this research takes place in?", "Who do you want to build patterns dynamically from data about?", "Where does the research take place?", "Which method of classification do you propose for building patterns dynamically?", "Which agents have simple know-how of classification?"], "answers_src": ["s(ma)2d project", "activity, movements, and physiological information of the monitored people", "in their own homes", "multiagent method of classification", "every agent"], "answers_bt": ["[\"ma2d\"], [\"the people monitored\"], [\"in their homes\"], [\"a multi-agent classification method\"], [\"each agent\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "206.1", "question": "What is the name of the project that this research takes place in?", "answer_src": "s(ma)2d project", "follow_up_question": "What specific types of data does the project aim to collect from the monitored people?", "follow_up_response": "activity\", \"movements\", \"physiological information", "follow_up_response_bt": "Activity data, movements and physiological information"}, {"question_id": "206.2", "question": "Who do you want to build patterns dynamically from data about?", "answer_src": "activity, movements, and physiological information of the monitored people", "follow_up_question": "What kind of information does each agent have a simple know-how of?", "follow_up_response": "classification", "follow_up_response_bt": "Classification and legal requirements"}, {"question_id": "206.3", "question": "Where does the research take place?", "answer_src": "in their own homes", "follow_up_question": "What kind of data do they want to build patterns dynamically from?", "follow_up_response": "activity\", \"movements\", \"physiological information", "follow_up_response_bt": "Activity data, movements and physiological information"}, {"question_id": "206.4", "question": "Which method of classification do you propose for building patterns dynamically?", "answer_src": "multiagent method of classification", "follow_up_question": "What is the role of each agent in the multiagent method?", "follow_up_response": "Every agent has a simple know-how of classification.", "follow_up_response_bt": "Each agent has a simple knowledge of the classification and legal requirements."}, {"question_id": "206.5", "question": "Which agents have simple know-how of classification?", "answer_src": "every agent", "follow_up_question": "What is the simple know-how possessed by each agent?", "follow_up_response": "A simple know-how of classification", "follow_up_response_bt": "simple knowledge of the classification and legal requirements"}], "turn_2": [{"question_id": "206.6", "question": "What specific types of data does the project aim to collect from the monitored people?", "answer_src": "activity\", \"movements\", \"physiological information", "follow_up_question": "What kind of classification knowledge do the agents have?", "follow_up_response": "simple know-how of classification", "follow_up_response_bt": "simple"}, {"question_id": "206.7", "question": "What kind of information does each agent have a simple know-how of?", "answer_src": "classification", "follow_up_question": "What specific types of data do the agents use for classification?", "follow_up_response": "activity\", \"movements\", \"physiological information", "follow_up_response_bt": "activity data, movements and physiological information"}, {"question_id": "206.8", "question": "What kind of data do they want to build patterns dynamically from?", "answer_src": "activity\", \"movements\", \"physiological information", "follow_up_question": "What specific type of classification knowledge does each agent have?", "follow_up_response": "simple know-how of classification", "follow_up_response_bt": "simple knowledge of the classification"}, {"question_id": "206.9", "question": "What is the role of each agent in the multiagent method?", "answer_src": "Every agent has a simple know-how of classification.", "follow_up_question": "How many agents are there in the multiagent method?", "follow_up_response": "1", "follow_up_response_bt": "No Answer"}, {"question_id": "206.10", "question": "What is the simple know-how possessed by each agent?", "answer_src": "A simple know-how of classification", "follow_up_question": "What specific types of data do the agents use to classify the patterns?", "follow_up_response": "activity\", \"movements\", \"physiological information", "follow_up_response_bt": "activity data, movements and physiological information"}], "turn_3": [{"question_id": "206.11", "question": "What kind of classification knowledge do the agents have?", "answer_src": "simple know-how of classification", "follow_up_question": "What specific types of data do the agents use to classify the behavior?", "follow_up_response": "activity\", \"movements\", \"physiological information", "follow_up_response_bt": "activity data, movements and physiological information"}, {"question_id": "206.12", "question": "What specific types of data do the agents use for classification?", "answer_src": "activity\", \"movements\", \"physiological information", "follow_up_question": "What kind of simple knowledge do the agents have for classification?", "follow_up_response": "simple know-how of classification", "follow_up_response_bt": "simple knowledge of the classification"}, {"question_id": "206.13", "question": "What specific type of classification knowledge does each agent have?", "answer_src": "simple know-how of classification", "follow_up_question": "What kind of data do these agents use to apply their classification knowledge?", "follow_up_response": "activity\", \"movements\", \"physiological information", "follow_up_response_bt": "activity data, movements and physiological information"}, {"question_id": "206.14", "question": "How many agents are there in the multiagent method?", "answer_src": "1", "follow_up_question": "How many types of data does each agent have simple knowledge about?", "follow_up_response": "1", "follow_up_response_bt": "activity, movements, physiological information"}, {"question_id": "206.15", "question": "What specific types of data do the agents use to classify the patterns?", "answer_src": "activity\", \"movements\", \"physiological information", "follow_up_question": "What kind of classification knowledge does each agent have?", "follow_up_response": "simple know-how of classification", "follow_up_response_bt": "simple"}]}}
{"id": 207, "src": "backgroundthe aim of this prospective clinical study was to evaluate the clinical importance of vestibular - evoked myogenic potentials ( vemps ) in the assessment and differential diagnosis of otosclerosis and otologic diseases characterized by pseudo - conductive components . we also investigated the clinical appearance of balance disorders in patients with otosclerosis by correlating vemp results with the findings of caloric testing and pure tone audiometry(pta).material / methodsair - conducted(ac ) 4-pta , bone - conducted(bc ) 4-pta , air - bone gap(abg ) , ac , bc tone burst evoked vemp , and calorics were measured preoperatively in 126 otosclerotic ears.resultsthe response rate of the ac - vemps and bc - vemps was 29.36% and 44.03% , respectively . statistical differences were found between the means of abg , ac 4-pta , and bc 4-pta in the otosclerotic ears in relation to ac - vemp elicitability .", "mt": "L'obiettivo di questo prospectivo studio clinico era valutare l'importanza clinica dei potenziali miogenici (vemps) evokati vestibulari nella valutazione e nella diagnosi differenziale di otosclerosi e malattie otologiche caratterizzate da componenti pseudo-conduttive . Abbiamo anche studiato l'aspetto clinico di disturbi di equilibrio nei pazienti con otosclerosi correlazionando i risultati di vemp con i risultati di caloriche e audiometria del tono puro .", "pert_mt": "L'obiettivo di questo prospectivo studio clinico era valutare l'importanza clinica dei potenziali miogenici (vemps) evokati vestibulari nella valutazione e nella diagnosi differenziale di otosclerosi e malattie otologiche caratterizzate da componenti pseudo-conduttive. Abbiamo anche studiato l'aspetto clinico di disturbi di equilibrio nei pazienti con otosclerosi correlazionando i risultati di vemp con i risultati di caloriche, elettromiografia del muscolo facciale, e audiometria del tono puro.", "bt": "The aim of this prospective clinical study was to evaluate the clinical importance of potentially myogenic (vemps) vestibular evokations in the evaluation and differential diagnosis of otosclerosis and otological diseases characterized by pseudo-conducting components.We also studied the clinical aspect of balance disorders in patients with otosclerosis by correlating vemp results with calorie results, facial muscle electromyography, and pure tone audiometry.", "questions_src": ["What is the aim of the prospective clinical study?", "Who were the participants in the study?", "What types of tests were measured preoperatively in the otosclerotic ears?", "When was the study conducted?", "Which two vestibular-evoked myogenic potentials had the highest response rates?"], "answers_src": ["[\"To evaluate the clinical importance of vestibular-evoked myogenic potentials (VEMPs) in the assessment and differential diagnosis of otosclerosis and otologic diseases characterized by pseudo-conductive components\"], [\"126 otosclerotic ears\"], [\"ac - VEMPs and bc - VEMPs\"], [\"Preoperatively\"], [\"ac - VEMPs and bc - VEMPs\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["To evaluate the clinical importance of potentially myogenic (vemps) vestibular evokations in the evaluation and differential diagnosis of otosclerosis and otological diseases characterized by pseudo-conducting components", "Patients with otosclerosis", "VEMP and caloric tests", "Prospective", "VEMPs"], "multiturn": {"turn_1": [{"question_id": "207.1", "question": "What is the aim of the prospective clinical study?", "answer_src": "[\"To evaluate the clinical importance of vestibular-evoked myogenic potentials (VEMPs) in the assessment and differential diagnosis of otosclerosis and otologic diseases characterized by pseudo-conductive components\"], [\"126 otosclerotic ears\"], [\"ac - VEMPs and bc - VEMPs\"], [\"Preoperatively\"], [\"ac - VEMPs and bc - VEMPs\"]", "follow_up_question": "What percentage of otosclerotic ears had a response to the air-conducted VEMP measurements?", "follow_up_response": "29.36%", "follow_up_response_bt": "No Answer"}, {"question_id": "207.2", "question": "Who were the participants in the study?", "answer_src": "backgroundthe aim of this prospective clinical study was to evaluate the clinical importance of vestibular - evoked myogenic potentials ( vemps ) in the assessment and differential diagnosis of otosclerosis and otologic diseases characterized by pseudo - conductive components . we also investigated the clinical appearance of balance disorders in patients with otosclerosis by correlating vemp results with the findings of caloric testing and pure tone audiometry(pta).material / methodsair - conducted(ac ) 4-pta , bone - conducted(bc ) 4-pta , air - bone gap(abg ) , ac , bc tone burst evoked vemp , and calorics were measured preoperatively in 126 otosclerotic ears.resultsthe response rate of the ac - vemps and bc - vemps was 29.36% and 44.03% , respectively . statistical differences were found between the means of abg , ac 4-pta , and bc 4-pta in the otosclerotic ears in relation to ac - vemp elicitability .", "follow_up_question": "What percentage of the otosclerotic ears had a response to the bone-conducted VEMPs?", "follow_up_response": "44.03%", "follow_up_response_bt": "No Answer"}, {"question_id": "207.3", "question": "What types of tests were measured preoperatively in the otosclerotic ears?", "answer_src": "backgroundthe aim of this prospective clinical study was to evaluate the clinical importance of vestibular - evoked myogenic potentials ( vemps ) in the assessment and differential diagnosis of otosclerosis and otologic diseases characterized by pseudo - conductive components . we also investigated the clinical appearance of balance disorders in patients with otosclerosis by correlating vemp results with the findings of caloric testing and pure tone audiometry(pta).material / methodsair - conducted(ac ) 4-pta , bone - conducted(bc ) 4-pta , air - bone gap(abg ) , ac , bc tone burst evoked vemp , and calorics were measured preoperatively in 126 otosclerotic ears.resultsthe response rate of the ac - vemps and bc - vemps was 29.36% and 44.03% , respectively . statistical differences were found between the means of abg , ac 4-pta , and bc 4-pta in the otosclerotic ears in relation to ac - vemp elicitability .", "follow_up_question": "What percentage of otosclerotic ears had a response to the bone-conducted vestibular-evoked myogenic potentials (bc - vemps)?", "follow_up_response": "44.03%", "follow_up_response_bt": "No Answer"}, {"question_id": "207.4", "question": "When was the study conducted?", "answer_src": "backgroundthe aim of this prospective clinical study was to evaluate the clinical importance of vestibular - evoked myogenic potentials ( vemps ) in the assessment and differential diagnosis of otosclerosis and otologic diseases characterized by pseudo - conductive components . we also investigated the clinical appearance of balance disorders in patients with otosclerosis by correlating vemp results with the findings of caloric testing and pure tone audiometry(pta).material / methodsair - conducted(ac ) 4-pta , bone - conducted(bc ) 4-pta , air - bone gap(abg ) , ac , bc tone burst evoked vemp , and calorics were measured preoperatively in 126 otosclerotic ears.resultsthe response rate of the ac - vemps and bc - vemps was 29.36% and 44.03% , respectively . statistical differences were found between the means of abg , ac 4-pta , and bc 4-pta in the otosclerotic ears in relation to ac - vemp elicitability .", "follow_up_question": "What percentage of otosclerotic ears had a response to the bone-conducted VEMPs?", "follow_up_response": "44.03%", "follow_up_response_bt": "No Answer"}, {"question_id": "207.5", "question": "Which two vestibular-evoked myogenic potentials had the highest response rates?", "answer_src": "backgroundthe aim of this prospective clinical study was to evaluate the clinical importance of vestibular - evoked myogenic potentials ( vemps ) in the assessment and differential diagnosis of otosclerosis and otologic diseases characterized by pseudo - conductive components . we also investigated the clinical appearance of balance disorders in patients with otosclerosis by correlating vemp results with the findings of caloric testing and pure tone audiometry(pta).material / methodsair - conducted(ac ) 4-pta , bone - conducted(bc ) 4-pta , air - bone gap(abg ) , ac , bc tone burst evoked vemp , and calorics were measured preoperatively in 126 otosclerotic ears.resultsthe response rate of the ac - vemps and bc - vemps was 29.36% and 44.03% , respectively . statistical differences were found between the means of abg , ac 4-pta , and bc 4-pta in the otosclerotic ears in relation to ac - vemp elicitability .", "follow_up_question": "What was the statistical difference found between the means of ABG, AC 4-PTA, and BC 4-PTA in the otosclerotic ears?", "follow_up_response": "statistical differences were found between the means of ABG, AC 4-PTA, and BC 4-PTA", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "207.6", "question": "What percentage of otosclerotic ears had a response to the air-conducted VEMP measurements?", "answer_src": "29.36%", "follow_up_question": "What was the response rate for the bone-conducted VEMP measurements?", "follow_up_response": "44.03%", "follow_up_response_bt": "No Answer"}, {"question_id": "207.7", "question": "What percentage of the otosclerotic ears had a response to the bone-conducted VEMPs?", "answer_src": "44.03%", "follow_up_question": "What was the mean difference in air-bone gap (ABG) values between otosclerotic ears compared to non-otosclerotic ears?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "207.8", "question": "What percentage of otosclerotic ears had a response to the bone-conducted vestibular-evoked myogenic potentials (bc - vemps)?", "answer_src": "44.03%", "follow_up_question": "What was the mean difference in air-bone gap (abg) values between otosclerotic ears compared to non-otosclerotic ears?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "207.9", "question": "What percentage of otosclerotic ears had a response to the bone-conducted VEMPs?", "answer_src": "44.03%", "follow_up_question": "What was the mean difference in air-bone gap (ABG) values between otosclerotic ears compared to non-otosclerotic ears?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "207.10", "question": "What was the statistical difference found between the means of ABG, AC 4-PTA, and BC 4-PTA in the otosclerotic ears?", "answer_src": "statistical differences were found between the means of ABG, AC 4-PTA, and BC 4-PTA", "follow_up_question": "What specific statistical test was used to compare these means?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "207.11", "question": "What was the response rate for the bone-conducted VEMP measurements?", "answer_src": "44.03%", "follow_up_question": "What was the average air-conducted VEMP elicitability rate?", "follow_up_response": "29.36%", "follow_up_response_bt": "No Answer"}, {"question_id": "207.12", "question": "What was the mean difference in air-bone gap (ABG) values between otosclerotic ears compared to non-otosclerotic ears?", "answer_src": "backgroundthe aim of this prospective clinical study was to evaluate the clinical importance of vestibular - evoked myogenic potentials ( vemps ) in the assessment and differential diagnosis of otosclerosis and otologic diseases characterized by pseudo - conductive components . we also investigated the clinical appearance of balance disorders in patients with otosclerosis by correlating vemp results with the findings of caloric testing and pure tone audiometry(pta).material / methodsair - conducted(ac ) 4-pta , bone - conducted(bc ) 4-pta , air - bone gap(abg ) , ac , bc tone burst evoked vemp , and calorics were measured preoperatively in 126 otosclerotic ears.resultsthe response rate of the ac - vemps and bc - vemps was 29.36% and 44.03% , respectively . statistical differences were found between the means of abg , ac 4-pta , and bc 4-pta in the otosclerotic ears in relation to ac - vemp elicitability .", "follow_up_question": "What was the response rate of ac-VEMPs in the otosclerotic ears?", "follow_up_response": "29.36%", "follow_up_response_bt": "No Answer"}, {"question_id": "207.13", "question": "What was the mean difference in air-bone gap (abg) values between otosclerotic ears compared to non-otosclerotic ears?", "answer_src": "backgroundthe aim of this prospective clinical study was to evaluate the clinical importance of vestibular - evoked myogenic potentials ( vemps ) in the assessment and differential diagnosis of otosclerosis and otologic diseases characterized by pseudo - conductive components . we also investigated the clinical appearance of balance disorders in patients with otosclerosis by correlating vemp results with the findings of caloric testing and pure tone audiometry(pta).material / methodsair - conducted(ac ) 4-pta , bone - conducted(bc ) 4-pta , air - bone gap(abg ) , ac , bc tone burst evoked vemp , and calorics were measured preoperatively in 126 otosclerotic ears.resultsthe response rate of the ac - vemps and bc - vemps was 29.36% and 44.03% , respectively . statistical differences were found between the means of abg , ac 4-pta , and bc 4-pta in the otosclerotic ears in relation to ac - vemp elicitability .", "follow_up_question": "What was the response rate of ac-VEMPs in the otosclerotic ears?", "follow_up_response": "29.36%", "follow_up_response_bt": "No Answer"}, {"question_id": "207.14", "question": "What was the mean difference in air-bone gap (ABG) values between otosclerotic ears compared to non-otosclerotic ears?", "answer_src": "backgroundthe aim of this prospective clinical study was to evaluate the clinical importance of vestibular - evoked myogenic potentials ( vemps ) in the assessment and differential diagnosis of otosclerosis and otologic diseases characterized by pseudo - conductive components . we also investigated the clinical appearance of balance disorders in patients with otosclerosis by correlating vemp results with the findings of caloric testing and pure tone audiometry(pta).material / methodsair - conducted(ac ) 4-pta , bone - conducted(bc ) 4-pta , air - bone gap(abg ) , ac , bc tone burst evoked vemp , and calorics were measured preoperatively in 126 otosclerotic ears.resultsthe response rate of the ac - vemps and bc - vemps was 29.36% and 44.03% , respectively . statistical differences were found between the means of abg , ac 4-pta , and bc 4-pta in the otosclerotic ears in relation to ac - vemp elicitability .", "follow_up_question": "What was the response rate of ac-VEMPs in the otosclerotic ears?", "follow_up_response": "29.36%", "follow_up_response_bt": "No Answer"}, {"question_id": "207.15", "question": "What specific statistical test was used to compare these means?", "answer_src": "backgroundthe aim of this prospective clinical study was to evaluate the clinical importance of vestibular - evoked myogenic potentials ( vemps ) in the assessment and differential diagnosis of otosclerosis and otologic diseases characterized by pseudo - conductive components . we also investigated the clinical appearance of balance disorders in patients with otosclerosis by correlating vemp results with the findings of caloric testing and pure tone audiometry(pta).material / methodsair - conducted(ac ) 4-pta , bone - conducted(bc ) 4-pta , air - bone gap(abg ) , ac , bc tone burst evoked vemp , and calorics were measured preoperatively in 126 otosclerotic ears.resultsthe response rate of the ac - vemps and bc - vemps was 29.36% and 44.03% , respectively . statistical differences were found between the means of abg , ac 4-pta , and bc 4-pta in the otosclerotic ears in relation to ac - vemp elicitability .", "follow_up_question": "What was the threshold for eliciting a positive response in the air-conducted vestibular-evoked myogenic potentials (AC-VEMPs)?", "follow_up_response": "29.36%", "follow_up_response_bt": "No Answer"}]}}
{"id": 208, "src": "chronic hepatitis c infection poses a major global health predicament and appears to be potent threat to mankind . the treatment in wide use is interferon / ribavirin combination therapy which is generally effective in about 60 - 70 per cent of patients carrying genotype 3 and causes significant morbidity . the response to therapy is largely guided by limited number of factors such as genotype of virus , rapid virological response , ethnicity , pre - therapy viral load , etc .", "mt": "L'infezione cronica di epatite c rappresenta un grave problema di salute globale e sembra essere una potente minaccia per l'umanità . Il trattamento in uso è l'interferone / ribavirina terapia combinata che è generalmente efficace in circa il 60 - 70% dei pazienti con genotipo 3 e causa una significativa morbilità . La risposta alla terapia è in gran parte guidata da un numero limitato di fattori come il genotipo del virus , risposta virologica rapida , etnia , carico virale pre-terapia , ecc", "pert_mt": "L'infezione cronica di epatite c rappresenta un grave problema di salute globale e sembra essere una potente minaccia per l'umanità. Il trattamento in uso è l'interferone / ribavirina terapia combinata che è generalmente efficace in circa il 60 - 70% dei pazienti con genotipo 3 e causa una significativa morbilità. La risposta alla terapia è in gran parte guidata da un numero limitato di fattori come il genotipo del virus, risposta virologica rapida, etnia, carico virale pre-terapia, e la dieta del paziente.", "bt": "Chronic hepatitis C infection is a serious global health problem and appears to be a potent threat to humanity.The treatment in use is interferon/ribavirin combination therapy that is generally effective in about 60 - 70% of patients with genotype 3 and causes significant morbidity.The response to therapy is largely guided by a limited number of factors such as the genotype of the virus, rapid virological response, ethnicity, pre-therapy viral caries, and patient diet.", "questions_src": ["What does chronic hepatitis C infection pose?", "Who is generally effective with the treatment interferon/ribavirin combination therapy?", "Where can the treatment interferon/ribavirin combination therapy be found?", "When might a patient's response to therapy be largely guided?", "Which factors are considered when guiding a patient's response to therapy?"], "answers_src": ["a major global health predicament and appears to be a potent threat to mankind", "patients carrying genotype 3", "in wide use", "limited number of factors such as genotype of virus, rapid virological response, ethnicity, pre-therapy viral load, etc.", "genotype of virus, rapid virological response, ethnicity, pre-therapy viral load"], "answers_bt": ["a serious global health problem and appears to be a potent threat to humanity", "about 60 - 70% of patients", "in use", "the limited number of factors such as the genotype of the virus, rapid virological response, ethnicity, pre-therapy viral caries, and patient diet", "the genotype of the virus, rapid virological response, ethnicity, pre-therapy viral caries, and patient diet"], "multiturn": {"turn_1": [{"question_id": "208.1", "question": "What does chronic hepatitis C infection pose?", "answer_src": "a major global health predicament and appears to be a potent threat to mankind", "follow_up_question": "What percentage of patients carrying genotype 3 responds effectively to the treatment?", "follow_up_response": "60 - 70 per cent", "follow_up_response_bt": "60 - 70%"}, {"question_id": "208.2", "question": "Who is generally effective with the treatment interferon/ribavirin combination therapy?", "answer_src": "patients carrying genotype 3", "follow_up_question": "What percentage of patients carrying genotype 3 are generally effective with the treatment interferon/ribavirin combination therapy?", "follow_up_response": "60 - 70 per cent", "follow_up_response_bt": "60 - 70%"}, {"question_id": "208.3", "question": "Where can the treatment interferon/ribavirin combination therapy be found?", "answer_src": "in wide use", "follow_up_question": "What percentage of patients does this treatment generally help?", "follow_up_response": "60 - 70 per cent", "follow_up_response_bt": "60 - 70%"}, {"question_id": "208.4", "question": "When might a patient's response to therapy be largely guided?", "answer_src": "limited number of factors such as genotype of virus, rapid virological response, ethnicity, pre-therapy viral load, etc.", "follow_up_question": "What factor among genotype of virus, rapid virological response, ethnicity, pre-therapy viral load, and treatment duration is most commonly considered when guiding a patient's response to therapy?", "follow_up_response": "genotype of virus", "follow_up_response_bt": "Genotype of the virus"}, {"question_id": "208.5", "question": "Which factors are considered when guiding a patient's response to therapy?", "answer_src": "genotype of virus, rapid virological response, ethnicity, pre-therapy viral load", "follow_up_question": "What percentage of patients with genotype 3 responds effectively to the treatment?", "follow_up_response": "60 - 70 per cent", "follow_up_response_bt": "60 - 70%"}], "turn_2": [{"question_id": "208.6", "question": "What percentage of patients carrying genotype 3 responds effectively to the treatment?", "answer_src": "60 - 70 per cent", "follow_up_question": "What factors are primarily used to guide the response to therapy?", "follow_up_response": "Genotype of virus, rapid virological response, ethnicity, pre-therapy viral load, etc.", "follow_up_response_bt": "The genotype of the virus, rapid virological response, ethnicity, pre-therapy viral caries, and patient diet"}, {"question_id": "208.7", "question": "What percentage of patients carrying genotype 3 are generally effective with the treatment interferon/ribavirin combination therapy?", "answer_src": "60 - 70 per cent", "follow_up_question": "What factors are primarily used to guide the response to this treatment?", "follow_up_response": "Genotype of virus, rapid virological response, ethnicity, pre-therapy viral load, etc.", "follow_up_response_bt": "The genotype of the virus, rapid virological response, ethnicity, pre-therapy viral caries, and patient diet"}, {"question_id": "208.8", "question": "What percentage of patients does this treatment generally help?", "answer_src": "60 - 70 per cent", "follow_up_question": "What factors are most important in determining the response to this treatment?", "follow_up_response": "Genotype of virus, rapid virological response, ethnicity, pre-therapy viral load, etc.", "follow_up_response_bt": "The genotype of the virus, rapid virological response, ethnicity, pre-therapy viral caries, and patient diet"}, {"question_id": "208.9", "question": "What factor among genotype of virus, rapid virological response, ethnicity, pre-therapy viral load, and treatment duration is most commonly considered when guiding a patient's response to therapy?", "answer_src": "genotype of virus", "follow_up_question": "What percentage of patients with genotype 3 respond effectively to interferon/ribavirin combination therapy?", "follow_up_response": "60 - 70 per cent", "follow_up_response_bt": "60 - 70%"}, {"question_id": "208.10", "question": "What percentage of patients with genotype 3 responds effectively to the treatment?", "answer_src": "60 - 70 per cent", "follow_up_question": "What other factors besides genotype guide the response to therapy?", "follow_up_response": "rapid virological response\", \"ethnicity\", \"pre-therapy viral load", "follow_up_response_bt": "rapid virological response, ethnicity, pre-therapy viral caries, and patient diet"}], "turn_3": [{"question_id": "208.11", "question": "What factors are primarily used to guide the response to therapy?", "answer_src": "Genotype of virus, rapid virological response, ethnicity, pre-therapy viral load, etc.", "follow_up_question": "How many factors are mentioned in total for guiding the response to therapy?", "follow_up_response": "5", "follow_up_response_bt": "5"}, {"question_id": "208.12", "question": "What factors are primarily used to guide the response to this treatment?", "answer_src": "Genotype of virus, rapid virological response, ethnicity, pre-therapy viral load, etc.", "follow_up_question": "How many factors are mentioned in total for guiding the response to the treatment?", "follow_up_response": "5", "follow_up_response_bt": "5"}, {"question_id": "208.13", "question": "What factors are most important in determining the response to this treatment?", "answer_src": "Genotype of virus, rapid virological response, ethnicity, pre-therapy viral load, etc.", "follow_up_question": "How does the pre-therapy viral load affect the response to the treatment?", "follow_up_response": "Largely", "follow_up_response_bt": "No Answer"}, {"question_id": "208.14", "question": "What percentage of patients with genotype 3 respond effectively to interferon/ribavirin combination therapy?", "answer_src": "60 - 70 per cent", "follow_up_question": "What other factors besides genotype influence the response to therapy according to the text?", "follow_up_response": "rapid virological response\", \"ethnicity\", \"pre-therapy viral load", "follow_up_response_bt": "rapid virological response, ethnicity, pre-therapy viral caries, and patient diet"}, {"question_id": "208.15", "question": "What other factors besides genotype guide the response to therapy?", "answer_src": "rapid virological response\", \"ethnicity\", \"pre-therapy viral load", "follow_up_question": "What percentage of patients with genotype 3 respond positively to the treatment?", "follow_up_response": "60 - 70 per cent", "follow_up_response_bt": "60 - 70%"}]}}
{"id": 209, "src": "these loading conditions produced stress distributions within the intact mandible that were very different and more complex than the customary lever - based gradient . the analyses also demonstrated the entirely different mechanical environments within intact and plated mandibles . because the loading and geometry of the lever - idealized mandible is incomplete , the associated widely accepted bone stress distribution ( tension on top and compression on the bottom ) should not be assumed .", "mt": "Le condizioni di carico hanno prodotto distribuzioni di stress all'interno della mandibola intatta che erano molto diverse e più complesse del solito gradiente a leva . Le analisi hanno anche dimostrato ambienti meccanici completamente diversi all'interno di mandiboli intatti e rivestiti . Poiché il carico e la geometria della mandibola idealizzata a leva sono incompleti , non si deve assumere la distribuzione di stress osseo ampiamente accettata (tensione in alto e compressione in basso).", "pert_mt": "Le condizioni di carico hanno prodotto distribuzioni di stress all'interno della mandibola intatta che erano molto diverse e più complesse del solito gradiente a leva. Le analisi hanno anche dimostrato ambienti meccanici completamente diversi all'interno di mandiboli intatti e rivestiti. Poiché il carico e la geometria della mandibola idealizzata a leva sono incompleti, non si deve assumere la distribuzione di stress osseo ampiamente accettata (tensione in alto e compressione in basso). Tuttavia, questi risultati indicano la necessità di ulteriori studi per comprendere le dinamiche precise dei materiali ossei sotto diversi tipi di carico.", "bt": "The caricosa conditions produced stress distributions within the intact mandible that were very diverse and more complex than the usual gradient a lev. Analyses also showed completely different mechanical environments within intact and riveted mandibles. Since the caricosa and the geometry of the idealized mandible a lev are incomplete, it is not necessary to assume the widely accepted bone stress distribution (high tension and low compression).", "questions_src": ["What type of stress distributions were found within the intact mandible?", "Where did the analyses show different mechanical environments compared to?", "Who conducted the analyses that showed these differences?", "When was it noted that the lever-based gradient assumption might not be valid?", "Which loading conditions were considered in the study?"], "answers_src": ["very different and more complex than the customary lever - based gradient", "intact and plated mandibles", "the analyses", "no answer", "these loading conditions"], "answers_bt": ["very diverse and more complex than the usual gradient a lev", "intact and riveted mandibles", "not specified in the sentence", "not specified in the sentence", "caricosa and the geometry of the idealized mandible a lev"], "multiturn": {"turn_1": [{"question_id": "209.1", "question": "What type of stress distributions were found within the intact mandible?", "answer_src": "very different and more complex than the customary lever - based gradient", "follow_up_question": "What specific differences were observed between the stress distributions in the intact and plated mandibles?", "follow_up_response": "the entirely different mechanical environments", "follow_up_response_bt": "completely different mechanical environments"}, {"question_id": "209.2", "question": "Where did the analyses show different mechanical environments compared to?", "answer_src": "intact and plated mandibles", "follow_up_question": "What specific differences did the analyses reveal in the mechanical environments of intact and plated mandibles?", "follow_up_response": "the entirely different mechanical environments", "follow_up_response_bt": "Completely different mechanical environments"}, {"question_id": "209.3", "question": "Who conducted the analyses that showed these differences?", "answer_src": "the analyses", "follow_up_question": "What specific aspects of the mechanical environments did the analyses demonstrate differed between intact and plated mandibles?", "follow_up_response": "entirely different mechanical environments", "follow_up_response_bt": "completely different mechanical environments"}, {"question_id": "209.4", "question": "When was it noted that the lever-based gradient assumption might not be valid?", "answer_src": "no answer", "follow_up_question": "What specific loading conditions were found to produce stress distributions different from the customary tension on top and compression on the bottom?", "follow_up_response": "these loading conditions", "follow_up_response_bt": "The caricosa conditions"}, {"question_id": "209.5", "question": "Which loading conditions were considered in the study?", "answer_src": "these loading conditions", "follow_up_question": "What specific differences did the analyses reveal between intact and plated mandibles?", "follow_up_response": "the entirely different mechanical environments", "follow_up_response_bt": "Completely different mechanical environments"}], "turn_2": [{"question_id": "209.6", "question": "What specific differences were observed between the stress distributions in the intact and plated mandibles?", "answer_src": "the entirely different mechanical environments", "follow_up_question": "What aspects of the mechanical environment differed between the intact and plated mandibles?", "follow_up_response": "the entirely different mechanical environments", "follow_up_response_bt": "completely different mechanical environments"}, {"question_id": "209.7", "question": "What specific differences did the analyses reveal in the mechanical environments of intact and plated mandibles?", "answer_src": "the entirely different mechanical environments", "follow_up_question": "What aspects of the mechanical environment differed between intact and plated mandibles according to the analyses?", "follow_up_response": "the entirely different mechanical environments", "follow_up_response_bt": "completely different mechanical environments"}, {"question_id": "209.8", "question": "What specific aspects of the mechanical environments did the analyses demonstrate differed between intact and plated mandibles?", "answer_src": "entirely different mechanical environments", "follow_up_question": "What aspects of the mechanical environment were found to differ specifically in the intact mandible compared to the plated mandible?", "follow_up_response": "the entirely different mechanical environments", "follow_up_response_bt": "Mechanical environments"}, {"question_id": "209.9", "question": "What specific loading conditions were found to produce stress distributions different from the customary tension on top and compression on the bottom?", "answer_src": "these loading conditions", "follow_up_question": "What types of stress distributions were observed within the intact mandible according to the analyses?", "follow_up_response": "very different and more complex than the customary lever - based gradient", "follow_up_response_bt": "very diverse and more complex than the usual gradient"}, {"question_id": "209.10", "question": "What specific differences did the analyses reveal between intact and plated mandibles?", "answer_src": "the entirely different mechanical environments", "follow_up_question": "What aspects of the mechanical environment differed between intact and plated mandibles?", "follow_up_response": "the entirely different mechanical environments", "follow_up_response_bt": "completely different mechanical environments"}], "turn_3": [{"question_id": "209.11", "question": "What aspects of the mechanical environment differed between the intact and plated mandibles?", "answer_src": "the entirely different mechanical environments", "follow_up_question": "What specific mechanical environment was found to be different within the intact mandible?", "follow_up_response": "the entirely different mechanical environments", "follow_up_response_bt": "completely different mechanical environments"}, {"question_id": "209.12", "question": "What aspects of the mechanical environment differed between intact and plated mandibles according to the analyses?", "answer_src": "the entirely different mechanical environments", "follow_up_question": "What specific differences were observed in the mechanical environments within the intact mandible compared to the plated mandible?", "follow_up_response": "entirely different mechanical environments", "follow_up_response_bt": "completely different mechanical environments"}, {"question_id": "209.13", "question": "What aspects of the mechanical environment were found to differ specifically in the intact mandible compared to the plated mandible?", "answer_src": "the entirely different mechanical environments", "follow_up_question": "What specific differences were observed in the mechanical environments of the intact and plated mandibles?", "follow_up_response": "entirely different mechanical environments", "follow_up_response_bt": "completely different mechanical environments"}, {"question_id": "209.14", "question": "What types of stress distributions were observed within the intact mandible according to the analyses?", "answer_src": "very different and more complex than the customary lever - based gradient", "follow_up_question": "What specific differences did the analyses identify between the stress distributions in the intact and plated mandibles?", "follow_up_response": "the entirely different mechanical environments", "follow_up_response_bt": "completely different mechanical environments"}, {"question_id": "209.15", "question": "What aspects of the mechanical environment differed between intact and plated mandibles?", "answer_src": "the entirely different mechanical environments", "follow_up_question": "What specific mechanical environment was found to be different within an intact mandible?", "follow_up_response": "the entirely different mechanical environments", "follow_up_response_bt": "completely different mechanical environments"}]}}
{"id": 210, "src": "the increment of the erosive tooth wear was calculated . in the case of dentin , this final measurement was done with and without the demineralized organic matrix ( dom ) . enamel and dentin data were analyzed using anova / tukey s and kruskal - wallis / dunn tests , respectively ( p<0.05).", "mt": "Nel caso della dentina , questa misurazione finale è stata effettuata con e senza la matrice organica demineralizzata (dom) . Sono stati analizzati dati di smalto e dentina utilizzando rispettivamente test anova / tukey s e kruskal - wallis / dunn (p<0.05).", "pert_mt": "Nel caso della dentina, questa misurazione finale è stata effettuata con e senza la matrice organica demineralizzata (DOM). Sono stati analizzati dati di smalto e dentina utilizzando rispettivamente test ANOVA/Tukey e Kruskal-Wallis/Dunn (p<0.05) e questi risultati sono stati confrontati con quelli ottenuti da un esperimento parallelo.", "bt": "In the case of dentin, this final measurement was performed with and without the demineralized organic matrix (DOM).Smalto and dentin data were analyzed using the ANOVA/Tukey and Kruskal-Wallis/Dunn tests (p<0.05) respectively, and these results were compared with those obtained from a parallel experiment.", "questions_src": ["What was calculated in the sentence?", "Who performed the final measurement for dentin?", "Where were enamel and dentin data analyzed?", "When was the demineralized organic matrix used?", "Which statistical tests were used for enamel and dentin analysis?"], "answers_src": ["the increment of the erosive tooth wear", "with and without the demineralized organic matrix (dom)", "anova / tukey s and kruskal - wallis / dunn tests", "in the case of dentin", "anova / tukey s and kruskal - wallis / dunn tests"], "answers_bt": ["Final measurement for dentin", "With and without the demineralized organic matrix (DOM)", "Not explicitly mentioned", "In the case of dentin", "ANOVA/Tukey and Kruskal-Wallis/Dunn tests"], "multiturn": {"turn_1": [{"question_id": "210.1", "question": "What was calculated in the sentence?", "answer_src": "the increment of the erosive tooth wear", "follow_up_question": "How were the enamel data analyzed?", "follow_up_response": "anova / tukey s", "follow_up_response_bt": "No Answer"}, {"question_id": "210.2", "question": "Who performed the final measurement for dentin?", "answer_src": "with and without the demineralized organic matrix (dom)", "follow_up_question": "What statistical test was used for analyzing enamel data?", "follow_up_response": "kruskal - wallis / dunn tests", "follow_up_response_bt": "No Answer"}, {"question_id": "210.3", "question": "Where were enamel and dentin data analyzed?", "answer_src": "anova / tukey s and kruskal - wallis / dunn tests", "follow_up_question": "What specific type of analysis was used for enamel data?", "follow_up_response": "kruskal - wallis / dunn tests", "follow_up_response_bt": "No Answer"}, {"question_id": "210.4", "question": "When was the demineralized organic matrix used?", "answer_src": "in the case of dentin", "follow_up_question": "What specific test was used for analyzing enamel data?", "follow_up_response": "kruskal - wallis / dunn tests", "follow_up_response_bt": "No Answer"}, {"question_id": "210.5", "question": "Which statistical tests were used for enamel and dentin analysis?", "answer_src": "anova / tukey s and kruskal - wallis / dunn tests", "follow_up_question": "What was the significance level (p-value) used for these analyses?", "follow_up_response": "0.05", "follow_up_response_bt": "0.05"}], "turn_2": [{"question_id": "210.6", "question": "How were the enamel data analyzed?", "answer_src": "anova / tukey s", "follow_up_question": "How were the dentin data analyzed?", "follow_up_response": "anova / tukey s", "follow_up_response_bt": "Using the ANOVA/Tukey and Kruskal-Wallis/Dunn tests"}, {"question_id": "210.7", "question": "What statistical test was used for analyzing enamel data?", "answer_src": "kruskal - wallis / dunn tests", "follow_up_question": "What was the significance of the demineralized organic matrix (DOM) in the measurement of erosive tooth wear for dentin?", "follow_up_response": "The demineralized organic matrix (DOM) was used in the final measurement of erosive tooth wear for dentin.", "follow_up_response_bt": "The demineralized organic matrix (DOM)"}, {"question_id": "210.8", "question": "What specific type of analysis was used for enamel data?", "answer_src": "kruskal - wallis / dunn tests", "follow_up_question": "What specific type of analysis was used for dentin data?", "follow_up_response": "anova / tukey s", "follow_up_response_bt": "ANOVA/Tukey and Kruskal-Wallis/Dunn tests"}, {"question_id": "210.9", "question": "What specific test was used for analyzing enamel data?", "answer_src": "kruskal - wallis / dunn tests", "follow_up_question": "What statistical test was applied to analyze dentin data?", "follow_up_response": "anova / tukey s", "follow_up_response_bt": "ANOVA/Tukey"}, {"question_id": "210.10", "question": "What was the significance level (p-value) used for these analyses?", "answer_src": "0.05", "follow_up_question": "What specific test was used for analyzing enamel data?", "follow_up_response": "kruskal - wallis / dunn tests", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "210.11", "question": "How were the dentin data analyzed?", "answer_src": "anova / tukey s", "follow_up_question": "What test was used for enamel data analysis?", "follow_up_response": "kruskal - wallis / dunn tests", "follow_up_response_bt": "No Answer"}, {"question_id": "210.12", "question": "What was the significance of the demineralized organic matrix (DOM) in the measurement of erosive tooth wear for dentin?", "answer_src": "The demineralized organic matrix (DOM) was used in the final measurement of erosive tooth wear for dentin.", "follow_up_question": "How did the presence or absence of DOM affect the statistical analysis methods used for dentin?", "follow_up_response": "anova / tukey s", "follow_up_response_bt": "The ANOVA/Tukey and Kruskal-Wallis/Dunn tests"}, {"question_id": "210.13", "question": "What specific type of analysis was used for dentin data?", "answer_src": "anova / tukey s", "follow_up_question": "What specific type of analysis was used for enamel data?", "follow_up_response": "kruskal - wallis / dunn tests", "follow_up_response_bt": "No Answer"}, {"question_id": "210.14", "question": "What statistical test was applied to analyze dentin data?", "answer_src": "anova / tukey s", "follow_up_question": "What was the significance of performing the analysis with and without the demineralized organic matrix (DOM) on dentin?", "follow_up_response": "p<0.05", "follow_up_response_bt": "p<0.05"}, {"question_id": "210.15", "question": "What specific test was used for analyzing enamel data?", "answer_src": "kruskal - wallis / dunn tests", "follow_up_question": "What statistical test was applied to analyze dentin data?", "follow_up_response": "anova / tukey s", "follow_up_response_bt": "ANOVA/Tukey"}]}}
{"id": 211, "src": "diabetes mellitus is a metabolic disorder and its subsequent complications such as retinopathy , nephropathy , ulcers , disability , and amputation increase the burden of the disease . patient knowledge - improving programs are employed to prevent disease progression and to improve the quality of life of the patients . in this way , we need to characterize the groups of patients in urgent need for more and rich - in - content programs .", "mt": "Il diabete è un disturbo metabolico e le sue complicazioni successive come retinopatia , nefropatia , ulcere , disabilità e amputazione aumentano il peso della malattia . I programmi di miglioramento della conoscenza del paziente sono impiegati per prevenire la progressione della malattia e migliorare la qualità della vita dei pazienti . In questo modo , dobbiamo caratterizzare i gruppi di pazienti che hanno un urgente bisogno di più e ricchi di programmi di contenuto .", "pert_mt": "Il diabete è un disturbo metabolico e le sue complicazioni successive come retinopatia, nefropatia, ulcere, disabilità e amputazione aumentano il peso della malattia. I programmi di miglioramento della conoscenza del paziente sono impiegati per prevenire la progressione della malattia e migliorare la qualità della vita dei pazienti. In questo modo, dobbiamo caratterizzare i gruppi di pazienti che hanno un urgente bisogno di più e ricchi di programmi di contenuto e supporto psicologico.", "bt": "Diabetes is a metabolic disorder and its successive complications such as retinopathy, nephropathy, ulcers, disability and amputation increase the severity of the disease.Patient awareness-raising programs are employed to prevent the progression of the disease and improve the quality of life of patients.Thus, we must characterize groups of patients who urgently need more and are rich in content programs and psychological support.", "questions_src": ["What is the main cause of diabetes mellitus?", "When can diabetes mellitus lead to complications like retinopathy?", "Where can diabetes mellitus complications result in disability or amputation?", "Which group of patients are in urgent need for more content-rich programs?", "Who can benefit from patient knowledge-improving programs?"], "answers_src": ["a metabolic disorder", "No Answer", "disability or amputation", "groups of patients in urgent need", "patients"], "answers_bt": ["a metabolic disorder", "No Answer", "disability or amputation", "groups of patients who urgently need more and are rich in content programs", "patients"], "multiturn": {"turn_1": [{"question_id": "211.1", "question": "What is the main cause of diabetes mellitus?", "answer_src": "a metabolic disorder", "follow_up_question": "What specific complications does diabetes mellitus lead to?", "follow_up_response": "retinopathy, nephropathy, ulcers, disability, and amputation", "follow_up_response_bt": "retinopathy, nephropathy, ulcers, disability and amputation"}, {"question_id": "211.2", "question": "When can diabetes mellitus lead to complications like retinopathy?", "answer_src": "diabetes mellitus is a metabolic disorder and its subsequent complications such as retinopathy , nephropathy , ulcers , disability , and amputation increase the burden of the disease . patient knowledge - improving programs are employed to prevent disease progression and to improve the quality of life of the patients . in this way , we need to characterize the groups of patients in urgent need for more and rich - in - content programs .", "follow_up_question": "What specific complications does diabetes mellitus lead to?", "follow_up_response": "retinopathy, nephropathy, ulcers, disability, and amputation", "follow_up_response_bt": "retinopathy, nephropathy, ulcers, disability and amputation"}, {"question_id": "211.3", "question": "Where can diabetes mellitus complications result in disability or amputation?", "answer_src": "disability or amputation", "follow_up_question": "What specific type of patient group does the text suggest requires more and richer-content programs?", "follow_up_response": "groups of patients in urgent need", "follow_up_response_bt": "groups of patients"}, {"question_id": "211.4", "question": "Which group of patients are in urgent need for more content-rich programs?", "answer_src": "groups of patients in urgent need", "follow_up_question": "What specific characteristics define these groups of patients?", "follow_up_response": "No Answer", "follow_up_response_bt": "Characterization groups of patients who urgently need more and are rich in content programs and psychological support"}, {"question_id": "211.5", "question": "Who can benefit from patient knowledge-improving programs?", "answer_src": "patients", "follow_up_question": "What specific complications do these programs aim to prevent?", "follow_up_response": "retinopathy , nephropathy , ulcers , disability , and amputation", "follow_up_response_bt": "Retinopathy, nephropathy, ulcers, disability and amputation"}], "turn_2": [{"question_id": "211.6", "question": "What specific complications does diabetes mellitus lead to?", "answer_src": "retinopathy, nephropathy, ulcers, disability, and amputation", "follow_up_question": "What percentage of diabetic patients might fall into the group needing more and rich-in-content programs according to the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "211.7", "question": "What specific complications does diabetes mellitus lead to?", "answer_src": "retinopathy, nephropathy, ulcers, disability, and amputation", "follow_up_question": "What percentage of diabetic patients might fall into the group needing more and rich-in-content programs according to the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "211.8", "question": "What specific type of patient group does the text suggest requires more and richer-content programs?", "answer_src": "groups of patients in urgent need", "follow_up_question": "What characteristics define the groups of patients in urgent need?", "follow_up_response": "More and rich-in-content programs", "follow_up_response_bt": "Characterized by urgency and richness in content programs and psychological support"}, {"question_id": "211.9", "question": "What specific characteristics define these groups of patients?", "answer_src": "diabetes mellitus is a metabolic disorder and its subsequent complications such as retinopathy , nephropathy , ulcers , disability , and amputation increase the burden of the disease . patient knowledge - improving programs are employed to prevent disease progression and to improve the quality of life of the patients . in this way , we need to characterize the groups of patients in urgent need for more and rich - in - content programs .", "follow_up_question": "What types of complications do these groups of patients face?", "follow_up_response": "retinopathy, nephropathy, ulcers, disability, and amputation", "follow_up_response_bt": "retinopathy, nephropathy, ulcers, disability and amputation"}, {"question_id": "211.10", "question": "What specific complications do these programs aim to prevent?", "answer_src": "retinopathy , nephropathy , ulcers , disability , and amputation", "follow_up_question": "Which complication has the highest potential to lead to disability according to the text?", "follow_up_response": "ulcers", "follow_up_response_bt": "ulcers"}], "turn_3": [{"question_id": "211.11", "question": "What percentage of diabetic patients might fall into the group needing more and rich-in-content programs according to the text?", "answer_src": "diabetes mellitus is a metabolic disorder and its subsequent complications such as retinopathy , nephropathy , ulcers , disability , and amputation increase the burden of the disease . patient knowledge - improving programs are employed to prevent disease progression and to improve the quality of life of the patients . in this way , we need to characterize the groups of patients in urgent need for more and rich - in - content programs .", "follow_up_question": "What specific complications does the text mention that necessitate more and rich-in-content patient knowledge programs?", "follow_up_response": "retinopathy, nephropathy, ulcers, disability, and amputation", "follow_up_response_bt": "retinopathy, nephropathy, ulcers, disability and amputation"}, {"question_id": "211.12", "question": "What percentage of diabetic patients might fall into the group needing more and rich-in-content programs according to the text?", "answer_src": "diabetes mellitus is a metabolic disorder and its subsequent complications such as retinopathy , nephropathy , ulcers , disability , and amputation increase the burden of the disease . patient knowledge - improving programs are employed to prevent disease progression and to improve the quality of life of the patients . in this way , we need to characterize the groups of patients in urgent need for more and rich - in - content programs .", "follow_up_question": "What specific complications does the text mention that necessitate more and rich-in-content patient knowledge programs?", "follow_up_response": "retinopathy, nephropathy, ulcers, disability, and amputation", "follow_up_response_bt": "retinopathy, nephropathy, ulcers, disability and amputation"}, {"question_id": "211.13", "question": "What characteristics define the groups of patients in urgent need?", "answer_src": "More and rich-in-content programs", "follow_up_question": "What type of patients does the text suggest would benefit most from these programs?", "follow_up_response": "Patients in urgent need", "follow_up_response_bt": "Groups of patients who urgently need more and are rich in content programs and psychological support"}, {"question_id": "211.14", "question": "What types of complications do these groups of patients face?", "answer_src": "retinopathy, nephropathy, ulcers, disability, and amputation", "follow_up_question": "What percentage of these patients might experience each of these complications?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "211.15", "question": "Which complication has the highest potential to lead to disability according to the text?", "answer_src": "ulcers", "follow_up_question": "What specific type of patient group is the text suggesting requires more and richer-content programs?", "follow_up_response": "groups of patients in urgent need", "follow_up_response_bt": "groups of patients"}]}}
{"id": 212, "src": "lipid apheresis is used to treat patients with severe hyperlipidemia by reducing low - density lipoprotein cholesterol ( ldl - c ) . this study examines the effect of apheresis on the lipid panel and cardiac event rates before and after apheresis . an electronic health record screen of ambulatory patients identified 11 active patients undergoing lipid apheresis with 10/11 carrying a diagnosis of fh .", "mt": "L'aferesia lipidico è usata per trattare i pazienti con iperlipidemia grave riducendo il colesterolo lipoproteico di bassa densità (ldl - c) . Questo studio esamina l'effetto dell'aferesia sul pannello lipidico e i tassi di eventi cardiaci prima e dopo l'aferesia . Un monitor elettronico dei dati sanitari dei pazienti ambulatori ha identificato 11 pazienti attivi sottoposti a aferesia lipidico con 10/11 con diagnosi di fh.", "pert_mt": "L'aferesia lipidico è usata per trattare i pazienti con iperlipidemia grave riducendo il colesterolo lipoproteico di bassa densità (ldl - c). Questo studio esamina l'effetto dell'aferesia sul pannello lipidico e i tassi di eventi cardiaci prima e dopo l'aferesia. Un monitor elettronico dei dati sanitari dei pazienti ambulatori ha identificato 11 pazienti attivi sottoposti a aferesia lipidico con 10/11 con diagnosi di fh e mostrano miglioramento clinico significativo.", "bt": "Lipid apheresia is used to treat patients with severe hyperlipidemia by reducing low-density lipoprotein cholesterol (ldl - c).This study examines the effect of apheresia on the lipid panel and rates of heart events before and after apheresia.An electronic monitor of health data from outpatients has identified 11 active patients undergoing lipid apheresia with 10/11 diagnoses and demonstrated significant clinical improvement.", "questions_src": ["What is the primary goal of lipid apheresis?", "Who is the target population for the study?", "Where were the patients identified for the study?", "When was lipid apheresis first mentioned in the sentence?", "Which lipid profile is reduced by lipid apheresis?"], "answers_src": ["[\"To reduce low-density lipoprotein cholesterol (ldl-c)\"], [\"Ambulatory patients\"], [\"An electronic health record screen\"], [\"Before and after apheresis\"], [\"Low-density lipoprotein cholesterol (ldl-c)\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"To treat patients with severe hyperlipidemia\"], [\"Outpatients\"], [\"An electronic monitor of health data\"], [0], [\"Low-density lipoprotein cholesterol (ldl - c)\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "212.1", "question": "What is the primary goal of lipid apheresis?", "answer_src": "[\"To reduce low-density lipoprotein cholesterol (ldl-c)\"], [\"Ambulatory patients\"], [\"An electronic health record screen\"], [\"Before and after apheresis\"], [\"Low-density lipoprotein cholesterol (ldl-c)\"]", "follow_up_question": "How many patients out of the 11 undergoing lipid apheresis had a diagnosis of familial hypercholesterolemia?", "follow_up_response": "10", "follow_up_response_bt": "No Answer"}, {"question_id": "212.2", "question": "Who is the target population for the study?", "answer_src": "lipid apheresis is used to treat patients with severe hyperlipidemia by reducing low - density lipoprotein cholesterol ( ldl - c ) . this study examines the effect of apheresis on the lipid panel and cardiac event rates before and after apheresis . an electronic health record screen of ambulatory patients identified 11 active patients undergoing lipid apheresis with 10/11 carrying a diagnosis of fh .", "follow_up_question": "What percentage of the study participants had Familial Hypercholesterolemia (FH)?", "follow_up_response": "100%", "follow_up_response_bt": "No Answer"}, {"question_id": "212.3", "question": "Where were the patients identified for the study?", "answer_src": "lipid apheresis is used to treat patients with severe hyperlipidemia by reducing low - density lipoprotein cholesterol ( ldl - c ) . this study examines the effect of apheresis on the lipid panel and cardiac event rates before and after apheresis . an electronic health record screen of ambulatory patients identified 11 active patients undergoing lipid apheresis with 10/11 carrying a diagnosis of fh .", "follow_up_question": "What was the primary diagnosis for 10 out of 11 patients identified for the study?", "follow_up_response": "familial hypercholesterolemia", "follow_up_response_bt": "severe hyperlipidemia"}, {"question_id": "212.4", "question": "When was lipid apheresis first mentioned in the sentence?", "answer_src": "lipid apheresis is used to treat patients with severe hyperlipidemia by reducing low - density lipoprotein cholesterol ( ldl - c ) . this study examines the effect of apheresis on the lipid panel and cardiac event rates before and after apheresis . an electronic health record screen of ambulatory patients identified 11 active patients undergoing lipid apheresis with 10/11 carrying a diagnosis of fh .", "follow_up_question": "What percentage of the patients identified had FH?", "follow_up_response": "55%", "follow_up_response_bt": "No Answer"}, {"question_id": "212.5", "question": "Which lipid profile is reduced by lipid apheresis?", "answer_src": "lipid apheresis is used to treat patients with severe hyperlipidemia by reducing low - density lipoprotein cholesterol ( ldl - c ) . this study examines the effect of apheresis on the lipid panel and cardiac event rates before and after apheresis . an electronic health record screen of ambulatory patients identified 11 active patients undergoing lipid apheresis with 10/11 carrying a diagnosis of fh .", "follow_up_question": "What is the diagnosis of 10 out of 11 patients identified in the study?", "follow_up_response": "FH", "follow_up_response_bt": "hyperlipidemia"}], "turn_2": [{"question_id": "212.6", "question": "How many patients out of the 11 undergoing lipid apheresis had a diagnosis of familial hypercholesterolemia?", "answer_src": "10", "follow_up_question": "How many patients did not have a diagnosis of familial hypercholesterolemia?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "212.7", "question": "What percentage of the study participants had Familial Hypercholesterolemia (FH)?", "answer_src": "100%", "follow_up_question": "How many of the 11 active patients undergoing lipid apheresis did not have a diagnosis of FH?", "follow_up_response": "1", "follow_up_response_bt": "No Answer"}, {"question_id": "212.8", "question": "What was the primary diagnosis for 10 out of 11 patients identified for the study?", "answer_src": "familial hypercholesterolemia", "follow_up_question": "What percentage of the patients identified for the study had familial hypercholesterolemia?", "follow_up_response": "54.5%", "follow_up_response_bt": "No Answer"}, {"question_id": "212.9", "question": "What percentage of the patients identified had FH?", "answer_src": "55%", "follow_up_question": "What was the average reduction in LDL-C levels observed in the study participants before and after apheresis?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "212.10", "question": "What is the diagnosis of 10 out of 11 patients identified in the study?", "answer_src": "FH", "follow_up_question": "What percentage of the patients had FH?", "follow_up_response": "54.5%", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "212.11", "question": "How many patients did not have a diagnosis of familial hypercholesterolemia?", "answer_src": "lipid apheresis is used to treat patients with severe hyperlipidemia by reducing low - density lipoprotein cholesterol ( ldl - c ) . this study examines the effect of apheresis on the lipid panel and cardiac event rates before and after apheresis . an electronic health record screen of ambulatory patients identified 11 active patients undergoing lipid apheresis with 10/11 carrying a diagnosis of fh .", "follow_up_question": "How many patients had a diagnosis of familial hypercholesterolemia?", "follow_up_response": "10", "follow_up_response_bt": "No Answer"}, {"question_id": "212.12", "question": "How many of the 11 active patients undergoing lipid apheresis did not have a diagnosis of FH?", "answer_src": "1", "follow_up_question": "How many of the 11 active patients undergoing lipid apheresis had a diagnosis of FH?", "follow_up_response": "10", "follow_up_response_bt": "No Answer"}, {"question_id": "212.13", "question": "What percentage of the patients identified for the study had familial hypercholesterolemia?", "answer_src": "54.5%", "follow_up_question": "What was the average reduction in LDL-C levels observed in the study participants after lipid apheresis?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "212.14", "question": "What was the average reduction in LDL-C levels observed in the study participants before and after apheresis?", "answer_src": "lipid apheresis is used to treat patients with severe hyperlipidemia by reducing low - density lipoprotein cholesterol ( ldl - c ) . this study examines the effect of apheresis on the lipid panel and cardiac event rates before and after apheresis . an electronic health record screen of ambulatory patients identified 11 active patients undergoing lipid apheresis with 10/11 carrying a diagnosis of fh .", "follow_up_question": "What percentage of the study participants had FH?", "follow_up_response": "54.5%", "follow_up_response_bt": "No Answer"}, {"question_id": "212.15", "question": "What percentage of the patients had FH?", "answer_src": "54.5%", "follow_up_question": "What was the average reduction in LDL-C levels before and after apheresis for the patients in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 213, "src": "therefore , we have tested the interaction of human oat2 with various substances using tritium - labeled cgmp . human oat2 showed no interaction with diabetes - related metabolites , diabetic drugs , and ace - inhibitors . however , oat2-dependent uptake of cgmp was inhibited by furosemide .", "mt": "Pertanto , abbiamo testato l'interazione dell' avena umana2 con varie sostanze utilizzando tritio - etichettato cgmp . l' avena umana non ha mostrato alcuna interazione con metaboliti legati al diabete , farmaci per il diabete e inibitori dell' ace . Tuttavia , l' assorbimento di cgmp dipendente dall' avena è stato inibito dal furosemide .", "pert_mt": "Pertanto, abbiamo testato l'interazione dell'avena umana2 con varie sostanze utilizzando tritio-etichettato cgmp. L'avena umana non ha mostrato alcuna interazione con metaboliti legati al diabete, farmaci per il diabete e inibitori dell'ace. Tuttavia, l'assorbimento di cgmp dipendente dall'avena è stato inibito dal furosemide e dallos索茶因。", "bt": "Therefore, we have tested the interaction of human ointment2 with various substances using tritio-labelled cgmp. Human ointment has not shown any interaction with metabolites related to diabetes, diabetes medicines and acne inhibitors.However, the absorption of cgmp depending on the ointment has been inhibited by furosemide and dallos索茶因。", "questions_src": ["What substance inhibited oat2-dependent uptake of CGMP?", "When did we test the interaction of human OAT2?", "Which drug class showed no interaction with human OAT2?", "Where were the CGMP molecules labeled?", "Who or what is OAT2?"], "answers_src": ["Furosemide", "Therefore", "Diabetes-related metabolites, diabetic drugs, and ACE-inhibitors", "Tritium", "Human OAT2"], "answers_bt": ["Furosemide and dallos索茶因", "No Answer", "Diabetes, diabetes medicines, and acne inhibitors", "CGMP", "OAT2"], "multiturn": {"turn_1": [{"question_id": "213.1", "question": "What substance inhibited oat2-dependent uptake of CGMP?", "answer_src": "Furosemide", "follow_up_question": "How did furosemide inhibit oat2-dependent uptake of CGMP?", "follow_up_response": "Furosemide inhibited oat2-dependent uptake of CGMP", "follow_up_response_bt": "furosemide"}, {"question_id": "213.2", "question": "When did we test the interaction of human OAT2?", "answer_src": "Therefore", "follow_up_question": "What substance inhibited oat2-dependent uptake of CGMP?", "follow_up_response": "furosemide", "follow_up_response_bt": "furosemide and dallos索茶因"}, {"question_id": "213.3", "question": "Which drug class showed no interaction with human OAT2?", "answer_src": "Diabetes-related metabolites, diabetic drugs, and ACE-inhibitors", "follow_up_question": "Which substance inhibited oat2-dependent uptake of CGMP?", "follow_up_response": "furosemide", "follow_up_response_bt": "furosemide and dallos索茶因"}, {"question_id": "213.4", "question": "Where were the CGMP molecules labeled?", "answer_src": "Tritium", "follow_up_question": "What molecule was inhibited by furosemide?", "follow_up_response": "cgmp", "follow_up_response_bt": "cgmp"}, {"question_id": "213.5", "question": "Who or what is OAT2?", "answer_src": "Human OAT2", "follow_up_question": "What effect does furosemide have on OAT2-dependent CGMP uptake?", "follow_up_response": "Furosemide inhibits OAT2-dependent uptake of CGMP", "follow_up_response_bt": "Furosemide has inhibited OAT2-dependent CGMP uptake."}], "turn_2": [{"question_id": "213.6", "question": "How did furosemide inhibit oat2-dependent uptake of CGMP?", "answer_src": "Furosemide inhibited oat2-dependent uptake of CGMP", "follow_up_question": "What specific mechanism did furosemide use to inhibit oat2-dependent uptake of CGMP?", "follow_up_response": "furosemide", "follow_up_response_bt": "furosemide"}, {"question_id": "213.7", "question": "What substance inhibited oat2-dependent uptake of CGMP?", "answer_src": "furosemide", "follow_up_question": "How did furosemide inhibit oat2-dependent uptake of CGMP?", "follow_up_response": "Furosemide inhibited oat2-dependent uptake of CGMP", "follow_up_response_bt": "furosemide"}, {"question_id": "213.8", "question": "Which substance inhibited oat2-dependent uptake of CGMP?", "answer_src": "furosemide", "follow_up_question": "What is the mechanism by which furosemide inhibits oat2-dependent uptake of CGMP?", "follow_up_response": "furosemide", "follow_up_response_bt": "furosemide"}, {"question_id": "213.9", "question": "What molecule was inhibited by furosemide?", "answer_src": "cgmp", "follow_up_question": "What effect did furosemide have on oat2-dependent cgmp uptake?", "follow_up_response": "Furosemide inhibited oat2-dependent uptake of CGMP.", "follow_up_response_bt": "Has been inhibited"}, {"question_id": "213.10", "question": "What effect does furosemide have on OAT2-dependent CGMP uptake?", "answer_src": "Furosemide inhibits OAT2-dependent uptake of CGMP", "follow_up_question": "How is the inhibition of OAT2-dependent CGMP uptake by furosemide related to its function as an osmotic diuretic?", "follow_up_response": "OAT2-dependent uptake of CGMP was inhibited by furosemide.", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "213.11", "question": "What specific mechanism did furosemide use to inhibit oat2-dependent uptake of CGMP?", "answer_src": "furosemide", "follow_up_question": "How does furosemide specifically inhibit oat2-dependent uptake of CGMP?", "follow_up_response": "furosemide", "follow_up_response_bt": "furosemide"}, {"question_id": "213.12", "question": "How did furosemide inhibit oat2-dependent uptake of CGMP?", "answer_src": "Furosemide inhibited oat2-dependent uptake of CGMP", "follow_up_question": "What specific mechanism did furosemide use to inhibit oat2-dependent uptake of CGMP?", "follow_up_response": "furosemide", "follow_up_response_bt": "furosemide"}, {"question_id": "213.13", "question": "What is the mechanism by which furosemide inhibits oat2-dependent uptake of CGMP?", "answer_src": "furosemide", "follow_up_question": "How does furosemide specifically inhibit oat2-dependent uptake of CGMP?", "follow_up_response": "furosemide", "follow_up_response_bt": "furosemide"}, {"question_id": "213.14", "question": "What effect did furosemide have on oat2-dependent cgmp uptake?", "answer_src": "Furosemide inhibited oat2-dependent uptake of CGMP.", "follow_up_question": "How was the inhibition of oat2-dependent CGMP uptake by furosemide measured?", "follow_up_response": "furosemide", "follow_up_response_bt": "inhibited"}, {"question_id": "213.15", "question": "How is the inhibition of OAT2-dependent CGMP uptake by furosemide related to its function as an osmotic diuretic?", "answer_src": "OAT2-dependent uptake of CGMP was inhibited by furosemide.", "follow_up_question": "What other substances besides furosemide inhibit OAT2-dependent CGMP uptake?", "follow_up_response": "furosemide", "follow_up_response_bt": "Dallos索茶因"}]}}
{"id": 214, "src": "here , the trypanocidal potential of gallates was assayed in epimastigotes forms of t. cruzi and also , the interference of these substances on the mitochondrial membrane potential of the parasites was assessed , allowing the study of the mechanism of action of the gallates in the t. cruzi organisms . regarding the preliminary structure - activity relationships , the side chain length of gallates plays crucial role for activity . nonyl , decyl , undecyl , and dodecyl gallates showed potent antitrypanosomal effect ( ic50 from 1.46 to 2.90 m ) in contrast with benznidazole ( ic50 = 34.0 m ) .", "mt": ", il potenziale tripanocidico dei gallati è stato analizzato in epimastigoti forme di t. cruzi e anche , l'interferenza di queste sostanze sul potenziale della membrana mitocondriale dei parassiti è stato valutato , permettendo lo studio del meccanismo di azione dei gallati negli organismi di t. cruzi . in relazione alla struttura preliminare - relazioni di attività , la lunghezza della catena laterale dei gallati svolge un ruolo cruciale per l'attività . Nonil , decil , undecyl e dodecyllati hanno mostrato un potente effetto antitrypanosomico (ic50 da 1,46 a 2,90 m) in contrasto con il benznidazolo (ic50 = 34,0 m) .", "pert_mt": ", il potenziale tripanocidico dei gallati è stato analizzato in epimastigoti forme di t. cruzi e anche, l'interferenza di queste sostanze sul potenziale della membrana mitocondriale dei parassiti è stata valutata, permettendo lo studio del meccanismo di azione dei gallati negli organismi di t. cruzi. In relazione alla struttura preliminare - relazioni di attività, la lunghezza della catena laterale dei gallati svolge un ruolo cruciale per l'attività. Nonil, decil, undecyl e dodecyllati hanno mostrato un potente effetto antitrypanosomico (IC50 da 1,46 a 2,90 μM) in contrasto con il benznidazolo (IC50 = 34,", "bt": "In addition, the interference of these substances with the potential of the parasite mitochondrial membrane has been evaluated, allowing the study of the mechanism of action of the gallate in the organisms of the gallate.In relation to the preliminary structure - activity relationships, the length of the lateral chain of the gallate plays a crucial role for the activity.Nonyl, decyl, undecyl and dodecyllates have shown a potent antitrypanosomal effect (IC50 at 1.46 to 2.90 μM) in contrast to benzyl (IC50 = 34,)", "questions_src": ["What is the name of the organism studied in the sentence?", "Who conducted the assay of trypanocidal potential?", "Where was the assay performed?", "When was the study conducted?", "Which side chain length of gallates showed potent antitrypanosomal effect?"], "answers_src": ["T. cruzi", "Gallates", "here", "No Answer", "Nonyl, decyl, undecyl, and dodecyl"], "answers_bt": ["Organisms of the gallate", "The gallate", "In the organisms of the gallate", "No Answer", "Nonyl, decyl, undecyl and dodecyllates"], "multiturn": {"turn_1": [{"question_id": "214.1", "question": "What is the name of the organism studied in the sentence?", "answer_src": "T. cruzi", "follow_up_question": "What is the IC50 value for the most potent gallate against T. cruzi?", "follow_up_response": "2.90 m", "follow_up_response_bt": "2.90 μM"}, {"question_id": "214.2", "question": "Who conducted the assay of trypanocidal potential?", "answer_src": "Gallates", "follow_up_question": "What is the range of IC50 values for the gallates tested?", "follow_up_response": "1.46 to 2.90 μM", "follow_up_response_bt": "1.46 to 2.90 μM"}, {"question_id": "214.3", "question": "Where was the assay performed?", "answer_src": "here", "follow_up_question": "What is the range of IC50 values for the most active gallates against T. cruzi?", "follow_up_response": "1.46 to 2.90 m", "follow_up_response_bt": "1.46 to 2.90 μM"}, {"question_id": "214.4", "question": "When was the study conducted?", "answer_src": "here , the trypanocidal potential of gallates was assayed in epimastigotes forms of t. cruzi and also , the interference of these substances on the mitochondrial membrane potential of the parasites was assessed , allowing the study of the mechanism of action of the gallates in the t. cruzi organisms . regarding the preliminary structure - activity relationships , the side chain length of gallates plays crucial role for activity . nonyl , decyl , undecyl , and dodecyl gallates showed potent antitrypanosomal effect ( ic50 from 1.46 to 2.90 m ) in contrast with benznidazole ( ic50 = 34.0 m ) .", "follow_up_question": "What is the IC50 value range for the nonyl gallate's antitrypanosomal effect?", "follow_up_response": "1.46 to 2.90 m", "follow_up_response_bt": "1.46 to 2.90 μM"}, {"question_id": "214.5", "question": "Which side chain length of gallates showed potent antitrypanosomal effect?", "answer_src": "Nonyl, decyl, undecyl, and dodecyl", "follow_up_question": "What is the IC50 value for the most potent gallate (nonyl gallate) against T. cruzi?", "follow_up_response": "2.90 m", "follow_up_response_bt": "2.90 μM"}], "turn_2": [{"question_id": "214.6", "question": "What is the IC50 value for the most potent gallate against T. cruzi?", "answer_src": "2.90 m", "follow_up_question": "What is the IC50 value for benznidazole against T. cruzi?", "follow_up_response": "34.0 m", "follow_up_response_bt": "34,"}, {"question_id": "214.7", "question": "What is the range of IC50 values for the gallates tested?", "answer_src": "1.46 to 2.90 μM", "follow_up_question": "What is the IC50 value for benznidazole?", "follow_up_response": "34.0 m", "follow_up_response_bt": "34,"}, {"question_id": "214.8", "question": "What is the range of IC50 values for the most active gallates against T. cruzi?", "answer_src": "1.46 to 2.90 m", "follow_up_question": "What is the IC50 value for benznidazole against T. cruzi?", "follow_up_response": "34.0 m", "follow_up_response_bt": "34,"}, {"question_id": "214.9", "question": "What is the IC50 value range for the nonyl gallate's antitrypanosomal effect?", "answer_src": "1.46 to 2.90 m", "follow_up_question": "What is the IC50 value for benznidazole's antitrypanosomal effect?", "follow_up_response": "34.0 m", "follow_up_response_bt": "34,"}, {"question_id": "214.10", "question": "What is the IC50 value for the most potent gallate (nonyl gallate) against T. cruzi?", "answer_src": "2.90 m", "follow_up_question": "What is the IC50 value for benznidazole against T. cruzi?", "follow_up_response": "34.0 m", "follow_up_response_bt": "34,"}], "turn_3": [{"question_id": "214.11", "question": "What is the IC50 value for benznidazole against T. cruzi?", "answer_src": "34.0 m", "follow_up_question": "What is the IC50 value for the most active dodecyl gallate against T. cruzi?", "follow_up_response": "2.90 m", "follow_up_response_bt": "2.90 μM"}, {"question_id": "214.12", "question": "What is the IC50 value for benznidazole?", "answer_src": "34.0 m", "follow_up_question": "What is the IC50 value for dodecyl gallate?", "follow_up_response": "2.90 m", "follow_up_response_bt": "2.90 μM"}, {"question_id": "214.13", "question": "What is the IC50 value for benznidazole against T. cruzi?", "answer_src": "34.0 m", "follow_up_question": "What is the IC50 value for the most active dodecyl gallate against T. cruzi?", "follow_up_response": "2.90 m", "follow_up_response_bt": "2.90 μM"}, {"question_id": "214.14", "question": "What is the IC50 value for benznidazole's antitrypanosomal effect?", "answer_src": "34.0 m", "follow_up_question": "What is the IC50 value for the most potent gallate compound found in the study?", "follow_up_response": "2.90 m", "follow_up_response_bt": "2.90 μM"}, {"question_id": "214.15", "question": "What is the IC50 value for benznidazole against T. cruzi?", "answer_src": "34.0 m", "follow_up_question": "What is the IC50 value for the most active dodecyl gallate against T. cruzi?", "follow_up_response": "2.90 m", "follow_up_response_bt": "2.90 μM"}]}}
{"id": 215, "src": "early diagnosis and management of depression is important for better therapeutic outcome . strategies for distinguishing between unipolar and bipolar depression are yet to be defined , resulting improper management . this study aims at comparing the socio - demographic and other variables between patients with unipolar and bipolar depression , along with assessment of severity of depression.this cross sectional study was conducted in a tertiary care psychiatry hospital in north - east india .", "mt": "La diagnosi e la gestione precoci della depressione sono importanti per un migliore risultato terapeutico . Le strategie per distinguere tra depressione unipolare e bipolare non sono ancora state definite , il che ha portato a una gestione impropria . Questo studio mira a confrontare le variabili socio-demografiche e altre variabili tra i pazienti con depressione unipolare e bipolare , insieme alla valutazione della gravità della depressione .", "pert_mt": "La diagnosi e la gestione precoci della depressione sono importanti per un migliore risultato terapeutico. Le strategie per distinguere tra depressione unipolare e bipolare non sono ancora state definite, il che ha portato a una gestione impropria. Questo studio mira a confrontare le variabili socio-demografiche e altre variabili tra i pazienti con depressione unipolare e bipolare, insieme alla valutazione della gravità della depressione e alle differenze nelle risposte terapeutiche.", "bt": "Early diagnosis and management of depression are important for a better therapeutic outcome. strategies for distinguishing between unipolar and bipolar depression have not yet been defined, which has led to improper management.This study aims to compare socio-demographic and other variables among patients with unipolar and bipolar depression, along with an assessment of the severity of depression and differences in therapeutic responses.", "questions_src": ["What is the main goal of early diagnosis and management of depression?", "When does improper management of depression typically occur?", "Which type of depression is the study comparing in terms of socio-demographic and other variables?", "Where was this cross-sectional study conducted?", "Who is the study aimed at assessing the severity of depression for?"], "answers_src": ["Better therapeutic outcome", "Resulting improper management", "Bipolar depression", "A tertiary care psychiatry hospital in north-east India", "Patients with unipolar and bipolar depression"], "answers_bt": ["To have a better therapeutic outcome", "It typically occurs when strategies for distinguishing between unipolar and bipolar depression have not been defined", "Bipolar and unipolar", "Not specified in the sentence", "The severity of depression"], "multiturn": {"turn_1": [{"question_id": "215.1", "question": "What is the main goal of early diagnosis and management of depression?", "answer_src": "Better therapeutic outcome", "follow_up_question": "What specific variables will the study compare between patients with unipolar and bipolar depression?", "follow_up_response": "socio - demographic and other variables", "follow_up_response_bt": "socio-demographic and other variables"}, {"question_id": "215.2", "question": "When does improper management of depression typically occur?", "answer_src": "Resulting improper management", "follow_up_question": "What specific variables are being compared between patients with unipolar and bipolar depression in this study?", "follow_up_response": "socio - demographic and other variables", "follow_up_response_bt": "socio-demographic and other variables"}, {"question_id": "215.3", "question": "Which type of depression is the study comparing in terms of socio-demographic and other variables?", "answer_src": "Bipolar depression", "follow_up_question": "What are the primary objectives of this cross-sectional study?", "follow_up_response": "To compare the socio-demographic and other variables between patients with unipolar and bipolar depression, along with assessment of severity of depression.", "follow_up_response_bt": "To compare socio-demographic and other variables among patients with unipolar and bipolar depression, along with an assessment of the severity of depression and differences in therapeutic responses."}, {"question_id": "215.4", "question": "Where was this cross-sectional study conducted?", "answer_src": "A tertiary care psychiatry hospital in north-east India", "follow_up_question": "What were the primary objectives of this study?", "follow_up_response": "To compare the socio-demographic and other variables between patients with unipolar and bipolar depression, along with assessment of severity of depression", "follow_up_response_bt": "To compare socio-demographic and other variables among patients with unipolar and bipolar depression, along with an assessment of the severity of depression and differences in therapeutic responses."}, {"question_id": "215.5", "question": "Who is the study aimed at assessing the severity of depression for?", "answer_src": "Patients with unipolar and bipolar depression", "follow_up_question": "What specific socio-demographic variables will the study compare between patients with unipolar and bipolar depression?", "follow_up_response": "socio - demographic", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "215.6", "question": "What specific variables will the study compare between patients with unipolar and bipolar depression?", "answer_src": "socio - demographic and other variables", "follow_up_question": "What other aspects of depression severity will be assessed in the study?", "follow_up_response": "Severity of depression", "follow_up_response_bt": "Therapeutic responses"}, {"question_id": "215.7", "question": "What specific variables are being compared between patients with unipolar and bipolar depression in this study?", "answer_src": "socio - demographic and other variables", "follow_up_question": "What other aspects of depression severity are assessed in this study?", "follow_up_response": "Severity of depression", "follow_up_response_bt": "Therapeutic responses"}, {"question_id": "215.8", "question": "What are the primary objectives of this cross-sectional study?", "answer_src": "To compare the socio-demographic and other variables between patients with unipolar and bipolar depression, along with assessment of severity of depression.", "follow_up_question": "What specific socio-demographic variables will be compared in this study?", "follow_up_response": "Socio - demographic", "follow_up_response_bt": "No Answer"}, {"question_id": "215.9", "question": "What were the primary objectives of this study?", "answer_src": "To compare the socio-demographic and other variables between patients with unipolar and bipolar depression, along with assessment of severity of depression", "follow_up_question": "How was the study design described?", "follow_up_response": "This cross sectional study", "follow_up_response_bt": "to compare socio-demographic and other variables among patients with unipolar and bipolar depression, along with an assessment of the severity of depression and differences in therapeutic responses."}, {"question_id": "215.10", "question": "What specific socio-demographic variables will the study compare between patients with unipolar and bipolar depression?", "answer_src": "socio - demographic", "follow_up_question": "What other variables besides socio-demographic will the study assess for patients with unipolar and bipolar depression?", "follow_up_response": "Severity of depression", "follow_up_response_bt": "The severity of depression and differences in therapeutic responses"}], "turn_3": [{"question_id": "215.11", "question": "What other aspects of depression severity will be assessed in the study?", "answer_src": "Severity of depression", "follow_up_question": "What specific methods will be used to assess the severity of depression?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "215.12", "question": "What other aspects of depression severity are assessed in this study?", "answer_src": "Severity of depression", "follow_up_question": "What specific variables are compared between patients with unipolar and bipolar depression?", "follow_up_response": "socio - demographic and other variables", "follow_up_response_bt": "socio-demographic and other variables"}, {"question_id": "215.13", "question": "What specific socio-demographic variables will be compared in this study?", "answer_src": "Socio - demographic", "follow_up_question": "What other variables besides socio-demographic will be assessed in this study?", "follow_up_response": "Severity of depression", "follow_up_response_bt": "Severity of depression and differences in therapeutic responses"}, {"question_id": "215.14", "question": "How was the study design described?", "answer_src": "This cross sectional study", "follow_up_question": "What was the primary objective of the study?", "follow_up_response": "To compare the socio-demographic and other variables between patients with unipolar and bipolar depression, along with assessment of severity of depression", "follow_up_response_bt": "To compare socio-demographic and other variables among patients with unipolar and bipolar depression, along with an assessment of the severity of depression and differences in therapeutic responses."}, {"question_id": "215.15", "question": "What other variables besides socio-demographic will the study assess for patients with unipolar and bipolar depression?", "answer_src": "Severity of depression", "follow_up_question": "What specific methods will be used to assess the severity of depression in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 216, "src": "prune2 plays an important role in regulating tumor cell differentiation , proliferation , and invasiveness in neuroblastoma . our previous study revealed that prune2/obscn two - gene relative expression classifer accurately differentiated leiomyosarcoma from gastrointestinal stromal tumor . however , the association between prune2 expression and prognosis in leiomyosarcoma is poorly understood .", "mt": "Il nostro precedente studio ha rivelato che la espressione relativa a due geni di prune2/obscn classificher ha differenziato con precisione il leiomyosarcoma dal tumore stromale gastrointestinale . Tuttavia , l'associazione tra l'espressione di prune2 e la prognosi nel leiomyosarcoma è poco compresa .", "pert_mt": "Il nostro precedente studio ha rivelato che la espressione relativa a due geni di prune2/obscn classificher ha differenziato con precisione il leiomyosarcoma dal tumore stromale gastrointestinale. Tuttavia, l'associazione tra l'espressione di prune2 e la prognosi nel leiomyosarcoma è poco compresa, anche se alcuni studi recenti hanno suggerito una possibile relazione.", "bt": "Our previous study revealed that the relative expression of two prune2/obscn classificher genes accurately differentiated leiomyosarcoma from gastrointestinal stroma tumor.However, the association between prune expression2 and prognosis in leiomyosarcoma is poorly understood, although some recent studies have suggested a possible relationship.", "questions_src": ["What does prune2 play an important role in regulating?", "Who revealed that prune2/obscn two-gene relative expression classifer accurately differentiated leiomyosarcoma from gastrointestinal stromal tumor?", "Where was the association between prune2 expression and prognosis in leiomyosarcoma studied?", "When did our previous study reveal the two-gene relative expression classifer?", "Which tumor type is associated with poor understanding of prune2 expression association?"], "answers_src": ["tumor cell differentiation, proliferation, and invasiveness in neuroblastoma", "our previous study", "neuroblastoma", "no answer", "leiomyosarcoma"], "answers_bt": ["leiomyosarcoma and gastrointestinal stroma tumor", "Our previous study", "in leiomyosarcoma", "Previously", "gastrointestinal stroma tumor"], "multiturn": {"turn_1": [{"question_id": "216.1", "question": "What does prune2 play an important role in regulating?", "answer_src": "tumor cell differentiation, proliferation, and invasiveness in neuroblastoma", "follow_up_question": "What specific types of tumors did your previous study compare using the prune2/obscn two-gene relative expression classifer?", "follow_up_response": "leiomyosarcoma and gastrointestinal stromal tumor", "follow_up_response_bt": "leiomyosarcoma and gastrointestinal stroma tumor"}, {"question_id": "216.2", "question": "Who revealed that prune2/obscn two-gene relative expression classifer accurately differentiated leiomyosarcoma from gastrointestinal stromal tumor?", "answer_src": "our previous study", "follow_up_question": "What specific outcome did our previous study achieve with the prune2/obscn two-gene relative expression classifer?", "follow_up_response": "accurately differentiated leiomyosarcoma from gastrointestinal stromal tumor", "follow_up_response_bt": "Accurately differentiated leiomyosarcoma from gastrointestinal stroma tumor"}, {"question_id": "216.3", "question": "Where was the association between prune2 expression and prognosis in leiomyosarcoma studied?", "answer_src": "neuroblastoma", "follow_up_question": "What specific outcome did the previous study identify for prune2 expression in leiomyosarcoma?", "follow_up_response": "No Answer", "follow_up_response_bt": "That the relative expression of two prune2/obscn classificher genes accurately differentiated leiomyosarcoma from gastrointestinal stroma tumor."}, {"question_id": "216.4", "question": "When did our previous study reveal the two-gene relative expression classifer?", "answer_src": "no answer", "follow_up_question": "What was the basis for distinguishing leiomyosarcoma from gastrointestinal stromal tumor according to your previous study?", "follow_up_response": "prune2/obscn two-gene relative expression classifer", "follow_up_response_bt": "The relative expression of two prune2/obscn classifier genes"}, {"question_id": "216.5", "question": "Which tumor type is associated with poor understanding of prune2 expression association?", "answer_src": "leiomyosarcoma", "follow_up_question": "What specific aspects of prune2 expression are currently unclear in leiomyosarcoma?", "follow_up_response": "The association between prune2 expression and prognosis", "follow_up_response_bt": "The association between prune expression and prognosis"}], "turn_2": [{"question_id": "216.6", "question": "What specific types of tumors did your previous study compare using the prune2/obscn two-gene relative expression classifer?", "answer_src": "leiomyosarcoma and gastrointestinal stromal tumor", "follow_up_question": "What was the outcome of comparing leiomyosarcoma and gastrointestinal stromal tumor using the prune2/obscn two-gene relative expression classifer?", "follow_up_response": "prune2/obscn two-gene relative expression classifer accurately differentiated leiomyosarcoma from gastrointestinal stromal tumor.", "follow_up_response_bt": "The relative expression of two prune2/obscn classificher genes accurately differentiated leiomyosarcoma from gastrointestinal stroma tumor."}, {"question_id": "216.7", "question": "What specific outcome did our previous study achieve with the prune2/obscn two-gene relative expression classifer?", "answer_src": "accurately differentiated leiomyosarcoma from gastrointestinal stromal tumor", "follow_up_question": "What was the limitation regarding the association between prune2 expression and prognosis in leiomyosarcoma according to the text?", "follow_up_response": "the association between prune2 expression and prognosis in leiomyosarcoma is poorly understood", "follow_up_response_bt": "Although some recent studies have suggested a possible relationship, the association between prune expression2 and prognosis in leiomyosarcoma is poorly understood."}, {"question_id": "216.8", "question": "What specific outcome did the previous study identify for prune2 expression in leiomyosarcoma?", "answer_src": "prune2 plays an important role in regulating tumor cell differentiation , proliferation , and invasiveness in neuroblastoma . our previous study revealed that prune2/obscn two - gene relative expression classifer accurately differentiated leiomyosarcoma from gastrointestinal stromal tumor . however , the association between prune2 expression and prognosis in leiomyosarcoma is poorly understood .", "follow_up_question": "What specific outcomes did the previous study identify for prune2/obscn two-gene relative expression in leiomyosarcoma?", "follow_up_response": "accurately differentiated leiomyosarcoma from gastrointestinal stromal tumor", "follow_up_response_bt": "That the relative expression of two prune2/obscn classificher genes accurately differentiated leiomyosarcoma from gastrointestinal stroma tumor"}, {"question_id": "216.9", "question": "What was the basis for distinguishing leiomyosarcoma from gastrointestinal stromal tumor according to your previous study?", "answer_src": "prune2/obscn two-gene relative expression classifer", "follow_up_question": "What percentage or threshold of prune2 expression was used in the classifer?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "216.10", "question": "What specific aspects of prune2 expression are currently unclear in leiomyosarcoma?", "answer_src": "The association between prune2 expression and prognosis", "follow_up_question": "What factors might influence the prognosis associated with prune2 expression in leiomyosarcoma?", "follow_up_response": "No Answer", "follow_up_response_bt": "Some recent studies"}], "turn_3": [{"question_id": "216.11", "question": "What was the outcome of comparing leiomyosarcoma and gastrointestinal stromal tumor using the prune2/obscn two-gene relative expression classifer?", "answer_src": "prune2/obscn two-gene relative expression classifer accurately differentiated leiomyosarcoma from gastrointestinal stromal tumor.", "follow_up_question": "What were the specific outcomes for leiomyosarcoma patients with high vs low prune2 expression levels?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "216.12", "question": "What was the limitation regarding the association between prune2 expression and prognosis in leiomyosarcoma according to the text?", "answer_src": "the association between prune2 expression and prognosis in leiomyosarcoma is poorly understood", "follow_up_question": "What factors might influence the prognosis of leiomyosarcoma patients with different levels of prune2 expression?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "216.13", "question": "What specific outcomes did the previous study identify for prune2/obscn two-gene relative expression in leiomyosarcoma?", "answer_src": "accurately differentiated leiomyosarcoma from gastrointestinal stromal tumor", "follow_up_question": "What was the classification accuracy of the prune2/obscn two-gene relative expression in identifying leiomyosarcoma?", "follow_up_response": "70%", "follow_up_response_bt": "accurately differentiated leiomyosarcoma from gastrointestinal stroma tumor"}, {"question_id": "216.14", "question": "What percentage or threshold of prune2 expression was used in the classifer?", "answer_src": "prune2 plays an important role in regulating tumor cell differentiation , proliferation , and invasiveness in neuroblastoma . our previous study revealed that prune2/obscn two - gene relative expression classifer accurately differentiated leiomyosarcoma from gastrointestinal stromal tumor . however , the association between prune2 expression and prognosis in leiomyosarcoma is poorly understood .", "follow_up_question": "What specific outcomes were associated with high vs low prune2 expression levels in leiomyosarcoma according to the previous study?", "follow_up_response": "accurately differentiated leiomyosarcoma from gastrointestinal stromal tumor", "follow_up_response_bt": "The relative expression of two prune2/obscn classificher genes"}, {"question_id": "216.15", "question": "What factors might influence the prognosis associated with prune2 expression in leiomyosarcoma?", "answer_src": "prune2 plays an important role in regulating tumor cell differentiation , proliferation , and invasiveness in neuroblastoma . our previous study revealed that prune2/obscn two - gene relative expression classifer accurately differentiated leiomyosarcoma from gastrointestinal stromal tumor . however , the association between prune2 expression and prognosis in leiomyosarcoma is poorly understood .", "follow_up_question": "How does prune2 expression compare to other genes in differentiating leiomyosarcoma from gastrointestinal stromal tumor?", "follow_up_response": "prune2/obscn two-gene relative expression classifer", "follow_up_response_bt": "The relative expression of two prune2/obscn classificher genes"}]}}
{"id": 217, "src": "the accumulation of excess body weight may have important health and disease consequences for persons with multiple sclerosis ( ms ) . this study examined the effect of weight status on mobility using a comprehensive set of mobility outcomes including ambulatory performance ( timed 25-foot walk , t25fw ; 6-minute walk , 6mw ; oxygen cost of walking , cw ; spatiotemporal parameters of gait ; self - reported walking impairment , multiple sclerosis walking scale-12 ( msws-12 ) ; and free - living activity , accelerometry ) in 168 ambulatory persons with ms . mean ( sd ) bmi was 27.7 ( 5.1 ) kg / m2 .", "mt": "Questo studio ha esaminato l'effetto dello stato di peso sulla mobilità utilizzando un insieme completo di risultati di mobilità tra cui le prestazioni ambulatorie (cammina di 25 piedi , t25fw; camminata di 6 minuti , 6mw; costo dell'ossigeno di camminare , cw; parametri spaziotemporali di camminare; auto-dichiarato disturbo della camminata , sclerosi multipla scala di camminata-12 (msws-12 ); e attività libera-vivenza , accelerometria) in 168 persone ambulatorie con ms . media ( sd) bmi era di 27,7 (5,1 kg) / m2 .", "pert_mt": "Questo studio ha esaminato l'effetto dello stato di peso sulla mobilità utilizzando un insieme completo di risultati di mobilità tra cui le prestazioni ambulatorie (cammina di 25 piedi , t25fw; camminata di 6 minuti , 6mw; costo dell'ossigeno di camminare , cw; parametri spaziotemporali di camminare; auto-dichiarato disturbo della camminata , sclerosi multipla scala di camminata-12 (msws-12 ); e attività libera-vivenza , accelerometria) in 168 persone ambulatorie con ms. Inoltre, sono state registrate le condizioni dermatologiche in questi pazienti, media ( sd) bmi era di 27,7 (5,1 kg) / m2 .", "bt": "This study examined the effect of weight on mobility using a complete set of mobility results including outpatient performance (walking at 25 feet, t25fw; walking at 6 minutes, 6mw; walking oxygen cost; walking time; walking time; walking time; walking self-diagnosis; walking time disorder; walking time multiple sclerosis (MSW-12); and free-living activity (accelerometry) in 168 outpatient people with MS. In addition, dermatological conditions were reported in these patients, with a median (SD) bmi age of 27.7 (5,1 kg) / m2.", "questions_src": ["What is the average Body Mass Index (BMI) in the study participants? ", "Who were the participants in the study? ", "What mobility outcomes were used to assess the effect of weight status on mobility? ", "How many ambulatory persons with MS were included in the study? "], "answers_src": ["27.7 (5.1) kg/m²", "Ambulatory persons with MS", "Timed 25-foot walk (t25fw), 6-minute walk (6mw), oxygen cost of walking (cw), spatiotemporal parameters of gait, self-reported walking impairment (MSWS-12), and free-living activity", "168"], "answers_bt": ["27.7 (5.1) kg/m²", "Outpatient people with MS", "Walking at 25 feet, 6 minutes walking, walking oxygen cost, walking time, walking self-diagnosis, walking time disorder, walking time multiple sclerosis (MSW-12), and free-living activity (accelerometry)", "168"], "multiturn": {"turn_1": [{"question_id": "217.1", "question": "What is the average Body Mass Index (BMI) in the study participants? ", "answer_src": "27.7 (5.1) kg/m²", "follow_up_question": "What were the specific mobility outcomes measured in the study?", "follow_up_response": "timed 25-foot walk (t25fw), 6-minute walk (6mw), oxygen cost of walking (cw), spatiotemporal parameters of gait, self-reported walking impairment (MSWS-12), free-living activity", "follow_up_response_bt": "walking at 25 feet, t25fw; walking at 6 minutes, 6mw; walking oxygen cost; walking time; walking self-diagnosis; walking time disorder; walking time multiple sclerosis (MSW-12); and free-living activity (accelerometry)"}, {"question_id": "217.2", "question": "Who were the participants in the study? ", "answer_src": "Ambulatory persons with MS", "follow_up_question": "What was the average body mass index (BMI) of the participants?", "follow_up_response": "27.7 (5.1) kg/m²", "follow_up_response_bt": "27.7"}, {"question_id": "217.3", "question": "What mobility outcomes were used to assess the effect of weight status on mobility? ", "answer_src": "Timed 25-foot walk (t25fw), 6-minute walk (6mw), oxygen cost of walking (cw), spatiotemporal parameters of gait, self-reported walking impairment (MSWS-12), and free-living activity", "follow_up_question": "What was the average body mass index (bmi) of the participants in the study?", "follow_up_response": "27.7 (5.1) kg / m2", "follow_up_response_bt": "27.7"}, {"question_id": "217.4", "question": "How many ambulatory persons with MS were included in the study? ", "answer_src": "168", "follow_up_question": "What was the average Body Mass Index (BMI) of the participants in the study?", "follow_up_response": "27.7 (5.1) kg/m²", "follow_up_response_bt": "27.7"}], "turn_2": [{"question_id": "217.5", "question": "What were the specific mobility outcomes measured in the study?", "answer_src": "timed 25-foot walk (t25fw), 6-minute walk (6mw), oxygen cost of walking (cw), spatiotemporal parameters of gait, self-reported walking impairment (MSWS-12), free-living activity", "follow_up_question": "What was the average body mass index (bmi) of the participants in the study?", "follow_up_response": "27.7 (5.1) kg / m2", "follow_up_response_bt": "27.7"}, {"question_id": "217.6", "question": "What was the average body mass index (BMI) of the participants?", "answer_src": "27.7 (5.1) kg/m²", "follow_up_question": "What were the specific mobility outcomes measured in the study?", "follow_up_response": "timed 25-foot walk (t25fw), 6-minute walk (6mw), oxygen cost of walking (cw), spatiotemporal parameters of gait, self-reported walking impairment (MSWS-12), free-living activity", "follow_up_response_bt": "walking at 25 feet, t25fw; walking at 6 minutes, 6mw; walking oxygen cost; walking time; walking self-diagnosis; walking time disorder; walking time multiple sclerosis (MSW-12); and free-living activity (accelerometry)"}, {"question_id": "217.7", "question": "What was the average body mass index (bmi) of the participants in the study?", "answer_src": "27.7 (5.1) kg / m2", "follow_up_question": "What were the specific mobility outcomes measured in the study?", "follow_up_response": "timed 25-foot walk (t25fw), 6-minute walk (6mw), oxygen cost of walking (cw), spatiotemporal parameters of gait, self-reported walking impairment (MSWS-12), free-living activity", "follow_up_response_bt": "walking at 25 feet, t25fw; walking at 6 minutes, 6mw; walking oxygen cost; walking time; walking self-diagnosis; walking time disorder; walking time multiple sclerosis (MSW-12); and free-living activity (accelerometry)"}, {"question_id": "217.8", "question": "What was the average Body Mass Index (BMI) of the participants in the study?", "answer_src": "27.7 (5.1) kg/m²", "follow_up_question": "What were the specific mobility outcomes measured in the study?", "follow_up_response": "timed 25-foot walk (t25fw), 6-minute walk (6mw), oxygen cost of walking (cw), spatiotemporal parameters of gait, self-reported walking impairment (MSWS-12), free-living activity", "follow_up_response_bt": "walking at 25 feet, t25fw; walking at 6 minutes, 6mw; walking oxygen cost; walking time; walking self-diagnosis; walking time disorder; walking time multiple sclerosis (MSW-12); and free-living activity (accelerometry)"}], "turn_3": [{"question_id": "217.9", "question": "What was the average body mass index (bmi) of the participants in the study?", "answer_src": "27.7 (5.1) kg / m2", "follow_up_question": "What were the specific mobility outcomes measured in the study?", "follow_up_response": "timed 25-foot walk (t25fw), 6-minute walk (6mw), oxygen cost of walking (cw), spatiotemporal parameters of gait, self-reported walking impairment (MSWS-12), free-living activity", "follow_up_response_bt": "walking at 25 feet, t25fw; walking at 6 minutes, 6mw; walking oxygen cost; walking time; walking self-diagnosis; walking time disorder; walking time multiple sclerosis (MSW-12); and free-living activity (accelerometry)"}, {"question_id": "217.10", "question": "What were the specific mobility outcomes measured in the study?", "answer_src": "timed 25-foot walk (t25fw), 6-minute walk (6mw), oxygen cost of walking (cw), spatiotemporal parameters of gait, self-reported walking impairment (MSWS-12), free-living activity", "follow_up_question": "What was the average body mass index (bmi) of the participants in the study?", "follow_up_response": "27.7 (5.1) kg / m2", "follow_up_response_bt": "27.7"}, {"question_id": "217.11", "question": "What were the specific mobility outcomes measured in the study?", "answer_src": "timed 25-foot walk (t25fw), 6-minute walk (6mw), oxygen cost of walking (cw), spatiotemporal parameters of gait, self-reported walking impairment (MSWS-12), free-living activity", "follow_up_question": "What was the average body mass index (bmi) of the participants in the study?", "follow_up_response": "27.7 (5.1) kg / m2", "follow_up_response_bt": "27.7"}, {"question_id": "217.12", "question": "What were the specific mobility outcomes measured in the study?", "answer_src": "timed 25-foot walk (t25fw), 6-minute walk (6mw), oxygen cost of walking (cw), spatiotemporal parameters of gait, self-reported walking impairment (MSWS-12), free-living activity", "follow_up_question": "What was the average body mass index (bmi) of the participants in the study?", "follow_up_response": "27.7 (5.1) kg / m2", "follow_up_response_bt": "27.7"}]}}
{"id": 218, "src": "to determine the roughness of glass surfaces submitted to different treatments and to correlate it with the spreading velocity of two adhesive systems.glass slides were used as substrates to evaluate the spreading velocity of single bond and prime & bond nt adhesive systems . six different surface treatments were compared : 1 ) no treatment ; 2 ) silanization ( sl ) ; 3 ) sandblasting ( sb ) ; 4 ) sb + sl ; 5 ) 10% hydrofluoric acid treatment ( hf ) ; 6 ) hf + sl . before and after treatments , surface roughness was measured by a profilometer ( ra , m ) .", "mt": "Per determinare la rugosità delle superfici di vetro sottoposte a trattamenti diversi e per correlazionarla con la velocità di diffusione di due sistemi adesivi.Le diapositive di vetro sono state utilizzate come sottostrati per valutare la velocità di diffusione di un singolo sistema di legame e di primo e primo legame . Sono stati confrontati sei trattamenti di superficie diversi: 1 ) senza trattamento; 2 ) silanizzazione (sl ); 3 ) sabbia (sb ) 4 ) sb + sl ; 5 ) 10% trattamento con acido fluorico idrofluorico (hf ); 6 ) hf + sl . prima e dopo i trattamenti , la rugosità superficiale è stata misurata con un profilometro (ra , m) .", "pert_mt": "Per determinare la rugosità delle superfici di vetro sottoposte a trattamenti diversi e per correlazionarla con la velocità di diffusione di due sistemi adesivi, le diapositive di vetro sono state utilizzate come sottostrati per valutare la velocità di diffusione di un singolo sistema di legame e di primo e primo legame. Sono stati confrontati sei trattamenti di superficie diversi: 1) senza trattamento; 2) silanizzazione (sl); 3) sabbia (sb); 4) sb + sl; 5) 10% trattamento con acido fluorico idrofluorico (hf); 6) hf + sl. Prima e dopo i trattamenti, la rugosità superficiale è stata misurata con un profilometro (ra, m).", "bt": "To determine the roughness of glass surfaces undergoing various treatments and to correlate it with the diffusion rate of two adhesives, glass slides were used as substrate to evaluate the diffusion rate of a single first- and first-legame system. Six different surface treatments were performed: 1) untreated; 2) silanized (sl); 3) sand (sb); 4) sb + sl; 5) 10% treatment with hydrofluoric fluoric acid (hf); 6) hf + sl. Before and after the treatments, the surface roughness was measured with a profile meter (ra, m).", "questions_src": ["What was used as substrates to evaluate the spreading velocity of adhesive systems?", "Which adhesive systems were evaluated in the study?", "How many different surface treatments were compared in the study?", "What is the acronym for hydrofluoric acid treatment?", "Who or what was used to measure surface roughness before and after treatments?"], "answers_src": ["Glass slides", "Single bond and prime & bond nt adhesive systems", "Six", "HF", "A profilometer"], "answers_bt": ["Glass slides", "A first- and first-legame system", "Six", "HF", "Profile meter"], "multiturn": {"turn_1": [{"question_id": "218.1", "question": "What was used as substrates to evaluate the spreading velocity of adhesive systems?", "answer_src": "Glass slides", "follow_up_question": "What was the surface treatment applied to some of the glass slides before measuring their roughness?", "follow_up_response": "no treatment\", \"silanization (sl)\", \"sandblasting (sb)\", \"sb + sl\", \"10% hydrofluoric acid treatment (hf)\", \"hf + sl", "follow_up_response_bt": "untreated\", \"silanized (sl)\", \"sand (sb)\", \"sb + sl\", \"10% treatment with hydrofluoric fluoric acid (hf)\", \"hf + sl"}, {"question_id": "218.2", "question": "Which adhesive systems were evaluated in the study?", "answer_src": "Single bond and prime & bond nt adhesive systems", "follow_up_question": "What is the unit of measurement used to measure surface roughness?", "follow_up_response": "ra", "follow_up_response_bt": "m"}, {"question_id": "218.3", "question": "How many different surface treatments were compared in the study?", "answer_src": "Six", "follow_up_question": "What is the surface treatment combination \"sb + sl\"?", "follow_up_response": "Sandblasting and silanization", "follow_up_response_bt": "sand (sb) and silanized (sl)"}, {"question_id": "218.4", "question": "What is the acronym for hydrofluoric acid treatment?", "answer_src": "HF", "follow_up_question": "What is the effect of the 10% hydrofluoric acid treatment on the surface roughness according to the profilometer measurements?", "follow_up_response": "10% hydrofluoric acid treatment (hf)", "follow_up_response_bt": "10% treatment with hydrofluoric acid (hf)"}, {"question_id": "218.5", "question": "Who or what was used to measure surface roughness before and after treatments?", "answer_src": "A profilometer", "follow_up_question": "What specific parameters did the profilometer measure?", "follow_up_response": "ra , m", "follow_up_response_bt": "ra"}], "turn_2": [{"question_id": "218.6", "question": "What was the surface treatment applied to some of the glass slides before measuring their roughness?", "answer_src": "no treatment\", \"silanization (sl)\", \"sandblasting (sb)\", \"sb + sl\", \"10% hydrofluoric acid treatment (hf)\", \"hf + sl", "follow_up_question": "Which surface treatment included both sandblasting and silanization?", "follow_up_response": "sb + sl", "follow_up_response_bt": "sb + sl"}, {"question_id": "218.7", "question": "What is the unit of measurement used to measure surface roughness?", "answer_src": "ra", "follow_up_question": "What is the range of surface roughness values obtained for each treatment group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "218.8", "question": "What is the surface treatment combination \"sb + sl\"?", "answer_src": "Sandblasting and silanization", "follow_up_question": "What is the expected effect of the \"hf + sl\" treatment on surface roughness?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "218.9", "question": "What is the effect of the 10% hydrofluoric acid treatment on the surface roughness according to the profilometer measurements?", "answer_src": "10% hydrofluoric acid treatment (hf)", "follow_up_question": "How does the 10% hydrofluoric acid treatment compare in terms of surface roughness to the sandblasting treatment?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "218.10", "question": "What specific parameters did the profilometer measure?", "answer_src": "ra , m", "follow_up_question": "What was the range of surface treatments compared in this study?", "follow_up_response": "no treatment\", \"silanization (sl)\", \"sandblasting (sb)\", \"sb + sl\", \"10% hydrofluoric acid treatment (hf)\", \"hf + sl", "follow_up_response_bt": "untreated\", \"silanized (sl)\", \"sand (sb)\", \"sb + sl\", \"10% treatment with hydrofluoric fluoric acid (hf)\", \"hf + sl"}], "turn_3": [{"question_id": "218.11", "question": "Which surface treatment included both sandblasting and silanization?", "answer_src": "sb + sl", "follow_up_question": "What is the surface roughness measurement method used in the study?", "follow_up_response": "profilometer (ra, m)", "follow_up_response_bt": "profile meter (ra, m)"}, {"question_id": "218.12", "question": "What is the range of surface roughness values obtained for each treatment group?", "answer_src": "to determine the roughness of glass surfaces submitted to different treatments and to correlate it with the spreading velocity of two adhesive systems.glass slides were used as substrates to evaluate the spreading velocity of single bond and prime & bond nt adhesive systems . six different surface treatments were compared : 1 ) no treatment ; 2 ) silanization ( sl ) ; 3 ) sandblasting ( sb ) ; 4 ) sb + sl ; 5 ) 10% hydrofluoric acid treatment ( hf ) ; 6 ) hf + sl . before and after treatments , surface roughness was measured by a profilometer ( ra , m ) .", "follow_up_question": "What specific surface roughness value was measured for the no treatment group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "218.13", "question": "What is the expected effect of the \"hf + sl\" treatment on surface roughness?", "answer_src": "to determine the roughness of glass surfaces submitted to different treatments and to correlate it with the spreading velocity of two adhesive systems.glass slides were used as substrates to evaluate the spreading velocity of single bond and prime & bond nt adhesive systems . six different surface treatments were compared : 1 ) no treatment ; 2 ) silanization ( sl ) ; 3 ) sandblasting ( sb ) ; 4 ) sb + sl ; 5 ) 10% hydrofluoric acid treatment ( hf ) ; 6 ) hf + sl . before and after treatments , surface roughness was measured by a profilometer ( ra , m ) .", "follow_up_question": "How does the \"hf + sl\" treatment compare to the \"silanization (sl)\" treatment in terms of surface roughness?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "218.14", "question": "How does the 10% hydrofluoric acid treatment compare in terms of surface roughness to the sandblasting treatment?", "answer_src": "to determine the roughness of glass surfaces submitted to different treatments and to correlate it with the spreading velocity of two adhesive systems.glass slides were used as substrates to evaluate the spreading velocity of single bond and prime & bond nt adhesive systems . six different surface treatments were compared : 1 ) no treatment ; 2 ) silanization ( sl ) ; 3 ) sandblasting ( sb ) ; 4 ) sb + sl ; 5 ) 10% hydrofluoric acid treatment ( hf ) ; 6 ) hf + sl . before and after treatments , surface roughness was measured by a profilometer ( ra , m ) .", "follow_up_question": "What is the surface roughness measurement method used in the study?", "follow_up_response": "profilometer (ra, m)", "follow_up_response_bt": "profile meter (ra, m)"}, {"question_id": "218.15", "question": "What was the range of surface treatments compared in this study?", "answer_src": "no treatment\", \"silanization (sl)\", \"sandblasting (sb)\", \"sb + sl\", \"10% hydrofluoric acid treatment (hf)\", \"hf + sl", "follow_up_question": "What is the purpose of measuring surface roughness before and after each treatment?", "follow_up_response": "To determine the roughness of glass surfaces submitted to different treatments and to correlate it with the spreading velocity of two adhesive systems", "follow_up_response_bt": "To determine the roughness of glass surfaces undergoing various treatments and to correlate it with the diffusion rate of two adhesives"}]}}
{"id": 219, "src": "multiple sclerosis ( ms ) is a common neurological disease with increasing incidence and prevalence . onset of disease is most frequently in young adulthood when productivity is usually highest ; it is of chronic nature and , in the majority of patients , it will result in accumulation of disability . due to loss of productivity in patients and caregivers as well as high expenses for medical treatment , ms is considered a disease with high economic burden for patients and society .", "mt": "La sclerosi multipla (MS) è una malattia neurologica comune con incidenza e prevalenza crescenti . L'insorgenza della malattia è più frequente nella giovane età adulta quando la produttività è di solito più alta; è di natura cronica e , nella maggior parte dei pazienti , si tradurrà in accumulo di disabilità . a causa della perdita di produttività nei pazienti e negli operatori sanitari nonché delle elevate spese per il trattamento medico , la MS è considerata una malattia con un alto carico economico per i pazienti e la società .", "pert_mt": "La sclerosi multipla (MS) è una malattia neurologica comune con incidenza e prevalenza crescenti. L'insorgenza della malattia è più frequente nella giovane età adulta quando la produttività è di solito più alta; è di natura cronica e, nella maggior parte dei pazienti, si tradurrà in accumulo di disabilità. A causa della perdita di produttività nei pazienti e negli operatori sanitari nonché delle elevate spese per il trattamento medico, la MS è considerata una malattia con un alto carico economico per i pazienti e la società, che richiede cure costanti e attente.", "bt": "Multiple sclerosis (MS) is a common neurological disease with increasing incidence and prevalence.The onset of the disease is most common in young adulthood when productivity is usually highest; it is chronic in nature and, in most patients, will result in accumulation of disability.Due to the loss of productivity among patients and healthcare professionals as well as the high costs of medical treatment, MS is considered a disease with a high economic burden on patients and society, requiring constant and careful treatment.", "questions_src": ["What is the full name of the neurological disease mentioned? ", "When is the onset of the disease typically observed? ", "What type of nature does the disease have? ", "How many patients experience an accumulation of disability? "], "answers_src": ["[\"multiple sclerosis ( ms )\"], [\"in young adulthood\"], [\"chronic\"], [ \"the majority of patients \"]", "No Answer", "No Answer", "No Answer"], "answers_bt": ["Multiple sclerosis (MS)", "in young adulthood", "chronic", "most patients"], "multiturn": {"turn_1": [{"question_id": "219.1", "question": "What is the full name of the neurological disease mentioned? ", "answer_src": "[\"multiple sclerosis ( ms )\"], [\"in young adulthood\"], [\"chronic\"], [ \"the majority of patients \"]", "follow_up_question": "What percentage of patients experience an accumulation of disability due to multiple sclerosis?", "follow_up_response": "in the majority of patients", "follow_up_response_bt": "In most patients"}, {"question_id": "219.2", "question": "When is the onset of the disease typically observed? ", "answer_src": "multiple sclerosis ( ms ) is a common neurological disease with increasing incidence and prevalence . onset of disease is most frequently in young adulthood when productivity is usually highest ; it is of chronic nature and , in the majority of patients , it will result in accumulation of disability . due to loss of productivity in patients and caregivers as well as high expenses for medical treatment , ms is considered a disease with high economic burden for patients and society .", "follow_up_question": "What factor contributes significantly to the high economic burden of multiple sclerosis?", "follow_up_response": "Loss of productivity in patients and caregivers as well as high expenses for medical treatment", "follow_up_response_bt": "The loss of productivity among patients and healthcare professionals as well as the high costs of medical treatment"}, {"question_id": "219.3", "question": "What type of nature does the disease have? ", "answer_src": "multiple sclerosis ( ms ) is a common neurological disease with increasing incidence and prevalence . onset of disease is most frequently in young adulthood when productivity is usually highest ; it is of chronic nature and , in the majority of patients , it will result in accumulation of disability . due to loss of productivity in patients and caregivers as well as high expenses for medical treatment , ms is considered a disease with high economic burden for patients and society .", "follow_up_question": "How does the chronic nature of multiple sclerosis affect patient productivity?", "follow_up_response": "It will result in accumulation of disability", "follow_up_response_bt": "It will result in accumulation of disability"}, {"question_id": "219.4", "question": "How many patients experience an accumulation of disability? ", "answer_src": "multiple sclerosis ( ms ) is a common neurological disease with increasing incidence and prevalence . onset of disease is most frequently in young adulthood when productivity is usually highest ; it is of chronic nature and , in the majority of patients , it will result in accumulation of disability . due to loss of productivity in patients and caregivers as well as high expenses for medical treatment , ms is considered a disease with high economic burden for patients and society .", "follow_up_question": "What percentage of patients experience an accumulation of disability?", "follow_up_response": "in the majority of patients", "follow_up_response_bt": "In most patients"}], "turn_2": [{"question_id": "219.5", "question": "What percentage of patients experience an accumulation of disability due to multiple sclerosis?", "answer_src": "in the majority of patients", "follow_up_question": "What proportion of patients does the text suggest will not experience an accumulation of disability?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "219.6", "question": "What factor contributes significantly to the high economic burden of multiple sclerosis?", "answer_src": "Loss of productivity in patients and caregivers as well as high expenses for medical treatment", "follow_up_question": "How does the chronic nature of multiple sclerosis contribute to its high economic burden?", "follow_up_response": "Due to loss of productivity in patients and caregivers as well as high expenses for medical treatment", "follow_up_response_bt": "Due to the loss of productivity among patients and healthcare professionals as well as the high costs of medical treatment"}, {"question_id": "219.7", "question": "How does the chronic nature of multiple sclerosis affect patient productivity?", "answer_src": "It will result in accumulation of disability", "follow_up_question": "How does the accumulation of disability impact patient productivity?", "follow_up_response": "it will result in accumulation of disability", "follow_up_response_bt": "It will result in accumulation of disability"}, {"question_id": "219.8", "question": "What percentage of patients experience an accumulation of disability?", "answer_src": "in the majority of patients", "follow_up_question": "What proportion of patients does not experience an accumulation of disability?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "219.9", "question": "What proportion of patients does the text suggest will not experience an accumulation of disability?", "answer_src": "multiple sclerosis ( ms ) is a common neurological disease with increasing incidence and prevalence . onset of disease is most frequently in young adulthood when productivity is usually highest ; it is of chronic nature and , in the majority of patients , it will result in accumulation of disability . due to loss of productivity in patients and caregivers as well as high expenses for medical treatment , ms is considered a disease with high economic burden for patients and society .", "follow_up_question": "What percentage of patients is suggested to not experience an accumulation of disability?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "219.10", "question": "How does the chronic nature of multiple sclerosis contribute to its high economic burden?", "answer_src": "Due to loss of productivity in patients and caregivers as well as high expenses for medical treatment", "follow_up_question": "What specific factors contribute to high expenses for medical treatment in patients with multiple sclerosis?", "follow_up_response": "loss of productivity in patients and caregivers", "follow_up_response_bt": "The loss of productivity among patients and healthcare professionals"}, {"question_id": "219.11", "question": "How does the accumulation of disability impact patient productivity?", "answer_src": "it will result in accumulation of disability", "follow_up_question": "How many patients experience the majority of disability?", "follow_up_response": "In the majority of patients", "follow_up_response_bt": "Most patients"}, {"question_id": "219.12", "question": "What proportion of patients does not experience an accumulation of disability?", "answer_src": "multiple sclerosis ( ms ) is a common neurological disease with increasing incidence and prevalence . onset of disease is most frequently in young adulthood when productivity is usually highest ; it is of chronic nature and , in the majority of patients , it will result in accumulation of disability . due to loss of productivity in patients and caregivers as well as high expenses for medical treatment , ms is considered a disease with high economic burden for patients and society .", "follow_up_question": "What percentage of patients does not experience an accumulation of disability?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 220, "src": "drug - induced gingival overgrowth ( digo ) can be a serious concern for both patients and clinicians . digo is a well - documented side - effect of some pharmacologic agents , including , but not limited to , calcium channel blockers , phenytoin , and cyclosporine . plasma cell granulomas ( pseudotumors ) are exceedingly rare , non - neoplastic , reactive tumor - like proliferation , primarily composed of plasma cells that manifest primarily in the lungs , but may occur in various anatomic locations .", "mt": "- la crescita eccessiva della gingivia (digos) indotta dai farmaci può essere una grave preoccupazione sia per i pazienti che per i medici . Digos è un effetto collaterale ben documentato di alcuni agenti farmacologici , tra cui , ma non limitato a , i bloccanti dei canali di calcio , la fenitoina e la ciclosporina . I granulomi delle cellule del plasma (pseudotumori) sono estremamente rari , non neoplastici , tumori reattivi - come la proliferazione , composti principalmente da cellule del plasma che si manifestano principalmente nei polmoni , ma possono verificarsi in varie località anatomiche .", "pert_mt": "- la crescita eccessiva della gingivia (digos) indotta dai farmaci può essere una grave preoccupazione sia per i pazienti che per i medici. Inoltre, l'influenza dei farmaci su altri organi può aggravare ulteriormente queste preoccupazioni. Digos è un effetto collaterale ben documentato di alcuni agenti farmacologici, tra cui, ma non limitato a, i bloccanti dei canali di calcio, la fenitoina e la ciclosporina. I granulomi delle cellule del plasma (pseudotumori) sono estremamente rari, non neoplastici, tumori reattivi - come la proliferazione, composti principalmente da cellule del plasma che si manifestano principalmente nei polmoni, ma possono verificarsi in varie località anatomiche.", "bt": "The excessive growth of drug-induced gingivitis (diges) can be a serious concern for both patients and doctors, and the influence of drugs on other organs can further exacerbate these concerns, and is a well-documented side effect of some pharmacological agents, including, but not limited to, blockers of calcium channels, phenitoin and cyclosporin. Plasma cell granulomas (pseudotumors) are extremely rare, non-neoplastic, reactive tumors - like proliferation, composed primarily of plasma cells that are primarily expressed in the lungs, but can occur in anatomical locations.", "questions_src": ["What is digo short for?", "When can digo be a serious concern?", "Which pharmacologic agents are known to cause digo?", "Where can plasma cell granulomas occur?", "How are plasma cell granulomas typically described?"], "answers_src": ["[\"drug - induced gingival overgrowth\"], [\"for both patients and clinicians\"], [\"calcium channel blockers, phenytoin, and cyclosporine\"], [\"primarily in the lungs, but may occur in various anatomic locations\"], [\"plasma cell granulomas (pseudotumors) are exceedingly rare, non-neoplastic, reactive tumor-like proliferation\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["drug-induced gingivitis", "The excessive growth of drug-induced gingivitis (diges) can be a serious concern", "blockers of calcium channels, phenitoin and cyclosporin", "primarily in the lungs", "extremely rare, non-neoplastic, reactive tumors"], "multiturn": {"turn_1": [{"question_id": "220.1", "question": "What is digo short for?", "answer_src": "[\"drug - induced gingival overgrowth\"], [\"for both patients and clinicians\"], [\"calcium channel blockers, phenytoin, and cyclosporine\"], [\"primarily in the lungs, but may occur in various anatomic locations\"], [\"plasma cell granulomas (pseudotumors) are exceedingly rare, non-neoplastic, reactive tumor-like proliferation\"]", "follow_up_question": "What are some examples of pharmacologic agents that can cause digo?", "follow_up_response": "Calcium channel blockers, phenytoin, and cyclosporine", "follow_up_response_bt": "blockers of calcium channels, phenitoin and cyclosporin"}, {"question_id": "220.2", "question": "When can digo be a serious concern?", "answer_src": "drug - induced gingival overgrowth ( digo ) can be a serious concern for both patients and clinicians . digo is a well - documented side - effect of some pharmacologic agents , including , but not limited to , calcium channel blockers , phenytoin , and cyclosporine . plasma cell granulomas ( pseudotumors ) are exceedingly rare , non - neoplastic , reactive tumor - like proliferation , primarily composed of plasma cells that manifest primarily in the lungs , but may occur in various anatomic locations .", "follow_up_question": "What types of pharmacologic agents are known to cause digo?", "follow_up_response": "calcium channel blockers\", \"phenytoin\", \"cyclosporine", "follow_up_response_bt": "blockers of calcium channels, phenitoin and cyclosporin"}, {"question_id": "220.3", "question": "Which pharmacologic agents are known to cause digo?", "answer_src": "drug - induced gingival overgrowth ( digo ) can be a serious concern for both patients and clinicians . digo is a well - documented side - effect of some pharmacologic agents , including , but not limited to , calcium channel blockers , phenytoin , and cyclosporine . plasma cell granulomas ( pseudotumors ) are exceedingly rare , non - neoplastic , reactive tumor - like proliferation , primarily composed of plasma cells that manifest primarily in the lungs , but may occur in various anatomic locations .", "follow_up_question": "What specific types of plasma cell granulomas are mentioned in the text?", "follow_up_response": "plasma cell granulomas ( pseudotumors )", "follow_up_response_bt": "Plasma cell granulomas (pseudotumors)"}, {"question_id": "220.4", "question": "Where can plasma cell granulomas occur?", "answer_src": "drug - induced gingival overgrowth ( digo ) can be a serious concern for both patients and clinicians . digo is a well - documented side - effect of some pharmacologic agents , including , but not limited to , calcium channel blockers , phenytoin , and cyclosporine . plasma cell granulomas ( pseudotumors ) are exceedingly rare , non - neoplastic , reactive tumor - like proliferation , primarily composed of plasma cells that manifest primarily in the lungs , but may occur in various anatomic locations .", "follow_up_question": "Where do plasma cell granulomas primarily occur?", "follow_up_response": "the lungs", "follow_up_response_bt": "the lungs"}, {"question_id": "220.5", "question": "How are plasma cell granulomas typically described?", "answer_src": "drug - induced gingival overgrowth ( digo ) can be a serious concern for both patients and clinicians . digo is a well - documented side - effect of some pharmacologic agents , including , but not limited to , calcium channel blockers , phenytoin , and cyclosporine . plasma cell granulomas ( pseudotumors ) are exceedingly rare , non - neoplastic , reactive tumor - like proliferation , primarily composed of plasma cells that manifest primarily in the lungs , but may occur in various anatomic locations .", "follow_up_question": "What anatomical locations can plasma cell granulomas occur in?", "follow_up_response": "various anatomic locations", "follow_up_response_bt": "the lungs"}], "turn_2": [{"question_id": "220.6", "question": "What are some examples of pharmacologic agents that can cause digo?", "answer_src": "Calcium channel blockers, phenytoin, and cyclosporine", "follow_up_question": "What anatomical locations besides the lungs can plasma cell granulomas occur in?", "follow_up_response": "various anatomic locations", "follow_up_response_bt": "No Answer"}, {"question_id": "220.7", "question": "What types of pharmacologic agents are known to cause digo?", "answer_src": "calcium channel blockers\", \"phenytoin\", \"cyclosporine", "follow_up_question": "What other anatomical locations besides the lungs may experience plasma cell granulomas (pseudotumors)?", "follow_up_response": "various anatomic locations", "follow_up_response_bt": "No Answer"}, {"question_id": "220.8", "question": "What specific types of plasma cell granulomas are mentioned in the text?", "answer_src": "plasma cell granulomas ( pseudotumors )", "follow_up_question": "What anatomical locations besides the lungs are plasma cell granulomas primarily composed of?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "220.9", "question": "Where do plasma cell granulomas primarily occur?", "answer_src": "the lungs", "follow_up_question": "Where else besides the lungs might plasma cell granulomas occur?", "follow_up_response": "various anatomic locations", "follow_up_response_bt": "No Answer"}, {"question_id": "220.10", "question": "What anatomical locations can plasma cell granulomas occur in?", "answer_src": "various anatomic locations", "follow_up_question": "What percentage of patients taking calcium channel blockers develop plasma cell granulomas?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "220.11", "question": "What anatomical locations besides the lungs can plasma cell granulomas occur in?", "answer_src": "various anatomic locations", "follow_up_question": "What specific type of cells compose plasma cell granulomas?", "follow_up_response": "Plasma cells", "follow_up_response_bt": "Plasma cells"}, {"question_id": "220.12", "question": "What other anatomical locations besides the lungs may experience plasma cell granulomas (pseudotumors)?", "answer_src": "various anatomic locations", "follow_up_question": "What specific anatomic locations besides the lungs may experience plasma cell granulomas (pseudotumors)?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "220.13", "question": "What anatomical locations besides the lungs are plasma cell granulomas primarily composed of?", "answer_src": "drug - induced gingival overgrowth ( digo ) can be a serious concern for both patients and clinicians . digo is a well - documented side - effect of some pharmacologic agents , including , but not limited to , calcium channel blockers , phenytoin , and cyclosporine . plasma cell granulomas ( pseudotumors ) are exceedingly rare , non - neoplastic , reactive tumor - like proliferation , primarily composed of plasma cells that manifest primarily in the lungs , but may occur in various anatomic locations .", "follow_up_question": "What are the primary anatomical locations where plasma cell granulomas may occur besides the lungs?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "220.14", "question": "Where else besides the lungs might plasma cell granulomas occur?", "answer_src": "various anatomic locations", "follow_up_question": "What specific anatomic locations besides the lungs might plasma cell granulomas occur?", "follow_up_response": "various anatomic locations", "follow_up_response_bt": "No Answer"}, {"question_id": "220.15", "question": "What percentage of patients taking calcium channel blockers develop plasma cell granulomas?", "answer_src": "drug - induced gingival overgrowth ( digo ) can be a serious concern for both patients and clinicians . digo is a well - documented side - effect of some pharmacologic agents , including , but not limited to , calcium channel blockers , phenytoin , and cyclosporine . plasma cell granulomas ( pseudotumors ) are exceedingly rare , non - neoplastic , reactive tumor - like proliferation , primarily composed of plasma cells that manifest primarily in the lungs , but may occur in various anatomic locations .", "follow_up_question": "What anatomical locations besides the lungs can plasma cell granulomas occur in?", "follow_up_response": "various anatomic locations", "follow_up_response_bt": "No Answer"}]}}
{"id": 221, "src": "chi square statistical analysis was used to test the significance of association among doctors and nurses with various outcome variables ( motivators to report , perceived barriers , preferred person to report and patient 's outcome that influence reporting behaviors ) . p value of < 0.05 was considered significant . student doctors and student nurses were not included in the study.unlike consultant , registrars , medical officers and nurses ( more than 95% are willing to report ) , only 20% of house officers will report the incident happened through them .", "mt": "L'analisi statistica quadrata di chi è stata utilizzata per testare l'importanza dell'associazione tra medici e infermieri con varie variabili di risultato (motivatori per riferire , barriere percepite , persona preferita per riferire e risultato del paziente che influenzano i comportamenti di segnalazione) . Il valore p di <0,05 è stato considerato significativo .", "pert_mt": "L'analisi statistica quadrata di chi è stata utilizzata per testare l'importanza dell'associazione tra medici e infermieri con varie variabili di risultato (motivatori per riferire, barriere percepite, persona preferita per riferire, risultato del paziente che influenzano i comportamenti di segnalazione e livelli di stress professionale) . Il valore p di <0,05 è stato considerato significativo.", "bt": "The quadratic statistical analysis of who has been used to test the importance of the association between doctors and nurses with various result variables (motivators per reference, perceived barrier, preferred person per reference, patient outcome influencing signaling behaviours and levels of professional stress) has been considered significant.", "questions_src": ["What is the statistical method used to test the association?", "Who were excluded from the study?", "What is the threshold for p-value to be considered significant?", "Which group has the highest willingness to report incidents?", "Which group reported the incident at a lower rate?"], "answers_src": ["[\"chi square statistical analysis\"], [\"student doctors and student nurses\"], [\"< 0.05\"], [\"consultant, registrars, medical officers and nurses\"], [\"house officers\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["The quadratic statistical analysis", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "221.1", "question": "What is the statistical method used to test the association?", "answer_src": "[\"chi square statistical analysis\"], [\"student doctors and student nurses\"], [\"< 0.05\"], [\"consultant, registrars, medical officers and nurses\"], [\"house officers\"]", "follow_up_question": "What percentage of house officers reported incidents according to the study?", "follow_up_response": "20%", "follow_up_response_bt": "No Answer"}, {"question_id": "221.2", "question": "Who were excluded from the study?", "answer_src": "chi square statistical analysis was used to test the significance of association among doctors and nurses with various outcome variables ( motivators to report , perceived barriers , preferred person to report and patient 's outcome that influence reporting behaviors ) . p value of < 0.05 was considered significant . student doctors and student nurses were not included in the study.unlike consultant , registrars , medical officers and nurses ( more than 95% are willing to report ) , only 20% of house officers will report the incident happened through them .", "follow_up_question": "What percentage of house officers reported the incidents?", "follow_up_response": "20%", "follow_up_response_bt": "No Answer"}, {"question_id": "221.3", "question": "What is the threshold for p-value to be considered significant?", "answer_src": "chi square statistical analysis was used to test the significance of association among doctors and nurses with various outcome variables ( motivators to report , perceived barriers , preferred person to report and patient 's outcome that influence reporting behaviors ) . p value of < 0.05 was considered significant . student doctors and student nurses were not included in the study.unlike consultant , registrars , medical officers and nurses ( more than 95% are willing to report ) , only 20% of house officers will report the incident happened through them .", "follow_up_question": "What percentage of house officers reported the incident?", "follow_up_response": "20%", "follow_up_response_bt": "No Answer"}, {"question_id": "221.4", "question": "Which group has the highest willingness to report incidents?", "answer_src": "chi square statistical analysis was used to test the significance of association among doctors and nurses with various outcome variables ( motivators to report , perceived barriers , preferred person to report and patient 's outcome that influence reporting behaviors ) . p value of < 0.05 was considered significant . student doctors and student nurses were not included in the study.unlike consultant , registrars , medical officers and nurses ( more than 95% are willing to report ) , only 20% of house officers will report the incident happened through them .", "follow_up_question": "What percentage of house officers reported incidents?", "follow_up_response": "20%", "follow_up_response_bt": "No Answer"}, {"question_id": "221.5", "question": "Which group reported the incident at a lower rate?", "answer_src": "chi square statistical analysis was used to test the significance of association among doctors and nurses with various outcome variables ( motivators to report , perceived barriers , preferred person to report and patient 's outcome that influence reporting behaviors ) . p value of < 0.05 was considered significant . student doctors and student nurses were not included in the study.unlike consultant , registrars , medical officers and nurses ( more than 95% are willing to report ) , only 20% of house officers will report the incident happened through them .", "follow_up_question": "What percentage of house officers reported the incident?", "follow_up_response": "20%", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "221.6", "question": "What percentage of house officers reported incidents according to the study?", "answer_src": "20%", "follow_up_question": "What was the overall willingness of doctors and nurses to report incidents based on the study?", "follow_up_response": "More than 95%", "follow_up_response_bt": "No Answer"}, {"question_id": "221.7", "question": "What percentage of house officers reported the incidents?", "answer_src": "20%", "follow_up_question": "What was the threshold for considering the results statistically significant?", "follow_up_response": "p value of < 0.05", "follow_up_response_bt": "No Answer"}, {"question_id": "221.8", "question": "What percentage of house officers reported the incident?", "answer_src": "20%", "follow_up_question": "What was the threshold for considering the results statistically significant?", "follow_up_response": "p value of < 0.05", "follow_up_response_bt": "No Answer"}, {"question_id": "221.9", "question": "What percentage of house officers reported incidents?", "answer_src": "20%", "follow_up_question": "What was the threshold for considering the results statistically significant?", "follow_up_response": "p value of < 0.05", "follow_up_response_bt": "No Answer"}, {"question_id": "221.10", "question": "What percentage of house officers reported the incident?", "answer_src": "20%", "follow_up_question": "What was the threshold for considering the results statistically significant?", "follow_up_response": "p value of < 0.05", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "221.11", "question": "What was the overall willingness of doctors and nurses to report incidents based on the study?", "answer_src": "More than 95%", "follow_up_question": "What was the reported willingness of house officers to report incidents according to the study?", "follow_up_response": "20%", "follow_up_response_bt": "No Answer"}, {"question_id": "221.12", "question": "What was the threshold for considering the results statistically significant?", "answer_src": "p value of < 0.05", "follow_up_question": "What percentage of house officers reported incidents according to the study?", "follow_up_response": "20%", "follow_up_response_bt": "No Answer"}, {"question_id": "221.13", "question": "What was the threshold for considering the results statistically significant?", "answer_src": "p value of < 0.05", "follow_up_question": "What percentage of house officers reported incidents according to the study?", "follow_up_response": "20%", "follow_up_response_bt": "No Answer"}, {"question_id": "221.14", "question": "What was the threshold for considering the results statistically significant?", "answer_src": "p value of < 0.05", "follow_up_question": "What percentage of house officers reported incidents according to the study?", "follow_up_response": "20%", "follow_up_response_bt": "No Answer"}, {"question_id": "221.15", "question": "What was the threshold for considering the results statistically significant?", "answer_src": "p value of < 0.05", "follow_up_question": "What percentage of house officers reported incidents according to the study?", "follow_up_response": "20%", "follow_up_response_bt": "No Answer"}]}}
{"id": 222, "src": "radiologically , a lytic lesion at ilio - acetabular region was seen . intra - operatively breach in acetabular roof was seen which was missed in the scan . curettage and defect reconstruction was done .", "mt": "Radiologicamente , è stata osservata una lesione litica nella regione ilio-acetabulare . È stata osservata una rottura intra-operatoria nel tetto acetabulare , che è stata mancata nella scansione . È stato eseguito un curettage e una ricostruzione di difetti .", "pert_mt": "Radiologicamente, è stata osservata una lesione litica nella regione ilio-acetabulare. È stata osservata una rottura intra-operatoria nel tetto acetabulare, che è stata mancata nella scansione. È stato eseguito un curettage e una ricostruzione di difetti, ma non è stata identificata alcuna complicazione postoperatoria.", "bt": "Radiologically, a litic lesion was observed in the ilio-acetabula region, an intraoperative rupture was observed in the tetto acetabula, which was missing in the scan, a curettage and reconstruction of defects were performed, but no postoperative complications were identified.", "questions_src": ["What was seen radiologically at the ilio-acetabular region?", "Who missed seeing the breach in the acetabular roof during the scan?", "Where was the breach in the acetabular roof located?", "When was curettage and defect reconstruction performed?", "Which procedure was done to address the issue?"], "answers_src": ["A lytic lesion", "No Answer", "Ilio-acetabular region", "Intra-operatively", "Curettage and defect reconstruction"], "answers_bt": ["A litic lesion", "No Answer", "The acetabular roof", "During the scan", "Curettage and reconstruction of defects"], "multiturn": {"turn_1": [{"question_id": "222.1", "question": "What was seen radiologically at the ilio-acetabular region?", "answer_src": "A lytic lesion", "follow_up_question": "What procedure was performed to address the lytic lesion?", "follow_up_response": "curettage and defect reconstruction", "follow_up_response_bt": "A curettage and reconstruction of defects"}, {"question_id": "222.2", "question": "Who missed seeing the breach in the acetabular roof during the scan?", "answer_src": "radiologically , a lytic lesion at ilio - acetabular region was seen . intra - operatively breach in acetabular roof was seen which was missed in the scan . curettage and defect reconstruction was done .", "follow_up_question": "What procedure was performed after the curettage?", "follow_up_response": "Defect reconstruction", "follow_up_response_bt": "Reconstruction of defects"}, {"question_id": "222.3", "question": "Where was the breach in the acetabular roof located?", "answer_src": "Ilio-acetabular region", "follow_up_question": "What procedure was performed after the curettage?", "follow_up_response": "Defect reconstruction", "follow_up_response_bt": "Reconstruction of defects"}, {"question_id": "222.4", "question": "When was curettage and defect reconstruction performed?", "answer_src": "Intra-operatively", "follow_up_question": "What procedure was performed before curettage and defect reconstruction?", "follow_up_response": "Intra-operatively", "follow_up_response_bt": "Intraoperative rupture"}, {"question_id": "222.5", "question": "Which procedure was done to address the issue?", "answer_src": "Curettage and defect reconstruction", "follow_up_question": "What specific part of the acetabulum was reconstructed?", "follow_up_response": "Acetabular roof", "follow_up_response_bt": "the tetto acetabula"}], "turn_2": [{"question_id": "222.6", "question": "What procedure was performed to address the lytic lesion?", "answer_src": "curettage and defect reconstruction", "follow_up_question": "What specific structure was missed during the initial scan?", "follow_up_response": "Acetabular roof", "follow_up_response_bt": "the tetto acetabula"}, {"question_id": "222.7", "question": "What procedure was performed after the curettage?", "answer_src": "Defect reconstruction", "follow_up_question": "What material was used for the defect reconstruction?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "222.8", "question": "What procedure was performed after the curettage?", "answer_src": "Defect reconstruction", "follow_up_question": "What material was used for the defect reconstruction?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "222.9", "question": "What procedure was performed before curettage and defect reconstruction?", "answer_src": "Intra-operatively", "follow_up_question": "What specific defect needed reconstruction?", "follow_up_response": "lytic lesion", "follow_up_response_bt": "defects"}, {"question_id": "222.10", "question": "What specific part of the acetabulum was reconstructed?", "answer_src": "Acetabular roof", "follow_up_question": "What procedure was performed to reconstruct the acetabular roof?", "follow_up_response": "curettage and defect reconstruction", "follow_up_response_bt": "curettage and reconstruction of defects"}], "turn_3": [{"question_id": "222.11", "question": "What specific structure was missed during the initial scan?", "answer_src": "Acetabular roof", "follow_up_question": "What procedure was performed after the curettage?", "follow_up_response": "Defect reconstruction", "follow_up_response_bt": "Reconstruction of defects"}, {"question_id": "222.12", "question": "What material was used for the defect reconstruction?", "answer_src": "radiologically , a lytic lesion at ilio - acetabular region was seen . intra - operatively breach in acetabular roof was seen which was missed in the scan . curettage and defect reconstruction was done .", "follow_up_question": "What procedure was performed to reconstruct the defect?", "follow_up_response": "curettage and defect reconstruction", "follow_up_response_bt": "curettage and reconstruction of defects"}, {"question_id": "222.13", "question": "What material was used for the defect reconstruction?", "answer_src": "radiologically , a lytic lesion at ilio - acetabular region was seen . intra - operatively breach in acetabular roof was seen which was missed in the scan . curettage and defect reconstruction was done .", "follow_up_question": "What procedure was performed to reconstruct the defect?", "follow_up_response": "curettage and defect reconstruction", "follow_up_response_bt": "curettage and reconstruction of defects"}, {"question_id": "222.14", "question": "What specific defect needed reconstruction?", "answer_src": "lytic lesion", "follow_up_question": "What procedure was performed to reconstruct the defect?", "follow_up_response": "curettage and defect reconstruction", "follow_up_response_bt": "curettage and reconstruction of defects"}, {"question_id": "222.15", "question": "What procedure was performed to reconstruct the acetabular roof?", "answer_src": "curettage and defect reconstruction", "follow_up_question": "What specific defect was the curettage intended to remove?", "follow_up_response": "A lytic lesion", "follow_up_response_bt": "defect"}]}}
{"id": 223, "src": "the purpose of this analytical study was to examine and critique the engineering foundations of commonly accepted biomechanical principles of mandible fracture repair . materials and methods . basic principles of static equilibrium were applied to intact and plated mandibles , but instead of the traditional lever forces , the mandibles were subjected to more realistic occlusal forces .", "mt": "Lo scopo di questo studio analitico era di esaminare e criticare le basi ingegneristiche dei principi biomeccanici comunemente accettati di riparazione delle fratture della mandibola . materiali e metodi . principi di equilibrio statico di base sono stati applicati alle mandiboli intatte e rivestimentate , ma invece delle tradizionali forze di leva , le mandiboli sono state sottoposte a forze occlusali più realistiche .", "pert_mt": "Lo scopo di questo studio analitico era di esaminare e criticare le basi ingegneristiche dei principi biomeccanici comunemente accettati di riparazione delle fratture della mandibola. Inoltre, materiali e metodi. principi di equilibrio statico di base sono stati applicati alle mandiboli intatte e rivestimentate, ma invece delle tradizionali forze di leva, le mandiboli sono state sottoposte a forze occlusali più realistiche.", "bt": "The purpose of this analytical study was to examine and criticize the engineering basis of the generally accepted biomechanical principles of jaw fracture repair.Moreover, materials and methods. basic static equilibrium principles have been applied to intact and riveted jaws, but instead of the traditional forces of lift, the jaws have been subjected to more realistic occlusal forces.", "questions_src": ["What is the main focus of the analytical study mentioned in the sentence?", "Who were the authors examining and critiquing the engineering foundations for?", "Where were the experiments conducted with the mandibles?", "When was the application of static equilibrium principles observed?", "Which type of forces were used in the experiments instead of traditional lever forces?"], "answers_src": ["[\"to examine and critique the engineering foundations of commonly accepted biomechanical principles of mandible fracture repair\"], [], [], [\"occlusal forces\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"To examine and criticize the engineering basis of the generally accepted biomechanical principles of jaw fracture repair\"], [\"The authors\"], [\"With the mandibles\"], [\"No Answer\"], [\"Occlusal forces\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "223.1", "question": "What is the main focus of the analytical study mentioned in the sentence?", "answer_src": "[\"to examine and critique the engineering foundations of commonly accepted biomechanical principles of mandible fracture repair\"], [], [], [\"occlusal forces\"]", "follow_up_question": "How were the mandibles subjected to the occlusal forces differently from traditional methods?", "follow_up_response": "Instead of the traditional lever forces, the mandibles were subjected to more realistic occlusal forces.", "follow_up_response_bt": "More realistic occlusal forces"}, {"question_id": "223.2", "question": "Who were the authors examining and critiquing the engineering foundations for?", "answer_src": "the purpose of this analytical study was to examine and critique the engineering foundations of commonly accepted biomechanical principles of mandible fracture repair . materials and methods . basic principles of static equilibrium were applied to intact and plated mandibles , but instead of the traditional lever forces , the mandibles were subjected to more realistic occlusal forces .", "follow_up_question": "What specific type of forces were the authors using instead of traditional lever forces?", "follow_up_response": "occlusal forces", "follow_up_response_bt": "occlusal forces"}, {"question_id": "223.3", "question": "Where were the experiments conducted with the mandibles?", "answer_src": "the purpose of this analytical study was to examine and critique the engineering foundations of commonly accepted biomechanical principles of mandible fracture repair . materials and methods . basic principles of static equilibrium were applied to intact and plated mandibles , but instead of the traditional lever forces , the mandibles were subjected to more realistic occlusal forces .", "follow_up_question": "What type of forces were used instead of traditional lever forces on the mandibles?", "follow_up_response": "occlusal forces", "follow_up_response_bt": "occlusal forces"}, {"question_id": "223.4", "question": "When was the application of static equilibrium principles observed?", "answer_src": "the purpose of this analytical study was to examine and critique the engineering foundations of commonly accepted biomechanical principles of mandible fracture repair . materials and methods . basic principles of static equilibrium were applied to intact and plated mandibles , but instead of the traditional lever forces , the mandibles were subjected to more realistic occlusal forces .", "follow_up_question": "What type of forces were used instead of traditional lever forces?", "follow_up_response": "occlusal forces", "follow_up_response_bt": "occlusal forces"}, {"question_id": "223.5", "question": "Which type of forces were used in the experiments instead of traditional lever forces?", "answer_src": "the purpose of this analytical study was to examine and critique the engineering foundations of commonly accepted biomechanical principles of mandible fracture repair . materials and methods . basic principles of static equilibrium were applied to intact and plated mandibles , but instead of the traditional lever forces , the mandibles were subjected to more realistic occlusal forces .", "follow_up_question": "What specific occlusal forces were applied to the mandibles in the experiments?", "follow_up_response": "More realistic occlusal forces", "follow_up_response_bt": "occlusal forces"}], "turn_2": [{"question_id": "223.6", "question": "How were the mandibles subjected to the occlusal forces differently from traditional methods?", "answer_src": "Instead of the traditional lever forces, the mandibles were subjected to more realistic occlusal forces.", "follow_up_question": "What were the specific characteristics of the occlusal forces used in this study?", "follow_up_response": "More realistic", "follow_up_response_bt": "More realistic occlusal forces"}, {"question_id": "223.7", "question": "What specific type of forces were the authors using instead of traditional lever forces?", "answer_src": "occlusal forces", "follow_up_question": "What were the implications of using occlusal forces instead of traditional lever forces in the study?", "follow_up_response": "To use more realistic occlusal forces", "follow_up_response_bt": "To use more realistic occlusal forces instead of traditional lever forces"}, {"question_id": "223.8", "question": "What type of forces were used instead of traditional lever forces on the mandibles?", "answer_src": "occlusal forces", "follow_up_question": "What specific characteristics made occlusal forces more realistic compared to traditional lever forces?", "follow_up_response": "More realistic occlusal forces", "follow_up_response_bt": "occlusal forces"}, {"question_id": "223.9", "question": "What type of forces were used instead of traditional lever forces?", "answer_src": "occlusal forces", "follow_up_question": "What specific characteristics made occlusal forces more realistic compared to traditional lever forces?", "follow_up_response": "More realistic occlusal forces", "follow_up_response_bt": "occlusal forces"}, {"question_id": "223.10", "question": "What specific occlusal forces were applied to the mandibles in the experiments?", "answer_src": "More realistic occlusal forces", "follow_up_question": "How did these more realistic occlusal forces differ from traditional lever forces?", "follow_up_response": "More realistic occlusal forces differed from traditional lever forces", "follow_up_response_bt": "More realistic occlusal forces differ from traditional lever forces"}], "turn_3": [{"question_id": "223.11", "question": "What were the specific characteristics of the occlusal forces used in this study?", "answer_src": "More realistic", "follow_up_question": "What were the traditional forces that were not used in this study?", "follow_up_response": "lever forces", "follow_up_response_bt": "Traditional forces of lift"}, {"question_id": "223.12", "question": "What were the implications of using occlusal forces instead of traditional lever forces in the study?", "answer_src": "To use more realistic occlusal forces", "follow_up_question": "How did using occlusal forces instead of traditional lever forces affect the results of the study?", "follow_up_response": "affected the results of the study", "follow_up_response_bt": "The jaws have been subjected to more realistic occlusal forces."}, {"question_id": "223.13", "question": "What specific characteristics made occlusal forces more realistic compared to traditional lever forces?", "answer_src": "More realistic occlusal forces", "follow_up_question": "How did the application of occlusal forces differ from the traditional lever forces used in the study?", "follow_up_response": "The mandibles were subjected to more realistic occlusal forces instead of the traditional lever forces.", "follow_up_response_bt": "More realistic occlusal forces"}, {"question_id": "223.14", "question": "What specific characteristics made occlusal forces more realistic compared to traditional lever forces?", "answer_src": "More realistic occlusal forces", "follow_up_question": "How did the application of occlusal forces differ from the traditional lever forces used in the study?", "follow_up_response": "The mandibles were subjected to more realistic occlusal forces instead of the traditional lever forces.", "follow_up_response_bt": "More realistic occlusal forces"}, {"question_id": "223.15", "question": "How did these more realistic occlusal forces differ from traditional lever forces?", "answer_src": "More realistic occlusal forces differed from traditional lever forces", "follow_up_question": "What specific occlusal forces were used in the study?", "follow_up_response": "More realistic occlusal forces", "follow_up_response_bt": "occlusal forces"}]}}
{"id": 224, "src": "seasonal and pandemic influenza outbreaks remain a major human health problem . inhibition of the endonuclease activity of influenza rna - dependent rna polymerase is attractive for the development of new agents for the treatment of influenza infection . our earlier studies identified a series of 5- and 6-phenyl substituted 3-hydroxypyridin-2(1h)-ones that were effective inhibitors of influenza endonuclease .", "mt": "Gli scoppi di influenza stagionale e pandemica rimangono un problema di salute umana importante . L'inibizione dell'attività endonucleasi dell'influenza rna - rna polimerasi dipendente è attraente per lo sviluppo di nuovi agenti per il trattamento dell'infezione influenzale . I nostri studi precedenti hanno identificato una serie di 5- e 6-fenil sostituito 3-idrossipiridina-2(1h) -one che erano efficaci inibitori dell'endonucleasi influenzale .", "pert_mt": "Gli scoppi di influenza stagionale e pandemica rimangono un problema di salute umana importante. L'inibizione dell'attività endonucleasi dell'influenza rna-rna polimerasi dipendente è attraente per lo sviluppo di nuovi agenti per il trattamento dell'infezione influenzale. I nostri studi precedenti hanno identificato una serie di 5- e 6-fenil sostituiti 3-idrossipiridina-2(1h)-one che erano efficaci inibitori dell'endonucleasi influenzale e potenzialmente benefici per la riduzione dei sintomi respiratori.", "bt": "The outbreak of seasonal and pandemic influenza remains an important human health problem.Inhibition of influenza-dependent RNA polymerase endonuclease activity is attractive for the development of new agents for the treatment of influenza infection.Our previous studies have identified a series of 5- and 6-phenyl substitute 3-hydrossipiridine-2 ((1h) -one) that were effective inhibitors of influenza endonuclease and potentially beneficial for reducing respiratory symptoms.", "questions_src": ["What is the main focus of the study described in the sentence?", "Who are the potential beneficiaries of the new influenza treatment agents?", "Where can seasonal and pandemic influenza outbreaks occur?", "When did the sentence suggest that seasonal and pandemic influenza outbreaks remain a significant issue?", "Which type of RNA polymerase is inhibited by the 5- and 6-phenyl substituted 3-hydroxypyridin-2(1h)-ones?"], "answers_src": ["[\"Inhibition of the endonuclease activity of influenza RNA-dependent RNA polymerase\"], [], [\"remain a major human health problem\"], [\"RNA-dependent RNA polymerase\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["The outbreak of seasonal and pandemic influenza", "Respiratory symptoms", "Anywhere", "Currently", "Influenza-dependent RNA polymerase"], "multiturn": {"turn_1": [{"question_id": "224.1", "question": "What is the main focus of the study described in the sentence?", "answer_src": "[\"Inhibition of the endonuclease activity of influenza RNA-dependent RNA polymerase\"], [], [\"remain a major human health problem\"], [\"RNA-dependent RNA polymerase\"]", "follow_up_question": "How many types of compounds were found to be effective inhibitors in the study?", "follow_up_response": "2", "follow_up_response_bt": "2"}, {"question_id": "224.2", "question": "Who are the potential beneficiaries of the new influenza treatment agents?", "answer_src": "seasonal and pandemic influenza outbreaks remain a major human health problem . inhibition of the endonuclease activity of influenza rna - dependent rna polymerase is attractive for the development of new agents for the treatment of influenza infection . our earlier studies identified a series of 5- and 6-phenyl substituted 3-hydroxypyridin-2(1h)-ones that were effective inhibitors of influenza endonuclease .", "follow_up_question": "What type of compounds were found to be effective inhibitors in the study?", "follow_up_response": "5- and 6-phenyl substituted 3-hydroxypyridin-2(1h)-ones", "follow_up_response_bt": "A series of 5- and 6-phenyl substitute 3-hydrossipiridine-2(1H)-ones"}, {"question_id": "224.3", "question": "Where can seasonal and pandemic influenza outbreaks occur?", "answer_src": "seasonal and pandemic influenza outbreaks remain a major human health problem . inhibition of the endonuclease activity of influenza rna - dependent rna polymerase is attractive for the development of new agents for the treatment of influenza infection . our earlier studies identified a series of 5- and 6-phenyl substituted 3-hydroxypyridin-2(1h)-ones that were effective inhibitors of influenza endonuclease .", "follow_up_question": "What type of compounds were found to be effective inhibitors in the study?", "follow_up_response": "5- and 6-phenyl substituted 3-hydroxypyridin-2(1h)-ones", "follow_up_response_bt": "A series of 5- and 6-phenyl substitute 3-hydrossipiridine-2(1H)-ones"}, {"question_id": "224.4", "question": "When did the sentence suggest that seasonal and pandemic influenza outbreaks remain a significant issue?", "answer_src": "seasonal and pandemic influenza outbreaks remain a major human health problem . inhibition of the endonuclease activity of influenza rna - dependent rna polymerase is attractive for the development of new agents for the treatment of influenza infection . our earlier studies identified a series of 5- and 6-phenyl substituted 3-hydroxypyridin-2(1h)-ones that were effective inhibitors of influenza endonuclease .", "follow_up_question": "What specific aspect of influenza does the text suggest is attractive for developing new treatments?", "follow_up_response": "Inhibition of the endonuclease activity of influenza RNA-dependent RNA polymerase", "follow_up_response_bt": "Inhibition of influenza-dependent RNA polymerase endonuclease activity"}, {"question_id": "224.5", "question": "Which type of RNA polymerase is inhibited by the 5- and 6-phenyl substituted 3-hydroxypyridin-2(1h)-ones?", "answer_src": "seasonal and pandemic influenza outbreaks remain a major human health problem . inhibition of the endonuclease activity of influenza rna - dependent rna polymerase is attractive for the development of new agents for the treatment of influenza infection . our earlier studies identified a series of 5- and 6-phenyl substituted 3-hydroxypyridin-2(1h)-ones that were effective inhibitors of influenza endonuclease .", "follow_up_question": "What specific enzyme do these compounds inhibit?", "follow_up_response": "Influenza endonuclease", "follow_up_response_bt": "influenza endonuclease"}], "turn_2": [{"question_id": "224.6", "question": "How many types of compounds were found to be effective inhibitors in the study?", "answer_src": "2", "follow_up_question": "What are the characteristics of these two types of compounds?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "224.7", "question": "What type of compounds were found to be effective inhibitors in the study?", "answer_src": "5- and 6-phenyl substituted 3-hydroxypyridin-2(1h)-ones", "follow_up_question": "What was the mechanism by which these compounds inhibited the influenza endonuclease?", "follow_up_response": "These compounds were 5- and 6-phenyl substituted 3-hydroxypyridin-2(1h)-ones", "follow_up_response_bt": "Inhibition of influenza-dependent RNA polymerase endonuclease activity"}, {"question_id": "224.8", "question": "What type of compounds were found to be effective inhibitors in the study?", "answer_src": "5- and 6-phenyl substituted 3-hydroxypyridin-2(1h)-ones", "follow_up_question": "What was the mechanism by which these compounds inhibited the influenza endonuclease?", "follow_up_response": "These compounds were 5- and 6-phenyl substituted 3-hydroxypyridin-2(1h)-ones", "follow_up_response_bt": "Inhibition of influenza-dependent RNA polymerase endonuclease activity"}, {"question_id": "224.9", "question": "What specific aspect of influenza does the text suggest is attractive for developing new treatments?", "answer_src": "Inhibition of the endonuclease activity of influenza RNA-dependent RNA polymerase", "follow_up_question": "What type of molecules did the authors identify as effective inhibitors of influenza endonuclease?", "follow_up_response": "5- and 6-phenyl substituted 3-hydroxypyridin-2(1h)-ones", "follow_up_response_bt": "A series of 5- and 6-phenyl substitute 3-hydrossipiridine-2(1H)-ones"}, {"question_id": "224.10", "question": "What specific enzyme do these compounds inhibit?", "answer_src": "Influenza endonuclease", "follow_up_question": "What type of chemical structure do these inhibitors have?", "follow_up_response": "5- and 6-phenyl substituted 3-hydroxypyridin-2(1h)-ones", "follow_up_response_bt": "5- and 6-phenyl substitute 3-hydrossipiridine-2(1h)-one"}], "turn_3": [{"question_id": "224.11", "question": "What are the characteristics of these two types of compounds?", "answer_src": "seasonal and pandemic influenza outbreaks remain a major human health problem . inhibition of the endonuclease activity of influenza rna - dependent rna polymerase is attractive for the development of new agents for the treatment of influenza infection . our earlier studies identified a series of 5- and 6-phenyl substituted 3-hydroxypyridin-2(1h)-ones that were effective inhibitors of influenza endonuclease .", "follow_up_question": "What type of chemical structure do these inhibitors have?", "follow_up_response": "5- and 6-phenyl substituted 3-hydroxypyridin-2(1h)-ones", "follow_up_response_bt": "5- and 6-phenyl substitute 3-hydrossipiridine-2(1h)-one"}, {"question_id": "224.12", "question": "What was the mechanism by which these compounds inhibited the influenza endonuclease?", "answer_src": "These compounds were 5- and 6-phenyl substituted 3-hydroxypyridin-2(1h)-ones", "follow_up_question": "What was the effect of these compounds on influenza replication?", "follow_up_response": "Inhibition of influenza endonuclease", "follow_up_response_bt": "Reduction of respiratory symptoms"}, {"question_id": "224.13", "question": "What was the mechanism by which these compounds inhibited the influenza endonuclease?", "answer_src": "These compounds were 5- and 6-phenyl substituted 3-hydroxypyridin-2(1h)-ones", "follow_up_question": "What was the effect of these compounds on influenza replication?", "follow_up_response": "Inhibition of influenza endonuclease", "follow_up_response_bt": "Reduction of respiratory symptoms"}, {"question_id": "224.14", "question": "What type of molecules did the authors identify as effective inhibitors of influenza endonuclease?", "answer_src": "5- and 6-phenyl substituted 3-hydroxypyridin-2(1h)-ones", "follow_up_question": "What was the mechanism by which these molecules inhibited the influenza endonuclease?", "follow_up_response": "Inhibition of the endonuclease activity", "follow_up_response_bt": "Inhibition of influenza-dependent RNA polymerase endonuclease activity"}, {"question_id": "224.15", "question": "What type of chemical structure do these inhibitors have?", "answer_src": "5- and 6-phenyl substituted 3-hydroxypyridin-2(1h)-ones", "follow_up_question": "What is the role of the hydroxyl group in these inhibitors?", "follow_up_response": "No Answer", "follow_up_response_bt": "3-hydrossipiridine-2"}]}}
{"id": 225, "src": "based on evidence that patients with type 2 diabetes ( t2 dm ) , obese insulin - resistant individuals , and lean insulin - resistant offspring of parents with t2 dm have 30% less mitochondria in their muscles than lean control subjects , it appears to be widely accepted that mitochondrial deficiency is responsible for insulin resistance . the proposed mechanism for this effect is an impaired ability to oxidize fat , resulting in lipid accumulation in muscle . the purpose of this counterpoint article is to review the evidence against the mitochondrial deficiency concept .", "mt": "Sulla base delle prove che i pazienti con diabete di tipo 2 (t2 dm), individui obesi resistenti all'insulina e i figli magri resistenti all'insulina di genitori con t2 dm hanno il 30% in meno di mitocondrie nei muscoli rispetto ai soggetti di controllo magri , sembra essere ampiamente accettato che la carenza mitocondriale sia responsabile della resistenza all'insulina . Il meccanismo proposto per questo effetto è una capacità compromessa di ossidare il grasso , con conseguente accumulo di lipidi nel muscolo . Lo scopo di questo articolo è di rivedere le prove contro il concetto di carenza mitocondriale .", "pert_mt": "Sulla base delle prove che i pazienti con diabete di tipo 2 (t2 dm), individui obesi resistenti all'insulina e i figli magri resistenti all'insulina di genitori con t2 dm hanno il 30% in meno di mitocondrie nei muscoli rispetto ai soggetti di controllo magri, sembra essere ampiamente accettato che la carenza mitocondriale sia responsabile della resistenza all'insulina. Il meccanismo proposto per questo effetto è una capacità compromessa di ossidare il grasso, con conseguente accumulo di lipidi nel muscolo. Lo scopo di questo articolo è di rivedere le prove contro il concetto di carenza mitocondriale, ma non tutti concordano su questa interpretazione.", "bt": "Based on the evidence that patients with type 2 diabetes (t2dm), insulin-resistant obese individuals and insulin-resistant lean children of parents with t2dm have 30% less mitochondria in the muscles than lean control subjects, it seems to be widely accepted that mitochondrial deficiency is responsible for insulin resistance.The proposed mechanism for this effect is a compromised ability to oxidize fat, resulting in lipid accumulation in the muscle.The purpose of this article is to review the evidence against the concept of mitochondrial deficiency, but not all agree on this interpretation.", "questions_src": ["What is the primary cause of insulin resistance according to the evidence presented?", "Who are the groups mentioned to have less mitochondria in their muscles compared to lean control subjects?", "Where does the impaired ability to oxidize fat result in lipid accumulation?", "When was the proposed mechanism for mitochondrial deficiency first suggested?", "Which concept is being reviewed for its validity in relation to insulin resistance?"], "answers_src": ["[\"Mitochondrial deficiency\"], [\"Patients with type 2 diabetes (t2 dm), obese insulin-resistant individuals, and lean insulin-resistant offspring of parents with t2 dm\"], [\"In muscle\"], [\"The proposed mechanism for this effect\"], [\"Mitochondrial deficiency concept\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"Mitochondrial deficiency\"], [\"Patients with type 2 diabetes, insulin-resistant obese individuals, and insulin-resistant lean children of parents with t2dm\"], [\"In the muscle\"], [\"The proposed mechanism for this effect\"], [\"Mitochondrial deficiency\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "225.1", "question": "What is the primary cause of insulin resistance according to the evidence presented?", "answer_src": "[\"Mitochondrial deficiency\"], [\"Patients with type 2 diabetes (t2 dm), obese insulin-resistant individuals, and lean insulin-resistant offspring of parents with t2 dm\"], [\"In muscle\"], [\"The proposed mechanism for this effect\"], [\"Mitochondrial deficiency concept\"]", "follow_up_question": "How does the evidence suggest insulin resistance may occur instead of mitochondrial deficiency?", "follow_up_response": "an impaired ability to oxidize fat, resulting in lipid accumulation in muscle", "follow_up_response_bt": "A compromised ability to oxidize fat, resulting in lipid accumulation in the muscle."}, {"question_id": "225.2", "question": "Who are the groups mentioned to have less mitochondria in their muscles compared to lean control subjects?", "answer_src": "based on evidence that patients with type 2 diabetes ( t2 dm ) , obese insulin - resistant individuals , and lean insulin - resistant offspring of parents with t2 dm have 30% less mitochondria in their muscles than lean control subjects , it appears to be widely accepted that mitochondrial deficiency is responsible for insulin resistance . the proposed mechanism for this effect is an impaired ability to oxidize fat , resulting in lipid accumulation in muscle . the purpose of this counterpoint article is to review the evidence against the mitochondrial deficiency concept .", "follow_up_question": "What evidence supports the claim that patients with type 2 diabetes and obese insulin-resistant individuals have less mitochondria in their muscles?", "follow_up_response": "based on evidence that patients with type 2 diabetes (t2 dm), obese insulin-resistant individuals, and lean insulin-resistant offspring of parents with t2 dm have 30% less mitochondria in their muscles than lean control subjects", "follow_up_response_bt": "Based on the evidence that patients with type 2 diabetes (t2dm), insulin-resistant obese individuals and insulin-resistant lean children of parents with t2dm have 30% less mitochondria in the muscles than lean control subjects"}, {"question_id": "225.3", "question": "Where does the impaired ability to oxidize fat result in lipid accumulation?", "answer_src": "based on evidence that patients with type 2 diabetes ( t2 dm ) , obese insulin - resistant individuals , and lean insulin - resistant offspring of parents with t2 dm have 30% less mitochondria in their muscles than lean control subjects , it appears to be widely accepted that mitochondrial deficiency is responsible for insulin resistance . the proposed mechanism for this effect is an impaired ability to oxidize fat , resulting in lipid accumulation in muscle . the purpose of this counterpoint article is to review the evidence against the mitochondrial deficiency concept .", "follow_up_question": "What specific organ experiences lipid accumulation due to the impaired ability to oxidize fat?", "follow_up_response": "Muscle", "follow_up_response_bt": "Muscles"}, {"question_id": "225.4", "question": "When was the proposed mechanism for mitochondrial deficiency first suggested?", "answer_src": "based on evidence that patients with type 2 diabetes ( t2 dm ) , obese insulin - resistant individuals , and lean insulin - resistant offspring of parents with t2 dm have 30% less mitochondria in their muscles than lean control subjects , it appears to be widely accepted that mitochondrial deficiency is responsible for insulin resistance . the proposed mechanism for this effect is an impaired ability to oxidize fat , resulting in lipid accumulation in muscle . the purpose of this counterpoint article is to review the evidence against the mitochondrial deficiency concept .", "follow_up_question": "What evidence supports the proposed mechanism of impaired fat oxidation leading to lipid accumulation in muscle?", "follow_up_response": "Based on evidence that patients with type 2 diabetes (t2 dm), obese insulin-resistant individuals, and lean insulin-resistant offspring of parents with t2 dm have 30% less mitochondria in their muscles than lean control subjects", "follow_up_response_bt": "Based on the evidence that patients with type 2 diabetes (t2dm), insulin-resistant obese individuals and insulin-resistant lean children of parents with t2dm have 30% less mitochondria in the muscles than lean control subjects"}, {"question_id": "225.5", "question": "Which concept is being reviewed for its validity in relation to insulin resistance?", "answer_src": "based on evidence that patients with type 2 diabetes ( t2 dm ) , obese insulin - resistant individuals , and lean insulin - resistant offspring of parents with t2 dm have 30% less mitochondria in their muscles than lean control subjects , it appears to be widely accepted that mitochondrial deficiency is responsible for insulin resistance . the proposed mechanism for this effect is an impaired ability to oxidize fat , resulting in lipid accumulation in muscle . the purpose of this counterpoint article is to review the evidence against the mitochondrial deficiency concept .", "follow_up_question": "What evidence supports the claim that mitochondrial deficiency is not responsible for insulin resistance?", "follow_up_response": "Based on evidence that patients with type 2 diabetes (t2 dm), obese insulin-resistant individuals, and lean insulin-resistant offspring of parents with t2 dm have 30% less mitochondria in their muscles than lean control subjects", "follow_up_response_bt": "The proposed mechanism for this effect is a compromised ability to oxidize fat, resulting in lipid accumulation in the muscle."}], "turn_2": [{"question_id": "225.6", "question": "How does the evidence suggest insulin resistance may occur instead of mitochondrial deficiency?", "answer_src": "an impaired ability to oxidize fat, resulting in lipid accumulation in muscle", "follow_up_question": "What other mechanisms might the authors propose in their counterpoint article?", "follow_up_response": "An impaired ability to oxidize fat", "follow_up_response_bt": "A compromised ability to oxidize fat, resulting in lipid accumulation in the muscle"}, {"question_id": "225.7", "question": "What evidence supports the claim that patients with type 2 diabetes and obese insulin-resistant individuals have less mitochondria in their muscles?", "answer_src": "based on evidence that patients with type 2 diabetes (t2 dm), obese insulin-resistant individuals, and lean insulin-resistant offspring of parents with t2 dm have 30% less mitochondria in their muscles than lean control subjects", "follow_up_question": "What evidence contradicts the proposed mechanism that impaired fat oxidation leads to lipid accumulation in muscle?", "follow_up_response": "There is no direct evidence provided in the sentence that contradicts the proposed mechanism that impaired fat oxidation leads to lipid accumulation in muscle.", "follow_up_response_bt": "The proposed mechanism for this effect is a compromised ability to oxidize fat, resulting in lipid accumulation in the muscle."}, {"question_id": "225.8", "question": "What specific organ experiences lipid accumulation due to the impaired ability to oxidize fat?", "answer_src": "Muscle", "follow_up_question": "What evidence supports the claim that mitochondrial deficiency is not responsible for insulin resistance?", "follow_up_response": "Based on evidence that patients with type 2 diabetes (t2 dm), obese insulin-resistant individuals, and lean insulin-resistant offspring of parents with t2 dm have 30% less mitochondria in their muscles than lean control subjects", "follow_up_response_bt": "The proposed mechanism for this effect is a compromised ability to oxidize fat, resulting in lipid accumulation in the muscle."}, {"question_id": "225.9", "question": "What evidence supports the proposed mechanism of impaired fat oxidation leading to lipid accumulation in muscle?", "answer_src": "Based on evidence that patients with type 2 diabetes (t2 dm), obese insulin-resistant individuals, and lean insulin-resistant offspring of parents with t2 dm have 30% less mitochondria in their muscles than lean control subjects", "follow_up_question": "How does the text suggest these individuals with reduced muscle mitochondria differ from lean control subjects in terms of fat metabolism?", "follow_up_response": "an impaired ability to oxidize fat", "follow_up_response_bt": "A compromised ability to oxidize fat, resulting in lipid accumulation in the muscle"}, {"question_id": "225.10", "question": "What evidence supports the claim that mitochondrial deficiency is not responsible for insulin resistance?", "answer_src": "Based on evidence that patients with type 2 diabetes (t2 dm), obese insulin-resistant individuals, and lean insulin-resistant offspring of parents with t2 dm have 30% less mitochondria in their muscles than lean control subjects", "follow_up_question": "How does the text suggest we should interpret the reduced mitochondria levels in the muscles of these groups?", "follow_up_response": "mitochondrial deficiency is responsible for insulin resistance", "follow_up_response_bt": "mitochondrial deficiency is responsible for insulin resistance"}], "turn_3": [{"question_id": "225.11", "question": "What other mechanisms might the authors propose in their counterpoint article?", "answer_src": "An impaired ability to oxidize fat", "follow_up_question": "What evidence supports the claim that lipid accumulation in muscle is not solely responsible for insulin resistance?", "follow_up_response": "Based on evidence that patients with type 2 diabetes (t2 dm), obese insulin-resistant individuals, and lean insulin-resistant offspring of parents with t2 dm have 30% less mitochondria in their muscles than lean control subjects", "follow_up_response_bt": "Based on the evidence that patients with type 2 diabetes (t2dm), insulin-resistant obese individuals and insulin-resistant lean children of parents with t2dm have 30% less mitochondria in the muscles than lean control subjects"}, {"question_id": "225.12", "question": "What evidence contradicts the proposed mechanism that impaired fat oxidation leads to lipid accumulation in muscle?", "answer_src": "There is no direct evidence provided in the sentence that contradicts the proposed mechanism that impaired fat oxidation leads to lipid accumulation in muscle.", "follow_up_question": "What other mechanism does the text suggest instead of impaired fat oxidation leading to lipid accumulation?", "follow_up_response": "an impaired ability to oxidize fat", "follow_up_response_bt": "Compromised ability to oxidize fat"}, {"question_id": "225.13", "question": "What evidence supports the claim that mitochondrial deficiency is not responsible for insulin resistance?", "answer_src": "Based on evidence that patients with type 2 diabetes (t2 dm), obese insulin-resistant individuals, and lean insulin-resistant offspring of parents with t2 dm have 30% less mitochondria in their muscles than lean control subjects", "follow_up_question": "How does the text suggest we should interpret the reduced mitochondria levels in the muscles of these groups?", "follow_up_response": "mitochondrial deficiency is responsible for insulin resistance", "follow_up_response_bt": "mitochondrial deficiency is responsible for insulin resistance"}, {"question_id": "225.14", "question": "How does the text suggest these individuals with reduced muscle mitochondria differ from lean control subjects in terms of fat metabolism?", "answer_src": "an impaired ability to oxidize fat", "follow_up_question": "What specific consequence of lipid accumulation in muscle is suggested by the text?", "follow_up_response": "an impaired ability to oxidize fat", "follow_up_response_bt": "A compromised ability to oxidize fat"}, {"question_id": "225.15", "question": "How does the text suggest we should interpret the reduced mitochondria levels in the muscles of these groups?", "answer_src": "mitochondrial deficiency is responsible for insulin resistance", "follow_up_question": "What evidence does the text provide against the mitochondrial deficiency concept?", "follow_up_response": "The evidence provided against the mitochondrial deficiency concept is an impaired ability to oxidize fat, resulting in lipid accumulation in muscle.", "follow_up_response_bt": "The proposed mechanism for this effect is a compromised ability to oxidize fat, resulting in lipid accumulation in the muscle"}]}}
{"id": 226, "src": "the management of amatoxin poisoning consists of preliminary medical care , supportive measures , detoxification therapies , and orthotopic liver transplantation . the clinical efficacy of any modality of treatment is difficult to demonstrate since randomized , controlled clinical trials have not been reported . the use of extracorporeal liver assist devices as well as auxiliary liver transplantation may represent additional therapeutic options .", "mt": "La gestione dell' avvelenamento da amatoxina consiste in cure mediche preliminari , misure di supporto , terapie di disintossicazione e trapianto di fegato ortotopo . L' efficacia clinica di qualsiasi modalità di trattamento è difficile da dimostrare poiché non sono stati riportati studi clinici randomizzati e controllati . L' uso di dispositivi di assistenza epatica extracorporea e trapianto di fegato ausiliario possono rappresentare ulteriori opzioni terapeutiche .", "pert_mt": "La gestione dell'avvelenamento da amatoxina consiste in cure mediche preliminari, misure di supporto, terapie di disintossicazione e trapianto di fegato ortotopo. L'efficacia clinica di qualsiasi modalità di trattamento è difficile da dimostrare poiché non sono stati riportati studi clinici randomizzati e controllati. L'uso di dispositivi di assistenza epatica extracorporea e trapianto di fegato ausiliario possono rappresentare ulteriori opzioni terapeutiche e ridurre i tempi di recupero.", "bt": "The management of amatoxin poisoning consists of preliminary medical treatment, supportive measures, detoxification therapy and orthopedic liver transplantation.The clinical efficacy of any treatment method is difficult to demonstrate as no randomized and controlled clinical trials have been reported.The use of extracorporeal liver assist devices and auxiliary liver transplantation may represent additional therapeutic options and reduce recovery times.", "questions_src": ["What is the first step in managing amatoxin poisoning?", "Who can be affected by amatoxin poisoning?", "Where might a patient receive preliminary medical care for amatoxin poisoning?", "When is extracorporeal liver assist devices typically used?", "Which type of liver transplantation is described as orthotopic?"], "answers_src": ["Preliminary medical care", "Patients", "At the hospital or medical facility", "Extracorporeal liver assist devices are typically used during the treatment process", "Orthotopic"], "answers_bt": ["Preliminary medical treatment", "Patients", "At the hospital or medical facility", "Extracorporeal liver assist devices are typically used during the treatment process", "Orthotopic"], "multiturn": {"turn_1": [{"question_id": "226.1", "question": "What is the first step in managing amatoxin poisoning?", "answer_src": "Preliminary medical care", "follow_up_question": "What supportive measures might be included in the management of amatoxin poisoning?", "follow_up_response": "supportive measures", "follow_up_response_bt": "Supportive measures"}, {"question_id": "226.2", "question": "Who can be affected by amatoxin poisoning?", "answer_src": "Patients", "follow_up_question": "What specific treatments are mentioned for amatoxin poisoning?", "follow_up_response": "preliminary medical care, supportive measures, detoxification therapies, and orthotopic liver transplantation", "follow_up_response_bt": "Preliminary medical treatment, supportive measures, detoxification therapy and orthopedic liver transplantation"}, {"question_id": "226.3", "question": "Where might a patient receive preliminary medical care for amatoxin poisoning?", "answer_src": "At the hospital or medical facility", "follow_up_question": "What kind of medical care does preliminary medical care for amatoxin poisoning typically involve?", "follow_up_response": "Preliminary medical care for amatoxin poisoning typically involves supportive measures, detoxification therapies, and orthotopic liver transplantation.", "follow_up_response_bt": "Preliminary medical treatment"}, {"question_id": "226.4", "question": "When is extracorporeal liver assist devices typically used?", "answer_src": "Extracorporeal liver assist devices are typically used during the treatment process", "follow_up_question": "What are the other therapeutic options mentioned besides extracorporeal liver assist devices and auxiliary liver transplantation?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "226.5", "question": "Which type of liver transplantation is described as orthotopic?", "answer_src": "Orthotopic", "follow_up_question": "What are the two additional therapeutic options mentioned for treating amatoxin poisoning?", "follow_up_response": "Extracorporeal liver assist devices as well as auxiliary liver transplantation", "follow_up_response_bt": "Extracorporeal liver assist devices and auxiliary liver transplantation"}], "turn_2": [{"question_id": "226.6", "question": "What supportive measures might be included in the management of amatoxin poisoning?", "answer_src": "supportive measures", "follow_up_question": "What kind of extracorporeal liver assist devices are being discussed?", "follow_up_response": "Extracorporeal liver assist devices", "follow_up_response_bt": "Extracorporeal liver assist devices"}, {"question_id": "226.7", "question": "What specific treatments are mentioned for amatoxin poisoning?", "answer_src": "preliminary medical care, supportive measures, detoxification therapies, and orthotopic liver transplantation", "follow_up_question": "What are some alternative therapeutic options discussed for amatoxin poisoning?", "follow_up_response": "Extracorporeal liver assist devices as well as auxiliary liver transplantation", "follow_up_response_bt": "Extracorporeal liver assist devices and auxiliary liver transplantation"}, {"question_id": "226.8", "question": "What kind of medical care does preliminary medical care for amatoxin poisoning typically involve?", "answer_src": "Preliminary medical care for amatoxin poisoning typically involves supportive measures, detoxification therapies, and orthotopic liver transplantation.", "follow_up_question": "What specific supportive measures might be included in preliminary medical care for amatoxin poisoning?", "follow_up_response": "Supportive measures", "follow_up_response_bt": "Supportive measures"}, {"question_id": "226.9", "question": "What are the other therapeutic options mentioned besides extracorporeal liver assist devices and auxiliary liver transplantation?", "answer_src": "the management of amatoxin poisoning consists of preliminary medical care , supportive measures , detoxification therapies , and orthotopic liver transplantation . the clinical efficacy of any modality of treatment is difficult to demonstrate since randomized , controlled clinical trials have not been reported . the use of extracorporeal liver assist devices as well as auxiliary liver transplantation may represent additional therapeutic options .", "follow_up_question": "What are extracorporeal liver assist devices used for in the management of amatoxin poisoning?", "follow_up_response": "Additional therapeutic options", "follow_up_response_bt": "reduce recovery times"}, {"question_id": "226.10", "question": "What are the two additional therapeutic options mentioned for treating amatoxin poisoning?", "answer_src": "Extracorporeal liver assist devices as well as auxiliary liver transplantation", "follow_up_question": "What is the primary purpose of extracorporeal liver assist devices in treating amatoxin poisoning?", "follow_up_response": "Additional therapeutic options", "follow_up_response_bt": "Reduce recovery times"}], "turn_3": [{"question_id": "226.11", "question": "What kind of extracorporeal liver assist devices are being discussed?", "answer_src": "Extracorporeal liver assist devices", "follow_up_question": "What are the potential benefits of using extracorporeal liver assist devices?", "follow_up_response": "Additional therapeutic options", "follow_up_response_bt": "Reduce recovery times"}, {"question_id": "226.12", "question": "What are some alternative therapeutic options discussed for amatoxin poisoning?", "answer_src": "Extracorporeal liver assist devices as well as auxiliary liver transplantation", "follow_up_question": "What are the limitations mentioned regarding the treatment efficacy of amatoxin poisoning?", "follow_up_response": "Randomized, controlled clinical trials have not been reported", "follow_up_response_bt": "The clinical efficacy of any treatment method is difficult to demonstrate as no randomized and controlled clinical trials have been reported."}, {"question_id": "226.13", "question": "What specific supportive measures might be included in preliminary medical care for amatoxin poisoning?", "answer_src": "Supportive measures", "follow_up_question": "What kind of extracorporeal liver assist devices are being discussed?", "follow_up_response": "Extracorporeal liver assist devices", "follow_up_response_bt": "Extracorporeal liver assist devices"}, {"question_id": "226.14", "question": "What are extracorporeal liver assist devices used for in the management of amatoxin poisoning?", "answer_src": "Additional therapeutic options", "follow_up_question": "What specific type of liver transplantation does auxiliary liver transplantation refer to?", "follow_up_response": "Orthotopic", "follow_up_response_bt": "Orthopedic liver transplantation"}, {"question_id": "226.15", "question": "What is the primary purpose of extracorporeal liver assist devices in treating amatoxin poisoning?", "answer_src": "Additional therapeutic options", "follow_up_question": "What specific type of liver transplantation does extracorporeal liver assist devices complement?", "follow_up_response": "Orthotopic", "follow_up_response_bt": "Orthopedic liver transplantation"}]}}
{"id": 227, "src": "the variant morphometry of bicipital groove is reported to be associated with pathologies of biceps tendon and is useful in surgical procedures in this region . the pathologies of biceps tendon are frequent causes of shoulder pain . therefore , under the condition of paucity of data pertaining to north indians , not only morphometric analysis of bicipital groove and a new definition of narrow / shallow groove to provide logical explanation for dependence of pathologies of biceps tendon on groove morphology is done but also a review of the literature has been carried out .", "mt": "La variante morfometria del groove biscipitale è stata riferita come associata a patologie del tendine del biceps ed è utile nelle procedure chirurgiche in questa regione . Le patologie del tendine del biceps sono cause frequenti di dolore alle spalle . Pertanto , in condizione di scarsità di dati relativi agli indiani del nord , non solo l'analisi morfometrica del groove biscipitale e una nuova definizione del groove stretto / poco profondo per fornire una spiegazione logica della dipendenza delle patologie del tendine del biceps dalla morfologia del groove sono state fatte , ma è stata anche condotta una revisione della letteratura .", "pert_mt": "La variante morfometria del groove biscipitale è stata riferita come associata a patologie del tendine del biceps ed è utile nelle procedure chirurgiche in questa regione. Le patologie del tendine del biceps sono cause frequenti di dolore alle spalle. Pertanto, in condizione di scarsità di dati relativi agli indiani del nord, non solo l'analisi morfometrica del groove biscipitale e una nuova definizione del groove stretto / poco profondo per fornire una spiegazione logica della dipendenza delle patologie del tendine del biceps dalla morfologia del groove sono state fatte, ma è stata anche condotta una revisione della letteratura e un'analisi dei risultati clinici.", "bt": "The variation of the morphometry of the biscipital groove has been reported as associated with the pathology of the biceps tendon and is useful in surgical procedures in this region.Biceps tendon pathology is a frequent cause of back pain.Therefore, in the face of scarcity of data regarding North Indians, not only has the morphometric analysis of the biscipital groove and a new definition of the stretto/shallow groove to provide a logical explanation of the dependence of the pathologies of the biceps tendon on the morphology of the groove been made, but a literature review and a clinical results analysis have also been conducted.", "questions_src": ["What is reported to be associated with pathologies of biceps tendon?", "What is used in surgical procedures in the bicipital groove region?", "Where is a new definition of narrow / shallow groove proposed?", "When is a review of the literature conducted?", "Which cause is frequent for shoulder pain?"], "answers_src": ["the variant morphometry of bicipital groove", "the variant morphometry of bicipital groove", "north indians", "paucity of data pertaining to north indians", "pathologies of biceps tendon"], "answers_bt": ["The morphometry of the biscipital groove", "The morphometry of the biscipital groove", "In the bicipital groove region", "Not specified in the text", "Back pain"], "multiturn": {"turn_1": [{"question_id": "227.1", "question": "What is reported to be associated with pathologies of biceps tendon?", "answer_src": "the variant morphometry of bicipital groove", "follow_up_question": "What surgical procedures in the bicipital groove region are made possible by this association?", "follow_up_response": "surgical procedures", "follow_up_response_bt": "surgical procedures"}, {"question_id": "227.2", "question": "What is used in surgical procedures in the bicipital groove region?", "answer_src": "the variant morphometry of bicipital groove", "follow_up_question": "What specific pathologies of biceps tendon are frequently associated with shoulder pain according to the text?", "follow_up_response": "pathologies of biceps tendon", "follow_up_response_bt": "back pain"}, {"question_id": "227.3", "question": "Where is a new definition of narrow / shallow groove proposed?", "answer_src": "north indians", "follow_up_question": "What specific condition led to the need for a new definition of the narrow / shallow groove?", "follow_up_response": "Paucity of data pertaining to north indians", "follow_up_response_bt": "Biceps tendon pathology"}, {"question_id": "227.4", "question": "When is a review of the literature conducted?", "answer_src": "paucity of data pertaining to north indians", "follow_up_question": "What condition leads to the need for a review of the literature?", "follow_up_response": "Paucity of data pertaining to north indians", "follow_up_response_bt": "The scarcity of data regarding North Indians"}, {"question_id": "227.5", "question": "Which cause is frequent for shoulder pain?", "answer_src": "pathologies of biceps tendon", "follow_up_question": "What specific condition does the narrow / shallow bicipital groove provide a logical explanation for?", "follow_up_response": "Dependence of pathologies of biceps tendon", "follow_up_response_bt": "The pathologies of the biceps tendon"}], "turn_2": [{"question_id": "227.6", "question": "What surgical procedures in the bicipital groove region are made possible by this association?", "answer_src": "surgical procedures", "follow_up_question": "What specific pathologies of the biceps tendon are frequent causes of shoulder pain according to the text?", "follow_up_response": "pathologies of biceps tendon", "follow_up_response_bt": "back pain"}, {"question_id": "227.7", "question": "What specific pathologies of biceps tendon are frequently associated with shoulder pain according to the text?", "answer_src": "pathologies of biceps tendon", "follow_up_question": "What surgical procedures might benefit from the morphometry of bicipital groove as discussed in the text?", "follow_up_response": "surgical procedures in this region", "follow_up_response_bt": "surgical procedures in this region"}, {"question_id": "227.8", "question": "What specific condition led to the need for a new definition of the narrow / shallow groove?", "answer_src": "Paucity of data pertaining to north indians", "follow_up_question": "What were the consequences of the paucity of data for the study?", "follow_up_response": "Not only morphometric analysis of bicipital groove and a new definition of narrow / shallow groove to provide logical explanation for dependence of pathologies of biceps tendon on groove morphology is done but also a review of the literature has been carried out.", "follow_up_response_bt": "A literature review and a clinical results analysis have also been conducted"}, {"question_id": "227.9", "question": "What condition leads to the need for a review of the literature?", "answer_src": "Paucity of data pertaining to north indians", "follow_up_question": "What specific condition does the narrow / shallow bicipital groove lead to?", "follow_up_response": "pathologies of biceps tendon", "follow_up_response_bt": "back pain"}, {"question_id": "227.10", "question": "What specific condition does the narrow / shallow bicipital groove provide a logical explanation for?", "answer_src": "Dependence of pathologies of biceps tendon", "follow_up_question": "Why is the narrow / shallow bicipital groove considered a logical explanation for the dependence of pathologies of biceps tendon?", "follow_up_response": "a new definition of narrow / shallow groove to provide logical explanation for dependence of pathologies of biceps tendon on groove morphology", "follow_up_response_bt": "The morphometric analysis of the biscipital groove and a new definition of the stretto/shallow groove"}], "turn_3": [{"question_id": "227.11", "question": "What specific pathologies of the biceps tendon are frequent causes of shoulder pain according to the text?", "answer_src": "pathologies of biceps tendon", "follow_up_question": "What surgical procedures in the bicipital groove region are made possible by the morphometry of the bicipital groove?", "follow_up_response": "surgical procedures", "follow_up_response_bt": "surgical procedures"}, {"question_id": "227.12", "question": "What surgical procedures might benefit from the morphometry of bicipital groove as discussed in the text?", "answer_src": "surgical procedures in this region", "follow_up_question": "what specific surgical procedures are mentioned in the text?", "follow_up_response": "surgical procedures in this region", "follow_up_response_bt": "not provided"}, {"question_id": "227.13", "question": "What were the consequences of the paucity of data for the study?", "answer_src": "Not only morphometric analysis of bicipital groove and a new definition of narrow / shallow groove to provide logical explanation for dependence of pathologies of biceps tendon on groove morphology is done but also a review of the literature has been carried out.", "follow_up_question": "What specific changes were made to the definition of the bicipital groove morphology?", "follow_up_response": "a new definition of narrow / shallow groove", "follow_up_response_bt": "a new definition of the stretto/shallow groove"}, {"question_id": "227.14", "question": "What specific condition does the narrow / shallow bicipital groove lead to?", "answer_src": "pathologies of biceps tendon", "follow_up_question": "What types of shoulder pain are caused by these pathologies?", "follow_up_response": "Shoulder pain", "follow_up_response_bt": "back pain"}, {"question_id": "227.15", "question": "Why is the narrow / shallow bicipital groove considered a logical explanation for the dependence of pathologies of biceps tendon?", "answer_src": "a new definition of narrow / shallow groove to provide logical explanation for dependence of pathologies of biceps tendon on groove morphology", "follow_up_question": "What specific pathologies of biceps tendon are frequently associated with the narrow / shallow bicipital groove according to the text?", "follow_up_response": "pathologies of biceps tendon", "follow_up_response_bt": "back pain"}]}}
{"id": 228, "src": "a positive association between the time of diabetes duration and higher serum tgf-1 concentrations was observed . similarly , the prevalence of microvascular complications , such as retinopathy and nephropathy , increased with the duration of diabetes . logistic regression analysis showed that serum tgf-1 concentrations and the duration of the disease are independent risk factors of microangiopathy development .", "mt": "Si è osservata un'associazione positiva tra il tempo di durata del diabete e concentrazioni serine superiori di tgf-1 . Allo stesso modo , la prevalenza di complicazioni microvascolari , come la retinopatia e la nefropatia , è aumentata con la durata del diabete . L' analisi di regressione logistica ha mostrato che le concentrazioni serine di tgf-1 e la durata della malattia sono fattori di rischio indipendenti dello sviluppo della microangiopatia .", "pert_mt": "Si è osservata un'associazione positiva tra il tempo di durata del diabete e concentrazioni serine superiori di tgf-1. Allo stesso modo, la prevalenza di complicazioni microvascolari, come la retinopatia e la nefropatia, è aumentata con la durata del diabete. L'analisi di regressione logistica ha mostrato che le concentrazioni serine di tgf-1, la durata della malattia e l'elevata pressione arteriosa sono fattori di rischio indipendenti dello sviluppo della microangiopatia.", "bt": "A positive association was observed between the duration of diabetes and higher serum levels of tgf-1. Similarly, the prevalence of microvascular complications, such as retinopathy and nephropathy, increased with the duration of diabetes.Logistic regression analysis has shown that serine levels of tgf-1, duration of the disease and high blood pressure are independent risk factors for the development of microangiopathy.", "questions_src": ["What is the relationship between diabetes duration and serum tgf-1 concentrations?", "Who are the independent risk factors for microangiopathy development according to the logistic regression analysis?", "Where do microvascular complications like retinopathy and nephropathy typically occur?", "When does the prevalence of microvascular complications increase in relation to diabetes duration?", "Which factors are associated with the longer duration of diabetes?"], "answers_src": ["A positive association", "Serum tgf-1 concentrations and the duration of the disease", "In the body", "With the duration of diabetes", "Serum tgf-1 concentrations and the duration of the disease"], "answers_bt": ["A positive association", "Serine levels of tgf-1, duration of the disease and high blood pressure", "In the vessels", "With the duration of diabetes", "Duration of diabetes"], "multiturn": {"turn_1": [{"question_id": "228.1", "question": "What is the relationship between diabetes duration and serum tgf-1 concentrations?", "answer_src": "A positive association", "follow_up_question": "How does the duration of diabetes relate to the risk of developing microangiopathy?", "follow_up_response": "Serum tgf-1 concentrations and the duration of the disease are independent risk factors of microangiopathy development.", "follow_up_response_bt": "The duration of diabetes is an independent risk factor for the development of microangiopathy"}, {"question_id": "228.2", "question": "Who are the independent risk factors for microangiopathy development according to the logistic regression analysis?", "answer_src": "Serum tgf-1 concentrations and the duration of the disease", "follow_up_question": "What is the relationship between serum tgf-1 concentrations and the duration of diabetes in terms of microangiopathy development?", "follow_up_response": "A positive association", "follow_up_response_bt": "A positive association"}, {"question_id": "228.3", "question": "Where do microvascular complications like retinopathy and nephropathy typically occur?", "answer_src": "In the body", "follow_up_question": "What specific body systems are affected by microangiopathy?", "follow_up_response": "No Answer", "follow_up_response_bt": "Retinopathy and nephropathy"}, {"question_id": "228.4", "question": "When does the prevalence of microvascular complications increase in relation to diabetes duration?", "answer_src": "With the duration of diabetes", "follow_up_question": "What specific microvascular complications are associated with longer diabetes duration?", "follow_up_response": "retinopathy and nephropathy", "follow_up_response_bt": "retinopathy and nephropathy"}, {"question_id": "228.5", "question": "Which factors are associated with the longer duration of diabetes?", "answer_src": "Serum tgf-1 concentrations and the duration of the disease", "follow_up_question": "What specific type of microangiopathy is more common in patients with longer diabetes duration?", "follow_up_response": "Retinopathy and nephropathy", "follow_up_response_bt": "retinopathy and nephropathy"}], "turn_2": [{"question_id": "228.6", "question": "How does the duration of diabetes relate to the risk of developing microangiopathy?", "answer_src": "Serum tgf-1 concentrations and the duration of the disease are independent risk factors of microangiopathy development.", "follow_up_question": "What is the specific type of microangiopathy that the text mentions as being associated with longer diabetes duration?", "follow_up_response": "microangiopathy", "follow_up_response_bt": "retinopathy and nephropathy"}, {"question_id": "228.7", "question": "What is the relationship between serum tgf-1 concentrations and the duration of diabetes in terms of microangiopathy development?", "answer_src": "A positive association", "follow_up_question": "How does the prevalence of microvascular complications change with the duration of diabetes?", "follow_up_response": "The prevalence of microvascular complications, such as retinopathy and nephropathy, increases with the duration of diabetes.", "follow_up_response_bt": "The prevalence of microvascular complications, such as retinopathy and nephropathy, increases with the duration of diabetes."}, {"question_id": "228.8", "question": "What specific body systems are affected by microangiopathy?", "answer_src": "a positive association between the time of diabetes duration and higher serum tgf-1 concentrations was observed . similarly , the prevalence of microvascular complications , such as retinopathy and nephropathy , increased with the duration of diabetes . logistic regression analysis showed that serum tgf-1 concentrations and the duration of the disease are independent risk factors of microangiopathy development .", "follow_up_question": "What other microvascular complications besides retinopathy and nephropathy were found to increase with diabetes duration?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "228.9", "question": "What specific microvascular complications are associated with longer diabetes duration?", "answer_src": "retinopathy and nephropathy", "follow_up_question": "What is the relationship between increased serum tgf-1 concentrations and longer diabetes duration according to the text?", "follow_up_response": "A positive association", "follow_up_response_bt": "A positive association"}, {"question_id": "228.10", "question": "What specific type of microangiopathy is more common in patients with longer diabetes duration?", "answer_src": "Retinopathy and nephropathy", "follow_up_question": "What percentage increase in microangiopathy risk is associated with each additional year of diabetes duration according to the logistic regression analysis?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "228.11", "question": "What is the specific type of microangiopathy that the text mentions as being associated with longer diabetes duration?", "answer_src": "microangiopathy", "follow_up_question": "What other microvascular complication besides retinopathy and nephropathy is mentioned in the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "228.12", "question": "How does the prevalence of microvascular complications change with the duration of diabetes?", "answer_src": "The prevalence of microvascular complications, such as retinopathy and nephropathy, increases with the duration of diabetes.", "follow_up_question": "What is the relationship between serum TGF-1 concentrations and the duration of diabetes according to the logistic regression analysis?", "follow_up_response": "Serum TGF-1 concentrations and the duration of the disease are independent risk factors of microangiopathy development.", "follow_up_response_bt": "A positive association"}, {"question_id": "228.13", "question": "What other microvascular complications besides retinopathy and nephropathy were found to increase with diabetes duration?", "answer_src": "a positive association between the time of diabetes duration and higher serum tgf-1 concentrations was observed . similarly , the prevalence of microvascular complications , such as retinopathy and nephropathy , increased with the duration of diabetes . logistic regression analysis showed that serum tgf-1 concentrations and the duration of the disease are independent risk factors of microangiopathy development .", "follow_up_question": "What specific type of microangiopathy is associated with higher serum tgf-1 concentrations according to the logistic regression analysis?", "follow_up_response": "No Answer", "follow_up_response_bt": "microangiopathy"}, {"question_id": "228.14", "question": "What is the relationship between increased serum tgf-1 concentrations and longer diabetes duration according to the text?", "answer_src": "A positive association", "follow_up_question": "How does the duration of diabetes affect the risk of developing microangiopathy?", "follow_up_response": "Serum tgf-1 concentrations and the duration of the disease are independent risk factors of microangiopathy development.", "follow_up_response_bt": "The duration of diabetes increases the risk of developing microangiopathy"}, {"question_id": "228.15", "question": "What percentage increase in microangiopathy risk is associated with each additional year of diabetes duration according to the logistic regression analysis?", "answer_src": "a positive association between the time of diabetes duration and higher serum tgf-1 concentrations was observed . similarly , the prevalence of microvascular complications , such as retinopathy and nephropathy , increased with the duration of diabetes . logistic regression analysis showed that serum tgf-1 concentrations and the duration of the disease are independent risk factors of microangiopathy development .", "follow_up_question": "How does the increase in microangiopathy risk compare between patients with short-term and long-term diabetes?", "follow_up_response": "The duration of the disease", "follow_up_response_bt": "The increase in microangiopathy risk is compared between patients with short-term and long-term diabetes"}]}}
{"id": 229, "src": "distribution of hbv , hcv and hiv results of the inpatients or outpatients , who had been treated for various diagnoses in diyarbakr training and research hospital between 2005 and 2012 , among years was investigated.files of the patients , who had been treated as inpatient or outpatient 992 . to any diagnosis between 01/01/2005 and 31/12/2012 in the clinics or policlinics of diyarbakr 581 due training and research hospital , were retrospectively reviewed using patient file database . serum samples ( 235.534 for hbsag , 196.727 for anti - hbs antibody , 98.497 for hbeag , 97.417 for anti - hbe antibody , 225.483 for hcv and 138.923 for hiv ) of these patients , which had been processed in microbiology laboratory , were studied by chemiluminescence technique using roche e-170 ( modular analytics system ) device.prevalence rates between 2005 and 2012 were as follows : 15.9%-9% for hbsag , 32.9%-52.3% for anti - hbs , 2.5%-1.8% for hbeag , 30.4%-25.2% for anti - hbe , 1%-0.7% for anti - hcv , and 0.1%-1% for anti - hiv .", "mt": "I risultati di hbv , hcv e HIV dei pazienti o ambulatori che erano stati trattati per varie diagnosi in ospedale di formazione e ricerca diyarbakr tra il 2005 e il 2012 , tra gli anni sono stati investigati.files dei pazienti , che erano stati trattati come pazienti o ambulatori 992 . a qualsiasi diagnosi tra il 01/01/2005 e il 31/12/2012 nelle cliniche o policliniche di ospedale di formazione e ricerca diyarbakr 581 due due , sono stati rivisti retrospettivamente utilizzando il database dei file dei pazienti . campioni di siero (235.534 per hbsag , 196.727 per anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti", "pert_mt": "I risultati di hbv, hcv e HIV dei pazienti o ambulatori che erano stati trattati per varie diagnosi in ospedale di formazione e ricerca diyarbakr tra il 2005 e il 2012, tra gli anni sono stati investigati. files dei pazienti, che erano stati trattati come pazienti o ambulatori 992. A qualsiasi diagnosi tra il 01/01/2005 e il 31/12/2012 nelle cliniche o policliniche di ospedale di formazione e ricerca diyarbakr 581, due, due, sono stati rivisti retrospettivamente utilizzando il database dei file dei pazienti. Campioni di siero (235.534 per hbsag, 196.727 per anti", "bt": "The results of hbv, hcv and HIV of patients or outpatients who had been treated for various diagnoses at the diyarbakr training and research hospital between 2005 and 2012, between the years were investigated. files of patients, who had been treated as patients or outpatients 992.", "questions_src": ["What year did the study start?", "Who were the patients included in the study?", "Which virus had the highest prevalence rate?", "How many patients were reviewed?", "Where were the serum samples processed?"], "answers_src": ["2005", "inpatients or outpatients who had been treated for various diagnoses in Diyarbakr Training and Research Hospital", "HCV", "992", "microbiology laboratory"], "answers_bt": ["2005", "patients or outpatients who had been treated for various diagnoses", "No Answer", "992", "Diyarbakr training and research hospital"], "multiturn": {"turn_1": [{"question_id": "229.1", "question": "What year did the study start?", "answer_src": "2005", "follow_up_question": "In what year did the study end?", "follow_up_response": "2012", "follow_up_response_bt": "2012"}, {"question_id": "229.2", "question": "Who were the patients included in the study?", "answer_src": "inpatients or outpatients who had been treated for various diagnoses in Diyarbakr Training and Research Hospital", "follow_up_question": "What was the total number of patients included in the study?", "follow_up_response": "992", "follow_up_response_bt": "992"}, {"question_id": "229.3", "question": "Which virus had the highest prevalence rate?", "answer_src": "HCV", "follow_up_question": "What was the prevalence rate of HCV?", "follow_up_response": "1%-0.7%", "follow_up_response_bt": "No Answer"}, {"question_id": "229.4", "question": "How many patients were reviewed?", "answer_src": "992", "follow_up_question": "What was the total number of serum samples processed in the microbiology laboratory?", "follow_up_response": "235.534, 196.727, 98.497, 97.417, 225.483, 138.923", "follow_up_response_bt": "992"}, {"question_id": "229.5", "question": "Where were the serum samples processed?", "answer_src": "microbiology laboratory", "follow_up_question": "What percentage of patients tested positive for anti-HBs antibody?", "follow_up_response": "52.3%", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "229.6", "question": "In what year did the study end?", "answer_src": "2012", "follow_up_question": "What was the highest prevalence rate found for any of the three viruses studied?", "follow_up_response": "32.9% for anti-hbs", "follow_up_response_bt": "992"}, {"question_id": "229.7", "question": "What was the total number of patients included in the study?", "answer_src": "992", "follow_up_question": "How many more patients were inpatients compared to outpatients?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "229.8", "question": "What was the prevalence rate of HCV?", "answer_src": "1%-0.7%", "follow_up_question": "What was the prevalence rate of HIV?", "follow_up_response": "0.1%-1%", "follow_up_response_bt": "No Answer"}, {"question_id": "229.9", "question": "What was the total number of serum samples processed in the microbiology laboratory?", "answer_src": "235.534, 196.727, 98.497, 97.417, 225.483, 138.923", "follow_up_question": "What was the average number of serum samples processed per year?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "229.10", "question": "What percentage of patients tested positive for anti-HBs antibody?", "answer_src": "52.3%", "follow_up_question": "What was the total number of serum samples tested for anti-HBs antibody?", "follow_up_response": "196.727", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "229.11", "question": "What was the highest prevalence rate found for any of the three viruses studied?", "answer_src": "32.9% for anti-hbs", "follow_up_question": "What was the lowest prevalence rate found for any of the three viruses studied?", "follow_up_response": "0.1%", "follow_up_response_bt": "No Answer"}, {"question_id": "229.12", "question": "How many more patients were inpatients compared to outpatients?", "answer_src": "distribution of hbv , hcv and hiv results of the inpatients or outpatients , who had been treated for various diagnoses in diyarbakr training and research hospital between 2005 and 2012 , among years was investigated.files of the patients , who had been treated as inpatient or outpatient 992 . to any diagnosis between 01/01/2005 and 31/12/2012 in the clinics or policlinics of diyarbakr 581 due training and research hospital , were retrospectively reviewed using patient file database . serum samples ( 235.534 for hbsag , 196.727 for anti - hbs antibody , 98.497 for hbeag , 97.417 for anti - hbe antibody , 225.483 for hcv and 138.923 for hiv ) of these patients , which had been processed in microbiology laboratory , were studied by chemiluminescence technique using roche e-170 ( modular analytics system ) device.prevalence rates between 2005 and 2012 were as follows : 15.9%-9% for hbsag , 32.9%-52.3% for anti - hbs , 2.5%-1.8% for hbeag , 30.4%-25.2% for anti - hbe , 1%-0.7% for anti - hcv , and 0.1%-1% for anti - hiv .", "follow_up_question": "What is the difference in percentage points between the prevalence of anti-HBs antibody and anti-HBe antibody?", "follow_up_response": "40.3", "follow_up_response_bt": "No Answer"}, {"question_id": "229.13", "question": "What was the prevalence rate of HIV?", "answer_src": "0.1%-1%", "follow_up_question": "What was the prevalence rate of HCV?", "follow_up_response": "1%-0.7%", "follow_up_response_bt": "No Answer"}, {"question_id": "229.14", "question": "What was the average number of serum samples processed per year?", "answer_src": "distribution of hbv , hcv and hiv results of the inpatients or outpatients , who had been treated for various diagnoses in diyarbakr training and research hospital between 2005 and 2012 , among years was investigated.files of the patients , who had been treated as inpatient or outpatient 992 . to any diagnosis between 01/01/2005 and 31/12/2012 in the clinics or policlinics of diyarbakr 581 due training and research hospital , were retrospectively reviewed using patient file database . serum samples ( 235.534 for hbsag , 196.727 for anti - hbs antibody , 98.497 for hbeag , 97.417 for anti - hbe antibody , 225.483 for hcv and 138.923 for hiv ) of these patients , which had been processed in microbiology laboratory , were studied by chemiluminescence technique using roche e-170 ( modular analytics system ) device.prevalence rates between 2005 and 2012 were as follows : 15.9%-9% for hbsag , 32.9%-52.3% for anti - hbs , 2.5%-1.8% for hbeag , 30.4%-25.2% for anti - hbe , 1%-0.7% for anti - hcv , and 0.1%-1% for anti - hiv .", "follow_up_question": "How many more serum samples were tested for anti-HBs antibodies than for HBeAg?", "follow_up_response": "148.96", "follow_up_response_bt": "No Answer"}, {"question_id": "229.15", "question": "What was the total number of serum samples tested for anti-HBs antibody?", "answer_src": "196.727", "follow_up_question": "What was the prevalence rate of anti-HBs antibody in 2012?", "follow_up_response": "52.3%", "follow_up_response_bt": "No Answer"}]}}
{"id": 230, "src": "diabetic maculopathy ( dm ) is one of the major causes of vision impairment in individuals with diabetes . the traditional approach to diagnosis of dm includes fundus ophthalmoscopy and fluorescein angiography . although very useful clinically , these methods do not contribute much to the evaluation of retinal morphology and its thickness profile .", "mt": "La maculopatia diabetica (DM) è una delle principali cause di problemi di vista nei pazienti con diabete . L' approccio tradizionale alla diagnosi di DM include l' oftalmoscopia del fondo e l' angiografia fluoresceina . Benché molto utili clinicamente , questi metodi non contribuiscono molto alla valutazione della morfologia della retina e del suo profilo di spessore .", "pert_mt": "La maculopatia diabetica (DM) è una delle principali cause di problemi di vista nei pazienti con diabete. L'approccio tradizionale alla diagnosi di DM include l'oftalmoscopia del fondo e l'angiografia fluoresceina. Benché molto utili clinicamente, questi metodi non contribuiscono molto alla valutazione della morfologia della retina e del suo profilo di spessore e della sua sensibilità ai danni neurosensoriali.", "bt": "Diabetic maculopathy (DM) is one of the leading causes of vision problems in patients with diabetes.The traditional approach to diagnosing DM includes background ophthalmoscopy and fluorescein angiography.Although these methods are very useful clinically, they do not contribute much to the assessment of the morphology of the retina and its thickness profile and sensitivity to neurosensory damage.", "questions_src": ["What is diabetic maculopathy?", "Who are the major causes of vision impairment in individuals with diabetes?", "Where does the traditional approach to diagnosis of dm include?", "When is fundus ophthalmoscopy used?", "Which methods do not contribute much to the evaluation of retinal morphology and its thickness profile?"], "answers_src": ["diabetic maculopathy (dm)", "individuals with diabetes", "fundus ophthalmoscopy and fluorescein angiography", "clinically", "fundus ophthalmoscopy and fluorescein angiography"], "answers_bt": ["Diabetic maculopathy (DM)", "Patients with diabetes", "Background ophthalmoscopy and fluorescein angiography", "Fundus ophthalmoscopy is used traditionally", "Fluorescein angiography"], "multiturn": {"turn_1": [{"question_id": "230.1", "question": "What is diabetic maculopathy?", "answer_src": "diabetic maculopathy (dm)", "follow_up_question": "What alternative method does the text suggest for evaluating retinal morphology and thickness profile?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "230.2", "question": "Who are the major causes of vision impairment in individuals with diabetes?", "answer_src": "individuals with diabetes", "follow_up_question": "What traditional method is used for the diagnosis of diabetic maculopathy?", "follow_up_response": "fundus ophthalmoscopy and fluorescein angiography", "follow_up_response_bt": "background ophthalmoscopy and fluorescein angiography"}, {"question_id": "230.3", "question": "Where does the traditional approach to diagnosis of dm include?", "answer_src": "fundus ophthalmoscopy and fluorescein angiography", "follow_up_question": "What limitations do fundus ophthalmoscopy and fluorescein angiography have in evaluating retinal morphology and thickness?", "follow_up_response": "These methods do not contribute much", "follow_up_response_bt": "They do not contribute much"}, {"question_id": "230.4", "question": "When is fundus ophthalmoscopy used?", "answer_src": "clinically", "follow_up_question": "What is the limitation of fundus ophthalmoscopy in evaluating retinal morphology?", "follow_up_response": "These methods do not contribute much", "follow_up_response_bt": "They do not contribute much to the assessment of the morphology of the retina and its thickness profile and sensitivity to neurosensory damage."}, {"question_id": "230.5", "question": "Which methods do not contribute much to the evaluation of retinal morphology and its thickness profile?", "answer_src": "fundus ophthalmoscopy and fluorescein angiography", "follow_up_question": "What alternative method might be more effective for evaluating retinal morphology and thickness profile?", "follow_up_response": "Optical Coherence Tomography", "follow_up_response_bt": "Optical Coherence Tomography"}], "turn_2": [{"question_id": "230.6", "question": "What alternative method does the text suggest for evaluating retinal morphology and thickness profile?", "answer_src": "diabetic maculopathy ( dm ) is one of the major causes of vision impairment in individuals with diabetes . the traditional approach to diagnosis of dm includes fundus ophthalmoscopy and fluorescein angiography . although very useful clinically , these methods do not contribute much to the evaluation of retinal morphology and its thickness profile .", "follow_up_question": "What specific aspect of retinal morphology and thickness profile do these traditional methods fail to evaluate?", "follow_up_response": "retinal morphology and its thickness profile", "follow_up_response_bt": "neurosensory damage"}, {"question_id": "230.7", "question": "What traditional method is used for the diagnosis of diabetic maculopathy?", "answer_src": "fundus ophthalmoscopy and fluorescein angiography", "follow_up_question": "What alternative method is suggested for evaluating retinal morphology and thickness profile?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "230.8", "question": "What limitations do fundus ophthalmoscopy and fluorescein angiography have in evaluating retinal morphology and thickness?", "answer_src": "These methods do not contribute much", "follow_up_question": "How does this limitation affect the overall assessment of diabetic maculopathy?", "follow_up_response": "These methods do not contribute much to the evaluation of retinal morphology and its thickness profile.", "follow_up_response_bt": "They do not contribute much to the assessment of the morphology of the retina and its thickness profile and sensitivity to neurosensory damage."}, {"question_id": "230.9", "question": "What is the limitation of fundus ophthalmoscopy in evaluating retinal morphology?", "answer_src": "These methods do not contribute much", "follow_up_question": "What specific aspect of retinal morphology does fundus ophthalmoscopy fail to evaluate?", "follow_up_response": "retinal morphology and its thickness profile", "follow_up_response_bt": "retina and its thickness profile"}, {"question_id": "230.10", "question": "What alternative method might be more effective for evaluating retinal morphology and thickness profile?", "answer_src": "Optical Coherence Tomography", "follow_up_question": "How does Optical Coherence Tomography differ from fundus ophthalmoscopy and fluorescein angiography in terms of evaluating retinal morphology and thickness?", "follow_up_response": "Optical Coherence Tomography", "follow_up_response_bt": "Optical Coherence Tomography differs from fundus ophthalmoscopy and fluorescein angiography in terms of evaluating retinal morphology and thickness."}], "turn_3": [{"question_id": "230.11", "question": "What specific aspect of retinal morphology and thickness profile do these traditional methods fail to evaluate?", "answer_src": "retinal morphology and its thickness profile", "follow_up_question": "How do these traditional methods fail to provide information about retinal morphology and thickness profile?", "follow_up_response": "These traditional methods do not contribute much to the evaluation of retinal morphology and its thickness profile.", "follow_up_response_bt": "They do not contribute much to the assessment of the morphology of the retina and its thickness profile"}, {"question_id": "230.12", "question": "What alternative method is suggested for evaluating retinal morphology and thickness profile?", "answer_src": "diabetic maculopathy ( dm ) is one of the major causes of vision impairment in individuals with diabetes . the traditional approach to diagnosis of dm includes fundus ophthalmoscopy and fluorescein angiography . although very useful clinically , these methods do not contribute much to the evaluation of retinal morphology and its thickness profile .", "follow_up_question": "What other diagnostic tool is mentioned for assessing retinal morphology besides fundus ophthalmoscopy and fluorescein angiography?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "230.13", "question": "How does this limitation affect the overall assessment of diabetic maculopathy?", "answer_src": "These methods do not contribute much to the evaluation of retinal morphology and its thickness profile.", "follow_up_question": "What specific aspects of retinal morphology and thickness profile cannot be evaluated with these methods?", "follow_up_response": "retinal morphology and its thickness profile", "follow_up_response_bt": "Neurosensory damage"}, {"question_id": "230.14", "question": "What specific aspect of retinal morphology does fundus ophthalmoscopy fail to evaluate?", "answer_src": "retinal morphology and its thickness profile", "follow_up_question": "What method does fundus ophthalmoscopy use to visualize the retina?", "follow_up_response": "fundus ophthalmoscopy", "follow_up_response_bt": "background ophthalmoscopy"}, {"question_id": "230.15", "question": "How does Optical Coherence Tomography differ from fundus ophthalmoscopy and fluorescein angiography in terms of evaluating retinal morphology and thickness?", "answer_src": "Optical Coherence Tomography", "follow_up_question": "What specific advantages does Optical Coherence Tomography have over these traditional methods in assessing retinal morphology and thickness?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 231, "src": "it is well - known that estimation of 24-h urine protein and spot urine protein / creatinine ( p / c ) ratio are commonly performed investigations to assess proteinuria in preeclamptic women . serum uric acid has been shown to correlate well with disease severity in preeclampsia.a total of 24-h urine protein estimation , spot urine p / c ratio , and serum uric acid measurements were carried out in 75 pregnant preeclamptic women and the correlation between these investigations , as also the association between proteinuria and hyperuricemia with adverse fetomaternal outcomes were studied.pearson's correlation test showed a positive correlation between 24-h urine protein and spot urine p / c ratio . a statistically significant and direct correlation was also found between serum uric acid and spot urine p / c ratio , while there was no statistically significant difference between proteinuria and hyperuricemia with respect to the various fetal and maternal outcome parameters studied.in the present study , we found a moderate correlation between 24-h urine protein and spot urine p / c ratio .", "mt": "È noto che la stima del rapporto di proteine nelle urine e proteine nelle urine spot (p / c) è comunemente eseguita nelle indagini per valutare la proteinuria nelle donne preeclampsie . Si è dimostrato che l'acido urico si correlazioni bene con la gravità della malattia nella preeclampsia.un totale di 24 ore di stima delle proteine nelle urine , rapporto p / c nelle urine spot , e misurazioni dell'acido urico nel siero sono state eseguite in 75 donne in gravidanza preeclampsia e la correlazione tra queste indagini , così come l'associazione tra proteinauria e iperuricemia con risultati avversi materni.Il test di correlazione di Pearson ha mostrato una correlazione positiva tra proteine nelle urine 24 ore e punti urine / c.Si è anche trovato un rapporto statisticamente significativo e diretto tra proteine nelle urine, mentre non c'è stata alcuna differenza tra la p / h e la correlazione tra i parametri di analisi urina e la correlazione urina p / h, mentre", "pert_mt": "È noto che la stima del rapporto di proteine nelle urine e proteine nelle urine spot (p/c) è comunemente eseguita nelle indagini per valutare la proteinuria nelle donne preeclampsie. Si è dimostrato che l'acido urico si correla bene con la gravità della malattia nella preeclampsia. Un totale di 24 ore di stima delle proteine nelle urine, rapporto p/c nelle urine spot, e misurazioni dell'acido urico nel siero sono state eseguite in 75 donne in gravidanza preeclampsia e la correlazione tra queste indagini, così come l'associazione tra proteinauria e iperuricemia con risultati avversi materni. Il test di correlazione di Pearson ha mostrato una correlazione positiva tra proteine nelle urine 24 ore e", "bt": "It is noted that estimation of protein in urine and protein in urine spot (p/c) ratio is commonly performed in surveys to evaluate proteinuria in preeclampsia women. It has been shown that uric acid correlates well with the severity of preeclampsia disease. A total of 24 hours of protein estimation in urine, p/c ratio in urine spot, and measurements of uric acid in serum were performed in 75 pregnant women with preeclampsia and positive correlation to these surveys, as well as the association of proteinuria and hyperuricemia with maternal adverse outcomes. Pearson's correlation test showed a protein correlation to urine in 24 hours and a positive correlation to these surveys.", "questions_src": ["What is commonly performed to assess proteinuria in preeclamptic women?", "Which investigation showed a positive correlation between 24-h urine protein and spot urine p/c ratio?", "Which two parameters were statistically significantly correlated in the study?", "What was the sample size for the study on preeclamptic women?", "Which parameter had no statistically significant difference with respect to fetal and maternal outcome parameters?"], "answers_src": ["[\"24-h urine protein and spot urine protein / creatinine (p/c) ratio\"], [\"24-h urine protein and spot urine p/c ratio\"], [\"spot urine p/c ratio and serum uric acid\"], [75], [\"proteinuria\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"Estimation of protein in urine and protein in urine spot (p/c) ratio\"], [\"Pearson\"s correlation test\"], [\"24-h urine protein and spot urine p/c ratio\"], [75], [\"No Answer\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "231.1", "question": "What is commonly performed to assess proteinuria in preeclamptic women?", "answer_src": "[\"24-h urine protein and spot urine protein / creatinine (p/c) ratio\"], [\"24-h urine protein and spot urine p/c ratio\"], [\"spot urine p/c ratio and serum uric acid\"], [75], [\"proteinuria\"]", "follow_up_question": "What specific correlation did Pearson's correlation test show between the two commonly performed investigations?", "follow_up_response": "A positive correlation between 24-h urine protein and spot urine p/c ratio", "follow_up_response_bt": "A correlation to urine in 24 hours"}, {"question_id": "231.2", "question": "Which investigation showed a positive correlation between 24-h urine protein and spot urine p/c ratio?", "answer_src": "it is well - known that estimation of 24-h urine protein and spot urine protein / creatinine ( p / c ) ratio are commonly performed investigations to assess proteinuria in preeclamptic women . serum uric acid has been shown to correlate well with disease severity in preeclampsia.a total of 24-h urine protein estimation , spot urine p / c ratio , and serum uric acid measurements were carried out in 75 pregnant preeclamptic women and the correlation between these investigations , as also the association between proteinuria and hyperuricemia with adverse fetomaternal outcomes were studied.pearson's correlation test showed a positive correlation between 24-h urine protein and spot urine p / c ratio . a statistically significant and direct correlation was also found between serum uric acid and spot urine p / c ratio , while there was no statistically significant difference between proteinuria and hyperuricemia with respect to the various fetal and maternal outcome parameters studied.in the present study , we found a moderate correlation between 24-h urine protein and spot urine p / c ratio .", "follow_up_question": "What specific statistical test was used to show the positive correlation between 24-h urine protein and spot urine p/c ratio?", "follow_up_response": "Pearson's correlation test", "follow_up_response_bt": "Pearson's correlation test"}, {"question_id": "231.3", "question": "Which two parameters were statistically significantly correlated in the study?", "answer_src": "it is well - known that estimation of 24-h urine protein and spot urine protein / creatinine ( p / c ) ratio are commonly performed investigations to assess proteinuria in preeclamptic women . serum uric acid has been shown to correlate well with disease severity in preeclampsia.a total of 24-h urine protein estimation , spot urine p / c ratio , and serum uric acid measurements were carried out in 75 pregnant preeclamptic women and the correlation between these investigations , as also the association between proteinuria and hyperuricemia with adverse fetomaternal outcomes were studied.pearson's correlation test showed a positive correlation between 24-h urine protein and spot urine p / c ratio . a statistically significant and direct correlation was also found between serum uric acid and spot urine p / c ratio , while there was no statistically significant difference between proteinuria and hyperuricemia with respect to the various fetal and maternal outcome parameters studied.in the present study , we found a moderate correlation between 24-h urine protein and spot urine p / c ratio .", "follow_up_question": "What was the nature of the correlation found between serum uric acid and spot urine p/c ratio?", "follow_up_response": "A statistically significant and direct correlation", "follow_up_response_bt": "No Answer"}, {"question_id": "231.4", "question": "What was the sample size for the study on preeclamptic women?", "answer_src": "it is well - known that estimation of 24-h urine protein and spot urine protein / creatinine ( p / c ) ratio are commonly performed investigations to assess proteinuria in preeclamptic women . serum uric acid has been shown to correlate well with disease severity in preeclampsia.a total of 24-h urine protein estimation , spot urine p / c ratio , and serum uric acid measurements were carried out in 75 pregnant preeclamptic women and the correlation between these investigations , as also the association between proteinuria and hyperuricemia with adverse fetomaternal outcomes were studied.pearson's correlation test showed a positive correlation between 24-h urine protein and spot urine p / c ratio . a statistically significant and direct correlation was also found between serum uric acid and spot urine p / c ratio , while there was no statistically significant difference between proteinuria and hyperuricemia with respect to the various fetal and maternal outcome parameters studied.in the present study , we found a moderate correlation between 24-h urine protein and spot urine p / c ratio .", "follow_up_question": "What was the correlation coefficient between 24-h urine protein and spot urine p/c ratio in the study?", "follow_up_response": "A positive correlation", "follow_up_response_bt": "No Answer"}, {"question_id": "231.5", "question": "Which parameter had no statistically significant difference with respect to fetal and maternal outcome parameters?", "answer_src": "it is well - known that estimation of 24-h urine protein and spot urine protein / creatinine ( p / c ) ratio are commonly performed investigations to assess proteinuria in preeclamptic women . serum uric acid has been shown to correlate well with disease severity in preeclampsia.a total of 24-h urine protein estimation , spot urine p / c ratio , and serum uric acid measurements were carried out in 75 pregnant preeclamptic women and the correlation between these investigations , as also the association between proteinuria and hyperuricemia with adverse fetomaternal outcomes were studied.pearson's correlation test showed a positive correlation between 24-h urine protein and spot urine p / c ratio . a statistically significant and direct correlation was also found between serum uric acid and spot urine p / c ratio , while there was no statistically significant difference between proteinuria and hyperuricemia with respect to the various fetal and maternal outcome parameters studied.in the present study , we found a moderate correlation between 24-h urine protein and spot urine p / c ratio .", "follow_up_question": "What was the relationship between proteinuria and hyperuricemia regarding fetal and maternal outcome parameters?", "follow_up_response": "No Answer", "follow_up_response_bt": "A positive correlation"}], "turn_2": [{"question_id": "231.6", "question": "What specific correlation did Pearson's correlation test show between the two commonly performed investigations?", "answer_src": "A positive correlation between 24-h urine protein and spot urine p/c ratio", "follow_up_question": "What was the strength of the correlation between 24-h urine protein and spot urine p/c ratio according to the study?", "follow_up_response": "Moderate", "follow_up_response_bt": "No Answer"}, {"question_id": "231.7", "question": "What specific statistical test was used to show the positive correlation between 24-h urine protein and spot urine p/c ratio?", "answer_src": "Pearson's correlation test", "follow_up_question": "What was the nature of the correlation found between serum uric acid and spot urine p/c ratio?", "follow_up_response": "A statistically significant and direct correlation", "follow_up_response_bt": "No Answer"}, {"question_id": "231.8", "question": "What was the nature of the correlation found between serum uric acid and spot urine p/c ratio?", "answer_src": "A statistically significant and direct correlation", "follow_up_question": "What was the strength of the correlation found between serum uric acid and spot urine p/c ratio?", "follow_up_response": "A statistically significant and direct correlation", "follow_up_response_bt": "No Answer"}, {"question_id": "231.9", "question": "What was the correlation coefficient between 24-h urine protein and spot urine p/c ratio in the study?", "answer_src": "A positive correlation", "follow_up_question": "What was the nature of the correlation between serum uric acid and spot urine p/c ratio?", "follow_up_response": "A statistically significant and direct correlation", "follow_up_response_bt": "No Answer"}, {"question_id": "231.10", "question": "What was the relationship between proteinuria and hyperuricemia regarding fetal and maternal outcome parameters?", "answer_src": "it is well - known that estimation of 24-h urine protein and spot urine protein / creatinine ( p / c ) ratio are commonly performed investigations to assess proteinuria in preeclamptic women . serum uric acid has been shown to correlate well with disease severity in preeclampsia.a total of 24-h urine protein estimation , spot urine p / c ratio , and serum uric acid measurements were carried out in 75 pregnant preeclamptic women and the correlation between these investigations , as also the association between proteinuria and hyperuricemia with adverse fetomaternal outcomes were studied.pearson's correlation test showed a positive correlation between 24-h urine protein and spot urine p / c ratio . a statistically significant and direct correlation was also found between serum uric acid and spot urine p / c ratio , while there was no statistically significant difference between proteinuria and hyperuricemia with respect to the various fetal and maternal outcome parameters studied.in the present study , we found a moderate correlation between 24-h urine protein and spot urine p / c ratio .", "follow_up_question": "What was the correlation between serum uric acid and spot urine p/c ratio?", "follow_up_response": "A statistically significant and direct correlation", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "231.11", "question": "What was the strength of the correlation between 24-h urine protein and spot urine p/c ratio according to the study?", "answer_src": "Moderate", "follow_up_question": "What was the statistical significance level of the correlation between serum uric acid and spot urine p/c ratio?", "follow_up_response": "Statistically significant", "follow_up_response_bt": "No Answer"}, {"question_id": "231.12", "question": "What was the nature of the correlation found between serum uric acid and spot urine p/c ratio?", "answer_src": "A statistically significant and direct correlation", "follow_up_question": "What was the strength of the correlation found between serum uric acid and spot urine p/c ratio?", "follow_up_response": "A statistically significant and direct correlation", "follow_up_response_bt": "No Answer"}, {"question_id": "231.13", "question": "What was the strength of the correlation found between serum uric acid and spot urine p/c ratio?", "answer_src": "A statistically significant and direct correlation", "follow_up_question": "What was the nature of the correlation found between 24-h urine protein and spot urine p/c ratio?", "follow_up_response": "A positive correlation", "follow_up_response_bt": "Positive correlation"}, {"question_id": "231.14", "question": "What was the nature of the correlation between serum uric acid and spot urine p/c ratio?", "answer_src": "A statistically significant and direct correlation", "follow_up_question": "What was the nature of the correlation between 24-h urine protein and spot urine p/c ratio?", "follow_up_response": "Positive\"], [\"Direct", "follow_up_response_bt": "Positive correlation"}, {"question_id": "231.15", "question": "What was the correlation between serum uric acid and spot urine p/c ratio?", "answer_src": "A statistically significant and direct correlation", "follow_up_question": "What was the relationship between 24-h urine protein and spot urine p/c ratio?", "follow_up_response": "A positive correlation", "follow_up_response_bt": "Positive correlation"}]}}
{"id": 232, "src": "bacteriology was positive for ascites in only 58.1% of cases , for peritoneal biopsy in 73.3% , while granuloma was found in 95.5% . tb polymerase chain reaction ( pcr ) was positive in 25% of peritoneal biopsy . mycobacterium bovis was isolated in 23.1% of cases and mycobacterium tuberculosis in 76.9% .", "mt": "La bacteriologia è stata positiva per l' ascite nel solo 58,1% dei casi , per la biopsia peritoneale nel 73,3% , mentre il granuloma è stato trovato nel 95,5% . La reazione a catena della polymerase della tubercolosi (pcr) è stata positiva nel 25% della biopsia peritoneale . Il mycobacterium bovis è stato isolato nel 23,1% dei casi e il mycobacterium tuberculosis nel 76,9% .", "pert_mt": "La bacteriologia è stata positiva per l'ascite nel solo 58,1% dei casi, per la biopsia peritoneale nel 73,3%, mentre il granuloma è stato trovato nel 95,5%. La reazione a catena della polymerase della tubercolosi (PCR) è stata positiva nel 25% della biopsia peritoneale. Il mycobacterium bovis è stato isolato nel 23,1% dei casi e il mycobacterium tuberculosis nel 76,9%. Inoltre, i sintomi clinici associati sono stati osservati in quasi tutti i pazienti.", "bt": "Bacteriology was positive for ascites in only 58.1% of cases, for peritoneal biopsy in 73.3%, while granuloma was found in 95.5%.The chain reaction of the polymerase of tuberculosis (PCR) was positive in 25% of peritoneal biopsy.Mycobacterium bovis was isolated in 23.1% of cases and mycobacterium tuberculosis in 76.9%. Furthermore, associated clinical symptoms were observed in almost all patients.", "questions_src": ["What percentage of cases had bacteriology positive for ascites?", "What percentage of peritoneal biopsies showed bacteriology positive for granuloma?", "In how many percent of cases was TB PCR positive for peritoneal biopsy?", "What percentage of cases had Mycobacterium bovis isolated?", "What percentage of cases had Mycobacterium tuberculosis isolated?"], "answers_src": ["58.1%", "73.3%", "25%", "23.1%", "76.9%"], "answers_bt": ["58.1%", "73.3%", "25%", "23.1%", "76.9%"], "multiturn": {"turn_1": [{"question_id": "232.1", "question": "What percentage of cases had bacteriology positive for ascites?", "answer_src": "58.1%", "follow_up_question": "What was the percentage of cases with bacteriology positive for peritoneal biopsy?", "follow_up_response": "73.3%", "follow_up_response_bt": "73.3%"}, {"question_id": "232.2", "question": "What percentage of peritoneal biopsies showed bacteriology positive for granuloma?", "answer_src": "73.3%", "follow_up_question": "What was the overall positivity rate for bacteriology in peritoneal biopsies?", "follow_up_response": "73.3%", "follow_up_response_bt": "73.3%"}, {"question_id": "232.3", "question": "In how many percent of cases was TB PCR positive for peritoneal biopsy?", "answer_src": "25%", "follow_up_question": "In what percentage of cases was granuloma found?", "follow_up_response": "95.5%", "follow_up_response_bt": "95.5%"}, {"question_id": "232.4", "question": "What percentage of cases had Mycobacterium bovis isolated?", "answer_src": "23.1%", "follow_up_question": "What was the percentage of cases with TB PCR being positive?", "follow_up_response": "25%", "follow_up_response_bt": "25%"}, {"question_id": "232.5", "question": "What percentage of cases had Mycobacterium tuberculosis isolated?", "answer_src": "76.9%", "follow_up_question": "What was the percentage of cases with granuloma found?", "follow_up_response": "95.5%", "follow_up_response_bt": "95.5%"}], "turn_2": [{"question_id": "232.6", "question": "What was the percentage of cases with bacteriology positive for peritoneal biopsy?", "answer_src": "73.3%", "follow_up_question": "What was the percentage of cases with granuloma found?", "follow_up_response": "95.5%", "follow_up_response_bt": "95.5%"}, {"question_id": "232.7", "question": "What was the overall positivity rate for bacteriology in peritoneal biopsies?", "answer_src": "73.3%", "follow_up_question": "What was the positivity rate for granuloma detection in peritoneal biopsies?", "follow_up_response": "95.5%", "follow_up_response_bt": "95.5%"}, {"question_id": "232.8", "question": "In what percentage of cases was granuloma found?", "answer_src": "95.5%", "follow_up_question": "In what percentage of cases was mycobacterium tuberculosis isolated?", "follow_up_response": "76.9%", "follow_up_response_bt": "76.9%"}, {"question_id": "232.9", "question": "What was the percentage of cases with TB PCR being positive?", "answer_src": "25%", "follow_up_question": "What was the percentage of cases with granuloma being found?", "follow_up_response": "95.5%", "follow_up_response_bt": "95.5%"}, {"question_id": "232.10", "question": "What was the percentage of cases with granuloma found?", "answer_src": "95.5%", "follow_up_question": "What was the percentage of cases where TB PCR was positive?", "follow_up_response": "25%", "follow_up_response_bt": "25%"}], "turn_3": [{"question_id": "232.11", "question": "What was the percentage of cases with granuloma found?", "answer_src": "95.5%", "follow_up_question": "What was the percentage of cases where TB PCR was positive?", "follow_up_response": "25%", "follow_up_response_bt": "25%"}, {"question_id": "232.12", "question": "What was the positivity rate for granuloma detection in peritoneal biopsies?", "answer_src": "95.5%", "follow_up_question": "What was the positivity rate for M. tuberculosis isolation in peritoneal biopsies?", "follow_up_response": "76.9%", "follow_up_response_bt": "76.9%"}, {"question_id": "232.13", "question": "In what percentage of cases was mycobacterium tuberculosis isolated?", "answer_src": "76.9%", "follow_up_question": "In what percentage of cases was mycobacterium bovis isolated?", "follow_up_response": "23.1%", "follow_up_response_bt": "23.1%"}, {"question_id": "232.14", "question": "What was the percentage of cases with granuloma being found?", "answer_src": "95.5%", "follow_up_question": "What was the percentage of cases where TB PCR was positive?", "follow_up_response": "25%", "follow_up_response_bt": "25%"}, {"question_id": "232.15", "question": "What was the percentage of cases where TB PCR was positive?", "answer_src": "25%", "follow_up_question": "What was the percentage of cases where granuloma was found?", "follow_up_response": "95.5%", "follow_up_response_bt": "95.5%"}]}}
{"id": 233, "src": "by using a pathway - oriented analysis strategy we were able to identify a network of 105 genes modulated by l1 through the predicted activation of five transcription factors : stat1 , stat2 , stat3 , irf7 , and atf4 . indeed , l1 overexpression resulted in the strong induction of stat3 phosphorylation which was abolished by antibody - mediated neutralization of il-6r. these results indicated that l1 promoted stat3 activation via the il-6/il-6r axis .", "mt": "Usando una strategia di analisi orientata al percorso siamo stati in grado di identificare una rete di 105 geni modulati da l1 attraverso l'attivazione prevista di cinque fattori di trascrizione: stat1 , stat2 , stat3 , irf7 e atf4 . Infatti , l1 overexpressione ha portato alla forte induzione di fosforilazione di stat3 che è stata abolita dalla neutralizzazione mediata da anticorpi di il-6r. questi risultati hanno indicato che l1 ha promosso l'attivazione di stat3 attraverso l'asse il-6/il-6r .", "pert_mt": "Usando una strategia di analisi orientata al percorso siamo stati in grado di identificare una rete di 105 geni modulati da l1 attraverso l'attivazione prevista di cinque fattori di trascrizione: stat1 , stat2 , stat3 , irf7 e atf4 . Infatti , l1 overexpressione ha portato alla forte induzione di fosforilazione di stat3 che è stata abolita dalla neutralizzazione mediata da anticorpi di il-6r. questi risultati hanno indicato che l1 ha promosso l'attivazione di stat3 attraverso l'asse il-6/il-6r e la regolazione di gene correlati.", "bt": "Using a path-oriented analysis strategy we were able to identify a network of 105 genes modulated by l1 through the predicted activation of five transcription factors: stat1 , stat2 , stat3 , irf7 and atf4 .In fact, l1 overexpression led to the strong induction of phosphorylation of stat3 which was abolished by the mediated neutralization of the antibodies of l-6r.These results indicated that l1 promoted the activation of stat3 through the il-6/il-6r axis and the regulation of related genes.", "questions_src": ["What pathway-oriented analysis strategy did you use?", "Which transcription factors were activated by L1?", "What gene expression was identified?", "Which cytokine receptor was neutralized to inhibit IL-6 signaling?", "What was the role of STAT3 in this pathway?"], "answers_src": ["a pathway - oriented analysis strategy", "stat1, stat2, stat3, irf7, and atf4", "a network of 105 genes", "IL-6R", "STAT3 activation"], "answers_bt": ["A path-oriented analysis strategy", "stat1, stat2, stat3, irf7, atf4", "a network of 105 genes", "L-6R", "promoted the activation of stat3"], "multiturn": {"turn_1": [{"question_id": "233.1", "question": "What pathway-oriented analysis strategy did you use?", "answer_src": "a pathway - oriented analysis strategy", "follow_up_question": "Which transcription factor was most strongly activated by L1 according to the text?", "follow_up_response": "stat3", "follow_up_response_bt": "stat3"}, {"question_id": "233.2", "question": "Which transcription factors were activated by L1?", "answer_src": "stat1, stat2, stat3, irf7, and atf4", "follow_up_question": "Which transcription factor's activation was inhibited by IL-6/IL-6R neutralization?", "follow_up_response": "atf4", "follow_up_response_bt": "atf4"}, {"question_id": "233.3", "question": "What gene expression was identified?", "answer_src": "a network of 105 genes", "follow_up_question": "Which transcription factor was most strongly activated by L1 according to the text?", "follow_up_response": "stat3", "follow_up_response_bt": "stat3"}, {"question_id": "233.4", "question": "Which cytokine receptor was neutralized to inhibit IL-6 signaling?", "answer_src": "IL-6R", "follow_up_question": "What is the role of STAT3 in the pathway activated by L1?", "follow_up_response": "STAT3 activation", "follow_up_response_bt": "STAT3 was strongly induced by L1 and its phosphorylation was abolished by neutralizing antibodies against IL-6R."}, {"question_id": "233.5", "question": "What was the role of STAT3 in this pathway?", "answer_src": "STAT3 activation", "follow_up_question": "How does STAT3 activation contribute to gene modulation by L1?", "follow_up_response": "L1 overexpression resulted in the strong induction of STAT3 phosphorylation", "follow_up_response_bt": "L1 overexpression leads to the strong induction of phosphorylation of STAT3, which is then regulated to promote the activation of related genes."}], "turn_2": [{"question_id": "233.6", "question": "Which transcription factor was most strongly activated by L1 according to the text?", "answer_src": "stat3", "follow_up_question": "Which other cytokine receptor was found to inhibit stat3 activation?", "follow_up_response": "il-6r", "follow_up_response_bt": "l-6r"}, {"question_id": "233.7", "question": "Which transcription factor's activation was inhibited by IL-6/IL-6R neutralization?", "answer_src": "atf4", "follow_up_question": "Which transcription factor was not involved in the IL-6/IL-6R signaling pathway according to the text?", "follow_up_response": "atf4", "follow_up_response_bt": "atf4"}, {"question_id": "233.8", "question": "Which transcription factor was most strongly activated by L1 according to the text?", "answer_src": "stat3", "follow_up_question": "Which other cytokine receptor was found to inhibit stat3 activation?", "follow_up_response": "il-6r", "follow_up_response_bt": "l-6r"}, {"question_id": "233.9", "question": "What is the role of STAT3 in the pathway activated by L1?", "answer_src": "STAT3 activation", "follow_up_question": "How does STAT3 activation contribute to gene modulation by L1?", "follow_up_response": "L1 overexpression resulted in the strong induction of STAT3 phosphorylation", "follow_up_response_bt": "L1 overexpression leads to the strong induction of phosphorylation of STAT3, which is then regulated to promote the activation of related genes."}, {"question_id": "233.10", "question": "How does STAT3 activation contribute to gene modulation by L1?", "answer_src": "L1 overexpression resulted in the strong induction of STAT3 phosphorylation", "follow_up_question": "What evidence supports that STAT3 activation is promoted by the IL-6/IL-6R axis?", "follow_up_response": "L1 overexpression resulted in the strong induction of STAT3 phosphorylation which was abolished by antibody-mediated neutralization of IL-6R.", "follow_up_response_bt": "These results indicated that l1 promoted the activation of stat3 through the il-6/il-6r axis"}], "turn_3": [{"question_id": "233.11", "question": "Which other cytokine receptor was found to inhibit stat3 activation?", "answer_src": "il-6r", "follow_up_question": "Which transcription factor was not activated by L1 according to the text?", "follow_up_response": "atf4", "follow_up_response_bt": "atf4"}, {"question_id": "233.12", "question": "Which transcription factor was not involved in the IL-6/IL-6R signaling pathway according to the text?", "answer_src": "atf4", "follow_up_question": "Which transcription factor showed phosphorylation in response to L1 overexpression?", "follow_up_response": "stat3", "follow_up_response_bt": "stat3"}, {"question_id": "233.13", "question": "Which other cytokine receptor was found to inhibit stat3 activation?", "answer_src": "il-6r", "follow_up_question": "Which transcription factor was not activated by L1 according to the text?", "follow_up_response": "atf4", "follow_up_response_bt": "atf4"}, {"question_id": "233.14", "question": "How does STAT3 activation contribute to gene modulation by L1?", "answer_src": "L1 overexpression resulted in the strong induction of STAT3 phosphorylation", "follow_up_question": "What evidence supports that STAT3 activation is promoted by the IL-6/IL-6R axis?", "follow_up_response": "L1 overexpression resulted in the strong induction of STAT3 phosphorylation which was abolished by antibody-mediated neutralization of IL-6R.", "follow_up_response_bt": "These results indicated that l1 promoted the activation of stat3 through the il-6/il-6r axis"}, {"question_id": "233.15", "question": "What evidence supports that STAT3 activation is promoted by the IL-6/IL-6R axis?", "answer_src": "L1 overexpression resulted in the strong induction of STAT3 phosphorylation which was abolished by antibody-mediated neutralization of IL-6R.", "follow_up_question": "How does L1 overexpression lead to STAT3 phosphorylation?", "follow_up_response": "L1 overexpression resulted in the strong induction of STAT3 phosphorylation", "follow_up_response_bt": "Through the IL-6/IL-6R axis"}]}}
{"id": 234, "src": "the cross - cultural exchanges between the people of india and their colonial rulers provides a fascinating insight into how these encounters shaped medicine and medical education in india . this article traces the history of how indian medicine was transformed in the backdrop of colonialism and hegemony . it goes on to show how six decades after independence , we have have still been unable to convincingly shrug off the colonial yoke .", "mt": "Gli scambi interculturali tra il popolo indiano e i suoi governanti coloniali forniscono una visione affascinante di come questi incontri hanno plasmato la medicina e l'istruzione medica in India . Questo articolo ripercorre la storia di come la medicina indiana è stata trasformata sullo sfondo del colonialismo e dell'egemonia .", "pert_mt": "Gli scambi interculturali tra il popolo indiano e i suoi governanti coloniali forniscono una visione affascinante di come questi incontri hanno plasmato la medicina e l'istruzione medica in India. Questo articolo ripercorre la storia di come la medicina indiana è stata trasformata sullo sfondo del colonialismo e dell'egemonia, e come queste dinamiche hanno influenzato anche la cultura culinaria indiana.", "bt": "The intercultural exchanges between the Indian people and their colonial rulers provide a fascinating insight into how these encounters have shaped medicine and medical education in India.This article traces the story of how Indian medicine has been transformed against the backdrop of colonialism and hegemony, and how these dynamics have also influenced Indian culinary culture.", "questions_src": ["What is the main subject of the article?", "Who were the people of India in relation to their colonial rulers?", "Where did the cross-cultural exchanges between India and its colonial rulers take place?", "When did the history of Indian medicine transformation start?", "Which period saw the most significant impact on Indian medicine due to colonialism?"], "answers_src": ["the cross-cultural exchanges between the people of india and their colonial rulers", "peoples of india were in relation to their colonial rulers as interacted and influenced each other", "between india and its colonial rulers", "six decades after independence", "colonialism"], "answers_bt": ["The history of Indian medicine transformation against the backdrop of colonialism and hegemony", "Indian people and their colonial rulers", "Between the Indian people and their colonial rulers", "Against the backdrop of colonialism and hegemony", "Colonialism"], "multiturn": {"turn_1": [{"question_id": "234.1", "question": "What is the main subject of the article?", "answer_src": "the cross-cultural exchanges between the people of india and their colonial rulers", "follow_up_question": "How does the article describe the impact of colonialism on Indian medicine?", "follow_up_response": "it was transformed", "follow_up_response_bt": "This article traces the story of how Indian medicine has been transformed against the backdrop of colonialism and hegemony"}, {"question_id": "234.2", "question": "Who were the people of India in relation to their colonial rulers?", "answer_src": "peoples of india were in relation to their colonial rulers as interacted and influenced each other", "follow_up_question": "How did the interactions between Indians and their colonial rulers impact Indian medicine?", "follow_up_response": "Indian medicine was transformed in the backdrop of colonialism and hegemony", "follow_up_response_bt": "These interactions have shaped medicine and medical education in India"}, {"question_id": "234.3", "question": "Where did the cross-cultural exchanges between India and its colonial rulers take place?", "answer_src": "between india and its colonial rulers", "follow_up_question": "What specific areas of medicine were transformed during the colonial period according to the article?", "follow_up_response": "medicine", "follow_up_response_bt": "medicine"}, {"question_id": "234.4", "question": "When did the history of Indian medicine transformation start?", "answer_src": "six decades after independence", "follow_up_question": "How long after independence has it taken for India to convincingly overcome the colonial influence on its medical system?", "follow_up_response": "six decades", "follow_up_response_bt": "No Answer"}, {"question_id": "234.5", "question": "Which period saw the most significant impact on Indian medicine due to colonialism?", "answer_src": "colonialism", "follow_up_question": "How long after independence did India struggle to overcome the effects of colonialism?", "follow_up_response": "Six decades", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "234.6", "question": "How does the article describe the impact of colonialism on Indian medicine?", "answer_src": "it was transformed", "follow_up_question": "How long after independence did the author suggest it has taken for India to convincingly reject the colonial influence?", "follow_up_response": "six decades", "follow_up_response_bt": "No Answer"}, {"question_id": "234.7", "question": "How did the interactions between Indians and their colonial rulers impact Indian medicine?", "answer_src": "Indian medicine was transformed in the backdrop of colonialism and hegemony", "follow_up_question": "What specific areas of Indian medicine were most significantly impacted by colonial influences?", "follow_up_response": "medicine and medical education", "follow_up_response_bt": "Colonialism and hegemony"}, {"question_id": "234.8", "question": "What specific areas of medicine were transformed during the colonial period according to the article?", "answer_src": "medicine", "follow_up_question": "How did the colonial period influence medical education in India?", "follow_up_response": "how indian medicine was transformed in the backdrop of colonialism", "follow_up_response_bt": "These dynamics have also influenced Indian culinary culture"}, {"question_id": "234.9", "question": "How long after independence has it taken for India to convincingly overcome the colonial influence on its medical system?", "answer_src": "six decades", "follow_up_question": "What specific areas of Indian medicine were most significantly influenced by colonialism according to the text?", "follow_up_response": "medicine and medical education", "follow_up_response_bt": "colonialism"}, {"question_id": "234.10", "question": "How long after independence did India struggle to overcome the effects of colonialism?", "answer_src": "Six decades", "follow_up_question": "How many years after independence were colonial influences still being felt?", "follow_up_response": "60", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "234.11", "question": "How long after independence did the author suggest it has taken for India to convincingly reject the colonial influence?", "answer_src": "six decades", "follow_up_question": "What year marks the beginning of the period the author refers to as \"six decades after independence\"?", "follow_up_response": "None of the provided questions can be answered directly from the given sentence.", "follow_up_response_bt": "No Answer"}, {"question_id": "234.12", "question": "What specific areas of Indian medicine were most significantly impacted by colonial influences?", "answer_src": "medicine and medical education", "follow_up_question": "How did the impact of colonial influences differ between medicine and medical education?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "234.13", "question": "How did the colonial period influence medical education in India?", "answer_src": "how indian medicine was transformed in the backdrop of colonialism", "follow_up_question": "What specific aspects of Indian medicine were transformed during the colonial period?", "follow_up_response": "medicine", "follow_up_response_bt": "colonialism and hegemony"}, {"question_id": "234.14", "question": "What specific areas of Indian medicine were most significantly influenced by colonialism according to the text?", "answer_src": "medicine and medical education", "follow_up_question": "How did the influence of colonialism differ in medicine versus medical education according to the text?", "follow_up_response": "the backdrop of colonialism", "follow_up_response_bt": "No Answer"}, {"question_id": "234.15", "question": "How many years after independence were colonial influences still being felt?", "answer_src": "60", "follow_up_question": "How did colonial influences manifest in Indian medicine according to the article?", "follow_up_response": "Indian medicine was transformed in the backdrop of colonialism and hegemony", "follow_up_response_bt": "These dynamics have also influenced Indian culinary culture"}]}}
{"id": 235, "src": "after 24 h of incubation , exendin-4 caused rapid activation of extracellular signal - related kinase 1/2 ( erk1/2 ) under lipotoxic conditions . the erk1/2 inhibitor pd98059 blocked the antilipotoxic effect of exendin-4 on min6 cells . exendin-4 also inhibited the mitochondrial pathway of apoptosis .", "mt": "Dopo 24 ore di incubazione , l'esendina-4 ha causato un rapido attivamento della kinasi extracellulare legata al segnale 1/2 (erk1/2) in condizioni lipotossie . l'inhibitore dell'erk1/2 pd98059 ha bloccato l'effetto antilipotossico dell'esendina-4 sulle cellule min6. l'esendina-4 ha anche inibito il percorso mitocondriale dell'apoptosi .", "pert_mt": "Dopo 24 ore di incubazione, l'esendina-4 ha causato un rapido attivamento della kinasi extracellulare legata al segnale 1/2 (erk1/2) in condizioni lipotossie. L'inhibitore dell'erk1/2 PD98059 ha bloccato l'effetto antilipotossico dell'esendina-4 sulle cellule MIN6. L'esendina-4 ha anche inibito il percorso mitocondriale dell'apoptosi e la proliferazione delle cellule.", "bt": "After 24 hours of incubation, esendine-4 caused a rapid activation of extracellular kinase related to the signal 1/2 (erk1/2) in lipotosis conditions. The erk1/2 inhibitor PD98059 blocked the antilipoptosis effect of esendine-4 on MIN6 cells.", "questions_src": ["What did exendin-4 cause under lipotoxic conditions?", "When does exendin-4 cause rapid activation of erk1/2?", "Which inhibitor blocked the antilipotoxic effect of exendin-4?", "Where is the mitochondrial pathway of apoptosis inhibited by exendin-4?", "Which kinase was activated by exendin-4?"], "answers_src": ["rapid activation of extracellular signal - related kinase 1/2 ( erk1/2 )", "after 24 h of incubation", "pd98059", "min6 cells", "extracellular signal - related kinase 1/2 ( erk1/2 )"], "answers_bt": ["A rapid activation of extracellular kinase related to the signal 1/2 (erk1/2)", "After 24 hours of incubation", "PD98059", "MIN6 cells", "Erk1/2"], "multiturn": {"turn_1": [{"question_id": "235.1", "question": "What did exendin-4 cause under lipotoxic conditions?", "answer_src": "rapid activation of extracellular signal - related kinase 1/2 ( erk1/2 )", "follow_up_question": "What specific pathway was inhibited by exendin-4 according to the text?", "follow_up_response": "the mitochondrial pathway of apoptosis", "follow_up_response_bt": "signal 1/2"}, {"question_id": "235.2", "question": "When does exendin-4 cause rapid activation of erk1/2?", "answer_src": "after 24 h of incubation", "follow_up_question": "Under what conditions does exendin-4 inhibit the mitochondrial pathway of apoptosis?", "follow_up_response": "lipotoxic conditions", "follow_up_response_bt": "lipotosis conditions"}, {"question_id": "235.3", "question": "Which inhibitor blocked the antilipotoxic effect of exendin-4?", "answer_src": "pd98059", "follow_up_question": "What mechanism did pd98059 block with exendin-4?", "follow_up_response": "the antilipotoxic effect of exendin-4", "follow_up_response_bt": "The antilipoptosis effect"}, {"question_id": "235.4", "question": "Where is the mitochondrial pathway of apoptosis inhibited by exendin-4?", "answer_src": "min6 cells", "follow_up_question": "What specific mechanism does exendin-4 use to inhibit the mitochondrial pathway of apoptosis?", "follow_up_response": "exendin-4", "follow_up_response_bt": "The specific mechanism that exendin-4 uses to inhibit the mitochondrial pathway of apoptosis is not directly mentioned.\", \"The specific mechanism that exendin-4 uses to inhibit the mitochondrial pathway of apoptosis is a rapid activation of extracellular kinase related to the signal 1/2 (erk1/2)."}, {"question_id": "235.5", "question": "Which kinase was activated by exendin-4?", "answer_src": "extracellular signal - related kinase 1/2 ( erk1/2 )", "follow_up_question": "Which specific pathway did exendin-4 inhibit according to the text?", "follow_up_response": "the mitochondrial pathway of apoptosis", "follow_up_response_bt": "The signal 1/2 (erk1/2) pathway"}], "turn_2": [{"question_id": "235.6", "question": "What specific pathway was inhibited by exendin-4 according to the text?", "answer_src": "the mitochondrial pathway of apoptosis", "follow_up_question": "What role did exendin-4 play in inhibiting apoptosis according to the text?", "follow_up_response": "exendin-4 inhibited the mitochondrial pathway of apoptosis", "follow_up_response_bt": "exendin-4 inhibited apoptosis"}, {"question_id": "235.7", "question": "Under what conditions does exendin-4 inhibit the mitochondrial pathway of apoptosis?", "answer_src": "lipotoxic conditions", "follow_up_question": "What specific mechanism does exendin-4 use to inhibit the mitochondrial pathway of apoptosis?", "follow_up_response": "exendin-4", "follow_up_response_bt": "The specific mechanism that exendin-4 uses to inhibit the mitochondrial pathway of apoptosis is not directly mentioned.\", \"The specific mechanism that exendin-4 uses to inhibit the mitochondrial pathway of apoptosis is a rapid activation of extracellular kinase related to the signal 1/2 (erk1/2)."}, {"question_id": "235.8", "question": "What mechanism did pd98059 block with exendin-4?", "answer_src": "the antilipotoxic effect of exendin-4", "follow_up_question": "How did exendin-4 inhibit apoptosis?", "follow_up_response": "The mitochondrial pathway", "follow_up_response_bt": "The erk1/2 inhibitor PD98059 blocked the antilipoptosis effect of esendine-4"}, {"question_id": "235.9", "question": "What specific mechanism does exendin-4 use to inhibit the mitochondrial pathway of apoptosis?", "answer_src": "exendin-4", "follow_up_question": "How does exendin-4 inhibit the mitochondrial pathway of apoptosis according to the text?", "follow_up_response": "exendin-4 inhibited the mitochondrial pathway of apoptosis.", "follow_up_response_bt": "The erk1/2 inhibitor PD98059 blocked the antilipoptosis effect of esendine-4 on MIN6 cells."}, {"question_id": "235.10", "question": "Which specific pathway did exendin-4 inhibit according to the text?", "answer_src": "the mitochondrial pathway of apoptosis", "follow_up_question": "What mechanism did exendin-4 use to inhibit the mitochondrial pathway?", "follow_up_response": "No Answer", "follow_up_response_bt": "The erk1/2 mechanism"}], "turn_3": [{"question_id": "235.11", "question": "What role did exendin-4 play in inhibiting apoptosis according to the text?", "answer_src": "exendin-4 inhibited the mitochondrial pathway of apoptosis", "follow_up_question": "How did exendin-4 inhibit the mitochondrial pathway of apoptosis?", "follow_up_response": "Exendin-4 inhibited the mitochondrial pathway of apoptosis.", "follow_up_response_bt": "The erk1/2 inhibitor PD98059 blocked the antilipoptosis effect of esendin-4"}, {"question_id": "235.12", "question": "What specific mechanism does exendin-4 use to inhibit the mitochondrial pathway of apoptosis?", "answer_src": "exendin-4", "follow_up_question": "How does exendin-4 inhibit the mitochondrial pathway of apoptosis according to the text?", "follow_up_response": "exendin-4 inhibited the mitochondrial pathway of apoptosis.", "follow_up_response_bt": "The erk1/2 inhibitor PD98059 blocked the antilipoptosis effect of esendine-4 on MIN6 cells."}, {"question_id": "235.13", "question": "How did exendin-4 inhibit apoptosis?", "answer_src": "The mitochondrial pathway", "follow_up_question": "What specific mechanism did exendin-4 use to inhibit the mitochondrial pathway?", "follow_up_response": "No Answer", "follow_up_response_bt": "The erk1/2 mechanism"}, {"question_id": "235.14", "question": "How does exendin-4 inhibit the mitochondrial pathway of apoptosis according to the text?", "answer_src": "exendin-4 inhibited the mitochondrial pathway of apoptosis.", "follow_up_question": "What mechanism did exendin-4 use to inhibit the mitochondrial pathway of apoptosis?", "follow_up_response": "exendin-4", "follow_up_response_bt": "The erk1/2 mechanism"}, {"question_id": "235.15", "question": "What mechanism did exendin-4 use to inhibit the mitochondrial pathway?", "answer_src": "after 24 h of incubation , exendin-4 caused rapid activation of extracellular signal - related kinase 1/2 ( erk1/2 ) under lipotoxic conditions . the erk1/2 inhibitor pd98059 blocked the antilipotoxic effect of exendin-4 on min6 cells . exendin-4 also inhibited the mitochondrial pathway of apoptosis .", "follow_up_question": "How did exendin-4 inhibit the mitochondrial pathway specifically?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 236, "src": "the maldi - tof provides accurate mass intensity data for the peptides of the digested protein , in this case protein kinase pak2 ( also called -pak ) . proteolysis of pak 2 is carried out in an offline pepsin digestion . this alternative method , when the user does not have access to a hplc and pepsin column connected to mass spectrometry , or when the pepsin column on hplc does not result in an optimal digestion map , for example , the heavily disulfide - bonded secreted phospholipase a2 ( spla2 ) .", "mt": "il maldi - tof fornisce dati precisi sull'intensità di massa dei peptidi della proteina digerita , in questo caso la proteina kinasi pak2 (chiamata anche -pak) . La proteolisi di pak 2 viene effettuata in una digestione di pepsina offline . questo metodo alternativo , quando l'utente non ha accesso a una colonna di hplc e pepsina connessa alla spettrometria di massa , o quando la colonna di pepsina su hplc non produce una mappa ottimale di digestione , ad esempio la fosfolipasi secreta a2 (spla2 ) fortemente disulfida-legata .", "pert_mt": "Il maldi - tof fornisce dati precisi sull'intensità di massa dei peptidi della proteina digerita, in questo caso la proteina kinasi pak2 (chiamata anche -pak). La proteolisi di pak 2 viene effettuata in una digestione di pepsina offline. Questo metodo alternativo, quando l'utente non ha accesso a una colonna di HPLC e pepsina connessa alla spettrometria di massa, o quando la colonna di pepsina su HPLC non produce una mappa ottimale di digestione, ad esempio la fosfolipasi secreta a2 (SPLA2) fortemente disolfida-legata, può includere l'utilizzo di enzimi alternative come trypsin.", "bt": "The maldi-tof provides accurate data on the mass intensity of the digested protein peptides, in this case protein kinase pak2 (also called -pak).Pak 2 proteolysis is performed in an offline pepsin digestion.This alternative method, when the user does not have access to a column of HPLC and pepsin is connected to the mass spectrometry, or when the pepsin column on HPLC does not produce an optimal digestion map, for example the strongly disulfide-ligated secret phospholipase a2 (SPLA2), may include the use of alternative enzymes such as trypsin.", "questions_src": ["What is used to provide accurate mass intensity data for peptides?", "Who is the alternative method suitable for?", "Where is the offline pepsin digestion carried out?", "When might the alternative method be preferred?", "Which enzyme is used for proteolysis of Pak2?"], "answers_src": ["[\"Maldi-tof\"], [\"The user\"], [\"Offline\"], [\"When the user does not have access to a HPLC and pepsin column connected to mass spectrometry, or when the pepsin column on HPLC does not result in an optimal digestion map\"], [\"Pepsin\"]}", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"The maldi-tof\"], [\"The user\"], [\"An offline\"], [\"When the user does not have access to a column of HPLC and pepsin is connected to the mass spectrometry, or when the pepsin column on HPLC does not produce an optimal digestion map\"], [\"Trypsin\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "236.1", "question": "What is used to provide accurate mass intensity data for peptides?", "answer_src": "[\"Maldi-tof\"], [\"The user\"], [\"Offline\"], [\"When the user does not have access to a HPLC and pepsin column connected to mass spectrometry, or when the pepsin column on HPLC does not result in an optimal digestion map\"], [\"Pepsin\"]}", "follow_up_question": "What type of proteolysis is used for the digestion of Pak2?", "follow_up_response": "pepsin digestion", "follow_up_response_bt": "Pepsin digestion"}, {"question_id": "236.2", "question": "Who is the alternative method suitable for?", "answer_src": "the maldi - tof provides accurate mass intensity data for the peptides of the digested protein , in this case protein kinase pak2 ( also called -pak ) . proteolysis of pak 2 is carried out in an offline pepsin digestion . this alternative method , when the user does not have access to a hplc and pepsin column connected to mass spectrometry , or when the pepsin column on hplc does not result in an optimal digestion map , for example , the heavily disulfide - bonded secreted phospholipase a2 ( spla2 ) .", "follow_up_question": "When is the offline pepsin digestion method not suitable?", "follow_up_response": "When the user does not have access to a HPLC and pepsin column connected to mass spectrometry, or when the pepsin column on HPLC does not result in an optimal digestion map.", "follow_up_response_bt": "When the user does not have access to a column of HPLC and pepsin is connected to the mass spectrometry, or when the pepsin column on HPLC does not produce an optimal digestion map"}, {"question_id": "236.3", "question": "Where is the offline pepsin digestion carried out?", "answer_src": "the maldi - tof provides accurate mass intensity data for the peptides of the digested protein , in this case protein kinase pak2 ( also called -pak ) . proteolysis of pak 2 is carried out in an offline pepsin digestion . this alternative method , when the user does not have access to a hplc and pepsin column connected to mass spectrometry , or when the pepsin column on hplc does not result in an optimal digestion map , for example , the heavily disulfide - bonded secreted phospholipase a2 ( spla2 ) .", "follow_up_question": "What alternative method is described when the pepsin column on HPLC does not result in an optimal digestion map?", "follow_up_response": "this alternative method", "follow_up_response_bt": "This alternative method"}, {"question_id": "236.4", "question": "When might the alternative method be preferred?", "answer_src": "the maldi - tof provides accurate mass intensity data for the peptides of the digested protein , in this case protein kinase pak2 ( also called -pak ) . proteolysis of pak 2 is carried out in an offline pepsin digestion . this alternative method , when the user does not have access to a hplc and pepsin column connected to mass spectrometry , or when the pepsin column on hplc does not result in an optimal digestion map , for example , the heavily disulfide - bonded secreted phospholipase a2 ( spla2 ) .", "follow_up_question": "What specific condition indicates that the pepsin column on HPLC does not result in an optimal digestion map?", "follow_up_response": "No Answer", "follow_up_response_bt": "strongly disulfide-ligated secret phospholipase a2 (SPLA2)"}, {"question_id": "236.5", "question": "Which enzyme is used for proteolysis of Pak2?", "answer_src": "the maldi - tof provides accurate mass intensity data for the peptides of the digested protein , in this case protein kinase pak2 ( also called -pak ) . proteolysis of pak 2 is carried out in an offline pepsin digestion . this alternative method , when the user does not have access to a hplc and pepsin column connected to mass spectrometry , or when the pepsin column on hplc does not result in an optimal digestion map , for example , the heavily disulfide - bonded secreted phospholipase a2 ( spla2 ) .", "follow_up_question": "What alternative method is described when the pepsin column on HPLC does not result in an optimal digestion map?", "follow_up_response": "this alternative method", "follow_up_response_bt": "This alternative method"}], "turn_2": [{"question_id": "236.6", "question": "What type of proteolysis is used for the digestion of Pak2?", "answer_src": "pepsin digestion", "follow_up_question": "What is the limitation of using the pepsin column on HPLC for digesting Pak2?", "follow_up_response": "when the pepsin column on hplc does not result in an optimal digestion map", "follow_up_response_bt": "when the pepsin column on HPLC does not produce an optimal digestion map"}, {"question_id": "236.7", "question": "When is the offline pepsin digestion method not suitable?", "answer_src": "When the user does not have access to a HPLC and pepsin column connected to mass spectrometry, or when the pepsin column on HPLC does not result in an optimal digestion map.", "follow_up_question": "What specific protein is mentioned as an example where the pepsin column on HPLC might not result in an optimal digestion map?", "follow_up_response": "heavily disulfide-bonded secreted phospholipase A2 (SPLA2)", "follow_up_response_bt": "strongly disulfide-ligated secret phospholipase a2 (SPLA2)"}, {"question_id": "236.8", "question": "What alternative method is described when the pepsin column on HPLC does not result in an optimal digestion map?", "answer_src": "this alternative method", "follow_up_question": "What specific protease is used in this alternative method?", "follow_up_response": "pepsin", "follow_up_response_bt": "trypsin"}, {"question_id": "236.9", "question": "What specific condition indicates that the pepsin column on HPLC does not result in an optimal digestion map?", "answer_src": "the maldi - tof provides accurate mass intensity data for the peptides of the digested protein , in this case protein kinase pak2 ( also called -pak ) . proteolysis of pak 2 is carried out in an offline pepsin digestion . this alternative method , when the user does not have access to a hplc and pepsin column connected to mass spectrometry , or when the pepsin column on hplc does not result in an optimal digestion map , for example , the heavily disulfide - bonded secreted phospholipase a2 ( spla2 ) .", "follow_up_question": "What other protein besides spla2 might require this alternative method?", "follow_up_response": "protein kinase pak2", "follow_up_response_bt": "protein kinase pak2"}, {"question_id": "236.10", "question": "What alternative method is described when the pepsin column on HPLC does not result in an optimal digestion map?", "answer_src": "this alternative method", "follow_up_question": "What specific protease is used in this alternative method?", "follow_up_response": "pepsin", "follow_up_response_bt": "trypsin"}], "turn_3": [{"question_id": "236.11", "question": "What is the limitation of using the pepsin column on HPLC for digesting Pak2?", "answer_src": "when the pepsin column on hplc does not result in an optimal digestion map", "follow_up_question": "What specific issue does the absence of an optimal digestion map indicate?", "follow_up_response": "an optimal digestion map", "follow_up_response_bt": "The strongly disulfide-ligated secret phospholipase a2 (SPLA2)"}, {"question_id": "236.12", "question": "What specific protein is mentioned as an example where the pepsin column on HPLC might not result in an optimal digestion map?", "answer_src": "heavily disulfide-bonded secreted phospholipase A2 (SPLA2)", "follow_up_question": "What is the reason given for using an alternative proteolysis method like offline pepsin digestion?", "follow_up_response": "the user does not have access to a hplc and pepsin column connected to mass spectrometry, or when the pepsin column on hplc does not result in an optimal digestion map", "follow_up_response_bt": "When the user does not have access to a column of HPLC and pepsin is connected to the mass spectrometry, or when the pepsin column on HPLC does not produce an optimal digestion map"}, {"question_id": "236.13", "question": "What specific protease is used in this alternative method?", "answer_src": "pepsin", "follow_up_question": "What is the limitation of using the pepsin column on HPLC in this alternative method?", "follow_up_response": "when the pepsin column on hplc does not result in an optimal digestion map", "follow_up_response_bt": "When the pepsin column on HPLC does not produce an optimal digestion map"}, {"question_id": "236.14", "question": "What other protein besides spla2 might require this alternative method?", "answer_src": "protein kinase pak2", "follow_up_question": "What is the name of the alternative method mentioned for proteolysis?", "follow_up_response": "proteolysis of pak 2", "follow_up_response_bt": "This alternative method"}, {"question_id": "236.15", "question": "What specific protease is used in this alternative method?", "answer_src": "pepsin", "follow_up_question": "What is the limitation of using the pepsin column on HPLC in this alternative method?", "follow_up_response": "when the pepsin column on hplc does not result in an optimal digestion map", "follow_up_response_bt": "When the pepsin column on HPLC does not produce an optimal digestion map"}]}}
{"id": 237, "src": "it was observed that approximately 6.6% and 7.0% dispersed tonsil cells and 5.8% and 0.44% dispersed lung cells are ifn-2 + mast cells and macrophages . moreover , tryptase and agonist peptides of par-2 induced enhanced ifn-2 mrna expression in a549 cells . in conclusion , the elevated levels of ifn-2 in the plasma of ar and ar + as indicate that ifn-2 is likely to contribute to the pathogenesis of allergic airway disorders .", "mt": "Si è osservato che circa il 6,6% e il 7,0% delle cellule tonsillee disperse e il 5,8% e lo 0,44% delle cellule polmonari disperse sono i mastociti e macrofagi ifn-2 + . Inoltre , la triptasi e gli agonisti peptidi di par-2 indotti una maggiore espressione di ifn-2 mrna in a549 cellule . In conclusione , gli elevati livelli di ifn-2 nel plasma di ar e ar + indicano che ifn-2 è probabile che contribuisca alla patogenesi di disturbi allergici delle vie aeree .", "pert_mt": "Si è osservato che circa il 6,6% e il 7,0% delle cellule tonsillee disperse e il 5,8% e lo 0,44% delle cellule polmonari disperse sono i mastociti e macrofagi ifn-2 + . Inoltre, la triptasi e gli agonisti peptidi di par-2 indotti una maggiore espressione di ifn-2 mrna in a549 cellule. In conclusione, gli elevati livelli di ifn-2 nel plasma di ar e ar + indicano che ifn-2 è probabile che contribuisca alla patogenesi di disturbi allergici delle vie aeree e queste condizioni possono aggravare i sintomi respiratori.", "bt": "It was observed that about 6.6% and 7.0% of even-dispersed tonsil cells and 5.8% and 0.44% of dispersed lung cells are ifn-2+ mast cells and macrophages . Furthermore, the triptase and par-2 peptide agonists induced a higher expression of ifn-2 in a549 cells.", "questions_src": ["What percentage of dispersed tonsil cells are ifn-2 + mast cells and macrophages?", "Where did the enhanced ifn-2 mrna expression occur in the A549 cells?", "Which peptide induced enhanced ifn-2 mrna expression in A549 cells?", "When was it observed that approximately 6.6% and 7.0% of dispersed tonsil cells were ifn-2 + mast cells and macrophages?", "Which cells had elevated levels of ifn-2 in their plasma according to the conclusion?"], "answers_src": ["6.6%", "A549 cells", "Tryptase and agonist peptides of par-2", "It was observed", "Ar and Ar + As"], "answers_bt": ["5.8% and 0.44%", "A549 cells", "Triptase and par-2 peptide agonists", "It was observed", "Tonsil cells and A549 cells"], "multiturn": {"turn_1": [{"question_id": "237.1", "question": "What percentage of dispersed tonsil cells are ifn-2 + mast cells and macrophages?", "answer_src": "6.6%", "follow_up_question": "What percentage of dispersed lung cells are ifn-2 + mast cells and macrophages?", "follow_up_response": "5.8% and 0.44%", "follow_up_response_bt": "5.8%, 0.44%"}, {"question_id": "237.2", "question": "Where did the enhanced ifn-2 mrna expression occur in the A549 cells?", "answer_src": "A549 cells", "follow_up_question": "What specific conditions were used to induce the enhanced ifn-2 mrna expression in A549 cells?", "follow_up_response": "Tryptase and agonist peptides of par-2", "follow_up_response_bt": "Triptase and par-2 peptide agonists"}, {"question_id": "237.3", "question": "Which peptide induced enhanced ifn-2 mrna expression in A549 cells?", "answer_src": "Tryptase and agonist peptides of par-2", "follow_up_question": "What percentage of lung cells were induced to express ifn-2 by tryptase and agonist peptides of par-2?", "follow_up_response": "5.8% and 0.44%", "follow_up_response_bt": "0.44%"}, {"question_id": "237.4", "question": "When was it observed that approximately 6.6% and 7.0% of dispersed tonsil cells were ifn-2 + mast cells and macrophages?", "answer_src": "It was observed", "follow_up_question": "What percentage of dispersed lung cells were ifn-2 + mast cells and macrophages?", "follow_up_response": "5.8% and 0.44%", "follow_up_response_bt": "5.8%, 0.44%"}, {"question_id": "237.5", "question": "Which cells had elevated levels of ifn-2 in their plasma according to the conclusion?", "answer_src": "Ar and Ar + As", "follow_up_question": "What percentage of lung cells had elevated levels of ifn-2?", "follow_up_response": "0.44%", "follow_up_response_bt": "0.44%"}], "turn_2": [{"question_id": "237.6", "question": "What percentage of dispersed lung cells are ifn-2 + mast cells and macrophages?", "answer_src": "5.8% and 0.44%", "follow_up_question": "What percentage of dispersed tonsil cells are ifn-2 + mast cells?", "follow_up_response": "7.0%", "follow_up_response_bt": "7.0%"}, {"question_id": "237.7", "question": "What specific conditions were used to induce the enhanced ifn-2 mrna expression in A549 cells?", "answer_src": "Tryptase and agonist peptides of par-2", "follow_up_question": "What concentration or dose of tryptase and agonist peptides of par-2 was used to induce the enhanced ifn-2 mrna expression?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "237.8", "question": "What percentage of lung cells were induced to express ifn-2 by tryptase and agonist peptides of par-2?", "answer_src": "5.8% and 0.44%", "follow_up_question": "What percentage of tonsil cells were induced to express ifn-2 by tryptase and agonist peptides of par-2?", "follow_up_response": "6.6%\", \"7.0%", "follow_up_response_bt": "6.6%\", \"7.0%"}, {"question_id": "237.9", "question": "What percentage of dispersed lung cells were ifn-2 + mast cells and macrophages?", "answer_src": "5.8% and 0.44%", "follow_up_question": "What percentage of dispersed tonsil cells were ifn-2 + mast cells and macrophages?", "follow_up_response": "6.6%\", \"7.0%", "follow_up_response_bt": "7.0%"}, {"question_id": "237.10", "question": "What percentage of lung cells had elevated levels of ifn-2?", "answer_src": "0.44%", "follow_up_question": "What percentage of tonsil cells had elevated levels of ifn-2?", "follow_up_response": "6.6%\", \"7.0%", "follow_up_response_bt": "6.6%\", \"7.0%"}], "turn_3": [{"question_id": "237.11", "question": "What percentage of dispersed tonsil cells are ifn-2 + mast cells?", "answer_src": "7.0%", "follow_up_question": "What percentage of dispersed lung cells are ifn-2 + macrophages?", "follow_up_response": "0.44%", "follow_up_response_bt": "0.44%"}, {"question_id": "237.12", "question": "What concentration or dose of tryptase and agonist peptides of par-2 was used to induce the enhanced ifn-2 mrna expression?", "answer_src": "it was observed that approximately 6.6% and 7.0% dispersed tonsil cells and 5.8% and 0.44% dispersed lung cells are ifn-2 + mast cells and macrophages . moreover , tryptase and agonist peptides of par-2 induced enhanced ifn-2 mrna expression in a549 cells . in conclusion , the elevated levels of ifn-2 in the plasma of ar and ar + as indicate that ifn-2 is likely to contribute to the pathogenesis of allergic airway disorders .", "follow_up_question": "What specific type of cells were the tryptase and agonist peptides of par-2 applied to in the A549 cells?", "follow_up_response": "A549 cells", "follow_up_response_bt": "A549 cells"}, {"question_id": "237.13", "question": "What percentage of tonsil cells were induced to express ifn-2 by tryptase and agonist peptides of par-2?", "answer_src": "6.6%\", \"7.0%", "follow_up_question": "What percentage of lung cells were not induced to express ifn-2 by tryptase and agonist peptides of par-2?", "follow_up_response": "5.8%", "follow_up_response_bt": "0.44%"}, {"question_id": "237.14", "question": "What percentage of dispersed tonsil cells were ifn-2 + mast cells and macrophages?", "answer_src": "6.6%\", \"7.0%", "follow_up_question": "What percentage of dispersed lung cells were ifn-2 + mast cells and macrophages?", "follow_up_response": "5.8% and 0.44%", "follow_up_response_bt": "5.8%, 0.44%"}, {"question_id": "237.15", "question": "What percentage of tonsil cells had elevated levels of ifn-2?", "answer_src": "6.6%\", \"7.0%", "follow_up_question": "What percentage of lung cells had elevated levels of ifn-2?", "follow_up_response": "0.44%", "follow_up_response_bt": "0.44%"}]}}
{"id": 238, "src": "sexual assault occurs with alarming frequency in canada . the prevalence of posttraumatic stress disorder ( ptsd ) in assault survivors is drastically higher than the national prevalence of the disorder , which is a strong indication that the current therapies for sexual - assault - related ptsd are in need of improvement . increasing knowledge and understanding of the pathologies associated with rape trauma in biological , psychological and sociological domains will help to develop more effective treatments for survivors .", "mt": "L' incidenza del disturbo di stress post-traumatico (PTSD) nei sopravvissuti ad aggressioni è drasticamente superiore alla prevalenza nazionale del disturbo , che è un forte indizio che le attuali terapie per il PTSD sessuale-assalto-relato hanno bisogno di essere migliorate .", "pert_mt": "L' incidenza del disturbo di stress post-traumatico (PTSD) nei sopravvissuti ad aggressioni è drasticamente superiore alla prevalenza nazionale del disturbo, che è un forte indizio che le attuali terapie per il PTSD sessuale-assalto-relato hanno bisogno di essere migliorate, e questo potrebbe essere dovuto alla mancanza di supporto psicologico adeguato.", "bt": "The incidence of post-traumatic stress disorder (PTSD) among aggression survivors is dramatically higher than the national prevalence of the disorder, which is a strong indication that the current treatment for PTSD-sexual assault-related needs to be improved, and this could be due to a lack of adequate psychological support.", "questions_src": ["What is the current prevalence of posttraumatic stress disorder (PTSD) in Canada?", "Who are the main subjects of the study mentioned in the sentence?", "Where does the information about PTSD prevalence come from?", "When did the statement about the need for improved therapies for sexual-assault-related PTSD occur?", "Which therapies are currently being used for sexual-assault-related PTSD?"], "answers_src": ["a strong indication that the current therapies for sexual - assault - related ptsd are in need of improvement", "assault survivors", "the national prevalence of the disorder", "the current therapies for sexual - assault - related ptsd are in need of improvement", "No Answer"], "answers_bt": ["a strong indication that the national prevalence", "aggression survivors", "the national prevalence of the disorder", "the current statement", "no answer"], "multiturn": {"turn_1": [{"question_id": "238.1", "question": "What is the current prevalence of posttraumatic stress disorder (PTSD) in Canada?", "answer_src": "a strong indication that the current therapies for sexual - assault - related ptsd are in need of improvement", "follow_up_question": "How does the high prevalence of PTSD in sexual assault survivors suggest improvements are needed for current therapies?", "follow_up_response": "The current therapies for sexual-assault-related PTSD are in need of improvement", "follow_up_response_bt": "This could be due to a lack of adequate psychological support."}, {"question_id": "238.2", "question": "Who are the main subjects of the study mentioned in the sentence?", "answer_src": "assault survivors", "follow_up_question": "What specific biological pathologies are associated with rape trauma according to the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "238.3", "question": "Where does the information about PTSD prevalence come from?", "answer_src": "the national prevalence of the disorder", "follow_up_question": "What percentage is the PTSD prevalence in assault survivors compared to the national prevalence?", "follow_up_response": "a strong indication that the current therapies for sexual - assault - related ptsd are in need of improvement", "follow_up_response_bt": "dramatically higher"}, {"question_id": "238.4", "question": "When did the statement about the need for improved therapies for sexual-assault-related PTSD occur?", "answer_src": "the current therapies for sexual - assault - related ptsd are in need of improvement", "follow_up_question": "What specific areas of biology, psychology, and sociology are needed to be better understood to improve treatments?", "follow_up_response": "Biological, psychological and sociological", "follow_up_response_bt": "No Answer"}, {"question_id": "238.5", "question": "Which therapies are currently being used for sexual-assault-related PTSD?", "answer_src": "sexual assault occurs with alarming frequency in canada . the prevalence of posttraumatic stress disorder ( ptsd ) in assault survivors is drastically higher than the national prevalence of the disorder , which is a strong indication that the current therapies for sexual - assault - related ptsd are in need of improvement . increasing knowledge and understanding of the pathologies associated with rape trauma in biological , psychological and sociological domains will help to develop more effective treatments for survivors .", "follow_up_question": "What kind of treatments does the text suggest would be more effective?", "follow_up_response": "more effective treatments for survivors", "follow_up_response_bt": "a lack of adequate psychological support"}], "turn_2": [{"question_id": "238.6", "question": "How does the high prevalence of PTSD in sexual assault survivors suggest improvements are needed for current therapies?", "answer_src": "The current therapies for sexual-assault-related PTSD are in need of improvement", "follow_up_question": "What specific areas of current therapies might benefit from improved approaches based on the high prevalence of PTSD?", "follow_up_response": "Sexual - assault - related PTSD", "follow_up_response_bt": "Psychological support"}, {"question_id": "238.7", "question": "What specific biological pathologies are associated with rape trauma according to the text?", "answer_src": "sexual assault occurs with alarming frequency in canada . the prevalence of posttraumatic stress disorder ( ptsd ) in assault survivors is drastically higher than the national prevalence of the disorder , which is a strong indication that the current therapies for sexual - assault - related ptsd are in need of improvement . increasing knowledge and understanding of the pathologies associated with rape trauma in biological , psychological and sociological domains will help to develop more effective treatments for survivors .", "follow_up_question": "What does the text suggest are the domains in which increasing knowledge and understanding should be focused?", "follow_up_response": "Biological, psychological and sociological", "follow_up_response_bt": "Increasing knowledge and understanding of the lack of adequate psychological support"}, {"question_id": "238.8", "question": "What percentage is the PTSD prevalence in assault survivors compared to the national prevalence?", "answer_src": "a strong indication that the current therapies for sexual - assault - related ptsd are in need of improvement", "follow_up_question": "How does increased knowledge and understanding of rape trauma contribute to developing better treatments?", "follow_up_response": "Increasing knowledge and understanding of the pathologies associated with rape trauma in biological, psychological, and sociological domains will help to develop more effective treatments for survivors.", "follow_up_response_bt": "No Answer"}, {"question_id": "238.9", "question": "What specific areas of biology, psychology, and sociology are needed to be better understood to improve treatments?", "answer_src": "Biological, psychological and sociological", "follow_up_question": "What aspects of rape trauma require increased knowledge in these three fields?", "follow_up_response": "Biological, psychological, and sociological domains", "follow_up_response_bt": "No Answer"}, {"question_id": "238.10", "question": "What kind of treatments does the text suggest would be more effective?", "answer_src": "more effective treatments for survivors", "follow_up_question": "What specific pathologies in biological, psychological, and sociological domains should be better understood?", "follow_up_response": "Rape trauma", "follow_up_response_bt": "A lack of adequate psychological support"}], "turn_3": [{"question_id": "238.11", "question": "What specific areas of current therapies might benefit from improved approaches based on the high prevalence of PTSD?", "answer_src": "Sexual - assault - related PTSD", "follow_up_question": "How does the high prevalence of PTSD in sexual assault survivors suggest current therapies may not be fully effective?", "follow_up_response": "The current therapies for sexual-assault-related PTSD are in need of improvement", "follow_up_response_bt": "This could be due to a lack of adequate psychological support."}, {"question_id": "238.12", "question": "What does the text suggest are the domains in which increasing knowledge and understanding should be focused?", "answer_src": "Biological, psychological and sociological", "follow_up_question": "What specific pathologies within these domains are associated with rape trauma according to the text?", "follow_up_response": "biological\", \"psychological\", \"sociological", "follow_up_response_bt": "No Answer"}, {"question_id": "238.13", "question": "How does increased knowledge and understanding of rape trauma contribute to developing better treatments?", "answer_src": "Increasing knowledge and understanding of the pathologies associated with rape trauma in biological, psychological, and sociological domains will help to develop more effective treatments for survivors.", "follow_up_question": "What specific pathologies in biological, psychological, and sociological domains should researchers focus on?", "follow_up_response": "Pathologies associated with rape trauma", "follow_up_response_bt": "No Answer"}, {"question_id": "238.14", "question": "What aspects of rape trauma require increased knowledge in these three fields?", "answer_src": "Biological, psychological, and sociological domains", "follow_up_question": "What specific pathologies in each domain have been identified as requiring further study?", "follow_up_response": "biological, psychological and sociological domains", "follow_up_response_bt": "No Answer"}, {"question_id": "238.15", "question": "What specific pathologies in biological, psychological, and sociological domains should be better understood?", "answer_src": "Rape trauma", "follow_up_question": "What kind of treatments for survivors does increased understanding of rape trauma aim to develop?", "follow_up_response": "more effective treatments", "follow_up_response_bt": "No Answer"}]}}
{"id": 239, "src": "aging is a major contributor to musculoskeletal degeneration and the development of osteoarthritis ( oa ) . oa is a degenerative disease that involves structural changes to joint tissues including synovial inflammation , catabolic destruction of articular cartilage and alterations in subchondral bone . cartilage degradation and structural changes in subchondral bone result in the production of fragments of extracellular matrix molecules .", "mt": "L'invecchiamento è un importante fattore che contribuisce alla degenerazione muscolo-scheletrica e allo sviluppo di osteoartrite (oA) . OA è una malattia degenerativa che comporta cambiamenti strutturali nei tessuti articolari tra cui infiammazione sinoviale , distruzione catabolica della cartilagine articolare e alterazioni nell'osso subcondriale .", "pert_mt": "L'invecchiamento è un importante fattore che contribuisce alla degenerazione muscolo-scheletrica e allo sviluppo di osteoartrite (oA). OA è una malattia degenerativa che comporta cambiamenti strutturali nei tessuti articolari tra cui infiammazione sinoviale, distruzione catabolica della cartilagine articolare e alterazioni nell'osso subcondriale e perdita di funzionalità articolare.", "bt": "Ageing is an important contributing factor to musculoskeletal degeneration and the development of osteoarthritis (oA).OA is a degenerative disease that involves structural changes in joint tissues including synovial inflammation, catabolic destruction of joint cartilage and alterations in subchondrial bone and loss of joint function.", "questions_src": ["What causes musculoskeletal degeneration?", "When does osteoarthritis typically develop?", "Where do joint tissues change due to osteoarthritis?", "Which tissue type is primarily affected by catabolic destruction in osteoarthritis?", "Which disease involves structural changes to joint tissues including synovial inflammation, catabolic destruction of articular cartilage and alterations in subchondral bone?"], "answers_src": ["[\"aging\"], [\"aging\"], [\"joint tissues\"], [\"articular cartilage\"], [\"osteoarthritis\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["Ageing", "typically develops", "joint tissues", "articular cartilage", "osteoarthritis"], "multiturn": {"turn_1": [{"question_id": "239.1", "question": "What causes musculoskeletal degeneration?", "answer_src": "[\"aging\"], [\"aging\"], [\"joint tissues\"], [\"articular cartilage\"], [\"osteoarthritis\"]", "follow_up_question": "How does cartilage degradation contribute to the development of osteoarthritis?", "follow_up_response": "Cartilage degradation and structural changes in subchondral bone result in the production of fragments of extracellular matrix molecules.", "follow_up_response_bt": "Catabolic destruction of joint cartilage"}, {"question_id": "239.2", "question": "When does osteoarthritis typically develop?", "answer_src": "aging is a major contributor to musculoskeletal degeneration and the development of osteoarthritis ( oa ) . oa is a degenerative disease that involves structural changes to joint tissues including synovial inflammation , catabolic destruction of articular cartilage and alterations in subchondral bone . cartilage degradation and structural changes in subchondral bone result in the production of fragments of extracellular matrix molecules .", "follow_up_question": "What specific changes occur in joint tissues due to osteoarthritis?", "follow_up_response": "Synovial inflammation, catabolic destruction of articular cartilage and alterations in subchondral bone", "follow_up_response_bt": "Synovial inflammation, catabolic destruction of joint cartilage and alterations in subchondrial bone"}, {"question_id": "239.3", "question": "Where do joint tissues change due to osteoarthritis?", "answer_src": "aging is a major contributor to musculoskeletal degeneration and the development of osteoarthritis ( oa ) . oa is a degenerative disease that involves structural changes to joint tissues including synovial inflammation , catabolic destruction of articular cartilage and alterations in subchondral bone . cartilage degradation and structural changes in subchondral bone result in the production of fragments of extracellular matrix molecules .", "follow_up_question": "What specific changes occur in subchondral bone due to osteoarthritis?", "follow_up_response": "Alterations", "follow_up_response_bt": "Alterations"}, {"question_id": "239.4", "question": "Which tissue type is primarily affected by catabolic destruction in osteoarthritis?", "answer_src": "aging is a major contributor to musculoskeletal degeneration and the development of osteoarthritis ( oa ) . oa is a degenerative disease that involves structural changes to joint tissues including synovial inflammation , catabolic destruction of articular cartilage and alterations in subchondral bone . cartilage degradation and structural changes in subchondral bone result in the production of fragments of extracellular matrix molecules .", "follow_up_question": "What specific structural change occurs in subchondral bone in osteoarthritis?", "follow_up_response": "Alterations", "follow_up_response_bt": "Alterations"}, {"question_id": "239.5", "question": "Which disease involves structural changes to joint tissues including synovial inflammation, catabolic destruction of articular cartilage and alterations in subchondral bone?", "answer_src": "aging is a major contributor to musculoskeletal degeneration and the development of osteoarthritis ( oa ) . oa is a degenerative disease that involves structural changes to joint tissues including synovial inflammation , catabolic destruction of articular cartilage and alterations in subchondral bone . cartilage degradation and structural changes in subchondral bone result in the production of fragments of extracellular matrix molecules .", "follow_up_question": "What specific structural changes occur in subchondral bone due to osteoarthritis?", "follow_up_response": "Alterations", "follow_up_response_bt": "Alterations"}], "turn_2": [{"question_id": "239.6", "question": "How does cartilage degradation contribute to the development of osteoarthritis?", "answer_src": "Cartilage degradation and structural changes in subchondral bone result in the production of fragments of extracellular matrix molecules.", "follow_up_question": "What specific changes occur in subchondral bone due to cartilage degradation?", "follow_up_response": "Alterations", "follow_up_response_bt": "Alterations"}, {"question_id": "239.7", "question": "What specific changes occur in joint tissues due to osteoarthritis?", "answer_src": "Synovial inflammation, catabolic destruction of articular cartilage and alterations in subchondral bone", "follow_up_question": "What causes the catabolic destruction of articular cartilage in osteoarthritis?", "follow_up_response": "aging", "follow_up_response_bt": "Ageing"}, {"question_id": "239.8", "question": "What specific changes occur in subchondral bone due to osteoarthritis?", "answer_src": "Alterations", "follow_up_question": "What other changes occur in cartilage due to osteoarthritis?", "follow_up_response": "Synovial inflammation, catabolic destruction of articular cartilage and alterations in subchondral bone", "follow_up_response_bt": "catabolic destruction of joint cartilage"}, {"question_id": "239.9", "question": "What specific structural change occurs in subchondral bone in osteoarthritis?", "answer_src": "Alterations", "follow_up_question": "What other joint tissue is affected by these structural changes in subchondral bone?", "follow_up_response": "No Answer", "follow_up_response_bt": "Synovial inflammation"}, {"question_id": "239.10", "question": "What specific structural changes occur in subchondral bone due to osteoarthritis?", "answer_src": "Alterations", "follow_up_question": "What other joint tissues besides subchondral bone experience structural changes in osteoarthritis?", "follow_up_response": "synovial inflammation", "follow_up_response_bt": "Synovial inflammation, catabolic destruction of joint cartilage"}], "turn_3": [{"question_id": "239.11", "question": "What specific changes occur in subchondral bone due to cartilage degradation?", "answer_src": "Alterations", "follow_up_question": "What other structural changes occur in subchondral bone besides alterations?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "239.12", "question": "What causes the catabolic destruction of articular cartilage in osteoarthritis?", "answer_src": "aging", "follow_up_question": "What specific structural changes occur in subchondral bone due to aging-related catabolic destruction?", "follow_up_response": "Catabolic destruction", "follow_up_response_bt": "Alterations"}, {"question_id": "239.13", "question": "What other changes occur in cartilage due to osteoarthritis?", "answer_src": "Synovial inflammation, catabolic destruction of articular cartilage and alterations in subchondral bone", "follow_up_question": "What specific type of damage does catabolic destruction of articular cartilage cause?", "follow_up_response": "Catabolic destruction of articular cartilage causes the catabolic destruction of articular cartilage.", "follow_up_response_bt": "Loss of joint function"}, {"question_id": "239.14", "question": "What other joint tissue is affected by these structural changes in subchondral bone?", "answer_src": "aging is a major contributor to musculoskeletal degeneration and the development of osteoarthritis ( oa ) . oa is a degenerative disease that involves structural changes to joint tissues including synovial inflammation , catabolic destruction of articular cartilage and alterations in subchondral bone . cartilage degradation and structural changes in subchondral bone result in the production of fragments of extracellular matrix molecules .", "follow_up_question": "What specific type of joint tissue undergoes catabolic destruction in osteoarthritis?", "follow_up_response": "articular cartilage", "follow_up_response_bt": "Joint cartilage"}, {"question_id": "239.15", "question": "What other joint tissues besides subchondral bone experience structural changes in osteoarthritis?", "answer_src": "synovial inflammation", "follow_up_question": "What specific type of joint tissue undergoes catabolic destruction in osteoarthritis?", "follow_up_response": "articular cartilage", "follow_up_response_bt": "Joint cartilage"}]}}
{"id": 240, "src": "the purpose of this study was to estimate and assess any correlation between random capillary blood glucose ( rcbg ) and unstimulated whole salivary glucose ( uwsg ) , as well as to estimate various salivary parameters , such as flow rate , ph , buffering capacity , and the influence of these factors on the oral health status in type 2 diabetes mellitus ( dm).sixty individuals suffering from type 2 dm and 40 healthy individuals in the age group of 3060 years were included in the study . rcbg was estimated using glucometer and uwsg was estimated using photocolorimeter . salivary parameters such as flow rate , ph , and buffering capacity were assessed using gc saliva kit .", "mt": "Lo scopo di questo studio era quello di stimare e valutare qualsiasi correlazione tra il glucosio nel sangue capillare casuale (rcbg) e il glucosio salivarico intero non stimulato (uwsg), nonché di stimare vari parametri della saliva , come il flusso , il pH , la capacità di buffering , e l'influenza di questi fattori sullo stato di salute orale nel diabete mellitus di tipo 2 (dm).Sessanta persone affette da tipo 2 dm e 40 persone sane nel gruppo di età di 3060 anni sono state incluse nello studio . rcbg è stato stimato utilizzando un glucometro e uwsg è stato stimato utilizzando un fotocolorimetro . Parametri della saliva come il flusso , il pH e il kit di capacità di buffering sono stati valutati utilizzando la saliva .", "pert_mt": "Lo scopo di questo studio era quello di stimare e valutare qualsiasi correlazione tra il glucosio nel sangue capillare casuale (rcbg) e il glucosio salivarico intero non stimulato (uwsg), nonché di stimare vari parametri della saliva, come il flusso, il pH, la capacità di buffering, e l'influenza di questi fattori sullo stato di salute orale nel diabete mellitus di tipo 2 (dm). **Inoltre**, sessanta persone affette da tipo 2 dm e 40 persone sane nel gruppo di età di 30-60 anni sono state incluse nello studio. rcbg è stato stimato utilizzando un glucometro e uwsg è stato stimato utilizzando un fotocolorimetro. Parametri della saliva come il flusso, il pH e la capacità di", "bt": "The purpose of this study was to estimate and evaluate any correlation between the glucose in the random capillary blood (rcbg) and the unstimulated whole salivary glucose (uwsg), as well as to estimate various parameters of saliva, such as flow, pH, buffering capacity, and the influence of these factors on oral health status in type 2 diabetes mellitus (dm). **In addition**, sixty people with type 2 dm and 40 people in the age group of 30-60 years were included in the study. rcbg was estimated using a glucometer and healthy uwsg was estimated using a photocolormeter.", "questions_src": ["What was the main purpose of the study?", "Who were included in the study?", "What method was used to estimate rcbg?", "Which factors were estimated to have an influence on the oral health status?", "How many individuals with type 2 diabetes mellitus were included in the study?"], "answers_src": ["[\"To estimate and assess any correlation between rcbg and uwsg, as well as to estimate various salivary parameters\"], [\"Sixty individuals suffering from type 2 DM and 40 healthy individuals in the age group of 30-60 years\"], [\"Glucometer\"], [\"Random capillary blood glucose (rcbg), unstimulated whole salivary glucose (uwsg), flow rate, pH, and buffering capacity\"], [60]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"To estimate and evaluate any correlation between the glucose in the random capillary blood (rcbg) and the unstimulated whole salivary glucose (uwsg), as well as to estimate various parameters of saliva\"], [\"Sixty people with type 2 dm and 40 people in the age group of 30-60 years\"], [\"a glucometer\"], [\"the influence of these factors on oral health status\"], [60]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "240.1", "question": "What was the main purpose of the study?", "answer_src": "[\"To estimate and assess any correlation between rcbg and uwsg, as well as to estimate various salivary parameters\"], [\"Sixty individuals suffering from type 2 DM and 40 healthy individuals in the age group of 30-60 years\"], [\"Glucometer\"], [\"Random capillary blood glucose (rcbg), unstimulated whole salivary glucose (uwsg), flow rate, pH, and buffering capacity\"], [60]", "follow_up_question": "What specific salivary parameter was not assessed in the study?", "follow_up_response": "buffering capacity", "follow_up_response_bt": "flow"}, {"question_id": "240.2", "question": "Who were included in the study?", "answer_src": "the purpose of this study was to estimate and assess any correlation between random capillary blood glucose ( rcbg ) and unstimulated whole salivary glucose ( uwsg ) , as well as to estimate various salivary parameters , such as flow rate , ph , buffering capacity , and the influence of these factors on the oral health status in type 2 diabetes mellitus ( dm).sixty individuals suffering from type 2 dm and 40 healthy individuals in the age group of 3060 years were included in the study . rcbg was estimated using glucometer and uwsg was estimated using photocolorimeter . salivary parameters such as flow rate , ph , and buffering capacity were assessed using gc saliva kit .", "follow_up_question": "What method was used to assess the salivary parameters?", "follow_up_response": "gc saliva kit", "follow_up_response_bt": "Glucometer and photocolormeter"}, {"question_id": "240.3", "question": "What method was used to estimate rcbg?", "answer_src": "the purpose of this study was to estimate and assess any correlation between random capillary blood glucose ( rcbg ) and unstimulated whole salivary glucose ( uwsg ) , as well as to estimate various salivary parameters , such as flow rate , ph , buffering capacity , and the influence of these factors on the oral health status in type 2 diabetes mellitus ( dm).sixty individuals suffering from type 2 dm and 40 healthy individuals in the age group of 3060 years were included in the study . rcbg was estimated using glucometer and uwsg was estimated using photocolorimeter . salivary parameters such as flow rate , ph , and buffering capacity were assessed using gc saliva kit .", "follow_up_question": "What instrument was used to measure the salivary flow rate?", "follow_up_response": "gc saliva kit", "follow_up_response_bt": "photocolormeter"}, {"question_id": "240.4", "question": "Which factors were estimated to have an influence on the oral health status?", "answer_src": "the purpose of this study was to estimate and assess any correlation between random capillary blood glucose ( rcbg ) and unstimulated whole salivary glucose ( uwsg ) , as well as to estimate various salivary parameters , such as flow rate , ph , buffering capacity , and the influence of these factors on the oral health status in type 2 diabetes mellitus ( dm).sixty individuals suffering from type 2 dm and 40 healthy individuals in the age group of 3060 years were included in the study . rcbg was estimated using glucometer and uwsg was estimated using photocolorimeter . salivary parameters such as flow rate , ph , and buffering capacity were assessed using gc saliva kit .", "follow_up_question": "What specific salivary parameters were assessed using the GC saliva kit?", "follow_up_response": "flow rate, ph, and buffering capacity", "follow_up_response_bt": "Flow, pH, buffering capacity"}, {"question_id": "240.5", "question": "How many individuals with type 2 diabetes mellitus were included in the study?", "answer_src": "the purpose of this study was to estimate and assess any correlation between random capillary blood glucose ( rcbg ) and unstimulated whole salivary glucose ( uwsg ) , as well as to estimate various salivary parameters , such as flow rate , ph , buffering capacity , and the influence of these factors on the oral health status in type 2 diabetes mellitus ( dm).sixty individuals suffering from type 2 dm and 40 healthy individuals in the age group of 3060 years were included in the study . rcbg was estimated using glucometer and uwsg was estimated using photocolorimeter . salivary parameters such as flow rate , ph , and buffering capacity were assessed using gc saliva kit .", "follow_up_question": "How many healthy individuals were included in the study?", "follow_up_response": "40", "follow_up_response_bt": "40"}], "turn_2": [{"question_id": "240.6", "question": "What specific salivary parameter was not assessed in the study?", "answer_src": "buffering capacity", "follow_up_question": "What method was used to measure rcbg?", "follow_up_response": "Glucometer", "follow_up_response_bt": "a glucometer"}, {"question_id": "240.7", "question": "What method was used to assess the salivary parameters?", "answer_src": "gc saliva kit", "follow_up_question": "What was the range of ages for the participants in the study?", "follow_up_response": "30-60", "follow_up_response_bt": "30-60 years"}, {"question_id": "240.8", "question": "What instrument was used to measure the salivary flow rate?", "answer_src": "gc saliva kit", "follow_up_question": "What parameter was not assessed using the gc saliva kit?", "follow_up_response": "influence", "follow_up_response_bt": "No Answer"}, {"question_id": "240.9", "question": "What specific salivary parameters were assessed using the GC saliva kit?", "answer_src": "flow rate, ph, and buffering capacity", "follow_up_question": "What was the method used to estimate unstimulated whole salivary glucose?", "follow_up_response": "using photocolorimeter", "follow_up_response_bt": "using a photocolormeter"}, {"question_id": "240.10", "question": "How many healthy individuals were included in the study?", "answer_src": "40", "follow_up_question": "How many individuals with type 2 diabetes mellitus were included in the study?", "follow_up_response": "60", "follow_up_response_bt": "60"}], "turn_3": [{"question_id": "240.11", "question": "What method was used to measure rcbg?", "answer_src": "Glucometer", "follow_up_question": "What instrument was used to measure uwsg?", "follow_up_response": "photocolorimeter", "follow_up_response_bt": "photocolormeter"}, {"question_id": "240.12", "question": "What was the range of ages for the participants in the study?", "answer_src": "30-60", "follow_up_question": "What specific salivary parameter was not assessed in the study?", "follow_up_response": "buffering capacity", "follow_up_response_bt": "flow"}, {"question_id": "240.13", "question": "What parameter was not assessed using the gc saliva kit?", "answer_src": "influence", "follow_up_question": "What was the method used to estimate rcbg?", "follow_up_response": "Glucometer", "follow_up_response_bt": "A glucometer"}, {"question_id": "240.14", "question": "What was the method used to estimate unstimulated whole salivary glucose?", "answer_src": "using photocolorimeter", "follow_up_question": "What other salivary parameter was assessed using the gc saliva kit?", "follow_up_response": "buffering capacity", "follow_up_response_bt": "Buffering capacity"}, {"question_id": "240.15", "question": "How many individuals with type 2 diabetes mellitus were included in the study?", "answer_src": "60", "follow_up_question": "How many healthy individuals were included in the study?", "follow_up_response": "40", "follow_up_response_bt": "40"}]}}
{"id": 241, "src": "this study aimed to evaluate outcomes from the use of a sodium hyaluronate ( sh)-based comfort drop , instilled before the insertion of contact lenses , in a population of symptomatic contact lens wearers . this was a cross - over , open - label , multi - sites study . subjects were fitted with silicone hydrogel lenses and followed for two months .", "mt": "Questo studio mirava a valutare i risultati dell' uso di una goccia di comfort basata su ialuronato di sodio (sh), instillata prima dell' inserimento delle lenti a contatto , in una popolazione di portatori sintomatici di lenti a contatto . Si trattava di uno studio cross-over , open-label , multi-site . I soggetti erano dotati di lenti di silicone idrogel e seguiti per due mesi .", "pert_mt": "Questo studio mirava a valutare i risultati dell' uso di una goccia di comfort basata su ialuronato di sodio (sh), instillata prima dell' inserimento delle lenti a contatto, in una popolazione di portatori sintomatici di lenti a contatto. Si trattava di uno studio cross-over, open-label, multi-site. I soggetti erano dotati di lenti di silicone idrogel e seguiti per due mesi, e non presentavano miglioramenti significativi.", "bt": "This study evaluated the results of using a comfort drop based on sodium ialuronate (sh), instilled before the insertion of contact lenses, in a population of symptomatic contact lens wearers.It was a cross-over, open-label, multi-site study.The subjects were fitted with silicone hydrogel lenses and followed up for two months, and showed no significant improvements.", "questions_src": ["What was the main purpose of the study?", "Who were the participants in the study?", "Where was the study conducted?", "When did the study last for?", "Which type of contact lens was used in the study?"], "answers_src": ["To evaluate outcomes from the use of a sodium hyaluronate (sh)-based comfort drop", "Symptomatic contact lens wearers", "Multi-sites", "Two months", "Silicone hydrogel"], "answers_bt": ["[\"To evaluate the results of using a comfort drop based on sodium ialuronate before the insertion of contact lenses\"], [\"Symptomatic contact lens wearers\"], [\"Multi-site\"], [\"Two months\"], [\"Silicone hydrogel\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "241.1", "question": "What was the main purpose of the study?", "answer_src": "To evaluate outcomes from the use of a sodium hyaluronate (sh)-based comfort drop", "follow_up_question": "How long did the study follow the subjects?", "follow_up_response": "two months", "follow_up_response_bt": "Two months"}, {"question_id": "241.2", "question": "Who were the participants in the study?", "answer_src": "Symptomatic contact lens wearers", "follow_up_question": "What type of lenses did the subjects wear during the study?", "follow_up_response": "Silicone hydrogel lenses", "follow_up_response_bt": "Silicone hydrogel lenses"}, {"question_id": "241.3", "question": "Where was the study conducted?", "answer_src": "Multi-sites", "follow_up_question": "What type of study design was used?", "follow_up_response": "cross-over", "follow_up_response_bt": "cross-over, open-label, multi-site study"}, {"question_id": "241.4", "question": "When did the study last for?", "answer_src": "Two months", "follow_up_question": "How many sites participated in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "241.5", "question": "Which type of contact lens was used in the study?", "answer_src": "Silicone hydrogel", "follow_up_question": "What was the duration of the study?", "follow_up_response": "Two months", "follow_up_response_bt": "Two months"}], "turn_2": [{"question_id": "241.6", "question": "How long did the study follow the subjects?", "answer_src": "two months", "follow_up_question": "What type of lenses were subjects initially fitted with?", "follow_up_response": "Silicone hydrogel lenses", "follow_up_response_bt": "Silicone hydrogel lenses"}, {"question_id": "241.7", "question": "What type of lenses did the subjects wear during the study?", "answer_src": "Silicone hydrogel lenses", "follow_up_question": "What was the duration of the study?", "follow_up_response": "Two months", "follow_up_response_bt": "Two months"}, {"question_id": "241.8", "question": "What type of study design was used?", "answer_src": "cross-over", "follow_up_question": "How long did the follow-up period last?", "follow_up_response": "Two months", "follow_up_response_bt": "Two months"}, {"question_id": "241.9", "question": "How many sites participated in the study?", "answer_src": "this study aimed to evaluate outcomes from the use of a sodium hyaluronate ( sh)-based comfort drop , instilled before the insertion of contact lenses , in a population of symptomatic contact lens wearers . this was a cross - over , open - label , multi - sites study . subjects were fitted with silicone hydrogel lenses and followed for two months .", "follow_up_question": "How long were the subjects followed?", "follow_up_response": "two months", "follow_up_response_bt": "Two months"}, {"question_id": "241.10", "question": "What was the duration of the study?", "answer_src": "Two months", "follow_up_question": "How many sites participated in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "241.11", "question": "What type of lenses were subjects initially fitted with?", "answer_src": "Silicone hydrogel lenses", "follow_up_question": "What was the duration of the follow-up period for the study?", "follow_up_response": "Two months", "follow_up_response_bt": "Two months"}, {"question_id": "241.12", "question": "What was the duration of the study?", "answer_src": "Two months", "follow_up_question": "How many sites participated in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "241.13", "question": "How long did the follow-up period last?", "answer_src": "Two months", "follow_up_question": "What type of lenses were subjects initially fitted with?", "follow_up_response": "Silicone hydrogel lenses", "follow_up_response_bt": "Silicone hydrogel lenses"}, {"question_id": "241.14", "question": "How long were the subjects followed?", "answer_src": "two months", "follow_up_question": "What type of lenses did the subjects initially wear?", "follow_up_response": "Silicone hydrogel lenses", "follow_up_response_bt": "Silicone hydrogel lenses"}, {"question_id": "241.15", "question": "How many sites participated in the study?", "answer_src": "this study aimed to evaluate outcomes from the use of a sodium hyaluronate ( sh)-based comfort drop , instilled before the insertion of contact lenses , in a population of symptomatic contact lens wearers . this was a cross - over , open - label , multi - sites study . subjects were fitted with silicone hydrogel lenses and followed for two months .", "follow_up_question": "How long were the subjects followed?", "follow_up_response": "two months", "follow_up_response_bt": "Two months"}]}}
{"id": 242, "src": "in recent years , internet addiction disorder ( iad ) has become more prevalent worldwide and the recognition of its devastating impact on the users and society has rapidly increased . however , the neurobiological mechanism of iad has not bee fully expressed . the present study was designed to determine if the striatal dopamine transporter ( dat ) levels measured by 99mtc - trodat-1 single photon emission computed tomography ( spect ) brain scans were altered in individuals with iad .", "mt": "Negli ultimi anni, il disturbo di dipendenza da Internet (ID) è diventato più diffuso in tutto il mondo e il riconoscimento del suo impatto devastante sugli utenti e sulla società è aumentato rapidamente . Tuttavia, il meccanismo neurobiologico dell'ID non è ancora stato pienamente espresso . Il presente studio è stato progettato per determinare se i livelli di dopamina striatale misurati da 99mtc - trodat-1 singoli scansioni di emissione di fotoni computed tomography (spect brain) sono stati alterati negli individui con l'ID .", "pert_mt": "Negli ultimi anni, il disturbo di dipendenza da Internet (ID) è diventato più diffuso in tutto il mondo e il riconoscimento del suo impatto devastante sugli utenti e sulla società è aumentato rapidamente. Tuttavia, il meccanismo neurobiologico dell'ID non è ancora stato pienamente compreso. Il presente studio è stato progettato per determinare se i livelli di dopamina striale misurati da 99mtc - trodat-1 singoli scansioni di emissione di fotoni computed tomography (spect brain) sono stati alterati negli individui con l'ID.", "bt": "In recent years, the Internet addiction disorder (ID) has become more widespread worldwide and the recognition of its devastating impact on users and society has increased rapidly, however, the neurobiological mechanism of the ID has not yet been fully understood.The present study is designed to determine whether the levels of stral dopamine measured by 99mtc-trodat-1 single photon emission scans computed tomography (spect brain) have been altered in individuals with the ID.", "questions_src": ["What is the full name of the disorder discussed in the sentence?", "Who has recognized the impact of internet addiction disorder on users and society?", "Where has internet addiction disorder become more prevalent according to the sentence?", "When has the recognition of internet addiction disorder's impact increased rapidly?", "Which neurobiological mechanism of internet addiction disorder has not been fully expressed yet?"], "answers_src": ["internet addiction disorder (iad)", "users and society", "worldwide", "recent years", "the neurobiological mechanism"], "answers_bt": ["Internet addiction disorder (ID)", "users and society", "worldwide", "recent years", "neurobiological mechanism"], "multiturn": {"turn_1": [{"question_id": "242.1", "question": "What is the full name of the disorder discussed in the sentence?", "answer_src": "internet addiction disorder (iad)", "follow_up_question": "What specific aspect of individuals with iad does the study aim to investigate?", "follow_up_response": "Striatal dopamine transporter (DAT) levels", "follow_up_response_bt": "Whether the levels of stral dopamine"}, {"question_id": "242.2", "question": "Who has recognized the impact of internet addiction disorder on users and society?", "answer_src": "users and society", "follow_up_question": "What specific aspect of internet addiction disorder is the present study trying to investigate?", "follow_up_response": "Striatal dopamine transporter (DAT) levels", "follow_up_response_bt": "Whether the levels of stral dopamine"}, {"question_id": "242.3", "question": "Where has internet addiction disorder become more prevalent according to the sentence?", "answer_src": "worldwide", "follow_up_question": "What specific neurobiological mechanism is the present study trying to determine?", "follow_up_response": "The neurobiological mechanism of internet addiction disorder (iad)", "follow_up_response_bt": "Whether the levels of striatal dopamine measured by 99mTc-tetrodotoxin single photon emission computed tomography (SPECT brain) have been altered"}, {"question_id": "242.4", "question": "When has the recognition of internet addiction disorder's impact increased rapidly?", "answer_src": "recent years", "follow_up_question": "What specific aspect of internet addiction disorder is the present study trying to determine?", "follow_up_response": "If the striatal dopamine transporter (DAT) levels measured by 99mTc-trodat-1 single photon emission computed tomography (SPECT) brain scans are altered in individuals with IAD", "follow_up_response_bt": "Whether the levels of stral dopamine"}, {"question_id": "242.5", "question": "Which neurobiological mechanism of internet addiction disorder has not been fully expressed yet?", "answer_src": "the neurobiological mechanism", "follow_up_question": "What specific brain scan technique did the present study use to measure striatal dopamine transporter levels?", "follow_up_response": "99mtc-trodat-1 single photon emission computed tomography (SPECT)", "follow_up_response_bt": "99mtc-trodat-1 single photon emission scans computed tomography (spect brain)"}], "turn_2": [{"question_id": "242.6", "question": "What specific aspect of individuals with iad does the study aim to investigate?", "answer_src": "Striatal dopamine transporter (DAT) levels", "follow_up_question": "How is the striatal dopamine transporter (DAT) level measurement conducted in this study?", "follow_up_response": "by 99mTc-trodat-1 single photon emission computed tomography (SPECT) brain scans", "follow_up_response_bt": "99mtc-trodat-1 single photon emission scans computed tomography (spect brain)"}, {"question_id": "242.7", "question": "What specific aspect of internet addiction disorder is the present study trying to investigate?", "answer_src": "Striatal dopamine transporter (DAT) levels", "follow_up_question": "How does the present study plan to measure the striatal dopamine transporter (DAT) levels?", "follow_up_response": "by 99mTc-trodat-1 single photon emission computed tomography (SPECT) brain scans", "follow_up_response_bt": "By 99mTc-tetrodaxol-1 single photon emission computed tomography (SPECT) brain"}, {"question_id": "242.8", "question": "What specific neurobiological mechanism is the present study trying to determine?", "answer_src": "The neurobiological mechanism of internet addiction disorder (iad)", "follow_up_question": "What type of brain scan will be used to measure the striatal dopamine transporter (dat) levels in the study?", "follow_up_response": "99mtc-trodat-1 single photon emission computed tomography (SPECT) brain scans", "follow_up_response_bt": "99mtc-trodat-1 single photon emission computed tomography (spect brain)"}, {"question_id": "242.9", "question": "What specific aspect of internet addiction disorder is the present study trying to determine?", "answer_src": "If the striatal dopamine transporter (DAT) levels measured by 99mTc-trodat-1 single photon emission computed tomography (SPECT) brain scans are altered in individuals with IAD", "follow_up_question": "How does the alteration in DAT levels potentially relate to the development or severity of internet addiction disorder?", "follow_up_response": "The alteration in striatal dopamine transporter (DAT) levels measured by 99mTc-trodat-1 single photon emission computed tomography (SPECT) brain scans potentially relates to the development or severity of internet addiction disorder.", "follow_up_response_bt": "No Answer"}, {"question_id": "242.10", "question": "What specific brain scan technique did the present study use to measure striatal dopamine transporter levels?", "answer_src": "99mtc-trodat-1 single photon emission computed tomography (SPECT)", "follow_up_question": "What was the primary hypothesis of the present study regarding striatal dopamine transporter levels in individuals with iad?", "follow_up_response": "To determine if the striatal dopamine transporter (DAT) levels measured by 99mTc-trodat-1 single photon emission computed tomography (SPECT) brain scans were altered in individuals with internet addiction disorder (iad).", "follow_up_response_bt": "Whether the levels of striatal dopamine transporter have been altered"}], "turn_3": [{"question_id": "242.11", "question": "How is the striatal dopamine transporter (DAT) level measurement conducted in this study?", "answer_src": "by 99mTc-trodat-1 single photon emission computed tomography (SPECT) brain scans", "follow_up_question": "What does the alteration in DAT levels suggest about the pathophysiology of IAD according to the study?", "follow_up_response": "The alteration in striatal dopamine transporter (DAT) levels suggests changes in the pathophysiology of IAD.", "follow_up_response_bt": "Whether the levels of striatal dopamine measured by 99mTc-tetrodotoxin single photon emission computed tomography (SPECT brain) have been altered in individuals with Internet addiction disorder"}, {"question_id": "242.12", "question": "How does the present study plan to measure the striatal dopamine transporter (DAT) levels?", "answer_src": "by 99mTc-trodat-1 single photon emission computed tomography (SPECT) brain scans", "follow_up_question": "What specific outcome is the study aiming to investigate regarding these altered DAT levels?", "follow_up_response": "Are the striatal dopamine transporter (DAT) levels altered in individuals with internet addiction disorder (iad)?", "follow_up_response_bt": "Whether the levels of striatal dopamine measured by 99mTc-tetrodotoxin single photon emission computed tomography (SPECT brain) have been altered in individuals with Internet addiction disorder"}, {"question_id": "242.13", "question": "What type of brain scan will be used to measure the striatal dopamine transporter (dat) levels in the study?", "answer_src": "99mtc-trodat-1 single photon emission computed tomography (SPECT) brain scans", "follow_up_question": "How many individuals with iad will be included in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "242.14", "question": "How does the alteration in DAT levels potentially relate to the development or severity of internet addiction disorder?", "answer_src": "The alteration in striatal dopamine transporter (DAT) levels measured by 99mTc-trodat-1 single photon emission computed tomography (SPECT) brain scans potentially relates to the development or severity of internet addiction disorder.", "follow_up_question": "What specific changes in DAT levels were observed in the individuals with IAD compared to control subjects?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "242.15", "question": "What was the primary hypothesis of the present study regarding striatal dopamine transporter levels in individuals with iad?", "answer_src": "To determine if the striatal dopamine transporter (DAT) levels measured by 99mTc-trodat-1 single photon emission computed tomography (SPECT) brain scans were altered in individuals with internet addiction disorder (iad).", "follow_up_question": "How many individuals participated in the SPECT brain scans for this study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 243, "src": "a 42-year - old man with chronic hepatitis c and ulcerative colitis ( uc ) was referred to our hospital in august 2004 because of bloody diarrhea . he was clinically and endoscopically diagnosed with flare of uc . after informed consent had been obtained , he was treated with peg - ifn--2a .", "mt": "Un 42enne affetto da epatite cronica c e colite ulcerosa (UC) è stato ricondotto al nostro ospedale nell'agosto 2004 a causa di diarrea sanguinosa .", "pert_mt": "Un 42enne affetto da epatite cronica cè colite ulcerosa (UC) è stato ricondotto al nostro ospedale nell'agosto 2004 a causa di diarrea sanguinosa e di febbre elevata.", "bt": "A 42-year-old patient with chronic hepatitis and ulcerative colitis (UC) was admitted to our hospital in August 2004 due to high blood diarrhea and fever.", "questions_src": ["What is the patient's age?", "When was the patient referred to the hospital?", "What condition is the patient clinically and endoscopically diagnosed with?", "Where did the patient get treated?", "Which treatment did the patient receive after being diagnosed?"], "answers_src": ["42-year-old man", "August 2004", "Flare of UC", "Our hospital", "Peg-IFN-α"], "answers_bt": ["42-year-old", "August 2004", "chronic hepatitis and ulcerative colitis (UC)", "our hospital", "No Answer"], "multiturn": {"turn_1": [{"question_id": "243.1", "question": "What is the patient's age?", "answer_src": "42-year-old man", "follow_up_question": "How long did it take for the patient to be clinically and endoscopically diagnosed?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "243.2", "question": "When was the patient referred to the hospital?", "answer_src": "August 2004", "follow_up_question": "What treatment did the patient receive after being diagnosed with a flare of UC?", "follow_up_response": "peg—ifn—2a", "follow_up_response_bt": "No Answer"}, {"question_id": "243.3", "question": "What condition is the patient clinically and endoscopically diagnosed with?", "answer_src": "Flare of UC", "follow_up_question": "What treatment did the patient receive after being diagnosed with a flare of UC?", "follow_up_response": "peg—ifn—2a", "follow_up_response_bt": "No Answer"}, {"question_id": "243.4", "question": "Where did the patient get treated?", "answer_src": "Our hospital", "follow_up_question": "What treatment did the patient receive at our hospital?", "follow_up_response": "peg—ifn—2a", "follow_up_response_bt": "No Answer"}, {"question_id": "243.5", "question": "Which treatment did the patient receive after being diagnosed?", "answer_src": "Peg-IFN-α", "follow_up_question": "What was the duration of the treatment?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "243.6", "question": "How long did it take for the patient to be clinically and endoscopically diagnosed?", "answer_src": "a 42-year - old man with chronic hepatitis c and ulcerative colitis ( uc ) was referred to our hospital in august 2004 because of bloody diarrhea . he was clinically and endoscopically diagnosed with flare of uc . after informed consent had been obtained , he was treated with peg - ifn--2a .", "follow_up_question": "How many months passed between his referral to the hospital and his clinical and endoscopic diagnosis?", "follow_up_response": "30", "follow_up_response_bt": "No Answer"}, {"question_id": "243.7", "question": "What treatment did the patient receive after being diagnosed with a flare of UC?", "answer_src": "peg—ifn—2a", "follow_up_question": "What was the duration of the treatment with peg—ifn—2a?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "243.8", "question": "What treatment did the patient receive after being diagnosed with a flare of UC?", "answer_src": "peg—ifn—2a", "follow_up_question": "What was the duration of the treatment with peg—ifn—2a?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "243.9", "question": "What treatment did the patient receive at our hospital?", "answer_src": "peg—ifn—2a", "follow_up_question": "What was the duration of the treatment with peg—ifn—2a?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "243.10", "question": "What was the duration of the treatment?", "answer_src": "a 42-year - old man with chronic hepatitis c and ulcerative colitis ( uc ) was referred to our hospital in august 2004 because of bloody diarrhea . he was clinically and endoscopically diagnosed with flare of uc . after informed consent had been obtained , he was treated with peg - ifn--2a .", "follow_up_question": "How long did the patient need to take peg - ifn--2a ?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "243.11", "question": "How many months passed between his referral to the hospital and his clinical and endoscopic diagnosis?", "answer_src": "30", "follow_up_question": "How many months did it take for the patient to start treatment after his clinical and endoscopic diagnosis?", "follow_up_response": "3", "follow_up_response_bt": "No Answer"}, {"question_id": "243.12", "question": "What was the duration of the treatment with peg—ifn—2a?", "answer_src": "a 42-year - old man with chronic hepatitis c and ulcerative colitis ( uc ) was referred to our hospital in august 2004 because of bloody diarrhea . he was clinically and endoscopically diagnosed with flare of uc . after informed consent had been obtained , he was treated with peg - ifn--2a .", "follow_up_question": "How long did the patient wait between being diagnosed with a flare of UC and starting the treatment?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "243.13", "question": "What was the duration of the treatment with peg—ifn—2a?", "answer_src": "a 42-year - old man with chronic hepatitis c and ulcerative colitis ( uc ) was referred to our hospital in august 2004 because of bloody diarrhea . he was clinically and endoscopically diagnosed with flare of uc . after informed consent had been obtained , he was treated with peg - ifn--2a .", "follow_up_question": "How long did the patient wait between being diagnosed with a flare of UC and starting the treatment?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "243.14", "question": "What was the duration of the treatment with peg—ifn—2a?", "answer_src": "a 42-year - old man with chronic hepatitis c and ulcerative colitis ( uc ) was referred to our hospital in august 2004 because of bloody diarrhea . he was clinically and endoscopically diagnosed with flare of uc . after informed consent had been obtained , he was treated with peg - ifn--2a .", "follow_up_question": "How long did the patient wait between being diagnosed with a flare of UC and starting the treatment?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "243.15", "question": "How long did the patient need to take peg - ifn--2a ?", "answer_src": "a 42-year - old man with chronic hepatitis c and ulcerative colitis ( uc ) was referred to our hospital in august 2004 because of bloody diarrhea . he was clinically and endoscopically diagnosed with flare of uc . after informed consent had been obtained , he was treated with peg - ifn--2a .", "follow_up_question": "For how many months was the patient treated with peg - ifn--2a ?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 244, "src": "furthermore , an examination of ectopic breast tissue tends to be omitted from a screening mammography . especially , the microcalcifications of ectopic breast tissue are difficult to delineate on mammography . herein , the authors report a case of ectopic breast carcinoma that showed clustered microcalcifications on screening mammography , and discuss the interpretation and implications of microcalcification in ectopic breast tissue .", "mt": "Inoltre , un esame del tessuto mammario ectopotico tende ad essere omesso da una mammografia di screening . in particolare , le microcalcificazioni del tessuto mammario ectopotico sono difficili da delineare sulla mammografia . qui , gli autori riportano un caso di carcinoma del seno ectopotico che ha mostrato microcalcificazioni clusterate sulla mammografia di screening , e discutono l'interpretazione e le implicazioni della microcalcificazione nel tessuto mammario ectopotico .", "pert_mt": "Inoltre, un esame del tessuto mammario ectopotico tende ad essere omesso da una mammografia di screening. In particolare, le microcalcificazioni del tessuto mammario ectopotico sono difficili da delineare sulla mammografia. Qui, gli autori riportano un caso di carcinoma del seno ectopotico che ha mostrato microcalcificazioni clusterate sulla mammografia di screening, e discutono l'interpretazione e le implicazioni della microcalcificazione nel tessuto mammario ectopotico e nella diagnosi precoce del cancro al seno.", "bt": "In addition, an examination of ectopic breast tissue tends to be omitted by a screening mammography.In particular, the microcalcification of ectopic breast tissue is difficult to delineate on mammography.Here, the authors report a case of ectopic breast cancer that has shown clusterate microcalcification on screening mammography, and discuss the interpretation and implications of microcalcification in ectopic breast tissue and in early diagnosis of breast cancer.", "questions_src": ["What type of tissue is examined in an examination mentioned in the sentence?", "When is ectopic breast tissue typically omitted from a screening mammography?", "Where can microcalcifications of ectopic breast tissue be difficult to delineate on mammography?", "Which case does the author report involving ectopic breast carcinoma with clustered microcalcifications?", "Which term refers to the difficulty in interpreting microcalcifications in ectopic breast tissue discussed by the authors?"], "answers_src": ["[\"Ectopic breast tissue\"], [\"an examination\"], [\"mammography\"], [\"a case of ectopic breast carcinoma\"], [\"the interpretation\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"Ectopic breast tissue\"], [\"In an examination\"], [\"On mammography\"], [\"A case of ectopic breast carcinoma\"], [\"Difficulty in interpreting microcalcifications\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "244.1", "question": "What type of tissue is examined in an examination mentioned in the sentence?", "answer_src": "[\"Ectopic breast tissue\"], [\"an examination\"], [\"mammography\"], [\"a case of ectopic breast carcinoma\"], [\"the interpretation\"]", "follow_up_question": "What specific feature of ectopic breast tissue is described as difficult to delineate on mammography?", "follow_up_response": "Microcalcifications", "follow_up_response_bt": "microcalcification"}, {"question_id": "244.2", "question": "When is ectopic breast tissue typically omitted from a screening mammography?", "answer_src": "furthermore , an examination of ectopic breast tissue tends to be omitted from a screening mammography . especially , the microcalcifications of ectopic breast tissue are difficult to delineate on mammography . herein , the authors report a case of ectopic breast carcinoma that showed clustered microcalcifications on screening mammography , and discuss the interpretation and implications of microcalcification in ectopic breast tissue .", "follow_up_question": "What specific feature of ectopic breast tissue makes it challenging to detect on mammography?", "follow_up_response": "Microcalcifications", "follow_up_response_bt": "Microcalcification"}, {"question_id": "244.3", "question": "Where can microcalcifications of ectopic breast tissue be difficult to delineate on mammography?", "answer_src": "furthermore , an examination of ectopic breast tissue tends to be omitted from a screening mammography . especially , the microcalcifications of ectopic breast tissue are difficult to delineate on mammography . herein , the authors report a case of ectopic breast carcinoma that showed clustered microcalcifications on screening mammography , and discuss the interpretation and implications of microcalcification in ectopic breast tissue .", "follow_up_question": "What specific feature did the authors discuss in their report regarding microcalcification in ectopic breast tissue?", "follow_up_response": "The interpretation and implications of microcalcification in ectopic breast tissue", "follow_up_response_bt": "clusterate microcalcification"}, {"question_id": "244.4", "question": "Which case does the author report involving ectopic breast carcinoma with clustered microcalcifications?", "answer_src": "furthermore , an examination of ectopic breast tissue tends to be omitted from a screening mammography . especially , the microcalcifications of ectopic breast tissue are difficult to delineate on mammography . herein , the authors report a case of ectopic breast carcinoma that showed clustered microcalcifications on screening mammography , and discuss the interpretation and implications of microcalcification in ectopic breast tissue .", "follow_up_question": "What is the main challenge described in the text regarding the detection of microcalcifications in ectopic breast tissue?", "follow_up_response": "The microcalcifications of ectopic breast tissue are difficult to delineate on mammography.", "follow_up_response_bt": "The microcalcification of ectopic breast tissue is difficult to delineate on mammography."}, {"question_id": "244.5", "question": "Which term refers to the difficulty in interpreting microcalcifications in ectopic breast tissue discussed by the authors?", "answer_src": "furthermore , an examination of ectopic breast tissue tends to be omitted from a screening mammography . especially , the microcalcifications of ectopic breast tissue are difficult to delineate on mammography . herein , the authors report a case of ectopic breast carcinoma that showed clustered microcalcifications on screening mammography , and discuss the interpretation and implications of microcalcification in ectopic breast tissue .", "follow_up_question": "What specific feature did the authors observe on the screening mammography that was characteristic of the ectopic breast carcinoma?", "follow_up_response": "Clustered microcalcifications", "follow_up_response_bt": "Clusterate microcalcification"}], "turn_2": [{"question_id": "244.6", "question": "What specific feature of ectopic breast tissue is described as difficult to delineate on mammography?", "answer_src": "Microcalcifications", "follow_up_question": "What was the final diagnosis in the case described?", "follow_up_response": "Ectopic breast carcinoma", "follow_up_response_bt": "Ectopic breast cancer"}, {"question_id": "244.7", "question": "What specific feature of ectopic breast tissue makes it challenging to detect on mammography?", "answer_src": "Microcalcifications", "follow_up_question": "How do the clustered microcalcifications affect the diagnosis of ectopic breast carcinoma?", "follow_up_response": "The clustered microcalcifications make it difficult to diagnose ectopic breast carcinoma.", "follow_up_response_bt": "The clustered microcalcifications affect the diagnosis of ectopic breast carcinoma by being difficult to delineate on mammography."}, {"question_id": "244.8", "question": "What specific feature did the authors discuss in their report regarding microcalcification in ectopic breast tissue?", "answer_src": "The interpretation and implications of microcalcification in ectopic breast tissue", "follow_up_question": "What were the clustered microcalcifications observed in the case study?", "follow_up_response": "Clustered microcalcifications", "follow_up_response_bt": "Clusterate microcalcification"}, {"question_id": "244.9", "question": "What is the main challenge described in the text regarding the detection of microcalcifications in ectopic breast tissue?", "answer_src": "The microcalcifications of ectopic breast tissue are difficult to delineate on mammography.", "follow_up_question": "What type of microcalcifications were found in the case reported by the authors?", "follow_up_response": "Clustered", "follow_up_response_bt": "clusterate microcalcification"}, {"question_id": "244.10", "question": "What specific feature did the authors observe on the screening mammography that was characteristic of the ectopic breast carcinoma?", "answer_src": "Clustered microcalcifications", "follow_up_question": "What was the challenge in interpreting these clustered microcalcifications on the screening mammography?", "follow_up_response": "The clustered microcalcifications in ectopic breast tissue are difficult to delineate on mammography.", "follow_up_response_bt": "The interpretation and implications of microcalcification in ectopic breast tissue and in early diagnosis of breast cancer."}], "turn_3": [{"question_id": "244.11", "question": "What was the final diagnosis in the case described?", "answer_src": "Ectopic breast carcinoma", "follow_up_question": "What were the characteristics of the microcalcifications observed on the screening mammography?", "follow_up_response": "Clustered microcalcifications", "follow_up_response_bt": "Clusterate microcalcification"}, {"question_id": "244.12", "question": "How do the clustered microcalcifications affect the diagnosis of ectopic breast carcinoma?", "answer_src": "The clustered microcalcifications make it difficult to diagnose ectopic breast carcinoma.", "follow_up_question": "What specific type of microcalcifications were observed in the case study?", "follow_up_response": "Clustered microcalcifications", "follow_up_response_bt": "clusterate microcalcification"}, {"question_id": "244.13", "question": "What were the clustered microcalcifications observed in the case study?", "answer_src": "Clustered microcalcifications", "follow_up_question": "What was the initial challenge in interpreting these clustered microcalcifications on the screening mammography?", "follow_up_response": "The interpretation and implications of microcalcification in ectopic breast tissue", "follow_up_response_bt": "The interpretation and implications of microcalcification in ectopic breast tissue and in early diagnosis of breast cancer"}, {"question_id": "244.14", "question": "What type of microcalcifications were found in the case reported by the authors?", "answer_src": "Clustered", "follow_up_question": "What was the outcome of the clustered microcalcifications on the screening mammography?", "follow_up_response": "Clustered microcalcifications were interpreted as ectopic breast carcinoma.", "follow_up_response_bt": "Clusterate microcalcification"}, {"question_id": "244.15", "question": "What was the challenge in interpreting these clustered microcalcifications on the screening mammography?", "answer_src": "The clustered microcalcifications in ectopic breast tissue are difficult to delineate on mammography.", "follow_up_question": "What specific type of cancer did the authors report in their case study?", "follow_up_response": "Ectopic breast carcinoma", "follow_up_response_bt": "Ectopic breast cancer"}]}}
{"id": 245, "src": "we quantified chicken calpain 2 ( capn2 ) expression in two chinese chicken breeds ( mountainous black - bone chicken breed [ mb ] and a commercial meat type chicken breed [ s01 ] ) to discern the tissue and ontogenic expression pattern and its effect on muscle metabolism . real - time quantitative pcr assay was developed for accurate measurement of the capn2 mrna expression in various tissues from chickens of different ages ( 0 , 2 , 4 , 6 , 8 , 10 , and 12 weeks ) . results showed that the breast muscle and leg muscle tissues had the highest expression of capn2 compared to the other tissues from the same individual ( p < .05 ) .", "mt": "Abbiamo quantificato l'espressione di calpain 2 (capn2) di pollo in due razze di pollo cinesi (razza di pollo di montagna nera-osso [ mb ] e una razza di pollo di tipo carne commerciale [ s01 ]) per discernere il modello di espressione tissutale e ontogenica e il suo effetto sul metabolismo muscolare . È stato sviluppato un assay quantitativo pcr in tempo reale per misurare con precisione l'espressione di capn2 mrna in vari tessuti di polli di diverse età (0, 2, 4, 6, 8, 10 e 12 settimane).", "pert_mt": "Abbiamo quantificato l'espressione di calpain 2 (capn2) di pollo in due razze di pollo cinesi (razza di pollo di montagna nera-osso [mb] e una razza di tipo carne commerciale [s01]) per discernere il modello di espressione tissutale e ontogenica e il suo effetto sul metabolismo muscolare. È stato sviluppato un assay quantitativo PCR in tempo reale per misurare con precisione l'espressione di capn2 mRNA in vari tessuti di polli di diverse età (0, 2, 4, 6, 8, 10 e 12 settimane) e abbiamo scoperto che l'espressione varia notevolmente tra le due razze studiate.", "bt": "We quantified the expression of calpain 2 (capn2) in chicken in two breeds of Chinese chicken (black-bone mountain chicken [mb] and a commercial meat breed [s01]) to discern the pattern of tissue and ontogenic expression and its effect on muscle metabolism.A quantitative real-time PCR assay was developed to accurately measure the expression of capn2 mRNA in various chicken tissues of different ages (0, 2, 4, 6, 8, 10 and 12 weeks) and we found that expression varies significantly between studies of the two breeds.", "questions_src": ["What did you quantify in the chicken breeds?", "Who developed the real-time quantitative PCR assay?", "Where were the tissues sampled from the chickens?", "When were the chickens sampled (in weeks)?", "Which muscle tissue had the highest expression of capn2?"], "answers_src": ["Chicken calpain 2 (capn2) expression", "We developed the real-time quantitative PCR assay", "Various tissues from chickens of different ages", "[0, 2, 4, 6, 8, 10, 12] weeks", "Breast muscle and leg muscle"], "answers_bt": ["[\"The expression of calpain 2 (capn2)\"], [\"We\"], [\"Various chicken tissues of different ages\"], [0, 2, 4, 6, 8, 10, 12], \"No Answer\"", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "245.1", "question": "What did you quantify in the chicken breeds?", "answer_src": "Chicken calpain 2 (capn2) expression", "follow_up_question": "What were the highest expressing tissues for capn2 according to the study?", "follow_up_response": "breast muscle and leg muscle", "follow_up_response_bt": "No Answer"}, {"question_id": "245.2", "question": "Who developed the real-time quantitative PCR assay?", "answer_src": "We developed the real-time quantitative PCR assay", "follow_up_question": "What were the specific tissues with the highest expression of capn2 according to the results?", "follow_up_response": "breast muscle and leg muscle", "follow_up_response_bt": "No Answer"}, {"question_id": "245.3", "question": "Where were the tissues sampled from the chickens?", "answer_src": "Various tissues from chickens of different ages", "follow_up_question": "What specific age groups of chickens were used in the study?", "follow_up_response": "0, 2, 4, 6, 8, 10, and 12 weeks", "follow_up_response_bt": "0, 2, 4, 6, 8, 10, and 12 weeks"}, {"question_id": "245.4", "question": "When were the chickens sampled (in weeks)?", "answer_src": "[0, 2, 4, 6, 8, 10, 12] weeks", "follow_up_question": "What was the age range of the chickens sampled?", "follow_up_response": "0 , 2 , 4 , 6 , 8 , 10 , and 12 weeks", "follow_up_response_bt": "0, 2, 4, 6, 8, 10, and 12 weeks"}, {"question_id": "245.5", "question": "Which muscle tissue had the highest expression of capn2?", "answer_src": "Breast muscle and leg muscle", "follow_up_question": "What was the age range of the chickens used in the study?", "follow_up_response": "0 , 2 , 4 , 6 , 8 , 10 , and 12 weeks", "follow_up_response_bt": "0, 2, 4, 6, 8, 10, and 12 weeks"}], "turn_2": [{"question_id": "245.6", "question": "What were the highest expressing tissues for capn2 according to the study?", "answer_src": "breast muscle and leg muscle", "follow_up_question": "What was the age range of chickens used in the study for which capn2 expression was measured?", "follow_up_response": "0 , 2 , 4 , 6 , 8 , 10 , and 12 weeks", "follow_up_response_bt": "0, 12 weeks"}, {"question_id": "245.7", "question": "What were the specific tissues with the highest expression of capn2 according to the results?", "answer_src": "breast muscle and leg muscle", "follow_up_question": "What was the age range of chickens used in the study as indicated by the tissue samples?", "follow_up_response": "0 , 2 , 4 , 6 , 8 , 10 , and 12 weeks", "follow_up_response_bt": "0, 2, 4, 6, 8, 10, and 12 weeks"}, {"question_id": "245.8", "question": "What specific age groups of chickens were used in the study?", "answer_src": "0, 2, 4, 6, 8, 10, and 12 weeks", "follow_up_question": "What was the highest expression level of capn2 observed in the study?", "follow_up_response": "breast muscle and leg muscle tissues", "follow_up_response_bt": "No Answer"}, {"question_id": "245.9", "question": "What was the age range of the chickens sampled?", "answer_src": "0 , 2 , 4 , 6 , 8 , 10 , and 12 weeks", "follow_up_question": "What were the results regarding the expression levels of capn2 in different tissues?", "follow_up_response": "The breast muscle and leg muscle tissues had the highest expression of capn2 compared to the other tissues from the same individual (p < .05)", "follow_up_response_bt": "Expression varies significantly between studies of the two breeds"}, {"question_id": "245.10", "question": "What was the age range of the chickens used in the study?", "answer_src": "0 , 2 , 4 , 6 , 8 , 10 , and 12 weeks", "follow_up_question": "What were the specific tissues with the highest expression of capn2 according to the study?", "follow_up_response": "breast muscle and leg muscle", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "245.11", "question": "What was the age range of chickens used in the study for which capn2 expression was measured?", "answer_src": "0 , 2 , 4 , 6 , 8 , 10 , and 12 weeks", "follow_up_question": "What were the specific tissues found to have the highest capn2 expression according to the study?", "follow_up_response": "breast muscle and leg muscle", "follow_up_response_bt": "No Answer"}, {"question_id": "245.12", "question": "What was the age range of chickens used in the study as indicated by the tissue samples?", "answer_src": "0 , 2 , 4 , 6 , 8 , 10 , and 12 weeks", "follow_up_question": "What were the specific tissues with the highest expression of capn2 according to the study?", "follow_up_response": "breast muscle and leg muscle", "follow_up_response_bt": "No Answer"}, {"question_id": "245.13", "question": "What was the highest expression level of capn2 observed in the study?", "answer_src": "breast muscle and leg muscle tissues", "follow_up_question": "What was the age range of the chickens used in the study when capn2 expression was highest?", "follow_up_response": "10 and 12 weeks", "follow_up_response_bt": "12 weeks"}, {"question_id": "245.14", "question": "What were the results regarding the expression levels of capn2 in different tissues?", "answer_src": "The breast muscle and leg muscle tissues had the highest expression of capn2 compared to the other tissues from the same individual (p < .05)", "follow_up_question": "What was the age range of the chickens used in the study?", "follow_up_response": "0 , 2 , 4 , 6 , 8 , 10 , and 12 weeks", "follow_up_response_bt": "0, 2, 4, 6, 8, 10, and 12 weeks"}, {"question_id": "245.15", "question": "What were the specific tissues with the highest expression of capn2 according to the study?", "answer_src": "breast muscle and leg muscle", "follow_up_question": "What was the age range of chickens used in the study for which the highest capn2 expression was observed in breast and leg muscles?", "follow_up_response": "0 , 2 , 4 , 6 , 8 , 10 , 12 weeks", "follow_up_response_bt": "No Answer"}]}}
{"id": 246, "src": "most of these patients developed hypoglycemia and were of lower age group , whereas a majority of higher age group patients developed hyperglycemia . in majority of the cases , abnormal glucose developed after three doses of l - asp . hypoglycemia subsided whereas hyperglycemia persisted till the end of our observation period.l-asp produces more incidences of hypoglycemia than hyperglycemia in a good number of all patients towards which clinicians should be more vigilant .", "mt": "Nella maggior parte dei casi , il glucosio anormale sviluppato dopo tre dosi di l-asp. è diminuito mentre l-asp. è persistito fino alla fine del nostro periodo di osservazione.l-asp produce più incidenze di ipoglicemia di iperglicemia in un buon numero di pazienti verso i quali i medici dovrebbero essere più attenti .", "pert_mt": "Nella maggior parte dei casi, il glucosio anormale sviluppato dopo tre dosi di l-asp è diminuito mentre l-asp è persistito fino alla fine del nostro periodo di osservazione. l-asp produce più incidenze di ipoglicemia di iperglicemia in un buon numero di pazienti verso i quali i medici dovrebbero essere più attenti e questo effetto si verifica più frequentemente nei primi giorni di trattamento.", "bt": "In most cases, the abnormal glucose developed after three doses of l-asp decreases while l-asp persists until the end of our observation period. l-asp produces more incidence of hyperglycemic hypoglycemia in a good number of patients towards whom doctors should be more attentive and this effect occurs more frequently in the first days of treatment.", "questions_src": ["What is the primary symptom observed in most patients?", "Who developed hypoglycemia according to the sentence?", "Where does the sentence mention that l-asp was administered?", "When did abnormal glucose levels typically occur?", "Which age group had a higher incidence of developing hyperglycemia?"], "answers_src": ["Hypoglycemia", "Most of these patients", "In majority of the cases", "After three doses of l-asp", "Higher age group"], "answers_bt": ["Hyperglycemic hypoglycemia", "Patients", "In most cases", "After three doses", "No Answer"], "multiturn": {"turn_1": [{"question_id": "246.1", "question": "What is the primary symptom observed in most patients?", "answer_src": "Hypoglycemia", "follow_up_question": "What percentage of patients experienced hypoglycemia according to the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "246.2", "question": "Who developed hypoglycemia according to the sentence?", "answer_src": "Most of these patients", "follow_up_question": "What was the age group of most patients who developed hypoglycemia?", "follow_up_response": "Lower age group", "follow_up_response_bt": "No Answer"}, {"question_id": "246.3", "question": "Where does the sentence mention that l-asp was administered?", "answer_src": "In majority of the cases", "follow_up_question": "What is the duration mentioned for abnormal glucose levels to develop after administering l-asp?", "follow_up_response": "Three doses", "follow_up_response_bt": "Three doses"}, {"question_id": "246.4", "question": "When did abnormal glucose levels typically occur?", "answer_src": "After three doses of l-asp", "follow_up_question": "How long did it take for hypoglycemia to subside?", "follow_up_response": "No Answer", "follow_up_response_bt": "three doses"}, {"question_id": "246.5", "question": "Which age group had a higher incidence of developing hyperglycemia?", "answer_src": "Higher age group", "follow_up_question": "Which age group had a higher incidence of developing hypoglycemia?", "follow_up_response": "lower age group", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "246.6", "question": "What percentage of patients experienced hypoglycemia according to the text?", "answer_src": "most of these patients developed hypoglycemia and were of lower age group , whereas a majority of higher age group patients developed hyperglycemia . in majority of the cases , abnormal glucose developed after three doses of l - asp . hypoglycemia subsided whereas hyperglycemia persisted till the end of our observation period.l-asp produces more incidences of hypoglycemia than hyperglycemia in a good number of all patients towards which clinicians should be more vigilant .", "follow_up_question": "What was the duration of hypoglycemia according to the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "246.7", "question": "What was the age group of most patients who developed hypoglycemia?", "answer_src": "Lower age group", "follow_up_question": "What percentage of patients experienced hypoglycemia according to the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "246.8", "question": "What is the duration mentioned for abnormal glucose levels to develop after administering l-asp?", "answer_src": "Three doses", "follow_up_question": "What was the outcome of hypoglycemia in most cases?", "follow_up_response": "Hypoglycemia subsided", "follow_up_response_bt": "Hyperglycemic hypoglycemia"}, {"question_id": "246.9", "question": "How long did it take for hypoglycemia to subside?", "answer_src": "most of these patients developed hypoglycemia and were of lower age group , whereas a majority of higher age group patients developed hyperglycemia . in majority of the cases , abnormal glucose developed after three doses of l - asp . hypoglycemia subsided whereas hyperglycemia persisted till the end of our observation period.l-asp produces more incidences of hypoglycemia than hyperglycemia in a good number of all patients towards which clinicians should be more vigilant .", "follow_up_question": "How long did it take for hyperglycemia to persist?", "follow_up_response": "till the end of our observation period.", "follow_up_response_bt": "More frequent in the first days of treatment"}, {"question_id": "246.10", "question": "Which age group had a higher incidence of developing hypoglycemia?", "answer_src": "lower age group", "follow_up_question": "Which age group had a higher incidence of developing hyperglycemia?", "follow_up_response": "Higher age group", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "246.11", "question": "What was the duration of hypoglycemia according to the text?", "answer_src": "most of these patients developed hypoglycemia and were of lower age group , whereas a majority of higher age group patients developed hyperglycemia . in majority of the cases , abnormal glucose developed after three doses of l - asp . hypoglycemia subsided whereas hyperglycemia persisted till the end of our observation period.l-asp produces more incidences of hypoglycemia than hyperglycemia in a good number of all patients towards which clinicians should be more vigilant .", "follow_up_question": "How long did hyperglycemia persist according to the text?", "follow_up_response": "till the end of our observation period.", "follow_up_response_bt": "the end of our observation period"}, {"question_id": "246.12", "question": "What percentage of patients experienced hypoglycemia according to the text?", "answer_src": "most of these patients developed hypoglycemia and were of lower age group , whereas a majority of higher age group patients developed hyperglycemia . in majority of the cases , abnormal glucose developed after three doses of l - asp . hypoglycemia subsided whereas hyperglycemia persisted till the end of our observation period.l-asp produces more incidences of hypoglycemia than hyperglycemia in a good number of all patients towards which clinicians should be more vigilant .", "follow_up_question": "What was the duration of hypoglycemia according to the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "246.13", "question": "What was the outcome of hypoglycemia in most cases?", "answer_src": "Hypoglycemia subsided", "follow_up_question": "What was the outcome of hyperglycemia in most cases?", "follow_up_response": "Hyperglycemia persisted till the end of our observation period.", "follow_up_response_bt": "The abnormal glucose developed"}, {"question_id": "246.14", "question": "How long did it take for hyperglycemia to persist?", "answer_src": "till the end of our observation period.", "follow_up_question": "How many doses of l-asp were needed for abnormal glucose to develop?", "follow_up_response": "3", "follow_up_response_bt": "3"}, {"question_id": "246.15", "question": "Which age group had a higher incidence of developing hyperglycemia?", "answer_src": "Higher age group", "follow_up_question": "Which age group had a higher incidence of developing hypoglycemia?", "follow_up_response": "lower age group", "follow_up_response_bt": "No Answer"}]}}
{"id": 247, "src": "conversion of the cellular prion protein ( prpc ) into its altered conformation , prpsc , is believed to be the major cause of prion diseases . although prp is the only identified agent for these diseases , there is increasing evidence that other molecules can modulate the conversion . we have found that interaction of prp with double - stranded dna leads to a protein with higher -sheet content and characteristics similar to those of prpsc .", "mt": "La conversione della proteina prionistica cellulare (prpc) nella sua conformazione alterata , prpsc , è ritenuta la causa principale delle malattie prioniche . Anche se prp è l' unico agente identificato per queste malattie , ci sono sempre più prove che altre molecole possano modulare la conversione . abbiamo scoperto che l'interazione di prp con il DNA a doppio strato porta a una proteina con un contenuto di fogli più elevato e caratteristiche simili a quelle di prpsc .", "pert_mt": "La conversione della proteina prionistica cellulare (prpc) nella sua conformazione alterata, prpsc, è ritenuta la causa principale delle malattie prioniche. Anche se prp è l'unico agente identificato per queste malattie, ci sono sempre più prove che altre molecole possano modulare la conversione. Abbiamo scoperto che l'interazione di prp con il DNA a doppio strato porta a una proteina con un contenuto di fogli più elevato e caratteristiche simili a quelle di prpsc, influenzando significativamente la progressione delle malattie.", "bt": "The conversion of cellular prion protein (prpc) into its altered conformation, prpsc, is considered the main cause of prionic diseases. although prp is the only agent identified for these diseases, there is increasing evidence that other molecules may modulate the conversion. we have found that the interaction of prp with double-stranded DNA leads to a protein with a higher foil content and characteristics similar to those of prpsc, significantly influencing the progression of diseases.", "questions_src": ["What does prp convert into?", "Who is believed to be the major cause of prion diseases?", "Where does interaction of prp with double-stranded DNA occur?", "Which type of sheet content does the protein with higher-sheet content have?", "Which molecules are believed to modulate the conversion of prp into its altered conformation?"], "answers_src": ["prpsc", "conversion of the cellular prion protein (prpc)", "in the interaction of prp with double-stranded DNA", "higher-sheet", "other molecules"], "answers_bt": ["prpsc", "The conversion of cellular prion protein (prpc) into its altered conformation, prpsc", "in the interaction of prp with double-stranded DNA", "higher-sheet", "other molecules"], "multiturn": {"turn_1": [{"question_id": "247.1", "question": "What does prp convert into?", "answer_src": "prpsc", "follow_up_question": "What characteristic of prp changes when it interacts with double-stranded DNA?", "follow_up_response": "Higher-sheet content", "follow_up_response_bt": "Higher foil content"}, {"question_id": "247.2", "question": "Who is believed to be the major cause of prion diseases?", "answer_src": "conversion of the cellular prion protein (prpc)", "follow_up_question": "What characteristic of the protein formed by prp interacting with double-stranded DNA is similar to prpsc?", "follow_up_response": "higher-sheet content", "follow_up_response_bt": "Higher foil content"}, {"question_id": "247.3", "question": "Where does interaction of prp with double-stranded DNA occur?", "answer_src": "in the interaction of prp with double-stranded DNA", "follow_up_question": "What characteristic of the protein formed by this interaction is similar to prpsc?", "follow_up_response": "higher-sheet content", "follow_up_response_bt": "Higher foil content"}, {"question_id": "247.4", "question": "Which type of sheet content does the protein with higher-sheet content have?", "answer_src": "higher-sheet", "follow_up_question": "What are the characteristics of this protein that make it similar to prpsc?", "follow_up_response": "higher-sheet content", "follow_up_response_bt": "higher foil content"}, {"question_id": "247.5", "question": "Which molecules are believed to modulate the conversion of prp into its altered conformation?", "answer_src": "other molecules", "follow_up_question": "What specific characteristic of the prp-protein changes when it interacts with double-stranded DNA?", "follow_up_response": "Higher-sheet content", "follow_up_response_bt": "Higher foil content"}], "turn_2": [{"question_id": "247.6", "question": "What characteristic of prp changes when it interacts with double-stranded DNA?", "answer_src": "Higher-sheet content", "follow_up_question": "How does the higher-sheet content affect the behavior of prp?", "follow_up_response": "No Answer", "follow_up_response_bt": "Significantly influences the progression of diseases"}, {"question_id": "247.7", "question": "What characteristic of the protein formed by prp interacting with double-stranded DNA is similar to prpsc?", "answer_src": "higher-sheet content", "follow_up_question": "What specific molecular changes lead to the higher-sheet content in the protein formed by prp interacting with double-stranded DNA?", "follow_up_response": "higher-sheet content", "follow_up_response_bt": "A protein with a higher sheet content"}, {"question_id": "247.8", "question": "What characteristic of the protein formed by this interaction is similar to prpsc?", "answer_src": "higher-sheet content", "follow_up_question": "What specific molecular characteristics make the protein formed by this interaction similar to prpsc?", "follow_up_response": "higher-sheet content", "follow_up_response_bt": "A higher foil content"}, {"question_id": "247.9", "question": "What are the characteristics of this protein that make it similar to prpsc?", "answer_src": "higher-sheet content", "follow_up_question": "What specific changes in the protein's structure result in higher-sheet content?", "follow_up_response": "Interaction of prp with double-stranded DNA", "follow_up_response_bt": "The interaction of prp with double-stranded DNA"}, {"question_id": "247.10", "question": "What specific characteristic of the prp-protein changes when it interacts with double-stranded DNA?", "answer_src": "Higher-sheet content", "follow_up_question": "What are the characteristics of the prp-protein that become similar to those of prpsc?", "follow_up_response": "Higher-sheet content", "follow_up_response_bt": "Higher foil content"}], "turn_3": [{"question_id": "247.11", "question": "How does the higher-sheet content affect the behavior of prp?", "answer_src": "conversion of the cellular prion protein ( prpc ) into its altered conformation , prpsc , is believed to be the major cause of prion diseases . although prp is the only identified agent for these diseases , there is increasing evidence that other molecules can modulate the conversion . we have found that interaction of prp with double - stranded dna leads to a protein with higher -sheet content and characteristics similar to those of prpsc .", "follow_up_question": "What characteristics of prpsc are similar to the protein formed when prp interacts with double-stranded DNA?", "follow_up_response": "Higher-sheet content", "follow_up_response_bt": "Higher foil content"}, {"question_id": "247.12", "question": "What specific molecular changes lead to the higher-sheet content in the protein formed by prp interacting with double-stranded DNA?", "answer_src": "higher-sheet content", "follow_up_question": "What characteristics of the protein formed by prp interacting with double-stranded DNA are similar to those of prpsc?", "follow_up_response": "higher-sheet content", "follow_up_response_bt": "Higher foil content"}, {"question_id": "247.13", "question": "What specific molecular characteristics make the protein formed by this interaction similar to prpsc?", "answer_src": "higher-sheet content", "follow_up_question": "What are the characteristics of the protein with higher-sheet content?", "follow_up_response": "Characteristics similar to those of prpsc", "follow_up_response_bt": "Protein with a higher-sheet content and characteristics similar to those of prpsc"}, {"question_id": "247.14", "question": "What specific changes in the protein's structure result in higher-sheet content?", "answer_src": "Interaction of prp with double-stranded DNA", "follow_up_question": "What characteristics of the resulting protein are similar to those of prpsc?", "follow_up_response": "Higher-sheet content", "follow_up_response_bt": "Higher foil content"}, {"question_id": "247.15", "question": "What are the characteristics of the prp-protein that become similar to those of prpsc?", "answer_src": "Higher-sheet content", "follow_up_question": "What specific molecular changes lead to the higher-sheet content in prp-protein when it interacts with double-stranded DNA?", "follow_up_response": "a protein with higher-sheet content", "follow_up_response_bt": "A protein with a higher sheet content"}]}}
{"id": 248, "src": "in the functional characterization , neutralization of xcina toxicity by immunity domain of ximb gene was determined by endogenous assay . exogenous toxic assays results showed that only the purified recombinant xenocin - immunity domain ( 10 kda ) protein complex had toxic activity . atypical cognate immunity protein ( 42 kda ) of xenocin was fusion of immunity domain ( 10 kda ) and hemolysin domain ( 32 kda ) .", "mt": "Nella caratterizzazione funzionale , la neutralizzazione della tossicità di xcina da dominio immunitario del gene ximb è stata determinata da assay endogeno . I risultati degli assays tossici esogeni hanno mostrato che solo il complesso proteico ricombinante purificato di xenocina - dominio immunitario (10 kda) aveva attività tossica .", "pert_mt": "Nella caratterizzazione funzionale, la neutralizzazione della tossicità di xcina da dominio immunitario del gene ximb è stata determinata da assay endogeno. I risultati degli assays tossici esogeni hanno mostrato che solo il complesso proteico ricombinante purificato di xenocina - dominio immunitario (10 kda) aveva attività tossica e non causava reazioni allergiche.", "bt": "In functional characterization, the neutralization of xcina toxicity and immune domain of the ximb gene was determined by endogenous assay.Results of exogenous toxic assays showed that only the recombinant protein complex purified of xenocin - immune domain (10 kda) had toxic activity and did not cause allergic reactions.", "questions_src": ["What is the name of the gene whose immunity domain neutralizes xcina toxicity?", "Who is the atypical cognate immunity protein made up of?", "Where was the endogenous assay performed?", "When did the exogenous toxic assays take place?", "Which protein complex had toxic activity?"], "answers_src": ["Ximb", "fusion of immunity domain (10 kda) and hemolysin domain (32 kda)", "in the functional characterization", "atypical cognate immunity protein (42 kda) of xenocin was fusion of immunity domain (10 kda) and hemolysin domain (32 kda)", "purified recombinant xenocin - immunity domain (10 kda) protein complex"], "answers_bt": ["ximb", "xenocin - immune domain", "endogenous", "no answer", "recombinant protein complex purified of xenocin - immune domain"], "multiturn": {"turn_1": [{"question_id": "248.1", "question": "What is the name of the gene whose immunity domain neutralizes xcina toxicity?", "answer_src": "Ximb", "follow_up_question": "What is the size of the exogenous toxic xenocin-immunity domain protein complex?", "follow_up_response": "10 kda", "follow_up_response_bt": "10 kda"}, {"question_id": "248.2", "question": "Who is the atypical cognate immunity protein made up of?", "answer_src": "fusion of immunity domain (10 kda) and hemolysin domain (32 kda)", "follow_up_question": "What is the size of the atypical cognate immunity protein?", "follow_up_response": "42 kda", "follow_up_response_bt": "10 kda"}, {"question_id": "248.3", "question": "Where was the endogenous assay performed?", "answer_src": "in the functional characterization", "follow_up_question": "What is the size of the purified recombinant xenocin-immunity domain (10 kDa) protein complex?", "follow_up_response": "10 kDa", "follow_up_response_bt": "10 kDa"}, {"question_id": "248.4", "question": "When did the exogenous toxic assays take place?", "answer_src": "atypical cognate immunity protein (42 kda) of xenocin was fusion of immunity domain (10 kda) and hemolysin domain (32 kda)", "follow_up_question": "What is the size of the atypical cognate immunity protein (42 kda)?", "follow_up_response": "42 kda", "follow_up_response_bt": "No Answer"}, {"question_id": "248.5", "question": "Which protein complex had toxic activity?", "answer_src": "purified recombinant xenocin - immunity domain (10 kda) protein complex", "follow_up_question": "What is the size of the atypical cognate immunity protein mentioned?", "follow_up_response": "42 kda", "follow_up_response_bt": "10 kda"}], "turn_2": [{"question_id": "248.6", "question": "What is the size of the exogenous toxic xenocin-immunity domain protein complex?", "answer_src": "10 kda", "follow_up_question": "What is the size of the atypical cognate immunity protein?", "follow_up_response": "42 kda", "follow_up_response_bt": "10 kda"}, {"question_id": "248.7", "question": "What is the size of the atypical cognate immunity protein?", "answer_src": "42 kda", "follow_up_question": "What is the size of the immunity domain of Xenocin?", "follow_up_response": "10 kda", "follow_up_response_bt": "10 kda"}, {"question_id": "248.8", "question": "What is the size of the purified recombinant xenocin-immunity domain (10 kDa) protein complex?", "answer_src": "10 kDa", "follow_up_question": "What is the size of the hemolysin domain in the xenocin-atypical cognate immunity protein?", "follow_up_response": "32 kda", "follow_up_response_bt": "No Answer"}, {"question_id": "248.9", "question": "What is the size of the atypical cognate immunity protein (42 kda)?", "answer_src": "42 kda", "follow_up_question": "What is the size of the immunity domain (10 kda) in the atypical cognate immunity protein?", "follow_up_response": "32 kda", "follow_up_response_bt": "10 kda"}, {"question_id": "248.10", "question": "What is the size of the atypical cognate immunity protein mentioned?", "answer_src": "42 kda", "follow_up_question": "What is the size of the hemolysin domain in the atypical cognate immunity protein?", "follow_up_response": "32 kda", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "248.11", "question": "What is the size of the atypical cognate immunity protein?", "answer_src": "42 kda", "follow_up_question": "What is the size of the immunity domain of Xenocin?", "follow_up_response": "10 kda", "follow_up_response_bt": "10 kda"}, {"question_id": "248.12", "question": "What is the size of the immunity domain of Xenocin?", "answer_src": "10 kda", "follow_up_question": "What is the size of the hemolysin domain of Xenocin?", "follow_up_response": "32 kda", "follow_up_response_bt": "No Answer"}, {"question_id": "248.13", "question": "What is the size of the hemolysin domain in the xenocin-atypical cognate immunity protein?", "answer_src": "32 kda", "follow_up_question": "What is the size of the immunity domain in the xenocin-atypical cognate immunity protein?", "follow_up_response": "10 kda", "follow_up_response_bt": "10 kda"}, {"question_id": "248.14", "question": "What is the size of the immunity domain (10 kda) in the atypical cognate immunity protein?", "answer_src": "32 kda", "follow_up_question": "What is the size of the hemolysin domain in the atypical cognate immunity protein?", "follow_up_response": "32 kda", "follow_up_response_bt": "No Answer"}, {"question_id": "248.15", "question": "What is the size of the hemolysin domain in the atypical cognate immunity protein?", "answer_src": "32 kda", "follow_up_question": "What is the size of the immunity domain in the atypical cognate immunity protein?", "follow_up_response": "42 kda", "follow_up_response_bt": "No Answer"}]}}
{"id": 249, "src": "many afflictions whether they are somatic ( degenerative , ischemic and traumatic brain lesions ) , psychosomatic ( psychomotor disadaptation syndrome , confinement to bed , nonuse situations ) or psychological ( depression ) can cause backward disequilibrium . a vicious circle of falls , and loss of autonomy can arise and this is the main consequence of backward disequilibrium . thus , in this paper , we review backward disequilibrium in elderly subjects with regard to the causes , consequences , assessment , and management .", "mt": "Molti disturbi , che siano somatici (lesione cerebrali degenerative , ischemico e traumatico), psicosomatici (sindrome di disadattamento psicomotorio , confinamento a letto , situazioni di non uso) o psicologici (depressione) possono causare un squilibrio retrogrado . Si può creare un circolo vizioso di cadute e perdita di autonomia e questa è la conseguenza principale di un squilibrio retrogrado . Così , in questo articolo , rivistiamo l' squilibrio retrogrado nei soggetti anziani per le cause , le conseguenze , la valutazione e la gestione .", "pert_mt": "Molti disturbi, che siano somatici (lesione cerebrali degenerative, ischemico e traumatico), psicosomatici (sindrome di disadattamento psicomotorio, confinamento a letto, situazioni di non uso), o psicologici (depressione) possono causare un squilibrio retrogrado. Si può creare un circolo vizioso di cadute e perdita di autonomia e questa è la conseguenza principale di un squilibrio retrogrado. Così, in questo articolo, rivistiamo l'squilibrio retrogrado nei soggetti anziani per le cause, le conseguenze, la valutazione e la gestione e questo aspetto ha un impatto significativo sulla qualità della vita dei pazienti.", "bt": "Many disorders, whether somatic (degenerative, ischemic and traumatic brain injury), psychosomatic (psychomotor disadaptation syndrome, confinement to bed, non-use situations), or psychological (depression) can cause a retrograde imbalance. A vicious cycle of falling and loss of autonomy can be created, and this is the main consequence of a retrograde imbalance. Thus, in this article, we review the retrograde imbalance in older subjects for the causes, consequences, evaluation and management and this aspect has a significant impact on the quality of life of patients.", "questions_src": ["What are the three types of afflictions mentioned in the sentence?", "Who can cause backward disequilibrium according to the sentence?", "Where does a vicious circle of falls and loss of autonomy typically arise?", "When can a person experience backward disequilibrium based on the information provided?", "Which condition is described as 'psychomotor disadaptation syndrome'?"], "answers_src": ["[\"somatic, psychosomatic, and psychological\"], [\"many afflictions\"], [\"in this paper\"], [\"in elderly subjects\"], [\"psychomotor disadaptation syndrome\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"somatic, psychosomatic, and psychological\"], [\"Many disorders\"], [\"older subjects\"], [\"No Answer\"], [\"psychomotor disadaptation syndrome\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "249.1", "question": "What are the three types of afflictions mentioned in the sentence?", "answer_src": "[\"somatic, psychosomatic, and psychological\"], [\"many afflictions\"], [\"in this paper\"], [\"in elderly subjects\"], [\"psychomotor disadaptation syndrome\"]", "follow_up_question": "What are some examples of psychosomatic afflictions mentioned in the text?", "follow_up_response": "psychomotor disadaptation syndrome, confinement to bed, nonuse situations", "follow_up_response_bt": "psychomotor disadaptation syndrome, confinement to bed, non-use situations"}, {"question_id": "249.2", "question": "Who can cause backward disequilibrium according to the sentence?", "answer_src": "many afflictions whether they are somatic ( degenerative , ischemic and traumatic brain lesions ) , psychosomatic ( psychomotor disadaptation syndrome , confinement to bed , nonuse situations ) or psychological ( depression ) can cause backward disequilibrium . a vicious circle of falls , and loss of autonomy can arise and this is the main consequence of backward disequilibrium . thus , in this paper , we review backward disequilibrium in elderly subjects with regard to the causes , consequences , assessment , and management .", "follow_up_question": "What are some examples of psychosomatic causes of backward disequilibrium?", "follow_up_response": "psychomotor disadaptation syndrome, confinement to bed, nonuse situations", "follow_up_response_bt": "psychomotor disadaptation syndrome, confinement to bed, non-use situations"}, {"question_id": "249.3", "question": "Where does a vicious circle of falls and loss of autonomy typically arise?", "answer_src": "many afflictions whether they are somatic ( degenerative , ischemic and traumatic brain lesions ) , psychosomatic ( psychomotor disadaptation syndrome , confinement to bed , nonuse situations ) or psychological ( depression ) can cause backward disequilibrium . a vicious circle of falls , and loss of autonomy can arise and this is the main consequence of backward disequilibrium . thus , in this paper , we review backward disequilibrium in elderly subjects with regard to the causes , consequences , assessment , and management .", "follow_up_question": "What are some examples of causes that can lead to backward disequilibrium?", "follow_up_response": "Degenerative , ischemic and traumatic brain lesions , psychomotor disadaptation syndrome , confinement to bed , nonuse situations , depression", "follow_up_response_bt": "Somatic (degenerative, ischemic and traumatic brain injury)\", \"Psychosomatic (psychomotor disadaptation syndrome, confinement to bed, non-use situations)\", \"Psychological (depression)"}, {"question_id": "249.4", "question": "When can a person experience backward disequilibrium based on the information provided?", "answer_src": "many afflictions whether they are somatic ( degenerative , ischemic and traumatic brain lesions ) , psychosomatic ( psychomotor disadaptation syndrome , confinement to bed , nonuse situations ) or psychological ( depression ) can cause backward disequilibrium . a vicious circle of falls , and loss of autonomy can arise and this is the main consequence of backward disequilibrium . thus , in this paper , we review backward disequilibrium in elderly subjects with regard to the causes , consequences , assessment , and management .", "follow_up_question": "What are some of the consequences of backward disequilibrium as discussed in the text?", "follow_up_response": "a vicious circle of falls, and loss of autonomy", "follow_up_response_bt": "A vicious cycle of falling and loss of autonomy"}, {"question_id": "249.5", "question": "Which condition is described as 'psychomotor disadaptation syndrome'?", "answer_src": "many afflictions whether they are somatic ( degenerative , ischemic and traumatic brain lesions ) , psychosomatic ( psychomotor disadaptation syndrome , confinement to bed , nonuse situations ) or psychological ( depression ) can cause backward disequilibrium . a vicious circle of falls , and loss of autonomy can arise and this is the main consequence of backward disequilibrium . thus , in this paper , we review backward disequilibrium in elderly subjects with regard to the causes , consequences , assessment , and management .", "follow_up_question": "What are two examples of psychosomatic conditions listed in the text?", "follow_up_response": "psychomotor disadaptation syndrome, confinement to bed", "follow_up_response_bt": "psychomotor disadaptation syndrome, confinement to bed, non-use situations"}], "turn_2": [{"question_id": "249.6", "question": "What are some examples of psychosomatic afflictions mentioned in the text?", "answer_src": "psychomotor disadaptation syndrome, confinement to bed, nonuse situations", "follow_up_question": "What are some examples of psychological afflictions mentioned in the text?", "follow_up_response": "depression", "follow_up_response_bt": "depression"}, {"question_id": "249.7", "question": "What are some examples of psychosomatic causes of backward disequilibrium?", "answer_src": "psychomotor disadaptation syndrome, confinement to bed, nonuse situations", "follow_up_question": "What are some consequences of the vicious circle of falls and loss of autonomy?", "follow_up_response": "Backward disequilibrium", "follow_up_response_bt": "This is the main consequence of a retrograde imbalance"}, {"question_id": "249.8", "question": "What are some examples of causes that can lead to backward disequilibrium?", "answer_src": "Degenerative , ischemic and traumatic brain lesions , psychomotor disadaptation syndrome , confinement to bed , nonuse situations , depression", "follow_up_question": "What are some consequences of backward disequilibrium mentioned in the text?", "follow_up_response": "falls\", \"loss of autonomy", "follow_up_response_bt": "A vicious cycle of falling and loss of autonomy"}, {"question_id": "249.9", "question": "What are some of the consequences of backward disequilibrium as discussed in the text?", "answer_src": "a vicious circle of falls, and loss of autonomy", "follow_up_question": "What factors contribute to the vicious circle of falls and loss of autonomy mentioned in the text?", "follow_up_response": "somatic (degenerative, ischemic and traumatic brain lesions), psychosomatic (psychomotor disadaptation syndrome, confinement to bed, nonuse situations) or psychological (depression)", "follow_up_response_bt": "Whether somatic (degenerative, ischemic and traumatic brain injury), psychosomatic (psychomotor disadaptation syndrome, confinement to bed, non-use situations), or psychological (depression)"}, {"question_id": "249.10", "question": "What are two examples of psychosomatic conditions listed in the text?", "answer_src": "psychomotor disadaptation syndrome, confinement to bed", "follow_up_question": "What are two examples of psychological conditions listed in the text?", "follow_up_response": "depression", "follow_up_response_bt": "depression"}], "turn_3": [{"question_id": "249.11", "question": "What are some examples of psychological afflictions mentioned in the text?", "answer_src": "depression", "follow_up_question": "What are some examples of psychosomatic afflictions mentioned in the text?", "follow_up_response": "psychomotor disadaptation syndrome, confinement to bed, nonuse situations", "follow_up_response_bt": "psychomotor disadaptation syndrome, confinement to bed, non-use situations"}, {"question_id": "249.12", "question": "What are some consequences of the vicious circle of falls and loss of autonomy?", "answer_src": "Backward disequilibrium", "follow_up_question": "What specific factors contribute to the development of backward disequilibrium?", "follow_up_response": "somatic (degenerative, ischemic and traumatic brain lesions), psychosomatic (psychomotor disadaptation syndrome, confinement to bed, nonuse situations) or psychological (depression)", "follow_up_response_bt": "Somatic (degenerative, ischemic and traumatic brain injury), psychosomatic (psychomotor disadaptation syndrome, confinement to bed, non-use situations), and psychological (depression)"}, {"question_id": "249.13", "question": "What are some consequences of backward disequilibrium mentioned in the text?", "answer_src": "falls\", \"loss of autonomy", "follow_up_question": "What specific condition can lead to the vicious circle of falls and loss of autonomy mentioned in the text?", "follow_up_response": "backward disequilibrium", "follow_up_response_bt": "degenerative, ischemic and traumatic brain injury\", \"psychomotor disadaptation syndrome\", \"confinement to bed\", \"non-use situations\", \"depression"}, {"question_id": "249.14", "question": "What factors contribute to the vicious circle of falls and loss of autonomy mentioned in the text?", "answer_src": "somatic (degenerative, ischemic and traumatic brain lesions), psychosomatic (psychomotor disadaptation syndrome, confinement to bed, nonuse situations) or psychological (depression)", "follow_up_question": "What are some specific consequences of the vicious circle of falls and loss of autonomy described in the text?", "follow_up_response": "Backward disequilibrium", "follow_up_response_bt": "A vicious cycle of falling and loss of autonomy"}, {"question_id": "249.15", "question": "What are two examples of psychological conditions listed in the text?", "answer_src": "depression", "follow_up_question": "What are two examples of psychosomatic conditions listed in the text?", "follow_up_response": "psychomotor disadaptation syndrome, confinement to bed", "follow_up_response_bt": "psychomotor disadaptation syndrome, confinement to bed, non-use situations"}]}}
{"id": 250, "src": "hpv detect by pcr , and cytokines by elisa ( il-2 , il-6 , il-10 , il-12 , tnf- , and ifn- cytokines ) . of 173 women , 60 were control group ( 34.7% ) and 113 were distributed in hpv ( n=36 , 20.8% ) , bv ( n=36 , 20.8% ) , vaginitis ( n=30 , 17.3% ) and , bv and hpv - associated groups ( n=11 , 6.4% ) . vaginal ph > 4.5 was related with hpv infection .", "mt": "di 173 donne , 60 erano nel gruppo di controllo (34,7%) e 113 erano distribuiti in hpv (n=36 , 20,8%) , bv (n=36 , 20,8%) , vaginite (n=30 , 17,3%) e , bv e hpv - gruppi associati (n=11, 6,4%).", "pert_mt": "di 173 donne, 60 erano nel gruppo di controllo (34,7%) e 113 erano distribuiti in hpv (n=36, 20,8%), bv (n=36, 20,8%), vaginite (n=30, 17,3%), e candida (n=10, 5,7%), e bv e hpv - gruppi associati (n=11, 6,4%).", "bt": "173 women, 60 were in the control group (34.7%) and 113 were distributed in hpv (n=36, 20.8%), bv (n=36, 20.8%), vaginitis (n=30, 17.3%), e candida (n=10, 5.7%), and bv e hpv - associate groups (n=11, 6.4%).", "questions_src": ["What is the name of the test used to detect HPV?", "Who were included in the control group?", "Where was the study conducted?", "When was the study published?", "Which cytokine levels were measured using ELISA?"], "answers_src": ["PCR", "173 women", "Not specified", "Not specified", "il-2, il-6, il-10, il-12, tnf-, and ifn-"], "answers_bt": ["HPV", "173 women", "Not provided", "Not provided", "Not provided"], "multiturn": {"turn_1": [{"question_id": "250.1", "question": "What is the name of the test used to detect HPV?", "answer_src": "PCR", "follow_up_question": "What percentage of the women were in the HPV-associated groups?", "follow_up_response": "6.4%", "follow_up_response_bt": "6.4%"}, {"question_id": "250.2", "question": "Who were included in the control group?", "answer_src": "173 women", "follow_up_question": "What percentage of the participants were in the control group?", "follow_up_response": "34.7%", "follow_up_response_bt": "34.7%"}, {"question_id": "250.3", "question": "Where was the study conducted?", "answer_src": "Not specified", "follow_up_question": "What percentage of the study participants had vaginal pH greater than 4.5?", "follow_up_response": "6.4%", "follow_up_response_bt": "No Answer"}, {"question_id": "250.4", "question": "When was the study published?", "answer_src": "Not specified", "follow_up_question": "What percentage of the study participants had vaginal pH greater than 4.5?", "follow_up_response": "6.4%", "follow_up_response_bt": "No Answer"}, {"question_id": "250.5", "question": "Which cytokine levels were measured using ELISA?", "answer_src": "il-2, il-6, il-10, il-12, tnf-, and ifn-", "follow_up_question": "What percentage of the women in the study had a vaginal pH greater than 4.5?", "follow_up_response": "6.4%", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "250.6", "question": "What percentage of the women were in the HPV-associated groups?", "answer_src": "6.4%", "follow_up_question": "What is the vaginal pH range for women in the HPV-associated groups?", "follow_up_response": "4.5", "follow_up_response_bt": "No Answer"}, {"question_id": "250.7", "question": "What percentage of the participants were in the control group?", "answer_src": "34.7%", "follow_up_question": "What percentage of the participants had vaginal pH greater than 4.5?", "follow_up_response": "6.4%", "follow_up_response_bt": "No Answer"}, {"question_id": "250.8", "question": "What percentage of the study participants had vaginal pH greater than 4.5?", "answer_src": "6.4%", "follow_up_question": "What is the percentage of participants in the bv and hpv-associated group?", "follow_up_response": "6.4%", "follow_up_response_bt": "6.4%"}, {"question_id": "250.9", "question": "What percentage of the study participants had vaginal pH greater than 4.5?", "answer_src": "6.4%", "follow_up_question": "What is the percentage of participants in the bv and hpv-associated group?", "follow_up_response": "6.4%", "follow_up_response_bt": "6.4%"}, {"question_id": "250.10", "question": "What percentage of the women in the study had a vaginal pH greater than 4.5?", "answer_src": "6.4%", "follow_up_question": "What is the percentage of women in the bv and hpv-associated group?", "follow_up_response": "6.4%", "follow_up_response_bt": "6.4%"}], "turn_3": [{"question_id": "250.11", "question": "What is the vaginal pH range for women in the HPV-associated groups?", "answer_src": "4.5", "follow_up_question": "What percentage of women in the BV (bacterial vaginosis) group had a vaginal pH greater than 4.5?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "250.12", "question": "What percentage of the participants had vaginal pH greater than 4.5?", "answer_src": "6.4%", "follow_up_question": "What is the percentage of participants in the bv and hpv-associated group?", "follow_up_response": "6.4%", "follow_up_response_bt": "6.4%"}, {"question_id": "250.13", "question": "What is the percentage of participants in the bv and hpv-associated group?", "answer_src": "6.4%", "follow_up_question": "What is the percentage of participants with vaginal pH greater than 4.5?", "follow_up_response": "6.4%", "follow_up_response_bt": "No Answer"}, {"question_id": "250.14", "question": "What is the percentage of participants in the bv and hpv-associated group?", "answer_src": "6.4%", "follow_up_question": "What is the percentage of participants with vaginal pH greater than 4.5?", "follow_up_response": "6.4%", "follow_up_response_bt": "No Answer"}, {"question_id": "250.15", "question": "What is the percentage of women in the bv and hpv-associated group?", "answer_src": "6.4%", "follow_up_question": "What is the percentage of women with vaginal pH > 4.5?", "follow_up_response": "6.4%", "follow_up_response_bt": "No Answer"}]}}
{"id": 251, "src": "the single - nucleotide polymorphisms were determined by sequenom massarray rs1000 and statistical analysis was performed using spss software and snpstats software.resultsusing the 2 test , we found that rs2297440 and rs6010620 in rtel1 increased risk of gbm . in the recessive model , we also found that the genotypes cc of rs2297440 and gg of rs6010620 in rtel1 significantly increased gbm risk . the variant tt genotype of treh rs17748 and the variant tt genotype of phldb1 rs498872 decreased gbm risk in the recessive model .", "mt": "I polimorfismi singoli nucleotidi sono stati determinati da sequenom massarray rs1000 e l'analisi statistica è stata eseguita utilizzando software spss e software snpstats.resultsusing the 2 test , abbiamo scoperto che rs2297440 e rs6010620 in rtel1 aumentano il rischio di gbm . nel modello recessivo , abbiamo anche scoperto che i genotipi cc di rs2297440 e gg di rs6010620 in rtel1 aumentano significativamente il rischio di gbm . il genotipo tt di treh rs17748 e il genotipo tt di phldb1 rs498872 diminuiscono il rischio di gbm nel modello recessivo .", "pert_mt": "I polimorfismi singoli nucleotidi sono stati determinati da sequenom massarray rs1000 e l'analisi statistica è stata eseguita utilizzando software spss e software snpstats. Utilizzando il test chi quadrato, abbiamo scoperto che rs2297440 e rs6010620 in rtel1 aumentano il rischio di gbm. Nel modello recessivo, abbiamo anche scoperto che i genotipi cc di rs2297440 e gg di rs6010620 in rtel1 aumentano significativamente il rischio di gbm. Il genotipo tt di treh rs17748 e il genotipo tt di phldb1 rs498872 diminuiscono il rischio di gbm nel modello recessivo.", "bt": "The polymorphism of individual nucleotides was determined by the massarray sequence rs1000 and statistical analysis was performed using spss software and snpstats software.Using the chi quadrat test, we found that rs2297440 and rs6010620 in rtel1 increased the risk of gbm.In the recessive model, we also found that the cc genotype of rs2297440 and gg of rs6010620 in rtel1 significantly increased the risk of gbm.The tt genotype of three rs17748 and the tt genotype of phldb1 rs498872 decreased the risk of gbm in the recessive model.", "questions_src": ["What did the single-nucleotide polymorphisms determine?", "Which two SNPs in RTEL1 showed an increased risk of GBM?", "In what model did the genotypes cc of rs2297440 and gg of rs6010620 show a significant increase in GBM risk?", "What genotypes of TREH rs17748 and PHLDL1 rs498872 showed a decrease in GBM risk?", "When was the statistical analysis performed using SPSS and SNPStats software?"], "answers_src": ["the single-nucleotide polymorphisms", "rs2297440 and rs6010620 in rtel1", "recessive model", "tt genotype of treh rs17748 and the variant tt genotype of phldb1 rs498872", "results"], "answers_bt": ["[\"The polymorphism of individual nucleotides\"], [\"rs2297440 and rs6010620\"], [\"the recessive model\"], [\"tt genotype of three rs17748 and the tt genotype of phldb1 rs498872\"], [\"statistical analysis was performed\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "251.1", "question": "What did the single-nucleotide polymorphisms determine?", "answer_src": "the single-nucleotide polymorphisms", "follow_up_question": "What specific SNPs were found to increase the risk of GMB according to the recessive model?", "follow_up_response": "rs2297440 and rs6010620", "follow_up_response_bt": "rs2297440 and rs6010620"}, {"question_id": "251.2", "question": "Which two SNPs in RTEL1 showed an increased risk of GBM?", "answer_src": "rs2297440 and rs6010620 in rtel1", "follow_up_question": "Which genotypes of rs2297440 and rs6010620 in RTEL1 significantly increased the risk of GBM in the recessive model?", "follow_up_response": "cc of rs2297440 and gg of rs6010620", "follow_up_response_bt": "cc genotype of rs2297440 and gg of rs6010620"}, {"question_id": "251.3", "question": "In what model did the genotypes cc of rs2297440 and gg of rs6010620 show a significant increase in GBM risk?", "answer_src": "recessive model", "follow_up_question": "What specific genotypes of treh rs17748 and phldb1 rs498872 showed a decrease in GBM risk according to the recessive model?", "follow_up_response": "tt genotype", "follow_up_response_bt": "tt genotype"}, {"question_id": "251.4", "question": "What genotypes of TREH rs17748 and PHLDL1 rs498872 showed a decrease in GBM risk?", "answer_src": "tt genotype of treh rs17748 and the variant tt genotype of phldb1 rs498872", "follow_up_question": "What genotypes of RTEL1 showed an increase in GBM risk?", "follow_up_response": "cc of rs2297440 and gg of rs6010620", "follow_up_response_bt": "cc genotype of rs2297440 and gg of rs6010620"}, {"question_id": "251.5", "question": "When was the statistical analysis performed using SPSS and SNPStats software?", "answer_src": "results", "follow_up_question": "In which genetic models did the study find significant increases in GMB risk?", "follow_up_response": "recessive model", "follow_up_response_bt": "recessive model"}], "turn_2": [{"question_id": "251.6", "question": "What specific SNPs were found to increase the risk of GMB according to the recessive model?", "answer_src": "rs2297440 and rs6010620", "follow_up_question": "What genotypes of rs2297440 and rs6010620 in RTEL1 significantly increased the GMB risk in the recessive model?", "follow_up_response": "cc of rs2297440 and gg of rs6010620", "follow_up_response_bt": "cc genotype of rs2297440 and gg of rs6010620"}, {"question_id": "251.7", "question": "Which genotypes of rs2297440 and rs6010620 in RTEL1 significantly increased the risk of GBM in the recessive model?", "answer_src": "cc of rs2297440 and gg of rs6010620", "follow_up_question": "What genotypes of TREH rs17748 and PHLDL1 rs498872 decreased the risk of GBM in the recessive model?", "follow_up_response": "tt genotype of TREH rs17748 and the tt genotype of PHLDL1 rs498872", "follow_up_response_bt": "tt genotype of three rs17748 and the tt genotype of phldb1 rs498872"}, {"question_id": "251.8", "question": "What specific genotypes of treh rs17748 and phldb1 rs498872 showed a decrease in GBM risk according to the recessive model?", "answer_src": "tt genotype", "follow_up_question": "What specific genotypes of rs2297440 and rs6010620 in RTEL1 showed an increase in GBM risk according to the recessive model?", "follow_up_response": "cc of rs2297440 and gg of rs6010620", "follow_up_response_bt": "cc genotype of rs2297440 and gg of rs6010620"}, {"question_id": "251.9", "question": "What genotypes of RTEL1 showed an increase in GBM risk?", "answer_src": "cc of rs2297440 and gg of rs6010620", "follow_up_question": "What genotypes of TREH and PHLDL1 showed a decrease in GBM risk in the recessive model?", "follow_up_response": "tt genotype of TREH and the tt genotype of PHLDL1", "follow_up_response_bt": "tt genotype of three rs17748 and the tt genotype of phldb1 rs498872"}, {"question_id": "251.10", "question": "In which genetic models did the study find significant increases in GMB risk?", "answer_src": "recessive model", "follow_up_question": "Which specific genotypes showed a significant decrease in GMB risk according to the study?", "follow_up_response": "tt genotype of treh rs17748 and the tt genotype of phldb1 rs498872", "follow_up_response_bt": "tt genotype of three rs17748 and the tt genotype of phldb1 rs498872"}], "turn_3": [{"question_id": "251.11", "question": "What genotypes of rs2297440 and rs6010620 in RTEL1 significantly increased the GMB risk in the recessive model?", "answer_src": "cc of rs2297440 and gg of rs6010620", "follow_up_question": "What genotypes of TREH rs17748 and PHLDL1 rs498872 decreased the GMB risk in the recessive model?", "follow_up_response": "tt genotype of TREH rs17748 and the tt genotype of PHLDL1 rs498872", "follow_up_response_bt": "tt genotype of three rs17748 and the tt genotype of phldb1 rs498872"}, {"question_id": "251.12", "question": "What genotypes of TREH rs17748 and PHLDL1 rs498872 decreased the risk of GBM in the recessive model?", "answer_src": "tt genotype of TREH rs17748 and the tt genotype of PHLDL1 rs498872", "follow_up_question": "What genotypes of RTEL1 rs2297440 and rs6010620 significantly increased the risk of GBM in the recessive model?", "follow_up_response": "cc of rs2297440 and gg of rs6010620", "follow_up_response_bt": "cc genotype of rs2297440 and gg of rs6010620"}, {"question_id": "251.13", "question": "What specific genotypes of rs2297440 and rs6010620 in RTEL1 showed an increase in GBM risk according to the recessive model?", "answer_src": "cc of rs2297440 and gg of rs6010620", "follow_up_question": "What genotypes of TREH rs17748 and PHLDL1 rs498872 showed a decrease in GBM risk according to the recessive model?", "follow_up_response": "tt genotype", "follow_up_response_bt": "tt genotype"}, {"question_id": "251.14", "question": "What genotypes of TREH and PHLDL1 showed a decrease in GBM risk in the recessive model?", "answer_src": "tt genotype of TREH and the tt genotype of PHLDL1", "follow_up_question": "What genotypes of RTEL1 showed an increase in GBM risk in the recessive model?", "follow_up_response": "cc of rs2297440 and gg of rs6010620", "follow_up_response_bt": "cc genotype of rs2297440 and gg of rs6010620"}, {"question_id": "251.15", "question": "Which specific genotypes showed a significant decrease in GMB risk according to the study?", "answer_src": "tt genotype of treh rs17748 and the tt genotype of phldb1 rs498872", "follow_up_question": "Which genotypes showed an increase in GMB risk according to the study?", "follow_up_response": "cc of rs2297440 and gg of rs6010620 in rtel1", "follow_up_response_bt": "cc genotype of rs2297440 and gg of rs6010620 in rtel1"}]}}
{"id": 252, "src": "we measured nirs and plasma monoamine metabolite levels in a patient with bipolar disorder . a 22-year - old man was admitted due to major depression . at admission , nirs findings showed oxygenated hemoglobin reincrease in the posttask period , which is characteristic of schizophrenia .", "mt": "Abbiamo misurato i livelli di Nirs e di monoamine metaboliti plasmatici in un paziente con disturbo bipolare . Un uomo di 22 anni è stato ricoverato a causa di depressione grave . all'ammissione , i risultati di Nirs hanno mostrato un aumento della emoglobina ossigenata nel periodo post-task , che è caratteristico della schizofrenia .", "pert_mt": "Abbiamo misurato i livelli di Nirs e di monoamine metaboliti plasmatici in un paziente con disturbo bipolare. Un uomo di 22 anni è stato ricoverato a causa di depressione grave. all'ammissione, i risultati di Nirs hanno mostrato un aumento della emoglobina ossigenata nel periodo post-task, che è caratteristico della schizofrenia e della depressione.", "bt": "We measured the levels of Nirs and monoamine plasma metabolites in a patient with bipolar disorder.A 22-year-old man was hospitalized for severe depression.All in all, Nirs' results showed an increase in oxygenated hemoglobin in the post-task period, which is characteristic of schizophrenia and depression.", "questions_src": ["What condition was the patient with bipolar disorder being treated for at admission?", "Who was admitted due to major depression?", "Where were the NIRS findings taken?", "When was the patient admitted?", "Which mental health condition is characterized by the oxygenated hemoglobin reincrease in the posttask period according to the sentence?"], "answers_src": ["Major depression", "A 22-year-old man", "In the patient with bipolar disorder", "At admission", "Schizophrenia"], "answers_bt": ["Severe depression", "A 22-year-old man", "Not specified in the sentence", "At admission", "Schizophrenia"], "multiturn": {"turn_1": [{"question_id": "252.1", "question": "What condition was the patient with bipolar disorder being treated for at admission?", "answer_src": "Major depression", "follow_up_question": "What does the reincrease in oxygenated hemoglobin suggest about the patient's condition?", "follow_up_response": "Schizophrenia", "follow_up_response_bt": "It suggests the patient's condition is characteristic of schizophrenia and depression."}, {"question_id": "252.2", "question": "Who was admitted due to major depression?", "answer_src": "A 22-year-old man", "follow_up_question": "What is unusual about the NIRS findings at admission?", "follow_up_response": "Oxygenated hemoglobin reincrease is characteristic of schizophrenia", "follow_up_response_bt": "An increase in oxygenated hemoglobin in the post-task period"}, {"question_id": "252.3", "question": "Where were the NIRS findings taken?", "answer_src": "In the patient with bipolar disorder", "follow_up_question": "What does the reincrease in oxygenated hemoglobin indicate about the patient's condition?", "follow_up_response": "Schizophrenia", "follow_up_response_bt": "It indicates the patient's condition is characteristic of schizophrenia and depression."}, {"question_id": "252.4", "question": "When was the patient admitted?", "answer_src": "At admission", "follow_up_question": "What specific symptom led to the patient's admission?", "follow_up_response": "Major depression", "follow_up_response_bt": "Severe depression"}, {"question_id": "252.5", "question": "Which mental health condition is characterized by the oxygenated hemoglobin reincrease in the posttask period according to the sentence?", "answer_src": "Schizophrenia", "follow_up_question": "What other symptom did the patient exhibit upon admission besides the oxygenated hemoglobin reincrease?", "follow_up_response": "No Answer", "follow_up_response_bt": "Severe depression"}], "turn_2": [{"question_id": "252.6", "question": "What does the reincrease in oxygenated hemoglobin suggest about the patient's condition?", "answer_src": "Schizophrenia", "follow_up_question": "What other characteristic of schizophrenia does the reincrease in oxygenated hemoglobin suggest?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "252.7", "question": "What is unusual about the NIRS findings at admission?", "answer_src": "Oxygenated hemoglobin reincrease is characteristic of schizophrenia", "follow_up_question": "What does the reincrease in oxygenated hemoglobin indicate about the patient's condition?", "follow_up_response": "Schizophrenia", "follow_up_response_bt": "It indicates the patient's condition is characteristic of schizophrenia and depression."}, {"question_id": "252.8", "question": "What does the reincrease in oxygenated hemoglobin indicate about the patient's condition?", "answer_src": "Schizophrenia", "follow_up_question": "What other characteristic of schizophrenia does the reincrease in oxygenated hemoglobin suggest?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "252.9", "question": "What specific symptom led to the patient's admission?", "answer_src": "Major depression", "follow_up_question": "What psychiatric condition does the nirs finding suggest might be present?", "follow_up_response": "schizophrenia", "follow_up_response_bt": "schizophrenia and depression"}, {"question_id": "252.10", "question": "What other symptom did the patient exhibit upon admission besides the oxygenated hemoglobin reincrease?", "answer_src": "we measured nirs and plasma monoamine metabolite levels in a patient with bipolar disorder . a 22-year - old man was admitted due to major depression . at admission , nirs findings showed oxygenated hemoglobin reincrease in the posttask period , which is characteristic of schizophrenia .", "follow_up_question": "What mental health condition does the oxygenated hemoglobin reincrease suggest the patient might have?", "follow_up_response": "Schizophrenia", "follow_up_response_bt": "depression"}], "turn_3": [{"question_id": "252.11", "question": "What other characteristic of schizophrenia does the reincrease in oxygenated hemoglobin suggest?", "answer_src": "we measured nirs and plasma monoamine metabolite levels in a patient with bipolar disorder . a 22-year - old man was admitted due to major depression . at admission , nirs findings showed oxygenated hemoglobin reincrease in the posttask period , which is characteristic of schizophrenia .", "follow_up_question": "What other symptoms or conditions might this reincrease in oxygenated hemoglobin suggest besides schizophrenia?", "follow_up_response": "No Answer", "follow_up_response_bt": "depression"}, {"question_id": "252.12", "question": "What does the reincrease in oxygenated hemoglobin indicate about the patient's condition?", "answer_src": "Schizophrenia", "follow_up_question": "What other characteristic of schizophrenia does the reincrease in oxygenated hemoglobin suggest?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "252.13", "question": "What other characteristic of schizophrenia does the reincrease in oxygenated hemoglobin suggest?", "answer_src": "we measured nirs and plasma monoamine metabolite levels in a patient with bipolar disorder . a 22-year - old man was admitted due to major depression . at admission , nirs findings showed oxygenated hemoglobin reincrease in the posttask period , which is characteristic of schizophrenia .", "follow_up_question": "What other symptoms or conditions might this reincrease in oxygenated hemoglobin suggest besides schizophrenia?", "follow_up_response": "No Answer", "follow_up_response_bt": "depression"}, {"question_id": "252.14", "question": "What psychiatric condition does the nirs finding suggest might be present?", "answer_src": "schizophrenia", "follow_up_question": "What specific nirs finding is characteristic of schizophrenia according to the text?", "follow_up_response": "Oxygenated hemoglobin reincrease in the posttask period", "follow_up_response_bt": "an increase in oxygenated hemoglobin"}, {"question_id": "252.15", "question": "What mental health condition does the oxygenated hemoglobin reincrease suggest the patient might have?", "answer_src": "Schizophrenia", "follow_up_question": "What other characteristic of schizophrenia did the nirs findings show?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 253, "src": "twenty - eight studies out of 3934 results retrieved were identified . in the overall analysis , 46.4% and 51.6% of deaths were related to noncardiovascular causes within and after the first 30 days , respectively . within 30 days of tavr , infection / sepsis ( 18.5% ) , heart failure ( 14.7% ) , and multiorgan failure ( 13.2% ) were the top 3 causes of death .", "mt": "Sono stati identificati ventiotto studi su 3934 risultati recuperati . Nell'analisi complessiva , il 46,4% e il 51,6% delle morti erano correlati a cause non cardiovascolari entro e dopo i primi 30 giorni , rispettivamente . entro 30 giorni di tavr , infezione / sepsis ( 18,5%), insufficienza cardiaca ( 14,7%) e insufficienza multiorgana ( 13,2%) erano le prime 3 cause di morte .", "pert_mt": "Sono stati identificati ventiotto studi su 3934 risultati recuperati. Nell'analisi complessiva, il 46,4% e il 51,6% delle morti erano correlati a cause non cardiovascolari entro e dopo i primi 30 giorni, rispettivamente. Entro 30 giorni di TAVR, infezione/sepsis (18,5%), insufficienza cardiaca (14,7%), e insufficienza multiorgana (13,2%) erano le prime 3 cause di morte. Inoltre, la maggior parte dei pazienti ha presentato febbre e dolori articolari.", "bt": "Twenty-eight studies on 3934 recovered results have been identified.In the overall analysis, 46.4% and 51.6% of deaths were related to non-cardiovascular causes within and after the first 30 days, respectively.During 30 days of TAVR, infection/sepsis (18.5%), heart failure (14.7%), and multiorgan failure (13.2%) were the top 3 causes of death.Moreover, most patients had fever and joint pain.", "questions_src": ["What was the percentage of deaths related to noncardiovascular causes within the first 30 days?", "Which condition was the leading cause of death within 30 days of TAVR?", "How many studies were identified out of the total retrieved?", "In what percentage did infections/sepsis contribute to deaths within 30 days of TAVR?", "What percentage of deaths occurred after the first 30 days?"], "answers_src": ["46.4%", "Infection/ sepsis", "28", "18.5%", "51.6%"], "answers_bt": ["46.4%", "Multiorgan failure", "Twenty-eight", "18.5%", "51.6%"], "multiturn": {"turn_1": [{"question_id": "253.1", "question": "What was the percentage of deaths related to noncardiovascular causes within the first 30 days?", "answer_src": "46.4%", "follow_up_question": "What was the second leading cause of death within the first 30 days after TAVR?", "follow_up_response": "Heart failure", "follow_up_response_bt": "Heart failure"}, {"question_id": "253.2", "question": "Which condition was the leading cause of death within 30 days of TAVR?", "answer_src": "Infection/ sepsis", "follow_up_question": "What was the second leading cause of death within 30 days of TAVR?", "follow_up_response": "Heart failure", "follow_up_response_bt": "Heart failure"}, {"question_id": "253.3", "question": "How many studies were identified out of the total retrieved?", "answer_src": "28", "follow_up_question": "What was the percentage of deaths related to heart failure within the first 30 days?", "follow_up_response": "14.7%", "follow_up_response_bt": "14.7%"}, {"question_id": "253.4", "question": "In what percentage did infections/sepsis contribute to deaths within 30 days of TAVR?", "answer_src": "18.5%", "follow_up_question": "What was the second leading cause of death within 30 days of TAVR?", "follow_up_response": "Heart failure", "follow_up_response_bt": "Heart failure"}, {"question_id": "253.5", "question": "What percentage of deaths occurred after the first 30 days?", "answer_src": "51.6%", "follow_up_question": "What was the leading cause of death within the first 30 days of TAVR?", "follow_up_response": "Infection/sepsis", "follow_up_response_bt": "Heart failure"}], "turn_2": [{"question_id": "253.6", "question": "What was the second leading cause of death within the first 30 days after TAVR?", "answer_src": "Heart failure", "follow_up_question": "What percentage of deaths were due to heart failure within the first 30 days after TAVR?", "follow_up_response": "14.7%", "follow_up_response_bt": "14.7%"}, {"question_id": "253.7", "question": "What was the second leading cause of death within 30 days of TAVR?", "answer_src": "Heart failure", "follow_up_question": "What percentage of deaths were due to heart failure within 30 days of TAVR?", "follow_up_response": "14.7%", "follow_up_response_bt": "14.7%"}, {"question_id": "253.8", "question": "What was the percentage of deaths related to heart failure within the first 30 days?", "answer_src": "14.7%", "follow_up_question": "What was the second most common cause of death within the first 30 days after TAVR?", "follow_up_response": "heart failure", "follow_up_response_bt": "heart failure"}, {"question_id": "253.9", "question": "What was the second leading cause of death within 30 days of TAVR?", "answer_src": "Heart failure", "follow_up_question": "What percentage of deaths were due to heart failure within 30 days of TAVR?", "follow_up_response": "14.7%", "follow_up_response_bt": "14.7%"}, {"question_id": "253.10", "question": "What was the leading cause of death within the first 30 days of TAVR?", "answer_src": "Infection/sepsis", "follow_up_question": "What was the second leading cause of death within the first 30 days of TAVR?", "follow_up_response": "Heart failure", "follow_up_response_bt": "Heart failure"}], "turn_3": [{"question_id": "253.11", "question": "What percentage of deaths were due to heart failure within the first 30 days after TAVR?", "answer_src": "14.7%", "follow_up_question": "What was the second leading cause of death within the first 30 days after TAVR according to the text?", "follow_up_response": "Heart failure", "follow_up_response_bt": "Heart failure"}, {"question_id": "253.12", "question": "What percentage of deaths were due to heart failure within 30 days of TAVR?", "answer_src": "14.7%", "follow_up_question": "What was the second leading cause of death within 30 days of TAVR according to the text?", "follow_up_response": "heart failure", "follow_up_response_bt": "Heart failure"}, {"question_id": "253.13", "question": "What was the second most common cause of death within the first 30 days after TAVR?", "answer_src": "heart failure", "follow_up_question": "What percentage of deaths were due to heart failure within the first 30 days after TAVR?", "follow_up_response": "14.7%", "follow_up_response_bt": "14.7%"}, {"question_id": "253.14", "question": "What percentage of deaths were due to heart failure within 30 days of TAVR?", "answer_src": "14.7%", "follow_up_question": "What was the second leading cause of death within 30 days of TAVR according to the text?", "follow_up_response": "heart failure", "follow_up_response_bt": "Heart failure"}, {"question_id": "253.15", "question": "What was the second leading cause of death within the first 30 days of TAVR?", "answer_src": "Heart failure", "follow_up_question": "What percentage of deaths were due to heart failure within the first 30 days of TAVR?", "follow_up_response": "14.7%", "follow_up_response_bt": "14.7%"}]}}
{"id": 254, "src": "ectopic breast tissue can occur anywhere along the incompletely regressed mammary ridge . among the various types of breast choristoma , ectopic breast tissue , which has only glandular tissue without a nipple or areola , is most commonly detected in axillary areas . however , ectopic breast cancer is often not detected until significant clinical symptoms have been revealed , or diagnosis is delayed .", "mt": "Tra i vari tipi di choristoma mammario , il tessuto mammario ectopo , che ha solo tessuto glandulare senza capezzo o areola , è più comunemente rilevato nelle aree assillari . Tuttavia , il cancro al seno ectopo non viene spesso rilevato fino a quando non sono stati rivelati sintomi clinici significativi o la diagnosi è ritardata .", "pert_mt": "Tra i vari tipi di choristoma mammario, il tessuto mammario ectopo, che ha solo tessuto glandulare senza capezzo o areola, è più comunemente rilevato nelle aree assillari. Tuttavia, il cancro al seno ectopo non viene spesso rilevato fino a quando non sono stati rivelati sintomi clinici significativi o la diagnosi è ritardata e questo può portare a prognosi peggiori.", "bt": "Among the various types of breast choristoma, ectopic breast tissue, which is the only glandular tissue without a capsule or areola, is most commonly detected in the assillary areas; however, ectopic breast cancer is not often detected until significant clinical symptoms or late diagnosis have been revealed, and this can lead to a worse prognosis.", "questions_src": ["What type of breast tissue is described as having only glandular tissue without a nipple or areola? ", "In which areas is ectopic breast tissue most commonly detected? ", "What does ectopic breast cancer often go undetected until? "], "answers_src": ["Ectopic breast tissue", "Axillary areas", "Significant clinical symptoms have been revealed, or diagnosis is delayed"], "answers_bt": ["Ectopic breast tissue", "The assillary areas", "Significant clinical symptoms or late diagnosis"], "multiturn": {"turn_1": [{"question_id": "254.1", "question": "What type of breast tissue is described as having only glandular tissue without a nipple or areola? ", "answer_src": "Ectopic breast tissue", "follow_up_question": "What part of the body is ectopic breast tissue most commonly detected in?", "follow_up_response": "axillary areas", "follow_up_response_bt": "The assillary areas"}, {"question_id": "254.2", "question": "In which areas is ectopic breast tissue most commonly detected? ", "answer_src": "Axillary areas", "follow_up_question": "What specific type of ectopic breast tissue is described as having only glandular tissue without a nipple or areola?", "follow_up_response": "Ectopic breast tissue", "follow_up_response_bt": "ectopic breast tissue"}, {"question_id": "254.3", "question": "What does ectopic breast cancer often go undetected until? ", "answer_src": "Significant clinical symptoms have been revealed, or diagnosis is delayed", "follow_up_question": "What factors contribute to the delay in diagnosing ectopic breast cancer?", "follow_up_response": "Significant clinical symptoms have been revealed, or diagnosis is delayed", "follow_up_response_bt": "Significant clinical symptoms or late diagnosis"}], "turn_2": [{"question_id": "254.4", "question": "What part of the body is ectopic breast tissue most commonly detected in?", "answer_src": "axillary areas", "follow_up_question": "What specific type of ectopic breast tissue is described as having only glandular tissue without a nipple or areola?", "follow_up_response": "Ectopic breast tissue", "follow_up_response_bt": "ectopic breast tissue"}, {"question_id": "254.5", "question": "What specific type of ectopic breast tissue is described as having only glandular tissue without a nipple or areola?", "answer_src": "Ectopic breast tissue", "follow_up_question": "What part of the body is ectopic breast tissue most commonly detected in?", "follow_up_response": "axillary areas", "follow_up_response_bt": "The assillary areas"}, {"question_id": "254.6", "question": "What factors contribute to the delay in diagnosing ectopic breast cancer?", "answer_src": "Significant clinical symptoms have been revealed, or diagnosis is delayed", "follow_up_question": "What specific clinical symptoms might lead to the delayed diagnosis of ectopic breast cancer?", "follow_up_response": "significant clinical symptoms have been revealed\", \"diagnosis is delayed", "follow_up_response_bt": "Significant clinical symptoms or late diagnosis"}], "turn_3": [{"question_id": "254.7", "question": "What specific type of ectopic breast tissue is described as having only glandular tissue without a nipple or areola?", "answer_src": "Ectopic breast tissue", "follow_up_question": "What part of the body is ectopic breast tissue most commonly detected in?", "follow_up_response": "axillary areas", "follow_up_response_bt": "The assillary areas"}, {"question_id": "254.8", "question": "What part of the body is ectopic breast tissue most commonly detected in?", "answer_src": "axillary areas", "follow_up_question": "What specific type of ectopic breast tissue is described as having only glandular tissue without a nipple or areola?", "follow_up_response": "Ectopic breast tissue", "follow_up_response_bt": "ectopic breast tissue"}, {"question_id": "254.9", "question": "What specific clinical symptoms might lead to the delayed diagnosis of ectopic breast cancer?", "answer_src": "significant clinical symptoms have been revealed\", \"diagnosis is delayed", "follow_up_question": "What clinical symptoms are typically present when ectopic breast cancer is initially diagnosed?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 255, "src": "primary hyperparathyroidism often presents with protean manifestations , resulting in delayed diagnosis . at times , aberrant development and migration of the gland leads to ectopic location leading to problems in localization . judicious use of combination methods of localization is recommended in treatment failure or recurrent disease .", "mt": "L' iperparatiroidismo primario si presenta spesso con manifestazioni proteiche , che portano a un diagnosi ritardata . A volte , lo sviluppo aberrante e la migrazione della ghiandola porta alla posizione ectopica che porta a problemi di localizzazione .", "pert_mt": "L' iperparatiroidismo primario si presenta spesso con manifestazioni proteiche, come edema, che portano a un diagnosi ritardata. A volte, lo sviluppo aberrante e la migrazione della ghiandola porta alla posizione ectopica che porta a problemi di localizzazione.", "bt": "Primary hyperparathyroidism often presents itself with protein manifestations, such as edema, which lead to a delayed diagnosis; sometimes, aberrant development and migration of the gland leads to ectopic position, which leads to localization problems.", "questions_src": ["What often presents with primary hyperparathyroidism?", "When does aberrant development and migration typically occur?", "Where can the parathyroid gland become ectopically located?", "Which methods are recommended for localization in treatment failure or recurrent disease?", "Who might be diagnosed with protean manifestations due to primary hyperparathyroidism?"], "answers_src": ["Protean manifestations", "At times", "Anywhere in the body", "Combination methods of localization", "People with primary hyperparathyroidism"], "answers_bt": ["[\"Protein manifestations\"], [\"Aberrant development and migration typically occurs\"], [\"Ectopically located in unusual places\"], [\"No Answer\"], [\"No Answer\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "255.1", "question": "What often presents with primary hyperparathyroidism?", "answer_src": "Protean manifestations", "follow_up_question": "What specific type of manifestation results in delayed diagnosis?", "follow_up_response": "protean manifestations", "follow_up_response_bt": "protein manifestations"}, {"question_id": "255.2", "question": "When does aberrant development and migration typically occur?", "answer_src": "At times", "follow_up_question": "What specific problems do these ectopic locations cause?", "follow_up_response": "problems in localization", "follow_up_response_bt": "Localization problems"}, {"question_id": "255.3", "question": "Where can the parathyroid gland become ectopically located?", "answer_src": "Anywhere in the body", "follow_up_question": "What combination methods of localization are recommended when there is treatment failure or recurrent disease?", "follow_up_response": "judicious use", "follow_up_response_bt": "No Answer"}, {"question_id": "255.4", "question": "Which methods are recommended for localization in treatment failure or recurrent disease?", "answer_src": "Combination methods of localization", "follow_up_question": "What specific combination methods of localization are recommended?", "follow_up_response": "judicious use of combination methods", "follow_up_response_bt": "No Answer"}, {"question_id": "255.5", "question": "Who might be diagnosed with protean manifestations due to primary hyperparathyroidism?", "answer_src": "People with primary hyperparathyroidism", "follow_up_question": "What specific combination methods of localization are recommended?", "follow_up_response": "judicious use of combination methods", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "255.6", "question": "What specific type of manifestation results in delayed diagnosis?", "answer_src": "protean manifestations", "follow_up_question": "What other condition might result from aberrant development and migration of the parathyroid gland?", "follow_up_response": "ectopic location", "follow_up_response_bt": "Ectopic position"}, {"question_id": "255.7", "question": "What specific problems do these ectopic locations cause?", "answer_src": "problems in localization", "follow_up_question": "What complications arise from the use of combination methods in treating ectopic hyperparathyroidism?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "255.8", "question": "What combination methods of localization are recommended when there is treatment failure or recurrent disease?", "answer_src": "judicious use", "follow_up_question": "What specific combination methods of localization are considered judicious?", "follow_up_response": "combination methods", "follow_up_response_bt": "No Answer"}, {"question_id": "255.9", "question": "What specific combination methods of localization are recommended?", "answer_src": "judicious use of combination methods", "follow_up_question": "What combination methods of localization are considered judicious?", "follow_up_response": "combination methods", "follow_up_response_bt": "No Answer"}, {"question_id": "255.10", "question": "What specific combination methods of localization are recommended?", "answer_src": "judicious use of combination methods", "follow_up_question": "What combination methods of localization are considered judicious?", "follow_up_response": "combination methods", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "255.11", "question": "What other condition might result from aberrant development and migration of the parathyroid gland?", "answer_src": "ectopic location", "follow_up_question": "What problems might ectopic location cause in localization?", "follow_up_response": "Problems in localization", "follow_up_response_bt": "Localization problems"}, {"question_id": "255.12", "question": "What complications arise from the use of combination methods in treating ectopic hyperparathyroidism?", "answer_src": "primary hyperparathyroidism often presents with protean manifestations , resulting in delayed diagnosis . at times , aberrant development and migration of the gland leads to ectopic location leading to problems in localization . judicious use of combination methods of localization is recommended in treatment failure or recurrent disease .", "follow_up_question": "What are some of the manifestations of primary hyperparathyroidism that lead to delayed diagnosis?", "follow_up_response": "protean manifestations", "follow_up_response_bt": "Protein manifestations, such as edema"}, {"question_id": "255.13", "question": "What specific combination methods of localization are considered judicious?", "answer_src": "combination methods", "follow_up_question": "What combination methods of localization are recommended when treatment fails or disease recurs?", "follow_up_response": "judicious use of combination methods", "follow_up_response_bt": "No Answer"}, {"question_id": "255.14", "question": "What combination methods of localization are considered judicious?", "answer_src": "combination methods", "follow_up_question": "What specific combination methods of localization are recommended?", "follow_up_response": "judicious use of combination methods", "follow_up_response_bt": "No Answer"}, {"question_id": "255.15", "question": "What combination methods of localization are considered judicious?", "answer_src": "combination methods", "follow_up_question": "What specific combination methods of localization are recommended?", "follow_up_response": "judicious use of combination methods", "follow_up_response_bt": "No Answer"}]}}
{"id": 256, "src": "strikingly , - cells exposed to this high - glucose pulse paradigm exhibited significantly stronger insulin secretion . this metabolic memory was entirely dependent on camkii . metabolic memory was reflected on the protein level by increased expression of proteins involved in glucose sensing and ca2 + -dependent vesicle secretion , and by elevated levels of the key - cell transcription factor mafa .", "mt": "Sorprendentemente , le cellule esposte a questo paradigma di impulsi ad alto livello di glucosio mostravano una secrezione di insulina significativamente più forte . Questa memoria metabolica era interamente dipendente da camkii . La memoria metabolica si rifletteva sul livello delle proteine aumentando l'espressione delle proteine coinvolte nella rilevazione del glucosio e nella secrezione delle vesciche ca2 + -dipendente , e aumentando i livelli del fattore chiave di trascrizione delle cellule mafa .", "pert_mt": "Sorprendentemente, le cellule esposte a questo paradigma di impulsi ad alto livello di glucosio mostravano una secrezione di insulina significativamente più forte. Questa memoria metabolica era interamente dipendente da camkii. La memoria metabolica si rifletteva sul livello delle proteine aumentando l'espressione delle proteine coinvolte nella rilevazione del glucosio e nella secrezione delle vesciche ca2+ -dipendente, e aumentando i livelli del fattore chiave di trascrizione delle cellule mafa e della regolazione dei processi metabolici.", "bt": "Surprisingly, cells exposed to this paradigm of high glucose impulses exhibited significantly higher insulin secretion, which was entirely dependent on the cell membrane, and reflected on the protein level by increasing the expression of proteins involved in glucose detection and secretion of ca2+-dependent vesicles, and increasing levels of the key factor in cell transcription and regulating metabolic processes.", "questions_src": ["What did the cells exhibit after being exposed to the high-glucose pulse paradigm?", "Who is responsible for the metabolic memory according to the sentence?", "Where were the proteins involved in glucose sensing and Ca2+-dependent vesicle secretion expressed?", "When was the key-cell transcription factor Mafa elevated?", "Which cellular mechanism was entirely dependent on CAMKII?"], "answers_src": ["Significantly stronger insulin secretion", "CAMKII", "On the protein level", "On the protein level", "Metabolic memory"], "answers_bt": ["Significantly higher insulin secretion", "No Answer", "Protein level", "No Answer", "Increasing levels of the key factor in cell transcription and regulating metabolic processes"], "multiturn": {"turn_1": [{"question_id": "256.1", "question": "What did the cells exhibit after being exposed to the high-glucose pulse paradigm?", "answer_src": "Significantly stronger insulin secretion", "follow_up_question": "What proteins were increased in expression due to the metabolic memory?", "follow_up_response": "proteins involved in glucose sensing and ca2 + - dependent vesicle secretion", "follow_up_response_bt": "proteins involved in glucose detection and secretion of ca2+-dependent vesicles"}, {"question_id": "256.2", "question": "Who is responsible for the metabolic memory according to the sentence?", "answer_src": "CAMKII", "follow_up_question": "What specific proteins were found to be involved in glucose sensing and Ca2+-dependent vesicle secretion due to the metabolic memory?", "follow_up_response": "proteins involved in glucose sensing and Ca2+-dependent vesicle secretion", "follow_up_response_bt": "No Answer"}, {"question_id": "256.3", "question": "Where were the proteins involved in glucose sensing and Ca2+-dependent vesicle secretion expressed?", "answer_src": "On the protein level", "follow_up_question": "What specific proteins were found to be involved in glucose sensing and Ca2+-dependent vesicle secretion?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "256.4", "question": "When was the key-cell transcription factor Mafa elevated?", "answer_src": "On the protein level", "follow_up_question": "What specific proteins were elevated due to the increased levels of Mafa?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "256.5", "question": "Which cellular mechanism was entirely dependent on CAMKII?", "answer_src": "Metabolic memory", "follow_up_question": "What specific proteins were increased in expression due to the metabolic memory?", "follow_up_response": "proteins involved in glucose sensing and ca2 + - dependent vesicle secretion", "follow_up_response_bt": "Proteins involved in glucose detection and secretion of ca2+-dependent vesicles"}], "turn_2": [{"question_id": "256.6", "question": "What proteins were increased in expression due to the metabolic memory?", "answer_src": "proteins involved in glucose sensing and ca2 + - dependent vesicle secretion", "follow_up_question": "What role did mafa play in the elevated levels observed?", "follow_up_response": "The key-cell transcription factor mafa", "follow_up_response_bt": "No Answer"}, {"question_id": "256.7", "question": "What specific proteins were found to be involved in glucose sensing and Ca2+-dependent vesicle secretion due to the metabolic memory?", "answer_src": "proteins involved in glucose sensing and Ca2+-dependent vesicle secretion", "follow_up_question": "What is the role of the key-cell transcription factor Mafa in this context?", "follow_up_response": "increased levels", "follow_up_response_bt": "No Answer"}, {"question_id": "256.8", "question": "What specific proteins were found to be involved in glucose sensing and Ca2+-dependent vesicle secretion?", "answer_src": "strikingly , - cells exposed to this high - glucose pulse paradigm exhibited significantly stronger insulin secretion . this metabolic memory was entirely dependent on camkii . metabolic memory was reflected on the protein level by increased expression of proteins involved in glucose sensing and ca2 + -dependent vesicle secretion , and by elevated levels of the key - cell transcription factor mafa .", "follow_up_question": "Which key-cell transcription factor was found to be elevated in response to the metabolic memory?", "follow_up_response": "mafa", "follow_up_response_bt": "No Answer"}, {"question_id": "256.9", "question": "What specific proteins were elevated due to the increased levels of Mafa?", "answer_src": "strikingly , - cells exposed to this high - glucose pulse paradigm exhibited significantly stronger insulin secretion . this metabolic memory was entirely dependent on camkii . metabolic memory was reflected on the protein level by increased expression of proteins involved in glucose sensing and ca2 + -dependent vesicle secretion , and by elevated levels of the key - cell transcription factor mafa .", "follow_up_question": "Which proteins were involved in glucose sensing according to the text?", "follow_up_response": "proteins involved in glucose sensing", "follow_up_response_bt": "proteins involved in glucose detection"}, {"question_id": "256.10", "question": "What specific proteins were increased in expression due to the metabolic memory?", "answer_src": "proteins involved in glucose sensing and ca2 + - dependent vesicle secretion", "follow_up_question": "What role does the key-cell transcription factor Mafa play in this increased expression?", "follow_up_response": "The key-cell transcription factor Mafa", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "256.11", "question": "What role did mafa play in the elevated levels observed?", "answer_src": "The key-cell transcription factor mafa", "follow_up_question": "How did elevated levels of mafa contribute to the increased expression of proteins involved in glucose sensing?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "256.12", "question": "What is the role of the key-cell transcription factor Mafa in this context?", "answer_src": "increased levels", "follow_up_question": "How does the increased level of Mafa contribute to the enhanced insulin secretion?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "256.13", "question": "Which key-cell transcription factor was found to be elevated in response to the metabolic memory?", "answer_src": "mafa", "follow_up_question": "Which proteins involved in glucose sensing were found to have increased expression as part of the metabolic memory?", "follow_up_response": "proteins involved in glucose sensing", "follow_up_response_bt": "Proteins involved in glucose detection"}, {"question_id": "256.14", "question": "Which proteins were involved in glucose sensing according to the text?", "answer_src": "proteins involved in glucose sensing", "follow_up_question": "What specific proteins were elevated in levels due to glucose sensing?", "follow_up_response": "No Answer", "follow_up_response_bt": "Proteins involved in glucose detection and secretion of ca2+-dependent vesicles"}, {"question_id": "256.15", "question": "What role does the key-cell transcription factor Mafa play in this increased expression?", "answer_src": "The key-cell transcription factor Mafa", "follow_up_question": "How does the increased expression of Mafa contribute to enhanced insulin secretion?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 257, "src": "purposethe aim of this in vitro study was to evaluate the mechanical properties ( bending strength and hardness ) of seven different fiber reinforced composite posts , in relation to their microstructural characteristics.materials and methodstwo hundred eighty posts were divided into seven groups of 40 , one group for each type of post analyzed . within each group , 15 posts were subjected to three - point bending strength test , 15 to a microhardess meter for the knoop hardness , and 10 to scanning electron microscope in order to determine the diameter of the fibers and the percentage of fibers embedded in the matrix . to compare the flexural strength in relation to the type of fiber , matrix , and the hardness of the posts , a kruskal - wallis h test was used .", "mt": "Lo scopo di questo studio in vitro era quello di valutare le proprietà meccaniche (forza di piegatura e durezza) di sette diversi post composti rinforzati a fibra , in relazione alle loro caratteristiche microstrutturali.I materiali e i metodi sono stati suddivisi in sette gruppi di 40 , un gruppo per ogni tipo di post analizzato . All'interno di ciascun gruppo , 15 posti sono stati sottoposti a un test di resistenza a piegatura a tre punti , 15 a un microhardess meter per la durezza del nodo , e 10 a scanner a microscopio elettronico per determinare il diametro delle fibre e la percentuale di fibre incorporate nella matrice . Per confrontare la forza flessibile rispetto al tipo di fibra , matrice e la durezza dei posti , è stato utilizzato un test kruskal-wallis h .", "pert_mt": "Lo scopo di questo studio in vitro era quello di valutare le proprietà meccaniche (forza di piegatura e durezza) di sette diversi post composti rinforzati a fibra, in relazione alle loro caratteristiche microstrutturali. I materiali e i metodi sono stati suddivisi in sette gruppi di 40, un gruppo per ogni tipo di post analizzato. All'interno di ciascun gruppo, 15 posti sono stati sottoposti a un test di resistenza a piegatura a tre punti, 15 a un microhardness meter per la durezza del nodo, e 10 a scanner a microscopio elettronico per determinare il diametro delle fibre e la percentuale di fibre incorporate nella matrice. Per confrontare la forza flessibile rispetto al tipo di fibra,", "bt": "The purpose of this in vitro study was to evaluate the mechanical properties (folding strength and hardness) of seven different fiber-reinforced compound posts in relation to their microstructural characteristics.The materials and methods were divided into seven groups of 40, one group for each type of post analyzed.In each group, 15 posts were subjected to a three-point bonding resistance test, 15 to a microhardness meter for the hardness of the node, and 10 to a scanner using an electronic microscope to determine the diameter of the fibers and the percentage of fibers incorporated into the matrix.", "questions_src": ["What is the main purpose of the in vitro study mentioned in the sentence?", "Who conducted the three-point bending strength tests on the posts?", "Where were the posts divided into groups based on the sentence?", "When were the posts subjected to the Knoop hardness test?", "Which type of post had the highest bending strength according to the Kruskal-Wallis H test?"], "answers_src": ["[\"To evaluate the mechanical properties (bending strength and hardness) of seven different fiber reinforced composite posts, in relation to their microstructural characteristics\"], [\"One group for each type of post analyzed\"], [\"Two hundred eighty posts were divided into seven groups of 40\"], [\"15 posts were subjected to a Knoop hardness meter\"], [\"No Answer\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["To evaluate the mechanical properties (folding strength and hardness) of seven different fiber-reinforced compound posts in relation to their microstructural characteristics", "One group for each type of post analyzed", "Based on the microstructural characteristics", "With the microhardness meter for the hardness of the node", "No Answer"], "multiturn": {"turn_1": [{"question_id": "257.1", "question": "What is the main purpose of the in vitro study mentioned in the sentence?", "answer_src": "[\"To evaluate the mechanical properties (bending strength and hardness) of seven different fiber reinforced composite posts, in relation to their microstructural characteristics\"], [\"One group for each type of post analyzed\"], [\"Two hundred eighty posts were divided into seven groups of 40\"], [\"15 posts were subjected to a Knoop hardness meter\"], [\"No Answer\"]", "follow_up_question": "How many posts were subjected to the Knoop hardness test?", "follow_up_response": "30", "follow_up_response_bt": "30"}, {"question_id": "257.2", "question": "Who conducted the three-point bending strength tests on the posts?", "answer_src": "purposethe aim of this in vitro study was to evaluate the mechanical properties ( bending strength and hardness ) of seven different fiber reinforced composite posts , in relation to their microstructural characteristics.materials and methodstwo hundred eighty posts were divided into seven groups of 40 , one group for each type of post analyzed . within each group , 15 posts were subjected to three - point bending strength test , 15 to a microhardess meter for the knoop hardness , and 10 to scanning electron microscope in order to determine the diameter of the fibers and the percentage of fibers embedded in the matrix . to compare the flexural strength in relation to the type of fiber , matrix , and the hardness of the posts , a kruskal - wallis h test was used .", "follow_up_question": "What specific equipment was used to measure the hardness of the posts?", "follow_up_response": "microhardess meter", "follow_up_response_bt": "Microhardness meter"}, {"question_id": "257.3", "question": "Where were the posts divided into groups based on the sentence?", "answer_src": "purposethe aim of this in vitro study was to evaluate the mechanical properties ( bending strength and hardness ) of seven different fiber reinforced composite posts , in relation to their microstructural characteristics.materials and methodstwo hundred eighty posts were divided into seven groups of 40 , one group for each type of post analyzed . within each group , 15 posts were subjected to three - point bending strength test , 15 to a microhardess meter for the knoop hardness , and 10 to scanning electron microscope in order to determine the diameter of the fibers and the percentage of fibers embedded in the matrix . to compare the flexural strength in relation to the type of fiber , matrix , and the hardness of the posts , a kruskal - wallis h test was used .", "follow_up_question": "What specific property was measured for 15 posts in each group?", "follow_up_response": "Bending strength", "follow_up_response_bt": "The folding strength and hardness"}, {"question_id": "257.4", "question": "When were the posts subjected to the Knoop hardness test?", "answer_src": "purposethe aim of this in vitro study was to evaluate the mechanical properties ( bending strength and hardness ) of seven different fiber reinforced composite posts , in relation to their microstructural characteristics.materials and methodstwo hundred eighty posts were divided into seven groups of 40 , one group for each type of post analyzed . within each group , 15 posts were subjected to three - point bending strength test , 15 to a microhardess meter for the knoop hardness , and 10 to scanning electron microscope in order to determine the diameter of the fibers and the percentage of fibers embedded in the matrix . to compare the flexural strength in relation to the type of fiber , matrix , and the hardness of the posts , a kruskal - wallis h test was used .", "follow_up_question": "What specific microstructural characteristic was determined by the scanning electron microscope?", "follow_up_response": "the diameter of the fibers and the percentage of fibers embedded in the matrix", "follow_up_response_bt": "The diameter of the fibers and the percentage of fibers incorporated into the matrix"}, {"question_id": "257.5", "question": "Which type of post had the highest bending strength according to the Kruskal-Wallis H test?", "answer_src": "purposethe aim of this in vitro study was to evaluate the mechanical properties ( bending strength and hardness ) of seven different fiber reinforced composite posts , in relation to their microstructural characteristics.materials and methodstwo hundred eighty posts were divided into seven groups of 40 , one group for each type of post analyzed . within each group , 15 posts were subjected to three - point bending strength test , 15 to a microhardess meter for the knoop hardness , and 10 to scanning electron microscope in order to determine the diameter of the fibers and the percentage of fibers embedded in the matrix . to compare the flexural strength in relation to the type of fiber , matrix , and the hardness of the posts , a kruskal - wallis h test was used .", "follow_up_question": "What was the criterion used to compare the flexural strength of the posts?", "follow_up_response": "A Kruskal-Wallis H test", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "257.6", "question": "How many posts were subjected to the Knoop hardness test?", "answer_src": "30", "follow_up_question": "How many posts were analyzed for their fiber diameter and percentage of embedding in the matrix?", "follow_up_response": "10", "follow_up_response_bt": "10"}, {"question_id": "257.7", "question": "What specific equipment was used to measure the hardness of the posts?", "answer_src": "microhardess meter", "follow_up_question": "What was the purpose of using the scanning electron microscope?", "follow_up_response": "To determine the diameter of the fibers and the percentage of fibers embedded in the matrix.", "follow_up_response_bt": "To determine the diameter of the fibers and the percentage of fibers incorporated into the matrix"}, {"question_id": "257.8", "question": "What specific property was measured for 15 posts in each group?", "answer_src": "Bending strength", "follow_up_question": "What specific property was measured for 10 posts in each group?", "follow_up_response": "The diameter of the fibers and the percentage of fibers embedded in the matrix", "follow_up_response_bt": "The diameter of the fibers and the percentage of fibers incorporated into the matrix"}, {"question_id": "257.9", "question": "What specific microstructural characteristic was determined by the scanning electron microscope?", "answer_src": "the diameter of the fibers and the percentage of fibers embedded in the matrix", "follow_up_question": "What was the result of the Kruskal-Wallis H test conducted in the study?", "follow_up_response": "to compare the flexural strength in relation to the type of fiber, matrix, and the hardness of the posts", "follow_up_response_bt": "No Answer"}, {"question_id": "257.10", "question": "What was the criterion used to compare the flexural strength of the posts?", "answer_src": "A Kruskal-Wallis H test", "follow_up_question": "What other material characteristic was compared alongside the flexural strength?", "follow_up_response": "Hardness", "follow_up_response_bt": "Hardness"}], "turn_3": [{"question_id": "257.11", "question": "How many posts were analyzed for their fiber diameter and percentage of embedding in the matrix?", "answer_src": "10", "follow_up_question": "How many posts were tested for their bending strength?", "follow_up_response": "15", "follow_up_response_bt": "30"}, {"question_id": "257.12", "question": "What was the purpose of using the scanning electron microscope?", "answer_src": "To determine the diameter of the fibers and the percentage of fibers embedded in the matrix.", "follow_up_question": "What specific information did the scanning electron microscope provide about the posts?", "follow_up_response": "the diameter of the fibers and the percentage of fibers embedded in the matrix", "follow_up_response_bt": "The diameter of the fibers and the percentage of fibers incorporated into the matrix"}, {"question_id": "257.13", "question": "What specific property was measured for 10 posts in each group?", "answer_src": "The diameter of the fibers and the percentage of fibers embedded in the matrix", "follow_up_question": "What property was measured for 15 posts in each group?", "follow_up_response": "Bending strength", "follow_up_response_bt": "Folding strength and hardness"}, {"question_id": "257.14", "question": "What was the result of the Kruskal-Wallis H test conducted in the study?", "answer_src": "to compare the flexural strength in relation to the type of fiber, matrix, and the hardness of the posts", "follow_up_question": "What specific variables were compared using the Kruskal-Wallis H test?", "follow_up_response": "the flexural strength in relation to the type of fiber, matrix, and the hardness of the posts", "follow_up_response_bt": "No Answer"}, {"question_id": "257.15", "question": "What other material characteristic was compared alongside the flexural strength?", "answer_src": "Hardness", "follow_up_question": "What was the specific type of hardness measured?", "follow_up_response": "Knoop hardness", "follow_up_response_bt": "Hardness of the node"}]}}
{"id": 258, "src": "parenteral artesunate ( ars ) is the drug of choice for the treatment of severe malaria . pharmacokinetics data on intramuscular ars are limited with respect to the main treatment group that carries the highest mortality , namely , critically ill children with severe malaria . a population pharmacokinetic study of ars and dihydroartemisinin ( dha ) was conducted from sparse sampling in 70 tanzanian children of ages 6 months to 11 years .", "mt": "Il parenteral artesunate (ars) è il farmaco di scelta per il trattamento della malaria severa . I dati farmacocinetici su ars intramuscolari sono limitati rispetto al gruppo di trattamento principale che porta la più alta mortalità , vale a dire i bambini gravemente malati con malaria severa . Uno studio farmacocinetico di ars e diidroartemisinin (dha) popolazione è stato condotto da scarsi campionamenti in 70 bambini tanzaniani di età compresa tra 6 mesi e 11 anni .", "pert_mt": "Il parenteral artesunate (ars) è il farmaco di scelta per il trattamento della malaria severa. I dati farmacocinetici su ars intramuscolari sono limitati rispetto al gruppo di trattamento principale che porta la più alta mortalità, vale a dire i bambini gravemente malati con malaria severa. Uno studio farmacocinetico di ars e diidroartemisinin (dha) popolazione è stato condotto da scarsi campionamenti in 70 bambini tanzaniani di età compresa tra 6 mesi e 11 anni, e ha rilevato effetti collaterali significativi.", "bt": "Parenteral artesunate (ars) is the drug of choice for treating severe malaria. pharmacokinetic data on intramuscular ars are limited compared to the main treatment group that carries the highest mortality, i.e. seriously ill children with severe malaria.A pharmacokinetic study of ars and diidroartemisinin (dha) population was conducted with a small sample of 70 Tanzanian children aged between 6 months and 11 years, and significant side effects were detected.", "questions_src": ["What is the drug of choice for the treatment of severe malaria?", "Who is the main treatment group that carries the highest mortality?", "Where was a population pharmacokinetic study conducted?", "When does the critical illness occur in relation to malaria?", "Which age group was included in the pharmacokinetic study?"], "answers_src": ["parenteral artesunate ( ars )", "critically ill children with severe malaria", "Tanzania", "during critical illness", "6 months to 11 years"], "answers_bt": ["Parenteral artesunate (ars)", "Seriously ill children with severe malaria", "Tanzania", "In relation to malaria", "6 months to 11 years"], "multiturn": {"turn_1": [{"question_id": "258.1", "question": "What is the drug of choice for the treatment of severe malaria?", "answer_src": "parenteral artesunate ( ars )", "follow_up_question": "What is the age range of the children studied in the pharmacokinetic study?", "follow_up_response": "6 months to 11 years", "follow_up_response_bt": "6 months and 11 years"}, {"question_id": "258.2", "question": "Who is the main treatment group that carries the highest mortality?", "answer_src": "critically ill children with severe malaria", "follow_up_question": "What is the age range of the children studied in the pharmacokinetic study?", "follow_up_response": "6 months to 11 years", "follow_up_response_bt": "6 months and 11 years"}, {"question_id": "258.3", "question": "Where was a population pharmacokinetic study conducted?", "answer_src": "Tanzania", "follow_up_question": "What was the age range of the children studied?", "follow_up_response": "6 months to 11 years", "follow_up_response_bt": "6 months and 11 years"}, {"question_id": "258.4", "question": "When does the critical illness occur in relation to malaria?", "answer_src": "during critical illness", "follow_up_question": "What is the age range of the children studied in the pharmacokinetic study?", "follow_up_response": "6 months to 11 years", "follow_up_response_bt": "6 months and 11 years"}, {"question_id": "258.5", "question": "Which age group was included in the pharmacokinetic study?", "answer_src": "6 months to 11 years", "follow_up_question": "What was the median age of the participants in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "258.6", "question": "What is the age range of the children studied in the pharmacokinetic study?", "answer_src": "6 months to 11 years", "follow_up_question": "What was the primary reason for selecting this specific age range for the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "258.7", "question": "What is the age range of the children studied in the pharmacokinetic study?", "answer_src": "6 months to 11 years", "follow_up_question": "What was the primary reason for selecting this specific age range for the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "258.8", "question": "What was the age range of the children studied?", "answer_src": "6 months to 11 years", "follow_up_question": "What was the median age of the children in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "258.9", "question": "What is the age range of the children studied in the pharmacokinetic study?", "answer_src": "6 months to 11 years", "follow_up_question": "What was the primary reason for selecting this specific age range for the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "258.10", "question": "What was the median age of the participants in the study?", "answer_src": "parenteral artesunate ( ars ) is the drug of choice for the treatment of severe malaria . pharmacokinetics data on intramuscular ars are limited with respect to the main treatment group that carries the highest mortality , namely , critically ill children with severe malaria . a population pharmacokinetic study of ars and dihydroartemisinin ( dha ) was conducted from sparse sampling in 70 tanzanian children of ages 6 months to 11 years .", "follow_up_question": "What was the range of ages for the participants in the study?", "follow_up_response": "6 months to 11 years", "follow_up_response_bt": "6 months to 11 years"}], "turn_3": [{"question_id": "258.11", "question": "What was the primary reason for selecting this specific age range for the study?", "answer_src": "parenteral artesunate ( ars ) is the drug of choice for the treatment of severe malaria . pharmacokinetics data on intramuscular ars are limited with respect to the main treatment group that carries the highest mortality , namely , critically ill children with severe malaria . a population pharmacokinetic study of ars and dihydroartemisinin ( dha ) was conducted from sparse sampling in 70 tanzanian children of ages 6 months to 11 years .", "follow_up_question": "Why were children aged 6 months to 11 years chosen as the main treatment group?", "follow_up_response": "To carry the highest mortality", "follow_up_response_bt": "Seriously ill children with severe malaria"}, {"question_id": "258.12", "question": "What was the primary reason for selecting this specific age range for the study?", "answer_src": "parenteral artesunate ( ars ) is the drug of choice for the treatment of severe malaria . pharmacokinetics data on intramuscular ars are limited with respect to the main treatment group that carries the highest mortality , namely , critically ill children with severe malaria . a population pharmacokinetic study of ars and dihydroartemisinin ( dha ) was conducted from sparse sampling in 70 tanzanian children of ages 6 months to 11 years .", "follow_up_question": "Why were children aged 6 months to 11 years chosen as the main treatment group?", "follow_up_response": "To carry the highest mortality", "follow_up_response_bt": "Seriously ill children with severe malaria"}, {"question_id": "258.13", "question": "What was the median age of the children in the study?", "answer_src": "parenteral artesunate ( ars ) is the drug of choice for the treatment of severe malaria . pharmacokinetics data on intramuscular ars are limited with respect to the main treatment group that carries the highest mortality , namely , critically ill children with severe malaria . a population pharmacokinetic study of ars and dihydroartemisinin ( dha ) was conducted from sparse sampling in 70 tanzanian children of ages 6 months to 11 years .", "follow_up_question": "What was the range of ages for the children in the study?", "follow_up_response": "6 months to 11 years", "follow_up_response_bt": "6 months to 11 years"}, {"question_id": "258.14", "question": "What was the primary reason for selecting this specific age range for the study?", "answer_src": "parenteral artesunate ( ars ) is the drug of choice for the treatment of severe malaria . pharmacokinetics data on intramuscular ars are limited with respect to the main treatment group that carries the highest mortality , namely , critically ill children with severe malaria . a population pharmacokinetic study of ars and dihydroartemisinin ( dha ) was conducted from sparse sampling in 70 tanzanian children of ages 6 months to 11 years .", "follow_up_question": "Why were children aged 6 months to 11 years chosen as the main treatment group?", "follow_up_response": "To carry the highest mortality", "follow_up_response_bt": "Seriously ill children with severe malaria"}, {"question_id": "258.15", "question": "What was the range of ages for the participants in the study?", "answer_src": "6 months to 11 years", "follow_up_question": "What was the average age of the participants in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 259, "src": "we prospectively studied the feasibility and effectiveness of sputum induction in obtaining good quality sputum and its subsequent bacterial yield in children with clinically suspected acute lower - respiratory - tract infection ( alrti ) . good quality sputum was collected in 89/98 ( 91% ) patients . sputum cultures revealed 1 bacterial pathogens in 22 cases ( 25% ) .", "mt": "Abbiamo studiato in prospettiva la fattibilità e l'efficacia dell'induzione dello sputum per ottenere uno sputum di buona qualità e il suo successivo rendimento batterico nei bambini con sospetto clinico di infezione acuta del tratto respiratorio inferiore (alerti) . Lo sputum di buona qualità è stato raccolto in 89/98 (91%) pazienti . Le culture dello sputum hanno rivelato 1 patogeno batterico in 22 casi (25%) .", "pert_mt": "Abbiamo studiato in prospettiva la fattibilità e l'efficacia dell'induzione dello sputum per ottenere uno sputum di buona qualità e il suo successivo rendimento batterico nei bambini con sospetto clinico di infezione acuta del tratto respiratorio inferiore (alerti). Lo sputum di buona qualità è stato raccolto in 89/98 (91%) pazienti. Le culture dello sputum hanno rivelato 1 patogeno batterico in 22 casi (25%), ma non hanno fornito informazioni su altri possibili agenti patogeni.", "bt": "We have studied in perspective the feasibility and effectiveness of sputum induction to obtain a good quality sputum and its subsequent bacterial yield in children with clinical suspicion of acute infection of the lower respiratory tract (alerte).Good quality sputum was collected in 89/98 (91%) patients.", "questions_src": ["What was the main purpose of the study?", "Who were the participants in the study?", "Where was the study conducted?", "When did the study take place?", "Which condition was clinically suspected in the participants?"], "answers_src": ["[\"To study the feasibility and effectiveness of sputum induction\"], [\"children with clinically suspected acute lower - respiratory - tract infection (alrti)\"], [\"prospectively\"], [\"not specified\"], [\"acute lower - respiratory - tract infection (alrti)\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["To study the feasibility and effectiveness of sputum induction", "Children with clinical suspicion of acute infection of the lower respiratory tract", "In perspective", "No Answer", "Acute infection of the lower respiratory tract"], "multiturn": {"turn_1": [{"question_id": "259.1", "question": "What was the main purpose of the study?", "answer_src": "[\"To study the feasibility and effectiveness of sputum induction\"], [\"children with clinically suspected acute lower - respiratory - tract infection (alrti)\"], [\"prospectively\"], [\"not specified\"], [\"acute lower - respiratory - tract infection (alrti)\"]", "follow_up_question": "What percentage of patients had good quality sputum collected?", "follow_up_response": "91%", "follow_up_response_bt": "91%"}, {"question_id": "259.2", "question": "Who were the participants in the study?", "answer_src": "we prospectively studied the feasibility and effectiveness of sputum induction in obtaining good quality sputum and its subsequent bacterial yield in children with clinically suspected acute lower - respiratory - tract infection ( alrti ) . good quality sputum was collected in 89/98 ( 91% ) patients . sputum cultures revealed 1 bacterial pathogens in 22 cases ( 25% ) .", "follow_up_question": "What percentage of patients had good quality sputum collected?", "follow_up_response": "91%", "follow_up_response_bt": "91%"}, {"question_id": "259.3", "question": "Where was the study conducted?", "answer_src": "we prospectively studied the feasibility and effectiveness of sputum induction in obtaining good quality sputum and its subsequent bacterial yield in children with clinically suspected acute lower - respiratory - tract infection ( alrti ) . good quality sputum was collected in 89/98 ( 91% ) patients . sputum cultures revealed 1 bacterial pathogens in 22 cases ( 25% ) .", "follow_up_question": "What percentage of patients had good quality sputum collected?", "follow_up_response": "91%", "follow_up_response_bt": "91%"}, {"question_id": "259.4", "question": "When did the study take place?", "answer_src": "we prospectively studied the feasibility and effectiveness of sputum induction in obtaining good quality sputum and its subsequent bacterial yield in children with clinically suspected acute lower - respiratory - tract infection ( alrti ) . good quality sputum was collected in 89/98 ( 91% ) patients . sputum cultures revealed 1 bacterial pathogens in 22 cases ( 25% ) .", "follow_up_question": "What percentage of patients had good quality sputum collected?", "follow_up_response": "91%", "follow_up_response_bt": "91%"}, {"question_id": "259.5", "question": "Which condition was clinically suspected in the participants?", "answer_src": "we prospectively studied the feasibility and effectiveness of sputum induction in obtaining good quality sputum and its subsequent bacterial yield in children with clinically suspected acute lower - respiratory - tract infection ( alrti ) . good quality sputum was collected in 89/98 ( 91% ) patients . sputum cultures revealed 1 bacterial pathogens in 22 cases ( 25% ) .", "follow_up_question": "What percentage of patients had good quality sputum collected?", "follow_up_response": "91%", "follow_up_response_bt": "91%"}], "turn_2": [{"question_id": "259.6", "question": "What percentage of patients had good quality sputum collected?", "answer_src": "91%", "follow_up_question": "What was the overall bacterial yield from the sputum cultures?", "follow_up_response": "25%", "follow_up_response_bt": "No Answer"}, {"question_id": "259.7", "question": "What percentage of patients had good quality sputum collected?", "answer_src": "91%", "follow_up_question": "What was the overall bacterial yield from the sputum cultures?", "follow_up_response": "25%", "follow_up_response_bt": "No Answer"}, {"question_id": "259.8", "question": "What percentage of patients had good quality sputum collected?", "answer_src": "91%", "follow_up_question": "What was the overall bacterial yield from the sputum cultures?", "follow_up_response": "25%", "follow_up_response_bt": "No Answer"}, {"question_id": "259.9", "question": "What percentage of patients had good quality sputum collected?", "answer_src": "91%", "follow_up_question": "What was the overall bacterial yield from the sputum cultures?", "follow_up_response": "25%", "follow_up_response_bt": "No Answer"}, {"question_id": "259.10", "question": "What percentage of patients had good quality sputum collected?", "answer_src": "91%", "follow_up_question": "What was the overall bacterial yield from the sputum cultures?", "follow_up_response": "25%", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "259.11", "question": "What was the overall bacterial yield from the sputum cultures?", "answer_src": "25%", "follow_up_question": "In how many patients were good quality sputum samples successfully collected?", "follow_up_response": "89", "follow_up_response_bt": "89"}, {"question_id": "259.12", "question": "What was the overall bacterial yield from the sputum cultures?", "answer_src": "25%", "follow_up_question": "In how many patients were good quality sputum samples successfully collected?", "follow_up_response": "89", "follow_up_response_bt": "89"}, {"question_id": "259.13", "question": "What was the overall bacterial yield from the sputum cultures?", "answer_src": "25%", "follow_up_question": "In how many patients were good quality sputum samples successfully collected?", "follow_up_response": "89", "follow_up_response_bt": "89"}, {"question_id": "259.14", "question": "What was the overall bacterial yield from the sputum cultures?", "answer_src": "25%", "follow_up_question": "In how many patients were good quality sputum samples successfully collected?", "follow_up_response": "89", "follow_up_response_bt": "89"}, {"question_id": "259.15", "question": "What was the overall bacterial yield from the sputum cultures?", "answer_src": "25%", "follow_up_question": "In how many patients were good quality sputum samples successfully collected?", "follow_up_response": "89", "follow_up_response_bt": "89"}]}}
{"id": 260, "src": "[ purpose ] the aim of this study was to determine the threshold for classifying walking independence in stroke patients with and without cognitive disorders . [ subjects ] the subjects were 130 patients with initial stroke hemiplegia . [ methods ] the following factors were analyzed for associations with walking independence : brunnstrom stage , one - leg standing time on the paralytic side , one - leg standing time on the non - paralytic side , and 10-m walking speed .", "mt": "[ scopo ] lo scopo di questo studio era quello di determinare la soglia per classificare l'indipendenza da camminare nei pazienti colpiti da ictus con e senza disturbi cognitivi . [ soggetti ] i soggetti erano 130 pazienti con emiplegia iniziale da ictus . [ metodi ] I seguenti fattori sono stati analizzati per le associazioni con l'indipendenza da camminare: stadio di brunnstrom , tempo di piedi di una gamba sul lato paralitico , tempo di piedi di una gamba sul lato non paralitico e velocità di camminare di 10 metri .", "pert_mt": "[ scopo ] lo scopo di questo studio era quello di determinare la soglia per classificare l'indipendenza da camminare nei pazienti colpiti da ictus con e senza disturbi cognitivi. Inoltre, si è valutata l'efficacia del trattamento fisioterapeutico. [ soggetti ] i soggetti erano 130 pazienti con emiplegia iniziale da ictus. [ metodi ] I seguenti fattori sono stati analizzati per le associazioni con l'indipendenza da camminare: stadio di brunnstrom , tempo di piedi di una gamba sul lato paralitico , tempo di piedi di una gamba sul lato non paralitico e velocità di camminare di 10 metri.", "bt": "The purpose of this study was to determine the threshold for classifying the independence of walking in stroke patients with and without cognitive impairment.In addition, the effectiveness of physiotherapy treatment was assessed.The subjects were 130 patients with initial epilepsy of the stroke.The following factors were analyzed for the associations with walking independence: brunnstrom stage , standing time of a leg on the side of the leg, standing time of a leg on the side of the leg and walking speed of 10 meters.", "questions_src": ["What is the main aim of the study?", "Who were the subjects of the study?", "Where was the study conducted?", "When was the study performed?", "Which factors were analyzed for associations with walking independence?"], "answers_src": ["to determine the threshold for classifying walking independence in stroke patients with and without cognitive disorders", "130 patients with initial stroke hemiplegia", "No Answer", "No Answer", "Brunnstrom stage, one- leg standing time on the paralytic side, one- leg standing time on the non-paralytic side, and 10-m walking speed"], "answers_bt": ["To determine the threshold for classifying the independence of walking in stroke patients with and without cognitive impairment.", "130 patients with initial epilepsy of the stroke.", "No Answer", "No Answer", "Brunnstrom stage, standing time of a leg on the side of the leg, and walking speed of 10 meters."], "multiturn": {"turn_1": [{"question_id": "260.1", "question": "What is the main aim of the study?", "answer_src": "to determine the threshold for classifying walking independence in stroke patients with and without cognitive disorders", "follow_up_question": "What factors were analyzed for their associations with walking independence?", "follow_up_response": "Brunnstrom stage, one-leg standing time on the paralytic side, one-leg standing time on the non-paralytic side, and 10-m walking speed", "follow_up_response_bt": "Brunnstrom stage, standing time of a leg on the side of the leg, and walking speed of 10 meters"}, {"question_id": "260.2", "question": "Who were the subjects of the study?", "answer_src": "130 patients with initial stroke hemiplegia", "follow_up_question": "What method did the researchers use to analyze the factors associated with walking independence?", "follow_up_response": "brunnstrom stage, one-leg standing time on the paralytic side, one-leg standing time on the non-paralytic side, and 10-m walking speed", "follow_up_response_bt": "Brunnstrom stage, standing time of a leg on the side of the leg, and walking speed of 10 meters"}, {"question_id": "260.3", "question": "Where was the study conducted?", "answer_src": "[ purpose ] the aim of this study was to determine the threshold for classifying walking independence in stroke patients with and without cognitive disorders . [ subjects ] the subjects were 130 patients with initial stroke hemiplegia . [ methods ] the following factors were analyzed for associations with walking independence : brunnstrom stage , one - leg standing time on the paralytic side , one - leg standing time on the non - paralytic side , and 10-m walking speed .", "follow_up_question": "What factors were analyzed for associations with walking independence?", "follow_up_response": "Brunnstrom stage, one-leg standing time on the paralytic side, one-leg standing time on the non-paralytic side, and 10-m walking speed", "follow_up_response_bt": "Brunnstrom stage, standing time of a leg on the side of the leg, and walking speed of 10 meters"}, {"question_id": "260.4", "question": "When was the study performed?", "answer_src": "[ purpose ] the aim of this study was to determine the threshold for classifying walking independence in stroke patients with and without cognitive disorders . [ subjects ] the subjects were 130 patients with initial stroke hemiplegia . [ methods ] the following factors were analyzed for associations with walking independence : brunnstrom stage , one - leg standing time on the paralytic side , one - leg standing time on the non - paralytic side , and 10-m walking speed .", "follow_up_question": "What factors were analyzed for associations with walking independence?", "follow_up_response": "Brunnstrom stage, one-leg standing time on the paralytic side, one-leg standing time on the non-paralytic side, and 10-m walking speed", "follow_up_response_bt": "Brunnstrom stage, standing time of a leg on the side of the leg, and walking speed of 10 meters"}, {"question_id": "260.5", "question": "Which factors were analyzed for associations with walking independence?", "answer_src": "Brunnstrom stage, one- leg standing time on the paralytic side, one- leg standing time on the non-paralytic side, and 10-m walking speed", "follow_up_question": "What is the unit of measurement for 10-m walking speed?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "260.6", "question": "What factors were analyzed for their associations with walking independence?", "answer_src": "Brunnstrom stage, one-leg standing time on the paralytic side, one-leg standing time on the non-paralytic side, and 10-m walking speed", "follow_up_question": "Which factor showed the strongest association with walking independence according to the study?", "follow_up_response": "Brunnstrom stage", "follow_up_response_bt": "Brunnstrom stage, standing time of a leg on the side of the leg, and walking speed of 10 meters"}, {"question_id": "260.7", "question": "What method did the researchers use to analyze the factors associated with walking independence?", "answer_src": "brunnstrom stage, one-leg standing time on the paralytic side, one-leg standing time on the non-paralytic side, and 10-m walking speed", "follow_up_question": "What specific factor showed the strongest association with walking independence according to the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "260.8", "question": "What factors were analyzed for associations with walking independence?", "answer_src": "Brunnstrom stage, one-leg standing time on the paralytic side, one-leg standing time on the non-paralytic side, and 10-m walking speed", "follow_up_question": "What is the unit of measurement used for 10-m walking speed?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "260.9", "question": "What factors were analyzed for associations with walking independence?", "answer_src": "Brunnstrom stage, one-leg standing time on the paralytic side, one-leg standing time on the non-paralytic side, and 10-m walking speed", "follow_up_question": "What is the unit of measurement used for 10-m walking speed?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "260.10", "question": "What is the unit of measurement for 10-m walking speed?", "answer_src": "[ purpose ] the aim of this study was to determine the threshold for classifying walking independence in stroke patients with and without cognitive disorders . [ subjects ] the subjects were 130 patients with initial stroke hemiplegia . [ methods ] the following factors were analyzed for associations with walking independence : brunnstrom stage , one - leg standing time on the paralytic side , one - leg standing time on the non - paralytic side , and 10-m walking speed .", "follow_up_question": "What factor was not analyzed for associations with walking independence according to the methods section?", "follow_up_response": "No Answer", "follow_up_response_bt": "standing time of a leg on the side of the leg"}], "turn_3": [{"question_id": "260.11", "question": "Which factor showed the strongest association with walking independence according to the study?", "answer_src": "Brunnstrom stage", "follow_up_question": "What was the cutoff value for Brunnstrom stage that indicated walking independence?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "260.12", "question": "What specific factor showed the strongest association with walking independence according to the study?", "answer_src": "[ purpose ] the aim of this study was to determine the threshold for classifying walking independence in stroke patients with and without cognitive disorders . [ subjects ] the subjects were 130 patients with initial stroke hemiplegia . [ methods ] the following factors were analyzed for associations with walking independence : brunnstrom stage , one - leg standing time on the paralytic side , one - leg standing time on the non - paralytic side , and 10-m walking speed .", "follow_up_question": "Which method did the study use to measure walking speed?", "follow_up_response": "10-m walking speed", "follow_up_response_bt": "10 meters"}, {"question_id": "260.13", "question": "What is the unit of measurement used for 10-m walking speed?", "answer_src": "[ purpose ] the aim of this study was to determine the threshold for classifying walking independence in stroke patients with and without cognitive disorders . [ subjects ] the subjects were 130 patients with initial stroke hemiplegia . [ methods ] the following factors were analyzed for associations with walking independence : brunnstrom stage , one - leg standing time on the paralytic side , one - leg standing time on the non - paralytic side , and 10-m walking speed .", "follow_up_question": "What factor was not analyzed for associations with walking independence according to the methods section?", "follow_up_response": "No Answer", "follow_up_response_bt": "standing time of a leg on the side of the leg"}, {"question_id": "260.14", "question": "What is the unit of measurement used for 10-m walking speed?", "answer_src": "[ purpose ] the aim of this study was to determine the threshold for classifying walking independence in stroke patients with and without cognitive disorders . [ subjects ] the subjects were 130 patients with initial stroke hemiplegia . [ methods ] the following factors were analyzed for associations with walking independence : brunnstrom stage , one - leg standing time on the paralytic side , one - leg standing time on the non - paralytic side , and 10-m walking speed .", "follow_up_question": "What factor was not analyzed for associations with walking independence according to the methods section?", "follow_up_response": "No Answer", "follow_up_response_bt": "standing time of a leg on the side of the leg"}, {"question_id": "260.15", "question": "What factor was not analyzed for associations with walking independence according to the methods section?", "answer_src": "[ purpose ] the aim of this study was to determine the threshold for classifying walking independence in stroke patients with and without cognitive disorders . [ subjects ] the subjects were 130 patients with initial stroke hemiplegia . [ methods ] the following factors were analyzed for associations with walking independence : brunnstrom stage , one - leg standing time on the paralytic side , one - leg standing time on the non - paralytic side , and 10-m walking speed .", "follow_up_question": "What other factor besides brunnstrom stage, one-leg standing time on the paralytic side, one-leg standing time on the non-paralytic side, and 10-m walking speed was analyzed for associations with walking independence?", "follow_up_response": "No Answer", "follow_up_response_bt": "standing time of a leg on the side of the leg"}]}}
{"id": 261, "src": "viral hepatitis also provides a model to study the nk cell response to both endogenous and exogenous type i interferon ( ifn ) . levels of ifn - stimulated genes increase in both acute and chronic hcv infection and pegylated ifn has been the mainstay of hcv and hbv treatment for decades . in chronic viral hepatitis , nk cells display decreased production of antiviral cytokines .", "mt": "L'epatite virale fornisce anche un modello per studiare la risposta delle NK cellule sia ad interferone endogeno che esogeno di tipo i (ifn) . I livelli di geni stimolati da IFn aumentano sia nell' infezione da HCV acuta che cronica e pegilati sen sono stati il pilastro principale del trattamento da HCV e HbV per decenni .", "pert_mt": "L'epatite virale fornisce anche un modello per studiare la risposta delle NK cellule sia ad interferone endogeno che esogeno di tipo i (ifn). I livelli di geni stimolati da IFn aumentano sia nell'infezione da HCV acuta che cronica e pegilati sono stati il pilastro principale del trattamento da HCV e HbV per decenni, e questo ha influenzato significativamente l'approccio terapeutico nel campo dell'infezione virale.", "bt": "Viral hepatitis also provides a model for studying the response of NK cells to both endogenous and exogenous interferon type i (ifn).The levels of IFn-stimulated genes increase in both acute and chronic HCV infection and pegylates have been the main pillar of treatment for HCV and HbV for decades, and this has significantly influenced the therapeutic approach in the field of viral infection.", "questions_src": ["What is the mainstay of HCV and HBV treatment for decades?", "What type of interferon increases levels of IFN-stimulated genes in both acute and chronic HCV infection?", "Where do NK cells display decreased production of antiviral cytokines in chronic viral hepatitis?", "When has pegylated IFN been used as the mainstay of HCV and HBV treatment?", "Who studies the NK cell response to type I interferon using viral hepatitis as a model?"], "answers_src": ["Pegylated IFN", "Type I interferon", "In chronic viral hepatitis", "Decades ago", "Researchers"], "answers_bt": ["Pegylates", "Type I interferon", "No Answer", "Decades", "Viruses"], "multiturn": {"turn_1": [{"question_id": "261.1", "question": "What is the mainstay of HCV and HBV treatment for decades?", "answer_src": "Pegylated IFN", "follow_up_question": "What specific antiviral cytokines do NK cells display decreased production of in chronic viral hepatitis?", "follow_up_response": "antiviral cytokines", "follow_up_response_bt": "No Answer"}, {"question_id": "261.2", "question": "What type of interferon increases levels of IFN-stimulated genes in both acute and chronic HCV infection?", "answer_src": "Type I interferon", "follow_up_question": "How does the production of antiviral cytokines change in NK cells in chronic viral hepatitis?", "follow_up_response": "Decreased", "follow_up_response_bt": "The levels of IFn-stimulated genes increase"}, {"question_id": "261.3", "question": "Where do NK cells display decreased production of antiviral cytokines in chronic viral hepatitis?", "answer_src": "In chronic viral hepatitis", "follow_up_question": "What specific antiviral cytokines do NK cells produce less of in chronic viral hepatitis?", "follow_up_response": "antiviral cytokines", "follow_up_response_bt": "No Answer"}, {"question_id": "261.4", "question": "When has pegylated IFN been used as the mainstay of HCV and HBV treatment?", "answer_src": "Decades ago", "follow_up_question": "What specific antiviral cytokines do NK cells display decreased production of in chronic viral hepatitis?", "follow_up_response": "antiviral cytokines", "follow_up_response_bt": "No Answer"}, {"question_id": "261.5", "question": "Who studies the NK cell response to type I interferon using viral hepatitis as a model?", "answer_src": "Researchers", "follow_up_question": "What specific types of interferons are studied in this context?", "follow_up_response": "type i interferon", "follow_up_response_bt": "ifn"}], "turn_2": [{"question_id": "261.6", "question": "What specific antiviral cytokines do NK cells display decreased production of in chronic viral hepatitis?", "answer_src": "antiviral cytokines", "follow_up_question": "What types of interferons are known to stimulate the increase in ifn-stimulated genes in both acute and chronic HCV infection?", "follow_up_response": "type i interferon", "follow_up_response_bt": "interferon type i"}, {"question_id": "261.7", "question": "How does the production of antiviral cytokines change in NK cells in chronic viral hepatitis?", "answer_src": "Decreased", "follow_up_question": "What specific antiviral cytokines do NK cells produce less of in chronic viral hepatitis?", "follow_up_response": "antiviral cytokines", "follow_up_response_bt": "No Answer"}, {"question_id": "261.8", "question": "What specific antiviral cytokines do NK cells produce less of in chronic viral hepatitis?", "answer_src": "antiviral cytokines", "follow_up_question": "Which antiviral cytokines do NK cells produce less of specifically in chronic HCV infection?", "follow_up_response": "antiviral cytokines", "follow_up_response_bt": "No Answer"}, {"question_id": "261.9", "question": "What specific antiviral cytokines do NK cells display decreased production of in chronic viral hepatitis?", "answer_src": "antiviral cytokines", "follow_up_question": "What types of interferons are known to stimulate the increase in ifn-stimulated genes in both acute and chronic HCV infection?", "follow_up_response": "type i interferon", "follow_up_response_bt": "interferon type i"}, {"question_id": "261.10", "question": "What specific types of interferons are studied in this context?", "answer_src": "type i interferon", "follow_up_question": "What is the effect of increased ifn-stimulated genes in chronic viral hepatitis?", "follow_up_response": "Levels of IFN-stimulated genes increase", "follow_up_response_bt": "Increase"}], "turn_3": [{"question_id": "261.11", "question": "What types of interferons are known to stimulate the increase in ifn-stimulated genes in both acute and chronic HCV infection?", "answer_src": "type i interferon", "follow_up_question": "What is the effect of increased ifn-stimulated genes on nk cells in chronic viral hepatitis?", "follow_up_response": "Decreased production of antiviral cytokines", "follow_up_response_bt": "Increases"}, {"question_id": "261.12", "question": "What specific antiviral cytokines do NK cells produce less of in chronic viral hepatitis?", "answer_src": "antiviral cytokines", "follow_up_question": "Which antiviral cytokines do NK cells produce less of specifically in chronic HCV infection?", "follow_up_response": "antiviral cytokines", "follow_up_response_bt": "No Answer"}, {"question_id": "261.13", "question": "Which antiviral cytokines do NK cells produce less of specifically in chronic HCV infection?", "answer_src": "antiviral cytokines", "follow_up_question": "What specific antiviral cytokines do NK cells produce less of in chronic HCV infection?", "follow_up_response": "antiviral cytokines", "follow_up_response_bt": "No Answer"}, {"question_id": "261.14", "question": "What types of interferons are known to stimulate the increase in ifn-stimulated genes in both acute and chronic HCV infection?", "answer_src": "type i interferon", "follow_up_question": "What is the effect of increased ifn-stimulated genes on nk cells in chronic viral hepatitis?", "follow_up_response": "Decreased production of antiviral cytokines", "follow_up_response_bt": "Increases"}, {"question_id": "261.15", "question": "What is the effect of increased ifn-stimulated genes in chronic viral hepatitis?", "answer_src": "Levels of IFN-stimulated genes increase", "follow_up_question": "How does this affect NK cell function in chronic viral hepatitis?", "follow_up_response": "NK cells display decreased production of antiviral cytokines", "follow_up_response_bt": "The levels of IFn-stimulated genes increase"}]}}
{"id": 262, "src": "blood neutrophil to lymphocyte ratio ( nlr ) and mean platelet volume ( mpv ) both have been used as a simple marker of inflammation in many disorders . here , we aimed to investigate the relationship between nlr , mpv , and familial mediterranean fever ( fmf).in this retrospective study , the files of fmf patients in pediatric rheumatology outpatient clinic were reviewed . there were 160 participants ( 68.4% ) in the fmf patient group and 74 participants ( 31.6% ) in the control group .", "mt": "Il rapporto neutrofili-linfociti (nlr) e il volume medio di piastrine (mpv) sono stati entrambi usati come semplice marcatore di infiammazione nel sangue in molti disturbi . Qui , abbiamo cercato di indagare sulla relazione tra nlr , mpv e febbre mediterranea familiare (fmf).In questo studio retrospettivo , i file dei pazienti fmf in ambulatoriale di reumatologia pediatrica sono stati esaminati . C'erano 160 partecipanti (68,4%) nel gruppo dei pazienti fmf e 74 partecipanti ( 31,6%) nel gruppo di controllo .", "pert_mt": "Il rapporto neutrofili-linfociti (nlr) e il volume medio di piastrine (mpv) sono stati entrambi usati come semplice marcatore di infiammazione nel sangue in molti disturbi. Qui, abbiamo cercato di indagare sulla relazione tra nlr, mpv e febbre mediterranea familiare (fmf). In questo studio retrospettivo, i file dei pazienti fmf in ambulatoriale di reumatologia pediatrica sono stati esaminati. C'erano 160 partecipanti (68,4%) nel gruppo dei pazienti fmf e 74 partecipanti (31,6%) nel gruppo di controllo. Ecco risultati interessanti che potrebbero indicare una correlazione significativa.", "bt": "Neutrophil-lymphocyte (nlr) and mean volume of platelets (mpv) have both been used as a simple marker of inflammation in the blood in many disorders.There, we sought to investigate the relationship between nlr, mpv and familial Mediterranean fever (fmf).In this retrospective study, the files of fmf patients in pediatric rheumatology were examined.There were 160 participants (68.4%) in the fmf patient group and 74 participants (31.6%) in the control group.Here are interesting findings that could indicate a significant correlation.", "questions_src": ["What is the name of the simple marker of inflammation studied in this research?", "Who are the participants in the control group?", "Where was the data for the study collected?", "When did the study involve reviewing patient files?", "Which disorder is being investigated in relation to NLR and MPV?"], "answers_src": ["blood neutrophil to lymphocyte ratio ( nlr ) and mean platelet volume ( mpv )", "74 participants ( 31.6% ) in the control group", "in pediatric rheumatology outpatient clinic", "retrospectively", "familial mediterranean fever ( fmf)"], "answers_bt": ["Neutrophil-lymphocyte (nlr) and mean volume of platelets (mpv)", "74 participants (31.6%)", "In the files of fmf patients in pediatric rheumatology", "Retrospectively", "Familial Mediterranean fever (FMF)"], "multiturn": {"turn_1": [{"question_id": "262.1", "question": "What is the name of the simple marker of inflammation studied in this research?", "answer_src": "blood neutrophil to lymphocyte ratio ( nlr ) and mean platelet volume ( mpv )", "follow_up_question": "What percentage of the fmf patient group had a blood neutrophil to lymphocyte ratio (nlr) measurement?", "follow_up_response": "68.4%", "follow_up_response_bt": "68.4%"}, {"question_id": "262.2", "question": "Who are the participants in the control group?", "answer_src": "74 participants ( 31.6% ) in the control group", "follow_up_question": "What is the percentage of FTM patients in the study?", "follow_up_response": "68.4%", "follow_up_response_bt": "68.4%"}, {"question_id": "262.3", "question": "Where was the data for the study collected?", "answer_src": "in pediatric rheumatology outpatient clinic", "follow_up_question": "What was the ratio of FMC patients to controls in the study?", "follow_up_response": "1.6", "follow_up_response_bt": "2.15"}, {"question_id": "262.4", "question": "When did the study involve reviewing patient files?", "answer_src": "retrospectively", "follow_up_question": "What was the ratio of FMC patients to controls in the study?", "follow_up_response": "1.6", "follow_up_response_bt": "2.15"}, {"question_id": "262.5", "question": "Which disorder is being investigated in relation to NLR and MPV?", "answer_src": "familial mediterranean fever ( fmf)", "follow_up_question": "What is the ratio of FFMF patients to controls in the study?", "follow_up_response": "1.6", "follow_up_response_bt": "2.15"}], "turn_2": [{"question_id": "262.6", "question": "What percentage of the fmf patient group had a blood neutrophil to lymphocyte ratio (nlr) measurement?", "answer_src": "68.4%", "follow_up_question": "What was the average mean platelet volume (mpv) measured in the fmf patient group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "262.7", "question": "What is the percentage of FTM patients in the study?", "answer_src": "68.4%", "follow_up_question": "What is the percentage of controls in the study?", "follow_up_response": "31.6%", "follow_up_response_bt": "31.6%"}, {"question_id": "262.8", "question": "What was the ratio of FMC patients to controls in the study?", "answer_src": "1.6", "follow_up_question": "What was the average age of the FMC patients in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "262.9", "question": "What was the ratio of FMC patients to controls in the study?", "answer_src": "1.6", "follow_up_question": "What was the average age of the FMC patients in the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "262.10", "question": "What is the ratio of FFMF patients to controls in the study?", "answer_src": "1.6", "follow_up_question": "What is the percentage of FFMF patients in the study?", "follow_up_response": "68.4%", "follow_up_response_bt": "68.4%"}], "turn_3": [{"question_id": "262.11", "question": "What was the average mean platelet volume (mpv) measured in the fmf patient group?", "answer_src": "blood neutrophil to lymphocyte ratio ( nlr ) and mean platelet volume ( mpv ) both have been used as a simple marker of inflammation in many disorders . here , we aimed to investigate the relationship between nlr , mpv , and familial mediterranean fever ( fmf).in this retrospective study , the files of fmf patients in pediatric rheumatology outpatient clinic were reviewed . there were 160 participants ( 68.4% ) in the fmf patient group and 74 participants ( 31.6% ) in the control group .", "follow_up_question": "What percentage of the fmf patient group had an mpv measurement?", "follow_up_response": "31.6%", "follow_up_response_bt": "31.6%"}, {"question_id": "262.12", "question": "What is the percentage of controls in the study?", "answer_src": "31.6%", "follow_up_question": "What is the total number of participants in the study?", "follow_up_response": "160", "follow_up_response_bt": "334"}, {"question_id": "262.13", "question": "What was the average age of the FMC patients in the study?", "answer_src": "blood neutrophil to lymphocyte ratio ( nlr ) and mean platelet volume ( mpv ) both have been used as a simple marker of inflammation in many disorders . here , we aimed to investigate the relationship between nlr , mpv , and familial mediterranean fever ( fmf).in this retrospective study , the files of fmf patients in pediatric rheumatology outpatient clinic were reviewed . there were 160 participants ( 68.4% ) in the fmf patient group and 74 participants ( 31.6% ) in the control group .", "follow_up_question": "What percentage of the FMC patients were included in the study?", "follow_up_response": "68.4%", "follow_up_response_bt": "68.4%"}, {"question_id": "262.14", "question": "What was the average age of the FMC patients in the study?", "answer_src": "blood neutrophil to lymphocyte ratio ( nlr ) and mean platelet volume ( mpv ) both have been used as a simple marker of inflammation in many disorders . here , we aimed to investigate the relationship between nlr , mpv , and familial mediterranean fever ( fmf).in this retrospective study , the files of fmf patients in pediatric rheumatology outpatient clinic were reviewed . there were 160 participants ( 68.4% ) in the fmf patient group and 74 participants ( 31.6% ) in the control group .", "follow_up_question": "What percentage of the FMC patients were included in the study?", "follow_up_response": "68.4%", "follow_up_response_bt": "68.4%"}, {"question_id": "262.15", "question": "What is the percentage of FFMF patients in the study?", "answer_src": "68.4%", "follow_up_question": "What is the percentage of control group participants?", "follow_up_response": "31.6%", "follow_up_response_bt": "31.6%"}]}}
{"id": 263, "src": "we found common features in the patterns of this generic decamer on mif profiles among primate species , and interestingly we found conspicuous but dissimilar mif profiles for each archaea tested . the overall mif profiles for each chromosome in each primate species also follow a similar pattern . trifonov 's generic decamer may be a highly conserved motif for the nucleosome positioning , but we argue that this is not the only motif .", "mt": "Abbiamo trovato caratteristiche comuni nei modelli di questo decamero generico sui profili di mif tra le specie di primati , e curiosamente abbiamo trovato profili di mif visibili ma diversi per ogni archea testata . I profili di mif complessivi per ogni cromosoma in ogni specie di primati seguono anche un modello simile . Il decamero generico di trifonov può essere un motivo altamente conservato per il posizionamento del nucleosoma , ma sosteniamo che questo non sia l'unico motivo .", "pert_mt": "Abbiamo trovato caratteristiche comuni nei modelli di questo decamero generico sui profili di mif tra le specie di primati, e curiosamente abbiamo trovato profili di mif visibili ma diversi per ogni archea testata. I profili di mif complessivi per ogni cromosoma in ogni specie di primati seguono anche un modello simile. Il decamero generico di trifonov può essere un motivo altamente conservato per il posizionamento del nucleosoma, ma sosteniamo che questo non sia l'unico motivo e possa variare in funzione delle specifiche condizioni genetiche.", "bt": "We found common features in the models of this generic decamer on mycophonous profiles between primate species, and curiously we found visible but diverse mycophonous profiles for each testate archaea.The overall mycophonous profiles for each chromosome in each primate species also follow a similar model.The trifonov generic decamer may be a highly conservative motif for the nucleosome positioning, but we hold that this is not the only motif and may vary depending on specific genetic conditions.", "questions_src": ["What is the name of the person mentioned in the sentence?", "When did you find common features in the patterns of the generic decamer on MIF profiles?", "Where were the MIF profiles found to be both similar and different across primate species?", "Which motif does the sentence suggest may be highly conserved for nucleosome positioning?", "Which other factor besides the generic decamer does the sentence mention could influence MIF profiles?"], "answers_src": ["[\"Trifonov\"], [\"No Answer\"], [\"Among primate species\"], [\"Generic decamer\"], [\"Other motifs\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"We\"], [\"No Answer\"], [\"mycophonous profiles\"], [\"trifonov generic decamer\"], [\"specific genetic conditions\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "263.1", "question": "What is the name of the person mentioned in the sentence?", "answer_src": "[\"Trifonov\"], [\"No Answer\"], [\"Among primate species\"], [\"Generic decamer\"], [\"Other motifs\"]", "follow_up_question": "What does the author suggest is not the only motif for nucleosome positioning?", "follow_up_response": "generic decamer", "follow_up_response_bt": "trifonov generic decamer"}, {"question_id": "263.2", "question": "When did you find common features in the patterns of the generic decamer on MIF profiles?", "answer_src": "we found common features in the patterns of this generic decamer on mif profiles among primate species , and interestingly we found conspicuous but dissimilar mif profiles for each archaea tested . the overall mif profiles for each chromosome in each primate species also follow a similar pattern . trifonov 's generic decamer may be a highly conserved motif for the nucleosome positioning , but we argue that this is not the only motif .", "follow_up_question": "What other type of organisms did you find dissimilar MIF profiles for?", "follow_up_response": "archaea", "follow_up_response_bt": "testate archaea"}, {"question_id": "263.3", "question": "Where were the MIF profiles found to be both similar and different across primate species?", "answer_src": "we found common features in the patterns of this generic decamer on mif profiles among primate species , and interestingly we found conspicuous but dissimilar mif profiles for each archaea tested . the overall mif profiles for each chromosome in each primate species also follow a similar pattern . trifonov 's generic decamer may be a highly conserved motif for the nucleosome positioning , but we argue that this is not the only motif .", "follow_up_question": "What specific feature of the MIF profiles was found to be highly conserved according to the text?", "follow_up_response": "the generic decamer", "follow_up_response_bt": "The trifonov generic decamer"}, {"question_id": "263.4", "question": "Which motif does the sentence suggest may be highly conserved for nucleosome positioning?", "answer_src": "we found common features in the patterns of this generic decamer on mif profiles among primate species , and interestingly we found conspicuous but dissimilar mif profiles for each archaea tested . the overall mif profiles for each chromosome in each primate species also follow a similar pattern . trifonov 's generic decamer may be a highly conserved motif for the nucleosome positioning , but we argue that this is not the only motif .", "follow_up_question": "What other motif does the text suggest might be involved in nucleosome positioning besides Trifonov's generic decamer?", "follow_up_response": "Trifonov's generic decamer", "follow_up_response_bt": "Trifonov's generic decamer"}, {"question_id": "263.5", "question": "Which other factor besides the generic decamer does the sentence mention could influence MIF profiles?", "answer_src": "we found common features in the patterns of this generic decamer on mif profiles among primate species , and interestingly we found conspicuous but dissimilar mif profiles for each archaea tested . the overall mif profiles for each chromosome in each primate species also follow a similar pattern . trifonov 's generic decamer may be a highly conserved motif for the nucleosome positioning , but we argue that this is not the only motif .", "follow_up_question": "What other type of organisms besides primates and archaea did the study find similar MIF profiles for?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "263.6", "question": "What does the author suggest is not the only motif for nucleosome positioning?", "answer_src": "generic decamer", "follow_up_question": "What other motifs might be involved according to the author?", "follow_up_response": "nucleosome positioning", "follow_up_response_bt": "trifonov generic decamer"}, {"question_id": "263.7", "question": "What other type of organisms did you find dissimilar MIF profiles for?", "answer_src": "archaea", "follow_up_question": "What specific characteristics were the MIF profiles for the archaea tested?", "follow_up_response": "conspicuous but dissimilar", "follow_up_response_bt": "visible but diverse"}, {"question_id": "263.8", "question": "What specific feature of the MIF profiles was found to be highly conserved according to the text?", "answer_src": "the generic decamer", "follow_up_question": "What other type of organism's MIF profiles were found to have dissimilar patterns?", "follow_up_response": "archaea", "follow_up_response_bt": "testate archaea"}, {"question_id": "263.9", "question": "What other motif does the text suggest might be involved in nucleosome positioning besides Trifonov's generic decamer?", "answer_src": "Trifonov's generic decamer", "follow_up_question": "What evidence does the text provide against Trifonov's generic decamer being the sole motif for nucleosome positioning?", "follow_up_response": "we argue that this is not the only motif", "follow_up_response_bt": "we hold that this is not the only motif and may vary depending on specific genetic conditions"}, {"question_id": "263.10", "question": "What other type of organisms besides primates and archaea did the study find similar MIF profiles for?", "answer_src": "we found common features in the patterns of this generic decamer on mif profiles among primate species , and interestingly we found conspicuous but dissimilar mif profiles for each archaea tested . the overall mif profiles for each chromosome in each primate species also follow a similar pattern . trifonov 's generic decamer may be a highly conserved motif for the nucleosome positioning , but we argue that this is not the only motif .", "follow_up_question": "What evidence does the text provide against trifonov's generic decamer being the only motif for nucleosome positioning?", "follow_up_response": "we argue that this is not the only motif", "follow_up_response_bt": "we hold that this is not the only motif and may vary depending on specific genetic conditions"}], "turn_3": [{"question_id": "263.11", "question": "What other motifs might be involved according to the author?", "answer_src": "nucleosome positioning", "follow_up_question": "What evidence supports the argument that nucleosome positioning is not the only motif?", "follow_up_response": "Trifonov's generic decamer may be a highly conserved motif for the nucleosome positioning, but we argue that this is not the only motif.", "follow_up_response_bt": "The trifonov generic decamer may be a highly conservative motif for the nucleosome positioning, but we hold that this is not the only motif and may vary depending on specific genetic conditions."}, {"question_id": "263.12", "question": "What specific characteristics were the MIF profiles for the archaea tested?", "answer_src": "conspicuous but dissimilar", "follow_up_question": "What does \"conspicuous but dissimilar\" imply about the MIF profiles for the archaea tested?", "follow_up_response": "The MIF profiles for each archaea tested are noticeable and different from each other.", "follow_up_response_bt": "The MIF profiles for the tested archaea are visible but diverse"}, {"question_id": "263.13", "question": "What other type of organism's MIF profiles were found to have dissimilar patterns?", "answer_src": "archaea", "follow_up_question": "What specific archaea were tested and why did their MIF profiles differ?", "follow_up_response": "each archaea tested\", \"interestingly they found conspicuous but dissimilar MIF profiles for each archaea tested", "follow_up_response_bt": "testate archaea\", \"No Answer"}, {"question_id": "263.14", "question": "What evidence does the text provide against Trifonov's generic decamer being the sole motif for nucleosome positioning?", "answer_src": "we argue that this is not the only motif", "follow_up_question": "What other motifs does the text suggest might be involved in nucleosome positioning besides Trifonov's generic decamer?", "follow_up_response": "Trifonov's generic decamer", "follow_up_response_bt": "Trifonov's generic decamer"}, {"question_id": "263.15", "question": "What evidence does the text provide against trifonov's generic decamer being the only motif for nucleosome positioning?", "answer_src": "we argue that this is not the only motif", "follow_up_question": "What other evidence besides trifonov's generic decamer does the text suggest for nucleosome positioning?", "follow_up_response": "the only motif", "follow_up_response_bt": "the nucleosome positioning may vary depending on specific genetic conditions"}]}}
{"id": 264, "src": "the short half - life property , inherent to rna , benefits cells that do not need to express their entire repertoire of proteins . the cellular machinery turns off the production of a given protein by shutting down the transcription of its cognate coding gene and by either actively degrading the remaining mrna or allowing it to decay on its own . the steady - state level of each mrna in a given cell varies continuously and is specified by changing kinetics of synthesis and degradation .", "mt": "La proprietà di mezza vita breve , inerente al rna , beneficia le cellule che non hanno bisogno di esprimere l'intero loro repertorio di proteine . il meccanismo cellulare spegne la produzione di una determinata proteina chiudendo la trascrizione del suo gene di codifica cognato e degradando attivamente il resto del mrna o permettendogli di decadere da solo . Il livello di stato stabile di ogni mrna in una determinata cellula varia continuamente e viene specificato cambiando la cinetica della sintesi e della degradazione .", "pert_mt": "La proprietà di mezza vita breve, inerente al rna, beneficia le cellule che non hanno bisogno di esprimere l'intero loro repertorio di proteine. Il meccanismo cellulare spegne la produzione di una determinata proteina chiudendo la trascrizione del suo gene di codifica cognato e degradando attivamente il resto del mrna o permettendogli di decadere da solo. Il livello di stato stabile di ogni mrna in una determinata cellula varia continuamente e viene specificato cambiando la cinetica della sintesi e della degradazione, influenzando così l'attività delle proteine espressi.", "bt": "The short half-life property inherent in RNA benefits cells that do not need to express their entire protein repertoire, and the cellular mechanism mirrors the production of a particular protein by shutting down the transcription of its cognate coding gene and actively degrading the rest of the RNA or allowing it to decay on its own.The stable state level of each RNA in a particular cell varies continuously and is specified by changing the kinetics of synthesis and degradation, thus influencing the activity of the expressed proteins.", "questions_src": ["What does RNA have that benefits cells?", "Who turns off the production of a given protein?", "Where is the steady-state level of mRNA specified?", "When does the cellular machinery shut down transcription?", "Which process involves synthesizing and degrading mRNA?"], "answers_src": ["the short half-life property", "the cellular machinery", "changing kinetics of synthesis and degradation", "by shutting down the transcription of its cognate coding gene", "shutting down the transcription of its cognate coding gene and by either actively degrading the remaining mrna or allowing it to decay on its own"], "answers_bt": ["The short half-life property", "The cellular machinery", "Changing the kinetics of synthesis and degradation", "Not specified", "Synthesizing and degrading mRNA"], "multiturn": {"turn_1": [{"question_id": "264.1", "question": "What does RNA have that benefits cells?", "answer_src": "the short half-life property", "follow_up_question": "How does RNA's short half-life benefit cells?", "follow_up_response": "Cells that do not need to express their entire repertoire of proteins", "follow_up_response_bt": "Cells that do not need to express their entire protein repertoire"}, {"question_id": "264.2", "question": "Who turns off the production of a given protein?", "answer_src": "the cellular machinery", "follow_up_question": "What mechanism does the cellular machinery use to shut down the transcription of a cognate coding gene?", "follow_up_response": "By shutting down the transcription of its cognate coding gene", "follow_up_response_bt": "The cellular mechanism mirrors the production of a particular protein by shutting down the transcription of its cognate coding gene and actively degrading the rest of the RNA or allowing it to decay on its own."}, {"question_id": "264.3", "question": "Where is the steady-state level of mRNA specified?", "answer_src": "changing kinetics of synthesis and degradation", "follow_up_question": "What factors change the kinetics of synthesis and degradation?", "follow_up_response": "Changing kinetics", "follow_up_response_bt": "Changing the kinetics of synthesis and degradation"}, {"question_id": "264.4", "question": "When does the cellular machinery shut down transcription?", "answer_src": "by shutting down the transcription of its cognate coding gene", "follow_up_question": "What mechanism does the cellular machinery use to degrade remaining mRNA?", "follow_up_response": "allowing it to decay on its own", "follow_up_response_bt": "actively degrading the rest of the RNA or allowing it to decay on its own"}, {"question_id": "264.5", "question": "Which process involves synthesizing and degrading mRNA?", "answer_src": "shutting down the transcription of its cognate coding gene and by either actively degrading the remaining mrna or allowing it to decay on its own", "follow_up_question": "What mechanism does the text describe for allowing mrna to decay on its own?", "follow_up_response": "allowing it to decay on its own", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "264.6", "question": "How does RNA's short half-life benefit cells?", "answer_src": "Cells that do not need to express their entire repertoire of proteins", "follow_up_question": "What mechanism do cells use to turn off the production of a specific protein?", "follow_up_response": "by shutting down the transcription of its cognate coding gene and by either actively degrading the remaining mrna or allowing it to decay on its own", "follow_up_response_bt": "shutting down the transcription of its cognate coding gene"}, {"question_id": "264.7", "question": "What mechanism does the cellular machinery use to shut down the transcription of a cognate coding gene?", "answer_src": "By shutting down the transcription of its cognate coding gene", "follow_up_question": "How does the cellular machinery ensure the active degradation of remaining mRNA?", "follow_up_response": "By actively degrading the remaining mRNA", "follow_up_response_bt": "The cellular mechanism mirrors the production of a particular protein by shutting down the transcription of its cognate coding gene and actively degrading the rest of the RNA or allowing it to decay on its own."}, {"question_id": "264.8", "question": "What factors change the kinetics of synthesis and degradation?", "answer_src": "Changing kinetics", "follow_up_question": "What specific mechanisms determine the changing kinetics of synthesis and degradation?", "follow_up_response": "No Answer", "follow_up_response_bt": "Changing the kinetics of synthesis and degradation"}, {"question_id": "264.9", "question": "What mechanism does the cellular machinery use to degrade remaining mRNA?", "answer_src": "allowing it to decay on its own", "follow_up_question": "What happens to the remaining mRNA if the cellular machinery does not allow it to decay?", "follow_up_response": "the cellular machinery allows it to decay on its own", "follow_up_response_bt": "The remaining mRNA is allowed to decay on its own"}, {"question_id": "264.10", "question": "What mechanism does the text describe for allowing mrna to decay on its own?", "answer_src": "allowing it to decay on its own", "follow_up_question": "What factors specify the steady-state level of each mrna in a given cell?", "follow_up_response": "changing kinetics of synthesis and degradation", "follow_up_response_bt": "Changing the kinetics of synthesis and degradation"}], "turn_3": [{"question_id": "264.11", "question": "What mechanism do cells use to turn off the production of a specific protein?", "answer_src": "by shutting down the transcription of its cognate coding gene and by either actively degrading the remaining mrna or allowing it to decay on its own", "follow_up_question": "What happens to the remaining mRNA if the cell does not degrade it?", "follow_up_response": "It allows it to decay on its own", "follow_up_response_bt": "It allows it to decay on its own"}, {"question_id": "264.12", "question": "How does the cellular machinery ensure the active degradation of remaining mRNA?", "answer_src": "By actively degrading the remaining mRNA", "follow_up_question": "What mechanism does the cellular machinery use to allow mRNA to decay on its own?", "follow_up_response": "allowing it to decay on its own", "follow_up_response_bt": "No Answer"}, {"question_id": "264.13", "question": "What specific mechanisms determine the changing kinetics of synthesis and degradation?", "answer_src": "the short half - life property , inherent to rna , benefits cells that do not need to express their entire repertoire of proteins . the cellular machinery turns off the production of a given protein by shutting down the transcription of its cognate coding gene and by either actively degrading the remaining mrna or allowing it to decay on its own . the steady - state level of each mrna in a given cell varies continuously and is specified by changing kinetics of synthesis and degradation .", "follow_up_question": "What factors contribute to the varying steady-state level of each mRNA in a given cell?", "follow_up_response": "changing kinetics of synthesis and degradation", "follow_up_response_bt": "Changing the kinetics of synthesis and degradation"}, {"question_id": "264.14", "question": "What happens to the remaining mRNA if the cellular machinery does not allow it to decay?", "answer_src": "the cellular machinery allows it to decay on its own", "follow_up_question": "What mechanism does the cellular machinery use to degrade the remaining mRNA?", "follow_up_response": "allowing it to decay on its own", "follow_up_response_bt": "actively degrading the rest of the RNA or allowing it to decay on its own."}, {"question_id": "264.15", "question": "What factors specify the steady-state level of each mrna in a given cell?", "answer_src": "changing kinetics of synthesis and degradation", "follow_up_question": "How does the cellular machinery ensure the proper regulation of mrna levels?", "follow_up_response": "By turning off the production of a given protein by shutting down the transcription of its cognate coding gene and by either actively degrading the remaining mRNA or allowing it to decay on its own.", "follow_up_response_bt": "By changing the kinetics of synthesis and degradation"}]}}
{"id": 265, "src": "autosomal - recessive renal tubular dysgenesis ( ar - rtd ) is a rare disorder caused by a genetic defect in the renin angiotensin system . although ar - rtd has typically been known as a lethal disease due to refractory hypotension and renal failure immediately after birth , few cases have reported survival of the neonatal period . we report here an additional case of ar - rtd , who had novel ace mutations and survived over 2 years and provide a review of the five previously reported surviving cases .", "mt": "L'autosomal - recessive renal tubular dysgenesis (ar - rtd) è un raro disturbo causato da un difetto genetico del sistema angiotensino-reninico . anche se ar - rtd è stato tipicamente conosciuto come una malattia letale a causa di ipotensione refrattoria e insufficienza renale immediatamente dopo la nascita , pochi casi hanno riportato sopravvivenza nel periodo neonatale . segnaliamo qui un caso aggiuntivo di ar - rtd , che ha avuto mutazioni di novella ace e sopravvissuto oltre 2 anni e fornisce una revisione dei cinque casi sopravvissuti precedentemente segnalati .", "pert_mt": "L'autosomal - recessive renal tubular dysgenesis (ar - rtd) è un raro disturbo causato da un difetto genetico del sistema angiotensino-reninico. Anche se ar - rtd è stato tipicamente conosciuto come una malattia letale a causa di ipotensione refrattoria e insufficienza renale immediatamente dopo la nascita, pochi casi hanno riportato sopravvivenza nel periodo neonatale. Segnaliamo qui un caso aggiuntivo di ar - rtd, che ha avuto mutazioni di novella ace e sopravvissuto oltre 2 anni, e forniamo una revisione dei cinque casi sopravvissuti precedentemente segnalati.", "bt": "Autosomal recessive renal tubular dysgenesis (ar - rtd) is a rare disorder caused by a genetic defect of the angiotensino-renin system.Although ar - rtd has typically been known as a fatal disease due to refractory hypotension and renal failure immediately after birth, few cases have reported survival in the neonatal period.Secondly, an additional case of ar - rtd, which has had mutations in the novella ace and survived over 2 years, provides a review of the five surviving cases previously reported.", "questions_src": ["What is the name of the genetic disorder described in the sentence?", "Who causes autosomal recessive renal tubular dysgenesis?", "Where can genetic defects related to AR-RTD be found?", "When does AR-RTD typically become fatal?", "Which enzyme's mutations have been reported in some cases of AR-RTD?"], "answers_src": ["autosomal - recessive renal tubular dysgenesis (ar - rtd)", "a genetic defect in the renin angiotensin system", "the renin angiotensin system", "immediately after birth", "ACE"], "answers_bt": ["Autosomal recessive renal tubular dysgenesis (ar - rtd)", "a genetic defect of the angiotensino-renin system", "the angiotensino-renin system", "immediately after birth", "ace"], "multiturn": {"turn_1": [{"question_id": "265.1", "question": "What is the name of the genetic disorder described in the sentence?", "answer_src": "autosomal - recessive renal tubular dysgenesis (ar - rtd)", "follow_up_question": "What specific genetic defect causes this disorder?", "follow_up_response": "a genetic defect in the renin angiotensin system", "follow_up_response_bt": "a genetic defect of the angiotensino-renin system"}, {"question_id": "265.2", "question": "Who causes autosomal recessive renal tubular dysgenesis?", "answer_src": "a genetic defect in the renin angiotensin system", "follow_up_question": "What specific mutations were found in the ACE gene in this case?", "follow_up_response": "novel ace mutations", "follow_up_response_bt": "No Answer"}, {"question_id": "265.3", "question": "Where can genetic defects related to AR-RTD be found?", "answer_src": "the renin angiotensin system", "follow_up_question": "What specific mutations were found in the ACE gene in this case?", "follow_up_response": "novel ace mutations", "follow_up_response_bt": "No Answer"}, {"question_id": "265.4", "question": "When does AR-RTD typically become fatal?", "answer_src": "immediately after birth", "follow_up_question": "How long did the reported case survive?", "follow_up_response": "over 2 years", "follow_up_response_bt": "over 2 years"}, {"question_id": "265.5", "question": "Which enzyme's mutations have been reported in some cases of AR-RTD?", "answer_src": "ACE", "follow_up_question": "What specific mutations were found in the ACE gene in this case?", "follow_up_response": "novel ace mutations", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "265.6", "question": "What specific genetic defect causes this disorder?", "answer_src": "a genetic defect in the renin angiotensin system", "follow_up_question": "What novel ACE mutations were found in the case that survived over 2 years?", "follow_up_response": "novel ace mutations", "follow_up_response_bt": "novella ace"}, {"question_id": "265.7", "question": "What specific mutations were found in the ACE gene in this case?", "answer_src": "novel ace mutations", "follow_up_question": "What was the outcome of this patient who survived over 2 years?", "follow_up_response": "Survived over 2 years", "follow_up_response_bt": "Survived over 2 years"}, {"question_id": "265.8", "question": "What specific mutations were found in the ACE gene in this case?", "answer_src": "novel ace mutations", "follow_up_question": "What was the outcome of this patient who survived over 2 years?", "follow_up_response": "Survived over 2 years", "follow_up_response_bt": "Survived over 2 years"}, {"question_id": "265.9", "question": "How long did the reported case survive?", "answer_src": "over 2 years", "follow_up_question": "What specific ACE mutations were identified in this case?", "follow_up_response": "novel ace mutations", "follow_up_response_bt": "novella ace"}, {"question_id": "265.10", "question": "What specific mutations were found in the ACE gene in this case?", "answer_src": "novel ace mutations", "follow_up_question": "What was the outcome of this patient who survived over 2 years?", "follow_up_response": "Survived over 2 years", "follow_up_response_bt": "Survived over 2 years"}], "turn_3": [{"question_id": "265.11", "question": "What novel ACE mutations were found in the case that survived over 2 years?", "answer_src": "novel ace mutations", "follow_up_question": "What specific symptoms did this case with novel ACE mutations exhibit that allowed for survival over 2 years?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "265.12", "question": "What was the outcome of this patient who survived over 2 years?", "answer_src": "Survived over 2 years", "follow_up_question": "What specific genetic mutation did this patient have that allowed for survival?", "follow_up_response": "ace mutations", "follow_up_response_bt": "novella ace"}, {"question_id": "265.13", "question": "What was the outcome of this patient who survived over 2 years?", "answer_src": "Survived over 2 years", "follow_up_question": "What specific genetic mutation did this patient have that allowed for survival?", "follow_up_response": "ace mutations", "follow_up_response_bt": "novella ace"}, {"question_id": "265.14", "question": "What specific ACE mutations were identified in this case?", "answer_src": "novel ace mutations", "follow_up_question": "What was the outcome of this patient who survived over 2 years?", "follow_up_response": "Survived over 2 years", "follow_up_response_bt": "Survived over 2 years"}, {"question_id": "265.15", "question": "What was the outcome of this patient who survived over 2 years?", "answer_src": "Survived over 2 years", "follow_up_question": "What specific genetic mutation did this patient have that allowed for survival?", "follow_up_response": "ace mutations", "follow_up_response_bt": "novella ace"}]}}
{"id": 266, "src": "this review is a a series of the authors ' studies designed to test the hypothesis that administration of trichloroethylene ( tce ) , dichloroethylene ( dce ) , their metabolites , and related compounds are responsible for fetal cardiac teratogenesis when given to pregnant rats during organogenesis . identification of teratogenic compounds will allow more accurate assessment of environmental contaminants and public health risks . epidemiologic studies and previous teratogenic studies using chick embryos and fetal rats have reported an increased number of congenital cardiac defects when exposed to tce or dce during fetal development .", "mt": "Questa revisione è una serie di studi condotti dagli autori per testare l'ipotesi che l' somministrazione di tricloroetilene (tce), di dichloroetilene (dce), dei loro metaboliti e composti correlati siano responsabili della teratogenesi cardiaca fetale quando somministrata a topi incinti durante l'organogenesi . L'identificazione dei composti teratogeni consentirà una valutazione più accurata dei contaminanti ambientali e dei rischi per la salute pubblica . Studi epidemiologici e precedenti studi teratogenici che hanno utilizzato embrioni di polli e topi fetali hanno riportato un aumento del numero di difetti cardiaci congeniti quando esposti a tce o dce durante lo sviluppo fetale .", "pert_mt": "Questa revisione è una serie di studi condotti dagli autori per testare l'ipotesi che l' somministrazione di tricloroetilene (tce), di dichloroetilene (dce), dei loro metaboliti e composti correlati siano responsabili della teratogenesi cardiaca fetale quando somministrata a topi incinti durante l'organogenesi . L'identificazione dei composti teratogeni consentirà una valutazione più accurata dei contaminanti ambientali e dei rischi per la salute pubblica . Studi epidemiologici e precedenti studi teratogenici che hanno utilizzato embrioni di polli e topi fetali hanno riportato un aumento del numero di difetti cardiaci congeniti quando esposti a tce o dce durante lo sviluppo fetale . Inoltre, questi compost", "bt": "The review is a series of studies conducted by the authors to test the hypothesis that the administration of trichloroethylene (tce), dichlorohethylene (dce), their metabolites and related compounds are responsible for fetal cardiac teratogenesis when administered to incised mice during organogenesis . The identification of teratogenic compounds allows a more accurate assessment of environmental contaminants and public health risks .", "questions_src": ["What is the primary hypothesis being tested in the studies mentioned? ", "Who were the authors of the studies described? ", "Where was the research conducted, specifically with regards to the animal models? ", "When did the researchers administer trichloroethylene and dichloroethylene to the pregnant rats? ", "Which specific congenital cardiac defects were observed in the study? "], "answers_src": ["Administration of trichloroethylene (tce), dichloroethylene (dce), their metabolites, and related compounds are responsible for fetal cardiac teratogenesis when given to pregnant rats during organogenesis", "the authors", "fetal rats", "during fetal development", "an increased number of congenital cardiac defects"], "answers_bt": ["The administration of trichloroethylene (tce), dichlorohethylene (dce), their metabolites and related compounds are responsible for fetal cardiac teratogenesis when administered to incised mice during organogenesis", "The authors", "Incised mice", "During organogenesis", "No Answer"], "multiturn": {"turn_1": [{"question_id": "266.1", "question": "What is the primary hypothesis being tested in the studies mentioned? ", "answer_src": "Administration of trichloroethylene (tce), dichloroethylene (dce), their metabolites, and related compounds are responsible for fetal cardiac teratogenesis when given to pregnant rats during organogenesis", "follow_up_question": "What specific fetal cardiac defects were reported in the previous teratogenic studies using fetal rats?", "follow_up_response": "an increased number of congenital cardiac defects", "follow_up_response_bt": "No Answer"}, {"question_id": "266.2", "question": "Who were the authors of the studies described? ", "answer_src": "the authors", "follow_up_question": "What specific types of congenital cardiac defects were observed in the studies involving fetal rats?", "follow_up_response": "an increased number of congenital cardiac defects", "follow_up_response_bt": "No Answer"}, {"question_id": "266.3", "question": "Where was the research conducted, specifically with regards to the animal models? ", "answer_src": "fetal rats", "follow_up_question": "What specific congenital cardiac defects were observed in the fetal rats exposed to tce or dce?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "266.4", "question": "When did the researchers administer trichloroethylene and dichloroethylene to the pregnant rats? ", "answer_src": "during fetal development", "follow_up_question": "What specific types of congenital cardiac defects were observed in the previous studies using chick embryos and fetal rats?", "follow_up_response": "an increased number of congenital cardiac defects", "follow_up_response_bt": "No Answer"}, {"question_id": "266.5", "question": "Which specific congenital cardiac defects were observed in the study? ", "answer_src": "an increased number of congenital cardiac defects", "follow_up_question": "What types of teratogenic compounds were identified in the studies?", "follow_up_response": "trichloroethylene (tce) , dichloroethylene (dce) , their metabolites , and related compounds", "follow_up_response_bt": "trichloroethylene (tce), dichlorohethylene (dce), their metabolites and related compounds"}], "turn_2": [{"question_id": "266.6", "question": "What specific fetal cardiac defects were reported in the previous teratogenic studies using fetal rats?", "answer_src": "an increased number of congenital cardiac defects", "follow_up_question": "What other types of fetal malformations were not specifically mentioned in the previous teratogenic studies?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "266.7", "question": "What specific types of congenital cardiac defects were observed in the studies involving fetal rats?", "answer_src": "an increased number of congenital cardiac defects", "follow_up_question": "What other teratogenic compounds besides trichloroethylene (tce) and dichloroethylene (dce) were identified in the studies?", "follow_up_response": "Their metabolites and related compounds", "follow_up_response_bt": "Their metabolites and related compounds"}, {"question_id": "266.8", "question": "What specific congenital cardiac defects were observed in the fetal rats exposed to tce or dce?", "answer_src": "this review is a a series of the authors ' studies designed to test the hypothesis that administration of trichloroethylene ( tce ) , dichloroethylene ( dce ) , their metabolites , and related compounds are responsible for fetal cardiac teratogenesis when given to pregnant rats during organogenesis . identification of teratogenic compounds will allow more accurate assessment of environmental contaminants and public health risks . epidemiologic studies and previous teratogenic studies using chick embryos and fetal rats have reported an increased number of congenital cardiac defects when exposed to tce or dce during fetal development .", "follow_up_question": "What other types of animals besides fetal rats were used in previous teratogenic studies?", "follow_up_response": "Chick embryos", "follow_up_response_bt": "No Answer"}, {"question_id": "266.9", "question": "What specific types of congenital cardiac defects were observed in the previous studies using chick embryos and fetal rats?", "answer_src": "an increased number of congenital cardiac defects", "follow_up_question": "What other teratogenic compounds besides trichloroethylene (tce) and dichloroethylene (dce) were identified in the studies?", "follow_up_response": "Their metabolites and related compounds", "follow_up_response_bt": "Their metabolites and related compounds"}, {"question_id": "266.10", "question": "What types of teratogenic compounds were identified in the studies?", "answer_src": "trichloroethylene (tce) , dichloroethylene (dce) , their metabolites , and related compounds", "follow_up_question": "What specific fetal cardiac defects were observed in the studies exposing rats to tce or dce?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "266.11", "question": "What other types of fetal malformations were not specifically mentioned in the previous teratogenic studies?", "answer_src": "this review is a a series of the authors ' studies designed to test the hypothesis that administration of trichloroethylene ( tce ) , dichloroethylene ( dce ) , their metabolites , and related compounds are responsible for fetal cardiac teratogenesis when given to pregnant rats during organogenesis . identification of teratogenic compounds will allow more accurate assessment of environmental contaminants and public health risks . epidemiologic studies and previous teratogenic studies using chick embryos and fetal rats have reported an increased number of congenital cardiac defects when exposed to tce or dce during fetal development .", "follow_up_question": "What other types of fetal malformations were not specifically mentioned in the previous teratogenic studies besides congenital cardiac defects?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "266.12", "question": "What other teratogenic compounds besides trichloroethylene (tce) and dichloroethylene (dce) were identified in the studies?", "answer_src": "Their metabolites and related compounds", "follow_up_question": "What specific types of related compounds were identified as teratogenic?", "follow_up_response": "trichloroethylene (tce) , dichloroethylene (dce) , their metabolites", "follow_up_response_bt": "trichloroethylene (tce), dichlorohethylene (dce) their metabolites"}, {"question_id": "266.13", "question": "What other types of animals besides fetal rats were used in previous teratogenic studies?", "answer_src": "Chick embryos", "follow_up_question": "What other teratogenic studies involving fetal development were conducted besides those with tce, dce, and related compounds?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "266.14", "question": "What other teratogenic compounds besides trichloroethylene (tce) and dichloroethylene (dce) were identified in the studies?", "answer_src": "Their metabolites and related compounds", "follow_up_question": "What specific types of related compounds were identified as teratogenic?", "follow_up_response": "trichloroethylene (tce) , dichloroethylene (dce) , their metabolites", "follow_up_response_bt": "trichloroethylene (tce), dichlorohethylene (dce) their metabolites"}, {"question_id": "266.15", "question": "What specific fetal cardiac defects were observed in the studies exposing rats to tce or dce?", "answer_src": "this review is a a series of the authors ' studies designed to test the hypothesis that administration of trichloroethylene ( tce ) , dichloroethylene ( dce ) , their metabolites , and related compounds are responsible for fetal cardiac teratogenesis when given to pregnant rats during organogenesis . identification of teratogenic compounds will allow more accurate assessment of environmental contaminants and public health risks . epidemiologic studies and previous teratogenic studies using chick embryos and fetal rats have reported an increased number of congenital cardiac defects when exposed to tce or dce during fetal development .", "follow_up_question": "What other types of animals besides rats were used in previous teratogenic studies?", "follow_up_response": "Chick embryos", "follow_up_response_bt": "No Answer"}]}}
{"id": 267, "src": "limitations to practicing ebhc included lack of time , clinical workload , limited access to internet and resources , knowledge and skills . one quarter of the respondents indicated that they teach ebhc . perceived barriers to teaching ebhc reported related to students ( e.g. lack of interest ) , context ( e.g. access to databases ) and educators ( e.g. competing priorities ) .", "mt": "I limiti di pratica dell'EBC includono la mancanza di tempo , il carico di lavoro clinico , l'accesso limitato a internet e risorse , le conoscenze e le competenze . Un quarto degli intervistati ha indicato di insegnare l'EBC .", "pert_mt": "I limiti di pratica dell'EBC includono la mancanza di tempo, il carico di lavoro clinico, l'accesso limitato a internet e risorse, le conoscenze e le competenze, la difficoltà di implementazione. Un quarto degli intervistati ha indicato di insegnare l'EBC.", "bt": "The limitations of EBC practice include lack of time, clinical workload, limited access to the Internet and resources, knowledge and competence, and difficulty in implementation.", "questions_src": ["What is one limitation to practicing EBHC mentioned in the text?", "Who reported indicating that they teach EBHC according to the survey?", "Where do you think the limited access to internet and resources in EBHC practice could be addressed?", "When did you hear about EBHC for the first time?", "Which group among educators, students, or context was cited as having competing priorities in EBHC teaching?"], "answers_src": ["[\"lack of time, clinical workload, limited access to internet and resources, and knowledge and skills\"], [\"one quarter of the respondents\"], [\"No Answer\"], [\"No Answer\"], [\"educators\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"Lack of time, clinical workload, limited access to the Internet and resources, knowledge and competence, and difficulty in implementation\"], [\"Educators\"], [\"No Answer\"], [\"No Answer\"], [\"Educators\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "267.1", "question": "What is one limitation to practicing EBHC mentioned in the text?", "answer_src": "[\"lack of time, clinical workload, limited access to internet and resources, and knowledge and skills\"], [\"one quarter of the respondents\"], [\"No Answer\"], [\"No Answer\"], [\"educators\"]", "follow_up_question": "What percentage of respondents indicated they teach EBHC?", "follow_up_response": "25", "follow_up_response_bt": "No Answer"}, {"question_id": "267.2", "question": "Who reported indicating that they teach EBHC according to the survey?", "answer_src": "limitations to practicing ebhc included lack of time , clinical workload , limited access to internet and resources , knowledge and skills . one quarter of the respondents indicated that they teach ebhc . perceived barriers to teaching ebhc reported related to students ( e.g. lack of interest ) , context ( e.g. access to databases ) and educators ( e.g. competing priorities ) .", "follow_up_question": "What specific barriers did respondents report related to educators when teaching EBHC?", "follow_up_response": "competing priorities", "follow_up_response_bt": "Lack of time, clinical workload, limited access to the Internet and resources, knowledge and competence, and difficulty in implementation"}, {"question_id": "267.3", "question": "Where do you think the limited access to internet and resources in EBHC practice could be addressed?", "answer_src": "limitations to practicing ebhc included lack of time , clinical workload , limited access to internet and resources , knowledge and skills . one quarter of the respondents indicated that they teach ebhc . perceived barriers to teaching ebhc reported related to students ( e.g. lack of interest ) , context ( e.g. access to databases ) and educators ( e.g. competing priorities ) .", "follow_up_question": "How does the lack of interest among students impact their ability to learn EBHC?", "follow_up_response": "Lack of interest", "follow_up_response_bt": "No Answer"}, {"question_id": "267.4", "question": "When did you hear about EBHC for the first time?", "answer_src": "limitations to practicing ebhc included lack of time , clinical workload , limited access to internet and resources , knowledge and skills . one quarter of the respondents indicated that they teach ebhc . perceived barriers to teaching ebhc reported related to students ( e.g. lack of interest ) , context ( e.g. access to databases ) and educators ( e.g. competing priorities ) .", "follow_up_question": "What were some of the perceived barriers to teaching EBHC mentioned in the text?", "follow_up_response": "lack of interest\", \"access to databases\", \"competing priorities", "follow_up_response_bt": "Lack of time, clinical workload, limited access to the Internet and resources, knowledge and competence, and difficulty in implementation"}, {"question_id": "267.5", "question": "Which group among educators, students, or context was cited as having competing priorities in EBHC teaching?", "answer_src": "limitations to practicing ebhc included lack of time , clinical workload , limited access to internet and resources , knowledge and skills . one quarter of the respondents indicated that they teach ebhc . perceived barriers to teaching ebhc reported related to students ( e.g. lack of interest ) , context ( e.g. access to databases ) and educators ( e.g. competing priorities ) .", "follow_up_question": "What specific competing priority did educators report regarding their EBHC teaching?", "follow_up_response": "competing priorities", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "267.6", "question": "What percentage of respondents indicated they teach EBHC?", "answer_src": "25", "follow_up_question": "What were the main perceived barriers to teaching EBHC mentioned by respondents?", "follow_up_response": "Lack of interest in students, access to databases in context, and competing priorities in educators", "follow_up_response_bt": "Lack of time, clinical workload, limited access to the Internet and resources, knowledge and competence, and difficulty in implementation"}, {"question_id": "267.7", "question": "What specific barriers did respondents report related to educators when teaching EBHC?", "answer_src": "competing priorities", "follow_up_question": "What other factors did respondents mention as barriers to teaching EBHC?", "follow_up_response": "Students (e.g., lack of interest), context (e.g., access to databases), and educators (e.g., competing priorities)", "follow_up_response_bt": "lack of time\", \"clinical workload\", \"limited access to the Internet and resources\", \"knowledge and competence\", \"difficulty in implementation"}, {"question_id": "267.8", "question": "How does the lack of interest among students impact their ability to learn EBHC?", "answer_src": "Lack of interest", "follow_up_question": "What are some specific contexts that educators face as barriers to teaching EBHC?", "follow_up_response": "access to databases", "follow_up_response_bt": "Lack of time\", \"Clinical workload\", \"Limited access to the Internet and resources\", \"Knowledge and competence\", \"Difficulty in implementation"}, {"question_id": "267.9", "question": "What were some of the perceived barriers to teaching EBHC mentioned in the text?", "answer_src": "lack of interest\", \"access to databases\", \"competing priorities", "follow_up_question": "What specific context-related barrier did respondents mention for teaching EBHC?", "follow_up_response": "access to databases", "follow_up_response_bt": "Lack of time\", \"Clinical workload\", \"Limited access to the Internet and resources\", \"Knowledge and competence\", \"Difficulty in implementation"}, {"question_id": "267.10", "question": "What specific competing priority did educators report regarding their EBHC teaching?", "answer_src": "competing priorities", "follow_up_question": "What were some of the contexts that educators reported as barriers to teaching EBHC?", "follow_up_response": "access to databases", "follow_up_response_bt": "Lack of time, clinical workload, limited access to the Internet and resources, knowledge and competence, and difficulty in implementation"}], "turn_3": [{"question_id": "267.11", "question": "What were the main perceived barriers to teaching EBHC mentioned by respondents?", "answer_src": "Lack of interest in students, access to databases in context, and competing priorities in educators", "follow_up_question": "How does the lack of interest in students as a barrier impact the effectiveness of teaching EBHC?", "follow_up_response": "Lack of interest", "follow_up_response_bt": "No Answer"}, {"question_id": "267.12", "question": "What other factors did respondents mention as barriers to teaching EBHC?", "answer_src": "Students (e.g., lack of interest), context (e.g., access to databases), and educators (e.g., competing priorities)", "follow_up_question": "What percentage of respondents indicated they teach EBHC?", "follow_up_response": "25", "follow_up_response_bt": "No Answer"}, {"question_id": "267.13", "question": "What are some specific contexts that educators face as barriers to teaching EBHC?", "answer_src": "access to databases", "follow_up_question": "What are some specific challenges faced by educators due to competing priorities?", "follow_up_response": "competing priorities", "follow_up_response_bt": "Lack of time\", \"Clinical workload\", \"Limited access to the Internet and resources\", \"Knowledge and competence\", \"Difficulty in implementation"}, {"question_id": "267.14", "question": "What specific context-related barrier did respondents mention for teaching EBHC?", "answer_src": "access to databases", "follow_up_question": "What were some of the educator-related barriers mentioned for teaching EBHC?", "follow_up_response": "competing priorities", "follow_up_response_bt": "Lack of time, clinical workload, limited access to the Internet and resources, knowledge and competence, and difficulty in implementation"}, {"question_id": "267.15", "question": "What were some of the contexts that educators reported as barriers to teaching EBHC?", "answer_src": "access to databases", "follow_up_question": "What were some of the barriers educators reported related to students?", "follow_up_response": "lack of interest", "follow_up_response_bt": "Lack of time, clinical workload, limited access to the Internet and resources, knowledge and competence, and difficulty in implementation"}]}}
{"id": 268, "src": "from 2001 to 2011 , the proportion of patients whose eligibility for spironolactone was not assessed decreased ( 66.9% in 2001 to 32.8% in 2011 ) . spironolactone use significantly increased among ideal patients over this period ( 28.6% to 72.4% ; p<0.001 for trend ) , but also in contraindicated patients ( 11.4% to 27.5% ; p=0.002 for trend ) and in other patients groups ( not indicated : 27.5% to 38.3% ; unknown indications : 21.3% to 35.1% ; both p<0.01 for trend ) . in all 4 groups , patients presenting with hf on admission were more likely to receive spironolactone.conclusionsalthough the appropriate use of spironolactone and assessment of eligibility increased in china over the past decade , there remains marked opportunities for improvement.clinical trial registrationurl : http://www.clinicaltrials.nct01624883 .", "mt": "Dal 2001 al 2011 la percentuale di pazienti la cui idoneità per lo spironolactone non è stata valutata è diminuita (66,9% nel 2001 al 32,8% nel 2011). L'uso dello spironolactone è aumentato significativamente da un paziente ideale a un paziente ideale durante questo periodo ( 28,6% al 72,4%; p<0,001 per tendenza) ma anche nei pazienti controindicati ( 11,4% al 27,5%; p=0,002 per tendenza) e in altri gruppi di pazienti (non indicati: 27,5% al 38,3%; indicazioni sconosciute: 21,3% al 35,1%; entrambi i p<0,01 per tendenza) . In tutti e quattro i gruppi , i pazienti che presentavano hf all'ammissione erano più propensi a ricevere spironolactone.conclusions.Anche se l'uso appropriato di spironolactone e la valutazione dell'idoneità sono aumentati in Cina nell'ultimo decennio , rimangono notevoli opportunità di studio per migliorare l'iscrizione clinica.", "pert_mt": "Dal 2001 al 2011 la percentuale di pazienti la cui idoneità per lo spironolactone non è stata valutata è diminuita (66,9% nel 2001 al 32,8% nel 2011). L'uso dello spironolactone è aumentato significativamente da un paziente ideale a un paziente ideale durante questo periodo ( 28,6% al 72,4%; p<0,001 per tendenza) ma anche nei pazienti controindicati ( 11,4% al 27,5%; p=0,002 per tendenza) e in altri gruppi di pazienti (non indicati: 27,5% al 38,3%; indicazioni sconosciute: 21,3% al 35", "bt": "From 2001 to 2011 the percentage of patients whose fitness for spironolactone has not been evaluated decreased (66.9% in 2001 to 32.8% in 2011).The use of spironolactone has increased significantly from an ideal patient to an ideal patient during this period (28.6% to 72.4%; p<0.001 per trend) but also in contraindicated patients (11.4% to 27.5%; p=0.002 per trend) and in other patient groups (unindicated: 27.5% to 38.3%; unknown indications: 21.3% to 35 Dal).", "questions_src": ["What year did the proportion of patients whose eligibility for spironolactone was not assessed decrease from 66.9% to 32.8%? ", "Which group saw an increase in spironolactone use from 11.4% to 27.5%? ", "In what year was the proportion of patients whose eligibility for spironolactone was not assessed at 66.9%? "], "answers_src": ["2001 to 2011", "Contraindicated patients", "2001"], "answers_bt": ["2001 to 2011", "Contraindicated patients", "2001"], "multiturn": {"turn_1": [{"question_id": "268.1", "question": "What year did the proportion of patients whose eligibility for spironolactone was not assessed decrease from 66.9% to 32.8%? ", "answer_src": "2001 to 2011", "follow_up_question": "In which years did the proportion of patients whose eligibility for spironolactone was not assessed decrease from 66.9% to 32.8%?", "follow_up_response": "2001 to 2011", "follow_up_response_bt": "2001 to 2011"}, {"question_id": "268.2", "question": "Which group saw an increase in spironolactone use from 11.4% to 27.5%? ", "answer_src": "Contraindicated patients", "follow_up_question": "Which group saw the largest increase in spironolactone use from 2001 to 2011?", "follow_up_response": "Ideal patients", "follow_up_response_bt": "Contraindicated patients"}, {"question_id": "268.3", "question": "In what year was the proportion of patients whose eligibility for spironolactone was not assessed at 66.9%? ", "answer_src": "2001", "follow_up_question": "In which year was the proportion of patients whose eligibility for spironolactone was not assessed at 32.8%?", "follow_up_response": "2011", "follow_up_response_bt": "2011"}], "turn_2": [{"question_id": "268.4", "question": "In which years did the proportion of patients whose eligibility for spironolactone was not assessed decrease from 66.9% to 32.8%?", "answer_src": "2001 to 2011", "follow_up_question": "What was the change in the proportion of patients whose eligibility for spironolactone was not assessed in 2011?", "follow_up_response": "32.8%", "follow_up_response_bt": "32.8%"}, {"question_id": "268.5", "question": "Which group saw the largest increase in spironolactone use from 2001 to 2011?", "answer_src": "Ideal patients", "follow_up_question": "Which group had the smallest increase in spironolactone use from 2001 to 2011?", "follow_up_response": "contraindicated patients", "follow_up_response_bt": "Contraindicated patients"}, {"question_id": "268.6", "question": "In which year was the proportion of patients whose eligibility for spironolactone was not assessed at 32.8%?", "answer_src": "2011", "follow_up_question": "In which year was the proportion of patients whose eligibility for spironolactone was not assessed at 66.9%?", "follow_up_response": "2001", "follow_up_response_bt": "2001"}], "turn_3": [{"question_id": "268.7", "question": "What was the change in the proportion of patients whose eligibility for spironolactone was not assessed in 2011?", "answer_src": "32.8%", "follow_up_question": "What was the change in the proportion of patients whose eligibility for spironolactone was not assessed between 2001 and 2011?", "follow_up_response": "Decreased from 66.9% in 2001 to 32.8% in 2011", "follow_up_response_bt": "From 66.9% in 2001 to 32.8% in 2011"}, {"question_id": "268.8", "question": "Which group had the smallest increase in spironolactone use from 2001 to 2011?", "answer_src": "contraindicated patients", "follow_up_question": "Which group had the largest increase in spironolactone use from 2001 to 2011?", "follow_up_response": "Contraindicated patients", "follow_up_response_bt": "Contraindicated patients"}, {"question_id": "268.9", "question": "In which year was the proportion of patients whose eligibility for spironolactone was not assessed at 66.9%?", "answer_src": "2001", "follow_up_question": "In which year was the proportion of patients whose eligibility for spironolactone was not assessed at 32.8%?", "follow_up_response": "2011", "follow_up_response_bt": "2011"}]}}
{"id": 269, "src": "in a randomized controlled trial , twelve male rats , aged 120 days and with a mean weight of 250 to 300 g , were divided randomly into 5 groups based on drug treatments : aloe vera gel ( av ) , thyroid hormone cream ( tc ) , silver sulfadiazine 1% ( s ) , vehicle ( v ) and control . to evaluate the efficacy of each treatment technique , a biomechanical approach was used to assess tensile stress after 14 days of treatment . tensile stress was significantly improved in the aloe vera gel group as compared with the other four groups ( p0.05 ) .", "mt": "In uno studio randomizzato controllato , dodici topi maschi , di età compresa tra 120 giorni e con un peso medio di 250 e 300 g , sono stati suddivisi in 5 gruppi a caso in base ai trattamenti farmacologici: gel di aloe vera (av) , crema ormonale tiroidea (tc) , sulfadiazina argento 1% (s) , veicolo (v) e controllo . Per valutare l' efficacia di ciascuna tecnica di trattamento , è stato utilizzato un approccio biomeccanico per valutare lo stress di trazione dopo 14 giorni di trattamento . Lo stress di trazione è stato significativamente migliorato nel gruppo di aloe vera rispetto agli altri quattro gruppi di gel (p0.05).", "pert_mt": "In uno studio randomizzato controllato, dodici topi maschi, di età compresa tra 120 giorni e con un peso medio di 250 e 300 g, sono stati suddivisi in 5 gruppi a caso in base ai trattamenti farmacologici: gel di aloe vera (av), crema ormonale tiroidea (tc), sulfadiazina argento 1% (s), veicolo (v), e controllo. Per valutare l'efficacia di ciascuna tecnica di trattamento, è stato utilizzato un approccio biomeccanico per valutare lo stress di trazione dopo 14 giorni di trattamento. Lo stress di trazione è stato significativamente migliorato nel gruppo di aloe vera rispetto agli altri quattro gruppi di gel (p<0.05). Gli esperimenti hanno", "bt": "In one randomized controlled study, twelve male rats, aged between 120 days and with an average weight of 250 and 300 g, were divided into 5 groups on a case-by-case basis based on the pharmacological treatments: aloe vera gel (av), thyroid hormone cream (tc), sulfadiazine argento 1% (s), vehicle (v), and control.To evaluate the effectiveness of each treatment technique, a biomechanical approach was used to evaluate traction stress after 14 days of treatment.", "questions_src": ["What was the mean weight of the rats in the study?", "Who was divided into five groups based on drug treatments?", "Which treatment group showed significant improvement in tensile stress?", "When was the assessment of tensile stress conducted?", "Where was the biomechanical approach used to evaluate the treatments?"], "answers_src": ["250 to 300 g", "twelve male rats", "aloe vera gel group", "14 days of treatment", "in a biomechanical approach"], "answers_bt": ["275 g", "Male rats", "No Answer", "14 days", "In vivo"], "multiturn": {"turn_1": [{"question_id": "269.1", "question": "What was the mean weight of the rats in the study?", "answer_src": "250 to 300 g", "follow_up_question": "How many days did the treatment period last?", "follow_up_response": "14", "follow_up_response_bt": "14"}, {"question_id": "269.2", "question": "Who was divided into five groups based on drug treatments?", "answer_src": "twelve male rats", "follow_up_question": "What was the mean weight range of the rats?", "follow_up_response": "250 to 300 g", "follow_up_response_bt": "250 and 300 g"}, {"question_id": "269.3", "question": "Which treatment group showed significant improvement in tensile stress?", "answer_src": "aloe vera gel group", "follow_up_question": "What was the p-value for the aloe vera gel group compared to the other groups?", "follow_up_response": "0.05", "follow_up_response_bt": "No Answer"}, {"question_id": "269.4", "question": "When was the assessment of tensile stress conducted?", "answer_src": "14 days of treatment", "follow_up_question": "What was the mean tensile stress value for the aloe vera gel group compared to the other groups?", "follow_up_response": "significantly improved", "follow_up_response_bt": "No Answer"}, {"question_id": "269.5", "question": "Where was the biomechanical approach used to evaluate the treatments?", "answer_src": "in a biomechanical approach", "follow_up_question": "What specific biomechanical parameter was measured to assess the efficacy of the treatments?", "follow_up_response": "tensile stress", "follow_up_response_bt": "traction stress"}], "turn_2": [{"question_id": "269.6", "question": "How many days did the treatment period last?", "answer_src": "14", "follow_up_question": "What was the effect of the thyroid hormone cream group on tensile stress?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "269.7", "question": "What was the mean weight range of the rats?", "answer_src": "250 to 300 g", "follow_up_question": "How much improvement in tensile stress did the aloe vera gel group show compared to the other groups?", "follow_up_response": "significantly improved", "follow_up_response_bt": "No Answer"}, {"question_id": "269.8", "question": "What was the p-value for the aloe vera gel group compared to the other groups?", "answer_src": "0.05", "follow_up_question": "What was the tensile stress improvement percentage for the aloe vera gel group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "269.9", "question": "What was the mean tensile stress value for the aloe vera gel group compared to the other groups?", "answer_src": "significantly improved", "follow_up_question": "By how much did the tensile stress increase in the aloe vera gel group compared to the vehicle group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "269.10", "question": "What specific biomechanical parameter was measured to assess the efficacy of the treatments?", "answer_src": "tensile stress", "follow_up_question": "How much improvement in tensile stress was observed in the aloe vera gel group compared to the other groups?", "follow_up_response": "tensile stress was significantly improved", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "269.11", "question": "What was the effect of the thyroid hormone cream group on tensile stress?", "answer_src": "in a randomized controlled trial , twelve male rats , aged 120 days and with a mean weight of 250 to 300 g , were divided randomly into 5 groups based on drug treatments : aloe vera gel ( av ) , thyroid hormone cream ( tc ) , silver sulfadiazine 1% ( s ) , vehicle ( v ) and control . to evaluate the efficacy of each treatment technique , a biomechanical approach was used to assess tensile stress after 14 days of treatment . tensile stress was significantly improved in the aloe vera gel group as compared with the other four groups ( p0.05 ) .", "follow_up_question": "What was the result of the tensile stress assessment for the silver sulfadiazine 1% group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "269.12", "question": "How much improvement in tensile stress did the aloe vera gel group show compared to the other groups?", "answer_src": "significantly improved", "follow_up_question": "By how many percentage points was tensile stress improved in the aloe vera gel group compared to the vehicle group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "269.13", "question": "What was the tensile stress improvement percentage for the aloe vera gel group?", "answer_src": "in a randomized controlled trial , twelve male rats , aged 120 days and with a mean weight of 250 to 300 g , were divided randomly into 5 groups based on drug treatments : aloe vera gel ( av ) , thyroid hormone cream ( tc ) , silver sulfadiazine 1% ( s ) , vehicle ( v ) and control . to evaluate the efficacy of each treatment technique , a biomechanical approach was used to assess tensile stress after 14 days of treatment . tensile stress was significantly improved in the aloe vera gel group as compared with the other four groups ( p0.05 ) .", "follow_up_question": "By how much did tensile stress increase in the aloe vera gel group compared to the vehicle group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "269.14", "question": "By how much did the tensile stress increase in the aloe vera gel group compared to the vehicle group?", "answer_src": "in a randomized controlled trial , twelve male rats , aged 120 days and with a mean weight of 250 to 300 g , were divided randomly into 5 groups based on drug treatments : aloe vera gel ( av ) , thyroid hormone cream ( tc ) , silver sulfadiazine 1% ( s ) , vehicle ( v ) and control . to evaluate the efficacy of each treatment technique , a biomechanical approach was used to assess tensile stress after 14 days of treatment . tensile stress was significantly improved in the aloe vera gel group as compared with the other four groups ( p0.05 ) .", "follow_up_question": "By what percentage did the tensile stress improve in the aloe vera gel group compared to the vehicle group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "269.15", "question": "How much improvement in tensile stress was observed in the aloe vera gel group compared to the other groups?", "answer_src": "tensile stress was significantly improved", "follow_up_question": "By how much did tensile stress improve in the aloe vera gel group compared to the vehicle group?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 270, "src": "a multicenter , retrospective case series.in the past several years , screw fixation of the cervical spine has become commonplace . for the most part , this is a safe , low - risk procedure . while rare , screw backout or misplaced screws can lead to morbidity and increased costs .", "mt": "In questi ultimi anni , la fissazione di viti della colonna vertebrale cervicale è diventata comune . per la maggior parte , si tratta di una procedura sicura e a basso rischio . mentre le rare, scrofe di retrocesso o viti sbagliati possono portare a morbilità e a costi aumentati .", "pert_mt": "In questi ultimi anni, la fissazione di viti della colonna vertebrale cervicale è diventata comune. Per la maggior parte, si tratta di una procedura sicura e a basso rischio. Tuttavia, mentre le rare, scrofe di retrocesso o viti sbagliati possono portare a morbilità e a costi aumentati, questo può anche causare problemi alla mobilità del paziente.", "bt": "In recent years, fixing cervical spine screws has become common, for the most part a safe and low-risk procedure, but while rare, recoil screws or incorrect screws can lead to morbidity and increased costs, this can also cause problems with patient mobility.", "questions_src": ["What is the main topic of the sentence?", "Who is commonly performing the procedure mentioned?", "Where does the sentence mention the procedure being used?", "When did the sentence indicate that screw fixation became common?", "Which complications can occur with the procedure?"], "answers_src": ["A multicenter retrospective case series", "Not specified in the sentence", "The cervical spine", "In the past several years", "Screw backout and misplaced screws"], "answers_bt": ["[\"Fixing cervical spine screws\"], [\"Doctors/surgeons\"], [\"Cervical spine\"], [\"Recent years\"], [\"Recoil screws\", \"Incorrect screws\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "270.1", "question": "What is the main topic of the sentence?", "answer_src": "A multicenter retrospective case series", "follow_up_question": "What is the primary indication for screw fixation mentioned in the text?", "follow_up_response": "The cervical spine", "follow_up_response_bt": "Fixing cervical spine"}, {"question_id": "270.2", "question": "Who is commonly performing the procedure mentioned?", "answer_src": "Not specified in the sentence", "follow_up_question": "What specific complications can occur with screw fixation?", "follow_up_response": "Screw backout or misplaced screws", "follow_up_response_bt": "Recoil screws or incorrect screws"}, {"question_id": "270.3", "question": "Where does the sentence mention the procedure being used?", "answer_src": "The cervical spine", "follow_up_question": "What specific complications can occur with screw fixation of the cervical spine?", "follow_up_response": "screw backout or misplaced screws", "follow_up_response_bt": "Recoil screws or incorrect screws"}, {"question_id": "270.4", "question": "When did the sentence indicate that screw fixation became common?", "answer_src": "In the past several years", "follow_up_question": "What specific complications can occur with screw backout or misplaced screws?", "follow_up_response": "morbidity and increased costs", "follow_up_response_bt": "morbidity and increased costs\", \"problems with patient mobility"}, {"question_id": "270.5", "question": "Which complications can occur with the procedure?", "answer_src": "Screw backout and misplaced screws", "follow_up_question": "What are the consequences of these complications?", "follow_up_response": "Morbidity and increased costs", "follow_up_response_bt": "morbidity and increased costs\", \"problems with patient mobility"}], "turn_2": [{"question_id": "270.6", "question": "What is the primary indication for screw fixation mentioned in the text?", "answer_src": "The cervical spine", "follow_up_question": "What specific complications can occur with screw fixation as described in the text?", "follow_up_response": "screw backout or misplaced screws", "follow_up_response_bt": "Recoil screws\", \"Incorrect screws"}, {"question_id": "270.7", "question": "What specific complications can occur with screw fixation?", "answer_src": "Screw backout or misplaced screws", "follow_up_question": "What are the consequences of these complications?", "follow_up_response": "Morbidity and increased costs", "follow_up_response_bt": "morbidity and increased costs\", \"problems with patient mobility"}, {"question_id": "270.8", "question": "What specific complications can occur with screw fixation of the cervical spine?", "answer_src": "screw backout or misplaced screws", "follow_up_question": "What are the consequences of screw backout or misplaced screws?", "follow_up_response": "morbidity and increased costs", "follow_up_response_bt": "morbidity and increased costs\", \"problems with patient mobility"}, {"question_id": "270.9", "question": "What specific complications can occur with screw backout or misplaced screws?", "answer_src": "morbidity and increased costs", "follow_up_question": "What types of morbidity can result from screw backout or misplaced screws?", "follow_up_response": "morbidity", "follow_up_response_bt": "morbidity"}, {"question_id": "270.10", "question": "What are the consequences of these complications?", "answer_src": "Morbidity and increased costs", "follow_up_question": "What percentage of cases experience these complications?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "270.11", "question": "What specific complications can occur with screw fixation as described in the text?", "answer_src": "screw backout or misplaced screws", "follow_up_question": "What are the consequences of these complications?", "follow_up_response": "Morbidity and increased costs", "follow_up_response_bt": "morbidity and increased costs\", \"problems with patient mobility"}, {"question_id": "270.12", "question": "What are the consequences of these complications?", "answer_src": "Morbidity and increased costs", "follow_up_question": "What percentage of cases experience these complications?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "270.13", "question": "What are the consequences of screw backout or misplaced screws?", "answer_src": "morbidity and increased costs", "follow_up_question": "What percentage of screw fixation procedures result in these complications?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "270.14", "question": "What types of morbidity can result from screw backout or misplaced screws?", "answer_src": "morbidity", "follow_up_question": "What specific complications might occur due to screw backout or misplaced screws?", "follow_up_response": "morbidity and increased costs", "follow_up_response_bt": "morbidity and increased costs\", \"problems with patient mobility"}, {"question_id": "270.15", "question": "What percentage of cases experience these complications?", "answer_src": "a multicenter , retrospective case series.in the past several years , screw fixation of the cervical spine has become commonplace . for the most part , this is a safe , low - risk procedure . while rare , screw backout or misplaced screws can lead to morbidity and increased costs .", "follow_up_question": "What specific outcomes can result from screw backout or misplaced screws?", "follow_up_response": "morbidity and increased costs", "follow_up_response_bt": "morbidity and increased costs\", \"problems with patient mobility"}]}}
{"id": 271, "src": "all procedures were performed by the same surgeon using the same technique . in no case was the mesenteric defect closed . a prospectively maintained database was used for data collection .", "mt": "Tutte le procedure sono state eseguite dallo stesso chirurgo utilizzando la stessa tecnica . in nessun caso il difetto mesenterico è stato chiuso .", "pert_mt": "Tutte le procedure sono state eseguite dallo stesso chirurgo utilizzando la stessa tecnica. In nessun caso il difetto mesenterico è stato chiuso, anche se il rischio di complesso era presente.", "bt": "The entire procedure was performed by the same surgeon using the same technique, and in no case was the mesenteric defect closed, although the risk of complications was present.", "questions_src": ["What was the main technique used during the procedures?", "Who performed the procedures?", "Where was the mesenteric defect left open?", "When was the prospectively maintained database established?", "Which surgical technique was not used?"], "answers_src": ["the same technique", "the same surgeon", "the mesenteric defect", "no answer", "not closed"], "answers_bt": ["same technique", "the same surgeon", "the mesenteric defect", "No Answer", "the mesenteric defect"], "multiturn": {"turn_1": [{"question_id": "271.1", "question": "What was the main technique used during the procedures?", "answer_src": "the same technique", "follow_up_question": "What specific part of the procedure was not closed?", "follow_up_response": "mesenteric defect", "follow_up_response_bt": "mesenteric defect"}, {"question_id": "271.2", "question": "Who performed the procedures?", "answer_src": "the same surgeon", "follow_up_question": "What technique was used for the procedures?", "follow_up_response": "the same technique", "follow_up_response_bt": "the same technique"}, {"question_id": "271.3", "question": "Where was the mesenteric defect left open?", "answer_src": "the mesenteric defect", "follow_up_question": "What was the method used for data collection?", "follow_up_response": "A prospectively maintained database", "follow_up_response_bt": "No Answer"}, {"question_id": "271.4", "question": "When was the prospectively maintained database established?", "answer_src": "no answer", "follow_up_question": "What was the purpose of the prospectively maintained database?", "follow_up_response": "For data collection", "follow_up_response_bt": "No Answer"}, {"question_id": "271.5", "question": "Which surgical technique was not used?", "answer_src": "not closed", "follow_up_question": "What was the mesenteric defect left in all cases?", "follow_up_response": "No Answer", "follow_up_response_bt": "The mesenteric defect"}], "turn_2": [{"question_id": "271.6", "question": "What specific part of the procedure was not closed?", "answer_src": "mesenteric defect", "follow_up_question": "What was the consequence of not closing the mesenteric defect?", "follow_up_response": "No Answer", "follow_up_response_bt": "The risk of complications"}, {"question_id": "271.7", "question": "What technique was used for the procedures?", "answer_src": "the same technique", "follow_up_question": "What was the outcome regarding the mesenteric defect closure?", "follow_up_response": "The mesenteric defect was not closed", "follow_up_response_bt": "The mesenteric defect was not closed"}, {"question_id": "271.8", "question": "What was the method used for data collection?", "answer_src": "A prospectively maintained database", "follow_up_question": "What type of defects were not closed during the procedures?", "follow_up_response": "mesenteric defect", "follow_up_response_bt": "mesenteric defect"}, {"question_id": "271.9", "question": "What was the purpose of the prospectively maintained database?", "answer_src": "For data collection", "follow_up_question": "What specific types of data were collected using this database?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "271.10", "question": "What was the mesenteric defect left in all cases?", "answer_src": "all procedures were performed by the same surgeon using the same technique . in no case was the mesenteric defect closed . a prospectively maintained database was used for data collection .", "follow_up_question": "What technique was used for all procedures?", "follow_up_response": "the same technique", "follow_up_response_bt": "the same technique"}], "turn_3": [{"question_id": "271.11", "question": "What was the consequence of not closing the mesenteric defect?", "answer_src": "all procedures were performed by the same surgeon using the same technique . in no case was the mesenteric defect closed . a prospectively maintained database was used for data collection .", "follow_up_question": "What technique did the surgeon use for all procedures?", "follow_up_response": "the same technique", "follow_up_response_bt": "the same technique"}, {"question_id": "271.12", "question": "What was the outcome regarding the mesenteric defect closure?", "answer_src": "The mesenteric defect was not closed", "follow_up_question": "What technique was used for all procedures?", "follow_up_response": "the same technique", "follow_up_response_bt": "the same technique"}, {"question_id": "271.13", "question": "What type of defects were not closed during the procedures?", "answer_src": "mesenteric defect", "follow_up_question": "What specific procedure was not performed due to the mesenteric defect?", "follow_up_response": "The mesenteric defect was not closed", "follow_up_response_bt": "The mesenteric defect"}, {"question_id": "271.14", "question": "What specific types of data were collected using this database?", "answer_src": "all procedures were performed by the same surgeon using the same technique . in no case was the mesenteric defect closed . a prospectively maintained database was used for data collection .", "follow_up_question": "What information about the surgeries was recorded in the database?", "follow_up_response": "Data collection", "follow_up_response_bt": "The entire procedure was performed by the same surgeon using the same technique, and in no case was the mesenteric defect closed, although the risk of complications was present."}, {"question_id": "271.15", "question": "What technique was used for all procedures?", "answer_src": "the same technique", "follow_up_question": "What was the outcome when the mesenteric defect was not closed in any case?", "follow_up_response": "No Answer", "follow_up_response_bt": "The risk of complications"}]}}
{"id": 272, "src": "size , multifocality , and bilateralism of ptm foci , thyroid capsule invasion , and presence of lymphovascular invasion were histopathological parameters . we analysed adjuvant medical and nuclear treatment and patients ' outcome during follow - up period of 102 ( 61144 ) months . the prevalence rates of i - ptm were 9.4% in 395 thyroidectomy cases .", "mt": "La dimensione , la multifocalità e il bilateralismo dei foci ptm , l'invasione delle capsule tiroidei e la presenza di invasioni linfovascolari erano parametri istopatologici . Abbiamo analizzato il trattamento medico e nucleare adjuvante e il risultato dei pazienti durante il follow-up di 102 mesi .", "pert_mt": "La dimensione, la multifocalità e il bilateralismo dei foci ptm, l'invasione delle capsule tiroidee e la presenza di invasioni linfovascolari erano parametri istopatologici. Abbiamo analizzato il trattamento medico e nucleare adjuvante e il risultato dei pazienti durante il follow-up di 102 mesi, e abbiamo notato una relazione significativa con l'età dei pazienti.", "bt": "The size, multifocalism and bilateralism of the PTM focuses, the invasion of the thyroid capsules and the presence of lymphovascular invasions were histopathological parameters.We analyzed adjuvant medical and nuclear treatment and patient outcomes during the 102 month follow-up, and noted a significant relationship with patient age.", "questions_src": ["What was the prevalence rate of i-ptm in the thyroidectomy cases?", "When was the follow-up period analyzed?", "Who performed the adjuvant medical and nuclear treatments?", "Where were the histopathological parameters analyzed?", "Which treatment had a prevalence rate of 9.4% in 395 cases?"], "answers_src": ["9.4%", "102 (61144) months", "No Answer", "Thyroid", "i-PTM"], "answers_bt": ["i-PTM", "102 months", "Adjuvant medical and nuclear treatments were performed by the team", "Histopathological parameters were analyzed in the thyroidectomy cases", "No Answer"], "multiturn": {"turn_1": [{"question_id": "272.1", "question": "What was the prevalence rate of i-ptm in the thyroidectomy cases?", "answer_src": "9.4%", "follow_up_question": "What was the total number of thyroidectomy cases analyzed?", "follow_up_response": "395", "follow_up_response_bt": "No Answer"}, {"question_id": "272.2", "question": "When was the follow-up period analyzed?", "answer_src": "102 (61144) months", "follow_up_question": "What was the average follow-up period per patient?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "272.3", "question": "Who performed the adjuvant medical and nuclear treatments?", "answer_src": "size , multifocality , and bilateralism of ptm foci , thyroid capsule invasion , and presence of lymphovascular invasion were histopathological parameters . we analysed adjuvant medical and nuclear treatment and patients ' outcome during follow - up period of 102 ( 61144 ) months . the prevalence rates of i - ptm were 9.4% in 395 thyroidectomy cases .", "follow_up_question": "What was the duration of the follow-up period?", "follow_up_response": "102 ( 61144 ) months", "follow_up_response_bt": "102 months"}, {"question_id": "272.4", "question": "Where were the histopathological parameters analyzed?", "answer_src": "Thyroid", "follow_up_question": "What was the prevalence rate of i-ptm in the analyzed cases?", "follow_up_response": "9.4%", "follow_up_response_bt": "No Answer"}, {"question_id": "272.5", "question": "Which treatment had a prevalence rate of 9.4% in 395 cases?", "answer_src": "i-PTM", "follow_up_question": "What was the median follow-up period for the patients?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "272.6", "question": "What was the total number of thyroidectomy cases analyzed?", "answer_src": "395", "follow_up_question": "What was the median follow-up period for the patients?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "272.7", "question": "What was the average follow-up period per patient?", "answer_src": "size , multifocality , and bilateralism of ptm foci , thyroid capsule invasion , and presence of lymphovascular invasion were histopathological parameters . we analysed adjuvant medical and nuclear treatment and patients ' outcome during follow - up period of 102 ( 61144 ) months . the prevalence rates of i - ptm were 9.4% in 395 thyroidectomy cases .", "follow_up_question": "What was the total number of months of follow-up?", "follow_up_response": "102 (61144)", "follow_up_response_bt": "102"}, {"question_id": "272.8", "question": "What was the duration of the follow-up period?", "answer_src": "102 ( 61144 ) months", "follow_up_question": "What was the average follow-up period per patient?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "272.9", "question": "What was the prevalence rate of i-ptm in the analyzed cases?", "answer_src": "9.4%", "follow_up_question": "What was the total number of thyroidectomy cases analyzed?", "follow_up_response": "395", "follow_up_response_bt": "No Answer"}, {"question_id": "272.10", "question": "What was the median follow-up period for the patients?", "answer_src": "size , multifocality , and bilateralism of ptm foci , thyroid capsule invasion , and presence of lymphovascular invasion were histopathological parameters . we analysed adjuvant medical and nuclear treatment and patients ' outcome during follow - up period of 102 ( 61144 ) months . the prevalence rates of i - ptm were 9.4% in 395 thyroidectomy cases .", "follow_up_question": "What was the total number of months of follow-up for the patients?", "follow_up_response": "102 (61144)", "follow_up_response_bt": "102"}], "turn_3": [{"question_id": "272.11", "question": "What was the median follow-up period for the patients?", "answer_src": "size , multifocality , and bilateralism of ptm foci , thyroid capsule invasion , and presence of lymphovascular invasion were histopathological parameters . we analysed adjuvant medical and nuclear treatment and patients ' outcome during follow - up period of 102 ( 61144 ) months . the prevalence rates of i - ptm were 9.4% in 395 thyroidectomy cases .", "follow_up_question": "What was the total number of months of follow-up for the patients?", "follow_up_response": "102 (61144)", "follow_up_response_bt": "102"}, {"question_id": "272.12", "question": "What was the total number of months of follow-up?", "answer_src": "102 (61144)", "follow_up_question": "What was the average follow-up duration per patient?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "272.13", "question": "What was the average follow-up period per patient?", "answer_src": "size , multifocality , and bilateralism of ptm foci , thyroid capsule invasion , and presence of lymphovascular invasion were histopathological parameters . we analysed adjuvant medical and nuclear treatment and patients ' outcome during follow - up period of 102 ( 61144 ) months . the prevalence rates of i - ptm were 9.4% in 395 thyroidectomy cases .", "follow_up_question": "What was the total number of months of follow-up?", "follow_up_response": "102 (61144)", "follow_up_response_bt": "102"}, {"question_id": "272.14", "question": "What was the total number of thyroidectomy cases analyzed?", "answer_src": "395", "follow_up_question": "What was the median follow-up period for the patients?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "272.15", "question": "What was the total number of months of follow-up for the patients?", "answer_src": "102 (61144)", "follow_up_question": "What was the average follow-up duration per patient?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 273, "src": "driver fatigue is one of the major implications in transportation safety and accounted for up to 40% of road accidents . this study aimed to analyze the eeg alpha power changes in partially sleep - deprived drivers while performing a simulated driving task.twelve healthy male car drivers participated in an overnight study . continuous eeg and eog records were taken during driving on a virtual reality simulator on a monotonous road .", "mt": "La fatica è una delle principali implicazioni della sicurezza dei trasporti e rappresenta fino al 40% degli incidenti stradali . Questo studio mirava ad analizzare i cambiamenti di potenza di un'egg alfa nei conducenti parzialmente sognati mentre eseguivano un compito di guida simulato.Dodici conducenti di automobili maschi sani hanno partecipato a uno studio notturno .", "pert_mt": "La fatica è una delle principali implicazioni della sicurezza dei trasporti e rappresenta fino al 40% degli incidenti stradali. Questo studio mirava ad analizzare i cambiamenti di potenza di un'egg alfa nei conducenti parzialmente sognati mentre eseguivano un compito di guida simulato. Dodici conducenti di automobili maschi sani hanno partecipato a uno studio notturno e hanno mostrato una maggiore fatica durante l'esperimento.", "bt": "Fatigue is one of the main implications of transport safety and accounts for up to 40% of road accidents.This study aimed to analyze the power changes of an alpha egg in drivers partially dreamed while performing a simulated driving task.Twelve healthy male car drivers participated in a nightly study and showed greater fatigue during the experiment.", "questions_src": ["What was the percentage of road accidents caused by driver fatigue?", "Who participated in the overnight study?", "Where were the eeg and eog records taken?", "When did the study take place?", "Which type of driving task was performed during the simulation?"], "answers_src": ["40%", "Twelve healthy male car drivers", "On a virtual reality simulator on a monotonous road", "Overnight", "Simulated driving"], "answers_bt": ["40%", "Twelve healthy male car drivers", "Not specified", "Overnight", "Simulated driving task"], "multiturn": {"turn_1": [{"question_id": "273.1", "question": "What was the percentage of road accidents caused by driver fatigue?", "answer_src": "40%", "follow_up_question": "What specific type of driving task did the participants perform in the study?", "follow_up_response": "a simulated driving task", "follow_up_response_bt": "a simulated driving task"}, {"question_id": "273.2", "question": "Who participated in the overnight study?", "answer_src": "Twelve healthy male car drivers", "follow_up_question": "What specific condition did the participants have regarding their sleep?", "follow_up_response": "partially sleep-deprived", "follow_up_response_bt": "partial sleep deprivation"}, {"question_id": "273.3", "question": "Where were the eeg and eog records taken?", "answer_src": "On a virtual reality simulator on a monotonous road", "follow_up_question": "What was the duration of the overnight study?", "follow_up_response": "overnight", "follow_up_response_bt": "No Answer"}, {"question_id": "273.4", "question": "When did the study take place?", "answer_src": "Overnight", "follow_up_question": "What specific tasks did the partially sleep-deprived drivers perform during the study?", "follow_up_response": "perform a simulated driving task", "follow_up_response_bt": "Perform a simulated driving task"}, {"question_id": "273.5", "question": "Which type of driving task was performed during the simulation?", "answer_src": "Simulated driving", "follow_up_question": "What specific condition did the participants experience before the driving task?", "follow_up_response": "Partial sleep deprivation", "follow_up_response_bt": "Fatigue"}], "turn_2": [{"question_id": "273.6", "question": "What specific type of driving task did the participants perform in the study?", "answer_src": "a simulated driving task", "follow_up_question": "What was the duration of the sleep deprivation for the participants?", "follow_up_response": "overnight", "follow_up_response_bt": "No Answer"}, {"question_id": "273.7", "question": "What specific condition did the participants have regarding their sleep?", "answer_src": "partially sleep-deprived", "follow_up_question": "What percentage of road accidents is driver fatigue estimated to cause?", "follow_up_response": "40%", "follow_up_response_bt": "40%"}, {"question_id": "273.8", "question": "What was the duration of the overnight study?", "answer_src": "overnight", "follow_up_question": "How many hours into the study did the participants begin driving?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "273.9", "question": "What specific tasks did the partially sleep-deprived drivers perform during the study?", "answer_src": "perform a simulated driving task", "follow_up_question": "What type of virtual reality simulator was used for the driving task?", "follow_up_response": "virtual reality simulator", "follow_up_response_bt": "No Answer"}, {"question_id": "273.10", "question": "What specific condition did the participants experience before the driving task?", "answer_src": "Partial sleep deprivation", "follow_up_question": "What percentage of road accidents is driver fatigue estimated to account for?", "follow_up_response": "40%", "follow_up_response_bt": "40%"}], "turn_3": [{"question_id": "273.11", "question": "What was the duration of the sleep deprivation for the participants?", "answer_src": "overnight", "follow_up_question": "How long did the simulated driving task last?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "273.12", "question": "What percentage of road accidents is driver fatigue estimated to cause?", "answer_src": "40%", "follow_up_question": "How long did the participants in the study spend without sleep?", "follow_up_response": "overnight", "follow_up_response_bt": "No Answer"}, {"question_id": "273.13", "question": "How many hours into the study did the participants begin driving?", "answer_src": "driver fatigue is one of the major implications in transportation safety and accounted for up to 40% of road accidents . this study aimed to analyze the eeg alpha power changes in partially sleep - deprived drivers while performing a simulated driving task.twelve healthy male car drivers participated in an overnight study . continuous eeg and eog records were taken during driving on a virtual reality simulator on a monotonous road .", "follow_up_question": "How long was the simulated driving task conducted?", "follow_up_response": "overnight", "follow_up_response_bt": "No Answer"}, {"question_id": "273.14", "question": "What type of virtual reality simulator was used for the driving task?", "answer_src": "virtual reality simulator", "follow_up_question": "What was the duration of the sleep deprivation for the participants?", "follow_up_response": "overnight", "follow_up_response_bt": "No Answer"}, {"question_id": "273.15", "question": "What percentage of road accidents is driver fatigue estimated to account for?", "answer_src": "40%", "follow_up_question": "How long did the participants in the study drive on the virtual reality simulator?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 274, "src": "in addition to its anti - inflammatory activity , meriva , a proprietary lecithin formulation of curcumin , has been anecdotally reported to decrease acute pain in patients with various chronic diseases . given that curcumin can desensitize transient receptor potential a1 , a nociceptor seemingly also mediating the analgesic effect of acetaminophen , as well as inhibiting and downregulating the expression of cyclo - oxygenase 2 , the selective target of nimesulide , a nonsteroidal anti - inflammatory agent , we carried out a pilot comparative study of the acute pain - relieving properties of these three agents . at a dose of 2 g ( corresponding to 400 mg of curcumin ) , meriva showed clear analgesic activity , comparable with that of a standard dose ( 1 g ) of acetaminophen , but lower than that of a therapeutic ( 100 mg ) dose of nimesulide .", "mt": "Oltre alla sua attività anti-infiammatoria , Meriva , una formulazione di lecitina proprietaria della curcumina , è stata annotata per ridurre il dolore acuto nei pazienti con varie malattie croniche . dato che la curcumina può disensibilizzare il potenziale del recettore transitorio a1 , un nociceptor che sembra anche mediare l' effetto analgesico dell' acetaminophen , nonché inibire e ridurre l' espressione della ciclo-ossigenasi 2 , il bersaglio selettivo del nimesulide , un agente antinfiammatorio non steroide , abbiamo condotto uno studio comparativo pilota delle proprietà analgetiche acute di questi tre agenti . A una dose di 2 g (corrispondente a 400 mg di curcuminophen), Meriva ha mostrato un' attività nettamente analgesico , paragonabile a quella di una dose standard di 1 g di acetaminophen , ma inferiore a 100 mg di analgesic acid () in una dose terapeutica di 400 mg ().", "pert_mt": "Oltre alla sua attività anti-infiammatoria, Meriva, una formulazione di lecitina proprietaria della curcumina, è stata annotata per ridurre il dolore acuto nei pazienti con varie malattie croniche. Dato che la curcumina può disensibilizzare il potenziale del recettore transitorio a1, un nociceptor che sembra anche mediare l'effetto analgesico dell'acetaminophen, nonché inibire e ridurre l'espressione della ciclo-ossigenasi 2, il bersaglio selettivo del nimesulide, un agente antinfiammatorio non steroide, abbiamo condotto uno studio comparativo pilota delle proprietà analgetiche acute di questi tre agenti. A una dose di 2 g (corrispondente a 400 mg di curcuminophen), Meriva ha mostrato", "bt": "In addition to its anti-inflammatory activity, Meriva, a lecitin formula that is proprietary to curcumin, has been noted to reduce acute pain in patients with various chronic diseases.Since curcumin can desensitize the potential of the transitional receptor a1, a nociceptor that also appears to mediate the analgesic effect of acetaminophen, as well as inhibit and reduce the expression of cyclo-oxygenase 2, the selective bersaglio of nimesulide, a non-steroidal anti-inflammatory agent, we conducted a pilot comparative study of the acute genetic properties of these three agents.A dose of 2 g Meriva (equivalent to 400 mg of curcuminophen), showed that curcumin has analgesic properties.", "questions_src": ["What is the dose of meriva that showed clear analgesic activity?", "Who can desensitize transient receptor potential a1 according to the study?", "Where does the analgesic effect of acetaminophen seem to be mediated?", "When was the pilot comparative study carried out?", "Which nonsteroidal anti-inflammatory agent targets cyclo-oxygenase 2?"], "answers_src": ["2 g ( corresponding to 400 mg of curcumin )", "curcumin", "transient receptor potential a1", "a pilot comparative study", "nimesulide"], "answers_bt": ["2 g Meriva (equivalent to 400 mg of curcuminophen)", "curcumin", "transitional receptor potential a1", "a pilot comparative study", "nimesulide"], "multiturn": {"turn_1": [{"question_id": "274.1", "question": "What is the dose of meriva that showed clear analgesic activity?", "answer_src": "2 g ( corresponding to 400 mg of curcumin )", "follow_up_question": "What was the dose of acetaminophen used in the study?", "follow_up_response": "1 g", "follow_up_response_bt": "No Answer"}, {"question_id": "274.2", "question": "Who can desensitize transient receptor potential a1 according to the study?", "answer_src": "curcumin", "follow_up_question": "Which agent showed lower analgesic activity compared to nimesulide at a therapeutic dose?", "follow_up_response": "Meriva", "follow_up_response_bt": "No Answer"}, {"question_id": "274.3", "question": "Where does the analgesic effect of acetaminophen seem to be mediated?", "answer_src": "transient receptor potential a1", "follow_up_question": "How does the analgesic effect of nimesulide differ from that of acetaminophen?", "follow_up_response": "The analgesic effect of nimesulide is lower than that of acetaminophen.", "follow_up_response_bt": "No Answer"}, {"question_id": "274.4", "question": "When was the pilot comparative study carried out?", "answer_src": "a pilot comparative study", "follow_up_question": "What was the dose of curcumin used in the study?", "follow_up_response": "400 mg", "follow_up_response_bt": "2 g Meriva (equivalent to 400 mg of curcumin)"}, {"question_id": "274.5", "question": "Which nonsteroidal anti-inflammatory agent targets cyclo-oxygenase 2?", "answer_src": "nimesulide", "follow_up_question": "What is the dose of meriva that showed clear analgesic activity?", "follow_up_response": "2 g ( corresponding to 400 mg of curcumin )", "follow_up_response_bt": "2 g Meriva (equivalent to 400 mg of curcuminophen)"}], "turn_2": [{"question_id": "274.6", "question": "What was the dose of acetaminophen used in the study?", "answer_src": "1 g", "follow_up_question": "What was the dose of nimesulide used in the study?", "follow_up_response": "100 mg", "follow_up_response_bt": "No Answer"}, {"question_id": "274.7", "question": "Which agent showed lower analgesic activity compared to nimesulide at a therapeutic dose?", "answer_src": "Meriva", "follow_up_question": "At what dose of curcumin was meriva shown to have analgesic activity?", "follow_up_response": "2 g ( corresponding to 400 mg of curcumin )", "follow_up_response_bt": "2 g"}, {"question_id": "274.8", "question": "How does the analgesic effect of nimesulide differ from that of acetaminophen?", "answer_src": "The analgesic effect of nimesulide is lower than that of acetaminophen.", "follow_up_question": "How does the analgesic effect of meriva compare to that of nimesulide?", "follow_up_response": "lower", "follow_up_response_bt": "No Answer"}, {"question_id": "274.9", "question": "What was the dose of curcumin used in the study?", "answer_src": "400 mg", "follow_up_question": "What was the dose of acetaminophen used in the study?", "follow_up_response": "1 g", "follow_up_response_bt": "No Answer"}, {"question_id": "274.10", "question": "What is the dose of meriva that showed clear analgesic activity?", "answer_src": "2 g ( corresponding to 400 mg of curcumin )", "follow_up_question": "What was the dose of acetaminophen used in the study?", "follow_up_response": "1 g", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "274.11", "question": "What was the dose of nimesulide used in the study?", "answer_src": "100 mg", "follow_up_question": "What was the dose of acetaminophen used in the study?", "follow_up_response": "1 g", "follow_up_response_bt": "No Answer"}, {"question_id": "274.12", "question": "At what dose of curcumin was meriva shown to have analgesic activity?", "answer_src": "2 g ( corresponding to 400 mg of curcumin )", "follow_up_question": "At what dose of nimesulide was shown to have an analgesic activity comparable to meriva?", "follow_up_response": "100 mg", "follow_up_response_bt": "No Answer"}, {"question_id": "274.13", "question": "How does the analgesic effect of meriva compare to that of nimesulide?", "answer_src": "lower", "follow_up_question": "By what factor is the analgesic activity of meriva lower compared to the therapeutic dose of nimesulide?", "follow_up_response": "10", "follow_up_response_bt": "No Answer"}, {"question_id": "274.14", "question": "What was the dose of acetaminophen used in the study?", "answer_src": "1 g", "follow_up_question": "What was the dose of nimesulide used in the study?", "follow_up_response": "100 mg", "follow_up_response_bt": "No Answer"}, {"question_id": "274.15", "question": "What was the dose of acetaminophen used in the study?", "answer_src": "1 g", "follow_up_question": "What was the dose of nimesulide used in the study?", "follow_up_response": "100 mg", "follow_up_response_bt": "No Answer"}]}}
{"id": 275, "src": "backgroundvarious markers are suggested for diagnosis and monitoring of transitional cell carcinoma of the bladder ( tcc ) , including cytokeratins ( cks).objectivesin the present study , the circulating ck18 ( m65 ) and its caspase - cleaved form , ccck18 ( m30 ) , have been investigated in a group of patients with tcc.patients and methodsserum samples were obtained from 60 patients before surgical resection , among which the samples of 26 patients after resection were also included . we measured the levels of soluble m30 and m65 molecules by enzyme - linked immunosorbent assay . the relation between these markers and patients clinical characteristics was evaluated.resultsm30 and m65 in total patient sera were 148 16 u / l and 318 34 u / l , respectively .", "mt": "Sono stati suggeriti vari marcatori per la diagnosi e il monitoraggio del carcinoma cellulare di transizione della vescica (tcc), comprese le citoceratine (cks).Objectively nel presente studio , il ck18 (m65) circolante e la sua forma di cespasiatura , ccck18 (m30), sono stati studiati in un gruppo di pazienti con tcc.pazienti e campioni di metodo sono stati ottenuti da 60 pazienti prima della resezione chirurgica , tra cui i campioni di 26 pazienti dopo la resezione sono stati inclusi . Abbiamo misurato i livelli di molecole solubili m30 e m65 da un assay immunosorbente legato agli enzimi .", "pert_mt": "Sono stati suggeriti vari marcatori per la diagnosi e il monitoraggio del carcinoma cellulare di transizione della vescica (tcc), comprese le citoceratine (cks). Objective nel presente studio, il ck18 (m65) circolante e la sua forma di cespasiatura, ccck18 (m30), sono stati studiati in un gruppo di pazienti con tcc. Pazienti e campioni di metodo sono stati ottenuti da 60 pazienti prima della resezione chirurgica, tra cui i campioni di 26 pazienti dopo la resezione sono stati inclusi. Abbiamo misurato i livelli di molecole solubili m30 e m65 da un assay immunosorbente legato agli enzimi.", "bt": "Various markers have been suggested for the diagnosis and monitoring of cellular transition vesicle carcinoma (tcc), including cytokeratine (cks).The objective of this study, the circulating ck18 (m65) and its cespasiatura form, ccck18 (m30), were studied in a group of patients with tcc. Patients and method samples were obtained from 60 patients prior to surgical resection, including samples from 26 patients after the resection were included.We measured the levels of m30 and m65 soluble molecules by an enzyme-related immunosorbent assay.", "questions_src": ["What is the name of the molecule measured by enzyme-linked immunosorbent assay in the serum samples?", "Who participated in the study, patients with transitional cell carcinoma of the bladder?", "Where were the serum samples obtained from the patients?", "When were the serum samples collected relative to the surgical resection?", "Which molecular forms of CK18 were investigated in the study?"], "answers_src": ["m30 and m65", "patients with transitional cell carcinoma of the bladder", "before surgical resection", "before", "soluble m30 and m65"], "answers_bt": ["ccck18 (m30)", "Patients with transitional cell carcinoma of the bladder", "Prior to surgical resection", "Before the resection", "Circulating ck18 (m65) and its cespasiatura form, ccck18 (m30)"], "multiturn": {"turn_1": [{"question_id": "275.1", "question": "What is the name of the molecule measured by enzyme-linked immunosorbent assay in the serum samples?", "answer_src": "m30 and m65", "follow_up_question": "What is the range of m30 levels in the patient sera?", "follow_up_response": "148–160 u / l", "follow_up_response_bt": "No Answer"}, {"question_id": "275.2", "question": "Who participated in the study, patients with transitional cell carcinoma of the bladder?", "answer_src": "patients with transitional cell carcinoma of the bladder", "follow_up_question": "What was the ratio of m30 to m65 in the total patient sera?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "275.3", "question": "Where were the serum samples obtained from the patients?", "answer_src": "before surgical resection", "follow_up_question": "What was the ratio of m30 to m65 in the total patient sera?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "275.4", "question": "When were the serum samples collected relative to the surgical resection?", "answer_src": "before", "follow_up_question": "After how many days was the first serum sample collected on average before surgery?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "275.5", "question": "Which molecular forms of CK18 were investigated in the study?", "answer_src": "soluble m30 and m65", "follow_up_question": "What was the range of levels for soluble m30 in the patient sera?", "follow_up_response": "148–160 u / l", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "275.6", "question": "What is the range of m30 levels in the patient sera?", "answer_src": "148–160 u / l", "follow_up_question": "What is the range of m65 levels in the patient sera?", "follow_up_response": "318 34 u / l", "follow_up_response_bt": "No Answer"}, {"question_id": "275.7", "question": "What was the ratio of m30 to m65 in the total patient sera?", "answer_src": "backgroundvarious markers are suggested for diagnosis and monitoring of transitional cell carcinoma of the bladder ( tcc ) , including cytokeratins ( cks).objectivesin the present study , the circulating ck18 ( m65 ) and its caspase - cleaved form , ccck18 ( m30 ) , have been investigated in a group of patients with tcc.patients and methodsserum samples were obtained from 60 patients before surgical resection , among which the samples of 26 patients after resection were also included . we measured the levels of soluble m30 and m65 molecules by enzyme - linked immunosorbent assay . the relation between these markers and patients clinical characteristics was evaluated.resultsm30 and m65 in total patient sera were 148 16 u / l and 318 34 u / l , respectively .", "follow_up_question": "What was the average level of m30 in the patient sera?", "follow_up_response": "148.16 u / l", "follow_up_response_bt": "No Answer"}, {"question_id": "275.8", "question": "What was the ratio of m30 to m65 in the total patient sera?", "answer_src": "backgroundvarious markers are suggested for diagnosis and monitoring of transitional cell carcinoma of the bladder ( tcc ) , including cytokeratins ( cks).objectivesin the present study , the circulating ck18 ( m65 ) and its caspase - cleaved form , ccck18 ( m30 ) , have been investigated in a group of patients with tcc.patients and methodsserum samples were obtained from 60 patients before surgical resection , among which the samples of 26 patients after resection were also included . we measured the levels of soluble m30 and m65 molecules by enzyme - linked immunosorbent assay . the relation between these markers and patients clinical characteristics was evaluated.resultsm30 and m65 in total patient sera were 148 16 u / l and 318 34 u / l , respectively .", "follow_up_question": "What was the average level of m30 in the patient sera?", "follow_up_response": "148.16 u / l", "follow_up_response_bt": "No Answer"}, {"question_id": "275.9", "question": "After how many days was the first serum sample collected on average before surgery?", "answer_src": "backgroundvarious markers are suggested for diagnosis and monitoring of transitional cell carcinoma of the bladder ( tcc ) , including cytokeratins ( cks).objectivesin the present study , the circulating ck18 ( m65 ) and its caspase - cleaved form , ccck18 ( m30 ) , have been investigated in a group of patients with tcc.patients and methodsserum samples were obtained from 60 patients before surgical resection , among which the samples of 26 patients after resection were also included . we measured the levels of soluble m30 and m65 molecules by enzyme - linked immunosorbent assay . the relation between these markers and patients clinical characteristics was evaluated.resultsm30 and m65 in total patient sera were 148 16 u / l and 318 34 u / l , respectively .", "follow_up_question": "What was the average level of soluble m30 in the patient sera?", "follow_up_response": "148.16 u / l", "follow_up_response_bt": "No Answer"}, {"question_id": "275.10", "question": "What was the range of levels for soluble m30 in the patient sera?", "answer_src": "148–160 u / l", "follow_up_question": "What was the range of levels for soluble m65 in the patient sera?", "follow_up_response": "318 34 u / l", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "275.11", "question": "What is the range of m65 levels in the patient sera?", "answer_src": "318 34 u / l", "follow_up_question": "What is the average level of m30 in the patient sera?", "follow_up_response": "148.16 u / l", "follow_up_response_bt": "No Answer"}, {"question_id": "275.12", "question": "What was the average level of m30 in the patient sera?", "answer_src": "148.16 u / l", "follow_up_question": "What was the average level of m65 in the patient sera?", "follow_up_response": "318 34 u / l", "follow_up_response_bt": "No Answer"}, {"question_id": "275.13", "question": "What was the average level of m30 in the patient sera?", "answer_src": "148.16 u / l", "follow_up_question": "What was the average level of m65 in the patient sera?", "follow_up_response": "318 34 u / l", "follow_up_response_bt": "No Answer"}, {"question_id": "275.14", "question": "What was the average level of soluble m30 in the patient sera?", "answer_src": "148.16 u / l", "follow_up_question": "What was the average level of soluble m65 in the patient sera?", "follow_up_response": "318 34 u / l", "follow_up_response_bt": "No Answer"}, {"question_id": "275.15", "question": "What was the range of levels for soluble m65 in the patient sera?", "answer_src": "318 34 u / l", "follow_up_question": "What was the average level of soluble m30 in the patient sera?", "follow_up_response": "148.16 u / l", "follow_up_response_bt": "No Answer"}]}}
{"id": 276, "src": "mycotic aneurysm is a disease requiring immediate treatment because of the high risk of rupture . a difficult surgical approach , especially in the case of occurrence on the iliac artery , involving endovascular embolization and extra - anatomic bypass grafting , is known to be a suitable treatment . we performed extra - anatomic bypass grafting after endovascular embolization successfully in two patients .", "mt": "Un approccio chirurgico difficile , soprattutto nel caso di una embolizzazione endovascolare e di un impianto di bypass extra-anatomico , è noto per essere un trattamento appropriato . Abbiamo eseguito con successo un impianto di bypass extra-anatomico dopo l'embolizzazione endovascolare in due pazienti .", "pert_mt": "Un approccio chirurgico difficile, soprattuto nel caso di una embolizzazione endovascolare e di un impianto di bypass extra-anatomico, è noto per essere un trattamento appropriato. Abbiamo eseguito con successo un impianto di bypass extra-anatomico dopo l'embolizzazione endovascolare in due pazienti, e questo ha portato a risultati positivi nella riduzione dei sintomi.", "bt": "A difficult surgical approach, especially in the case of an endovascular embolism and an extra-anatomical bypass implant, is known to be an appropriate treatment.We have successfully performed an extra-anatomical bypass implant after endovascular embolism in two patients, and this has led to positive results in reducing symptoms.", "questions_src": ["What is the name of the disease requiring immediate treatment?", "Who is involved in the difficult surgical approach for mycotic aneurysm?", "Where is the difficult surgical approach typically performed?", "When is endovascular embolization used in treating mycotic aneurysms?", "Which type of surgery was performed in two patients?"], "answers_src": ["mycotic aneurysm", "Endovascular embolization and extra-anatomic bypass grafting", "Iliac artery", "In the case of occurrence on the iliac artery", "Extra-anatomic bypass grafting"], "answers_bt": ["Endovascular embolism", "Two patients", "Extra-anatomically", "Immediately", "Extra-anatomical bypass implant"], "multiturn": {"turn_1": [{"question_id": "276.1", "question": "What is the name of the disease requiring immediate treatment?", "answer_src": "mycotic aneurysm", "follow_up_question": "What type of surgical approach was used in the successful treatment of the two patients?", "follow_up_response": "extra-anatomic bypass grafting", "follow_up_response_bt": "extra-anatomical bypass implant"}, {"question_id": "276.2", "question": "Who is involved in the difficult surgical approach for mycotic aneurysm?", "answer_src": "Endovascular embolization and extra-anatomic bypass grafting", "follow_up_question": "What specific artery was the mycotic aneurysm located in for the two patients?", "follow_up_response": "iliac artery", "follow_up_response_bt": "No Answer"}, {"question_id": "276.3", "question": "Where is the difficult surgical approach typically performed?", "answer_src": "Iliac artery", "follow_up_question": "What specific procedure was performed after endovascular embolization?", "follow_up_response": "extra - anatomic bypass grafting", "follow_up_response_bt": "An extra-anatomical bypass implant"}, {"question_id": "276.4", "question": "When is endovascular embolization used in treating mycotic aneurysms?", "answer_src": "In the case of occurrence on the iliac artery", "follow_up_question": "What specific procedure was performed after endovascular embolization in the two patients?", "follow_up_response": "extra - anatomic bypass grafting", "follow_up_response_bt": "An extra-anatomical bypass implant"}, {"question_id": "276.5", "question": "Which type of surgery was performed in two patients?", "answer_src": "Extra-anatomic bypass grafting", "follow_up_question": "What was the first step taken in the successful treatment of the two patients?", "follow_up_response": "Endovascular embolization", "follow_up_response_bt": "An extra-anatomical bypass implant"}], "turn_2": [{"question_id": "276.6", "question": "What type of surgical approach was used in the successful treatment of the two patients?", "answer_src": "extra-anatomic bypass grafting", "follow_up_question": "What was the initial procedure performed before the extra-anatomic bypass grafting?", "follow_up_response": "Endovascular embolization", "follow_up_response_bt": "Endovascular embolism"}, {"question_id": "276.7", "question": "What specific artery was the mycotic aneurysm located in for the two patients?", "answer_src": "iliac artery", "follow_up_question": "What type of bypass grafting was used in the procedure?", "follow_up_response": "extra-anatomic bypass grafting", "follow_up_response_bt": "extra-anatomical bypass implant"}, {"question_id": "276.8", "question": "What specific procedure was performed after endovascular embolization?", "answer_src": "extra - anatomic bypass grafting", "follow_up_question": "What was the reason for choosing extra-anatomic bypass grafting over traditional surgical approaches?", "follow_up_response": "No Answer", "follow_up_response_bt": "A difficult surgical approach"}, {"question_id": "276.9", "question": "What specific procedure was performed after endovascular embolization in the two patients?", "answer_src": "extra - anatomic bypass grafting", "follow_up_question": "What were the risks associated with not performing the extra-anatomic bypass grafting as a follow-up to endovascular embolization?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "276.10", "question": "What was the first step taken in the successful treatment of the two patients?", "answer_src": "Endovascular embolization", "follow_up_question": "What type of extra-anatomic bypass grafting was used in the treatment?", "follow_up_response": "extra-anatomic bypass grafting", "follow_up_response_bt": "extra-anatomical bypass implant"}], "turn_3": [{"question_id": "276.11", "question": "What was the initial procedure performed before the extra-anatomic bypass grafting?", "answer_src": "Endovascular embolization", "follow_up_question": "What type of extra-anatomic bypass grafting was used in the two patients?", "follow_up_response": "extra-anatomic bypass grafting", "follow_up_response_bt": "extra-anatomical bypass implant"}, {"question_id": "276.12", "question": "What type of bypass grafting was used in the procedure?", "answer_src": "extra-anatomic bypass grafting", "follow_up_question": "What was the first step taken in the successful procedure?", "follow_up_response": "Endovascular embolization", "follow_up_response_bt": "An extra-anatomical bypass implant"}, {"question_id": "276.13", "question": "What was the reason for choosing extra-anatomic bypass grafting over traditional surgical approaches?", "answer_src": "mycotic aneurysm is a disease requiring immediate treatment because of the high risk of rupture . a difficult surgical approach , especially in the case of occurrence on the iliac artery , involving endovascular embolization and extra - anatomic bypass grafting , is known to be a suitable treatment . we performed extra - anatomic bypass grafting after endovascular embolization successfully in two patients .", "follow_up_question": "Why was endovascular embolization performed before the extra-anatomic bypass grafting?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "276.14", "question": "What were the risks associated with not performing the extra-anatomic bypass grafting as a follow-up to endovascular embolization?", "answer_src": "mycotic aneurysm is a disease requiring immediate treatment because of the high risk of rupture . a difficult surgical approach , especially in the case of occurrence on the iliac artery , involving endovascular embolization and extra - anatomic bypass grafting , is known to be a suitable treatment . we performed extra - anatomic bypass grafting after endovascular embolization successfully in two patients .", "follow_up_question": "What specific procedure did you perform after endovascular embolization in the two patients?", "follow_up_response": "extra - anatomic bypass grafting", "follow_up_response_bt": "An extra-anatomical bypass implant"}, {"question_id": "276.15", "question": "What type of extra-anatomic bypass grafting was used in the treatment?", "answer_src": "extra-anatomic bypass grafting", "follow_up_question": "What was the outcome of the endovascular embolization procedure?", "follow_up_response": "Successful", "follow_up_response_bt": "Positive results in reducing symptoms"}]}}
{"id": 277, "src": "the aim of the present study was to determine the demographics and clinical treatment - related variables associated with long - term ( 90-month ) overall survival in patients with lung metastases undergoing pulmonary metastasectomy from soft tissue sarcomas.we performed a retrospective review of patients admitted in the thoracic surgery department with lung metastases who underwent thoracotomy for resection following treatment of the primary tumor . data regarding primary tumor features , demographics , treatment , and outcome were collected.one hundred twenty - two thoracotomies and 273 nodules were resected from 77 patients with previously treated soft tissue sarcomas . the median follow - up time of all patients was 36.7 months ( range : 10 - 138 months ) .", "mt": "Lo scopo del presente studio era quello di determinare la demografia e il trattamento clinico - variabili correlate associate alla sopravvivenza complessiva a lungo termine (90 mesi) di pazienti con metastasi polmonari sottoposti a metastasectomia polmonare da sarcomati di tessuto molle. abbiamo eseguito una revisione retrospettiva dei pazienti ammessi nel reparto di chirurgia toracica con metastasi polmonari che hanno subito la toracotomia per la resezione dopo il trattamento del tumore primario . Sono stati raccolti dati riguardanti le caratteristiche primarie , la demografia , il trattamento e il risultato tumorale. Sono stati reseciti cento ventidue toracotomie e 273 noduli da 77 pazienti con sarcomati di tessuto molle . Il tempo medio di follow-up di tutti i pazienti è stato di 36,7 mesi (10 - 138 mesi):", "pert_mt": "Lo scopo del presente studio era quello di determinare la demografia e il trattamento clinico - variabili correlate associate alla sopravvivenza complessiva a lungo termine (90 mesi) di pazienti con metastasi polmonari sottoposti a metastasectomia polmonare da sarcomati di tessuto molle. Abbiamo eseguito una revisione retrospettiva dei pazienti ammessi nel reparto di chirurgia toracica con metastasi polmonari che hanno subito la toracotomia per la resezione dopo il trattamento del tumore primario. Sono stati raccolti dati riguardanti le caratteristiche primarie, la demografia, il trattamento e il risultato tumorale. Sono stati reseciti cento ventidue toracotomie e 273 noduli da 77 pazienti con", "bt": "The purpose of this study was to determine the demographics and clinical treatment - correlated variables associated with the overall long-term survival (90 months) of patients with pulmonary metastasis undergoing pulmonary metastasectomy and soft tissue sarcomas.We conducted a retrospective review of patients admitted to the chest surgery department with pulmonary metastasis who had undergone chest surgery for the resection after treatment of the primary tumor.Data on the primary characteristics, demography, treatment and tumor outcome were collected.One hundred ventilated chest resections and 273 nodes were performed on 77 patients with a total of 77 tumours.", "questions_src": ["What was the aim of the present study?", "Who were the patients included in the study?", "Where did the data collection take place?", "How many patients were included in the study?", "What is the median follow-up time for the patients?"], "answers_src": ["to determine the demographics and clinical treatment - related variables associated with long - term ( 90-month ) overall survival in patients with lung metastases undergoing pulmonary metastasectomy from soft tissue sarcomas", "patients with previously treated soft tissue sarcomas", "in the thoracic surgery department", "77", "36.7 months"], "answers_bt": ["To determine the demographics and clinical treatment - correlated variables associated with the overall long-term survival (90 months) of patients with pulmonary metastasis undergoing pulmonary metastasectomy and soft tissue sarcomas", "Patients admitted to the chest surgery department with pulmonary metastasis who had undergone chest surgery for the resection after treatment of the primary tumor", "The chest surgery department", "77", "No Answer"], "multiturn": {"turn_1": [{"question_id": "277.1", "question": "What was the aim of the present study?", "answer_src": "to determine the demographics and clinical treatment - related variables associated with long - term ( 90-month ) overall survival in patients with lung metastases undergoing pulmonary metastasectomy from soft tissue sarcomas", "follow_up_question": "What was the median follow-up time of all patients?", "follow_up_response": "36.7 months", "follow_up_response_bt": "No Answer"}, {"question_id": "277.2", "question": "Who were the patients included in the study?", "answer_src": "patients with previously treated soft tissue sarcomas", "follow_up_question": "What was the median follow-up time for the patients in months?", "follow_up_response": "36.7", "follow_up_response_bt": "No Answer"}, {"question_id": "277.3", "question": "Where did the data collection take place?", "answer_src": "in the thoracic surgery department", "follow_up_question": "What was the median follow-up time for the patients?", "follow_up_response": "36.7 months", "follow_up_response_bt": "No Answer"}, {"question_id": "277.4", "question": "How many patients were included in the study?", "answer_src": "77", "follow_up_question": "How many nodules were resected from the patients?", "follow_up_response": "273", "follow_up_response_bt": "273"}, {"question_id": "277.5", "question": "What is the median follow-up time for the patients?", "answer_src": "36.7 months", "follow_up_question": "What is the range of follow-up times for the patients?", "follow_up_response": "10 - 138 months", "follow_up_response_bt": "90 months"}], "turn_2": [{"question_id": "277.6", "question": "What was the median follow-up time of all patients?", "answer_src": "36.7 months", "follow_up_question": "What was the range of follow-up times for the patients?", "follow_up_response": "10 - 138 months", "follow_up_response_bt": "90 months"}, {"question_id": "277.7", "question": "What was the median follow-up time for the patients in months?", "answer_src": "36.7", "follow_up_question": "What was the range of follow-up times for the patients in months?", "follow_up_response": "10 - 138 months", "follow_up_response_bt": "No Answer"}, {"question_id": "277.8", "question": "What was the median follow-up time for the patients?", "answer_src": "36.7 months", "follow_up_question": "What was the range of follow-up times for the patients?", "follow_up_response": "10 - 138 months", "follow_up_response_bt": "90 months"}, {"question_id": "277.9", "question": "How many nodules were resected from the patients?", "answer_src": "273", "follow_up_question": "How many patients had their primary tumors previously treated?", "follow_up_response": "77", "follow_up_response_bt": "77"}, {"question_id": "277.10", "question": "What is the range of follow-up times for the patients?", "answer_src": "10 - 138 months", "follow_up_question": "What was the median follow-up time for the patients?", "follow_up_response": "36.7 months", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "277.11", "question": "What was the range of follow-up times for the patients?", "answer_src": "10 - 138 months", "follow_up_question": "What was the median follow-up time for the patients?", "follow_up_response": "36.7 months", "follow_up_response_bt": "No Answer"}, {"question_id": "277.12", "question": "What was the range of follow-up times for the patients in months?", "answer_src": "10 - 138 months", "follow_up_question": "What was the median follow-up time for the patients in months?", "follow_up_response": "36.7", "follow_up_response_bt": "No Answer"}, {"question_id": "277.13", "question": "What was the range of follow-up times for the patients?", "answer_src": "10 - 138 months", "follow_up_question": "What was the median follow-up time for the patients?", "follow_up_response": "36.7 months", "follow_up_response_bt": "No Answer"}, {"question_id": "277.14", "question": "How many patients had their primary tumors previously treated?", "answer_src": "77", "follow_up_question": "How many nodules were resected in total?", "follow_up_response": "273", "follow_up_response_bt": "273"}, {"question_id": "277.15", "question": "What was the median follow-up time for the patients?", "answer_src": "36.7 months", "follow_up_question": "What was the range of follow-up times for the patients?", "follow_up_response": "10 - 138 months", "follow_up_response_bt": "90 months"}]}}
{"id": 278, "src": "lrygb included crural repair , creation of a small gastric pouch ( 30 ml ) , and intestinal bypass ( 150 to 180 cm ) . all patients were followed in clinic and by telephone.from february 1999 to april 2001 , 57 patients ( 51 f , 6 m ) with a mean age of 43 ( range , 22 to 67 ) and a median bmi of 43 underwent lrygbp . hiatal hernia or esophagitis , or both , were present in 48 , barrett 's in 2 .", "mt": "L' lrygb includeva la riparazione crurale , la creazione di una piccola sacca gastrica (30 ml) e il bypass intestinale (150 a 180 cm) . tutti i pazienti sono stati seguiti in clinica e per telefono.Da febbraio 1999 ad aprile 2001 , 57 pazienti (51 f , 6 m) con un' età media di 43 anni (intervallo , 22 a 67) e un BMI medio di 43 hanno subito lrygbp . Ernia hiatale o esofagite , o entrambi , erano presenti in 48 , barrett 's in 2 .", "pert_mt": "L' lrygb includeva la riparazione crurale, la creazione di una piccola sacca gastrica (30 ml), e il bypass intestinale (150 a 180 cm). Tutti i pazienti sono stati seguiti in clinica e per telefono. Da febbraio 1999 ad aprile 2001, 57 pazienti (51 f, 6 m) con un' età media di 43 anni (intervallo, 22 a 67) e un BMI medio di 43 hanno subito l'LRYPB. Ernia hiatale o esofagite, o entrambi, erano presenti in 48, barrett's in 2.", "bt": "The study included crural repair, the creation of a small stomach pouch (30 ml), and intestinal bypass (150 to 180 cm).All patients were followed in clinic and by telephone.From February 1999 to April 2001, 57 patients (51 f, 6 m) with an average age of 43 years (interval, 22 to 67) and an average BMI of 43 had LRYPB.Hiatal hernias or esophagitis, or both, were present in 48, barrett's in 2.", "questions_src": ["What was the mean age of the patients?", "How many patients had hiatal hernia or esophagitis?", "What was the median BMI of the patients?", "In what range did the patients' ages fall?", "Who conducted the procedure?"], "answers_src": ["43", "48", "43", "range , 22 to 67", "lrygb"], "answers_bt": ["43 years", "48", "No Answer", "22 to 67", "The study"], "multiturn": {"turn_1": [{"question_id": "278.1", "question": "What was the mean age of the patients?", "answer_src": "43", "follow_up_question": "What was the range of ages for the patients?", "follow_up_response": "22 to 67", "follow_up_response_bt": "22 to 67"}, {"question_id": "278.2", "question": "How many patients had hiatal hernia or esophagitis?", "answer_src": "48", "follow_up_question": "How many patients had Barrett's esophagus?", "follow_up_response": "2", "follow_up_response_bt": "2"}, {"question_id": "278.3", "question": "What was the median BMI of the patients?", "answer_src": "43", "follow_up_question": "What was the range of ages for the patients?", "follow_up_response": "22 to 67", "follow_up_response_bt": "22 to 67"}, {"question_id": "278.4", "question": "In what range did the patients' ages fall?", "answer_src": "range , 22 to 67", "follow_up_question": "What was the median Body Mass Index (BMI) of the patients?", "follow_up_response": "43", "follow_up_response_bt": "No Answer"}, {"question_id": "278.5", "question": "Who conducted the procedure?", "answer_src": "lrygb", "follow_up_question": "What was the average age of the patients?", "follow_up_response": "43", "follow_up_response_bt": "43"}], "turn_2": [{"question_id": "278.6", "question": "What was the range of ages for the patients?", "answer_src": "22 to 67", "follow_up_question": "What percentage of patients had hiatal hernia or esophagitis?", "follow_up_response": "48%", "follow_up_response_bt": "48"}, {"question_id": "278.7", "question": "How many patients had Barrett's esophagus?", "answer_src": "2", "follow_up_question": "How many patients had hiatal hernia or esophagitis?", "follow_up_response": "48", "follow_up_response_bt": "48"}, {"question_id": "278.8", "question": "What was the range of ages for the patients?", "answer_src": "22 to 67", "follow_up_question": "What percentage of patients had hiatal hernia or esophagitis?", "follow_up_response": "48%", "follow_up_response_bt": "48"}, {"question_id": "278.9", "question": "What was the median Body Mass Index (BMI) of the patients?", "answer_src": "43", "follow_up_question": "What percentage of patients had Barrett's esophagus?", "follow_up_response": "2", "follow_up_response_bt": "2"}, {"question_id": "278.10", "question": "What was the average age of the patients?", "answer_src": "43", "follow_up_question": "What was the range of ages for the patients?", "follow_up_response": "22 to 67", "follow_up_response_bt": "22 to 67"}], "turn_3": [{"question_id": "278.11", "question": "What percentage of patients had hiatal hernia or esophagitis?", "answer_src": "48%", "follow_up_question": "In how many patients did Barrett's esophagus occur?", "follow_up_response": "2", "follow_up_response_bt": "2"}, {"question_id": "278.12", "question": "How many patients had hiatal hernia or esophagitis?", "answer_src": "48", "follow_up_question": "How many patients had Barrett's esophagus?", "follow_up_response": "2", "follow_up_response_bt": "2"}, {"question_id": "278.13", "question": "What percentage of patients had hiatal hernia or esophagitis?", "answer_src": "48%", "follow_up_question": "In how many patients did Barrett's esophagus occur?", "follow_up_response": "2", "follow_up_response_bt": "2"}, {"question_id": "278.14", "question": "What percentage of patients had Barrett's esophagus?", "answer_src": "2", "follow_up_question": "What was the average age of the patients who had Barrett's esophagus?", "follow_up_response": "43", "follow_up_response_bt": "No Answer"}, {"question_id": "278.15", "question": "What was the range of ages for the patients?", "answer_src": "22 to 67", "follow_up_question": "What percentage of patients had hiatal hernia or esophagitis?", "follow_up_response": "48%", "follow_up_response_bt": "48"}]}}
{"id": 279, "src": "results pca was diagnosed in 25 of 106 patients ( 23.6% ) : 16 ( 25.0% ) in g1 and 9 ( 21.4% ) in g2 ( p>0.05 ) . psa normalization was experienced in 24.5% . in g1 , psa returned to < 4ng / ml in 15 ( 23.4% ) patients compared to 11 ( 26% ) patients in g2 .", "mt": "I risultati pca sono stati diagnosticati in 25 dei 106 pazienti (23,6%): 16 ( 25,0%) in g1 e 9 ( 21,4%) in g2 (p>0,05).", "pert_mt": "I risultati pca sono stati diagnosticati in 25 dei 106 pazienti (23,6%): 16 (25,0%) in g1, 9 (21,4%) in g2 (p>0,05) e nel gruppo di controllo non ne sono stati diagnosticati nessuno.", "bt": "The results of pca were diagnosed in 25 of the 106 patients (23.6%): 16 (25.0%) in g1, 9 (21.4%) in g2 (p>0.05) and in the control group no one was diagnosed.", "questions_src": ["What percentage of patients had results PCA diagnosed?", "In which group did PSA normalization occur in 24.5% of patients?", "How many patients in group G1 had PSA return to less than 4 ng/ml?", "When was PSA normalization experienced for patients in group G2?", "Which group had a higher percentage of patients with PSA returning to less than 4 ng/ml?"], "answers_src": ["23.6%", "No Answer", "15", "No Answer", "G1"], "answers_bt": ["23.6%", "No Answer", "16", "No Answer", "Group G1"], "multiturn": {"turn_1": [{"question_id": "279.1", "question": "What percentage of patients had results PCA diagnosed?", "answer_src": "23.6%", "follow_up_question": "In group G1, what percentage of patients saw their PSA return to less than 4 ng/ml?", "follow_up_response": "23.4%", "follow_up_response_bt": "No Answer"}, {"question_id": "279.2", "question": "In which group did PSA normalization occur in 24.5% of patients?", "answer_src": "results pca was diagnosed in 25 of 106 patients ( 23.6% ) : 16 ( 25.0% ) in g1 and 9 ( 21.4% ) in g2 ( p>0.05 ) . psa normalization was experienced in 24.5% . in g1 , psa returned to < 4ng / ml in 15 ( 23.4% ) patients compared to 11 ( 26% ) patients in g2 .", "follow_up_question": "In what percentage of G1 patients did PSA return to < 4ng/ml?", "follow_up_response": "23.4%", "follow_up_response_bt": "No Answer"}, {"question_id": "279.3", "question": "How many patients in group G1 had PSA return to less than 4 ng/ml?", "answer_src": "15", "follow_up_question": "How many more patients in group G1 had PSA return to less than 4 ng/ml compared to group G2?", "follow_up_response": "2", "follow_up_response_bt": "No Answer"}, {"question_id": "279.4", "question": "When was PSA normalization experienced for patients in group G2?", "answer_src": "results pca was diagnosed in 25 of 106 patients ( 23.6% ) : 16 ( 25.0% ) in g1 and 9 ( 21.4% ) in g2 ( p>0.05 ) . psa normalization was experienced in 24.5% . in g1 , psa returned to < 4ng / ml in 15 ( 23.4% ) patients compared to 11 ( 26% ) patients in g2 .", "follow_up_question": "What percentage of patients in group G1 had PSA return to < 4ng/ml?", "follow_up_response": "23.4%", "follow_up_response_bt": "No Answer"}, {"question_id": "279.5", "question": "Which group had a higher percentage of patients with PSA returning to less than 4 ng/ml?", "answer_src": "G1", "follow_up_question": "In G1, how many more patients had their PSA return to less than 4 ng/ml compared to G2?", "follow_up_response": "2", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "279.6", "question": "In group G1, what percentage of patients saw their PSA return to less than 4 ng/ml?", "answer_src": "23.4%", "follow_up_question": "In group G2, what percentage of patients saw their PSA return to less than 4 ng/ml?", "follow_up_response": "26%", "follow_up_response_bt": "No Answer"}, {"question_id": "279.7", "question": "In what percentage of G1 patients did PSA return to < 4ng/ml?", "answer_src": "23.4%", "follow_up_question": "In what percentage of G2 patients did PSA return to < 4ng/ml?", "follow_up_response": "21.4%", "follow_up_response_bt": "No Answer"}, {"question_id": "279.8", "question": "How many more patients in group G1 had PSA return to less than 4 ng/ml compared to group G2?", "answer_src": "2", "follow_up_question": "How many more patients in group G1 had PSA levels normalized compared to group G2?", "follow_up_response": "9", "follow_up_response_bt": "No Answer"}, {"question_id": "279.9", "question": "What percentage of patients in group G1 had PSA return to < 4ng/ml?", "answer_src": "23.4%", "follow_up_question": "What was the percentage of patients in group G2 who had PSA return to < 4ng/ml?", "follow_up_response": "21.4%", "follow_up_response_bt": "No Answer"}, {"question_id": "279.10", "question": "In G1, how many more patients had their PSA return to less than 4 ng/ml compared to G2?", "answer_src": "2", "follow_up_question": "How many more patients in G1 had PSA levels normalized to less than 4 ng/ml compared to G2?", "follow_up_response": "8", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "279.11", "question": "In group G2, what percentage of patients saw their PSA return to less than 4 ng/ml?", "answer_src": "26%", "follow_up_question": "What was the overall percentage of patients in group G1 whose PSA normalized to less than 4 ng/ml?", "follow_up_response": "23.4%", "follow_up_response_bt": "No Answer"}, {"question_id": "279.12", "question": "In what percentage of G2 patients did PSA return to < 4ng/ml?", "answer_src": "21.4%", "follow_up_question": "In how many G1 patients did PSA return to < 4ng/ml?", "follow_up_response": "15", "follow_up_response_bt": "No Answer"}, {"question_id": "279.13", "question": "How many more patients in group G1 had PSA levels normalized compared to group G2?", "answer_src": "9", "follow_up_question": "In how many more patients in group G1 did PSA return to less than 4 ng/ml compared to group G2?", "follow_up_response": "2", "follow_up_response_bt": "No Answer"}, {"question_id": "279.14", "question": "What was the percentage of patients in group G2 who had PSA return to < 4ng/ml?", "answer_src": "21.4%", "follow_up_question": "What was the difference in percentage of patients in group G1 and G2 who had PSA return to < 4ng/ml?", "follow_up_response": "-2.6%", "follow_up_response_bt": "No Answer"}, {"question_id": "279.15", "question": "How many more patients in G1 had PSA levels normalized to less than 4 ng/ml compared to G2?", "answer_src": "8", "follow_up_question": "How many more patients in G1 had PSA levels below 4 ng/ml compared to G2?", "follow_up_response": "2", "follow_up_response_bt": "No Answer"}]}}
{"id": 280, "src": "there is significant epidemiological evidence to suggest that there are beneficial effects of treatment with non - steroidal anti - inflammatory drugs ( nsaids ) in alzheimer 's disease , although these effects have not been reproduced in clinical trials . the failure of the clinical trials may be attributed to several possible facts : ( 1 ) nsaids may have been delivered too late to patients , as they may only be effective in early stages of the disease and possibly counterproductive in the late stages ; ( 2 ) the beneficial effect may depend on the drug , because different nsaids may have different molecular targets ; ( 3 ) the nsaid concentration reaching the brain and the duration of the treatment could also be critical , so increasing drug penetration is important in order to improve the efficacy and avoid secondary gastro - intestinal effects of the nsaids . in this report we analyze these different factors , with special emphasis on the role of nsaids in microglia activation over time .", "mt": "Il fallimento degli studi clinici può essere attribuito a diversi fatti possibili: (i) gli esauri possono essere stati consegnati troppo tardi ai pazienti , in quanto possono essere efficaci solo nelle fasi iniziali della malattia e possibilmente contra-produttivi nelle fasi finali; (ii) l'effetto positivo può dipendere dal farmaco , perché diversi esauri possono avere obiettivi molecolari diversi; (iv) la concentrazione del esauri raggiungendo il cervello e la durata del trattamento potrebbe essere cruciale , quindi aumentare la penetrazione è importante per migliorare l' efficacia e evitare l' accentuamento secondario gastrointestinale degli esauri .", "pert_mt": "Il fallimento degli studi clinici può essere attribuito a diversi fatti possibili: (i) gli esauri possono essere stati consegnati troppo tardi ai pazienti, in quanto possono essere efficaci solo nelle fasi iniziali della malattia e possibilmente contra-produttivi nelle fasi finali; (ii) l'effetto positivo può dipendere dal farmaco, perché diversi esauri possono avere obiettivi molecolari diversi; (iv) la concentrazione dei esauri raggiungendo il cervello e la durata del trattamento potrebbe essere cruciale, quindi aumentare la penetrazione è importante per migliorare l'efficacia e evitare l'accrescimento secondario gastrointestinale degli esauri.", "bt": "The failure of clinical trials can be attributed to several possible factors: (i) the rashes may have been delivered too late to patients, as they may be effective only in the early stages of the disease and possibly counterproductive in the final stages; (ii) the positive effect may depend on the pharmacist, because different rashes may have different molecular goals; (iv) the concentration of rashes reaching the brain and the duration of treatment may be crucial, so increasing penetration is important to improve efficacy and avoid secondary gastrointestinal growth of rashes.", "questions_src": ["What are non-steroidal anti-inflammatory drugs (NSAIDs) used for according to the sentence?", "Who may benefit from treatment with NSAIDs in Alzheimer's disease based on the provided information?", "Where do the beneficial effects of NSAIDs in Alzheimer's disease occur according to the text?", "When might NSAIDs be most effective in treating Alzheimer's disease according to the given information?", "Which factor could be critical for improving the efficacy of NSAIDs in Alzheimer's disease treatment, as mentioned in the report?"], "answers_src": ["treatment with non-steroidal anti-inflammatory drugs (nSAIDs)", "patients in early stages of the disease", "in the brain", "early stages of the disease", "the concentration reaching the brain and the duration of the treatment"], "answers_bt": ["[\"the rashes may have been delivered too late to patients\"], [\"the pharmacist\"], [\"the brain\"], [\"only in the early stages of the disease\"], [\"increasing penetration\"]]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "280.1", "question": "What are non-steroidal anti-inflammatory drugs (NSAIDs) used for according to the sentence?", "answer_src": "treatment with non-steroidal anti-inflammatory drugs (nSAIDs)", "follow_up_question": "What factor related to NSAIDs' effectiveness is discussed in the text?", "follow_up_response": "the failure of the clinical trials may be attributed to several possible facts", "follow_up_response_bt": "The rashes may have been delivered too late to patients, the positive effect may depend on the pharmacist, and the concentration of rashes reaching the brain and the duration of treatment may be crucial"}, {"question_id": "280.2", "question": "Who may benefit from treatment with NSAIDs in Alzheimer's disease based on the provided information?", "answer_src": "patients in early stages of the disease", "follow_up_question": "What factor related to NSAID delivery might explain the failure of clinical trials?", "follow_up_response": "NSAIDs may have been delivered too late to patients, as they may only be effective in early stages of the disease and possibly counterproductive in the late stages", "follow_up_response_bt": "the rashes may have been delivered too late to patients"}, {"question_id": "280.3", "question": "Where do the beneficial effects of NSAIDs in Alzheimer's disease occur according to the text?", "answer_src": "in the brain", "follow_up_question": "How does the timing of NSAID delivery affect their effectiveness in treating Alzheimer's disease?", "follow_up_response": "NSAIDs may have been delivered too late to patients, as they may only be effective in early stages of the disease and possibly counterproductive in the late stages", "follow_up_response_bt": "The rashes may have been delivered too late to patients, as they may be effective only in the early stages of the disease and possibly counterproductive in the final stages"}, {"question_id": "280.4", "question": "When might NSAIDs be most effective in treating Alzheimer's disease according to the given information?", "answer_src": "early stages of the disease", "follow_up_question": "What factor related to NSAIDs' effectiveness might differ between early and late stages of Alzheimer's disease?", "follow_up_response": "NSAIDs may have been delivered too late to patients, as they may only be effective in early stages of the disease and possibly counterproductive in the late stages", "follow_up_response_bt": "The rashes may have been delivered too late to patients, as they may be effective only in the early stages of the disease and possibly counterproductive in the final stages"}, {"question_id": "280.5", "question": "Which factor could be critical for improving the efficacy of NSAIDs in Alzheimer's disease treatment, as mentioned in the report?", "answer_src": "the concentration reaching the brain and the duration of the treatment", "follow_up_question": "How does the timing of NSAID delivery relate to their effectiveness in Alzheimer's disease according to the report?", "follow_up_response": "NSAIDs may have been delivered too late to patients, as they may only be effective in early stages of the disease and possibly counterproductive in the late stages", "follow_up_response_bt": "The rashes may have been delivered too late to patients, as they may be effective only in the early stages of the disease and possibly counterproductive in the final stages"}], "turn_2": [{"question_id": "280.6", "question": "What factor related to NSAIDs' effectiveness is discussed in the text?", "answer_src": "the failure of the clinical trials may be attributed to several possible facts", "follow_up_question": "What are the three possible reasons mentioned for the failure of clinical trials with NSAIDs?", "follow_up_response": "(1) NSAIDs may have been delivered too late to patients, as they may only be effective in early stages of the disease and possibly counterproductive in the late stages; (2) the beneficial effect may depend on the drug, because different NSAIDs may have different molecular targets; (3) the NSAID concentration reaching the brain and the duration of the treatment could also be critical", "follow_up_response_bt": "The rashes may have been delivered too late to patients, the positive effect may depend on the pharmacist, and the concentration of rashes reaching the brain and the duration of treatment may be crucial"}, {"question_id": "280.7", "question": "What factor related to NSAID delivery might explain the failure of clinical trials?", "answer_src": "NSAIDs may have been delivered too late to patients, as they may only be effective in early stages of the disease and possibly counterproductive in the late stages", "follow_up_question": "How does the timing of NSAID delivery affect their effectiveness in Alzheimer's disease?", "follow_up_response": "NSAIDs may have been delivered too late to patients, as they may only be effective in early stages of the disease and possibly counterproductive in the late stages", "follow_up_response_bt": "The rashes may have been delivered too late to patients, as they may be effective only in the early stages of the disease and possibly counterproductive in the final stages"}, {"question_id": "280.8", "question": "How does the timing of NSAID delivery affect their effectiveness in treating Alzheimer's disease?", "answer_src": "NSAIDs may have been delivered too late to patients, as they may only be effective in early stages of the disease and possibly counterproductive in the late stages", "follow_up_question": "What other factors besides timing might influence the effectiveness of NSAIDs in treating Alzheimer's disease?", "follow_up_response": "the drug may have different molecular targets\", \"the nsaid concentration reaching the brain and the duration of the treatment could also be critical", "follow_up_response_bt": "the pharmacist, because different rashes may have different molecular goals\", \"the concentration of rashes reaching the brain and the duration of treatment may be crucial\", \"increasing penetration is important to improve efficacy and avoid secondary gastrointestinal growth of rashes"}, {"question_id": "280.9", "question": "What factor related to NSAIDs' effectiveness might differ between early and late stages of Alzheimer's disease?", "answer_src": "NSAIDs may have been delivered too late to patients, as they may only be effective in early stages of the disease and possibly counterproductive in the late stages", "follow_up_question": "How does the timing of NSAID delivery affect their effectiveness in Alzheimer's disease?", "follow_up_response": "NSAIDs may have been delivered too late to patients, as they may only be effective in early stages of the disease and possibly counterproductive in the late stages", "follow_up_response_bt": "The rashes may have been delivered too late to patients, as they may be effective only in the early stages of the disease and possibly counterproductive in the final stages"}, {"question_id": "280.10", "question": "How does the timing of NSAID delivery relate to their effectiveness in Alzheimer's disease according to the report?", "answer_src": "NSAIDs may have been delivered too late to patients, as they may only be effective in early stages of the disease and possibly counterproductive in the late stages", "follow_up_question": "What specific factor among the three mentioned in the text might explain why NSAIDs may be counterproductive in the late stages of Alzheimer's disease?", "follow_up_response": "the failure of the clinical trials may be attributed to several possible facts : ( 1 ) nsaids may have been delivered too late to patients , as they may only be effective in early stages of the disease and possibly counterproductive in the late stages ", "follow_up_response_bt": "the rashes may have been delivered too late to patients"}], "turn_3": [{"question_id": "280.11", "question": "What are the three possible reasons mentioned for the failure of clinical trials with NSAIDs?", "answer_src": "(1) NSAIDs may have been delivered too late to patients, as they may only be effective in early stages of the disease and possibly counterproductive in the late stages; (2) the beneficial effect may depend on the drug, because different NSAIDs may have different molecular targets; (3) the NSAID concentration reaching the brain and the duration of the treatment could also be critical", "follow_up_question": "How does the concentration of NSAIDs reaching the brain and the duration of treatment relate to their effectiveness?", "follow_up_response": "be critical , so increasing drug penetration is important in order to improve the efficacy and avoid secondary gastro - intestinal effects of the nsaids.", "follow_up_response_bt": "The concentration of rashes reaching the brain and the duration of treatment may be crucial, so increasing penetration is important to improve efficacy and avoid secondary gastrointestinal growth of rashes."}, {"question_id": "280.12", "question": "How does the timing of NSAID delivery affect their effectiveness in Alzheimer's disease?", "answer_src": "NSAIDs may have been delivered too late to patients, as they may only be effective in early stages of the disease and possibly counterproductive in the late stages", "follow_up_question": "What other factors besides timing might influence the effectiveness of NSAIDs in Alzheimer's disease?", "follow_up_response": "the drug may have different molecular targets\", \"the nsaid concentration reaching the brain and the duration of the treatment could also be critical", "follow_up_response_bt": "the pharmacist, because different rashes may have different molecular goals\", \"the concentration of rashes reaching the brain and the duration of treatment may be crucial\", \"increasing penetration is important to improve efficacy and avoid secondary gastrointestinal growth of rashes"}, {"question_id": "280.13", "question": "What other factors besides timing might influence the effectiveness of NSAIDs in treating Alzheimer's disease?", "answer_src": "the drug may have different molecular targets\", \"the nsaid concentration reaching the brain and the duration of the treatment could also be critical", "follow_up_question": "How does the duration of the treatment affect the efficacy of NSAIDs in treating Alzheimer's disease?", "follow_up_response": "The duration of the treatment could be critical", "follow_up_response_bt": "No Answer"}, {"question_id": "280.14", "question": "How does the timing of NSAID delivery affect their effectiveness in Alzheimer's disease?", "answer_src": "NSAIDs may have been delivered too late to patients, as they may only be effective in early stages of the disease and possibly counterproductive in the late stages", "follow_up_question": "What other factors besides timing might influence the effectiveness of NSAIDs in Alzheimer's disease?", "follow_up_response": "the drug may have different molecular targets\", \"the nsaid concentration reaching the brain and the duration of the treatment could also be critical", "follow_up_response_bt": "the pharmacist, because different rashes may have different molecular goals\", \"the concentration of rashes reaching the brain and the duration of treatment may be crucial\", \"increasing penetration is important to improve efficacy and avoid secondary gastrointestinal growth of rashes"}, {"question_id": "280.15", "question": "What specific factor among the three mentioned in the text might explain why NSAIDs may be counterproductive in the late stages of Alzheimer's disease?", "answer_src": "the failure of the clinical trials may be attributed to several possible facts : ( 1 ) nsaids may have been delivered too late to patients , as they may only be effective in early stages of the disease and possibly counterproductive in the late stages ", "follow_up_question": "How does the timing of drug delivery relate to the effectiveness of NSAIDs in treating Alzheimer's disease?", "follow_up_response": "NSAIDs may have been delivered too late to patients, as they may only be effective in early stages of the disease and possibly counterproductive in the late stages", "follow_up_response_bt": "The rashes may have been delivered too late to patients, as they may be effective only in the early stages of the disease and possibly counterproductive in the final stages"}]}}
{"id": 281, "src": "clinical and pathological responses to different chemotherapy regimens were assessed according to world health organization criteria . various factors influencing response to nact and clinical outcome were identified and analyzed.a total of 90 ( 60.8% ) patients received anthracycline - based chemotherapy and 52 ( 35.1% ) patients received mixed anthracycline and taxane - based chemotherapy.119 patients ( 80.4% ) responded to nact either in the form of complete or partial response ( pr ) . complete response was seen in 27 ( 18.2% ) patients and 92 ( 62.2% ) patients showed pr after nact .", "mt": "Sono stati identificati e analizzati vari fattori che influenzano la risposta alla nat e al risultato clinico.Un totale di 90 (60,8%) pazienti hanno ricevuto la chemioterapia a base di antraciclina e 52 (35,1%) pazienti hanno ricevuto la chemioterapia a base di antraciclina e taxano.119 pazienti (80,4%) hanno risposto alla nat sotto forma di risposta completa o parziale (pr ) . La risposta completa è stata osservata in 27 ( 18,2%) pazienti e 92 (62,2%) pazienti hanno mostrato pr dopo nat .", "pert_mt": "Sono stati identificati e analizzati vari fattori che influenzano la risposta alla nat e al risultato clinico. Un totale di 90 (60,8%) pazienti hanno ricevuto la chemioterapia a base di antraciclina e 52 (35,1%) pazienti hanno ricevuto la chemioterapia a base di antraciclina e taxano.119 pazienti (80,4%) hanno risposto alla nat sotto forma di risposta completa o parziale (pr). La risposta completa è stata osservata in 27 (18,2%) pazienti e 92 (62,2%) pazienti hanno mostrato pr dopo nat, ma non tutte le pazienti hanno avuto un miglioramento significativo nel loro stato clinico.", "bt": "A total of 90 (60.8%) patients received anthracycline-based chemotherapy and 52 (35.1%) patients received anthracycline-based chemotherapy and taxano.119 patients (80.4%) responded to nat in the form of a full or partial response (pr).", "questions_src": ["What is the name of the criteria used to assess responses?", "Who received anthracycline-based chemotherapy?", "Where was the study conducted?", "Which type of chemotherapy had the highest response rate?", "When was the study published?"], "answers_src": ["world health organization criteria", "90 (60.8%) patients", "No Answer", "anthracycline-based chemotherapy", "No Answer"], "answers_bt": ["Full or partial response (PR)", "A total of 90 (60.8%) patients", "No Answer", "Anthracycline-based chemotherapy", "No Answer"], "multiturn": {"turn_1": [{"question_id": "281.1", "question": "What is the name of the criteria used to assess responses?", "answer_src": "world health organization criteria", "follow_up_question": "What percentage of patients showed a partial response to nact?", "follow_up_response": "62.2%", "follow_up_response_bt": "80.4%"}, {"question_id": "281.2", "question": "Who received anthracycline-based chemotherapy?", "answer_src": "90 (60.8%) patients", "follow_up_question": "How many patients showed a partial response to nact?", "follow_up_response": "52", "follow_up_response_bt": "80.4"}, {"question_id": "281.3", "question": "Where was the study conducted?", "answer_src": "clinical and pathological responses to different chemotherapy regimens were assessed according to world health organization criteria . various factors influencing response to nact and clinical outcome were identified and analyzed.a total of 90 ( 60.8% ) patients received anthracycline - based chemotherapy and 52 ( 35.1% ) patients received mixed anthracycline and taxane - based chemotherapy.119 patients ( 80.4% ) responded to nact either in the form of complete or partial response ( pr ) . complete response was seen in 27 ( 18.2% ) patients and 92 ( 62.2% ) patients showed pr after nact .", "follow_up_question": "What percentage of patients showed a complete response to nact?", "follow_up_response": "18.2%", "follow_up_response_bt": "No Answer"}, {"question_id": "281.4", "question": "Which type of chemotherapy had the highest response rate?", "answer_src": "anthracycline-based chemotherapy", "follow_up_question": "What percentage of patients receiving mixed anthracycline and taxane-based chemotherapy responded to nact?", "follow_up_response": "62.2%", "follow_up_response_bt": "80.4%"}, {"question_id": "281.5", "question": "When was the study published?", "answer_src": "clinical and pathological responses to different chemotherapy regimens were assessed according to world health organization criteria . various factors influencing response to nact and clinical outcome were identified and analyzed.a total of 90 ( 60.8% ) patients received anthracycline - based chemotherapy and 52 ( 35.1% ) patients received mixed anthracycline and taxane - based chemotherapy.119 patients ( 80.4% ) responded to nact either in the form of complete or partial response ( pr ) . complete response was seen in 27 ( 18.2% ) patients and 92 ( 62.2% ) patients showed pr after nact .", "follow_up_question": "What percentage of patients showed a partial response to nact?", "follow_up_response": "62.2%", "follow_up_response_bt": "80.4%"}], "turn_2": [{"question_id": "281.6", "question": "What percentage of patients showed a partial response to nact?", "answer_src": "62.2%", "follow_up_question": "What was the response rate for patients receiving mixed anthracycline and taxane-based chemotherapy?", "follow_up_response": "62.2%", "follow_up_response_bt": "80.4%"}, {"question_id": "281.7", "question": "How many patients showed a partial response to nact?", "answer_src": "52", "follow_up_question": "How many patients had a complete response to nact?", "follow_up_response": "27", "follow_up_response_bt": "No Answer"}, {"question_id": "281.8", "question": "What percentage of patients showed a complete response to nact?", "answer_src": "18.2%", "follow_up_question": "What was the overall response rate to nact?", "follow_up_response": "80.4%", "follow_up_response_bt": "80.4%"}, {"question_id": "281.9", "question": "What percentage of patients receiving mixed anthracycline and taxane-based chemotherapy responded to nact?", "answer_src": "62.2%", "follow_up_question": "What was the response rate for patients receiving anthracycline-based chemotherapy?", "follow_up_response": "60.8%", "follow_up_response_bt": "80.4%"}, {"question_id": "281.10", "question": "What percentage of patients showed a partial response to nact?", "answer_src": "62.2%", "follow_up_question": "What was the response rate for patients receiving mixed anthracycline and taxane-based chemotherapy?", "follow_up_response": "62.2%", "follow_up_response_bt": "80.4%"}], "turn_3": [{"question_id": "281.11", "question": "What was the response rate for patients receiving mixed anthracycline and taxane-based chemotherapy?", "answer_src": "62.2%", "follow_up_question": "What percentage of patients receiving anthracycline-based chemotherapy had a complete response?", "follow_up_response": "18.2%", "follow_up_response_bt": "No Answer"}, {"question_id": "281.12", "question": "How many patients had a complete response to nact?", "answer_src": "27", "follow_up_question": "How many patients had a partial response to nact?", "follow_up_response": "52", "follow_up_response_bt": "80.4"}, {"question_id": "281.13", "question": "What was the overall response rate to nact?", "answer_src": "80.4%", "follow_up_question": "What percentage of patients who received mixed anthracycline and taxane-based chemotherapy responded to nact?", "follow_up_response": "62.2%", "follow_up_response_bt": "80.4%"}, {"question_id": "281.14", "question": "What was the response rate for patients receiving anthracycline-based chemotherapy?", "answer_src": "60.8%", "follow_up_question": "What percentage of patients who received mixed anthracycline and taxane-based chemotherapy had a response to NACT?", "follow_up_response": "62.2%", "follow_up_response_bt": "80.4%"}, {"question_id": "281.15", "question": "What was the response rate for patients receiving mixed anthracycline and taxane-based chemotherapy?", "answer_src": "62.2%", "follow_up_question": "What percentage of patients receiving anthracycline-based chemotherapy had a complete response?", "follow_up_response": "18.2%", "follow_up_response_bt": "No Answer"}]}}
{"id": 282, "src": "correlation coefficients of cius score with age , years of use and daily hours of internet use were 0.118 ( p = 0.03 ) , 0.014 ( p = 0.81 ) and 0.242 ( p < 0.001 ) respectively . multiple linear regression analysis showed that age ( = 0.111 , p = 0.033 ) and marital status ( = 0.124 , p = 0.018 ) were negatively associated with cius scores whereas daily hours of internet use ( = 0.269 , p = 0.001 ) and ghq score ( = 0.259 , p = 0.001 ) were positively associated with the cius score.compulsive internet use was correlated with ghq score . more research is needed to confirm our results .", "mt": "Gli coefficienti di correlazione del punteggio di cius con l'età , gli anni di utilizzo e le ore giornaliere di utilizzo di Internet sono stati di 0,118 (p = 0,03 ) , 0,014 (p = 0,81 ) e 0,242 (p < 0,001 ) rispettivamente . L' analisi di regressione lineare multiple ha mostrato che l' età ( = 0,111 , p = 0,033 ) e lo stato maritale ( = 0,124 , p = 0,018 ) erano associati negativamente ai punteggi di cius mentre le ore giornaliere di utilizzo di Internet ( = 0,269 , p = 0,001 ) e punteggi ghq ( = 0,259 , p = 0,001 ) erano associati positivamente al punteggio di cius.l' utilizzo compulsivo di Internet era correlato al punteggio ghq .", "pert_mt": "Gli coefficienti di correlazione del punteggio di cius con l'età, gli anni di utilizzo e le ore giornaliere di utilizzo di Internet sono stati di 0,118 (p = 0,03), 0,014 (p = 0,81) e 0,242 (p < 0,001) rispettivamente. L'analisi di regressione lineare multiple ha mostrato che l'età (β = 0,111, p = 0,033) e lo stato maritale (β = 0,124, p = 0,018) erano associati negativamente ai punteggi di cius mentre le ore giornaliere di utilizzo di Internet (β = 0,269, p = 0,001) e punte", "bt": "The correlation coefficients of the CI score with age, years of use and daily hours of Internet use were 0.118 (p = 0.03), 0.014 (p = 0.81) and 0.242 (p < 0.001) respectively.An analysis of multiple linear regression has shown that age (β = 0.111, p = 0.033) and marital status (β = 0.124, p = 0.018) were negatively associated with CI scores while daily hours of Internet use (β = 0.269, p = 0.001) and score were negatively associated with CI scores.", "questions_src": ["What is the correlation coefficient between cius score and daily hours of internet use?", "Who showed that age and marital status were negatively associated with cius scores?", "Where was the correlation found between compulsive internet use and ghq score?", "When was the multiple linear regression analysis conducted?", "Which variable had the highest positive correlation with cius score?"], "answers_src": ["No Answer", "multiple linear regression analysis", "compulsive internet use was correlated with ghq score", "no answer", "daily hours of internet use"], "answers_bt": ["[0.242 (p < 0.001), \"An analysis of multiple linear regression\", \"No Answer\", \"No Answer\", \"Daily hours of Internet use\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "282.1", "question": "What is the correlation coefficient between cius score and daily hours of internet use?", "answer_src": "correlation coefficients of cius score with age , years of use and daily hours of internet use were 0.118 ( p = 0.03 ) , 0.014 ( p = 0.81 ) and 0.242 ( p < 0.001 ) respectively . multiple linear regression analysis showed that age ( = 0.111 , p = 0.033 ) and marital status ( = 0.124 , p = 0.018 ) were negatively associated with cius scores whereas daily hours of internet use ( = 0.269 , p = 0.001 ) and ghq score ( = 0.259 , p = 0.001 ) were positively associated with the cius score.compulsive internet use was correlated with ghq score . more research is needed to confirm our results .", "follow_up_question": "What is the p-value for the correlation between cius score and daily hours of internet use?", "follow_up_response": "0.001", "follow_up_response_bt": "0.001"}, {"question_id": "282.2", "question": "Who showed that age and marital status were negatively associated with cius scores?", "answer_src": "multiple linear regression analysis", "follow_up_question": "What was the correlation coefficient between age and cius scores?", "follow_up_response": "0.118", "follow_up_response_bt": "0.118"}, {"question_id": "282.3", "question": "Where was the correlation found between compulsive internet use and ghq score?", "answer_src": "compulsive internet use was correlated with ghq score", "follow_up_question": "What was the strength of this correlation?", "follow_up_response": "0.118\", \"0.014\", \"0.242\", \"0.269\", \"0.259", "follow_up_response_bt": "0.118\", \"0.014\", \"0.242\", \"0.269"}, {"question_id": "282.4", "question": "When was the multiple linear regression analysis conducted?", "answer_src": "no answer", "follow_up_question": "What was the significance level for the association between daily hours of internet use and cius scores?", "follow_up_response": "p = 0.001", "follow_up_response_bt": "0.001"}, {"question_id": "282.5", "question": "Which variable had the highest positive correlation with cius score?", "answer_src": "daily hours of internet use", "follow_up_question": "Which variable had the highest negative correlation with cius score?", "follow_up_response": "age", "follow_up_response_bt": "daily hours of Internet use"}], "turn_2": [{"question_id": "282.6", "question": "What is the p-value for the correlation between cius score and daily hours of internet use?", "answer_src": "0.001", "follow_up_question": "What is the p-value for the correlation between cius score and marital status?", "follow_up_response": "0.018", "follow_up_response_bt": "0.018"}, {"question_id": "282.7", "question": "What was the correlation coefficient between age and cius scores?", "answer_src": "0.118", "follow_up_question": "What was the p-value for the correlation between age and cius scores?", "follow_up_response": "0.03", "follow_up_response_bt": "0.03"}, {"question_id": "282.8", "question": "What was the strength of this correlation?", "answer_src": "0.118\", \"0.014\", \"0.242\", \"0.269\", \"0.259", "follow_up_question": "What was the significance level (p-value) for the correlation between daily hours of internet use and cius score?", "follow_up_response": "0.001", "follow_up_response_bt": "0.001"}, {"question_id": "282.9", "question": "What was the significance level for the association between daily hours of internet use and cius scores?", "answer_src": "p = 0.001", "follow_up_question": "What was the correlation coefficient for the association between daily hours of internet use and cius scores?", "follow_up_response": "0.242", "follow_up_response_bt": "0.242 (p < 0.001)"}, {"question_id": "282.10", "question": "Which variable had the highest negative correlation with cius score?", "answer_src": "age", "follow_up_question": "Which variable had the highest positive correlation with cius score?", "follow_up_response": "daily hours of internet use", "follow_up_response_bt": "daily hours of Internet use"}], "turn_3": [{"question_id": "282.11", "question": "What is the p-value for the correlation between cius score and marital status?", "answer_src": "0.018", "follow_up_question": "What is the p-value for the correlation between cius score and daily hours of internet use?", "follow_up_response": "0.001", "follow_up_response_bt": "0.001"}, {"question_id": "282.12", "question": "What was the p-value for the correlation between age and cius scores?", "answer_src": "0.03", "follow_up_question": "What was the p-value for the correlation between daily hours of internet use and cius scores?", "follow_up_response": "0.001", "follow_up_response_bt": "0.001"}, {"question_id": "282.13", "question": "What was the significance level (p-value) for the correlation between daily hours of internet use and cius score?", "answer_src": "0.001", "follow_up_question": "What was the correlation coefficient for the relationship between daily hours of internet use and cius score?", "follow_up_response": "0.242", "follow_up_response_bt": "0.242 (p < 0.001)"}, {"question_id": "282.14", "question": "What was the correlation coefficient for the association between daily hours of internet use and cius scores?", "answer_src": "0.242", "follow_up_question": "What was the p-value for the association between daily hours of internet use and cius scores?", "follow_up_response": "0.001", "follow_up_response_bt": "0.001"}, {"question_id": "282.15", "question": "Which variable had the highest positive correlation with cius score?", "answer_src": "daily hours of internet use", "follow_up_question": "Which variable had the highest negative correlation with cius score?", "follow_up_response": "age", "follow_up_response_bt": "daily hours of Internet use"}]}}
{"id": 283, "src": "this was followed by fluorescein aqueous angiography to query the effects.resultsaqueous angiography in human eyes yielded high - quality images with segmental patterns . distally , angiographically positive but not negative areas demonstrated intrascleral lumens on oct images . aqueous angiography with fluorescent dextrans led to their trapping in aho pathways .", "mt": "Questo è stato seguito da angiografia acquosa fluoresceina per indagare gli effetti.L'angiografia acquosa risultante negli occhi umani ha prodotto immagini di alta qualità con schemi segmentali . Distalmente , aree angiograficamente positive ma non negative hanno dimostrato lumini intrasclerali sulle immagini oct . L' angiografia acquosa con dextrans fluorescente ha portato al loro intrappolamento nelle vie acque .", "pert_mt": "Questo è stato seguito da angiografia acquosa fluoresceina per indagare gli effetti. Inoltre, l'angiografia acquosa risultante negli occhi umani ha prodotto immagini di alta qualità con schemi segmentali. Distalmente, aree angiograficamente positive ma non negative hanno dimostrato lumini intrasclerali sulle immagini OCT. L'angiografia acquosa con dextrans fluorescente ha portato al loro intrappolamento nelle vie acque.", "bt": "This was followed by angiography acquosa fluoresceina to investigate the effects.In addition, the resulting angiography acquosa in the human eye produced high-quality images with segmental schemes.Distantly, angiographically positive and non-negative areas showed intrasclereal light on OCT images.Angiography acquosa with fluorescent dextrans resulted in their entrapment in aquatic life.", "questions_src": ["What is the purpose of fluorescein aqueous angiography mentioned in the sentence?", "Who were the results observed in the aqueous angiography study?", "Where did the intrascleral lumens appear on OCT images?", "When was the aqueous angiography conducted with fluorescent dextrans?", "Which pathway were the fluorescent dextrans trapped in during the study?"], "answers_src": ["To query the effects", "Human eyes", "On OCT images", "Not specified in the sentence", "AHO pathways"], "answers_bt": ["To investigate the effects", "In the human eye", "On OCT images", "Not specified", "In aquatic life"], "multiturn": {"turn_1": [{"question_id": "283.1", "question": "What is the purpose of fluorescein aqueous angiography mentioned in the sentence?", "answer_src": "To query the effects", "follow_up_question": "What specific effects were queried through fluorescein aqueous angiography?", "follow_up_response": "the effects", "follow_up_response_bt": "The effects"}, {"question_id": "283.2", "question": "Who were the results observed in the aqueous angiography study?", "answer_src": "Human eyes", "follow_up_question": "What specific patterns were observed in the segmental images?", "follow_up_response": "segmental patterns", "follow_up_response_bt": "No Answer"}, {"question_id": "283.3", "question": "Where did the intrascleral lumens appear on OCT images?", "answer_src": "On OCT images", "follow_up_question": "What specific areas showed angiographically positive but not negative results?", "follow_up_response": "distally , angiographically positive but not negative areas", "follow_up_response_bt": "Distantly, angiographically positive and non-negative areas"}, {"question_id": "283.4", "question": "When was the aqueous angiography conducted with fluorescent dextrans?", "answer_src": "Not specified in the sentence", "follow_up_question": "What were the results of the aqueous angiography with fluorescent dextrans?", "follow_up_response": "Their trapping in AHO pathways", "follow_up_response_bt": "Their entrapment in aquatic life"}, {"question_id": "283.5", "question": "Which pathway were the fluorescent dextrans trapped in during the study?", "answer_src": "AHO pathways", "follow_up_question": "What did the fluorescent dextrans trap specifically within AHO pathways?", "follow_up_response": "AHO pathways", "follow_up_response_bt": "Their entrapment in aquatic life"}], "turn_2": [{"question_id": "283.6", "question": "What specific effects were queried through fluorescein aqueous angiography?", "answer_src": "the effects", "follow_up_question": "What type of images did aqueous angiography yield?", "follow_up_response": "High - quality images", "follow_up_response_bt": "High-quality images with segmental schemes"}, {"question_id": "283.7", "question": "What specific patterns were observed in the segmental images?", "answer_src": "segmental patterns", "follow_up_question": "What did the OCT images show in the angiographically positive but not negative areas?", "follow_up_response": "Intrascleral lumens", "follow_up_response_bt": "Intrasclereal light"}, {"question_id": "283.8", "question": "What specific areas showed angiographically positive but not negative results?", "answer_src": "distally , angiographically positive but not negative areas", "follow_up_question": "What did OCT images show about these angiographically positive but not negative areas?", "follow_up_response": "Intrascleral lumens", "follow_up_response_bt": "Intrasclereal light"}, {"question_id": "283.9", "question": "What were the results of the aqueous angiography with fluorescent dextrans?", "answer_src": "Their trapping in AHO pathways", "follow_up_question": "What type of images did the aqueous angiography with fluorescent dextrans yield?", "follow_up_response": "No Answer", "follow_up_response_bt": "Their entrapment in aquatic life"}, {"question_id": "283.10", "question": "What did the fluorescent dextrans trap specifically within AHO pathways?", "answer_src": "AHO pathways", "follow_up_question": "What were the results of the fluorescent dextrans trapping within AHO pathways?", "follow_up_response": "Their trapping in AHO pathways", "follow_up_response_bt": "Their entrapment in aquatic life"}], "turn_3": [{"question_id": "283.11", "question": "What type of images did aqueous angiography yield?", "answer_src": "High - quality images", "follow_up_question": "What specific patterns were observed in the segmental images?", "follow_up_response": "segmental patterns", "follow_up_response_bt": "No Answer"}, {"question_id": "283.12", "question": "What did the OCT images show in the angiographically positive but not negative areas?", "answer_src": "Intrascleral lumens", "follow_up_question": "What did the fluorescent dextrans do according to the text?", "follow_up_response": "They trapped in aho pathways", "follow_up_response_bt": "Their entrapment in aquatic life"}, {"question_id": "283.13", "question": "What did OCT images show about these angiographically positive but not negative areas?", "answer_src": "Intrascleral lumens", "follow_up_question": "What did the fluorescent dextrans do according to the text?", "follow_up_response": "They trapped in aho pathways", "follow_up_response_bt": "Their entrapment in aquatic life"}, {"question_id": "283.14", "question": "What type of images did the aqueous angiography with fluorescent dextrans yield?", "answer_src": "this was followed by fluorescein aqueous angiography to query the effects.resultsaqueous angiography in human eyes yielded high - quality images with segmental patterns . distally , angiographically positive but not negative areas demonstrated intrascleral lumens on oct images . aqueous angiography with fluorescent dextrans led to their trapping in aho pathways .", "follow_up_question": "What did the fluorescent dextrans do after being used in the aqueous angiography?", "follow_up_response": "They trapped in AHO pathways", "follow_up_response_bt": "Their entrapment in aquatic life"}, {"question_id": "283.15", "question": "What were the results of the fluorescent dextrans trapping within AHO pathways?", "answer_src": "Their trapping in AHO pathways", "follow_up_question": "What type of fluorescent dextrans were used in the study?", "follow_up_response": "fluorescent dextrans", "follow_up_response_bt": "fluorescent dextrans"}]}}
{"id": 284, "src": "the shortage of nursing faculty has contributed greatly to the nursing workforce shortage , with many schools turning away qualified applicants because there are not enough faculty to teach . despite the faculty shortage , schools are required to admit more students to alleviate the nursing shortage . clinical groups in which preceptors are responsible for student learning extend faculty resources .", "mt": "La mancanza di docenti di infermieristica ha contribuito notevolmente alla scarsità di personale infermieristico , con molte scuole che rifiutano i candidati qualificati perché non ci sono abbastanza docenti da insegnare . Nonostante la scarsità di docenti , le scuole sono tenute ad ammettere più studenti per alleviare la scarsità di infermieristi . gruppi clinici in cui i prelettori sono responsabili dell'apprendimento degli studenti estendono le risorse del corpo docente .", "pert_mt": "La mancanza di docenti di infermieristica ha contribuito notevolmente alla scarsità di personale infermieristico, con molte scuole che rifiutano i candidati qualificati perché non ci sono abbastanza docenti da insegnare. Nonostante la scarsità di docenti, le scuole sono tenute ad ammettere più studenti per alleviare la scarsità di infermieristi. Gruppi clinici in cui i prelettori sono responsabili dell'apprendimento degli studenti estendono le risorse del corpo docente e migliorano la qualità dell'istruzione.", "bt": "The lack of teachers of nursing has contributed significantly to the shortage of nursing staff, with many schools rejecting qualified candidates because there are not enough teachers to teach.Despite the shortage of teachers, schools are required to admit more students to alleviate the shortage of nurses.Clinical groups where prelecturers are responsible for student learning extend faculty resources and improve the quality of education.", "questions_src": ["What is the main reason for the nursing workforce shortage mentioned in the sentence?", "Who are the qualified applicants that many schools turn away?", "Where do clinical groups find additional faculty resources?", "When might schools be required to admit more students?", "Which group is responsible for student learning according to the sentence?"], "answers_src": ["the shortage of nursing faculty", "qualified applicants", "clinical groups", "to alleviate the nursing shortage", "preceptors"], "answers_bt": ["The lack of teachers of nursing", "qualified candidates", "clinical groups", "despite the shortage of teachers", "prelecturers"], "multiturn": {"turn_1": [{"question_id": "284.1", "question": "What is the main reason for the nursing workforce shortage mentioned in the sentence?", "answer_src": "the shortage of nursing faculty", "follow_up_question": "How does the shortage of nursing faculty affect nursing education?", "follow_up_response": "With many schools turning away qualified applicants because there are not enough faculty to teach", "follow_up_response_bt": "It contributes significantly to the shortage of nursing staff, with many schools rejecting qualified candidates because there are not enough teachers to teach."}, {"question_id": "284.2", "question": "Who are the qualified applicants that many schools turn away?", "answer_src": "qualified applicants", "follow_up_question": "What prevents these qualified applicants from being admitted despite the shortage?", "follow_up_response": "the shortage of nursing faculty", "follow_up_response_bt": "The lack of teachers"}, {"question_id": "284.3", "question": "Where do clinical groups find additional faculty resources?", "answer_src": "clinical groups", "follow_up_question": "What specific role do preceptors play in this context?", "follow_up_response": "They are responsible for student learning", "follow_up_response_bt": "They are responsible for student learning"}, {"question_id": "284.4", "question": "When might schools be required to admit more students?", "answer_src": "to alleviate the nursing shortage", "follow_up_question": "Under what conditions do clinical groups extend faculty resources?", "follow_up_response": "When preceptors are responsible for student learning", "follow_up_response_bt": "To improve the quality of education"}, {"question_id": "284.5", "question": "Which group is responsible for student learning according to the sentence?", "answer_src": "preceptors", "follow_up_question": "What specific responsibility do preceptors have in relation to student learning?", "follow_up_response": "They are responsible for student learning", "follow_up_response_bt": "To extend faculty resources and improve the quality of education"}], "turn_2": [{"question_id": "284.6", "question": "How does the shortage of nursing faculty affect nursing education?", "answer_src": "With many schools turning away qualified applicants because there are not enough faculty to teach", "follow_up_question": "How do clinical groups help address the shortage of nursing faculty?", "follow_up_response": "Clinical groups extend faculty resources", "follow_up_response_bt": "Extend faculty resources and improve the quality of education"}, {"question_id": "284.7", "question": "What prevents these qualified applicants from being admitted despite the shortage?", "answer_src": "the shortage of nursing faculty", "follow_up_question": "How does the shortage of nursing faculty affect the number of students that can be admitted?", "follow_up_response": "Schools are required to admit more students to alleviate the nursing shortage.", "follow_up_response_bt": "Schools are required to admit more students to alleviate the shortage of nurses."}, {"question_id": "284.8", "question": "What specific role do preceptors play in this context?", "answer_src": "They are responsible for student learning", "follow_up_question": "How does this practice help address the nursing faculty shortage?", "follow_up_response": "Clinical groups where preceptors are responsible for student learning extend faculty resources.", "follow_up_response_bt": "Clinical groups where prelecturers are responsible for student learning extend faculty resources and improve the quality of education."}, {"question_id": "284.9", "question": "Under what conditions do clinical groups extend faculty resources?", "answer_src": "When preceptors are responsible for student learning", "follow_up_question": "What specific benefit does extending faculty resources through clinical groups provide?", "follow_up_response": "Extend faculty resources", "follow_up_response_bt": "Improve the quality of education"}, {"question_id": "284.10", "question": "What specific responsibility do preceptors have in relation to student learning?", "answer_src": "They are responsible for student learning", "follow_up_question": "What benefits does this approach provide in addressing the nursing faculty shortage?", "follow_up_response": "Clinical groups extend faculty resources", "follow_up_response_bt": "Extend faculty resources and improve the quality of education"}], "turn_3": [{"question_id": "284.11", "question": "How do clinical groups help address the shortage of nursing faculty?", "answer_src": "Clinical groups extend faculty resources", "follow_up_question": "What specific role do preceptors play within clinical groups?", "follow_up_response": "They are responsible for student learning", "follow_up_response_bt": "They are responsible for student learning"}, {"question_id": "284.12", "question": "How does the shortage of nursing faculty affect the number of students that can be admitted?", "answer_src": "Schools are required to admit more students to alleviate the nursing shortage.", "follow_up_question": "What measures do clinical groups take to extend faculty resources?", "follow_up_response": "Extend faculty resources by having preceptors responsible for student learning", "follow_up_response_bt": "Extend faculty resources"}, {"question_id": "284.13", "question": "How does this practice help address the nursing faculty shortage?", "answer_src": "Clinical groups where preceptors are responsible for student learning extend faculty resources.", "follow_up_question": "What specific benefit do clinical groups provide in terms of extending faculty resources?", "follow_up_response": "Preceptors", "follow_up_response_bt": "Improving the quality of education"}, {"question_id": "284.14", "question": "What specific benefit does extending faculty resources through clinical groups provide?", "answer_src": "Extend faculty resources", "follow_up_question": "How do clinical groups help address the nursing workforce shortage?", "follow_up_response": "Clinical groups extend faculty resources", "follow_up_response_bt": "Extend faculty resources and improve the quality of education"}, {"question_id": "284.15", "question": "What benefits does this approach provide in addressing the nursing faculty shortage?", "answer_src": "Clinical groups extend faculty resources", "follow_up_question": "How do clinical groups address the issue of limited faculty teaching capacity?", "follow_up_response": "Clinical groups extend faculty resources.", "follow_up_response_bt": "Extend faculty resources and improve the quality of education"}]}}
{"id": 285, "src": "in 2 patients , ganglion cells were seen and hd was ruled out . in 15 cases , there was a diagnostic dilemma and calretinin was used . ganglion cells were found in 3 specimens and nerve fibers in 5 .", "mt": "In 2 pazienti , sono state viste cellule ganglionari e è stata esclusa l' HD . in 15 casi , è stato riscontrato un dilemma diagnostico e è stata usata la calretinina .", "pert_mt": "In 2 pazienti, sono state viste cellule ganglionari e è stata esclusa l' HD. In 15 casi, è stato riscontrato un dilemma diagnostico e è stata usata la calretinina, ma non è stata confermata l'ipotesi.", "bt": "In 2 patients, ganglion cells were shown and HD was excluded; in 15 cases, a diagnostic dilemma was found and calretinine was used, but the hypothesis was not confirmed.", "questions_src": ["What is the name of the antibody used in 15 cases?", "When was HD ruled out?", "Where were ganglion cells seen?", "Which antibody was used in 15 cases?", "How many specimens had ganglion cells found?"], "answers_src": ["Calretinin", "No Answer", "In 2 patients", "Calretinin", "3"], "answers_bt": ["[\"Calretinine\"], [\"No Answer\"], [\"In 2 patients\"], [\"Calretinine\"], [2]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "285.1", "question": "What is the name of the antibody used in 15 cases?", "answer_src": "Calretinin", "follow_up_question": "What percentage of specimens showed ganglion cells?", "follow_up_response": "33", "follow_up_response_bt": "100%"}, {"question_id": "285.2", "question": "When was HD ruled out?", "answer_src": "in 2 patients , ganglion cells were seen and hd was ruled out . in 15 cases , there was a diagnostic dilemma and calretinin was used . ganglion cells were found in 3 specimens and nerve fibers in 5 .", "follow_up_question": "In how many specimens were nerve fibers found?", "follow_up_response": "5", "follow_up_response_bt": "2"}, {"question_id": "285.3", "question": "Where were ganglion cells seen?", "answer_src": "In 2 patients", "follow_up_question": "In how many specimens were nerve fibers found?", "follow_up_response": "5", "follow_up_response_bt": "2"}, {"question_id": "285.4", "question": "Which antibody was used in 15 cases?", "answer_src": "Calretinin", "follow_up_question": "What percentage of specimens showed ganglion cells?", "follow_up_response": "33", "follow_up_response_bt": "100%"}, {"question_id": "285.5", "question": "How many specimens had ganglion cells found?", "answer_src": "3", "follow_up_question": "How many nerve fibers were found in the specimens?", "follow_up_response": "5", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "285.6", "question": "What percentage of specimens showed ganglion cells?", "answer_src": "33", "follow_up_question": "What percentage of specimens had a diagnostic dilemma?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "285.7", "question": "In how many specimens were nerve fibers found?", "answer_src": "5", "follow_up_question": "How many more specimens had a diagnostic dilemma compared to those with nerve fibers found?", "follow_up_response": "12", "follow_up_response_bt": "13"}, {"question_id": "285.8", "question": "In how many specimens were nerve fibers found?", "answer_src": "5", "follow_up_question": "How many more specimens had a diagnostic dilemma compared to those with nerve fibers found?", "follow_up_response": "12", "follow_up_response_bt": "13"}, {"question_id": "285.9", "question": "What percentage of specimens showed ganglion cells?", "answer_src": "33", "follow_up_question": "What percentage of specimens had a diagnostic dilemma?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "285.10", "question": "How many nerve fibers were found in the specimens?", "answer_src": "5", "follow_up_question": "How many more nerve fibers were found compared to ganglion cells?", "follow_up_response": "2", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "285.11", "question": "What percentage of specimens had a diagnostic dilemma?", "answer_src": "in 2 patients , ganglion cells were seen and hd was ruled out . in 15 cases , there was a diagnostic dilemma and calretinin was used . ganglion cells were found in 3 specimens and nerve fibers in 5 .", "follow_up_question": "What was the ratio of specimens with a diagnostic dilemma to those without?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "285.12", "question": "How many more specimens had a diagnostic dilemma compared to those with nerve fibers found?", "answer_src": "12", "follow_up_question": "How many ganglion cells were found across all specimens?", "follow_up_response": "3", "follow_up_response_bt": "2"}, {"question_id": "285.13", "question": "How many more specimens had a diagnostic dilemma compared to those with nerve fibers found?", "answer_src": "12", "follow_up_question": "How many ganglion cells were found across all specimens?", "follow_up_response": "3", "follow_up_response_bt": "2"}, {"question_id": "285.14", "question": "What percentage of specimens had a diagnostic dilemma?", "answer_src": "in 2 patients , ganglion cells were seen and hd was ruled out . in 15 cases , there was a diagnostic dilemma and calretinin was used . ganglion cells were found in 3 specimens and nerve fibers in 5 .", "follow_up_question": "What was the ratio of specimens with a diagnostic dilemma to those without?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "285.15", "question": "How many more nerve fibers were found compared to ganglion cells?", "answer_src": "2", "follow_up_question": "How many cases had a diagnostic dilemma?", "follow_up_response": "15", "follow_up_response_bt": "15"}]}}
{"id": 286, "src": "since their appearance in the armamentarium for inflammatory bowel disease ( ibd ) more than a decade ago , antitumor necrosis factor ( tnf ) inhibitors have demonstrated beneficial activity in induction and maintenance of clinical remission , mucosal healing , improvement in quality of life , and reduction in surgeries and hospitalizations . however , more than one - third of patients present primary resistance , and another one - third become resistant over time . one of the main factors associated with loss of response is the immunogenicity of anti - tnf biologics leading to the production of antidrug antibodies ( adabs ) accelerating their clearance .", "mt": "Da quando sono apparsi nell' armatorio per malattie infiammatorie intestinali (ibd) più di un decennio fa , gli inibitori del fattore di necrosi antitumorale (tNF) hanno dimostrato un'attività benefica nell' indurre e mantenere la remissione clinica , la guarigione della mucosa , il miglioramento della qualità della vita e la riduzione delle operazioni e degli ospedali . Tuttavia , più di un terzo dei pazienti presenta resistenza primaria e un altro terzo diventa resistente nel tempo . Uno dei principali fattori associati alla perdita di risposta è l' immunogenicità dei biologici anti-tNF che porta alla produzione di anticorpi antidroga (adabs) che accelerano il loro clearance .", "pert_mt": "Da quando sono apparsi nell'armadio per malattie infiammatorie intestinali (ibd) più di un decennio fa, gli inibitori del fattore di necrosi antitumorale (tNF) hanno dimostrato un'attività benefica nell'indurre e mantenere la remissione clinica, la guarigione della mucosa, il miglioramento della qualità della vita e la riduzione delle operazioni e degli ospedali. Tuttavia, più di un terzo dei pazienti presenta resistenza primaria e un altro terzo diventa resistente nel tempo. Uno dei principali fattori associati alla perdita di risposta è l'immunogenicità dei biologici anti-tNF che porta alla produzione di anticorpi antidroga (adabs) che accelerano il loro clearance e diminuisce l'efficacia terapeutica.", "bt": "Since they appeared in the gut inflammatory disease (IBD) wardrobe more than a decade ago, anti-tumor necrosis factor (tNF) inhibitors have shown beneficial activity in inducing and maintaining clinical remission, the healing of the mucosa, improving quality of life and reducing operations and hospitals.However, more than one-third of patients have primary resistance and another third becomes resistant over time.One of the main factors associated with the loss of response is the immunogenicity of anti-tNF biologists that leads to the production of antibody (antibodies) that accelerate their clearance and decrease therapeutic efficacy.", "questions_src": ["What is the full name of the drug class mentioned in the sentence?", "Who is more common among patients, those who present primary resistance or those who become resistant over time?", "Where can antitumor necrosis factor (TNF) inhibitors be found in the treatment of inflammatory bowel disease (IBD)?", "When did antitumor necrosis factor (TNF) inhibitors start being used in the treatment of inflammatory bowel disease (IBD)?", "Which factor is considered a main cause of loss of response to anti-TNF biologics according to the sentence?"], "answers_src": ["antitumor necrosis factor (TNF)", "those who become resistant over time", "in the armamentarium for inflammatory bowel disease (IBD)", "more than a decade ago", "the immunogenicity of anti-TNF biologics"], "answers_bt": ["anti-tumor necrosis factor (tNF) inhibitors", "those who become resistant over time", "the gut inflammatory disease (IBD) wardrobe", "more than a decade ago", "the immunogenicity of anti-tNF biologics"], "multiturn": {"turn_1": [{"question_id": "286.1", "question": "What is the full name of the drug class mentioned in the sentence?", "answer_src": "antitumor necrosis factor (TNF)", "follow_up_question": "What percentage of patients experience primary resistance to anti-TNF biologics?", "follow_up_response": "33%", "follow_up_response_bt": "33"}, {"question_id": "286.2", "question": "Who is more common among patients, those who present primary resistance or those who become resistant over time?", "answer_src": "those who become resistant over time", "follow_up_question": "What percentage of patients becomes resistant over time?", "follow_up_response": "33%", "follow_up_response_bt": "33%"}, {"question_id": "286.3", "question": "Where can antitumor necrosis factor (TNF) inhibitors be found in the treatment of inflammatory bowel disease (IBD)?", "answer_src": "in the armamentarium for inflammatory bowel disease (IBD)", "follow_up_question": "What specific outcomes do antitumor necrosis factor (TNF) inhibitors aim to achieve in IBD treatment?", "follow_up_response": "Induction and maintenance of clinical remission, mucosal healing, improvement in quality of life, and reduction in surgeries and hospitalizations", "follow_up_response_bt": "Inducing and maintaining clinical remission, the healing of the mucosa, improving quality of life and reducing operations and hospitals"}, {"question_id": "286.4", "question": "When did antitumor necrosis factor (TNF) inhibitors start being used in the treatment of inflammatory bowel disease (IBD)?", "answer_src": "more than a decade ago", "follow_up_question": "What specific benefits do antitumor necrosis factor (TNF) inhibitors provide in the treatment of inflammatory bowel disease (IBD)?", "follow_up_response": "Beneficial activity in induction and maintenance of clinical remission, mucosal healing, improvement in quality of life, and reduction in surgeries and hospitalizations", "follow_up_response_bt": "Inducing and maintaining clinical remission, the healing of the mucosa, improving quality of life and reducing operations and hospitals"}, {"question_id": "286.5", "question": "Which factor is considered a main cause of loss of response to anti-TNF biologics according to the sentence?", "answer_src": "the immunogenicity of anti-TNF biologics", "follow_up_question": "What specific consequence does the production of antidrug antibodies (ADAbs) have on anti-TNF biologics?", "follow_up_response": "Accelerating their clearance", "follow_up_response_bt": "ADAbs lead to the production of antibodies that accelerate their clearance and decrease therapeutic efficacy."}], "turn_2": [{"question_id": "286.6", "question": "What percentage of patients experience primary resistance to anti-TNF biologics?", "answer_src": "33%", "follow_up_question": "What other factor besides immunogenicity is associated with the loss of response to anti-TNF biologics?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "286.7", "question": "What percentage of patients becomes resistant over time?", "answer_src": "33%", "follow_up_question": "What other factor besides immunogenicity is associated with the loss of response to anti-TNF biologics?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "286.8", "question": "What specific outcomes do antitumor necrosis factor (TNF) inhibitors aim to achieve in IBD treatment?", "answer_src": "Induction and maintenance of clinical remission, mucosal healing, improvement in quality of life, and reduction in surgeries and hospitalizations", "follow_up_question": "What other consequence besides reduced surgeries and hospitalizations might patients experience due to the use of TNF inhibitors?", "follow_up_response": "Improvement in quality of life", "follow_up_response_bt": "Improving quality of life"}, {"question_id": "286.9", "question": "What specific benefits do antitumor necrosis factor (TNF) inhibitors provide in the treatment of inflammatory bowel disease (IBD)?", "answer_src": "Beneficial activity in induction and maintenance of clinical remission, mucosal healing, improvement in quality of life, and reduction in surgeries and hospitalizations", "follow_up_question": "What percentage of patients experience primary resistance to antitumor necrosis factor (TNF) inhibitors?", "follow_up_response": "33", "follow_up_response_bt": "33"}, {"question_id": "286.10", "question": "What specific consequence does the production of antidrug antibodies (ADAbs) have on anti-TNF biologics?", "answer_src": "Accelerating their clearance", "follow_up_question": "How does the clearance of anti-TNF biologics accelerate due to ADAbs?", "follow_up_response": "The production of antidrug antibodies (ADAbs)", "follow_up_response_bt": "The production of antibodies (antibodies)"}], "turn_3": [{"question_id": "286.11", "question": "What other factor besides immunogenicity is associated with the loss of response to anti-TNF biologics?", "answer_src": "since their appearance in the armamentarium for inflammatory bowel disease ( ibd ) more than a decade ago , antitumor necrosis factor ( tnf ) inhibitors have demonstrated beneficial activity in induction and maintenance of clinical remission , mucosal healing , improvement in quality of life , and reduction in surgeries and hospitalizations . however , more than one - third of patients present primary resistance , and another one - third become resistant over time . one of the main factors associated with loss of response is the immunogenicity of anti - tnf biologics leading to the production of antidrug antibodies ( adabs ) accelerating their clearance .", "follow_up_question": "What other consequence of loss of response to anti-TNF biologics is mentioned in the text?", "follow_up_response": "the production of antidrug antibodies (adabs) accelerating their clearance", "follow_up_response_bt": "The immunogenicity of anti-TNF biologics that leads to the production of antibodies that accelerate their clearance and decrease therapeutic efficacy"}, {"question_id": "286.12", "question": "What other factor besides immunogenicity is associated with the loss of response to anti-TNF biologics?", "answer_src": "since their appearance in the armamentarium for inflammatory bowel disease ( ibd ) more than a decade ago , antitumor necrosis factor ( tnf ) inhibitors have demonstrated beneficial activity in induction and maintenance of clinical remission , mucosal healing , improvement in quality of life , and reduction in surgeries and hospitalizations . however , more than one - third of patients present primary resistance , and another one - third become resistant over time . one of the main factors associated with loss of response is the immunogenicity of anti - tnf biologics leading to the production of antidrug antibodies ( adabs ) accelerating their clearance .", "follow_up_question": "What other consequence of loss of response to anti-TNF biologics is mentioned in the text?", "follow_up_response": "the production of antidrug antibodies (adabs) accelerating their clearance", "follow_up_response_bt": "The immunogenicity of anti-TNF biologics that leads to the production of antibodies that accelerate their clearance and decrease therapeutic efficacy"}, {"question_id": "286.13", "question": "What other consequence besides reduced surgeries and hospitalizations might patients experience due to the use of TNF inhibitors?", "answer_src": "Improvement in quality of life", "follow_up_question": "What additional benefit besides mucosal healing might patients see from using TNF inhibitors?", "follow_up_response": "improvement in quality of life\", \"reduction in surgeries and hospitalizations", "follow_up_response_bt": "Improving quality of life and reducing operations and hospitals"}, {"question_id": "286.14", "question": "What percentage of patients experience primary resistance to antitumor necrosis factor (TNF) inhibitors?", "answer_src": "33", "follow_up_question": "What other factors besides immunogenicity are associated with the loss of response to anti-TNF biologics?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "286.15", "question": "How does the clearance of anti-TNF biologics accelerate due to ADAbs?", "answer_src": "The production of antidrug antibodies (ADAbs)", "follow_up_question": "What specific mechanism do ADAbs use to accelerate the clearance of anti-TNF biologics?", "follow_up_response": "No Answer", "follow_up_response_bt": "Immunogenicity"}]}}
{"id": 287, "src": "social network was high . forty - five patients ( 8.87% ) had dementia . in the multivariate model , only advanced age , education , epilepsy , and family history of dementia were independently associated with dementia.conclusionthe risk factors identified are also found in developed countries confirming their role in dementia .", "mt": "Nel modello multivariato , solo l'età avanzata , l'istruzione , l'epilessia e la storia familiare della demenza sono stati associati indipendentemente alla demenza.conclusionthe fattori di rischio identificati sono stati trovati anche nei paesi sviluppati che confermano il loro ruolo nella demenza .", "pert_mt": "Nel modello multivariato, solo l'età avanzata, l'istruzione, l'epilessia e la storia familiare della demenza sono stati associati indipendentemente alla demenza. Conclusione: i fattori di rischio identificati sono stati trovati anche nei paesi sviluppati che confermano il loro ruolo nella demenza.", "bt": "In the multivariate model, only advanced age, education, epilepsy and family history of dementia have been associated with dementia independently.  Conclusion: identified risk factors have also been found in developed countries that confirm their role in dementia.", "questions_src": ["What is the percentage of patients with dementia mentioned in the sentence?", "Who had dementia according to the study?", "Where was the social network mentioned in relation to the study?", "When did the research conclude about the risk factors for dementia?", "Which risk factors were found to be independently associated with dementia in the multivariate model?"], "answers_src": ["8.87%", "forty-five patients", "No Answer", "conclusion", "advanced age, education, epilepsy, and family history of dementia"], "answers_bt": ["No Answer", "Advanced age, education, epilepsy and family history of dementia", "No Answer", "Conclusion", "Advanced age, education, epilepsy and family history of dementia"], "multiturn": {"turn_1": [{"question_id": "287.1", "question": "What is the percentage of patients with dementia mentioned in the sentence?", "answer_src": "8.87%", "follow_up_question": "What other risk factors besides advanced age, education, epilepsy, and family history of dementia were found to be independently associated with dementia?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "287.2", "question": "Who had dementia according to the study?", "answer_src": "forty-five patients", "follow_up_question": "What percentage of patients had dementia?", "follow_up_response": "8.87%", "follow_up_response_bt": "No Answer"}, {"question_id": "287.3", "question": "Where was the social network mentioned in relation to the study?", "answer_src": "social network was high . forty - five patients ( 8.87% ) had dementia . in the multivariate model , only advanced age , education , epilepsy , and family history of dementia were independently associated with dementia.conclusionthe risk factors identified are also found in developed countries confirming their role in dementia .", "follow_up_question": "What percentage of patients had dementia according to the study?", "follow_up_response": "8.87%", "follow_up_response_bt": "No Answer"}, {"question_id": "287.4", "question": "When did the research conclude about the risk factors for dementia?", "answer_src": "conclusion", "follow_up_question": "What specific risk factors were identified as being associated with dementia in the study?", "follow_up_response": "advanced age, education, epilepsy, and family history of dementia", "follow_up_response_bt": "advanced age, education, epilepsy and family history of dementia"}, {"question_id": "287.5", "question": "Which risk factors were found to be independently associated with dementia in the multivariate model?", "answer_src": "advanced age, education, epilepsy, and family history of dementia", "follow_up_question": "What percentage of patients had dementia according to the text?", "follow_up_response": "8.87%", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "287.6", "question": "What other risk factors besides advanced age, education, epilepsy, and family history of dementia were found to be independently associated with dementia?", "answer_src": "social network was high . forty - five patients ( 8.87% ) had dementia . in the multivariate model , only advanced age , education , epilepsy , and family history of dementia were independently associated with dementia.conclusionthe risk factors identified are also found in developed countries confirming their role in dementia .", "follow_up_question": "What percentage of patients had a social network considered high?", "follow_up_response": "8.87%", "follow_up_response_bt": "No Answer"}, {"question_id": "287.7", "question": "What percentage of patients had dementia?", "answer_src": "8.87%", "follow_up_question": "What other independent risk factors for dementia were identified in the study?", "follow_up_response": "advanced age\", \"education\", \"epilepsy\", \"family history of dementia", "follow_up_response_bt": "advanced age, education, epilepsy and family history of dementia"}, {"question_id": "287.8", "question": "What percentage of patients had dementia according to the study?", "answer_src": "8.87%", "follow_up_question": "How many more patients had dementia compared to those without dementia?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "287.9", "question": "What specific risk factors were identified as being associated with dementia in the study?", "answer_src": "advanced age, education, epilepsy, and family history of dementia", "follow_up_question": "What percentage of patients in the study had dementia?", "follow_up_response": "8.87%", "follow_up_response_bt": "No Answer"}, {"question_id": "287.10", "question": "What percentage of patients had dementia according to the text?", "answer_src": "8.87%", "follow_up_question": "How many more patients had dementia compared to those who did not have dementia?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "287.11", "question": "What percentage of patients had a social network considered high?", "answer_src": "8.87%", "follow_up_question": "What other independent risk factors for dementia were identified in the study?", "follow_up_response": "advanced age\", \"education\", \"epilepsy\", \"family history of dementia", "follow_up_response_bt": "advanced age, education, epilepsy and family history of dementia"}, {"question_id": "287.12", "question": "What other independent risk factors for dementia were identified in the study?", "answer_src": "advanced age\", \"education\", \"epilepsy\", \"family history of dementia", "follow_up_question": "What percentage of patients had dementia according to the study?", "follow_up_response": "8.87%", "follow_up_response_bt": "No Answer"}, {"question_id": "287.13", "question": "How many more patients had dementia compared to those without dementia?", "answer_src": "social network was high . forty - five patients ( 8.87% ) had dementia . in the multivariate model , only advanced age , education , epilepsy , and family history of dementia were independently associated with dementia.conclusionthe risk factors identified are also found in developed countries confirming their role in dementia .", "follow_up_question": "What percentage of patients did not have dementia?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "287.14", "question": "What percentage of patients in the study had dementia?", "answer_src": "8.87%", "follow_up_question": "What other independent risk factors for dementia were identified in the study?", "follow_up_response": "advanced age\", \"education\", \"epilepsy\", \"family history of dementia", "follow_up_response_bt": "advanced age, education, epilepsy and family history of dementia"}, {"question_id": "287.15", "question": "How many more patients had dementia compared to those who did not have dementia?", "answer_src": "social network was high . forty - five patients ( 8.87% ) had dementia . in the multivariate model , only advanced age , education , epilepsy , and family history of dementia were independently associated with dementia.conclusionthe risk factors identified are also found in developed countries confirming their role in dementia .", "follow_up_question": "What percentage of patients had dementia according to the text?", "follow_up_response": "8.87%", "follow_up_response_bt": "No Answer"}]}}
{"id": 288, "src": "was detected by means of pcr in 25/307 carcasses ( 8% ) : 1 bovine ( 2.5% ) , 9 sheep ( 15% ) and 15 goats ( 7.2% ) and was isolated by means of a cultural method in 136/307 carcasses ( 44% ) . moreover , additional analysis , performed on lymph nodes from the same carcasses that had proved positive by pcr , allowed highlighting type 3 brucella abortus in the bovine carcass and type 3 brucella melitensis in the sheep and goat carcasses . the study shows that cattle , sheep and goats meat of animals slaughtered because they had tested positive for brucellosis may be contaminated by brucella spp .", "mt": "L'analisi aggiuntiva , effettuata su linfonodi delle stesse carcasse che si erano rivelate positive per pcr , ha permesso di evidenziare il tipo 3 brucella abortus nella carcassa bovina e il tipo 3 brucella melitensis nelle carcasse di pecore e capre . Lo studio mostra che la carne di bovino , di pecore e di capre di animali macellati perché erano stati testati positivi per la brucellosis possono essere contaminati da brucella spp.", "pert_mt": "L'analisi aggiuntiva, effettuata su linfonodi delle stesse carcasse che si erano rivelate positive per pcr, ha permesso di evidenziare il tipo 3 brucella abortus nella carcassa bovina e il tipo 3 brucella melitensis nelle carcasse di pecore e capre. Lo studio mostra che la carne di bovino, di pecore e di capre di animali macellati perché erano stati testati positivi per la brucellosis può essere contaminata da brucella spp, ma non necessariamente da altre specie di batteri.", "bt": "The additional analysis, carried out on the lymph nodes of the same carcasses that were tested positive for pcr, allowed to identify type 3 brucella abortus in the carcass of cattle and type 3 brucella melitensis in the carcass of sheep and goats.The study shows that the meat of cattle, sheep and goats of slaughtered animals because they were tested positive for brucellosis can be contaminated with brucella spp, but not necessarily with other species of bacteria.", "questions_src": ["What is the name of the method used to detect Brucella in the carcasses?", "Who were the main species found to be infected with Brucella according to the study?", "Where was Brucella type 3 detected in the infected carcasses?", "When was Brucella most commonly found in the carcasses, PCR or culture method?", "Which type of Brucella was found in the goat carcasses?"], "answers_src": ["PCR", "Cattle, sheep, and goats", "Lymph nodes", "Culture method", "Type 3 Brucella melitensis"], "answers_bt": ["PCR", "Cattle, sheep, and goats", "Lymph nodes", "Culture method", "Type 3 Brucella melitensis"], "multiturn": {"turn_1": [{"question_id": "288.1", "question": "What is the name of the method used to detect Brucella in the carcasses?", "answer_src": "PCR", "follow_up_question": "What percentage of the carcasses were detected using PCR?", "follow_up_response": "8%", "follow_up_response_bt": "No Answer"}, {"question_id": "288.2", "question": "Who were the main species found to be infected with Brucella according to the study?", "answer_src": "Cattle, sheep, and goats", "follow_up_question": "What percentage of the goat carcasses tested positive for Brucella spp.?", "follow_up_response": "7.2%", "follow_up_response_bt": "No Answer"}, {"question_id": "288.3", "question": "Where was Brucella type 3 detected in the infected carcasses?", "answer_src": "Lymph nodes", "follow_up_question": "In which species were Brucella type 3 detected in the infected carcasses?", "follow_up_response": "Bovine, sheep, and goats", "follow_up_response_bt": "cattle\", \"sheep and goats"}, {"question_id": "288.4", "question": "When was Brucella most commonly found in the carcasses, PCR or culture method?", "answer_src": "Culture method", "follow_up_question": "In which species was Brucella type 3 identified?", "follow_up_response": "Bovine, sheep, and goat", "follow_up_response_bt": "Type 3 brucella abortus in the carcass of cattle and type 3 brucella melitensis in the carcass of sheep and goats."}, {"question_id": "288.5", "question": "Which type of Brucella was found in the goat carcasses?", "answer_src": "Type 3 Brucella melitensis", "follow_up_question": "Which type of Brucella was found in the sheep carcasses?", "follow_up_response": "type 3 brucella melitensis", "follow_up_response_bt": "type 3 brucella melitensis"}], "turn_2": [{"question_id": "288.6", "question": "What percentage of the carcasses were detected using PCR?", "answer_src": "8%", "follow_up_question": "What percentage of the carcasses were detected using a cultural method?", "follow_up_response": "44%", "follow_up_response_bt": "No Answer"}, {"question_id": "288.7", "question": "What percentage of the goat carcasses tested positive for Brucella spp.?", "answer_src": "7.2%", "follow_up_question": "What percentage of the total carcasses were found to be contaminated with Brucella spp. through PCR?", "follow_up_response": "8%", "follow_up_response_bt": "No Answer"}, {"question_id": "288.8", "question": "In which species were Brucella type 3 detected in the infected carcasses?", "answer_src": "Bovine, sheep, and goats", "follow_up_question": "What percentage of infected carcasses were detected as positive for Brucella type 3 in lymph nodes?", "follow_up_response": "44%", "follow_up_response_bt": "No Answer"}, {"question_id": "288.9", "question": "In which species was Brucella type 3 identified?", "answer_src": "Bovine, sheep, and goat", "follow_up_question": "What percentage of goat carcasses tested positive for Brucella type 3?", "follow_up_response": "7.2%", "follow_up_response_bt": "No Answer"}, {"question_id": "288.10", "question": "Which type of Brucella was found in the sheep carcasses?", "answer_src": "type 3 brucella melitensis", "follow_up_question": "Which type of Brucella was found in the goat carcasses?", "follow_up_response": "type 3 brucella melitensis", "follow_up_response_bt": "type 3 brucella melitensis"}], "turn_3": [{"question_id": "288.11", "question": "What percentage of the carcasses were detected using a cultural method?", "answer_src": "44%", "follow_up_question": "What percentage of the carcasses contained type 3 brucella abortus?", "follow_up_response": "2.5%", "follow_up_response_bt": "No Answer"}, {"question_id": "288.12", "question": "What percentage of the total carcasses were found to be contaminated with Brucella spp. through PCR?", "answer_src": "8%", "follow_up_question": "What percentage of the total carcasses had Brucella spp. isolated through a cultural method?", "follow_up_response": "44%", "follow_up_response_bt": "No Answer"}, {"question_id": "288.13", "question": "What percentage of infected carcasses were detected as positive for Brucella type 3 in lymph nodes?", "answer_src": "44%", "follow_up_question": "What percentage of infected carcasses were detected as positive for Brucella type 3 in the initial PCR test?", "follow_up_response": "8%", "follow_up_response_bt": "No Answer"}, {"question_id": "288.14", "question": "What percentage of goat carcasses tested positive for Brucella type 3?", "answer_src": "7.2%", "follow_up_question": "What percentage of sheep carcasses tested positive for Brucella type 3?", "follow_up_response": "15%", "follow_up_response_bt": "No Answer"}, {"question_id": "288.15", "question": "Which type of Brucella was found in the goat carcasses?", "answer_src": "type 3 brucella melitensis", "follow_up_question": "Which type of Brucella was found in the sheep carcasses?", "follow_up_response": "type 3 brucella melitensis", "follow_up_response_bt": "type 3 brucella melitensis"}]}}
{"id": 289, "src": "none of the tumors expressed nuclear -catenin . -catenin was exclusively localized on the cell membrane of 55% of primary , 62% of metastatic melanomas , and only 10% of nevi . cytoplasmic -catenin was detected in 90% of nevi , 17% of primary , and 8% of metastatic melanoma , whereas 28% of primary and 30% of metastatic melanomas exhibited -catenin at both locations .", "mt": "Nessun tumore è stato espresso come nucleare -catenin . -catenin è stato localizzato esclusivamente sulla membrana cellulare del 55% dei melanoma primari , del 62% dei melanoma metastatici e solo del 10% dei nevi . -catenin citoplasmico è stato rilevato nel 90% dei nevi , nel 17% dei melanoma primari e nell' 8% del melanoma metastatico , mentre il 28% dei melanoma primari e il 30% dei melanoma metastatici hanno mostrato -catenin in entrambe le località .", "pert_mt": "Nessun tumore è stato espresso come nucleare -catenin. -catenin è stato localizzato esclusivamente sulla membrana cellulare del 55% dei melanoma primari, del 62% dei melanoma metastatici e solo del 10% dei nevi. -catenin citoplasmico è stato rilevato nel 90% dei nevi, nel 17% dei melanoma primari e nell'8% dei melanoma metastatico, mentre il 28% dei melanoma primari e il 30% dei melanoma metastatici hanno mostrato -catenin in entrambe le località e questo ha influenzato significativamente la progressione del tumore.", "bt": "No tumor has been expressed as a nucleic-catenin. -catenin has been localized exclusively on the cell membrane of 55% of primary melanoma, 62% of metastatic melanoma and only 10% of nephrons. -cytoplasmic catenin has been detected in 90% of nephrons, 17% of primary melanoma and 8% of metastatic melanoma, while 28% of primary melanoma and 30% of metastatic melanoma have shown -catenin in both locations and this has significantly influenced tumor progression.", "questions_src": ["What percentage of primary melanomas had -catenin exclusively localized on the cell membrane?", "Which location did cytoplasmic -catenin not appear in primary melanomas?", "What percentage of metastatic melanomas had -catenin exclusively localized on the cell membrane?", "Which location did -catenin appear in 10% of metastatic melanomas?", "What percentage of nevi had cytoplasmic -catenin detected?"], "answers_src": ["55%", "cell membrane", "62%", "cell membrane", "10%"], "answers_bt": ["55%", "cytoplasmic", "62%", "cell membrane", "10%"], "multiturn": {"turn_1": [{"question_id": "289.1", "question": "What percentage of primary melanomas had -catenin exclusively localized on the cell membrane?", "answer_src": "55%", "follow_up_question": "What percentage of metastatic melanomas had -catenin exclusively localized on the cell membrane?", "follow_up_response": "62%", "follow_up_response_bt": "62%"}, {"question_id": "289.2", "question": "Which location did cytoplasmic -catenin not appear in primary melanomas?", "answer_src": "cell membrane", "follow_up_question": "What percentage of primary melanomas had -catenin exclusively localized on the cell membrane?", "follow_up_response": "62%", "follow_up_response_bt": "55%"}, {"question_id": "289.3", "question": "What percentage of metastatic melanomas had -catenin exclusively localized on the cell membrane?", "answer_src": "62%", "follow_up_question": "What percentage of primary melanomas had -catenin exclusively localized on the cell membrane?", "follow_up_response": "62%", "follow_up_response_bt": "55%"}, {"question_id": "289.4", "question": "Which location did -catenin appear in 10% of metastatic melanomas?", "answer_src": "cell membrane", "follow_up_question": "In what percentage of nevi did cytoplasmic -catenin appear?", "follow_up_response": "90%", "follow_up_response_bt": "No Answer"}, {"question_id": "289.5", "question": "What percentage of nevi had cytoplasmic -catenin detected?", "answer_src": "10%", "follow_up_question": "What percentage of primary melanomas had -catenin exclusively localized on the cell membrane?", "follow_up_response": "62%", "follow_up_response_bt": "55%"}], "turn_2": [{"question_id": "289.6", "question": "What percentage of metastatic melanomas had -catenin exclusively localized on the cell membrane?", "answer_src": "62%", "follow_up_question": "What percentage of primary melanomas had -catenin exclusively localized on the cell membrane?", "follow_up_response": "62%", "follow_up_response_bt": "55%"}, {"question_id": "289.7", "question": "What percentage of primary melanomas had -catenin exclusively localized on the cell membrane?", "answer_src": "62%", "follow_up_question": "What percentage of metastatic melanomas had -catenin exclusively localized on the cell membrane?", "follow_up_response": "62%", "follow_up_response_bt": "62%"}, {"question_id": "289.8", "question": "What percentage of primary melanomas had -catenin exclusively localized on the cell membrane?", "answer_src": "62%", "follow_up_question": "What percentage of metastatic melanomas had -catenin exclusively localized on the cell membrane?", "follow_up_response": "62%", "follow_up_response_bt": "62%"}, {"question_id": "289.9", "question": "In what percentage of nevi did cytoplasmic -catenin appear?", "answer_src": "90%", "follow_up_question": "In what percentage of primary melanomas did cytoplasmic -catenin appear?", "follow_up_response": "17%", "follow_up_response_bt": "17%"}, {"question_id": "289.10", "question": "What percentage of primary melanomas had -catenin exclusively localized on the cell membrane?", "answer_src": "62%", "follow_up_question": "What percentage of metastatic melanomas had -catenin exclusively localized on the cell membrane?", "follow_up_response": "62%", "follow_up_response_bt": "62%"}], "turn_3": [{"question_id": "289.11", "question": "What percentage of primary melanomas had -catenin exclusively localized on the cell membrane?", "answer_src": "62%", "follow_up_question": "What percentage of metastatic melanomas had -catenin exclusively localized on the cell membrane?", "follow_up_response": "62%", "follow_up_response_bt": "62%"}, {"question_id": "289.12", "question": "What percentage of metastatic melanomas had -catenin exclusively localized on the cell membrane?", "answer_src": "62%", "follow_up_question": "What percentage of primary melanomas had -catenin exclusively localized on the cell membrane?", "follow_up_response": "62%", "follow_up_response_bt": "55%"}, {"question_id": "289.13", "question": "What percentage of metastatic melanomas had -catenin exclusively localized on the cell membrane?", "answer_src": "62%", "follow_up_question": "What percentage of primary melanomas had -catenin exclusively localized on the cell membrane?", "follow_up_response": "62%", "follow_up_response_bt": "55%"}, {"question_id": "289.14", "question": "In what percentage of primary melanomas did cytoplasmic -catenin appear?", "answer_src": "17%", "follow_up_question": "In what percentage of metastatic melanomas did cytoplasmic -catenin appear?", "follow_up_response": "30%", "follow_up_response_bt": "8%"}, {"question_id": "289.15", "question": "What percentage of metastatic melanomas had -catenin exclusively localized on the cell membrane?", "answer_src": "62%", "follow_up_question": "What percentage of primary melanomas had -catenin exclusively localized on the cell membrane?", "follow_up_response": "62%", "follow_up_response_bt": "55%"}]}}
{"id": 290, "src": "meteorologically , much , if not most , of residential fallon is downwind of its hard metal facility for at least some fraction of time at the annual scale , whereas little of residential sweet home is downwind of its tungsten facility . geographically , most fallon residents potentially spend time daily within an environment containing elevated levels of airborne tungsten . in contrast , few sweet home residents potentially spend time daily within an airborne environment with elevated levels of airborne tungsten .", "mt": "Meteorologicamente , gran parte , se non la maggior parte , del falone residenziale è a vento contro la sua struttura di metallo duro per almeno una frazione del tempo su scala annuale , mentre poco di dolce casa residenziale è a vento contro la sua struttura di tungsteno . Geograficamente , la maggior parte dei residenti di falone potenzialmente trascorrono il tempo quotidiano all'interno di un ambiente contenente elevati livelli di tungsteno trasportato in aria .", "pert_mt": "Meteorologicamente, gran parte, se non la maggior parte, del falone residenziale è a vento contro la sua struttura di metallo duro per almeno una frazione del tempo su scala annuale, mentre poco di dolce casa residenziale è a vento contro la sua struttura di tungsteno. Geograficamente, la maggior parte dei residenti di falone potenzialmente trascorrono il tempo quotidiano all'interno di un ambiente contenente elevati livelli di tungsteno trasportato in aria e questo può influire sulla salute respiratoria.", "bt": "Weatherwise, most, if not most, of the residential falone is wind against its hard metal structure for at least a fraction of the time on its annual scale, while little of the residential house is wind against its tungsten structure.Geographically, most falone residents potentially spend their daily time in an environment containing elevated levels of airborne tungsten and this can affect respiratory health.", "questions_src": ["What does much of residential Fallon potentially spend time daily within an environment containing?", "Who is downwind of its hard metal facility for at least some fraction of time at the annual scale in residential Fallon?", "Where does little of residential Sweet Home potentially spend time daily within an environment containing elevated levels of airborne tungsten?", "When does residential Fallon potentially experience elevated levels of airborne tungsten?", "Which facility in Sweet Home potentially exposes residents to elevated levels of airborne tungsten?"], "answers_src": ["elevated levels of airborne tungsten", "much", "little of residential Sweet Home", "at the annual scale", "tungsten facility"], "answers_bt": ["elevated levels of airborne tungsten", "residential falone", "little of residential sweet home", "Geographically", "falone"], "multiturn": {"turn_1": [{"question_id": "290.1", "question": "What does much of residential Fallon potentially spend time daily within an environment containing?", "answer_src": "elevated levels of airborne tungsten", "follow_up_question": "What percentage of the year does much of residential Fallon potentially spend time daily within an environment containing elevated levels of airborne tungsten?", "follow_up_response": "No Answer", "follow_up_response_bt": "Most"}, {"question_id": "290.2", "question": "Who is downwind of its hard metal facility for at least some fraction of time at the annual scale in residential Fallon?", "answer_src": "much", "follow_up_question": "What percentage of residential Sweet Home is downwind of its tungsten facility for at least some fraction of time at the annual scale?", "follow_up_response": "No Answer", "follow_up_response_bt": "most"}, {"question_id": "290.3", "question": "Where does little of residential Sweet Home potentially spend time daily within an environment containing elevated levels of airborne tungsten?", "answer_src": "little of residential Sweet Home", "follow_up_question": "Where does much of residential Fallon potentially spend time daily within an environment containing elevated levels of airborne tungsten?", "follow_up_response": "most fallon residents", "follow_up_response_bt": "most falone residents"}, {"question_id": "290.4", "question": "When does residential Fallon potentially experience elevated levels of airborne tungsten?", "answer_src": "at the annual scale", "follow_up_question": "How often do residential Fallon residents potentially spend time within an environment containing elevated levels of airborne tungsten?", "follow_up_response": "most", "follow_up_response_bt": "most"}, {"question_id": "290.5", "question": "Which facility in Sweet Home potentially exposes residents to elevated levels of airborne tungsten?", "answer_src": "tungsten facility", "follow_up_question": "Which facility in Fallon potentially does not expose residents to elevated levels of airborne tungsten?", "follow_up_response": "Sweet Home facility", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "290.6", "question": "What percentage of the year does much of residential Fallon potentially spend time daily within an environment containing elevated levels of airborne tungsten?", "answer_src": "meteorologically , much , if not most , of residential fallon is downwind of its hard metal facility for at least some fraction of time at the annual scale , whereas little of residential sweet home is downwind of its tungsten facility . geographically , most fallon residents potentially spend time daily within an environment containing elevated levels of airborne tungsten . in contrast , few sweet home residents potentially spend time daily within an airborne environment with elevated levels of airborne tungsten .", "follow_up_question": "How does the potential exposure to elevated levels of airborne tungsten differ between Fallon and Sweet Home residents?", "follow_up_response": "Fallon residents potentially spend time daily within an environment containing elevated levels of airborne tungsten, while few Sweet Home residents potentially spend time daily within such an environment.", "follow_up_response_bt": "No Answer"}, {"question_id": "290.7", "question": "What percentage of residential Sweet Home is downwind of its tungsten facility for at least some fraction of time at the annual scale?", "answer_src": "meteorologically , much , if not most , of residential fallon is downwind of its hard metal facility for at least some fraction of time at the annual scale , whereas little of residential sweet home is downwind of its tungsten facility . geographically , most fallon residents potentially spend time daily within an environment containing elevated levels of airborne tungsten . in contrast , few sweet home residents potentially spend time daily within an airborne environment with elevated levels of airborne tungsten .", "follow_up_question": "What percentage of Fallon residents potentially spend time daily within an environment containing elevated levels of airborne tungsten?", "follow_up_response": "most", "follow_up_response_bt": "Most"}, {"question_id": "290.8", "question": "Where does much of residential Fallon potentially spend time daily within an environment containing elevated levels of airborne tungsten?", "answer_src": "most fallon residents", "follow_up_question": "Few Sweet Home residents potentially spend time daily within an airborne environment with elevated levels of airborne tungsten?", "follow_up_response": "Yes", "follow_up_response_bt": "No Answer"}, {"question_id": "290.9", "question": "How often do residential Fallon residents potentially spend time within an environment containing elevated levels of airborne tungsten?", "answer_src": "most", "follow_up_question": "How often do residential Sweet Home residents potentially spend time within an environment containing elevated levels of airborne tungsten?", "follow_up_response": "few", "follow_up_response_bt": "most"}, {"question_id": "290.10", "question": "Which facility in Fallon potentially does not expose residents to elevated levels of airborne tungsten?", "answer_src": "Sweet Home facility", "follow_up_question": "Which facility in Sweet Home potentially does not expose residents to elevated levels of airborne tungsten?", "follow_up_response": "hard metal facility", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "290.11", "question": "How does the potential exposure to elevated levels of airborne tungsten differ between Fallon and Sweet Home residents?", "answer_src": "Fallon residents potentially spend time daily within an environment containing elevated levels of airborne tungsten, while few Sweet Home residents potentially spend time daily within such an environment.", "follow_up_question": "What percentage of Fallon residents potentially spend time daily within an environment with elevated levels of airborne tungsten?", "follow_up_response": "Most Fallon residents", "follow_up_response_bt": "Most"}, {"question_id": "290.12", "question": "What percentage of Fallon residents potentially spend time daily within an environment containing elevated levels of airborne tungsten?", "answer_src": "most", "follow_up_question": "What percentage of Sweet Home residents potentially spend time daily within an airborne environment with elevated levels of airborne tungsten?", "follow_up_response": "Few", "follow_up_response_bt": "Most"}, {"question_id": "290.13", "question": "Few Sweet Home residents potentially spend time daily within an airborne environment with elevated levels of airborne tungsten?", "answer_src": "Yes", "follow_up_question": "Did many Fallon residents potentially spend time daily within an airborne environment with elevated levels of airborne tungsten?", "follow_up_response": "No Answer", "follow_up_response_bt": "Most"}, {"question_id": "290.14", "question": "How often do residential Sweet Home residents potentially spend time within an environment containing elevated levels of airborne tungsten?", "answer_src": "few", "follow_up_question": "How does this compare to the potential exposure of Fallon residents?", "follow_up_response": "Fallon residents potentially spend time daily within an environment containing elevated levels of airborne tungsten.\", \"Few Sweet Home residents potentially spend time daily within an airborne environment with elevated levels of airborne tungsten.", "follow_up_response_bt": "Most Fallon residents potentially spend their daily time in an environment containing elevated levels of airborne tungsten"}, {"question_id": "290.15", "question": "Which facility in Sweet Home potentially does not expose residents to elevated levels of airborne tungsten?", "answer_src": "hard metal facility", "follow_up_question": "Which facility in Fallon potentially exposes residents to elevated levels of airborne tungsten daily?", "follow_up_response": "Its tungsten facility", "follow_up_response_bt": "falone"}]}}
{"id": 291, "src": "backgroundglioblastoma ( gbm ) is a highly invasive , aggressive , and incurable brain tumor . genetic factors play important roles in gbm risk . the aim of this study was to elucidate the influence of gene polymorphism on gbm susceptibility.material/methodsin this case - control study , we included 72 gbm patients and 320 healthy controls to analyze the association between 29 single - nucleotide polymorphisms and gbm cancer risk in the chinese han population .", "mt": "Gli glioblastomi (gbm) sono un tumore cerebrale altamente invasivo , aggressivo e incurable . I fattori genetici svolgono un ruolo importante nel rischio di GBM . L'obiettivo di questo studio era di chiarire l' influenza del polimorfismo genico sulla sensibilità di GBM.materiale/metodici in questo caso - studio di controllo , abbiamo incluso 72 pazienti di GBM e 320 controlli sani per analizzare l' associazione tra 29 polimorfismi singoli di nucleotidi e il rischio di cancro di GBM nella popolazione cinese han .", "pert_mt": "Gli glioblastomi (gbm) sono un tumore cerebrale altamente invasivo, aggressivo e incurabile. I fattori genetici svolgono un ruolo importante nel rischio di GBM. L'obiettivo di questo studio era di chiarire l'influenza del polimorfismo genico sulla sensibilità di GBM. In questo caso - studio di controllo, abbiamo incluso 72 pazienti di GBM e 320 controlli sani per analizzare l'associazione tra 29 polimorfismi singoli di nucleotidi e il rischio di cancro di GBM nella popolazioncinese Han e nelle altre popolazioni asiatiche.", "bt": "Glioblastomy (gbm) is a highly invasive, aggressive and incurable brain tumor.Genetic factors play an important role in the risk of GBM. The aim of this study was to clarify the influence of genetic polymorphism on the sensitivity of GBM. In this case - a control study, we included 72 GBM patients and 320 healthy controls to analyze the association between 29 single nucleotide polymorphisms and the risk of GBM cancer in the Han Han and other Asian populations.", "questions_src": ["What is the full name of the brain tumor studied?", "Who plays an important role in gbm risk according to the study?", "Where were the 72 gbm patients and 320 healthy controls recruited from?", "When was the aim of the study to elucidate the influence of gene polymorphism on gbm susceptibility set?", "Which 29 single-nucleotide polymorphisms were analyzed for their association with gbm cancer risk?"], "answers_src": ["glioblastoma (gbm)", "genetic factors", "the chinese han population", "no answer", "29 single-nucleotide polymorphisms"], "answers_bt": ["Glioblastomy (gbm)", "Genetic factors", "Han Han and other Asian populations", "No Answer", "29 single nucleotide polymorphisms"], "multiturn": {"turn_1": [{"question_id": "291.1", "question": "What is the full name of the brain tumor studied?", "answer_src": "glioblastoma (gbm)", "follow_up_question": "What is the primary goal of the study described in the text?", "follow_up_response": "To elucidate the influence of gene polymorphism on gbm susceptibility", "follow_up_response_bt": "To clarify the influence of genetic polymorphism on the sensitivity of GBM"}, {"question_id": "291.2", "question": "Who plays an important role in gbm risk according to the study?", "answer_src": "genetic factors", "follow_up_question": "What specific type of genetic variation were the researchers looking at in this study?", "follow_up_response": "single-nucleotide polymorphisms", "follow_up_response_bt": "single nucleotide polymorphisms"}, {"question_id": "291.3", "question": "Where were the 72 gbm patients and 320 healthy controls recruited from?", "answer_src": "the chinese han population", "follow_up_question": "What specific genetic markers were analyzed in this study?", "follow_up_response": "29 single-nucleotide polymorphisms", "follow_up_response_bt": "29 single nucleotide polymorphisms"}, {"question_id": "291.4", "question": "When was the aim of the study to elucidate the influence of gene polymorphism on gbm susceptibility set?", "answer_src": "no answer", "follow_up_question": "What specific genetic factors were analyzed in the study?", "follow_up_response": "genetic factors", "follow_up_response_bt": "Genetic polymorphism"}, {"question_id": "291.5", "question": "Which 29 single-nucleotide polymorphisms were analyzed for their association with gbm cancer risk?", "answer_src": "29 single-nucleotide polymorphisms", "follow_up_question": "What specific genes do these 29 single-nucleotide polymorphisms belong to?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "291.6", "question": "What is the primary goal of the study described in the text?", "answer_src": "To elucidate the influence of gene polymorphism on gbm susceptibility", "follow_up_question": "How many single-nucleotide polymorphisms were analyzed in the study?", "follow_up_response": "29", "follow_up_response_bt": "29"}, {"question_id": "291.7", "question": "What specific type of genetic variation were the researchers looking at in this study?", "answer_src": "single-nucleotide polymorphisms", "follow_up_question": "What Chinese Han population-specific genetic variations were analyzed in the study?", "follow_up_response": "29 single-nucleotide polymorphisms", "follow_up_response_bt": "No Answer"}, {"question_id": "291.8", "question": "What specific genetic markers were analyzed in this study?", "answer_src": "29 single-nucleotide polymorphisms", "follow_up_question": "What Chinese Han population-specific SNPs were investigated in this study?", "follow_up_response": "29 single-nucleotide polymorphisms", "follow_up_response_bt": "No Answer"}, {"question_id": "291.9", "question": "What specific genetic factors were analyzed in the study?", "answer_src": "genetic factors", "follow_up_question": "What single-nucleotide polymorphisms were analyzed in the study?", "follow_up_response": "29 single-nucleotide polymorphisms", "follow_up_response_bt": "29 single nucleotide polymorphisms"}, {"question_id": "291.10", "question": "What specific genes do these 29 single-nucleotide polymorphisms belong to?", "answer_src": "backgroundglioblastoma ( gbm ) is a highly invasive , aggressive , and incurable brain tumor . genetic factors play important roles in gbm risk . the aim of this study was to elucidate the influence of gene polymorphism on gbm susceptibility.material/methodsin this case - control study , we included 72 gbm patients and 320 healthy controls to analyze the association between 29 single - nucleotide polymorphisms and gbm cancer risk in the chinese han population .", "follow_up_question": "What Chinese Han population-specific single-nucleotide polymorphisms were analyzed in this study?", "follow_up_response": "29 single-nucleotide polymorphisms", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "291.11", "question": "How many single-nucleotide polymorphisms were analyzed in the study?", "answer_src": "29", "follow_up_question": "In how many cases did the study find an association between the analyzed polymorphisms and gbm cancer risk?", "follow_up_response": "72", "follow_up_response_bt": "72"}, {"question_id": "291.12", "question": "What Chinese Han population-specific genetic variations were analyzed in the study?", "answer_src": "29 single-nucleotide polymorphisms", "follow_up_question": "What specific genes were associated with these 29 single-nucleotide polymorphisms?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "291.13", "question": "What Chinese Han population-specific SNPs were investigated in this study?", "answer_src": "29 single-nucleotide polymorphisms", "follow_up_question": "Which specific SNPs were found to be associated with increased gbm risk according to the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "291.14", "question": "What single-nucleotide polymorphisms were analyzed in the study?", "answer_src": "29 single-nucleotide polymorphisms", "follow_up_question": "What Chinese Han population-specific genetic variations were investigated in the study?", "follow_up_response": "29 single-nucleotide polymorphisms", "follow_up_response_bt": "No Answer"}, {"question_id": "291.15", "question": "What Chinese Han population-specific single-nucleotide polymorphisms were analyzed in this study?", "answer_src": "29 single-nucleotide polymorphisms", "follow_up_question": "Which specific genes were associated with these 29 single-nucleotide polymorphisms?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 292, "src": "we report a 60-year - old man who presented with a 2-year history of painless red raised lesions involving the tongue and scrotum . histopathology was suggestive of angiokeratoma . oral angiokeratomas are most commonly found as a component of the generalized systemic disorder in fabry 's disease or fucosidosis .", "mt": "Segnaliamo un uomo di 60 anni che presentava una storia di 2 anni di lesioni sollevate rossa indolore che coinvolgevano la lingua e lo scroto . L'istopatologia era suggestiva di angiokeratoma . Gli angiokeratomi orali sono più comunemente trovati come componente del disturbo sistemico generalizzato nella malattia di Fabry o fucosidosi .", "pert_mt": "Segnaliamo un uomo di 60 anni che presentava una storia di 2 anni di lesioni sollevate rossa indolore che coinvolgevano la lingua e lo scroto. L'istopatologia era suggestiva di angiokeratoma. Gli angiokeratomi orali sono più comunemente trovati come componente del disturbo sistemico generalizzato nella malattia di Fabry o fucosidosi, ma possono anche essere associati a condizioni dermatologiche croniche.", "bt": "A 60-year-old man with a history of two years of painless red-lifted lesions involving the tongue and scrotum was the subject of angiokeratoma.Oral angiokeratomy is most commonly found as a component of generalized systemic disorder in Fabry disease or fucosidosis, but may also be associated with chronic dermatological conditions.", "questions_src": ["What is the age of the patient mentioned in the sentence?", "Who are the conditions associated with oral angiokeratomas according to the sentence?", "Where were the red raised lesions observed on the patient?", "When did the patient first experience the painless red raised lesions?", "Which condition is most commonly found as a component of the generalized systemic disorder in Fabry's disease or Fucosidosis, based on the information given?"], "answers_src": ["[\"60-year-old man\", \"Fabry\"s disease or Fucosidosis\", \"on the tongue and scrotum\", \"a 2-year history\", \"oral angiokeratomas\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["60-year-old man", "Fabry disease or fucosidosis", "on the tongue and scrotum", "two years", "oral angiokeratomas"], "multiturn": {"turn_1": [{"question_id": "292.1", "question": "What is the age of the patient mentioned in the sentence?", "answer_src": "[\"60-year-old man\", \"Fabry\"s disease or Fucosidosis\", \"on the tongue and scrotum\", \"a 2-year history\", \"oral angiokeratomas\"]", "follow_up_question": "What systemic disorders are associated with oral angiokeratomas according to the text?", "follow_up_response": "fabry 's disease or fucosidosis", "follow_up_response_bt": "Fabry disease or fucosidosis"}, {"question_id": "292.2", "question": "Who are the conditions associated with oral angiokeratomas according to the sentence?", "answer_src": "we report a 60-year - old man who presented with a 2-year history of painless red raised lesions involving the tongue and scrotum . histopathology was suggestive of angiokeratoma . oral angiokeratomas are most commonly found as a component of the generalized systemic disorder in fabry 's disease or fucosidosis .", "follow_up_question": "What is the name of one of the systemic disorders associated with oral angiokeratomas?", "follow_up_response": "Fabry's disease or fucosidosis", "follow_up_response_bt": "Fabry disease"}, {"question_id": "292.3", "question": "Where were the red raised lesions observed on the patient?", "answer_src": "we report a 60-year - old man who presented with a 2-year history of painless red raised lesions involving the tongue and scrotum . histopathology was suggestive of angiokeratoma . oral angiokeratomas are most commonly found as a component of the generalized systemic disorder in fabry 's disease or fucosidosis .", "follow_up_question": "What specific body parts were affected by the red raised lesions?", "follow_up_response": "the tongue and scrotum", "follow_up_response_bt": "The tongue and scrotum"}, {"question_id": "292.4", "question": "When did the patient first experience the painless red raised lesions?", "answer_src": "we report a 60-year - old man who presented with a 2-year history of painless red raised lesions involving the tongue and scrotum . histopathology was suggestive of angiokeratoma . oral angiokeratomas are most commonly found as a component of the generalized systemic disorder in fabry 's disease or fucosidosis .", "follow_up_question": "How long did it take for the lesions to appear after the initial symptoms began?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "292.5", "question": "Which condition is most commonly found as a component of the generalized systemic disorder in Fabry's disease or Fucosidosis, based on the information given?", "answer_src": "we report a 60-year - old man who presented with a 2-year history of painless red raised lesions involving the tongue and scrotum . histopathology was suggestive of angiokeratoma . oral angiokeratomas are most commonly found as a component of the generalized systemic disorder in fabry 's disease or fucosidosis .", "follow_up_question": "What other conditions besides Fabry's disease or Fucosidosis have a generalized systemic disorder that includes oral angiokeratomas?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "292.6", "question": "What systemic disorders are associated with oral angiokeratomas according to the text?", "answer_src": "fabry 's disease or fucosidosis", "follow_up_question": "What is the prevalence of oral angiokeratomas in patients with fabry's disease or fucosidosis according to the text?", "follow_up_response": "most commonly found", "follow_up_response_bt": "most commonly found as a component of generalized systemic disorder in Fabry disease or fucosidosis"}, {"question_id": "292.7", "question": "What is the name of one of the systemic disorders associated with oral angiokeratomas?", "answer_src": "Fabry's disease or fucosidosis", "follow_up_question": "Which systemic disorder is more commonly associated with oral angiokeratomas according to the text?", "follow_up_response": "Fabry's disease or fucosidosis", "follow_up_response_bt": "Fabry disease or fucosidosis"}, {"question_id": "292.8", "question": "What specific body parts were affected by the red raised lesions?", "answer_src": "the tongue and scrotum", "follow_up_question": "What is the most common underlying condition associated with oral angiokeratomas mentioned in the text?", "follow_up_response": "Fabry's disease or fucosidosis", "follow_up_response_bt": "Generalized systemic disorder in Fabry disease or fucosidosis"}, {"question_id": "292.9", "question": "How long did it take for the lesions to appear after the initial symptoms began?", "answer_src": "we report a 60-year - old man who presented with a 2-year history of painless red raised lesions involving the tongue and scrotum . histopathology was suggestive of angiokeratoma . oral angiokeratomas are most commonly found as a component of the generalized systemic disorder in fabry 's disease or fucosidosis .", "follow_up_question": "What is the typical duration between the onset of initial symptoms and the appearance of oral angiokeratomas?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "292.10", "question": "What other conditions besides Fabry's disease or Fucosidosis have a generalized systemic disorder that includes oral angiokeratomas?", "answer_src": "we report a 60-year - old man who presented with a 2-year history of painless red raised lesions involving the tongue and scrotum . histopathology was suggestive of angiokeratoma . oral angiokeratomas are most commonly found as a component of the generalized systemic disorder in fabry 's disease or fucosidosis .", "follow_up_question": "What is another condition besides Fabry's disease or Fucosidosis that has a generalized systemic disorder including oral angiokeratomas?", "follow_up_response": "No Answer", "follow_up_response_bt": "Chronic dermatological conditions"}], "turn_3": [{"question_id": "292.11", "question": "What is the prevalence of oral angiokeratomas in patients with fabry's disease or fucosidosis according to the text?", "answer_src": "most commonly found", "follow_up_question": "What specific systemic disorders are associated with oral angiokeratomas according to the text?", "follow_up_response": "fabry 's disease or fucosidosis", "follow_up_response_bt": "Fabry disease or fucosidosis"}, {"question_id": "292.12", "question": "Which systemic disorder is more commonly associated with oral angiokeratomas according to the text?", "answer_src": "Fabry's disease or fucosidosis", "follow_up_question": "What other symptoms might patients with Fabry's disease or fucosidosis experience besides oral angiokeratomas?", "follow_up_response": "No Answer", "follow_up_response_bt": "Chronic dermatological conditions"}, {"question_id": "292.13", "question": "What is the most common underlying condition associated with oral angiokeratomas mentioned in the text?", "answer_src": "Fabry's disease or fucosidosis", "follow_up_question": "What other conditions besides Fabry's disease or fucosidosis have been linked to oral angiokeratomas in the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "chronic dermatological conditions"}, {"question_id": "292.14", "question": "What is the typical duration between the onset of initial symptoms and the appearance of oral angiokeratomas?", "answer_src": "we report a 60-year - old man who presented with a 2-year history of painless red raised lesions involving the tongue and scrotum . histopathology was suggestive of angiokeratoma . oral angiokeratomas are most commonly found as a component of the generalized systemic disorder in fabry 's disease or fucosidosis .", "follow_up_question": "How long does it typically take for oral angiokeratomas to appear after the onset of initial symptoms?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "292.15", "question": "What is another condition besides Fabry's disease or Fucosidosis that has a generalized systemic disorder including oral angiokeratomas?", "answer_src": "we report a 60-year - old man who presented with a 2-year history of painless red raised lesions involving the tongue and scrotum . histopathology was suggestive of angiokeratoma . oral angiokeratomas are most commonly found as a component of the generalized systemic disorder in fabry 's disease or fucosidosis .", "follow_up_question": "What other condition besides Fabry's disease or Fucosidosis has oral angiokeratomas as a symptom?", "follow_up_response": "No Answer", "follow_up_response_bt": "Chronic dermatological conditions"}]}}
{"id": 293, "src": "one rabbit of the control group developed an infection . in all the animals of the study group from 4 weeks onward showed bone formation , wherein the control group only granulation tissue was observed . by 8 weeks in the study group , the canal was totally obliterated with the new bone formation which extended onto the periosteal area .", "mt": "In tutti gli animali del gruppo di studio a partire da 4 settimane si è manifestata una formazione ossea , mentre nel gruppo di controllo si è osservato solo il tessuto di granulazione . Entro 8 settimane nel gruppo di studio , il canale era completamente cancellato con la nuova formazione ossea che si estendeva sulla zona periosteale .", "pert_mt": "In tutti gli animali del gruppo di studio a partire da 4 settimane si è manifestata una formazione ossea, mentre nel gruppo di controllo si è osservato solo il tessuto di granulazione. Entro 8 settimane nel gruppo di studio, il canale era completamente cancellato con la nuova formazione ossea che si estendeva sulla zona periosteale e non presentava segni di regressione.", "bt": "In all animals in the study group from 4 weeks onward, bone formation was observed, while in the control group only the granulation tissue was observed; within 8 weeks in the study group, the channel was completely cancelled with the new bone formation that extended over the periosteal zone and showed no signs of regression.", "questions_src": ["What type of tissue was observed in the control group at 8 weeks?", "Where did the new bone formation extend to in the study group by 8 weeks?", "Who developed an infection in the experiment?", "When did bone formation start to be observed in the study group?", "Which group showed the development of new bone formation after 4 weeks?"], "answers_src": ["Granulation tissue", "The periosteal area", "One rabbit", "4 weeks", "Study group"], "answers_bt": ["Granulation tissue", "Over the periosteal zone", "No Answer", "4 weeks", "Study group"], "multiturn": {"turn_1": [{"question_id": "293.1", "question": "What type of tissue was observed in the control group at 8 weeks?", "answer_src": "Granulation tissue", "follow_up_question": "What type of tissue was observed in the study group at 8 weeks?", "follow_up_response": "New bone formation", "follow_up_response_bt": "The new bone formation"}, {"question_id": "293.2", "question": "Where did the new bone formation extend to in the study group by 8 weeks?", "answer_src": "The periosteal area", "follow_up_question": "How much of the canal was obliterated by 8 weeks in the study group?", "follow_up_response": "the canal was totally obliterated", "follow_up_response_bt": "the channel was completely cancelled"}, {"question_id": "293.3", "question": "Who developed an infection in the experiment?", "answer_src": "One rabbit", "follow_up_question": "How many rabbits in the study group showed bone formation by 8 weeks?", "follow_up_response": "3", "follow_up_response_bt": "No Answer"}, {"question_id": "293.4", "question": "When did bone formation start to be observed in the study group?", "answer_src": "4 weeks", "follow_up_question": "When did bone formation begin to extend onto the periosteal area in the study group?", "follow_up_response": "8 weeks", "follow_up_response_bt": "Within 8 weeks"}, {"question_id": "293.5", "question": "Which group showed the development of new bone formation after 4 weeks?", "answer_src": "Study group", "follow_up_question": "What percentage of animals in the study group showed new bone formation by 8 weeks?", "follow_up_response": "100", "follow_up_response_bt": "100%"}], "turn_2": [{"question_id": "293.6", "question": "What type of tissue was observed in the study group at 8 weeks?", "answer_src": "New bone formation", "follow_up_question": "What percentage of the canal was obliterated by 8 weeks in the study group?", "follow_up_response": "No Answer", "follow_up_response_bt": "100%"}, {"question_id": "293.7", "question": "How much of the canal was obliterated by 8 weeks in the study group?", "answer_src": "the canal was totally obliterated", "follow_up_question": "How much of the periosteal area was covered by new bone formation by 8 weeks in the study group?", "follow_up_response": "The periosteal area", "follow_up_response_bt": "The entire periosteal area"}, {"question_id": "293.8", "question": "How many rabbits in the study group showed bone formation by 8 weeks?", "answer_src": "3", "follow_up_question": "How much of the canal was obliterated by 8 weeks in the study group?", "follow_up_response": "the canal was totally obliterated", "follow_up_response_bt": "the channel was completely cancelled"}, {"question_id": "293.9", "question": "When did bone formation begin to extend onto the periosteal area in the study group?", "answer_src": "8 weeks", "follow_up_question": "How much earlier did bone formation start in the study group compared to the control group?", "follow_up_response": "4 weeks", "follow_up_response_bt": "4 weeks"}, {"question_id": "293.10", "question": "What percentage of animals in the study group showed new bone formation by 8 weeks?", "answer_src": "100", "follow_up_question": "How much of the periosteal area was covered by new bone formation by 8 weeks?", "follow_up_response": "The periosteal area", "follow_up_response_bt": "The entire periosteal area"}], "turn_3": [{"question_id": "293.11", "question": "What percentage of the canal was obliterated by 8 weeks in the study group?", "answer_src": "one rabbit of the control group developed an infection . in all the animals of the study group from 4 weeks onward showed bone formation , wherein the control group only granulation tissue was observed . by 8 weeks in the study group , the canal was totally obliterated with the new bone formation which extended onto the periosteal area .", "follow_up_question": "How much of the periosteal area was affected by new bone formation by 8 weeks in the study group?", "follow_up_response": "The periosteal area", "follow_up_response_bt": "The periosteal zone"}, {"question_id": "293.12", "question": "How much of the periosteal area was covered by new bone formation by 8 weeks in the study group?", "answer_src": "The periosteal area", "follow_up_question": "What percentage of the periosteal area was covered by new bone formation by 8 weeks in the study group?", "follow_up_response": "100%", "follow_up_response_bt": "100%"}, {"question_id": "293.13", "question": "How much of the canal was obliterated by 8 weeks in the study group?", "answer_src": "the canal was totally obliterated", "follow_up_question": "How much of the periosteal area was covered by new bone formation by 8 weeks in the study group?", "follow_up_response": "The periosteal area", "follow_up_response_bt": "The entire periosteal area"}, {"question_id": "293.14", "question": "How much earlier did bone formation start in the study group compared to the control group?", "answer_src": "4 weeks", "follow_up_question": "How long after the start of the study did the study group exhibit new bone formation?", "follow_up_response": "4 weeks", "follow_up_response_bt": "8 weeks"}, {"question_id": "293.15", "question": "How much of the periosteal area was covered by new bone formation by 8 weeks?", "answer_src": "The periosteal area", "follow_up_question": "What percentage of the periosteal area was covered by new bone formation by 8 weeks?", "follow_up_response": "100%", "follow_up_response_bt": "100%"}]}}
{"id": 294, "src": "genomic dna was isolated from parabronema skrjabini . rrna region was amplified and sequenced.the rna secondary structure was predicted using mfold software ( http://mfold.rit.albany.edu ) . the secondary structure with bulge , hairpins , helices , interior , external and multi loops was predicted for 5.8srdna of our sequence of p. skrjabini and a sequence of p. skrjabini and two species of habronema ( h. microstoma and h. muscae ) in genbank .", "mt": "La struttura secondaria dell'RNA è stata predetta utilizzando software mfold (http://mfold.rit.albany.edu) . La struttura secondaria con gonfiore , pinze di capelli , elices , interni , esterni e multi-loops è stata predetta per 5.8srdna della nostra sequenza di p. skrjabini e una sequenza di p. skrjabini e due specie di habronema (h. microstoma e h. muscae) nel genbank .", "pert_mt": "La struttura secondaria dell'RNA è stata predetta utilizzando software mfold (http://mfold.rit.albany.edu). La struttura secondaria con gonfiore, pinze di capelli, elices, interni, esterni e multi-loops è stata predetta per 5.8srdna della nostra sequenza di p. skrjabini e una sequenza di p. skrjabini e due specie di habronema (h. microstoma e h. muscae) nel genbank e nelle loro interazioni con altri RNA.", "bt": "The secondary structure of the RNA was predicted using mfold software (http://mfold.rit.albany.edu).The secondary structure with gonfiore, capillary pinze, elices, internal, external and multi-loops was predicted for 5.8srdna of our sequence of p. skrjabini and a sequence of p. skrjabini and two species of habronema (h. microstoma and h. muscae) in the genome and in their interactions with other RNAs.", "questions_src": ["What is the name of the organism whose genomic DNA was isolated?", "Who used the Mfold software to predict the RNA secondary structure?", "Where can one find sequences of Habronema microstoma and Habronema muscae in GenBank?", "When was the RRNA region amplified and sequenced relative to the prediction of the RNA secondary structure?", "Which region of DNA was sequenced and analyzed for the isolation process?"], "answers_src": ["Parabronema skrjabini", "Mfold software", "GenBank", "No Answer", "5.8s rDNA"], "answers_bt": ["P. skrjabini", "mfold software", "No Answer", "No Answer", "5.8S rDNA"], "multiturn": {"turn_1": [{"question_id": "294.1", "question": "What is the name of the organism whose genomic DNA was isolated?", "answer_src": "Parabronema skrjabini", "follow_up_question": "What specific RNA region was amplified and sequenced from Parabronema skrjabini?", "follow_up_response": "rrna region", "follow_up_response_bt": "5.8s rDNA"}, {"question_id": "294.2", "question": "Who used the Mfold software to predict the RNA secondary structure?", "answer_src": "Mfold software", "follow_up_question": "What specific regions of the 5.8s rDNA were predicted to have bulge, hairpins, helices, interior, and external loops?", "follow_up_response": "5.8s rDNA", "follow_up_response_bt": "gonfiore, capillary pinze, elices, internal, external and multi-loops"}, {"question_id": "294.3", "question": "Where can one find sequences of Habronema microstoma and Habronema muscae in GenBank?", "answer_src": "GenBank", "follow_up_question": "What specific regions of the 5.8S rDNA were predicted for the sequences of P. skrjabini and the two Habronema species?", "follow_up_response": "bulge, hairpins, helices, interior, external and multi loops", "follow_up_response_bt": "gonfiore, capillary pinze, elices, internal, external and multi-loops"}, {"question_id": "294.4", "question": "When was the RRNA region amplified and sequenced relative to the prediction of the RNA secondary structure?", "answer_src": "genomic dna was isolated from parabronema skrjabini . rrna region was amplified and sequenced.the rna secondary structure was predicted using mfold software ( http://mfold.rit.albany.edu ) . the secondary structure with bulge , hairpins , helices , interior , external and multi loops was predicted for 5.8srdna of our sequence of p. skrjabini and a sequence of p. skrjabini and two species of habronema ( h. microstoma and h. muscae ) in genbank .", "follow_up_question": "What other species besides Parabronema skrjabini were used to predict the RNA secondary structure?", "follow_up_response": "Habronema microstoma and Habronema muscae", "follow_up_response_bt": "Habronema microstoma and Habronema muscae"}, {"question_id": "294.5", "question": "Which region of DNA was sequenced and analyzed for the isolation process?", "answer_src": "5.8s rDNA", "follow_up_question": "What specific RNA secondary structures were predicted for the 5.8s rDNA?", "follow_up_response": "bulge, hairpins, helices, interior, external and multi loops", "follow_up_response_bt": "gonfiore, capillary pinze, elices, internal, external and multi-loops"}], "turn_2": [{"question_id": "294.6", "question": "What specific RNA region was amplified and sequenced from Parabronema skrjabini?", "answer_src": "rrna region", "follow_up_question": "What type of secondary structure did the 5.8s rDNA exhibit according to the prediction?", "follow_up_response": "bulge, hairpins, helices, interior, external and multi loops", "follow_up_response_bt": "gonfiore, capillary pinze, elices, internal, external and multi-loops"}, {"question_id": "294.7", "question": "What specific regions of the 5.8s rDNA were predicted to have bulge, hairpins, helices, interior, and external loops?", "answer_src": "5.8s rDNA", "follow_up_question": "Which species besides P. skrjabini had their 5.8s rDNA sequences analyzed?", "follow_up_response": "H. microstoma and H. muscae", "follow_up_response_bt": "Habronema microstoma and Habronema muscae"}, {"question_id": "294.8", "question": "What specific regions of the 5.8S rDNA were predicted for the sequences of P. skrjabini and the two Habronema species?", "answer_src": "bulge, hairpins, helices, interior, external and multi loops", "follow_up_question": "Which Habronema species had its 5.8S rDNA sequence analyzed alongside P. skrjabini?", "follow_up_response": "H. microstoma and H. muscae", "follow_up_response_bt": "h. microstoma and h. muscae"}, {"question_id": "294.9", "question": "What other species besides Parabronema skrjabini were used to predict the RNA secondary structure?", "answer_src": "Habronema microstoma and Habronema muscae", "follow_up_question": "What specific regions of the RNA secondary structures were identified in the sequences of P. skrjabini and the two Habronema species?", "follow_up_response": "bulge, hairpins, helices, interior, external and multi loops", "follow_up_response_bt": "gonfiore, capillary pinze, elices, internal, external and multi-loops"}, {"question_id": "294.10", "question": "What specific RNA secondary structures were predicted for the 5.8s rDNA?", "answer_src": "bulge, hairpins, helices, interior, external and multi loops", "follow_up_question": "Which species besides P. skrjabini had their 5.8s rDNA secondary structures predicted?", "follow_up_response": "H. microstoma\", \"H. muscae", "follow_up_response_bt": "Habronema microstoma and Habronema muscae"}], "turn_3": [{"question_id": "294.11", "question": "What type of secondary structure did the 5.8s rDNA exhibit according to the prediction?", "answer_src": "bulge, hairpins, helices, interior, external and multi loops", "follow_up_question": "Which specific rRNA gene was analyzed for its secondary structure?", "follow_up_response": "5.8s rRNA", "follow_up_response_bt": "5.8s rRNA"}, {"question_id": "294.12", "question": "Which species besides P. skrjabini had their 5.8s rDNA sequences analyzed?", "answer_src": "H. microstoma and H. muscae", "follow_up_question": "What is the difference in secondary structure predictions between P. skrjabini and the Habronema species?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "294.13", "question": "Which Habronema species had its 5.8S rDNA sequence analyzed alongside P. skrjabini?", "answer_src": "H. microstoma and H. muscae", "follow_up_question": "What is the difference in secondary structure predictions between P. skrjabini and H. microstoma?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "294.14", "question": "What specific regions of the RNA secondary structures were identified in the sequences of P. skrjabini and the two Habronema species?", "answer_src": "bulge, hairpins, helices, interior, external and multi loops", "follow_up_question": "Which specific RNA secondary structure elements were found in the 5.8srdna of P. skrjabini?", "follow_up_response": "bulge, hairpins, helices, interior, external and multi loops", "follow_up_response_bt": "gonfiore, capillary pinze, elices, internal, external and multi-loops"}, {"question_id": "294.15", "question": "Which species besides P. skrjabini had their 5.8s rDNA secondary structures predicted?", "answer_src": "H. microstoma\", \"H. muscae", "follow_up_question": "What is the difference in secondary structure predictions between P. skrjabini and H. microstoma?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 295, "src": "patients routinely received serum hiv eia testing at delivery , with positive results confirmed through immunofluorescent testing . demographics , hiv , hepatitis b surface antigen ( hbsag ) , and rapid plasma reagin ( rpr ) results were obtained . statistical analyses included pearson 's chi - square and student 's t - test .", "mt": "I pazienti che hanno ricevuto test serini per l'HIV eia al momento della consegna hanno ricevuto test serini di routine , con risultati positivi confermati attraverso test immunofluorescenti .", "pert_mt": "I pazienti che hanno ricevuto test serini per l'HIV eia al momento della consegna hanno ricevuto test serini di routine, con risultati positivi confermati attraverso test immunofluorescenti, ma non necessariamente all'istante della visita medica.", "bt": "Patients who received serine tests for HIV and at the time of delivery received routine serine tests, with positive results confirmed through immunofluorescence tests, but not necessarily immediately after the medical visit.", "questions_src": ["What is the full name of the test used for HIV screening during delivery?", "Who typically receives serum HIV EIA testing at delivery?", "Where were demographics, HIV, HBSAG, and RPR results obtained?", "When were positive results for HIV EIA confirmed?", "Which statistical tests were performed in the study?"], "answers_src": ["[\"serum hiv eia\", \"patients\", \"demographics, hiv, hepatitis b surface antigen (hbsag), and rapid plasma reagin (rpr) results were obtained\", \"through immunofluorescent testing\", \"pearson\"s chi-square and student\"s t-test\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"Serine tests\"], [\"Patients\"], [\"Not specified in the sentence\"], [\"Through immunofluorescence tests\"], [\"Immunofluorescence tests\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "295.1", "question": "What is the full name of the test used for HIV screening during delivery?", "answer_src": "[\"serum hiv eia\", \"patients\", \"demographics, hiv, hepatitis b surface antigen (hbsag), and rapid plasma reagin (rpr) results were obtained\", \"through immunofluorescent testing\", \"pearson\"s chi-square and student\"s t-test\"]", "follow_up_question": "What other tests besides HIV were performed on patients?", "follow_up_response": "Hepatitis B surface antigen (hbsag) and rapid plasma reagin (rpr)", "follow_up_response_bt": "serine tests"}, {"question_id": "295.2", "question": "Who typically receives serum HIV EIA testing at delivery?", "answer_src": "patients routinely received serum hiv eia testing at delivery , with positive results confirmed through immunofluorescent testing . demographics , hiv , hepatitis b surface antigen ( hbsag ) , and rapid plasma reagin ( rpr ) results were obtained . statistical analyses included pearson 's chi - square and student 's t - test .", "follow_up_question": "What method was used to confirm positive results of the serum HIV EIA testing?", "follow_up_response": "immunofluorescent testing", "follow_up_response_bt": "Immunofluorescence tests"}, {"question_id": "295.3", "question": "Where were demographics, HIV, HBSAG, and RPR results obtained?", "answer_src": "patients routinely received serum hiv eia testing at delivery , with positive results confirmed through immunofluorescent testing . demographics , hiv , hepatitis b surface antigen ( hbsag ) , and rapid plasma reagin ( rpr ) results were obtained . statistical analyses included pearson 's chi - square and student 's t - test .", "follow_up_question": "What specific tests were used to confirm positive HIV results?", "follow_up_response": "immunofluorescent testing", "follow_up_response_bt": "Immunofluorescence tests"}, {"question_id": "295.4", "question": "When were positive results for HIV EIA confirmed?", "answer_src": "patients routinely received serum hiv eia testing at delivery , with positive results confirmed through immunofluorescent testing . demographics , hiv , hepatitis b surface antigen ( hbsag ) , and rapid plasma reagin ( rpr ) results were obtained . statistical analyses included pearson 's chi - square and student 's t - test .", "follow_up_question": "What method was used to obtain demographic information?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "295.5", "question": "Which statistical tests were performed in the study?", "answer_src": "patients routinely received serum hiv eia testing at delivery , with positive results confirmed through immunofluorescent testing . demographics , hiv , hepatitis b surface antigen ( hbsag ) , and rapid plasma reagin ( rpr ) results were obtained . statistical analyses included pearson 's chi - square and student 's t - test .", "follow_up_question": "What was the purpose of performing the Pearson's chi-square test in the study?", "follow_up_response": "To analyze the association between categorical variables", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "295.6", "question": "What other tests besides HIV were performed on patients?", "answer_src": "Hepatitis B surface antigen (hbsag) and rapid plasma reagin (rpr)", "follow_up_question": "What statistical analysis method was used for the HIV test results?", "follow_up_response": "student's t-test", "follow_up_response_bt": "Immunofluorescence tests"}, {"question_id": "295.7", "question": "What method was used to confirm positive results of the serum HIV EIA testing?", "answer_src": "immunofluorescent testing", "follow_up_question": "What type of statistical analysis was used to compare demographic data?", "follow_up_response": "Pearson's chi-square", "follow_up_response_bt": "No Answer"}, {"question_id": "295.8", "question": "What specific tests were used to confirm positive HIV results?", "answer_src": "immunofluorescent testing", "follow_up_question": "What other serological markers were tested besides HBSAG?", "follow_up_response": "rapid plasma reagin", "follow_up_response_bt": "serine"}, {"question_id": "295.9", "question": "What method was used to obtain demographic information?", "answer_src": "patients routinely received serum hiv eia testing at delivery , with positive results confirmed through immunofluorescent testing . demographics , hiv , hepatitis b surface antigen ( hbsag ) , and rapid plasma reagin ( rpr ) results were obtained . statistical analyses included pearson 's chi - square and student 's t - test .", "follow_up_question": "What other tests besides HIV EIA were used for confirmation of positive results?", "follow_up_response": "Immunofluorescent", "follow_up_response_bt": "Immunofluorescence tests"}, {"question_id": "295.10", "question": "What was the purpose of performing the Pearson's chi-square test in the study?", "answer_src": "To analyze the association between categorical variables", "follow_up_question": "What types of variables were analyzed using Pearson's chi-square test?", "follow_up_response": "HIV", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "295.11", "question": "What statistical analysis method was used for the HIV test results?", "answer_src": "student's t-test", "follow_up_question": "What other tests were used to confirm positive HIV results?", "follow_up_response": "immunofluorescent testing", "follow_up_response_bt": "Immunofluorescence tests"}, {"question_id": "295.12", "question": "What type of statistical analysis was used to compare demographic data?", "answer_src": "Pearson's chi-square", "follow_up_question": "What statistical test was used to compare means of continuous variables?", "follow_up_response": "student's t-test", "follow_up_response_bt": "No Answer"}, {"question_id": "295.13", "question": "What other serological markers were tested besides HBSAG?", "answer_src": "rapid plasma reagin", "follow_up_question": "What statistical analysis method was used for the demographic data?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "295.14", "question": "What other tests besides HIV EIA were used for confirmation of positive results?", "answer_src": "Immunofluorescent", "follow_up_question": "What statistical analysis method was used for demographic data?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "295.15", "question": "What types of variables were analyzed using Pearson's chi-square test?", "answer_src": "HIV", "follow_up_question": "What other variables were tested using Pearson's chi-square test?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 296, "src": "the second is in four sections where much of it is not available yet . the third category is on materia medica covering the aspect of unani medicine , from which only 28 volumes of the comprehensive book on the traditional medicine have been found so far . the latter , introduces mono - ingredient medications in alphabetical order .", "mt": "La seconda è in quattro sezioni dove gran parte di essa non è ancora disponibile . La terza categoria è su materia medica che copre l'aspetto della medicina unani , da cui sono stati trovati fino ad ora solo 28 volumi del libro completo sulla medicina tradizionale . Quest'ultimo , introduce i farmaci mono-ingredienti in ordine alfabetico .", "pert_mt": "La seconda è in quattro sezioni dove gran parte di essa non è ancora disponibile. La terza categoria è su materia medica che copre l'aspetto della medicina unani, da cui sono stati trovati fino ad ora solo 28 volumi del libro completo sulla medicina tradizionale. Quest'ultimo, introduce i farmaci mono-ingredienti in ordine alfabetico e descrive le interazioni tra i diversi composti farmaceutici.", "bt": "The second is in four sections where much of it is not yet available.The third category is its medical subject covering the aspect of the medical unit, of which only 28 volumes have been found so far of the complete book on traditional medicine.The latter introduces pharmacies with mono-ingredients in alphabetical order and describes the interactions between the various pharmaceutical compounds.", "questions_src": ["What is the first category mentioned in the sentence?", "Who is covered in the materia medica section?", "Where can one find the comprehensive book on traditional medicine?", "When was the second category introduced?", "Which category discusses mono-ingredient medications?"], "answers_src": ["the second is in four sections", "unani medicine", "only 28 volumes of the comprehensive book on the traditional medicine have been found so far", "the latter", "the latter"], "answers_bt": ["The second is", "the medical unit", "only 28 volumes have been found so far", "The second is", "The latter"], "multiturn": {"turn_1": [{"question_id": "296.1", "question": "What is the first category mentioned in the sentence?", "answer_src": "the second is in four sections", "follow_up_question": "What are the topics covered in the first category?", "follow_up_response": "the second is in four sections where much of it is not available yet ", "follow_up_response_bt": "The second is in four sections where much of it is not yet available"}, {"question_id": "296.2", "question": "Who is covered in the materia medica section?", "answer_src": "unani medicine", "follow_up_question": "What specific aspect of unani medicine does the materia medica cover?", "follow_up_response": "the aspect of unani medicine", "follow_up_response_bt": "its medical subject covering the aspect of the medical unit"}, {"question_id": "296.3", "question": "Where can one find the comprehensive book on traditional medicine?", "answer_src": "only 28 volumes of the comprehensive book on the traditional medicine have been found so far", "follow_up_question": "What is the title of the comprehensive book on traditional medicine?", "follow_up_response": "comprehensive book on the traditional medicine", "follow_up_response_bt": "Its medical subject covering the aspect of the medical unit, of which only 28 volumes have been found so far of the complete book on traditional medicine"}, {"question_id": "296.4", "question": "When was the second category introduced?", "answer_src": "the latter", "follow_up_question": "What does \"the latter\" refer to in the text?", "follow_up_response": "Mono-ingredient medications", "follow_up_response_bt": "pharmacies with mono-ingredients in alphabetical order"}, {"question_id": "296.5", "question": "Which category discusses mono-ingredient medications?", "answer_src": "the latter", "follow_up_question": "What is the order in which mono-ingredient medications are introduced?", "follow_up_response": "alphabetical", "follow_up_response_bt": "alphabetical"}], "turn_2": [{"question_id": "296.6", "question": "What are the topics covered in the first category?", "answer_src": "the second is in four sections where much of it is not available yet ", "follow_up_question": "What is the focus of the third category?", "follow_up_response": "the aspect of unani medicine", "follow_up_response_bt": "Its medical subject covering the aspect of the medical unit"}, {"question_id": "296.7", "question": "What specific aspect of unani medicine does the materia medica cover?", "answer_src": "the aspect of unani medicine", "follow_up_question": "What is the total number of volumes of the comprehensive book on traditional medicine that have been found so far?", "follow_up_response": "28", "follow_up_response_bt": "28"}, {"question_id": "296.8", "question": "What is the title of the comprehensive book on traditional medicine?", "answer_src": "comprehensive book on the traditional medicine", "follow_up_question": "How many volumes of the comprehensive book on traditional medicine have been found so far?", "follow_up_response": "28", "follow_up_response_bt": "28"}, {"question_id": "296.9", "question": "What does \"the latter\" refer to in the text?", "answer_src": "Mono-ingredient medications", "follow_up_question": "What is the total number of volumes of the comprehensive book on traditional medicine that have been found?", "follow_up_response": "28", "follow_up_response_bt": "28"}, {"question_id": "296.10", "question": "What is the order in which mono-ingredient medications are introduced?", "answer_src": "alphabetical", "follow_up_question": "What is the total number of volumes of the comprehensive book on unani medicine that have been found?", "follow_up_response": "28", "follow_up_response_bt": "28"}], "turn_3": [{"question_id": "296.11", "question": "What is the focus of the third category?", "answer_src": "the aspect of unani medicine", "follow_up_question": "How many volumes of the comprehensive book on unani medicine have been found so far?", "follow_up_response": "28", "follow_up_response_bt": "28"}, {"question_id": "296.12", "question": "What is the total number of volumes of the comprehensive book on traditional medicine that have been found so far?", "answer_src": "28", "follow_up_question": "How many more volumes of the comprehensive book on traditional medicine need to be found?", "follow_up_response": "28", "follow_up_response_bt": "27"}, {"question_id": "296.13", "question": "How many volumes of the comprehensive book on traditional medicine have been found so far?", "answer_src": "28", "follow_up_question": "How many sections does the second category have?", "follow_up_response": "4", "follow_up_response_bt": "4"}, {"question_id": "296.14", "question": "What is the total number of volumes of the comprehensive book on traditional medicine that have been found?", "answer_src": "28", "follow_up_question": "How many more volumes of the comprehensive book on traditional medicine need to be found?", "follow_up_response": "28", "follow_up_response_bt": "27"}, {"question_id": "296.15", "question": "What is the total number of volumes of the comprehensive book on unani medicine that have been found?", "answer_src": "28", "follow_up_question": "How many more volumes of the comprehensive book on unani medicine need to be found?", "follow_up_response": "28", "follow_up_response_bt": "27"}]}}
{"id": 297, "src": "indeed , when gapdh was used as the reference , expression levels of elf5 , a tsc marker gene , stringently classified tsc colonies into two groups : a high expression groups consisting of type 1 and 2 colonies , and a lower expression group consisting of type 3 and 4 colonies . this clustering was consistent with our putative classification of undifferentiated / differentiated colonies based on their time - dependent colony transitions . by contrast , use of an unstable reference gene ( rn18s ) allowed no such clear classification .", "mt": ", quando gapdh è stato usato come riferimento , i livelli di espressione di elf5 , un gene di marcatore tsc , classificavano rigorosamente le colonie tsc in due gruppi: un gruppo di alta espressione composto da colonie di tipo 1 e 2 e un gruppo di espressione inferiore composto da colonie di tipo 3 e 4 . Questo raggruppamento era coerente con la nostra ipotetica classificazione delle colonie indifferentiate / differenziate in base alle loro transizioni coloniali dipendenti dal tempo .", "pert_mt": ", quando gapdh è stato usato come riferimento, i livelli di espressione di elf5, un gene di marcatore tsc, classificavano rigorosamente le colonie tsc in tre gruppi: un gruppo di alta espressione composto da colonie di tipo 1 e 2, un gruppo di espressione media composto da colonie di tipo 3, e un gruppo di espressione inferiore composto da colonie di tipo 4. Questo raggruppamento era coerente con la nostra ipotetica classificazione delle colonie indifferentiate/differenziate in base alle loro transizioni coloniali dipendenti dal tempo.", "bt": "When gapdh was used as a reference, the expression levels of elf5, a marker gene tsc, rigorously classified the tsc colony into three groups: a high-expression group consisting of type 1 and type 2 colony, a medium-expression group consisting of type 3 colony, and a lower expression group consisting of type 4 colony.", "questions_src": ["What was used as the reference gene in the study?", "Which marker gene, elf5, was classified along with tsc colonies?", "How many types of colonies were classified into the high expression group?", "What did the clustering based on gapdh expression indicate about the colonies?", "Which reference gene, rn18s, did not allow for clear classification of colonies?"], "answers_src": ["gapdh", "elf5", "2", "The colonies were classified into two groups based on their expression levels", "rn18s"], "answers_bt": ["gapdh", "elf5 and tsc", "2", "The colonies were clustered into three groups based on tsc expression levels", "No Answer"], "multiturn": {"turn_1": [{"question_id": "297.1", "question": "What was used as the reference gene in the study?", "answer_src": "gapdh", "follow_up_question": "What were the characteristics of the high expression group of colonies?", "follow_up_response": "a high expression groups consisting of type 1 and 2 colonies", "follow_up_response_bt": "a high-expression group consisting of type 1 and type 2 colony"}, {"question_id": "297.2", "question": "Which marker gene, elf5, was classified along with tsc colonies?", "answer_src": "elf5", "follow_up_question": "What were the two groups into which elf5 expression levels classified tsc colonies?", "follow_up_response": "a high expression groups consisting of type 1 and 2 colonies, and a lower expression group consisting of type 3 and 4 colonies", "follow_up_response_bt": "a high-expression group consisting of type 1 and type 2 colony"}, {"question_id": "297.3", "question": "How many types of colonies were classified into the high expression group?", "answer_src": "2", "follow_up_question": "How many types of colonies were classified into the low expression group?", "follow_up_response": "2", "follow_up_response_bt": "1"}, {"question_id": "297.4", "question": "What did the clustering based on gapdh expression indicate about the colonies?", "answer_src": "The colonies were classified into two groups based on their expression levels", "follow_up_question": "How many groups were the colonies classified into based on gapdh expression?", "follow_up_response": "2", "follow_up_response_bt": "3"}, {"question_id": "297.5", "question": "Which reference gene, rn18s, did not allow for clear classification of colonies?", "answer_src": "rn18s", "follow_up_question": "What were the colony types in the high expression group classified by gapdh?", "follow_up_response": "type 1 and 2", "follow_up_response_bt": "type 1 and type 2"}], "turn_2": [{"question_id": "297.6", "question": "What were the characteristics of the high expression group of colonies?", "answer_src": "a high expression groups consisting of type 1 and 2 colonies", "follow_up_question": "What were the characteristics of the low expression group of colonies?", "follow_up_response": "a lower expression group consisting of type 3 and 4 colonies", "follow_up_response_bt": "a lower expression group consisting of type 4 colony"}, {"question_id": "297.7", "question": "What were the two groups into which elf5 expression levels classified tsc colonies?", "answer_src": "a high expression groups consisting of type 1 and 2 colonies, and a lower expression group consisting of type 3 and 4 colonies", "follow_up_question": "What was the basis for classifying the tsc colonies into these two groups?", "follow_up_response": "when gapdh was used as the reference", "follow_up_response_bt": "gapdh"}, {"question_id": "297.8", "question": "How many types of colonies were classified into the low expression group?", "answer_src": "2", "follow_up_question": "How many types of colonies were classified into the high expression group?", "follow_up_response": "2", "follow_up_response_bt": "2"}, {"question_id": "297.9", "question": "How many groups were the colonies classified into based on gapdh expression?", "answer_src": "2", "follow_up_question": "How many types of colonies were included in the higher expression group?", "follow_up_response": "2", "follow_up_response_bt": "2"}, {"question_id": "297.10", "question": "What were the colony types in the high expression group classified by gapdh?", "answer_src": "type 1 and 2", "follow_up_question": "What were the colony types in the lower expression group classified by gapdh?", "follow_up_response": "type 3 and 4 colonies", "follow_up_response_bt": "type 4 colony"}], "turn_3": [{"question_id": "297.11", "question": "What were the characteristics of the low expression group of colonies?", "answer_src": "a lower expression group consisting of type 3 and 4 colonies", "follow_up_question": "What were the characteristics of the high expression group of colonies?", "follow_up_response": "a high expression groups consisting of type 1 and 2 colonies", "follow_up_response_bt": "a high-expression group consisting of type 1 and type 2 colony"}, {"question_id": "297.12", "question": "What was the basis for classifying the tsc colonies into these two groups?", "answer_src": "when gapdh was used as the reference", "follow_up_question": "What were the characteristics of the high expression group of tsc colonies?", "follow_up_response": "a high expression groups consisting of type 1 and 2 colonies", "follow_up_response_bt": "a high-expression group consisting of type 1 and type 2 colony"}, {"question_id": "297.13", "question": "How many types of colonies were classified into the high expression group?", "answer_src": "2", "follow_up_question": "How many types of colonies were classified into the low expression group?", "follow_up_response": "2", "follow_up_response_bt": "1"}, {"question_id": "297.14", "question": "How many types of colonies were included in the higher expression group?", "answer_src": "2", "follow_up_question": "How many types of colonies were included in the lower expression group?", "follow_up_response": "2", "follow_up_response_bt": "1"}, {"question_id": "297.15", "question": "What were the colony types in the lower expression group classified by gapdh?", "answer_src": "type 3 and 4 colonies", "follow_up_question": "What were the colony types in the high expression group classified by gapdh?", "follow_up_response": "type 1 and 2", "follow_up_response_bt": "type 1 and type 2"}]}}
{"id": 298, "src": "patient 1 was diagnosed as having cataract 18 years after the onset of episodic ( and subsequently chronic ) ch . patient 2 began suffering from chronic ch at the age of 44 years and after 8 years he developed cataract . this is the first report of cataract in patient suffering of ch and occurring in the eye affected by the pain attack .", "mt": "Il paziente 1 è stato diagnosticato come cataratta 18 anni dopo l'inizio di una crisi epizodica (e successivamente cronica). Il paziente 2 ha iniziato a soffrire di una crisi cronica all'età di 44 anni e dopo 8 anni ha sviluppato una cataratta . Questa è la prima notizia di cataratta in pazienti affetti da crisi cronica e che si verifica nell' occhio colpito dall' attacco di dolore .", "pert_mt": "Il paziente 1 è stato diagnosticato come cataratta 18 anni dopo l'inizio di una crisi epizodica (e successivamente cronica). Il paziente 2 ha iniziato a soffrire di una crisi cronica all'età di 44 anni e dopo 8 anni ha sviluppato una cataratta. Questa è la prima notizia di cataratta in pazienti affetti da crisi cronica e che si verifica nell'occhio colpito dall'attacco di dolore e nel lato opposto dell'occhio.", "bt": "Patient 1 was diagnosed as cataract 18 years after the onset of an episodic (and subsequently chronic) seizure; patient 2 began to suffer from a chronic seizure at age 44 and after 8 years developed a cataract; this is the first reported case of cataract in patients with chronic seizure that occurs in the eye affected by the pain attack and on the opposite side of the eye.", "questions_src": ["What is the medical term for patient 1's condition?", "Who developed cataract according to the sentence?", "Where did the patient 2's pain attacks occur?", "When did patient 2 start suffering from chronic ch?", "Which patient had their cataract diagnosed 18 years after the onset of their condition?"], "answers_src": ["cataract", "patient 2", "in the eye affected by the pain attack", "44 years", "patient 1"], "answers_bt": ["Cataract", "Patient 1", "In the eye affected by the pain attack", "Age 44", "Patient 1"], "multiturn": {"turn_1": [{"question_id": "298.1", "question": "What is the medical term for patient 1's condition?", "answer_src": "cataract", "follow_up_question": "What is the age of patient 2 when they developed cataract?", "follow_up_response": "8", "follow_up_response_bt": "44"}, {"question_id": "298.2", "question": "Who developed cataract according to the sentence?", "answer_src": "patient 2", "follow_up_question": "What was the age of patient 2 when he developed cataract?", "follow_up_response": "8", "follow_up_response_bt": "44"}, {"question_id": "298.3", "question": "Where did the patient 2's pain attacks occur?", "answer_src": "in the eye affected by the pain attack", "follow_up_question": "What was the duration between the onset of chronic ch and the development of cataract for patient 2?", "follow_up_response": "2 years", "follow_up_response_bt": "8"}, {"question_id": "298.4", "question": "When did patient 2 start suffering from chronic ch?", "answer_src": "44 years", "follow_up_question": "When did patient 2 develop cataract?", "follow_up_response": "after 8 years he developed cataract.", "follow_up_response_bt": "8 years after the onset of a chronic seizure"}, {"question_id": "298.5", "question": "Which patient had their cataract diagnosed 18 years after the onset of their condition?", "answer_src": "patient 1", "follow_up_question": "Which specific symptom caused the onset of chronic ch for patient 1?", "follow_up_response": "No Answer", "follow_up_response_bt": "an episodic"}], "turn_2": [{"question_id": "298.6", "question": "What is the age of patient 2 when they developed cataract?", "answer_src": "8", "follow_up_question": "How long did it take for patient 2 to develop both chronic ch and cataract?", "follow_up_response": "12", "follow_up_response_bt": "8"}, {"question_id": "298.7", "question": "What was the age of patient 2 when he developed cataract?", "answer_src": "8", "follow_up_question": "How many years passed between the onset of chronic ch and the development of cataract for patient 2?", "follow_up_response": "8", "follow_up_response_bt": "8"}, {"question_id": "298.8", "question": "What was the duration between the onset of chronic ch and the development of cataract for patient 2?", "answer_src": "2 years", "follow_up_question": "How old was patient 2 when they were first diagnosed with cataract?", "follow_up_response": "8", "follow_up_response_bt": "8"}, {"question_id": "298.9", "question": "When did patient 2 develop cataract?", "answer_src": "after 8 years he developed cataract.", "follow_up_question": "How old was patient 2 when he developed cataract?", "follow_up_response": "8", "follow_up_response_bt": "8"}, {"question_id": "298.10", "question": "Which specific symptom caused the onset of chronic ch for patient 1?", "answer_src": "patient 1 was diagnosed as having cataract 18 years after the onset of episodic ( and subsequently chronic ) ch . patient 2 began suffering from chronic ch at the age of 44 years and after 8 years he developed cataract . this is the first report of cataract in patient suffering of ch and occurring in the eye affected by the pain attack .", "follow_up_question": "What was the duration between the onset of chronic ch and the diagnosis of cataract for patient 1?", "follow_up_response": "18 years", "follow_up_response_bt": "18 years"}], "turn_3": [{"question_id": "298.11", "question": "How long did it take for patient 2 to develop both chronic ch and cataract?", "answer_src": "12", "follow_up_question": "How many years passed between the onset of chronic ch and the development of cataract for patient 2?", "follow_up_response": "8", "follow_up_response_bt": "8"}, {"question_id": "298.12", "question": "How many years passed between the onset of chronic ch and the development of cataract for patient 2?", "answer_src": "8", "follow_up_question": "How old was patient 2 when they were diagnosed with cataract?", "follow_up_response": "8", "follow_up_response_bt": "8"}, {"question_id": "298.13", "question": "How old was patient 2 when they were first diagnosed with cataract?", "answer_src": "8", "follow_up_question": "How many years passed between the onset of chronic ch and the diagnosis of cataract for patient 2?", "follow_up_response": "8", "follow_up_response_bt": "8"}, {"question_id": "298.14", "question": "How old was patient 2 when he developed cataract?", "answer_src": "8", "follow_up_question": "How many years passed between the onset of chronic ch and the development of cataract for patient 2?", "follow_up_response": "8", "follow_up_response_bt": "8"}, {"question_id": "298.15", "question": "What was the duration between the onset of chronic ch and the diagnosis of cataract for patient 1?", "answer_src": "18 years", "follow_up_question": "How many years passed between the onset of chronic ch and the development of cataract for patient 2?", "follow_up_response": "8", "follow_up_response_bt": "8"}]}}
{"id": 299, "src": "children in a group of other disabilities had a higher proportion of impaired visual functioning . they were given low vision aids ( telescopes [ 22 ] , filters [ 7 ] , and magnifiers [ 3 ] ) in large numbers compared to those in other groups.visual functioning of children with other disabilities show great variation and difficult to group . the care , therefore , should be at individual level .", "mt": "I bambini in un gruppo di altri disabili avevano una maggiore percentuale di disturbi visivi . A loro sono stati dati assistenti per la visione bassa (telescopi [ 22 ] , filtri [ 7 ] e ingranditori [ 3 ]) in gran numero rispetto a quelli in altri gruppi . Il funzionamento visivo dei bambini con altri disabilità mostra grande variazione e difficile da raggruppare .", "pert_mt": "I bambini in un gruppo di altri disabili avevano una maggiore percentuale di disturbi visivi. A loro sono stati dati assistenti per la visione bassa (telescopi [22], filtri [7] e ingranditori [3]) in gran numero rispetto a quelli in altri gruppi. Il funzionamento visivo dei bambini con altre disabilità mostra grande variazione e difficile da raggruppare.", "bt": "Children in a group of other disabled people had a higher percentage of visual impairments, and they were given assistants for low vision (telescopes [22], filters [7] and magnifiers [3]) in large numbers compared to those in other groups, and the visual functioning of children with other disabilities showed great variation and difficulty in grouping.", "questions_src": ["What type of aids were given to children with other disabilities?", "Who received more low vision aids, children with other disabilities or others?", "Where did the information about the visual functioning of children with other disabilities come from?", "When was it noted that the visual functioning of children with other disabilities varies greatly?", "Which disabilities were mentioned in relation to visual impairment?"], "answers_src": ["[\"telescopes, filters, and magnifiers\"], [\"children in a group of other disabilities\"], [\"No Answer\"], [\"No Answer\"], [\"other disabilities\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"Telescopes, filters, and magnifiers\"], [\"Children in a group of other disabled people\"], [\"No Answer\"], [\"No Answer\"], [\"Visual impairments\"]]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "299.1", "question": "What type of aids were given to children with other disabilities?", "answer_src": "[\"telescopes, filters, and magnifiers\"], [\"children in a group of other disabilities\"], [\"No Answer\"], [\"No Answer\"], [\"other disabilities\"]", "follow_up_question": "How many children received each type of aid?", "follow_up_response": "22, 7, 3", "follow_up_response_bt": "22, 7, 3"}, {"question_id": "299.2", "question": "Who received more low vision aids, children with other disabilities or others?", "answer_src": "children in a group of other disabilities had a higher proportion of impaired visual functioning . they were given low vision aids ( telescopes [ 22 ] , filters [ 7 ] , and magnifiers [ 3 ] ) in large numbers compared to those in other groups.visual functioning of children with other disabilities show great variation and difficult to group . the care , therefore , should be at individual level .", "follow_up_question": "How many low vision aids were provided specifically to children with other disabilities?", "follow_up_response": "52", "follow_up_response_bt": "53"}, {"question_id": "299.3", "question": "Where did the information about the visual functioning of children with other disabilities come from?", "answer_src": "children in a group of other disabilities had a higher proportion of impaired visual functioning . they were given low vision aids ( telescopes [ 22 ] , filters [ 7 ] , and magnifiers [ 3 ] ) in large numbers compared to those in other groups.visual functioning of children with other disabilities show great variation and difficult to group . the care , therefore , should be at individual level .", "follow_up_question": "What specific types of low vision aids were provided to children with other disabilities?", "follow_up_response": "telescopes\", \"filters\", \"magnifiers", "follow_up_response_bt": "telescopes [22], filters [7] and magnifiers [3]"}, {"question_id": "299.4", "question": "When was it noted that the visual functioning of children with other disabilities varies greatly?", "answer_src": "children in a group of other disabilities had a higher proportion of impaired visual functioning . they were given low vision aids ( telescopes [ 22 ] , filters [ 7 ] , and magnifiers [ 3 ] ) in large numbers compared to those in other groups.visual functioning of children with other disabilities show great variation and difficult to group . the care , therefore , should be at individual level .", "follow_up_question": "What types of low vision aids were provided to children with other disabilities?", "follow_up_response": "telescopes\", \"filters\", \"magnifiers", "follow_up_response_bt": "telescopes [22], filters [7] and magnifiers [3]"}, {"question_id": "299.5", "question": "Which disabilities were mentioned in relation to visual impairment?", "answer_src": "children in a group of other disabilities had a higher proportion of impaired visual functioning . they were given low vision aids ( telescopes [ 22 ] , filters [ 7 ] , and magnifiers [ 3 ] ) in large numbers compared to those in other groups.visual functioning of children with other disabilities show great variation and difficult to group . the care , therefore , should be at individual level .", "follow_up_question": "What types of low vision aids were provided to children with other disabilities?", "follow_up_response": "telescopes\", \"filters\", \"magnifiers", "follow_up_response_bt": "telescopes [22], filters [7] and magnifiers [3]"}], "turn_2": [{"question_id": "299.6", "question": "How many children received each type of aid?", "answer_src": "22, 7, 3", "follow_up_question": "What is the range of visual functioning impairment among children with other disabilities?", "follow_up_response": "great variation", "follow_up_response_bt": "great variation and difficulty in grouping"}, {"question_id": "299.7", "question": "How many low vision aids were provided specifically to children with other disabilities?", "answer_src": "52", "follow_up_question": "What was the average number of low vision aids provided per child with other disabilities?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "299.8", "question": "What specific types of low vision aids were provided to children with other disabilities?", "answer_src": "telescopes\", \"filters\", \"magnifiers", "follow_up_question": "What was the ratio of low vision aids provided to children with other disabilities?", "follow_up_response": "22 : 7 : 3", "follow_up_response_bt": "No Answer"}, {"question_id": "299.9", "question": "What types of low vision aids were provided to children with other disabilities?", "answer_src": "telescopes\", \"filters\", \"magnifiers", "follow_up_question": "What was the ratio of low vision aids provided compared to children in other groups?", "follow_up_response": "great variation", "follow_up_response_bt": "22 : No Answer"}, {"question_id": "299.10", "question": "What types of low vision aids were provided to children with other disabilities?", "answer_src": "telescopes\", \"filters\", \"magnifiers", "follow_up_question": "What was the ratio of low vision aids provided compared to children in other groups?", "follow_up_response": "great variation", "follow_up_response_bt": "22 : No Answer"}], "turn_3": [{"question_id": "299.11", "question": "What is the range of visual functioning impairment among children with other disabilities?", "answer_src": "great variation", "follow_up_question": "What specific type of visual aids were provided to children with other disabilities?", "follow_up_response": "telescopes\", \"filters\", \"magnifiers", "follow_up_response_bt": "telescopes [22], filters [7] and magnifiers [3]"}, {"question_id": "299.12", "question": "What was the average number of low vision aids provided per child with other disabilities?", "answer_src": "children in a group of other disabilities had a higher proportion of impaired visual functioning . they were given low vision aids ( telescopes [ 22 ] , filters [ 7 ] , and magnifiers [ 3 ] ) in large numbers compared to those in other groups.visual functioning of children with other disabilities show great variation and difficult to group . the care , therefore , should be at individual level .", "follow_up_question": "What types of low vision aids were provided to children with other disabilities?", "follow_up_response": "telescopes\", \"filters\", \"magnifiers", "follow_up_response_bt": "telescopes [22], filters [7] and magnifiers [3]"}, {"question_id": "299.13", "question": "What was the ratio of low vision aids provided to children with other disabilities?", "answer_src": "22 : 7 : 3", "follow_up_question": "What is the total number of low vision aids provided to children with other disabilities?", "follow_up_response": "83", "follow_up_response_bt": "52"}, {"question_id": "299.14", "question": "What was the ratio of low vision aids provided compared to children in other groups?", "answer_src": "great variation", "follow_up_question": "How many times greater was the variation in visual functioning among children with other disabilities compared to other groups?", "follow_up_response": "great", "follow_up_response_bt": "No Answer"}, {"question_id": "299.15", "question": "What was the ratio of low vision aids provided compared to children in other groups?", "answer_src": "great variation", "follow_up_question": "How many times greater was the variation in visual functioning among children with other disabilities compared to other groups?", "follow_up_response": "great", "follow_up_response_bt": "No Answer"}]}}
{"id": 300, "src": "to describe both the functional and pathological alternations in neurosensory retina in a murine model of spontaneous type 2 diabetes ( db / db mouse ) . db / db ( bks / db/ ) mice and heterozygous littermates ( as control group ) at various ages ( 12 , 16 , 20 , 24 , and 28 weeks ) were inspected with pattern electroretinogram ( perg ) , fundus fluorescein angiography ( ffa ) , and optical coherence tomography ( oct ) . histological markers of neuroinflammation ( iba-1 and f4/80 ) were evaluated by immunohistochemistry .", "mt": "Per descrivere sia le alternanze funzionali che patologiche nella retina neurosensoriale in un modello murino di diabete di tipo 2 spontaneo (musco db / db) . i topi db / db (bks / db / ) e i compagni di letto eterosigioti (come gruppo di controllo) a varie età (12 , 16 , 20 , 24 e 28 settimane) sono stati ispezionati con un pattern electroretinogramma (perg) , un fundus fluorescein angiography (fa) e una tomografia di coerenza ottica (oc) . I marcatori histologici della neuroinfiammazione (-1 iba e f4/80) sono stati valutati da immunohistochemistry .", "pert_mt": "Per descrivere sia le alternanze funzionali che patologiche nella retina neurosensoriale in un modello murino di diabete di tipo 2 spontaneo (musco db / db), i topi db / db (bks / db / ) e i compagni di letto eterosigioti (come gruppo di controllo) a varie età (12 , 16 , 20 , 24 e 28 settimane) sono stati ispezionati con un pattern electroretinogramma (perg) , un fundus fluorescein angiography (fa) e una tomografia di coerenza ottica (oc). Inoltre, i marcatori histologici della neuroinfiammazione (-1 iba e f4/80) sono stati valutati da immunohistochemistry.", "bt": "Describe both the functional and pathological alternations in the neurosensory retina in a mouse model of spontaneous type 2 diabetes (muscle db/db), topics db/db (bks/db/) and heterosigiotid bed companions (as a control group) at various ages (12 , 16 , 20 , 24 and 28 weeks) were inspected with a pattern electroretinogram (perg), a fundus fluorescein angiography (fa) and an optical coherence tomography (oc).", "questions_src": ["What is the full name of the mouse strain used in the study?", "Who were the control group for the study?", "Where were the mice inspected with pattern electroretinogram?", "When were the different age groups of mice examined?", "Which imaging techniques were used to inspect the mice?"], "answers_src": ["db/db (bks/db/)", "heterozygous littermates", "with pattern electroretinogram (PERG)", "at various ages (12, 16, 20, 24, and 28 weeks)", "pattern electroretinogram (PERG), fundus fluorescein angiography (FFA), and optical coherence tomography (OCT)"], "answers_bt": ["muscle db/db, bks/db/ and heterosigiotid bed companions", "as a control group", "with a pattern electroretinogram (perg)", "at 12, 16, 20, 24 and 28 weeks", "a pattern electroretinogram (perg), a fundus fluorescein angiography (fa) and an optical coherence tomography (oc)"], "multiturn": {"turn_1": [{"question_id": "300.1", "question": "What is the full name of the mouse strain used in the study?", "answer_src": "db/db (bks/db/)", "follow_up_question": "What age groups were the db/db mice examined in the study?", "follow_up_response": "12, 16, 20, 24, and 28 weeks", "follow_up_response_bt": "12, 16, 20, 24 and 28 weeks"}, {"question_id": "300.2", "question": "Who were the control group for the study?", "answer_src": "heterozygous littermates", "follow_up_question": "What age groups were the db / db mice examined at?", "follow_up_response": "12, 16, 20, 24, and 28 weeks", "follow_up_response_bt": "12, 16, 20, 24 and 28 weeks"}, {"question_id": "300.3", "question": "Where were the mice inspected with pattern electroretinogram?", "answer_src": "with pattern electroretinogram (PERG)", "follow_up_question": "What other imaging techniques were used to inspect the mice?", "follow_up_response": "pattern electroretinogram (PREG), fundus fluorescein angiography (FFA), and optical coherence tomography (OCT)", "follow_up_response_bt": "Pattern electroretinogram (perg), a fundus fluorescein angiography (fa) and an optical coherence tomography (oc)"}, {"question_id": "300.4", "question": "When were the different age groups of mice examined?", "answer_src": "at various ages (12, 16, 20, 24, and 28 weeks)", "follow_up_question": "What specific imaging techniques were used to inspect the mice?", "follow_up_response": "pattern electroretinogram (PREG), fundus fluorescein angiography (FFA), and optical coherence tomography (OCT)", "follow_up_response_bt": "Pattern electroretinogram (perg), a fundus fluorescein angiography (fa) and an optical coherence tomography (oc)"}, {"question_id": "300.5", "question": "Which imaging techniques were used to inspect the mice?", "answer_src": "pattern electroretinogram (PERG), fundus fluorescein angiography (FFA), and optical coherence tomography (OCT)", "follow_up_question": "What age groups of db/db mice were inspected?", "follow_up_response": "12, 16, 20, 24, and 28 weeks", "follow_up_response_bt": "12, 16, 20, 24 and 28 weeks"}], "turn_2": [{"question_id": "300.6", "question": "What age groups were the db/db mice examined in the study?", "answer_src": "12, 16, 20, 24, and 28 weeks", "follow_up_question": "What specific tests were used to inspect the db/db mice?", "follow_up_response": "pattern electroretinogram (PREG), fundus fluorescein angiography (FFA), and optical coherence tomography (OCT)", "follow_up_response_bt": "Pattern electroretinogram (perg), a fundus fluorescein angiography (fa) and an optical coherence tomography (oc)"}, {"question_id": "300.7", "question": "What age groups were the db / db mice examined at?", "answer_src": "12, 16, 20, 24, and 28 weeks", "follow_up_question": "What specific tests were used to inspect the db / db mice?", "follow_up_response": "pattern electroretinogram (PREG), fundus fluorescein angiography (FFA), and optical coherence tomography (OCT)", "follow_up_response_bt": "Pattern electroretinogram (perg), a fundus fluorescein angiography (fa) and an optical coherence tomography (oc)"}, {"question_id": "300.8", "question": "What other imaging techniques were used to inspect the mice?", "answer_src": "pattern electroretinogram (PREG), fundus fluorescein angiography (FFA), and optical coherence tomography (OCT)", "follow_up_question": "What age groups of db/db mice were inspected?", "follow_up_response": "12, 16, 20, 24, and 28 weeks", "follow_up_response_bt": "12, 16, 20, 24 and 28 weeks"}, {"question_id": "300.9", "question": "What specific imaging techniques were used to inspect the mice?", "answer_src": "pattern electroretinogram (PREG), fundus fluorescein angiography (FFA), and optical coherence tomography (OCT)", "follow_up_question": "What age groups of db/db mice were inspected using these imaging techniques?", "follow_up_response": "12, 16, 20, 24, and 28 weeks", "follow_up_response_bt": "12, 16, 20, 24 and 28 weeks"}, {"question_id": "300.10", "question": "What age groups of db/db mice were inspected?", "answer_src": "12, 16, 20, 24, and 28 weeks", "follow_up_question": "Which imaging techniques were used to inspect the db/db mice?", "follow_up_response": "pattern electroretinogram (PREG), fundus fluorescein angiography (FFA), and optical coherence tomography (OCT)", "follow_up_response_bt": "pattern electroretinogram (perg), a fundus fluorescein angiography (fa) and an optical coherence tomography (oc)"}], "turn_3": [{"question_id": "300.11", "question": "What specific tests were used to inspect the db/db mice?", "answer_src": "pattern electroretinogram (PREG), fundus fluorescein angiography (FFA), and optical coherence tomography (OCT)", "follow_up_question": "What age groups of db/db mice were examined?", "follow_up_response": "12, 16, 20, 24, and 28 weeks", "follow_up_response_bt": "12, 16, 20, 24 and 28 weeks"}, {"question_id": "300.12", "question": "What specific tests were used to inspect the db / db mice?", "answer_src": "pattern electroretinogram (PREG), fundus fluorescein angiography (FFA), and optical coherence tomography (OCT)", "follow_up_question": "What age groups of db / db mice were examined?", "follow_up_response": "12, 16, 20, 24, and 28 weeks", "follow_up_response_bt": "12, 16, 20, 24 and 28 weeks"}, {"question_id": "300.13", "question": "What age groups of db/db mice were inspected?", "answer_src": "12, 16, 20, 24, and 28 weeks", "follow_up_question": "Which imaging techniques were used to inspect the db/db mice?", "follow_up_response": "pattern electroretinogram (PREG), fundus fluorescein angiography (FFA), and optical coherence tomography (OCT)", "follow_up_response_bt": "pattern electroretinogram (perg), a fundus fluorescein angiography (fa) and an optical coherence tomography (oc)"}, {"question_id": "300.14", "question": "What age groups of db/db mice were inspected using these imaging techniques?", "answer_src": "12, 16, 20, 24, and 28 weeks", "follow_up_question": "What imaging technique was used to evaluate histological markers of neuroinflammation?", "follow_up_response": "Immunohistochemistry", "follow_up_response_bt": "No Answer"}, {"question_id": "300.15", "question": "Which imaging techniques were used to inspect the db/db mice?", "answer_src": "pattern electroretinogram (PREG), fundus fluorescein angiography (FFA), and optical coherence tomography (OCT)", "follow_up_question": "What age groups of db/db mice were inspected using these imaging techniques?", "follow_up_response": "12, 16, 20, 24, and 28 weeks", "follow_up_response_bt": "12, 16, 20, 24 and 28 weeks"}]}}
{"id": 301, "src": "a 1.5 n force vector was loaded bilaterally to the center of the crown between first molar and canine , to retract the canine distally . the value of total deformation was used to assess the initial displacement of the canine and molar at the beginning of force loading . stress intensity and force distribution were analyzed and evaluated by ansys 13.0 through comparison of equivalent ( von mises ) stress and maximum shear stress .", "mt": "Un vettore di forza di 1,5 n è stato caricato bilateralmente al centro della corona tra primo molare e canino , per ritirare il canino distalmente . Il valore della deformazione totale è stato utilizzato per valutare il spostamento iniziale del canino e molare all'inizio del carico di forza . L'intensità dello stress e la distribuzione della forza sono stati analizzati e valutati da ansys 13.0 attraverso il confronto di stress equivalente (von mises) e stress massimo di taglio .", "pert_mt": "Un vettore di forza di 1,5 n è stato caricato bilateralmente al centro della corona tra primo molare e canino, per ritirare il canino distalmente. Il valore della deformazione totale è stato utilizzato per valutare il spostamento iniziale del canino e molare all'inizio del carico di forza. L'intensità dello stress e la distribuzione della forza sono stati analizzati e valutati da Ansys 13.0 attraverso il confronto di stress equivalente (von Mises) e stress massimo di taglio, e si è verificata una maggiore flessibilità del dente durante il processo.", "bt": "A force vector of 1.5 n was charged bilaterally to the center of the crown between the first molar and canine, to withdraw the canine distally.The value of total deformation was used to evaluate the initial movement of the canine and molar at the beginning of the force load.The intensity of stress and the distribution of force were analyzed and evaluated by Ansys 13.0 through the comparison of equivalent stress (von Mises) and maximum stress of the cutting, and thus increased flexibility of the tooth was observed during the process.", "questions_src": ["What type of force vector was loaded bilaterally?", "Where was the force vector applied on the teeth?", "Which teeth were involved in the described procedure?", "When was the analysis conducted using ANSYS?", "Who assessed the stress intensity and force distribution?"], "answers_src": ["1.5 n force vector", "between first molar and canine", "canine and molar", "by ansys 13.0", "by ansys 13.0"], "answers_bt": ["1.5 n force vector", "center of the crown between the first molar and canine", "canine and molar", "ANSYS 13.0", "Ansys"], "multiturn": {"turn_1": [{"question_id": "301.1", "question": "What type of force vector was loaded bilaterally?", "answer_src": "1.5 n force vector", "follow_up_question": "What was the purpose of loading the force vector bilaterally?", "follow_up_response": "To retract the canine distally", "follow_up_response_bt": "To withdraw the canine distally"}, {"question_id": "301.2", "question": "Where was the force vector applied on the teeth?", "answer_src": "between first molar and canine", "follow_up_question": "What specific type of stress was analyzed using ANSYS?", "follow_up_response": "von mises stress and maximum shear stress", "follow_up_response_bt": "von Mises"}, {"question_id": "301.3", "question": "Which teeth were involved in the described procedure?", "answer_src": "canine and molar", "follow_up_question": "What specific location within the mouth was the force vector applied?", "follow_up_response": "between first molar and canine", "follow_up_response_bt": "The center of the crown between the first molar and canine"}, {"question_id": "301.4", "question": "When was the analysis conducted using ANSYS?", "answer_src": "by ansys 13.0", "follow_up_question": "What specific parameters were compared using ANSYS?", "follow_up_response": "Equivalent (von Mises) stress and maximum shear stress", "follow_up_response_bt": "The comparison of equivalent stress (von Mises) and maximum stress"}, {"question_id": "301.5", "question": "Who assessed the stress intensity and force distribution?", "answer_src": "by ansys 13.0", "follow_up_question": "What software was used to analyze and evaluate the stress intensity and force distribution?", "follow_up_response": "ansys 13.0", "follow_up_response_bt": "Ansys 13.0"}], "turn_2": [{"question_id": "301.6", "question": "What was the purpose of loading the force vector bilaterally?", "answer_src": "To retract the canine distally", "follow_up_question": "How was the effectiveness of the retraction measured?", "follow_up_response": "The value of total deformation was used to assess the initial displacement of the canine and molar at the beginning of force loading.", "follow_up_response_bt": "The intensity of stress and the distribution of force were analyzed and evaluated by Ansys 13.0 through the comparison of equivalent stress (von Mises) and maximum stress of the cutting"}, {"question_id": "301.7", "question": "What specific type of stress was analyzed using ANSYS?", "answer_src": "von mises stress and maximum shear stress", "follow_up_question": "What was the basis for comparing the von mises stress and maximum shear stress?", "follow_up_response": "Ansys 13.0", "follow_up_response_bt": "The distribution of force"}, {"question_id": "301.8", "question": "What specific location within the mouth was the force vector applied?", "answer_src": "between first molar and canine", "follow_up_question": "What was the purpose of using the value of total deformation?", "follow_up_response": "To assess the initial displacement of the canine and molar at the beginning of force loading", "follow_up_response_bt": "To evaluate the initial movement of the canine and molar at the beginning of the force load."}, {"question_id": "301.9", "question": "What specific parameters were compared using ANSYS?", "answer_src": "Equivalent (von Mises) stress and maximum shear stress", "follow_up_question": "What was the purpose of comparing these specific stress parameters?", "follow_up_response": "To evaluate the initial displacement of the canine and molar at the beginning of force loading", "follow_up_response_bt": "To increase flexibility of the tooth during the process"}, {"question_id": "301.10", "question": "What software was used to analyze and evaluate the stress intensity and force distribution?", "answer_src": "ansys 13.0", "follow_up_question": "What was the basis for comparing the equivalent (von Mises) stress and maximum shear stress?", "follow_up_response": "Ansys 13.0", "follow_up_response_bt": "The distribution of force"}], "turn_3": [{"question_id": "301.11", "question": "How was the effectiveness of the retraction measured?", "answer_src": "The value of total deformation was used to assess the initial displacement of the canine and molar at the beginning of force loading.", "follow_up_question": "What specific parameters were compared to evaluate the force distribution?", "follow_up_response": "equivalent (von mises) stress and maximum shear stress", "follow_up_response_bt": "Equivalent stress (von Mises) and maximum stress"}, {"question_id": "301.12", "question": "What was the basis for comparing the von mises stress and maximum shear stress?", "answer_src": "Ansys 13.0", "follow_up_question": "What specific parameters were compared using Ansys 13.0?", "follow_up_response": "Equivalent (von Mises) stress and maximum shear stress", "follow_up_response_bt": "The intensity of stress and the distribution of force"}, {"question_id": "301.13", "question": "What was the purpose of using the value of total deformation?", "answer_src": "To assess the initial displacement of the canine and molar at the beginning of force loading", "follow_up_question": "How was the initial displacement of the canine and molar measured?", "follow_up_response": "The value of total deformation", "follow_up_response_bt": "The value of total deformation"}, {"question_id": "301.14", "question": "What was the purpose of comparing these specific stress parameters?", "answer_src": "To evaluate the initial displacement of the canine and molar at the beginning of force loading", "follow_up_question": "How did the analysis of stress intensity and force distribution contribute to this evaluation?", "follow_up_response": "Ansys 13.0 was used through comparison of equivalent (von Mises) stress and maximum shear stress", "follow_up_response_bt": "The analysis of stress intensity and force distribution were compared using equivalent stress (von Mises) and maximum stress, and this comparison helped evaluate the increased flexibility of the tooth during the process."}, {"question_id": "301.15", "question": "What was the basis for comparing the equivalent (von Mises) stress and maximum shear stress?", "answer_src": "Ansys 13.0", "follow_up_question": "What specific parameters were compared using Ansys 13.0?", "follow_up_response": "Equivalent (von Mises) stress and maximum shear stress", "follow_up_response_bt": "The intensity of stress and the distribution of force"}]}}
{"id": 302, "src": "in this article , the authors estimate a multiple - output cost function for a sample of 2,235 hospitals during the period 1984 - 88 to disaggregate total costs into inpatient and outpatient components . the results suggest that outpatient cost growth is roughly proportional to that of inpatient cost , despite much higher relative growth in revenues and utilization on the outpatient side . the stability in the outpatient / inpatient cost ratio implies that the increase in the outpatient - to - inpatient utilization ratio was offset by a decline in their relative unit costs .", "mt": "In questo articolo , gli autori stimano una funzione multiple - output cost per un campione di 2.235 ospedali nel periodo 1984 - 88 per disaggregare i costi totali in componenti ambulatoriali e ambulatoriali . I risultati suggeriscono che la crescita dei costi ambulatoriali è approssimativamente proporzionale a quella dei costi ambulatoriali , nonostante la crescita relativa dei ricavi e dell'utilizzo sul lato ambulatorio sia molto più elevata . La stabilità del rapporto costo ambulatorio / ambulatorio implica che l'aumento del rapporto utilizzo ambulatorio - da paziente a paziente è stato compensato da una diminuzione dei loro costi unitari relativi .", "pert_mt": "In questo articolo, gli autori stimano una funzione multiple-output cost per un campione di 2.235 ospedali nel periodo 1984-88 per disaggregare i costi totali in componenti ambulatoriali e inpatient. I risultati suggeriscono che la crescita dei costi ambulatoriali è approssimativamente proporzionale a quella dei costi inpatient, nonostante la crescita relativa dei ricavi e dell'utilizzo sul lato ambulatorio sia molto più elevata. La stabilità del rapporto costo ambulatorio/inpatient implica che l'aumento del rapporto utilizzo ambulatorio-da paziente a paziente è stato compensato da una diminuzione dei loro costi unitari relativi.", "bt": "In this article, the authors estimate a multiple-output cost function per sample of 2,235 hospitals in the period 1984-88 to break down total costs into ambulatory and inpatient components.The results suggest that the growth of ambulatory costs is approximately proportional to that of inpatient costs, although the relative growth in revenue and use on the outpatient side is much higher.The stability of the outpatient/outpatient cost ratio implies that the increase in the outpatient-patient outpatient use ratio has been offset by a decrease in their relative unit costs.", "questions_src": ["What is the time period used in the study? ", "Who estimated the multiple-output cost function? ", "What do the results suggest about outpatient cost growth compared to inpatient cost growth? ", "What ratio remained stable according to the study's findings? "], "answers_src": ["1984 - 88", "the authors", "roughly proportional", "outpatient / inpatient"], "answers_bt": ["1984-88", "the authors", "approximately proportional", "outpatient/outpatient cost"], "multiturn": {"turn_1": [{"question_id": "302.1", "question": "What is the time period used in the study? ", "answer_src": "1984 - 88", "follow_up_question": "What does the stability in the outpatient/inpatient cost ratio imply about the relationship between utilization and unit costs?", "follow_up_response": "The increase in the outpatient-to-inpatient utilization ratio was offset by a decline in their relative unit costs.", "follow_up_response_bt": "The increase in the outpatient-to-inpatient use ratio has been offset by a decrease in their relative unit costs."}, {"question_id": "302.2", "question": "Who estimated the multiple-output cost function? ", "answer_src": "the authors", "follow_up_question": "What does the stability in the outpatient/inpatient cost ratio imply about the relationship between utilization and unit costs?", "follow_up_response": "The increase in the outpatient-to-inpatient utilization ratio was offset by a decline in their relative unit costs.", "follow_up_response_bt": "The increase in the outpatient-to-inpatient use ratio has been offset by a decrease in their relative unit costs."}, {"question_id": "302.3", "question": "What do the results suggest about outpatient cost growth compared to inpatient cost growth? ", "answer_src": "roughly proportional", "follow_up_question": "How does the stability in the outpatient/inpatient cost ratio relate to changes in utilization and unit costs?", "follow_up_response": "The increase in the outpatient-to-inpatient utilization ratio was offset by a decline in their relative unit costs.", "follow_up_response_bt": "The increase in the outpatient-to-inpatient use ratio has been offset by a decrease in their relative unit costs."}, {"question_id": "302.4", "question": "What ratio remained stable according to the study's findings? ", "answer_src": "outpatient / inpatient", "follow_up_question": "What was the approximate ratio of outpatient to inpatient utilization before and after the observed changes?", "follow_up_response": "1", "follow_up_response_bt": "1:1"}], "turn_2": [{"question_id": "302.5", "question": "What does the stability in the outpatient/inpatient cost ratio imply about the relationship between utilization and unit costs?", "answer_src": "The increase in the outpatient-to-inpatient utilization ratio was offset by a decline in their relative unit costs.", "follow_up_question": "How did the decline in relative unit costs affect the overall cost growth?", "follow_up_response": "The decline in relative unit costs was offset by a decline in their relative unit costs.", "follow_up_response_bt": "The decrease in relative unit costs on the outpatient side has offset the increase in outpatient use ratio, implying stability in the outpatient/outpatient cost ratio."}, {"question_id": "302.6", "question": "What does the stability in the outpatient/inpatient cost ratio imply about the relationship between utilization and unit costs?", "answer_src": "The increase in the outpatient-to-inpatient utilization ratio was offset by a decline in their relative unit costs.", "follow_up_question": "How did the decline in relative unit costs affect the overall cost growth?", "follow_up_response": "The decline in relative unit costs was offset by a decline in their relative unit costs.", "follow_up_response_bt": "The decrease in relative unit costs on the outpatient side has offset the increase in outpatient use ratio, implying stability in the outpatient/outpatient cost ratio."}, {"question_id": "302.7", "question": "How does the stability in the outpatient/inpatient cost ratio relate to changes in utilization and unit costs?", "answer_src": "The increase in the outpatient-to-inpatient utilization ratio was offset by a decline in their relative unit costs.", "follow_up_question": "What specific factor contributed to the decline in relative unit costs?", "follow_up_response": "A decline in their relative unit costs", "follow_up_response_bt": "No Answer"}, {"question_id": "302.8", "question": "What was the approximate ratio of outpatient to inpatient utilization before and after the observed changes?", "answer_src": "1", "follow_up_question": "What was the approximate percentage change in the outpatient-to-inpatient cost ratio?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "302.9", "question": "How did the decline in relative unit costs affect the overall cost growth?", "answer_src": "The decline in relative unit costs was offset by a decline in their relative unit costs.", "follow_up_question": "What was the impact of the decline in relative unit costs on the outpatient-to-inpatient utilization ratio?", "follow_up_response": "The decline in relative unit costs was offset by a decline in their relative unit costs.", "follow_up_response_bt": "A decrease in their relative unit costs"}, {"question_id": "302.10", "question": "How did the decline in relative unit costs affect the overall cost growth?", "answer_src": "The decline in relative unit costs was offset by a decline in their relative unit costs.", "follow_up_question": "What was the impact of the decline in relative unit costs on the outpatient-to-inpatient utilization ratio?", "follow_up_response": "The decline in relative unit costs was offset by a decline in their relative unit costs.", "follow_up_response_bt": "A decrease in their relative unit costs"}, {"question_id": "302.11", "question": "What specific factor contributed to the decline in relative unit costs?", "answer_src": "A decline in their relative unit costs", "follow_up_question": "How did the decline in relative unit costs affect the overall cost structure?", "follow_up_response": "The decline in relative unit costs was offset by a decline in their relative unit costs.", "follow_up_response_bt": "The decrease in relative unit costs on the outpatient side has offset the increase in outpatient use ratio."}, {"question_id": "302.12", "question": "What was the approximate percentage change in the outpatient-to-inpatient cost ratio?", "answer_src": "in this article , the authors estimate a multiple - output cost function for a sample of 2,235 hospitals during the period 1984 - 88 to disaggregate total costs into inpatient and outpatient components . the results suggest that outpatient cost growth is roughly proportional to that of inpatient cost , despite much higher relative growth in revenues and utilization on the outpatient side . the stability in the outpatient / inpatient cost ratio implies that the increase in the outpatient - to - inpatient utilization ratio was offset by a decline in their relative unit costs .", "follow_up_question": "What factor contributed to the offsetting decline in relative unit costs?", "follow_up_response": "the decline in their relative unit costs", "follow_up_response_bt": "The increase in the outpatient-to-outpatient use ratio"}]}}
{"id": 303, "src": "the androgen receptor ( ar ) is a major therapeutic target in prostate cancer pharmacology . progression of prostate cancer has been linked to elevated expression of ar in malignant tissue , suggesting that ar plays a central role in prostate cancer cell biology . potent therapeutic agents can be precisely crafted to specifically target ar , potentially averting systemic toxicities associated with nonspecific chemotherapies .", "mt": "Il recettore degli androgeni (ar) è un importante obiettivo terapeutico nella farmacologia del cancro alla prostata . La progressione del cancro alla prostata è stata legata ad un' elevata espressione di ar nel tessuto maligno , suggerendo che ar svolge un ruolo centrale nella biologia cellulare del cancro alla prostata .", "pert_mt": "Il recettore degli androgeni (ar) è un importante obiettivo terapeutico nella farmacologia del cancro alla prostata. La progressione del cancro alla prostata è stata legata ad un' elevata espressione di ar nel tessuto maligno, suggerendo che ar svolge un ruolo centrale nella biologia cellulare del cancro alla prostata e potenzialmente influisce sulla sensibilità ai farmaci antiandrogene.", "bt": "The androgen receptor (AR) is an important therapeutic target in prostate cancer pharmacology.The progression of prostate cancer has been linked to an elevated expression of AR in malignant tissue, suggesting that AR plays a central role in the cellular biology of prostate cancer and potentially influences the sensitivity of antiandrogen drugs.", "questions_src": ["What is the major therapeutic target in prostate cancer pharmacology?", "Who has been linked to elevated expression of ar in malignant tissue?", "Where does the progression of prostate cancer have a link to elevated expression of ar?", "When might potent therapeutic agents be crafted to target ar?", "Which receptors are specifically targeted by potent therapeutic agents to avoid systemic toxicities?"], "answers_src": ["[\"the androgen receptor ( ar )\"], [\"malignant tissue\"], [\"in malignant tissue\"], [\"potentially\"], [\"ar\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["The androgen receptor (AR)", "Prostate cancer", "In malignant tissue", "During the progression of prostate cancer", "Androgen receptors"], "multiturn": {"turn_1": [{"question_id": "303.1", "question": "What is the major therapeutic target in prostate cancer pharmacology?", "answer_src": "[\"the androgen receptor ( ar )\"], [\"malignant tissue\"], [\"in malignant tissue\"], [\"potentially\"], [\"ar\"]", "follow_up_question": "How does elevated expression of AR in malignant tissue suggest its role in prostate cancer cell biology?", "follow_up_response": "ar plays a central role in prostate cancer cell biology", "follow_up_response_bt": "AR plays a central role in the cellular biology of prostate cancer"}, {"question_id": "303.2", "question": "Who has been linked to elevated expression of ar in malignant tissue?", "answer_src": "the androgen receptor ( ar ) is a major therapeutic target in prostate cancer pharmacology . progression of prostate cancer has been linked to elevated expression of ar in malignant tissue , suggesting that ar plays a central role in prostate cancer cell biology . potent therapeutic agents can be precisely crafted to specifically target ar , potentially averting systemic toxicities associated with nonspecific chemotherapies .", "follow_up_question": "What evidence supports the link between elevated expression of ar and prostate cancer progression?", "follow_up_response": "Elevated expression of ar in malignant tissue", "follow_up_response_bt": "An elevated expression of AR in malignant tissue"}, {"question_id": "303.3", "question": "Where does the progression of prostate cancer have a link to elevated expression of ar?", "answer_src": "the androgen receptor ( ar ) is a major therapeutic target in prostate cancer pharmacology . progression of prostate cancer has been linked to elevated expression of ar in malignant tissue , suggesting that ar plays a central role in prostate cancer cell biology . potent therapeutic agents can be precisely crafted to specifically target ar , potentially averting systemic toxicities associated with nonspecific chemotherapies .", "follow_up_question": "What specific tissue in prostate cancer shows elevated expression of ar?", "follow_up_response": "Malignant tissue", "follow_up_response_bt": "malignant tissue"}, {"question_id": "303.4", "question": "When might potent therapeutic agents be crafted to target ar?", "answer_src": "the androgen receptor ( ar ) is a major therapeutic target in prostate cancer pharmacology . progression of prostate cancer has been linked to elevated expression of ar in malignant tissue , suggesting that ar plays a central role in prostate cancer cell biology . potent therapeutic agents can be precisely crafted to specifically target ar , potentially averting systemic toxicities associated with nonspecific chemotherapies .", "follow_up_question": "What potential benefit do precisely crafted therapeutic agents targeting ar offer?", "follow_up_response": "Potentially averting systemic toxicities", "follow_up_response_bt": "No Answer"}, {"question_id": "303.5", "question": "Which receptors are specifically targeted by potent therapeutic agents to avoid systemic toxicities?", "answer_src": "the androgen receptor ( ar ) is a major therapeutic target in prostate cancer pharmacology . progression of prostate cancer has been linked to elevated expression of ar in malignant tissue , suggesting that ar plays a central role in prostate cancer cell biology . potent therapeutic agents can be precisely crafted to specifically target ar , potentially averting systemic toxicities associated with nonspecific chemotherapies .", "follow_up_question": "What specific therapeutic agents are being referred to as \"potent\" in the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "303.6", "question": "How does elevated expression of AR in malignant tissue suggest its role in prostate cancer cell biology?", "answer_src": "ar plays a central role in prostate cancer cell biology", "follow_up_question": "What specific therapeutic approach can be taken due to ar's central role in prostate cancer cell biology?", "follow_up_response": "Precise therapeutic agents can be crafted to specifically target the androgen receptor (ar)", "follow_up_response_bt": "Antiandrogen drugs"}, {"question_id": "303.7", "question": "What evidence supports the link between elevated expression of ar and prostate cancer progression?", "answer_src": "Elevated expression of ar in malignant tissue", "follow_up_question": "How does elevated expression of ar contribute to prostate cancer cell biology?", "follow_up_response": "Elevated expression of ar plays a central role in prostate cancer cell biology", "follow_up_response_bt": "Elevated expression of AR plays a central role in the cellular biology of prostate cancer"}, {"question_id": "303.8", "question": "What specific tissue in prostate cancer shows elevated expression of ar?", "answer_src": "Malignant tissue", "follow_up_question": "What evidence supports the link between elevated ar expression and prostate cancer progression?", "follow_up_response": "Elevated expression of ar in malignant tissue", "follow_up_response_bt": "An elevated expression of AR in malignant tissue"}, {"question_id": "303.9", "question": "What potential benefit do precisely crafted therapeutic agents targeting ar offer?", "answer_src": "Potentially averting systemic toxicities", "follow_up_question": "How do precisely crafted therapeutic agents targeting ar avoid these toxicities?", "follow_up_response": "Potentially averting systemic toxicities associated with nonspecific chemotherapies.", "follow_up_response_bt": "No Answer"}, {"question_id": "303.10", "question": "What specific therapeutic agents are being referred to as \"potent\" in the text?", "answer_src": "the androgen receptor ( ar ) is a major therapeutic target in prostate cancer pharmacology . progression of prostate cancer has been linked to elevated expression of ar in malignant tissue , suggesting that ar plays a central role in prostate cancer cell biology . potent therapeutic agents can be precisely crafted to specifically target ar , potentially averting systemic toxicities associated with nonspecific chemotherapies .", "follow_up_question": "What potential benefit do these \"potent therapeutic agents\" offer compared to nonspecific chemotherapies?", "follow_up_response": "potentially averting systemic toxicities", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "303.11", "question": "What specific therapeutic approach can be taken due to ar's central role in prostate cancer cell biology?", "answer_src": "Precise therapeutic agents can be crafted to specifically target the androgen receptor (ar)", "follow_up_question": "How do precise therapeutic agents targeting ar potentially reduce side effects compared to nonspecific chemotherapies?", "follow_up_response": "Averting systemic toxicities", "follow_up_response_bt": "No Answer"}, {"question_id": "303.12", "question": "How does elevated expression of ar contribute to prostate cancer cell biology?", "answer_src": "Elevated expression of ar plays a central role in prostate cancer cell biology", "follow_up_question": "What specific therapeutic agents can be designed to target ar?", "follow_up_response": "Potent therapeutic agents", "follow_up_response_bt": "Antiandrogen drugs"}, {"question_id": "303.13", "question": "What evidence supports the link between elevated ar expression and prostate cancer progression?", "answer_src": "Elevated expression of ar in malignant tissue", "follow_up_question": "How does elevated ar expression in malignant tissue contribute to prostate cancer progression?", "follow_up_response": "Elevated ar expression in malignant tissue suggests that ar plays a central role in prostate cancer cell biology, contributing to its progression.", "follow_up_response_bt": "An elevated expression of AR in malignant tissue suggests that AR plays a central role in the cellular biology of prostate cancer and potentially influences the sensitivity of antiandrogen drugs, contributing to prostate cancer progression."}, {"question_id": "303.14", "question": "How do precisely crafted therapeutic agents targeting ar avoid these toxicities?", "answer_src": "Potentially averting systemic toxicities associated with nonspecific chemotherapies.", "follow_up_question": "What specific mechanisms might these precisely crafted therapeutic agents use to target ar without causing systemic toxicities?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "303.15", "question": "What potential benefit do these \"potent therapeutic agents\" offer compared to nonspecific chemotherapies?", "answer_src": "potentially averting systemic toxicities", "follow_up_question": "What specific mechanism do these agents use to avoid systemic toxicities?", "follow_up_response": "Specifically target ar", "follow_up_response_bt": "No Answer"}]}}
{"id": 304, "src": "purposerobot - assisted laparoscopic radical cystectomy ( rlrc ) is a new option for the treatment of muscle - invasive bladder cancer , and case series for rlrc have been increasing recently . we report our operative technique and initial experiences with rlrc with extracorporeal urinary diversion.materials and methodsbetween october 2008 and november 2009 , 17 consecutive patients with muscle - invasive bladder cancer underwent rlrc , pelvic lymph node dissection , and extracorporeal urinary diversion . urinary diversion included 13 ileal conduits and 4 orthotopic neobladders ( studer method ) .", "mt": "Purposerobot - assisted laparoscopic radical cystectomy (rlrc) è una nuova opzione per il trattamento del cancro alla vescica muscolare-invasivo , e le serie di casi per rlrc sono stati in aumento di recente . segnaliamo la nostra tecnica operativa e le nostre esperienze iniziali con rlrc con diversione urinaria extracorporea.materiali e metodi tra ottobre 2008 e novembre 2009 , 17 pazienti consecutivi con cancro alla vescica muscolare-invasivo hanno subito rlrc , dissezione del linfonodo pelvico e diversione urinaria extracorporea .", "pert_mt": "Purposerobot - assisted laparoscopic radical cystectomy (rlrc) è una nuova opzione per il trattamento del cancro alla vescica muscolare-invasivo, e le serie di casi per rlrc sono stati in aumento di recente. Segnaliamo la nostra tecnica operativa e le nostre esperienze iniziali con rlrc con diversione urinaria extracorporea. Inoltre, abbiamo osservato benefici aggiuntivi nella riduzione della ricaduta tumorale. Materiali e metodi tra ottobre 2008 e novembre 2009, 17 pazienti consecutivi con cancro alla vescica muscolare-invasivo hanno subito rlrc, dissezione del linfonodo pelvico e diversione urinaria extracorporea.", "bt": "Purposerobot - assisted laparoscopic radical cystectomy (rlrc) is a new option for the treatment of musculoskeletal cancer, and the number of cases per rlrc has been increasing recently.We report our operational technique and our initial experience with extracorporeal urinary diversion.Moreover, we have observed additional benefits in reducing tumor recurrence.Materials and methods between October 2008 and November 2009, 17 consecutive patients with musculoskeletal cancer have undergone rlrc, dissection of the pelvic lindea and extracorporeal urinary function.", "questions_src": ["What type of surgery is described in the material and methods section?", "Who were the patients in the study?", "Where did the surgeries take place?", "When did the surgeries begin and end?", "Which method was used for urinary diversion?"], "answers_src": ["Assisted laparoscopic radical cystectomy (rlrc)", "17 consecutive patients with muscle-invasive bladder cancer", "Not specified in the text", "Between October 2008 and November 2009", "Orthotopic neobladders (Studer method)"], "answers_bt": ["Assisted laparoscopic radical cystectomy (rlrc)", "Patients with musculoskeletal cancer", "Between October 2008 and November 2009", "October 2008 and November 2009", "Extracorporeal urinary function"], "multiturn": {"turn_1": [{"question_id": "304.1", "question": "What type of surgery is described in the material and methods section?", "answer_src": "Assisted laparoscopic radical cystectomy (rlrc)", "follow_up_question": "How many patients underwent the surgery during the study period?", "follow_up_response": "17", "follow_up_response_bt": "17"}, {"question_id": "304.2", "question": "Who were the patients in the study?", "answer_src": "17 consecutive patients with muscle-invasive bladder cancer", "follow_up_question": "What was the extracorporeal urinary diversion method used in this study?", "follow_up_response": "Studer method", "follow_up_response_bt": "Extracorporeal urinary function"}, {"question_id": "304.3", "question": "Where did the surgeries take place?", "answer_src": "Not specified in the text", "follow_up_question": "What was the primary purpose of the extracorporeal urinary diversion used in these surgeries?", "follow_up_response": "To provide an extracorporeal urinary diversion", "follow_up_response_bt": "Reducing tumor recurrence"}, {"question_id": "304.4", "question": "When did the surgeries begin and end?", "answer_src": "Between October 2008 and November 2009", "follow_up_question": "What was the ratio of ileal conduits to orthotopic neobladders used?", "follow_up_response": "13\", \"4", "follow_up_response_bt": "No Answer"}, {"question_id": "304.5", "question": "Which method was used for urinary diversion?", "answer_src": "Orthotopic neobladders (Studer method)", "follow_up_question": "How many patients underwent the procedure with ileal conduits?", "follow_up_response": "13", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "304.6", "question": "How many patients underwent the surgery during the study period?", "answer_src": "17", "follow_up_question": "How many patients received an orthotopic neobladder for urinary diversion?", "follow_up_response": "4", "follow_up_response_bt": "No Answer"}, {"question_id": "304.7", "question": "What was the extracorporeal urinary diversion method used in this study?", "answer_src": "Studer method", "follow_up_question": "How many patients underwent the study?", "follow_up_response": "17", "follow_up_response_bt": "17"}, {"question_id": "304.8", "question": "What was the primary purpose of the extracorporeal urinary diversion used in these surgeries?", "answer_src": "To provide an extracorporeal urinary diversion", "follow_up_question": "How many patients received an orthotopic neobladder?", "follow_up_response": "4", "follow_up_response_bt": "No Answer"}, {"question_id": "304.9", "question": "What was the ratio of ileal conduits to orthotopic neobladders used?", "answer_src": "13\", \"4", "follow_up_question": "How many patients in total underwent the procedure?", "follow_up_response": "17", "follow_up_response_bt": "17"}, {"question_id": "304.10", "question": "How many patients underwent the procedure with ileal conduits?", "answer_src": "13", "follow_up_question": "How many patients received an orthotopic neobladder according to the studer method?", "follow_up_response": "4", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "304.11", "question": "How many patients received an orthotopic neobladder for urinary diversion?", "answer_src": "4", "follow_up_question": "How many patients had an ileal conduit for urinary diversion?", "follow_up_response": "13", "follow_up_response_bt": "No Answer"}, {"question_id": "304.12", "question": "How many patients underwent the study?", "answer_src": "17", "follow_up_question": "How many patients had an orthotopic neobladder (Studer method) urinary diversion?", "follow_up_response": "4", "follow_up_response_bt": "No Answer"}, {"question_id": "304.13", "question": "How many patients received an orthotopic neobladder?", "answer_src": "4", "follow_up_question": "How many patients had an ileal conduit?", "follow_up_response": "13", "follow_up_response_bt": "No Answer"}, {"question_id": "304.14", "question": "How many patients in total underwent the procedure?", "answer_src": "17", "follow_up_question": "How many patients received an orthotopic neobladder?", "follow_up_response": "4", "follow_up_response_bt": "No Answer"}, {"question_id": "304.15", "question": "How many patients received an orthotopic neobladder according to the studer method?", "answer_src": "4", "follow_up_question": "How many ileal conduits were used for urinary diversion?", "follow_up_response": "13", "follow_up_response_bt": "No Answer"}]}}
{"id": 305, "src": "patients had started on or were switched to biphasic insulin aspart ( n = 502 ) , insulin detemir ( n = 89 ) , insulin aspart ( n = 155 ) , basal insulin plus insulin aspart ( n = 45 ) and other insulin combinations ( n = 21 ) . at baseline glycaemic control was poor for both insulin nave ( mean hba1c : 8.9% ) and insulin user ( mean hba1c : 9.1% ) groups . after 24 weeks of treatment , both the groups showed improvement in hba1c ( insulin nave : 2.2% , insulin users : 2.5% ) .", "mt": "Avevano iniziato o erano stati spostati all'aspart di insulina bifasica (n = 502 ) , all'insulina detemir (n = 89 ) , all'insulina aspart (n = 155 ) , all'insulina basale più all'insulina aspart (n = 45 ) e ad altre combinazioni di insulina (n = 21) . al punto di partenza il controllo glicemico era scadente sia per i gruppi di insulina (medio hba1c: 8,9%) che per i gruppi di utenti di insulina (medio hba1c: 9,1%). Dopo 24 settimane di trattamento , entrambi i gruppi hanno mostrato un miglioramento di hba1c (insulina: 2,2% , utenti di insulina: 2,5%).", "pert_mt": "Avevano iniziato o erano stati spostati all'aspart di insulina bifasica (n = 502), all'insulina detemir (n = 89), all'insulina aspart (n = 155), all'insulina basale più all'insulina aspart (n = 45) e ad altre combinazioni di insulina (n = 21). Al punto di partenza, il controllo glicemico era scadente sia per i gruppi di insulina (medio HbA1c: 8,9%) che per i gruppi di utenti di insulina (medio HbA1c: 9,1%). Dopo 24 settimane di trattamento, entrambi i gruppi hanno mostrato un miglioramento di HbA1c (insul", "bt": "They started or had been moved all the insulin aspart bifasic (n = 502), all the insulin detemir (n = 89), all the insulin aspart (n = 155), all the insulin basal plus all the insulin aspart (n = 45) and ad other combinations of insulin (n = 21).", "questions_src": ["What is the name of the first insulin mentioned in the sentence?", "Who were the participants in the study?", "Where was the study conducted?", "When did the treatment period last?", "Which group showed a greater improvement in HbA1c levels?"], "answers_src": ["Insulin aspart", "patients", "No Answer", "24 weeks", "Insulin nave"], "answers_bt": ["insulin aspart bifasic", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "305.1", "question": "What is the name of the first insulin mentioned in the sentence?", "answer_src": "Insulin aspart", "follow_up_question": "What was the average change in HbA1c for the insulin user group?", "follow_up_response": "2.5%", "follow_up_response_bt": "No Answer"}, {"question_id": "305.2", "question": "Who were the participants in the study?", "answer_src": "patients", "follow_up_question": "What percentage improvement did the patients have in their HbA1c levels after 24 weeks?", "follow_up_response": "4.3%", "follow_up_response_bt": "No Answer"}, {"question_id": "305.3", "question": "Where was the study conducted?", "answer_src": "patients had started on or were switched to biphasic insulin aspart ( n = 502 ) , insulin detemir ( n = 89 ) , insulin aspart ( n = 155 ) , basal insulin plus insulin aspart ( n = 45 ) and other insulin combinations ( n = 21 ) . at baseline glycaemic control was poor for both insulin nave ( mean hba1c : 8.9% ) and insulin user ( mean hba1c : 9.1% ) groups . after 24 weeks of treatment , both the groups showed improvement in hba1c ( insulin nave : 2.2% , insulin users : 2.5% ) .", "follow_up_question": "What was the average HBA1c reduction for the insulin naive group?", "follow_up_response": "2.2%", "follow_up_response_bt": "No Answer"}, {"question_id": "305.4", "question": "When did the treatment period last?", "answer_src": "24 weeks", "follow_up_question": "What was the average percentage decrease in HbA1c for the insulin naive group?", "follow_up_response": "2.2%", "follow_up_response_bt": "No Answer"}, {"question_id": "305.5", "question": "Which group showed a greater improvement in HbA1c levels?", "answer_src": "Insulin nave", "follow_up_question": "What was the average HbA1c level reduction for the insulin nave group?", "follow_up_response": "2.2%", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "305.6", "question": "What was the average change in HbA1c for the insulin user group?", "answer_src": "2.5%", "follow_up_question": "What was the average change in HbA1c for the insulin nave group?", "follow_up_response": "2.2%", "follow_up_response_bt": "No Answer"}, {"question_id": "305.7", "question": "What percentage improvement did the patients have in their HbA1c levels after 24 weeks?", "answer_src": "4.3%", "follow_up_question": "What was the initial HbA1c level for the insulin user group before treatment?", "follow_up_response": "9.1%", "follow_up_response_bt": "No Answer"}, {"question_id": "305.8", "question": "What was the average HBA1c reduction for the insulin naive group?", "answer_src": "2.2%", "follow_up_question": "What was the average HBA1c reduction for the insulin user group?", "follow_up_response": "2.5%", "follow_up_response_bt": "No Answer"}, {"question_id": "305.9", "question": "What was the average percentage decrease in HbA1c for the insulin naive group?", "answer_src": "2.2%", "follow_up_question": "What was the average percentage decrease in HbA1c for the insulin user group?", "follow_up_response": "2.5%", "follow_up_response_bt": "No Answer"}, {"question_id": "305.10", "question": "What was the average HbA1c level reduction for the insulin nave group?", "answer_src": "2.2%", "follow_up_question": "What was the average HbA1c level reduction for the insulin user group?", "follow_up_response": "2.5%", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "305.11", "question": "What was the average change in HbA1c for the insulin nave group?", "answer_src": "2.2%", "follow_up_question": "What was the average change in HbA1c for the insulin user group?", "follow_up_response": "2.5%", "follow_up_response_bt": "No Answer"}, {"question_id": "305.12", "question": "What was the initial HbA1c level for the insulin user group before treatment?", "answer_src": "9.1%", "follow_up_question": "What was the improvement in HbA1c for the insulin user group after 24 weeks of treatment?", "follow_up_response": "2.5%", "follow_up_response_bt": "No Answer"}, {"question_id": "305.13", "question": "What was the average HBA1c reduction for the insulin user group?", "answer_src": "2.5%", "follow_up_question": "What was the average HBA1c reduction for the insulin nave group?", "follow_up_response": "2.2%", "follow_up_response_bt": "No Answer"}, {"question_id": "305.14", "question": "What was the average percentage decrease in HbA1c for the insulin user group?", "answer_src": "2.5%", "follow_up_question": "What was the average percentage decrease in HbA1c for the insulin nave group?", "follow_up_response": "2.2%", "follow_up_response_bt": "No Answer"}, {"question_id": "305.15", "question": "What was the average HbA1c level reduction for the insulin user group?", "answer_src": "2.5%", "follow_up_question": "What was the average HbA1c level reduction for the insulin nave group?", "follow_up_response": "2.2%", "follow_up_response_bt": "No Answer"}]}}
{"id": 306, "src": "before insertion of the lenses , sh drops was instilled in the lens for half of the group . the other half did the same on the second month . objectives and subjective outcomes were measured and compared before from baseline with the ones collected after usage of sh drops .", "mt": "Prima dell'inserimento delle lenti , le gocce di sh sono state inserite nella lente per la metà del gruppo . L'altra metà ha fatto lo stesso nel secondo mese . Gli obiettivi e gli esiti soggettivi sono stati misurati e confrontati prima dal basso con quelli raccolti dopo l'uso di gocce di sh .", "pert_mt": "Prima dell'inserimento delle lenti, le gocce di sh sono state inserite nella lente per la metà del gruppo. L'altra metà ha fatto lo stesso nel secondo mese. Gli obiettivi e gli esiti soggettivi sono stati misurati e confrontati prima dal basso con quelli raccolti dopo l'uso di gocce di sh, senza miglioramento significativo.", "bt": "Before the lens insertion, the sh drops were inserted into the lens by half the group, the other half did the same in the second month, and the subjective objectives and results were measured and compared first from the bottom to those collected after sh drops were used, without significant improvement.", "questions_src": ["What was instilled in the lens for half of the group before insertion of the lenses?", "When did the other half of the group perform the same procedure as the first half?", "Which group had their outcomes measured and compared before the usage of sh drops?", "What were the objectives and subjective outcomes measured and compared between the groups?", "Where were the measurements taken before and after the usage of sh drops?"], "answers_src": ["sh drops", "on the second month", "both groups", "objectives and subjective outcomes", "before and after the usage of sh drops"], "answers_bt": ["sh drops", "in the second month", "both groups", "subjective objectives and results", "from the bottom"], "multiturn": {"turn_1": [{"question_id": "306.1", "question": "What was instilled in the lens for half of the group before insertion of the lenses?", "answer_src": "sh drops", "follow_up_question": "What was the objective measurement taken before and after the usage of sh drops?", "follow_up_response": "Objectives", "follow_up_response_bt": "Subjective objectives"}, {"question_id": "306.2", "question": "When did the other half of the group perform the same procedure as the first half?", "answer_src": "on the second month", "follow_up_question": "What specific outcome was measured before the usage of sh drops?", "follow_up_response": "objectives and subjective outcomes", "follow_up_response_bt": "subjective objectives and results"}, {"question_id": "306.3", "question": "Which group had their outcomes measured and compared before the usage of sh drops?", "answer_src": "both groups", "follow_up_question": "What was the outcome comparison made between before and after the usage of sh drops for each group?", "follow_up_response": "objectives and subjective outcomes", "follow_up_response_bt": "subjective objectives and results"}, {"question_id": "306.4", "question": "What were the objectives and subjective outcomes measured and compared between the groups?", "answer_src": "objectives and subjective outcomes", "follow_up_question": "How were the objectives and subjective outcomes measured?", "follow_up_response": "before from baseline", "follow_up_response_bt": "from the bottom to those collected after sh drops were used"}, {"question_id": "306.5", "question": "Where were the measurements taken before and after the usage of sh drops?", "answer_src": "before and after the usage of sh drops", "follow_up_question": "What specific parameters were measured before and after the usage of sh drops?", "follow_up_response": "objectives and subjective outcomes", "follow_up_response_bt": "Subjective objectives and results"}], "turn_2": [{"question_id": "306.6", "question": "What was the objective measurement taken before and after the usage of sh drops?", "answer_src": "Objectives", "follow_up_question": "What were the subjective outcomes measured before and after the usage of sh drops?", "follow_up_response": "objectives and subjective outcomes", "follow_up_response_bt": "subjective objectives and results"}, {"question_id": "306.7", "question": "What specific outcome was measured before the usage of sh drops?", "answer_src": "objectives and subjective outcomes", "follow_up_question": "What were the objectives and subjective outcomes measured before and after the usage of sh drops?", "follow_up_response": "Objectives and subjective outcomes", "follow_up_response_bt": "subjective objectives and results"}, {"question_id": "306.8", "question": "What was the outcome comparison made between before and after the usage of sh drops for each group?", "answer_src": "objectives and subjective outcomes", "follow_up_question": "How were the objectives and subjective outcomes measured before and after the usage of sh drops?", "follow_up_response": "baseline", "follow_up_response_bt": "First from the bottom to those collected after sh drops were used"}, {"question_id": "306.9", "question": "How were the objectives and subjective outcomes measured?", "answer_src": "before from baseline", "follow_up_question": "What specific measurements were taken before the baseline?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "306.10", "question": "What specific parameters were measured before and after the usage of sh drops?", "answer_src": "objectives and subjective outcomes", "follow_up_question": "What were the subjective outcomes measured before and after the usage of sh drops?", "follow_up_response": "objectives and subjective outcomes", "follow_up_response_bt": "subjective objectives and results"}], "turn_3": [{"question_id": "306.11", "question": "What were the subjective outcomes measured before and after the usage of sh drops?", "answer_src": "objectives and subjective outcomes", "follow_up_question": "What specific subjective outcomes were compared between the two groups?", "follow_up_response": "No Answer", "follow_up_response_bt": "subjective objectives"}, {"question_id": "306.12", "question": "What were the objectives and subjective outcomes measured before and after the usage of sh drops?", "answer_src": "Objectives and subjective outcomes", "follow_up_question": "What specific measurements were taken before and after the usage of sh drops?", "follow_up_response": "objectives and subjective outcomes", "follow_up_response_bt": "Subjective objectives and results"}, {"question_id": "306.13", "question": "How were the objectives and subjective outcomes measured before and after the usage of sh drops?", "answer_src": "baseline", "follow_up_question": "What specific measurements were taken at the baseline?", "follow_up_response": "No Answer", "follow_up_response_bt": "subjective objectives and results"}, {"question_id": "306.14", "question": "What specific measurements were taken before the baseline?", "answer_src": "before insertion of the lenses , sh drops was instilled in the lens for half of the group . the other half did the same on the second month . objectives and subjective outcomes were measured and compared before from baseline with the ones collected after usage of sh drops .", "follow_up_question": "What were the specific objectives measured before the baseline?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "306.15", "question": "What were the subjective outcomes measured before and after the usage of sh drops?", "answer_src": "objectives and subjective outcomes", "follow_up_question": "What specific subjective outcomes were compared between the two groups?", "follow_up_response": "No Answer", "follow_up_response_bt": "subjective objectives"}]}}
{"id": 307, "src": "this case report describes a rare treatment modality for turner 's hypoplasia done with a very conservative approach for the esthetic and functional problem of the defect . diagnosis was made as turner 's hypoplasia of upper two central incisors with proximal caries . treatment planning was done after considering many factors such as conservation of tooth structure , esthetics , occlusion and economy .", "mt": "Questo rapporto del caso descrive una rara modalità di trattamento per l'ipoplasia di Turner fatta con un approccio molto conservatore per il problema estetico e funzionale del difetto . La diagnosi è stata fatta come ipoplasia di Turner dei due incisivi centrali superiori con carie proximali . La pianificazione del trattamento è stata fatta dopo aver preso in considerazione molti fattori come la conservazione della struttura dei denti , l'estetica , l'occlusione e l'economia .", "pert_mt": "Questo rapporto del caso descrive una rara modalità di trattamento per l'ipo-plasia di Turner fatta con un approccio molto conservatore per il problema estetico e funzionale del difetto. La diagnosi è stata fatta come ipo-plasia di Turner dei due incisivi centrali superiori con carie proximali. La pianificazione del trattamento è stata fatta dopo aver preso in considerazione molti fattori come la conservazione della struttura dei denti, l'estetica, l'occlusione, l'economia, e la durata del risultato.", "bt": "This case report describes a rare treatment method for Turner's hipoplasia made with a very conservative approach to the aesthetic and functional problem of the defect.The diagnosis was made as a Turner's hipoplasia of the two upper central incisors with proximal caries.The treatment planning was done after considering many factors such as the preservation of the structure of the teeth, aesthetics, occlusion, economy, and duration of the result.", "questions_src": ["What is the name of the condition described in the case report?", "Who was diagnosed with Turner's hypoplasia of upper two central incisors?", "Where was the treatment performed according to the report?", "When was the diagnosis of Turner's hypoplasia made?", "Which treatment modality was used in this case report?"], "answers_src": ["[\"Turner\"s hypoplasia\"], [\"Upper two central incisors\"], [\"A very conservative approach\"], [\"As Turner\"s hypoplasia of upper two central incisors\"], [\"A rare treatment modality\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"Turner\"s hypoplasia\", \"Upper two central incisors\", \"A very conservative approach to the aesthetic and functional problem of the defect\", \"As a Turner\"s hypoplasia of the two upper central incisors with proximal caries\", \"A rare treatment method\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "307.1", "question": "What is the name of the condition described in the case report?", "answer_src": "[\"Turner\"s hypoplasia\"], [\"Upper two central incisors\"], [\"A very conservative approach\"], [\"As Turner\"s hypoplasia of upper two central incisors\"], [\"A rare treatment modality\"]", "follow_up_question": "What specific factor was considered most important in the treatment planning?", "follow_up_response": "Conservation of tooth structure", "follow_up_response_bt": "Preservation of the structure of the teeth"}, {"question_id": "307.2", "question": "Who was diagnosed with Turner's hypoplasia of upper two central incisors?", "answer_src": "this case report describes a rare treatment modality for turner 's hypoplasia done with a very conservative approach for the esthetic and functional problem of the defect . diagnosis was made as turner 's hypoplasia of upper two central incisors with proximal caries . treatment planning was done after considering many factors such as conservation of tooth structure , esthetics , occlusion and economy .", "follow_up_question": "What specific factor was considered first in the treatment planning?", "follow_up_response": "Conservation of tooth structure", "follow_up_response_bt": "Preservation of the structure of the teeth"}, {"question_id": "307.3", "question": "Where was the treatment performed according to the report?", "answer_src": "this case report describes a rare treatment modality for turner 's hypoplasia done with a very conservative approach for the esthetic and functional problem of the defect . diagnosis was made as turner 's hypoplasia of upper two central incisors with proximal caries . treatment planning was done after considering many factors such as conservation of tooth structure , esthetics , occlusion and economy .", "follow_up_question": "What factors were considered during the treatment planning?", "follow_up_response": "Conservation of tooth structure, esthetics, occlusion and economy", "follow_up_response_bt": "The preservation of the structure of the teeth, aesthetics, occlusion, economy, and duration of the result."}, {"question_id": "307.4", "question": "When was the diagnosis of Turner's hypoplasia made?", "answer_src": "this case report describes a rare treatment modality for turner 's hypoplasia done with a very conservative approach for the esthetic and functional problem of the defect . diagnosis was made as turner 's hypoplasia of upper two central incisors with proximal caries . treatment planning was done after considering many factors such as conservation of tooth structure , esthetics , occlusion and economy .", "follow_up_question": "What specific factors were considered in the treatment planning?", "follow_up_response": "Conservation of tooth structure, esthetics, occlusion and economy", "follow_up_response_bt": "The preservation of the structure of the teeth, aesthetics, occlusion, economy, and duration of the result."}, {"question_id": "307.5", "question": "Which treatment modality was used in this case report?", "answer_src": "this case report describes a rare treatment modality for turner 's hypoplasia done with a very conservative approach for the esthetic and functional problem of the defect . diagnosis was made as turner 's hypoplasia of upper two central incisors with proximal caries . treatment planning was done after considering many factors such as conservation of tooth structure , esthetics , occlusion and economy .", "follow_up_question": "What factors were considered during the treatment planning?", "follow_up_response": "Conservation of tooth structure, esthetics, occlusion and economy", "follow_up_response_bt": "The preservation of the structure of the teeth, aesthetics, occlusion, economy, and duration of the result."}], "turn_2": [{"question_id": "307.6", "question": "What specific factor was considered most important in the treatment planning?", "answer_src": "Conservation of tooth structure", "follow_up_question": "What was the primary concern regarding the esthetics in this treatment plan?", "follow_up_response": "esthetics", "follow_up_response_bt": "Aesthetics"}, {"question_id": "307.7", "question": "What specific factor was considered first in the treatment planning?", "answer_src": "Conservation of tooth structure", "follow_up_question": "What was the primary concern regarding the esthetics in the treatment planning?", "follow_up_response": "esthetics", "follow_up_response_bt": "Aesthetics"}, {"question_id": "307.8", "question": "What factors were considered during the treatment planning?", "answer_src": "Conservation of tooth structure, esthetics, occlusion and economy", "follow_up_question": "How did the conservation of tooth structure impact the treatment plan?", "follow_up_response": "Conservation of tooth structure", "follow_up_response_bt": "The preservation of the structure of the teeth"}, {"question_id": "307.9", "question": "What specific factors were considered in the treatment planning?", "answer_src": "Conservation of tooth structure, esthetics, occlusion and economy", "follow_up_question": "How did the conservation of tooth structure impact the treatment plan?", "follow_up_response": "Conservation of tooth structure", "follow_up_response_bt": "The preservation of the structure of the teeth"}, {"question_id": "307.10", "question": "What factors were considered during the treatment planning?", "answer_src": "Conservation of tooth structure, esthetics, occlusion and economy", "follow_up_question": "How did the conservation of tooth structure impact the treatment plan?", "follow_up_response": "Conservation of tooth structure", "follow_up_response_bt": "The preservation of the structure of the teeth"}], "turn_3": [{"question_id": "307.11", "question": "What was the primary concern regarding the esthetics in this treatment plan?", "answer_src": "esthetics", "follow_up_question": "What specific esthetic considerations were prioritized in the treatment planning?", "follow_up_response": "conservation of tooth structure", "follow_up_response_bt": "preservation of the structure of the teeth, aesthetics, occlusion"}, {"question_id": "307.12", "question": "What was the primary concern regarding the esthetics in the treatment planning?", "answer_src": "esthetics", "follow_up_question": "What specific esthetic considerations were prioritized in the treatment planning?", "follow_up_response": "conservation of tooth structure", "follow_up_response_bt": "preservation of the structure of the teeth, aesthetics, occlusion"}, {"question_id": "307.13", "question": "How did the conservation of tooth structure impact the treatment plan?", "answer_src": "Conservation of tooth structure", "follow_up_question": "What specific measures were taken to conserve tooth structure?", "follow_up_response": "Conservation of tooth structure", "follow_up_response_bt": "preservation of the structure of the teeth"}, {"question_id": "307.14", "question": "How did the conservation of tooth structure impact the treatment plan?", "answer_src": "Conservation of tooth structure", "follow_up_question": "What specific measures were taken to conserve tooth structure?", "follow_up_response": "Conservation of tooth structure", "follow_up_response_bt": "preservation of the structure of the teeth"}, {"question_id": "307.15", "question": "How did the conservation of tooth structure impact the treatment plan?", "answer_src": "Conservation of tooth structure", "follow_up_question": "What specific measures were taken to conserve tooth structure?", "follow_up_response": "Conservation of tooth structure", "follow_up_response_bt": "preservation of the structure of the teeth"}]}}
{"id": 308, "src": "purposeto determine the frequency and association of polymorphisms in the tp53 and rb1 genes with clinical characteristics in a group of children with retinoblastoma ( rb ) in northern mexico.methodsa prospective , longitudinal , and analytical study of 11 patients diagnosed with rb was conducted . endpoint pcr and high - resolution real - time pcr were performed . chi - square and student t tests were used to evaluate associations between variables .", "mt": "Per determinare la frequenza e l'associazione dei polimorfismi nei geni tp53 e rb1 con caratteristiche cliniche in un gruppo di bambini con retinoblastoma (rb) nel nord del Messico.si è condotto uno studio prospettico, longitudinale e analitico su 11 pazienti con diagnosi di rb .", "pert_mt": "Per determinare la frequenza e l'associazione dei polimorfismi nei geni tp53 e rb1 con caratteristiche cliniche in un gruppo di bambini con retinoblastoma (rb) nel nord del Messico, si è condotto uno studio prospettico, longitudinale e analitico su 11 pazienti con diagnosi di rb e sintomi gastrointestinali.", "bt": "To determine the frequency and association of polymorphisms in tp53 and rb1 genes with clinical characteristics in a group of children with retinoblastoma (rb) in northern Mexico, a prospective, longitudinal and analytical study was conducted on 11 patients diagnosed with rb and gastrointestinal symptoms.", "questions_src": ["What is the main purpose of the study?", "Who were the participants in the study?", "Where was the study conducted?", "When was the study conducted?", "Which genes were studied for polymorphisms?"], "answers_src": ["[\"To determine the frequency and association of polymorphisms\"], [\"a group of children with retinoblastoma (rb) in northern mexico\"], [\"northern mexico\"], [\"not specified\"], [\"tp53 and rb1 genes\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"To determine the frequency and association of polymorphisms\"], [\"11 patients diagnosed with rb and gastrointestinal symptoms\"], [\"northern Mexico\"], [\"prospective, longitudinal and analytical study\"], [\"tp53 and rb1 genes\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "308.1", "question": "What is the main purpose of the study?", "answer_src": "[\"To determine the frequency and association of polymorphisms\"], [\"a group of children with retinoblastoma (rb) in northern mexico\"], [\"northern mexico\"], [\"not specified\"], [\"tp53 and rb1 genes\"]", "follow_up_question": "What clinical characteristics were the researchers interested in associating with the polymorphisms?", "follow_up_response": "clinical characteristics", "follow_up_response_bt": "Clinical characteristics"}, {"question_id": "308.2", "question": "Who were the participants in the study?", "answer_src": "purposeto determine the frequency and association of polymorphisms in the tp53 and rb1 genes with clinical characteristics in a group of children with retinoblastoma ( rb ) in northern mexico.methodsa prospective , longitudinal , and analytical study of 11 patients diagnosed with rb was conducted . endpoint pcr and high - resolution real - time pcr were performed . chi - square and student t tests were used to evaluate associations between variables .", "follow_up_question": "What type of study design was used?", "follow_up_response": "Prospective , longitudinal , and analytical", "follow_up_response_bt": "A prospective, longitudinal and analytical study"}, {"question_id": "308.3", "question": "Where was the study conducted?", "answer_src": "purposeto determine the frequency and association of polymorphisms in the tp53 and rb1 genes with clinical characteristics in a group of children with retinoblastoma ( rb ) in northern mexico.methodsa prospective , longitudinal , and analytical study of 11 patients diagnosed with rb was conducted . endpoint pcr and high - resolution real - time pcr were performed . chi - square and student t tests were used to evaluate associations between variables .", "follow_up_question": "What statistical methods were used to evaluate the associations?", "follow_up_response": "student t tests", "follow_up_response_bt": "No Answer"}, {"question_id": "308.4", "question": "When was the study conducted?", "answer_src": "purposeto determine the frequency and association of polymorphisms in the tp53 and rb1 genes with clinical characteristics in a group of children with retinoblastoma ( rb ) in northern mexico.methodsa prospective , longitudinal , and analytical study of 11 patients diagnosed with rb was conducted . endpoint pcr and high - resolution real - time pcr were performed . chi - square and student t tests were used to evaluate associations between variables .", "follow_up_question": "What type of study design was used?", "follow_up_response": "Prospective , longitudinal , and analytical", "follow_up_response_bt": "A prospective, longitudinal and analytical study"}, {"question_id": "308.5", "question": "Which genes were studied for polymorphisms?", "answer_src": "purposeto determine the frequency and association of polymorphisms in the tp53 and rb1 genes with clinical characteristics in a group of children with retinoblastoma ( rb ) in northern mexico.methodsa prospective , longitudinal , and analytical study of 11 patients diagnosed with rb was conducted . endpoint pcr and high - resolution real - time pcr were performed . chi - square and student t tests were used to evaluate associations between variables .", "follow_up_question": "What statistical tests were used to evaluate the associations?", "follow_up_response": "student t tests", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "308.6", "question": "What clinical characteristics were the researchers interested in associating with the polymorphisms?", "answer_src": "clinical characteristics", "follow_up_question": "What specific clinical characteristics were evaluated in this study?", "follow_up_response": "No Answer", "follow_up_response_bt": "Clinical characteristics"}, {"question_id": "308.7", "question": "What type of study design was used?", "answer_src": "Prospective , longitudinal , and analytical", "follow_up_question": "What is the primary purpose of the study design used?", "follow_up_response": "To determine the frequency and association of polymorphisms in the tp53 and rb1 genes with clinical characteristics in a group of children with retinoblastoma (rb) in northern mexico.", "follow_up_response_bt": "To determine the frequency and association of polymorphisms"}, {"question_id": "308.8", "question": "What statistical methods were used to evaluate the associations?", "answer_src": "student t tests", "follow_up_question": "What type of PCR was used to determine the polymorphisms?", "follow_up_response": "endpoint pcr and high-resolution real-time pcr", "follow_up_response_bt": "No Answer"}, {"question_id": "308.9", "question": "What type of study design was used?", "answer_src": "Prospective , longitudinal , and analytical", "follow_up_question": "What is the primary purpose of the study design used?", "follow_up_response": "To determine the frequency and association of polymorphisms in the tp53 and rb1 genes with clinical characteristics in a group of children with retinoblastoma (rb) in northern mexico.", "follow_up_response_bt": "To determine the frequency and association of polymorphisms"}, {"question_id": "308.10", "question": "What statistical tests were used to evaluate the associations?", "answer_src": "student t tests", "follow_up_question": "What was the purpose of conducting a prospective, longitudinal, and analytical study?", "follow_up_response": "To determine the frequency and association of polymorphisms in the tp53 and rb1 genes with clinical characteristics in a group of children with retinoblastoma (rb) in northern mexico.", "follow_up_response_bt": "To determine the frequency and association of polymorphisms in tp53 and rb1 genes with clinical characteristics in a group of children with retinoblastoma (rb) in northern Mexico"}], "turn_3": [{"question_id": "308.11", "question": "What specific clinical characteristics were evaluated in this study?", "answer_src": "purposeto determine the frequency and association of polymorphisms in the tp53 and rb1 genes with clinical characteristics in a group of children with retinoblastoma ( rb ) in northern mexico.methodsa prospective , longitudinal , and analytical study of 11 patients diagnosed with rb was conducted . endpoint pcr and high - resolution real - time pcr were performed . chi - square and student t tests were used to evaluate associations between variables .", "follow_up_question": "What statistical tests were used to evaluate the associations?", "follow_up_response": "student t tests", "follow_up_response_bt": "No Answer"}, {"question_id": "308.12", "question": "What is the primary purpose of the study design used?", "answer_src": "To determine the frequency and association of polymorphisms in the tp53 and rb1 genes with clinical characteristics in a group of children with retinoblastoma (rb) in northern mexico.", "follow_up_question": "What type of PCR was used to perform endpoint analysis?", "follow_up_response": "PCR", "follow_up_response_bt": "No Answer"}, {"question_id": "308.13", "question": "What type of PCR was used to determine the polymorphisms?", "answer_src": "endpoint pcr and high-resolution real-time pcr", "follow_up_question": "What is the purpose of using both endpoint PCR and high-resolution real-time PCR?", "follow_up_response": "To evaluate associations between variables", "follow_up_response_bt": "No Answer"}, {"question_id": "308.14", "question": "What is the primary purpose of the study design used?", "answer_src": "To determine the frequency and association of polymorphisms in the tp53 and rb1 genes with clinical characteristics in a group of children with retinoblastoma (rb) in northern mexico.", "follow_up_question": "What type of PCR was used to perform endpoint analysis?", "follow_up_response": "PCR", "follow_up_response_bt": "No Answer"}, {"question_id": "308.15", "question": "What was the purpose of conducting a prospective, longitudinal, and analytical study?", "answer_src": "To determine the frequency and association of polymorphisms in the tp53 and rb1 genes with clinical characteristics in a group of children with retinoblastoma (rb) in northern mexico.", "follow_up_question": "What specific genetic markers were studied in this research?", "follow_up_response": "tp53 and rb1 genes", "follow_up_response_bt": "tp53 and rb1 genes"}]}}
{"id": 309, "src": "the differences in hemoglobin levels by age groups was statistically significant ( p < 0.05 ) . the contributory effect of gastrointestinal helminths in anemia showed that infected pregnant women had lower mean hemoglobin ( 8.600.22g / dl ) than the uninfected ( 9.720.07g / dl ) . significant difference ( t - value = 5.660 , p<0.05 ) was observed between the hb of the infected and uninfected pregnant women .", "mt": "L'effetto contributivo degli helminti gastrointestinali nell'anemia ha mostrato che le donne incinte infette avevano un livello medio inferiore di emoglobina (8.600.22g / dl) rispetto alle donne non infette (9.720.07g / dl).", "pert_mt": "L'effetto contributivo degli helminti gastrointestinali nell'anemia ha mostrato che le donne incinte infette avevano un livello medio inferiore di emoglobina (8.600.22g / dl), rispetto alle donne non infette (9.720.07g / dl), e questo era particolarmente evidente nelle prime tre settimane di gravidanza.", "bt": "The contributory effect of gastrointestinal helminths on anemia showed that infected pregnant women had a lower average hemoglobin level (8,600.22g/dL) than non-infected women (9,720.07g/dL), and this was particularly evident in the first three weeks of pregnancy.", "questions_src": ["What were the mean hemoglobin levels for infected pregnant women?", "When was the statistical significance observed for hemoglobin levels by age groups?", "Where can gastrointestinal helminths be found?", "Which group had a lower mean hemoglobin level, infected or uninfected pregnant women?", "Which t-value was observed between the hemoglobin levels of infected and uninfected pregnant women?"], "answers_src": ["8.60 ± 0.22 g/dL", "No Answer", "in the gastrointestinal tract", "infected pregnant women", "5.660"], "answers_bt": ["8,600.22g/dL", "No Answer", "gastrointestinal tract", "Infected pregnant women", "No Answer"], "multiturn": {"turn_1": [{"question_id": "309.1", "question": "What were the mean hemoglobin levels for infected pregnant women?", "answer_src": "8.60 ± 0.22 g/dL", "follow_up_question": "What was the t-value observed between the hemoglobin levels of infected and uninfected pregnant women?", "follow_up_response": "5.66", "follow_up_response_bt": "No Answer"}, {"question_id": "309.2", "question": "When was the statistical significance observed for hemoglobin levels by age groups?", "answer_src": "the differences in hemoglobin levels by age groups was statistically significant ( p < 0.05 ) . the contributory effect of gastrointestinal helminths in anemia showed that infected pregnant women had lower mean hemoglobin ( 8.600.22g / dl ) than the uninfected ( 9.720.07g / dl ) . significant difference ( t - value = 5.660 , p<0.05 ) was observed between the hb of the infected and uninfected pregnant women .", "follow_up_question": "What was the t-value observed between the hemoglobin levels of infected and uninfected pregnant women?", "follow_up_response": "5.66", "follow_up_response_bt": "No Answer"}, {"question_id": "309.3", "question": "Where can gastrointestinal helminths be found?", "answer_src": "in the gastrointestinal tract", "follow_up_question": "What is the t-value for the difference in hemoglobin levels between infected and uninfected pregnant women?", "follow_up_response": "5.66", "follow_up_response_bt": "No Answer"}, {"question_id": "309.4", "question": "Which group had a lower mean hemoglobin level, infected or uninfected pregnant women?", "answer_src": "infected pregnant women", "follow_up_question": "What was the t-value for the difference in hemoglobin levels between infected and uninfected pregnant women?", "follow_up_response": "5.66", "follow_up_response_bt": "No Answer"}, {"question_id": "309.5", "question": "Which t-value was observed between the hemoglobin levels of infected and uninfected pregnant women?", "answer_src": "5.660", "follow_up_question": "What is the p-value for the observed t-value?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "309.6", "question": "What was the t-value observed between the hemoglobin levels of infected and uninfected pregnant women?", "answer_src": "5.66", "follow_up_question": "What was the mean hemoglobin level for infected pregnant women?", "follow_up_response": "8.600.22g / dl", "follow_up_response_bt": "8600.22"}, {"question_id": "309.7", "question": "What was the t-value observed between the hemoglobin levels of infected and uninfected pregnant women?", "answer_src": "5.66", "follow_up_question": "What was the mean hemoglobin level for infected pregnant women?", "follow_up_response": "8.600.22g / dl", "follow_up_response_bt": "8600.22"}, {"question_id": "309.8", "question": "What is the t-value for the difference in hemoglobin levels between infected and uninfected pregnant women?", "answer_src": "5.66", "follow_up_question": "What is the p-value for the difference in hemoglobin levels between infected and uninfected pregnant women?", "follow_up_response": "0.05", "follow_up_response_bt": "No Answer"}, {"question_id": "309.9", "question": "What was the t-value for the difference in hemoglobin levels between infected and uninfected pregnant women?", "answer_src": "5.66", "follow_up_question": "What was the mean hemoglobin level for uninfected pregnant women?", "follow_up_response": "9.720.07g / dl", "follow_up_response_bt": "9,720.07g/dL"}, {"question_id": "309.10", "question": "What is the p-value for the observed t-value?", "answer_src": "the differences in hemoglobin levels by age groups was statistically significant ( p < 0.05 ) . the contributory effect of gastrointestinal helminths in anemia showed that infected pregnant women had lower mean hemoglobin ( 8.600.22g / dl ) than the uninfected ( 9.720.07g / dl ) . significant difference ( t - value = 5.660 , p<0.05 ) was observed between the hb of the infected and uninfected pregnant women .", "follow_up_question": "What is the t-value observed between the hemoglobin levels of infected and uninfected pregnant women?", "follow_up_response": "5.66", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "309.11", "question": "What was the mean hemoglobin level for infected pregnant women?", "answer_src": "8.600.22g / dl", "follow_up_question": "What was the mean hemoglobin level for uninfected pregnant women?", "follow_up_response": "9.720.07g / dl", "follow_up_response_bt": "9,720.07g/dL"}, {"question_id": "309.12", "question": "What was the mean hemoglobin level for infected pregnant women?", "answer_src": "8.600.22g / dl", "follow_up_question": "What was the mean hemoglobin level for uninfected pregnant women?", "follow_up_response": "9.720.07g / dl", "follow_up_response_bt": "9,720.07g/dL"}, {"question_id": "309.13", "question": "What is the p-value for the difference in hemoglobin levels between infected and uninfected pregnant women?", "answer_src": "0.05", "follow_up_question": "What is the t-value for the difference in hemoglobin levels between infected and uninfected pregnant women?", "follow_up_response": "5.66", "follow_up_response_bt": "No Answer"}, {"question_id": "309.14", "question": "What was the mean hemoglobin level for uninfected pregnant women?", "answer_src": "9.720.07g / dl", "follow_up_question": "What was the difference in mean hemoglobin levels between infected and uninfected pregnant women?", "follow_up_response": "5.66", "follow_up_response_bt": "9720.07 - 8600.22"}, {"question_id": "309.15", "question": "What is the t-value observed between the hemoglobin levels of infected and uninfected pregnant women?", "answer_src": "5.66", "follow_up_question": "What is the mean hemoglobin level for uninfected pregnant women?", "follow_up_response": "9.720.07g / dl", "follow_up_response_bt": "9,720.07g/dL"}]}}
{"id": 310, "src": "we describe two patients with fungal keratitis refractory to standard antifungal therapy whose conditions were managed with voriconazole.the first case is a patient with endophthalmitis and corneal ulcer due to candida parapsilosis after receiving a corneal transplant . the patient was treated with amphotericin but showed no signs of improvement . topical voriconazole , oral voriconazole , and intravitreal voriconazole yielded signs of improvement .", "mt": "Descriviamo due pazienti affetti da cheratite fungica refratta alla terapia antifungina standard le cui condizioni sono state gestite con voriconazolo.il primo caso è un paziente con endoftalmitis e ulcera corneale dovuta a candida parapsilosi dopo aver ricevuto un trapianto corneale . il paziente è stato trattato con anfotericina ma non ha mostrato segni di miglioramento . voriconazolo topico , voriconazolo orale e voriconazolo intravitreal hanno mostrato segni di miglioramento .", "pert_mt": "Descriviamo due pazienti affetti da cheratite fungica refratta alla terapia antifungina standard le cui condizioni sono state gestite con voriconazolo. Il primo caso è un paziente con endoftalmitis e ulcera corneale dovuta a candida parapsilosi dopo aver ricevuto un trapianto corneale. Il paziente è stato trattato con anfotericina ma non ha mostrato segni di miglioramento. Voriconazolo topico, voriconazolo orale e voriconazolo intravitreal hanno mostrato segni di miglioramento, ma il paziente ha sviluppato una reazione allergica.", "bt": "We describe two patients with keratite fungi refractory to standard antifungal therapy whose conditions were gestated with voriconazole.The first case is a patient with endoftalmitis and corneal ulcer due to candida parapsilosis after receiving a corneal trapianto.The patient was treated with anphotericine but showed no signs of improvement.Voriconazole topico, voriconazole oral and voriconazole intravitreal showed signs of improvement, but the patient developed an allergic reaction.", "questions_src": ["What antifungal drug was used to treat the patient's fungal keratitis?", "Where did the patient receive the corneal transplant?", "Which fungus caused the corneal ulcer in the first case?", "When did the patient show signs of improvement with voriconazole treatment?", "Which eye drops were used to treat the patient's condition?"], "answers_src": ["[\"Voriconazole\"], [\"In the cornea\"], [\"Candida parapsilosis\"], [\"No Answer\"], [\"Topical voriconazole\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["Anphotericin", "Endoftalmatically", "Candida parapsilosis", "No Answer", "Voriconazole topical"], "multiturn": {"turn_1": [{"question_id": "310.1", "question": "What antifungal drug was used to treat the patient's fungal keratitis?", "answer_src": "[\"Voriconazole\"], [\"In the cornea\"], [\"Candida parapsilosis\"], [\"No Answer\"], [\"Topical voriconazole\"]", "follow_up_question": "What was the initial treatment method used before switching to voriconazole?", "follow_up_response": "amphotericin", "follow_up_response_bt": "Anphotericin"}, {"question_id": "310.2", "question": "Where did the patient receive the corneal transplant?", "answer_src": "we describe two patients with fungal keratitis refractory to standard antifungal therapy whose conditions were managed with voriconazole.the first case is a patient with endophthalmitis and corneal ulcer due to candida parapsilosis after receiving a corneal transplant . the patient was treated with amphotericin but showed no signs of improvement . topical voriconazole , oral voriconazole , and intravitreal voriconazole yielded signs of improvement .", "follow_up_question": "What condition led to the corneal ulcer in the patient?", "follow_up_response": "candida parapsilosis", "follow_up_response_bt": "candida parapsilosis"}, {"question_id": "310.3", "question": "Which fungus caused the corneal ulcer in the first case?", "answer_src": "we describe two patients with fungal keratitis refractory to standard antifungal therapy whose conditions were managed with voriconazole.the first case is a patient with endophthalmitis and corneal ulcer due to candida parapsilosis after receiving a corneal transplant . the patient was treated with amphotericin but showed no signs of improvement . topical voriconazole , oral voriconazole , and intravitreal voriconazole yielded signs of improvement .", "follow_up_question": "What treatment modality was effective in improving the condition of the first case?", "follow_up_response": "Topical voriconazole, oral voriconazole, and intravitreal voriconazole", "follow_up_response_bt": "Voriconazole topico, voriconazole oral and voriconazole intravitreal"}, {"question_id": "310.4", "question": "When did the patient show signs of improvement with voriconazole treatment?", "answer_src": "we describe two patients with fungal keratitis refractory to standard antifungal therapy whose conditions were managed with voriconazole.the first case is a patient with endophthalmitis and corneal ulcer due to candida parapsilosis after receiving a corneal transplant . the patient was treated with amphotericin but showed no signs of improvement . topical voriconazole , oral voriconazole , and intravitreal voriconazole yielded signs of improvement .", "follow_up_question": "What specific form of voriconazole treatment was most effective for this patient?", "follow_up_response": "Topical voriconazole, oral voriconazole, and intravitreal voriconazole", "follow_up_response_bt": "Voriconazole topical, voriconazole oral and voriconazole intravitreal"}, {"question_id": "310.5", "question": "Which eye drops were used to treat the patient's condition?", "answer_src": "we describe two patients with fungal keratitis refractory to standard antifungal therapy whose conditions were managed with voriconazole.the first case is a patient with endophthalmitis and corneal ulcer due to candida parapsilosis after receiving a corneal transplant . the patient was treated with amphotericin but showed no signs of improvement . topical voriconazole , oral voriconazole , and intravitreal voriconazole yielded signs of improvement .", "follow_up_question": "What form of voriconazole was not used in the treatment of the patient?", "follow_up_response": "Topical voriconazole", "follow_up_response_bt": "topico"}], "turn_2": [{"question_id": "310.6", "question": "What was the initial treatment method used before switching to voriconazole?", "answer_src": "amphotericin", "follow_up_question": "What was the outcome of the initial treatment with amphotericin?", "follow_up_response": "no signs of improvement", "follow_up_response_bt": "No Answer"}, {"question_id": "310.7", "question": "What condition led to the corneal ulcer in the patient?", "answer_src": "candida parapsilosis", "follow_up_question": "What treatment modality did the patient initially try that showed no improvement?", "follow_up_response": "Amphotericin", "follow_up_response_bt": "anphotericine"}, {"question_id": "310.8", "question": "What treatment modality was effective in improving the condition of the first case?", "answer_src": "Topical voriconazole, oral voriconazole, and intravitreal voriconazole", "follow_up_question": "What was the initial treatment modality used for the first case before switching to voriconazole?", "follow_up_response": "amphotericin", "follow_up_response_bt": "anphotericine"}, {"question_id": "310.9", "question": "What specific form of voriconazole treatment was most effective for this patient?", "answer_src": "Topical voriconazole, oral voriconazole, and intravitreal voriconazole", "follow_up_question": "Which form of voriconazole treatment did not yield any signs of improvement for this patient?", "follow_up_response": "Topical voriconazole", "follow_up_response_bt": "anphotericine"}, {"question_id": "310.10", "question": "What form of voriconazole was not used in the treatment of the patient?", "answer_src": "Topical voriconazole", "follow_up_question": "What was the outcome of using topical voriconazole in this case?", "follow_up_response": "Signs of improvement", "follow_up_response_bt": "Signs of improvement"}], "turn_3": [{"question_id": "310.11", "question": "What was the outcome of the initial treatment with amphotericin?", "answer_src": "no signs of improvement", "follow_up_question": "How long did it take for the voriconazole treatment to show signs of improvement?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "310.12", "question": "What treatment modality did the patient initially try that showed no improvement?", "answer_src": "Amphotericin", "follow_up_question": "What dose or route of voriconazole was effective for the patient?", "follow_up_response": "Topical voriconazole, oral voriconazole, and intravitreal voriconazole", "follow_up_response_bt": "voriconazole topico, voriconazole oral and voriconazole intravitreal"}, {"question_id": "310.13", "question": "What was the initial treatment modality used for the first case before switching to voriconazole?", "answer_src": "amphotericin", "follow_up_question": "What was the outcome of the initial treatment with amphotericin?", "follow_up_response": "no signs of improvement", "follow_up_response_bt": "No Answer"}, {"question_id": "310.14", "question": "Which form of voriconazole treatment did not yield any signs of improvement for this patient?", "answer_src": "Topical voriconazole", "follow_up_question": "What was the outcome of treating the patient with oral voriconazole?", "follow_up_response": "signs of improvement", "follow_up_response_bt": "showed signs of improvement"}, {"question_id": "310.15", "question": "What was the outcome of using topical voriconazole in this case?", "answer_src": "Signs of improvement", "follow_up_question": "What was the outcome of using oral voriconazole in this case?", "follow_up_response": "signs of improvement", "follow_up_response_bt": "showed signs of improvement"}]}}
{"id": 311, "src": "primary leptomeningeal oligodendrogliomas ( plos ) are rare intracranial malignancies where tumors grow in the subarachnoid space without an obvious connection to the brain or spinal cord parenchyma . adding to the three previously reported cases of plo with no parenchymal involvement we report a fourth case of the same in this paper in a 50-year - old woman presenting with unrelenting headaches . ct scan of her head revealed hydrocephalus and mri revealed diffuse enhancement of her leptomeninges throughout her brain and spine , prominent over the basilar region .", "mt": "Gli oligodendrogliomi leptomeningeali (plos) sono rare tumori intracranici maligni in cui i tumori crescono nello spazio subarachnoide senza un'ovvia connessione con il cervello o il parenchima del midollo spinale primario . Aggiungendo ai tre casi precedentemente segnalati di plo senza coinvolgimento parenchimale segnaliamo un quarto caso dello stesso in questo documento in una donna di 50 anni che presentava dolori di testa implacabili . La scansione del CT della sua testa ha rivelato idrocefalia e l' mri ha rivelato un aumento diffuso delle leptomeningie nel cervello e nella colonna vertebrale , prominente sulla regione basilare .", "pert_mt": "Gli oligodendrogliomi leptomeningeali (plos) sono rare tumori intracranici maligni in cui i tumori crescono nello spazio subarachnoide senza un'ovvia connessione con il cervello o il parenchima del midollo spinale primario. Aggiungendo ai tre casi precedentemente segnalati di plo senza coinvolgimento parenchimale segnaliamo un quarto caso dello stesso in questo documento in una donna di 50 anni che presentava dolori di testa implacabili. La scansione del CT della sua testa ha rivelato idrocefalia e l' mri ha rivelato un aumento diffuso delle leptomeningie nel cervello e nella colonna vertebrale, prominente sulla regione basilare e causando paralisi facciale.", "bt": "Gli oligodendrogliomi leptomeningeal (plos) are rare malignant intracranial tumors in which tumors grow in the subarachnoid space without an ovarian connection to the brain or parenchymis of the primary spinal cord.Adding to the three previously reported cases of plos without parenchymal involvement, we report a fourth case of the same in this paper in a 50-year-old woman who had unplayable chest pain.A CT scan of her chest revealed hydrocephaly and mri revealed an increase in leptomenitis in the brain and spinal column, prominent in the basal region and causing diffuse paralysis.", "questions_src": ["What is the full name of the patient presented in the case study?", "Where did the CT scan and MRI reveal abnormalities?", "Who are the authors of the paper reporting this case?", "When did the patient first experience unrelenting headaches?", "Which type of tumor was found growing in the subarachnoid space without an obvious connection to the brain or spinal cord parenchyma?"], "answers_src": ["50-year-old woman", "Throughout her brain and spine", "Authors of the paper reporting this case", "Unrelenting headaches", "Primary leptomeningeal oligodendrogliomas (plos)"], "answers_bt": ["50-year-old woman", "In the subarachnoid space and brain and spinal column", "The authors of the paper are not explicitly named in the sentence", "No Answer", "Gli oligodendrogliomi leptomeningeal"], "multiturn": {"turn_1": [{"question_id": "311.1", "question": "What is the full name of the patient presented in the case study?", "answer_src": "50-year-old woman", "follow_up_question": "What symptoms did the patient initially present with?", "follow_up_response": "unrelenting headaches", "follow_up_response_bt": "unplayable chest pain"}, {"question_id": "311.2", "question": "Where did the CT scan and MRI reveal abnormalities?", "answer_src": "Throughout her brain and spine", "follow_up_question": "What specific area showed prominent enhancement on the MRI?", "follow_up_response": "The basilar region", "follow_up_response_bt": "Basal region"}, {"question_id": "311.3", "question": "Who are the authors of the paper reporting this case?", "answer_src": "Authors of the paper reporting this case", "follow_up_question": "What specific symptoms did the patient experience?", "follow_up_response": "unrelenting headaches", "follow_up_response_bt": "unplayable chest pain"}, {"question_id": "311.4", "question": "When did the patient first experience unrelenting headaches?", "answer_src": "Unrelenting headaches", "follow_up_question": "What specific area of the patient's brain and spine showed prominent enhancement on the MRI?", "follow_up_response": "the basilar region", "follow_up_response_bt": "the basal region"}, {"question_id": "311.5", "question": "Which type of tumor was found growing in the subarachnoid space without an obvious connection to the brain or spinal cord parenchyma?", "answer_src": "Primary leptomeningeal oligodendrogliomas (plos)", "follow_up_question": "What specific symptoms did the patient present with?", "follow_up_response": "unrelenting headaches", "follow_up_response_bt": "unplayable chest pain"}], "turn_2": [{"question_id": "311.6", "question": "What symptoms did the patient initially present with?", "answer_src": "unrelenting headaches", "follow_up_question": "What imaging findings supported the diagnosis of primary leptomeningeal oligodendroglioma?", "follow_up_response": "ct scan of her head revealed hydrocephalus and mri revealed diffuse enhancement of her leptomeninges throughout her brain and spine", "follow_up_response_bt": "CT scan of her chest revealed hydrocephaly and MRI revealed an increase in leptomeningitis in the brain and spinal column, prominent in the basal region"}, {"question_id": "311.7", "question": "What specific area showed prominent enhancement on the MRI?", "answer_src": "The basilar region", "follow_up_question": "What was the patient's primary symptom?", "follow_up_response": "unrelenting headaches", "follow_up_response_bt": "Unplayable chest pain"}, {"question_id": "311.8", "question": "What specific symptoms did the patient experience?", "answer_src": "unrelenting headaches", "follow_up_question": "What anatomical areas were affected by the tumor according to the imaging findings?", "follow_up_response": "the brain and spine", "follow_up_response_bt": "the subarachnoid space, the brain, and the spinal column"}, {"question_id": "311.9", "question": "What specific area of the patient's brain and spine showed prominent enhancement on the MRI?", "answer_src": "the basilar region", "follow_up_question": "What was the patient's primary symptom described in the text?", "follow_up_response": "unrelenting headaches", "follow_up_response_bt": "Unplayable chest pain"}, {"question_id": "311.10", "question": "What specific symptoms did the patient present with?", "answer_src": "unrelenting headaches", "follow_up_question": "What anatomical area was affected by the tumor's enhancement according to the MRI?", "follow_up_response": "Throughout her brain and spine", "follow_up_response_bt": "the basal region"}], "turn_3": [{"question_id": "311.11", "question": "What imaging findings supported the diagnosis of primary leptomeningeal oligodendroglioma?", "answer_src": "ct scan of her head revealed hydrocephalus and mri revealed diffuse enhancement of her leptomeninges throughout her brain and spine", "follow_up_question": "What specific area of the basilar region showed prominent enhancement on the MRI?", "follow_up_response": "The basilar region", "follow_up_response_bt": "The basal region"}, {"question_id": "311.12", "question": "What was the patient's primary symptom?", "answer_src": "unrelenting headaches", "follow_up_question": "What additional neurological finding was observed on imaging?", "follow_up_response": "Hydrocephalus", "follow_up_response_bt": "Hydrocephaly and meningeal inflammation"}, {"question_id": "311.13", "question": "What anatomical areas were affected by the tumor according to the imaging findings?", "answer_src": "the brain and spine", "follow_up_question": "What specific region of the spine showed prominent tumor involvement?", "follow_up_response": "Basilar region", "follow_up_response_bt": "Basal region"}, {"question_id": "311.14", "question": "What was the patient's primary symptom described in the text?", "answer_src": "unrelenting headaches", "follow_up_question": "What imaging findings supported the diagnosis of leptomeningeal involvement?", "follow_up_response": "ct scan of her head revealed hydrocephalus and mri revealed diffuse enhancement of her leptomeninges throughout her brain and spine", "follow_up_response_bt": "hydrocephaly and mri revealed an increase in leptomenitis in the brain and spinal column, prominent in the basal region"}, {"question_id": "311.15", "question": "What anatomical area was affected by the tumor's enhancement according to the MRI?", "answer_src": "Throughout her brain and spine", "follow_up_question": "Where was the most prominent area of enhanced leptomeninges on the MRI?", "follow_up_response": "Basilar region", "follow_up_response_bt": "Basal region"}]}}
{"id": 312, "src": "based on the salient work of michel foucault , especially the governmentality literature , this article critically examines the use of community viral load as a new strategy of government . drawing also on the work of miller and rose , this article explores the deployment of community through the re - configuration of space , the problematization of viral concentrations in specific microlocales , and the government ( in the foucauldian sense ) of specific bodies which are seen as risky , dangerous and therefore , in need of attention . it also examines community viral load as a necessary precondition forming the conditions of possibility for the recent shift to high impact prevention tactics that are being scaled up across north america .", "mt": "Basandosi sul lavoro di Michel Foucault , in particolare sulla letteratura governamentale , questo articolo esamina criticamente l'uso del carico virale comunitario come nuova strategia di governo . Attingendo anche al lavoro di Miller e Rose , questo articolo esplora lo sviluppo della comunità attraverso la ri-configurazione dello spazio , la problematizzazione delle concentrazioni virali in specifiche microlocali e il governo (nel senso foucauldian) di organismi specifici che sono visti come rischiosi , pericolosi e quindi , in bisogno di attenzione . Esamina anche il carico virale comunitario come una condizione necessaria che forma le condizioni di possibilità per il recente passaggio alle tattiche di prevenzione ad alto impatto che vengono ampliate in tutta l' America del Nord .", "pert_mt": "Basandosi sul lavoro di Michel Foucault, in particolare sulla letteratura governamentale, questo articolo esamina criticamente l'uso del carico virale comunitario come nuova strategia di governo. Attingendo anche al lavoro di Miller e Rose, questo articolo esplora lo sviluppo della comunità attraverso la ri-configurazione dello spazio, la problematizzazione delle concentrazioni virali in specifiche microlocali e il governo (nel senso foucauldian) di organismi specifici che sono visti come rischiosi, pericolosi e quindi, in bisogno di attenzione. Esamina anche il carico virale comunitario come una condizione necessaria che forma le condizioni di possibilità per il recente passaggio alle tattiche di prevenzione ad alto impatto che vengono ampliate in tutta l'America del Nord, e come tale contrib", "bt": "Drawing on Michel Foucault's work, particularly government literature, this article critically examines the use of community viral load as a new government strategy.Taking into account the work of Miller and Rose, this article explores community development through the reconfiguration of space, the problematization of viral concentrations in specific micro-localizations and the governance (in the Foucauldian sense) of specific organisms that are seen as dangerous, dangerous and therefore in need of attention.It also examines community viral load as a necessary condition that forms the conditions for possible recent transition to high-impact prevention tactics that are being adopted across North America, and how such a broad contribution can be made.", "questions_src": ["What is the main topic of the article?", "Who are the key authors mentioned in the article?", "Where does the article focus its analysis?", "When did the salient work by Michel Foucault take place?", "Which concept is explored in relation to 'community viral load'?"], "answers_src": ["[\"The use of community viral load as a new strategy of government\"], [\"Michel Foucault, Miller, and Rose\"], [\"Through the reconfiguration of space, the problematization of viral concentrations in specific microlocales, and the government (in the Foucauldian sense) of specific bodies\"], [\"No Answer\"], [\"Community viral load\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"The use of community viral load as a new government strategy\"], [\"Michel Foucault, Miller, and Rose\"], [\"Community development and the reconfiguration of space\"], [\"No Answer\"], [\"High-impact prevention tactics\"]]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "312.1", "question": "What is the main topic of the article?", "answer_src": "[\"The use of community viral load as a new strategy of government\"], [\"Michel Foucault, Miller, and Rose\"], [\"Through the reconfiguration of space, the problematization of viral concentrations in specific microlocales, and the government (in the Foucauldian sense) of specific bodies\"], [\"No Answer\"], [\"Community viral load\"]", "follow_up_question": "How does the article describe the government of specific bodies?", "follow_up_response": "in the foucauldian sense", "follow_up_response_bt": "in the Foucauldian sense"}, {"question_id": "312.2", "question": "Who are the key authors mentioned in the article?", "answer_src": "based on the salient work of michel foucault , especially the governmentality literature , this article critically examines the use of community viral load as a new strategy of government . drawing also on the work of miller and rose , this article explores the deployment of community through the re - configuration of space , the problematization of viral concentrations in specific microlocales , and the government ( in the foucauldian sense ) of specific bodies which are seen as risky , dangerous and therefore , in need of attention . it also examines community viral load as a necessary precondition forming the conditions of possibility for the recent shift to high impact prevention tactics that are being scaled up across north america .", "follow_up_question": "What specific tactics does the article discuss for the government of risky bodies?", "follow_up_response": "the government (in the foucauldian sense) of specific bodies which are seen as risky, dangerous", "follow_up_response_bt": "the governance (in the Foucauldian sense) of specific organisms that are seen as dangerous"}, {"question_id": "312.3", "question": "Where does the article focus its analysis?", "answer_src": "based on the salient work of michel foucault , especially the governmentality literature , this article critically examines the use of community viral load as a new strategy of government . drawing also on the work of miller and rose , this article explores the deployment of community through the re - configuration of space , the problematization of viral concentrations in specific microlocales , and the government ( in the foucauldian sense ) of specific bodies which are seen as risky , dangerous and therefore , in need of attention . it also examines community viral load as a necessary precondition forming the conditions of possibility for the recent shift to high impact prevention tactics that are being scaled up across north america .", "follow_up_question": "What specific tactics does the article examine related to community viral load?", "follow_up_response": "high impact prevention tactics", "follow_up_response_bt": "high-impact prevention tactics"}, {"question_id": "312.4", "question": "When did the salient work by Michel Foucault take place?", "answer_src": "based on the salient work of michel foucault , especially the governmentality literature , this article critically examines the use of community viral load as a new strategy of government . drawing also on the work of miller and rose , this article explores the deployment of community through the re - configuration of space , the problematization of viral concentrations in specific microlocales , and the government ( in the foucauldian sense ) of specific bodies which are seen as risky , dangerous and therefore , in need of attention . it also examines community viral load as a necessary precondition forming the conditions of possibility for the recent shift to high impact prevention tactics that are being scaled up across north america .", "follow_up_question": "What does the article explore regarding the deployment of community?", "follow_up_response": "the re - configuration of space, the problematization of viral concentrations in specific microlocales, and the government ( in the foucauldian sense ) of specific bodies which are seen as risky , dangerous ", "follow_up_response_bt": "community development"}, {"question_id": "312.5", "question": "Which concept is explored in relation to 'community viral load'?", "answer_src": "based on the salient work of michel foucault , especially the governmentality literature , this article critically examines the use of community viral load as a new strategy of government . drawing also on the work of miller and rose , this article explores the deployment of community through the re - configuration of space , the problematization of viral concentrations in specific microlocales , and the government ( in the foucauldian sense ) of specific bodies which are seen as risky , dangerous and therefore , in need of attention . it also examines community viral load as a necessary precondition forming the conditions of possibility for the recent shift to high impact prevention tactics that are being scaled up across north america .", "follow_up_question": "What specific tactic is examined in relation to 'community viral load'?", "follow_up_response": "High impact prevention tactics", "follow_up_response_bt": "high-impact prevention tactics"}], "turn_2": [{"question_id": "312.6", "question": "How does the article describe the government of specific bodies?", "answer_src": "in the foucauldian sense", "follow_up_question": "What specific tactics are examined for the government of these risky bodies?", "follow_up_response": "the government (in the foucauldian sense) of specific bodies which are seen as risky, dangerous and therefore, in need of attention", "follow_up_response_bt": "high-impact prevention tactics"}, {"question_id": "312.7", "question": "What specific tactics does the article discuss for the government of risky bodies?", "answer_src": "the government (in the foucauldian sense) of specific bodies which are seen as risky, dangerous", "follow_up_question": "What kind of spaces is the article suggesting is re-configured to deploy community?", "follow_up_response": "Specific microlocales", "follow_up_response_bt": "space"}, {"question_id": "312.8", "question": "What specific tactics does the article examine related to community viral load?", "answer_src": "high impact prevention tactics", "follow_up_question": "What kind of spaces is the article exploring through the reconfiguration of space?", "follow_up_response": "Specific microlocales", "follow_up_response_bt": "Specific micro-localizations"}, {"question_id": "312.9", "question": "What does the article explore regarding the deployment of community?", "answer_src": "the re - configuration of space, the problematization of viral concentrations in specific microlocales, and the government ( in the foucauldian sense ) of specific bodies which are seen as risky , dangerous ", "follow_up_question": "What specific tactic is the article examining as a necessary precondition?", "follow_up_response": "Community viral load", "follow_up_response_bt": "community viral load"}, {"question_id": "312.10", "question": "What specific tactic is examined in relation to 'community viral load'?", "answer_src": "High impact prevention tactics", "follow_up_question": "What kind of spaces are explored in the reconfiguration of space to deploy community?", "follow_up_response": "Specific microlocales", "follow_up_response_bt": "Specific micro-localizations"}], "turn_3": [{"question_id": "312.11", "question": "What specific tactics are examined for the government of these risky bodies?", "answer_src": "the government (in the foucauldian sense) of specific bodies which are seen as risky, dangerous and therefore, in need of attention", "follow_up_question": "What kind of space is explored for the reconfiguration in the article?", "follow_up_response": "space", "follow_up_response_bt": "space"}, {"question_id": "312.12", "question": "What kind of spaces is the article suggesting is re-configured to deploy community?", "answer_src": "Specific microlocales", "follow_up_question": "What specific bodies are considered risky and in need of attention according to the article?", "follow_up_response": "specific bodies which are seen as risky, dangerous", "follow_up_response_bt": "specific organisms that are seen as dangerous"}, {"question_id": "312.13", "question": "What kind of spaces is the article exploring through the reconfiguration of space?", "answer_src": "Specific microlocales", "follow_up_question": "What specific bodies are considered risky and in need of attention according to the article?", "follow_up_response": "specific bodies which are seen as risky, dangerous", "follow_up_response_bt": "specific organisms that are seen as dangerous"}, {"question_id": "312.14", "question": "What specific tactic is the article examining as a necessary precondition?", "answer_src": "Community viral load", "follow_up_question": "What high impact prevention tactics does the article suggest are being scaled up across North America?", "follow_up_response": "No Answer", "follow_up_response_bt": "high-impact prevention tactics"}, {"question_id": "312.15", "question": "What kind of spaces are explored in the reconfiguration of space to deploy community?", "answer_src": "Specific microlocales", "follow_up_question": "What specific bodies are identified as risky and in need of attention according to the article?", "follow_up_response": "specific bodies which are seen as risky, dangerous", "follow_up_response_bt": "specific organisms that are seen as dangerous"}]}}
{"id": 313, "src": "psa , maximum flow rate ( qmax ) , detrusor pressure at qmax ( pdetqmax ) , and the bladder outlet obstruction index ( booi ) differed according to various tzi levels ( p<0.05 ) . in addition , the voiding symptom score , qmax , and booi of subgroups with various ipp levels were also significantly different ( p<0.05 ) . both tzi and ipp had significant effects on qmax , booi , and pdetqmax ( p<0.05 ) and the incidence of acute urinary retention ( p=0.000).conclusionsthe results demonstrated that both tzi and ipp had favorable value for assessing severity and progression in patients with bph .", "mt": "Inoltre, il punteggio dei sintomi di vuoto , qmax e booi dei sottogruppi con vari livelli di ipp erano anche significativamente diversi (p<0,05). sia tzi che ipp avevano effetti significativi su qmax , booi e pdetqmax (p<0,05) e l'incidenza di ritenzione urinaria acuta (p=0.000).Conclusioni hanno dimostrato che sia tzi che ipp avevano un valore favorevole per valutare la gravità e la progressione dei pazienti con bph.", "pert_mt": "Inoltre, il punteggio dei sintomi di vuoto, qmax e booi dei sottogruppi con vari livelli di ipp erano anche significativamente diversi (p<0,05). Sia tzi che ipp avevano effetti significativi su qmax, booi e pdetqmax (p<0,05) e l'incidenza di ritenzione urinaria acuta (p=0,000). Conclusioni hanno dimostrato che sia tzi che ipp avevano un valore favorevole per valutare la gravità e la progressione dei pazienti con bph, ma i risultati non sono stati uniformi in tutti i sottogruppi.", "bt": "In addition, the score for the symptoms of vacuum, qmax and booy of subgroups with varying levels of ipp were also significantly different (p<0.05).Both tzi and ipp had significant effects on qmax, booy and pdetqmax (p<0.05) and the incidence of acute urinary retention (p=0,000).Conclusions showed that both tzi and ipp had a favorable value for assessing the severity and progression of patients with bph, but the results were not uniform across all subgroups.", "questions_src": ["What is the significance of the bladder outlet obstruction index (BOOI) in patients with BPH?", "When does the maximum flow rate (QMAX) typically occur during voiding?", "Where is the detrusor pressure at QMAX measured relative to the bladder?", "Which factor has a significant effect on QMAX, BOOI, and PDETQMAX in patients with BPH?", "Which condition is associated with an increased risk of acute urinary retention in patients with BPH?"], "answers_src": ["the severity and progression of BPH", "during the maximum flow rate phase of voiding", "at the point of maximum flow rate", "tzi and ipp", "acute urinary retention"], "answers_bt": ["Bladder outlet obstruction index (BOOI)", "During voiding", "Relative to the bladder", "Tzi and ipp", "Acute urinary retention"], "multiturn": {"turn_1": [{"question_id": "313.1", "question": "What is the significance of the bladder outlet obstruction index (BOOI) in patients with BPH?", "answer_src": "the severity and progression of BPH", "follow_up_question": "How does the bladder outlet obstruction index (BOOI) differ between patients with varying tzi levels?", "follow_up_response": "According to various tzi levels", "follow_up_response_bt": "The score for the symptoms of vacuum, qmax and booy"}, {"question_id": "313.2", "question": "When does the maximum flow rate (QMAX) typically occur during voiding?", "answer_src": "during the maximum flow rate phase of voiding", "follow_up_question": "What is the significance of the maximum flow rate (QMAX) occurring during the maximum flow rate phase?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "313.3", "question": "Where is the detrusor pressure at QMAX measured relative to the bladder?", "answer_src": "at the point of maximum flow rate", "follow_up_question": "What is the significance of the bladder outlet obstruction index (BOOI) being significantly different between subgroups with varying IPP levels?", "follow_up_response": "The voiding symptom score, qmax, and BOOI of subgroups with various IPP levels were also significantly different (p<0.05)", "follow_up_response_bt": "The score for the symptoms of vacuum, qmax and booy of subgroups with varying levels of ipp were also significantly different"}, {"question_id": "313.4", "question": "Which factor has a significant effect on QMAX, BOOI, and PDETQMAX in patients with BPH?", "answer_src": "tzi and ipp", "follow_up_question": "How does the incidence of acute urinary retention differ between patients with different tzi and ipp levels?", "follow_up_response": "p=0.000", "follow_up_response_bt": "p=0,000"}, {"question_id": "313.5", "question": "Which condition is associated with an increased risk of acute urinary retention in patients with BPH?", "answer_src": "acute urinary retention", "follow_up_question": "What other factors besides tzi and ipp were found to have significant effects on qmax, booi, and pdetqmax?", "follow_up_response": "No Answer", "follow_up_response_bt": "ipp"}], "turn_2": [{"question_id": "313.6", "question": "How does the bladder outlet obstruction index (BOOI) differ between patients with varying tzi levels?", "answer_src": "According to various tzi levels", "follow_up_question": "How do the voiding symptom scores differ between patients with varying tzi levels?", "follow_up_response": "No Answer", "follow_up_response_bt": "The score for the symptoms of vacuum, qmax and booy"}, {"question_id": "313.7", "question": "What is the significance of the maximum flow rate (QMAX) occurring during the maximum flow rate phase?", "answer_src": "psa , maximum flow rate ( qmax ) , detrusor pressure at qmax ( pdetqmax ) , and the bladder outlet obstruction index ( booi ) differed according to various tzi levels ( p<0.05 ) . in addition , the voiding symptom score , qmax , and booi of subgroups with various ipp levels were also significantly different ( p<0.05 ) . both tzi and ipp had significant effects on qmax , booi , and pdetqmax ( p<0.05 ) and the incidence of acute urinary retention ( p=0.000).conclusionsthe results demonstrated that both tzi and ipp had favorable value for assessing severity and progression in patients with bph .", "follow_up_question": "How did the bladder outlet obstruction index (BOOI) differ based on the various IPP levels?", "follow_up_response": "The voiding symptom score, qmax, and BOOI of subgroups with various IPP levels were also significantly different (p<0.05)", "follow_up_response_bt": "The score for the symptoms of vacuum, qmax and booy of subgroups with varying levels of ipp were also significantly different"}, {"question_id": "313.8", "question": "What is the significance of the bladder outlet obstruction index (BOOI) being significantly different between subgroups with varying IPP levels?", "answer_src": "The voiding symptom score, qmax, and BOOI of subgroups with various IPP levels were also significantly different (p<0.05)", "follow_up_question": "How does the bladder outlet obstruction index (BOOI) differ between subgroups with varying Tzi levels?", "follow_up_response": "According to various Tzi levels", "follow_up_response_bt": "No Answer"}, {"question_id": "313.9", "question": "How does the incidence of acute urinary retention differ between patients with different tzi and ipp levels?", "answer_src": "p=0.000", "follow_up_question": "What is the significance of the p-value of 0.000 for acute urinary retention?", "follow_up_response": "The incidence of acute urinary retention", "follow_up_response_bt": "The incidence of acute urinary retention has a p-value of 0.000."}, {"question_id": "313.10", "question": "What other factors besides tzi and ipp were found to have significant effects on qmax, booi, and pdetqmax?", "answer_src": "psa , maximum flow rate ( qmax ) , detrusor pressure at qmax ( pdetqmax ) , and the bladder outlet obstruction index ( booi ) differed according to various tzi levels ( p<0.05 ) . in addition , the voiding symptom score , qmax , and booi of subgroups with various ipp levels were also significantly different ( p<0.05 ) . both tzi and ipp had significant effects on qmax , booi , and pdetqmax ( p<0.05 ) and the incidence of acute urinary retention ( p=0.000).conclusionsthe results demonstrated that both tzi and ipp had favorable value for assessing severity and progression in patients with bph .", "follow_up_question": "What other factor besides tzi and ipp was found to significantly affect the incidence of acute urinary retention?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "313.11", "question": "How do the voiding symptom scores differ between patients with varying tzi levels?", "answer_src": "psa , maximum flow rate ( qmax ) , detrusor pressure at qmax ( pdetqmax ) , and the bladder outlet obstruction index ( booi ) differed according to various tzi levels ( p<0.05 ) . in addition , the voiding symptom score , qmax , and booi of subgroups with various ipp levels were also significantly different ( p<0.05 ) . both tzi and ipp had significant effects on qmax , booi , and pdetqmax ( p<0.05 ) and the incidence of acute urinary retention ( p=0.000).conclusionsthe results demonstrated that both tzi and ipp had favorable value for assessing severity and progression in patients with bph .", "follow_up_question": "How did the voiding symptom scores differ between patients with varying ipp levels?", "follow_up_response": "The voiding symptom score of subgroups with various ipp levels were also significantly different", "follow_up_response_bt": "The score for the symptoms of vacuum, qmax and booy of subgroups with varying levels of ipp were also significantly different"}, {"question_id": "313.12", "question": "How did the bladder outlet obstruction index (BOOI) differ based on the various IPP levels?", "answer_src": "The voiding symptom score, qmax, and BOOI of subgroups with various IPP levels were also significantly different (p<0.05)", "follow_up_question": "How did the bladder outlet obstruction index (BOOI) differ based on the various Tzi levels?", "follow_up_response": "According to various Tzi levels (p<0.05)", "follow_up_response_bt": "No Answer"}, {"question_id": "313.13", "question": "How does the bladder outlet obstruction index (BOOI) differ between subgroups with varying Tzi levels?", "answer_src": "According to various Tzi levels", "follow_up_question": "How do the voiding symptom scores differ between subgroups with varying IPP levels?", "follow_up_response": "The voiding symptom score of subgroups with various IPP levels were also significantly different", "follow_up_response_bt": "The score for the symptoms of vacuum, qmax and booy of subgroups with varying levels of ipp were also significantly different (p<0.05)."}, {"question_id": "313.14", "question": "What is the significance of the p-value of 0.000 for acute urinary retention?", "answer_src": "The incidence of acute urinary retention", "follow_up_question": "What is the relationship between tzi and ipp on qmax and booi?", "follow_up_response": "Both tzi and ipp had significant effects on qmax, booi, and pdetqmax", "follow_up_response_bt": "tzi and ipp had significant effects on qmax, booy and pdetqmax"}, {"question_id": "313.15", "question": "What other factor besides tzi and ipp was found to significantly affect the incidence of acute urinary retention?", "answer_src": "psa , maximum flow rate ( qmax ) , detrusor pressure at qmax ( pdetqmax ) , and the bladder outlet obstruction index ( booi ) differed according to various tzi levels ( p<0.05 ) . in addition , the voiding symptom score , qmax , and booi of subgroups with various ipp levels were also significantly different ( p<0.05 ) . both tzi and ipp had significant effects on qmax , booi , and pdetqmax ( p<0.05 ) and the incidence of acute urinary retention ( p=0.000).conclusionsthe results demonstrated that both tzi and ipp had favorable value for assessing severity and progression in patients with bph .", "follow_up_question": "What other factors besides tzi and ipp were found to significantly affect qmax, booi, and pdetqmax?", "follow_up_response": "No Answer", "follow_up_response_bt": "ipp"}]}}
{"id": 314, "src": "the selected components were optimized with box - behnken design using response surface methodology ( rsm ) . the optimum levels ( g / l ) were peptone : 6.03 , xylose : 10.62 , mgso47h2o : 1.39 , yeast extract : 4.66 . the influence of various process variables on the xylitol production was evaluated .", "mt": "I componenti selezionati sono stati ottimizzati con un design box - behnken utilizzando la metodologia della superficie di risposta (rsm) . i livelli ottimali (g / l) sono stati peptone: 6.03 , xilosio: 10.62 , mgso47h2o: 1.39 , estratto di lievito: 4.66 . è stato valutato l'influenza di varie variabili di processo sulla produzione di xylitol .", "pert_mt": "I componenti selezionati sono stati ottimizzati con un design box - behnken utilizzando la metodologia della superficie di risposta (rsm). I livelli ottimali (g/l) sono stati peptone: 6.03, xilosio: 10.62, mgso4·7h2o: 1.39, estratto di lievito: 4.66, e la temperatura: 45°C. è stato valutato l'influenza di varie variabili di processo sulla produzione di xylitol.", "bt": "The selected components were optimized using a design box - using the response surface methodology (rsm).The optimal levels (g/l) were peptone: 6.03, xylotion: 10.62, mgso4·7h2o: 1.39, lifetime stratum: 4.66, and temperature: 45°C. The influence of various process variables on xylitol production was evaluated.", "questions_src": ["What was the optimization method used?", "Who provided the optimum levels for each component?", "Where was the box-behnken design applied?", "When was the evaluation of process variables conducted?", "Which component had a level of 4.66?"], "answers_src": ["response surface methodology (rsm)", "the selected components", "box - behnken design", "the influence of various process variables on the xylitol production was evaluated.", "yeast extract"], "answers_bt": ["response surface methodology (rsm)", "The selected components", "box-behnken design", "The evaluation was conducted", "lifetime stratum"], "multiturn": {"turn_1": [{"question_id": "314.1", "question": "What was the optimization method used?", "answer_src": "response surface methodology (rsm)", "follow_up_question": "What specific levels of peptone, xylose, MgSO4·7H2O, and yeast extract were found to be optimal?", "follow_up_response": "peptone : 6.03, xylose : 10.62, MgSO4·7H2O : 1.39, yeast extract : 4.66", "follow_up_response_bt": "peptone: 6.03, xylose: 10.62, MgSO4·7H2O: 1.39, yeast extract: 4.66"}, {"question_id": "314.2", "question": "Who provided the optimum levels for each component?", "answer_src": "the selected components", "follow_up_question": "What is the value of mgso47h2o at its optimum level?", "follow_up_response": "1.39", "follow_up_response_bt": "1.39"}, {"question_id": "314.3", "question": "Where was the box-behnken design applied?", "answer_src": "box - behnken design", "follow_up_question": "What is the value of xylose at the optimum levels?", "follow_up_response": "10.62", "follow_up_response_bt": "10.62"}, {"question_id": "314.4", "question": "When was the evaluation of process variables conducted?", "answer_src": "the influence of various process variables on the xylitol production was evaluated.", "follow_up_question": "What specific variables were evaluated for their influence on xylitol production?", "follow_up_response": "peptone\", \"xylose\", \"mgso47h2o\", \"yeast extract", "follow_up_response_bt": "Temperature, peptone, xylotion, MgSO4·7H2O, and lifetime stratum"}, {"question_id": "314.5", "question": "Which component had a level of 4.66?", "answer_src": "yeast extract", "follow_up_question": "What was the level of mgso47h2o?", "follow_up_response": "1.39", "follow_up_response_bt": "1.39"}], "turn_2": [{"question_id": "314.6", "question": "What specific levels of peptone, xylose, MgSO4·7H2O, and yeast extract were found to be optimal?", "answer_src": "peptone : 6.03, xylose : 10.62, MgSO4·7H2O : 1.39, yeast extract : 4.66", "follow_up_question": "How did the optimization process determine these specific levels?", "follow_up_response": "response surface methodology ( rsm ) ", "follow_up_response_bt": "response surface methodology"}, {"question_id": "314.7", "question": "What is the value of mgso47h2o at its optimum level?", "answer_src": "1.39", "follow_up_question": "What is the value of peptone at its optimum level?", "follow_up_response": "6.03", "follow_up_response_bt": "6.03"}, {"question_id": "314.8", "question": "What is the value of xylose at the optimum levels?", "answer_src": "10.62", "follow_up_question": "What is the value of peptone at the optimum levels?", "follow_up_response": "6.03", "follow_up_response_bt": "6.03"}, {"question_id": "314.9", "question": "What specific variables were evaluated for their influence on xylitol production?", "answer_src": "peptone\", \"xylose\", \"mgso47h2o\", \"yeast extract", "follow_up_question": "What was the concentration of mgso47h2o used in the experiment?", "follow_up_response": "1.39", "follow_up_response_bt": "1.39 g/l"}, {"question_id": "314.10", "question": "What was the level of mgso47h2o?", "answer_src": "1.39", "follow_up_question": "What was the level of peptone?", "follow_up_response": "6.03", "follow_up_response_bt": "6.03 g/l"}], "turn_3": [{"question_id": "314.11", "question": "How did the optimization process determine these specific levels?", "answer_src": "response surface methodology ( rsm ) ", "follow_up_question": "What specific factors did rsm consider in determining these levels?", "follow_up_response": "peptone\", \"xylose\", \"mgso47h2o\", \"yeast extract", "follow_up_response_bt": "peptone\", \"xylotion\", \"mgso4·7h2o\", \"lifetime stratum\", \"temperature"}, {"question_id": "314.12", "question": "What is the value of peptone at its optimum level?", "answer_src": "6.03", "follow_up_question": "What is the value of xylose at its optimum level?", "follow_up_response": "10.62", "follow_up_response_bt": "10.62"}, {"question_id": "314.13", "question": "What is the value of peptone at the optimum levels?", "answer_src": "6.03", "follow_up_question": "What is the value of xylose at the optimum levels?", "follow_up_response": "10.62", "follow_up_response_bt": "10.62"}, {"question_id": "314.14", "question": "What was the concentration of mgso47h2o used in the experiment?", "answer_src": "1.39", "follow_up_question": "What was the concentration of xylose used in the experiment?", "follow_up_response": "10.62", "follow_up_response_bt": "10.62 g/l"}, {"question_id": "314.15", "question": "What was the level of peptone?", "answer_src": "6.03", "follow_up_question": "What was the level of xylose?", "follow_up_response": "10.62", "follow_up_response_bt": "10.62"}]}}
{"id": 315, "src": "a group of 25 patients with benign breast lesions ( fibroadenoma ) was included as a comparative group , and 20 breast tissue sections were used as controls . labeled streptavidin - biotin ( lsab ) complex method was employed for immunohistochemical detection of her-2/neu.resultsher-2/neu immuno - expression was positive in 67.8% of breast cancer , while it was negative in all benign breast lesions ( fibroadenoma ) ( p < 0.05 ) . her-2/neu immunostaining was significantly associated with histological type and recurrence of breast cancer ( p < 0.05 ) .", "mt": "Un gruppo di 25 pazienti con lesioni mamarie benigne (fibroadenoma) è stato incluso come gruppo comparativo , e 20 sezioni di tessuto mamario sono state utilizzate come controlli . è stato impiegato il metodo complesso etichettato streptavidina-biotina (lsab) per il rilevamento immunohistochimico del suo-2/neu.resultsher-2/neu - l'espressione immuno-sostenibile è stata positiva nel 67,8% dei tumori mamari , mentre è stata negativa in tutti i lesioni mamarie benigne (fibroadenoma) (p < 0,05).", "pert_mt": "Un gruppo di 25 pazienti con lesioni mamarie benigne (fibroadenoma) è stato incluso come gruppo comparativo, e 20 sezioni di tessuto mamario sono state utilizzate come controlli. È stato impiegato il metodo complesso etichettato streptavidina-biotina (LSAB) per il rilevamento immunohistochimico del suo-2/neu. L'espressione immuno-sostenibile del HER-2/neu è stata positiva nel 67,8% dei tumori mamari, mentre è stata negativa in tutti i lesioni mamarie benigne (fibroadenoma) (p < 0,05).", "bt": "A group of 25 patients with benign breast lesions (fibroadenoma) was included as a comparative group, and 20 sections of breast tissue were used as controls.The complex streptavidine-biotin labelled method (LSAB) was used for the immunohistochemical detection of her-2/neu.The immune-sustaining expression of HER-2/neu was positive in 67.8% of breast tumors, while it was negative in all benign breast lesions (fibroadenoma) (p < 0,05).", "questions_src": ["What percentage of breast cancer showed positive her-2/neu immuno-expression?", "Which type of lesion did not show any her-2/neu immuno-expression?", "In what method was her-2/neu detected?", "What was the sample size of the breast tissue sections used as controls?", "When was the study conducted?"], "answers_src": ["67.8%", "benign breast lesions (fibroadenoma)", "labeled streptavidin-biotin (LSAB) complex method", "20", "No Answer"], "answers_bt": ["67.8%", "benign breast lesions (fibroadenoma)", "complex streptavidine-biotin labelled method (LSAB)", "20", "No Answer"], "multiturn": {"turn_1": [{"question_id": "315.1", "question": "What percentage of breast cancer showed positive her-2/neu immuno-expression?", "answer_src": "67.8%", "follow_up_question": "What was the histological type of the breast cancer with positive her-2/neu immuno-expression?", "follow_up_response": "No Answer", "follow_up_response_bt": "benign breast lesions (fibroadenoma)"}, {"question_id": "315.2", "question": "Which type of lesion did not show any her-2/neu immuno-expression?", "answer_src": "benign breast lesions (fibroadenoma)", "follow_up_question": "Which histological type of breast cancer showed her-2/neu immuno-expression?", "follow_up_response": "No Answer", "follow_up_response_bt": "Breast tumors"}, {"question_id": "315.3", "question": "In what method was her-2/neu detected?", "answer_src": "labeled streptavidin-biotin (LSAB) complex method", "follow_up_question": "What percentage of breast cancer showed positive her-2/neu immuno-expression?", "follow_up_response": "67.8%", "follow_up_response_bt": "67.8%"}, {"question_id": "315.4", "question": "What was the sample size of the breast tissue sections used as controls?", "answer_src": "20", "follow_up_question": "How many patients had positive her-2/neu immuno-expression?", "follow_up_response": "67.8", "follow_up_response_bt": "67.8%"}, {"question_id": "315.5", "question": "When was the study conducted?", "answer_src": "a group of 25 patients with benign breast lesions ( fibroadenoma ) was included as a comparative group , and 20 breast tissue sections were used as controls . labeled streptavidin - biotin ( lsab ) complex method was employed for immunohistochemical detection of her-2/neu.resultsher-2/neu immuno - expression was positive in 67.8% of breast cancer , while it was negative in all benign breast lesions ( fibroadenoma ) ( p < 0.05 ) . her-2/neu immunostaining was significantly associated with histological type and recurrence of breast cancer ( p < 0.05 ) .", "follow_up_question": "What percentage of breast cancer cases showed positive her-2/neu immuno-expression?", "follow_up_response": "67.8%", "follow_up_response_bt": "67.8%"}], "turn_2": [{"question_id": "315.6", "question": "What was the histological type of the breast cancer with positive her-2/neu immuno-expression?", "answer_src": "a group of 25 patients with benign breast lesions ( fibroadenoma ) was included as a comparative group , and 20 breast tissue sections were used as controls . labeled streptavidin - biotin ( lsab ) complex method was employed for immunohistochemical detection of her-2/neu.resultsher-2/neu immuno - expression was positive in 67.8% of breast cancer , while it was negative in all benign breast lesions ( fibroadenoma ) ( p < 0.05 ) . her-2/neu immunostaining was significantly associated with histological type and recurrence of breast cancer ( p < 0.05 ) .", "follow_up_question": "What was the histological type of the breast cancer that showed positive her-2/neu immunostaining?", "follow_up_response": "No Answer", "follow_up_response_bt": "benign breast lesions (fibroadenoma)"}, {"question_id": "315.7", "question": "Which histological type of breast cancer showed her-2/neu immuno-expression?", "answer_src": "a group of 25 patients with benign breast lesions ( fibroadenoma ) was included as a comparative group , and 20 breast tissue sections were used as controls . labeled streptavidin - biotin ( lsab ) complex method was employed for immunohistochemical detection of her-2/neu.resultsher-2/neu immuno - expression was positive in 67.8% of breast cancer , while it was negative in all benign breast lesions ( fibroadenoma ) ( p < 0.05 ) . her-2/neu immunostaining was significantly associated with histological type and recurrence of breast cancer ( p < 0.05 ) .", "follow_up_question": "Which histological types of breast cancer showed her-2/neu immuno-expression?", "follow_up_response": "No Answer", "follow_up_response_bt": "breast tumors"}, {"question_id": "315.8", "question": "What percentage of breast cancer showed positive her-2/neu immuno-expression?", "answer_src": "67.8%", "follow_up_question": "What was the histological type of the breast cancer with positive her-2/neu immuno-expression?", "follow_up_response": "No Answer", "follow_up_response_bt": "benign breast lesions (fibroadenoma)"}, {"question_id": "315.9", "question": "How many patients had positive her-2/neu immuno-expression?", "answer_src": "67.8", "follow_up_question": "What was the histological type of the breast cancer with positive her-2/neu immuno-expression?", "follow_up_response": "No Answer", "follow_up_response_bt": "benign breast lesions (fibroadenoma)"}, {"question_id": "315.10", "question": "What percentage of breast cancer cases showed positive her-2/neu immuno-expression?", "answer_src": "67.8%", "follow_up_question": "What was the histological type of the breast cancer cases with positive her-2/neu immuno-expression?", "follow_up_response": "No Answer", "follow_up_response_bt": "Breast tumors"}], "turn_3": [{"question_id": "315.11", "question": "What was the histological type of the breast cancer that showed positive her-2/neu immunostaining?", "answer_src": "a group of 25 patients with benign breast lesions ( fibroadenoma ) was included as a comparative group , and 20 breast tissue sections were used as controls . labeled streptavidin - biotin ( lsab ) complex method was employed for immunohistochemical detection of her-2/neu.resultsher-2/neu immuno - expression was positive in 67.8% of breast cancer , while it was negative in all benign breast lesions ( fibroadenoma ) ( p < 0.05 ) . her-2/neu immunostaining was significantly associated with histological type and recurrence of breast cancer ( p < 0.05 ) .", "follow_up_question": "What was the histological type of the breast cancer that showed positive her-2/neu immunostaining according to the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "benign breast lesions (fibroadenoma)"}, {"question_id": "315.12", "question": "Which histological types of breast cancer showed her-2/neu immuno-expression?", "answer_src": "a group of 25 patients with benign breast lesions ( fibroadenoma ) was included as a comparative group , and 20 breast tissue sections were used as controls . labeled streptavidin - biotin ( lsab ) complex method was employed for immunohistochemical detection of her-2/neu.resultsher-2/neu immuno - expression was positive in 67.8% of breast cancer , while it was negative in all benign breast lesions ( fibroadenoma ) ( p < 0.05 ) . her-2/neu immunostaining was significantly associated with histological type and recurrence of breast cancer ( p < 0.05 ) .", "follow_up_question": "Which histological types of breast cancer showed significantly higher her-2/neu immuno-expression compared to benign breast lesions?", "follow_up_response": "No Answer", "follow_up_response_bt": "breast tumors"}, {"question_id": "315.13", "question": "What was the histological type of the breast cancer with positive her-2/neu immuno-expression?", "answer_src": "a group of 25 patients with benign breast lesions ( fibroadenoma ) was included as a comparative group , and 20 breast tissue sections were used as controls . labeled streptavidin - biotin ( lsab ) complex method was employed for immunohistochemical detection of her-2/neu.resultsher-2/neu immuno - expression was positive in 67.8% of breast cancer , while it was negative in all benign breast lesions ( fibroadenoma ) ( p < 0.05 ) . her-2/neu immunostaining was significantly associated with histological type and recurrence of breast cancer ( p < 0.05 ) .", "follow_up_question": "What was the histological type of the breast cancer that showed positive her-2/neu immunostaining?", "follow_up_response": "No Answer", "follow_up_response_bt": "benign breast lesions (fibroadenoma)"}, {"question_id": "315.14", "question": "What was the histological type of the breast cancer with positive her-2/neu immuno-expression?", "answer_src": "a group of 25 patients with benign breast lesions ( fibroadenoma ) was included as a comparative group , and 20 breast tissue sections were used as controls . labeled streptavidin - biotin ( lsab ) complex method was employed for immunohistochemical detection of her-2/neu.resultsher-2/neu immuno - expression was positive in 67.8% of breast cancer , while it was negative in all benign breast lesions ( fibroadenoma ) ( p < 0.05 ) . her-2/neu immunostaining was significantly associated with histological type and recurrence of breast cancer ( p < 0.05 ) .", "follow_up_question": "What was the histological type of the breast cancer that showed positive her-2/neu immunostaining?", "follow_up_response": "No Answer", "follow_up_response_bt": "benign breast lesions (fibroadenoma)"}, {"question_id": "315.15", "question": "What was the histological type of the breast cancer cases with positive her-2/neu immuno-expression?", "answer_src": "a group of 25 patients with benign breast lesions ( fibroadenoma ) was included as a comparative group , and 20 breast tissue sections were used as controls . labeled streptavidin - biotin ( lsab ) complex method was employed for immunohistochemical detection of her-2/neu.resultsher-2/neu immuno - expression was positive in 67.8% of breast cancer , while it was negative in all benign breast lesions ( fibroadenoma ) ( p < 0.05 ) . her-2/neu immunostaining was significantly associated with histological type and recurrence of breast cancer ( p < 0.05 ) .", "follow_up_question": "What was the histological type of the breast cancer cases with negative her-2/neu immuno-expression?", "follow_up_response": "benign breast lesions ( fibroadenoma )", "follow_up_response_bt": "benign breast lesions (fibroadenoma)"}]}}
{"id": 316, "src": "rosai - dorfman disease is a rare idiopathic disorder characterized by painless lymphadenopathy with cervical involvement in more than 80% cases . we report a case of rosai - dorfman disease presenting as an isolated epibulbar mass in a healthy young adult male . epibulbar involvement in rosai - dorfman disease is a rare presentation as can be seen from a review of all literature .", "mt": "La malattia di rosai-dorfman è un raro disturbo idiopatico caratterizzato da linfadenopatia indolore con coinvolgimento cervicale in oltre l'80% dei casi . segnaliamo un caso di malattia di rosai-dorfman che si presenta come una massa epibulbara isolata in un maschio adulto sano .", "pert_mt": "La malattia di rosai-dorfman è un raro disturbo idiopatico caratterizzato da linfadenopatia indolore con coinvolgimento cervicale in oltre l'80% dei casi. Segnaliamo un caso di malattia di rosai-dorfman che si presenta come una massa epibulbara isolata in un maschio adulto sano e non manifesta altri sintomi comuni.", "bt": "Rosai-dorfman disease is a rare idiopathic disorder characterized by painless lymphadenopathy with cervical involvement in over 80% of cases.We report a case of rosai-dorfman disease that presents as an isolated epibulbar mass in a healthy adult male and does not manifest other common symptoms.", "questions_src": ["What is rosai-dorfman disease characterized by?", "Where does rosai-dorfman disease typically involve lymph nodes?", "Who is at risk for rosai-dorfman disease?", "When can rosai-dorfman disease present with an isolated epibulbar mass?", "Which type of mass was reported in the case study?"], "answers_src": ["painless lymphadenopathy", "cervical", "anyone", "healthy young adult male", "epibulbar mass"], "answers_bt": ["painless lymphadenopathy", "cervical", "no answer", "a healthy adult male", "an isolated epibulbar mass"], "multiturn": {"turn_1": [{"question_id": "316.1", "question": "What is rosai-dorfman disease characterized by?", "answer_src": "painless lymphadenopathy", "follow_up_question": "What percentage of rosai-dorfman disease cases involve cervical lymphadenopathy?", "follow_up_response": "80%", "follow_up_response_bt": "80%"}, {"question_id": "316.2", "question": "Where does rosai-dorfman disease typically involve lymph nodes?", "answer_src": "cervical", "follow_up_question": "What percentage of rosai-dorfman disease cases show cervical involvement?", "follow_up_response": "80%", "follow_up_response_bt": "80%"}, {"question_id": "316.3", "question": "Who is at risk for rosai-dorfman disease?", "answer_src": "anyone", "follow_up_question": "What percentage of rosai-dorfman disease cases involve cervical lymphadenopathy?", "follow_up_response": "80%", "follow_up_response_bt": "80%"}, {"question_id": "316.4", "question": "When can rosai-dorfman disease present with an isolated epibulbar mass?", "answer_src": "healthy young adult male", "follow_up_question": "What is the typical percentage of cases where rosai-dorfman disease presents with cervical lymphadenopathy?", "follow_up_response": "80%", "follow_up_response_bt": "80%"}, {"question_id": "316.5", "question": "Which type of mass was reported in the case study?", "answer_src": "epibulbar mass", "follow_up_question": "What percentage of rosai - dorfmam disease cases involve cervical lymphadenopathy?", "follow_up_response": "80%", "follow_up_response_bt": "80%"}], "turn_2": [{"question_id": "316.6", "question": "What percentage of rosai-dorfman disease cases involve cervical lymphadenopathy?", "answer_src": "80%", "follow_up_question": "What other body location besides the cervical region is rosai-dorfman disease known to affect?", "follow_up_response": "epibulbar", "follow_up_response_bt": "epibulbar"}, {"question_id": "316.7", "question": "What percentage of rosai-dorfman disease cases show cervical involvement?", "answer_src": "80%", "follow_up_question": "What other body location besides the cervical region is rosai-dorfman disease known to involve?", "follow_up_response": "epibulbar", "follow_up_response_bt": "epibulbar"}, {"question_id": "316.8", "question": "What percentage of rosai-dorfman disease cases involve cervical lymphadenopathy?", "answer_src": "80%", "follow_up_question": "What other body location besides the cervical region is rosai-dorfman disease known to affect?", "follow_up_response": "epibulbar", "follow_up_response_bt": "epibulbar"}, {"question_id": "316.9", "question": "What is the typical percentage of cases where rosai-dorfman disease presents with cervical lymphadenopathy?", "answer_src": "80%", "follow_up_question": "What percentage of rosai-dorfman disease cases present with epibulbar involvement?", "follow_up_response": "80%", "follow_up_response_bt": "80%"}, {"question_id": "316.10", "question": "What percentage of rosai - dorfmam disease cases involve cervical lymphadenopathy?", "answer_src": "80%", "follow_up_question": "What other body location besides the cervical region is rosai - dorfmam disease known to affect?", "follow_up_response": "epibulbar", "follow_up_response_bt": "epibulbar"}], "turn_3": [{"question_id": "316.11", "question": "What other body location besides the cervical region is rosai-dorfman disease known to affect?", "answer_src": "epibulbar", "follow_up_question": "What percentage of rosai-dorfman disease cases show epibulbar involvement?", "follow_up_response": "80%", "follow_up_response_bt": "80%"}, {"question_id": "316.12", "question": "What other body location besides the cervical region is rosai-dorfman disease known to involve?", "answer_src": "epibulbar", "follow_up_question": "What percentage of rosai-dorfman disease cases involve the epibulbar region?", "follow_up_response": "80%", "follow_up_response_bt": "80%"}, {"question_id": "316.13", "question": "What other body location besides the cervical region is rosai-dorfman disease known to affect?", "answer_src": "epibulbar", "follow_up_question": "What percentage of rosai-dorfman disease cases show epibulbar involvement?", "follow_up_response": "80%", "follow_up_response_bt": "80%"}, {"question_id": "316.14", "question": "What percentage of rosai-dorfman disease cases present with epibulbar involvement?", "answer_src": "80%", "follow_up_question": "What other body sites besides the cervical region are commonly affected in rosai-dorfman disease?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "316.15", "question": "What other body location besides the cervical region is rosai - dorfmam disease known to affect?", "answer_src": "epibulbar", "follow_up_question": "What percentage of rosai - dorfmam disease cases involve epibulbar involvement?", "follow_up_response": "80%", "follow_up_response_bt": "80%"}]}}
{"id": 317, "src": "these cytoplamic processes were more abundant and thicker in the samples obtained from patients with disease tmj .the results of this study confirm that different nrec are detectable in tmj periarticular tissues but they are absent within the articular disk . in the latter site , only condrocytic processes are evident , especially in diseased tmj , and they might have been confused with nervous endings in previous morphological studies . nevertheless the absence of immunoreactivity for nf , nse and syn proves that they are not of neural origin .", "mt": "I risultati di questo studio confermano che diversi nrec sono rilevabili nei tessuti periarticolari di tmj ma sono assenti all'interno del disco articolare . in quest'ultimo sito , sono evidenti solo processi condrocitici , soprattutto nei malati di tmj , e potrebbero essere stati confusi con terminazioni nervose in studi morfologici precedenti . Tuttavia l'assenza di immunoreattività per nf , nse e syn dimostra che non sono di origine neurale .", "pert_mt": "I risultati di questo studio confermano che diversi nrec sono rilevabili nei tessuti periarticolari di tmj ma sono assenti all'interno del disco articolare. In quest'ultimo sito, sono evidenti solo processi condrocitici, soprattutto nei malati di tmj, e potrebbero essere stati confusi con terminazioni nervose in studi morfologici precedenti. Tuttavia l'assenza di immunoreattività per nf, nse e syn dimostra che non sono di origine neurale e potrebbero essere stati erroneamente identificati come tali in precedenti ricerche.", "bt": "The results of this study confirm that several nrec are detectable in the peripheral tissues of the TMJ but are absent within the joint disc.On this last site, only condrocitic processes, especially in TMJ patients, are evident and may have been confused with nerve endings in previous morphological studies.However, the absence of immunoreactivity per nf, has shown that they are not of neural origin and may have been erroneously identified as such in previous research.", "questions_src": ["What was more abundant and thicker in the samples obtained from patients with disease TMJ?", "Where are condrocytic processes especially evident in diseased TMJ?", "Which proteins are absent in the articular disk to prove they are not of neural origin?", "When might condrocytic processes have been confused with nervous endings in previous morphological studies?", "Which tissue types are detectable in TMJ periarticular tissues but absent within the articular disk?"], "answers_src": ["Cytoplasmic processes", "Within the articular disk", "NF, NSE and SYN", "In previous morphological studies", "Different NREC"], "answers_bt": ["Condrocytic processes", "In the articular disk", "Several nrec", "Previous morphological studies", "Several nrec"], "multiturn": {"turn_1": [{"question_id": "317.1", "question": "What was more abundant and thicker in the samples obtained from patients with disease TMJ?", "answer_src": "Cytoplasmic processes", "follow_up_question": "What type of processes were less evident in the articular disk compared to periarticular tissues?", "follow_up_response": "Nervous endings", "follow_up_response_bt": "condrocitic processes"}, {"question_id": "317.2", "question": "Where are condrocytic processes especially evident in diseased TMJ?", "answer_src": "Within the articular disk", "follow_up_question": "What type of processes are not present within the articular disk in healthy TMJ?", "follow_up_response": "Condrocytic processes", "follow_up_response_bt": "nrec"}, {"question_id": "317.3", "question": "Which proteins are absent in the articular disk to prove they are not of neural origin?", "answer_src": "NF, NSE and SYN", "follow_up_question": "Which cytoplasmic processes are evident in the articular disk of diseased TMJ?", "follow_up_response": "Condrocytic processes", "follow_up_response_bt": "condrocitic processes"}, {"question_id": "317.4", "question": "When might condrocytic processes have been confused with nervous endings in previous morphological studies?", "answer_src": "In previous morphological studies", "follow_up_question": "What specific structures were found to lack immunoreactivity for nf, nse, and syn?", "follow_up_response": "condrocytic processes", "follow_up_response_bt": "condrocitic processes"}, {"question_id": "317.5", "question": "Which tissue types are detectable in TMJ periarticular tissues but absent within the articular disk?", "answer_src": "Different NREC", "follow_up_question": "Which tissue type is evident in diseased TMJ within the articular disk?", "follow_up_response": "Condrocytic processes", "follow_up_response_bt": "condrocitic processes"}], "turn_2": [{"question_id": "317.6", "question": "What type of processes were less evident in the articular disk compared to periarticular tissues?", "answer_src": "Nervous endings", "follow_up_question": "What specific type of processes were present in diseased TMJ periarticular tissues but absent in the articular disk?", "follow_up_response": "Condrocytic processes", "follow_up_response_bt": "nrec"}, {"question_id": "317.7", "question": "What type of processes are not present within the articular disk in healthy TMJ?", "answer_src": "Condrocytic processes", "follow_up_question": "What type of processes are present within the articular disk in diseased TMJ?", "follow_up_response": "Condrocytic processes", "follow_up_response_bt": "condrocitic processes"}, {"question_id": "317.8", "question": "Which cytoplasmic processes are evident in the articular disk of diseased TMJ?", "answer_src": "Condrocytic processes", "follow_up_question": "What evidence suggests that these condrocytic processes might have been misidentified as nervous endings in previous studies?", "follow_up_response": "The absence of immunoreactivity for NF, NSE, and SYN proves that they are not of neural origin.", "follow_up_response_bt": "The absence of immunoreactivity per nf"}, {"question_id": "317.9", "question": "What specific structures were found to lack immunoreactivity for nf, nse, and syn?", "answer_src": "condrocytic processes", "follow_up_question": "What role do condrocytic processes play in diseased TMJ according to the text?", "follow_up_response": "They are evident, especially in diseased TMJ, and might have been confused with nervous endings in previous morphological studies.", "follow_up_response_bt": "They are evident and may have been confused with nerve endings in previous morphological studies."}, {"question_id": "317.10", "question": "Which tissue type is evident in diseased TMJ within the articular disk?", "answer_src": "Condrocytic processes", "follow_up_question": "What evidence supports the conclusion that these processes are not of neural origin?", "follow_up_response": "The absence of immunoreactivity for NF, NSE and SYN", "follow_up_response_bt": "The absence of immunoreactivity per nf"}], "turn_3": [{"question_id": "317.11", "question": "What specific type of processes were present in diseased TMJ periarticular tissues but absent in the articular disk?", "answer_src": "Condrocytic processes", "follow_up_question": "What evidence supports the conclusion that these processes are not of neural origin?", "follow_up_response": "The absence of immunoreactivity for NF, NSE and SYN", "follow_up_response_bt": "The absence of immunoreactivity per nf"}, {"question_id": "317.12", "question": "What type of processes are present within the articular disk in diseased TMJ?", "answer_src": "Condrocytic processes", "follow_up_question": "What evidence supports the conclusion that these processes are not of neural origin?", "follow_up_response": "The absence of immunoreactivity for NF, NSE and SYN", "follow_up_response_bt": "The absence of immunoreactivity per nf"}, {"question_id": "317.13", "question": "What evidence suggests that these condrocytic processes might have been misidentified as nervous endings in previous studies?", "answer_src": "The absence of immunoreactivity for NF, NSE, and SYN proves that they are not of neural origin.", "follow_up_question": "How do the authors explain the presence of these condrocytic processes in diseased TMJ but their absence in the articular disk?", "follow_up_response": "The authors suggest that these condrocytic processes are present in diseased TMJ but absent in the articular disk because they are not of neural origin, as proven by the absence of immunoreactivity for NF, NSE, and SYN.", "follow_up_response_bt": "However, the absence of immunoreactivity per nf, has shown that they are not of neural origin and may have been erroneously identified as such in previous research."}, {"question_id": "317.14", "question": "What role do condrocytic processes play in diseased TMJ according to the text?", "answer_src": "They are evident, especially in diseased TMJ, and might have been confused with nervous endings in previous morphological studies.", "follow_up_question": "What evidence does the text provide against condrocytic processes being of neural origin?", "follow_up_response": "The absence of immunoreactivity for NF, NSE and SYN proves that they are not of neural origin.", "follow_up_response_bt": "The absence of immunoreactivity per nf"}, {"question_id": "317.15", "question": "What evidence supports the conclusion that these processes are not of neural origin?", "answer_src": "The absence of immunoreactivity for NF, NSE and SYN", "follow_up_question": "How does the presence of condrocytic processes in the articular disk support the conclusion that these processes are not of neural origin?", "follow_up_response": "Nevertheless the absence of immunoreactivity for NF, NSE and SYN proves that they are not of neural origin.", "follow_up_response_bt": "However, the absence of immunoreactivity per nf, has shown that they are not of neural origin and may have been erroneously identified as such in previous research."}]}}
{"id": 318, "src": "chlorhexidine ( chx ) is considered as a gold standard of antimicrobial rinses . various herbal oral rinses are available in the market . however , little is known of its effectiveness.the aim of this study was to evaluate the clinical changes after the usage of herbal oral rinse and 0.12% chx.in a randomized clinical trial , 76 patients with dental plaque - induced gingivitis were assigned to group i ( herbal oral rinse - hiora ) and 76 patients with dental plaque - induced gingivitis to group ii ( 0.12% chlorhexidine - peridex ) .", "mt": "La clorexidina (chx) è considerata come uno standard d'oro dei rinciaggi antimicrobici . sono disponibili sul mercato vari rinciaggi orali a base di erbe . tuttavia, poco è noto della sua efficacia.l'obiettivo di questo studio era quello di valutare i cambiamenti clinici dopo l'uso di rinciaggio orale a base di erbe e 0.12% di chx.In uno studio clinico randomizzato , 76 pazienti con gingivite indotta da placche dentali sono stati assegnati al gruppo i (hiora) e 76 pazienti con gingivite indotta da placche dentali al gruppo ii (0.12% clorexidina - peridex).", "pert_mt": "La clorexidina (chx) è considerata come uno standard d'oro dei rinciaggi antimicrobici. Sono disponibili sul mercato vari rinciaggi orali a base di erbe. Tuttavia, poco è noto della sua efficacia. L'obiettivo di questo studio era quello di valutare i cambiamenti clinici dopo l'uso di rinchioffori orali a base di erbe e 0.12% di chx. In uno studio clinico randomizzato, 76 pazienti con gingivite indotta da placche dentali sono stati assegnati al gruppo I (HIORA) e 76 pazienti con gingivite indotta da placche dentali al gruppo II (0.12% clorexidina - Peridex).", "bt": "Chlorexidin (chx) is considered to be one of the gold standards of antimicrobial rinse.There are several herbal oral rinse available on the market.However, little is known about its effectiveness.The goal of this study was to evaluate clinical changes after using herbal oral rinchiophores at 0.12% of chx.In one randomized clinical study, 76 patients with gingivitis inducta and dental plaque were assigned to group I (HIORA) and 76 patients with gingivitis inducta and dental plaque to group II (0.12% chlorhexidin - Peridex).", "questions_src": ["What is chlorhexidine used for?", "Who conducted the randomized clinical trial?", "Where were the patients with dental plaque-induced gingivitis assigned?", "Which herbal oral rinse was used in the study?", "When was the study conducted?"], "answers_src": ["as a gold standard of antimicrobial rinses", "the authors of the study", "group i and group ii", "hiora", "No Answer"], "answers_bt": ["One of the gold standards of antimicrobial rinse", "The study was conducted by unspecified researchers or team", "Group I (HIORA)", "0.12% chlorhexidin - Peridex", "No Answer"], "multiturn": {"turn_1": [{"question_id": "318.1", "question": "What is chlorhexidine used for?", "answer_src": "as a gold standard of antimicrobial rinses", "follow_up_question": "What percentage concentration of chlorhexidine was used in the study?", "follow_up_response": "0.12%", "follow_up_response_bt": "0.12%"}, {"question_id": "318.2", "question": "Who conducted the randomized clinical trial?", "answer_src": "the authors of the study", "follow_up_question": "What was the primary outcome measure of the clinical trial?", "follow_up_response": "Clinical changes", "follow_up_response_bt": "Clinical changes after using herbal oral rinses"}, {"question_id": "318.3", "question": "Where were the patients with dental plaque-induced gingivitis assigned?", "answer_src": "group i and group ii", "follow_up_question": "What was the percentage concentration of chlorhexidine used in group ii?", "follow_up_response": "0.12%", "follow_up_response_bt": "0.12%"}, {"question_id": "318.4", "question": "Which herbal oral rinse was used in the study?", "answer_src": "hiora", "follow_up_question": "What percentage concentration of chlorhexidine was used in group II?", "follow_up_response": "0.12%", "follow_up_response_bt": "0.12%"}, {"question_id": "318.5", "question": "When was the study conducted?", "answer_src": "chlorhexidine ( chx ) is considered as a gold standard of antimicrobial rinses . various herbal oral rinses are available in the market . however , little is known of its effectiveness.the aim of this study was to evaluate the clinical changes after the usage of herbal oral rinse and 0.12% chx.in a randomized clinical trial , 76 patients with dental plaque - induced gingivitis were assigned to group i ( herbal oral rinse - hiora ) and 76 patients with dental plaque - induced gingivitis to group ii ( 0.12% chlorhexidine - peridex ) .", "follow_up_question": "What was the primary objective of the study?", "follow_up_response": "To evaluate the clinical changes after the usage of herbal oral rinse and 0.12% chx.", "follow_up_response_bt": "To evaluate clinical changes after using herbal oral rinses at 0.12% of chx"}], "turn_2": [{"question_id": "318.6", "question": "What percentage concentration of chlorhexidine was used in the study?", "answer_src": "0.12%", "follow_up_question": "How many patients were in each group?", "follow_up_response": "76", "follow_up_response_bt": "76"}, {"question_id": "318.7", "question": "What was the primary outcome measure of the clinical trial?", "answer_src": "Clinical changes", "follow_up_question": "What specific condition did the patients have before the trial?", "follow_up_response": "dental plaque - induced gingivitis", "follow_up_response_bt": "gingivitis inducta and dental plaque"}, {"question_id": "318.8", "question": "What was the percentage concentration of chlorhexidine used in group ii?", "answer_src": "0.12%", "follow_up_question": "How many patients were in each group?", "follow_up_response": "76", "follow_up_response_bt": "76"}, {"question_id": "318.9", "question": "What percentage concentration of chlorhexidine was used in group II?", "answer_src": "0.12%", "follow_up_question": "How many patients were in each group?", "follow_up_response": "76", "follow_up_response_bt": "76"}, {"question_id": "318.10", "question": "What was the primary objective of the study?", "answer_src": "To evaluate the clinical changes after the usage of herbal oral rinse and 0.12% chx.", "follow_up_question": "How many patients were in each group?", "follow_up_response": "76", "follow_up_response_bt": "76"}], "turn_3": [{"question_id": "318.11", "question": "How many patients were in each group?", "answer_src": "76", "follow_up_question": "How many patients had dental plaque-induced gingivitis in total?", "follow_up_response": "152", "follow_up_response_bt": "152"}, {"question_id": "318.12", "question": "What specific condition did the patients have before the trial?", "answer_src": "dental plaque - induced gingivitis", "follow_up_question": "What was the duration of the trial according to the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "318.13", "question": "How many patients were in each group?", "answer_src": "76", "follow_up_question": "How many patients had dental plaque-induced gingivitis in total?", "follow_up_response": "152", "follow_up_response_bt": "152"}, {"question_id": "318.14", "question": "How many patients were in each group?", "answer_src": "76", "follow_up_question": "How many patients had dental plaque-induced gingivitis in total?", "follow_up_response": "152", "follow_up_response_bt": "152"}, {"question_id": "318.15", "question": "How many patients were in each group?", "answer_src": "76", "follow_up_question": "How many patients had dental plaque-induced gingivitis in total?", "follow_up_response": "152", "follow_up_response_bt": "152"}]}}
{"id": 319, "src": "the prakriti was determined on the phenotype description of ayurvedic texts and simultaneously by the use of a computer - aided prakriti assessment tool . kappa statistical analysis was employed to validate the prakriti assessment and chi - square , cramer 's v test to determine the relatedness in the dominant prakriti to various attributes.we found 80% concordance between ayurvedic physician and software in predicting the prakriti of an individual . the kappa value of 0.77 showed moderate agreement in prakriti assessment .", "mt": "L'analisi statistica di kappa è stata utilizzata per convalidare la valutazione di prakriti e chi-square , il test di cramer v per determinare la correlazione nel prakriti dominante a vari attributi. abbiamo trovato un 80% di concordanza tra il medico ayurvedico e il software per prevedere la prakriti di un individuo . il valore di kappa di 0,77 ha mostrato un moderato accordo nella valutazione di prakriti .", "pert_mt": "L'analisi statistica di kappa è stata utilizzata per convalidare la valutazione di prakriti e chi-square, il test di cramer v per determinare la correlazione nel prakriti dominante a vari attributi. Abbiamo trovato un 80% di concordanza tra il medico ayurvedico e il software per prevedere la prakriti di un individuo. Il valore di kappa di 0,77 ha mostrato un moderato accordo nella valutazione di prakriti e nel genotipo ereditario.", "bt": "The statistical analysis of kappa was used to validate the assessment of prakriti and chi-square, the cramer v test to determine the correlation in the dominant prakriti to various attributes.We found an 80% concordance between the Ayurvedic physician and the software to predict an individual's prakriti.The value of kappa of 0.77 has shown a moderate agreement in the assessment of prakriti and in the hereditary genotype.", "questions_src": ["What is the main method used to validate the prakriti assessment?", "Who conducted the kappa statistical analysis?", "Where was the prakriti assessment tool used?", "When was the kappa value of 0.77 reported?", "Which statistical tests were used to determine the relatedness in the dominant prakriti to various attributes?"], "answers_src": ["[\"Kappa statistical analysis\", \"Ayurvedic physician and software\", \"Computer-aided prakriti assessment tool\", \"No Answer\", \"Chi-square, Cramer\"s v test\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["Statistical analysis of kappa", "Ayurvedic physician and the software", "Not specified", "Not specified", "Cramer V test"], "multiturn": {"turn_1": [{"question_id": "319.1", "question": "What is the main method used to validate the prakriti assessment?", "answer_src": "[\"Kappa statistical analysis\", \"Ayurvedic physician and software\", \"Computer-aided prakriti assessment tool\", \"No Answer\", \"Chi-square, Cramer\"s v test\"]", "follow_up_question": "What was the kappa value indicating in the prakriti assessment?", "follow_up_response": "0.77", "follow_up_response_bt": "0.77"}, {"question_id": "319.2", "question": "Who conducted the kappa statistical analysis?", "answer_src": "the prakriti was determined on the phenotype description of ayurvedic texts and simultaneously by the use of a computer - aided prakriti assessment tool . kappa statistical analysis was employed to validate the prakriti assessment and chi - square , cramer 's v test to determine the relatedness in the dominant prakriti to various attributes.we found 80% concordance between ayurvedic physician and software in predicting the prakriti of an individual . the kappa value of 0.77 showed moderate agreement in prakriti assessment .", "follow_up_question": "What was the kappa value obtained in the study?", "follow_up_response": "0.77", "follow_up_response_bt": "0.77"}, {"question_id": "319.3", "question": "Where was the prakriti assessment tool used?", "answer_src": "the prakriti was determined on the phenotype description of ayurvedic texts and simultaneously by the use of a computer - aided prakriti assessment tool . kappa statistical analysis was employed to validate the prakriti assessment and chi - square , cramer 's v test to determine the relatedness in the dominant prakriti to various attributes.we found 80% concordance between ayurvedic physician and software in predicting the prakriti of an individual . the kappa value of 0.77 showed moderate agreement in prakriti assessment .", "follow_up_question": "What was the kappa value indicating in the prakriti assessment?", "follow_up_response": "0.77", "follow_up_response_bt": "0.77"}, {"question_id": "319.4", "question": "When was the kappa value of 0.77 reported?", "answer_src": "the prakriti was determined on the phenotype description of ayurvedic texts and simultaneously by the use of a computer - aided prakriti assessment tool . kappa statistical analysis was employed to validate the prakriti assessment and chi - square , cramer 's v test to determine the relatedness in the dominant prakriti to various attributes.we found 80% concordance between ayurvedic physician and software in predicting the prakriti of an individual . the kappa value of 0.77 showed moderate agreement in prakriti assessment .", "follow_up_question": "What does the kappa value of 0.77 indicate about the agreement in prakriti assessment?", "follow_up_response": "Moderate agreement", "follow_up_response_bt": "A moderate agreement"}, {"question_id": "319.5", "question": "Which statistical tests were used to determine the relatedness in the dominant prakriti to various attributes?", "answer_src": "the prakriti was determined on the phenotype description of ayurvedic texts and simultaneously by the use of a computer - aided prakriti assessment tool . kappa statistical analysis was employed to validate the prakriti assessment and chi - square , cramer 's v test to determine the relatedness in the dominant prakriti to various attributes.we found 80% concordance between ayurvedic physician and software in predicting the prakriti of an individual . the kappa value of 0.77 showed moderate agreement in prakriti assessment .", "follow_up_question": "What was the kappa value obtained for the prakriti assessment?", "follow_up_response": "0.77", "follow_up_response_bt": "0.77"}], "turn_2": [{"question_id": "319.6", "question": "What was the kappa value indicating in the prakriti assessment?", "answer_src": "0.77", "follow_up_question": "What is the kappa value indicating in the prakriti assessment?", "follow_up_response": "Moderate agreement", "follow_up_response_bt": "0.77"}, {"question_id": "319.7", "question": "What was the kappa value obtained in the study?", "answer_src": "0.77", "follow_up_question": "What is the kappa value's interpretation based on Cohen's criteria?", "follow_up_response": "Moderate", "follow_up_response_bt": "Moderate"}, {"question_id": "319.8", "question": "What was the kappa value indicating in the prakriti assessment?", "answer_src": "0.77", "follow_up_question": "What is the kappa value indicating in the prakriti assessment?", "follow_up_response": "Moderate agreement", "follow_up_response_bt": "0.77"}, {"question_id": "319.9", "question": "What does the kappa value of 0.77 indicate about the agreement in prakriti assessment?", "answer_src": "Moderate agreement", "follow_up_question": "What is the kappa statistical analysis used for in this study?", "follow_up_response": "To validate the prakriti assessment", "follow_up_response_bt": "To validate the assessment of prakriti"}, {"question_id": "319.10", "question": "What was the kappa value obtained for the prakriti assessment?", "answer_src": "0.77", "follow_up_question": "What is the kappa value's interpretation based on Cohen's criteria?", "follow_up_response": "Moderate", "follow_up_response_bt": "Moderate"}], "turn_3": [{"question_id": "319.11", "question": "What is the kappa value indicating in the prakriti assessment?", "answer_src": "Moderate agreement", "follow_up_question": "What is the kappa value indicating in the prakriti assessment?", "follow_up_response": "Moderate agreement", "follow_up_response_bt": "0.77"}, {"question_id": "319.12", "question": "What is the kappa value's interpretation based on Cohen's criteria?", "answer_src": "Moderate", "follow_up_question": "What is the kappa value according to Cohen's criteria?", "follow_up_response": "0.77", "follow_up_response_bt": "0.77"}, {"question_id": "319.13", "question": "What is the kappa value indicating in the prakriti assessment?", "answer_src": "Moderate agreement", "follow_up_question": "What is the kappa value indicating in the prakriti assessment?", "follow_up_response": "Moderate agreement", "follow_up_response_bt": "0.77"}, {"question_id": "319.14", "question": "What is the kappa statistical analysis used for in this study?", "answer_src": "To validate the prakriti assessment", "follow_up_question": "What was the kappa value obtained in this study?", "follow_up_response": "0.77", "follow_up_response_bt": "0.77"}, {"question_id": "319.15", "question": "What is the kappa value's interpretation based on Cohen's criteria?", "answer_src": "Moderate", "follow_up_question": "What is the kappa value according to Cohen's criteria?", "follow_up_response": "0.77", "follow_up_response_bt": "0.77"}]}}
{"id": 320, "src": "the release of lysosomal enzymes induced by fixed quartz particles was a secondary phenomenon following cell death.imagesfigure 4 . afigure 4 . bfigure 4 .", "mt": "Il rilascio di enzimi lisosomali indotti da particelle fisse di quarzo è stato un fenomeno secondario dopo la morte cellulare.", "pert_mt": "Il rilascio di enzimi lisosomali indotti da particelle fisse di quarzo è stato un fenomeno secondario dopo la morte cellulare, ma non correlato a processi patologici attivi.", "bt": "The release of lysosomal enzymes induced by the particles of quarzoic solids was a secondary phenomenon after cell death, but not related to active pathological processes.", "questions_src": ["What is released by fixed quartz particles?", "When does the release occur?", "Where can you find images figure 4?", "Which phenomenon follows cell death?", "Who conducted the research shown in these figures?"], "answers_src": ["Lysosomal enzymes", "Secondary", "imagesfigure 4", "Cell death", "No Answer"], "answers_bt": ["Lysosomal enzymes", "After cell death", "No Answer", "The release of lysosomal enzymes", "No Answer"], "multiturn": {"turn_1": [{"question_id": "320.1", "question": "What is released by fixed quartz particles?", "answer_src": "Lysosomal enzymes", "follow_up_question": "What type of cell death was observed in this study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "320.2", "question": "When does the release occur?", "answer_src": "Secondary", "follow_up_question": "What triggers the secondary release?", "follow_up_response": "the release of lysosomal enzymes", "follow_up_response_bt": "The particles of quarzoic solids"}, {"question_id": "320.3", "question": "Where can you find images figure 4?", "answer_src": "imagesfigure 4", "follow_up_question": "What do figures 4a and 4b show?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "320.4", "question": "Which phenomenon follows cell death?", "answer_src": "Cell death", "follow_up_question": "What specific type of cell death is associated with this phenomenon?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "320.5", "question": "Who conducted the research shown in these figures?", "answer_src": "the release of lysosomal enzymes induced by fixed quartz particles was a secondary phenomenon following cell death.imagesfigure 4 . afigure 4 . bfigure 4 .", "follow_up_question": "What type of particles were found to induce the release of lysosomal enzymes?", "follow_up_response": "Fixed quartz particles", "follow_up_response_bt": "quarzoic solids"}], "turn_2": [{"question_id": "320.6", "question": "What type of cell death was observed in this study?", "answer_src": "the release of lysosomal enzymes induced by fixed quartz particles was a secondary phenomenon following cell death.imagesfigure 4 . afigure 4 . bfigure 4 .", "follow_up_question": "What does \"secondary phenomenon\" imply about the timing of lysosomal enzyme release?", "follow_up_response": "It implies the lysosomal enzyme release follows cell death.", "follow_up_response_bt": "It implies the lysosomal enzyme release occurs after cell death."}, {"question_id": "320.7", "question": "What triggers the secondary release?", "answer_src": "the release of lysosomal enzymes", "follow_up_question": "What does the secondary release not directly involve?", "follow_up_response": "Cell death", "follow_up_response_bt": "Active pathological processes"}, {"question_id": "320.8", "question": "What do figures 4a and 4b show?", "answer_src": "the release of lysosomal enzymes induced by fixed quartz particles was a secondary phenomenon following cell death.imagesfigure 4 . afigure 4 . bfigure 4 .", "follow_up_question": "What does \"imagesfigure 4 . afigure 4 . bfigure 4 .\" suggest about the nature of the images in figures 4a and 4b?", "follow_up_response": "The images in figures 4a and 4b suggest that the release of lysosomal enzymes induced by fixed quartz particles was a secondary phenomenon following cell death.", "follow_up_response_bt": "No Answer"}, {"question_id": "320.9", "question": "What specific type of cell death is associated with this phenomenon?", "answer_src": "the release of lysosomal enzymes induced by fixed quartz particles was a secondary phenomenon following cell death.imagesfigure 4 . afigure 4 . bfigure 4 .", "follow_up_question": "What does \"secondary phenomenon\" imply about the sequence of events?", "follow_up_response": "It implies that the release of lysosomal enzymes follows cell death.", "follow_up_response_bt": "It implies that the release of lysosomal enzymes occurs after cell death."}, {"question_id": "320.10", "question": "What type of particles were found to induce the release of lysosomal enzymes?", "answer_src": "Fixed quartz particles", "follow_up_question": "What evidence in the text supports the finding that cell death preceded the release of lysosomal enzymes?", "follow_up_response": "the release of lysosomal enzymes induced by fixed quartz particles was a secondary phenomenon following cell death", "follow_up_response_bt": "The release of lysosomal enzymes induced by the particles of quarzoic solids was a secondary phenomenon after cell death"}], "turn_3": [{"question_id": "320.11", "question": "What does \"secondary phenomenon\" imply about the timing of lysosomal enzyme release?", "answer_src": "It implies the lysosomal enzyme release follows cell death.", "follow_up_question": "How does the presence of fixed quartz particles relate to the occurrence of cell death?", "follow_up_response": "The presence of fixed quartz particles induced the release of lysosomal enzymes as a secondary phenomenon following cell death.", "follow_up_response_bt": "not related"}, {"question_id": "320.12", "question": "What does the secondary release not directly involve?", "answer_src": "Cell death", "follow_up_question": "What other cellular processes might be involved alongside cell death?", "follow_up_response": "No Answer", "follow_up_response_bt": "Active pathological"}, {"question_id": "320.13", "question": "What does \"imagesfigure 4 . afigure 4 . bfigure 4 .\" suggest about the nature of the images in figures 4a and 4b?", "answer_src": "The images in figures 4a and 4b suggest that the release of lysosomal enzymes induced by fixed quartz particles was a secondary phenomenon following cell death.", "follow_up_question": "How do figures 4a and 4b depict the relationship between cell death and the release of lysosomal enzymes?", "follow_up_response": "figures 4a and 4b depict the relationship between cell death and the release of lysosomal enzymes", "follow_up_response_bt": "No Answer"}, {"question_id": "320.14", "question": "What does \"secondary phenomenon\" imply about the sequence of events?", "answer_src": "It implies that the release of lysosomal enzymes follows cell death.", "follow_up_question": "How does the presence of fixed quartz particles relate to cell death?", "follow_up_response": "The presence of fixed quartz particles induced the release of lysosomal enzymes as a secondary phenomenon following cell death.", "follow_up_response_bt": "not related"}, {"question_id": "320.15", "question": "What evidence in the text supports the finding that cell death preceded the release of lysosomal enzymes?", "answer_src": "the release of lysosomal enzymes induced by fixed quartz particles was a secondary phenomenon following cell death", "follow_up_question": "How did the presence of fixed quartz particles lead to cell death according to the text?", "follow_up_response": "the release of lysosomal enzymes", "follow_up_response_bt": "The release of lysosomal enzymes"}]}}
{"id": 321, "src": "cases of primary neuroendocrine carcinoma ( nec ) of the breast have been reported , though rare . we report the case of a 45-year - old woman presented with jaundice and evaluated to have liver metastasis from neuroendocrine origin . she underwent whole body positron emission tomography / computed tomography , which showed left breast lesion and bone metastasis .", "mt": "Sono stati segnalati casi di carcinoma primario neuroendocrino (nec) del seno , sebbene rari . segnaliamo il caso di una donna di 45 anni presentata con ictericia e valutata per avere metastasi epatiche di origine neuroendocrina . Lei ha subito tomografia a emissione di positroni / tomografia computerizzata di tutto il corpo , che ha mostrato lesione al seno sinistro e metastasi ossea .", "pert_mt": "Sono stati segnalati casi di carcinoma primario neuroendocrino (nec) del seno, sebbene rari. Segnaliamo il caso di una donna di 45 anni presentata con icterizia e valutata per avere metastasi epatiche di origine neuroendocrina. Lei ha subito tomografia a emissione di positroni/tomografia computerizzata di tutto il corpo, che ha mostrato lesione al seno sinistro e metastasi ossee e ha presentato sintomi gastrointestinali.", "bt": "There have been reported cases of primary neuroendocrine (nec) breast cancer, although rare.We have reported the case of a 45-year-old woman presented with icterizia and evaluated for hepatic metastasis of neuroendocrine origin.She has undergone positron emission tomography/computerized tomography of the entire body, which has shown damage to the left breast and bone metastasis and has presented gastrointestinal symptoms.", "questions_src": ["What is the age of the patient in the case study?", "Where was the primary tumor located in the case study?", "When did the patient present with symptoms?", "Which type of cancer is described in the case study?", "Who underwent the whole body positron emission tomography/computed tomography scan?"], "answers_src": ["45-year-old woman", "left breast", "not specified", "primary neuroendocrine carcinoma (nec) of the breast", "the patient"], "answers_bt": ["45-year-old woman", "left breast", "not specified", "primary neuroendocrine (nec) breast cancer", "the patient"], "multiturn": {"turn_1": [{"question_id": "321.1", "question": "What is the age of the patient in the case study?", "answer_src": "45-year-old woman", "follow_up_question": "How many primary lesions were found in the patient's body according to the imaging studies?", "follow_up_response": "2", "follow_up_response_bt": "2"}, {"question_id": "321.2", "question": "Where was the primary tumor located in the case study?", "answer_src": "left breast", "follow_up_question": "What additional findings were revealed by the whole body PET/CT scan?", "follow_up_response": "left breast lesion and bone metastasis", "follow_up_response_bt": "Damage to the left breast and bone metastasis and presented gastrointestinal symptoms"}, {"question_id": "321.3", "question": "When did the patient present with symptoms?", "answer_src": "not specified", "follow_up_question": "What were the specific symptoms the patient initially presented with?", "follow_up_response": "jaundice", "follow_up_response_bt": "Icterizia"}, {"question_id": "321.4", "question": "Which type of cancer is described in the case study?", "answer_src": "primary neuroendocrine carcinoma (nec) of the breast", "follow_up_question": "What part of the body did the liver metastasis originate from?", "follow_up_response": "Neuroendocrine origin", "follow_up_response_bt": "Neuroendocrine origin"}, {"question_id": "321.5", "question": "Who underwent the whole body positron emission tomography/computed tomography scan?", "answer_src": "the patient", "follow_up_question": "What was the primary finding of the whole body positron emission tomography/computed tomography scan?", "follow_up_response": "Left breast lesion and bone metastasis", "follow_up_response_bt": "Damage to the left breast and bone metastasis"}], "turn_2": [{"question_id": "321.6", "question": "How many primary lesions were found in the patient's body according to the imaging studies?", "answer_src": "2", "follow_up_question": "How many of these lesions were located in the liver?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "321.7", "question": "What additional findings were revealed by the whole body PET/CT scan?", "answer_src": "left breast lesion and bone metastasis", "follow_up_question": "What is the significance of finding a left breast lesion on the PET/CT scan?", "follow_up_response": "No Answer", "follow_up_response_bt": "Damage to the left breast"}, {"question_id": "321.8", "question": "What were the specific symptoms the patient initially presented with?", "answer_src": "jaundice", "follow_up_question": "What additional body part did the imaging show had metastasis?", "follow_up_response": "Bone", "follow_up_response_bt": "Bone"}, {"question_id": "321.9", "question": "What part of the body did the liver metastasis originate from?", "answer_src": "Neuroendocrine origin", "follow_up_question": "What specific organ was the left breast lesion found to be a metastasis of?", "follow_up_response": "Neuroendocrine origin", "follow_up_response_bt": "neuroendocrine origin"}, {"question_id": "321.10", "question": "What was the primary finding of the whole body positron emission tomography/computed tomography scan?", "answer_src": "Left breast lesion and bone metastasis", "follow_up_question": "What is the significance of the left breast lesion found on the scan?", "follow_up_response": "No Answer", "follow_up_response_bt": "Damage to the left breast"}], "turn_3": [{"question_id": "321.11", "question": "How many of these lesions were located in the liver?", "answer_src": "cases of primary neuroendocrine carcinoma ( nec ) of the breast have been reported , though rare . we report the case of a 45-year - old woman presented with jaundice and evaluated to have liver metastasis from neuroendocrine origin . she underwent whole body positron emission tomography / computed tomography , which showed left breast lesion and bone metastasis .", "follow_up_question": "How many sites of metastasis were identified in the patient?", "follow_up_response": "3", "follow_up_response_bt": "3"}, {"question_id": "321.12", "question": "What is the significance of finding a left breast lesion on the PET/CT scan?", "answer_src": "cases of primary neuroendocrine carcinoma ( nec ) of the breast have been reported , though rare . we report the case of a 45-year - old woman presented with jaundice and evaluated to have liver metastasis from neuroendocrine origin . she underwent whole body positron emission tomography / computed tomography , which showed left breast lesion and bone metastasis .", "follow_up_question": "What additional findings were revealed by the PET/CT scan besides the left breast lesion?", "follow_up_response": "Bone metastasis", "follow_up_response_bt": "Gastrointestinal symptoms"}, {"question_id": "321.13", "question": "What additional body part did the imaging show had metastasis?", "answer_src": "Bone", "follow_up_question": "What was the initial presenting symptom of the patient?", "follow_up_response": "Jaundice", "follow_up_response_bt": "Icterizia"}, {"question_id": "321.14", "question": "What specific organ was the left breast lesion found to be a metastasis of?", "answer_src": "Neuroendocrine origin", "follow_up_question": "What additional body part did the bone metastasis originate from?", "follow_up_response": "Neuroendocrine origin", "follow_up_response_bt": "The left breast"}, {"question_id": "321.15", "question": "What is the significance of the left breast lesion found on the scan?", "answer_src": "cases of primary neuroendocrine carcinoma ( nec ) of the breast have been reported , though rare . we report the case of a 45-year - old woman presented with jaundice and evaluated to have liver metastasis from neuroendocrine origin . she underwent whole body positron emission tomography / computed tomography , which showed left breast lesion and bone metastasis .", "follow_up_question": "What does the presence of a left breast lesion suggest about the patient's condition?", "follow_up_response": "The presence of a left breast lesion suggests that the patient has primary neuroendocrine carcinoma (nec) of the breast.", "follow_up_response_bt": "Damage to the left breast"}]}}
{"id": 322, "src": "after about 4 days , each rat received an i.m . injection of estradiol valerate ( aburaihan co. , iran ) , 2 mg in 0.2 ml of corn oil , to induce pco . corn oil was injected to the rats in the control group .", "mt": "Circa 4 giorni dopo , ogni ratti ricevette un'iniezione interna di valerato di estradiolo (aburaihan co. , iran) di 2 mg in 0,2 ml di olio di mais , per indurre la pco.", "pert_mt": "Circa 4 giorni dopo, ogni ratto ricevette un'iniezione interna di valerato di estradiolo (aburaihan co., Iran) di 2 mg in 0.2 ml di olio di mais, per indurre la pco e modificare il comportamento sociale.", "bt": "About 4 days later, each rat received an internal injection of estradiol valerate (aburaihan co., Iran) of 2 mg in 0.2 ml of corn oil, to induce pco and modify social behavior.", "questions_src": ["What is the chemical name for the hormone given to the rats?", "When were the injections administered to the rats?", "Who provided the estradiol valerate used in the study?", "Where was the corn oil injected into the rats?", "Which group did not receive any hormone injections?"], "answers_src": ["estradiol valerate", "after about 4 days", "aburaihan co.", "into the muscle", "control"], "answers_bt": ["estradiol valerate", "About 4 days later", "aburaihan co.", "injected internally", "No Answer"], "multiturn": {"turn_1": [{"question_id": "322.1", "question": "What is the chemical name for the hormone given to the rats?", "answer_src": "estradiol valerate", "follow_up_question": "What company manufactures the estradiol valerate used in the experiment?", "follow_up_response": "aburaihan co. , iran", "follow_up_response_bt": "aburaihan co., Iran"}, {"question_id": "322.2", "question": "When were the injections administered to the rats?", "answer_src": "after about 4 days", "follow_up_question": "What volume of corn oil was injected with the estradiol valerate?", "follow_up_response": "0.2 ml", "follow_up_response_bt": "0.2 ml"}, {"question_id": "322.3", "question": "Who provided the estradiol valerate used in the study?", "answer_src": "aburaihan co.", "follow_up_question": "What is the concentration of estradiol valerate in the injection?", "follow_up_response": "2 mg/ml", "follow_up_response_bt": "2 mg"}, {"question_id": "322.4", "question": "Where was the corn oil injected into the rats?", "answer_src": "into the muscle", "follow_up_question": "What volume of corn oil was injected into the rats?", "follow_up_response": "0.2 ml", "follow_up_response_bt": "0.2 ml"}, {"question_id": "322.5", "question": "Which group did not receive any hormone injections?", "answer_src": "control", "follow_up_question": "What volume of corn oil was used for the hormone injections?", "follow_up_response": "0.2 ml", "follow_up_response_bt": "0.2 ml"}], "turn_2": [{"question_id": "322.6", "question": "What company manufactures the estradiol valerate used in the experiment?", "answer_src": "aburaihan co. , iran", "follow_up_question": "What is the concentration of estradiol valerate in the injection?", "follow_up_response": "2 mg/ml", "follow_up_response_bt": "2 mg"}, {"question_id": "322.7", "question": "What volume of corn oil was injected with the estradiol valerate?", "answer_src": "0.2 ml", "follow_up_question": "How many milliliters of corn oil were used in total for all the injections?", "follow_up_response": "0.2", "follow_up_response_bt": "No Answer"}, {"question_id": "322.8", "question": "What is the concentration of estradiol valerate in the injection?", "answer_src": "2 mg/ml", "follow_up_question": "What volume of corn oil was used for the estradiol valerate injection?", "follow_up_response": "0.2 ml", "follow_up_response_bt": "0.2 ml"}, {"question_id": "322.9", "question": "What volume of corn oil was injected into the rats?", "answer_src": "0.2 ml", "follow_up_question": "How many milliliters of corn oil were used in total for all the rats?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "322.10", "question": "What volume of corn oil was used for the hormone injections?", "answer_src": "0.2 ml", "follow_up_question": "How many milliliters of corn oil were injected into each rat?", "follow_up_response": "0.2", "follow_up_response_bt": "0.2"}], "turn_3": [{"question_id": "322.11", "question": "What is the concentration of estradiol valerate in the injection?", "answer_src": "2 mg/ml", "follow_up_question": "What volume of corn oil was used for the estradiol valerate injection?", "follow_up_response": "0.2 ml", "follow_up_response_bt": "0.2 ml"}, {"question_id": "322.12", "question": "How many milliliters of corn oil were used in total for all the injections?", "answer_src": "0.2", "follow_up_question": "How many milliliters of corn oil were used in each injection?", "follow_up_response": "0.2", "follow_up_response_bt": "0.2"}, {"question_id": "322.13", "question": "What volume of corn oil was used for the estradiol valerate injection?", "answer_src": "0.2 ml", "follow_up_question": "How many milliliters of corn oil were injected into each rat?", "follow_up_response": "0.2", "follow_up_response_bt": "0.2"}, {"question_id": "322.14", "question": "How many milliliters of corn oil were used in total for all the rats?", "answer_src": "after about 4 days , each rat received an i.m . injection of estradiol valerate ( aburaihan co. , iran ) , 2 mg in 0.2 ml of corn oil , to induce pco . corn oil was injected to the rats in the control group .", "follow_up_question": "How many rats received the corn oil injection according to the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "322.15", "question": "How many milliliters of corn oil were injected into each rat?", "answer_src": "0.2", "follow_up_question": "What is the total volume of the estradiol valerate injection for each rat?", "follow_up_response": "0.2", "follow_up_response_bt": "0.2"}]}}
{"id": 323, "src": "objectivemicroscopic indocyanine green ( icg ) angiography is useful for identifying the completeness of aneurysm clipping and the preservation of parent arteries and small perforators . neuroendoscopy is helpful for visualizing structures beyond the straight line of the microscopic view . we evaluated our prototype of endoscopic icg fluorescence angiography in swine , which we developed in order to combine the merits of microscopic icg angiography and endoscopy.methodsour endoscopic icg system consists of a camera , a light source , a display and software .", "mt": "L'angiografia indocyanina verde (icg) obiettivo-microscopica è utile per identificare la completezza dell'aneurisma e la conservazione delle arterie genitrici e dei piccoli perforatori . La neuroendoscopia è utile per visualizzare le strutture oltre la linea retta della vista microscopica . Abbiamo valutato il nostro prototipo di angiografia fluorescenza icg endoscopica nei suini , che abbiamo sviluppato per combinare i meriti dell' angiografia icg microscopica e dell' endoscopia.Il sistema di icg endoscopico consiste in una fotocamera , una sorgente di luce , un display e software .", "pert_mt": "L'angiografia indocyanina verde (icg) obiettivo-microscopica è utile per identificare la completezza dell'aneurisma e la conservazione delle arterie genitrici e dei piccoli perforatori. La neuroendoscopia è utile per visualizzare le strutture oltre la linea retta della vista microscopica. Abbiamo valutato il nostro prototipo di angiografia fluorescenza icg endoscopica nei suini, che abbiamo sviluppato per combinare i meriti dell' angiografia icg microscopica e dell' endoscopia. Il sistema di icg endoscopico consiste in una fotocamera, una sorgente di luce, un display, software e un algoritmo di elaborazione delle immagini.", "bt": "The objective-microscopic green indocyanine (icg) angiography is useful for identifying the completeness of the aneurysm and the preservation of genital arteries and small perforators.Neuroendoscopy is useful for visualizing structures beyond the microscopic line of sight.We evaluated our prototype of fluorescent endoscopic icg angiography in pigs, which we developed to combine the merits of microscopic and endoscopic icg angiography.The endoscopic icg system consists of a camera, a light source, a display, software and an image processing algorithm.", "questions_src": ["What is the purpose of objectivemicroscopic indocyanine green (ICG) angiography?", "Who can visualize structures beyond the straight line of the microscopic view using neuroendoscopy?", "Where was the prototype of endoscopic ICG fluorescence angiography evaluated?", "When were methods for developing the endoscopic ICG system published?", "Which two imaging techniques does the prototype system aim to combine?"], "answers_src": ["Identifying the completeness of aneurysm clipping and the preservation of parent arteries and small perforators", "Neuroendoscopy", "In swine", "No Answer", "Microscopic ICG angiography and endoscopy"], "answers_bt": ["Identifying the completeness of the aneurysm and the preservation of genital arteries and small perforators", "Neuroendoscopy", "In pigs", "No Answer", "Microscopic and endoscopic ICG angiography"], "multiturn": {"turn_1": [{"question_id": "323.1", "question": "What is the purpose of objectivemicroscopic indocyanine green (ICG) angiography?", "answer_src": "Identifying the completeness of aneurysm clipping and the preservation of parent arteries and small perforators", "follow_up_question": "What structures does neuroendoscopy help visualize besides those visible through the microscope?", "follow_up_response": "Structures beyond the straight line of the microscopic view", "follow_up_response_bt": "structures beyond the microscopic line of sight"}, {"question_id": "323.2", "question": "Who can visualize structures beyond the straight line of the microscopic view using neuroendoscopy?", "answer_src": "Neuroendoscopy", "follow_up_question": "What specific structures can neuroendoscopy help visualize beyond the microscopic view?", "follow_up_response": "Structures beyond the straight line of the microscopic view", "follow_up_response_bt": "structures beyond the microscopic line of sight"}, {"question_id": "323.3", "question": "Where was the prototype of endoscopic ICG fluorescence angiography evaluated?", "answer_src": "In swine", "follow_up_question": "What specific structures were the researchers able to visualize with their endoscopic ICG system that they couldn't see with microscopic angiography alone?", "follow_up_response": "structures beyond the straight line of the microscopic view", "follow_up_response_bt": "structures beyond the microscopic line of sight"}, {"question_id": "323.4", "question": "When were methods for developing the endoscopic ICG system published?", "answer_src": "objectivemicroscopic indocyanine green ( icg ) angiography is useful for identifying the completeness of aneurysm clipping and the preservation of parent arteries and small perforators . neuroendoscopy is helpful for visualizing structures beyond the straight line of the microscopic view . we evaluated our prototype of endoscopic icg fluorescence angiography in swine , which we developed in order to combine the merits of microscopic icg angiography and endoscopy.methodsour endoscopic icg system consists of a camera , a light source , a display and software .", "follow_up_question": "What components make up the endoscopic ICG system described in the text?", "follow_up_response": "a camera, a light source, a display and software", "follow_up_response_bt": "a camera, a light source, a display, software and an image processing algorithm"}, {"question_id": "323.5", "question": "Which two imaging techniques does the prototype system aim to combine?", "answer_src": "Microscopic ICG angiography and endoscopy", "follow_up_question": "What specific advantages does combining these techniques offer over using either method alone?", "follow_up_response": "The combination offers the advantage of identifying the completeness of aneurysm clipping and the preservation of parent arteries and small perforators through microscopic ICg angiography, while also providing visualization of structures beyond the straight line of the microscopic view through endoscopy.", "follow_up_response_bt": "The combination offers the advantage of identifying the completeness of the aneurysm and the preservation of genital arteries and small perforators through microscopic angiography, while also allowing visualization of structures beyond the microscopic line of sight with endoscopic angiography."}], "turn_2": [{"question_id": "323.6", "question": "What structures does neuroendoscopy help visualize besides those visible through the microscope?", "answer_src": "Structures beyond the straight line of the microscopic view", "follow_up_question": "What specific structures were beyond the straight line of the microscopic view that neuroendoscopy helped visualize?", "follow_up_response": "Structures beyond the straight line of the microscopic view", "follow_up_response_bt": "Structures beyond the microscopic line of sight"}, {"question_id": "323.7", "question": "What specific structures can neuroendoscopy help visualize beyond the microscopic view?", "answer_src": "Structures beyond the straight line of the microscopic view", "follow_up_question": "How does the endoscopic icg system differ from microscopic icg angiography?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "323.8", "question": "What specific structures were the researchers able to visualize with their endoscopic ICG system that they couldn't see with microscopic angiography alone?", "answer_src": "structures beyond the straight line of the microscopic view", "follow_up_question": "What types of structures did the researchers aim to visualize with their endoscopic ICG system?", "follow_up_response": "Structures beyond the straight line of the microscopic view", "follow_up_response_bt": "Structures beyond the microscopic line of sight"}, {"question_id": "323.9", "question": "What components make up the endoscopic ICG system described in the text?", "answer_src": "a camera, a light source, a display and software", "follow_up_question": "How does the endoscopic ICG system enhance the visualization compared to microscopic ICG angiography?", "follow_up_response": "It combines the merits of microscopic ICG angiography and endoscopy", "follow_up_response_bt": "Combining the merits of microscopic and endoscopic ICG angiography"}, {"question_id": "323.10", "question": "What specific advantages does combining these techniques offer over using either method alone?", "answer_src": "The combination offers the advantage of identifying the completeness of aneurysm clipping and the preservation of parent arteries and small perforators through microscopic ICg angiography, while also providing visualization of structures beyond the straight line of the microscopic view through endoscopy.", "follow_up_question": "How does the endoscopic ICg system contribute to the visualization of structures beyond the straight line of the microscopic view?", "follow_up_response": "Neuroendoscopy", "follow_up_response_bt": "Neuroendoscopy"}], "turn_3": [{"question_id": "323.11", "question": "What specific structures were beyond the straight line of the microscopic view that neuroendoscopy helped visualize?", "answer_src": "Structures beyond the straight line of the microscopic view", "follow_up_question": "Which structures did the endoscopic icg system help visualize beyond the microscopic view?", "follow_up_response": "Structures beyond the straight line of the microscopic view", "follow_up_response_bt": "Structures beyond the microscopic line of sight"}, {"question_id": "323.12", "question": "How does the endoscopic icg system differ from microscopic icg angiography?", "answer_src": "objectivemicroscopic indocyanine green ( icg ) angiography is useful for identifying the completeness of aneurysm clipping and the preservation of parent arteries and small perforators . neuroendoscopy is helpful for visualizing structures beyond the straight line of the microscopic view . we evaluated our prototype of endoscopic icg fluorescence angiography in swine , which we developed in order to combine the merits of microscopic icg angiography and endoscopy.methodsour endoscopic icg system consists of a camera , a light source , a display and software .", "follow_up_question": "What components make up the endoscopic icg system described in the text?", "follow_up_response": "a camera, a light source, a display and software", "follow_up_response_bt": "a camera, a light source, a display, software and an image processing algorithm"}, {"question_id": "323.13", "question": "What types of structures did the researchers aim to visualize with their endoscopic ICG system?", "answer_src": "Structures beyond the straight line of the microscopic view", "follow_up_question": "What specific structures were the researchers able to visualize with their endoscopic ICG system in the swine study?", "follow_up_response": "structures beyond the straight line of the microscopic view", "follow_up_response_bt": "structures beyond the microscopic line of sight"}, {"question_id": "323.14", "question": "How does the endoscopic ICG system enhance the visualization compared to microscopic ICG angiography?", "answer_src": "It combines the merits of microscopic ICG angiography and endoscopy", "follow_up_question": "What specific structures beyond the straight line of the microscopic view can neuroendoscopy visualize?", "follow_up_response": "Structures beyond the straight line of the microscopic view", "follow_up_response_bt": "Structures beyond the microscopic line of sight"}, {"question_id": "323.15", "question": "How does the endoscopic ICg system contribute to the visualization of structures beyond the straight line of the microscopic view?", "answer_src": "Neuroendoscopy", "follow_up_question": "What specific structures beyond the microscopic view were successfully visualized with the endoscopic ICg system in the swine study?", "follow_up_response": "structures beyond the straight line of the microscopic view", "follow_up_response_bt": "structures beyond the microscopic line of sight"}]}}
{"id": 324, "src": "the subjects underwent behavioral observation for 6 months , and the postoperative eabr was tested every two weeks from the 1st month after implant surgery.the implant surgery lasted an average of 5.2 h , and no monkey died or sacrificed . the averaged latencies of peaks i , ii and iv were 1.27 , 2.34 and 3.98 ms , respectively in the abr . one - peak eabr wave was elicited in the operation , and one- or two - peak waves were elicited during the postoperative period .", "mt": "I soggetti sono stati sottoposti ad osservazioni comportamentali per 6 mesi e l'eabr postoperativo è stato testato ogni due settimane dal primo mese dopo l'intervento chirurgico degli impianti.L'intervento chirurgico degli impianti ha durato in media 5.2 ore e nessuna scimmia è morta o sacrificata . Le latenze medie dei picchi i , ii e iv sono state di 1,27 , 2,34 e 3,98 ms , rispettivamente nell'onda eabr postoperatoria è stata sollevata nell'operazione e nell'intero periodo postoperatorio sono state sollevate onde di picco uno o due .", "pert_mt": "I soggetti sono stati sottoposti ad osservazioni comportamentali per 6 mesi e l'eabr postoperativo è stato testato ogni due settimane dal primo mese dopo l'intervento chirurgico degli impianti. L'intervento chirurgico degli impianti ha durato in media 5.2 ore e nessuna scimmia è morta o sacrificata. Le latenze medie dei picchi i, ii e iv sono state di 1,27, 2,34 e 3,98 ms, rispettivamente. Nell'onda eabr postoperatoria è stata sollevata una reazione immunitaria, e nell'intero periodo postoperatorio sono state sollevate onde di picco uno o due.", "bt": "The subjects were subjected to behavioral observations for 6 months and the postoperative eabr was tested every two weeks from the first month after the implant surgery.The implant surgery lasted an average of 5.2 hours and no monkeys were killed or sacrificed.The average latency of the picchi i, ii and iv was 1.27, 2.34 and 3.98 ms, respectively.In the postoperative eabr wave an immune response was raised, and throughout the postoperative period they were raised where one or two picchies were.", "questions_src": ["What was the average duration of the implant surgery?", "Who elicited the one-peak EABR wave during the operation?", "Where was the behavioral observation conducted for the subjects?", "When were the postoperative eABR tests performed every two weeks?", "Which latency values were recorded for peaks I, II, and IV in the ABR?"], "answers_src": ["5.2 h", "One-peak EABR wave", "Subjects", "From the 1st month after implant surgery", "1.27, 2.34 and 3.98 ms"], "answers_bt": ["5.2 hours", "The picchi", "Subjects", "From the first month after the implant surgery", "1.27, 2.34 and 3.98 ms"], "multiturn": {"turn_1": [{"question_id": "324.1", "question": "What was the average duration of the implant surgery?", "answer_src": "5.2 h", "follow_up_question": "What was the latency of peak I in milliseconds?", "follow_up_response": "1.27", "follow_up_response_bt": "1.27"}, {"question_id": "324.2", "question": "Who elicited the one-peak EABR wave during the operation?", "answer_src": "One-peak EABR wave", "follow_up_question": "What was the latency of peak I in milliseconds?", "follow_up_response": "1.27", "follow_up_response_bt": "1.27"}, {"question_id": "324.3", "question": "Where was the behavioral observation conducted for the subjects?", "answer_src": "Subjects", "follow_up_question": "What was the duration of the behavioral observation?", "follow_up_response": "6 months", "follow_up_response_bt": "6 months"}, {"question_id": "324.4", "question": "When were the postoperative eABR tests performed every two weeks?", "answer_src": "From the 1st month after implant surgery", "follow_up_question": "What was the average latency of peak I in the ABR?", "follow_up_response": "1.27 ms", "follow_up_response_bt": "1.27 ms"}, {"question_id": "324.5", "question": "Which latency values were recorded for peaks I, II, and IV in the ABR?", "answer_src": "1.27, 2.34 and 3.98 ms", "follow_up_question": "What was the duration of the implant surgery?", "follow_up_response": "5.2 h", "follow_up_response_bt": "5.2 hours"}], "turn_2": [{"question_id": "324.6", "question": "What was the latency of peak I in milliseconds?", "answer_src": "1.27", "follow_up_question": "What was the latency of peak IV in milliseconds?", "follow_up_response": "3.98", "follow_up_response_bt": "3.98 ms"}, {"question_id": "324.7", "question": "What was the latency of peak I in milliseconds?", "answer_src": "1.27", "follow_up_question": "What was the latency of peak IV in milliseconds?", "follow_up_response": "3.98", "follow_up_response_bt": "3.98 ms"}, {"question_id": "324.8", "question": "What was the duration of the behavioral observation?", "answer_src": "6 months", "follow_up_question": "What was the average latency of peak I in the ABR?", "follow_up_response": "1.27 ms", "follow_up_response_bt": "1.27 ms"}, {"question_id": "324.9", "question": "What was the average latency of peak I in the ABR?", "answer_src": "1.27 ms", "follow_up_question": "What was the average latency of peak IV in the ABR?", "follow_up_response": "3.98 ms", "follow_up_response_bt": "3.98 ms"}, {"question_id": "324.10", "question": "What was the duration of the implant surgery?", "answer_src": "5.2 h", "follow_up_question": "What was the average latency of peak I in the ABR?", "follow_up_response": "1.27 ms", "follow_up_response_bt": "1.27 ms"}], "turn_3": [{"question_id": "324.11", "question": "What was the latency of peak IV in milliseconds?", "answer_src": "3.98", "follow_up_question": "What was the total duration of the behavioral observation?", "follow_up_response": "6 months", "follow_up_response_bt": "6 months"}, {"question_id": "324.12", "question": "What was the latency of peak IV in milliseconds?", "answer_src": "3.98", "follow_up_question": "What was the total duration of the behavioral observation?", "follow_up_response": "6 months", "follow_up_response_bt": "6 months"}, {"question_id": "324.13", "question": "What was the average latency of peak I in the ABR?", "answer_src": "1.27 ms", "follow_up_question": "What was the average latency of peak IV in the ABR?", "follow_up_response": "3.98 ms", "follow_up_response_bt": "3.98 ms"}, {"question_id": "324.14", "question": "What was the average latency of peak IV in the ABR?", "answer_src": "3.98 ms", "follow_up_question": "What was the duration of the implant surgery?", "follow_up_response": "5.2 h", "follow_up_response_bt": "5.2 hours"}, {"question_id": "324.15", "question": "What was the average latency of peak I in the ABR?", "answer_src": "1.27 ms", "follow_up_question": "What was the average latency of peak IV in the ABR?", "follow_up_response": "3.98 ms", "follow_up_response_bt": "3.98 ms"}]}}
{"id": 325, "src": "these imaging findings and family history suggested that the patient suffered from multiple gastric carcinomas associated with potter type iii cystic disease of the liver , mesenterium and kidney . reports on the association of malignant neoplasm with potter type iii cystic disease are extremely rare . especially , no case of the association of gastric carcinoma with potter type iii cystic disease of the liver and kidney has been described previously .", "mt": "Questi risultati di imaging e la storia familiare suggeriscono che il paziente soffriva di carcinomi gastrici multipli associati alla malattia cistica del fegato, del mesenterio e dei reni di tipo potter iii . Le segnalazioni sull'associazione di neoplasmi maligni con la malattia cistica di tipo potter iii sono estremamente rare . in particolare , nessun caso di associazione di carcinoma gastrico con la malattia cistica del fegato e dei reni di tipo potter iii è stato descritto in precedenza .", "pert_mt": "Questi risultati di imaging e la storia familiare suggeriscono che il paziente soffriva di carcinomi gastrici multipli associati alla malattia cistica del fegato, del mesenterio e dei reni di tipo potter III. Le segnalazioni sull'associazione di neoplasmi maligni con la malattia cistica di tipo potter III sono estremamente rare. In particolare, nessun caso di associazione di carcinoma gastrico con la malattia cistica del fegato e dei reni di tipo potter III è stato descritto in precedenza. Tuttavia, questi tumori mostrano una forte correlazione con alterazioni genetiche specifiche.", "bt": "These imaging results and family history suggest that the patient suffered from multiple gastric carcinomas associated with cystic disease of the liver, mesentery and kidneys type potter III. Reports of the association of malignant neoplasms with cystic disease type potter III are extremely rare. In particular, no case of association of gastric carcinoma with cystic disease of the liver and kidneys type potter III has been described before.", "questions_src": ["What type of disease was mentioned to be associated with the patient's condition?", "Who is described in the report as having a rare association with malignant neoplasm?", "Where were cystic diseases found in the patient besides the liver?", "When might the association between cancer and cystic disease be considered rare?", "Which organ is specifically mentioned to have the Potter Type III cystic disease?"], "answers_src": ["Potter type III cystic disease", "No Answer", "Mesenterium and kidney", "Extremely rare", "Liver"], "answers_bt": ["[\"Cystic disease of the liver, mesentery and kidneys type potter III\"], [\"The report\"], [\"kidneys\"], [\"extremely rare\"], [\"gastric\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "325.1", "question": "What type of disease was mentioned to be associated with the patient's condition?", "answer_src": "Potter type III cystic disease", "follow_up_question": "What specific organs were affected by the Potter type III cystic disease?", "follow_up_response": "the liver, mesenterium and kidney", "follow_up_response_bt": "Liver, mesentery and kidneys"}, {"question_id": "325.2", "question": "Who is described in the report as having a rare association with malignant neoplasm?", "answer_src": "these imaging findings and family history suggested that the patient suffered from multiple gastric carcinomas associated with potter type iii cystic disease of the liver , mesenterium and kidney . reports on the association of malignant neoplasm with potter type iii cystic disease are extremely rare . especially , no case of the association of gastric carcinoma with potter type iii cystic disease of the liver and kidney has been described previously .", "follow_up_question": "What specific type of neoplasm is mentioned in the report?", "follow_up_response": "malignant neoplasm", "follow_up_response_bt": "malignant neoplasms"}, {"question_id": "325.3", "question": "Where were cystic diseases found in the patient besides the liver?", "answer_src": "Mesenterium and kidney", "follow_up_question": "What other organ was affected by gastric carcinoma in this case?", "follow_up_response": "Liver and kidney", "follow_up_response_bt": "Liver and kidneys"}, {"question_id": "325.4", "question": "When might the association between cancer and cystic disease be considered rare?", "answer_src": "Extremely rare", "follow_up_question": "What specific cancers are most commonly associated with Potter Type III cystic disease according to the text?", "follow_up_response": "gastric carcinomas", "follow_up_response_bt": "gastric carcinomas"}, {"question_id": "325.5", "question": "Which organ is specifically mentioned to have the Potter Type III cystic disease?", "answer_src": "Liver", "follow_up_question": "Which other organs besides the liver are affected by the Potter Type III cystic disease according to the text?", "follow_up_response": "mesenterium and kidney", "follow_up_response_bt": "mesentery and kidneys"}], "turn_2": [{"question_id": "325.6", "question": "What specific organs were affected by the Potter type III cystic disease?", "answer_src": "the liver, mesenterium and kidney", "follow_up_question": "What other significant condition was found in the patient besides the Potter type III cystic disease?", "follow_up_response": "Potter type III cystic disease of the liver, mesenterium and kidney", "follow_up_response_bt": "Cystic disease of the liver, mesentery and kidneys"}, {"question_id": "325.7", "question": "What specific type of neoplasm is mentioned in the report?", "answer_src": "malignant neoplasm", "follow_up_question": "What other organs besides the liver and kidney are affected by the potter type iii cystic disease in this case?", "follow_up_response": "mesenterium", "follow_up_response_bt": "mesentery"}, {"question_id": "325.8", "question": "What other organ was affected by gastric carcinoma in this case?", "answer_src": "Liver and kidney", "follow_up_question": "What specific type of cystic disease of the liver and kidney was present in this case?", "follow_up_response": "Potter type III", "follow_up_response_bt": "type potter III"}, {"question_id": "325.9", "question": "What specific cancers are most commonly associated with Potter Type III cystic disease according to the text?", "answer_src": "gastric carcinomas", "follow_up_question": "What other organs besides the liver and kidney are affected by Potter Type III cystic disease in patients with gastric carcinomas?", "follow_up_response": "Mesenterium", "follow_up_response_bt": "Mesentery"}, {"question_id": "325.10", "question": "Which other organs besides the liver are affected by the Potter Type III cystic disease according to the text?", "answer_src": "mesenterium and kidney", "follow_up_question": "What specific type of cancer is the patient diagnosed with based on the imaging findings?", "follow_up_response": "gastric carcinomas", "follow_up_response_bt": "gastric carcinomas"}], "turn_3": [{"question_id": "325.11", "question": "What other significant condition was found in the patient besides the Potter type III cystic disease?", "answer_src": "Potter type III cystic disease of the liver, mesenterium and kidney", "follow_up_question": "What specific type of cancer was identified in the patient's stomach?", "follow_up_response": "gastric carcinomas", "follow_up_response_bt": "gastric carcinomas"}, {"question_id": "325.12", "question": "What other organs besides the liver and kidney are affected by the potter type iii cystic disease in this case?", "answer_src": "mesenterium", "follow_up_question": "What specific condition is associated with the potter type iii cystic disease mentioned in this case?", "follow_up_response": "Multiple gastric carcinomas", "follow_up_response_bt": "Multiple gastric carcinomas"}, {"question_id": "325.13", "question": "What specific type of cystic disease of the liver and kidney was present in this case?", "answer_src": "Potter type III", "follow_up_question": "What other organs were affected by the Potter type III cystic disease besides the liver?", "follow_up_response": "Mesenterium and kidney", "follow_up_response_bt": "Mesentery and kidneys"}, {"question_id": "325.14", "question": "What other organs besides the liver and kidney are affected by Potter Type III cystic disease in patients with gastric carcinomas?", "answer_src": "Mesenterium", "follow_up_question": "What is the rarity of reports on the association of malignant neoplasms with Potter Type III cystic disease?", "follow_up_response": "Reports on the association of malignant neoplasms with Potter Type III cystic disease are extremely rare.", "follow_up_response_bt": "Reports of the association of malignant neoplasms with Potter Type III cystic disease are extremely rare."}, {"question_id": "325.15", "question": "What specific type of cancer is the patient diagnosed with based on the imaging findings?", "answer_src": "gastric carcinomas", "follow_up_question": "What other organs besides the liver and kidney are affected by the potter type iii cystic disease in this case?", "follow_up_response": "mesenterium", "follow_up_response_bt": "mesentery"}]}}
{"id": 326, "src": "data were analyzed using repeated - measures analysis of variance and t - tests . adverse events and ophthalmic , physiologic , and laboratory parameters were measured throughout the study as safety endpoints . a total of 126 patients ( mean sd age , 6312 years ) were enrolled , and 125 received brinz / tim - fc.resultsmean intraocular pressure was significantly reduced from baseline at weeks 4 through 52 , with changes ranging from 4.1 mmhg to 5.7 mmhg ( p<0.0001 , all time points ) .", "mt": "Sono stati analizzati utilizzando analisi ripetuta di variazioni e test t . Gli eventi avversi e i parametri oftalmologici , fisiologici e di laboratorio sono stati misurati durante tutto lo studio come punti di sicurezza . Sono stati arruolati un totale di 126 pazienti (età media sd , 6312 anni) e 125 hanno ricevuto brinz / tim - fc.resultsmean pressione intraoculare è stata significativamente ridotta dal valore di riferimento alle settimane 4-52, con variazioni che vanno da 4.1 mmhg a 5.7 mmhg (p<0.0001 , tutti i punti temporali).", "pert_mt": "Sono stati analizzati utilizzando analisi ripetuta di variazioni e test t. Gli eventi avversi e i parametri oftalmologici, fisiologici e di laboratorio sono stati misurati durante tutto lo studio come punti di sicurezza. Sono stati arruolati un totale di 126 pazienti (età media sd, 6312 anni) e 125 hanno ricevuto brinz/tim-fc. La pressione intraoculare è stata significativamente ridotta dal valore di riferimento alle settimane 4-52, con variazioni che vanno da 4.1 mmHg a 5.7 mmHg (p<0.0001, tutti i punti temporali).", "bt": "Reverse events and ophthalmological, physiological and laboratory parameters were measured throughout the study as safety points.A total of 126 patients (median age sd, 6312 years) and 125 patients were enrolled who received brinz/tim-fc. The intraocular pressure was significantly reduced from the reference value at weeks 4-52, with variations ranging from 4.1 mmHg to 5.7 mmHg (p<0.0001, all time points).", "questions_src": ["What is the primary statistical method used to analyze the data?", "Who were the participants in the study?", "What are the three types of parameters measured for safety endpoints?", "What is the mean age of the enrolled patients?", "When did the mean intraocular pressure start showing significant reduction?"], "answers_src": ["Repeated-measures analysis of variance and t-tests", "126 patients", "ophthalmic, physiologic, and laboratory", "6312 years", "Weeks 4"], "answers_bt": ["No Answer", "126 patients (median age 63 ± 12 years) and 125 patients", "ophthalmological, physiological and laboratory", "63 ± 12", "Weeks 4-52"], "multiturn": {"turn_1": [{"question_id": "326.1", "question": "What is the primary statistical method used to analyze the data?", "answer_src": "Repeated-measures analysis of variance and t-tests", "follow_up_question": "How many weeks did the significant reduction in mean intraocular pressure occur?", "follow_up_response": "4 through 52", "follow_up_response_bt": "52"}, {"question_id": "326.2", "question": "Who were the participants in the study?", "answer_src": "126 patients", "follow_up_question": "What was the average change in intraocular pressure from baseline?", "follow_up_response": "4.1 mmhg to 5.7 mmhg", "follow_up_response_bt": "4.4 mmHg"}, {"question_id": "326.3", "question": "What are the three types of parameters measured for safety endpoints?", "answer_src": "ophthalmic, physiologic, and laboratory", "follow_up_question": "How many patients were enrolled in the study?", "follow_up_response": "126", "follow_up_response_bt": "251"}, {"question_id": "326.4", "question": "What is the mean age of the enrolled patients?", "answer_src": "6312 years", "follow_up_question": "What was the average change in intraocular pressure from baseline at the end of the study (week 52)?", "follow_up_response": "5.7 mmhg", "follow_up_response_bt": "5.7 mmHg"}, {"question_id": "326.5", "question": "When did the mean intraocular pressure start showing significant reduction?", "answer_src": "Weeks 4", "follow_up_question": "How many weeks after baseline did the mean intraocular pressure show a reduction of at least 5 mmHg?", "follow_up_response": "52", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "326.6", "question": "How many weeks did the significant reduction in mean intraocular pressure occur?", "answer_src": "4 through 52", "follow_up_question": "For how many weeks was the mean intraocular pressure significantly reduced?", "follow_up_response": "52", "follow_up_response_bt": "52"}, {"question_id": "326.7", "question": "What was the average change in intraocular pressure from baseline?", "answer_src": "4.1 mmhg to 5.7 mmhg", "follow_up_question": "What was the significance level (p-value) for the changes in intraocular pressure?", "follow_up_response": "p<0.0001", "follow_up_response_bt": "p<0.0001"}, {"question_id": "326.8", "question": "How many patients were enrolled in the study?", "answer_src": "126", "follow_up_question": "What was the range of change in mean intraocular pressure from baseline?", "follow_up_response": "4.1 mmhg to 5.7 mmhg", "follow_up_response_bt": "4.1 mmHg to 5.7 mmHg"}, {"question_id": "326.9", "question": "What was the average change in intraocular pressure from baseline at the end of the study (week 52)?", "answer_src": "5.7 mmhg", "follow_up_question": "What was the maximum change in intraocular pressure observed from baseline at any point during the study?", "follow_up_response": "5.7 mmhg", "follow_up_response_bt": "5.7 mmHg"}, {"question_id": "326.10", "question": "How many weeks after baseline did the mean intraocular pressure show a reduction of at least 5 mmHg?", "answer_src": "52", "follow_up_question": "How many patients had at least one adverse event reported during the study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "326.11", "question": "For how many weeks was the mean intraocular pressure significantly reduced?", "answer_src": "52", "follow_up_question": "By how many millimeters of mercury did the mean intraocular pressure change from baseline?", "follow_up_response": "4.1 mmhg to 5.7 mmhg", "follow_up_response_bt": "4.1, 5.7"}, {"question_id": "326.12", "question": "What was the significance level (p-value) for the changes in intraocular pressure?", "answer_src": "p<0.0001", "follow_up_question": "What was the range of change in intraocular pressure from baseline?", "follow_up_response": "4.1 mmhg to 5.7 mmhg", "follow_up_response_bt": "4.1 mmHg to 5.7 mmHg"}, {"question_id": "326.13", "question": "What was the range of change in mean intraocular pressure from baseline?", "answer_src": "4.1 mmhg to 5.7 mmhg", "follow_up_question": "At which time points was the mean intraocular pressure significantly reduced from baseline?", "follow_up_response": "weeks 4 through 52", "follow_up_response_bt": "weeks 4-52"}, {"question_id": "326.14", "question": "What was the maximum change in intraocular pressure observed from baseline at any point during the study?", "answer_src": "5.7 mmhg", "follow_up_question": "What was the minimum change in intraocular pressure observed from baseline at any point during the study?", "follow_up_response": "4.1 mmhg", "follow_up_response_bt": "4.1 mmHg"}, {"question_id": "326.15", "question": "How many patients had at least one adverse event reported during the study?", "answer_src": "data were analyzed using repeated - measures analysis of variance and t - tests . adverse events and ophthalmic , physiologic , and laboratory parameters were measured throughout the study as safety endpoints . a total of 126 patients ( mean sd age , 6312 years ) were enrolled , and 125 received brinz / tim - fc.resultsmean intraocular pressure was significantly reduced from baseline at weeks 4 through 52 , with changes ranging from 4.1 mmhg to 5.7 mmhg ( p<0.0001 , all time points ) .", "follow_up_question": "What was the range of changes in intraocular pressure from baseline?", "follow_up_response": "4.1 mmhg to 5.7 mmhg", "follow_up_response_bt": "4.1 mmHg to 5.7 mmHg"}]}}
{"id": 327, "src": "it is shown experimentally , for the first time , that the al - soc - mof platform can address the challenging department of energy dual target of 0.5 g / g ( gravimetric ) and 264 cm3 ( stp)/cm3 ( volumetric ) methane storage . furthermore , al - soc - mof exhibited the highest total gravimetric and volumetric uptake for carbon dioxide and the utmost total and deliverable uptake for oxygen at relatively high pressures among all microporous mofs . in order to correlate the mof pore structure and functionality to the gas storage properties , to better understand the structure property relationship , we performed a molecular simulation study and evaluated the methane storage performance of the al - soc - mof platform using diverse organic linkers .", "mt": "È dimostrato sperimentalmente , per la prima volta , che la piattaforma al-soc-mof può affrontare il difficile settore di energia doppio obiettivo di 0,5 g / g (gravimetrico) e 264 cm3 (stp) / cm3 (volumetrico) stoccaggio del metano . Inoltre , al-soc-mof ha mostrato il più alto totale gravimetrico e volumetrico assorbimento per anidride carbonica e il massimo totale e consegnabile assorbimento per ossigeno a pressioni relativamente elevate tra tutti i mof microporous . Per correlare la struttura e la funzionalità del porus mof alle proprietà di stoccaggio del gas , per comprendere meglio la relazione strutturale , abbiamo eseguito uno studio di simulazione molecolare e valutato la performance dello stoccaggio del metano della piattaforma al-soc-mof utilizzando diversi collegatori organici .", "pert_mt": "È dimostrato sperimentalmente, per la prima volta, che la piattaforma al-soc-mof può affrontare il difficile settore di energia doppio obiettivo di 0,5 g/g (gravimetrico) e 264 cm³ (stp) / cm³ (volumetrico) stoccaggio del metano. Inoltre, al-soc-mof ha mostrato il più alto totale gravimetrico e volumetrico assorbimento per anidride carbonica e il massimo totale e consegnabile assorbimento per ossigeno a pressioni relativamente elevate tra tutti i mof microporous. Per correlare la struttura e la funzionalità del porus mof alle proprietà di stoccaggio del gas, per comprendere meglio la relazione strutturale, abbiamo eseguito uno studio di simulazione molecolare e val", "bt": "It has been demonstrated experimentally, for the first time, that the al-soc-mof platform can cope with the difficult dual energy sector of 0.5 g/g (gravimetric) and 264 cm3 (stp) /cm3 (volume) methane storage.Also, al-soc-mof has shown the highest total gravimetric and volumetric absorption per carbon dioxide and the highest total and maximum oxygen delivery absorption per oxygen at relatively high pressures across all microporous moferous moons.To simulate the structure and functionality of the mous moferous pores to all gas storage properties, to better understand the structural relationship, we have run a dictionary and val correctional study.", "questions_src": ["What is the first time experimentally shown that the al-soc-mof platform can achieve 0.5 g/g gravimetric and 264 cm³ (STP)/cm³ volumetric methane storage?", "Who exhibited the highest total gravimetric and volumetric uptake for carbon dioxide and the utmost total and deliverable uptake for oxygen among all microporous MOFs?", "Where was the molecular simulation study conducted to correlate the MOF pore structure and functionality to the gas storage properties?", "When was it demonstrated experimentally that the al-soc-mof platform could address the DOE dual target of 0.5 g/g gravimetric and 264 cm³ (STP)/cm³ volumetric methane storage?", "Which organic linkers were used to evaluate the methane storage performance of the al-soc-mof platform in the molecular simulation study?"], "answers_src": ["the al-soc-mof platform", "al-soc-mof", "not specified", "for the first time", "diverse"], "answers_bt": ["The al-soc-mof platform", "Al-soc-mof", "All gas storage properties", "It has been demonstrated experimentally", "No Answer"], "multiturn": {"turn_1": [{"question_id": "327.1", "question": "What is the first time experimentally shown that the al-soc-mof platform can achieve 0.5 g/g gravimetric and 264 cm³ (STP)/cm³ volumetric methane storage?", "answer_src": "the al-soc-mof platform", "follow_up_question": "What specific pressure range was used in the molecular simulation study to evaluate the methane storage performance of the al-soc-mof platform?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "327.2", "question": "Who exhibited the highest total gravimetric and volumetric uptake for carbon dioxide and the utmost total and deliverable uptake for oxygen among all microporous MOFs?", "answer_src": "al-soc-mof", "follow_up_question": "What was the pressure range used in the molecular simulation study to evaluate the methane storage performance of the al-soc-mof platform?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "327.3", "question": "Where was the molecular simulation study conducted to correlate the MOF pore structure and functionality to the gas storage properties?", "answer_src": "not specified", "follow_up_question": "What specific organic linkers were used in the molecular simulation study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "327.4", "question": "When was it demonstrated experimentally that the al-soc-mof platform could address the DOE dual target of 0.5 g/g gravimetric and 264 cm³ (STP)/cm³ volumetric methane storage?", "answer_src": "for the first time", "follow_up_question": "What specific organic linkers were used in the molecular simulation study to evaluate the methane storage performance of the al-soc-mof platform?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "327.5", "question": "Which organic linkers were used to evaluate the methane storage performance of the al-soc-mof platform in the molecular simulation study?", "answer_src": "diverse", "follow_up_question": "What was the range of pressures tested in the molecular simulation study?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "327.6", "question": "What specific pressure range was used in the molecular simulation study to evaluate the methane storage performance of the al-soc-mof platform?", "answer_src": "it is shown experimentally , for the first time , that the al - soc - mof platform can address the challenging department of energy dual target of 0.5 g / g ( gravimetric ) and 264 cm3 ( stp)/cm3 ( volumetric ) methane storage . furthermore , al - soc - mof exhibited the highest total gravimetric and volumetric uptake for carbon dioxide and the utmost total and deliverable uptake for oxygen at relatively high pressures among all microporous mofs . in order to correlate the mof pore structure and functionality to the gas storage properties , to better understand the structure property relationship , we performed a molecular simulation study and evaluated the methane storage performance of the al - soc - mof platform using diverse organic linkers .", "follow_up_question": "What were the specific gas storage properties evaluated by the molecular simulation study?", "follow_up_response": "Methane storage", "follow_up_response_bt": "Gravimetric and volumetric absorption"}, {"question_id": "327.7", "question": "What was the pressure range used in the molecular simulation study to evaluate the methane storage performance of the al-soc-mof platform?", "answer_src": "it is shown experimentally , for the first time , that the al - soc - mof platform can address the challenging department of energy dual target of 0.5 g / g ( gravimetric ) and 264 cm3 ( stp)/cm3 ( volumetric ) methane storage . furthermore , al - soc - mof exhibited the highest total gravimetric and volumetric uptake for carbon dioxide and the utmost total and deliverable uptake for oxygen at relatively high pressures among all microporous mofs . in order to correlate the mof pore structure and functionality to the gas storage properties , to better understand the structure property relationship , we performed a molecular simulation study and evaluated the methane storage performance of the al - soc - mof platform using diverse organic linkers .", "follow_up_question": "What were the specific gas storage properties evaluated by the molecular simulation study?", "follow_up_response": "Methane storage", "follow_up_response_bt": "Gravimetric and volumetric absorption"}, {"question_id": "327.8", "question": "What specific organic linkers were used in the molecular simulation study?", "answer_src": "it is shown experimentally , for the first time , that the al - soc - mof platform can address the challenging department of energy dual target of 0.5 g / g ( gravimetric ) and 264 cm3 ( stp)/cm3 ( volumetric ) methane storage . furthermore , al - soc - mof exhibited the highest total gravimetric and volumetric uptake for carbon dioxide and the utmost total and deliverable uptake for oxygen at relatively high pressures among all microporous mofs . in order to correlate the mof pore structure and functionality to the gas storage properties , to better understand the structure property relationship , we performed a molecular simulation study and evaluated the methane storage performance of the al - soc - mof platform using diverse organic linkers .", "follow_up_question": "What was the highest total gravimetric and volumetric uptake achieved by al - soc - mof for any gas?", "follow_up_response": "Carbon dioxide", "follow_up_response_bt": "Total gravimetric and volumetric absorption"}, {"question_id": "327.9", "question": "What specific organic linkers were used in the molecular simulation study to evaluate the methane storage performance of the al-soc-mof platform?", "answer_src": "it is shown experimentally , for the first time , that the al - soc - mof platform can address the challenging department of energy dual target of 0.5 g / g ( gravimetric ) and 264 cm3 ( stp)/cm3 ( volumetric ) methane storage . furthermore , al - soc - mof exhibited the highest total gravimetric and volumetric uptake for carbon dioxide and the utmost total and deliverable uptake for oxygen at relatively high pressures among all microporous mofs . in order to correlate the mof pore structure and functionality to the gas storage properties , to better understand the structure property relationship , we performed a molecular simulation study and evaluated the methane storage performance of the al - soc - mof platform using diverse organic linkers .", "follow_up_question": "What was the highest total gravimetric and volumetric uptake achieved by al-soc-mof for any gas among those tested?", "follow_up_response": "Carbon dioxide", "follow_up_response_bt": "carbon dioxide"}, {"question_id": "327.10", "question": "What was the range of pressures tested in the molecular simulation study?", "answer_src": "it is shown experimentally , for the first time , that the al - soc - mof platform can address the challenging department of energy dual target of 0.5 g / g ( gravimetric ) and 264 cm3 ( stp)/cm3 ( volumetric ) methane storage . furthermore , al - soc - mof exhibited the highest total gravimetric and volumetric uptake for carbon dioxide and the utmost total and deliverable uptake for oxygen at relatively high pressures among all microporous mofs . in order to correlate the mof pore structure and functionality to the gas storage properties , to better understand the structure property relationship , we performed a molecular simulation study and evaluated the methane storage performance of the al - soc - mof platform using diverse organic linkers .", "follow_up_question": "At what pressure did al-soc-mof exhibit the highest total gravimetric and volumetric uptake for methane?", "follow_up_response": "relatively high pressures", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "327.11", "question": "What were the specific gas storage properties evaluated by the molecular simulation study?", "answer_src": "Methane storage", "follow_up_question": "What other gases had their storage performance evaluated in the molecular simulation study?", "follow_up_response": "Carbon dioxide and oxygen", "follow_up_response_bt": "No Answer"}, {"question_id": "327.12", "question": "What were the specific gas storage properties evaluated by the molecular simulation study?", "answer_src": "Methane storage", "follow_up_question": "What other gases had their storage performance evaluated in the molecular simulation study?", "follow_up_response": "Carbon dioxide and oxygen", "follow_up_response_bt": "No Answer"}, {"question_id": "327.13", "question": "What was the highest total gravimetric and volumetric uptake achieved by al - soc - mof for any gas?", "answer_src": "Carbon dioxide", "follow_up_question": "What was the highest total and deliverable uptake for oxygen achieved by al - soc - mof at relatively high pressures?", "follow_up_response": "the utmost total and deliverable uptake", "follow_up_response_bt": "The highest total and maximum oxygen delivery absorption"}, {"question_id": "327.14", "question": "What was the highest total gravimetric and volumetric uptake achieved by al-soc-mof for any gas among those tested?", "answer_src": "Carbon dioxide", "follow_up_question": "What was the highest total and deliverable uptake for oxygen achieved by al-soc-mof at relatively high pressures?", "follow_up_response": "the utmost total and deliverable uptake", "follow_up_response_bt": "The highest total and maximum oxygen delivery absorption"}, {"question_id": "327.15", "question": "At what pressure did al-soc-mof exhibit the highest total gravimetric and volumetric uptake for methane?", "answer_src": "relatively high pressures", "follow_up_question": "What was the highest total gravimetric and volumetric uptake for methane reported by the al-soc-mof at relatively high pressures?", "follow_up_response": "the utmost total and deliverable uptake", "follow_up_response_bt": "the highest total gravimetric and volumetric absorption per carbon dioxide"}]}}
{"id": 328, "src": "fifty - six eligible studies were included . increasing trends in the prevalence , treatment , and control of diabetes in mainland china from 1979 to 2012 were observed . the pooled prevalence , awareness , treatment , and control of diabetes mellitus were 6.41% , 45.81% , 42.54% , and 20.87% , respectively .", "mt": "Sono stati inclusi 56 studi ammissibili . Si sono osservati tendenze crescenti nella prevalenza , nel trattamento e nel controllo del diabete in Cina continentale dal 1979 al 2012 . La prevalenza , la consapevolezza , il trattamento e il controllo del diabete sono stati complessivi del 6,41% , 45,81% , 42,54% e 20,87% rispettivamente .", "pert_mt": "Sono stati inclusi 56 studi ammissibili. Si sono osservate tendenze crescenti nella prevalenza, nel trattamento e nel controllo del diabete in Cina continentale dal 1979 al 2012. La prevalenza, la consapevolezza, il trattamento e il controllo del diabete sono stati complessivamente del 6,41%, 45,81%, 42,54% e 20,87% rispettivamente.", "bt": "56 eligible studies were included, and there were increasing trends in the prevalence, treatment and control of diabetes in mainland China from 1979 to 2012.The prevalence, awareness, treatment and control of diabetes were 6.41%, 45.81%, 42.54% and 20.87%, respectively.", "questions_src": ["What is the total number of eligible studies included?", "When did increasing trends in diabetes prevalence, treatment, and control in China start?", "Which year saw the end of the observation period for diabetes trends?", "What percentage of the population had diabetes mellitus according to the pooled prevalence?", "Which statistic was not mentioned in the pooled data: awareness, treatment, or control of diabetes mellitus?"], "answers_src": ["No Answer", "1979", "2012", "6.41%", "awareness"], "answers_bt": ["No Answer", "No Answer", "No Answer", "No Answer", "awareness"], "multiturn": {"turn_1": [{"question_id": "328.1", "question": "What is the total number of eligible studies included?", "answer_src": "fifty - six eligible studies were included . increasing trends in the prevalence , treatment , and control of diabetes in mainland china from 1979 to 2012 were observed . the pooled prevalence , awareness , treatment , and control of diabetes mellitus were 6.41% , 45.81% , 42.54% , and 20.87% , respectively .", "follow_up_question": "What was the pooled prevalence of diabetes mellitus?", "follow_up_response": "6.41%", "follow_up_response_bt": "6.41%"}, {"question_id": "328.2", "question": "When did increasing trends in diabetes prevalence, treatment, and control in China start?", "answer_src": "1979", "follow_up_question": "In what year did the highest prevalence of diabetes mellitus occur according to the pooled data?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "328.3", "question": "Which year saw the end of the observation period for diabetes trends?", "answer_src": "2012", "follow_up_question": "What was the overall pooled prevalence of diabetes mellitus across all studies?", "follow_up_response": "6.41%", "follow_up_response_bt": "6.41%"}, {"question_id": "328.4", "question": "What percentage of the population had diabetes mellitus according to the pooled prevalence?", "answer_src": "6.41%", "follow_up_question": "What was the average percentage of the population that was aware of their diabetes mellitus?", "follow_up_response": "45.81%", "follow_up_response_bt": "45.81%"}, {"question_id": "328.5", "question": "Which statistic was not mentioned in the pooled data: awareness, treatment, or control of diabetes mellitus?", "answer_src": "awareness", "follow_up_question": "What is the percentage of patients with diabetes who were treated?", "follow_up_response": "42.54%", "follow_up_response_bt": "42.54%"}], "turn_2": [{"question_id": "328.6", "question": "What was the pooled prevalence of diabetes mellitus?", "answer_src": "6.41%", "follow_up_question": "What was the pooled treatment rate of diabetes mellitus?", "follow_up_response": "42.54%", "follow_up_response_bt": "42.54%"}, {"question_id": "328.7", "question": "In what year did the highest prevalence of diabetes mellitus occur according to the pooled data?", "answer_src": "fifty - six eligible studies were included . increasing trends in the prevalence , treatment , and control of diabetes in mainland china from 1979 to 2012 were observed . the pooled prevalence , awareness , treatment , and control of diabetes mellitus were 6.41% , 45.81% , 42.54% , and 20.87% , respectively .", "follow_up_question": "What was the pooled prevalence of diabetes mellitus in 2012 according to the pooled data?", "follow_up_response": "6.41", "follow_up_response_bt": "No Answer"}, {"question_id": "328.8", "question": "What was the overall pooled prevalence of diabetes mellitus across all studies?", "answer_src": "6.41%", "follow_up_question": "What was the pooled awareness rate of diabetes mellitus across all studies?", "follow_up_response": "45.81%", "follow_up_response_bt": "No Answer"}, {"question_id": "328.9", "question": "What was the average percentage of the population that was aware of their diabetes mellitus?", "answer_src": "45.81%", "follow_up_question": "What was the average percentage of the population that was treated for their diabetes mellitus?", "follow_up_response": "42.54%", "follow_up_response_bt": "42.54%"}, {"question_id": "328.10", "question": "What is the percentage of patients with diabetes who were treated?", "answer_src": "42.54%", "follow_up_question": "What was the overall pooled prevalence of diabetes mellitus?", "follow_up_response": "6.41%", "follow_up_response_bt": "6.41%"}], "turn_3": [{"question_id": "328.11", "question": "What was the pooled treatment rate of diabetes mellitus?", "answer_src": "42.54%", "follow_up_question": "What was the pooled awareness rate of diabetes mellitus?", "follow_up_response": "45.81%", "follow_up_response_bt": "No Answer"}, {"question_id": "328.12", "question": "What was the pooled prevalence of diabetes mellitus in 2012 according to the pooled data?", "answer_src": "6.41", "follow_up_question": "What was the pooled treatment rate of diabetes mellitus in 2012 according to the pooled data?", "follow_up_response": "42.54%", "follow_up_response_bt": "No Answer"}, {"question_id": "328.13", "question": "What was the pooled awareness rate of diabetes mellitus across all studies?", "answer_src": "45.81%", "follow_up_question": "What was the pooled treatment rate of diabetes mellitus across all studies?", "follow_up_response": "42.54%", "follow_up_response_bt": "42.54%"}, {"question_id": "328.14", "question": "What was the average percentage of the population that was treated for their diabetes mellitus?", "answer_src": "42.54%", "follow_up_question": "What was the average percentage of the population that knew they had diabetes mellitus?", "follow_up_response": "45.81%", "follow_up_response_bt": "45.81%"}, {"question_id": "328.15", "question": "What was the overall pooled prevalence of diabetes mellitus?", "answer_src": "6.41%", "follow_up_question": "What was the pooled awareness rate of diabetes mellitus?", "follow_up_response": "45.81%", "follow_up_response_bt": "No Answer"}]}}
{"id": 329, "src": "four patients in group 1 and five patients in group 2 had significant but nonpermanent increase at iop values . there were one and two pupillary irregularity in group 1 and group 2 , respectively . in one patient , a shallow and inferior located retinal detachment were encountered in anterior chamber group.the results were not significantly different between the two fixation techniques for iris - claw lens .", "mt": "In un paziente , un distacco retinico superficiale e inferiore situato nel gruppo di camera anteriore . i risultati non erano significativamente diversi tra le due tecniche di fissazione per l'iris-guglia .", "pert_mt": "In un paziente, un distacco retinico superficiale e inferiore situato nel gruppo di camera anteriore. I risultati non erano significativamente diversi tra le due tecniche di fissazione per l'iris-guglia e il trattamento con laser.", "bt": "In one patient, a superficial and inferior retinal detachment located in the front camera group.The results were not significantly different between the two fixation techniques for the iris-guglia and the laser treatment.", "questions_src": ["What was the difference in the number of patients with significant but nonpermanent increase at IOP values between the two groups?", "Who encountered a shallow and inferior located retinal detachment in the anterior chamber group?", "Where did the pupillary irregularities occur in group 1 and group 2?", "When was the significant but nonpermanent increase at IOP values observed?", "Which fixation technique showed no significant difference in the results between the two groups?"], "answers_src": ["3 patients", "One patient", "In group 1 and group 2", "At the time of significant but nonpermanent increase at IOP values", "Iris-claw lens"], "answers_bt": ["No Answer", "In one patient", "No Answer", "No Answer", "Laser treatment"], "multiturn": {"turn_1": [{"question_id": "329.1", "question": "What was the difference in the number of patients with significant but nonpermanent increase at IOP values between the two groups?", "answer_src": "3 patients", "follow_up_question": "How many more patients in group 2 had pupillary irregularity compared to group 1?", "follow_up_response": "2", "follow_up_response_bt": "No Answer"}, {"question_id": "329.2", "question": "Who encountered a shallow and inferior located retinal detachment in the anterior chamber group?", "answer_src": "One patient", "follow_up_question": "What type of retinal detachment was encountered in the patient with the shallow and inferior location?", "follow_up_response": "a shallow and inferior located retinal detachment", "follow_up_response_bt": "Superficial and inferior retinal detachment"}, {"question_id": "329.3", "question": "Where did the pupillary irregularities occur in group 1 and group 2?", "answer_src": "In group 1 and group 2", "follow_up_question": "What was the specific location of the retinal detachment found in the anterior chamber group?", "follow_up_response": "a shallow and inferior located", "follow_up_response_bt": "superficial and inferior retinal detachment located in the front camera group"}, {"question_id": "329.4", "question": "When was the significant but nonpermanent increase at IOP values observed?", "answer_src": "At the time of significant but nonpermanent increase at IOP values", "follow_up_question": "What specific type of retinal detachment was found in the patient?", "follow_up_response": "a shallow and inferior located retinal detachment", "follow_up_response_bt": "A superficial and inferior retinal detachment"}, {"question_id": "329.5", "question": "Which fixation technique showed no significant difference in the results between the two groups?", "answer_src": "Iris-claw lens", "follow_up_question": "What was the result for the anterior chamber group?", "follow_up_response": "a shallow and inferior located retinal detachment", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "329.6", "question": "How many more patients in group 2 had pupillary irregularity compared to group 1?", "answer_src": "2", "follow_up_question": "How many patients in total had a shallow and inferior located retinal detachment?", "follow_up_response": "one", "follow_up_response_bt": "1"}, {"question_id": "329.7", "question": "What type of retinal detachment was encountered in the patient with the shallow and inferior location?", "answer_src": "a shallow and inferior located retinal detachment", "follow_up_question": "What was the location of the retinal detachment encountered in the patient?", "follow_up_response": "Shallow and inferior located", "follow_up_response_bt": "superficial and inferior retinal detachment located in the front camera group"}, {"question_id": "329.8", "question": "What was the specific location of the retinal detachment found in the anterior chamber group?", "answer_src": "a shallow and inferior located", "follow_up_question": "What was the exact nature of the pupillary irregularity observed in group 2?", "follow_up_response": "one", "follow_up_response_bt": "No Answer"}, {"question_id": "329.9", "question": "What specific type of retinal detachment was found in the patient?", "answer_src": "a shallow and inferior located retinal detachment", "follow_up_question": "What was the location of the retinal detachment found in the patient?", "follow_up_response": "Shallow and inferior located", "follow_up_response_bt": "superficial and inferior retinal detachment located in the front camera group"}, {"question_id": "329.10", "question": "What was the result for the anterior chamber group?", "answer_src": "a shallow and inferior located retinal detachment", "follow_up_question": "What type of detachment was found in the anterior chamber group?", "follow_up_response": "a shallow and inferior located retinal detachment", "follow_up_response_bt": "Superficial and inferior retinal detachment"}], "turn_3": [{"question_id": "329.11", "question": "How many patients in total had a shallow and inferior located retinal detachment?", "answer_src": "one", "follow_up_question": "How many patients in group 1 had a pupillary irregularity?", "follow_up_response": "one", "follow_up_response_bt": "No Answer"}, {"question_id": "329.12", "question": "What was the location of the retinal detachment encountered in the patient?", "answer_src": "Shallow and inferior located", "follow_up_question": "What was the exact description of the retinal detachment encountered?", "follow_up_response": "a shallow and inferior located retinal detachment", "follow_up_response_bt": "A superficial and inferior retinal detachment located in the front camera group."}, {"question_id": "329.13", "question": "What was the exact nature of the pupillary irregularity observed in group 2?", "answer_src": "one", "follow_up_question": "How many patients in group 1 had a shallow and inferior located retinal detachment in the anterior chamber?", "follow_up_response": "one", "follow_up_response_bt": "1"}, {"question_id": "329.14", "question": "What was the location of the retinal detachment found in the patient?", "answer_src": "Shallow and inferior located", "follow_up_question": "What was the exact description of the retinal detachment found in the patient?", "follow_up_response": "a shallow and inferior located retinal detachment", "follow_up_response_bt": "A superficial and inferior retinal detachment located in the front camera group."}, {"question_id": "329.15", "question": "What type of detachment was found in the anterior chamber group?", "answer_src": "a shallow and inferior located retinal detachment", "follow_up_question": "What was the location of the retinal detachment found in the anterior chamber group?", "follow_up_response": "a shallow and inferior located", "follow_up_response_bt": "superficial and inferior retinal detachment located in the front camera group"}]}}
{"id": 330, "src": "here , pun treatment increased ho-1 expression together with its upstream mediator nuclear factor - erythroid 2 p45-related factor 2 ( nrf2 ) . however , specific inhibition of nrf2 by brusatol ( a specific nrf2 inhibitor ) dramatically blocked pun - induced ho-1 expression . previous research has demonstrated that the pi3k / akt pathway plays a critical role in modulating nrf2/ho-1 protein expression as an upstream signaling molecule .", "mt": ", il trattamento del pun ha aumentato l'espressione ho-1 insieme al suo mediatore nucleare upstream - eritroide 2 p45-related factor 2 (here nrf2 ) . tuttavia , la specifica inibizione di nrf2 da brusatol (un specifico inibitore del nrf2) ha bloccato in modo drammatico l'espressione ho-1 induciuta dal pun . Ricerche precedenti hanno dimostrato che la via pi3k / akt svolge un ruolo critico nel modulare l'espressione proteica nrf2/ho-1 come molecola di segnalazione upstream .", "pert_mt": ", il trattamento del pun ha aumentato l'espressione ho-1 insieme al suo mediatore nucleare upstream - eritroide 2 p45-related factor 2 (qui chiamato NRF2) . tuttavia , la specifica inibizione di NRF2 da brusatol (un specifico inibitore di NRF2) ha bloccato in modo drammatico l'espressione ho-1 induciuta dal pun . Ricerche precedenti hanno dimostrato che la via PI3K / AKT svolge un ruolo critico nel modulare l'espressione proteica NRF2/HO-1 come molecola di segnalazione upstream .", "bt": "Pun treatment has increased ho-1 expression along with its upstream nuclear mediator - erythroid 2 p45-related factor 2 (also called NRF2) . However , the specific inhibition of NRF2 by brusatol (a specific inhibitor of NRF2) has dramatically blocked pun-induced ho-1 expression . Previous research has shown that the PI3K / AKT pathway plays a critical role in modulating the protein expression of NRF2/HO-1 as an upstream signaling molecule .", "questions_src": ["What is the upstream mediator of nuclear factor - erythroid 2 p45-related factor 2 (nrf2) mentioned in the sentence?", "Who specifically inhibited nrf2 to block pun-induced ho-1 expression?", "Where was the pi3k / akt pathway previously researched for its role in modulating nrf2/ho-1 protein expression?", "When did specific inhibition of nrf2 by brusatol occur?", "Which pathway plays a critical role in modulating nrf2/ho-1 protein expression as an upstream signaling molecule?"], "answers_src": ["nuclear factor - erythroid 2 p45-related factor 2 (nrf2)", "brusatol", "previous research", "specific inhibition of nrf2 by brusatol", "pi3k / akt"], "answers_bt": ["erythroid 2 p45-related factor 2 (also called NRF2)", "brusatol", "previous research", "specific inhibition of NRF2 by brusatol", "PI3K / AKT"], "multiturn": {"turn_1": [{"question_id": "330.1", "question": "What is the upstream mediator of nuclear factor - erythroid 2 p45-related factor 2 (nrf2) mentioned in the sentence?", "answer_src": "nuclear factor - erythroid 2 p45-related factor 2 (nrf2)", "follow_up_question": "What is the role of the PI3K/AKT pathway in modulating nrf2/ho-1 protein expression?", "follow_up_response": "It plays a critical role in modulating nrf2/ho-1 protein expression as an upstream signaling molecule.", "follow_up_response_bt": "The PI3K / AKT pathway plays a critical role in modulating the protein expression of NRF2/HO-1 as an upstream signaling molecule."}, {"question_id": "330.2", "question": "Who specifically inhibited nrf2 to block pun-induced ho-1 expression?", "answer_src": "brusatol", "follow_up_question": "What is the mechanism by which brusatol inhibits nrf2?", "follow_up_response": "Specific inhibition", "follow_up_response_bt": "Specific inhibition of NRF2"}, {"question_id": "330.3", "question": "Where was the pi3k / akt pathway previously researched for its role in modulating nrf2/ho-1 protein expression?", "answer_src": "previous research", "follow_up_question": "What evidence supports the role of the pi3k / akt pathway in modulating nrf2/ho-1 protein expression?", "follow_up_response": "Previous research has demonstrated that the PI3K / Akt pathway plays a critical role in modulating Nrf2/HO-1 protein expression as an upstream signaling molecule.", "follow_up_response_bt": "Previous research"}, {"question_id": "330.4", "question": "When did specific inhibition of nrf2 by brusatol occur?", "answer_src": "specific inhibition of nrf2 by brusatol", "follow_up_question": "What mechanism does the PI3K/AKT pathway use to regulate nrf2/ho-1 protein expression?", "follow_up_response": "a critical role in modulating nrf2/ho-1 protein expression as an upstream signaling molecule.", "follow_up_response_bt": "The PI3K / AKT pathway"}, {"question_id": "330.5", "question": "Which pathway plays a critical role in modulating nrf2/ho-1 protein expression as an upstream signaling molecule?", "answer_src": "pi3k / akt", "follow_up_question": "How does the PI3K/AKT pathway specifically regulate nrf2 and ho-1 protein expression?", "follow_up_response": "The PI3K/AKT pathway plays a critical role in modulating nrf2/ho-1 protein expression as an upstream signaling molecule.", "follow_up_response_bt": "The PI3K / AKT pathway plays a critical role in modulating the protein expression of NRF2/HO-1 as an upstream signaling molecule."}], "turn_2": [{"question_id": "330.6", "question": "What is the role of the PI3K/AKT pathway in modulating nrf2/ho-1 protein expression?", "answer_src": "It plays a critical role in modulating nrf2/ho-1 protein expression as an upstream signaling molecule.", "follow_up_question": "How does the PI3K/AKT pathway specifically regulate nrf2/ho-1 protein expression?", "follow_up_response": "The PI3K/AKT pathway plays a critical role in modulating nrf2/ho-1 protein expression as an upstream signaling molecule.", "follow_up_response_bt": "The PI3K / AKT pathway plays a critical role in modulating the protein expression of NRF2/HO-1 as an upstream signaling molecule."}, {"question_id": "330.7", "question": "What is the mechanism by which brusatol inhibits nrf2?", "answer_src": "Specific inhibition", "follow_up_question": "How does the PI3K/AKT pathway regulate nrf2/ho-1 protein expression?", "follow_up_response": "It plays a critical role in modulating nrf2/ho-1 protein expression as an upstream signaling molecule.", "follow_up_response_bt": "The PI3K / AKT pathway plays a critical role in modulating the protein expression of NRF2/HO-1 as an upstream signaling molecule."}, {"question_id": "330.8", "question": "What evidence supports the role of the pi3k / akt pathway in modulating nrf2/ho-1 protein expression?", "answer_src": "Previous research has demonstrated that the PI3K / Akt pathway plays a critical role in modulating Nrf2/HO-1 protein expression as an upstream signaling molecule.", "follow_up_question": "How does the PI3K/Akt pathway specifically regulate Nrf2/HO-1 protein expression?", "follow_up_response": "The PI3K/AKT pathway plays a critical role in modulating Nrf2/HO-1 protein expression as an upstream signaling molecule.", "follow_up_response_bt": "The PI3K / AKT pathway plays a critical role in modulating the protein expression of NRF2/HO-1 as an upstream signaling molecule."}, {"question_id": "330.9", "question": "What mechanism does the PI3K/AKT pathway use to regulate nrf2/ho-1 protein expression?", "answer_src": "a critical role in modulating nrf2/ho-1 protein expression as an upstream signaling molecule.", "follow_up_question": "How does the PI3K/AKT pathway specifically activate nrf2?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "330.10", "question": "How does the PI3K/AKT pathway specifically regulate nrf2 and ho-1 protein expression?", "answer_src": "The PI3K/AKT pathway plays a critical role in modulating nrf2/ho-1 protein expression as an upstream signaling molecule.", "follow_up_question": "What evidence supports the role of the PI3K/AKT pathway in modulating nrf2/ho-1 protein expression?", "follow_up_response": "Previous research has demonstrated that the PI3K / AKT pathway plays a critical role in modulating nrf2 / ho-1 protein expression as an upstream signaling molecule.", "follow_up_response_bt": "Previous research has shown that the PI3K / AKT pathway plays a critical role in modulating the protein expression of NRF2/HO-1 as an upstream signaling molecule."}], "turn_3": [{"question_id": "330.11", "question": "How does the PI3K/AKT pathway specifically regulate nrf2/ho-1 protein expression?", "answer_src": "The PI3K/AKT pathway plays a critical role in modulating nrf2/ho-1 protein expression as an upstream signaling molecule.", "follow_up_question": "What evidence supports the role of the PI3K/AKT pathway in modulating nrf2/ho-1 protein expression?", "follow_up_response": "Previous research has demonstrated that the PI3K / AKT pathway plays a critical role in modulating nrf2 / ho-1 protein expression as an upstream signaling molecule.", "follow_up_response_bt": "Previous research has shown that the PI3K / AKT pathway plays a critical role in modulating the protein expression of NRF2/HO-1 as an upstream signaling molecule."}, {"question_id": "330.12", "question": "How does the PI3K/AKT pathway regulate nrf2/ho-1 protein expression?", "answer_src": "It plays a critical role in modulating nrf2/ho-1 protein expression as an upstream signaling molecule.", "follow_up_question": "What evidence supports the role of the PI3K/AKT pathway in modulating nrf2/ho-1 protein expression?", "follow_up_response": "Previous research has demonstrated that the PI3K / AKT pathway plays a critical role in modulating nrf2 / ho-1 protein expression as an upstream signaling molecule.", "follow_up_response_bt": "Previous research has shown that the PI3K / AKT pathway plays a critical role in modulating the protein expression of NRF2/HO-1 as an upstream signaling molecule."}, {"question_id": "330.13", "question": "How does the PI3K/Akt pathway specifically regulate Nrf2/HO-1 protein expression?", "answer_src": "The PI3K/AKT pathway plays a critical role in modulating Nrf2/HO-1 protein expression as an upstream signaling molecule.", "follow_up_question": "What evidence supports the role of the PI3K/AKT pathway in modulating Nrf2/HO-1 protein expression?", "follow_up_response": "Previous research has demonstrated that the PI3K / AKT pathway plays a critical role in modulating Nrf2 / HO-1 protein expression as an upstream signaling molecule.", "follow_up_response_bt": "Previous research has shown that the PI3K / AKT pathway plays a critical role in modulating the protein expression of NRF2/HO-1 as an upstream signaling molecule."}, {"question_id": "330.14", "question": "How does the PI3K/AKT pathway specifically activate nrf2?", "answer_src": "here , pun treatment increased ho-1 expression together with its upstream mediator nuclear factor - erythroid 2 p45-related factor 2 ( nrf2 ) . however , specific inhibition of nrf2 by brusatol ( a specific nrf2 inhibitor ) dramatically blocked pun - induced ho-1 expression . previous research has demonstrated that the pi3k / akt pathway plays a critical role in modulating nrf2/ho-1 protein expression as an upstream signaling molecule .", "follow_up_question": "What evidence supports the role of the PI3K/AKT pathway in modulating nrf2/ho-1 protein expression?", "follow_up_response": "Previous research has demonstrated that the PI3K / AKT pathway plays a critical role in modulating nrf2 / ho-1 protein expression as an upstream signaling molecule.", "follow_up_response_bt": "Previous research has shown that the PI3K / AKT pathway plays a critical role in modulating the protein expression of NRF2/HO-1 as an upstream signaling molecule."}, {"question_id": "330.15", "question": "What evidence supports the role of the PI3K/AKT pathway in modulating nrf2/ho-1 protein expression?", "answer_src": "Previous research has demonstrated that the PI3K / AKT pathway plays a critical role in modulating nrf2 / ho-1 protein expression as an upstream signaling molecule.", "follow_up_question": "How does the PI3K/AKT pathway specifically regulate nrf2/ho-1 protein expression?", "follow_up_response": "The PI3K/AKT pathway plays a critical role in modulating nrf2/ho-1 protein expression as an upstream signaling molecule.", "follow_up_response_bt": "The PI3K / AKT pathway plays a critical role in modulating the protein expression of NRF2/HO-1 as an upstream signaling molecule."}]}}
{"id": 331, "src": "spinal epidural lipomatosis ( sel ) is an abnormal localized accumulation of fat tissues in the epidural space . it is strongly related with steroid administration . the symptoms of sel are various and range from back pain to paraplegia .", "mt": "La lipomatosi epidurale spinale (cellula) è un'anomalia di accumulo localizzato di tessuti grassi nello spazio epidurale . è fortemente correlata con l'amministrazione di steroidi . I sintomi della cellula sono vari e vanno dal mal di schiena alla paraplegia .", "pert_mt": "La lipomatosi epidurale spinale (cellula) è un'anomalia di accumulo localizzato di tessuti grassi nello spazio epidurale. È fortemente correlata con l'amministrazione di steroidi. I sintomi della cellula sono vari e vanno dal mal di schiena alla paraplegia, inclusi i problemi respiratori.", "bt": "Spinal epidural lipomatosis (cell) is a localized abnormality of fat tissue accumulation in the epidural space.It is strongly correlated with steroid administration.The symptoms of the cell range from back pain to paraplegia, including respiratory problems.", "questions_src": ["What does spinal epidural lipomatosis (sel) involve?", "Where is the abnormal localized accumulation of fat tissues located?", "Which condition is sel strongly related to?", "What are some possible symptoms of sel?", "When might someone experience back pain due to sel?"], "answers_src": ["an abnormal localized accumulation of fat tissues in the epidural space", "the epidural space", "steroid administration", "back pain to paraplegia", "No Answer"], "answers_bt": ["A localized abnormality of fat tissue accumulation in the epidural space", "In the epidural space", "Steroid administration", "Back pain, paraplegia, including respiratory problems", "No Answer"], "multiturn": {"turn_1": [{"question_id": "331.1", "question": "What does spinal epidural lipomatosis (sel) involve?", "answer_src": "an abnormal localized accumulation of fat tissues in the epidural space", "follow_up_question": "What specific condition is sel strongly related to?", "follow_up_response": "Steroid administration", "follow_up_response_bt": "Steroid administration"}, {"question_id": "331.2", "question": "Where is the abnormal localized accumulation of fat tissues located?", "answer_src": "the epidural space", "follow_up_question": "What are some potential symptoms of spinal epidural lipomatosis?", "follow_up_response": "back pain to paraplegia", "follow_up_response_bt": "Back pain to paraplegia, including respiratory problems"}, {"question_id": "331.3", "question": "Which condition is sel strongly related to?", "answer_src": "steroid administration", "follow_up_question": "What specific symptoms can sel cause besides back pain?", "follow_up_response": "paraplegia", "follow_up_response_bt": "respiratory problems"}, {"question_id": "331.4", "question": "What are some possible symptoms of sel?", "answer_src": "back pain to paraplegia", "follow_up_question": "What conditions might increase the risk of developing sel?", "follow_up_response": "Steroid administration", "follow_up_response_bt": "Steroid administration"}, {"question_id": "331.5", "question": "When might someone experience back pain due to sel?", "answer_src": "spinal epidural lipomatosis ( sel ) is an abnormal localized accumulation of fat tissues in the epidural space . it is strongly related with steroid administration . the symptoms of sel are various and range from back pain to paraplegia .", "follow_up_question": "What other symptom besides back pain could someone with sel experience?", "follow_up_response": "paraplegia", "follow_up_response_bt": "respiratory problems"}], "turn_2": [{"question_id": "331.6", "question": "What specific condition is sel strongly related to?", "answer_src": "Steroid administration", "follow_up_question": "What are some potential symptoms of spinal epidural lipomatosis?", "follow_up_response": "back pain to paraplegia", "follow_up_response_bt": "Back pain to paraplegia, including respiratory problems"}, {"question_id": "331.7", "question": "What are some potential symptoms of spinal epidural lipomatosis?", "answer_src": "back pain to paraplegia", "follow_up_question": "What other symptoms besides back pain have been reported with spinal epidural lipomatosis?", "follow_up_response": "paraplegia", "follow_up_response_bt": "respiratory problems"}, {"question_id": "331.8", "question": "What specific symptoms can sel cause besides back pain?", "answer_src": "paraplegia", "follow_up_question": "What other symptoms besides back pain can sel cause?", "follow_up_response": "paraplegia", "follow_up_response_bt": "respiratory problems"}, {"question_id": "331.9", "question": "What conditions might increase the risk of developing sel?", "answer_src": "Steroid administration", "follow_up_question": "How does steroid administration lead to the development of sel?", "follow_up_response": "it is strongly related with steroid administration.", "follow_up_response_bt": "Strongly correlated with steroid administration"}, {"question_id": "331.10", "question": "What other symptom besides back pain could someone with sel experience?", "answer_src": "paraplegia", "follow_up_question": "What percentage of patients with sel experience back pain according to the text?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "331.11", "question": "What are some potential symptoms of spinal epidural lipomatosis?", "answer_src": "back pain to paraplegia", "follow_up_question": "What other symptoms besides back pain have been reported with spinal epidural lipomatosis?", "follow_up_response": "paraplegia", "follow_up_response_bt": "respiratory problems"}, {"question_id": "331.12", "question": "What other symptoms besides back pain have been reported with spinal epidural lipomatosis?", "answer_src": "paraplegia", "follow_up_question": "What percentage of patients with spinal epidural lipomatosis experience paraplegia?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "331.13", "question": "What other symptoms besides back pain can sel cause?", "answer_src": "paraplegia", "follow_up_question": "What percentage of patients with sel experience paraplegia?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "331.14", "question": "How does steroid administration lead to the development of sel?", "answer_src": "it is strongly related with steroid administration.", "follow_up_question": "What specific symptoms might result from steroid administration leading to sel?", "follow_up_response": "back pain to paraplegia", "follow_up_response_bt": "Back pain to paraplegia, including respiratory problems"}, {"question_id": "331.15", "question": "What percentage of patients with sel experience back pain according to the text?", "answer_src": "spinal epidural lipomatosis ( sel ) is an abnormal localized accumulation of fat tissues in the epidural space . it is strongly related with steroid administration . the symptoms of sel are various and range from back pain to paraplegia .", "follow_up_question": "What other symptom besides back pain can patients with sel experience according to the text?", "follow_up_response": "paraplegia", "follow_up_response_bt": "respiratory problems"}]}}
{"id": 332, "src": "the organism was isolated from both blood and urine cultures . treatment consisted of 14 days of intravenous ceftriaxone and oral amoxicillin one after than other and insertion of a left ureteral stent . after discharge , he underwent extracorporeal shock wave lithotrity for the left ureteral calculus .", "mt": "L' organismo è stato isolato sia dal sangue che dalle culture di urina . Il trattamento consisteva in 14 giorni di ceftriaxone per via endovenosa e di amoxicillina orale uno dopo l' altro e l' inserimento di uno stent ureterale sinistro . Dopo il rilascio , ha subito una litotritia a onde di shock extracorporee per il calcolo ureterale sinistro .", "pert_mt": "L' organismo è stato isolato sia dal sangue che dalle culture di urina. Il trattamento consisteva in 14 giorni di ceftriaxone per via endovenosa e di amoxicillina orale uno dopo l' altro e l' inserimento di uno stent ureterale sinistro. Dopo il rilascio, ha subito una litotritia a onde di shock extracorporee per il calcolo ureterale sinistro e una terapia antinfiammatoria.", "bt": "The body was isolated from both blood and urine cultures, and treatment consisted of 14 days of ceftriaxone intravenously and oral amoxicillin followed by the insertion of a left urethral stent, after release, he underwent an extracorporeal shock wave litotrity for the left urethral calculus and an anti-inflammatory therapy.", "questions_src": ["What was the primary treatment given to the patient?", "When did the patient undergo extracorporeal shock wave lithotripsy?", "Where were the cultures isolated from?", "Who performed the intravenous ceftriaxone treatment?", "Which organ had a calculus removed?"], "answers_src": ["Intravenous ceftriaxone and oral amoxicillin", "After discharge", "Blood and urine", "The patient", "Left ureter"], "answers_bt": ["14 days of ceftriaxone intravenously and oral amoxicillin", "After release", "Both blood and urine", "Intravenously", "Left urethral"], "multiturn": {"turn_1": [{"question_id": "332.1", "question": "What was the primary treatment given to the patient?", "answer_src": "Intravenous ceftriaxone and oral amoxicillin", "follow_up_question": "What complication did the patient have that required extracorporeal shock wave lithotrity?", "follow_up_response": "Left ureteral calculus", "follow_up_response_bt": "Left urethral calculus"}, {"question_id": "332.2", "question": "When did the patient undergo extracorporeal shock wave lithotripsy?", "answer_src": "After discharge", "follow_up_question": "What procedure was performed before the extracorporeal shock wave lithotripsy?", "follow_up_response": "Insertion of a left ureteral stent", "follow_up_response_bt": "Anti-inflammatory therapy"}, {"question_id": "332.3", "question": "Where were the cultures isolated from?", "answer_src": "Blood and urine", "follow_up_question": "What was the purpose of the left ureteral stent?", "follow_up_response": "To treat the infection", "follow_up_response_bt": "After release"}, {"question_id": "332.4", "question": "Who performed the intravenous ceftriaxone treatment?", "answer_src": "The patient", "follow_up_question": "What was the reason for inserting the left ureteral stent?", "follow_up_response": "To manage left ureteral obstruction", "follow_up_response_bt": "After release"}, {"question_id": "332.5", "question": "Which organ had a calculus removed?", "answer_src": "Left ureter", "follow_up_question": "What procedure was performed on the left ureter?", "follow_up_response": "Extracorporeal shock wave lithotrity", "follow_up_response_bt": "an extracorporeal shock wave lithotripsy for the left urethral calculus"}], "turn_2": [{"question_id": "332.6", "question": "What complication did the patient have that required extracorporeal shock wave lithotrity?", "answer_src": "Left ureteral calculus", "follow_up_question": "What procedure was performed before the extracorporeal shock wave lithotrity?", "follow_up_response": "Insertion of a left ureteral stent", "follow_up_response_bt": "Anti-inflammatory therapy"}, {"question_id": "332.7", "question": "What procedure was performed before the extracorporeal shock wave lithotripsy?", "answer_src": "Insertion of a left ureteral stent", "follow_up_question": "What antibiotic was administered first during treatment?", "follow_up_response": "oral amoxicillin", "follow_up_response_bt": "oral amoxicillin"}, {"question_id": "332.8", "question": "What was the purpose of the left ureteral stent?", "answer_src": "To treat the infection", "follow_up_question": "What condition led to the need for extracorporeal shock wave lithotrity?", "follow_up_response": "The left ureteral calculus", "follow_up_response_bt": "The left urethral calculus"}, {"question_id": "332.9", "question": "What was the reason for inserting the left ureteral stent?", "answer_src": "To manage left ureteral obstruction", "follow_up_question": "What type of procedure did the patient undergo after discharge?", "follow_up_response": "Extracorporeal shock wave lithotrity", "follow_up_response_bt": "an extracorporeal shock wave lithotripsy for the left urethral calculus"}, {"question_id": "332.10", "question": "What procedure was performed on the left ureter?", "answer_src": "Extracorporeal shock wave lithotrity", "follow_up_question": "What type of calculus was treated with lithotrity?", "follow_up_response": "left ureteral calculus", "follow_up_response_bt": "left urethral calculus"}], "turn_3": [{"question_id": "332.11", "question": "What procedure was performed before the extracorporeal shock wave lithotrity?", "answer_src": "Insertion of a left ureteral stent", "follow_up_question": "What type of antibiotic was administered first in the treatment regimen?", "follow_up_response": "oral amoxicillin", "follow_up_response_bt": "oral amoxicillin"}, {"question_id": "332.12", "question": "What antibiotic was administered first during treatment?", "answer_src": "oral amoxicillin", "follow_up_question": "What was the reason for inserting the left ureteral stent?", "follow_up_response": "To manage left ureteral obstruction", "follow_up_response_bt": "After release"}, {"question_id": "332.13", "question": "What condition led to the need for extracorporeal shock wave lithotrity?", "answer_src": "The left ureteral calculus", "follow_up_question": "What was the reason for inserting the left ureteral stent?", "follow_up_response": "To manage left ureteral obstruction", "follow_up_response_bt": "After release"}, {"question_id": "332.14", "question": "What type of procedure did the patient undergo after discharge?", "answer_src": "Extracorporeal shock wave lithotrity", "follow_up_question": "What was the reason for inserting the left ureteral stent?", "follow_up_response": "To manage left ureteral obstruction", "follow_up_response_bt": "After release"}, {"question_id": "332.15", "question": "What type of calculus was treated with lithotrity?", "answer_src": "left ureteral calculus", "follow_up_question": "What procedure preceded the treatment of the left ureteral calculus?", "follow_up_response": "Extracorporeal shock wave lithotrity", "follow_up_response_bt": "Anti-inflammatory therapy"}]}}
{"id": 333, "src": "all intravaginal imidazoles purchased , regardless of treatment duration or active ingredient , were found to be of proven efficacy . we were unable to find an rct confirming the effectiveness of vaginal anti - itch creams and homeopathic treatments for vaginitis . 45% of products available to women in the feminine hygiene section of the stores surveyed could not be confirmed to be effective for treating infectious vaginitis .", "mt": "Tutti gli imidazoli intravaginali acquistati , indipendentemente dalla durata del trattamento o dall'ingrediente attivo , sono stati rilevati come efficaci . non siamo stati in grado di trovare un rct che confermi l'efficacia delle creme anti prurito vaginali e dei trattamenti omeopatici per la vaginite . Il 45% dei prodotti disponibili per le donne nella sezione igiene femminile dei negozi intervistati non è stato possibile confermare che siano efficaci per il trattamento della vaginite infettiva .", "pert_mt": "Tutti gli imidazoli intravaginali acquistati, indipendentemente dalla durata del trattamento o dall'ingrediente attivo, sono stati rilevati come efficaci. Non siamo stati in grado di trovare un RCT che confermi l'efficacia delle creme anti prurito vaginali e dei trattamenti omeopatici per la vaginite. Il 45% dei prodotti disponibili per le donne nella sezione igiene femminile dei negozi intervistati non è stato possibile confermare che siano efficaci per il trattamento della vaginite infettiva e possano causare effetti collaterali negativi.", "bt": "All intravaginal imidazoles purchased, regardless of the duration of treatment or the active ingredient, were found to be effective.We were unable to find an RCT confirming the effectiveness of vaginal itch-relieving creams and homeopathic vaginal treatments.45 percent of the products available to women in the women's hygiene section of the stores interviewed could not be confirmed to be effective for the treatment of infectious vaginitis and could cause negative side effects.", "questions_src": ["What is the main finding regarding imidazoles?", "Who was unable to find an RCT on vaginal anti-itch creams?", "Where can products be found that may not be effective for treating infectious vaginitis?", "When might imidazoles be considered ineffective?", "Which type of treatment was not confirmed to be effective?"], "answers_src": ["[\"Imidazoles are found to be of proven efficacy\"], [\"No one specific was unable to find an RCT\"], [\"In the feminine hygiene section of the stores surveyed\"], [\"No Answer\"], [\"Vaginal anti-itch creams and homeopathic treatments\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"Imidazoles are effective\"], [\"We\"], [\"In the women\"s hygiene section of the stores\"], [\"Regardless of the duration of treatment\"], [\"Vaginal anti-itch creams\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "333.1", "question": "What is the main finding regarding imidazoles?", "answer_src": "[\"Imidazoles are found to be of proven efficacy\"], [\"No one specific was unable to find an RCT\"], [\"In the feminine hygiene section of the stores surveyed\"], [\"No Answer\"], [\"Vaginal anti-itch creams and homeopathic treatments\"]", "follow_up_question": "What percentage of products in the feminine hygiene section could not be confirmed to be effective for treating infectious vaginitis?", "follow_up_response": "45", "follow_up_response_bt": "45"}, {"question_id": "333.2", "question": "Who was unable to find an RCT on vaginal anti-itch creams?", "answer_src": "all intravaginal imidazoles purchased , regardless of treatment duration or active ingredient , were found to be of proven efficacy . we were unable to find an rct confirming the effectiveness of vaginal anti - itch creams and homeopathic treatments for vaginitis . 45% of products available to women in the feminine hygiene section of the stores surveyed could not be confirmed to be effective for treating infectious vaginitis .", "follow_up_question": "What percentage of products in the feminine hygiene section could not be confirmed to be effective for treating infectious vaginitis?", "follow_up_response": "45", "follow_up_response_bt": "45"}, {"question_id": "333.3", "question": "Where can products be found that may not be effective for treating infectious vaginitis?", "answer_src": "all intravaginal imidazoles purchased , regardless of treatment duration or active ingredient , were found to be of proven efficacy . we were unable to find an rct confirming the effectiveness of vaginal anti - itch creams and homeopathic treatments for vaginitis . 45% of products available to women in the feminine hygiene section of the stores surveyed could not be confirmed to be effective for treating infectious vaginitis .", "follow_up_question": "What percentage of products in the feminine hygiene section were found ineffective for treating infectious vaginitis?", "follow_up_response": "45", "follow_up_response_bt": "45"}, {"question_id": "333.4", "question": "When might imidazoles be considered ineffective?", "answer_src": "all intravaginal imidazoles purchased , regardless of treatment duration or active ingredient , were found to be of proven efficacy . we were unable to find an rct confirming the effectiveness of vaginal anti - itch creams and homeopathic treatments for vaginitis . 45% of products available to women in the feminine hygiene section of the stores surveyed could not be confirmed to be effective for treating infectious vaginitis .", "follow_up_question": "What percentage of products in the feminine hygiene section were not confirmed to be effective for treating infectious vaginitis?", "follow_up_response": "45", "follow_up_response_bt": "45"}, {"question_id": "333.5", "question": "Which type of treatment was not confirmed to be effective?", "answer_src": "all intravaginal imidazoles purchased , regardless of treatment duration or active ingredient , were found to be of proven efficacy . we were unable to find an rct confirming the effectiveness of vaginal anti - itch creams and homeopathic treatments for vaginitis . 45% of products available to women in the feminine hygiene section of the stores surveyed could not be confirmed to be effective for treating infectious vaginitis .", "follow_up_question": "What percentage of products in the feminine hygiene section were not confirmed to be effective for treating infectious vaginitis?", "follow_up_response": "45", "follow_up_response_bt": "45"}], "turn_2": [{"question_id": "333.6", "question": "What percentage of products in the feminine hygiene section could not be confirmed to be effective for treating infectious vaginitis?", "answer_src": "45", "follow_up_question": "What is the treatment duration considered when determining the efficacy of intravaginal imidazoles?", "follow_up_response": "Regardless of treatment duration", "follow_up_response_bt": "Regardless of the duration of treatment"}, {"question_id": "333.7", "question": "What percentage of products in the feminine hygiene section could not be confirmed to be effective for treating infectious vaginitis?", "answer_src": "45", "follow_up_question": "What is the treatment duration considered when determining the efficacy of intravaginal imidazoles?", "follow_up_response": "Regardless of treatment duration", "follow_up_response_bt": "Regardless of the duration of treatment"}, {"question_id": "333.8", "question": "What percentage of products in the feminine hygiene section were found ineffective for treating infectious vaginitis?", "answer_src": "45", "follow_up_question": "What was the treatment duration considered when determining the efficacy of imidazoles?", "follow_up_response": "regardless of treatment duration", "follow_up_response_bt": "Regardless of the duration of treatment"}, {"question_id": "333.9", "question": "What percentage of products in the feminine hygiene section were not confirmed to be effective for treating infectious vaginitis?", "answer_src": "45", "follow_up_question": "What was the treatment duration considered when determining the efficacy of intravaginal imidazoles?", "follow_up_response": "regardless of treatment duration", "follow_up_response_bt": "Regardless of the duration of treatment"}, {"question_id": "333.10", "question": "What percentage of products in the feminine hygiene section were not confirmed to be effective for treating infectious vaginitis?", "answer_src": "45", "follow_up_question": "What was the treatment duration considered when determining the efficacy of intravaginal imidazoles?", "follow_up_response": "regardless of treatment duration", "follow_up_response_bt": "Regardless of the duration of treatment"}], "turn_3": [{"question_id": "333.11", "question": "What is the treatment duration considered when determining the efficacy of intravaginal imidazoles?", "answer_src": "Regardless of treatment duration", "follow_up_question": "What percentage of products in the feminine hygiene section could not be confirmed to be effective for treating infectious vaginitis?", "follow_up_response": "45", "follow_up_response_bt": "45"}, {"question_id": "333.12", "question": "What is the treatment duration considered when determining the efficacy of intravaginal imidazoles?", "answer_src": "Regardless of treatment duration", "follow_up_question": "What percentage of products in the feminine hygiene section could not be confirmed to be effective for treating infectious vaginitis?", "follow_up_response": "45", "follow_up_response_bt": "45"}, {"question_id": "333.13", "question": "What was the treatment duration considered when determining the efficacy of imidazoles?", "answer_src": "regardless of treatment duration", "follow_up_question": "What percentage of products in the feminine hygiene section could not be confirmed to be effective for treating infectious vaginitis?", "follow_up_response": "45", "follow_up_response_bt": "45"}, {"question_id": "333.14", "question": "What was the treatment duration considered when determining the efficacy of intravaginal imidazoles?", "answer_src": "regardless of treatment duration", "follow_up_question": "What percentage of products in the feminine hygiene section could not be confirmed to be effective for treating infectious vaginitis?", "follow_up_response": "45", "follow_up_response_bt": "45"}, {"question_id": "333.15", "question": "What was the treatment duration considered when determining the efficacy of intravaginal imidazoles?", "answer_src": "regardless of treatment duration", "follow_up_question": "What percentage of products in the feminine hygiene section could not be confirmed to be effective for treating infectious vaginitis?", "follow_up_response": "45", "follow_up_response_bt": "45"}]}}
{"id": 334, "src": "inflammation and cancer are related . it is well known that persistent inflammatory conditions can induce cancer formation , due to production of cytokines and chemokines , which play a crucial role in promoting angiogenesis , metastasis , and subversion of adaptive immunity . tlr signaling in tumor cells can mediate tumor cell immune escape and tumor progression , and it is regarded as one of the mechanisms for chronic inflammation in tumorigenesis and progression .", "mt": "L'infiammazione e il cancro sono correlati . è noto che le condizioni infiammatorie persistenti possono indurre la formazione di cancro , a causa della produzione di citochine e chemichine , che svolgono un ruolo cruciale nel promuovere l'angiogenesi , la metastasi e la sovversione dell'immunità adattabile .", "pert_mt": "L'infiammazione e il cancro sono correlati. È noto che le condizioni infiammatorie persistenti possono indurre la formazione di cancro, a causa della produzione di citochine e chemichine, che svolgono un ruolo cruciale nel promuovere l'angiogenesi, la metastasi e la sovversione dell'immunità adattabile, anche se molte persone non mostrano sintomi evidenti durante la fase infiammatoria.", "bt": "It is well known that persistent inflammatory conditions can induce cancer formation, due to the production of cytokines and chemokines, which play a crucial role in promoting angiogenesis, metastasis and subversion of adaptive immunity, although many people do not show obvious symptoms during the inflammatory phase.", "questions_src": ["What does inflammation lead to according to the sentence?", "Who can induce cancer formation through persistent inflammatory conditions?", "Where do cytokines and chemokines primarily act in relation to cancer?", "When might tumor cells use TLR signaling to avoid immune response?", "Which mechanism is associated with chronic inflammation in tumorigenesis and progression?"], "answers_src": ["[\"cancer formation\"], [\"persistent inflammatory conditions\"], [\"promoting angiogenesis, metastasis, and subversion of adaptive immunity\"], [\"tumor cells might use TLR signaling to avoid immune response\"], [\"TLR signaling in tumor cells\"])", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["[\"cancer formation\"], [\"persistent inflammatory conditions\"], [\"promoting angiogenesis, metastasis and subversion of adaptive immunity\"], [\"no answer\"], [\"TLR signaling to avoid immune response\"], [\"chronic inflammation\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "334.1", "question": "What does inflammation lead to according to the sentence?", "answer_src": "[\"cancer formation\"], [\"persistent inflammatory conditions\"], [\"promoting angiogenesis, metastasis, and subversion of adaptive immunity\"], [\"tumor cells might use TLR signaling to avoid immune response\"], [\"TLR signaling in tumor cells\"])", "follow_up_question": "How does TLR signaling in tumor cells contribute to tumor progression?", "follow_up_response": "TLR signaling in tumor cells can mediate tumor cell immune escape and tumor progression", "follow_up_response_bt": "No Answer"}, {"question_id": "334.2", "question": "Who can induce cancer formation through persistent inflammatory conditions?", "answer_src": "inflammation and cancer are related . it is well known that persistent inflammatory conditions can induce cancer formation , due to production of cytokines and chemokines , which play a crucial role in promoting angiogenesis , metastasis , and subversion of adaptive immunity . tlr signaling in tumor cells can mediate tumor cell immune escape and tumor progression , and it is regarded as one of the mechanisms for chronic inflammation in tumorigenesis and progression .", "follow_up_question": "What factors do persistent inflammatory conditions produce that contribute to cancer formation?", "follow_up_response": "cytokines and chemokines", "follow_up_response_bt": "Cytokines and chemokines"}, {"question_id": "334.3", "question": "Where do cytokines and chemokines primarily act in relation to cancer?", "answer_src": "inflammation and cancer are related . it is well known that persistent inflammatory conditions can induce cancer formation , due to production of cytokines and chemokines , which play a crucial role in promoting angiogenesis , metastasis , and subversion of adaptive immunity . tlr signaling in tumor cells can mediate tumor cell immune escape and tumor progression , and it is regarded as one of the mechanisms for chronic inflammation in tumorigenesis and progression .", "follow_up_question": "What role do cytokines and chemokines play in promoting cancer progression?", "follow_up_response": "They play a crucial role in promoting angiogenesis, metastasis, and subversion of adaptive immunity.", "follow_up_response_bt": "promoting angiogenesis, metastasis and subversion of adaptive immunity"}, {"question_id": "334.4", "question": "When might tumor cells use TLR signaling to avoid immune response?", "answer_src": "inflammation and cancer are related . it is well known that persistent inflammatory conditions can induce cancer formation , due to production of cytokines and chemokines , which play a crucial role in promoting angiogenesis , metastasis , and subversion of adaptive immunity . tlr signaling in tumor cells can mediate tumor cell immune escape and tumor progression , and it is regarded as one of the mechanisms for chronic inflammation in tumorigenesis and progression .", "follow_up_question": "What mechanism does TLR signaling in tumor cells use to evade the immune system?", "follow_up_response": "TLR signaling in tumor cells can mediate tumor cell immune escape", "follow_up_response_bt": "No Answer"}, {"question_id": "334.5", "question": "Which mechanism is associated with chronic inflammation in tumorigenesis and progression?", "answer_src": "inflammation and cancer are related . it is well known that persistent inflammatory conditions can induce cancer formation , due to production of cytokines and chemokines , which play a crucial role in promoting angiogenesis , metastasis , and subversion of adaptive immunity . tlr signaling in tumor cells can mediate tumor cell immune escape and tumor progression , and it is regarded as one of the mechanisms for chronic inflammation in tumorigenesis and progression .", "follow_up_question": "What role does TLR signaling play in tumor cell immune escape?", "follow_up_response": "mediates tumor cell immune escape", "follow_up_response_bt": "No Answer"}], "turn_2": [{"question_id": "334.6", "question": "How does TLR signaling in tumor cells contribute to tumor progression?", "answer_src": "TLR signaling in tumor cells can mediate tumor cell immune escape and tumor progression", "follow_up_question": "What mechanism does TLR signaling use to achieve tumor cell immune escape?", "follow_up_response": "mediate tumor cell immune escape", "follow_up_response_bt": "No Answer"}, {"question_id": "334.7", "question": "What factors do persistent inflammatory conditions produce that contribute to cancer formation?", "answer_src": "cytokines and chemokines", "follow_up_question": "How do cytokines and chemokines promote cancer progression?", "follow_up_response": "by playing a crucial role in promoting angiogenesis, metastasis, and subversion of adaptive immunity", "follow_up_response_bt": "by promoting angiogenesis, metastasis and subversion of adaptive immunity"}, {"question_id": "334.8", "question": "What role do cytokines and chemokines play in promoting cancer progression?", "answer_src": "They play a crucial role in promoting angiogenesis, metastasis, and subversion of adaptive immunity.", "follow_up_question": "How do TLR signaling in tumor cells contribute to tumor progression?", "follow_up_response": "TLR signaling in tumor cells can mediate tumor cell immune escape and tumor progression", "follow_up_response_bt": "No Answer"}, {"question_id": "334.9", "question": "What mechanism does TLR signaling in tumor cells use to evade the immune system?", "answer_src": "TLR signaling in tumor cells can mediate tumor cell immune escape", "follow_up_question": "How does TLR signaling contribute to tumor progression?", "follow_up_response": "TLR signaling in tumor cells can mediate tumor cell immune escape and tumor progression", "follow_up_response_bt": "No Answer"}, {"question_id": "334.10", "question": "What role does TLR signaling play in tumor cell immune escape?", "answer_src": "mediates tumor cell immune escape", "follow_up_question": "How does TLR signaling contribute to tumor progression?", "follow_up_response": "TLR signaling in tumor cells can mediate tumor cell immune escape and tumor progression", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "334.11", "question": "What mechanism does TLR signaling use to achieve tumor cell immune escape?", "answer_src": "mediate tumor cell immune escape", "follow_up_question": "How does TLR signaling contribute to tumor progression?", "follow_up_response": "TLR signaling in tumor cells can mediate tumor cell immune escape and tumor progression", "follow_up_response_bt": "No Answer"}, {"question_id": "334.12", "question": "How do cytokines and chemokines promote cancer progression?", "answer_src": "by playing a crucial role in promoting angiogenesis, metastasis, and subversion of adaptive immunity", "follow_up_question": "What specific mechanism does TLR signaling in tumor cells use to facilitate tumor cell immune escape?", "follow_up_response": "mediate tumor cell immune escape", "follow_up_response_bt": "No Answer"}, {"question_id": "334.13", "question": "How do TLR signaling in tumor cells contribute to tumor progression?", "answer_src": "TLR signaling in tumor cells can mediate tumor cell immune escape and tumor progression", "follow_up_question": "What mechanism does TLR signaling use to promote tumor cell immune escape?", "follow_up_response": "mediate tumor cell immune escape", "follow_up_response_bt": "No Answer"}, {"question_id": "334.14", "question": "How does TLR signaling contribute to tumor progression?", "answer_src": "TLR signaling in tumor cells can mediate tumor cell immune escape and tumor progression", "follow_up_question": "What specific mechanisms does TLR signaling use to promote tumor progression?", "follow_up_response": "mediate tumor cell immune escape and tumor progression", "follow_up_response_bt": "No Answer"}, {"question_id": "334.15", "question": "How does TLR signaling contribute to tumor progression?", "answer_src": "TLR signaling in tumor cells can mediate tumor cell immune escape and tumor progression", "follow_up_question": "What specific mechanisms does TLR signaling use to promote tumor progression?", "follow_up_response": "mediate tumor cell immune escape and tumor progression", "follow_up_response_bt": "No Answer"}]}}
{"id": 335, "src": "unilateral taste loss is usually observed on the side contralateral to a thalamic infarction , despite gustatory function being represented bilaterally . we report a rare case of bilateral taste loss in a patient with an acute left unilateral thalamic infarction , with unilateral left insular hypometabolism demonstrated by statistical parametric map analysis of pet images . our observations suggest that the left insular cortex and left ventroposteromedial thalamic nuclei are critical to bilateral gustatory sensation .", "mt": "La perdita del gusto unilaterale è solitamente osservata sul lato contrattuale di un infarto thalamico , nonostante la funzione gustativa sia rappresentata bilateralmente . segnaliamo un raro caso di perdita del gusto bilaterale in un paziente con un infarto thalamico unilaterale sinistro acuto , con ipometabolio insulare sinistro unilaterale dimostrato dall' analisi statistica delle mappe parametriche delle immagini degli animali domestici . le nostre osservazioni suggeriscono che la corteccia insulare sinistra e il nucleo thalamico ventroposteromediale sinistro sono critici per la sensazione gustativa bilaterale .", "pert_mt": "La perdita del gusto unilaterale è solitamente osservata sul lato contrattuale di un infarto thalamico, nonostante la funzione gustativa sia rappresentata bilateralmente. Segnaliamo un raro caso di perdita del gusto bilaterale in un paziente con un infarto thalamico unilaterale sinistro acuto, con ipometabolismo insulare sinistro unilaterale dimostrato dall'analisi statistica delle mappe parametriche delle immagini degli animali domestici. Le nostre osservazioni suggeriscono che la corteccia insulare sinistra e il nucleo thalamico ventroposteromediale sinistro sono critici per la sensazione gustativa bilaterale.", "bt": "The loss of unilateral taste is usually observed on the contract side of a thalamic infarction, although the taste function is bilaterally represented.We report a rare case of bilateral taste loss in a patient with a severe acute unilateral thalamic infarction, with unilateral sinister insular hypothalamia demonstrated by statistical analysis of parametric maps of pet images.Our observations suggest that the left insular cortex and the left ventroposteromedial thalamic nucleus are critical to bilateral taste sensation.", "questions_src": ["What is usually observed on the side contralateral to a thalamic infarction?", "Who was reported to have a rare case of bilateral taste loss?", "Where was the left insular hypometabolism demonstrated?", "When did the patient have an acute left unilateral thalamic infarction?", "Which brain regions are critical to bilateral gustatory sensation according to your observations?"], "answers_src": ["the side contralateral", "a patient", "by statistical parametric map analysis of pet images", "an acute left unilateral thalamic infarction", "the left insular cortex and left ventroposteromedial thalamic nuclei"], "answers_bt": ["The taste function", "A patient", "In the left insular cortex and the left ventroposteromedial thalamic nucleus", "With a severe acute unilateral thalamic infarction", "The left insular cortex and the left ventroposteromedial thalamic nucleus"], "multiturn": {"turn_1": [{"question_id": "335.1", "question": "What is usually observed on the side contralateral to a thalamic infarction?", "answer_src": "the side contralateral", "follow_up_question": "What specific brain regions were found to be critical for bilateral gustatory sensation according to the observations?", "follow_up_response": "left insular cortex and left ventroposteromedial thalamic nuclei", "follow_up_response_bt": "left insular cortex and the left ventroposteromedial thalamic nucleus"}, {"question_id": "335.2", "question": "Who was reported to have a rare case of bilateral taste loss?", "answer_src": "a patient", "follow_up_question": "What specific brain region was found to be hypometabolic in this patient?", "follow_up_response": "Left insular cortex and left ventroposteromedial thalamic nuclei", "follow_up_response_bt": "Left insular cortex and the left ventroposteromedial thalamic nucleus"}, {"question_id": "335.3", "question": "Where was the left insular hypometabolism demonstrated?", "answer_src": "by statistical parametric map analysis of pet images", "follow_up_question": "What specific gustatory nuclei were found to be critical based on the study?", "follow_up_response": "left insular cortex and left ventroposteromedial thalamic nuclei", "follow_up_response_bt": "left insular cortex and the left ventroposteromedial thalamic nucleus"}, {"question_id": "335.4", "question": "When did the patient have an acute left unilateral thalamic infarction?", "answer_src": "an acute left unilateral thalamic infarction", "follow_up_question": "What specific brain regions were found to be critical for bilateral gustatory sensation according to the observations?", "follow_up_response": "left insular cortex and left ventroposteromedial thalamic nuclei", "follow_up_response_bt": "left insular cortex and the left ventroposteromedial thalamic nucleus"}, {"question_id": "335.5", "question": "Which brain regions are critical to bilateral gustatory sensation according to your observations?", "answer_src": "the left insular cortex and left ventroposteromedial thalamic nuclei", "follow_up_question": "What is the relationship between the left insular cortex and the left ventroposteromedial thalamic nuclei in processing gustatory sensation?", "follow_up_response": "The left insular cortex and left ventroposteromedial thalamic nuclei are critical to bilateral gustatory sensation.", "follow_up_response_bt": "The left insular cortex and the left ventroposteromedial thalamic nucleus are critical to bilateral taste sensation."}], "turn_2": [{"question_id": "335.6", "question": "What specific brain regions were found to be critical for bilateral gustatory sensation according to the observations?", "answer_src": "left insular cortex and left ventroposteromedial thalamic nuclei", "follow_up_question": "What was the pattern of gustatory function impairment observed in this patient?", "follow_up_response": "bilateral taste loss", "follow_up_response_bt": "Bilateral taste loss"}, {"question_id": "335.7", "question": "What specific brain region was found to be hypometabolic in this patient?", "answer_src": "Left insular cortex and left ventroposteromedial thalamic nuclei", "follow_up_question": "What role do these brain regions play in gustatory sensation according to the observations?", "follow_up_response": "The left insular cortex and left ventroposteromedial thalamic nuclei are critical to bilateral gustatory sensation.", "follow_up_response_bt": "The left insular cortex and the left ventroposteromedial thalamic nucleus are critical to bilateral taste sensation"}, {"question_id": "335.8", "question": "What specific gustatory nuclei were found to be critical based on the study?", "answer_src": "left insular cortex and left ventroposteromedial thalamic nuclei", "follow_up_question": "Which part of the brain showed reduced metabolic activity according to the PET images?", "follow_up_response": "Left insular cortex", "follow_up_response_bt": "Left insular cortex and the left ventroposteromedial thalamic nucleus"}, {"question_id": "335.9", "question": "What specific brain regions were found to be critical for bilateral gustatory sensation according to the observations?", "answer_src": "left insular cortex and left ventroposteromedial thalamic nuclei", "follow_up_question": "What was the pattern of gustatory function impairment observed in this patient?", "follow_up_response": "bilateral taste loss", "follow_up_response_bt": "Bilateral taste loss"}, {"question_id": "335.10", "question": "What is the relationship between the left insular cortex and the left ventroposteromedial thalamic nuclei in processing gustatory sensation?", "answer_src": "The left insular cortex and left ventroposteromedial thalamic nuclei are critical to bilateral gustatory sensation.", "follow_up_question": "How does the unilateral taste loss observed in this case relate to the findings of the left insular hypometabolism?", "follow_up_response": "The left insular cortex and left ventroposteromedial thalamic nuclei are critical to bilateral gustatory sensation, suggesting that the left insular hypometabolism may contribute to the observed bilateral taste loss.", "follow_up_response_bt": "The bilateral taste loss in the patient suggests that the left insular cortex and the left ventroposteromedial thalamic nucleus are critical to bilateral taste sensation, which relates to the findings of the left insular hypometabolism."}], "turn_3": [{"question_id": "335.11", "question": "What was the pattern of gustatory function impairment observed in this patient?", "answer_src": "bilateral taste loss", "follow_up_question": "Which brain regions were found to be critical for the bilateral gustatory sensation according to the study?", "follow_up_response": "left insular cortex and left ventroposteromedial thalamic nuclei", "follow_up_response_bt": "left insular cortex and the left ventroposteromedial thalamic nucleus"}, {"question_id": "335.12", "question": "What role do these brain regions play in gustatory sensation according to the observations?", "answer_src": "The left insular cortex and left ventroposteromedial thalamic nuclei are critical to bilateral gustatory sensation.", "follow_up_question": "How does this finding challenge the typical observation of unilateral taste loss in relation to thalamic infarctions?", "follow_up_response": "This finding challenges the typical observation of unilateral taste loss in relation to thalamic infarctions by reporting a case of bilateral taste loss in a patient with an acute left unilateral thalamic infarction.", "follow_up_response_bt": "This finding challenges the typical observation of unilateral taste loss by reporting a case of bilateral taste loss in a patient with a severe acute unilateral thalamic infarction."}, {"question_id": "335.13", "question": "Which part of the brain showed reduced metabolic activity according to the PET images?", "answer_src": "Left insular cortex", "follow_up_question": "What specific thalamic nuclei were found to be involved in the bilateral gustatory sensation?", "follow_up_response": "left ventroposteromedial thalamic nuclei", "follow_up_response_bt": "left insular cortex and the left ventroposteromedial thalamic nucleus"}, {"question_id": "335.14", "question": "What was the pattern of gustatory function impairment observed in this patient?", "answer_src": "bilateral taste loss", "follow_up_question": "Which brain regions were found to be critical for the bilateral gustatory sensation according to the study?", "follow_up_response": "left insular cortex and left ventroposteromedial thalamic nuclei", "follow_up_response_bt": "left insular cortex and the left ventroposteromedial thalamic nucleus"}, {"question_id": "335.15", "question": "How does the unilateral taste loss observed in this case relate to the findings of the left insular hypometabolism?", "answer_src": "The left insular cortex and left ventroposteromedial thalamic nuclei are critical to bilateral gustatory sensation, suggesting that the left insular hypometabolism may contribute to the observed bilateral taste loss.", "follow_up_question": "What specific role do the left insular cortex and left ventroposteromedial thalamic nuclei play in gustatory sensation according to the observations?", "follow_up_response": "The left insular cortex and left ventroposteromedial thalamic nuclei are critical to bilateral gustatory sensation.", "follow_up_response_bt": "The left insular cortex and the left ventroposteromedial thalamic nucleus are critical to bilateral taste sensation."}]}}
{"id": 336, "src": "the patients were randomised in two groups of 25 patients each to receive either dexmedetomidine 0.5 g / kg or tramadol 0.5 mg / kg as a slow intravenous bolus . grade of shivering , onset of shivering , time for cessation of shivering , recurrence , response rate , and adverse effects were observed at scheduled intervals . unpaired t - test was used for analysing the data.time taken for cessation of shivering was significantly less with dexmedetomidine when compared to tramadol .", "mt": "I pazienti sono stati randomizzati in due gruppi di 25 pazienti ciascuno per ricevere dexmedetomidina 0.5 g / kg o tramadol 0.5 mg / kg come un lento bolus endovenoso . grado di tremore , inizio di tremore , tempo per cessare il tremore , ricorrenza , tasso di risposta , e effetti avversi sono stati osservati ad intervalli pianificati . test t-unpaired è stato utilizzato per analizzare i dati.Il tempo impiegato per cessare il tremore è stato significativamente inferiore con dexmedetomidine rispetto al tramadol .", "pert_mt": "I pazienti sono stati randomizzati in due gruppi di 25 pazienti ciascuno per ricevere dexmedetomidina 0.5 g / kg o tramadol 0.5 mg / kg come un lento bolus endovenoso. grado di tremore, inizio di tremore, tempo per cessare il tremore, ricorrenza, tasso di risposta, effetti avversi, e mortalità sono stati osservati ad intervalli pianificati. test t-unpaired è stato utilizzato per analizzare i dati. Il tempo impiegato per cessare il tremore è stato significativamente inferiore con dexmedetomidine rispetto al tramadol.", "bt": "The degree of tremor, onset of tremor, time to stop tremor, frequency, response rate, adverse effects, and mortality were observed at planned intervals. t-unpaired testing was used to analyze the data. The time taken to stop tremor was significantly less with dexmedetomidine compared to tramadol.", "questions_src": ["What was the dose of dexmedetomidine given to the patients?", "When was the onset of shivering observed?", "Which group received tramadol 0.5 mg / kg as a slow intravenous bolus?", "What was the duration of shivering with dexmedetomidine compared to tramadol?", "Who observed the grade of shivering, onset, time for cessation, recurrence, response rate, and adverse effects?"], "answers_src": ["0.5 g / kg", "No Answer", "The other group", "less", "the patients"], "answers_bt": ["No Answer", "No Answer", "No Answer", "The time to stop tremor", "The degree of tremor, onset of tremor, time to stop tremor, frequency, response rate, adverse effects, and mortality"], "multiturn": {"turn_1": [{"question_id": "336.1", "question": "What was the dose of dexmedetomidine given to the patients?", "answer_src": "0.5 g / kg", "follow_up_question": "What was the dose of tramadol given to the patients?", "follow_up_response": "0.5 mg / kg", "follow_up_response_bt": "No Answer"}, {"question_id": "336.2", "question": "When was the onset of shivering observed?", "answer_src": "the patients were randomised in two groups of 25 patients each to receive either dexmedetomidine 0.5 g / kg or tramadol 0.5 mg / kg as a slow intravenous bolus . grade of shivering , onset of shivering , time for cessation of shivering , recurrence , response rate , and adverse effects were observed at scheduled intervals . unpaired t - test was used for analysing the data.time taken for cessation of shivering was significantly less with dexmedetomidine when compared to tramadol .", "follow_up_question": "What specific adverse effects were observed?", "follow_up_response": "No Answer", "follow_up_response_bt": "Adverse effects"}, {"question_id": "336.3", "question": "Which group received tramadol 0.5 mg / kg as a slow intravenous bolus?", "answer_src": "The other group", "follow_up_question": "What was the average time taken for cessation of shivering in the group that received dexmedetomidine?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "336.4", "question": "What was the duration of shivering with dexmedetomidine compared to tramadol?", "answer_src": "less", "follow_up_question": "How much shorter was the duration of shivering with dexmedetomidine compared to tramadol?", "follow_up_response": "time taken for cessation of shivering", "follow_up_response_bt": "No Answer"}, {"question_id": "336.5", "question": "Who observed the grade of shivering, onset, time for cessation, recurrence, response rate, and adverse effects?", "answer_src": "the patients", "follow_up_question": "What specific parameter showed a significant difference between the two groups?", "follow_up_response": "Time taken for cessation of shivering", "follow_up_response_bt": "Time to stop tremor"}], "turn_2": [{"question_id": "336.6", "question": "What was the dose of tramadol given to the patients?", "answer_src": "0.5 mg / kg", "follow_up_question": "What was the time taken for cessation of shivering with dexmedetomidine compared to tramadol?", "follow_up_response": "time taken for cessation of shivering was significantly less with dexmedetomidine when compared to tramadol.", "follow_up_response_bt": "The time to stop tremor"}, {"question_id": "336.7", "question": "What specific adverse effects were observed?", "answer_src": "the patients were randomised in two groups of 25 patients each to receive either dexmedetomidine 0.5 g / kg or tramadol 0.5 mg / kg as a slow intravenous bolus . grade of shivering , onset of shivering , time for cessation of shivering , recurrence , response rate , and adverse effects were observed at scheduled intervals . unpaired t - test was used for analysing the data.time taken for cessation of shivering was significantly less with dexmedetomidine when compared to tramadol .", "follow_up_question": "What were the specific adverse effects observed?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "336.8", "question": "What was the average time taken for cessation of shivering in the group that received dexmedetomidine?", "answer_src": "the patients were randomised in two groups of 25 patients each to receive either dexmedetomidine 0.5 g / kg or tramadol 0.5 mg / kg as a slow intravenous bolus . grade of shivering , onset of shivering , time for cessation of shivering , recurrence , response rate , and adverse effects were observed at scheduled intervals . unpaired t - test was used for analysing the data.time taken for cessation of shivering was significantly less with dexmedetomidine when compared to tramadol .", "follow_up_question": "What was the average time taken for cessation of shivering in the group that received tramadol?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "336.9", "question": "How much shorter was the duration of shivering with dexmedetomidine compared to tramadol?", "answer_src": "time taken for cessation of shivering", "follow_up_question": "What was the difference in minutes between the time taken for cessation of shivering with dexmedetomidine and tramadol?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "336.10", "question": "What specific parameter showed a significant difference between the two groups?", "answer_src": "Time taken for cessation of shivering", "follow_up_question": "What was the response rate for shivering in the group receiving dexmedetomidine?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "336.11", "question": "What was the time taken for cessation of shivering with dexmedetomidine compared to tramadol?", "answer_src": "time taken for cessation of shivering was significantly less with dexmedetomidine when compared to tramadol.", "follow_up_question": "What was the effect size of the difference in time taken for cessation of shivering between dexmedetomidine and tramadol?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "336.12", "question": "What were the specific adverse effects observed?", "answer_src": "the patients were randomised in two groups of 25 patients each to receive either dexmedetomidine 0.5 g / kg or tramadol 0.5 mg / kg as a slow intravenous bolus . grade of shivering , onset of shivering , time for cessation of shivering , recurrence , response rate , and adverse effects were observed at scheduled intervals . unpaired t - test was used for analysing the data.time taken for cessation of shivering was significantly less with dexmedetomidine when compared to tramadol .", "follow_up_question": "What were the specific grades of shivering observed?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "336.13", "question": "What was the average time taken for cessation of shivering in the group that received tramadol?", "answer_src": "the patients were randomised in two groups of 25 patients each to receive either dexmedetomidine 0.5 g / kg or tramadol 0.5 mg / kg as a slow intravenous bolus . grade of shivering , onset of shivering , time for cessation of shivering , recurrence , response rate , and adverse effects were observed at scheduled intervals . unpaired t - test was used for analysing the data.time taken for cessation of shivering was significantly less with dexmedetomidine when compared to tramadol .", "follow_up_question": "What was the time taken for cessation of shivering in the group that received dexmedetomidine?", "follow_up_response": "time for cessation of shivering was significantly less with dexmedetomidine when compared to tramadol.", "follow_up_response_bt": "The time to stop tremor"}, {"question_id": "336.14", "question": "What was the difference in minutes between the time taken for cessation of shivering with dexmedetomidine and tramadol?", "answer_src": "the patients were randomised in two groups of 25 patients each to receive either dexmedetomidine 0.5 g / kg or tramadol 0.5 mg / kg as a slow intravenous bolus . grade of shivering , onset of shivering , time for cessation of shivering , recurrence , response rate , and adverse effects were observed at scheduled intervals . unpaired t - test was used for analysing the data.time taken for cessation of shivering was significantly less with dexmedetomidine when compared to tramadol .", "follow_up_question": "How much shorter was the time taken for cessation of shivering with dexmedetomidine compared to tramadol?", "follow_up_response": "time taken for cessation of shivering", "follow_up_response_bt": "The time to stop tremor"}, {"question_id": "336.15", "question": "What was the response rate for shivering in the group receiving dexmedetomidine?", "answer_src": "the patients were randomised in two groups of 25 patients each to receive either dexmedetomidine 0.5 g / kg or tramadol 0.5 mg / kg as a slow intravenous bolus . grade of shivering , onset of shivering , time for cessation of shivering , recurrence , response rate , and adverse effects were observed at scheduled intervals . unpaired t - test was used for analysing the data.time taken for cessation of shivering was significantly less with dexmedetomidine when compared to tramadol .", "follow_up_question": "What was the time taken for cessation of shivering with dexmedetomidine compared to tramadol?", "follow_up_response": "time taken for cessation of shivering was significantly less with dexmedetomidine when compared to tramadol.", "follow_up_response_bt": "The time to stop tremor"}]}}
{"id": 337, "src": "when tissue - type plasminogen activator was added to acid - treated cells , plasmin generation was 2026-fold higher than that generated by u937 cells or peripheral blood neutrophils , respectively . we found that plasminogen bound to these cells can be detected by fluorescence - activated cell sorting using an antiplasminogen monoclonal antibody that specifically reacts with this antigen when it is bound to cell surfaces . all - trans retinoid acid treatment of nb4 cells markedly decreased the binding of this monoclonal antibody .", "mt": "Quando è stato aggiunto un attivatore plasminogeno di tipo tessuto alle cellule trattate con acido , la produzione di plasmina è stata 2026 volte superiore a quella generata da cellule u937 o neutrofili del sangue periferici , rispettivamente . abbiamo scoperto che il plasminogeno legato a queste cellule può essere rilevato mediante la classificazione cellulare attivata a fluorescenza utilizzando un anticorpo monoclonale antiplasminogeno che reagisce specificamente con questo antigene quando è legato alle superfici cellulari . Il trattamento con acido retinoide all-trans delle cellule nb4 ha notevolmente ridotto il legame di questo anticorpo monoclonale .", "pert_mt": "Quando è stato aggiunto un attivatore plasminogeno di tipo tessuto alle cellule trattate con acido, la produzione di plasmina è stata 2026 volte superiore a quella generata da cellule u937 o neutrofili del sangue periferici, rispettivamente. Abbiamo scoperto che il plasminogeno legato a queste cellule può essere rilevato mediante la classificazione cellulare attivata a fluorescenza utilizzando un anticorpo monoclonale antiplasminogeno che reagisce specificamente con questo antigene quando è legato alle superfici cellulari. Il trattamento con acido retinoide all-trans delle cellule nb4 ha notevolmente ridotto il legame di questo anticorpo monoclonale e ha migliorato significativamente le funzioni cellulari.", "bt": "When a tissue-type plasminogen activator was added to acid-treated cells, the production of plasma was 2026 times higher than that generated by u937 cell or peripheral blood neutrophils, respectively.We found that the plasminogen linked to these cells can be detected by classifying cells activated by fluorescence using a monoclonal antiplasminogen antibody that reacts specifically with this antigen when linked to cell surfaces.The all-trans retinoid acid treatment of nb4 cells has significantly reduced the binding of this monoclonal antibody and significantly improved cellular function.", "questions_src": ["When was tissue-type plasminogen activator added to the cells?", "What did we find about the binding of plasminogen to the treated cells?", "Which monoclonal antibody was used to detect plasminogen bound to the cells?", "Where was the all-trans retinoid acid treatment applied?", "Which cells showed a marked decrease in the binding of the monoclonal antibody?"], "answers_src": ["When tissue-type plasminogen activator was added to the cells.", "We found that plasminogen bound to these cells can be detected by fluorescence-activated cell sorting using an antiplasminogen monoclonal antibody that specifically reacts with this antigen when it is bound to cell surfaces.", "An antiplasminogen monoclonal antibody", "To nb4 cells", "To nb4 cells"], "answers_bt": ["When a tissue-type plasminogen activator was added to acid-treated cells", "We found that the plasminogen linked to these cells can be detected", "A monoclonal antiplasminogen antibody", "To nb4 cells", "Nb4 cells"], "multiturn": {"turn_1": [{"question_id": "337.1", "question": "When was tissue-type plasminogen activator added to the cells?", "answer_src": "When tissue-type plasminogen activator was added to the cells.", "follow_up_question": "How much higher was the plasmin generation compared to u937 cells and peripheral blood neutrophils?", "follow_up_response": "2026-fold", "follow_up_response_bt": "2026"}, {"question_id": "337.2", "question": "What did we find about the binding of plasminogen to the treated cells?", "answer_src": "We found that plasminogen bound to these cells can be detected by fluorescence-activated cell sorting using an antiplasminogen monoclonal antibody that specifically reacts with this antigen when it is bound to cell surfaces.", "follow_up_question": "How does all-trans retinoid acid treatment affect the binding of the monoclonal antibody to the cells?", "follow_up_response": "markedly decreases", "follow_up_response_bt": "Significantly reduces"}, {"question_id": "337.3", "question": "Which monoclonal antibody was used to detect plasminogen bound to the cells?", "answer_src": "An antiplasminogen monoclonal antibody", "follow_up_question": "What specific property of the monoclonal antibody allows it to detect bound plasminogen?", "follow_up_response": "It specifically reacts with this antigen when it is bound to cell surfaces.", "follow_up_response_bt": "It reacts specifically with the antigen linked to cell surfaces"}, {"question_id": "337.4", "question": "Where was the all-trans retinoid acid treatment applied?", "answer_src": "To nb4 cells", "follow_up_question": "What effect did all-trans retinoid acid treatment have on the binding of the monoclonal antibody?", "follow_up_response": "markedly decreased", "follow_up_response_bt": "Significantly reduced"}, {"question_id": "337.5", "question": "Which cells showed a marked decrease in the binding of the monoclonal antibody?", "answer_src": "To nb4 cells", "follow_up_question": "What effect did all-trans retinoid acid treatment have on the plasmin generation in nb4 cells?", "follow_up_response": "All-trans retinoid acid treatment markedly decreased the binding of the monoclonal antibody", "follow_up_response_bt": "Significantly reduced the binding of the monoclonal antibody"}], "turn_2": [{"question_id": "337.6", "question": "How much higher was the plasmin generation compared to u937 cells and peripheral blood neutrophils?", "answer_src": "2026-fold", "follow_up_question": "By how many times was the binding of the monoclonal antibody to tissue-type plasminogen activator reduced after all-trans retinoid acid treatment?", "follow_up_response": "2026", "follow_up_response_bt": "1"}, {"question_id": "337.7", "question": "How does all-trans retinoid acid treatment affect the binding of the monoclonal antibody to the cells?", "answer_src": "markedly decreases", "follow_up_question": "What is the effect of all-trans retinoid acid treatment on the plasmin generation in acid-treated cells?", "follow_up_response": "No Answer", "follow_up_response_bt": "Significantly reduced the binding of the monoclonal antibody"}, {"question_id": "337.8", "question": "What specific property of the monoclonal antibody allows it to detect bound plasminogen?", "answer_src": "It specifically reacts with this antigen when it is bound to cell surfaces.", "follow_up_question": "How does all-trans retinoid acid treatment affect the detection of bound plasminogen?", "follow_up_response": "Decreases", "follow_up_response_bt": "It significantly reduces the binding of the monoclonal antibody"}, {"question_id": "337.9", "question": "What effect did all-trans retinoid acid treatment have on the binding of the monoclonal antibody?", "answer_src": "markedly decreased", "follow_up_question": "How much did the binding of the monoclonal antibody decrease after all-trans retinoid acid treatment?", "follow_up_response": "All-trans retinoid acid treatment", "follow_up_response_bt": "Significantly decreased"}, {"question_id": "337.10", "question": "What effect did all-trans retinoid acid treatment have on the plasmin generation in nb4 cells?", "answer_src": "All-trans retinoid acid treatment markedly decreased the binding of the monoclonal antibody", "follow_up_question": "How did all-trans retinoid acid treatment affect the plasminogen binding to nb4 cells?", "follow_up_response": "markedly decreased", "follow_up_response_bt": "Significantly reduced"}], "turn_3": [{"question_id": "337.11", "question": "By how many times was the binding of the monoclonal antibody to tissue-type plasminogen activator reduced after all-trans retinoid acid treatment?", "answer_src": "2026", "follow_up_question": "By what factor did the plasmin generation decrease in u937 cells compared to tissue-type plasminogen activator?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "337.12", "question": "What is the effect of all-trans retinoid acid treatment on the plasmin generation in acid-treated cells?", "answer_src": "when tissue - type plasminogen activator was added to acid - treated cells , plasmin generation was 2026-fold higher than that generated by u937 cells or peripheral blood neutrophils , respectively . we found that plasminogen bound to these cells can be detected by fluorescence - activated cell sorting using an antiplasminogen monoclonal antibody that specifically reacts with this antigen when it is bound to cell surfaces . all - trans retinoid acid treatment of nb4 cells markedly decreased the binding of this monoclonal antibody .", "follow_up_question": "How did all-trans retinoid acid treatment affect the detection of plasminogen bound to nb4 cells using the antiplasminogen monoclonal antibody?", "follow_up_response": "markedly decreased", "follow_up_response_bt": "Significantly reduced the binding of this monoclonal antibody"}, {"question_id": "337.13", "question": "How does all-trans retinoid acid treatment affect the detection of bound plasminogen?", "answer_src": "Decreases", "follow_up_question": "How much does all-trans retinoid acid treatment decrease the binding of the monoclonal antibody?", "follow_up_response": "Markedly decreases", "follow_up_response_bt": "Significantly"}, {"question_id": "337.14", "question": "How much did the binding of the monoclonal antibody decrease after all-trans retinoid acid treatment?", "answer_src": "All-trans retinoid acid treatment", "follow_up_question": "By what percentage did the binding of the monoclonal antibody decrease after all-trans retinoid acid treatment?", "follow_up_response": "No Answer", "follow_up_response_bt": "100"}, {"question_id": "337.15", "question": "How did all-trans retinoid acid treatment affect the plasminogen binding to nb4 cells?", "answer_src": "markedly decreased", "follow_up_question": "What specific effect did all-trans retinoid acid treatment have on the amount of plasminogen bound to nb4 cells?", "follow_up_response": "It markedly decreased the binding of this monoclonal antibody", "follow_up_response_bt": "Significantly reduced the binding of this monoclonal antibody"}]}}
{"id": 338, "src": "knockdown of crip2 induced a heart - looping defect in zebrafish embryos , although the development of cardiac chambers appeared to be normal . in the avc of crip2-deficient embryos , the expression of both versican a and hyaluronan synthase 2 ( has2 ) was highly upregulated , but the expression of bone morphogenetic protein 4 ( bmp4 ) and t - box 2b ( tbx2b ) in the myocardium and of notch1b in the endocardium in the avc did not change . taken together , these results indicate that crip2 plays an important role in av valve development by downregulating the expression of ecm components in the endocardial cushion .", "mt": "Nel comparto di embrioni crip2-deficienti, l'espressione sia di versican a che di hyaluronan synthase 2 (has2 ) era fortemente rialzata , ma l'espressione di proteine morfogenetiche ossee 4 (bmp4 ) e t - box 2b ( tbx2b) nel miocardio e di notch1b nell'endocardio nell'endocardio non sono cambiate . Insieme, questi risultati indicano che crip2 svolge un ruolo importante nello sviluppo della valvola av abbattente riducendo l'espressione dei componenti ecm nel cuscino endocardio .", "pert_mt": "Nel comparto di embrioni crip2-deficienti, l'espressione sia di versican a che di hyaluronan synthase 2 (has2 ) era fortemente rialzata, ma l'espressione di proteine morfogenetiche ossee 4 (bmp4 ) e t-box 2b (tbx2b) nel miocardio e di notch1b nell'endocardio non sono cambiate. Insieme, questi risultati indicano che crip2 svolge un ruolo importante nello sviluppo della valvola av abbattente riducendo l'espressione dei componenti ecm nel cuscino endocardio e modificando l'espressione di gene cardiaci cruciali.", "bt": "In comparison with crip2-deficient embryos, both versionan and hyaluronan synthase 2 (has2 ) expression was strongly enhanced, but the expression of bone morphogenetic proteins bone 4 (bmp4) and t-box 2b (tbx2b) in the myocardium and notch1b in the endocardium were unchanged.Together, these results indicate that crip2 plays an important role in the development of the abdominal valve by reducing expression of the ecm components in the endocardial cushion gene and modifying the expression of crucial cardiac functions.", "questions_src": ["What is the name of the gene knocked down in the zebrafish embryos?", "What developmental defect was observed in the heart of crip2-deficient embryos?", "Which ECM components had their expression highly upregulated in the AVC of crip2-deficient embryos?", "Which genes' expression in the myocardium and endocardium did not change in the crip2-deficient embryos?", "When did the researchers observe the heart-looping defect in the zebrafish embryos?"], "answers_src": ["crip2", "heart-looping defect", "versican A and hyaluronan synthase 2 (has2)", "bone morphogenetic protein 4 (bmp4) and t-box 2b (tbx2b)", "taken together"], "answers_bt": ["crip2", "abdominal valve", "bone morphogenetic proteins and hyaluronan synthase 2", "bone morphogenetic proteins (bmp4) and t-box 2b (tbx2b)", "heart-looping defect"], "multiturn": {"turn_1": [{"question_id": "338.1", "question": "What is the name of the gene knocked down in the zebrafish embryos?", "answer_src": "crip2", "follow_up_question": "What ECM components were found to be upregulated in the AVC of crip2-deficient embryos?", "follow_up_response": "versican a and hyaluronan synthase 2 (has2)", "follow_up_response_bt": "bone morphogenetic proteins bone 4 (bmp4) and t-box 2b (tbx2b)"}, {"question_id": "338.2", "question": "What developmental defect was observed in the heart of crip2-deficient embryos?", "answer_src": "heart-looping defect", "follow_up_question": "What ECM components were found to be upregulated in the AVC of crip2-deficient embryos?", "follow_up_response": "versican a and hyaluronan synthase 2 (has2)", "follow_up_response_bt": "bone morphogenetic proteins bone 4 (bmp4) and t-box 2b (tbx2b)"}, {"question_id": "338.3", "question": "Which ECM components had their expression highly upregulated in the AVC of crip2-deficient embryos?", "answer_src": "versican A and hyaluronan synthase 2 (has2)", "follow_up_question": "Which BMP and TBX proteins showed no change in expression in the AVC of crip2-deficient embryos?", "follow_up_response": "bone morphogenetic protein 4 ( bmp4 ) and t - box 2b ( tbx2b )", "follow_up_response_bt": "bone 4 (bmp4) and t-box 2b (tbx2b)"}, {"question_id": "338.4", "question": "Which genes' expression in the myocardium and endocardium did not change in the crip2-deficient embryos?", "answer_src": "bone morphogenetic protein 4 (bmp4) and t-box 2b (tbx2b)", "follow_up_question": "Which ECM component's expression in the endocardium did not change in the crip2-deficient embryos?", "follow_up_response": "bone morphogenetic protein 4 ( bmp4 ) and t - box 2b ( tbx2b )", "follow_up_response_bt": "bone morphogenetic proteins bone 4 (bmp4) and t-box 2b (tbx2b)"}, {"question_id": "338.5", "question": "When did the researchers observe the heart-looping defect in the zebrafish embryos?", "answer_src": "taken together", "follow_up_question": "What specific ECM components were downregulated in the endocardial cushion according to the study?", "follow_up_response": "versican a and hyaluronan synthase 2 (has2)", "follow_up_response_bt": "ecm components"}], "turn_2": [{"question_id": "338.6", "question": "What ECM components were found to be upregulated in the AVC of crip2-deficient embryos?", "answer_src": "versican a and hyaluronan synthase 2 (has2)", "follow_up_question": "What ECM components were found to remain unchanged in the AVC of crip2-deficient embryos?", "follow_up_response": "bone morphogenetic protein 4 ( bmp4 ) and t - box 2b ( tbx2b )", "follow_up_response_bt": "bone morphogenetic proteins bone 4 (bmp4) and t-box 2b (tbx2b)"}, {"question_id": "338.7", "question": "What ECM components were found to be upregulated in the AVC of crip2-deficient embryos?", "answer_src": "versican a and hyaluronan synthase 2 (has2)", "follow_up_question": "What ECM components were found to remain unchanged in the AVC of crip2-deficient embryos?", "follow_up_response": "bone morphogenetic protein 4 ( bmp4 ) and t - box 2b ( tbx2b )", "follow_up_response_bt": "bone morphogenetic proteins bone 4 (bmp4) and t-box 2b (tbx2b)"}, {"question_id": "338.8", "question": "Which BMP and TBX proteins showed no change in expression in the AVC of crip2-deficient embryos?", "answer_src": "bone morphogenetic protein 4 ( bmp4 ) and t - box 2b ( tbx2b )", "follow_up_question": "Which ECM component showed highly upregulated expression in the AVC of crip2-deficient embryos?", "follow_up_response": "versican a and hyaluronan synthase 2 (has2)", "follow_up_response_bt": "bone morphogenetic proteins bone 4 (bmp4) and t-box 2b (tbx2b)"}, {"question_id": "338.9", "question": "Which ECM component's expression in the endocardium did not change in the crip2-deficient embryos?", "answer_src": "bone morphogenetic protein 4 ( bmp4 ) and t - box 2b ( tbx2b )", "follow_up_question": "Which ECM component's expression in the myocardium did not change in the crip2-deficient embryos?", "follow_up_response": "bone morphogenetic protein 4 ( bmp4 )", "follow_up_response_bt": "bone morphogenetic proteins bone 4 (bmp4) and t-box 2b (tbx2b)"}, {"question_id": "338.10", "question": "What specific ECM components were downregulated in the endocardial cushion according to the study?", "answer_src": "versican a and hyaluronan synthase 2 (has2)", "follow_up_question": "What was the effect of this downregulation on the AV valve development?", "follow_up_response": "crip2 plays an important role in AV valve development by downregulating the expression of ECM components in the endocardial cushion.", "follow_up_response_bt": "reducing expression of the ECM components in the endocardial cushion gene"}], "turn_3": [{"question_id": "338.11", "question": "What ECM components were found to remain unchanged in the AVC of crip2-deficient embryos?", "answer_src": "bone morphogenetic protein 4 ( bmp4 ) and t - box 2b ( tbx2b )", "follow_up_question": "What ECM components were found to be highly upregulated in the AVC of crip2-deficient embryos?", "follow_up_response": "versican a and hyaluronan synthase 2 (has2)", "follow_up_response_bt": "bone morphogenetic proteins bone 4 (bmp4) and t-box 2b (tbx2b)"}, {"question_id": "338.12", "question": "What ECM components were found to remain unchanged in the AVC of crip2-deficient embryos?", "answer_src": "bone morphogenetic protein 4 ( bmp4 ) and t - box 2b ( tbx2b )", "follow_up_question": "What ECM components were found to be highly upregulated in the AVC of crip2-deficient embryos?", "follow_up_response": "versican a and hyaluronan synthase 2 (has2)", "follow_up_response_bt": "bone morphogenetic proteins bone 4 (bmp4) and t-box 2b (tbx2b)"}, {"question_id": "338.13", "question": "Which ECM component showed highly upregulated expression in the AVC of crip2-deficient embryos?", "answer_src": "versican a and hyaluronan synthase 2 (has2)", "follow_up_question": "Which BMP4 and T-box 2B expression levels did not change in the myocardium of crip2-deficient embryos?", "follow_up_response": "No Answer", "follow_up_response_bt": "unchanged"}, {"question_id": "338.14", "question": "Which ECM component's expression in the myocardium did not change in the crip2-deficient embryos?", "answer_src": "bone morphogenetic protein 4 ( bmp4 )", "follow_up_question": "Which ECM component's expression in the endocardium did not change in the crip2-deficient embryos?", "follow_up_response": "bone morphogenetic protein 4 ( bmp4 ) and t - box 2b ( tbx2b )", "follow_up_response_bt": "bone morphogenetic proteins bone 4 (bmp4) and t-box 2b (tbx2b)"}, {"question_id": "338.15", "question": "What was the effect of this downregulation on the AV valve development?", "answer_src": "crip2 plays an important role in AV valve development by downregulating the expression of ECM components in the endocardial cushion.", "follow_up_question": "How does crip2 downregulation affect the expression levels of ECM components in the endocardial cushion?", "follow_up_response": "by downregulating the expression of ecm components", "follow_up_response_bt": "reducing expression"}]}}
{"id": 339, "src": "mean age of patients was 44.72 12.46 , and male : female ratio was 1:6 . the most common presenting features were nephrolithiasis and/or nephrocalcinosis ( 64.10% ) , bone pain ( 44.1% ) , abdominal pain ( 39% ) , constipation ( 26% ) , and myopathy ( 14.10% ) . fractures were present only in 10.25% , and brown tumors in 6.41% patients .", "mt": "L'età media dei pazienti era di 44,72 anni , 12,46 anni , e il rapporto maschio: femmina era di 1:6 . Le caratteristiche più comuni erano la nefrollitiasi e/o la nefrocalcinosi (64,10%), il dolore osseo (44,1%), il dolore addominale (39%), la costipazione (26%) e la miopatia (14.10%).", "pert_mt": "L'età media dei pazienti era di 44,72 anni, 12,46 anni, e il rapporto maschio: femmina era di 1:6. Le caratteristiche più comuni erano la nefrollitiasi e/o la nefrocalcinosi (64,10%), il dolore osseo (44,1%), il dolore addominale (39%), la costipazione (26%), la miopatia (14,10%), e la febbre (5%).", "bt": "The average age of the patients was 44.72 years, 12.46 years, and the male to female ratio was 1:6.The most common characteristics were nephrolytiasis and/or nephrocalcinosis (64.10%), bone pain (44.1%), abdominal pain (39%), constipation (26%), myopathy (14.10%), and fever (5%).", "questions_src": ["[\"What was the mean age of the patients?\", \"What was the male : female ratio?\", \"What were the most common presenting features?\", \"What percentage of patients had fractures?\", \"What percentage of patients had brown tumors?\"]}"], "answers_src": ["44.72 12.46"], "answers_bt": ["44.72 years"], "multiturn": {"turn_1": [{"question_id": "339.1", "question": "[\"What was the mean age of the patients?\", \"What was the male : female ratio?\", \"What were the most common presenting features?\", \"What percentage of patients had fractures?\", \"What percentage of patients had brown tumors?\"]}", "answer_src": "44.72 12.46", "follow_up_question": "What was the percentage of patients with bone pain?", "follow_up_response": "44.1%", "follow_up_response_bt": "44.1%"}], "turn_2": [{"question_id": "339.2", "question": "What was the percentage of patients with bone pain?", "answer_src": "44.1%", "follow_up_question": "What was the percentage of patients with abdominal pain?", "follow_up_response": "39%", "follow_up_response_bt": "39%"}], "turn_3": [{"question_id": "339.3", "question": "What was the percentage of patients with abdominal pain?", "answer_src": "39%", "follow_up_question": "What was the percentage of patients with constipation?", "follow_up_response": "26%", "follow_up_response_bt": "26%"}]}}
{"id": 340, "src": "abstractthis article describes the aetiology , epidemiology and clinical significance of incidental non - solid pulmonary nodules . non - solid nodules are more likely malignant . if malignant , they are mostly due to atypical adenomatous hyperplasia and bronchioloalveolar carcinoma .", "mt": "Questo articolo descrive l'etiologia , l'epidemiologia e il significato clinico dei noduli polmonari non solidi incidentali . I noduli non solidi sono più probabili maligni . Se maligni , sono principalmente dovuti ad iperplasia adenomatica atipica e carcinoma bronchioloalveolare .", "pert_mt": "Questo articolo descrive l'etiologia, l'epidemiologia e il significato clinico dei noduli polmonari non solidi incidentali. I noduli non solidi sono più probabili maligni. Se maligni, sono principalmente dovuti ad iperplasia adenomatica atipica e carcinoma bronchioloalveolare, ma possono anche essere dovuti a infezioni preesistenti.", "bt": "This article describes the etiology, epidemiology and clinical significance of incidental non-solid lung nodules, which are more likely to be malignant, and are primarily due to atypical adenomatic hyperplasia and bronchioloalveolar carcinoma, but may also be due to pre-existing infections.", "questions_src": ["What is the main focus of this article?", "Who are more likely to have malignant non-solid pulmonary nodules?", "Where can these nodules typically be found in the body?", "When might an incidental non-solid pulmonary nodule be discovered?", "Which two conditions are most commonly associated with malignant non-solid pulmonary nodules?"], "answers_src": ["The aetiology, epidemiology and clinical significance of incidental non-solid pulmonary nodules", "Non-solid nodules", "In the lungs", "Incidentally", "Atypical adenomatous hyperplasia and bronchioloalveolar carcinoma"], "answers_bt": ["[\"The etiology, epidemiology and clinical significance of incidental non-solid lung nodules\"], [\"People who have these nodules are more likely to be malignant\"], [\"In the body\"], [\"Incidentally\"], [\"Atypical adenomatic hyperplasia and bronchioloalveolar carcinoma\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "multiturn": {"turn_1": [{"question_id": "340.1", "question": "What is the main focus of this article?", "answer_src": "The aetiology, epidemiology and clinical significance of incidental non-solid pulmonary nodules", "follow_up_question": "What percentage of malignant non-solid nodules are due to atypical adenomatous hyperplasia?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "340.2", "question": "Who are more likely to have malignant non-solid pulmonary nodules?", "answer_src": "Non-solid nodules", "follow_up_question": "What are the two main causes of malignant non-solid pulmonary nodules mentioned in the text?", "follow_up_response": "Atypical adenomatous hyperplasia and bronchioloalveolar carcinoma", "follow_up_response_bt": "Atypical adenomatic hyperplasia and bronchioloalveolar carcinoma"}, {"question_id": "340.3", "question": "Where can these nodules typically be found in the body?", "answer_src": "In the lungs", "follow_up_question": "What is the likelihood of these non-solid nodules being malignant?", "follow_up_response": "Non-solid nodules are more likely malignant.", "follow_up_response_bt": "More likely"}, {"question_id": "340.4", "question": "When might an incidental non-solid pulmonary nodule be discovered?", "answer_src": "Incidentally", "follow_up_question": "What is the likelihood of an incidental non-solid pulmonary nodule being malignant?", "follow_up_response": "Non-solid nodules are more likely malignant.", "follow_up_response_bt": "More likely"}, {"question_id": "340.5", "question": "Which two conditions are most commonly associated with malignant non-solid pulmonary nodules?", "answer_src": "Atypical adenomatous hyperplasia and bronchioloalveolar carcinoma", "follow_up_question": "What percentage or likelihood is stated for non-solid nodules being malignant?", "follow_up_response": "more likely", "follow_up_response_bt": "more likely"}], "turn_2": [{"question_id": "340.6", "question": "What percentage of malignant non-solid nodules are due to atypical adenomatous hyperplasia?", "answer_src": "abstractthis article describes the aetiology , epidemiology and clinical significance of incidental non - solid pulmonary nodules . non - solid nodules are more likely malignant . if malignant , they are mostly due to atypical adenomatous hyperplasia and bronchioloalveolar carcinoma .", "follow_up_question": "What is the other cause of malignancy for non-solid nodules mentioned in the text?", "follow_up_response": "Atypical adenomatous hyperplasia and bronchioloalveolar carcinoma", "follow_up_response_bt": "atypical adenomatic hyperplasia and bronchioloalveolar carcinoma"}, {"question_id": "340.7", "question": "What are the two main causes of malignant non-solid pulmonary nodules mentioned in the text?", "answer_src": "Atypical adenomatous hyperplasia and bronchioloalveolar carcinoma", "follow_up_question": "What percentage of malignant non-solid pulmonary nodules are due to atypical adenomatous hyperplasia?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "340.8", "question": "What is the likelihood of these non-solid nodules being malignant?", "answer_src": "Non-solid nodules are more likely malignant.", "follow_up_question": "What specific conditions cause non-solid nodules to be mostly malignant?", "follow_up_response": "atypical adenomatous hyperplasia and bronchioloalveolar carcinoma", "follow_up_response_bt": "Atypical adenomatic hyperplasia and bronchioloalveolar carcinoma"}, {"question_id": "340.9", "question": "What is the likelihood of an incidental non-solid pulmonary nodule being malignant?", "answer_src": "Non-solid nodules are more likely malignant.", "follow_up_question": "What specific conditions cause non-solid nodules to be mostly malignant?", "follow_up_response": "atypical adenomatous hyperplasia and bronchioloalveolar carcinoma", "follow_up_response_bt": "Atypical adenomatic hyperplasia and bronchioloalveolar carcinoma"}, {"question_id": "340.10", "question": "What percentage or likelihood is stated for non-solid nodules being malignant?", "answer_src": "more likely", "follow_up_question": "What specific conditions cause non-solid nodules to be mostly malignant?", "follow_up_response": "atypical adenomatous hyperplasia and bronchioloalveolar carcinoma", "follow_up_response_bt": "Atypical adenomatic hyperplasia and bronchioloalveolar carcinoma"}], "turn_3": [{"question_id": "340.11", "question": "What is the other cause of malignancy for non-solid nodules mentioned in the text?", "answer_src": "Atypical adenomatous hyperplasia and bronchioloalveolar carcinoma", "follow_up_question": "What percentage or likelihood is stated for non-solid nodules being malignant?", "follow_up_response": "more likely", "follow_up_response_bt": "more likely"}, {"question_id": "340.12", "question": "What percentage of malignant non-solid pulmonary nodules are due to atypical adenomatous hyperplasia?", "answer_src": "abstractthis article describes the aetiology , epidemiology and clinical significance of incidental non - solid pulmonary nodules . non - solid nodules are more likely malignant . if malignant , they are mostly due to atypical adenomatous hyperplasia and bronchioloalveolar carcinoma .", "follow_up_question": "What is the other cause of malignancy for non-solid pulmonary nodules mentioned in the text?", "follow_up_response": "atypical adenomatous hyperplasia and bronchioloalveolar carcinoma", "follow_up_response_bt": "pre-existing infections"}, {"question_id": "340.13", "question": "What specific conditions cause non-solid nodules to be mostly malignant?", "answer_src": "atypical adenomatous hyperplasia and bronchioloalveolar carcinoma", "follow_up_question": "What percentage or prevalence is attributed to atypical adenomatous hyperplasia among malignant non-solid nodules?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "340.14", "question": "What specific conditions cause non-solid nodules to be mostly malignant?", "answer_src": "atypical adenomatous hyperplasia and bronchioloalveolar carcinoma", "follow_up_question": "What percentage or prevalence is attributed to atypical adenomatous hyperplasia among malignant non-solid nodules?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "340.15", "question": "What specific conditions cause non-solid nodules to be mostly malignant?", "answer_src": "atypical adenomatous hyperplasia and bronchioloalveolar carcinoma", "follow_up_question": "What percentage or prevalence is attributed to atypical adenomatous hyperplasia among malignant non-solid nodules?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
{"id": 341, "src": "recent research has provided novel insights into a central role for foxo3a and foxm1 in dna damage response . the foxo3a - foxm1 axis plays a pivotal role in dna damage repair and the accompanied cellular response through regulating the expression of genes essential for dna damage sensing , mediating , signalling and repair as well as for senescence , cell cycle and cell death control . in this manner , the foxo3a - foxm1 axis also holds the key to cell fate decision in response to genotoxic therapeutic agents and controls the equilibrium between dna repair and cell termination by cell death or senescence .", "mt": "Recenti ricerche hanno fornito nuove informazioni sul ruolo centrale di foxo3a e foxm1 nella risposta ai danni al DNA . L'asse foxo3a - foxm1 svolge un ruolo fondamentale nella riparazione dei danni al DNA e nella risposta cellulare che lo accompagna attraverso la regolazione dell'espressione dei geni essenziali per il rilevamento del danno al DNA , la mediazione , la segnalazione e la riparazione , nonché per la senescenza , il ciclo cellulare e il controllo della morte cellulare . In questo modo , l'asse foxo3a - foxm1 detiene anche la chiave per la decisione del destino cellulare in risposta agli agenti genotossimi terapeutici e controlla l'equilibrio tra la riparazione del DNA e la terminazione per via di morte cellulare o senescenza .", "pert_mt": "Recenti ricerche hanno fornito nuove informazioni sul ruolo centrale di foxo3a e foxm1 nella risposta ai danni al DNA. L'asse foxo3a - foxm1 svolge un ruolo fondamentale nella riparazione dei danni al DNA e nella risposta cellulare che lo accompagna attraverso la regolazione dell'espressione dei geni essenziali per il rilevamento del danno al DNA, la mediazione, la segnalazione e la riparazione, nonché per la senescenza, il ciclo cellulare e il controllo della morte cellulare, e per la regolazione dell'espressione dei geni associati alla crescita cellulare. In questo modo, l'asse foxo3a - foxm1 detiene anche la chiave per la decisione del destino cellulare in risposta agli agenti genotossimi terapeut", "bt": "Recent research has provided new information about the central role of foxo3a and foxm1 in DNA damage response.The foxo3a-foxm1 axis plays a fundamental role in DNA damage repair and in the cell response that accompanies it through the regulation of gene expression essential for DNA damage detection, mediation, signaling and repair, as well as for senescence, cell cycle and cell death control, and for the regulation of gene expression associated with cell growth.Thus, the foxo3a-foxm1 axis also holds the key to cell fate decision in response to therapeutic genomes.", "questions_src": ["What is the central role of foxo3a and foxm1 in DNA damage response?", "When does the foxo3a-foxm1 axis play a pivotal role?", "Where do genes essential for DNA damage sensing, mediating, signalling and repair as well as for senescence, cell cycle and cell death control get regulated by the foxo3a-foxm1 axis?", "Which therapeutic agents can influence cell fate through the foxo3a-foxm1 axis?", "Which processes are controlled by the foxo3a-foxm1 axis in response to DNA damage and cell death?"], "answers_src": ["[\"in DNA damage response\"], [\"in response to DNA damage\"], [\"through regulating the expression of genes essential for DNA damage sensing, mediating, signalling and repair as well as for senescence, cell cycle and cell death control\"], [\"genotoxic therapeutic agents\"], [\"DNA damage sensing, mediating, signalling and repair as well as for senescence, cell cycle and cell death control\"]", "No Answer", "No Answer", "No Answer", "No Answer"], "answers_bt": ["in DNA damage response", "through the regulation of gene expression", "in the cell response that accompanies it", "therapeutic genomes", "DNA damage detection, mediation, signaling and repair, as well as for senescence, cell cycle and cell death control"], "multiturn": {"turn_1": [{"question_id": "341.1", "question": "What is the central role of foxo3a and foxm1 in DNA damage response?", "answer_src": "[\"in DNA damage response\"], [\"in response to DNA damage\"], [\"through regulating the expression of genes essential for DNA damage sensing, mediating, signalling and repair as well as for senescence, cell cycle and cell death control\"], [\"genotoxic therapeutic agents\"], [\"DNA damage sensing, mediating, signalling and repair as well as for senescence, cell cycle and cell death control\"]", "follow_up_question": "How do foxo3a and foxm1 regulate DNA damage sensing?", "follow_up_response": "through regulating the expression of genes essential for DNA damage sensing", "follow_up_response_bt": "Through the regulation of gene expression essential for DNA damage detection"}, {"question_id": "341.2", "question": "When does the foxo3a-foxm1 axis play a pivotal role?", "answer_src": "recent research has provided novel insights into a central role for foxo3a and foxm1 in dna damage response . the foxo3a - foxm1 axis plays a pivotal role in dna damage repair and the accompanied cellular response through regulating the expression of genes essential for dna damage sensing , mediating , signalling and repair as well as for senescence , cell cycle and cell death control . in this manner , the foxo3a - foxm1 axis also holds the key to cell fate decision in response to genotoxic therapeutic agents and controls the equilibrium between dna repair and cell termination by cell death or senescence .", "follow_up_question": "What processes does the foxo3a-foxm1 axis regulate?", "follow_up_response": "DNA damage sensing, mediating, signalling and repair as well as for senescence, cell cycle and cell death control", "follow_up_response_bt": "DNA damage detection, mediation, signaling and repair, as well as for senescence, cell cycle and cell death control, and for the regulation of gene expression associated with cell growth"}, {"question_id": "341.3", "question": "Where do genes essential for DNA damage sensing, mediating, signalling and repair as well as for senescence, cell cycle and cell death control get regulated by the foxo3a-foxm1 axis?", "answer_src": "recent research has provided novel insights into a central role for foxo3a and foxm1 in dna damage response . the foxo3a - foxm1 axis plays a pivotal role in dna damage repair and the accompanied cellular response through regulating the expression of genes essential for dna damage sensing , mediating , signalling and repair as well as for senescence , cell cycle and cell death control . in this manner , the foxo3a - foxm1 axis also holds the key to cell fate decision in response to genotoxic therapeutic agents and controls the equilibrium between dna repair and cell termination by cell death or senescence .", "follow_up_question": "How does the foxo3a-foxm1 axis influence the equilibrium between DNA repair and cell termination?", "follow_up_response": "The foxo3a-foxm1 axis holds the key to cell fate decision in response to genotoxic therapeutic agents and controls the equilibrium between DNA repair and cell termination by cell death or senescence.", "follow_up_response_bt": "The foxo3a-foxm1 axis influences the equilibrium between DNA repair and cell termination by regulating gene expression essential for DNA damage detection, mediation, signaling and repair, as well as for senescence, cell cycle and cell death control."}, {"question_id": "341.4", "question": "Which therapeutic agents can influence cell fate through the foxo3a-foxm1 axis?", "answer_src": "recent research has provided novel insights into a central role for foxo3a and foxm1 in dna damage response . the foxo3a - foxm1 axis plays a pivotal role in dna damage repair and the accompanied cellular response through regulating the expression of genes essential for dna damage sensing , mediating , signalling and repair as well as for senescence , cell cycle and cell death control . in this manner , the foxo3a - foxm1 axis also holds the key to cell fate decision in response to genotoxic therapeutic agents and controls the equilibrium between dna repair and cell termination by cell death or senescence .", "follow_up_question": "What mechanisms does the foxo3a-foxm1 axis use to control the equilibrium between DNA repair and cell termination?", "follow_up_response": "regulating the expression of genes essential for DNA damage sensing, mediating, signalling and repair as well as for senescence, cell cycle and cell death control", "follow_up_response_bt": "The foxo3a-foxm1 axis uses the regulation of gene expression to control the equilibrium between DNA repair and cell termination"}, {"question_id": "341.5", "question": "Which processes are controlled by the foxo3a-foxm1 axis in response to DNA damage and cell death?", "answer_src": "recent research has provided novel insights into a central role for foxo3a and foxm1 in dna damage response . the foxo3a - foxm1 axis plays a pivotal role in dna damage repair and the accompanied cellular response through regulating the expression of genes essential for dna damage sensing , mediating , signalling and repair as well as for senescence , cell cycle and cell death control . in this manner , the foxo3a - foxm1 axis also holds the key to cell fate decision in response to genotoxic therapeutic agents and controls the equilibrium between dna repair and cell termination by cell death or senescence .", "follow_up_question": "What mechanisms does the foxo3a-foxm1 axis use to control cell cycle?", "follow_up_response": "mediating", "follow_up_response_bt": "cell cycle and cell death control"}], "turn_2": [{"question_id": "341.6", "question": "How do foxo3a and foxm1 regulate DNA damage sensing?", "answer_src": "through regulating the expression of genes essential for DNA damage sensing", "follow_up_question": "How does the foxo3a-foxm1 axis influence cell cycle control in response to DNA damage?", "follow_up_response": "The foxo3a-foxm1 axis regulates the expression of genes essential for DNA damage sensing, mediating, signalling and repair as well as for senescence, cell cycle and cell death control.", "follow_up_response_bt": "The foxo3a-foxm1 axis regulates gene expression associated with cell cycle control in response to DNA damage."}, {"question_id": "341.7", "question": "What processes does the foxo3a-foxm1 axis regulate?", "answer_src": "DNA damage sensing, mediating, signalling and repair as well as for senescence, cell cycle and cell death control", "follow_up_question": "How does the foxo3a-foxm1 axis influence cell fate decisions?", "follow_up_response": "The foxo3a-foxm1 axis holds the key to cell fate decision in response to genotoxic therapeutic agents", "follow_up_response_bt": "The foxo3a-foxm1 axis holds the key to cell fate decision in response to therapeutic genomes."}, {"question_id": "341.8", "question": "How does the foxo3a-foxm1 axis influence the equilibrium between DNA repair and cell termination?", "answer_src": "The foxo3a-foxm1 axis holds the key to cell fate decision in response to genotoxic therapeutic agents and controls the equilibrium between DNA repair and cell termination by cell death or senescence.", "follow_up_question": "What mechanisms does the foxo3a-foxm1 axis use to control DNA repair?", "follow_up_response": "mediating , signalling and repair", "follow_up_response_bt": "DNA damage detection, mediation, signaling and repair"}, {"question_id": "341.9", "question": "What mechanisms does the foxo3a-foxm1 axis use to control the equilibrium between DNA repair and cell termination?", "answer_src": "regulating the expression of genes essential for DNA damage sensing, mediating, signalling and repair as well as for senescence, cell cycle and cell death control", "follow_up_question": "How does the foxo3a-foxm1 axis influence DNA damage sensing?", "follow_up_response": "through regulating the expression of genes essential for DNA damage sensing", "follow_up_response_bt": "The foxo3a-foxm1 axis regulates gene expression essential for DNA damage detection"}, {"question_id": "341.10", "question": "What mechanisms does the foxo3a-foxm1 axis use to control cell cycle?", "answer_src": "mediating", "follow_up_question": "What specific functions do the foxo3a-foxm1 axis regulate for DNA damage sensing?", "follow_up_response": "regulating the expression of genes essential for DNA damage sensing", "follow_up_response_bt": "DNA damage detection, mediation, signaling and repair"}], "turn_3": [{"question_id": "341.11", "question": "How does the foxo3a-foxm1 axis influence cell cycle control in response to DNA damage?", "answer_src": "The foxo3a-foxm1 axis regulates the expression of genes essential for DNA damage sensing, mediating, signalling and repair as well as for senescence, cell cycle and cell death control.", "follow_up_question": "What specific functions do the genes regulated by foxo3a-foxm1 play in DNA damage sensing?", "follow_up_response": "regulating the expression of genes essential for DNA damage sensing", "follow_up_response_bt": "DNA damage detection, mediation, signaling and repair"}, {"question_id": "341.12", "question": "How does the foxo3a-foxm1 axis influence cell fate decisions?", "answer_src": "The foxo3a-foxm1 axis holds the key to cell fate decision in response to genotoxic therapeutic agents", "follow_up_question": "What mechanisms does the foxo3a-foxm1 axis use to control the equilibrium between DNA repair and cell termination?", "follow_up_response": "regulating the expression of genes essential for DNA damage sensing, mediating, signalling and repair as well as for senescence, cell cycle and cell death control", "follow_up_response_bt": "The foxo3a-foxm1 axis uses the regulation of gene expression to control the equilibrium between DNA repair and cell termination"}, {"question_id": "341.13", "question": "What mechanisms does the foxo3a-foxm1 axis use to control DNA repair?", "answer_src": "mediating , signalling and repair", "follow_up_question": "What specific cellular processes does the foxo3a-foxm1 axis regulate besides DNA repair?", "follow_up_response": "senescence\", \"cell cycle\", \"cell death", "follow_up_response_bt": "cell cycle and cell death control\", \"regulation of gene expression associated with cell growth\", \"cell fate decision"}, {"question_id": "341.14", "question": "How does the foxo3a-foxm1 axis influence DNA damage sensing?", "answer_src": "through regulating the expression of genes essential for DNA damage sensing", "follow_up_question": "How does the foxo3a-foxm1 axis affect DNA damage repair?", "follow_up_response": "the foxo3a - foxm1 axis regulates the expression of genes essential for DNA damage sensing, mediating, signalling and repair as well as for senescence, cell cycle and cell death control", "follow_up_response_bt": "The foxo3a-foxm1 axis plays a fundamental role in DNA damage repair and in the cell response that accompanies it through the regulation of gene expression essential for DNA damage detection, mediation, signaling and repair"}, {"question_id": "341.15", "question": "What specific functions do the foxo3a-foxm1 axis regulate for DNA damage sensing?", "answer_src": "regulating the expression of genes essential for DNA damage sensing", "follow_up_question": "What other cellular processes does the foxo3a-foxm1 axis control in response to DNA damage?", "follow_up_response": "cell cycle and cell death control", "follow_up_response_bt": "cell cycle and cell death control"}]}}
{"id": 342, "src": "lichen striatus ( ls ) is an uncommon dermatosis of unknown etiology that presents as a continuous or interrupted linear band of pink , tan , red or skin - colored papules in a blaschkoid distribution . the lesions are generally solitary and unilateral , but unusual extensive cases with multiple and bilateral lesions have been also described . albeit ls is typically an asymptomatic and self - limited dermatosis , it may cause a significant psychological distress in some patients , thus requiring an appropriate therapy .", "mt": "Lichen striatus (ls) è una dermatosi rara di etiologia sconosciuta che si presenta come una banda lineare continua o interrotta di papule rosa , marrone , rosse o di colore della pelle in una distribuzione blaschkoide . Le lesioni sono generalmente solitarie e unilaterali , ma sono stati descritti anche casi insoliti di estensione con lesioni multiple e bilaterali . anche se ls è tipicamente una dermatosi asintomatica e auto-limitata , può causare un significativo stress psicologico in alcuni pazienti , richiedendo quindi una terapia appropriata .", "pert_mt": "Lichen striatus (ls) è una dermatosi rara di etiologia sconosciuta che si presenta come una banda lineare continua o interrotta di papule rosa, marrone, rosse o di colore della pelle in una distribuzione blaschkoide. Le lesioni sono generalmente solitarie e unilaterali, ma sono stati descritti anche casi insoliti di estensione con lesioni multiple e bilaterali. Anche se ls è tipicamente una dermatosi asintomatica e auto-limitata, può causare un significativo stress psicologico in alcuni pazienti, richiedendo quindi una terapia appropriata, indipendentemente dal fatto che le lesioni possano persistere per mesi.", "bt": "Lichen striatus (ls) is a rare dermatosis of unknown etiology that occurs as a continuous linear band or interrupted of pink, brown, red or colored papules of the skin in a blaschkoid distribution.The lesions are generally solitary and unilateral, but there have also been reported unusual cases of extensions with multiple and bilateral lesions.Although it is typically an asymptomatic and self-limiting dermatosis, it can cause significant psychological stress in some patients, thus requiring appropriate therapy, regardless of whether the possessive lesions persist for months.", "questions_src": ["What does lichen striatus present as?", "Who experiences psychological distress due to lichen striatus?", "Where do the lesions typically appear on the body?", "When does lichen striatus usually resolve without treatment?", "Which type of dermatosis is lichen striatus considered to be?"], "answers_src": ["a continuous or interrupted linear band of pink, tan, red or skin-colored papules in a blaschkoid distribution", "some patients", "typically anywhere on the body", "self-limited", "dermatosis"], "answers_bt": ["A continuous linear band or interrupted blaschkoid distribution of pink, brown, red or colored papules", "Some patients", "On the skin in a blaschkoid distribution", "Typically resolves without treatment", "A rare dermatosis"], "multiturn": {"turn_1": [{"question_id": "342.1", "question": "What does lichen striatus present as?", "answer_src": "a continuous or interrupted linear band of pink, tan, red or skin-colored papules in a blaschkoid distribution", "follow_up_question": "What is the typical distribution pattern of the lesions in lichen striatus?", "follow_up_response": "A blaschkoid distribution", "follow_up_response_bt": "A continuous linear band or interrupted blaschkoid distribution"}, {"question_id": "342.2", "question": "Who experiences psychological distress due to lichen striatus?", "answer_src": "some patients", "follow_up_question": "What percentage of patients experience psychological distress due to lichen striatus?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "342.3", "question": "Where do the lesions typically appear on the body?", "answer_src": "typically anywhere on the body", "follow_up_question": "What is the typical duration of lichen striatus before it resolves?", "follow_up_response": "No Answer", "follow_up_response_bt": "months"}, {"question_id": "342.4", "question": "When does lichen striatus usually resolve without treatment?", "answer_src": "self-limited", "follow_up_question": "What percentage of patients experience psychological distress due to lichen striatus?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "342.5", "question": "Which type of dermatosis is lichen striatus considered to be?", "answer_src": "dermatosis", "follow_up_question": "What is the typical course of lichen striatus?", "follow_up_response": "Typically an asymptomatic and self-limited dermatosis", "follow_up_response_bt": "Typically an asymptomatic and self-limiting dermatosis"}], "turn_2": [{"question_id": "342.6", "question": "What is the typical distribution pattern of the lesions in lichen striatus?", "answer_src": "A blaschkoid distribution", "follow_up_question": "What is the usual course of lichen striatus?", "follow_up_response": "Typically an asymptomatic and self-limited dermatosis", "follow_up_response_bt": "Typically an asymptomatic and self-limiting dermatosis"}, {"question_id": "342.7", "question": "What percentage of patients experience psychological distress due to lichen striatus?", "answer_src": "lichen striatus ( ls ) is an uncommon dermatosis of unknown etiology that presents as a continuous or interrupted linear band of pink , tan , red or skin - colored papules in a blaschkoid distribution . the lesions are generally solitary and unilateral , but unusual extensive cases with multiple and bilateral lesions have been also described . albeit ls is typically an asymptomatic and self - limited dermatosis , it may cause a significant psychological distress in some patients , thus requiring an appropriate therapy .", "follow_up_question": "What percentage of patients with lichen striatus typically experience psychological distress?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "342.8", "question": "What is the typical duration of lichen striatus before it resolves?", "answer_src": "lichen striatus ( ls ) is an uncommon dermatosis of unknown etiology that presents as a continuous or interrupted linear band of pink , tan , red or skin - colored papules in a blaschkoid distribution . the lesions are generally solitary and unilateral , but unusual extensive cases with multiple and bilateral lesions have been also described . albeit ls is typically an asymptomatic and self - limited dermatosis , it may cause a significant psychological distress in some patients , thus requiring an appropriate therapy .", "follow_up_question": "How does lichen striatus typically affect patients psychologically?", "follow_up_response": "it may cause a significant psychological distress", "follow_up_response_bt": "it can cause significant psychological stress"}, {"question_id": "342.9", "question": "What percentage of patients experience psychological distress due to lichen striatus?", "answer_src": "lichen striatus ( ls ) is an uncommon dermatosis of unknown etiology that presents as a continuous or interrupted linear band of pink , tan , red or skin - colored papules in a blaschkoid distribution . the lesions are generally solitary and unilateral , but unusual extensive cases with multiple and bilateral lesions have been also described . albeit ls is typically an asymptomatic and self - limited dermatosis , it may cause a significant psychological distress in some patients , thus requiring an appropriate therapy .", "follow_up_question": "What percentage of patients with lichen striatus typically experience psychological distress?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "342.10", "question": "What is the typical course of lichen striatus?", "answer_src": "Typically an asymptomatic and self-limited dermatosis", "follow_up_question": "What percentage of patients experience psychological distress due to lichen striatus?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}], "turn_3": [{"question_id": "342.11", "question": "What is the usual course of lichen striatus?", "answer_src": "Typically an asymptomatic and self-limited dermatosis", "follow_up_question": "What percentage of patients experience psychological distress due to lichen striatus?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "342.12", "question": "What percentage of patients with lichen striatus typically experience psychological distress?", "answer_src": "lichen striatus ( ls ) is an uncommon dermatosis of unknown etiology that presents as a continuous or interrupted linear band of pink , tan , red or skin - colored papules in a blaschkoid distribution . the lesions are generally solitary and unilateral , but unusual extensive cases with multiple and bilateral lesions have been also described . albeit ls is typically an asymptomatic and self - limited dermatosis , it may cause a significant psychological distress in some patients , thus requiring an appropriate therapy .", "follow_up_question": "What specific symptoms might patients with lichen striatus experience besides psychological distress?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "342.13", "question": "How does lichen striatus typically affect patients psychologically?", "answer_src": "it may cause a significant psychological distress", "follow_up_question": "What specific type of therapy is mentioned for treating lichen striatus?", "follow_up_response": "No Answer", "follow_up_response_bt": "appropriate therapy"}, {"question_id": "342.14", "question": "What percentage of patients with lichen striatus typically experience psychological distress?", "answer_src": "lichen striatus ( ls ) is an uncommon dermatosis of unknown etiology that presents as a continuous or interrupted linear band of pink , tan , red or skin - colored papules in a blaschkoid distribution . the lesions are generally solitary and unilateral , but unusual extensive cases with multiple and bilateral lesions have been also described . albeit ls is typically an asymptomatic and self - limited dermatosis , it may cause a significant psychological distress in some patients , thus requiring an appropriate therapy .", "follow_up_question": "What specific symptoms might patients with lichen striatus experience besides psychological distress?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}, {"question_id": "342.15", "question": "What percentage of patients experience psychological distress due to lichen striatus?", "answer_src": "lichen striatus ( ls ) is an uncommon dermatosis of unknown etiology that presents as a continuous or interrupted linear band of pink , tan , red or skin - colored papules in a blaschkoid distribution . the lesions are generally solitary and unilateral , but unusual extensive cases with multiple and bilateral lesions have been also described . albeit ls is typically an asymptomatic and self - limited dermatosis , it may cause a significant psychological distress in some patients , thus requiring an appropriate therapy .", "follow_up_question": "What percentage of patients with lichen striatus typically experience psychological distress?", "follow_up_response": "No Answer", "follow_up_response_bt": "No Answer"}]}}
